66 FR 212 pgs. 55244-55503 - Medicare Program; Revisions to Payment Policies and Five-Year Review of and Adjustments to the Relative Value Units Under the Physician Fee Schedule for Calendar Year 2002
Type: RULEVolume: 66Number: 212Pages: 55244 - 55503
Docket number: [CMS-1169-FC]
FR document: [FR Doc. 01-27275 Filed 10-31-01; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Medicare Medicaid Services
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare Medicaid Services
42 CFR Parts 405, 410, 411, 414, and 415
[CMS-1169-FC]
RIN 0938-AK57
Medicare Program; Revisions to Payment Policies and Five-Year Review of and Adjustments to the Relative Value Units Under the Physician Fee Schedule for Calendar Year 2002
AGENCY:
Centers for Medicare Medicaid Services (CMS), HHS.
ACTION:
Final rule with comment period.
SUMMARY:
This final rule with comment period makes several changes affecting Medicare Part B payment. The changes affect: refinement of resource-based practice expense relative value units (RVUs); services and supplies incident to a physician's professional service; anesthesia base unit variations; recognition of CPT tracking codes; and nurse practitioners, physician assistants, and clinical nurse specialists performing screening sigmoidoscopies. It also addresses comments received on the June 8, 2001 proposed notice for the 5-year review of work RVUs and finalizes these work RVUs. In addition, we acknowledge comments received on our request for information on our policy for CPT modifier 62 that is used to report the work of co-surgeons. The rule also updates the list of certain services subject to the physician self-referral prohibitions to reflect changes to CPT codes and Healthcare Common Procedure Coding System codes effective January 1, 2002. These refinements and changes will ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services.
The Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 modernizes the mammography screening benefit and authorizes payment under the physician fee schedule effective January 1, 2002; provides for biennial screening pelvic examinations for certain beneficiaries effective July 1, 2001; provides for annual glaucoma screenings for high-risk beneficiaries effective January 1, 2002; expands coverage for screening colonoscopies to all beneficiaries effective July 1, 2001; establishes coverage for medical nutrition therapy services for certain beneficiaries effective January 1, 2002; expands payment for telehealth services effective October 1, 2001; requires certain Indian Health Service providers to be paid for some services under the physician fee schedule effective July 1, 2001; and revises the payment for certain physician pathology services effective January 1, 2001. This final rule will conform our regulations to reflect these statutory provisions.
In addition, we are finalizing the calendar year (CY) 2001 interim RVUs and are issuing interim RVUs for new and revised procedure codes for calendar year (CY) 2002. As required by the statute, we are announcing that the physician fee schedule update for CY 2002 is -4.8 percent, the initial estimate of the Sustainable Growth Rate (SGR) for CY 2002 is 5.6 percent, and the conversion factor for CY 2002 is $36.1992.
DATES:
Effective date: This rule is effective January 1, 2002.
Comment date: We will consider comments on the Clinical Practice Expert Panel data, the physician self-referral designated health services identified in Table 8, and the interim RVUs for selected procedure codes identified in Addendum C if we receive them at the appropriate address, as provided below, no later than 5 p.m. on December 31, 2001.
ADDRESSES:
Mail written comments (1 original and 2 copies) to the following address: Centers for Medicare Medicaid Services, Department of Health and Human Services, Attention: CMS-1169-FC, P.O. Box 8013, Baltimore, MD 21244-8013.
To insure that mailed comments are received in time for us to consider them, please allow for possible delays in delivering them. If you prefer, you may deliver your written comments (1 original and 2 copies) by courier to one of the following addresses: Room C5-14-03, 7500 Security Boulevard, Baltimore, MD 21244-8013 or Room 443-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.
Comments mailed to the two above addresses may be delayed and received too late for us to consider them.
Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission. In commenting, please refer to file code CMS-1169-FC.
For information on viewing public comments, please see the beginning of the Supplementary Information section below.
FOR FURTHER INFORMATION CONTACT:
Carolyn Mullen, (410) 786-4589 or Marc Hartstein, (410) 786-4539 (for issues related to resource-based practice expense relative value units).
Carlos Cano, (410) 786-0245 (for issues related to screening sigmoidoscopies).
Paul W. Kim, (410) 786-7410 (for issues related to incident to services).
Rick Ensor, (410) 786-5617 (for issues related to screening mammography).
Bill Larson, (410) 786-4639 (for issues related to screening pelvic examinations, screening for glaucoma, and coverage for screening colonoscopies).
Bob Ulikowski, (410) 786-5721 (for issues related to the payment for screening colonoscopies).
Mary Stojak, (410) 786-6939 (for issues related to medical nutrition therapy).
Joan Mitchell, (410) 786-4508 (for issues related to the payment for medical nutrition therapy).
Craig Dobyski, (410) 786-4584 (for issues related to telehealth).
Terri Harris, (410) 786-6830 (for issues related to Indian Health Service providers).
Jim Menas, (410) 786-4507 (for issues related to anesthesia and pathology services).
Joanne Sinsheimer (410) 786-4620 (for issues related to updates to the list of certain services subject to the physician self-referral prohibitions).
Diane Milstead, (410) 786-3355 (for all other issues).
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments
Comments received timely will be available for public inspection as they are received, generally beginning approximately 3 weeks after publication of a document, at 7500 Security Blvd, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 5 p.m. Please call (410) 786-7197 to make an appointment to view the public comments.
Copies
To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 512-2250. The cost for each copy is $9. As an alternative, you can view and photocopy the Federal Register document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries throughout the country that receive the Federal Register .
To order the disks containing this document, send your request to: Superintendent of Documents, Attention: Electronic Products, P.O. Box 37082, Washington, DC 20013-7082. Please specify, "Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2001," and enclose a check or money order payable to the Superintendent of Documents, or enclose your VISA, Discover, or MasterCard number and expiration date. Credit card orders can be placed by calling the order clerk at (202) 512-1530 (or toll free at 1-888-293-6498) or by faxing to (202) 512-1262.
This Federal Register document is also available from the Federal Register online database through GPO Access, a service of the U.S. Government Printing Office. The Website address is: http://www.access.gpo.gov/nara/index.html.
Information on the physician fee schedule can be found on our homepage. You can access these data by using the following directions:
1. Go to the CMS homepage (http://www.cms.hhs.gov).
2. Click on "Professionals."
3. Under the heading "Physicians and Health Care Professionals," click on "Medicare Coding and Payment Systems."
4. Select Physician Fee Schedule.
Or, you can go directly to the Physician Fee Schedule page by typing the following: http://www.hcfa.gov/medicare/pfsmain.htm.
To assist readers in referencing sections contained in this preamble, we are providing the following table of contents. Some of the issues discussed in this preamble affect the payment policies but do not require changes to the regulations in the Code of Federal Regulations. Information on the regulation's impact appears throughout the preamble and is not exclusively in section XIII.
Table of Contents
I. Background
A. Legislative History
B. Published Changes to the Fee Schedule
C. Components of the Fee Schedule Payment Amounts
D. Development of the Relative Value Units
II. Specific Provisions for Calendar Year 2002
A. Resource-Based Practice Expense Relative Value Units
B. Nurse Practitioners, Physician Assistants, and Clinical Nurse Specialists Performing Screening Sigmoidoscopies
C. Services and Supplies Incident to a Physician's Professional Services: Conditions
D. Anesthesia Services
E. Performance Measurement and Emerging Technology Codes
F. Payment Policy for CPT Modifier 62 (Co-Surgery)
III. Implementation of Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000
A. Screening Mammography
B. Screening Pelvic Examinations
C. Screening for Glaucoma
D. Screening Colonoscopy
E. Medical Nutrition Therapy
F. Telehealth Services
G. Indian Health Service
H. Pathology Services
IV. Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule; Responses to Public Comments on the Five-Year Review of Work Relative Value Units
V. Refinement of Relative Value Units for Calendar Year 2002 and Response to Public Comments on Interim Relative Value Units for 2001 (Including the Interim Relative Value Units Contained in the August 2001 Proposed Rule)
A. Summary of Issues Discussed Related to the Adjustment of Relative Value Units
B. Process for Establishing Work Relative Value Units for the 2002 Physician Fee Schedule
VI. Physician Self-Referral Prohibitions
VII. Physician Fee Schedule Update for Calendar Year 2002
VIII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate for Calendar Year 2002
A. Medicare Sustainable Growth Rate
B. Physicians' Services
C. Provisions Related to the SGR
D. Preliminary Estimate of the SGR for 2002
E. Sustainable Growth Rate for CY 2001
F. Sustainable Growth Rate for FY 2001
G. Calculation of the FY 2001, CY 2001, and CY 2002 Sustainable Growth Rates
IX. Anesthesia and Physician Fee Schedule Conversion Factors for CY 2002
X. Provisions of the Final Rule
XI. Collection of Information Requirements
XII. Response to Comments
XIII. Regulatory Impact Analysis
Addendum A-Explanation and Use of Addendum B
Addendum B-2002 Relative Value Units and Related Information Used in Determining Medicare Payments for 2002
Addendum C-Codes with Interim RVUs
Addendum D-2002 Geographic Practice Cost Indices by Medicare Carrier and Locality
Addendum E-Updated List of CPT/HCPCS Codes Used to Describe Certain Designated Health Services Under the Physician Self-Referral Provision
In addition, because of the many organizations and terms to which we refer by acronym in this final rule, we are listing these acronyms and their corresponding terms in alphabetical order below:
AMAAmerican Medical Association
BBABalanced Budget Act of 1997
BBRABalanced Budget Refinement Act of 1999
CFConversion factor
CFRCode of Federal Regulations
CPT[Physicians'] Current Procedural Terminology [4th Edition, 1997, copyrighted by the American Medical Association]
CPEPClinical Practice Expert Panel
CRNACertified Registered Nurse Anesthetist
E/MEvaluation and management
EBElectrical bioimpedance
FMRFair market rental
GAFGeographic adjustment factor
GPCIGeographic practice cost index
GDPGross Domestic Product
CMSCenters for Medicare Medicaid Services
HCPCSHealthcare Common Procedure Coding System
HHAHome health agency
HHS[Department of] Health and Human Services
IDTFsIndependent Diagnostic Testing Facilities
MCMMedicare Carrier Manual
MedPACMedicare Payment Advisory Commission
MEIMedicare Economic Index
MGMAMedical Group Management Association
MSAMetropolitan Statistical Area
NAMCSNational Ambulatory Medical Care Survey
NCDNational coverage determination
PCProfessional component
PEACPractice Expense Advisory Committee
PPACPracticing Physicians Advisory Council
PPSProspective payment system
RUC[AMA's Specialty Society] Relative [Value] Update Committee
RVURelative value unit
SGRSustainable growth rate
SMS[AMA's] Socioeconomic Monitoring System
TCTechnical component
I. Background
A. Legislative History
Since January 1, 1992, Medicare has paid for physicians' services under section 1848 of the Social Security Act (the Act), "Payment for Physicians' Services." This section provides for three major elements: (1) a fee schedule for the payment of physicians' services; (2) a sustainable growth rate for the rates of increase in Medicare expenditures for physicians' services; and (3) limits on the amounts that nonparticipating physicians can charge beneficiaries. The Act requires that payments under the fee schedule be based on national uniform relative value units (RVUs) based on the resources used in furnishing a service. Section 1848(c) of the Act requires that national RVUs be established for physician work, practice expense, and malpractice expense. Section 1848(c)(2)(B)(ii)(II) of the Act provides that adjustments in RVUs may not cause total physician fee schedule payments to differ by more than $20 million from what they would have been had the adjustments not been made. If adjustments to RVUs cause expenditures to change by more than $20 million, we must make adjustments to preserve budget neutrality.
B. Published Changes to the Fee Schedule
In the July 17, 2000 proposed rule (65 FR 44177), we listed all of the final rules published through November 1999 relating to the updates to the RVUs and revisions to payment policies under the physician fee schedule.
In the June 8, 2001 Federal Register (66 FR 31028), we published a proposed notice concerning the 5-year review of work RVUs.
In the August 2, 2001 proposed rule (66 FR 40373) we discussed revisions contained in the November 1, 2000 final rule with comment period and the following issues affecting Medicare payment under the physician fee schedule:
• We listed the revisions to payment policies under the physician fee schedule that were made in the November 2000 final rule with comment period (65 FR 65376).
• We discussed policy issues affecting Medicare payment for physicians' services, including-
-refinement of the resource-based practice expense relative value units;
-services and supplies incident to a physician's professional service;
-anesthesia base unit variations;
-recognition of CPT tracking codes; and
-nurse practitioners, physician assistants, and clinical nurse specialists performing screening sigmoidoscopies.
We also solicited comments on the payment policy for CPT modifier 62 used to report the work of co-surgeons.
In addition, the August 2, 2001 proposed rule addressed the following provisions of the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 (BIPA):
• Payment for the screening mammography benefit under the physician fee schedule effective January 1, 2002.
• Biennial screening pelvic examinations for certain beneficiaries effective July 1, 2001.
• Annual glaucoma screenings for high-risk beneficiaries effective January 1, 2002.
• Expansion of coverage for screening colonoscopies to all beneficiaries effective July 1, 2001.
• Coverage for medical nutrition therapy services for certain beneficiaries effective January 1, 2002.
• Expansion of payment for telehealth services effective October 1, 2001.
• Payment for some services of certain Indian Health Service providers under the physician fee schedule effective July 1, 2001.
• Revision to the payment for certain physician pathology services effective January 1, 2001.
This final rule affects the regulations set forth at Part 405, Federal health insurance for the aged and disabled; Part 410, Supplementary medical insurance (SMI) benefits; Part 411, Exclusions from Medicare and limitations on Medicare payment; Part 414, Payment for Part B medical and other health services; and Part 415, Services furnished by physicians in providers, supervising physicians in teaching settings, and residents in certain settings.
The information in this final rule finalizes information in the June 8, 2001 proposed notice and the August 2, 2001 proposed rule.
C. Components of the Fee Schedule Payment Amounts
Under the formula set forth in section 1848(b)(1) of the Act, the payment amount for each service paid under the physician fee schedule is the product of three factors-(1) a nationally uniform relative value for the service; (2) a geographic adjustment factor (GAF) for each physician fee schedule area; and (3) a nationally uniform conversion factor (CF) for the service. The CF converts the relative values into payment amounts.
For each physician fee schedule service, there are three relative values-(1) an RVU for physician work; (2) an RVU for practice expense; and (3) an RVU for malpractice expense. For each of these components of the fee schedule, there is a geographic practice cost index (GPCI) for each fee schedule area. The GPCIs reflect the relative costs of practice expenses, malpractice insurance, and physician work in an area compared to the national average for each component.
The general formula for calculating the Medicare fee schedule amount for a given service in a given fee schedule area can be expressed as:
Payment = [(RVU work × GPCI work) + (RVU practice expense × GPCI practice expense) + (RVU malpractice × GPCI malpractice)] × CF
The CF for calendar year (CY) 2002 appears in section XIII. The RVUs for CY 2002 are in Addendum B. The GPCIs for CY 2002 can be found in Addendum D.
Section 1848(e) of the Act requires us to develop GAFs for all physician fee schedule areas. The total GAF for a fee schedule area is equal to a weighted average of the individual GPCIs for each of the three components of the service. In accordance with the statute, however, the GAF for the physician's work reflects one-quarter of the relative cost of physician's work compared to the national average.
D. Development of the Relative Value System
1. Work Relative Value Units
Approximately 7,500 codes represent services included in the physician fee schedule. The work RVUs established for the implementation of the fee schedule in January 1992 were developed with extensive input from the physician community. A research team at the Harvard School of Public Health developed the original work RVUs for most codes in a cooperative agreement with us. In constructing the vignettes for the original RVUs, Harvard worked with expert panels of physicians and obtained input from physicians from numerous specialties.
The RVUs for radiology services were based on the American College of Radiology (ACR) relative value scale, which we integrated into the overall physician fee schedule. The RVUs for anesthesia services were based on RVUs from a uniform relative value guide. We established a separate CF for anesthesia services, and we continue to recognize time as a factor in determining payment for these services. As a result, there is a separate payment system for anesthesia services.
II. Specific Proposals for Calendar Year 2002
In response to the publication of the August 2001 proposed rule, we received approximately 2,000 comments. We received comments from individual physicians, health care workers, and professional associations and societies. The majority of comments addressed the proposals related to medical nutrition therapy and the practice expense refinement.
The proposed rule discussed policies that affected the number of RVUs on which payment for certain services would be based. Certain changes implemented through this final rule are subject to the $20 million limitation on annual adjustments contained in section 1848(c)(2)(B)(ii)(II) of the Act.
After reviewing the comments and determining the policies we would implement, we have estimated the costs and savings of these policies and added those costs and savings to the estimated costs associated with any other changes in RVUs for 2002. We discuss in detail the effects of these changes in the Regulatory Impact Analysis in section XIII.
For the convenience of the reader, the headings for the policy issues correspond to the headings used in the August 2001 proposed rule. More detailed background information for each issue can be found in the June 2001 proposed notice with comment period and the August 2001 proposed rule.
A. Resource-Based Practice Expense Relative Value Units
1. Resource-Based Practice Expense Legislation
Section 121 of the Social Security Act Amendments of 1994 (Public Law 103-432), enacted on October 31, 1994, required us to develop a methodology for a resource-based system for determining practice expense RVUs for each physician's service beginning in 1998. In developing the methodology, we were to consider the staff, equipment, and supplies used in providing medical and surgical services in various settings. The legislation specifically required that, in implementing the new system of practice expense RVUs, we apply the same budget-neutrality provisions that we apply to other adjustments under the physician fee schedule.
Section 4505(a) of the BBA amended section 1848(c)(2)(ii) of the Act and delayed the effective date of the resource-based practice expense RVU system until January 1, 1999. In addition, section 4505(b) of the BBA provided for a 4-year transition period from charge-based practice expense RVUs to resource-based RVUs. The practice expense RVUs for CY 1999 were the product of 75 percent of charge-based RVUs and 25 percent of the resource-based RVUs. For CY 2000, the RVUs were 50 percent charge-based RVUs and 50 percent resource-based RVUs. For CY 2001, the RVUs are 25 percent charge-based and 75 percent resource-based. After CY 2001, the RVUs will be totally resource-based.
Section 4505(e) of the BBA amended section 1848(c)(2) of the Act by providing that 1998 practice expense RVUs be adjusted for certain services in anticipation of implementation of resource-based practice expenses beginning in 1999. As a result, the statute required us to increase practice expense RVUs for office visits. For other services in which practice expense RVUs exceeded 110 percent of the work RVUs and were furnished less than 75 percent of the time in an office setting, the statute required us to reduce the 1998 practice expense RVUs to a number equal to 110 percent of the work RVUs. This reduction did not apply to services that had proposed resource-based practice expense RVUs that increased from their 1997 practice expense RVUs as reflected in the June 18, 1997 proposed rule (62 FR 33196). The services affected and the final RVUs for 1998 were published in the October 1997 final rule (62 FR 59103).
Further legislation affecting resource-based practice expense RVUs was included in the Balanced Budget Refinement Act of 1999 (BBRA) (Public Law 106-113). Section 212 of the BBRA amended section 1848(c)(2)(ii) of the Act by directing us to establish a process under which we accept and use, to the maximum extent practicable and consistent with sound data practices, data collected or developed by entities and organizations. These data would supplement the data we normally collect in determining the practice expense component of the physician fee schedule for payments in CY 2001 and CY 2002.
2. Current Methodology for Computing the Practice Expense Relative Value Unit System
Effective with services furnished on or after January 1, 1999, we established a new methodology for computing resource-based practice expense RVUs that used the two significant sources of actual practice expense data we have available-the Clinical Practice Expert Panel (CPEP) data and the American Medical Association's (AMA) Socioeconomic Monitoring System (SMS) data. The methodology was based on an assumption that current aggregate specialty practice costs are a reasonable way to establish initial estimates of relative resource costs for physicians' services across specialties. The methodology allocated these aggregate specialty practice costs to specific procedures and, thus, can be seen as a "top-down" approach. Discussion of the various elements of the methodology and their application follows.
a. Practice Expense Cost Pools
We used actual practice expense data by specialty, derived from the 1995 through 1998 SMS survey data, to create six cost pools-administrative labor, clinical labor, medical supplies, medical equipment, office supplies, and all other expenses. There were three steps in the creation of the cost pools. (Please note that the 1999 SMS data are being incorporated for CY 2002.)
• Step (1) We used the AMA's SMS survey of actual cost data to determine practice expenses per hour by cost category. The practice expenses per hour for each physician respondent's practice were calculated as the practice expenses for the practice divided by the total number of hours spent in patient care activities. The practice expenses per hour for the specialty were an average of the practice expenses per hour for the respondent physicians in that specialty. For the CY 2000 physician fee schedule, we also used data from a survey submitted by the Society of Thoracic Surgeons (STS) in calculating thoracic and cardiac surgeons' practice expenses per hour. (Please see the November 1999 final rule (64 FR 59391) for additional information concerning acceptance of these data.) For CY 2001, we used these STS data, as well as survey data submitted by the American Society of Vascular Surgery and the Society of Vascular Surgery. (Please see the November 2000 final rule (65 FR 65385) for additional information on the acceptance of these data.)
• Step (2) We determined the total number of physician hours (by specialty) spent treating Medicare patients. This was calculated from physician time data for each procedure code and from Medicare claims data.
• Step (3) We calculated the practice expense pools by specialty and by cost category by multiplying the specialty practice expenses per hour for each category by the total physician hours.
For services with work RVUs equal to zero (including the technical component (TC) of services with a TC and a professional component (PC)), we created a separate practice expense pool using the average clinical staff time from the Clinical Practice Expert Panel (CPEP) data (since these codes, by definition, do not have physician time) and the "all physicians" practice expense per hour.
b. Cost Allocation Methodology
For each specialty, we divided the six practice expense pools into two groups, based on whether direct or indirect costs were involved, and we used a different allocation basis for each group. The first group included clinical labor, medical supplies, and medical equipment. The second group included administrative labor, office expenses, and all other expenses.
(i) Direct Costs
For direct costs (including clinical labor, medical supplies, and medical equipment), we used the CPEP data as the allocation basis. The CPEP data for clinical labor, medical supplies, and medical equipment were used to allocate the costs for each of the respective cost pools.
For the separate practice expense pool for services with work RVUs equal to zero, we used adjusted 1998 practice expense RVUs as an interim measure to allocate the direct cost pools. (Please see the November 1998 final rule (63 FR 58891) for further information related to this adjustment.) Also, for all radiology services that are assigned work RVUs, we used the adjusted 1998 practice expense RVUs for radiology services as an interim measure to allocate the direct practice expense cost pool for radiology. For all other specialties that perform radiology services, we used the CPEP data for radiology services in the allocation of that specialty's direct practice expense cost pools.
(ii) Indirect Costs
To allocate the cost pools for indirect costs, including administrative labor, office expenses, and all other expenses, we used the total direct costs, as described above, in combination with the physician fee schedule work RVUs. We converted the work RVUs to dollars using the Medicare CF (expressed in 1995 dollars for consistency with the SMS survey years).
The SMS pool was divided by the CPEP pool for each specialty to produce a scaling factor that was applied to the CPEP direct cost inputs. This was intended to match costs counted as practice expenses in the SMS survey with items counted as practice expenses in the CPEP process. When the specialty-specific scaling factor exceeded the average scaling factor by more than 3 standard deviations, we used the average scaling factor. (Please see the November 1999 final rule (64 FR 59390) for further discussion of this issue.)
For procedures performed by more than one specialty, the final procedure code allocation was a weighted average of allocations for the specialties that perform the procedure, with the weights being the frequency with which each specialty performs the procedure on Medicare patients.
c. Other Methodological Issues
(i) Global Practice Expense Relative Value Units
For services with the PC and TC paid under the physician fee schedule, the global practice expense RVUs were set equal to the sum of the PC and TC.
(ii) Practice Expenses per Hour Adjustments and Specialty Crosswalks
Since many specialties identified in our claims data did not correspond exactly to the specialties included in the practice expense tables from the SMS survey data, it was necessary to crosswalk these specialties to the most appropriate SMS specialty category. We also made the following adjustments to the practice expense per hour data. (For the rationale for these adjustments to the practice expense per hour, see the November 1998 final rule (63 FR 58841)).
• We set the medical materials and supplies practice expenses per hour for the specialty of "oncology" equal to the "all physician" medical materials and supplies practice expenses per hour.
• We based the administrative payroll, office, and other practice expenses per hour for the specialties of "physical therapy" and "occupational therapy" on data used to develop the salary equivalency guidelines for these specialties. We set the remaining practice expense per hour categories equal to the "all physician" practice expenses per hour from the SMS survey data. (Note that in the November 2000 final rule (65 FR 65403), we increased the space allotment for therapy services to 750 square feet.)
• Due to uncertainty concerning the appropriate crosswalk and time data for the nonphysician specialty "audiologist," we derived the resource-based practice expense RVUs for codes performed by audiologists from the practice expenses per hour of the other specialties that perform these services.
• For the specialty of "emergency medicine," we used the "all physician" practice expense per hour to create practice expense cost pools for the categories "clerical payroll" and "other expenses."
• For the specialty of "podiatry," we used the "all physician" practice expense per hour to create the practice expense pool.
• For the specialty of "pathology," we removed the supervision and autopsy hours reimbursed through Part A of the Medicare program from the practice expense per hour calculation.
• For the specialty "maxillofacial prosthetics," we used the "all physician" practice expense per hour to create practice expense cost pools and, as an interim measure, allocated these pools using the adjusted 1998 practice expense RVUs.
• We split the practice expenses per hour for the specialty "radiology" into "radiation oncology" and "radiology other than radiation oncology" and used this split practice expense per hour to create practice expense cost pools for these specialties.
(iii) Time Associated With the Work RVUs
The time data resulting from the refinement of the work RVUs have been, on average, 25 percent greater than the time data obtained by the Harvard study for the same services. We adjusted the Harvard study's time data to ensure consistency between these data sources.
For services with no assigned physician time, such as dialysis, physical therapy, psychology, and many radiology and other diagnostic services, we calculated estimated total physician time based on work RVUs, maximum clinical staff time for each service as shown in the CPEP data, or the judgment of our clinical staff.
We calculated the time for CPT codes (hereafter referred to as "codes") 00100 through 01996 using the base and time units from the anesthesia fee schedule and the Medicare allowed claims data.
3. Refinement
a. Background
Section 4505(d)(1)(C) of the BBA directed us to develop a refinement process to be used during each of the 4 years of the transition period. We did not propose a specific long-term refinement process in the June 1998 proposed rule (63 FR 30835). Rather, we set out the parameters for an acceptable refinement process for practice expense RVUs and solicited comments on our proposal. We received a variety of comments about broad methodology issues, practice expense per-hour data, and detailed code-level data. We made adjustments to our proposal based on the comments we received. We also indicated that we would consider other comments for possible refinement and that the RVUs for all codes would be considered interim for 1999 and for future years during the transition period.
We outlined in the November 1998 final rule (63 FR 58832) the steps we were undertaking as part of the initial refinement process. These steps included the following:
• Establishment of a mechanism to receive independent advice for dealing with broad practice expense RVU technical and methodological issues.
• Evaluation of any additional recommendations from the General Accounting Office, the Medicare Payment Advisory Commission (MedPAC), and the Practicing Physicians Advisory Council (PPAC).
• Consultation with physician and other groups about these issues.
We also discussed a proposal submitted by the AMA's Specialty Society Relative Value Update Committee (RUC) for development of a new advisory committee, the Practice Expense Advisory Committee (PEAC), to review comments and recommendations on the code-specific CPEP data during the refinement period. In addition, we solicited comments and suggestions about our practice expense methodology from organizations that have a broad range of interests and expertise in practice expense and survey issues.
b. Current Status of Refinement Activities
In the 1999 and 2000 final rules and the 2001 proposed rule, we provided further information on refinement activities underway, including the AMA's formation of the PEAC and the support contract that we awarded to the Lewin Group to focus on methodologic issues. In addition, in these rules, we announced actions taken and decisions made in response to the hundreds of comments received on our resource-based physician practice expense initiative. Because the transition will be completed in CY 2002 and the practice expense RVUs will then be totally resource-based, it is appropriate to recap the specific achievements reached and decisions implemented during this refinement effort to date.
(i) Use of the Top-Down Approach
Most of the physician organizations commenting agreed that this methodology was preferred for computing resource-based practice expense RVUs and that it was in accordance with the requirements of the BBA. KPMG Peat Marwick, under contract to us, reviewed the top-down methodology in which aggregate specialty costs are applied to specific procedures and concluded that it followed reasonable cost accounting principles. A 1999 GAO report concludes, "HCFA's new approach represents a reasonable starting point for creating resource-based practice expense RVUs. It uses the best available data for this purpose and explicitly recognizes specialty differences in practice expense." Based on these comments and assessments, we made the decision to continue to use the top-down methodology to calculate the resource-based practice expense RVUs.
(ii) Use of the SMS Survey
The supplemental non-SMS survey data submitted by several specialties in response to the 1998 proposed rule, with the exception of the survey data from the thoracic surgeons, were not compatible with the format or methodology of the SMS. We awarded a contract to the Lewin Group to recommend criteria for the acceptance of specialty-specific practice expense data so that we could supplement the SMS data as appropriate. These recommended criteria are contained in the final report, "An Evaluation of the Health Care Financing Administration's Resource-Based Practice Expense Methodology." This report is available on our web page under the same title. (Access to our web site is discussed in the Supplementary Information section above.)
The report also contains recommendations for revisions to the SMS or other surveys to efficiently meet the needs of our practice expense methodology. We augmented these recommendations and forwarded our suggestions for revisions to any future surveys to the AMA. For example, we developed supplementary survey questions that would allow us to distinguish both costs and direct patient care hours for all midlevel practitioners. We also suggested revisions that would capture the necessary information on separately billable supplies and services so that we could eliminate these costs from the specialty-specific practice expense per-hour calculations.
To obtain supplementary specialty-specific practice expense data that could be used in computing practice expense RVUs beginning January 1, 2001, we published an interim final rule on May 3, 2000 (65 FR 25664) that set forth the criteria applicable to supplemental survey data submitted to us by August 1, 2000.
We also provided a 60-day period for submission of public comments on our criteria for survey data submitted between August 2, 2000 and August 1, 2001 for use in computing the practice expense RVUs for the CY 2002 physician fee schedule.
In the November 1, 2000 final rule (65 FR 65385), we responded to comments received on the interim final rule and made modifications to the criteria for supplemental survey data that will be considered in computing practice expense RVUs for the CY 2002 physician fee schedule. These data can then be used to supplement the SMS survey data currently used to estimate each specialty's aggregate practice costs or to replace the crosswalks used for specialties not represented in the SMS.
In our November 1999 final rule, we accepted supplementary data submitted by the thoracic surgeons and, in our November 2000 final rule, we accepted survey data from the vascular surgeons that replaced the previously crosswalked practice expense per hour data for that specialty. In the November 2000 final rule, we also stated that if we received additional specialty-specific survey data before August 1, 2001 that met the criteria outlined in that rule, we would use these supplementary data in calculating the CY 2002 practice expense RVUs.
We accepted our contractor's recommendation to incorporate the latest SMS data into our practice expense per hour calculations. For CY 2001, we incorporated the 1998 SMS data into a 4-year average, and we are incorporating the 1999 SMS data into a 5-year average to calculate the CY 2002 practice expense RVUs.
We also accepted the contractor's recommendation to standardize the survey practice expense data to a common year. We adjusted the data to reflect a 1995 cost year.
We received comments that urged us to use the median SMS specialty-specific data instead of the mean, as well as comments supporting our use of the mean values. We made a decision to continue to use the mean in calculating the specialty-specific practice expense per hour. We believe that, in a small sample, using the median could eliminate outlying data from the calculation that represent real costs and thus should be considered.
(iii) CPEP Data
The AMA has formed a multispecialty sub-committee of their Relative Value Update Committee (RUC), the Practice Expense Advisory Committee (PEAC), to review the CPEP clinical staff, equipment, and supply data for all physicians' services. This multispecialty committee, which includes representatives from all major specialty societies, will then make recommendations on suggested refinements to these data. We indicated in our November 1998 final rule (63 FR 58833) that we would work with the PEAC and RUC to refine the practice expense direct cost inputs. This refinement process was supported in comments we received from almost every major physician specialty society.
In our November 1999 physician fee schedule final rule, we implemented most clinical staff time, supply and equipment refinements recommended by the RUC. For the November 2000 final rule, the RUC forwarded to us significant additional refinement recommendations that reflected multispecialty agreement on the typical resources for many important services, including visit codes, which account for approximately 24 percent of Medicare spending for physicians' services. Again we accepted almost all of these RUC recommendations. In addition, at its October 2000, February 2001, and April 2001 meetings, the PEAC focused on refining high-volume services and on standardizing inputs across wide ranges of services. The RUC and PEAC forwarded to us recommendation on refinements for over 1,100 services. We anticipate that the pace of refinement of the CPEP inputs will continue to accelerate.
In addition to implementing most of the RUC-recommended refinements, we responded to comments on errors and anomalies in the CPEP data in both the November 1999 and November 2000 final rules. For example, we removed separately billable casting supplies and drugs from all services; we adjusted the prices of certain supplies that were clearly in error; we removed duplicated equipment from the direct inputs of the nuclear medicine codes; we added clearly essential equipment that was missing from the lithotripsy and photochemotherapy codes; we corrected anomalies in inputs within several families of codes; and we changed the crosswalks for the CPEP inputs of several codes not valued by the CPEP panels when a commenter suggested more appropriate crosswalks.
We simplified the refinement of equipment inputs by combining both the procedure-specific and overhead equipment into a single equipment category. We also deleted stand-by equipment and equipment used for multiple services at one time from the direct cost inputs because of the difficulty of allocating these costs at the code-specific level.
We are resolving issues related to averaging input costs for codes that were valued by more than one CPEP panel. While we have received comments agreeing and disagreeing with our use of mean costs, the issue is moot because we are substituting refined data for the data previously produced by multiple CPEPs.
(iv) Physician Time Data
In the November 1999 rule (64 FR 59404), we stated that, in general, requests for revisions for the procedure-specific physician times should be deferred to either the RUC process or the 5-year review process. However, we did adopt the newer data to correct the physician time for the pediatric surgery codes and made the requested revisions to correct anomalies in the times of certain psychotherapy codes.
In response to comments on the times associated with physical and occupational therapy services, we added preservice and postservice times to all of these codes.
(v) Crosswalk Issues
In response to concerns expressed by specialty societies representing emergency medicine that the SMS data did not capture the costs of uncompensated care, we crosswalked emergency medicine's cost pools for administrative labor and other expenses to the practice expense per hour for "all physicians."
We resolved issues related to the specialty crosswalk for nursing specialties by eliminating the separate practice expense pools for midlevel practitioners.
(vi) Calculation of Practice Expense Pools-Other Issues
We addressed concerns that potential errors in our specialty utilization data will have an effect on the calculation of practice expense RVUs. In the July 2000 proposed rule (65 FR 44178), we discussed our simulations that demonstrated that the small percentage of potential errors in our very large database have no adverse effect on specialty-specific practice expense RVUs.
We have created the zero-work pool for services with no physician work to ensure that these services are not inappropriately disadvantaged by our methodology. We have also agreed with the request of all the specialty societies that commented that their services should be moved out of the zero-work pool and into the specialty-specific pool. The specialties whose services remain in the zero-work pool have indicated that they wish their services to remain there. We plan to eliminate this separate pool for services with no physician work only when we have determined what revisions to our methodology are required so that we can value these services appropriately outside of the zero-work pool.
(vii) Calculation of Indirect Cost
We requested that our contractor evaluate various options for calculating indirect costs. The final report, referenced above, contains an analysis of the impacts of six alternative allocation methodologies. In confirming the suitability of our allocation methodology, the report concludes that "HCFA's approach is broadly consistent with most of the alternative methods. This consistency suggests that, from a broad perspective, no other allocation methodology offers a compelling reason to abandon the current HCFA approach."
(viii) Site-of-Service
The practice expense RVUs would be expected to be higher in the nonfacility setting, where the practitioner bears the costs of the necessary staff, supplies, and equipment, than in the facility setting. To prevent potential anomalies in our calculations due to the different mix of specialties performing a given service in different settings, we capped the practice expense RVUs for a physician service in facilities at the nonfacility practice expense level for each specific service.
In the November 1999 final rule (64 FR 59407), in response to a comment from the Renal Physicians Association, we agreed that the monthly capitated service codes should always be reported using the nonfacility designation. The site-of-service designations are not meaningful for a monthly service that may be provided in different settings for the same patient during a given month.
Although we are continuing our refinement of all practice expense RVUs, we believe that the above description of our actions to date illustrates that much has been accomplished. We also believe that it demonstrates that we have been responsive to comments from the medical community and have established a process that enables this community to participate fully in the refinement of both the specialty-specific practice expense per hour and the CPEP code-specific inputs.
4. Practice Expense Provisions for Calendar Year 2002
a. SMS Data
(i) Use of 1999 SMS Survey Data
We are currently using data from the 1995 through the 1998 SMS surveys (1994 through 1997 practice expense data) in order to calculate the specialty-specific practice expense per hour. The 1999 SMS survey data are now available. Because we want to incorporate the most recent survey data into our methodology during the transition period, we proposed in our August 2001 rule (66 FR 40377) to add this 1999 data to the 4 years of data we are currently using.
We proposed to use these 5 years of data in addition to any supplemental specialty-specific data that meet our criteria as the basis of the practice expense per hour calculations until the first 5-year review of practice expense RVUs in 2007. At that time, we anticipate that newer practice expense survey data might be available.
Comment: Specialty societies representing internal medicine, family practice and a number of their subspecialties were opposed to using the 1999 SMS data in the calculation of the practice expense RVUs. While many of these commenters were generally supportive of incorporating the most current SMS data, they are concerned that the sample size and results from the 1999 SMS data may not warrant their inclusion. Several of these commenters indicated that the American Medical Association is on record stating that "it normally would not provide or publish data with so few responses for some specialties."
A number of these commenters suggested that the practice expense information from the 1999 SMS would be less reliable because the data were collected after CMS announced the new resource-based practice expense methodology in the Federal Register . These commenters suggested that the opportunity for "gaming" now exists because the public was aware that the SMS data were used to calculate Medicare payments.
One commenter noted that the practice expense per hour for cardiology dropped by 15 percent in one year and doubted that the actual change in practice expense of this magnitude could have occurred. Another commenter indicated that the cardiac subspecialty of electrophysiology is very likely not represented at all in this flawed data set.
One association that represents eye surgeons commented that the 1999 SMS survey included about half as many usable responses as the 1995 through 1997 surveys. This commenter questioned our decision to disregard responses received by mail and indicated that an already poor response rate to the survey has become even lower. Another commenter that represents ophthalmology indicated that use of 1999 data with such low response rates violates good statistical practice. The 1999 responses included only 23 ophthalmologists, while over 200 offered responses to the survey in years before 1999. Another commenter that represents gastroenterology indicated that the SMS is perhaps the best available source of data on multispecialty practice costs. However, this comment indicated that it is by no means a perfect data source for the manner in which it has been used by CMS and is even less reliable for certain specialties, such as gastroenterology. This commenter appreciates our willingness to accept supplementary data from specialties, but believes that it is our responsibility to overcome data deficiencies. We were encouraged to develop a uniform and fair process to overcome data deficiencies, without relying on individual medical specialties to provide such data.
In light of AMA's suspension of the SMS survey, this commenter urged us to discuss in the final rule our plans for updating practice expense RVUs in future years beginning with 2003, and, if need be, for replacing the SMS survey with an alternative data source. Another commenter expressed concern that the newer data from the SMS surveys will not be incorporated until the first 5-year review of practice expense RVUs in 2007; by that time, some of the practice expense data will have been in existence for 13 years.
Similarly, another commenter expressed concern that using the SMS data set from 1995 through 1999 until 2007 will mean that the data will not accurately reflect the changes in technology that will increase costs, particularly for specialties with rapid changes in technology.
Response: In response to the comment that the SMS data are not a perfect data source for developing practice expense RVUs, as we have said previously, we believe the SMS survey is the best available source of data on multispecialty practice costs. This comment was echoed by one of the same commenters that objected to including the 1999 SMS data in the practice expense methodology for determining 2002 RVUs. While we have previously acknowledged that the data have potential limitations for determining practice expense RVUs, there are no alternative data sources that are better for this purpose.
Since there are no other data on aggregate multispecialty practice costs that are better than the SMS, our only alternative would be to eliminate the SMS data from the methodology and rely solely on estimates of practice expense inputs for individual codes. We believe a better approach would be to continue using the SMS data in the practice expense methodology and to work with the physician community to develop even better data for establishing practice expense RVUs in the future.
One commenter noted that we only included telephone survey responses and not mail responses from the 1999 SMS and suggested that this decision further reduces an already low response rate. Our understanding is that the AMA, as a result of concerns about a declining number of responses to the SMS survey, used several approaches to obtain more surveys in the 1999 SMS. As part of this effort, some survey respondents received a mail survey instead of the normal telephone survey. Our review of information from the AMA suggested that there were significant differences between the mail and telephone surveys on questions related to practice expense. Since our objective has been to use a consistent approach to obtaining practice expense data for use in our methodology, we felt that it would be better to incorporate only the traditional telephone survey responses in the methodology consistent with how the data were obtained in earlier years.
While a few commenters indicated that the SMS data are not representative of a particular specialty's costs, they provided no information to support the contention. One commenter suggested that electrophysiology, a subspecialty of cardiology, was unlikely to be included in the SMS survey. Since the SMS survey draws a random sample from the AMA's Physician Masterfile, we believe all physicians are equally likely to be selected for participation in the survey. We would further note that the SMS weights response information based on known characteristics of the population to make the final figures as representative of the self-employed population as possible. As we have stated previously, we believe the SMS survey is the best source of data for specialty practice expenses. If a specialty believes that the SMS is unrepresentative of their actual practice expenses, we have established a process by which additional data can be submitted to us. To date, we have used two specialty practice expense surveys in addition to or in place of the SMS survey. We encourage specialties to use this process to provide us with additional practice expense data that improve the representativeness of the data that we are using to determine the practice expense RVUs.
One commenter doubted that cardiology practice expense could have declined as much as suggested by the 1999 SMS data. We would note that the practice expense per hour in any given year can show more variability than the change in practice expense per hour over time. While the specialty of cardiology shows some level of variability in practice expense per hour, with some years showing a higher value than the average and other years a lower value, the change in practice expense per hour including the 1999 SMS data is far more modest than that suggested by the commenter. There is a -2.0 percent change in practice expense per hour as a result of including the 1999 SMS data. As indicated below, use of the 1999 SMS data changed average specialty level payments to cardiologists by less than 0.5 percent.
We acknowledge that response rates and the number of usable responses from the 1999 SMS are lower than in prior years. Nevertheless, as we have stated previously, it is unclear to us why this alone indicates that we should reject incorporating the data. To the extent that there are few responses to the latest SMS survey, there will be less impact on a given specialty because the practice expense per hour calculation is weighted by the number of respondents from each respective year. Further, we believe inclusion of more survey data will improve the data's representativeness and lead to more stability in the practice expense per hour. The use of the 1999 SMS data appears to have little effect on the practice expense RVUs. In our August 2, 2001 proposed rule (66 FR 40397), we simulated the impact of including the 1999 SMS data on average specialty level payments. The increase or decrease in average specialty level payment was less than 0.5 percent for 29 of the 35 specialties listed, including nearly all of the specialties that expressed concern about including the latest SMS data. For 4 of the remaining 6 specialties, the increase or decrease in payments was between 0.5 and 1.0 percent. Payments for the remaining two specialties (pathology and suppliers) increased by more than 2 percent.
We are doubtful that respondents "gamed" responses in the 1999 SMS because of an awareness that reporting higher practice expenses would lead to increased payments from Medicare. We observed no noticeable increase in practice expense per hour from the 1999 SMS survey than from earlier years. In fact, the inflation-adjusted all-physician practice expense per hour from the 1999 SMS data is lower than the same figure from the 1998 SMS data. Further, if the concern is that physicians were aware of how the data would be used and would "game" responses to obtain higher payments from Medicare, our expectation would be that the number of responses in the 1999 SMS would be higher, not lower, than in prior years. For these reasons, we are doubtful that there is any reason to assume that the 1999 SMS survey would show more bias than surveys from previous years.
We welcome the comments that suggest that we develop a long-term strategy for using aggregate specialty practice expense data to make refinements to RVUs. As noted by some commenters, the AMA is no longer conducting the SMS survey in its current form. We would like to engage physician specialty societies, as well as other practitioner groups and representatives of organizations affected by Medicare physician fee schedule payments, in discussions of how to best obtain practice expense data that will be useful in updating our methodology for determining practice expense RVUs. Although it has been beneficial to use 5 years of SMS data to develop practice expense RVUs, we believe that it may not be necessary to make annual updates to aggregate specialty practice cost data if relative practice expenses do not change significantly from year to year. However, it may be beneficial to periodically review aggregate practice expenses and make changes when necessary. For instance, one commenter suggested that technological innovation may change relative expenses among services. For this reason, we believe a review of aggregate practice costs at least every 5 years is necessary. In fact, the statute requires that we review RVUs at least every 5 years. At this time, we have incorporated all of the data from the SMS surveys into the practice expense methodology. We will consider public input on the best way to obtain practice expense data for use in future practice expense calculations.
(ii) Supplemental Practice Expense Survey Data
To ensure the maximum opportunity for specialties to submit supplementary practice expense data, we proposed to accept survey data that meet the criteria set forth in the November 2000 final rule for an additional 2 years. The deadlines for submission of such supplemental data to be considered in CY 2003 and CY 2004 are August 1, 2002 and August 1, 2003, respectively.
Comment: Several commenters expressed their strong support for our decision to accept specialty-specific practice expense surveys for an additional 2 years. Specialty societies representing podiatry, pediatrics, internal medicine, rheumatology and surgery, as well as the American Medical Association (AMA) stated their agreement with this decision.
An organization representing medical colleges commented that this will send an important message to the physician community about our willingness to consider all legitimate data sources in analyses of this critical portion of payments, and one that has been a subject of controversy within the community. A specialty society representing dermatology stated that the additional time will allow specialties to collect specialty-specific data that should be useful as we determine practice expense RVUs.
The AMA and a commenter representing podiatry expressed some concern about the criteria for the acceptance of survey data and the AMA also expressed hope that we would be flexible concerning any data submitted. The commenter representing emergency medicine argued that collecting specialty-specific data would be fruitless, due to a number of stringent criteria for submitting supplemental practice expense survey data.
On the other hand, three commenters indicated that we should accept only survey data that meet our criteria. The commenter representing rheumatology stated that it is critically important that any data accepted must meet the criteria in the November 2000 final rule.
Response: We received only comments supporting this proposal, and we will be extending the period of acceptance of supplemental survey data for another 2 years, as proposed. We hope to demonstrate flexibility in helping those specialties that conduct a survey to do so successfully, and we understand that for some specialties some revision to the survey format may be necessary. For example, questions regarding uncompensated care for emergency physicians or separately billable drugs for oncologists might need to be added to a survey to determine the appropriate practice expense for these specialties. However, like several of the commenters, we believe that fairness to all can only be achieved if we consistently apply the rules for determining validity to any survey that is submitted.
Comment: A specialty society representing geriatrics expressed concern regarding the use of SMS data in formulating practice expense costs because the sample size for geriatricians is not large enough to yield reliable data. The commenter stated that smaller specialty societies will be unable to provide supplementary survey data because of expense limitations and recommended that we continue to review alternative data sources that recognize the greater resources spent in caring for frail elderly persons. The society further recommended that we consider the use of "non-compliant" survey data for smaller specialty groups that do not meet our stringent and costly criteria.
Response: We could not justify accepting "non-compliant" surveys from some specialties, due solely to the specialty's size, while holding others to a more rigorous standard. However, though we would welcome survey data from any specialty that submits a survey that meets our criteria, we do recognize that performing a survey can be costly. We, therefore, suggest that the specialty society consider in advance the extent to which any possible survey result might actually alter the practice expense RVUs for their services. Note that we have only one payment amount for each service on the fee schedule. We have no authority to pay more to one specialty than to another for performing the same service. If a small specialty provides only a small percentage of a given service, a change in the practice expense per hour for that small specialty could have very little effect on the payment for the service. For example, if geriatricians perform mainly evaluation and management (E/M) services, even a survey that shows increased practice costs for geriatricians would not necessarily have any effect on the practice expense RVUs for E/M services because geriatricians' services would represent only a small part of the universe of E/M services. However, it is incumbent upon each specialty society to weigh both the costs and benefits to their specialty to determine whether conducting a practice expense survey would be worthwhile.
(iii) Submission of Supplemental Surveys
Three organizations submitted supplemental survey data for consideration for CY 2002. Survey data were submitted by the American Physical Therapy Association (APTA), the American Optometric Association (AOA), and the American Academy of Pediatrics (AAP). Our contractor, The Lewin Group, has evaluated the data submitted by each organization. They have recommended that we use the data submitted by APTA and AOA and reject the data submitted by AAP. The full recommendation and discussion will be made available on the CMS web site. (See the Supplementary Information section of this rule for directions on accessing our web site.)
We have decided not to use the data submitted by APTA, AOA, or AAP because none of the surveys met all of our stated criteria. In our May 3, 2000 interim final rule (65 FR 25666), we indicated that, based on our review of existing physician practice expense surveys, we believe that an achievable level of precision is a coefficient of variation (that is, the ratio of the standard error of the mean to the mean expressed as a percent) not greater than 10 percent for overall practice expenses or practice expenses per hour. For existing surveys, the standard deviation is frequently the same magnitude as the mean. We indicated in the May 2000 interim final rule that we would consider practice expenses for which the precision of practice expenses is equal to or better than this level of precision and that meet the other survey criteria. None of the surveys submitted for 2002 met the level of precision criteria; therefore, we have decided not to use the survey data.
b. CPEP Data
(i) 2000 RUC Recommendations on CPEP Inputs
In the November 2000 final rule (65 FR 65393), we responded to the RUC recommendations for the refinement of the direct inputs for 49 CPT codes and for the supply and equipment inputs for four additional services. These recommendations reflected multispecialty agreement on the typical resources for many important services, including visit codes, which account for approximately 24 percent of Medicare spending for physicians' services. We accepted almost all of these recommendations. We received the following comments on our responses to the RUC recommendations and on the PEAC/RUC refinement process:
Comment: Several specialty societies representing osteopaths, rheumatologists, neurologists, ophthalmologists, obstetricians, and gynecologists commended us for implementing the refinements submitted by the PEAC and RUC as part of the on-going refinement process. One specialty society stated that it was encouraged by the direction pursued with the physician fee schedule for 2001, because it demonstrated the ability to achieve refinement within the parameters of the fee schedule comment process. Another commenter expressed appreciation for our support of the PEAC and RUC refinement process because this relationship is critical to establishing fair and balanced payment policies.
In addition, other commenters praised our staff for being helpful in responding to the PEAC members' questions during meetings, as well as for the willingness to work with physician specialty societies toward establishing fair and appropriate reimbursement values. The RUC commented that it agreed that the PEAC has made significant progress in its ability to review and refine direct practice expense inputs for individual CPT codes.
Response: We appreciate the above comments and are also encouraged by the progress that the PEAC and RUC have made in refining the practice expense inputs.
Comment: The RUC agreed that the PEAC should continue to meet and refine the direct practice expense data. Therefore, it hopes that we will state that the practice expense RVUs will continue to be interim and subject to refinement as the PEAC continues its review. A specialty society representing ophthalmology echoed this request stating that, because the PEAC is continuing the refinement process, the interim status of the practice expense RVUs should be reaffirmed in the rule. The commenter requested that the RVUs remain interim and subject to change until 2007, that is, until the first update of the five-year review of practice expense RVUs.
Response: We are pleased that the RUC and PEAC are willing to continue the task of helping us to refine the practice expense inputs for the approximately 7,000 services in the physician fee schedule. We intend to keep the practice expense RVUs as interim as long as this refinement process is necessary. Also, as noted above, we will accept, for another 2 years, supplemental survey data that meet our criteria. During this period, we will also continue to make improvements to our practice expense methodology.
Comment: A commenter representing three ophthalmology sub-specialties, though appreciative of our implementation of the PEAC recommendations, expressed disappointment that we have not made the non-controversial revisions to correct additional errors in the CPEP database. The commenter encouraged us to explore alternative ways to improve the quality of the CPEP data without waiting for the PEAC to consider each of the thousands of alleged errors.
Response: We have made changes to the CPEP data in those instances when there was a clear anomaly in the data and when the more appropriate revision would be obvious, without the benefit of a multispecialty recommendation. However, we have found that the input and recommendations of a multispecialty group, such as the PEAC, have played a crucial role for the vast majority of suggested revisions when clinical judgment is involved.
Comment: An organization representing diagnostic imaging centers stated that it would be inappropriate for the PEAC to constitute the review body for direct cost data for technical component services, because the PEAC does not include any representatives of diagnostic imaging centers. The commenter requested that, if any of the CPEP direct cost data form the basis for future payment for technical component services, the accuracy of these data should be reviewed by representatives of centers that actually provide the services involved.
Response: We do not agree that it is inappropriate for the PEAC to review the direct cost inputs for imaging services. The presentations for each service discussed at the PEAC are based either on surveys or panels of individuals who are familiar with the procedure in question. In addition, any of the recommendations of the PEAC that we accept are subject to review and comment by any interested party.
Comment: Societies representing surgeons, urologists, ophthalmologists, pediatrics, internists, and family physicians strongly support our acceptance of the revisions of CPEP inputs for office-based E/M services. One specialty society commented that the refined inputs for these services reflect the work of a multidisciplinary workgroup and demonstrate a major positive step toward streamlining practice expense inputs. One surgical specialty society did not fully agree that it is appropriate to use these E/M inputs to refine postsurgical visits because the direct costs associated with these visits are not necessarily comparable to the typical E/M visit. On the other hand, a primary care specialty society commented that the "rolling" implementation of CPEP refinement creates an anomaly because the surgical global services have not yet had these lower PEAC estimates for the E/M visits applied.
Response: We also saw the refinement of the practice expense inputs for the E/M codes as a significant milestone in the whole refinement process. These codes not only represent a sizeable portion of Medicare payments, but they also are used by most medical specialties, and, thus, most members of the PEAC had a stake in the outcome of this issue. We believe that, as a result of the extensive multispecialty discussion held by the PEAC on this issue, the recommendations on the E/M codes represent the best available estimates of the direct inputs needed for performing these services. With respect to the issue of applying these E/M inputs to the surgical global services, we will not be taking separate action now, but will be responding to the specific PEAC recommendations. We understand that it is expected that all the 90-day global surgical services will be refined by the PEAC by next year.
Comment: A specialty society representing internal medicine commented that the registered nurse (RN) and licensed practical nurse (LPN) staff mix should be used for the E/M codes rather than the RN, LPN, and medical assistant staff mix, which is less typical. The commenter also stated that we should increase the postservice clinical staff work for these services by 20 percent.
Response: We do not agree with changing the staff mix at this time, particularly because the PEAC recommendations have used this staff mix across the majority of refined services. We also have seen no evidence to suggest that the post-times for these services were undervalued.
(ii) 2001 RUC Recommendations on CPEP Inputs
We have received recommendations from the PEAC on the refinement to the CPEP inputs for over 1,100 codes. These include refinements of large numbers of orthopedic, dermatology, pathology, physical medicine, and ophthalmology services. In addition, the PEAC confirmed that there were no inputs for over 150 ZZZ-global procedures that are performed only in the facility and no supply or equipment inputs for almost 700 facility-only services with an XXX or 0-day global period. We believe this large increase in the number of CPT codes that have been refined demonstrates that the PEAC refinement process is working due to the valiant efforts of the AMA staff and the specialty societies participating in this mammoth undertaking. There is also reason to believe that the pace of refinement will continue to increase because of the steps that the PEAC is taking to create standardized packages of clinical staff time, supplies, or equipment that can be applied over a wide range of services.
We have reviewed the submitted PEAC recommendations and have accepted most of them with only minor revisions. The complete PEAC recommendations and the revised CPEP database can be found on our web site. (See the Supplementary Information section of this rule for directions on accessing our web site.)The following is a list of the only revisions we made to the PEAC recommendations:
• We substituted the multispecialty minimum visit supply package or the ophthalmology supply package for the list of individual supplies, when appropriate.
• We deleted separately billable supplies, for example, drugs, fluids, and casting supplies, when listed in the recommended supply list.
• We rounded fractions of minutes of clinical staff time to the nearest minute.
• For CPT code 52281, cystoscopy and treatment, we deleted the bougie a boule from the equipment list. The specialty society supplied us with the price of $105 for this item, which does not meet the minimum cost of $500 for an item to be included in the equipment list.
• For several ophthalmology services that did not involve dilation of the pupil, we consulted with the specialty society and deleted the ophthalmology visit supply package that was listed for the post-procedure visit. This package is intended for those services where dilation is necessary. The society confirmed that no supplies are needed for the post-procedure visit for these services.
• The recommendation did not specify the number of EEG electrodes for CPT code 92585, auditory evoked potential, comprehensive. We added seven electrodes, which is the same number assigned to the visual evoked potential code.
• The PEAC/RUC recommendations included time for the clinical staff type, "Physical Therapy Assistant (PTA)," which currently is not included in our CPEP input database. We are pricing the PTAs by using the Bureau of Labor Statistics wage estimates for physical therapy assistants. The base annual salary we are using will be $33,690. After factoring in benefits and adjusting this to 2001 dollars, the per minute rate will be $0.386.
• We have two concerns about the PEAC recommendations for therapy services. First, we believe that some of the duties ascribed to the physical therapy assistant are actually therapist services that are already captured in the work RVUs. Therefore, we are deleting from all the therapy codes the clinical staff time for obtaining vital signs and measurements, patient education, and phone calls. Because we believe that the resulting clinical staff times may be too low for the physical therapy and occupational therapy evaluation and reevaluation services, we are adding 7 additional minutes for the therapy aide in each of these codes. In addition, some of the occupational therapy codes contain several pieces of very expensive equipment called environmental modules. Because it is unclear how many of these modules would typically be used for each service, we are only including one module for each code that might use this equipment. We note that for three services, CPT codes 97530, 97535, and 97537, the PEAC did not submit a recommendation for equipment, presumably because of the difficulty of determining what would be typically used. In those cases, as in those with a PEAC recommendation, we are allowing for one module and some smaller equipment that was suggested by the specialty. We would hope to work with the specialty societies to obtain more precise information on the appropriate equipment for all of these therapy services.
• We note that one of the services for which we received recommendations, the casting/strapping procedure CPT code 29799, is carrier-priced. In addition, we received recommendations for two fine needle aspiration services, CPT codes 88170 and 88171, which are now deleted.
(iii) Other Comments on Refinement of CPEP Inputs
Comment: Several commenters were pleased that we finalized certain proposals regarding CPEP inputs, such as the following:
• The reinstatement of the pre-procedure clinical staff time in the facility setting for certain 0-day global services as well as pre-service time for the vitrectomy codes.
• Our decision to uphold the proposed refinements regarding inpatient dialysis CPT codes 90935 and 90945.
• The clarification of Medicare payment policy for cast supplies when used for non-fracture/dislocation procedures.
• The decision to retain Unna boot in the supplies for CPT code 29580.
• The correction of the supply list for CPT code 88104 and the establishment of a separate nonfacility practice expense RVU for CPT code 85607 in the 2001 fee schedule.
• The extension of the code-specific refinement beyond 2002.
Response: We appreciate the above comments and will strive to continue refining the practice expense RVUs in a manner that is fair and beneficial to the medical community.
Comment: An allergy clinic commented that because of our definition of a dose for CPT code 95165, Allergy Immunotherapy, doctors will be forced to use a dosage that could be harmful to certain patients.
Response: The definition of a dose will be used only for pricing the practice expense inputs for this service. Physicians should use their clinical judgment in determining what dose to use for any particular patient.
Comment: A commenter noted that the two codes for anal balloon sphincterplasty (CPT codes 49505 and 49510) did not have the balloon listed in the supply inputs.
Response: We agree that this was an omission and have added the balloon to the supply list for both services.
Comment: A commenter stated that there are no practice expense inputs assigned to CPT code 36533, insertion of implantable venous access port, with or without subcutaneous reservoir, in the nonfacility setting, because the CPEP panels priced it only in the facility. In particular, the supply inputs do not contain the cost of the catheter that is an integral part of the procedure.
Response: It is true that the original CPEP panel did not price this in the nonfacility setting; however, we subsequently crosswalked the inputs from the facility to the nonfacility setting for supplies, equipment, and clinical staff, adding clinical staff time for the intraservice period in the office. However, we agree that the catheter is an appropriate supply and have added it to the supply list for this code.
Comment: A specialty society representing podiatrists questioned why the practice expense RVUs for the nail trimming codes G0127 and CPT code 11719 are not the same. The commenter stated that they should have the same CPEP inputs since both were refined by the PEAC this year with identical inputs.
Response: The CPEP inputs are now identical for both codes, except that the supplies recommendation for CPT code 11719 does not include a surgical mask. However, none of this year's PEAC recommendations were reflected in the August 2001 proposed rule. In addition, even codes with identical CPEP inputs can have different practice expense RVUs if a different mix of specialties performs each service.
Comment: Two specialty societies representing cardiologists and electrophysiologists commented that we have allowed 60 minutes of clinical staff time to arrange for surgical procedures with a 90-day global period, but we have not yet allowed the same for 0-day global period procedures in facilities. The commenters stated that they may present specific codes to the PEAC with the recommendation that this time be recognized for these services, and they hope that we will be receptive to these recommendations.
Response: We will be glad to review any PEAC recommendations on clinical staff pre-service time for 0-day global period services in the facility setting if and when we receive them.
(iv) Repricing of Clinical Staff Wage Rates
In the August 2, 2001 proposed rule (66 FR 40378), we proposed modifications of wage rates for the clinical staff types contained in the CPEP database. Our contractor, Abt Associates, assigned the costs of the original CPEP inputs for staff, supplies, and equipment based primarily on 1994 and 1995 pricing data.
The original Abt Associates' estimates of clinical staff wage rates relied primarily on the Bureau of Labor Statistics (BLS) data. Abt's report on the CPEP cost estimation stated that, "* * * the BLS data were considered to be the preferred data set. The BLS" reputation for publishing valid estimates that are nationally representative led to the choice of the BLS data as the main source. If more than one data set provided an exact mapping for a receptionist, then the BLS wage was chosen over any other mapping."
We agreed with this assessment and have used the most current BLS survey (1999) as the main source of wage data.
It should be noted that the BLS discontinued the Occupational Compensation Survey used by Abt in 1995 and now conducts the National Compensation Survey that has a breakdown of staff types different from the earlier survey. Also, this survey does not cover all the staff types contained in the CPEP data. Therefore, it was necessary for us to crosswalk or extrapolate the wages for several staff types using supplementary data sources for verification whenever possible.
We used three other data sources to price wages of staff types that were not referenced in the BLS data:
• The American Society of Clinical Pathologists' survey of laboratory staff salaries (found at www.ascp.org ).
• The survey performed by the American Academy of Health Physics and the American Board of Health Physics (found at www.hps1.org ).
• The national salary data from the Salary Expert, an Internet site that develops national and local salary ranges and averages for thousands of job titles using mainly government sources. (A detailed explanation of the methodology used to determine the specific job salaries can be found at www.salaryexpert.com ).
We also solicited any valid survey data that commenters might be able to submit to us.
The proposed cost per minute for each staff type was derived by dividing the proposed annual salary (converted to 2001 dollars using the Medicare Economic Index) by 2080 to arrive at the hourly wage rate and then again by 60 to arrive at the per minute cost. To account for the employers' cost of providing fringe benefits, such as sick leave, we used the same benefits multiplier of 1.366 used by Abt Associates.
Comment: We received several supportive comments on our efforts to update the clinical staff salaries used in calculating the practice expense RVUs. Specialty societies representing family physicians and surgeons supported the proposal to reprice clinical staff salaries to approximate current practice expenses. A specialty society representing rheumatology stated that the repricing of clinical staff salary data represents an overdue positive step toward more accurate refinement of practice expense inputs. A specialty society representing dermatology agreed with the appropriateness of bundling similar clinical staff types into more easily identified and easily tracked clinical labor blended categories.
Response: We agree that using current wage data to price the clinical staff CPEP inputs is one step in ensuring that the practice expense RVUs are based on the resources needed to perform each service. We also would like to express our appreciation to the groups that included salary survey data on various staff types as part of their comments. These additional data have helped us to make appropriate revisions to our original proposals.
The following is a discussion of the specific proposals we made on the pricing of clinical staff types.
• We received no comments on the following proposals. Therefore, they will be implemented as proposed.
• We will price as proposed the staff types physical therapy aide, LPN, RN, certified surgical technician, laboratory technician, cytotechnologist, cardiovascular technician, nuclear medicine technician, optician, respiratory therapist, speech pathologist, audiologist, and counselor.
• We will collapse the medical assistant, technical aide, medical technician, EKG technician, anesthesia technician, technician, and cast technician staff types into a new staff type, "medical or technical assistant (MTA)," that will be priced at the medical assistant wage rate of $0.26 per minute.
+ We will bundle the staff type "RN-cardiology" into the staff type "RN."
+ We will adjust the wage rate for the oncology-certified nurse to be 18 percent higher than the RN.
+ We will bundle the staff type "surgery assistant" into the staff type "certified surgical technician (CST)."
+ We will use the average hourly rate of $15.60 for histologic technologists from the 1998 American Society of Clinical Pathologists' survey to price the histotechnologist staff type.
+ We will use the BLS salary data for electroneurodiagnostic technologists contained in the BLS Occupational Outlook Handbook to price the electrodiagnostic technologist staff type.
+ We will price the wage rate for the EEG technician using survey data from the Salary Expert.
+ We will merge the nuclear cardiology technician in with the nuclear medicine technician staff type.
• We were unable to find any national salary data for the electron microscopy technician and, in the absence of such data, proposed crosswalking the salary from the wage rate for the histotechnologist. Though this represented an increase in the per minute cost for this staff type, we stated that we would welcome reliable national survey data from the specialty that we could use in pricing electron microscopy technicians.
Comment: The specialty society representing pathologists recommended that the wage rate for electron microscopy (EM) technician, which we proposed crosswalking from that of the histologic technologist, should more accurately be priced at the same wage rate as the cytotechnologist. The commenter stated that histologic technologists are generally bachelor degree level personnel, whereas EM technicians generally have post-baccalaureate education, parallel to that of a cytotechnologist. In addition, they receive salaries that are higher than general histotechnologists. The commenter also recommended that the title of the EM technician category be changed to EM technologist.
Response: We are persuaded that the commenter has proposed a more suitable crosswalk for this staff type. Therefore, we will crosswalk the wage rate for the EM technologist from that of the cytotechnologist. We will also change the title as suggested by the specialty society.
• We were unable to find any national salary data for registered electroencephalograph technologists (REEGTs) and proposed to maintain the current rate, since the speciality society had recently recommended this rate of pay. However, we also requested reliable national survey data from the specialty that we could use in pricing these three levels of neurodiagnostic staff.
Comment: The American Academy of Neurology (AAN), on behalf of seven related organizations, submitted an abbreviated version of the 2000 American Society of Electroneurodiagnostic Technologists (ASET) Salary Survey. The commenter stated that this national salary survey has been collected triennially by ASET, the main national body representing this allied health professional field, and was not collected for any purpose connected with the physician fee schedule. For office-based registered electroencephalograph technologists, there were 31 responses and a mean salary per hour of $20.11. For all REEGTs, there were 559 responses and a mean salary of $20.53 per hour. The commenters recommend that we substitute either of these salary rates to determine the costs for the REEGT staff type. The specialty society representing sleep medicine requested that we consider the updated salary data that AAN included in its comments on the proposed rule.
Response: We have reviewed this survey and believe that it provides a more appropriate estimate of the wage rate of REEGTs than did our crosswalk to a staff type used in a different specialty. We will use the data for the office-based REEGTS, which results in a wage rate of $0.47 per minute, which we note is not significantly different from our proposed rate for the REEGT staff type.
• We proposed to bundle the vascular technician with the cardiovascular technologist staff type. Currently both are priced at the same rate.
Comment: The American Association for Vascular Surgery, American Society of Neuroimaging, Society of Diagnostic Medical Sonography, Society for Vascular Surgery, and Society of Vascular Technology submitted a joint comment as "The Coalition." The Coalition argued that the BLS was wrong to classify vascular technologists with cardiovascular technologists and technicians because the BLS description of duties for this classification does not include any of the duties performed by a vascular technologist. In addition, the commenters contended that, unlike most cardiovascular technicians, a vascular technologist functions as a direct and largely independent health care practitioner. A skilled vascular technologist undergoes between 2 and 4 years of didactic and clinical post-secondary education as evidenced by the presence of a baccalaureate degree program in vascular technology.
The Coalition recommended that we base the salaries for vascular technologists on data from a survey conducted earlier this year by nVision Research that surveyed by mail 406 randomly selected vascular technologists from a variety of settings. The response rate for this survey was 55 percent. Based on the survey, nVision Research determined that the median annual salary of a vascular technologist is $49,758. A copy of the survey was included with the comment. The commenters also recommended that we change the description of the "vascular technician" to "vascular technologist." A specialty society representing echocardiography urged that we adopt the classification of "vascular technologist" as proposed by the above groups.
Response: We agree that the nomenclature of the staff type should be changed to "vascular technologist." We have studied the data provided by the Coalition and have consulted with our medical advisors and now also agree that the salary shown in the submitted survey better represents the current wage rate for vascular technologists. Therefore, we will assign the vascular technologist staff type the recommended yearly salary of $49,758 which results in a per minute wage rate of $0.54.
• We proposed to merge the x-ray technician and radiation technologist staff types, which are currently priced at the same rate, into a staff type called "Radiologic Technologist."
Comment: The American Society of Radiologic Technologists (ASRT) submitted with their comment the 2001 "Radiologic Technologist Wage and Salary Survey" commissioned by the organization. The comment disagreed with our proposal to merge the x-ray technician and radiation technologist staff types. The society stated that the radiation technologist has completed a formal educational program and has successfully passed a nationally recognized credentialing examination; an x-ray technician denotes a person who is most likely informally trained and who is often employed to perform only very limited x-ray examinations. On the other hand, a society representing therapeutic radiology and oncology recommended that we not crosswalk radiation technologists to "radiologic technologists and technicians," but, instead, change the crosswalk and the name to "radiation therapist."
Response: We can understand why the original nomenclature assigned by the CPEP panels to these staff types would be confusing to the commenters. However, it is clear from the imaging services to which the radiation technologist is assigned that this staff type was not considered to be a radiation therapist. In addition, we do not disagree with the distinction made by ASRT between an x-ray technician and a radiation technologist. However, the CPEP panel did not appear to make this same distinction. In fact, the x-ray technician is often assigned to more complex services than the radiation therapist and Abt Associates priced the two staff types at the same wage rate. Therefore, we have made the decision to consider both staff types to be at the same level and to change the title of both to "radiologic technologist." If it is necessary to make a distinction between different levels of radiologic staff, this can be done as part of the refinement process.
Comment: A commenter representing imaging centers recommended that we substitute the "more accurate and recent salary information" obtained by the ASRT for the pricing of radiologic technologists. The commenter stated that these data indicate that the mean salary of full-time radiologic technologists is $53,919.
Response: We have reviewed the survey submitted to us by ASRT and have found it to be both comprehensive and useful. We would note that the $53,919 referenced in the comment is the mean salary for all radiologic personnel and includes the salaries of staff level personnel as well as chief technologists and of radiography staff as well as dosimetrists. Therefore, this is not salary information that can be used to price the specific radiology staff types in our database. However, as discussed below, we have used other ASRT data to price certain staff types for which we had no other pricing information. It is interesting to note that the mean salary in the ASRT survey for radiography staff is $36,862, while the 2001 salary rate for the equivalent staff based on the BLS is $37,126; the use of either figure would result in an almost identical per-minute wage rate. This information gives us extra confidence in our proposed wage rate of $0.41 per minute for radiologic technologists, and we will be implementing this salary rate as proposed.
• Because we were unable to find any national survey data regarding the salaries for CAT scan technician, MRI technician, or angiographic technician, we proposed crosswalking these staff types to the BLS radiologic technologist pay scale. We also stated that we would welcome any reliable national survey data that would allow us to separately price these staff types.
Comment: The American Society of Radiologic Technologists (ASRT) recommended that we use the 2001 ASRT survey submitted with its comment to price the MRI, CAT scan and angiographic technologists, rather than crosswalking their wage rate from the radiologic technologist. The ASRT data show an annual salary of $42,143 for a CAT scan technologist and $43,118 for an MRI technologist.
Response: We have reviewed the ASRT data for MRI and CAT scan technologists and will use that data for MRI and CT staff to price these staff types. There is a close congruence between the ASRT and the BLS salaries for those radiologic staff for whom we have data from both sources. Therefore, we have confidence that the wage rate we will use for the CAT scan and MRI technologists will be relatively correct. The wage rate for the CAT scan technologist will be $0.46 per minute and for the MRI technologist $0.47 per minute. We could not find data in the ASRT survey corresponding to the angiographic technician. Therefore, until some reliable national data are available, we will continue to crosswalk this wage rate from that of the radiologic technologist.
• We proposed merging the cardiac sonographer and the ultrasound technician into the sonographer staff type. Currently, all three are priced at the same rate.
Comment: The group of specialty societies commenting as the "Coalition" recommended that we maintain the description, "cardiac sonographer," eliminate the description, "ultrasound technician," and change the description "sonographer" to "diagnostic medical sonographer." A specialty society representing echocardiography strongly urged that we adopt the above classifications proposed by the Coalition. This commenter also contended that crosswalking the salary for cardiac sonographers from that of diagnostic medical sonographers does not adequately reflect the salaries currently paid to cardiac sonographers. The society is currently seeking a reliable source of current survey information so that we can price cardiac sonographers separately.
Response: We have already proposed eliminating the description "ultrasound technician" and will accept the description of "diagnostic medical sonographer." We proposed merging the cardiac sonographer into the sonographer classification because the two staff types were currently priced the same and we did not have any other salary data for the cardiac sonographers. However, we will accept the recommendation to keep the category "cardiac sonographer" and would be willing to reconsider the pricing if valid salary data are submitted.
• Because we were unable to find salary information for the staff type "dosimetrist," we proposed crosswalking their salary from that of radiation therapists.
Comment: The American Society of Radiologic Technologists (ASRT) recommended that we review our proposed equal wages rates for radiation therapists and dosimetrists. The commenter reported that the annual salary of $57,330 for staff dosimetrists shown in the submitted 2001 ASRT survey is considerably higher than that for radiation therapists, which reflects their additional educational requirements. The specialty society representing radiology also opposed combining dosimetrists and radiation therapists in the same group because these two staff types provide very different services for radiation oncology procedures and are paid on different pay scales. This commenter agreed with the proposed increased wage rate for radiation therapists, but believed that the dosimetrists would be paid approximately 20 percent more than their proposed rate. Two other societies, one representing therapeutic radiology and oncology and one representing radiation oncology centers, also supported an increase for dosimetrists and one commenter suggested that we substitute the title "medical dosimetrist." In addition, these two commenters recommended that we use the ASRT data for radiation therapists as well.
Response: We appreciate receiving the ASRT data for dosimetrists and agree that the annual salary suggested by the ASRT survey more accurately reflects the appropriate wage rate for this staff type. The wage rate will be $0.63 per minute. We will also change the title for this staff type to "medical dosimetrist." We will continue to use the BLS data to determine the wage rate for radiation therapists since there has been no evidence presented to show that the BLS survey was in any way not representative.
• We proposed using the average salary data for all certified health physicists from the 1999 survey conducted by the American Academy of Health Physics and the American Board of Health Physics to price the "physicist" staff type.
Comment: Three specialty societies representing radiology, therapeutic radiology and oncology, and radiation oncology centers recommended that we use the Professional Information Survey data from The American Association of Physicists in Medicine (AAPM) rather than from the American Academy of Health Physics (AAHP). One commenter pointed out that the AAHP survey does not include physicists working in radiation oncology. The AAPM survey for CY 2000 had an overall response rate of 58 percent and demonstrated an average annual salary of $107,900. One commenter suggested that we also change the title to "medical physicist."
Response: No copy of the AAPM survey was included with any of the comments, and we have been unable to review it at this time. However, we would not question the commenters' assertion that the AAPM survey was more relevant to physicists working in radiation oncology than the survey we used to determine our proposed wage rate. Therefore, we are using the AAPM survey salary of $107,900 on an interim basis to price the physicist wage rate and will endeavor to obtain and review this survey to finalize this issue. The wage rate for 2002 will be $1.21 per minute. For clarity, we will also accept the recommendation to change the title to "medical physicist."
• We were unable to obtain representative national salary data for the certified ophthalmic technician (COT), the certified ophthalmic medical technologist (COMT), or the orthoptist staff types. We proposed to crosswalk the COT and COMT to the laboratory technician and histotechnician, respectively, since we believe that the skill and responsibility of these staff types would generally correspond. In the absence of any national salary data for the orthoptist, we proposed to crosswalk the salary from that of the COMT, the highest level of ophthalmic medical personnel. We also proposed crosswalking the salary data for the certified retinal angiographer from the data listed for ophthalmic photographers in the Salary Expert . We stated that we would welcome reliable and representative national salary data for these staff types.
Comment: The specialty society representing ophthalmologists commented that they would be pleased to offer additional assistance to validate the salaries for ophthalmic medical technicians and other ophthalmic clinical staff. At this time, the commenter agreed that the proposed crosswalks for these staff types are acceptable.
Response: We will be implementing these crosswalks as proposed.
• We proposed to crosswalk the wage rate for the staff type "dietitian" from the BLS salary data for dietitians and nutritionists.
Comment: The American Dietetic Association (ADA) commented that it believed that the BLS database includes salaries for non-credentialed dietitians and nutritionists and that we should reference ADA data from its membership surveys that estimates 2001 adjusted median annual income for dietitians to be $51,006.
Response: We would be willing to look at the ADA survey data if they were submitted to us. We would, of course, have to review and analyze these alternative survey data before we could substitute them for the BLS data that we have proposed to use. However, until we are convinced that the ADA data were equally or more representative of dietitians who serve as clinical staff for services on the fee schedule, we will continue to use the BLS data as our source of salary data for dietitians.
• We proposed to delete those clinical staff that can bill separately from the list of CPEP staff types. Therefore, we proposed substituting physical therapy aide for physical therapist, registered nurse for physician assistant, nurse practitioner and psychologist, and counselor for social worker.
Comment: Two specialty societies representing internal medicine and family practice expressed support for this proposal because these staff types, for example, nurse practitioners, are used as physician extenders and their salaries should not be considered as practice expense. A society representing geriatrics argued that we should not delete the clinical staff that can bill separately from the list of CPEP staff types because not all of these individuals bill separately, resulting in a negative impact on geriatrics.
Response: We will implement our proposal to delete clinical staff that can bill independently from our practice expense input database, with the two exceptions noted below. We believe that the costs of these staff types are not practice expenses and should be captured in the work RVUs. This revision to our clinical staff list should not have a negative impact on geriatrics because none of the deleted staff types were assigned to any of the E/M services that would make up a large percentage of geriatricians' case loads.
Comment: A society representing social workers commented that it was not opposed to the deletion from the practice expense inputs of staff types that can bill directly. However, the commenter pointed out that only clinical social workers are able to bill directly, while other social workers cannot. Therefore, the society is opposed to the deletion of the staff type, "social worker," from the CPEP inputs and the substitution of the staff type, "counselor." In addition, the society would at least want the BLS data for "social worker" to be used for pricing, though it believes that the BLS data does not differentiate enough between the various types of practice within social work.
Response: The commenter is correct in stating that not all social workers can bill directly. Therefore, we will keep the social worker staff type in our database and will use the BLS data for "social worker" to determine the appropriate wage rate. In addition, we will not delete the staff type, "psychologist," which is listed as the clinical staff for the psychological testing services. Because these services have no physician work RVUs, the work of the psychologist can only be captured through the practice expense RVUs. We can find no appropriate national salary at this time for this staff type. Therefore, we will use the current wage rate of $0.82 per minute.
• We proposed to delete, as redundant, the ophthalmic medical personnel (OMP) staff type and to substitute the COMT/COT/RN/CST blend that was suggested by the American Academy of Ophthalmology and recommended by the PEAC.
Comment: The specialty society representing optometrists agrees with our proposal to delete, as redundant, the ophthalmic medical personnel (OMP) staff type and substitute the COMT/COT/RN/CST staff blend.
Response: We will implement this as proposed. Table 1 lists each staff type remaining in our practice expense input database, the source of the data, the staff type crosswalk used, the proposed annual salary in 2001 dollars, the 2002 wage rate per minute (including benefits) and the current cost per minute (including benefits).
| Description | Source | Crosswalk | Mean yrly 2001 | Hrly + benefits | Revised per minute | Current per minute |
|---|---|---|---|---|---|---|
| Physical Therapy Aide | BLS | Physical Therapist Aides | 21,077 | 13.84 | 0.23 | 0.23 |
| Physical Therapy Assistant | BLS | Physical Therapist Assistants | 35,223 | 23.13 | 0.39 | N/A |
| Medical or Technical Assistant | BLS | Medical Assistants | 23,681 | 15.55 | 0.26 | 0.16 |
| LPN | BLS | Licensed Practical Nurses | 30,341 | 19.93 | 0.33 | 0.27 |
| RN | BLS | Registered Nurses | 46,494 | 30.53 | 0.51 | 0.42 |
| RN Oncology | BLS | Registered Nurses plus adjustment | 54,862 | 36.03 | 0.60 | 0.50 |
| Certified Surgical Technician | BLS | Surgical Technologists | 28,814 | 18.92 | 0.32 | 0.26 |
| Lab Technician | BLS | Medical and Clinical Laboratory Technicians | 29,724 | 19.52 | 0.33 | 0.29 |
| Histotechnologist | ASCP | Histologic Technologist | 33,925 | 22.28 | 0.37 | 0.31 |
| Electron Microscopy Technologist | X-WALK | Cytotechnologist | 41,099 | 26.99 | 0.45 | 0.31 |
| Cytotechnologist | BLS | Medical and Clinical Laboratory Technologists | 41,099 | 26.99 | 0.45 | 0.42 |
| EEG Technician | Salary Expert | Electroencephalographic Technician | 29,151 | 19.14 | 0.32 | 0.28 |
| Electrodiagnostic Technologist | BLS | Electroneurodiagnostic Technologists | 33,529 | 22.02 | 0.37 | 0.30 |
| Registered EEG Technologist | ASET | Registered EEG Technologist | 42,707 | 28.05 | 0.47 | 0.40 |
| Vascular Technologist | nVision Survey | Vascular Technologist | 49,758 | 32.68 | 0.54 | 0.35 |
| Cardiovascular Technician | BLS | Cardiovascular Technologists and Technicians | 34,794 | 22.85 | 0.38 | 0.35 |
| Radiologic Technologist | BLS | Radiologic Technologists and Technicians | 37,126 | 24.38 | 0.41 | 0.32 |
| Mammography Technologist | ASRT | Mammography Technologist | 39,212 | 25.75 | 0.43 | N/A |
| Angiographic Technician | BLS | Radiologic Technologists and Technicians | 37,126 | 24.38 | 0.41 | 0.35 |
| CAT Scan Technologist | ASRT | Computed Tomography Technologist | 42,143 | 27.68 | 0.46 | 0.32 |
| MRI Technologist | ASRT | Magnetic Resonance Imaging Technologist | 43,118 | 28.32 | 0.47 | 0.32 |
| Nuclear Medicine Technician | BLS | Nuclear Medicine Technologists | 44,361 | 29.13 | 0.49 | 0.39 |
| Diagnostic Medical Sonographer | BLS | Diagnostic Medical Sonographers | 45,751 | 30.05 | 0.50 | 0.39 |
| Cardiac Sonographer | BLS | Diagnostic Medical Sonographers | 45,751 | 30.05 | 0.50 | 0.39 |
| Radiation Technical Therapist | BLS | Radiation Therapists | 45,333 | 29.77 | 0.50 | 0.40 |
| Medical Dosimetrist | ASRT | Medical Dosimetrist | 57,330 | 37.65 | 0.63 | 0.50 |
| Medical Physicist | AAPM | Medical Physicist | 110,166 | 72.35 | 1.21 | 0.97 |
| COT | X-WALK | Lab Technician | 29,724 | 19.52 | 0.33 | 0.26 |
| COMT | X-WALK | Histotechnician | 33,925 | 22.28 | 0.37 | 0.28 |
| Optician | BLS | Opticians, Dispensing | 26,336 | 17.30 | 0.29 | 0.28 |
| Certified Retinal Angiographer | Salary Expert | Ophthalmic Photographer | 35,453 | 23.28 | 0.39 | 0.35 |
| Orthoptist | X-WALK | COMT | 33,925 | 22.28 | 0.37 | 0.32 |
| Respiratory Therapist | BLS | Respiratory Therapists | 38,537 | 25.31 | 0.42 | 0.42 |
| Speech Pathologist | BLS | Speech-Language Pathologists | 49,996 | 32.83 | 0.55 | 0.42 |
| Audiologist | BLS | Audiologists | 47,748 | 31.36 | 0.52 | 0.41 |
| Registered Dietician | BLS | Dieticians and Nutritionists | 39,050 | 25.65 | 0.43 | 0.37 |
| Counselor | BLS | Mental Health Counselors | 30,769 | 20.21 | 0.34 | 0.42 |
| Social Worker | BLS | Medical and Public Health Social Workers | 37,011 | 24.31 | 0.41 | 0.33 |
The CPEP clinical staff inputs also include blends of staff types that are used for those services when more than one type of clinical staff may be used in the performance of the service. We will establish the payment rates for these blends by calculating a simple average of the wage rates of the staff types included. Table 2 shows the blended staff types, the 2002 cost per minute and the current cost per minute.
Note:
We received no comments on the proposed cost per minute for the staff blends, so these rates will be implemented as proposed.
| Description | Revised per minute | Current per minute |
|---|---|---|
| COMT/COT/RN/CST | 0.38 | 0.307 |
| Lab Tech/Histotech | 0.35 | 0.297 |
| Lab Tech/MTA | 0.30 | 0.257 |
| Optician/COMT | 0.33 | 0.278 |
| RN/LPN | 0.42 | 0.389 |
| RN/LPN/MTA | 0.37 | 0.317 |
| RN/OCN | 0.56 | 0.497 |
| RN/Respiratory Therapist | 0.47 | 0.421 |
| RN/Sonographer | 0.51 | 0.405 |
| Dosimetrist/Physicist | 0.920 | N/A |
(v) Revision of the Ophthalmology Visit Supply Package
In its May 2000 submission to us, the RUC recommended the use of an ophthalmology visit supply package that would contain the routine supplies typically used in each 90-day global postsurgical visit for ophthalmology services. We accepted this recommendation. However, upon further review, we noted that two of the supplies, rev eyes and post myd spectacles, were not used in many of the postsurgical office visits. Therefore, after consulting with the ophthalmology specialty society, we proposed to remove these two items from the ophthalmology visit package. Instead, we proposed including these items as appropriate on a code-by-code basis.
Note:
Since we received no comments on this issue, we will implement this revision on the supply package as proposed.
(vi) Deletion of Contrast Agents from the Practice Expense Inputs
Section 430(b) of BIPA amends section 1861(t)(1) of the Act to include contrast agents in the definition of drugs and biologicals. Previously, contrast agents were defined as supplies and were included in the list of CPEP supplies for the appropriate services. Therefore, we proposed to delete the costs of the following contrast agents from our CPEP data: hypaque, methylene blue, high-density barium, polibar, telopaque tablets, barium paste contrast, effervescent sparkies (fizzies), and renographin-60 iodinated contrast.
Comment: The specialty society representing radiology had no comment on the suggested list of deletions from the CPEP supplies. However, the society expressed concern that there are no HCPCS codes established for these deleted items and wanted information on how to bill for these supplies.
Response: As stated above, we proposed to delete contrast agents from the practice expense inputs in response to legislation that included contrast agents in the definition of drugs. This proposal was made to ensure that we did not include in the practice expense the costs of items that could also be billed separately. However, section 1842(o)(1) of the Act makes clear that the payment of 95 percent of the average wholesale price (AWP) can be made only if the drug is not paid on a cost or prospective payment basis. We believe that if we do include payment for any contrast agent in the practice expense RVUs, no other payment should be made for this item. After further consideration of this issue, however, we will continue to include the contrast agents listed in our proposal in our practice expense inputs at this time. Therefore, we are withdrawing the proposal.
c. Physician Time
RUC Time Database
The primary sources for the physician time data used in creating the specialty-specific practice expense pools are the surveys performed for the initial establishment of the work RVUs and the surveys submitted to the AMA RUC. The AMA informed us that some of the times used for the November 1998 final rule (63 FR 58823) differed from the official RUC database, and we agreed to use the RUC-verified physician time database when we received it from the AMA. Subsequently, the AMA notified us that there were gaps in its own database for certain global surgery codes and that a revised time database would be sent to us once all the times were verified. We have now received this revised database and proposed to use it in the calculation of the specialty-specific practice expense pools. It should be noted that the RUC database reflects the physician times for those codes that were surveyed as part of the second 5-year review of physician work.
Comment: We received a number of comments that supported using the physician time data. One commenter indicated that the new time database is expected to provide greater accuracy and consistency in the practice expense calculations. While commenters representing family physicians, internists, and rheumatologists supported use of the new time data, they also indicated that improvement is still needed. Specifically, these commenters suggested that the number and level of postoperative visits and the corresponding physician time included in the global surgical period may be overstated. The commenters noted that we previously indicated that we would study length of stay data relative to the number of postoperative visits and included in the surgical period, and they encouraged us to use this information to further refine the physician time data. One commenter indicated that surgeons rarely meet the criteria for billing critical care services in the postoperative period even though the time and value of critical care services are proposed for inclusion in the global period of some surgical codes.
Organizations representing thoracic surgeons indicated that we should not incorporate the new time data that will result in additional practice expense reductions for thoracic and cardiac surgery. These commenters said that no further reductions in the practice expense RVUs for cardiac surgery should be made until new studies of practice expense related issues by the Office of Inspector General and the General Accounting Office are completed. This commenter indicated that the new physician time data covers only 585 of the 7,928 codes in the physician fee schedule but directly affects cardiothoracic surgery because there are revised times for many high volume heart and chest procedures. The commenter suggested that the new time information needs to be put in the context of changes in physician time that may have occurred in the last five to ten years on the remaining 7,343 procedure codes where there are no new physician times. Another commenter representing a cardiology subspecialty indicated that we incorporated RUC time data for only 1,900 of the more than 7,000 procedure codes. This commenter suggested that we should continue using available time from a single source until a consistent source that includes information on all CPT codes is available.
Response: As indicated in the proposed rule, the RUC submitted physician time data for nearly 2,000 CPT codes in May 2001 and recommended that we use these new physician times in the practice expense methodology. The RUC recently sent new time for use in the final rule that reflected refinements for a few codes. We note that the source of the RUC times are actually the physician specialty societies themselves, including those associations that have objected to our use of the data. The data largely come from the specialty society surveys that were forwarded to the RUC to support requests for physician work RVUs for new and revised codes or services that were part of the 5-year review. The RUC made a comprehensive effort to validate these times before forwarding them to us. The RUC indicated to us that, over a period of 2 years, specialties had been provided with an opportunity to review the data and determine that they were accurately recorded.
While the new times forwarded by the RUC represent a minority of CPT procedure codes, we note that they account for over 60 percent of the allowed services that are paid under the physician fee schedule. In response to the comment that we should make changes only when we have a single source of time data for all codes, we note that there has never been a single source of time for all codes. While time for some codes is based on the original work of Harvard University, there are many codes that came into existence since the Harvard survey was completed. The only data source for these codes is the RUC.
We acknowledge that the Office of Inspector General is studying issues related to physicians bringing clinical staff to the hospital and the General Accounting Office is reviewing our use of supplemental practice expense survey data. Since these studies are unrelated to physician time, we do not believe they constitute a reason to suspend incorporation of the new time data into the practice expense methodology.
In response to the comments that suggest that the physician times in the postoperative period may be overstated, the RUC indicated to us that "a number of improvements were made to the specifications regarding the level of postoperative visits to more accurately capture each element of physician time." While the total times we received from the RUC reflect the number, types, and level of E/M services furnished in the postoperative surgical period, these services are not separately paid when furnished as part of a global surgical service. Since these services are not paid separately, it is difficult to find objective information that indicates how E/M services are provided in the postoperative period. Currently, the only source of information we can use is information that the RUC has supplied and data that previously existed in our files. While we have undertaken research that combines information on inpatient hospital stays with claims for physicians' services, these data have limitations for determining the level or type of visit being furnished in the postoperative period. We would consider any further evaluation by the RUC on this issue.
d. Calculation of Practice Expense-Other Issues
Comment: Several commenters requested additional clarification and information concerning the cause of reductions of 9 to 13 percent in the practice expense RVUs for electrophysiology services. One commenter indicated that there was no explanation of the proposed reduction in practice expense for CPT codes 33207, 33208, 33249, and 93651. The commenter suggested that we should provide a more complete explanation of the proposed reductions or rescind them.
Response: Our observation is that there is no more than a 9 percent reduction in practice expense RVUs for any of these codes. We also note that the change in total payment for these codes as a result of the change in practice expense RVUs is less than half of this amount. We modeled five different changes to the practice expense methodology in our August 2, 2001 proposed rule (66 FR 40397). Of these changes, the change to physician time has the greatest effect on these codes. Since the change in the practice expense RVUs results from new information that affects payments for all procedure codes, we are continuing to implement the reduction in practice expense RVUs that were proposed for these codes.
Comment: We received one comment expressing concern that the separate professional interpretation and technical components for CPT code 95824 (cerebral death evaluation) have been eliminated. The commenter requested that we restore the professional and technical components of this service and crosswalk the technical component value from a similar code, CPT code 95822 (EEG, sleep only). The commenter also suggested that the work RVUs should be 1.08 RVUs, the same as similar EEG codes.
Response: We have restored the separate professional and technical components of this service. This service will likely be exclusively furnished for patients who are in an institutional setting. Thus, we will pay under the physician fee schedule only for the professional interpretation. Payment for the technical component of the service will be made through our payment to the institution for facility services. Since the technical component of this service is never provided outside of a hospital, we do not have enough information under the resource-based methodology to establish nonfacility pricing. In the unlikely event that this service is provided in the nonfacility setting, we are making the global and technical component of this service subject to carrier pricing. This change will apply to several other services that are not furnished in nonfacility settings. We are not making changes to the physician work RVUs for cerebral death evaluation in this final rule. There were no requests to revise the work RVUs for this code as part of the 5-year review of physician work.
Comment: An organization representing vascular surgeons stated that the methodology used to incorporate the supplemental practice expense survey data has failed. This commenter indicated that the practice expense per hour for vascular surgeons increased by 9 percent from using supplemental data; however, payments actually declined between the November 2000 final rule and the August 2001 proposed rule. The commenter provided potential explanations for the change to practice expense RVUs. The commenter suggested that the results are inconsistent with the statute that requires payments to recognize all costs and violates the Administrative Procedure Act that rulemaking cannot be arbitrary and capricious.
The commenter suggested an option that would result in a total increase in vascular surgery payments of 9 percent, consistent with the results of the supplemental survey. This option would involve identifying vascular surgery procedure codes that decreased in payment and reallocating RVUs such that aggregate payments to vascular surgeons would increase by 9 percent.
Response: While the commenter is correct in stating that the practice RVUs for several high-volume vascular surgery procedures declined in our proposed rule, it is important to note that the changes occurred independent of the use of supplemental practice expense survey data. The supplemental practice expense survey data were incorporated into the methodology in the November 1, 2000 final rule (65 FR 65385).
The changes that occurred between the November 2000 final rule and the August 2001 proposed rule were the result of the five changes to the methodology that we modeled and described in the August 2, 2001 (66 FR 40397) proposed rule. The additional reductions in practice expense payments for vascular surgery codes that concern this commenter are attributed to the changes we made to physician time. As we have stated previously, the explanation of how time affects specific codes is complex and requires extensive data analysis. We would be willing to meet with interested parties to discuss the effects of the practice expense methodology further.
The commenter suggests that we make decisions about an appropriate increase in value for specific services and reallocate RVUs consistent with these decisions. We do not believe that such a policy would be appropriate. We have established a methodology for determining practice expenses and have valued all services using that process with the exception of services that have no physician work RVUs. For these services, we have established RVUs using an alternative methodology. It is not possible to deviate from those methodologies and reallocate RVUs to achieve particular results that may be more desirable to some individuals than to others. Such decisions about "appropriateness" would become highly subjective and would, in our view, be more likely to be criticized as arbitrary and capricious.
Comment: We received comments from specialty societies representing technical component providers regarding the status of the zero-work pool. Commenters representing radiology, cardiology, echocardiography and radiation oncology centers strongly supported our position of maintaining the status of the zero-work pool until an appropriate alternative methodology can be determined. Two commenters argued that none of the direct or indirect cost information resulting from the CPEP process should be utilized to establish payment amounts for technical component services unless and until we further consider the entire methodology to be applied for technical component services. All commenters urged us to consult closely with associations representing the zero-work pool providers before making any changes in this regard. One commenter emphasized that no changes should be made without further research and discussion.
Response: We agree that the status of the zero-work pool should not be changed until an alternate approach that values technical component services appropriately can be developed. Over the next several months, we will be analyzing the options for such an alternative approach contained in the report, "The Resource-Based Practice Expense Methodology: An Analysis of Selected Topics," prepared by our contractor, The Lewin Group. This report can be found on our web site, and we would welcome comments on these options from all interested parties. (See the Supplementary Information section of this rule for directions on accessing our web site.) We also agree with the commenters that we should consult with the affected specialties as we proceed, and we will seek to maintain an open dialogue with the medical community on this issue.
Comment: A commenter representing speech, language, and hearing professionals recommended that the zero-work pool be modified to accept the clinical staff wage increases. Seventy percent of the procedure codes used by audiologists that are covered by Medicare are in that pool and, thus, even though the proposed wage rate for audiologist has increased by 24 percent, this increase will not be reflected for those non-work services.
Response: The commenter is correct in stating that, because the CPEP data are not used as allocators in the zero-work pool, the increases in the clinical staff wage rates will not affect the payments for audiology services at this time. However, as we mentioned above, we are seeking to develop an appropriate alternative for the zero-work pool and, when such an alternative is implemented, the revised wage rates will be applied to audiology services. In addition, we allow specialties to withdraw their services from the zero-work pool if the specialty believes that their services will be more appropriately valued outside that pool.
Comment: An organization representing diagnostic imaging centers stated that, if we adopt the suggestion in the report of The Lewin Group to establish specialty-specific zero-work pools, it has already conducted a survey that establishes the costs per hour of providing diagnostic imaging technical component services. The commenter added that, regardless of the approach that we choose, the organization welcomes the opportunity to work with us with respect to any changes that may be contemplated in the zero-work pool methodology.
Response: As we have noted above in our discussion on specialty-specific supplementary surveys, all of these surveys must meet the criteria stated in our November 2000 final rule. We would be willing to review the survey to see if the data can be used to develop a specialty-specific practice expense per hour. In addition, we, too, would welcome the opportunity to work with the organization as we develop an alternative to the zero-work methodology.
e. Site-of-Service
Comments on Site-of-Service Clarification of Payment Policy
In the November 2, 1998 final rule (63 FR 58830) and the November 2, 1999 final rule (64 FR 59407), we indicated the circumstances under which either the facility or the nonfacility RVUs are used to calculate payment for a service. Specifically, we indicated that the lower facility practice expense RVUs apply when the service is performed in an Ambulatory Surgical Center (ASC) and the procedure is on the ASC-approved procedures list. The higher nonfacility practice expense RVUs apply to procedures performed in an ASC that are not on the ASC-approved list because there will be no separate facility payment for these services. As explained in the August 2001 proposed rule, we have received a number of inquiries about the place-of-service that should be used on the Medicare claim when a service that is not on the ASC-approved procedures list is furnished in an ASC. In these circumstances, we stated that physicians should indicate ASC as the place-of-service on the Medicare claim. Other questions have arisen as to whether a beneficiary can be billed for the ASC facility fee when Medicare does not pay a facility fee because a procedure not on the ASC list is performed in a certified ASC. In this situation, Medicare pays the physician the higher nonfacility practice expense RVUs because the ASC is effectively serving as a physician's office, and Medicare's payment for the physician's service includes payment for all practice expenses incurred in furnishing the service. The ASC benefit is not implicated since the services do not meet the provisions of section 1833(i) of the Act. The services are covered as physicians' services and paid under the physician fee schedule. Therefore, payment to the physician reflects payment for the whole service, and the beneficiary cannot be charged in excess of the limiting charge for the physician fee schedule service.
Comment: Two commenters indicated that conditions of participation and/or survey and certification guidelines limit physicians in an ASC to furnishing only surgical procedures on the ASC approved list of procedures. They stated that such restrictions interfere with providing medical care that is in the patient's interest. The commenters request that we revise the regulations to allow physicians to furnish surgical and other medical procedures that are not on the approved ASC list in an ASC.
Response: Because our proposal relates only to payment policy, we are finalizing it as proposed. The payment policy will apply to services furnished in an ASC that are not on the ASC-approved list to the extent that such services are permitted under the conditions of participation developed by our Office of Clinical Standards and Quality (OCSQ) and by the survey rules developed by our Center for Medicaid and State Operations (CMSO). It is our understanding that current regulations that restrict ASCs to furnishing surgical services does not limit them to surgical services on the ASC-approved list, but rather, includes all surgical services. However, questions about rules that limit services that can be furnished in an ASC are beyond the scope of this final rule.
B. Nurse Practitioners, Physician Assistants, and Clinical Nurse Specialists Performing Screening Sigmoidoscopies
Based on our review of current medical literature, we believe that nurse practitioners (NPs), clinical nurse specialists (CNSs), and physician assistants (PAs) whose services are covered under Medicare and who have been trained are qualified to perform screening sigmoidoscopies safely and accurately. Therefore, in the August 2, 2001 proposed rule, we proposed revising § 410.37(d) to provide that, in order for screening sigmoidoscopies to be covered, they must be performed by medical doctors, doctors of osteopathy, PAs, NPs, and CNSs, if they meet the applicable Medicare qualification requirements in §§ 410.74, 410.75, and 410.76, and if they are authorized to perform these services under State law.
Comment: Fifteen commenters addressed the issue of whether to allow non-physician health care professionals to perform screening flexible sigmoidoscopies for Medicare coverage and payment purposes. Four of the commenters representing national non-physician health care professional organizations and a health care consultant group enthusiastically supported the proposal. Ten commenters, all national medical associations or medical specialty groups, expressed various concerns about the proposal but agreed that it was appropriate for NPs, PAs, and CNSs to perform these services. These commenters suggested clarification and revision of the rule in a number of different areas, such as the need for physician supervision and appropriate training and experience standards, to ensure quality of care in the non-physician performance of these examinations. Two of these ten commenters that suggested the need for additional requirements were national gastroenterological physician groups which were divided in their enthusiasm for the proposal. The American Gastroenterological Association indicated that properly trained physician assistants, nurse practitioners and clinical nurse specialists are capable and qualified to perform screening flexible sigmoidoscopies. However, the Association insisted that in no case should such practitioners be permitted to do so without being directly supervised by an appropriately trained and qualified onsite physician. In addition, the Association urged that these non-physician providers should never be allowed to perform these examinations without some assurance that they have been properly educated and trained to perform them. These comments were echoed by several other physician groups. On the other hand, the American College of Gastroenterologists supported the proposal without specifically mentioning the need for physician supervision and education and experience requirements. The College emphasized that there is a great need for sigmoidoscopy screening to be performed in the Medicare age group. Moreover, they observed that there may not be sufficient numbers of physicians available to perform the procedure, posing an access problem for our beneficiaries. The College stated that, if we proceed with the proposal, non-physician practitioners should be required to provide certain specific information to beneficiaries stating who had performed the examination and its impact on available benefits in future years.
Another organization representing family physicians also noted conditions which should be met if these practitioners provide this service as proposed, but indicated that the existing Medicare regulations for these practitioners suggested that these conditions are met. For example, existing Medicare regulations require general (not onsite) rather than direct (onsite) supervision of PAs. Several other physician organizations in their recommendations also appear to support a requirement less strict than direct physician supervision.
One other commenter-a national medical association-opposed the proposal because of concerns as to whether non-physician health care professionals could respond appropriately to problems or complications that might possibly occur during the performance of the screening procedure when a physician (with a higher level of medical skills) is not present at the facility. None of the commenters who suggested revisions to the proposed rule to specify requirements for physician supervision and/or formal training and experience, or who opposed it, produced scientific evidence in support of their views.
Response: As we indicated in the proposed rule, a growing body of evidence from the medical literature has shown that certain properly trained non-physician health care professionals can carry out screening by flexible sigmoidoscopy as accurately and safely as physicians. (Scheon et al. Archives of Internal Medicine 2000) This procedure requires fewer supervised examinations to attain objective measures of technical competency than other endoscopic procedures, does not require sedation, and has a low rate of related complications. In the studies reviewed, physician and non-physician endoscopists achieved similar polyp detection rates and depth of insertion in screening performed independently. No significant complications from sigmoidoscopy were reported in any of these studies. The level of satisfaction with the procedure was similar for all practitioners.
This demonstration of the ability of non-physician practitioners to perform flexible sigmoidoscopy screening safely and accurately is a very significant development. As the American College of Gastroenterology noted in its comments, there is a physician availability and a related beneficiary access problem of concern to CMS. The Balanced Budget Act of 1997, effective January 1, 1998, expanded Medicare coverage of non-physician practitioner services to address concerns about access to services, especially in rural and other areas of the United States where there is a lack of availability of physicians for performing certain services such as screening flexible sigmoidoscopies. The law and related regulations also outline the level of supervision or medical direction for these non-physician practitioners.
Flexible sigmoidoscopy is one of the promising modalities available for decreasing mortality from colorectal cancer. The American Cancer Society estimates that more than 56,000 Americans will die of colorectal cancer this year. Studies have found that the use of screening flexible sigmoidoscopy could lead to a 30 percent reduction in total colorectal cancer mortality. (Selby et al. New England Journal of Medicine 1992.) In view of limited Medicare beneficiary access in certain areas, because screening flexible sigmoidoscopy remains an underused cancer-prevention procedure, and, in the absence of any submitted scientific literature that contradicts the underlying medical evidence supporting the proposal, we do not believe that commenters have presented us with a basis for revising the proposal as they have suggested. However, we have found that a number of commenters have offered us interesting suggestions for implementing the proposal and clarifying the agency's intent in this regard, which we explain in our response to the more specific comments summarized below.
Comment: Several commenters referenced a recent OIG report entitled "Medicare Coverage of Non-Physician Practitioner Services" (OEI-02-00-00290), which they believe makes clear that CMS does not have systems in place to ensure that non-physician practitioners who provide beneficiaries with medical services and who bill Medicare directly, are performing their services in accordance with State law. One commenter states that the report implies that it is not possible for Medicare to ensure that a State law allows non-physician practitioners to provide flexible sigmoidoscopies or that the services are provided in an integrated practice arrangement with appropriate physician supervision. For example, the commenter pointed out that 16 carrier medical directors interviewed by the OIG reported that they do not verify that non-physician practitioners are performing services within their State scope of practice, and at least 22 carriers do not check the collaborative agreement required for nurse practitioners and clinical nurse specialists. The commenter indicated that the OIG concluded that services performed and billed by non-physician practitioners create potential payment and quality of care vulnerabilities since, (1) "non-physician practitioner billings are rising rapidly, but controls, which are based on scopes of practice, are limited", and (2) carriers "do not have sufficient guidance to distinguish which non-physician practitioner services should be reimbursed by the program and which should not." In light of these OIG findings, the commenter urges CMS to review whether and how the agency and its carriers can ensure that the above-mentioned concerns are resolved successfully when non-physician practitioners perform screening flexible sigmoidoscopies. The commenter says that "it is vital that CMS takes steps to ensure the fulfillment of these requirements to minimize any risk of experiencing the vulnerabilities referenced in the OIG report with respect to quality and payment issues."
Response: We agree with OIG's conclusion identifying program vulnerabilities when non-physician practitioners bill Medicare directly for their services. We also respect beneficiaries' choices and their need for access to medical services. While appreciative of OIG's suggestion that it may be appropriate to consider additional controls for Medicare payments to non-physician practitioners, we are sensitive to issues that might arise from different treatment of different classes of practitioners. As appropriate, we will monitor non-physician practitioner services for both overall trends and for complex services.
Medicare currently defers to State licensing boards for regulating and enforcing scope of practice laws. Before issuing a Medicare billing number to a nurse practitioner or a nurse clinical specialist, contractors first determine whether the applicant has a valid license within the State. If a licensing board subsequently acts to suspend a practitioner's license to practice, then Medicare suspends payments under the practitioner's Medicare billing number. This practice is the same for physician and non-physician practitioners.
To protect the integrity of the Medicare program, all claims submitted are subject to data analysis that may lead to a focused or a random review by a Medicare contractor. If Medicare is to begin monitoring practitioners for compliance with State laws and regulations, the program will have to develop additional regulations and policies and impose additional workloads on contractors and perhaps for all practitioners as well. In deciding whether such a process is necessary and appropriate, we will carefully consider these comments in this regard.
Comment: One commenter asked CMS, in implementing the proposal, to ensure that non-physician practitioners are required to tender a standard notification to Medicare beneficiaries providing them with a clear statement that the screening flexible sigmoidoscopy is being furnished by a non-physician practitioner. In addition, the commenter suggests that the beneficiary be notified that under the new colorectal cancer screening benefit, effective July 1, 2001, any average-risk individual receiving a covered screening flexible sigmoidoscopy will be precluded by law from receiving Medicare payment for a screening colonoscopy (which under Medicare regulations (§ 410.37(f) must be furnished by a physician)) for four years.
Response: We believe that our Medicare beneficiaries generally are knowledgeable about the identity of the Medicare practitioner that is furnishing them with a flexible sigmoidoscopy screening examination. Accordingly, we believe that there is no need for non-physician practitioners to provide beneficiaries with any formal notification statement in this regard. As for the suggestion that a non-physician practitioner should notify an average-risk beneficiary that providing him/her with a screening flexible sigmoidoscopy will preclude Medicare from paying for a screening colonoscopy (which must be performed by a physician) for four years, we believe that all Medicare practitioners should help to inform beneficiaries with respect to this limitation. However, we do not believe that any practitioner should be required to formally notify beneficiaries to this effect. While we believe that our Medicare contractors, and all our practitioners have an important role to play in educating our beneficiaries about the various conditions of coverage and payment limitations that apply to different colorectal cancer screening options that are available to them, we will not use these regulations as a mechanism for implementing the requested educational efforts.
Comment: One commenter suggested that we allow registered nurses to perform these as well, as a delegated act, under a physician's direction with the physician billing Medicare for the procedure.
Response: The regulation proposal to allow nurse practitioners, physician assistants, and clinical nurse specialists to perform screening flexible sigmoidoscopies for Medicare purposes was designed to increase beneficiary access to these screening services, especially in rural and other areas where there is a shortage or a lack of availability of physicians who are trained and qualified to perform these examinations. These non-physician practitioners are typically licensed independent practitioners who are recognized under the Medicare law and regulations for coverage and payment purposes. Under Medicare, these non-physician practitioners may be paid under the physician fee schedule for their tests (and treatments) that would be physicians' services if furnished by a physician when they are authorized by the State to perform such services. Registered nurses are not licensed independent practitioners who are recognized under Medicare law for coverage and payment purposes.
Comment: One commenter suggested that we should monitor beneficiary health outcomes that result from the performance of sigmoidoscopy examinations by non-physician practitioners to ensure that they are done safely and accurately.
Response: We had not planned to monitor beneficiary outcomes that might be related to implementation of the proposal to allow non-physician practitioners to perform flexible sigmoidoscopy screening because of the available evidence that they can provide these services safely and effectively. If we were to consider doing this, however, we would probably want to consider doing a comparative study of health outcomes of beneficiaries who have been screened by both physician and non-physician practitioners who have performed these examinations.
Such a study would mean that a number of physician and non-physician practitioners would have to collect and report data to us on their Medicare patients for a certain period of time, which could be burdensome for them. We may be interested in doing a study in this area in the future if we had any credible evidence of a serious problem in this area, but, at this time, we do not believe a study is necessary.
Result of Evaluation of Comments
We are adopting our proposal to allow certain non-physician practitioners to perform screening flexible sigmoidoscopies.
C. Services and Supplies Incident to a Physician's Professional Services: Conditions
Section 1861(s)(2)(A) of the Act authorizes coverage of services and supplies (including drugs and biologicals that are not usually self-administered by the patient) furnished incident to a physician's service. These drugs and biologicals are commonly furnished in physicians' offices without charge or included in the physicians' bills. This statutory "incident to" benefit differs from the "incident to" benefit in the hospital setting as set forth in section 1861(s)(2)(B) of the Act, which authorizes coverage of hospital services (including drugs and biologicals which are not usually self-administered by the patient) incident to a physician's service furnished to outpatients and partial hospitalization services furnished to outpatients incident to a physician's service. This provision only addresses coverage of "incident to" services under section 1861(s)(2)(A) of the Act. In addition, the statute provides Medicare coverage of services incident to practitioners other than physicians.
The Medicare Carriers Manual currently requires that the physician (or other practitioner) be either the employer of the auxiliary personnel or be an employee of the same entity that employs the auxiliary personnel. In the August 2, 2001 rule, we proposed to revise § 410.26 to codify our existing policy outlined in section 2050 of the manual. Specifically, we proposed to codify the definitions of auxiliary personnel, direct supervision, independent contractor, leased employment, non-institutional setting, practitioner, and services and supplies for purposes of services provided incident to a physician's service.
In addition, we proposed to allow auxiliary personnel to provide services incident to the services of physicians (or other practitioners) who supervise them, regardless of the employment relationship of the physician (or other practitioner) to the entity that employed the auxiliary personnel.
All commenters supported the proposal. Their specific comments are addressed below.
Comment: Commenters noted three errors in the proposed text of the regulation. First, in the definition of auxiliary personnel set forth in § 410.26(a)(1), after the phrase "under the supervision of a physician," the term "(or other practitioner)" was omitted. Second, in the definition of services and supplies set forth in § 410.26(a)(7), the phrase "(including drugs and biologicals that, as determined in accordance with regulations, cannot be self-administered)" should be changed to "(including drugs and biologicals which are not usually self-administered by the patient)" in accordance with section 112 of the BIPA, which amended sections 1861(s)(2)(A) and (B) of the Act. Third, in the supervision requirement set forth in § 410.26(b)(5), the word "direct" was omitted.
Response: We agree with these comments, and we have corrected these errors.
Comment: One commenter requested that independent contractor physicians also be recognized as employees under the reassignment policy set forth in section 3060 of the Medicare Carrier Manual.
Response: As stated in the August 2, 2001 rule, this proposal only applies to the incident to policy. Furthermore, we are not defining or re-defining the term employment. Instead, we proposed to permit physicians (or other practitioners) to directly supervise auxiliary personnel regardless of the employment relationship of the physicians (or other practitioners) with the entity that hired the auxiliary personnel. In order to bill and receive payment from Medicare under this policy, all other applicable requirements must also be met. For example, the service must be medically reasonable and necessary, and appropriate reassignment must be executed.
Comment: One commenter suggested using in § 410.26(b) all of the terms defined in § 410.26(a) or deleting the terms not used in § 410.26(b).
Response: We found one term-leased employment-that was not used in § 410.26(b). However, we will not eliminate this term because it is used to define the term auxiliary personnel.
Comment: Several commenters requested that we clarify and distinguish between the physician (or other practitioner) ordering the incident to service and the physician (or other practitioner) supervising the auxiliary personnel who perform the incident to service. They stated that confusion exists as to whose Medicare Part B billing number should be used on the claim form.
Response: Inherent in the definition of an incident to service is the requirement that the incident to service be furnished incident to a professional service of a physician (or other practitioner). When a claim is submitted to Medicare under the billing number of a physician (or other practitioner) for an incident to service, the physician is stating that he or she either performed the service or directly supervised the auxiliary personnel performing the service. Accordingly, the Medicare billing number of the ordering physician (or other practitioner) should not be used if that person did not directly supervise the auxiliary personnel. We added language to the supervision requirement set forth in § 410.26(b)(5) to reflect this clarification.
Comment: One commenter pointed out that the claim form currently requires the physician (or other practitioner) to certify that he or she personally supervised the employee. Therefore, the commenter requested that we update the claim form to reflect the proposed regulations.
Response: We plan to update not only the claim form but also section 2050 of the Medicare Carriers Manual to reflect the new regulations.
Comment: A few commenters noted that the individual does not always receive an IRS-1099 form under an independent contractor arrangement. Instead, when a clinic, for example, contracts with an entity that has hired individuals to be furnished to the clinic, then the entity (and not the individual) receives the IRS-1099 form.
Response: We agree with these commenters. Therefore, we have added language to the definition of an independent contractor set forth in § 410.26(a)(3) to reflect this practice. However, we again emphasize that the applicable reassignment rules must also be met and that this incident to policy does not in any way alter the current requirements for valid reassignment.
Comment: One commenter encouraged us to specify in the regulations the acceptability of forms (other than the IRS W-2 form) that the Internal Revenue Service recognizes as proof of employment, such as the Payroll Agent arrangement where IRS forms 2678 and 1997C are used instead.
Response: Under our proposal, the employment relationship is irrelevant to whether a physician (or other practitioner) can effectively furnish direct supervision of the auxiliary staff. Therefore, we decline to include language that may define or re-define the term employment.
Comment: One commenter suggested that we also include Ambulatory Surgical Centers (ASCs) and Community Mental Health Clinics (CMHCs) in the definition of a non-institutional setting because Medicare Part B payments for services provided in these settings are paid through the facility relative value units (RVUs) rather than the non-facility RVUs.
Response: The definition of a non-institutional setting is not derived from the definition of a facility used to determine the site of service and the application of the facility or non-facility RVUs. Because section 1861(s)(2)(B) of the Act authorizes payment for hospital incident to services, section 1861(s)(2)(A) of the Act cannot authorize payment for hospital incident to services. This provision is reiterated in § 411.15(m)(2). Similarly, § 411.15(p)(2)(ii) specifically excludes payment for incident to services in skilled nursing facilities (SNFs). Consequently, we defined non-institutional settings as all settings except hospitals and SNFs, and we do not plan to define ASCs and CMHCs as institutional settings.
Comment: Many commenters wanted us to restrict the definition of auxiliary personnel so that only certain individuals may perform a given incident to service. For example, they want us to mandate that only audiologists may perform cochlear implant rehabilitation services as incident to services. Likewise, they want us to permit only physical or occupational therapists to perform physical or occupational therapy as incident to services. In support, they noted that section 4541(b) of the BBA amended section 1862(a)(20) of the Act and required that physical or occupational therapy furnished as an incident to service meet the same requirements outlined in the physical or occupational therapy benefit set forth in sections 1861(g) and (p) of the Act.
Response: We have not further clarified who may serve as auxiliary personnel for a particular incident to service because the scope of practice of the auxiliary personnel and the supervising physician (or other practitioner) is determined by State law. We deliberately used the term any individual so that the physician (or other practitioner), under his or her discretion and license, may use the service of anyone ranging from another physician to a medical assistant. In addition, it is impossible to exhaustively list all incident to services and those specific auxiliary personnel who may perform each service.
Comment: Many commenters wanted us to re-emphasize that incident to services set forth in section 1861(s)(2)(A) of the Act do not include Medicare benefits separately and independently listed in the Act, such as diagnostic services set forth in section 1861(s)(3). Some even requested that we not permit these separately and independently listed services to be rendered as incident to services.
Response: We realize, as did the Congress with the enactment of section 4541(b) of the BBA, that many services-even those that are separately and independently listed-can be furnished as incident to services. However, this fact of medical practice is not inconsistent with our policy. We maintain that a separately and independently listed service can be furnished as an incident to service but is not required to be furnished as an incident to service. Furthermore, even if a separately and independently listed service is provided as an incident to service, the specific requirements of that separately and independently listed service must be met. For instance, a diagnostic test under section 1861(s)(3) may be furnished as an incident to service. Nevertheless, it must also meet the requirements of the diagnostic test benefit set forth in § 410.32. Namely, the test must be ordered by the treating practitioner, and it must be supervised by a physician. Thus, if a test requires a higher level of physician supervision than direct supervision, then that higher level of supervision must exist even if the test is furnished as an incident to service. Accordingly, we decline to prohibit a separately and independently listed service from being rendered as an incident to service. Instead, we reiterate that a separately and independently listed service need not meet the requirements of an incident to service.
Comment: Recognizing that this proposal affords flexibility in the way physicians (or other practitioners) are hired by an office or clinic, one commenter requested that non-physician practitioners be permitted to stand as locum tenens (taking the place of) for other non-physician practitioners as well.
Response: This proposed rule does not alter in any way the current locum tenens policy.
Result of Evaluation of Comments
We are finalizing our proposed revisions to § 410.26 with the corrections noted above.
D. Anesthesia Services
We generally use the 1988 American Society of Anesthesiologists' (ASA) Relative Value Guide as the basis for the uniform relative value guide. This guide is used in all carrier localities to determine payment for anesthesia services furnished by physicians under Medicare Part B. We proposed using the ASA base unit values from the 1999 guide beginning in CY 2002 for eight codes with ASA base unit values that were different from CMS's values (specifically, CPT codes 00810; 00902; 01150; 01214; 01432; 01440; 01770; and 01921). These are older codes and, while we accepted the ASA base unit value initially, the ASA has changed this base unit subsequently and no additional adjustment was made by us to the base unit. For CPT codes 00142 and 00147, we proposed maintaining the current base unit values although they differed from the ASA values because values for these two codes were established under the "inherent reasonableness" process in 1987.
Comment: The ASA identified additional CPT codes 00548, 00700, 00800, and 01916 with different base unit values in the most current ASA guide from our base unit values.
Response: We are accepting the ASA's comments subject to the following clarification. In all, 12 codes were presented where the ASA base unit differs from our base unit. Of these, code 01921, which appeared on the list in the August 2, 2001 proposed rule, will be deleted in 2002. Since this code has been deleted and will no longer be used, we will not assign base units to it and, as a result, only 11 codes will be considered.
These additional four codes were added to CPT before CY 2000. New and revised codes starting in CY 2000 and for subsequent years are evaluated on a code-specific basis under our usual process after we receive recommendations from the RUC. Thus, because we review the RUC recommendations and may make changes based on them, there could be differences between the ASA guide and our base unit values beginning in 2000. If the RUC or other commenters recommend and we agree to a base unit different from what ASA recommends, we will use that value and not the ASA value, even though it may be published in the ASA's guide.
Result of Evaluation of Comments
The complete list of 11 CPT codes for which we will assign the ASA base unit values instead of the current CMS base unit values are as follows:
| Code | CMS | ASA |
|---|---|---|
| 00548 | 15 | 17 |
| 00700 | 3 | 4 |
| 00800 | 3 | 4 |
| 00810 | 6 | 5 |
| 00902 | 4 | 5 |
| 01150 | 8 | 10 |
| 01214 | 10 | 8 |
| 01432 | 5 | 6 |
| 01440 | 5 | 8 |
| 01770 | 8 | 6 |
| 01916 | 5 | 6 |
A related issue is the treatment of base unit values for new codes for 2002 as discussed in section V. The RUC reviewed the work values for 19 new anesthesia codes for 2002. We agree with the RUC on 17 of these codes but recommend lower values for 2 codes. The RUC recommended 9 units for CPT code 00797 (anesthesia for gastric restrictive procedure for morbid obesity) and we proposed 8 units. The RUC recommended 3 units for CPT code 01968 (cesarean delivery following neuraxial labor analgesia/anesthesia-list separately in addition to the code for primary procedure), and we proposed 2 units. (See section V for additional information on the valuing of these new anesthesia services.)
Result of Evaluation of Comments
We are implementing the base units for the 11 existing codes where there are differences between the ASA's guide and our base units and for which we received comments. In addition, we are implementing the base units which the RUC recommended for 17 new codes and the base units which we recommended and which are lower than the RUC's recommendation for 2 new codes.
E. Performance Measurement and Emerging Technology Codes
In the August 2, 2001 proposed rule (66 FR 40383) we included a discussion of the two new categories of CPT codes: Performance Measure codes, referred to as Category II CPT codes, which are intended to facilitate data collection; and, Emerging Technology codes, referred to as Category III CPT codes, which are intended to track new and emerging technologies.
For the Performance Measure codes, which have a syntax of four digits followed by the letter "F," we stated that no values would be placed on the Performance Measure codes and no additional payment would be made for the use of these codes. Practitioners would, however, be able to report them on their Medicare bills to enable us to track these services.
For the Emerging Technology Codes, which have a syntax of four digits followed by the letter "T," we stated that we would pay, on a case-by-case basis in specific situations, when we determine that the codes represent services that are not, in fact, experimental, but have been shown to be safe and effective. If the coverage policy is not consistent with the existing tracking codes, a Medicare-specific code may need to be developed to allow payment for the service. Thus, only specific emerging technology codes would be recognized for Medicare payment.
Comment: Commenters expressed appreciation for our recognition of these new categories of CPT codes. However, one commenter believed that we should refrain from categorically denying payment for category III (emerging technology) CPT codes, because these CPT codes may sometimes warrant payment. Another commenter believed that we were proposing not to pay for these codes at all. The commenter recommended that we clarify in the final rule that carriers may determine if payment should be made for a particular emerging technology code.
Response: We believe that these codes will serve a useful purpose. We regret that some commenters believed that the discussion in the proposed rule implied that these services should not be covered. We only intended to indicate that by publishing these codes we are not indicating that we would pay for these services in all instances. As the commenter indicates, coverage of emerging technologies and payment for these services is at the discretion of the carriers. We also want to clarify that our carriers will be able to incorporate these codes only after they are entered into our system during our regularly scheduled updates and not as soon as the AMA posts them on the CPT web site.
Result of Evaluation of Comments
We would like to clarify the intent of our proposal regarding emerging technology CPT codes. The emerging technology CPT codes will be published in the physician fee schedule with a status indicator of "C" to indicate that coverage and payment of these services is at the discretion of the carrier. The only exceptions will be for those emerging technology CPT codes that describe services for which Medicare has issued an NCD. In these situations, coverage will be based on the NCD, and we may establish national payment or may leave payment to the discretion of the carriers. It is also possible that an NCD or an established payment policy may foreclose coverage and/or payment for an emerging technology CPT code. In summary, we will finalize our proposal to allow both the CPT Performance Measure Codes (that is, codes with four digits followed by the letter "F") and Emerging Technology Codes (that is, codes with four digits followed by the letter "T") to be listed on Medicare bills and provide payment for the emerging technology codes as determined by the carrier.
F. Payment Policy for CPT Modifier 62 (Co-Surgery)
The CPT modifier code 62 is used to report the work of co-surgeons. Currently, if we pay for co-surgery, we pay a total of 125 percent of the fee schedule amount to the co-surgeons who each receive half of this total payment. In the August 2, 2001 proposed rule (66 FR 40383), we stated that we would be examining our payment policies for co-surgery to consider possible ways to ensure that they reflect current clinical practices and properly reflect the relative resources and work effort required to perform these services. We outlined several issues under consideration and specifically solicited information to assist us in deciding whether to make a future proposal affecting payments for co-surgery.
Result of Evaluation of Comments
Commenters responded to the specific questions in the proposed rule. Many commenters believe that the current payment policy is reasonable and that the focus should be on education efforts to ensure the appropriate use of the modifier. We will review carefully the information the commenters have provided. If we determine that we need to proceed with a change in payment policy for co-surgery, the change would be proposed as part of future rulemaking.
III. Implementation of Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000
The Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 (BIPA) (Public Law 106-554), enacted on December 21, 2000, provides for revisions to policies applicable to the physician fee schedule. These revisions are presented below.
A. Screening Mammography
Medicare has paid for screening mammography since January 1, 1991. Section 1834(c) of the Act governing these screenings did not include screening mammography under the physician fee schedule; it provided for payment under a separate statutory methodology. Section 104 of BIPA amends section 1848(j)(3) of the Act to include screening mammography as a physician's service for which payment is made under the physician fee schedule beginning January 1, 2002. In the August 2001 proposed rule, we proposed amending §§ 405.534 and 405.535 to reflect the inclusion of screening mammography as a physician's service which will be payable under the physician fee schedule. In addition, we proposed amending § 414.2 to include screening mammography under the definition for physicians' services. In accordance with part 414, payments for screening mammography will be resource-based and will have geographic adjustments that reflect cost differences among areas as do all other services under the physician fee schedule, including diagnostic mammography.
The following is a summary of the RVUs proposed for the professional and technical components (PC and TC) of a screening mammography, CPT code 76092, under the physician fee schedule.
Professional Component
A screening mammography service typically requires the same number of views as a unilateral diagnostic mammography. Therefore, for screening mammography, we proposed a physician work RVU of 0.70 based on the physician work established for a unilateral diagnostic mammography. This value is equal to the proposed work RVUs from the 5-year review of physician work for CPT code 76090, unilateral diagnostic mammogram (see June 8, 2001 proposed notice, "Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule"). Since we believe that the practice expense and malpractice expense for the professional component of screening mammography is similar to the professional component of unilateral diagnostic mammography, we proposed establishing 0.25 practice expense RVUs and 0.03 malpractice RVUs for the PC of screening mammography.
Technical Component
We proposed valuing the technical component of screening mammography using a methodology that updates the original statutory limit for the technical component of screening mammography of $37.40, by the cumulative increase in physician fee schedule rates between 1992 and 2001 (see the August 2, 2001 proposed rule (66 FR 40384) for specific information on methodology). This resulted in proposed practice expense and malpractice RVUs for the technical component of screening mammography of 1.27 and 0.06, respectively.
Overall, the total proposed RVUs associated with the combined PC and TC of CPT code 76092 were 2.31 (0.70 work RVUs, 1.52 practice expense RVUs, and 0.09 malpractice expense RVUs).
New Technology Mammography
The BIPA also required us to determine whether the assignment of new HCPCS codes is appropriate for both screening and diagnostic mammography performed using new digital technologies.
We determined that new HCPCS codes are appropriate for the new digital technology mammography beginning January 1, 2002. We proposed three separate codes for directly taking a digital image (one for screening and one each for unilateral and bilateral diagnostic). We also proposed a single add-on code for computer-aided diagnosis with conversion of standard film images to digital images, since, at the time of the development of the proposed rule, the FDA approved computer-aided diagnosis only for screening mammography. Following is a summary of our proposed coding and payment methodologies for digital mammography.
Screening Mammography, Direct Digital Image (Gxxx1)
We proposed HCPCS code Gxxx1 to report screening mammography performed using direct digital images as opposed to mammography that is performed using the standard film images associated with CPT code 76092, or conversion of a standard film image to a digital image. For the PC of HCPCS code Gxxx1, we proposed 0.70 work RVUs, 0.28 practice expense RVUs, and 0.03 malpractice expense RVUs. For the TC of HCPCS code Gxxx1, for which there is no physician work associated, we proposed 2.50 practice expense RVUs and 0.06 malpractice RVUs.
Diagnostic Mammography, Unilateral, Direct Digital Image (Gxxx2)
We proposed HCPCS code Gxxx2 to report unilateral diagnostic mammography performed using direct digital images as opposed to mammography performed using the standard film images associated with CPT code 76090, or conversion of a standard film image to a digital image.
For the professional component of HCPCS code Gxxx2, we proposed 0.70 work RVUs, 0.28 practice expense RVUs, and 0.03 malpractice expense RVUs. For the TC of HCPCS code Gxxx2, with which there is no physician work associated, we proposed 1.99 practice expense RVUs and 0.05 malpractice expense RVUs.
Diagnostic Mammography, Bilateral, Direct Digital Image (Gxxx3)
We proposed HCPCS code Gxxx3 to report bilateral diagnostic mammography that is performed using direct digital images as opposed to mammography performed using the standard film images associated with CPT code 76091, or conversion of a standard film image to a digital image.
For the PC of HCPCS code Gxxx3, we proposed 0.87 work RVUs, 0.34 practice expense RVUs, and 0.03 malpractice expense RVUs. For the TC of HCPCS code Gxxx3, with which there is no physician work associated, we proposed 2.47 practice expense RVUs and 0.06 malpractice expense RVUs.
Computer-Aided Detection, With Either Direct Digital Image or Conversion of Standard Film Images to Digital Images (HCPCS Code Gxxx4)
We proposed HCPCS code Gxxx4 to report conversion of standard film images to digital images when used in conjunction with computer-aided diagnosis software. This code was proposed as an add-on code that can be billed only in conjunction with the primary service, CPT code 76092, based on our understanding that the only FDA-approved use of the computer-aided diagnosis mammography software is with screening film images. If there are other FDA-approved uses of computer-aided diagnosis, we stated we would allow for use of Gxxx4 as an add-on to other mammography services.
For the PC of code Gxxx4, we proposed 0.06 work RVUs, 0.02 practice expense RVUs, and 0.01 malpractice expense RVUs. For the TC of HCPCS code Gxxx4, with which there is no physician work associated, we proposed 0.41 practice expense RVUs and 0.01 malpractice expense RVUs.
Since publication of the proposed rule, the FDA has also approved the use of computer-aided diagnosis with diagnostic mammography.
Comment: The majority of comments received from manufacturers, specialty organizations, individuals, and representatives of the Congress were supportive of our proposed payment of mammography services beginning January 1, 2002. The general consensus from commenters was that the proposed 21 and 26 percent increase, respectively, in payments for unilateral and bilateral diagnostic mammography, as a result of the 5-year review of work (see section IV), the new resource-based payment for screening mammography, the new resource-based payments for both digital screening and digital diagnostic mammography, and the payments for computer-aided diagnosis reflect the relative resources associated with each individual service.
However, two commenters still believe that the 21 percent and 26 percent increase in payments for unilateral and bilateral diagnostic mammography, respectively, was still inadequate to cover the costs of these services.
Response: In agreement with the majority of comments received, we continue to believe that our proposed relative values are an accurate reflection of the resources associated with the provision of these services.
Comment: We received comments that suggested that Medicare payment is inadequate to cover the cost of screening mammography. One commenter stated that, due to the Federally-mandated Mammography Quality Standards Act (MQSA) requirements intrinsic to mammography (both screening and diagnostic), it is difficult to use the current methodology to account for all practice expenses. This commenter did indicate support for our proposal to develop practice expense RVUs for screening mammography using a comparison to unilateral diagnostic mammography.
Response: We are currently using the "no work" methodology to price the technical component of diagnostic mammography and a special method for the technical component of screening mammography. We believe that most costs associated with mammography services are likely to be associated with the technical component. At this time, we plan to continue using these methods to establish the practice expense relative value units for the technical component of mammography services. However, if we propose a change to the methodology for no-work services in the future, we agree that it is important to consider whether MQSA costs are incorporated in the data sources we are using to develop RVUs.
Comment: We received two comments that suggested Medicare should not pay for screening mammography using the physician fee schedule until payment is set at an appropriate level so as not to require reduction in payments for other services. The commenters were concerned about the reduction in payment for other services that would result from the increase in payment for screening mammography using the methodology we proposed. These commenters acknowledged that the statute requires us to pay for screening mammography using the physician fee schedule. One commenter appreciated the significant effort that CMS put forth to comply with the mandate.
Response: As indicated by the comments, section 104(a) of the BIPA requires us to pay for screening mammography using the Medicare physician fee schedule beginning January 1, 2002. We estimate that payment in 2002 for screening mammography under the statutory methodology would have been about $71, which is less than the $81 that Medicare will pay under the physician fee schedule. Since screening mammography is paid under the physician fee schedule, the increase in payment will be subject to the budget neutrality calculations under section 1848(c) of the Act. The increase in payment, although large, will have little effect on payment for other physician fee schedule services. The required adjustment to other physician fee schedule payments is less than -0.1 percent.
Comment: We received comments about coding for new technology screening mammograms. These comments indicated support for our proposed coding but noted that two developments have since occurred that we could not have taken into account in our proposed rule. First, CPT created a new code for computer-aided detection (CAD) as an add-on for screening mammography. Second, the Food and Drug Administration approved use of CAD for diagnostic mammography. The commenters requested that we use the CPT code for CAD as an add-on to screening mammography and create a slightly modified HCPCS alphanumeric code as an add-on for diagnostic mammography. The modification would specify that the alphanumeric code is to be used as an add-on for diagnostic mammography. Commenters also suggested that we accommodate potential future FDA approved uses of CAD as an add-on to digital mammography through necessary coding and payment changes as soon as possible without having to await the next rulemaking cycle.
Response: We agree with the comments about coding of CAD. Medicare will recognize CPT code 76085 for CAD as an add-on to screening mammography and procedure code G0236 as an add-on to diagnostic mammography. The code descriptors make clear that the CPT code is for use as an add-on to screening mammography and the alphanumeric code is an add-on to diagnostic mammography. Payment for the revised codes follows the proposed rule approach for physician work, practice expense and malpractice for all mammography services. There may be slight changes to the RVUs for practice expenses as a result of updated information included in this final rule that affect all physician fee schedule services.
In response to the comment about potential future FDA approved uses of CAD as add-on to digital mammography, it is possible that additional coding changes will be necessary or that editorial revisions to existing codes will allow for CAD to be paid as an add-on for digital mammography. We would like to coordinate our efforts with those of the CPT to minimize the need for alphanumeric codes and additional CPT codes.
Comment: One commenter expressed concern about the payment associated with the Outpatient Prospective Payment System for all forms of mammography.
Response: Any issues related to the Outpatient Prospective Payment System are outside the scope of this regulation and will be addressed by a separate regulation.
Comment: One commenter asked for clarification on Federally Qualified Health Centers (FQHC) reimbursement for screening mammography and other new services.
Response: Any issues related to FQHC reimbursement are outside the scope of this regulation.
Comment: One commenter expressed concern that CMS did not work more closely with the CPT codes in the establishment of coding for digital mammography.
Response: Whenever possible, CMS works with the American Medical Association's CPT Editorial Panel to establish coding for new technologies. The AMA CPT Editorial Panel has not established codes for digital mammography; therefore, CMS proactively established temporary G-codes for the digital mammography and computer-aided detection for diagnostic mammograms.
Comment: One commenter indicated that the malpractice expense for screening mammography should be higher than the unilateral diagnostic value of 0.03 since most mammography malpractice claims arise from allegations of cancers not detected or inappropriate follow-up of screening mammograms, not diagnostic studies. In addition, the screening mammography malpractice apportionment should be reversed for the PC and TC portions as the malpractice expense and risk is primarily with the interpreter of the screening mammogram, not the facility producing the technical component.
Response: We will consider the malpractice RVUs for these services interim for 2002 and will examine this issue with respect to the methodology used to establish malpractice RVUs.
Result of Evaluation of Comments
We will finalize our proposed relative values, because we believe they are an accurate reflection of the cost associated with the provision of these services. Additionally, we will also establish a temporary G-code (G0236) for the recent FDA approval of computer-aided detection used in conjunction with diagnostic mammography.
| CPT1 HCPCS | MOD | Descriptor | Work RVU | Practice Expense RVU | Malpractice RVU | Total |
|---|---|---|---|---|---|---|
| 76090 | Mammogram, one breast | 0.70 | 1.25 | 0.08 | 2.03 | |
| 76090 | 26 | Mammogram, one breast | 0.70 | 0.25 | 0.03 | 0.98 |
| 76090 | TC | Mammogram, one breast | 0.00 | 1.00 | 0.05 | 1.05 |
| 76091 | Mammogram, both breast | 0.87 | 1.54 | 0.09 | 2.50 | |
| 76091 | 26 | Mammogram, both breast | 0.87 | 0.30 | 0.03 | 1.20 |
| 76091 | TC | Mammogram, both breast | 0.00 | 1.24 | 0.06 | 1.30 |
| 76092 | Mammogram, screening | 0.70 | 1.44 | 0.09 | 2.23 | |
| 76092 | 26 | Mammogram, screening | 0.70 | 0.25 | 0.03 | 0.98 |
| 76092 | TC | Mammogram, screening | 0.00 | 1.19 | 0.06 | 1.25 |
| G0202 | Mammogram, screen, dir dig | 0.70 | 2.52 | 0.09 | 3.31 | |
| G0202 | 26 | Mammogram, screen, dir dig | 0.70 | 0.30 | 0.03 | 1.03 |
| G0202 | TC | Mammogram, screen, dir dig | 0.00 | 2.42 | 0.06 | 2.48 |
| G0204 | Diag mammo, bilat, dir dig | 0.87 | 2.73 | 0.09 | 3.69 | |
| G0204 | 26 | Diag mammo, bilat, dir dig | 0.87 | 0.35 | 0.03 | 1.25 |
| G0204 | TC | Diag mammo, bilat, dir dig | 0.00 | 2.38 | 0.06 | 2.44 |
| G0206 | Diag mammo, unilat, dir dig | 0.70 | 2.20 | 0.08 | 2.98 | |
| G0206 | 26 | Diag mammo, unilat, dir dig | 0.70 | 0.28 | 0.03 | 1.01 |
| G0206 | TC | Diag mammo, unilat, dir dig | 0.00 | 1.92 | 0.05 | 1.97 |
| G0236 | Computer aided detect, diag | 0.06 | 0.31 | 0.02 | 0.39 | |
| G0236 | 26 | Computer aided detect, diag | 0.06 | 0.02 | 0.01 | 0.09 |
| G0236 | TC | Computer aided detect, diag | 0.00 | 0.29 | 0.01 | 0.30 |
| 76085 | Computer aided detection | 0.06 | 0.31 | 0.02 | 0.39 | |
| 76085 | 26 | Computer aided detection | 0.06 | 0.02 | 0.01 | 0.09 |
| 76085 | TC | Computer aided detection | 0.00 | 0.29 | 0.01 | 0.30 |
| 1 CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. | ||||||
B. Screening Pelvic Examinations
Section 101 of the BIPA amends section 1861(nn)(2) of the Act (effective July 1, 2001) to provide that a woman who does not qualify for annual coverage of a screening pelvic examination under one of the statutory exceptions, qualifies for coverage of a screening pelvic examination (including a clinical breast examination) once every 2 years rather than once every 3 years.
In the August 2, 2001 proposed rule, we made conforming changes to § 410.56 (Screening Pelvic Examinations) of the regulations to reflect this statutory provision that has been implemented through sections 4603, 3628.1 and 4731 of the Medicare Carrier Manual, the Medicare Intermediary Manual, and the Medicare Hospital Manual, respectively.We received only one specific comment on the new screening pelvic examination proposal. That comment supported our proposed rule and recognized that the regulations are consistent with the Medicare law.
Result of Evaluation of Comments
We are adopting our proposal to conform the regulations to the law to provide coverage for biennial screening pelvic examination for women not at high risk for cervical or vaginal cancer, effective July 1, 2001.
C. Screening for Glaucoma
Section 102 of the BIPA provides for Medicare coverage under Part B for screening for glaucoma for individuals with diabetes, a family history of glaucoma, or others determined to be at "high risk" for glaucoma effective for services furnished on or after January 1, 2002. The statute provides for coverage of glaucoma screening, including (1) a dilated eye examination with an intraocular pressure measurement, and (2) a direct ophthalmoscopy or a slit-lamp biomicroscopic examination, subject to certain frequency and other limitations.
In the August 2, 2001 rule, we proposed a new § 410.23 (Screening for Glaucoma: Conditions for and Limitations on Coverage), to provide for coverage of the various types of glaucoma screening examinations specified in the statute. As provided in the statute, this new coverage allows payment for one glaucoma screening examination every year. To implement the statutory provisions, we proposed definitions for the following terms-screening for glaucoma, eligible beneficiaries, and direct supervision.
In keeping with the language of section 102(b) of the BIPA we proposed defining the term "screening for glaucoma" to mean a dilated eye examination with an intraocular pressure measurement and a direct ophthalmoscopy or a slit-lamp biomicroscopic examination for the early detection of glaucoma. This section also provides that the screening examinations that are to be covered under Medicare are to be furnished by or under the direct supervision of an optometrist or ophthalmologist who is legally authorized to furnish these services under State law (or the State regulatory mechanism provided by State law) of the State in which the services are furnished. These are services that would otherwise be covered if furnished by a physician or as incident to a physician's professional service. We also proposed incorporating this language in § 410.23.
We used the term "eligible beneficiaries" to indicate who may qualify for the new screening glaucoma benefit, and we proposed defining that term to include-individuals with diabetes mellitus, individuals with a family history of glaucoma, and African-Americans age 50 and over. As explained in the August 2 proposed rule, based on our review of the medical literature, and consultation with staff of the National Eye Institute and representatives of the American Academy of Ophthalmology and the American Optometric Association, we interpreted the statutory language, "individuals determined to be at high risk for glaucoma" to include Medicare beneficiaries who are African-Americans age 50 and over.
We felt that the medical evidence available at this time was only sufficient to support inclusion of African-Americans age 50 and over in the statutory "high risk" category, in addition to individuals with diabetes and those with a family history of glaucoma who are covered separately under the new screening benefit. However, we specifically solicited public comment on the appropriateness of including other individuals in the statutory definition of "high risk" for glaucoma, with supporting documentation from medical literature.
Section 102(b) of the BIPA provides that the glaucoma screening examination is to be furnished by or under the direct supervision of an ophthalmologist or optometrist who is legally authorized to furnish such services under State law or regulation in which the services are furnished. We proposed defining the term "direct supervision" as that term is defined in § 410.32(b)(3)(ii) for purposes of the oversight of covered diagnostic laboratory services as they are performed in the office setting. Specifically, for purposes of screening glaucoma we proposed defining the term "direct supervision" to mean that the ophthalmologist or optometrist must be present in the office suite and immediately available to furnish assistance and direction throughout the performance of the procedure. The definition states that the term "direct supervision" does not mean the physician must be present in the room when the procedure is performed.
We also proposed conforming changes to specify an exception to the list of examples of routine physical checkups excluded from coverage in §§ 411.15(a)(1) and 411.15(k)(9) for glaucoma screening examinations that meet the frequency limitation and the conditions for coverage that we are specifying under new § 410.23.
We received six comments that generally supported the proposal to implement section 102 of BIPA that provides for Medicare coverage of screening for glaucoma. Four of these comments were submitted by national medical associations, one was submitted by a pharmaceutical company, and another was provided by a consulting group. Only one commenter had a suggestion for revising the specific coverage provisions of the proposal.
Comment: One commenter responded to our invitation to the public in the proposed rule to submit comments on the question of whether it might be appropriate to include other individuals (and not just African-Americans over age 50) in the statutory definition of those at "high risk" for glaucoma. First, the commenter cites an article from the medical literature that notes that "one of the clearest factors relating to increased glaucoma prevalence is age." (Gilchrist. Ophthalmic Physiol Opt 2000) Second, the commenter refers to other eye experts in the research of the epidemiology of glaucoma who have suggested that "the appropriate age at which screening might be most effective is 6 to 10 years younger among those of African descent because of the earlier onset of disease." (Quigley and Vitale. Invest Ophthalmol Vis Sci 1997) Third, the commenter states that the latter conclusion is supported by data showing that in African-Americans who eventually develop glaucoma, the disease is present in 25 percent by age 54, 50 percent by age 65, and 75 percent by age 75. The commenter cites from the same Quigley article that comparable ages for these percentages of disease development in non-African-Americans are 64, 72, and 81 years, respectively. Finally, the commenter concludes that this literature supports a policy that would provide the glaucoma screening benefit for non-African Americans at an age 6 to 10 years older than for African-Americans (for example, 50 years of age), or beginning at age 56 to 60 years of age.
Response: We believe that the commenter has not interpreted the results of the Quigley and Vitale studies correctly. The article by Quigley and Vitale reported the results of a meta-analysis and statistical modeling to estimate the prevalence and incidence of glaucoma. In general, results from meta-analysis and remodeling are often limited by the quality and comparability of the original source data. In the proposed rule, we used data reported directly from the Baltimore Eye Study (Tielsch, et al. JAMA 1991) and the Beaver Dam Eye Study (Klein, et al. JAMA 1992), two of the largest published studies on glaucoma. These studies indicated that the prevalence of glaucoma in non-African-Americans starts to increase after the age of 65 to 70 years, whereas the prevalence increases much earlier in African-Americans. Our decision to include African-Americans in the statutory category of those at "high risk" for glaucoma was based on these studies and the increased prevalence of glaucoma in African-Americans.
Although we have decided not to add new populations to the definition of high risk at this time, the comment does raise the issue of how we should revise the definition in the future, if there is evidence to do so. We have decided to revise the proposed language in § 410.23(a)(2) so that it specifically refers to "individuals in the following high risk categories" to make it more consistent with the statute. This new structure for the regulation language will permit CMS to more easily add high risk groups to the glaucoma screening benefit through the rulemaking process should the evidence in the medical literature warrant it.
Payment for Glaucoma Screening
We believe that services provided as part of glaucoma screening will often overlap with services a physician provides during a patient encounter for ophthalmological services without requiring any additional work or practice expense. Therefore, we proposed bundling payment for glaucoma screening when it is provided on the same day as an evaluation and management (E/M) service or when it is provided as part of any ophthalmology service. In instances when glaucoma screening is the only service provided or when it is provided as part of an otherwise non-covered service (for example, CPT code 99397, preventive services visit,) we proposed the following HCPCS codes and payments: Gxxx5, Glaucoma Screening Furnished by a Physician for High Risk Patients.
For physician work and for malpractice, we proposed work and malpractice RVUs of 0.45 and 0.02, respectively, by crosswalking these values from CPT code 99212. Gxxx6, Glaucoma Screening Furnished Under the Direct Supervision of a Physician for High Risk Patients.
For physician work and for malpractice, we believe this new HCPCS code represents a level of work comparable to other E/M services performed "incident to" a physician's service and therefore proposed to crosswalk the work and malpractice RVUs from CPT code 99211 (E/M service that may not require the presence of a physician) which are 0.17 and 0.01, respectively.
For non-facility settings, we proposed the following practice expense inputs for both of the above HCPCS Codes- clinical staff time-certified ophthalmic medical technologist/certified ophthalmic technician/registered nurse: five minutes; equipment: screening lane; and supplies: ophthalmology visit supply package.
Comment: We received a comment from the American Academy of Ophthalmology (AAO) agreeing with our decision to bundle glaucoma screening with other E/M services and with our decision to create two levels of glaucoma screening services based on whether or not the physician performed the evaluation. The AAO also agreed with our proposal regarding RVUs for glaucoma screening performed "incident to" but commented that the level of payment for glaucoma screening performed by a physician was too low. They believe that payment rate should be a blend between CPT codes 99202 (Office or other outpatient visit for evaluation and management of a new patient) and 99213 (Office or other outpatient visit for evaluation and management of an established patient). This is based on the expectation that some patients receiving the service will be "new" patients to the ophthalmologist while others will have previously seen the ophthalmologist and therefore be "established" patients.
The AAO proposes that for 2002, payment be equivalent to CPT code 99202 for both physician work and practice expense, that for 2003, payment be equivalent to a 4.4 percent/95.6 percent blend of CPT codes 99202 and 99213 for both physician work and practice expense, that for 2004, payment be equivalent to a blend of 4.5 percent/95.5 percent blend of CPT codes 99202/99213, and that for 2005 and thereafter, payment be equivalent to a blend of 4.6 percent/95.4 percent of CPT codes 99202/99213. The AAO believes that the amount of history, physical examination, and medical decision making required for glaucoma screening approximates the amount of history, physical examination and medical decision making required for CPT code 99202 at the time of the first glaucoma screening and approximates the amount of history, physical examination, and medical decision making required for 99213 at the time of subsequent glaucoma screenings.
The American Optometric Association (AOA) echoed the AAO's comments concerning the crosswalk for physician work. They also noted that the practice expense inputs should be crosswalked to the intermediate ophthalmologic codes.
Response: We are finalizing our proposal to assign 0.45 work RVUs and .02 malpractice RVUs to Gxxx5, glaucoma screening performed by a physician (now G0117). This service is a screening service and therefore cannot be easily compared to the key components of a level III evaluation and management service (CPT code 99213). We also believe that the vast majority of beneficiaries receiving this service will be patients who have been previously seen by the ophthalmologist performing the service and, therefore, CPT code 99202 would not be an appropriate crosswalk for this service. We believe the work required for this service is similar whether or not the patient is "new" or "established". Patients undergoing a screening service have no chief complaint or history of present illness. To perform this service, the only historical information required is a determination as to whether the beneficiary meets the criteria in the law, (for example, is at high risk for glaucoma). Therefore, the requirements for taking a history are actually less than the requirements of CPT code 99212. Additionally, the physical examination requirements are specified in the statute and are similar to the requirements of CPT code 99212. Furthermore, the vast majority of patients undergoing screening will not have glaucoma, so the typical screening service will require routine medical decision making. For those few patients with glaucoma who will need to schedule a return visit, the medical decision making is straightforward. Therefore, the glaucoma screening requirements are similar to CPT code 99212. Our decision to assign 0.45 work RVUs to this service is also consistent with the time required to perform the service and places it in correct rank order with regard to other screening services payable under Medicare. We have decided to accept the recommendation of AOA on practice expense inputs and will crosswalk the inputs from CPT code 92012, brief ophthalmic exam performed on an established patient, rather than using the practice expense inputs from CPT codes 99202 and 99213 as suggested by AAO.
Because we received no comments on the RVUs for the Gxxx6 code, Glaucoma Screening Furnished Under the Direct Supervision of a Physician for High Risk Patients (now G0118), we will implement this as proposed and will assign .17 work RVUs and .01 malpractice RVUs. For practice expense, we will also crosswalk this code to CPT 92012.
Comment: Several commenters noted that medical technicians do not have the education or training to provide screening glaucoma services. One commenter noted that ophthalmic medical personnel (OMP) are not licensed by State regulatory agencies and are precluded from ordering medications, including eyedrops. The commenter states that, according to the Joint Commission on Allied Health Personnel in Ophthalmology and the Association of Technical Personnel in Ophthalmology, OMPs cannot be independent practitioners, cannot diagnose or treat eye disorders and cannot prescribe medications. Since a dilated eye exam requires medication, the OMP cannot perform the exam without the patient first being seen by an ophthalmologist or optometrist.
Response: The regulation is drafted based on the statutory provision; however, it does not supersede any State laws or licensing requirements.
Result of Evaluation of Comments
We are adopting our proposal to include only African-Americans age 50 and over in the statutory category of those at "high risk" for glaucoma. We are revising the regulation in § 410.23(a)(2) to read "Eligible beneficiary means individuals in the following high risk categories." This should allow CMS to more easily add high risk groups by rulemaking should the medical evidence warrant it.
For G0117Glaucoma Screening for High Risk Patients Furnished by an Optometrist or Ophthalmologist-we will assign 0.45 work RVUs, .02 malpractice RVUs and we will crosswalk practice expense inputs from CPT code 92012.
For G0118Glaucoma Screening for High Risk Patients Furnished Under the Direct Supervision of an Optometrist or Ophthalmologist-we will assign .17 work RVUs and .01 malpractice RVUs. For practice expense we will also crosswalk this code to CPT code 92012.
D. Screening Colonoscopy
Before the enactment of the BIPA, sections 1861(pp)(1)(C) and 1834(d)(3)(E) of the Act authorized Medicare coverage of screening colonoscopies once every 2 years for individuals at high risk for colorectal cancer. Individuals not at high risk for colorectal cancer did not qualify for coverage of screening colonoscopies under the colorectal cancer screening benefit, but they did qualify for coverage of other colorectal cancer screening examinations specified in the statute. These other examinations that were covered for individuals not at high risk for colorectal cancer included screening fecal-occult blood tests, screening flexible sigmoidoscopies, and screening barium enema examinations at certain frequency intervals specified in the statute and the regulations at § 410.37 (Colorectal cancer screening tests).
Section 103 of the BIPA amended sections 1861(pp)(1)(C), 1834(d)(2)(E)(ii), and 1834(d)(3)(F) of the Act to add coverage of screening colonoscopies once every 10 years for individuals not at high risk for colorectal cancer. However, in the case of an individual who is not at high risk for colorectal cancer, but who has had a screening flexible sigmoidoscopy within the last 4 years, the statute provides that payment may be made for a screening colonoscopy only after at least 47 months have passed following the month in which the last screening flexible sigmoidoscopy was performed. In addition, the statute provides that, in the case of an individual who is not at high risk for colorectal cancer but who does have a screening colonoscopy performed on or after July 1, 2001, payment may be made for a screening flexible sigmoidoscopy only after at least 119 months have passed following the month in which the last screening colonoscopy was performed.
In view of the statutory changes, we are conforming §§ 410.37(e) and 410.37(g) (related to limitations on coverage of screening colonoscopies and screening flexible sigmoidoscopies) to make them consistent with the new provisions of the statute that have been implemented through manual provisions of the Medicare Carriers Manual, the Medicare Intermediary Manual Part III, and the Medicare Hospital Manual in transmittal numbers 6097, 1824, and 7069, respectively, in February 2001.
Payment for Screening Colonoscopy
Payment for screening colonoscopy will be made under HCPCS code G0121: colorectal screening; colonoscopy for an individual not meeting criteria for high risk. As with current code G0105, screening colonoscopy for an individual at high risk, payment will be made at the level for a diagnostic colonoscopy, CPT code 45378, because the work is the same whether a procedure is screening or diagnostic. As the statute requires that, for both individuals who are or are not at high risk, if, during the course of the screening colonoscopy, a lesion or growth is detected that results in a biopsy or removal of the growth, the appropriate diagnostic procedure classified as colonoscopy with biopsy or removal should be billed and paid rather than HCPCS code G0105 or G0121.
We received four comments in support of the proposal to conform the regulations to the Medicare law implementing the new screening colonoscopy provision (section 103 of the BIPA) for individuals not at high risk for colorectal cancer. One of the commenters, however, did have a suggestion for how we could improve the manual instructions that we issue to our carriers on this subject.
Comment: The commenter suggests that we instruct our Medicare carriers to identify which International Classification of Diseases-Volume Nine (ICD-9) codes are acceptable to use in conjunction with the interim GO121 code that has been proposed for billing for covered screening colonoscopies performed for individuals not at high risk for colorectal cancer. The commenter stated that our failure to do this for screening flexible sigmoidoscopy code G0104 in the billing instructions we issued to our carriers in 1998 created problems for everyone concerned because individual carriers adopted a variety of acceptable ICD-9 codes, but did not inform the public under what circumstances the examinations were covered and when they were not.
Response: We are not aware of the problems stated above with respect to the Medicare billing codes for screening flexible sigmoidoscopies in 1998. In addition, we have not received any complaints about the new billing instructions that we released to our carriers in February of this year in conjunction with the interim G0121 code that was issued (effective July 1, 2001) for use in billing for screening colonoscopies for individuals not at high risk for colorectal cancer. Since individuals who might qualify for coverage under this new screening benefit are those who would not be at "high risk" for colorectal cancer, it is not clear to us why the physician billing for the service would need to provide any ICD-9 code for the examination to the carrier for Medicare payment to be made. We do not require that such information be submitted to the carrier at the present time in these circumstances.
Result of Evaluation of Comments
We are implementing our proposal as stated above. In view of the comment, we will review the matter, and we will take any necessary action that might be deemed appropriate.
E. Medical Nutrition Therapy
Section 105 of the BIPA amended section 1861(s)(2) of the Act to authorize Medicare Part B coverage of medical nutrition therapy (MNT) for certain beneficiaries who have diabetes or a renal disease, effective for services furnished on or after January 1, 2002. This new benefit is similar to a benefit initially established by section 4105 of the BBA as a component of the diabetes outpatient self-management training (DSMT) benefit. The DSMT benefit, described at section 1861(qq) of the Act, is a comprehensive diabetes training program, of which nutrition training is only one component.
Consistent with section 105(a)(3) of the BIPA, we considered the protocols of the American Dietetic Association (ADA) and the National Kidney Foundation (NKF) regarding medical nutrition therapy training for both diabetes and renal disease in order to establish criteria for coverage of these services. Because the protocols were inconclusive with respect to duration and frequency issues, we proposed to determine the duration and frequency of the benefit through the NCD process rather than through the rulemaking process.
We proposed to set forth the provisions regarding medical nutrition therapy at Part 410, subpart G and at § 414.64. The MNT provisions of the final rule follow.
Definitions (§ 410.130)
We defined "renal disease" for the purpose of this benefit as only chronic renal insufficiency and post-transplant care provided after discharge from the hospital. We proposed to limit post-transplant care to care furnished within 6 months after discharge from the hospital, if the transplant is viable and effective, because, under such conditions, we believe the beneficiary would no longer have renal disease and would not be eligible to receive the benefit under the statutory provision. We specifically solicited comments on this proposed time period, and requested that the commenters support their comments with articles from medical journals. We also established definitions of "diabetes", "renal disease", and "chronic renal insufficiency" for the purpose of this benefit using definitions from the Institute of Medicine report, "The Role of Nutrition in Maintaining Health in the Nation's Elderly," published in 2000.
We proposed defining "episode of care" as a time period not to exceed 12 months, starting with the assessment (based on a referral from a physician), and including all covered interventions. Finally, in accordance with the statute, we defined MNT services as nutritional diagnostic, therapy, and counseling services provided by a registered dietitian or nutrition professional for the purpose of managing disease.
Medical Nutrition Therapy (§ 410.132)
At § 410.132(a), we proposed the conditions for coverage of MNT services. Specifically, we proposed that Medicare Part B pay for MNT services furnished by a registered dietitian or nutrition professional as defined in § 410.134 when the beneficiary is referred for the service by the beneficiary's treating physician. We proposed to limit the definition of physician to "treating physician" to ensure that the physician establishing the need for MNT is actually treating the beneficiary for a covered chronic disease and that the therapy is coordinated with the care being provided by the treating physician.
We proposed that the services covered consist of nutritional assessment, interventions, reassessment, and follow-up interventions. We chose not to define the specific components of the benefit in more detail because we anticipated that registered dietitians and nutritionists would use nationally recognized protocols, such as those developed by the ADA, as they normally would in their practice. As previously mentioned, we also proposed to use the NCD process to develop duration and frequency limits.
At § 410.132(b), we set forth the coverage limitations for MNT services. In accordance with section 1861(s)(2)(V)(ii) of the Act, we provided that MNT services would not be covered for beneficiaries on dialysis for end-stage renal disease. We did not exclude all beneficiaries who are diagnosed with end-stage renal disease because a few individuals with end-stage renal disease do not receive maintenance dialysis, and the statute specifically excludes beneficiaries receiving maintenance dialysis under section 1881 of the Act. The other provisions of this section outlined the coordination of referrals for MNT for diabetes and renal disease, and coordination of MNT and DSMT services.
Eligibility for MNT services will be dependent upon diagnoses and referrals made by the treating physician. At § 410.132(c), we proposed that referral only be made by the treating physician when the beneficiary has been diagnosed with diabetes or a renal disease, with documentation maintained by the referring physician in the beneficiary's medical record. Referrals must be made for each episode of care.
At § 410.132(d), we discussed requirements regarding reassessment and follow-up interventions. Specifically, we proposed that reassessments and follow-up interventions would only be covered when the referring physician determined that there was a change of diagnosis or medical condition within an episode of care that made a change in diet necessary.
Provider Qualifications (§ 410.134)
The BIPA specifies how we must define "registered dietitian or nutrition professional" for the purposes of this benefit, and allows for the grandfathering of nutrition professionals licensed or certified by States at the time of its enactment. The proposed qualifications for a registered dietitian or nutrition professional are set forth at § 410.134, and include alternative criteria for recognition of registered dietitians in States that do not provide for licensure or certification of these individuals.
We received nearly 1,000 comments on the MNT portion of the proposed rule. The most frequently received comments concerned: the definitions of diabetes, renal disease, and treating physician; the coordination of the diabetes self-management training and MNT benefits; and proposed reimbursement. We also received comments about provider qualifications.
Comment: We received a large number of comments that stated we had defined diabetes and renal disease too narrowly and asked for further clarification of the definitions.
Response: Our definition of diabetes does not specifically state how physicians should perform lab tests to determine if a beneficiary should be diagnosed with diabetes. However, as with the national protocols for medical nutrition therapy, we assume that physicians will conduct tests in accordance with nationally accepted clinical guidelines, which require testing on multiple occasions to determine a diagnosis of diabetes. We are clarifying our definition of diabetes by adding a sentence to further explain the etiology of the disease. We also have extended coverage to include gestational diabetes for the few Medicare beneficiaries who would need such coverage. We believe that we do not have the statutory authority to extend coverage to beneficiaries who have not yet been diagnosed with diabetes.
We also expand the definition of renal disease in this final rule. First, we clarify that beneficiaries with end-stage renal disease who are not receiving dialysis are eligible for the service. In addition, we have expanded the time period in which we will cover MNT for beneficiaries who have received a renal transplant to 36 months, to bring the coverage into conformance with the Medicare eligibility period for individuals under age 65.
Comment: A few commenters requested that we change our definition for renal disease to encompass all patients with glomerular filtration rates (GFR) below 60. The GFR is the measurement of renal function and has a range in normal adult males of 98 to 150 ml/min/1.7m 2 and in normal adult females of 106 to 132 ml/min/1.7 2 . The commenters believe that we did not fulfill the intent of the Congress.
Response: We disagree with the comment. Neither the BIPA nor its legislative history indicates any specific intention regarding how to define renal disease for purposes of eligibility for this benefit. Section 4108 of the BBA required the Department of Health and Human Services to contract with the National Academy of Sciences (NAS) to examine the benefits and costs associated with extending Medicare coverage for certain services, including medical nutrition therapy. We believe the NAS Institute of Medicine (IOM) report, "The Role of Nutrition in Maintaining Health in the Nation's Elderly," published in 2000, provides a reasonable definition for determining the scope of the benefit. In that report, "renal disease" is defined as chronic renal insufficiency, end-stage renal disease, and the beneficiary's condition following renal transplant. The GFR rate for chronic renal insufficiency (GFR of 13 to 50 ml/min/1.73m 2 ) used in the proposed rule was also in the IOM report.
The IOM report did not cover the period of time MNT should be available to beneficiaries following a renal transplant. The Congress has authorized us to provide a reasonable interpretation of how much coverage will be provided for beneficiaries after renal transplant.
The suggested eligibility criterion of a GFR under 60 suggested by commentators appears to be too expansive, because typically the GFR for beneficiaries after they receive a transplant never goes above 60. We also received comments recommending that we match our coverage to the length of time an under-65 beneficiary is entitled to post-transplant coverage. We agree that this is a reasonable criterion for our coverage of MNT services for post-renal-transplant beneficiaries.
Comment: We received a large number of comments expressing concern about our use of the term "treating physician". Most commenters believe that the term does not include both primary care physicians and specialists. One commenter believes we exceeded our statutory authority. Also, some commenters believe that we should allow any physician to provide a referral for the service.
Response: We did not intend to exclude primary care physicians from the term "treating physician". In this final rule, we now define the term "treating physician" to mean the primary care physician or specialist coordinating care for the beneficiary with diabetes or renal disease.
Regarding our statutory authority, the statute, as amended at section 1861(s)(2)(V)(iii) of the Act, clearly states that the Secretary has authority to impose other criteria, after considering protocols established by dietetic or nutrition professional organizations. Requiring referral by the treating physician is within this statutory authority. We continue to believe that we must assure the quality of services received by Medicare beneficiaries. Therefore, our coverage guidelines must require coordination of care for beneficiaries with chronic diseases in order to assure that quality. We have not changed the final rule to allow any physician to make the referral for MNT.
Comment: We also received comments concerning the definition of the benefit and episode of care.
Response: As stated in the proposed rule, we relied on the national dietetic therapy protocols of major organizations to define the basic benefit. In seeking to understand the reason for these comments, we discovered that the use of the term "reassessment and follow-up interventions" in §§ 410.132(a) and (d) was confusing to many commenters. In the national protocols, reassessments and follow-up interventions are always considered part of the basic service. In the proposed rule, we had used the terms to define a special circumstance that happens only when a beneficiary has a change in medical condition or diagnosis.
In this final rule, we clarify our policy by eliminating the use of the terms "reassessment" and "follow-up interventions". We also have changed the language slightly in several other parts of the final rule to help clarify our intent, such as adding, "treatment regimen" as another reason why we would allow additional coverage in special circumstances. Our definition of "episode of care" (except in the case of coordination of services with initial DSMT and gestational diabetes) is based on our intent to pay providers of the service more efficiently by conforming the definition to our claims processing requirements. Our intent continues to be that dietitians and nutritionists should follow national MNT protocols.
Comment: Some commenters stated that the DSMT and MNT benefits for beneficiaries with diabetes should only be coordinated to the extent of reducing the total of number of MNT hours by one hour.
Response: In the proposed rule, we assumed that all of the MNT benefit for diabetes would be provided as part of the initial DSMT benefit and that follow-up DSMT and MNT for diabetes should be fully coordinated. In our discussions with interested organizations concerning the amount of services that should be covered for the NCD process, great concern was expressed about the coordination of the DSMT and MNT benefits. Therefore, we have spent a great deal of time researching this issue. We have found no evidence to date to suggest that the language of the proposed rule should be changed for this requirement. However, because we are still developing our NCD concerning the duration and frequency of the MNT benefit, we will continue to consider any evidence that might lead to the conclusion that additional hours should be covered when both benefits are provided during the same time period.
Until such time as an NCD alters this requirement, if initial DSMT and MNT benefits for diabetes are provided in the same 12 month episode of care, only 10 total hours of services will be covered, regardless of whether the hours are covered as MNT, DSMT, or a combination of both. In situations where follow-up DSMT and MNT for diabetes is provided, only the total amount of hours allowed under the MNT benefit will be covered. (The MNT cap will be applied to any DSMT services provided to a beneficiary during the follow-up period, until such time as an NCD alters this requirement.)
Comment: We received comments that MNT for a diagnosis of renal disease and MNT for a diagnosis of diabetes should not be fully coordinated.
Response: In this final rule, we are not changing this requirement because the provision at § 410.132(d) (in this final rule § 410.132(b)(5)) already provides for additional coverage in this situation and we believe that additional coverage is not necessary. However, we are clarifying that beneficiaries receiving initial DSMT can receive the full initial DSMT benefit.
Comment: One commenter was concerned that providers that had completed a full course of study of dietetics or nutrition after completion of a bachelor's degree would be excluded. We also received comments asking us to clarify the requirements further.
Response: We agree that individuals that complete the full course of study of an accredited dietetics or nutrition program after completion of a bachelor's degree would still meet the intent of the legislation. Therefore, we have altered the regulatory language to include these individuals. However, we will require our contractors to require the practitioner to provide proof of completion of the course of study in addition to proof of receiving the degree.
In situations where the individual is credentialed as a registered dietitian by an organization appropriate for this purpose, we will recognize that credential as proof that the individual meets both the education and experience required in the regulation. We have added language at §§ 410.134(a) and (d) to change the final rule.
Comment: A commenter noted that State licensure requirements vary considerably; providers will need to obtain multiple licenses when they perform services in more than one State; and providers will have to meet different requirements if State licensure provisions change.
Response: The statutory intent to recognize State licensure and State licensure requirements is clear. We cannot require States to have similar licensure requirements, recognize licensure by other States, or to provide for grandfathering of providers when State licensure laws change. Therefore, we have not changed the final rule to reflect these comments.
Payment for Medical Nutrition Therapy (§ 414.64)
Section 105(c) of the BIPA requires that we pay for medical nutrition therapy services at 80 percent of the lesser of the actual charge for the services or 85 percent of the amount determined under the physician fee schedule for the same services if the services had been furnished by a physician. Based upon consultation with the American Dietetic Association (ADA) to assess the types of resource inputs used to furnish a 15-minute medical nutrition therapy session by a registered dietitian or professional nutritionist, we proposed the following:
For CPT code 97802-Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes, we did not propose physician work RVUs for this service, based on the statutory provision that specifically provides that medical nutrition therapy services may only be furnished by registered dietitians or nutrition professionals. For practice expense, we proposed 0.47 RVUs and, for malpractice, we proposed 0.01 RVUs for a total of 0.48 RVUs.
For CPT code 97803-Reassessments and intervention, individual, face-to-face with the patient, each 15 minutes, we proposed 0.0 work RVUs, 0.34 practice expense RVUs and 0.01 malpractice RVUs for a total of 0.35 RVUs.
For CPT code 97804-Group, 2 or more individuals, each 30 minutes, we proposed 0.0 work RVUs, 0.14 practice expense RVUs and 0.01 malpractice RVUs for a total of 0.15 RVUs. To determine payment, the RVUs shown above would need to be multiplied by the physician fee schedule conversion factor and 0.85 (to reflect the statutory requirement that payment be 85 percent of the amount determined under the physician fee schedule).
We also stated that, consistent with the definition in the CPT's Physical Medicine Rehabilitation codes, a group is considered to be 2 or more individuals and that Medicare co-payments and deductibles would apply for medical nutritional therapy services.
Comment: The American Dietetic Association (ADA) and many individuals submitted comments concerning the proposed reimbursement rate for medical nutrition therapy services. They stated that the proposed reimbursement rate for these services is too low and would result in limited beneficiary access to these services since private practice dietitians will choose not to participate. Some commenters referenced reimbursement rates currently paid by private insurers of $85 to $125 for 1 to 1 1⁄2 hours for an initial visit and $85 per hour for follow-up. They believe that the proposed rate for Medicare is far short of what was envisioned by the Congress. Commenters indicated that the statute clearly states that medical nutrition therapy payment should be 80 percent of the lesser of the actual charge or 85 percent of the amount determined under the physician fee schedule for the same service, provided by a physician. According to commenters, physicians who are also registered dietitians, use E/M codes 99213 through 99215 and 99244 when providing medical nutrition therapy services. The commenters stated that E/M codes 99203 through 99205 are appropriate reference points for determining medical nutrition therapy payment. The commenters also stated that any refinement of medical nutrition therapy values should be based on the underlying E/M codes that they believe are the statutory basis for medical nutrition therapy payment. While commenters acknowledge that physicians may perform other tasks besides nutritional assessment, therapy and counseling during an office visit, they believe those additional services are the basis for the Congress' instruction to reimburse non-physician providers of medical nutrition therapy at 85 percent of the amount physicians receive. The AMA's Health Care Professionals Advisory Committee (HCPAC) submitted a comment that suggested there should be physician work for medical nutrition therapy. This group provides recommendations on valuing services for codes used by non-physician providers. The HCPAC indicated that it evaluated each of the medical nutrition therapy codes and compared them to services that are available to other providers but not nutritionists (for example, physical therapy services). The comment further stated that the 15 percent reduction should not apply because the HCPAC took this into account when developing the recommendations. The HCPAC further added that there should be work values for medical nutrition therapy just as there are for physical and occupational therapy.
Response: We have reviewed the statute and legislative history. There is no indication that Congress envisioned a particular payment amount or expected us to use an E/M service to determine the value of medical nutrition therapy. Section 105(c) of the BIPA states that "the amount paid shall be 80 percent of the lesser of the actual charge for the services or 85 percent of the amount determined under the fee schedule established under section 1848(b) of the Act for the same services if furnished by a physician." The BIPA Conference Report indicates that payment will equal "the lesser of the actual charge for the service or 85 percent of the amount that would be paid under the physician fee schedule if such services were provided by a physician." The statute and Conference Report direct us to establish the physician fee schedule amount for nutrition therapy services. The Medicare allowed charge would equal 100 percent of the physician fee schedule amount if the services are performed by a physician and 85 percent of the physician fee schedule amount if the services are performed by a registered dietitian or nutrition professional. The commenters suggest that physicians currently bill for an E/M service when they provide nutrition services. We do not believe that it is appropriate to compare medical nutrition therapy provided by a registered dietitian to an E/M service provided by a physician. Registered dietitians do not take medical histories, they are not trained to and do not perform physical examinations, nor do they make medical decisions. Furthermore, when physicians use an E/M code to report the provision of counseling or coordination of care, they typically have also performed a medical history, physical examination, and engaged in medical decision making as part of that service. If such an individual performed a service that met the requirements of an E/M service, then it would be be appropriate for him or her to report an E/M service. Further, we note that the E/M services include not only an amount attributable to physician work, but also payment for physician practice expenses. For instance, a level 3 new patient office visit (CPT code 99203) includes payment for 50 minutes of nurse time. A level 3 established patient office visit (CPT code 99213) includes 36 minutes of nurse time. Both of these codes include additional compensation for medical equipment and supplies that are typically used in an office visit but are not used as part of a medical nutrition therapy service. If we were to adopt the commenters' view and crosswalk values for medical nutrition therapy to an E/M service, we would be including payment not only for the counseling service of the practitioner, but also, inappropriately for the costs of clinical personnel that are not involved in the nutrition therapy service.
Commenters indicated that the statute established the 85 percent adjustment to account for activities that are typically performed by a physician during an E/M service are not performed by a nutritionist. The statute and legislative history do not indicate that the 85 percent adjustment is intended to serve this purpose. In fact, the commenters themselves note that "consistent with other non-physician providers, reimbursement is set at a percentage of the physician's fee schedule." Under the physician fee schedule, we will pay a physician 80 percent of 100 percent of the physician fee schedule amount, and, if a non-physician practitioner provides an identical service, Medicare pays 80 percent of 85 percent of the physician fee schedule amount. For instance, under CPT code 99213, a level 3 established patient office visit is one of the most common services provided by physicians, physician assistants and nurse practitioners. Even though the service is considered to be identical, we can by law pay a physician assistant and nurse practitioner only 85 percent of what we pay a physician to do the same service. Thus, in the case of other practitioners, the percentage does not reflect that a non-physician practitioner provides fewer services than a physician. Because there is no indication in the statute that the 85 percent adjustment should apply differently in the context of medical nutrition therapy than for other services performed by non-physician practitioners, we believe it is appropriate to pay 80 percent of 100 percent of the physician fee schedule amount when medical nutrition therapy is provided by a physician and 80 percent of 85 percent of the physician fee schedule amount when the service is provided by a registered dietitian or nutrition professional.
In response to the comment about payment rates of private insurers for medical nutrition therapy, we cannot use such information in a relative value system to establish payment. Section 1848(c) of the Act requires us to establish RVUs that recognize the relative resources involved in furnishing different physician fee schedule services. Thus, our role is to establish the appropriate relative payment amounts. The total payment amount is determined under a formula prescribed in section 1848(d) of the Act. We have no authority to change the formula.
In response to the HCPAC recommendation, we reiterate that it is inappropriate to compare medical nutrition therapy services to E/M services performed by physicians. While medical nutrition therapy may be performed by a physician who is also a registered dietitian, this does not make it a physician's service that requires a work RVU. Physicians may occasionally perform other services that have no physician work, such as chemotherapy administration or the technical component of a diagnostic x-ray test. When such services with no physician work are performed by a physician, we do not establish a physician work RVU just because the service was performed by a physician in that instance. Physicians will occasionally meet the statutory qualifications to be considered a registered dietitian or nutrition professional who can bill Medicare for medical nutrition therapy services. In these circumstances, we will pay the physician 80 percent of 100 percent of the physician fee schedule amount. In this unusual circumstance, we are paying for a medical nutrition therapy service provided by a physician under section 1861(s)(2)(V) and not a physician's service under section 1861(s)(1) of the Act.
Comment: One comment indicated that the 85 percent adjustment should not apply because the RVUs we used are not based on physician work or physician practice expenses to deliver the service. This commenter indicated that we proposed an inadequate payment by not following the statutory scheme and proceeded to apply a 15 percent discount that is neither fair nor reasonable.
Response: The statute requires us to establish a physician fee schedule amount for the service and pay 80 percent of 100 percent of the amount if the service is provided by a physician and 80 percent of 85 percent if the service is provided by a registered dietitian or nutrition professional. We initially anticipated that physicians would never bill Medicare for medical nutrition therapy services because they generally would not meet the statutory requirements to be considered registered dietitians or nutrition professionals. In this circumstance, we agree that it seems unusual to apply a reduction for a service that seldom would be furnished by a physician. However, we believe that the statute requires that Medicare payment be based on the 85 percent level. We understand that, although not common, there are physicians who do meet the statutory requirements to be considered registered dietitians or nutrition professionals. In these circumstances, our payment to the physician will be based on 100 percent of the physician fee schedule amount, not the 85 percent that we will pay to a registered dietitian or nutrition professional. We believe the statute would not allow a physician who does not meet the statutory requirements for a registered dietitian or nutrition professional to be paid for a medical nutrition therapy service. If a physician provides medical nutrition counseling as part of a patient encounter that meets the requirements for an E/M service, the physician can bill Medicare for a physician's service.
Comment: We received one comment requesting that we clarify that Medicare will pay qualified providers in private practice settings or physician offices where they may be independent contractors. The commenter also asked how we intend to pay for medical nutrition therapy in the hospital outpatient department. The commenter also asked for clarification on reassignment of payment if a registered dietitian is an employee of physicians or hospital outpatient facilities.
Response: Medicare will pay qualified dietitians and nutrition professionals who enroll in the Medicare program regardless of whether they provide medical nutrition therapy services in an independent practice setting, hospital outpatient department or any other setting, with the exception of services provided to patients in an inpatient stay in a hospital or skilled nursing facility. In these circumstances, our payment to the hospital or skilled nursing facility includes payment for medical nutrition therapy. If a qualified practitioner provides medical nutrition therapy in any other setting, including a private practice setting, section 1833(a)(1)(T) of the Act requires that Medicare payment equal 80 percent of the lesser of actual charges or 80 percent of 85 percent of the amount determined under the physician fee schedule. Payment in the hospital outpatient department will be made under the physician fee schedule, not under the hospital outpatient prospective payment system.
Current rules regarding reassignment of benefits would apply to medical nutrition therapy. We want to emphasize that medical nutrition therapy cannot be provided incident to a physician's service unless the physician also meets the qualifications to bill Medicare as a registered dietitian or nutrition professional.
Comment: Commenters objected to the methodology used to establish the proposed RVUs for this service. They believe it is inappropriate to use the top-down or no-work pool methodology to determine medical nutrition therapy payment. They believe that medical nutrition therapy payment should not be based on comparison to a preventive medicine code (CPT code 99401) in the zero-work pool methodology. The commenters indicated that preventive medicine services omit the problem-oriented components of the comprehensive history, as well as other essential assessment points, such as the patient's chief complaint and history of present illness. They disagree with our assertion in the proposed rule that physicians do not perform nutrition services and assert that it is inappropriate to use the top-down or zero-work methodology to establish the RVU for medical nutrition therapy.
Response: We use the top-down methodology or no-work pool methodology to price the practice expense RVUs for all services priced under the Medicare physician fee schedule. Given that the statute indicates that medical nutrition therapy should be paid using the physician fee schedule, we believe it is reasonable and appropriate to use the same methodologies that we use to develop RVUs for other physician fee schedule services. With respect to use of the preventive medicine service, we used a service that we felt had similar practice expenses to medical nutrition therapy. It is not clear why practice expenses for a counseling service would differ based on the health status of the patient.
Comment: A commenter representing dietitians asked us to review the relativity of payment across the three medical nutrition CPT codes. The commenter indicated that payment for CPT code 97803 was set at 72.9 percent of proposed RVUs for CPT code 97802 and 97804 was set at 31 percent of CPT code 97802. The commenter argues that, because reassessments are shorter than initial assessments, the proposed RVUs are actually discounted twice (that is, less payment per 15 minutes of time as well as less total time). They believe that the value of CPT codes 97802 and 97803 should be identical. The commenters indicated that E/M services provided by physicians do not receive the same discount. The commenter also stated that the payment for CPT code 97804 was less than for other group services and gave the example of a nurse or pharmacist providing nutrition instruction under the diabetes self-management training benefit.
Response: We have reviewed the payments for CPT codes 97802 and 97803 and agree with the commenter that these two codes should have the same values. The essential difference between an initial and follow up medical nutrition therapy service is the time spent performing the service. Initial visits will be longer than follow-up visits and will likely involve Medicare payment for more increments of service. We will pay less for follow up visits because they will typically involve fewer 15 minute increments of time than an initial visit. The payment rate we are establishing in this final rule for CPT code 97803 will be the same as the proposed rate for CPT code 97802. We have also changed the payment rate for CPT code 97804 assuming that the code will normally be billed for 4 to 6 patients with the average of 5. Using the revised values, the payment rate for group medical nutrition therapy would approximate the hourly rate paid for other medical nutrition therapy services. (We note that the RVU units between the proposed and final rule show some marginal change because of changes made in the practice expense methodology that affect all physician fee schedule services). We do not agree with the comment that "evaluation and management services provided by physicians do not receive the same discount." E/M service are not time based services and, as stated above, for many reasons are inappropriate comparisons to medical nutrition therapy service codes.
Comment: Many commenters stated that co-payments must be structured so that they are not barriers to the medical nutrition therapy benefit.
Response: Section 105(c) of the BIPA modifies section 1833(a)(1) of the Act to add subparagraph (T) that requires that Medicare payment equal 80 percent of the lesser of the actual charge for the services or 85 percent of the amount determined under physician fee schedule. The statute requires the same coinsurance for medical nutrition therapy services that applies to other Part B services.
Comment: Commenters suggested that initial medical nutrition therapy sessions for treatment of diabetes or renal disease should be billed under CPT code 97802 and subsequent medical nutrition therapy sessions should be billed under CPT code 97803. New diagnoses due to a change in medical condition or unanticipated complications should be billed under CPT code 97802 and subsequent medical nutrition therapy sessions should be billed under CPT code 97803.
Response: At the present time, we are requiring that medical nutrition therapy be reported by using CPT codes 97802, 97803, and 97804. We will revisit our coding requirements when we publish the NCD for medical nutrition therapy. The NCD will set forth the structure of the medical nutrition therapy benefit in detail. We will make a decision concerning creation or modification of codes and creation of modifiers for reporting medical nutrition therapy once the NCD has been published. Until the NCD is published, creation or modification of codes and creation of modifiers would be premature. Therefore, we are requiring that the initial individual medical nutrition therapy visit be reported as CPT code 97802 and all follow up visits (for interventions and reassessments) for individual medical nutrition therapy be reported as CPT code 97803. All group medical nutrition therapy visits should be reported as CPT code 97804 whether they are initial or follow up visits.
Comment: Commenters urged us to define medical nutrition therapy descriptors consistently. They stated that the descriptors in Table 5 of the proposed rule should agree with the descriptors in § 414.132.
Response: We agree. We will make the descriptors for medical nutrition therapy consistent with the nomenclature in CPT and our regulations.
Comment: We received a comment that recommended that we consider including additional items in the practice expense inputs for medical nutrition therapy. The commenter indicated that inputs should include staff costs for training on billing procedures, Health Insurance Portability and Accountability Act training, audit expenses, and other costs resulting from Medicare policies and procedures. The commenter indicated that expenses of registered dietitians in private practice differ little from other practitioners.
Response: There are two major data sources used in the practice expense methodology-estimates of direct inputs and aggregate practice expense per hour information from the AMA's Socioeconomic Monitoring Survey. At this time, we are using the practice expense per hour for all physicians to establish the practice expense RVUs for medical nutrition therapy. We are not currently using the estimates of direct expenses for medical nutrition therapy because the services are valued in the no-work pool. However, we are researching alternatives to the no-work pool that would allow all no-work services to be priced under the top-down methodology. If we develop such an alternative, the estimates of direct expenses will be important in determining the RVUs for medical nutrition therapy. Indirect expenses are based on physician work and direct inputs. We believe that many of the costs identified by this commenter are indirect costs that would likely be included in practice expenses reported through the SMS survey. Since the commenter has suggested that practice expenses for private practice registered dietitians differ little from other practitioners, we believe the average practice expense per hour for all physicians is sufficient to use in the practice expense methodology.
Result of Evaluation of Comments
The payment rate we are establishing in this final rule for CPT code 97803 will be the same as the rate for CPT code 97802. We are also changing the payment rate for CPT code 97804 using the assumption that the code will normally be billed for 4 to 6 patients with the average of 5. Using these revised values, the payment rate for group medical nutrition therapy will approximate the hourly rate paid for other medical nutrition therapy services.
F. Telehealth Services
Beginning October 1, 2001, the BIPA amended section 1834 of the Act to specify that we pay a physician (as defined in section 1861(r) of the Act) or a practitioner (described in section 1842(b)(18)(C) of the Act) for telehealth services that are furnished via a telecommunications system to an eligible telehealth individual.
The BIPA defined Medicare telehealth services as professional consultations, office or other outpatient visits, and office psychiatry services identified as of July 1, 2000, by CPT codes 99241 through 99275; 99201 through 99215, 90804 through 90809 and 90862 (and as we may subsequently modify) and any additional service we specify. The BIPA defines an eligible telehealth individual as an individual enrolled under Part B who receives a telehealth service furnished at an originating site.
Section 1834(m) of the Act, as added by the BIPA, limited an originating site to a physician's or practitioner's office, hospital, critical access hospital, rural health clinic, or Federally qualified health center. Additionally, the BIPA specified that the originating site must be located in one of the following geographic areas:
• In an area that is designated as a rural health professional shortage area (HPSA) under section 332(a)(1)(A) of the Public Health Service Act.
• In a county that is not included in a Metropolitan Statistical Area (MSA).
However, an entity participating in a Federal telemedicine demonstration project that has been approved by, or receives funding from us as of December 31, 2000 would not be required to be in a rural HPSA or non-MSA.
The BIPA also required that we pay a physician or practitioner located at a distant site that furnishes a telehealth service to an eligible telehealth beneficiary an amount equal to the amount that the physician or practitioner would have been paid under Medicare had the service been furnished without the use of a telecommunications system.
This section also provided for a facility fee payment for the period beginning October 1, 2001 through December 31, 2002, to the originating site of $20. For each subsequent year, the facility fee for the preceding year is increased by the percentage increase in the MEI as defined in section 1842(i)(3) of the Act. The BIPA also amended section 1833(a)(1) of the Act to specify that the amount paid must be 80 percent of the lesser of the actual charge or the amounts specified in new section 1834(m)(2) of the Act.
In order for us to have this benefit expansion implemented timely, we have used a program memorandum. The program memorandum was effective October 1, 2001. This final rule will be effective January 1, 2002.
The rule published on August 2, 2001 proposed to establish policies for implementing the provisions of section 1834(m) of the Act, as added by the BIPA, that change Medicare payment for telehealth services.
We proposed to revise § 410.78 to specify that Medicare beneficiaries are eligible for telehealth services only if they receive services from an originating site located in either a rural HPSA as defined by section 332(a)(1)(A) of the Public Health Services Act or in a county outside of a MSA as defined by section 1886(d)(2)(D) of the Act.
1. Definitions
Section 1834(m)(4)(F) of the Act, which was added by the BIPA and became effective for services beginning October 1, 2001, defined telehealth services as professional consultations, office and other outpatient visits, individual psychotherapy, pharmacologic management, and any additional service we specify. Additionally, this provision identified covered services by HCPCS codes identified as of July 1, 2000. We proposed to revise § 410.78 to implement this coverage expansion to include the following services (and corresponding CPT codes):
• Consultations (codes 99241 through 99275).
• Office and other outpatient visits (codes 99201 through 99215).
• Individual psychotherapy (codes 90804 through 90809).
• Pharmacologic management (code 90862).
We solicited comments regarding the guidelines that we should use to make additions or deletions of services. We also solicited comments about specific services that may be appropriate to be covered under the Medicare telehealth benefit.
In this final rule, we are specifying at § 410.78 that, except for the use of store and forward technology in the demonstration programs conducted in Alaska or Hawaii, an interactive telecommunications system must be used and the medical examination of the patient must be at the control of the physician or practitioner at the distant site. We are defining interactive telecommunications system as multimedia communications equipment that includes, at a minimum, audio and video equipment permitting two-way, real-time interactive communication between the patient and physician or practitioner at the distant site. We are also specifying that telephones, facsimile machines, and electronic mail systems do not meet the definition of an interactive telecommunications system.
A patient need not be present for a Federal telemedicine demonstration program conducted in Alaska or Hawaii. We are specifying that for Federal telemedicine demonstration programs conducted in Alaska or Hawaii, Medicare payment is permitted for telehealth when asynchronous store and forward technologies, in single or multimedia formats, are used as a substitute for an interactive telecommunications system. Additionally, we are specifying that the physician or practitioner at the distant site must be affiliated with the demonstration program.
We are defining asynchronous, store and forward technologies, as the transmission of the patient's medical information from an originating site to the physician or practitioner at the distant site. The physician or practitioner at the distant site can review the medical case without the patient being present. An asynchronous telecommunications system in single media format does not include telephone calls, images transmitted via facsimile machines, and text messages without visualization of the patient (electronic mail). Photographs must be specific to the patient's medical condition and adequate for rendering or confirming a diagnosis or treatment plan. Finally, we are defining the originating site as the location of an eligible telehealth individual at the time the service being furnished via a telecommunications system occurs.
2. Conditions of Payment
The BIPA changed the telepresenter requirements. In accordance with section 1834(m)(2)(C) of the Act, a telepresenter is not required to be present. Therefore, we would not require a telepresenter as a condition of Medicare payment.
Section 1834(m)(1) of the Act requires that Medicare make payments for telehealth services furnished via a telecommunications system by a physician or a practitioner (described in section 1842(b)(18)(C) of the Act). Non-physician practitioners described in this section of the Act include nurse practitioners, physician assistants, clinical nurse specialists, certified nurse midwives, clinical psychologists, clinical social workers, and certified registered nurse anesthetists or anesthesiologists' assistants. Section 1834(m)(2) of the Act specifies that we pay the physician or practitioner at the distant site who furnishes a telehealth service an amount equal to the amount that the physician or practitioner would have been paid under Medicare had the service been furnished without the use of a telecommunications system.
Certified registered nurse anesthetists and anesthesiologists' assistants would not be permitted to bill for and receive payment for a telehealth service under this provision. Under the Medicare program, these practitioners do not receive payment for office visits, consultation, individual psychotherapy, or pharmacologic management when these services are furnished without the use of a telecommunications system. Section 1834(m)(2) of the Act specifies that we pay to the distant site physician or practitioner an amount equal to what would have been paid for the service without the use of a telecommunications system. Therefore, certified registered nurse anesthetists and anesthesiologists' assistants would not receive payment for telehealth services.
We proposed at § 410.78 that, as a condition of Part B payment for telehealth services, the physician or practitioner at the distant site must be licensed to provide the service under State law.
Section 1834(m)(2)(A) of the Act specifies that the payment amount for the professional service is equal to the amount that would have been paid without the use of a telecommunications system. Medicare payment for physicians' services is generally based, under section 1848 of the Act, on the resource-based physician fee schedule. Payment to other health care practitioners listed earlier, authorized under section 1833 of the Act, is based on a percentage of the physician fee schedule payment amount. Therefore, we will pay for office or other outpatient visits, consultation, individual psychotherapy, and pharmacologic management services furnished by physicians at 80 percent of the lower of the actual charge or the fee schedule amount for physicians' services. We will also pay for services furnished by other practitioners at 80 percent of the lower of the actual charge or that practitioner's respective percentage of the physician fee schedule.
Section 1834(m)(2) of the Act provides for a professional fee for the physician or practitioner at the distant site (equal to the applicable Part B fee schedule amount) and a $20 facility fee for the originating site. Telepresenters are not required, unless one is deemed medically necessary by the physician or practitioner at the distant site. The BIPA does not address the issue of payment for the telepresenter. The Office of the Inspector General has advised us that permitting the physician or practitioner at the distant site to pay the telepresenter creates a significant risk under the anti-kickback statute. Therefore, we establish in § 414.65 that payments made to the distant site physician or practitioner for professional fees, including deductible and coinsurance (for the professional service), are not to be shared with the referring practitioner or telepresenter.
However, the telepresenter could bill and receive payment for services that are not telehealth services that a telepresenter would otherwise be allowed to provide under the Medicare statute, including services furnished on the same day as the telehealth service.
The BBA prohibited any payment for line charges or facility fees associated with a professional consultation via a telecommunications system. Section 1834(m)(2)(B) of the Act, as added by the BIPA, provides for a facility fee payment to the originating site, specifying that the amount of payment is 80 percent of the lesser of the actual charge or a facility fee of $20.00. The BIPA further specifies that, beginning January 1, 2003, the originating facility fee be increased annually by the Medicare Economic Index (MEI) as defined in section 1842(i)(3) of the Act. Additionally, we clarify that the Geographic Practice Cost Index (GPCI) would not apply to the facility fee for the originating site. This fee is statutorily set and is not subject to the geographic payment adjustments authorized under the physician's fee schedule. The beneficiary is responsible for any unmet deductible amount and Medicare coinsurance. We would revise § 414.65 to provide for payment of a facility fee to the originating site.
Section 1834(m)(3) of the Act specifies that sections 1842(b)(18)(A) and (B) apply to physicians and practitioners receiving payment for telehealth services and to originating sites receiving a facility fee, in the same manner as they apply to practitioners. This section requires that payment for such services may only be made on an assignment-related basis. We did not reflect this provision in the proposed rule. Because this requirement is specified in the BIPA and we have no discretion, we are implementing it in this final rule in new § 414.65(d).
Comment: One commenter believed that requiring an originating site to be located in a rural HPSA or non-MSA county would not permit medical practitioners located in urban and suburban areas to offer telehealth services.
Response: We clarify that, as a condition of payment under Medicare, the originating site must be located in a rural HPSA or non-MSA county. The physician or practitioner at the distant site, who provides the telehealth service, is not subject to these limitations. For example, a psychologist in Salt Lake City, Utah would be able to provide a mental health visit to a beneficiary at a physician's office located in a non-MSA county.
Comment: We received various comments on the definition of an originating site. Many commenters believe that the list of facilities eligible to be a telehealth originating site should be expanded beyond those specified in the statute. Specific suggestions were received to include the patient's residence, skilled nursing facilities, nursing homes, and community mental health centers as originating site facilities within this provision. Another commenter suggested that we recommend legislative changes to remove the requirement that an originating site facility be located in a HPSA or non-MSA county.
Moreover, one organization requested that all locations included within the Alaska Native Tribal Health Consortium, including but not limited to outpatient health facilities recognized by the Indian Health Service as tribal health facilities be included as an originating site. The commenter requested that these sites be defined as an originating site regardless of whether they are certified as a Medicare Federally qualified health center or not.
Response: Section 1834(m) of the Act defines an originating site facility to include only a physician's or practitioner's office, hospital, critical access hospital, rural health clinic or Federally qualified health center. Further, the Act specifies that the originating site must be located in a rural HPSA or non-MSA county. We do not have the legislative authority to expand the definition of a telehealth originating site beyond this provision. However, we will be studying this issue as part of a report to the Congress as authorized by section 223(d) of the BIPA.
Comment: One specialty college requested confirmation that the patient's medical information provided via store and forward telehealth is furnished to the physician or practitioner at the distant site in order to recommend or confirm a diagnosis and or treatment plan and not to provide a formal interpretation of imaging exams.
Response: The commenter is correct. Payment for services via store and forward technology under this provision does not include formal interpretation of an imaging exam. Medicare currently allows coverage and payment for medical services delivered via a telecommunications system that do not require a face-to-face "hands on" encounter. Section 2020(A) of the Medicare Carriers Manual addresses this issue and lists radiology, electrocardiogram, and electroencephalogram interpretations as examples of such services.
Comment: In the proposed rule, we requested comments on the guidelines that we should use to make additions or deletions to covered Medicare telehealth services. We also requested suggestions and comments about specific services that may be appropriate for payment under the Medicare telehealth benefit. In response to our solicitation, we received one comment regarding the guidelines we should use to make changes to the scope of Medicare telehealth coverage. Ten commenters provided specific suggestions regarding additional services that may be appropriate for the Medicare telehealth benefit.
Several commenters indicated that a psychiatric diagnostic interview, CPT code 90801, would be appropriate for Medicare telehealth payment. One association stated that the elements of this service are directly comparable to a new patient office visit, which the law defines as a telehealth service. Given that the law permits us to add additional services as appropriate, this commenter suggested that we include a psychiatric diagnostic interview within the definition of a telehealth service. Another association suggested that interactive psychotherapy, CPT codes 90810, 90812 and 90814, should be covered Medicare telehealth services. Interactive psychotherapy uses play equipment, physical devices and other mechanisms of non-verbal communication in an office or outpatient facility.
Several commenters suggested that telerehabilitation interventions that provide education, mentoring and consultation be included within the scope of Medicare telehealth coverage. The commenters specifically note that speech therapy and physical and occupational therapy should be included as telehealth services.
One consortium requested that all services provided under the Federal telehealth project in Alaska be included as covered telehealth services within this provision. The commenter believes that virtually all evaluation management and psychiatry services should be included as Medicare telehealth services. Additionally, the commenter notes that many respiratory, digestive, ophthalmology and otorhinolaryngology services are appropriate for telehealth coverage.
One organization suggested that we consider guidelines similar to those currently in place for non-telehealth services. For instance, the commenter stated the service should be reasonable and necessary, safe and effective, medically appropriate, and provided within the purview of accepted standards of medical practice. The commenter stresses that the type of technology used to deliver the service should be secondary to the reasonable and necessary criteria.
Response: We will use these comments and suggestions to assist us in establishing guidelines for a telehealth coverage process and the addition of specific telehealth services that may be appropriate for Medicare beneficiaries. However, we do not believe it would be appropriate to expand the scope of telehealth services beyond the services explicitly listed in the Act until we have a process in place for adding new telehealth services.
Comment: With regard to the definition of a "telecommunications system", one organization encouraged us to permit store and forward technologies in other circumstances beyond federal telemedicine demonstration projects conducted in Alaska or Hawaii. The commenter believes that emphasis should be given to whether a particular service is reasonable and necessary rather than specific technology requirements. Moreover, the commenter stated that the face-to-face requirement is outdated for telehealth as well as other areas of the Medicare fee schedule and suggested that current technology, such as electronic mail, permits physicians to care for their patients even when the patient is not present.
Response: Section 1834(m) of the Act defines a telehealth service as office and other outpatient visits (99201 through 99215), professional consultations (99241 through 99275), individual psychotherapy (90804 through 90809), and pharmacologic management (90862). Further, the law specifies that payment must be equal to what would have been paid without the use of a telecommunications system.
As a condition of payment under Medicare, these services require a face-to-face patient encounter. We believe that the patient's presence and use of an interactive audio and video telecommunications system permitting the distant site practitioner to interact with the patient provides a reasonable substitute for a face-to-face encounter. The law provides for the use of asynchronous, store and forward technologies for delivering telehealth services only for telemedicine demonstration projects conducted in Alaska or Hawaii. We do not have the authority to expand the use of store and forward technology in delivering telehealth services.
Comment: One organization in a remote region requested that a definition of a telepresenter be added to § 410.78. The commenter suggested we permit a certified community health aid to present a patient when the aide is the only medical professional available to act as a telepresenter.
Response: The physician or practitioner at the distant site has the authority to determine whether it is medically necessary to require a telepresenter and, if necessary, the appropriate medical professional needed to present the patient. We do not believe it is appropriate for us to specify the type of medical professionals that are necessary to act as a telepresenter.
Comment: We received conflicting comments concerning interstate telehealth services. One organization requested that we require the physician or practitioner at the distant site to be licensed in the State where the originating site is located. On the other hand, an association requested clarification that the physician or practitioner at the distant site only needs to be licensed in the State where he or she is located and does not need to be licensed in the State where the originating site is located. Another commenter requested that we clarify that the service is considered rendered where the distant site physician or practitioner is located.
Response: We defer to State law regarding licensure issues. When the State law for the originating site permits an out-of-State practitioner to provide a telehealth service, without being licensed in the State in which the originating site is located, Medicare would make payment for the telehealth service. However, when State law precludes an out-of-State practitioner from delivering a telehealth service, Medicare would not pay for that service.
We clarify that for payment purposes, the site of service for the telehealth service is the location of the physician or practitioner at the distant site. Given that section 1834(m) of the Act specifies that payment to the physician or practitioner at the distant site must be equal to the amount that would have been paid without the use of telehealth, it is appropriate to use the Geographic Practice Cost Index (GPCI) relevant to the distant site. However, our determination of the distant site physician's or practitioner's location as the site of service for Medicare payment is not intended to make a comment regarding the scope of medical practice.
Comment: One consortium believes that the proposed rule would not permit the physician or practitioner at the distant site to bill for a telehealth service when State or Federal law exempts a physician or practitioner from being licensed in the State in which he or she is currently employed. The consortium is a Federal telemedicine demonstration project that would be permitted to use store and forward telecommunications technologies in delivering telehealth services. The commenter notes that the State of Alaska exempts physicians or practitioners who are part of the military or Public Health Service that provide health care services in Alaska from its licensure requirements. Further, the commenter stated that Federal law authorizes health care professionals who are members of the military providing services for the Department of Defense to practice in any State provided the professionals are licensed in a State, the District of Columbia or other specific locations. The commenter also noted that current Medicare manual instructions specify that when a physician in a Federal hospital provides services to the public generally as a community institution, he or she may be considered as meeting the statutory definition of a physician even though he or she may not have a license to practice in the State in which he or she is employed.
Response: The telehealth provision does not affect State or Federal legislation providing certain physicians or practitioners an exemption from State licensure. When Federal or State law exempts a physician or practitioner from State licensure, then the physician or practitioner at the distant site is permitted to provide a telehealth service regardless of whether he or she is licensed within the State where he or she is employed.
Comment: One organization requested that § 414.65(a)(2) be revised to specify for what services the physician or practitioner who presents the patient could bill. The commenter believes that when the physician at the distant site determines that it is medically necessary for another practitioner to assist in providing the telehealth service, the telepresenter should be compensated. The commenter suggested that a telepresenter be permitted to bill for a consultation or confirmatory consultation.
Response: On the day the telehealth service occurs, the telepresenter may bill and receive payment for services that are not telehealth services that he or she would otherwise be allowed to provide under Medicare. A telepresenter, for example, a nurse practitioner, could bill for and be paid for a medically necessary office, outpatient or inpatient visit preceding or subsequent to a telehealth service. Additionally, the telepresenter could be paid for other medically necessary services requested by the physician or practitioner at the distant site. However, the physician at the distant site may not share any portion of the telehealth payment with the telepresenter or referring practitioner. We do not agree that § 414.65(a)(2) should be changed to specify the services for which a telepresenter can and cannot bill. This section implements payment for telehealth services only, and the Act does not provide for a payment to the telepresenter for telehealth services.
Comment: Many organizations and individual commenters expressed overall support for the revision of Medicare payment for telehealth. Specifically, commenters mentioned removal of the fee sharing requirement, relaxed conditions of payment, and the addition of non-MSA counties to the geographic areas eligible for telehealth under Medicare. The commenters noted that these changes will have a positive effect on health care delivery and will help provide services to areas where specialty care is sparse.
Response: We agree that the proposed revisions to Medicare telehealth coverage and payment policies, as authorized by the BIPA, remove significant barriers for physicians and practitioners wishing to provide telehealth services.
Comment: One commenter indicated that the cost of collecting the coinsurance for the originating site facility fee could easily exceed the amount the facility would collect from the beneficiary. The commenter encouraged us to permit originating sites to waive the coinsurance in those situations where the telehealth facility charge is the only amount to be billed to the beneficiary.
Response: We do not have the authority to eliminate the coinsurance requirement outright for telehealth originating sites. However, Medicare permits the waiver of coinsurance for limited situations. Section 5220 of the Medicare Carriers Manual specifies that physicians and suppliers may waive billing for or collection of coinsurance or deductibles for indigent patients or when the physicians' or suppliers' cost of billing or collecting exceeds or is disproportionate to the amounts to be collected. Documentation must be sufficient to support that costs for billing the beneficiary exceed or are disproportionate to the amount collected from the beneficiary. In this instance, the amount collected refers to 20 percent of the originating site telehealth facility fee.
We clarify that when the patient owes additional coinsurance to the originating site for other Medicare services, billing for the telehealth facility fee coinsurance amount may be consolidated with the coinsurance amount owed for those services. We believe that this would resolve the commenter's concern that the cost for billing and or collecting the coinsurance for a single facility fee could exceed or be disproportionate to the amount collected from the beneficiary.
Comment: One association submitted a number of comments that have payment implications for the Federally qualified health center benefit.
Response: These issues involve specific aspects of the Federally qualified health center payment methodology and are beyond the scope of this provision. We will take these comments into consideration in formulating future instructions for payment implications on FQHCs.
Result of Evaluation of Comments
We are implementing this provision as stated above.
G. Indian Health Service
The Indian health care system provides primary health care to many American Indian and Alaska Native Medicare beneficiaries. This system consists of programs operated by a Federal agency, the Indian Health Service (IHS), and Federally funded programs operated by Indian tribes, tribal organizations, and urban Indian organizations (as those terms are defined in section 4 of the Indian Health Care Improvement Act). These programs deliver a range of clinical and preventive health services to their beneficiaries through a network of facilities including hospitals and outpatient clinics. Programs operated in IHS-owned or leased facilities, by IHS or by tribes or tribal organizations, are considered "Federal providers" by Medicare. Sections 1814(c) and 1835(d) of the Act generally prohibit payment to Federal providers, subject to exceptions contained in section 1880 of the Act for these IHS facilities. Before enactment of the BIPA, the exception in section 1880 of the Act was applicable only to IHS owned or leased hospitals, provider-based clinics, and skilled nursing facilities (regardless of whether the entity is tribally operated). The exception did not permit Medicare to pay for services furnished by IHS owned or leased free-standing outpatient clinics or to pay any IHS owned or leased facilities for services by physicians and other practitioners paid under a fee schedule.
Effective July 1, 2001, section 432 of the BIPA extends the exception in section 1880 of the Act to permit Medicare payments to hospitals and outpatient clinics (provider-based or free-standing), operated by the IHS or by a tribe or tribal organization, for services furnished by physicians and specified non-physician practitioners in or at the direction of the hospital or outpatient clinic. Payments for these services are made to the hospital or outpatient clinic, not to the physician or other practitioner. These payments are subject to the same situations, terms, and conditions as would apply if the services were furnished in, or at the direction of, a hospital or outpatient clinic that is not operated by the IHS or by a tribe or tribal organization. The payments include incentive payments for physicians furnishing covered physicians' services in rural or urban health professional shortage areas (HPSAs) if the usual HPSA criteria are met. (For further information see section 1833 of the Act and § 414.42 of our regulations.) Payments will not be made under these provisions to the extent that Medicare is otherwise paying for the same services under other provisions (for example, as part of a bundled payment, or if a tribal outpatient clinic continues to bill as a Federally qualified health center (FQHC)).
We have added a new § 410.46 to our regulations to reflect this new statutory provision. Due to the statutory effective date of July 1, 2001, we implemented this BIPA provision through program memorandum instructions.
Result of Evaluation of Comments
We received no comments on the statutory requirement to pay Indian Health Service and tribal hospitals and clinics for the services of physicians and other practitioners under Medicare fee schedules.
H. Pathology Services
The November 2, 1999 final rule (64 FR 59380) provided that, for services furnished on or after January 1, 2001, carriers would no longer pay claims to independent laboratories under the physician fee schedule for the technical component (TC) of physician pathology services for hospital inpatients. Before that rule, independent laboratories could bill the carrier under the physician fee schedule for the TC of a physician pathology service furnished to a hospital inpatient. Also, under that rule, independent laboratories would still have been able to bill and receive payment for the TC of physician pathology services furnished to patients who are not hospital inpatients.
Section 542 of the BIPA requires the Medicare carrier to continue to pay for the TC of physician pathology services when an independent laboratory furnishes these services to an inpatient or outpatient of a covered hospital. The BIPA provisions apply to TC services furnished during the 2-year period beginning January 1, 2001 and continuing through December 31, 2002. We informed the carriers and the intermediaries of this provision through program memorandum AB-01-47, which was issued in March 2001. This program memorandum requested the carriers to notify independent laboratories of this provision in their next regularly scheduled bulletin and to place this bulletin on their Internet web site. In the absence of further legislation, the policy of the November 1999 final rule will take effect for the TC of physician pathology services furnished to hospital patients after December 31, 2002. We have revised § 415.130 to conform to the statutory change in section 542 of BIPA concerning the payment for the TC of physician pathology services.
Result of Evaluation of Comments
We have received no comments on this issue.
IV. Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule; Responses to Public Comments on the Five-Year Review of Work Relative Value Units
A. Scope of Five-Year Review
This final rule includes the culmination of the 5-year review of work RVUs required by statute. The work RVUs affected by this review will be effective for services furnished beginning January 1, 2002.
In our June 8, 2001 proposed notice (66 FR 31028), we explained the process used to conduct the 5-year review of work RVUs. During the comment period we received approximately 35 public comments on approximately 900 codes. After review by our medical staff, we forwarded all of the comments we received concerning potentially misvalued services to the AMA's Specialty Society Relative Value Update Committee (RUC).
The RUC submitted work RVU recommendations for all of the codes we forwarded with the exception of the anesthesia codes and conscious sedation codes. We analyzed all of the RUC recommendations and evaluated both the recommended work RVUs and the rationale for the recommendations. If we had concerns about the application of a particular methodology, but thought the recommended work RVUs were reasonable, we verified that the recommended work RVUs were appropriate by using alternative methodologies. (For additional information on the review process, please see the proposed notice published June 8, 2001.)
B. Review of Comments (Includes Table 4 Work RVU Refinements of 5-Year Review Codes Commented on in Response to the June 8, 2001 Proposed Notice)
During the comment period for our June 8, 2001 proposed notice, commenters generally supported our proposed changes. We received more than 125 comments on approximately 39 specific codes plus all the anesthesia services. The majority of these comments addressed the gastrointestinal endoscopy codes and anesthesia services.
We convened a multispecialty panel of physicians to assist us in the review of the comments. The comments we did not submit for panel review are discussed at the end of this section. The panel was moderated by our medical staff and consisted of:
• Clinicians representing the commenting specialties, based on our determination of those specialties which are most identified with the services in question. Although commenting specialties were welcomed to observe the entire refinement process, they were only involved in the discussion of those services for which they were invited to participate.
• Primary care clinicians nominated by the American Academy of Family Physicians and the American College of Physicians and American Society of Internal Medicine.
• Four carrier medical directors.
• Four clinicians with practices in related specialties who had knowledge of the services under review.
We submitted 6 codes for evaluation by the panel. The panel discussed the work RVUs involved in each procedure under review in comparison to the work RVUs associated with other services on the fee schedule. We assembled a set of reference services and asked each panel member to compare the clinical aspects for the services they believed were incorrectly valued to one or more of the reference services. In compiling the reference set, we attempted to include-(1) services that are commonly performed whose work RVUs are not controversial; (2) services that span the entire work spectrum from the easiest to the most difficult; and (3) at least three services performed by each of the major specialties so that each specialty would be represented. The reference set listed over 300 services. Group members were encouraged to make comparisons to these reference services. The intent of the panel process was to capture each participant's independent judgement based on the discussion and his or her clinical experience. Following each discussion, each participant rated the work for the procedure. Ratings were individual and confidential; there was no attempt to achieve consensus among the panel members.
We then analyzed the ratings based on a presumption that the RVUs in the proposed notice were correct. To overcome this presumption, the inaccuracy of the proposed RVUs had to be apparent to the broad range of physicians participating in each panel.
Ratings of work were analyzed for consistency among the groups represented on each panel. We used statistical tests to determine whether there was enough agreement among the groups on the panel, and whether the agreed-upon RVUs were significantly different from the proposed RVUs published in the June 8, 2001 proposed notice. We did not modify the RVUs unless there was a clear indication for a change. If there was agreement across groups for change, but the groups did not agree on what the new RVUs should be, we eliminated the outlier group, and looked for agreement among the remaining groups as the basis for new RVUs. We used the same methodology in analyzing the ratings that we first used in the refinement process for the 1993 fee schedule. The statistical tests we used are described in detail in the November 25, 1992 final rule (57 FR 55938).
Our decision to convene a multispecialty refinement panel of physicians and to apply the statistical tests referred to above was based on our need to balance the interests of those who commented on the work RVUs against the redistributive effects that would occur in other specialties. Of the 6 codes reviewed by the multispecialty panel, all were the subject of requests for increased values.
We also received comments that we did not submit to the panels for a variety of reasons. These comments are discussed later in this section. Of the proposed codes that were reviewed, 3 increased, and 3 were not changed.
Table 4.-Work Relative Value Unit Refinements of Five-Year Review Codes Commented on in Response to the June 8, 2001 Proposed Notice
Table 4 lists the codes reviewed during the 5-year review on which we received comments. This table includes the following information:
• CPT/HCPCS Code. This is the CPT or alphanumeric HCPCS code for a service.
• Modifier. A modifier-26 is shown if the work RVUs represent the professional component of the service.
• Description. This is an abbreviated version of the narrative description of the code.
• Proposed Work RVUs. This column includes the work RVUs proposed in the June 8, 2001 proposed notice for each reviewed code.
• Requested Work RVUs. This column identifies the work RVUs requested by the commenters. If the commenters requested different RVUs, the table lists the highest requested RVUs. For some codes we received recommendations for an increase but no specific RVUs were recommended.
• RUC Recommendation. This column identifies the work RVUs recommended by the RUC if the RUC made a specific work value recommendation as part of its comments on the June 8, 2001 proposed notice.
• 2002 Work RVUs. This column contains the 2002 work RVUs.
• Basis for Decision. This column indicates whether:
+ The recommendations of the multispecialty refinement panel were the basis upon which we determined that the proposed work RVUs published June 8, 2001 should be retained (indicator 1).
+ A new value emerged from our analysis of the refinement panel ratings (indicator 2).
+ A new or retained value came from review of the comment(s) received (indicator 3).
+ A new value came from the need to make a rank-order change to maintain or correct existing relationships among services (indicator 4).
+ A value is retained and the code has been referred to the RUC (indicator 5).
+ There is no change in value but we have adjusted the global period (indicator 6).
| CPT/HCPCS Code1 | Mod | Descriptor | Proposed Work RVU | Requested Work RVU | RUC REC | 2002 Work RVU | Basis for decision |
|---|---|---|---|---|---|---|---|
| 00100-01999 | Anesthesia services | (2 ) | (3 ) | (2 ) | #5 | ||
| 11055 | Trim skin lesion | 0.27 | 0.43 | 0.43 | #3 | ||
| 11056 | Trim skin lesion, 2 to 4 | 0.39 | 0.61 | 0.61 | #3 | ||
| 11057 | Trim skin lesions, over 4 | 0.50 | 0.79 | 0.79 | #3 | ||
| 11719 | Trim nail(s) | 0.11 | 0.17 | 0.17 | #3 | ||
| 27286 | Fusion of hip joint | 23.45 | 23.45 | #4 | |||
| 36400 | Drawing blood | 0.18 | 0.38 | 0.38 | #2 | ||
| 36405 | Drawing blood | 0.18 | 0.32 | 0.31 | #2 | ||
| 38510 | Biopsy/removal, lymph nodes | 6.43 | 6.43 | #6 | |||
| 38571 | Laparoscopy, lymphadenectomy | 12.38 | 19.84 | 14.68 | #2 | ||
| 38740 | Remove armpit lymphnodes | 10.02 | 10.03 | 10.03 | #3 | ||
| 38745 | Remove armpit lymph nodes | 13.00 | 13.10 | 13.10 | #3 | ||
| 38760 | Remove groin lymph nodes | 12.94 | 12.95 | 12.95 | #3 | ||
| 39503 | Repair of diaphragm hernia | 34.85 | 95.00 | 95.00 | #3 | ||
| 43219 | Esophagus endoscopy | 2.80 | 3.18 | 2.80 | #3 | ||
| 43239 | Upper GI endoscopy, biopsy | 2.69 | 2.87 | 1 2.87 | #3 | ||
| 43244 | Upper GI endoscopy/ligation | 4.59 | 5.05 | 5.05 | #3 | ||
| 43247 | Operative upper GI endoscopy | 3.39 | 3.40 | 3.39 | #3 | ||
| 43249 | Esoph endoscopy, dilation | 2.90 | 3.25 | 2.90 | #3 | ||
| 43255 | Operative upper GI endoscopy | 4.40 | 4.82 | 4.82 | #3 | ||
| 43259 | Endoscopic ultrasound exam | 4.89 | 6.53 | 4.89 | #3 | ||
| 43263 | Endo cholangiopancreatograph | 6.19 | 7.29 | 7.29 | #3 | ||
| 43265 | Endo cholangiopancreatograph | 8.90 | 10.02 | 10.02 | #3 | ||
| 43269 | Endo cholangiopancreatograph | 6.04 | 8.21 | 8.21 | #3 | ||
| 44388 | Colon endoscopy | 2.82 | 3.24 | 2.82 | #3 | ||
| 44389 | Colonoscopy with biopsy | 3.13 | 3.54 | 3.13 | #3 | ||
| 44390 | Colonoscopy for foreign body | 3.83 | 4.25 | 3.83 | #3 | ||
| 44391 | Colonoscopy for bleeding | 4.32 | 5.25 | 4.32 | #3 | ||
| 44392 | Colonoscopy and polypectomy | 3.82 | 4.23 | 3.82 | #3 | ||
| 44393 | Colonoscopy, lesion removal | 4.84 | 5.79 | 4.84 | #3 | ||
| 45380 | Colonoscopy and biopsy | 4.01 | 4.44 | 1 4.44 | #3 | ||
| 49605 | Repair umbilical lesion | 22.66 | 76.00 | 76.00 | #3 | ||
| 56515 | Destruction, vulva lesion(s) | 2.76 | 3.63 | 2.76 | #1 | ||
| 56605 | Biopsy of vulva/perineum | 1.10 | 1.10 | 4 1.10 | #3 | ||
| 56810 | Repair of perineum | 4.13 | 4.13 | 4 4.13 | #3 | ||
| 57500 | Biopsy of cervix | 0.97 | 0.97 | #5 | |||
| 58100 | Biopsy of uterus lining | 0.71 | 1.53 | 4 1.53 | #3 | ||
| 76090 | Mammogram, one breast | 0.70 | 0.93 | 0.70 | #1 | ||
| 76091 | Mammogram, both breasts | 0.87 | 1.10 | 0.87 | #1 | ||
| G0127 | Trim nail(s) | 0.11 | 0.17 | #3 | |||
| 1 All CPT codes and descriptors copyright 2000 American Medical Association. | |||||||
| 2 No change. | |||||||
| 3 26% incr. | |||||||
| 4 RVUS to remain interim for 2002. | |||||||
C. Discussion of Comments by Clinical Area
In this section, we discuss the comments we received on the 39 codes of the more than 900 codes for which we sought public comment. For the codes for which we did not receive any comments, our proposed RVUs are being made final. We have categorized the comments into the same clinical areas we used in the June 8, 2001 notice. Within each clinical area, listed below, we discuss the comments received in CPT code order.
1. Vascular Surgery
Comment: The American Association for Vascular Surgery and the Society for Vascular Surgery expressed appreciation that we agreed with the RUC recommendations for work RVUs for the vascular surgery codes reviewed under the second 5-year review. However, it indicated that some of these services may still be undervalued. It will be reviewing these services as well as a small number of vascular surgery services that were not submitted this year and possibly submit these under the next 5-year review.
Response and final decision: We will finalize the RVUs for the vascular surgery codes as proposed.
2. General Surgery and Colon and Rectal Surgery
Family 2Lymphadenectomy
Comment: The American College of Surgery (ACS) was supportive of the work performed by CMS medical officers to ensure that rank order anomalies were eliminated from 6 families of codes where acceptance of the RUC recommendations would create distortions in family work value relativity and the rest of the physician fee schedule.
The ACS pointed out a typographical error in the proposed notice. For Family 2 Lymphadenectomy, CMS disagreed with the RUC, and stated that the median survey result of 13 is appropriate for CPT code 38745. The ACS commented that the survey median is actually 13.10. The correction of this error would lead to increases for related family codes 38740 (from 10.02 to 10.03) and 38760 (from 12.94 to 12.95).
Response and final decision: We agree with the commenter's response and will adjust the work values for CPT code 38740 to 10.03; for CPT code 38745 to 13.10; and for CPT code 38760 to 12.95.
Family 3Lymph Nodes and Lymphatic Channels-Incision/Excision
Comment: The American Academy of Otolaryngology recommended that CMS change the global surgical period of CPT code 38510 from 90 days to 10 days following the RUC survey data for this CPT code. It alleges that there were no postoperative visits beyond 10 days associated with this procedure for the relative work established.
Response: The RUC valued this service based on the fact that it is typically furnished to an outpatient. The value of a hospital discharge day was subtracted from the median survey value. The median survey value is based on one followup office visit. We believe there is merit to the group's point and will change the global period from 90 days to 10 days.
3. Thoracic Surgery
Comment: The Society of Thoracic Surgeons expressed appreciation that we had accepted the RUC recommendations for corrections to work values of many thoracic and cardiac procedures.
Response and final decision: We will finalize the RVUs for these codes as proposed.
4. Orthopedic Surgery
We received no comments on these codes. Therefore, we will finalize all of the proposed work RVUs for the orthopedic surgery codes. We would also note that, in the June rule, we proposed to correct a rank order anomaly by increasing values for CPT code 27286. This code, however, was inadvertently omitted from the table and addendum; it is included in Table 4 and Addendum A of this final rule.
5. Ophthalmology
We received no comments on these codes. Therefore, we will finalize all of the proposed work RVUs for the ophthalmology codes.
6. Urology
We received no comments on these codes. Therefore, we will finalize all of the proposed work RVUs for the urology codes.
7. Obstetrics/Gynecology
CPT Code 38571, Laparoscopy, Surgical; With Bilateral Total Pelvic Lympadenectomy
Comment: The Society of Gynecologic Oncologists (SGO) stated that, while we had proposed an increase for CPT code 38572, an increase was not proposed for CPT code 38571. The SGO believes that both of these codes are undervalued based on insufficient work RVUs being assigned for the laparoscopy with bilateral total pelvic lymphadenectomy procedure, which is common to both codes. It requested that a proportional increase in work RVUs be made for CPT 38571 as well.
Response: We accepted the RUC recommendation that no increase be made in the work RVU for this service based on the lack of compelling evidence to support an increase, and we had proposed retaining the current work RVU for this service. However, based on the comments received, we referred this code to a multispecialty refinement panel for review.
Final decision: As a result of our analysis of the multispecialty refinement panel ratings, we are increasing the work RVUs for CPT code 38571 to 14.68 work RVUs.
CPT Code 56515, Destruction of Lesion(s), Vulva; Extensive, Any Method
Comment: For CPT code 56515, SGO disagreed with the rationale that CPT codes 56515 and 46924 have comparable physician and intraservice work time. It indicated that CPT code 56515 involves lasering a much larger area; therefore, the amount of intraservice time and the number of postoperative visits can be significantly higher.
Response: We had accepted the RUC recommendation of 2.76 work RVUs for this code which was lower than the 3.625 which had been requested by the specialty. Based on the comments received, we referred this code to a multispecialty refinement panel for review.
Final decision: As a result of our analysis of the refinement panel ratings, we are retaining the work RVU of 2.76.
CPT Code 57500, Biopsy, Single or Multiple, or Excision of Lesion, With or Without Fulguration (Separate Procedure)
Comment: In addition to comments on the 2 codes referenced above, SGO also recommended that, while CPT code 57500 was not considered part of the 5-year review, this gender-specific code be forwarded to the RUC for evaluation. It believes the amount of physician time and level of pre- and postoperative work for this procedure is similar to that for the male-specific procedures of CPT code 54100 (Biopsy of penis (separate procedure)), and CPT code 54505 (Biopsy of testis, incisional (separate procedure)), and thus the physician work for CPT code 57500 should be increased.
Response and final decision: We will refer this code to the RUC for review.
Comment: In our June 8, 2001 proposed notice, we also stated that we referred three female-specific procedure codes that appeared to be misvalued to the RUC for review. As part of its comments on the proposed notice, and in response to our request to review these services, the RUC has provided recommendations on work RVUs for the three codes as follows:
• CPT code 56605, Biopsy of vulva or perineum (separate procedure); one lesion.
The RUC stated that this code was reviewed during the first 5-year review and was increased at that time to double the original work RVU for CPT code 56605. While the current work RVU for this code is less than CPT code 54100, Biopsy of penis (WRVU 1.90), the structure of CPT code 56605 allows additional reporting when more than one lesion is biopsied, while the penile code (54100) may be only reported once, regardless of the number of biopsies. The RUC recommended that the current work RVU of 1.10 be maintained for CPT code 56605.
• CPT code 56810, Perineoplasty, repair of perineum, nonobsterical (separate procedure).
The RUC indicated that the specialty stated that this service may be undervalued; however, perineoplasty is performed so rarely as a separate procedure that it would be difficult to obtain valid survey data to appropriately value this service. In addition, the specialty is currently considering CPT revisions to this family of codes and will review this issue at that time. The RUC recommended that the current work RVU of 4.13 be maintained for the service.
• CPT code 58100, Endometrial sampling (biopsy) with or without endocervical sampling (biopsy), without cervical dilation, any method (separate procedure).
The RUC indicated that, based on a review of survey data, CPT code 58100 is undervalued. The RUC compared this code to CPT code 55700 and determined that these 2 services are similar in time and intensity. The RUC also agreed that 58100 is more work than the reference procedure, CPT code 57505, and recommended an increase in the work RVU for CPT code 58100 to 1.53. The RUC also provided refinements to the practice expense inputs for this code.
Response and final decision: We agree with the RUC recommendations for these three codes and will maintain the current work RVUs of 1.10 for CPT code 56605 and 4.13 for CPT code 56810 and increase the work RVUs for CPT code 58100 to 1.53. Because the public has not had a chance to comment on these work RVUs, we will consider them to be interim and will accept comments on values for these 3 codes.
8. Gastroenterology
In the June 8, 2001 proposed notice, we explained that, for the selected series of gastrointestinal endoscopy codes for the 5-year review, the RUC recommended increases in work RVUs for some of the codes and no change in work for other codes. While some of these endoscopy codes may be misvalued, we proposed to keep all work RVUs for gastrointestinal endoscopy codes unchanged. We also requested that the RUC perform a comprehensive review of all gastrointestinal endoscopy codes to ensure that all codes are properly valued and that no rank-order anomalies within and across specialties are created or exacerbated.
With respect to the RUC recommendation concerning permitting separate reporting and payment of conscious sedation codes 90141 and 90142, we stated we would be reviewing data concerning this issue. Any proposal we would have concerning payment and reporting of conscious sedation codes would be the subject of future rulemaking.
Comment: Many physicians and several medical organizations expressed concern about our decision to propose no changes for the 17 endoscopy codes for which the RUC had recommended increases. The American Society for Gastrointestinal Endoscopy, the American College of Gastroenterology, and the American Gastroenterological Association provided an extensive discussion on each of the codes which we will summarize and respond to below.
CPT Code 43219, Esophagoscopy, Rigid or Flexible; With Insertion of Plastic Tube or Stent
The RUC recommended an increase in work RVUs from 2.8 to 3.18 for CPT code 43219 based upon the increased complexity of the condition of the patients receiving these stents. We proposed to maintain the current work RVUs due to our concerns about creating rank order anomalies in the fee schedule.
Comment: We received comments regarding this code from several societies representing gastroenterologists who said that the incremental work involved with esophageal stent placement, presently valued at 1.21 RVUs, should be increased to 1.59 RVUs. The commenters agreed with CMS that several other stent codes were recently reviewed by the RUC and valued using the incremental work value of 1.21 RVUs. Increasing the incremental work value for CPT code 43219 to 1.59 RVUs would result in rank order anomalies for several codes. The commenters acknowledged that these anomalies resulted from the timing of the 5-year review and the valuation of new stent placement codes. In spite of this, the commenters felt the RUC-recommended value was appropriate.
Response: We feel the current work increment of 1.21 RVUs for placement of a stent over the base code 43200 is the appropriate value when assessing incremental work. We do not agree that the incremental work for stent placement should be increased to 1.59 RVUs. The upper GI endoscopy base CPT code 43235 has RVUs of 2.39 and CPT code 43256, upper GI endoscopy with stent placement (including predilation) has work RVUs of 4.35. This results in an incremental value of 1.96 RVUs which includes placement of the stent (1.21 RVUs) and predilation (0.75 RVUs).
Furthermore, diagnostic bronchoscopy, CPT code 31622, has work RVUs of 2.78, and bronchoscopy with tracheal dilation and placement of a tracheal stent (CPT code 31631) has an RVU of 4.37. This means that the incremental work value for tracheal dilation and stent placement is 1.59 RVUs which is significantly less than the work increment of 1.96 listed for CPT code 43256. We also note that CPT code 43219 will be billed with CPT code 43226 (dilation of the esophagus over a guidewire) which has an incremental value of 0.75 work RVUs. This means that when an esophageal stent is placed, the total work value is 1.59 (base code) plus 1.21 (stent placement) plus 0.75 (dilation) for a total of 3.55 RVUs.
More important, the incremental work of placing the stent is 1.96 RVUs which is similar to the incremental work of placing a stent elsewhere in the GI tract and more than the incremental work of placing a stent in the trachea. Increasing the incremental work of placing an esophageal stent to 1.59 RVUs from 1.21 would create a significant rank order anomaly in the physician fee schedule because esophageal stent placement would be valued more than stent placement elsewhere.
Lastly, we note that less work is required to place a plastic stent than to place a wire stent. Both, however, are coded using CPT code 43219 and are valued similarly. For these reasons, we have decided to maintain the current RVUs of 2.80 for this code, and we would like the RUC to review all of the GI endoscopic stent placement codes and all of the GI endoscopic dilation codes simultaneously. Because these services are performed by gastroenterologists and various surgical specialties (general surgery, thoracic surgery, otolaryngology, and colorectal surgery), the RUC should obtain input from all specialties performing these services.
CPT Code 43239, Upper Gastrointestinal Endoscopy Including Esophagus, Stomach, and Either the Duodenum and/or Jejunum as Appropriate, With Biopsy, Single or Multiple
The RUC recommended an increase in work RVUs from 2.69 to 2.87 based on an increase in the number of biopsies obtained during each procedure. The RUC also stated that technological advances allowing for greater precision and detail in finding abnormalities have increased the complexity of this service. The RUC also stated that technological advances have allowed results to be reported more quickly which increases the postservice work because biopsy information and treatment guidance are conveyed to the patient the same day as the procedure. We disagreed, and in the June rule we proposed to maintain the current work RVUs.
Comment: We received comments from several societies representing gastroenterologists and the following concerns were expressed: First, they did not feel that the work of performing biopsy procedures at different sites in the GI tract was the same. They commented that biopsy of lesions in different anatomic sites required different amounts of work. Second, they felt that even though CPT code 43239 was used to report both single and multiple biopsies, the typical patient requires multiple biopsies.
Response: We reviewed these comments and compared the intraservice time for this procedure to other endoscopic biopsy procedures and we have decided to accept the RUC recommendations for this code. However, we are making this value interim. Please see the discussion under CPT code 45380 regarding this issue.
CPT Code 43244, Upper Gastrointestinal Endoscopy Including Esophagus, Stomach, and Either the Duodenum and/or Jejunum as Appropriate; With Band Ligation of Esophageal and or Gastric Varices; CPT Code 43255, Upper Gastrointestinal Endoscopy Including Esophagus, Stomach, and Either the Duodenum and/or Jejunum as Appropriate; With Control of Bleeding, Any Method
The RUC recommended an increase in work RVUs for CPT code 43255 from 4.4 to 4.82 work RVUs, based on the use of new technology, such as lasers, to control bleeding. The RUC also recommended an increase in work RVUs for CPT code 43244 from 4.59 to 5.05 RVUs, based on the increased number of bands typically used to treat esophageal varices. We disagreed and proposed to maintain the current work RVUs.
Comment: We received comments from several societies representing gastroenterologists and the following concerns were expressed: First, they felt that we had incorrectly determined that these two services should be valued identically because the RUC stated that they were "similar" in terms of work. Second, although they acknowledged that the use of cautery to control bleeding is not new, they said that the service is undervalued irrespective of which method is used to control bleeding.
Response: We reviewed these comments and compared the intraservice time to other similar procedures and have decided to accept the RUC recommendations for the above CPT codes.
CPT Code 43247, Upper Gastrointestinal Endoscopy Including Esophagus, Stomach, and Either the Duodenum and/or Jejunum as Appropriate; With Removal of Foreign Body
The RUC recommended an increase in work RVUs for this CPT code from 3.39 to 3.59 work RVUs, based on increased complexity of patients undergoing this procedure with a concomitant increase in risk of morbidity. We disagreed and proposed to maintain the current work RVUs.
Comment: We received comments from several societies representing gastroenterologists with the following concerns: First, they felt the increase in the work RVU for this procedure was justified because the procedure is usually performed under emergent conditions. Second, they did not favor uniform incremental work values for removal of foreign bodies from different sites in the gastrointestinal tract.
Response: The RUC used a building-block approach to validate its acceptance of the median work RVUs from the survey. We do not believe the approach used by the RUC is valid for this CPT code. We compared this service to other similar services and continue to believe that the RUC recommendation does not represent the appropriate work increments for foreign body removal from various gastrointestinal sites. Furthermore, it would create a clear rank-order anomaly with CPT code 43215 that should have an identical work increment. Therefore, we will maintain the current work RVUs for this procedure. If the RUC reviews this service again, we ask that all GI endoscopic services for removal of foreign bodies be included in the review.
CPT Code 43249, Upper Gastrointestinal Endoscopy Including Esophagus, Stomach, and Either the Duodenum and/or Jejunum as Appropriate; With Balloon Dilation
The RUC recommended an increase from 2.9 to 3.35 work RVUs for this CPT code based on increased complexity of the condition of patients undergoing this procedure. We disagreed and proposed to maintain the current work RVUs.
Comment: We received comments from several organizations representing gastroenterologists who felt the increase in incremental work value was justified based on their survey. However, they admitted that revaluing CPT code 43249 would create a rank order anomaly with CPT code 43220, an identical procedure. They stated that CPT code 43220 is also undervalued.
Response: The current work increment for "balloon dilation of esophagus (less than 30mm diameter)" is 0.51 RVUs for both the esophagus and upper gastrointestinal endoscopy families. Since this is the same procedure in both families, it is unclear why the work should be increased for the upper gastrointestinal family only. This would create a rank-order anomaly. We have decided to maintain the current work RVUs for CPT code 43249. We plan to ask the RUC to review the incremental work RVUs for both CPT code 43249 and CPT code 43220.
CPT Code 43259, Upper Gastrointestinal Endoscopy Including Esophagus, Stomach, and Either the Duodenum and/or Jejunum as Appropriate; With Endoscopic Ultrasound Examination
The RUC recommended an increase in work RVUs from 4.59 to 8.59 based on the complexity of the equipment and the skill and judgement required. The RUC also noted that the survey results supported this procedure as requiring more work than CPT code 43260-diagnostic endoscopic retrograde cholangio-pancreatography (ERCP)-which has 5.96 work RVUs.
Comment: We received comments from several societies representing gastroenterologists who agreed with us that the RUC values for the new endoscopic ultrasound codes (EUS) were inconsistent with the value recommended by the RUC for CPT code 43259. They felt that new survey data should have been used by the RUC when valuing CPT code 43259 instead of the current incremental work values used by the RUC for the 5-year review.
Response: The RUC used the following building-block methodology to arrive at its recommendation for 43259-1) The RUC added 1.5 work RVUs, which is approximately 75 percent of the difference between the RUC recommendation from the last 5-year review (6.11 work RVUs) and the work RVUs that we assigned (4.0 work RVUs); (2) the RUC then added 2.2 work RVUs, which are the work RVUs of CPT code
93312(Echocardiography, Transesophageal, Real Time With Image Documentation (2D) (With or Without M-Mode Recording); Including Probe Placement, Image Acquisition, Interpretation and report)
Not only do we disagree with the RUC methodology for this recommendation, but we also note that the RUC has used the current work RVUs for CPT code 43259 to value not only other gastrointestinal transendoscopic ultrasound procedures but also many transendoscopic ultrasound guided biopsy codes. We also note that the RUC has recently re-evaluated CPT code 43231, Esophagoscopy, rigid or flexible; with endoscopic ultrasound examination, and recommended much lower RVUs for the incremental work of the ultrasound examination. Therefore, accepting the RUC recommendation for this code would be inconsistent with the RUC's reevaluation of CPT code 43231, would invalidate the work valuation of many other gastrointestinal endoscopy codes, and would create numerous rank-order anomalies. Therefore, we recommend that the RUC review CPT code 43259 along with all the other endoscopic ultrasound examination codes and all the transendoscopic ultrasound guided biopsy codes.
CPT Code 43263, Endoscopic Retrograde Cholangio-pancreatography (ERCP); With Pressure Measurement of Sphincter of Oddi (Pancreatic Duct or Common Bile Duct)
CPT Code 43265, Endoscopic Retrograde Cholangio-pancreatography (ERCP) With Endoscopic Retrograde Destruction, Lithotripsy of Stone(s), Any Method
CPT Code 43269, Endoscopic Retrograde Cholangio-pancreatography (ERCP); With Endoscopic Retrograde Removal of Foreign Body and/or Change of Tube or Stent
The RUC recommended an increase in work RVUs from 6.19 to 7.29 for CPT code 43263 based on the need to measure pressures in both the biliary and pancreatic sphincters, as well as the need for prolonged postoperative monitoring.
The RUC recommended an increase in work RVUs from 8.9 to 10.02 for CPT code 43265 based on a rank-order anomaly with code 43264 because this procedure is considered to be more time-consuming and complex than CPT code 43264.
The RUC recommended an increase in work RVUs from 6.04 to 8.21 for CPT code 43269 based on a rank-order anomaly between this code and CPT code 43268.
Comment: We received comments on these three codes from several organizations representing gastroenterologists. It was their position that these codes were commonly performed, undervalued procedures and that the survey data the organizations provided justify the increase in RVUs. We disagreed and proposed to maintain the current work RVUs for these three codes.
Response: We have reviewed the codes and compared their intraservice times to other similar procedures and have decided to accept the RUC recommendations.
CPT Code 44388, Colonoscopy Through Stoma; Diagnostic With or Without Collection of Specimen(s) by Brushing or Washing (Separate Procedure)
CPT Code 44389, Colonoscopy Through Stoma; With Biopsy, Single or Multiple
CPT Code 44390, Colonoscopy Through Stoma; With Removal of Foreign Body
CPT Code 44391, Colonoscopy Through Stoma; With Control of Bleeding, any Method
CPT Code 44392, Colonoscopy Through Stoma; With Removal of Tumor(s), Polyp(s), or Other Lesion(s) by Hot Biopsy Forceps or Bipolar Cautery
CPT Code 44393, Colonoscopy Through Stoma: With Ablation of Tumor(s), Polyp(s), or Other Lesion(s) Not Amenable to Removal by Hot Biopsy Forceps, Bipolar Cautery or Snare Technique
These 6 codes are in the same family, and the RUC recommended an increase for each code in this family primarily because it felt that the base CPT code, 44388, should be valued the same as CPT code 45378, diagnostic colonoscopy, at 3.7 work RVUs. The RUC also recommended that the values for the other codes in this family be increased to maintain their relativity to CPT code 44388. We disagreed and proposed to maintain the current work RVUs for all codes in this family.
Comment: We received comments from several societies representing gastroenterologists who commented that, although performing a colonoscopy through a stoma involves less physician work than performing a standard colonoscopy, they believed that performing a colonoscopy through a stoma is more technically challenging than performing a standard colonoscopy.
Response: We disagree with valuing the performance of a colonoscopy through a stoma identically to performing a standard colonoscopy. We feel the proposed valuation creates a series of rank-order anomalies. Consequently, we will finalize our proposal to maintain the current RVUs for this family of codes. In addition to determining that the RUC recommendation for the base code 44388 was incorrect, we note that the RUC recommendations create increments of work for performance of "biopsy, single or multiple," "control of bleeding, any method," "removal of tumors," and "ablation of tumors" during a colonoscopy through a stoma, which are inconsistent with the same increments for the complete colonoscopy family of codes that begins with code 45378. We note that, in addition to gastroenterologists, general surgeons and colorectal surgeons perform these procedures. Therefore, if the RUC reconsiders the work values of these codes, we believe that information should be obtained from all physicians who perform these services.
CPT Code 45380, Colonoscopy, Flexible Proximal to Splenic Flexure; With Biopsy, Single or Multiple
The RUC recommended an increase in work RVUs from 3.98 to 4.44 for this CPT code, based on the increased number of biopsies generally taken during this procedure and the increased difficulty in removing these polyps. We disagreed and proposed to maintain the current work RVUs for this service.
Comment: We received comments from several societies representing gastroenterologists who commented that work increments for performing biopsies at different sites within the gastrointestinal tract are different. Furthermore, the societies believe that the incremental work of biopsy procedures performed by different specialties (for example, gastrointestinal endoscopic biopsies and tracheobronchial endoscopic biopsies) need not be valued identically. They also note that even though this code is reported for both single and multiple biopsies, the "typical" patient usually has multiple biopsies performed.
Response: We have reviewed these comments and compared the intraservice time of this code to the intraservice time of other similar procedures. We have decided to accept the RUC recommendation. However, CMS believes the best approach to accurately value gastrointestinal endoscopy biopsy procedures is to evaluate all the biopsy procedures in the gastrointestinal tract. This would provide the opportunity to establish the correct incremental work RVUs and avoid creating rank-order anomalies. Therefore, we will make the work values for CPT code 43239 (as indicated earlier) and 45380, interim until we receive further recommendations from the RUC regarding the entire spectrum of gastrointestinal biopsy procedures.
9. Conscious Sedation
Comment: The American Academy of Family Physicians indicated that the RUC has appointed an ad hoc workgroup to review the issue of conscious sedation, including identifying codes where conscious sedation is not inherently included as a component of the physician work. It recommended that, when the workgroup and RUC complete this review, we allow separate reporting and payment for CPT codes 90141 and 90142 in conjunction with the identified codes. The AMA and the RUC also referred to the newly formed workgroup in their comments, and the AMA urged us to work with the RUC and the CPT to reach a solution on the coding and payment issues surrounding conscious sedation.
Response and Final Decision: We welcome suggestions on this issue from both the coding and payment perspective. When the workgroup review of these issues is complete, we will evaluate any recommendations we receive for the development of any future proposals.
10. Pulmonary Medicine/Critical Care
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the pulmonary medicine and critical care codes.
11. Cardiology
CPT Code 93350, Transthoracic Echocardiography
Comment: The American College of Cardiology expressed appreciation of our acceptance of the RUC recommendation to increase the work RVUs for this code.
Response and Final Decision: We are finalizing the proposed RVUs for CPT code 93350 and maintaining the work values for the other 2 CPT codes, 32234 and 32235, as discussed in the proposed notice.
12. Pediatrics
CPT Code 36400 (Venipuncture Under Age 3 Years; Femoral, Jugular or Sagittal Sinus) and CPT Code 36405 (Venipuncture, Under Age 3 Years, Scalp Vein)
Comment: The American Academy of Pediatrics (AAP) disagreed with our recommendations for CPT codes 36400 and 36405. The RUC recommended work RVUs of .38 and .32, respectively. We proposed that the work RVUs remain unchanged at .18 for each code. We do not believe it is appropriate to compare the work RVUs of a venipuncture to the work of an evaluation and management service. The AAP pointed out that the work involved in providing a venipuncture to a patient under age 3 is more intense than it has been in the past.
Response: Based on the comments received, we referred this code to a multispecialty refinement panel for review.
Final decision: As a result of our analysis of the multispecialty refinement panel ratings, we are increasing the work RVUs for CPT code 36400 to 0.38 and also increasing the work RVUs for CPT code 36405 to 0.31.
13. Pediatric Surgery
CPT Code 39503 (Repair, Neonatal Diaphragmatic Hernia, With or Without Chest Tube Insertion and With or Without Creation of Ventral Hernia) and CPT Code 49605 (Repair of Large Omphalacele or Gastroschisis; With or Without Prosthesis)
Comment: The AAP and the American Pediatric Surgical Association (ASPA) recommend that codes 39503 (Repair, neonatal diaphragmatic hernia, with or without chest tube insertion and with or without creation of ventral hernia), and 49605 (Repair of large omphalacele or gastroschisis; with or without prosthesis) receive interim values of 95 and 76, respectively, until the issue of critical care in the postoperative period is resolved. We had proposed to maintain the current work RVUs of 37.54 and 24.94, respectively, as interim 2002 work values and asked the RUC to resubmit recommendations for work RVUs for CPT codes 39503 and 49605 with either a 000 or 010 global period. As an option, pending resolution of the critical care issue, the APSA recommended that the interim work values for CPT codes 39503 and 49605 be 46.35 and 30.14, respectively.
The RUC agreed that the physician work in the postoperative period caring for these seriously ill neonates was significant and required the services of both surgeon and the neonatologist. The RUC requests that CMS treat these codes in the same manner as the other 90-day global codes that include extensive postoperative care.
Response: Upon further review, we agree with the RUC's recommendation and will establish the work values for CPT codes 39503 and 49605 at 95 and 76 units, respectively.
14. Radiology
CPT Code 76090, Mammography; Unilateral and CPT Code 76091 Mammography; Bilateral
Comment: The American College of Radiology (ACR) requested that CMS increase the work RVUs for unilateral mammography, that is, CPT code 76090, from the proposed .70, to .93 and for bilateral mammography, that is, code 76091, from the proposed .87, to 1.10. The ACR believes these values, which are the median survey values, more accurately reflect the work involved with these two procedures. The ACR points out that there is a significant amount of physician time associated with reviewing the results with these anxious patients and complying with the mandatory Mammography Quality Standards Act requirements.
The ACR commented that the chart at 66 FR 31045 of the June 8, 2001 proposed rule indicates that CPT code 76005 had a RUC recommendation of 10.60. However, that column should read .60.
The ACR also took exception to the requested work RVUs reported in the chart at 66 FR 31045 for codes 76065, 76090 and 76091. The chart displayed requested work RVUs of .60 for 76065, .64 for 76090, and .76 for code 76091. The ACR asked that the chart be corrected to reflect the actual requested work RVUs for each code. These corrected values, based on the median survey values, are .70 for CPT code 76065, .93 for 76090, and 1.10 for CPT code 76091.
Response: Based on the comments received, we referred these codes to a refinement panel for review. We regret the error in the chart concerning the requested work RVUs.
Final decision: As a result of our analysis of the multispecialty panel ratings, we are retaining the work RVU of 0.70 for CPT code 76090 and 0.87 for CPT code 76091, the work RVUs we proposed in the June 8 proposed rule.
CPT Code 76092, Screening Mammography, Bilateral Two View Film Study of Each Breast
In addition, we had requested the RUC to review the work RVUs for code 76092 (Screening mammography, bilateral two view film study of each breast). In its comments on the June 8, 2001 proposed rule, the RUC indicated it had placed this issue on the September 2001 meeting agenda and would provide recommendations to us following that meeting. The September meeting had to be cancelled and the issues to be addressed at that meeting will be discussed at the first meeting early next year. Therefore, we are finalizing the current RVUs for this code.
15. Plastic Surgery
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the plastic surgery codes.
B. Other Comments
1. Anesthesia Services
In our June 8, 2001 proposed rule (66 FR 31065), we stated that the American Society of Anesthesiologists (ASA) contended that the work of anesthesia services is undervalued and, based on discussions with the RUC, the ASA requested a 24 percent increase in anesthesia work. However, the RUC furnished no recommendation on anesthesia services; instead, it assigned to a newly created workgroup the responsibility for reviewing anesthesia services in the context of the physician fee schedule. We indicated that the ASA will be working with this workgroup on clinical issues, such as induction and postinduction intensity, and did not propose any changes to the anesthesia CF at this time to reflect the 5-year review of physician work for anesthesia services. However, we did indicate that we might make changes in response to recommendations the RUC may provide.
Comment: Many individual anesthesiologists commented that their services are undervalued. The American Society of Anesthesiologists also commented that its services are undervalued and asked that we accept the results of the first RUC workgroup (weighted average increase of 26 percent on representative codes) and extrapolate this to all anesthesia codes. We also received letters from individuals indicating that anesthesia services are undervalued.
In its comments, the RUC stated that it had not come to an agreement on extrapolating the results of the work of the 19 studied anesthesia codes to all anesthesia codes. The RUC agreed that the five quintiles for postinduction anesthesia and the examples associated with each quintile were appropriate. The RUC also examined the intensity values assigned to each quintile and made adjustments to the intensity values based on comparisons to evaluation and management codes and critical care services. It agreed to the following values-.224 for Level 1; .031 for Level 2; .051 for Level 3; .070 for Level 4; and .085 for Level 5.
The RUC approved the following intensity factors for the induction period-.067 for induction of general anesthesia; .067 for induction of spinal and epidural anesthesia; and .051 for induction of regional anesthesia.
Although the RUC recommended acceptance of the building block work values for the 19 codes studied, it did not resolve issues related to how often anesthesiologists provide the retrobulbar bloc for code 00142 and agreed that the distribution of postinduction time among the quintiles should be reviewed in more detail after it receives more input from surgical specialties.
Response and final decision : The RUC has informed us that it will continue to look at anesthesia work beginning at its first meeting in CY 2002. We will review the RUC recommendation and address anesthesia work in next year's proposed physician fee schedule rule.
2. Spine Injection Procedures
We received no comments on these codes. Therefore we will finalize the proposed work RVUs for the spine injection procedure codes.
3. Biofeedback
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the biofeedback codes.
4. Surgical Management of Burn Wounds
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the codes involving surgical management of burn wounds.
5. Transplantation
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the transplantation codes.
6. Arthroscopy Services
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the arthroscopy service codes.
7. Wheelchair Management
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the wheelchair management codes.
8. Psychological Testing
We received no comments on these codes. Therefore, we will finalize the proposed work RVUs for the psychological testing codes.
9. Podiatric Services
In our June 8, 2001 proposed notice (66 FR 31067), we stated the American Podiatric Medical Association (APMA) submitted 5 codes (trim skin lesions/trim nails) for review (11719, 11055, 11056, 11057, and G0127) and that the HCPAC requested we review our current utilization data to ensure that the original utilization assumptions were correct. The HCPAC recommended that the current review of data should be based on actual 1999 utilization data since these codes were not fully implemented until April 1, 1998. We stated that we would review the utilization data associated with the aforementioned codes to ensure the original assumptions are still correct and that we would publish our decision in the final rule.
Comment: The APMA was pleased that we would review the utilization data; however, it indicated that the work RVUs should not be revised based on current utilization. It recommended that we accept the original RUC recommendations since these values were based on the results of surveys of practicing podiatrists that were considered and approved by the RUC.
Response and final decision: Based on our review of the data and the APMA recommendation that we accept the original RUC recommended values, we are increasing the work values for these services as follows:
• CPT code 11719, Trimming of nondystrophic nails, any number , a work RVU of 0.17.
• CPT code 11055, Paring or cutting of benign hyperkeratotic lesion (for example, corn or callus) single lesion , a work RVU of 0.43.
• CPT code 11056, two to four lesions , a work RVU of 0.61.
CPT code 11057, more than four lesions , a work RVU of 0.79 .
For HCPCS code G0127, Trim nails , while we did not receive a RUC recommendation on this code (since we created the code), we are increasing the work RVU to 0.17 to be consistent with the increase made to CPT code 11719.
D. Other Issues
1. Critical Care Services in a Global Period
The June 8, 2001 proposed rule included a discussion on critical care services (66 FR 31067-68). We stated that current Medicare policy allows separate payment to the surgeon for postoperative critical care services during the surgical global period only when the patient has suffered trauma or burns. If the surgeon provides critical care services during the global period, for reasons unrelated to the surgery, that is separately payable as well. However, the approach the RUC used for the 5-year review had previously been used to validate postoperative work. That approach compared the work of a postoperative intensive care unit visit by the surgeon to code 99291, Critical care, evaluation and management of the critically ill or critically injured patient, first 30-74 minutes , which is valued at 4.00 work RVUs, rather than comparing a level three subsequent hospital visit (code 99233), which is valued at 1.51 work RVUs).
We indicated that valuing the surgeon's postoperative intensive care unit visits as critical care services had raised a number of issues that could require a change in payment policy to ensure that postoperative critical care is appropriately paid. In order to ensure that we make appropriate payments to physicians furnishing postoperative critical care services to Medicare beneficiaries, we specifically solicited information and comments on several questions and issues. We also proposed that the work RVUs for those surgical codes where any postoperative intensive care unit visits were valued as critical care remain interim, until we address the issues discussed above.
Many individual physicians, specialty societies, and health benefit programs provided comments and addressed the points we had outlined in the proposed notice. We appreciate their responses and will carefully review this information as we determine whether to make a future proposal.
2. Budget Neutrality
As explained in the proposed rule published June 8, 2001 (66 FR 31068-69), section 1848(c)(2)(B)(ii)(II) of the Act requires that increases or decreases in RVUs may not cause the amount of expenditures for the year to differ by more than $20 million from what expenditures would have been in the absence of these changes. If this threshold is exceeded, we make across-the-board adjustments to preserve budget neutrality. Based on the proposed changes in work RVUs, we indicated that budget-neutrality adjustments would be required. We proposed to reduce the conversion factor to meet the budget neutrality requirement, rather than applying a reduction to all work RVUs. We also indicated that revisions in payment policies, including the establishment of interim and final RVUs for coding changes contained in a separate proposed rule, might result in additional budget-neutrality adjustments.
Comment: The American Academy of Family Physicians, American College of Radiology, American College of Physicians, American Society for Internal Medicine, and the American Medical Association Specialty Society RVUs Update Committee indicated that they supported our proposal to maintain budget neutrality by adjusting the conversion factor.
Response and final decision: We will proceed with our proposal to maintain budget neutrality by adjusting the conversion factor.
V. Refinement of Relative Value Units for Calendar Year 2002 and Responses to Public Comments on Interim Relative Value Units for 2001
A. Summary of Issues Discussed Related to the Adjustment of Relative Value Units
Section V.B of this final rule describes the methodology used to review the comments received on the RVUs for physician work and the process used to establish RVUs for new and revised CPT codes. Changes to codes on the physician fee schedule (Addendum B) are effective for services furnished beginning January 1, 2002.
B. Process for Establishing Work Relative Value Units for the 2002 Fee Schedule and Clarification of CPT Definitions
Our November 1, 2000 final rule on the 2001 physician fee schedule (65 FR 65376) announced the final work RVUs for Medicare payment for existing procedure codes under the physician fee schedule and interim RVUs for new and revised codes. The RVUs contained in the rule applied to physician services furnished beginning January 1, 2001. We announced that we considered the RVUs for the interim codes to be subject to public comment under the annual refinement process. In this section, we summarize the refinements to the interim work RVUs that have occurred since publication of the November 2000 final rule and our establishment of the interim work RVUs for new and revised codes for the 2002 fee schedule.
1. Work Relative Value Unit Refinements of Interim and Related Relative Value Units
a. Methodology (Includes Table 5, Refinements of the 2001 Interim Work Relative Value Units)
Although the RVUs in the November 2000 final rule were used to calculate 2001 payment amounts, we considered the RVUs for the new or revised codes to be interim. We accepted comments for a period of 60 days. We received substantive comments from many individual physicians and several specialty societies on 52 CPT codes with interim work RVUs. Only comments on codes listed in Addendum C of the November 2000 final rule were considered.
We used a process similar to the process used in 1997 to address substantive comments. (See the October 31, 1997 final rule on the physician fee schedule (62 FR 59084) for the discussion of refinement of CPT codes with interim work RVUs.) We convened a multispecialty refinement panel of physicians to assist us in the review of the comments. The comments that we did not submit to panel review are discussed at the end of this section, as well as those comments that were reviewed by the panel. We invited representatives from each of the specialty societies from which substantive comments were received to attend a panel for discussion of the codes on which they had commented. The panel was moderated by our medical staff and consisted of the following voting members:
• One to two clinicians representing the commenting specialty or specialties, based upon our determination of those specialties which are most identified with the service(s) in question. Although commenting specialties were welcome to observe the entire refinement process, they were only involved in the discussion of those services for which they were invited to participate.
• Two primary care clinicians nominated by the American Academy of Family Physicians and the American Society of Internal Medicine.
• Four carrier medical directors.
• Four clinicians with practices in related specialties, who were expected to have knowledge of the services under review.
The panel discussed the work involved in each procedure under review in comparison to the work associated with other services on the fee schedule. We assembled a set of reference services and asked the panel members to compare the clinical aspects of the work of services they believed were incorrectly valued to one or more of the reference services. In compiling the set, we attempted to include-(1) services that are commonly performed whose work RVUs are not controversial; (2) services that span the entire spectrum from the easiest to the most difficult; and (3) at least three services performed by each of the major specialties so that each specialty would be represented. The set contained approximately 300 services. Group members were encouraged to make comparisons to reference services. The intent of the panel process was to capture each participant's independent judgement based on the discussion and his or her clinical experience. Following each discussion, each participant rated the work for the procedure. Ratings were individual and confidential, and there was no attempt to achieve consensus among the panel members.
We then analyzed the ratings based on a presumption that the interim RVUs were correct. To overcome this presumption, the inaccuracy of the interim RVUs had to be apparent to a broad range of physicians participating in the panel.
Ratings of work were analyzed for consistency among the groups represented on the panel. In general, we used statistical tests to determine whether there was enough agreement among the groups of the panel, and whether the agreed-upon RVUs were significantly different from the interim RVUs published in Addendum C of the November 2000 final rule. We did not modify the RVUs unless there was a clear indication for a change. If there was agreement across groups for change, but the groups did not agree on what the new RVUs should be, we eliminated the outlier group and looked for agreement among the remaining groups as the basis for new RVUs. We used the same methodology in analyzing the ratings that we first used in the refinement process for the 1993 fee schedule. The statistical tests were described in detail in the November 25, 1992 final rule (57 FR 55938).
Our decision to convene a multispecialty refinement panel of physicians and to apply the statistical tests described above was based on our need to balance the interests of those who commented on the work RVUs against the redistributive effects that would occur in other specialties. Of the 3 codes reviewed by the multispecialty panel, all were the subject of requests for increased values. Of the 3 interim work RVUs that were reviewed, 2 were increased and 1 was unchanged.
We also received comments on RVUs that were interim for 2001, but which we did not submit to the panel for review for a variety of reasons. These comments and our decisions on those comments are discussed in further detail below.
Table 5 lists the interim and related codes reviewed during the refinement process described in this section. This table includes the following information:
• CPT Code. This is the CPT code for a service.
• Descriptor. This is an abbreviated version of the narrative description of the code.
• 2001 Work RVU. The work RVUs that appeared in the November 2000 rule are shown for each reviewed code.
• Requested Work RVU. This column identifies the work RVUs requested by commenters.
• 2002 Work RVU. This column contains the final RVUs for physician work.
| 1 CPT code | Descriptor | 2001 work RVU | Requested work RVU | 2002 work RVU |
|---|---|---|---|---|
| 19102 | Bx breast percut w/image | 2.00 | 2.73 | 2.00 |
| 19103 | Bx breast percut w/device | 2.37 | 5.55 | 3.70 |
| 22522 | Percutaneous vertebroplasty, addl | 3.00 | 4.31 | 4.31 |
| 1 All CPT codes and descriptions copyright 2002 American Medical Association. | ||||
2. Interim 2001 Codes
Stenting Procedures-(CPT Codes 43256, 44370, 44379, 44383, 44397, 45345, 45387, and 45342)
We accepted the RUC recommended increase over the base code of 1.96 work RVUs. Commenters suggested that this increment should be increased to 2.59 work RVUs to reflect the work increase the RUC had recommended for CPT code 43219 (one of the codes used to arrive at this increase) as part of the 5-year review. Additionally, they also commented that the increment for the pre-dilation service should be from the dilation of gastric outlet in connection with an upper GI as opposed to the esophagoscopy code. Finally, commenters did not believe that these services should be subject to "within family work neutrality adjustments" (see Final Decision below) and instead believed that any increase in total RVUs should be addressed through the SGR or conversion factor. They felt that these stent placements are new technology and should not be viewed as code splitting/unbundling of services. They stated that stent placements have only been performed over the last 4-5 years and any work associated with them is not reflected in current work values for endoscopic codes.
Final decision: "Within family work neutrality adjustments" are used for new or revised services that are not considered new technologies. To achieve work neutrality within families of services, we compare the new or revised work RVUs (weighted by projected frequency) to the old work RVUs (weighted by actual frequency) to ensure that additional RVUs have not been added based on fragmentation of existing codes. We agree with the commenter that these services are new technologies and thus should not be subject to within family work neutrality adjustments. With regard to the final work value for CPT code 43219 and the use of dilation and stent placement codes in assigning a work value to 43219, please see our discussion elsewhere in this rule.
Cryosurgical Ablation of the Prostate-CPT Code 55873
We agreed with the RUC recommended work RVU for CPT code 55873 as we felt that the comparison to CPT code 55801, Prostatectomy, perineal, subtotal, was appropriate to aid in setting the work RVU of CPT code 55873. One commenter did not agree that this comparison was appropriate. The commenter indicated that the RUC was being requested to review this service again at its February meeting.
Final decision: The RUC provided comments on interim valued CPT code 55873 that re-visited the appropriate comparison service. Based upon comments received, the final work RVUs for CPT code 55873 will be increased to 19.47.
Percutaneous Vertebroplasty-CPT Code 22522
We disagreed with the RUC-recommended work RVUs of 4.31 for this service. CPT code 22522 is an add-on code that should have no associated pre- or postservice work. We removed the pre- and postservice work from the weighted average of CPT codes 22520 and 22521, which are the base services with which add-on CPT code 22522 should be billed in conjunction, and recalculated the value. Thus, we assigned interim work RVUs of 3.00 for CPT code 22522. Several commenters disagreed and do not believe that our methodology has appropriately valued this add-on service. Commenters felt we should sum the work RVUs of CPT codes 22520 and 22521 and then take 50 percent of this value. They believe that this is how we historically have calculated work RVUs for add-on services. Based on these comments, we referred this code to a multispecialty refinement panel for review.
Final decision: As a result of the statistical analysis of the refinement panel ratings, the final work RVUs are 4.31 for CPT code 22522.
Fetal Biophysical Stress Testing-CPT Codes 76818 and 76819
Although we agreed with the relativity presented by the RUC, we reduced the RVUs for these aforementioned services due to within family work neutrality adjustments. As previously discussed, within family work neutrality adjustments are used to ensure that additional relative values are not added based on fragmentation of existing codes. One specialty organization felt that we inappropriately determined that the work associated with the original CPT code 76818 (CPT code 76819 was added for January 1, 2001), included the average work of both with and without non-stress test. It believes that the survey data presented to the RUC suggest that this assumption is invalid and that the inappropriate within family neutralization of these services creates a rank-order anomaly in this family of codes.
The survey data indicated that CPT code 76818 required more time and greater mental effort than CPT code 76805 (Complete OB ultrasound), which has 0.99 work RVUs, since the ultrasound portion of CPT code 76818, while less extensive, is typically performed in a high-risk situation. In addition, CPT code 76818 also includes CPT code 59025 (Fetal non-stress test) with work RVUs of 0.53. The specialty organization also reported that CPT code 76819 requires more work than CPT code 76815 (Limited obstetric ultrasound) with work RVUs of 0.65. The assignment of 0.86 RVUs to CPT code 76818 and 0.63 RVUs to 76819 creates a rank-order anomaly with this family of obstetric ultrasound procedures.
Final Decision: We agree with the commenter that the within family neutrality adjustment we made for 2001 was not appropriate and created a rank-order anomaly within this family of services. We will remove the neutrality adjustments for January 1, 2002.
Cognitive Skills and Sensory Integrative Techniques-CPT Codes 97532 and 97533
We did not agree with the HCPAC recommendation for CPT codes 97532 and 97533 (work RVUs of 0.51 and 0.48, respectively). These two new services were created to replace deleted CPT code 97770. We believed that the work associated with these new services is analogous to deleted CPT code 97770 and therefore, we assigned work RVUs of 0.44 (the value assigned to the deleted code) to these new replacement codes. Commenters felt that assignment of this work value was arbitrary on our part, particularly since the HCPAC information had been based on information from a survey completed by the practitioners who provide these services.
Final Decision: We disagree with the commenters and are finalizing the interim work values. This is an example of replacing one CPT code with two new CPT codes that describe identical work. Because there is no new technology involved, we will finalize the interim work RVUs.
Wound Care CPT Codes
Absent a HCPAC recommendation for either of the aforementioned CPT codes, we valued the work of CPT code 97601 as 0.50 RVUs, the same as deleted service G0169 that described the work in the new code. We considered CPT code 97602 to be bundled into CPT code 97601 and therefore did not establish work RVUs for this service. Commenters believed that we inappropriately bundled CPT code 97602 into 97601 since they represent distinct services. The commenters requested that we reconsider bundling CPT code 97602.
Final Decision: We have re-examined our determination but have not changed our decision. CPT code 97602 describes services that typically involve placement of a wound covering, for example, wet-to-dry gauze or enzyme-treated dressing. It also includes nonspecific removal of devitalized tissue that is an inherent part of changing a dressing. This service is already included in the work and practice expenses of CPT code 97601. In the typical service described by 97601, the patient has a dressing placed over the wound. We would add that the services described by 97602 are also included in the work and practice expenses of the whirlpool code, CPT 97022. For this reason, we consider this a bundled service that is not paid separately.
Percutaneous Breast Biopsy-CPT Codes 19102 and 19103
We agreed with the RUC recommended work RVUs of CPT codes 19102 (RVU = 2.00) and 19103 (RVU = 2.37). Commenters believed that the work RVUs assigned to these codes were inappropriately low and did not accurately reflect the time and intensity of the work involved. Commenters supplied information to support their request for increasing the work RVUs for these services. Based on these comments, we referred this code to a multispecialty refinement panel for review.
Final decision: As a result of the statistical analysis of the multispecialty refinement panel ratings, the final work RVUs for CPT code 19102 are 2.00, and the final work RVUs for CPT code 19103 are 3.70.
Magnetic Resonance Imaging Procedures-CPT codes 70540, 70542, 70543, 71550, 71551, 71552, 72195, 72196, 72197, 73218, 73219, 73220, 73221, 73222, 73223, 73718, 73719, 73720, 73721, 73722, 73723, 74181, 74182, and 74183
We received a RUC recommendation for only 3 of these codes ( 70540, 70542, 70543 ) for January 1, 2001. However, this recommendation did not reflect the required within family work neutrality adjustment. The work RVUs of 0.98, 1.17, and 1.56 were assigned to these services to ensure that there would not be additional work RVUs introduced into the system. We did not receive work recommendations or utilization data for any of the other new MRI codes and assigned work RVUs for these other codes based on the methodology outlined in the November 2000 final rule.
Commenters expressed concern about the within family work neutrality adjustment applied to the RUC-recommended work RVUs, and the methodology that was used to establish work values for the other MRI procedures. Commenters requested that we re-evaluate the within family work neutrality adjustment based upon updated information supplied in their respective comments.
Final decision: We are accepting the work values for these services which were submitted by the RUC in its comment on the interim work values we assigned in last year's final rule. We note that these work values are virtually identical to the work values that we assigned as interim last year. Based upon comments received, we have re-evaluated the utilization crosswalks upon which our within family work neutrality adjustments were based.
Since 2001 is the first year for which actual data is available for these services, we used available data (first two quarters of 2001) to capture the actual utilization of these new services. This utilization was then subjected to a standard analysis of reporting trends to estimate the completion percentage of 2001 utilization data. The available utilization was then "aged" to represent one full year of data for 2001. After determining the utilization for 2001, we applied this revised within family work neutrality adjustment across the entire family of MRI procedures rather than applying this adjustment to subsets. We are finalizing these within family work neutral values and note that the re-calculation of this neutrality adjustment results in increases to the work RVUs of the MRI services referenced above.
Computed Tomographic Angiography (CTA)-CPT Codes 70496, 70498, 71275, 72191, 73206, 73706, 74175 and 75635
We agreed with the RUC recommendation of 1.75 for CPT codes 70496 and 70498 for January 1, 2001. However, the RUC did not submit work recommendations for the other CTA codes. We assigned work RVUs for these other codes based on the methodology outlined in the November 2000 rule. Commenters disagreed with the interim values we had proposed for CTA codes and provided additional information for valuing these services. The commenter felt that our decisions created rank-order anomalies between anatomic sites.
Final decision: We are accepting the work values for these services which were submitted by the RUC in its comment on the interim work values we assigned in last year's final rule. We will implement them as final values for 2002.
Practice Expense Refinements of 2001 Interim and Revised RVUs
Percutaneous Breast Biopsy-CPT Codes 19102 and 19103
Comment: A specialty organization representing breast surgeons submitted its suggested direct cost inputs for these two services and had several comments on their practice expenses. The commenter indicated that the price in the database for the biopsy driver was too low, that the clinical staff type should be a registered nurse rather than a technician and that there should be pre- and postservice clinical staff time when the procedure is performed in the facility setting. In addition, the commenter questioned whether the 50 percent utilization rate used to price equipment was realistic for new technology and recommended that device-specific utilization rates be determined. The society also questioned the lack of direct cost inputs for equipment and supplies for CPT 76095, the associated procedure for image guidance. A manufacturer commented that the equipment inputs for CPT 19102 were erroneously dropped from the CPEP database.
Response: We had accepted the RUC recommendations on these two services, making only the following technical changes to the supplies and equipment: we did not include the cost of the crash cart, because we consider this an indirect expense, nor the cost of the biopsy gun handle, because this was less than the $500 required for an item to be on the equipment list. We also did not include separately billable fluids, the formalin that would be supplied by the lab, or the biohazard bag and skin marking pen that could be used for more than one procedure.
If the specialty that was involved in the presentation of these codes to the RUC now believes that the direct inputs do not adequately represent the costs of performing these services, one option would be to have these codes refined by the PEAC. In the meantime, we are prepared to make certain changes to the CPEP data in response to the recommendations made by the commenters. We will add the power table and surgical lamp to both codes and will increase the price associated with the biopsy device driver, subject to verification when we undertake our repricing of the CPEP equipment inputs. Because the specialties presenting the codes to the RUC, and the RUC itself, recommended using radiologic staff for these services, we will not change the staff type to registered nurse at this time. However, we will substitute the higher-paid mammography technologist, which we have just added to our staff type list, for the current x-ray technician staff type.
We have in the past solicited information from the specialties regarding equipment-specific utilization rates, but we have never received sufficient information to propose any changes in our policy. Additionally, for most services, changing the utilization rate would have very little effect.
The commenter is correct that the associated procedure for image guidance, CPT 76095, currently does not have CPEP inputs assigned to the non-facility setting. However, at this time, it is priced as a part of the "zero work" pool, and the CPEP inputs are not used to calculate the practice expense RVUs for this service. We would hope that this code could be refined in the near future and given the appropriate inputs for the office setting.
CPT Codes 34812, 34820, 34830, 34831 and 34832 for Repair of Aortic Aneurysm
Comment: A specialty organization representing vascular surgery stated that CPT codes 34812 and 34820 should have clinical staff preservice time added and that CPT codes 34830, 34831 and 34832 were assigned inappropriately low postservice clinical staff times.
Response: We accepted the RUC recommendations for all of these services. There was no preservice time included in the RUC recommendation for CPT codes 34812 and 34820. In addition, we have assigned 99 minutes of clinical staff postservice time to CPT codes 34830, 34831 and 34832, as recommended by the RUC. These codes can be refined by the PEAC which now has a standard package for 90-day global pre- and postservice times for clinical staff and is also discussing the coordination of care clinical staff times for 0-day global services.
We received the following comments on HCPCS codes established in the November 1, 2000 final rule.
• G0169Removal of Devitalized tissue, without use of anesthesia.
Comment: The American Podiatric Medical Association recognized that, effective January 1, 2001, this code was eliminated and we have adopted CPT code 97601, which is sufficiently similar to the services described by G0169. However, it requested we address a policy issue related to the discussion of this service. In the November 2, 1999 Federal Register (64 FR 59426), we stated that G0169 was created because CPT codes 11040 through 11044 for debridement were created to describe "complex surgical services requiring the use of general anesthesia." APMA indicates that there had never been a policy requiring the use of any anesthesia, much less general anesthesia, when performing surgical debridement that is reported with CPT codes 11040 through 11044. However, as a result of the statement in the November 2 Federal Register , some carriers developed policies denying payment for these codes if anesthesia was not used. The APMA urged us to clarify that anesthesia, whether general or local, is not required when billing CPT codes 11040 through 11044.
Response: We acknowledge that the use of "general anesthesia" in the preamble to the November 2, 1999 rule was an error, and we believe all our contractors are aware of our misstatement. As the commenter stated, the code G0169 has been deleted and replaced by CPT code 97601, Removal of devitalized tissue from wound(s); selective debridement, without anesthesia (e.g., high pressure waterjet, shape selective debridement with scissors, scalpel, and tweezers) including topical application(s), wound assessment, and instruction(s) for ongoing care, one session. We expect that our contractors will develop policies to distinguish this service from the debridement codes, 11040 through 11044. We anticipate that they may consider a variety of factors, including the extent of the debridement and the amount of medical skill required to perform the service, and not simply whether a local anesthetic was used in the procedure.
Comment: The American College of Surgeons urged us to issue instructions to carriers specifying that the use of CPT code 97061 is limited to physical therapists and other non-physician practitioners and that the debridement of wounds by surgeons is properly reported with a code from the CPT debridement codes 11040-11044.
Response: As we stated in the response to the previous comment, we believe that our contractors are likely to make this distinction in their local policies. If we determine that relying on local carrier policies is unsatisfactory, then we will consider whether national guidance is needed.
• G0181 and G0182, Care plan Oversight.
Comment: A few organizations expressed disappointment that we finalized our proposal to establish two new G codes for care plan oversight services, rather than continue to recognize the CPT codes related to these services.
Response: The CPT codes for care plan oversight were modified so that they included services that extend beyond the limits of our current payment policy. As a result, we will continue to use the G-codes that are consistent with our payment policies.
• G0180 and G0179 Certification and Recertification of Medicare Covered Home Health Services.
Comment: Several specialty organizations expressed appreciation for our willingness to recognize and compensate physicians for these services and supported our decision to pursue this coding and reimbursement issue through the CPT and RUC processes. The American College of Surgeons expressed concern that claims submitted by surgeons for physician certification or recertification would be denied inappropriately due to longstanding rules that preclude payment for services that are provided during the global period.
Response: As was stated in the November 1, 2000 final rule (66 FR 65408), surgeons performing these services could be paid for G0179 and G0180 during the global period. We have heard no specific complaints that this policy has not been implemented appropriately.
G Codes Related to Swallowing Function
Comment: The American College of Surgeons objected to the creation of these G codes and requested that we discontinue their use and work with the otolaryngologists to submit a coding request on these services to the CPT Editorial Panel. The American Academy of Otolaryngology-Head and Neck Surgery, Inc. (AAO-HNS) also expressed concern about creation of these codes. It felt that our description of the codes was incomplete and inaccurate.
In the November 1, 2000 final rule we proposed 4 new G codes and stated that these would replace the more general CPT code 92525, Evaluation of swallowing and oral function for feeding. AAO-HNS believes that this incorrectly implies that the single code 92525 includes 4 unique services and, therefore, we have significantly understated the work and practice expenses required for these procedures.
For G0193, Endoscopy study of swallowing function, and GO194 Sensory testing during endoscoping study of swallowing, we stated that coverage of these services remains at the discretion of the carrier and that they would be carrier priced. AAO-HNS expressed concern that carriers might misinterpret this statement to mean the codes should not be covered and, if covered, the payment might be inappropriately low. AAO-HNS requested we clarify that these services should be covered and recommended that pricing for GO193 should equal to the sum of the RVUs for CPT code 31575, Laryngoscopy, flexible fiberoptic; diagnostic, and CPT code 92525.
AAO-HNS also did not agree with our decision to treat G0194 as an "add-on" code as this group felt this would create confusion. Rather, AAO-HNS suggested that GO194 be treated as a stand-alone code with RVUs equal to CPT codes 31575, 92525 and 92520 ( Laryngeal function studies ).
In addition, AAO-HNS was concerned about our statement that CPT code 31575 and CPT code 31579 ( Laryngoscopy, flexible or rigid fiberoptic, with stroboscopy ) should not be used for evaluations of swallowing and urged that we clarify that these codes could still be used to report flexible fiberoptic laryngosopies for patients with swallowing problems.
Response: These G codes related to swallowing function were created because of the ambiguity of the CPT code, 92525. The CPT editorial panel will be reviewing codes designed to substitute for the G-codes created. The specialty advisors, including AAO- HNS, will have the opportunity to comment on these proposals and to create codes that they believe will describe the services more accurately. If the CPT editorial panel adopts these revised codes, they could be in the 2003 CPT book.
Comment: The American Occupational Therapy Association stated that in the specific discussion of code GO195, and by implication the related codes, we stated these services are performed typically by a speech and language pathologist. While AOTA does not disagree with this characterization, it requested that we clarify that other professionals, specifically occupational therapists, also may be trained in these procedures. It noted that in some areas of the country occupational therapists typically perform swallowing evaluations, particularly in conjunction with feeding and eating deficits.
Response: These G codes did not specify which professionals could perform these services. The description of the new G codes only stated that these services would be most commonly performed by speech and language pathologists. Our contractors, who have the capacity to be responsive to local differences in practice patterns, will be aware of whether occupational therapists have the qualifications to perform these evaluations and will make the decisions about whether the service performed matches the services described by the code.
Comment: The American College of Radiology requested clarification on the specialties we anticipate using G0196; they asked if this G code would be used by the speech pathologist while the radiologist would use CPT code 74230. ACR expressed concern that provision of such a G code would promote performance of fluoroscopy by non-trained individuals.
Response: We do not believe that the development of these G codes should lead to non-trained individuals performing fluoroscopy. Prior to the development of the G codes, we were asked by speech and language pathologists if they could bill 74230 to describe the work they did in conjunction with a fluoroscopic or video evaluation of swallowing. We did not think that the speech and language pathologists should bill the code 74230 and created this G code to describe the portion of the examination that they typically performed.
We were also asked whether the services of a speech and language pathologist should have remained bundled into the technical portion of the 74230 examination, because this may have been the method of billing these services prior to the development of the G code. Because this new G code separates the services of the speech and language pathologists in this examination, we may need to clarify which services are included in the technical portion of 74230. None of these concerns would lead a non-skilled practitioner to perform either of these services.
G Codes Related to Speech Generating Devices and Voice Prostheses G0197-G0201
Comment: AAO-HNS expressed concern about the establishment of G codes related to speech generating devices and voice prostheses. It continues to believe that the creation of codes used to describe services that are already described in CPT makes compliance with Medicare policy difficult and confusing.
Response: The current CPT codes, 92597 and 92598, identify two distinct services-evaluation or modification of voice prosthetics and augmentative or alternative communicative devices. Since different types of patients require either voice prosthetics (for example, an artificial larynx) or augmentative or alternative communicative devices, we believe that separating these two services through the use of G-codes actually should make compliance with Medicare policies easier, since the services being delivered are more accurately described.
Revisions to Malpractice RVUs for New and Revised CPT Codes for 2001
Malpractice RVUs are calculated using the methodology described in detail at Addendum G of our November 1, 2000 final rule (65 FR 65589). Because of the timing of the release of new and revised CPT codes each year, the malpractice RVUs for the first year of these codes are extrapolated from existing similar codes, based on the advice of our medical consultants, and are considered interim subject to public comment and revision. The following year these codes are given values based on our malpractice RVU methodology and a review of comments received.
The malpractice RVUs for 2001 new and revised codes published in Addendum B of the November 1, 2000 final rule were thus extrapolated from (RVUs for existing similar codes). The malpractice RVUs for these codes in this year's Addendum B were calculated by our consultant, KPMG, using the same methodology used for all other codes. Likewise, the malpractice RVUs for new and revised 2002 codes are being extrapolated from existing similar codes and will be calculated using the malpractice RVU methodology next year.
Comment: One commenter stated that malpractice premiums are rapidly increasing all over the country and that we should ensure that the physician fee schedule reflect these increases.
Response: We agree that changes in malpractice premiums should, to the extent possible, be reflected in the physician fee schedule. The most recent malpractice data available were used in constructing the 2001 malpractice RVUs and the revised 2001 GPCIs. In addition, the relative weights of the component cost shares (work, practice expense, malpractice) in the physician fee schedule and in the MEI are periodically adjusted when the most recent AMA SMS data indicate significant shifts among physician practice cost components. However, because of the time needed to collect the data and propose changes through the rulemaking process, there is a time lag in making these changes.
Establishment of Interim Work Relative Value Units for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System Codes (HCPCS) for 2002 (Includes Table 6, AMA RUC and HCPAC Work RVU Recommendations and CMS Decisions for New and Revised 2002 CPT Codes)
One aspect of establishing RVUs for 2002 was related to the assignment of interim work RVUs for all new and revised CPT codes. As described in our November 25, 1992 notice in the 1993 fee schedule (57 FR 55983), and in section III.B. of our November 22, 1996 final rule (61 FR 59505-59506), we established a process, based on recommendations received from the AMA's RUC, for establishing interim work RVUs for new and revised codes.
This year we received RUC work RVU recommendations for approximately 314 new and revised CPT codes. Our staff and medical officers reviewed the RUC recommendations by comparing them to our reference set or to other comparable services for which work RVUs had been previously established, or to both of these criteria. We also considered the relationships among the new and revised codes for which we received RUC recommendations. We agreed with the majority of these relationships reflected in the RUC values. In some instances, when we agreed with the relationships, we revised the work RVUs to achieve work neutrality within families of codes, that is, the work RVUs have been adjusted so that the sum of the new or revised work RVUs (weighted by projected frequency of use) for a family will be the same as the sum of the current work RVUs (weighted by projected frequency of use for that family of codes). For approximately 93 percent of the RUC recommendations, proposed work RVUs were accepted, and for approximately 7 percent, we disagreed with the RUC recommendation. In a majority of instances, we agreed with the relativity proposed by the RUC, but needed to decrease work RVUs to retain budget neutrality.
There were also 10 CPT codes for which we did not receive a RUC recommendation. After a review of these CPT codes by our staff and medical officers, we established interim work RVUs for the majority of these services. For those services for which we could not arrive at interim work RVUs, we have assigned a carrier-priced status until such time as the RUC provides work RVU recommendations.
We received 18 recommendations from the Health Care Professionals Advisory Committee (HCPAC). We accepted 12, or 67 percent, of the HCPAC recommendations.
Table 6, AMA RUC and HCPAC Work RVU Recommendations and CMS Decisions for New and Revised 2002 CPT Codes, lists the new or revised CPT codes, and their associated work RVUs, that will be interim in 2002. This table includes the following information:
• A "#" identifies a new code for 2002.
• CPT code. This is the CPT code for a service.
• Modifier. A "26" in this column indicates that the work RVUs are for the professional component of the code.
• Description. This is an abbreviated version of the narrative description of the code.
• RUC recommendations. This column identifies the work RVUs recommended by the RUC.
• HCPAC recommendations. This column identifies the work RVUs recommended by the HCPAC.
• CMS decision. This column indicates whether we agreed with the RUC recommendation ("agree") or we disagreed with the RUC recommendation ("disagree"). Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table. An "(a)" indicates that no RUC recommendation was provided. A discussion follows the table.
• 2002 Work RVUs. This column establishes the 2002 work RVUs for physician work.
| * CPT CODE | Mod | Description | RUC recommendation | HCPAC recommendation | CMS decision | 2002 work RVU |
|---|---|---|---|---|---|---|
| 10021 # | 26 | FNA W/O IMAGE | 1.27 | Agree | 1.27 | |
| 10022 # | 26 | FNA W/IMAGE | 1.27 | Agree | 1.27 | |
| 11755 | BIOPSY, NAIL UNIT | 1.31 | Agree | 1.31 | ||
| 11981 # | INSERT DRUG IMPLANT DEVICE | 1.48 | Agree | 1.48 | ||
| 11982 # | REMOVE DRUG IMPLANT DEVICE | 1.78 | Agree | 1.78 | ||
| 11983 # | REMOVE/INSERT DRUG IMPLANT | 3.30 | Agree | 3.30 | ||
| 17000 | DESTROY BENIGN/PREMAL LESION | 0.60 | Agree | 0.60 | ||
| 17003 | DESTROY LESIONS, 2-14 | 0.15 | Agree | 0.15 | ||
| 17004 | DESTROY LESIONS, 15 OR MORE | 2.79 | Agree | 2.79 | ||
| 17110 | DESTRUCT LESION, 1-14 | 0.65 | Agree | 0.65 | ||
| 17111 | DESTRUCT LESION, 15 OR MORE | 0.92 | Agree | 0.92 | ||
| 17260 | DESTRUCTION OF SKIN LESIONS | 0.91 | Agree | 0.91 | ||
| 17261 | DESTRUCTION OF SKIN LESIONS | 1.71 | Agree | 1.71 | ||
| 17262 | DESTRUCTION OF SKIN LESIONS | 1.58 | Agree | 1.58 | ||
| 17263 | DESTRUCTION OF SKIN LESIONS | 1.79 | Agree | 1.79 | ||
| 17264 | DESTRUCTION OF SKIN LESIONS | 1.94 | Agree | 1.94 | ||
| 17266 | DESTRUCTION OF SKIN LESIONS | 2.34 | Agree | 2.34 | ||
| 17270 | DESTRUCTION OF SKIN LESIONS | 1.32 | Agree | 1.32 | ||
| 17271 | DESTRUCTION OF SKIN LESIONS | 1.49 | Agree | 1.49 | ||
| 17272 | DESTRUCTION OF SKIN LESIONS | 1.77 | Agree | 1.77 | ||
| 17273 | DESTRUCTION OF SKIN LESIONS | 2.05 | Agree | 2.05 | ||
| 17274 | DESTRUCTION OF SKIN LESIONS | 2.59 | Agree | 2.59 | ||
| 17276 | DESTRUCTION OF SKIN LESIONS | 3.20 | Agree | 3.20 | ||
| 17280 | DESTRUCTION OF SKIN LESIONS | 1.17 | Agree | 1.17 | ||
| 17281 | DESTRUCTION OF SKIN LESIONS | 1.72 | Agree | 1.72 | ||
| 17282 | DESTRUCTION OF SKIN LESIONS | 2.04 | Agree | 2.04 | ||
| 17283 | DESTRUCTION OF SKIN LESIONS | 2.64 | Agree | 2.64 | ||
| 17284 | DESTRUCTION OF SKIN LESIONS | 3.21 | Agree | 3.21 | ||
| 17286 | DESTRUCTION OF SKIN LESIONS | 4.44 | Agree | 4.44 | ||
| 20225 | BONE BIOPSY, TROCAR/NEEDLE | 1.87 | Agree | 1.87 | ||
| 20526 # | THER INJECTION, CARPAL TUNNEL | 0.86 | Agree | 0.86 | ||
| 20550 | INJECT TENDON/LIGAMENT/CYST | 0.86 | Agree | 0.86 | ||
| 20551 # | INJECT TENDON ORIGIN/INSERT | 0.86 | Agree | 0.86 | ||
| 20552 # | INJECT TRIGGER POINT, 1 OR 2 | 0.86 | Agree | 0.86 | ||
| 20553 # | INJECT TRIGGER POINTS, 3 | 0.86 | Agree | 0.86 | ||
| 23000 | REMOVAL OF CALCIUM DEPOSITS | 4.36 | Agree | 4.36 | ||
| 23350 | INJECTION FOR SHOULDER X-RAY | 1.00 | Agree | 1.00 | ||
| 24075 | REMOVE ARM/ELBOW LESION | 3.92 | Agree | 3.92 | ||
| 24076 | REMOVE ARM/ELBOW LESION | 6.30 | Agree | 6.30 | ||
| 24300 # | MANIPULATE ELBOW W/ANESTH | 3.75 | Agree | 3.75 | ||
| 24332 # | TENOLYSIS, TRICEPS | 7.45 | Agree | 7.45 | ||
| 24343 # | REPR ELBOW LAT LIGMNT W/TISS | 8.65 | Agree | 8.65 | ||
| 24344 # | RECONSTRUCT ELBOW LAT LIGMNT | 14.00 | Agree | 14.00 | ||
| 24345 # | REPR ELBW MED LIGMNT W/TISS | 8.65 | Agree | 8.65 | ||
| 24346 # | RECONSTRUCT ELBOW MED LIGMNT | 14.00 | Agree | 14.00 | ||
| 25001 # | INCISE FLEXOR CARPI RADIALIS | 3.38 | Agree | 3.38 | ||
| 25020 | DECOMPRESS FOREARM 1 SPACE | 5.92 | Agree | 5.92 | ||
| 25023 | DECOMPRESS FOREARM 1 SPACE | 12.96 | Agree | 12.96 | ||
| 25024 # | DECOMPRESS FOREARM 2 SPACES | 9.50 | Agree | 9.50 | ||
| 25025 # | DECOMPRESS FORAM 2 SPACES | 16.54 | Agree | 16.54 | ||
| 25075 | REMOVE FOREARM LESION SUBCUT | 3.74 | Agree | 3.74 | ||
| 25076 | REMOVE FOREARM LESION DEEP | 4.92 | Agree | 4.92 | ||
| 25259 # | MANIPULATE WRIST W/ANESTHES | 3.75 | Agree | 3.75 | ||
| 25274 | REPAIR FOREARM TENDON/MUSCLE | 8.75 | Agree | 8.75 | ||
| 25275 # | REPAIR FOREARM TENDON SHEATH | 8.50 | Agree | 8.50 | ||
| 25394 # | REPAIR CARPAL BONE, SHORTEN | 10.40 | Agree | 10.40 | ||
| 25405 | REPAIR/GRAFT RADIUS OR ULNA | 14.38 | Agree | 14.38 | ||
| 25420 | REPAIR/GRAFT RADIUS ULNA | 16.33 | Agree | 16.33 | ||
| 25430 # | VASC GRAFT INTO CARPAL BONE | 9.25 | Agree | 9.25 | ||
| 25431 # | REPAIR NONUNION CARPAL BONE | 10.44 | Agree | 10.44 | ||
| 25440 | REPAIR/GRAFT WRIST BONE | 10.44 | Agree | 10.44 | ||
| 25520 | TREAT FRACTURE OR RADIUS | 6.26 | Agree | 6.26 | ||
| 25526 | TREAT FRACTURE OF RADIUS | 12.98 | Agree | 12.98 | ||
| 25645 | TREAT WRITST BONE FRACTURE | 7.25 | Agree | 7.25 | ||
| 25651 # | PIN ULNAR STYLOID FRACTURE | 5.36 | Agree | 5.36 | ||
| 25652 # | TREAT FRACTURE ULNAR STYLOID | 7.60 | Agree | 7.60 | ||
| 25671 # | PIN RADIOULNAR DISLOCATION | 6.00 | Agree | 6.00 | ||
| 26115 | REMOVE HAND LESION SUBCUT | 3.86 | Agree | 3.86 | ||
| 26116 | REMOVE HAND LESION, DEEP | 5.53 | Agree | 5.53 | ||
| 26160 | REMOVE TENDON SHEATH LESION | 3.15 | Agree | 3.15 | ||
| 26250 | EXTENSIVE HAND SURGERY | 7.55 | Agree | 7.55 | ||
| 26255 | EXTENSIVE HAND SURGERY | 12.43 | Agree | 12.43 | ||
| 26340 # | MANIPULATE FINGER W/ANESTH | 2.50 | Agree | 2.50 | ||
| 26350 | REPAIR FINGER/HAND TENDON | 5.99 | Agree | 5.99 | ||
| 26352 | REPAIR/GRAFT HAND TENDON | 7.68 | Agree | 7.68 | ||
| 26356 | REPAIR FINGER/HAND TENDON | 8.07 | Agree | 8.07 | ||
| 26357 | REPAIR FINGER/HAND TENDON | 8.58 | Agree | 8.58 | ||
| 26358 | REPAIR/GRAFT HAND TENDON | 9.14 | Agree | 9.14 | ||
| 26390 | REVISE HAND/FINGER TENDON | 9.19 | Agree | 9.19 | ||
| 26392 | REPAIR/GRAFT HAND TENDON | 10.26 | Agree | 10.26 | ||
| 26415 | EXCISION, HAND/FINGER TENDON | 8.34 | Agree | 8.34 | ||
| 26416 | GRAFT HAND OR FINGER TENDON | 9.37 | Agree | 9.37 | ||
| 26426 | REPAIR FINGER/HAND TENDON | 6.15 | Agree | 6.15 | ||
| 26428 | REPAIR/GRAFT FINGER TENDON | 7.21 | Agree | 7.21 | ||
| 26445 | RELEASE HAND/FINGER TENDON | 4.31 | Agree | 4.31 | ||
| 26510 | THUMB TENDON TRANSFER | 5.43 | Agree | 5.43 | ||
| 26587 | RECONSTRUCT EXTRA FINGER | 14.05 | Agree | 14.05 | ||
| 26590 | REPAIR FINGER DEFORMITY | 17.96 | Agree | 17.96 | ||
| 26607 | TREAT METACARPAL FRACTURE | 5.36 | Agree | 5.36 | ||
| 26608 | TREAT METACARPAL FRACTURE | 5.36 | Agree | 5.36 | ||
| 26670 | TREAT HAND DISLOCATION | 3.69 | Agree | 3.69 | ||
| 26675 | TREAT HAND DISLOCATION | 4.54 | Agree | 4.54 | ||
| 26676 | PINE HAND DISLOCATION | 5.52 | Agree | 5.52 | ||
| 26685 | TREAT HAND DISLOCATION | 6.98 | Agree | 6.98 | ||
| 26843 | FUSION OF HAND JOINT | 7.61 | Agree | 7.61 | ||
| 26844 | FUSION/GRAFT OF HAND JOINT | 8.73 | Agree | 8.73 | ||
| 27096 | INJECT SACROILIAC JOINT | 1.40 | Agree | 1.40 | ||
| 28299 | CORRECTION OF BUNION | 10.58 | Agree | 10.58 | ||
| 29086 # | APPLY FINGER CAST | 0.62 | Agree | 0.62 | ||
| 29805 # | SHOULDER ARTHROSCOPY, DX | 5.89 | Agree | 5.89 | ||
| 29806 # | SHOULDER ARTHROSCOPY/SURGERY | 14.37 | Agree | 14.37 | ||
| 29807 # | SHOULDER ARTHROSCOPY/SURGERY | 13.90 | Agree | 13.90 | ||
| 29819 | SHOULDER ARTHROSCOPY/SURGERY | 7.62 | Agree | 7.62 | ||
| 29820 | SHOULDER ARTHROSCOPY/SURGERY | 7.07 | Agree | 7.07 | ||
| 29821 | SHOULDER ARTHROSCOPY/SURGERY | 7.72 | Agree | 7.72 | ||
| 29822 | SHOULDER ARTHROSCOPY/SURGERY | 7.43 | Agree | 7.43 | ||
| 29823 | SHOULDER ARTHROSCOPY/SURGERY | 8.17 | Agree | 8.17 | ||
| 29824 # | SHOULDER ARTHROSCOPY/SURGERY | 8.25 | Agree | 8.25 | ||
| 29900 # | MCP JOINT ARTHROSCOPY, DX | 5.42 | Agree | 5.42 | ||
| 29901 # | MCP JOINT ARTHROSCOPY, SURG | 6.13 | Agree | 6.13 | ||
| 29902 # | MCP JOINT ARTHROSCOPY, SURG | 6.70 | Agree | 6.70 | ||
| 30117 | REMOVAL OF INTRANASAL LESION | 3.16 | Agree | 3.16 | ||
| 30118 | REMOVAL OF INTRANASAL LESION | 9.69 | Agree | 9.69 | ||
| 31641 | BRONCHOSCOPY, TREAT BLOCKAGE | 5.03 | Agree | 5.03 | ||
| 32650 | THORACOSCOPY, SURGICAL | 10.75 | Agree | 10.75 | ||
| 33967 # | INSERT IA PERCUT DEVICE | 4.85 | Agree | 4.85 | ||
| 33975 | IMPLANT VENTRICULAR DEVICE | 21.00 | Agree | 21.00 | ||
| 33976 | IMPLANT VENTRICULAR DEVICE | 23.00 | Agree | 23.00 | ||
| 33977 | REMOVE VENTRICULAR DEVICE | 19.29 | Agree | 19.29 | ||
| 33978 | REMOVE VENTRICULAR DEVICE | 21.73 | Agree | 21.73 | ||
| 33979 # | INSERT INTRACORPOREAL DEVICE | carrier | Agree | carrier | ||
| 33980 # | REMOVE INTRACORPOREAL DEVICE | carrier | Agree | carrier | ||
| 35646 | ARTERY BYPASS GRAFT | 31.00 | Agree | 31.00 | ||
| 35647 # | ARTERY BYPASS GRAFT | 28.00 | Agree | 28.00 | ||
| 35685 | BYPASS GRAFT PATENCY/PATCH | 4.05 | Agree | 4.05 | ||
| 35686 # | BYPASS GRAFT/AV FIST PATENCY | 3.35 | Agree | 3.35 | ||
| 36002 # | PSEUDOANEURYSM INJECTION TRT | 1.96 | Agree | 1.96 | ||
| 36005 | INJECTION EXT VENOGRAPHY | 0.95 | Agree | 0.95 | ||
| 36400 | DRAWING BLOOD | 0.38 | Agree | 0.38 | ||
| 36819 | AV FUSION/UPPR ARM VEIN | 14.00 | Agree | 14.00 | ||
| 36820 # | AV FUSION/FOREARM VEIN | 14.00 | Agree | 14.00 | ||
| 36823 | INSERTION OF CANNULA(S) | 21.00 | Agree | 21.00 | ||
| 38220 # | BONE MARROW ASPIRATION | 1.08 | Agree | 1.08 | ||
| 38221 # | BONE MARROW BIOPSY | 1.37 | Agree | 1.37 | ||
| 43200 | ESOPHAGUS ENDOSCOPY | 1.59 | Agree | 1.59 | ||
| 43227 | ESOPH ENDOSCOPY, REPAIR | 3.60 | Agree | 3.60 | ||
| 43245 | OPERATIVE UPPER GI ENDOSCOPY | 3.39 | Agree | 3.39 | ||
| 43310 | REPAIR OF ESOPHAGUS | 27.47 | Agree | 27.47 | ||
| 43312 | REPAIR ESOPHAGUS AND FISTULA | 30.50 | Agree | 30.50 | ||
| 43313 # | ESOPHAGOPLASTY CONGENITAL | 45.28 | Agree | 45.28 | ||
| 43314 # | TRACHEO-ESOPHAGOPLASTY CONG | 50.27 | Agree | 50.27 | ||
| 44120 | REMOVAL OF SMALL INTESTINE | 17.00 | Agree | 17.00 | ||
| 44121 | REMOVAL OF SMALL INTESTINE | 4.45 | Agree | 4.45 | ||
| 44126 # | ENTERECTOMY W/TAPER, CONG | 35.50 | Agree | 35.50 | ||
| 44127 # | ENTERECTOMY W/O TAPER, CONG | 41.00 | Agree | 41.00 | ||
| 44128 # | ENTERECTOMY CONG, ADD-ON | 4.45 | Agree | 4.45 | ||
| 44140 | PARTIAL REMOVAL OF COLON | 18.35 | Agree | 18.35 | ||
| 44160 | REMOVAL OF COLON | 18.62 | Agree | 18.62 | ||
| 44202 | LAP RESPECT S/INTESTINE SINGL | 22.04 | Agree | 22.04 | ||
| 44203 # | LAP RESECT S/INTESTINE, ADDL | 4.45 | Agree | 4.45 | ||
| 44204 # | LAPARO PARTIAL COLECTOMY | 22.00 | Disagree | 25.08 | ||
| 44205 # | LAP COLECTOMY PART W/ILEUM | 19.50 | Disagree | 22.23 | ||
| 44366 | SMALL BOWEL ENDOSCOPY | 4.41 | Agree | 4.41 | ||
| 44378 | SMALL BOWEL ENDOSCOPY | 5.26 | Agree | 5.26 | ||
| 44391 | COLONOSCOPY FOR BLEEDING | 3.82 | Agree | 3.82 | ||
| 45136 # | EXCISE ILEOANAL RESERVOIR | 27.30 | Agree | 27.30 | ||
| 45190 | DESTRUCTION, RECTAL TUMOR | 8.28 | Agree | 8.28 | ||
| 45303 | PROCTOSIGMOIDOSCOPY DILATE | 0.44 | Agree | 0.44 | ||
| 45317 | PROTOSIGMOIDOSCOPY BLEED | 1.50 | Agree | 1.50 | ||
| 45334 | SIGMOIDOSCOPY FOR BLEEDING | 2.73 | Agree | 2.73 | ||
| 45382 | COLONOSCOPY/CONTROL BLEEDING | 5.69 | Agree | 5.69 | ||
| 46020 # | PLACEMENT OF SETON | 2.90 | Agree | 2.90 | ||
| 46604 | ANOSCOPY AND DILATION | 1.31 | Agree | 1.31 | ||
| 46614 | ANOSCOPY/CONTROL BLEEDING | 2.01 | Agree | 2.01 | ||
| 46924 | DESTRUCTION, ANAL LESION(S) | 2.76 | Agree | 2.76 | ||
| 47370 # | LAPARO ABLATE LIVER TUMORE RF | ( a ) | ( a ) | 18.00 | ||
| 47371 # | LAPARO ABLATE LIVER CRYOSUG | ( a ) | ( a ) | 16.94 | ||
| 47380 # | OPEN ABLATE LIVER TUMOR RF | ( a ) | ( a ) | 21.25 | ||
| 47381 # | OPEN ABLATE LIVER TUMOR CRYO | ( a ) | ( a ) | 21.00 | ||
| 47382 # | PERCUT ABLATE LIVER RF | ( a ) | ( a ) | 12.00 | ||
| 48100 | BIOPSY OF PANCREAS, OPEN | 11.08 | Agree | 11.08 | ||
| 49424 | ASSESS CYST, CONTRAST INJECT | 0.76 | Agree | 0.76 | ||
| 49491 # | REPAIRING HERN PREMIE REDUC | 11.13 | Agree | 11.13 | ||
| 49492 # | RPR ING HERN PREMIE, BLOCKED | 14.03 | Agree | 14.03 | ||
| 49495 | RPR ING HERNIA BABY, REDUC | 5.89 | Agree | 5.89 | ||
| 49496 | RPR ING HERNIA BABY, BLOCKED | 8.79 | Agree | 8.79 | ||
| 50220 | REMOVE KIDNEY, OPEN | 17.15 | Agree | 17.15 | ||
| 50225 | REMOVAL KIDNEY OPEN, COMPLEX | 20.23 | Agree | 20.23 | ||
| 50230 | REMOVAL KIDNEY OPEN, RADICAL | 22.07 | Agree | 22.07 | ||
| 51596 | REMOVE BLADDER/CREATE POUCH | 39.52 | Agree | 39.52 | ||
| 52001 # | CYSTOSCOPY, REMOVAL OF CLOTS | 5.45 | Disagree | 2.37 | ||
| 52347 # | CYSTOSCOPY, RESECT DUCTS | 5.28 | Agree | 5.28 | ||
| 52510 | DILATIONPROSTATIC URETHRA | 6.72 | Agree | 6.72 | ||
| 53431 # | RECONSTRUCT URETHRA/BLADDER | 19.89 | Agree | 19.89 | ||
| 53444 # | INSERT TANDEM CUFF | 13.40 | Agree | 13.40 | ||
| 53445 | INSERT URO./VES NCK SPHINCTER | 14.06 | Agree | 14.06 | ||
| 53446 # | REMOVE URO SPHINCTER | 10.23 | Agree | 10.23 | ||
| 53447 | REMOVE/REPLACE UR SPHINCTER | 13.49 | Agree | 13.49 | ||
| 53448 # | REMOVE/REPLC UR SPHINCTR COMP | 21.15 | Agree | 21.15 | ||
| 53449 | REPAIR URO SPHINCTER | 9.70 | Agree | 9.70 | ||
| 53853 # | PROSTATIC WATER THERMOTHER | 6.41 | Disagree | 4.14 | ||
| 54065 | DESTRUCTION, PENIS LESION(S) | 2.42 | Agree | 2.42 | ||
| 54162 # | LYSIS PENIL CIRCUMCIS LESION | 3.00 | Agree | 3.00 | ||
| 54163 # | REPAIR OF CIRCUMSION | 3.00 | Agree | 3.00 | ||
| 54164 # | FRENULOTOMY OF PENIS | 2.50 | Agree | 2.50 | ||
| 54400 | INSERT SEMI-RIGID PROSTHESIS | 8.99 | Agree | 8.99 | ||
| 54401 | INSERT SELF-CONTD PROSTHESIS | 10.28 | Agree | 10.28 | ||
| 54405 | INSERT MULTI-COMP PENIS PROS | 13.43 | Agree | 13.43 | ||
| 54406 # | REMOVE MULTI-COMP PENIS PROS | 12.10 | Agree | 12.10 | ||
| 54408 # | REPAIR MUTLI-COMP PENIS PROS | 12.75 | Agree | 12.75 | ||
| 54410 # | REMOVE/REPLACE PENIS PROSTH | 15.50 | Agree | 15.50 | ||
| 54411 # | REMV/REPLC PENIS PROS, COMP | 16.00 | Agree | 16.00 | ||
| 54415 # | REMOVE SELF-CONTD PENIS PROS | 8.20 | Agree | 8.20 | ||
| 54416 # | REMV/REPL PENIS CONTAIN PROS | 10.87 | Agree | 10.87 | ||
| 54417 # | REMV/REPLC PENIS PROS, COMPL | 14.19 | Agree | 14.19 | ||
| 54512 | EXCISE LESION TESTIS | 8.58 | Agree | 8.58 | ||
| 56501 | DESTROY, VULVA LESIONS, SIMP | 1.53 | Agree | 1.53 | ||
| 56515 | DESTROY VULVA LESION/S COMPL | 1.88 | Agree | 1.88 | ||
| 56605 | BIOPSY OF VULVA/PERINEUM | 1.10 | Agree | 1.10 | ||
| 56810 | REPAIR OF PERINEUM | 4.13 | Agree | 4.13 | ||
| 57022 | I D VAGINAL HEMATOMA, PP | 2.56 | Agree | 2.56 | ||
| 57061 | DESTROY VAG LESIONS, SIMPLE | 1.25 | Agree | 1.25 | ||
| 57065 | DESTROY VAG LESIONS, COMPLEX | 2.61 | Agree | 2.61 | ||
| 57155 # | INSERT UTERI TANDEMNS/OVOIDS | 6.27 | Agree | 6.27 | ||
| 58100 | BIOPSY OF UTERUS LINING | 1.53 | Agree | 1.53 | ||
| 58346 # | INSERT HEYMAN UTERI CAPSULE | 6.75 | Agree | 6.75 | ||
| 58563 | HYSTEROSCOPY, ABLATION | 6.17 | Agree | 6.17 | ||
| 58953 # | TAH, RAD DISSECT FOR DEBULK | 32.00 | Agree | 32.00 | ||
| 58954 # | TAH RAD DEBULK/LYMPH REMOVE | 35.00 | Agree | 35.00 | ||
| 59000 | AMNIOCENTESIS, DIAGNOSTIC | 1.30 | Agree | 1.30 | ||
| 59001 # | AMINOCENTESIS, THERAPEUTIC | 3.00 | Agree | 3.00 | ||
| 64555 | IMPLANT NEUROELECTRODES | 2.27 | Agree | 2.27 | ||
| 64561 # | IMPLANT NEUROELECTRODES | 6.74 | Agree | 6.74 | ||
| 64575 | IMPLANT NEUROELECTRODES | 4.53 | Agree | 4.53 | ||
| 64581 # | IMPLANT NEUROELECTRODES | 13.50 | Agree | 13.50 | ||
| 64820 | REMOVE SYMPATHETIC NERVES | 10.37 | Agree | 10.37 | ||
| 64821 # | REMOVE SYMPATHETIC NERVES | 8.75 | Agree | 8.75 | ||
| 64822 # | REMOVE SYMPATHETIC NERVES | 8.75 | Agree | 8.75 | ||
| 64823 # | REMOVE SYMPATHETIC NERVES | 10.37 | Agree | 10.37 | ||
| 66982 | CATARACT SURGERY, COMPLEX | 13.50 | Agree | 13.50 | ||
| 67225 # | EYE PHOTODYNAMIC THER ADD-ON | (a ) | (a ) | 0.47 | ||
| 69990 | MICROSURGERY ADD-ON | 3.47 | Agree | 3.47 | ||
| 74230 | 26 | CINE/VIDEO X-RAY, THROAT/ESO | 0.53 | Agree | 0.53 | |
| 74305 | 26 | X-RAY BILE DUCTS/PANCREAS | 0.42 | Agree | 0.42 | |
| 76066 | 26 | JOINT SURVEY, SINGLE VIEW | 0.31 | Agree | 0.31 | |
| 76078 | 26 | RADIOGRAPHIC ABSORPTIONMETRY | 0.20 | Agree | 0.20 | |
| 76085 # | 26 | COMPUTER MAMMOGRAM ADD-ON | (a ) | (a ) | 0.06 | |
| 76120 | 26 | CINE/VIDEO X-RAYS | 0.38 | Agree | 0.38 | |
| 76125 | 26 | CINE/VIDEO X-RAYS ADD-ON | 0.27 | Agree | 0.27 | |
| 76362 # | 26 | CAT SCAN FOR TISSUE ABLATION | (a ) | (a ) | 4.00 | |
| 76394 # | 26 | MRI FOR TISSUE ABLATION | (a ) | (a ) | 4.25 | |
| 76490 # | 26 | US FOR TISSUE ABLATION | (a ) | (a ) | 2.00 | |
| 76819 | 26 | FETAL BIOPHYS PROFIL W/O NST | 0.63 | Disagree | 0.77 | |
| 76885 | 26 | US EXAM INFANT HIPS, DYNAMIC | 0.74 | Agree | 0.74 | |
| 76886 | 26 | US EXAM INFANT HIPS, STATIC | 0.62 | Agree | 0.62 | |
| 77300 | 26 | RADIATION THERAPY DOSE PLAN | 0.62 | Agree | 0.62 | |
| 77301 # | 26 | RADIOL THERAPY DOSE PLAN, IMRT | 8.00 | Agree | 8.00 | |
| 77418 # | RADIATION TX DELIVERY, IMRT | 0.00 | Agree | 0.00 | ||
| 85097 | BONE MARROW INTERPRETATION | 0.94 | Agree | 0.94 | ||
| 88380 # | 26 | MICRODISSECTION | carrier | Agree | carrier | |
| 90471 | IMMUNIZATION ADMIN | 0.17 | Disagree | 0.00 | ||
| 90472 | IMMUNIZATION ADMIN, EACH ADD | 0.15 | Disagree | 0.00 | ||
| 90473 # | IMMUNE ADMIN ORAL/NASAL | 0.17 | Disagree | 0.00 | ||
| 90939 # | HEMODIALYSIS STUDY, TRANSCUT | 0.00 | Agree | 0.00 | ||
| 91123 # | IRRIGATE FECAL IMPACTION | 0.00 | Agree | 0.00 | ||
| 92136 # | 26 | OPHTHALMIC BIOMETRY | 0.54 | Agree | 0.54 | |
| 92973 # | PERCUT CORONARY THROMBECTOMY | 3.28 | Agree | 3.28 | ||
| 92974 # | CATH PLACE, CARDIO BRACHYTX | 3.00 | Agree | 3.00 | ||
| 93025 # | MICROVOLT T-WAVE ASSESS | 0.75 | Agree | 0.75 | ||
| 93609 | 26 | MAP TACHYCARDIA, ADD-ON | (a ) | Disagree | 4.81 | |
| 93612 | 26 | INTRAVENTRICULAR PACING | 3.02 | Agree | 3.02 | |
| 93613 # | 26 | ELECTROPHYS MAP, 3D, ADD-ON | carrier | Disagree | 7.00 | |
| 93619 | 26 | ELECTROPHYSIOLOGY EVALUATION | 7.32 | Agree | 7.32 | |
| 93620 | 2 | ELECTROPHYSIOLOGY EVALUATION | 11.59 | Agree | 11.59 | |
| 93621 | 26 | ELECTROPHYSIOLOGY EVALUATION | 2.10 | Agree | 2.10 | |
| 93622 | 26 | ELECTROPHYSIOLOGY EVALUATION | 3.10 | Agree | 3.10 | |
| 93701 # | 26 | BIOIMPEDANCE, THORACIC | 0.00 | Disagree | 0.17 | |
| 94720 | 26 | MONOXIDE DIFFUSING CAPACITY | 0.26 | Agree | 0.26 | |
| 94750 | 26 | PULMONARY COMPLIANCE STUDY | 0.23 | Agree | 0.23 | |
| 95144 | ANTIGEN THERAPY SERVICES | 0.06 | Agree | 0.06 | ||
| 95145 | ANTIGEN THERAPY SERVICES | 0.06 | Agree | 0.06 | ||
| 95165 | ANTIGEN THERAPY SERVICES | 0.06 | Agree | 0.06 | ||
| 95170 | ANTIGEN THERAPY SERVICES | 0.06 | Agree | 0.06 | ||
| 95250 # | GLUCOSE MONITORING, CONT | 0.00 | Agree | 0.00 | ||
| 95875 | 26 | LIMB EXERCISE TEST | 1.10 | Agree | 1.10 | |
| 95904 | 26 | SENSE NERVE CONDUCTION TEST | 0.34 | Agree | 0.34 | |
| 95965 # | 26 | MEG, SPONTANEOUS | 8.00 | Agree | 8.00 | |
| 95966 # | 26 | MEG, EVOKED, SINGLE | 4.00 | Agree | 4.00 | |
| 95967 # | 26 | MEG, EVOKED, EACH ADDL | 3.50 | Agree | 3.50 | |
| 96000 # | MOTION ANALYSIS, VIDEO/3D | carrier | Disagree | 1.80 | ||
| 96001 # | MOTION TEST W/FT PRESS MEAS | carrier | Disagree | 2.15 | ||
| 96002 # | DYNAMIC SURFACE EMG | carrier | Disagree | 0.41 | ||
| 96003 # | DYNAMIC FINE WIRE EMG | carrier | Disagree | 0.37 | ||
| 96004 # | PHYS REVIEW OF MOTION TESTS | carrier | Disagree | 1.80 | ||
| 96150 # | ASSESS HLTH/BEHAVE, INIT | 0.50 | Agree | 0.50 | ||
| 96151 # | ASSESS HLTH/BEHAVE, SUBSEQ | 0.48 | Agree | 0.48 | ||
| 96152 # | INTERVENE HLTH/BEHAVE, INDIV | 0.46 | Agree | 0.46 | ||
| 96153 # | INTERVENE HLTH/BEHAVE, GROUP | 0.10 | Agree | 0.10 | ||
| 96154 # | INTERV HLTH/BEHAV, FAM W/PT | 0.45 | Agree | 0.45 | ||
| 96155 # | INTERV HLTH/BEHAV FAM NO PT | 0.44 | Agree | 0.44 | ||
| 96567 # | PHOTODYNAMIC TX, SKIN | 0.00 | Agree | 0.00 | ||
| 97005 # | ATHLETIC TRAIN EVAL | ( a ) | Agree | 0.00 | ||
| 97006 # | ATHLETIC TRAIN REEVAL | ( a ) | Agree | 0.00 | ||
| 97112 | NEUROMUSCULAR REEDUCATION | 0.45 | Agree | 0.45 | ||
| 97504 | ORTHOTIC TRAINING | 0.45 | Agree | 0.45 | ||
| 97535 | SELF CARE MNGMENT TRAINING | 0.45 | Agree | 0.45 | ||
| 97601 | WOUND CARE SELECTIVE | 0.50 | Agree | 0.50 | ||
| 97602 | WOUND CARE NON-SELECTIVE | 0.32 | Disagree | 0.00 | ||
| 99090 | COMPUTER DATA ANALYSIS | 0.00 | Agree | 0.00 | ||
| 99091 # | COLLECT/REVIEW DATA FROM PT | 1.10 | Disagree | 0.00 | ||
| 99289 # | PT TRANSPORT, 30-74 MIN | 4.80 | Disagree | 0.00 | ||
| 99290 # | PT TRANSPORT, ADDL 30 MIN | 2.40 | Disagree | 0.00 | ||
| 99374 | HOME HEALTH CARE SUPERVISION | 1.10 | Agree | 1.10 | ||
| 99375 | HOME HEALTH CARE SUPERVISION | 1.73 | Agree | 1.73 | ||
| 99377 | HOSPICE CARE SUPERVISION | 1.10 | Agree | 1.10 | ||
| 99378 | HOSPICE CARE SUPERVISION | 1.73 | Agree | 1.73 | ||
| 99379 | NURSING FAC CARE SUPERVISION | 1.10 | Agree | 1.10 | ||
| 99380 | NURSING FAC CARE SUPERVISION | 1.73 | Agree | 1.73 | ||
| 99381 | PREV VISIT, NEW, INFANT | 1.19 | Agree | 1.19 | ||
| 99382 | PREV VISIT, NEW, AGE 1-4 | 1.36 | Agree | 1.36 | ||
| 99383 | PREV VISIT, NEW, AGE 5-11 | 1.36 | Agree | 1.36 | ||
| 99384 | PREV VISIT, NEW, AGE 12-17 | 1.53 | Agree | 1.53 | ||
| 99385 | PREV VISIT, NEW, AGE 18-39 | 1.53 | Agree | 1.53 | ||
| 99386 | PREV VISIT, NEW, AGE 40-64 | 1.88 | Agree | 1.88 | ||
| 99387 | PREV VISIT, NEW, 65 OVER | 2.06 | Agree | 2.06 | ||
| 99391 | PREV VISIT, EST, INFANT | 1.02 | Agree | 1.02 | ||
| 99392 | PREV VISIT, EST, AGE 1-4 | 1.19 | Agree | 1.19 | ||
| 99393 | PREV VISIT, EST, AGE 5-11 | 1.19 | Agree | 1.19 | ||
| 99394 | PREV VISIT, EST, AGE 12-17 | 1.36 | Agree | 1.36 | ||
| 99395 | PREV VISIT, EST, AGE 18-39 | 1.36 | Agree | 1.36 | ||
| 99396 | PREV VISIT, EST, AGE 40-64 | 1.53 | Agree | 1.53 | ||
| 99397 | PREV VISIT, EST, 65 OVER | 1.71 | Agree | 1.71 | ||
| ( a ) No RUC recommendation provided. | ||||||
| # New CPT codes. | ||||||
| * All CPT codes copyright 2002 American Medical Association. | ||||||
Table 7, AMA RUC Anesthesia Recommendations and CMS Decisions for New and Revised 2002 CPT Codes, lists the new or revised CPT codes for anesthesia and their base units that will be interim in 2002. This table includes the following information:
• CPT code. This is the CPT code for a service.
• Description. This is an abbreviated version of the narrative description of the code.
• RUC recommendations. This column identifies the base units recommended by the RUC.
• CMS decision. This column indicates whether we agreed with the RUC recommendation ("agree") or we disagreed with the RUC recommendation ("disagree"). Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table.
• 2002 Base Units. This column establishes the 2002 base units for these services.
| *CPT code | Description | RUC recommendation | CMS decision | 2002 Base units |
|---|---|---|---|---|
| 00797 | ANESTH, SURGERY FOR OBESITY | 9 | Disagree | 8 |
| 00851 | ANESTH, TUBAL LIGATION | 6 | Agree | 6 |
| 00869 | ANESTH, VASECTOMY | 3 | Agree | 3 |
| 01905 | ANES, SPINE INJECT, X-RAY/RE | 5 | Agree | 5 |
| 01916 | ANESTH, DX ARTERIOGRAPHY | 5 | Agree | 5 |
| 01924 | ANES, THER INTERVEN RAD, ART | 5 | Agree | 5 |
| 01925 | ANES, THER INTERVEN RAD, CAR | 7 | Agree | 7 |
| 01926 | ANES, TX INTERV RAD HRT/CRAN | 8 | Agree | 8 |
| 01930 | ANES, THER INTERVEN RAD, VEI | 5 | Agree | 5 |
| 01931 | ANES, THER INTERVEN RAD, TIP | 7 | Agree | 7 |
| 01932 | ANES, TX INTERV RAD, TH VEIN | 6 | Agree | 6 |
| 01933 | ANES, TX INTERV RAD, CRAN V | 7 | Agree | 7 |
| 01951 | ANESTH, BURN, LESS 4 PERCENT | 3 | Agree | 3 |
| 01952 | ANESTH, BURN, 4-9 PERCENT | 5 | Agree | 5 |
| 01960 | ANESTH, VAGINAL DELIVERY | 5 | Agree | 5 |
| 01961 | ANESTH, CS DELIVERY | 7 | Agree | 7 |
| 01962 | ANESTH, EMER HYSTERECTOMY | 8 | Agree | 8 |
| 01963 | ANESTH, CS HYSTERECTOMY | 8 | Agree | 8 |
| 01964 | ANESTH, ABORTION PROCEDURES | 4 | Agree | 4 |
| 01967 | ANESTH/ANALG, VAG DELIVERY | 5 | Agree | 5 |
| 01968 | ANES/ANALG CS DELIVER ADD-ON | 3 | Disagree | 2 |
| 01969 | ANESTH/ANALG CS HYST ADD-ON | 5 | Agree | 5 |
| * All CPT codes copyright 2002 American Medical Association. | ||||
Discussion of Codes for Which There Were No RUC Recommendations or for which the RUC Recommendations Were Not Accepted
The following is a summary of our rationale for not accepting particular RUC work RVU or base unit recommendations. It is arranged by type of service in CPT code order. Additionally, we also discuss those CPT codes for which we received no RUC recommendations for physician work RVUs. This summary refers only to work RVUs.
Anesthesia for Intraperitoneal Procedures in Upper Abdomen Including Laparoscopy; Gastric Restrictive Procedure for Morbid Obesity (CPT Code 00797).
The RUC recommended that 9 base units be assigned to this procedure based on a comparison to CPT code 00790 (Anesthesia for intraperitoneal procedures in the upper abdomen including laparoscopy; not otherwise specified). We disagree. We believe that assigning 9 base units to 00797 creates a rank order anomaly with CPT code 00794 (Anesthesia for intraperitoneal procedures in the upper abdomen including laparoscopy; pancreatectomy, partial or total (for example, Whipple procedure)) which is assigned 8 base units.
While obese patients do make the work of an anesthesiologist more difficult, we believe that the vignette used in the RUC survey was atypical and exaggerated the required work because the patient in the vignette was described as having asthma. We believe the work of an anesthesiologist is greater for patients undergoing Whipple procedures because, typically, these patients are sicker and require longer operative time and more intense anesthesia care than patients undergoing gastric restrictive procedures. Therefore, we are assigning 8 base units to 00797.
Cesarean Delivery Following Neuraxial Labor Analgesia/Anesthesia (List Separately in Addition to Code for Primary Procedure (CPT Code 01968))
The RUC recommended 3 base units for this add-on procedure. This procedure is reported in addition to CPT code 01967 (Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor)) , when a patient who has been given neuraxial anesthesia for a planned vaginal delivery requires conversion to a cesarian delivery and must be given anesthesia for the cesarian delivery. The RUC recommended 7 base units for CPT code 01961 (Anesthesia for, cesarian delivery only), a recommendation with which we agree. We note the following:
• The base units of 01961, anesthesia for cesarian delivery, are the same as the base units of 01967 plus 01968.
• The survey respondents valued the add-on code 01968 as if it were a stand-alone code with a median base unit of 7 and an intraservice time of 75 minutes. Both the median base units and the intraservice time are identical to the survey results for 01961.
• CPT code 01968 is currently reported (per the American Society of Anesthesiologists) as 00857 (Neuraxial analgesia/anesthesia for labor ending in a cesarian delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor) , which is valued at 7 base units. Moreover, the work of CPT code 01967 plus CPT code 01968 is completely described by CPT code 00857 so it is unclear why the sum of the base units assigned to 01967 and 01968 should not be identical to the base units currently assigned to CPT code 00857.
In view of these concerns, we are assigning 2 base units to CPT code 01968. We are also making a neutrality adjustment to the anesthesia conversion factor based on our analysis of the estimated difference in base units between previously repeated anesthesia codes and the new codes.
Injection, Therapeutic (Eg, Local Anesthetic, Corticosteroid); Carpal Canal, (CPT Code 20526) Injection; Tendon Sheath, Ligament, Ganglion Cyst, (CPT Code 20550)
Injection; Tendon Origin/Insertion, (CPT Code 20551)
Injection; Single or Multiple Trigger Point(s), One or Two Muscle Group(s) (CPT Code 20552), and
Injection; Single or Multiple Trigger Point(s), Three or More Muscle Groups (CPT Code 20553)
CPT codes 20526, 20551, 20552, and 20553 are new codes, while 20550 is being revised from its current descriptor "Injection, tendon sheath, ligament; ganglion cyst, or trigger points" to the descriptor above. We received an interim recommendation of 0.86 work RVUs for these codes, from the RUC, based on the fact that all these procedures are currently reported as 20550 which is valued at 0.86 RVUs.
CPT code 20550 comprises several procedures with varying amounts of physician work that will now be reported separately. We are assigning 0.86 RVUs to all these codes on an interim basis, and will review this further for 2002 if we receive recommendations from the RUC. At that time we will also have utilization data on these services to assist us in making work neutrality adjustments should any adjustments be required.
Laparoscopy, Surgical; Colectomy, Partial With Anastomosis (CPT Code 44204) and Laparoscopy, Surgical; Colectomy, Partial, With Removal of Terminal Ileum With Ileocecostomy (CPT Code 44205)
The RUC recommended 22.00 RVUs for CPT code 44204 and 19.50 RVUs for CPT Code 44205 based on the reference code 44140 ( Colectomy, partial; with anastomosis ) which, at the time of the recommendation, had a work RVU of 18.35. We increased the work RVU of CPT Code 44140 to 21 as part of the 5-year review of physician work. In order to prevent rank order anomalies we are assigning work RVUs of 25.08 and 22.23 to CPT Codes 44204 and 44205, respectively. These work RVUs represent a 14 percent increase over the RUC recommendation and are consistent with our valuation of CPT Code 44140.
Laparoscopy, Surgical, Ablation of One or More Liver Tumor(s); Radiofrequency (CPT Code 47370), Laparoscopy, Surgical, Ablation of One or More Liver Tumor(s); Cryosurgical (CPT Code 47371), Ablation, Open, of One or More Liver Tumor(s); Radiofrequency (CPT Code 47380), Ablation, Open, of One or More Liver Tumor(s); Cryosurgical (CPT Code 47381), Ablation, One or More Liver Tumor(s), Percutaneous, Radiofrequency (CPT Code 47382), Computerized Axial Tomography Guidance for, and Monitoring of, Tissue Ablation (CPT Code 76362), Magnetic Resonance Guidance for, and Monitoring of, Tissue Ablation (CPT Code 76394); and Ultrasound Guidance for, and Monitoring of, Tissue Ablation (CPT Code 76490)
We have not received recommendations from the RUC for these procedures. We have assigned work RVUs as follows:
47370-18 work RVUs
47371-16.94 work RVUs
47380-21.25 work RVUs
47381-21.00 work RVUs
47382-12.00 work RVUs
To arrive at the values listed above, we compared the time and intensity of these services to other open and laparoscopic liver, colon, and renal procedures. We believe that the RVUs assigned place them in the correct rank order with these other services and with respect to each other.
76362-4.00 work RVUs
76394-4.25 work RVUs
76490-2.00 work RVUs
To arrive at the values above, we compared the time and intensity of these procedures to other radiologic guidance codes and to radiologic supervision and interpretation codes. We believe that the assigned RVUs place them in correct rank order to other radiologic guidance services and to each other.
Cystourethroscopy with irrigation and evacuation of clots, (CPT Code 52001)
The RUC recommended 5.45 work RVUs based on a comparison to the reference procedures CPT code 52315 (Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); complicated), and CPT Code 52235 (Cystourethroscopy, with fulguration (including cryosurgery or laser surgery) and/or resection of; medium bladder tumor(s) (2.0 to 5.0 cm)).
We are concerned that 52001, with its current descriptor, will be reported whenever a cystoscopy is performed and blood is present during the examination. As written, the code may be reported whenever any blood clots are present. The RUC recommendation is based upon the urologists' response to a scenario where the bladder outlet was obstructed due to large blood clots and removal of the blood clots required a resectoscope. Unfortunately, the code descriptor does not require the presence of bladder obstruction due to blood clots, nor does it require the use of a resectoscope. Therefore, until the descriptor of this code is clarified by the AMA CPT editorial panel, we are assigning 2.37 RVUs to this procedure. As the CPT code is now written, the time and intensity of the physician work for this procedure are comparable to CPT Code 52005. (Cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service).
Transurethral Destruction of Prostatic Tissue; By Water Induced Thermotherapy (CPT Code 53853)
The RUC recommended 6.41 work RVUs for this procedure based on a comparison to CPT Code 54670 (Suture or repair of testicular injury) which has a similar work value and similar pre-, intra-, and postservice times to the median times in the survey for 53853. The RUC also noted that CPT Code 53850 (Transurethral destruction of prostate; by microwave thermotherapy) has 90 minutes of intraservice time as compared to 60 minutes for CPT code 53853 and that the recommended work value for CPT code 53853 was approximately 2⁄3 of the work value for CPT code 53850.
We note that although the intraservice time for CPT code 53853 is 60 minutes, most of that time is spent monitoring the flow of hot water through a catheter and balloon and checking the water's temperature. We estimate that the maximum amount of time spent on activities other than monitoring is 20 minutes. This means that the work intensity for the intraservice portion of this procedure is significantly less than it is for most other surgical procedures and, specifically, the reference codes examined by the RUC. Therefore, we believe it is more appropriate to compare CPT code 53853 to 90-day global procedures with less than 30 minutes of intraservice time. For these reasons we compared CPT code 58350 to the following procedures:
| CPT code | Work RVU | Intraservice time (minutes) | Pre/post service time |
|---|---|---|---|
| 53853Transurethral destruction of prostate tissue; by water-induced thermotherapy | RUC Recommendation-6.41 | 60 | *113 |
| CMS assigned RVU 4.14 | |||
| 30130Excision turbinate, partial or complete, any method | 3.38 | 27 | 78 |
| 42826Tonsillectomy, primary or secondary; age 12 or over | 3.38 | 28 | 82 |
| 46045Incision and drainage of intramural, intramuscular, or submucosal abscess, transanal, under anesthesia | 4.32 | 25 | 206 |
| 46946Ligation of internal hemorrhoids; multiple procedures | 3.0 | 25 | 75 |
| 58800Drainage of ovarian cyst(s), unilateral or bilateral, (separate procedure); vaginal approach | 4.14 | 23 | 100 |
| 61105Twist burr hole for subdural or ventricular puncture | 5.14 | 27 | 97 |
| 65810Paracentesis of anterior chamber of eye (separate procedure); with removal of vitreous and/or discission of anterior hyaloid membrane, with or without air injection | 4.87 | 28 | 104 |
| 67031Severing of vitreous strands, vitreous face adhesions, sheets, membranes, or opacities, laser surgery (one or more stages) | 3.67 | 26 | 79 |
| * see below. | |||
The RUC sent us a postservice time of 131 minutes, which we believe is incorrect. The RUC assigned 3 postservice visits to this procedure which have a combined time of 35 minutes, not 53 minutes as recommended by the RUC. Therefore, the correct postservice time is 118 minutes.
With respect to the services listed above, we note that all of them carry significant risks to the patient and have intraservice work of high intensity. In fact, we believe the intraservice work of all the above procedures is of greater intensity than any portion of the intraservice work of CPT code 53853. After review of the procedures considered by the RUC and the above procedures, we believe that the time and intensity of CPT code 53853 is most comparable to CPT code 58800 and are assigning 4.14 work RVUs to CPT code 53853. This places CPT code 53853 in the correct rank order with respect not only to the procedures listed above but also to the prostate ablation, cystourethroscopy, and testicular procedures considered by the RUC.
Destruction of Localized Lesion of Choroids (eg, Choroidal Neovascularization); Photodynamic Therapy, Second Eye, at Single Session (List Separately in Addition To Code for Primary Eye Treatment) CPT Code 67225
We did not receive a RUC recommendation on this code. We are assigning work RVUs of 0.47, which is the work value for G0184, the code previously used for reporting this service.
Immunization Administration (Includes Percutaneous, Intradermal, Subcutaneous, Intramuscular and Jet Injections); One Vaccine (Single or Combination Vaccine/Toxoid) (CPT Code 90471), Immunization Administration (Includes Percutaneous, Intradermal, Subcutaneous, Intramuscular and Jet Injections); Each Additional Vaccine/Toxoid (List Separately in Addition To Code for Primary Procedure) One Vaccine (CPT Code 90472)
The RUC recommended a work RVU of .17 for CPT code 90471 and .15 work RVUs for CPT code 90472. These services are analogous to CPT code 90872 (Therapeutic, prophylactic or diagnostic injection (specify material injected); subcutaneous or intramuscular) which has no physician work RVUs. They are services performed by a nurse and have no physician work. If the physician performs any counseling related to this service, it is considered part of the work of the preventive medicine visit during which the immunization was administered. If the vaccine is administered during a visit other than a preventive medicine service, any physician counseling should be billed separately as an E/M service. For these reasons we are not assigning work RVUs to these codes.
Immunization Administration by Intranasal or Oral Route; One Vaccine (Single or Combination Vaccine/Toxoid) (CPT Code 90473); and, Immunization Administration by Intranasal or Oral Route Each Additional Vaccine/Toxoid (List Separately in Addition To Code for Primary Procedure) CPT Code 90474
The RUC recommended a work RVU of .17 for CPT code 90473 and .15 work RVUs for CPT code 90474. These are noncovered services. Medicare does not cover self-administered vaccines, and, therefore, we are not assigning work RVUs to these services.
Intraventricular and/or Intra-Atrial Mapping of Tachycardia Site(s) With Catheter Manipulation to Record From Multiple Sites to Identify Origin of Tachycardia (CPT Code 93609)
We have not received a recommendation from the RUC for this service. The descriptor for this service has not changed but the AMA CPT editorial panel changed the global period for this service from a zero day global to a ZZZ global. This means that it is now an "add on" code and the physician work RVUs will no longer include any pre- or postservice work. It currently has a work RVU of 10.07. In order to appropriately value this add on service, we compared it to several other electrophysiology services, including CPT code 93619, (Comprehensive electrophyisologic evaluation with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording, including insertion and repositioning of multiple electrode catheters; without induction or attempted induction of arrhythmia) with a work RVU of 7.32, and CPT code 93618, Induction of arrhythmia by electrical pacing (work RVU 4.26), and CPT code 93624, (Electrophysiologic follow up study with pacing and recording to test effectiveness of therapy, including induction of attempted induction of arrhythmia), with a work RVU of 4.81. After reviewing these services, we believe that the time and intensity of physician work for CPT code 93609 as an add-on code is most similar to CPT code 93624 and are assigning a work RVU of 4.81 to CPT code 93609.
Intracardiac Electrophysiologic 3-Dimensional Mapping (CPT Code 93613)
This is a new add-on code for which we have not received a recommendation from the RUC. As an add-on code, this service does not include and pre- or postservice work. We compared this service to CPT code 93619 (Comprehensive electrophysiologic evaluation with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording, including insertion and repositioning of multiple electrode catheters; without induction or attempted induction of arrhythmia) with work RVUs of 7.32 and to CPT code 93651 (Intracardiac catheter ablation of arrhythmogenic focus; for treatment of supraventricular tachycardia by ablation of fast or slow atrioventricular pathways, accessory atrioventricular connections or other atrial foci, singly or in combination) with work RVUs of 16.25. We also wanted to ensure that the work value for this service was placed in correct rank order to CPT code 93609 (see above). We believe that the intraservice time and intensity of this service is slightly less than that of CPT code 93619 and are assigning 7.00 work RVUs to CPT code 93613.
Bioimpedence, Thoracic, Electrical CPT Code 93701
We received a RUC recommendation that this service has no physician work. We currently cover this service under the HCPCS code M0302. We assigned 0.17 physician work RVUs to this service in the November 2000 final rule after conducting a notice and comment period. We will consider the RUC recommendation. If we considered changing the work RVUs for this service, we would discuss any proposed change in a future notice of proposed rule making. However, we are going to discontinue HCPCS code M0302 and will recognize CPT Code 93701 for this service.
Comprehensive Computer-Based Motion Analysis by Video-Taping And 3-D Kinematics (CPT Code 96000), Comprehensive Computer-Based Motion Analysis by Video-Taping and 3-D Kinematics; With Dynamic Plantar Pressure Measurements During Walking (CPT Code 96001), Dynamic Surface Electromyography, During Walking or Other Functional Activities, 1-12 Muscles (CPT Code 96002), Dynamic Fine Wire Electromyography, During Walking or Other Functional Activities, 1 Muscle (CPT Code 96003), and Physician Review and Interpretation of Comprehensive Computer Based Motion Analysis, Dynamic Plantar Pressure Measurements, Dynamic Surface Electromyography During Walking or Other Functional Activities, and Dynamic Fine Wire Electromyography, With Written Report (CPT Code 96004)
HCPAC recommended that these services be carrier priced. We disagree and are assigning work RVUs to these services as follows:
CPT code 96000-1.8 work RVUs
CPT code 96001-2.15 work RVUs
CPT code 96002-.41 work RVUs
CPT code 96003-.37 work RVUs
CPT code 96004-1.8 work RVUs
To arrive at these values, we compared the time and intensity of CPT codes 96000 and 96001 to other physical therapy services. We believe that the assigned RVUs place these services in the correct rank order with other physical therapy services. We compared the time and intensity of CPT codes 96002 and 96003 to other electromyography services and believe that the assigned RVUs place these services in the correct rank order with other electromyography services. We compared the time and intensity of CPT code 96004 with other physical therapy services and physician consultation services and believe the assigned RVUs place CPT code 96004 in the correct rank order with these other services.
Removal of Devitalized Tissue From Wound(s); Non-Selective Debridement, Without Anesthesia (eg, Wet-To-Moist Dressings, Enzymatic, Abrasion), Including Topical Applications(s), Wound Assessment and Instruction(s) for Ongoing Care, Per Session, CPT 97602
The HCPAC recommended a work RVU of .32 for this service. We disagree with this recommendation as we continue to believe that this code is bundled into 97602 for the reasons discussed earlier in this section. Therefore, we are not establishing work RVUs for this service.
Collection and Interpretation of Physiologic Data (eg, ECG, Blood Pressure, Glucose Monitoring) Digitally Stored and/or Transmitted by the Patient and/or Caregiver to the Physician or Other Qualified Health Care Professional, Requiring a Minimum of 30 Minutes of Time CPT CODE 99091
The RUC recommended work RVUs of 1.10 for this code. We disagree as this work is considered part of the pre and postservice work of an E/M service and propose to bundle payment for this code. (Note that payment for similar CPT code, 99090, Analysis of clinical data in computers (eg, ECGs, blood pressures, hematologic data, is also currently bundled.)
CPT Codes 99289, Physician Constant Attention of the Critically Ill or Injured Patient During an Interfacility Transport; First 30-74 Minutes, and 99290 Each Additional 30 Minutes (List Separately in Addition To Code for Primary Service)
These two new codes were created for CPT 2002 that describe services provided during patient transport. The RUC recommended that CPT code 99289 be valued at 4.8 work RVUs and CPT code 99290 be valued at 2.4 work RVUs. The CPT explanatory notes accompanying these two new codes state:
The following codes 99289 and 99290 are used to report the physical attendance and direct face-to-face care by a physician during the interfacility transport of a critically ill or injured patient. For the purposes of reporting codes 99289 and 99290, face-to-face care begins when the physician assumes the primary responsibility of the patient at the referring hospital or facility, and ends when the receiving hospital or facility accepts responsibility for the patient's care. Only the time the physician spends in direct face-to-face contact the patient during the transport should be reported. Patient transport services involving less than 30 minutes of face-to-face physician care should not be reported using 99289, 99290.
Procedure(s) or service(s) performed by other members of the transporting team may not be reported by the supervising physician. Any procedure(s) or service(s) performed by the physician before or during transport that are identified in CPT may be reported separately with the exception of routine monitoring evaluations (eg, heart rate, respiratory rate, blood pressure, and pulse oximetry) and the initiation of mechanical ventilation.
The time spent by the physician performing separately reportable services or procedures should not be included in the face-to-face time reported by codes 99289, 99290. The direction of emergency care to transporting staff by a physician located in a hospital or other facility by two-way communication is not considered direct face-to-face care and should not be reported with codes 99289, 99290.
The CPT explanatory notes go on to state that physicians should report emergency department services codes, initial hospital care codes, and critical care codes only after the patient has been admitted to the emergency department, the inpatient floor, or the critical care unit of the receiving facility.
Decision: We would like to note that, currently, physician services provided to patients during interfacility transport are reported, and paid, using the appropriate E/M service codes (for example, outpatient visits, emergency visits, prolonged services, critical care).
We have several significant concerns about the new CPT codes, 99289 and 99290. First, other than requiring face-to-face contact with the patient, there is no requirement for delivery of any specific physician service. This is in contrast to requirements for reporting critical care services under CPT codes 99291, 99292, 99295, 99296, 99297, and 99298. When reporting CPT codes 99291 and 99292 the CPT requires that, in addition to the patient being critically ill or critically injured, and the physician devoting his or her full attention to the patient, "high complexity decision making to assess, manipulate, and support vital system function(s) to treat single or multiple vital organ system failure and/or to prevent further life-threatening deterioration of the patient's condition." These codes are valued at 4.0 work RVUs and 2.0 work RVUs, respectively.
The CPT goes on to state that-
"Although critical care typically requires interpretation of multiple physiologic parameters and/or application of advanced technology(s), critical care may be provided in life threatening situations when those elements are not present."
" * * * Providing medical care to a critically ill, injured, or postoperative patient qualifies as a critical care service only if both the illness or injury and the treatment being provided, meet the above requirements."
As the code descriptors are written, the care described by the new CPT patient transport codes 99289 and 99290 do not meet the requirements for critical care. In fact, some services that will be reported as 99289 and 99290 would also be more appropriately reported as a new or established outpatient visit, an emergency visit, or as prolonged services, depending on the type of care that was delivered. We believe that the descriptors for CPT codes 99289 and 99290 will make it difficult for physicians to know when to report 99289 and 99290 appropriately.
Second, the beginning and ending times for 99289 and 99290 are unclear. We do not believe time spent in the referring and receiving facility should be counted towards this service. Time spent in the facility prior to and after transfer may not require any physician services even though the physician is face-to-face with the patient. Furthermore, if services are provided at the referring or receiving facility they should be billed as the appropriate E/M service (for example, new patient visit, emergency visit).
Third, we note that the descriptors for 99289 and 99290 include the phrase " * * * critically ill or injured patient" while the descriptors for 99291 and 99292 include the phrase " * * * critically ill or critically injured patient." We realize that CPT descriptors are carefully developed, so we are concerned about this discrepancy and believe it needs to be clarified.
Fourth, we note that although CPT specifically includes (or bundles) certain services into critical care, it does not include those same services in the payment for 99289 and 99290 (for example, gastric intubation, temporary transcutaneous pacing).
Therefore, after careful review of the descriptors and explanatory notes for CPT codes 99289 and 99290, we have decided to not recognize these codes for Medicare purposes. Instead, we have created two HCPCS Level II codes to describe critical care services provided to patients during inter-facility transport. These codes are:
G0240-Critical Care Service delivered by a physician; face-to-face, during inter-facility transport of a critically ill or critically injured patient: first 30-74 minutes of active transport.
G0240 will be valued at 4.0 work RVUs.
G0241-each additional 30 minutes (list separately in addition to G0240)
G0241 will be valued at 2.0 work RVUs.
We believe that these two G codes carry out the intent of 99289 and 99290 with less ambiguity and thus will facilitate accurate reporting of these services by physicians. We have decided to value these services at the present value for 99291 (4.0 work RVUs) and 99292 (2.0 work RVUs). Although critical care is the most intense E/M service delivered by physicians, there is considerable variation in the intensity range of the services provided under the umbrella of critical care. We value all critical care services uniformly and do not believe there is a need to develop a tiered approach to valuing critical care services.
We will apply all the requirements for critical care services (CPT codes 99291 and 99292) to G0240 and G0241 with the following two exceptions: (1) All time counted towards patient transport time must be face-to-face time with the patient; (2) We will only allow face-to-face time spent in actual transport to be counted towards G0240 and G0241; E/M services delivered in the referring and receiving facilities may be reported under other appropriate E/M codes (for example, outpatient, emergency, or critical care services).
If the actual transportation time is less than 30 minutes and/or the service does not meet the requirements of G0240 and G0241, then the physician may report his or her services under the appropriate E/M code (for example, outpatient visit, emergency visit, prolonged services).
In order for G0240 and G0241 to be payable, the medical record must document the time spent in actual patient transport, the nature of the patient's critical illness or critical injury, and the critical care services delivered to the patient. Consistent with the teaching physician policies in section 15016 of the Medicare Carriers Manual, residents who provide this service are paid through graduate medical education payments. Therefore, their services are not payable through Medicare Part B.
Any services delivered, or face-to-face time spent with the patient, by a resident, nurse, emergency medical technician, or other non-physician may not be billed using G0240 or G0241. Nor may any services performed by any physician or non-physician who is not physically present with the patient during interfacility transport be billed. Time spent in the referring facility, the receiving facility, and time spent prior to transport are not countable towards G0240 and G0241. Additionally, any time spent performing separately billable procedures may not be counted towards G0240 and G0241 (for example, insertion of chest tubes, insertion of intravenous lines and pacemakers, and cardiopulmonary resuscitation). All services bundled into 99291 and 99292 will also be bundled into G0240 and G0241.
Establishment of Interim Practice Expense Relative Value Units for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New HCFA Common Procedure Coding System Codes for 2002
We have developed a process for establishing interim practice expense RVUs (PERVUs) for new and revised codes that is similar to that used for work RVUs. Under this process, the RUC recommends the practice expense direct inputs, that is, the staff time, supplies and equipment associated with each new code. We then review the recommendations in a manner similar to our evaluation of the recommended work RVUs.
The RUC recommendations on the practice expense inputs for the new and revised 2002 codes were submitted to us as interim recommendations. We, therefore, consider that these recommendations are still subject to further refinement by the PEAC, or by us, if it is determined that such future review is needed. We may also revisit these inputs in light of future decisions of the PEAC regarding supply and equipment packages and standardized approaches to pre- and postservice clinical staff times.
We have accepted, at least in the interim, almost all of the practice expense recommendations submitted by the RUC for the codes listed in table 6, AMA RUC and HCPAC Work RVU Recommendations and CMS Decisions for New and Revised 2002 CPT Codes." We made the following minor changes to the inputs where relevant:
• We substituted the RUC agreed-upon multispecialty minimum visit supply package for the list of individual supplies where appropriate.
• We deleted separately billable supplies, for example, drugs, fluids, casting supplies, when listed in the recommended supply list.
• We rounded fractions of minutes of clinical staff time to the nearest minute.
• The RUC agreed with the specialty society representing neurology that the magnetoencephalography codes, CPT 95965, 95966, 95967, are only performed in the facility setting and that they therefore had no direct practice expense inputs. However, we have subsequently heard from the specialty society that it has determined that a small number of practitioners do perform these services in the office setting and that there would be costs in that setting that should be reflected. We have accepted the suggestion that the TC of these codes be carrier-priced, at least until we can ascertain what direct cost inputs should be included when these services are performed in the non-facility setting.
• We are accepting the practice expense inputs recommended for CPT code 77418 (Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams (binary, dynamic, MLC, etc.) , per treatment session, with the exception of the time for the radiation therapist which we are reducing from the recommended 123 minutes to 60 minutes. We are concerned that there may be overlap in the staff time for other codes billed in conjunction with CPT code 77418, such as CPT code 76950 (Ultrasound guidance for placement of radiation therapy fields) and CPT code 77417 (Therapeutic radiology port film(s)).
Further, we understand that the code was valued assuming the typical time for the service was 60 minutes and included the time of two radiation therapists. We believe that the service commonly takes less than the recommended 123 minutes and it may involve only one therapist. As a result of these concerns, we are valuing the service using 60 minutes of radiation technician time. This valuation is considered interim during the refinement of practice expense RVUs. We also note that the practice expense RVUs for 77418 are being determined under the resource-based methodology even though the service has no physician work. We believe that the service will have a more appropriate relative payment amount if the practice expense RVUs are determined outside of the no work methodology.
• We did not receive a RUC recommendation for CPT code 93613, Intracardiac electrophysiology, or CPT 96004, Gait and motion studies. We have assumed that these services are performed only in the facility setting and have no direct inputs.
For the following CPT codes we did not receive practice expense recommendations. Therefore, we are providing practice expense inputs through crosswalking to an existing code as indicated below:
| New/revised CPT code | Existing CPT/HCPCS code |
|---|---|
| 20553Therapeutic Injections | 20550Therapeutic Injections. |
| 47370Ablation of Hepatic Tumors | 47562Laparoscopic cholecystectomy. |
| 47371Ablation of Hepatic Tumors | 47562Laparoscopic cholecystectomy. |
| 47380Ablation of Hepatic Tumors | 47350Repair liver wound. |
| 47381Ablation of Hepatic Tumors | 47350Repair liver wound. |
| 47382Ablation of Hepatic Tumors | 47525Change bile duct catheter. |
| 67225Ocular Photodynamic Therapy | G0184Ocular photodynamic tx, 2nd. |
| 76362Ablation of Hepatic Tumors | 76360CAT scan for needle biopsy. |
| 76394Ablation of Hepatic Tumors | 76393Mr guidance for needle place. |
| 76490Ablation of Hepatic Tumors | 76942Echo guide for biopsy. |
C. Other Changes to the 2002 Physician Fee Schedule and Clarification of CPT Definitions
For the 2002 physician fee schedule, we are establishing or revising several alpha-numeric HCPCS codes for reporting certain services that are not clearly described by existing CPT codes.
In addition to the two new HCPCS codes for patient transport we have discussed in section IV.B., "Establishment of Interim Work Relative Value Units for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System Codes (HCPCS) for 2002" above; we are also establishing the HCPCS codes for the respiratory therapy services below.
Respiratory Therapy Codes
Respiratory therapists can deliver services incident to a physician's service or in a provider setting such as an outpatient hospital or a comprehensive outpatient rehabilitation facility. In the past, services delivered by respiratory therapists or other health professionals often have not been clearly described by the existing CPT codes. In order to clarify coding of these services, typically delivered by respiratory therapists, but at times delivered by other specially trained health professionals, we are instituting new G codes to describe these services.
We developed three codes for use to describe services to improve respiratory function:
G0237Therapeutic Procedures To Increase Strength or Endurance of Respiratory Muscles, Face-to-Face, One-on-One, Each 15 Minutes (Includes Monitoring).
This service is to be billed when the therapist works with the patient to perform specific exercises aimed at strengthening the main and accessory muscles of respiration.
We have provided a specific value for this code based upon the time that a respiratory therapist, who we believe will be the typical professional providing this service, will spend performing this service and practice expenses crosswalked from other similar services. This code will have no physician work.
G0238Therapeutic Procedures To Improve Respiratory Function, Other Than Ones Described by G0237, One-on-One, Face-to-Face, per 15 Minutes (Includes Monitoring)
G0239Therapeutic Procedures To Improve Respiratory Function, Two or More Patients Treated During the Same Period, Face-to-Face (Includes Monitoring)
Codes G0237 and G0238 are billed in 15-minute increments. The method for "counting" the 15 minutes will be consistent with the method for counting minutes in many of the 97000 series CPT codes (see PM-01-68 for details). These codes would describe activities, such as monitored exercise, that improve respiratory function. Both G0238 and G0239 would be carrier-priced. The carriers have the authority to request information about the specific nature of the services delivered. CPT codes G0237-G0239 may not be billed with codes G0110 and G0111, which are restricted to services in the National Emphysema Treatment Trial (NETT), since they represent the same services.
These codes are designed to provide more specific information about the services being delivered. The availability of codes for services to improve respiratory function will make billing of CPT codes 97000-97799 inappropriate for professionals involved in treating respiratory conditions, unless these services are delivered by physical and occupational therapists and meet the other requirements for physical and occupational therapy services. We recognize that speech and language pathologists also occasionally treat patients to improve respiratory function as part of their treatment of speech and language disorders. Because the primary goal of these services is not to improve respiratory function, but to restore speech and communication, these services should be coded with 92507, "treatment of speech, language, voice, communication, and/or auditory processing disorder (includes aural rehabilitation, individual)."
VI. Update of the Codes for the Physician Self-Referral Prohibition
On January 4, 2001 we published in the Federal Register a final rule with comment period, "Medicare and Medicaid Programs; Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships" (66 FR 856). That final rule incorporated into regulations the provisions in paragraphs (a), (b) and (h) of section 1877 of the Social Security Act (the Act). Section 1877 of the Act prohibits a physician from referring a Medicare patient for certain "designated health services" to a health care entity with which the physician (or a member of the physician's immediate family) has a financial relationship, unless an exception applies. In the final rule, we published an attachment listing all of the CPT and HCPCS codes that defined the entire scope of the following designated health services for purposes of section 1877 of the Act: clinical laboratory services; physical therapy services (including speech-language pathology services); occupational therapy services; radiology and certain other imaging services; and radiation therapy services and supplies.
In the January 4, 2001 final rule, we stated that we would update the list of codes used to define these designated health services in an addendum to the annual final rule concerning physician fee schedule payment policies. Thus, we are now publishing an updated all-inclusive list of codes at Addendum E. We also will provide that update on our website at www.hcfa.gov/medlearn/refphys.htm. The purpose of this update is to conform the code list to the most recent publication of CPT and HCPCS codes. The list of codes will become effective on January 4, 2002. We are using the January 4, 2002 date because that is the effective date for all but one provision of the January 4, 2001 physician self-referral final rule (changes made to 42 CFR 424.22 in the final rule became effective on April 6, 2001). In future years, we intend to use a January 1 effective date to coincide with the effective date of the new CPT and HCPCS codes.
Table 8, below, identifies the CPT and HCPCS codes that have been added to or deleted from the list of codes published as an attachment to the January 4, 2001 physician self-referral final rule. In that final rule, we stated that we would consider timely comments regarding the updated code list. Accordingly, we will consider comments with respect to the codes listed in Table 8, below, if we receive them by the date specified in the date section of this final rule.
| CPT1 or HCPCS code |
|---|
| Additions |
| 76085Computer mammogram add-on. |
| 77301Radioltherapy dos plan, imrt. |
| 77418Radiation tx delivery, imrt. |
| 92974Cath place, cardio brachytx. |
| 96000Motion analysis, video/3d. |
| 96001Motion test w/ft press meas. |
| 96002Dynamic surface emg. |
| 96003Dynamic fine wire emg. |
| G0202Screening mammography digital. |
| G0204Diagnostic mammography digital. |
| G0206Diagnostic mammography digital. |
| G0236Digital film convert diag ma. |
| J1270Injection, doxercalciferol. |
| J1755Iron sucrose injection. |
| Q3018Hepatitis B vaccine. |
| Deletions |
| 90744 Hepb vacc ped/adol 3 dose im. |
| 90746Hep B vaccine, adult, im. |
| 90747Hepb vacc, ill pat 4 dose im. |
| 1 CPT codes, descriptions and other data only are copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Clauses Apply. |
Table 8 includes 2 codes (J1270 and J1755) that we have identified as dialysis-related outpatient prescription drugs. The physician self-referral prohibition will not apply to these services if they meet the conditions set forth in § 411.355(g) concerning the exception to the physician self-referral rule for EPO and other dialysis-related outpatient prescription drugs furnished in or by an ESRD facility. Table 8 also includes codes (G0202, 76085 and Q3018) that we have identified as screening tests and a vaccine. The physician self-referral prohibition will not apply to these services if they meet the conditions at § 411.355(h) concerning the exception for preventive screening tests, immunizations, and vaccines.
We note that, in response to our January 4, 2001 final rule with comment, we received a number of comments regarding designated health services. We intend to address those comments in a second final rule regarding the physician self-referral prohibition.
VII. Physician Fee Schedule Update for Calendar Year 2002
A. Physician Fee Schedule Update
The physician fee schedule update for 2002 is -4.8 percent. Under section 1848(d)(3) of the Act, the update is equal to 1 plus the product of the Medicare Economic Index (MEI) (divided by 100) and 1 plus the update adjustment factor. For 2002, the MEI is equal to 2.6 percent (1.026). A more detailed description of the MEI and its calculation follows. The update adjustment factor is equal to -7.0 percent (0.930). Section 1848(d)(4)(F) of the Act requires an additional -0.2 percent (0.998) reduction to the update for 2002. Thus, the product of the MEI (1.026), the update adjustment factor (0.930), and the statutory adjustment factor (0.998) equals the 2002 update of -4.8 percent (0.9523). The MEI and the update adjustment factor are described below.
B. The Percentage Change in the Medicare Economic Index
The MEI measures the weighted-average annual price change for various inputs needed to produce physicians' services. The MEI is a fixed-weight input price index, with an adjustment for the change in economy-wide labor productivity. This index, which has 1996 base weights, is comprised of two broad categories-physician's own time and physician's practice expense.
The physician's own time component represents the net income portion of business receipts and primarily reflects the input of the physician's own time into the production of physicians' services in physicians' offices. This category consists of two subcomponents-wages and salaries, and fringe benefits. These components are adjusted by the 10-year moving average annual percent change in output per man-hour for the nonfarm business sector to reflect productivity growth in physicians' offices.
The physician's practice expense category represents the rate of price growth in nonphysician inputs to the production of services in physicians' offices. This category consists of wages and salaries and fringe benefits for nonphysician staff and other nonlabor inputs. Like physician's own time, the nonphysician staff categories are adjusted for productivity using the 10-year moving average annual percent change in output per man-hour for the nonfarm business sector. The physician's practice expense component also includes the following categories of nonlabor inputs-office expense, medical materials and supplies, professional liability insurance, medical equipment, professional car, and other expense. Table 9 presents a listing of the MEI cost categories with associated weights and percent changes for price proxies for the 2002 update. The calendar year 2002 MEI is 2.6 percent.
| Cost categories and price measures | 1996 Weights2 | CY 2002 percent changes |
|---|---|---|
| Medicare Economic Index Total | 100.0 | 2.6 |
| 1. Physician's Own Time3 4 | 54.5 | 2.1 |
| a. Wages and Salaries: Average hourly earnings private nonfarm, net of productivity | 44.2 | 2.0 |
| b. Fringe Benefits: Employment Cost Index, benefits, private nonfarm, net of productivity | 10.3 | 3.2 |
| 2. Physician's Practice Expense3 4 | 45.5 | 3.0 |
| a. Nonphysician Employee Compensation | 16.8 | 2.5 |
| 1. Wages and Salaries: Employment Cost Index, wages and salaries, weighted by occupation, net of productivity | 12.4 | 2.3 |
| 2. Fringe Benefits: Employment Cost Index, fringe benefits, white collar, net of productivity | 4.4 | 3.7 |
| b. Office Expense: Consumer Price Index forUrban Consumers (CPI-U), housing | 11.6 | 4.2 |
| c. Medical Materials and Supplies: Producer Price Index (PPI), ethical drugs/PPI, surgical appliances and supplies/CPI-U, medical equipment and supplies (equally weighted) | 4.5 | 1.8 |
| d. Professional Liability Insurance: HCFA professional liability insurance survey5 | 3.2 | 4.0 |
| e. Medical Equipment: PPI, medical instruments and equipment | 1.9 | 0.6 |
| f. Other Professional Expense | 7.6 | 2.8 |
| 1. Professional Car: CP-U, private transportation | 1.3 | 3.9 |
| Other: CPI-U, all items less food and energy | 6.3 | 2.6 |
| Addendum: | ||
| Productivity: 10-year moving average of output per man-hour, nonfarm business sector | n/a | 2.0 |
| Physician's Own Time, not productivity adjusted | 54.5 | 4.3 |
| Wages and salaries, not productivity adjusted | 44.2 | 4.1 |
| Fringe benefits, not productivity adjusted | 10.3 | 5.3 |
| Nonphysician Employee Compensation, not productivity adjusted | 16.8 | 4.7 |
| Wages and salaries, not productivity adjusted | 12.4 | 4.3 |
| Fringe benefits, not productivity adjusted | 4.4 | 5.9 |
| 1 The rates of historical change are for the 12-month period endingJune 30, 2001, which is the period used for computing the calendar year 2002 update. The price proxy values are based upon the latest available Bureau of Labor Statistics data as of September 18, 2001. | ||
| 2 The weights shown for the MEI components are the 1996 base-year weights, which may not sum to subtotals or totals because of rounding. The MEI is a fixed-weight, Laspeyres-type input price index whose category weights indicate the distribution of expenditures among the inputs to physicians' services for calendar year 1996. To determine the MEI level for a given year, the price proxy level for each component is multiplied by its 1996 weight. The sum of these products (weights multiplied by the price index levels) over all cost categories yields the composite MEI level for a given year. The annual percent change in the MEI levels is an estimate of price change over time for a fixed market basket of inputs to physicians' services. | ||
| 3 The Physician's Own Time and Nonphysician Employee Compensation category price measures include an adjustment for productivity. The price measure for each category is divided by the 10-year moving average of output per man-hour in the nonfarm business sector. For example, the fringe benefits component of the Physician's Own Time category is calculated by dividing the rate of growth in the employment cost index-benefits for private, nonfarm workers by the 10-year moving average rate of growth of output per man-hour for the nonfarm business sector. Dividing one plus the decimal form of the percent change in the employment cost index-benefits (1+.053=1.053) by one plus the decimal form of the percent change in the 10-year moving average of labor productivity(1+.020=1.020) equals one plus the change in the employment cost index-benefits for white collar workers net of the change in output per manhour (1.053/1.020=1.032). All Physician's Own Time and Nonphysician Employee Compensation categories are adjusted in this way. Due to a higher level of precision the computer calculated quotient may differ from the quotient calculated from rounded individual percent changes. | ||
| 4 The measures of productivity, average hourly earnings, Employment Cost Indexes, as well as the various Producer and Consumer Price Indexes can be found on the Bureau of Labor Statistics website-http://stats.bls.gov. | ||
| 5 Derived from a CMS survey of several major insurers (the latest available historical percent change data are for the period ending second quarter of 2001). | ||
| n/a Productivity is factored into the MEI compensation categories as an adjustment to the price variables; therefore, no explicit weight exists for productivity in the MEI. | ||
C. The Update Adjustment Factor
Paragraphs (3) and (4) of section 1848(d)(3) of the Act indicate that the physician fee schedule update is equal to the product of the Medicare Economic Index and an "update adjustment factor." The update adjustment factor is applied to the inflation update to reflect success or failure in meeting the expenditure target that the law refers to as "allowed expenditures." Allowed expenditures are equal to actual expenditures in a base period updated each year by the sustainable growth rate (SGR). The SGR is a percentage increase that is determined by a formula specified in section 1848(f) of the Act. The next section of this final rule describes the SGR and its calculation in detail. The update adjustment factor is determined based on a comparison of actual and allowed expenditures. For years beginning with 1999, the BBA required that the update adjustment factor be determined under section 1848(d)(3) of the Act to equal-
• The difference between (1) the sum of the allowed expenditures for physicians' services (as determined under subparagraph (C)) for the period beginning April 1, 1997, and ending on March 31 of the year involved, and (2) the amount of actual expenditures for physicians' services furnished during the period beginning April 1, 1997, and ending on March 31 of the preceding year; divided by-
• The actual expenditures for physicians' services for the 12-month period ending on March 31 of the preceding year, increased by the sustainable growth rate under subsection (f) for the fiscal year which begins during such 12-month period.
The BBRA made changes to the methodology for determining the physician fee schedule update beginning in 2001. In particular, it established that the methodology in section 1848(d)(3) of the Act would only be used for determining the physician fee schedule update for 1999 and 2000; the physician fee schedule update for 2001 and subsequent years is determined under section 1848(d)(4) of the Act. While the general principle of adjusting the inflation update (the MEI) based on a comparison of actual and target expenditures (the update adjustment factor) is continuing, the BBRA made fundamental changes to the calculation of the update adjustment factor. These changes do two things. First, the measurement of actual expenditures will occur on the basis of a calendar year rather than a April 1 to March 31 year. This essentially conforms the measurement of actual expenditures with other aspects of the SGR system that are also occurring on the basis of a calendar year as a result of BBRA amendments. As explained in our April 10, 2000 SGR notice (65 FR 19000), the BBRA essentially changed the SGR system from one that spanned 3 different time periods (1-Measurement of actual expenditures on the basis of a April 1 to March 31 period; 2-calculation of the SGR rate of increase on a Federal fiscal year basis; and 3-application of the update on a calendar year basis) to one that spans only one time period (all three elements are computed on the basis of a calendar year). Second, it ensures that any deviation between cumulative actual expenditures and cumulative allowed expenditures will be corrected over several years rather than in a single year. This will result in less year-to-year volatility in the physician fee schedule update than will occur if adjustments to the update are made to bring expenditures in line with the target in one year.
Under section 1848(d)(4)(A) of the Act, the physician fee schedule update for a year is equal to the product of-(1) 1 plus the Secretary's estimate of the percentage increase in the MEI for the year, and (2) 1 plus the Secretary's estimate of the update adjustment factor for the year. Under section 1848(d)(4)(B) of the Act, the update adjustment factor for a year beginning with 2001 is equal to the sum of the following-
• Prior Year Adjustment Component. An amount determined by-
+ Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services for the prior year (the year prior to the year for which the update is being determined) and the amount of the actual expenditures for such services for that year;
+ Dividing that difference by the amount of the actual expenditures for such services for that year; and
+ Multiplying that quotient by 0.75.
• Cumulative Adjustment Component. An amount determined by-
+ Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services from April 1, 1996 through the end of the prior year and the amount of the actual expenditures for such services during that period;
+ Dividing that difference by actual expenditures for such services for the prior year as increased by the sustainable growth rate for the year for which the update adjustment factor is to be determined; and
+ Multiplying that quotient by 0.33.
Section 1848(d)(4)(D) of the Act indicates that the update adjustment factor determined under section 1848(d)(4)(B) for a year may not be less than -0.07 or greater than 0.03. At this time, we estimate that the sum of the prior year and cumulative adjustment components will be less than -0.07 limit. In a letter to the Medicare Payment Advisory Commission and in data we made available to the public on the CMS website in March, we indicated that the estimated update adjustment factor for 2002 would be -1.5 percent. However, we also indicated that a number of factors could change our estimate of the update adjustment factor. Since our March estimate, a number of factors have changed that lower our estimate of allowed expenditures and increase our estimate of actual expenditures. Allowed expenditures have declined because real per capita gross domestic product (GDP) growth for 2000 is lower than the estimates in March. This occurs because of changes to economic figures for 2000 made at the Bureau of Economic Analysis. Further, current estimates of real GDP per capita growth for 2001 and 2002 are lower than in March. We provide a more detailed explanation of factors that affect our estimate of allowed expenditures in the next section of this final regulation on the SGR. An explanation of changes to actual expenditures follows.
As indicated above, we are currently estimating higher 2001 actual expenditures than we did in March. We did not have any Medicare claims data to develop our March estimates of actual expenditures for 2001. At this time, we are using claims received through June 30 to estimate actual expenditures for all of 2001. Based on the claims received in the first half of the year, our current estimates of actual expenditures for 2001 are higher than earlier estimates. We will be revising the measurement of actual expenditures for CY 2001 based on claims received through June 30, 2002. These revised figures will be determined no later than November 1, 2002. If the revised figures are different than current estimates, the difference will be reflected in the update adjustment factor used in determining the 2003 physician fee schedule update.
After taking into account the factors described above that affect allowed and actual expenditures, we originally estimated that the update adjustment factor for 2002 would be -5.4 percent or 1.6 percentage points more than the -7.0 percent limit on the update adjustment factor. However, in making updates to the list of codes that are included in the SGR, we discovered that a number of new procedure codes were inadvertently not included in the measurement of actual expenditures beginning in 1998. Therefore, the measurement of actual expenditures for 1998, 1999, and 2000 was lower than it should have been. As a result, the physician fee schedule update was higher in 2000 and 2001 than if we had included these codes. Including these codes in the measurement of actual expenditures results in a lower update adjustment factor than we earlier estimated. We will be making no changes to physician fee schedule payments made for services furnished in 2000 and 2001. However, under section 1848(d) of the Act, we must include these codes in the measurement of actual expenditures for historical, current, and future periods. While we do not currently know the precise effect of not measuring expenditures for all codes included in the SGR on the update adjustment factor for 2002, we are certain that it is in excess of 1.6 percentage points and is of sufficient magnitude to result in the update adjustment factor being less than the -7.0 percent statutory limit. In the near future, we expect to complete this analysis and update information that we make available on the CMS website. We plan to provide complete data that show quarterly allowed and actual expenditures for all procedure codes included in the SGR, as well as a list of the codes themselves.
Section 1848(d)(4)(A)(ii) of the Act indicates that 1 should be added to the update adjustment factor determined under section 1848(d)(4)(B) of the Act. Thus, adding 1 to -0.070 makes the update adjustment factor equal to 0.930.
(As indicated in the SGR discussion below, allowed expenditures through the end of CY 2001 will be revised one more time, not later than November 1, 2002. We will also be revising the measurement of actual expenditures for CY 2001 based on claims received through June 30, 2002, not later than November 1, 2002. The SGR for 2001 will also be revised one more time, and the SGR for 2002 will be revised two more times. The resulting effect from revisions of estimates will be reflected in the update adjustment factor determined for 2003.)
VIII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate
A. Medicare Sustainable Growth Rate
Section 1848(f) of the Act, as amended by section 4503 of the BBA, replaced the Medicare Volume Performance Standard (MVPS) with a Sustainable Growth Rate (SGR). Section 1848(f)(2) of the Act specifies the formula for establishing yearly SGR targets for physicians' services under Medicare. The use of SGR targets is intended to control the actual growth in aggregate Medicare expenditures for physicians' services.
The SGR targets are not limits on expenditures. Payments for services are not withheld if the SGR target is exceeded by actual expenditures. Rather, the appropriate fee schedule update, as specified in section 1848(d)(3) of the Act, is adjusted to reflect the success or failure in meeting the SGR target. If expenditures exceed the target, the update is reduced. If expenditures are less than the target, the update is increased.
As with the MVPS, the statute specifies a formula to calculate the SGR based on our estimate of the change in each of four factors. The four factors for calculating the SGR are as follows-
(1) The estimated change in fees for physicians' services.
(2) The estimated change in the average number of Medicare fee-for-service beneficiaries.
(3) The estimated projected growth in real GDP per capita.
(4) The estimated change in expenditures due to changes in law or regulations.
Section 211 of the BBRA amended sections 1848(d) and 1848(f) of the Act with respect to the physician fee schedule update and the SGR. Section 211(b) of the BBRA maintains the formula for calculating the SGR, but amends section 1848(f)(2) of the Act to apply the SGR on a calendar year (CY) basis beginning with 2000 while maintaining the SGR on a fiscal year (FY) basis for FY 1998 through FY 2000. Specifically, section 1848(f)(2) of the Act, as amended by section 211(b) of the BBRA, states that "* * * [t]he sustainable growth rate for all physicians' services for a fiscal year (beginning with fiscal year 1998 and ending with fiscal year 2000) and a year beginning with 2000 shall be equal to the product of-
(1) 1 plus the Secretary's estimate of the weighted average percentage increase (divided by 100) in the fees for all physicians' services in the applicable period involved,
(2) 1 plus the Secretary's estimate of the percentage change (divided by 100) in the average number of individuals enrolled under this part (other than Medicare+Choice plan enrollees) from the previous applicable period to the applicable period involved,
(3) 1 plus the Secretary's estimate of the projected percentage growth in real gross domestic product per capita (divided by 100) from the previous applicable period to the applicable period involved; and
(4) 1 plus the Secretary's estimate of the percentage change (divided by 100) in expenditures for all physicians' services in the applicable period (compared with the previous applicable period) which will result from changes in law and regulations, determined without taking into account estimated changes in expenditures resulting from the update adjustment factor determined under section 1848 (d)(3)(B) or (d)(4)(B) of the Act, as the case may be, minus 1 and multiplied by 100."
Under section 1848(f)(4)(C) of the Act, the term "applicable period" means-(1) a FY, in the case of FY 1998, FY 1999 and FY 2000, and (2) a CY with respect to a year beginning with 2000.
Section 1848(d)(4)(C) of the Act requires us to make the transition from a FY SGR to a CY SGR in 1999 by using the FY 1999 SGR for the first 3 months of 1999 and the FY 2000 SGR for the 9-month period beginning April 1, 1999. Allowed expenditures for the year are equal to the sum of allowed expenditures for each respective period. The SGR for CY 2000 is then applied to allowed expenditures for CY 1999.
As stated in the April 10, 2000 final notice (65 FR 19000), the BBRA requires the estimates of the FY 2000 and CY 2000 SGRs to be revised based on more recent data, but, as explained below, the BBRA does not provide for revision of either the FY 1998 or the FY 1999 SGR. This means that, for the transition to a calendar year SGR system, allowed expenditures for the period April 1, 1999 through December 31, 1999 (determined by applying the FY 2000 SGR to allowed expenditures for the 12-month period ending March 31, 1999) are subject to change based on revision of the FY 2000 SGR; allowed expenditures for the period January 1, 1999 through March 31, 1999 (determined using the FY 1999 SGR) are not subject to revision.
In general, the BBRA requires us to publish SGRs for 3 different time periods, no later than November 1 of each year, using the best data available as of September 1 of each year. Under section 1848(f)(3)(C)(i) of the Act, as added by section 211(b)(5) of the BBRA, the SGR is estimated and subsequently revised twice (beginning with the FY and CY 2000 SGRs) based on later data. Under section 1848(f)(3)(C)(ii) of the Act, there are no further revisions to the SGR once it has been estimated and subsequently revised in each of the 2 years following the initial estimate.
The requirement of revisions to the SGR based on later data means that we will estimate and publish an SGR for the upcoming year, the contemporaneous year, and the preceding year by no later than November 1 of each year. For example, by no later than November 1, 2002, we will publish an estimate of the SGR for CY 2003, a revision of the CY 2002 SGR that is first being estimated in this notice, and a revision of the CY 2001 SGR first estimated in the final rule published on November 2, 2000 (65 FR 65429) and revised in this final rule. Under section 1848(f)(3)(C)(ii) of the Act, the final revision to the CY 2001 SGR will be announced in the Federal Register no later than November 1, 2002.
Subparagraphs (A) and (B) of section 1848(f)(3) of the Act, specify special rules with respect to the SGR and the CY 2001 and CY 2002 updates. Section 1848(f)(3)(A) of the Act required us, no later than November 1, 2000, to revise the SGRs for FY 2000 and CY 2000 and to establish the SGR for CY 2001, based on the best data available, as of September 1, 2000. We published our first estimate of the SGRs for FY 2000 and CY 2000 in a Federal Register notice on April 10, 2000 (65 FR 19000). Revised estimates of the SGRs for FY 2000 and CY 2000 and our original estimate of the SGR for CY 2001 appeared in the Federal Register on November 1, 2000 (65 FR 65429). We used each of the SGRs published in the November 1, 2000 Federal Register to determine the physician fee schedule update for 2001. Section 1848(f)(3)(B) of the Act requires us, by no later than November 1, 2001, to revise the SGRs for FY 2000 and CYs 2000 and 2001 and establish the SGR for CY 2002, based on the best data available as of September 1, 2001 and to use each of these SGRs to determine the physician fee schedule update for 2002. We are using each of the SGRs established in this notice to determine the 2002 physician fee schedule update. In accordance with section 1848(f)(3)(C)(ii) of the Act, there will be no further revisions to the FY 2000 and CY 2000 SGRs after the revisions we are making in this final rule.
B. Physicians' Services
Section 1848(f)(4)(A) of the Act defines the scope of physicians' services covered by the SGR. The statute indicates that the term "physicians' services" includes other items and services (such as clinical diagnostic laboratory tests and radiology services), specified by the Secretary, that are commonly performed or furnished by a physician or in a physician's office, but does not include services furnished to a Medicare+Choice plan enrollee. The BBA and BBRA made no changes to this definition which was also used for the MVPS. We published a definition of physicians' services for use in the MVPS and subsequent SGR in the Federal Register (61 FR 59717) on November 22, 1996. We defined "physicians' services" to include many of the medical and other health services listed in section 1861(s) of the Act. Since the statute has made a number of changes to the definition of medical and other health services included in section 1861(s), we are updating our definition of physicians' services consistent with the statutory changes. Our practice has been to make adjustments to the SGR for medical and other health services added to the statute that meet the criterion of being "commonly performed by a physician or a physicians' office." For instance, the BBA and the BIPA amended section 1861(s) of the Act to add new preventive benefits to the Medicare statute. Since these preventive services are generally provided by physicians or in physicians' offices, we made adjustments to the SGR to reflect additional Medicare expenditures for the newly-added Medicare benefits. Physicians' services for the SGR include the following medical and other health services if bills for the items and services are processed and paid by Medicare carriers:
• Physicians' services.
• Services and supplies furnished incident to physicians' services.
• Outpatient physical therapy services and outpatient occupational therapy services.
• Antigens prepared by or under the direct supervision of a physician.
• Services of physician assistants, certified registered nurse anesthetists, certified nurse midwives, clinical psychologists, clinical social workers, nurse practitioners, and clinical nurse specialists.
• Screening tests for prostate cancer, colorectal cancer, glaucoma.
• Screening mammography, screening pap smears and screening pelvic exams.
• Diabetes outpatient self-management training services.
• Medical nutrition therapy services.
• Diagnostic x-ray tests, diagnostic laboratory tests and other diagnostic tests.
• X-ray, radium, and radioactive isotope therapy.
• Surgical dressings, splints, casts, and other devices used for the reduction of fractures and dislocations.
• Bone mass measurements.
C. Provisions Related to the SGR
Section 211(b)(1) of the BBRA amends section 1848(f)(1) of the Act to require that SGR estimates be published in the Federal Register not later than November 1 of every year. In this notice, we are publishing our initial estimate of the SGR for 2002, a revised estimate of the SGR for 2001 and final estimates of the SGRs for FY and CY 2000.
In general, the update for a year is based on the Medicare Economic Index (MEI) as adjusted, within bounds, by the amount of actual expenditures for physicians' services compared to target (referred to as "allowed" in the statute) expenditures. A key difference between the MVPS and the SGR is that the comparison of actual and allowed expenditures is made on a cumulative basis under the SGR, while it was made on an annual basis under the MVPS. The "update adjustment factor" in section 1848(d)(4)(B) of the Act is an adjustment to the MEI that reflects the difference between actual expenditures and target expenditures.
Section 1848(d)(3)(C) of the Act, as modified by the BBA, defines allowed expenditures for the 12-month period ending March 31, 1997 to be equal to actual expenditures for physicians' services during that period (that is, April 1, 1996 through March 31, 1997), as we have estimated. Section 1848(d)(3)(C) of the Act defines allowed expenditures for subsequent 12-month periods to be equal to allowed expenditures for physicians' services for the previous year increased by the SGR for the FY which begins during the 12-month period. For example, allowed expenditures for the 12-month period April 1, 1997 through March 31, 1998 are equal to allowed expenditures for the 12 months ending March 31, 1997, increased by the SGR for FY 1998. The BBRA subsequently provided for a transition to a calendar year SGR system in 1999. Allowed expenditures for the first quarter of 1999 are determined using the FY 1999 SGR and allowed expenditures for the April 1, 1999 to December 31, 1999 period are determined using the FY 2000 SGR. Allowed expenditures in 2000 are equal to 1999 allowed expenditures increased by the 2000 SGR. Allowed expenditures for each subsequent year will equal expenditures from the prior year updated by the SGR.
Table 10 shows annual and cumulative allowed expenditures for physicians' services for each of the 12-month periods between April 1, 1996 and March 31, 2000, for 1999 and 2000.
| Period | Annual allowed expenditures (in billions) | Cumulative allowed expenditures (in billions) | FY or CY SGR |
|---|---|---|---|
| 4/1/96-3/31/97 | $48.9 | $48.9 | N/A |
| 4/1/97-3/31/98 | 49.6 | 98.5 | FY 1998=1.5% |
| 4/1/98-3/31/99 | 49.4 | 47.9 | FY 1998=-0.3% |
| 1/1/99-3/31/99 | 12.5 | (1) | FY 1999=-0.3% |
| 4/1/99-12/31/99 | 39.6 | (2) | FY 2000=6.9% |
| 1/1/99-12/31/99 | 52.1 | 187.6 | FY 1999/FY 2000 |
| 1/1/00-12/31/00 | 55.9 | 243.5 | CY 2000=7.3% |
| 1/1/01-12/31/01 | 59.3 | 302.7 | CY 2001=6.1% |
| 1/1/02-12/31/02 | 62.6 | 365.3 | CY 2002=5.6% |
| 1 Included in $147.9 above. | |||
| 2 Included in $187.6 below. | |||
Note:
Allowed Expenditures for the first quarter of 1999 are based on the FY 1999 SGR and allowed expenditures for the last three quarters of 1999 are based on the FY 2000 SGR.
Allowed Expenditures in the First Year
(April 1, 1996-March 31, 1997) are equal to actual expenditures. All subsequent figures are equal to quarterly allowed expenditure figures increased by the applicable SGR. Cumulative allowed expenditures are equal to the sum of annual allowed expenditures. We provide more detailed quarterly allowed and actual expenditure data on the CMS website under the Medicare Actuary's publications at the following address: http://www.hcfa.gov/pubforms/actuary/. We expect to update this information in November.
Allowed expenditures for the April 1, 1999 through the December 31, 1999 period are based on the FY 2000 SGR. As previously discussed, section 1848(f)(3) of the Act requires two revisions to the FY and CY 2000 SGR. We made the first revision to the FY and CY 2000 SGR in the physician fee schedule final rule published in the Federal Register on November 1, 2000 (65 FR 65427). We are making the second and final revision in this final rule. Consistent with section 1848(f)(3)(B) of the Act, the revised FY and CY 2000 SGR uses the best data available to us as of September 1, 2001.
D. Preliminary Estimate of the SGR for 2002
According to subparagraphs (A) through (D) of section 1848(f)(2) of the Act, as amended by section 211(b) of the BBRA, we have determined the preliminary estimate of the CY 2002 SGR to be 5.6 percent. We first estimated the CY 2002 SGR in March and made the estimate available to the Medicare Payment Advisory Commission and our website. Our March and current estimates of the four statutory factors are indicated in table 11:
| Statutory factors | March estimate | Current estimate |
|---|---|---|
| Fees | 1.6 | 2.3 |
| Enrollment | 0.4 | 0.7 |
| Real Per Capita GDP | 2.4 | 1.7 |
| Law and Regulation | 1.5 | 0.8 |
| Total | 6.0 | 5.6 |
Note:
Consistent with section 1848(f)(2) of the Act, the statutory factors are multiplied, not added, to produce the total (that is, 1.023 × 1.007 × 1.017 × 1.008 = 1.056.) A more detailed explanation of each figure is provided below in section H.1.
E. Sustainable Growth Rate for CY 2001
According to subparagraphs (A) through (D) of section 1848(f)(2) of the Act, as amended by section 211(b) of the BBRA, our current estimate of the CY 2001 SGR is 6.1 percent. Table 12 shows our original estimate of the CY 2001 SGR published in the Federal Register on November 1, 2000 (65 FR 65433) and current estimates of the four statutory factors that determine the CY 2001 SGR:
| Statutory factors | 11/1/00 estimate | Current estimate |
|---|---|---|
| Fees | 1.9 | 1.9 |
| Enrollment | 0.9 | 3.0 |
| Real Per Capita GDP | 2.7 | 0.7 |
| Law and Regulation | 0.0 | 0.4 |
| Total | 5.6 | 6.1 |
A more detailed explanation of each figure is provided below in section H.2.
F. Sustainable Growth Rate for CY 2000
According to subparagraphs (A) through (D) of section 1848(f)(2) of the Act, as amended by section 211(b) of the BBRA, our current estimate of the CY 2000 SGR is 7.3 percent. Table 13 shows estimates included in the November 1, 2000 Federal Register (65 FR 65433) and current estimates of the four statutory factors that determine the CY 2000 SGR:
| Statutory factors | 11/1/00 estimate | Current estimate |
|---|---|---|
| Fees | 2.1 | 2.1 |
| Enrollment | 1.0 | 1.0 |
| Real Per Capita GDP | 4.3 | 3.2 |
| Law and Regulation | 0.5 | 0.8 |
| Total | 8.1 | 7.3 |
A more detailed explanation of each figure is provided below in section H.3.
G. Sustainable Growth Rate for FY 2000
According to subparagraphs (A) through (D) of section 1848(f)(2) of the Act, as amended by section 211(b) of the BBRA, our current estimate of the FY 2000 SGR is 6.9 percent. Table 14 shows estimates included in the November 1, 2000 Federal Register (65 FR 65433) and current estimates of the four statutory factors that determine the FY 2000 SGR:
| Statutory factors | 11/1/00 estimate | Current estimate |
|---|---|---|
| Fees | 2.1 | 2.1 |
| Enrollment | 0.8 | 0.5 |
| Real Per Capita GDP | 4.5 | 3.6 |
| Law and Regulation | 0.3 | 0.6 |
| Total | 7.9 | 6.9 |
A more detailed explanation of each figure is provided below in section H.3.
H. Calculation of the FY 2000, CY 2000, CY 2001, and CY 2002 Sustainable Growth Rates
1. Detail on the CY 2002 SGR
A more detailed discussion of our preliminary estimates of the four elements of the 2002 SGR follows.
Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for CY 2002
This factor was calculated as a weighted average of the CY 2002 fee increases that apply for the different types of services included in the definition of physicians' services for the SGR.
Physicians' services as defined in sections 1861(s)(1) and (2) of the Act represent approximately 89 percent of allowed charges for physicians' services under the SGR and are updated by the Medicare Economic Index (MEI). Our current estimate of the MEI for 2002 is 2.6 percent. Diagnostic laboratory tests represent approximately 11 percent of the Medicare allowed charges for physicians' services under the SGR. The BBA provided for a 0.0 percent update for CY 2002 for laboratory services. Table 15 shows both the physicians' and laboratory service updates that were used to determine the percentage increase in physicians' fees for CY 2002.
| Weight | Update | |
|---|---|---|
| Physician | 0.89 | 2.6 |
| Laboratory | 0.11 | 0.0 |
| Weighted Average | 1.0 | 2.3 |
After taking into account the elements described in the table, we estimate that the weighted-average increase in fees for CY 2002 for physicians' services under the SGR (before applying any legislative adjustments) will be 2.3 percent.
Factor 2-The Percentage Change in the Average Number of Part B Enrollees From CY 2001 to CY 2002
This factor is our estimate of the percent change in the average number of fee-for-service enrollees for CY 2002 as compared to CY 2001 Medicare+Choice (M+C) plan enrollees, whose Medicare-covered medical care is outside the scope of the SGR, and who are excluded from this estimate. Our actuaries estimate that the average number of Medicare Part B fee-for-service enrollees (excluding beneficiaries enrolled in M+C plans) will increase by 0.7 percent in calendar year 2002. This estimate was derived by subtracting estimated M+C enrollment from estimated overall Medicare enrollment as illustrated in table 16.
| 2001 | 2002 | |
|---|---|---|
| Overall | 37.828 | 38.149 |
| Medicare+Choice | 5.662 | 5.761 |
| Net | 32.166 | 32.388 |
| Percent Increase: | 0.7 |
Since 2002 has yet to begin, we currently only have estimates of this figure for 2002. An important factor affecting fee-for-service enrollment is beneficiary enrollment in Medicare+Choice plans. At this time, we do not know how actual enrollment in Medicare+Choice plans will compare to current estimates. While we do receive information on whether a Medicare+Choice plan will continue to participate or withdraw from the program, it remains difficult to estimate the number of beneficiaries who will select a Medicare+Choice plan or fee-for-service before the start of the calendar year. While some plans will no longer offer a Medicare+Choice plan, other plans are available as an option to most beneficiaries in areas where there have been plan withdrawals. It is difficult to estimate the size of the Medicare+Choice enrollee population before the start of a calendar year. Because we determine the fee-for-service enrollment figure net of the change in Medicare+Choice enrollment, early estimates of this factor are difficult to make. Our estimate of this factor is preliminary and only has minimal effect on the physician fee schedule update for CY 2002. The CY 2002 SGR will also be used in the calculation of the 2003 physician fee schedule update in a final rule to be published no later than November 1, 2002. By that time, we will have information on actual enrollment in Medicare+Choice plans for the first 8 months of CY 2002 and will be better able to predict the change in fee-for-service enrollment for the year.
Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in CY 2002
Section 1848(f)(2)(C) of the Act, as amended by section 211 of the BBRA, requires us to estimate growth in real GDP per capita. This factor is applied on a CY basis beginning with the CY 2000 SGR. We estimate that the growth in real per capita GDP will be 1.7 percent in CY 2002. Our past experience indicates that there have also been large changes in estimates of real per capita GDP growth and the actual change in this factor. It is likely that this figure will change further as actual information on economic performance becomes available to us in 2002. Again, we note that we will use revised estimates of real per capita GDP growth in setting future year updates.
Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in CY 2002 Compared With CY 2001
Sections 101 through 104 of BIPA added Medicare coverage for screening glaucoma, authorized Medicare to pay for specific new technology mammography services, and changed coverage for screening pap smears, screening pelvic exams, and screening colonoscopy for average-risk individuals. In addition, section 105 of the BIPA also establishes a new benefit for medical nutrition therapy and expands access to telehealth services in section 223. Section 432 of the BIPA also requires that Medicare make payment to Indian Health Service hospitals and ambulatory clinics for physicians' and practitioners' services as well as outpatient physical and occupational therapy services that are included in the definition of physicians' services for purposes of the SGR. Since these provisions will increase Medicare expenditures for services that are included in the SGR, we are making an upward adjustment to reflect additional Medicare expenditures in 2002. Our estimates of the cost of these provisions for the period FY 2002-FY 2006 are included in our Notice of Proposed Rulemaking published in the Federal Register on August 2, 2001 (66 FR 40400).
We are making an adjustment to the SGR for one additional factor. In section VI.B. of this final rule, we provided a definition of physicians' services for purposes of the SGR. Historically, we have not measured expenditures for screening mammography under the SGR. However, section 1848(f)(4) of the Act indicates that "physicians" services includes other items and services (such as clinical diagnostic laboratory tests and radiology services), specified by the Secretary, that are commonly performed or furnished by a physician or in a physician's office." Screening mammography services are "radiology services" that are performed by "physicians or in a physician's office." As a result, we are using this rule to add screening mammography to the list of services that are part of the SGR definition. Since we have not previously measured expenditures for screening mammography services under the SGR, it is appropriate to make an adjustment to this factor for the change to the definition of physicians' services. We are making an adjustment that reflects estimated payments for screening mammography services in CY 2002. We will make a subsequent revision based on actual expenditures for screening mammography.
After taking these provisions into account, the percentage change in expenditures for physicians' services resulting from changes in law or regulations is estimated to be 0.8 percent for 2002. In March, we estimated that this figure would be 1.5 percent. The 0.7 percentage point difference is due to a change in our estimate of the BIPA provisions. In March, we had no information about implementation of these provisions. We used updated assumptions about pricing and utilization based on proposed policies published in the August 2, 2001 proposed rule (66 FR 40400).
2. Detail on the CY 2001 SGR
A more detailed discussion of our current estimates of the four elements of the 2001 SGR follows.
Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for CY 2001
We are continuing to use 1.9 percent for this element of the SGR for the CY 2001 SGR. This factor is unchanged from earlier estimates previously described for CY 2001 in the November 1, 2000 Federal Register (65 FR 65433).
Factor 2-The Percentage Change in the Average Number of Fee-for-Service Part B Enrollees From CY 2000 to CY 2001
This factor is our estimate of the percent change in the average number of fee-for-service enrollees for CY 2001 as compared to CY 2000. As we indicated above, this factor is difficult to estimate prior to the beginning of the period for which the estimates are being made because of the interaction of the fee-for-service and Medicare+Choice program and the lack of availability of actual data on beneficiary selection of Medicare+Choice enrollment. We currently have information on actual enrollment in the Medicare+Choice program for CY 2001 and CY 2000 that permits estimates of the change in fee-for-service enrollment for these years that will be more reflective of the final actual enrollment and percent year-to-year change. The estimates for CY 2000 and CY 2001 were derived by subtracting estimated M+C enrollment from estimated overall Medicare enrollment as illustrated in table 17.
| 2000 | 2001 | |
|---|---|---|
| Overall | 37.453 | 37.828 |
| Medicare+Choice | 6.233 | 5.662 |
| Net | 31.221 | 32.166 |
| Percent Increase | 3.0 |
Our actuaries estimate of the percent change in the average number of fee-for-service enrollees net of Medicare+Choice enrollment for 2001 compared to 2000 of 3.0 percent is more than our early estimate of this factor (0.9 percent for CY 2001 from the November 1, 2000 Federal Register (65 FR 65433)) because the historical base from which our actuarial estimate is made has changed. We currently have complete information on Medicare fee-for-service enrollment for 2000 that is lower than the figure we used one year ago. Further, we now have information on actual fee-for-service enrollment for the first 8 months of 2001. This figure is slightly higher than the figure used in the November 1, 2000 Federal Register (65 FR 65433). We would caution that our estimate of fee-for-service enrollment for 2001 may change once we have complete information for the entire year.
Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in CY 2001
Section 1848(f)(2)(C) of the Act, as amended by section 211 of the BBRA, requires us to estimate growth in real GDP per capita. We estimate that the growth in real per capita GDP will be 0.7 percent in CY 2001. There have also been large changes in initial estimates of real per capita GDP growth and the actual change in this factor. There could be further changes in this factor once we have complete information on economic performance for the entire year. Again, we note that we will use revised estimates of real per capita GDP growth in setting future year updates.
Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in CY 2001 Compared With CY 2000
As described above, the BIPA makes changes to the Act that affect Medicare expenditures for services that are included in the SGR. Some of these provisions have no effect on Medicare expenditures in 2001 because they do not go into effect until 2002. Other provisions are effective at some time during 2001. Provisions that become effective in 2001 relate to new technology mammography and coverage changes for screening pap smears, screening pelvic exams and screening colonoscopy, expanded access to telehealth services and Medicare payment for services provided in Indian Health Service hospitals and clinics. After taking these provisions into account, the percentage change in expenditures for physicians' services resulting from changes in law or regulations is estimated to be 0.4 percent for 2001.
3. Detail on Calculation of the FY 2000 and CY 2000 SGRs
A more detailed discussion of our revised estimates of the four elements of the FY 2000 and CY 2000 SGRs follows.
Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for FY 2000 SGR and CY 2000 SGR
We are continuing to use 2.1 percent for this element of the SGR for the FY 2000 SGR and the CY 2000 SGR. This factor is unchanged from earlier estimates previously described respectively for FY 2000 and CY 2000 in the October 1, 1999 Federal Register (64 FR 53395), the April 10, 2000 Federal Register (65 FR 19003) and the August 2, 2001 Federal Register (66 FR 40397).
Factor 2-The Percentage Change in the Average Number of Fee-for-Service Part B Enrollees for the FY 2000 SGR and CY 2000 SGR
This factor is our estimate of the percent change in the average number of fee-for-service enrollees for FY 2000 as compared to FY 1999 and CY 2000 as compared to CY 1999. We currently have complete information on actual enrollment in the Medicare+Choice program for FY 2000 and CY 2000 that permits a measure of change in fee-for-service enrollment for these years that reflects the actual change. The estimates for CY 2000 were derived by subtracting estimated M+C enrollment from estimated overall Medicare enrollment as illustrated in table 18.
| 1999 | 2000 | |
|---|---|---|
| Overall | 37.115 | 37.453 |
| Medicare+Choice | 6.191 | 6.233 |
| Net | 30.923 | 31.221 |
| Percent Increase | 1.0 |
Our actuaries' estimate of the percent change in the average number of fee-for-service enrollees net of Medicare+Choice enrollment for 2000 compared to 1999 of 1.0 percent is the same as our estimate of this factor at this time last year (1.0 percent). However, the current estimate of 0.5 percent for FY 2000 is lower than the 0.8 percent estimate of this factor at this time last year.
Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in FY 2000 and CY 2000
We estimate that real GDP per capita growth will be 3.6 percent for FY 2000 and 3.2 percent for CY 2000. In the FY 2000 SGR notice published on October 1, 1999 (64 FR 53396), we estimated that real GDP per capita growth for FY 2000 would be 1.8 percent. In our April 10, 2000 SGR notice, we estimated that real GDP per capita growth for CY 2000 would be 2.5 percent. In our November 1, 2000 final rule (65 FR 65433), we estimated that real GDP per capita growth would be 4.5 percent for FY 2000 and 4.3 percent CY 2000. The final figures that we will use for this factor are 3.6 percent for FY 2000 and 3.2 percent for CY 2000. The latest figures on real GDP per capita growth are approximately one percentage point less than estimated last year. The lower estimates are due to annual revisions of the National Income and Product Accounts (NIPA) by the Bureau of Economic Analysis. Usually, in annual revisions of the NIPA, new estimates incorporate source data that are more complete, more detailed, and otherwise more appropriate than those that were previously incorporated. In addition, several methodological changes have been made. (For detailed description of the NIPA revisions, see Brent R. Moulton, Eugene P. Seskin, and David F. Sullivan, "Annual Revision of the National Income and Product Accounts: Annual Estimates, 1998-2000, Quarterly Estimates, 1998: 1-2000: I, Survey of Current Business" (August, 2001): 7-32.)
Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in FY 2000 Compared with FY 1999, and CY 2000, Compared With CY 1999
As we explained in our October 1, 1999 and April 10, 2000 SGR notices, legislative changes contained in the BBA and the BBRA will have an impact on expenditures for physicians' services under the SGR in FY 2000 and CY 2000. Section 4103 of the BBA mandates a new prostate screening benefit effective January 1, 2000. Additionally, effective January 1, 2000, section 4513 of the BBA removes the requirement that a subluxation of the spine be demonstrated by an x-ray before Medicare payment can be made for chiropractic services furnished to a beneficiary. This provision will also result in a small increase in expenditures in FY 2000 and CY 2000. The impact of BBA Medicare Secondary Payer provisions will have small marginal impact on reducing expenditures in FY 2000 and CY 2000.
Certain BBRA provisions also have a small impact on expenditures in FY 2000 and CY 2000. Section 224 of the BBRA increases payments for pap smears and is slightly increasing expenditures. Section 221 of the BBRA postponed the implementation of payment caps on physical and occupational therapy and speech-language pathology services. The effect of this provision on physicians and independent practitioners is a small increase in expenditures for these years. Medicare expenditures for outpatient physical and occupational therapy services by therapists in independent practice are growing rapidly as a result of provisions of section 4541 of the BBA that require Medicare to make payments for facility-based therapy services under the physician fee schedule. Physical and occupational therapy services previously paid on the basis of a cost report through the Medicare fiscal intermediaries are more likely to be billed by therapists in independent practice because these services are no longer being paid on a cost basis. We analyzed growth in Medicare expenditures for physical and occupational therapy and believe that the larger rate of increase in Medicare expenditures for these services billed to carriers is likely a result of the statutory provisions that require the services to be paid under the Medicare physician fee schedule. We are making an upward adjustment to the SGR for this factor.
After taking into account these provisions, the percentage change in expenditures for physicians' services resulting from changes in law or regulations is estimated to be 0.6 percent for FY 2000 and 0.8 percent for CY 2000.
IX. Calculation of the 2002 Physician Fee Schedule and Anesthesia Conversion Factor
The 2002 physician fee schedule conversion factor is $36.1992. The separate 2002 national average anesthesia conversion factor is $16.60.
The specific calculations to determine the physician fee schedule and anesthesia conversion factor for calendar year 2002 are explained below.
Detail on Calculation of the Calendar Year 2002 Physician Fee Schedule Conversion Factor
• Physician Fee Schedule Conversion Factor
Under section 1848(d)(1)(A) of the Act, the physician fee schedule conversion factor is equal to the conversion factor for the previous year multiplied by the update determined under section 1848(d)(4) of the Act. In addition, section 1848(c)(2)(B)(ii)(II) of the Act requires that changes to relative value units (RVUs) cannot cause expenditures to increase or decrease by more than $20 million from the amount of expenditures that would have been made if such adjustments had not been made. We implement this requirement through a uniform budget neutrality adjustment to the conversion factor. There are two changes that will require us to make an adjustment to the conversion factor to comply with the budget neutrality requirement in section 1848(c)(2)(B)(ii)(II) of the Act. We are making a 0.460 percent reduction (0.9954) in the conversion factor to account for the increase in work RVUs resulting from the 5-year review. We are also making a 0.18 percent (0.9982) reduction in the conversion factor to account for an anticipated increase in the volume and intensity of services in response to the final year of the implementation of resource-based practice expense RVUs. As a result of the 5-year review of RVUs and additional budget-neutrality adjustments required by law, the conversion factor is 5.4 percent lower than last year's conversion factor.
The two budget neutrality factors are applied after the update is applied to the 2001 conversion factor:
| 2001Conversion Factor | $38.2581 |
| 2002Update | 0.9523 |
| Budget-Neutrality Adjustment: 5 Year Review | 0.9954 |
| Budget-Neutrality Adjustment: Practice Expense Transition | 0.9982 |
| 2002Conversion Factor | $36.1992 |
• Anesthesia Fee Schedule Conversion Factor
Section 1848(b)(2)(B) of the Act indicates that, to the extent practicable, the Secretary will use the anesthesia relative value guide with appropriate adjustment of the conversion factor, in a manner to assure that the fee schedule amounts for anesthesia services are consistent with the fee schedule amounts for other services. The statute also requires the Secretary to adjust the conversion factor by geographic adjustment factors in the same manner as for other physician fee schedule services. Unlike other physician fee schedule services, anesthesia services are paid using a system of base and time units. The base and time units are summed and multiplied by a conversion factor. The base unit is fixed depending upon the type of anesthesia procedure performed, and the time units will vary based on the length of the anesthesia time associated with the surgical procedure. Thus, Medicare's payment will increase as anesthesia time lengthens. The same anesthesia service provided in two different surgeries will be paid different amounts if the associated anesthesia time is different. This system differs from other physician fee schedule services where payment is determined based on the product of RVUs and a conversion factor; payment for a given procedure will not vary based on the length of time it takes to perform the procedure in a specific instance.
Since anesthesia services do not have RVUs like other physician fee schedule services, we have had to make appropriate adjustments to the anesthesia fee schedule conversion factor to simulate changes to RVUs. We modeled the resource-based practice expense methodology using imputed anesthesia RVUs that were made comparable to other physician fee schedule services. As a result of modeling these changes, we are incorporating a 1.89 percent reduction (0.9811) to the anesthesia fee schedule conversion factor. We are incorporating an additional increase of 0.2 percent (1.002) to account for base unit revisions for 2002, both for the five-year review and for the alignment of CMS base units with ASA base units. All other adjustments (physician fee schedule update, adjustment for 5-year review of physician work, adjustment for volume and intensity changes) made to the anesthesia fee schedule conversion factor are the same as those applied to the physician fee schedule. To determine the anesthesia fee schedule conversion factor for 2002, we used the following figures:
| 2001Anesthesia Conversion Factor | $17.83 |
| 2002Update | 0.9523 |
| Practice Expense RVU Adjustment for 2002 | 0.9823 |
| Adjustment for Base Unit Alignment | 1.0020 |
| 5-Year Review | 0.9954 |
| Volume and Intensity Adjustment | 0.9982 |
| 2003Conversion Factor | $16.60 |
X. Provisions of the Final Rule
The provisions of this final rule restate the provisions of the August 2001 proposed rule, except as noted elsewhere in the preamble. Following is a highlight of the changes made from the proposed rule:
For screening glaucoma, we are revising the regulation in § 410.23(a)(2) to read "Eligible beneficiary means individuals in the following high risk categories." This should allow us to more easily add high-risk groups by rulemaking should the medical evidence warrant it.
For G0117 Glaucoma Screening for High Risk Patients Furnished by an Optometrist or Ophthalmologist, we will assign 0.45 work RVUs, .02 malpractice RVUs, and we will crosswalk practice expense inputs from CPT code 92012.
For G0118 Glaucoma Screening for High Risk Patients Furnished Under the Direct Supervision of an Optometrist or Ophthalmologist, we will assign 0.17 work RVUs and 0.01 malpractice RVUs. For practice expense, we will also crosswalk this code to CPT code 92012.
For medical nutrition therapy, we made various changes in response to comments received. For detailed information, see section III.G.
For telehealth services section 1834(m)(3) of the Act specifies that sections 1842(b)(18)(A) and (B) apply to physicians and practitioners receiving payment for telehealth services and to originating sites receiving a facility fee, in the same manner as they apply to practitioners. This section requires that payment for these services may only be made on an assignment-related basis. We did not reflect this provision in the proposed rule. Nonetheless, because this requirement is required by the plain language of the law and because we are without discretion with respect to its application, we are implementing it in this final rule in new § 414.65(d).
Other Issues
Included in the comments we received were issues and topics that were not specifically included as proposals in the August 2, 2001 proposed rule such as coding issues on specific services, the need to expand dissemination of information on Medicare benefits and a variety of other topics. While we do not address these specifically in this rule, we will ensure that the appropriate CMS components are aware of the concerns expressed and would hope that these concerns can be addressed through appropriate channels.
XI. Collection of Information Requirements
Under the Paperwork Reduction Act (PRA) of 1995, we are required to provide 30-day notice in the Federal Register and solicit public comment before a collection of information requirement is submitted to the Office of Management and Budget (OMB) for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires that we solicit comment on the following issues:
• The need for the information collection and its usefulness in carrying out the proper functions of our agency.
• The accuracy of our estimate of the information collection burden.
• The quality, utility, and clarity of the information to be collected.
• Recommendations to minimize the information collection burden on the affected public, including automated collection techniques.
We are soliciting public comment on each of these issues for § 410.132 in this document, which contains information collection requirements.
Paragraph (c) of this section requires a referring physician or practitioner to maintain referral documentation in the beneficiary's medical record for each referral.
We believe the burden associated with these provisions is exempt in accordance with 5 CFR 1320.3(b)(2) because the time, effort, and financial resources necessary to comply with these requirements would be incurred by referring physicians and practitioners in the normal course of business activities.
If you comment on these information collection and recordkeeping requirements, please mail copies directly to the following:
Centers for Medicare Medicaid Services, Office of Information Services, Information Technology Investment Management Group, Attn.: John Burke, CMS-1169-FC, Room N2-14-26, 7500 Security Boulevard, Baltimore, MD 21244-1850.
Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503, Attn: Allison Eydt, CMS Desk Officer.
XII. Response to Comments
Because of the large number of items of correspondence we normally receive on Federal Register documents published for comment, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the DATES section of this preamble, and, if we proceed with a subsequent document, we will respond to the comments in the preamble to that document.
XIII. Regulatory Impact Analysis
We have examined the impact of this final rule as required by Executive Order 12866, the Unfunded Mandates Reform Act of 1995 (UMRA) (Pub. L. 104-4), the Regulatory Flexibility Act of 1980 (RFA) (Pub. L. 96-354), and Executive Order 13132 of August 4, 1999 (Federalism).
EO 12866 directs agencies to assess costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis (RIA) must be prepared for major rules with economically significant effects ($100 million or more annually). While the changes in the Medicare physician fee schedule are, for the most part, budget neutral, they do involve redistribution of Medicare spending among procedures and physician specialties. The redistributive effect of this rule on any particular specialty is in our estimate likely to exceed $100 million for at least one specialty group. For this reason we are considering this a major economic rule.
However, it is important to note, as indicated in section VII of this preamble, the physician fee update for 2002 under section 1848(d) of the Act is -4.8 percent of an estimated $41.2 billion in physician expenditures for 2001. Even though the physician fee schedule update is -4.8 percent, we project that the total Medicare expenditures for physicians' services will increase from $41.2 billion to $41.7 billion in 2002.
The UMRA also requires (in section 202) that agencies prepare an assessment of anticipated costs and benefits before developing any rule that may result in expenditure in any one year by State, local, or tribal governments, in the aggregate, or by the private sector, of $110 million or more. We have determined that this rule has no consequential effect on State, local, or tribal governments. We believe the private sector cost of this rule falls below the above-stated threshold as well.
The RFA requires that we analyze regulatory options for small businesses and other small entities. We prepare a Regulatory Flexibility Analysis unless we certify that a rule would not have a significant economic impact on a substantial number of small entities. The analysis must include a justification concerning the reason action is being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives and lessen significant adverse economic impact on the small entities.
In addition, section 1102(b) of the Act requires us to prepare a regulatory impact analysis if a rule may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside of a Metropolitan Statistical Area and has fewer than 100 beds.
For purposes of the RFA, all physicians are considered to be small entities. There are about 700,000 physicians and other practitioners who receive Medicare payment under the physician fee schedule.
For the purpose of EO 12866 and the RFA we have prepared the following analysis, which, together with the rest of this preamble, meets all four assessment requirements. It explains the rationale for and purpose of the rule, details the costs and benefits of the rule, analyzes alternatives, and presents the measures we considered to minimize the burden on small entities.
A. 5 Year Review of Physician Work and Resource-Based Practice Expense Relative Value Units
Revisions in physician work and resource-based practice expense RVUs for physicians' services are required by law to be budget neutral. We calculate total payments from the revisions to work and practice expense relative value units such that total payments do not change more than $20 million as a result of the revisions. Increases in payments for some services are necessarily offset by decreases in payments for other services. For revisions to physician work values that are occuring as part of the 5-year review, we are making a budget neutrality adjustment to the physician fee schedule conversion factor. For practice expense, we adjust all the practice expense RVUs upwards or downwards to meet the budget neutrality requirement in the statute. This means that increases in practice expense RVUs for some services will be offset by corresponding decreases in values for other services. We showed the impact of proposed changes in physician work and practice expense RVUs in our Notice of Proposed Rulemaking in the Federal Register on August 2, 2001 (65 FR 40397). Table 21 shows the impact on total allowed charges by specialty of this final rule's physician work and practice expense RVU changes. We are showing the impact of the proposed rule changes as well additional changes that are occurring as a result of this final rule. There are five changes we are adopting in this final rule that result in changes to the impacts displayed in the proposed rule. Table 21 incorporates additional impacts that result from using 2000 utilization data to determine the resource-based practice expense RVUs. This change has a very modest effect on payment for nearly all specialties. Based on public comments to our notice of proposed rulemaking, we have also made changes to physician work RVUs that were part of the 5-year review. These changes will increase payments to Gastronterology, General Surgery, Obstetrics and Gynecology and Podiatry. We also incorporated revised physician time data supplied to us by the Relative Value Update Committee (RUC). Relative to the physician times used in our proposed rule, there were slight refinements to some codes. With the exception of Nephrology, the new times have virtually no impact on specialty level payments. Nephrology payments will go up as a result of using new physician times supplied to us by the RUC. The RUC supplied us with a time of 186 minutes for the highest volume nephrology procedure code, 90921. This compared to a physician time of 153 minutes that was previously used. Finally, we also incorporated refinements to the practice expense inputs that are being recommended by the Practice Expense Advisory Committee (PEAC) and the RUC. These changes will result in a reduction in average payments to rheumatology of about 6 percent. This occurs primarily as a result of refinements to 4 codes that are frequently performed by rheumatologists (20610, 20550, 20605 and 20600). Based on the PEAC and RUC comments, we made changes to the practice expense inputs that result in a reduction in relative payments for these procedure codes. Other specialties that will experience a smaller reduction in payments as a result of the practice expense refinements for 2002 are Orthopedic Surgery, Podiatry and Urology. Since the changes are budget neutral, the reductions in practice expense RVUs will be offset by increases in practice expense payments that will be broadly distributed among other physician specialties.
Table 21 shows the impact of this final rule compared to the proposed rule that was published on August 2, 2001. We note that the table shows the impact of this rule only and does not incorporate practice expense changes from three other final rules, November 2, 1998 (63 FR 58895), November 2, 1999 (64 FR 59433) and November 1, 2000 (65 FR 65377). The table shows the average specialty change in payments in CY 2002 that are occurring as a result of this final rule relative to what would have occurred in 2002 had this rule not been published. The rule shows the redistributive (or relative) change in payments among specialties. It does not show the absolute average change in specialty level payments from 2001 to 2002 that are also affected by the final year of the transition to resource-based practice expense RVUs and the physician fee schedule update. The transition to resource-based RVUs is complete in CY 2002 and has no effect when comparing the impact on CY 2002 payments before and after changes made in this final rule. The physician fee schedule update and change to the conversion factor are discussed in sections VII and IX, respectively.
| Specialty | Allowed charges (billions) | Proposed rule impact (percent) | Final rule impact (percent) |
|---|---|---|---|
| Anesthesiology | $1.5 | 1 | 1 |
| Cardiac Surgery | 0.3 | 0 | 0 |
| Cardiology | 4.2 | 0 | -1 |
| Chiropractor | 0.4 | 0 | 0 |
| Clinics | 1.6 | 0 | 0 |
| Dermatology | 1.4 | 1 | 2 |
| Emergency Medicine | 1.0 | 0 | 0 |
| Family Practice | 3.3 | 0 | 0 |
| Gastroenterology | 1.2 | 1 | 3 |
| General Practice | 1.0 | 0 | 0 |
| General Surgery | 2.0 | 4 | 4 |
| Hematology Oncology | 0.6 | 0 | 1 |
| Internal Medicine | 7.1 | 0 | 1 |
| Nephrology | 1.0 | 0 | 2 |
| Neurology | 0.9 | 0 | 0 |
| Neurosurgery | 0.4 | 0 | 0 |
| Nonphysician Practitioner | 1.2 | 0 | 1 |
| Obstetrics/Gynecology | 0.4 | 1 | 2 |
| Ophthalmology | 3.9 | -1 | -1 |
| Optometrist | 0.5 | 0 | -3 |
| Orthopedic Surgery | 2.3 | 0 | -1 |
| Other Physician | 1.4 | 1 | 0 |
| Otolaryngology | 0.6 | 0 | 1 |
| Pathology | 0.6 | 3 | 3 |
| Plastic Surgery | 0.2 | 0 | 1 |
| Podiatry | 1.1 | 1 | 0 |
| Psychiatry | 1.1 | 0 | 0 |
| Pulmonary | 1.1 | 0 | 1 |
| Radiation Oncology | 0.7 | 0 | -2 |
| Radiology | 3.3 | 0 | -1 |
| Rheumatology | 0.3 | 0 | -6 |
| Suppliers | 0.7 | 2 | 0 |
| Thoracic Surgery | 0.5 | 1 | 0 |
| Urology | 1.3 | 1 | 1 |
| Vascular Surgery | 0.3 | 2 | 1 |
Table 22, titled Impact of 5-Year Review and Proposed Rule on Medicare Payments for Selected Procedures, shows the percentage change in total payment (in CY 2002 physician fee schedule dollars) for selected high-volume procedures that result from changes to the physician work, practice expense and malpractice announced in this final rule. These tables reflect the impact of this final rule only on the fully implemented fee schedule amount. The payments in these columns are determined using a conversion factor $36.1992. The RVUs used for calculating payment in the "old" columns are from the November 1, 2000 final rule. The RVUs used in calculating payments in the "new" columns are from this final rule. By using the same conversion factor of $36.1992 to calculate payments in both the "old" and "new" columns, the impact of changes to the RVUs that are included in this final rule are illustrated. These tables do not show the actual impact on payment from 2001 to 2002 that are also affected by the final year of the practice expense transition and physician fee schedule update.
| HCPCS | MOD | DESC | Old non- facility | New non- facility | Percent change | Old facility | New facility | Percent change |
|---|---|---|---|---|---|---|---|---|
| 11721 | Debride nail, 6 or more | $40.18 | $36.92 | -8 | $28.96 | $28.96 | 0 | |
| 17000 | Destroy benign/premal lesion | 60.45 | 62.62 | 4 | 32.58 | 32.94 | 1 | |
| 27130 | Total hip replacement | NA | NA | NA | 1,419.01 | 1,452.31 | 2 | |
| 27236 | Treat thigh fracture | NA | NA | NA | 1,088.87 | 1,113.85 | 2 | |
| 27244 | Treat thigh fracture | NA | NA | NA | 1,111.68 | 1,137.38 | 2 | |
| 27447 | Total knee replacement | NA | NA | NA | 1,483.08 | 1,514.21 | 2 | |
| 33533 | CABG, arterial, single | NA | NA | NA | 1,756.02 | 1,827.34 | 4 | |
| 35301 | Rechanneling of artery | NA | NA | NA | 1,107.33 | 1,061.36 | -4 | |
| 43239 | Upper GI endoscopy, biopsy | 281.99 | 354.75 | 26 | 148.78 | 154.93 | 4 | |
| 45385 | Lesion removal colonoscopy | 474.93 | 571.22 | 20 | 283.44 | 287.78 | 2 | |
| 66821 | After cataract laser surgery | 217.56 | 229.50 | 6 | 203.44 | 213.94 | 5 | |
| 66984 | Cataract surg w/iol, i stage | NA | NA | NA | 660.27 | 669.32 | 1 | |
| 67210 | Treatment of retinal lesion | 594.03 | 603.08 | 2 | 544.44 | 546.61 | 0 | |
| 71010 | 26 | Chest x-ray | 9.05 | 9.05 | 0 | 9.05 | 9.05 | 0 |
| 71020 | 26 | Chest x-ray | 11.22 | 11.22 | 0 | 11.22 | 11.22 | 0 |
| 76091 | Mammogram, both breasts | 84.34 | 90.50 | 7 | NA | NA | NA | |
| 76091 | 26 | Mammogram, both breasts | 35.11 | 43.44 | 24 | 35.11 | 43.44 | 24 |
| 76092 | Mammogram, screening | 71.03 | 80.72 | 14 | 71.03 | 80.72 | 14 | |
| 76092 | 26 | Mammogram, screening | 22.73 | 35.48 | 56 | 22.73 | 35.48 | 56 |
| 77427 | Radiation tx management, x5 | 167.24 | 167.96 | 0 | 167.24 | 167.96 | 0 | |
| 78465 | 26 | Heart image (3d), multiple | 75.29 | 74.93 | -1 | 75.29 | 74.93 | -1 |
| 88305 | 26 | Tissue exam by pathologist | 39.82 | 40.54 | 2 | 39.82 | 40.54 | 2 |
| 90801 | Psy dx interview | 145.52 | 144.80 | -1 | 137.19 | 137.19 | 0 | |
| 90806 | Psytx, off, 45-50 min | 96.65 | 95.93 | -1 | 91.22 | 91.22 | 0 | |
| 90807 | Psytx, off, 45-50 min w/em | 103.89 | 103.53 | 0 | 98.82 | 98.82 | 0 | |
| 90862 | Medication management | 51.04 | 51.04 | 0 | 46.33 | 46.33 | 0 | |
| 90921 | ESRD related services, month | 263.89 | 273.30 | 4 | 263.89 | 273.30 | 4 | |
| 90935 | Hemodialysis, one evaluation | NA | NA | NA | 73.48 | 76.38 | 4 | |
| 92004 | Eye exam, new patient | 124.16 | 123.44 | -1 | 87.60 | 87.96 | 0 | |
| 92012 | Eye exam established pat | 62.62 | 61.18 | -2 | 35.84 | 35.84 | 0 | |
| 92014 | Eye exam treatment | 89.77 | 91.22 | 2 | 59.00 | 58.64 | -1 | |
| 92980 | Insert intracoronary stent | NA | NA | NA | 799.64 | 790.59 | -1 | |
| 92982 | Coronary artery dilation | NA | NA | NA | 592.22 | 584.26 | -1 | |
| 93000 | Electrocardiogram, complete | 26.06 | 25.34 | -3 | NA | NA | NA | |
| 93010 | Electrocardiogram report | 9.05 | 9.05 | 0 | 9.05 | 9.05 | 0 | |
| 93015 | Cardiovascular stress test | 102.81 | 99.91 | -3 | NA | NA | NA | |
| 93307 | 26 | Echo exam of heart | 48.51 | 48.14 | -1 | 48.51 | 48.14 | -1 |
| 93510 | 26 | Left heart catheterization | 232.76 | 230.59 | -1 | 232.76 | 230.59 | -1 |
| 98941 | Chiropractic manipulation | 35.48 | 35.48 | 0 | 30.77 | 31.13 | 1 | |
| 99202 | Office/outpatient visit, new | 60.45 | 61.54 | 2 | 45.61 | 45.61 | 0 | |
| 99203 | Office/outpatient visit, new | 90.50 | 91.95 | 2 | 69.50 | 69.50 | 0 | |
| 99204 | Office/outpatient visit, new | 130.32 | 130.68 | 0 | 102.81 | 102.81 | 0 | |
| 99205 | Office/outpatient visit, new | 165.07 | 166.15 | 1 | 136.11 | 136.47 | 0 | |
| 99211 | Office/outpatient visit, est | 19.91 | 20.27 | 2 | 8.69 | 8.69 | 0 | |
| 99212 | Office/outpatient visit, est | 35.48 | 36.20 | 2 | 23.17 | 23.17 | 0 | |
| 99213 | Office/outpatient visit, est | 49.59 | 50.32 | 2 | 34.03 | 34.03 | 0 | |
| 99214 | Office/outpatient visit, est | 78.19 | 78.91 | 1 | 55.75 | 56.11 | 1 | |
| 99215 | Office/outpatient visit, est | 114.39 | 115.84 | 1 | 90.14 | 90.50 | 0 | |
| 99221 | Initial hospital care | NA | NA | NA | 65.16 | 65.16 | 0 | |
| 99222 | Initial hospital care | NA | NA | NA | 107.87 | 108.24 | 0 | |
| 99223 | Initial hospital care | NA | NA | NA | 150.59 | 150.95 | 0 | |
| 99231 | Subsequent hospital care | NA | NA | NA | 32.58 | 32.58 | 0 | |
| 99232 | Subsequent hospital care | NA | NA | NA | 53.21 | 53.57 | 1 | |
| 99233 | Subsequent hospital care | NA | NA | NA | 76.02 | 76.38 | 1 | |
| 99236 | Observ/hosp same date | NA | NA | NA | 213.58 | 214.66 | 1 | |
| 99238 | Hospital discharge day | NA | NA | NA | 64.07 | 66.24 | 3 | |
| 99239 | Hospital discharge day | NA | NA | NA | 87.60 | 90.86 | 4 | |
| 99241 | Office consultation | 46.33 | 47.06 | 2 | 32.94 | 33.30 | 1 | |
| 99242 | Office consultation | 86.15 | 87.24 | 1 | 67.69 | 68.05 | 1 | |
| 99243 | Office consultation | 114.39 | 115.84 | 1 | 90.14 | 90.14 | 0 | |
| 99244 | Office consultation | 162.53 | 164.34 | 1 | 133.21 | 133.58 | 0 | |
| 99245 | Office consultation | 211.04 | 212.85 | 1 | 176.65 | 177.01 | 0 | |
| 99251 | Initial inpatient consult | NA | NA | NA | 36.20 | 34.75 | -4 | |
| 99252 | Initial inpatient consult | NA | NA | NA | 71.31 | 69.86 | -2 | |
| 99253 | Initial inpatient consult | NA | NA | NA | 96.65 | 95.20 | -2 | |
| 99254 | Initial inpatient consult | NA | NA | NA | 138.28 | 136.83 | -1 | |
| 99255 | Initial inpatient consult | NA | NA | NA | 189.68 | 188.60 | -1 | |
| 99261 | Follow-up inpatient consult | NA | NA | NA | 23.53 | 21.72 | -8 | |
| 99262 | Follow-up inpatient consult | NA | NA | NA | 45.25 | 43.44 | -4 | |
| 99263 | Follow-up inpatient consult | NA | NA | NA | 66.24 | 64.80 | -2 | |
| 99282 | Emergency dept visit | NA | NA | NA | 26.43 | 26.43 | 0 | |
| 99283 | Emergency dept visit | NA | NA | NA | 59.37 | 59.37 | 0 | |
| 99284 | Emergency dept visit | NA | NA | NA | 92.67 | 92.67 | 0 | |
| 99285 | Emergency dept visit | NA | NA | NA | 144.43 | 144.80 | 0 | |
| 99291 | Critical care, first hour | NA | NA | NA | 197.65 | 198.37 | 0 | |
| 99292 | Critical care, addl 30 min | NA | NA | NA | 98.46 | 98.82 | 0 | |
| 99301 | Nursing facility care | 60.09 | 70.23 | 17 | 60.09 | 60.09 | 0 | |
| 99302 | Nursing facility care | 80.36 | 95.57 | 19 | 80.36 | 80.72 | 0 | |
| 99303 | Nursing facility care | 99.91 | 118.73 | 19 | 99.91 | 100.27 | 0 | |
| 99311 | Nursing fac care, subseq | 30.05 | 40.18 | 34 | 30.05 | 30.05 | 0 | |
| 99312 | Nursing fac care, subseq | 49.59 | 61.90 | 25 | 49.59 | 49.95 | 1 | |
| 99313 | Nursing fac care, subseq | 70.59 | 84.34 | 20 | 70.59 | 70.95 | 1 | |
| 99348 | Home visit, est patient | 73.12 | 73.85 | 1 | NA | NA | NA | |
| 99350 | Home visit, est patient | 166.88 | 166.52 | 0 | NA | NA | NA |
(In two different places above, we indicate that the tables do not include the effect of the "final" year of the practice expense transition. While we note that resource-based practice expense will be fully implemented in 2002, our expectation is that we would continue to make refinements that improve the practice expense relative value units. We acknowledge that the efforts of the PEAC and RUC to make useful comments on practice expense inputs have resulted in significant improvements to the data we are using to determine practice expense relative value units. The refinements we have made to date have affected hundreds of procedure codes accounting for a high percentage of Medicare expenditures paid under the physician fee schedule. Our expectation is that this work will continue and we continue, to welcome comments and input from all members of the public interested in these issues).
B. Nurse Practitioners, Physician Assistants, and Clinical Nurse Specialists Performing Screening Sigmoidoscopies
As discussed in section II.B. of the preamble, this regulation will expand the list of practitioners for whose services Medicare may make payment for screening flexible sigmoidoscopies to include nurse practitioners, physician assistants, and clinical nurse specialists, as long as those practitioners meet applicable Medicare qualification requirements, and they are authorized to perform those screening services under State law. At present, the Medicare condition of coverage for screening flexible sigmoidoscopies limits coverage of those services to those that are performed by either a doctor of medicine or osteopathy (as defined in section 1861(r)(1) of the Act) who is authorized under State law to perform the examination.
We estimate that this expansion in the scope of practitioners who can receive Medicare payment for screening flexible sigmoidoscopies will increase beneficiary access to these screening services and will result in an increase in the number of covered exams that are performed. At the same time, we estimate that this final rule will result in a decrease in payments that are made for certain screening flexible sigmoidoscopies because they will be performed by nurse practitioners, physician assistants, and clinical nurse specialists, since services they provide are paid at 85 percent of the amount of payment that is made to physicians for the same screening service. Taking these factors into account, we estimate that this provision will result in negligible additional Medicare program costs. For a more detailed discussion of this provision see section II.B. of this preamble.
C. Services and Supplies Incident to a Physician's Professional Services-Conditions
Under this rule auxiliary personnel may provide services incident to the services of physicians (or other practitioners) who supervise them, regardless of the employment relationship. There are no costs or savings to the Medicare program associated with this provision. This provision could result in increased beneficiary access to the auxiliary personnel. For a more detailed discussion of this provision see section II.C. of this preamble.
D. Anesthesia Services-Anesthesia Base Units
As previously discussed in section II.D. of the preamble, with the exception of codes 00142 and 00147, we are using the same anesthesia base unit per anesthesia code as the ASA provides in its uniform relative value guide. There are eleven codes where our base unit value for an anesthesia code differed from the corresponding ASA base unit. Using the ASA base units resulted in an increase for 8 codes and a decrease for 3 codes. New and revised codes starting in CY 2000 and for subsequent years are evaluated on a code-specific basis under our usual process after we receive recommendations from the RUC. Thus, because of our review of the RUC recommendations, there could be differences between the ASA's guide and our base units beginning in CY 2000.
We have determined the budget neutrality impact on the anesthesia CF for the 11 codes for which CMS's base units are equal to the ASA's base units as well as the addition of 19 new anesthesia codes in CY 2002. The impact was determined by estimating the increase or decrease in base units between our base units and the ASA's base units for existing codes as well as the increase and decrease in base units between the new 2002 codes and the previous codes by which the services would have been reported. This results in an increase of approximately .2 percent in the 2002 anesthesia CF. For a more detailed discussion of this provision see section II.D. of this preamble.
E. Performance Measurement and Emerging Technology Codes
As previously discussed in section II.E. of the preamble, the AMA has developed two new categories of codes-performance codes and emerging technology. Allowing the performance measurement code to be recorded on Medicare billing forms will have no budgetary impact since we are not proposing payment for these codes. We are allowing for carrier pricing of the emerging technology codes.
We expect that the emerging technology codes will be used infrequently and may be used in place of "unlisted" procedure codes that are also carrier-priced. There would be few, if any, Medicare program costs associated with this proposal. For a more detailed discussion of this provision see section II.E. of this preamble.
F. BIPA Provisions Included in This Final Rule
The following provisions of the BIPA are discussed in detail in section III of this preamble. This final rule conforms the regulations text to the BIPA provisions. We showed the anticipated costs associated with the BIPA provisions in our August 2, 2001 proposed rule (66 FR 40400). We are showing that same table again in table 23 below.
| BIPA provisions | FY 2002 | FY 2003 | FY 2004 | FY 2005 | FY 2006 |
|---|---|---|---|---|---|
| Sec. 101Biennial Pelvic Examinations | 10 | 20 | 20 | 20 | 20 |
| Sec. 102Screening Glaucoma | 30 | 50 | 50 | 60 | 60 |
| Sec. 103Screening Colonoscopy | 40 | 40 | 30 | 10 | 10 |
| Sec. 104Screening Mammography | 30 | 40 | 40 | 40 | 50 |
| Sec. 105Medical Nutrition | 20 | 50 | 60 | 70 | 70 |
| Sec. 223Telehealth Services | 20 | 30 | 40 | 50 | 60 |
| Sec. 432Indian Health | 60 | 70 | 80 | 80 | 90 |
1. Screening Mammography
As discussed in section III.A. of the preamble, the BIPA eliminates the statutorily prescribed payment rate for screening mammography and specifies that it will be paid under the physician fee schedule beginning January 1, 2002. To pay for the professional component of the screening mammography, we are using the work and malpractice RVUs that have been established for unilateral diagnostic mammography. We are establishing the practice expense RVUs for the professional component under the resource-based methodology. The process we used to establish the practice expense RVU for the TC is described in detail in section III.A. Currently, we pay for screening mammography under section 1834(c) of the Act. Payment for screening mammography under that section is not subject to the budget neutrality requirements that apply to physician fee schedule services under section 1848(c)(2)(B)(ii)(II) of the Act. However, effective January 1, 2002, screening mammography will be paid under the physician fee schedule and, thus, subject to the budget neutrality requirements that apply to physician fee schedule services. We will include the current payment amounts for screening mammography in aggregate physician fee schedule payments subject to the budget neutrality requirements. As a result, the BIPA requirement that we pay for screening mammography under the physician fee schedule will not result in an increase in Medicare program expenditures. However, the increase in payment for screening mammography under the physician fee schedule will be included in the budget neutrality adjustments that apply to physician fee schedule services. The BIPA also establishes a methodology for determining payment for certain types of new technology that are used in providing both diagnostic and screening mammography services. The statutory provisions are in effect from April 1, 2001 to December 31, 2001. The statute gives us the authority to determine whether separate codes and payment amounts are appropriate for screening and diagnostic mammography services that involve use of a new technology on or after January 1, 2002. We are establishing several new codes and fee schedule amounts for screening and diagnostic mammography services that involve use of a new technology. We believe this will help ensure that all Medicare beneficiaries have access to the benefits of mammography, including recent advances that further enhance the clinical capability of this vital health service for women. The BIPA provisions related to new technology mammography will result in the Medicare program costs shown in Table 23. The BIPA makes no changes to provisions for Medicare coverage of screening mammography.
2. Screening Pelvic Examinations
As discussed in section III.B. of the preamble, section 101 of the BIPA provides for expanded coverage for screening pelvic examinations (including a clinical breast examination) furnished on or after July 1, 2001. Specifically, the revised benefit will allow for biennial coverage of screening pelvic examination for all women who do not qualify under the law for annual coverage of such tests. We estimate that this change in the frequency of coverage for certain beneficiaries will result in an increase in Medicare payments. These payments will be made to a large number of physicians and other practitioners who provide these tests and for any medically necessary follow-up tests, or treatment that may be required as a result of the increased frequency of coverage of these tests. Medicare program expenditures associated with screening pelvic examinations have been included in the President's budget for Medicare expenditures. The impact of this provision is shown in Table 23.
3. Screening for Glaucoma
As discussed in section III.C. of the preamble, section 102 of the BIPA authorizes coverage of glaucoma screening examinations effective January 1, 2002, subject to certain frequency and other limitations. We believe services provided as part of glaucoma screening will often overlap with other services a physician provides during a patient encounter that is associated with a higher payment amount. We believe that physicians will more commonly provide glaucoma tests in conjunction with other services and will rarely provide only glaucoma screening to Medicare patients. Based on the projected utilization of these screening services and related medically necessary follow-up tests and treatment that may be required for the beneficiaries screened, we estimate that this new benefit will result in an increase in Medicare payments. These payments will be made to ophthalmologists or optometrists who will provide these screening tests and for any related follow-up tests and treatment that may be required. Medicare program expenditures associated with the BIPA provision that establishes coverage for screening glaucoma are shown in Table 23. The addition of the screening glaucoma benefit will allow a greater number of beneficiaries access to a preventive service.
4. Screening Colonoscopy
As discussed in section III.D. of the preamble, section 103 of the BIPA amended the Act to add coverage of screening colonoscopies once every 10 years for individuals not at high risk for colorectal cancer. We estimate that this new benefit will result in an increase in Medicare payments. These payments will be made to practitioners who will provide these screening tests and related follow-up tests and treatment that may be required. The addition of the screening colonoscopy benefit will allow beneficiaries who are not at high risk for colorectal cancer greater access to preventive services. The impact of this provision is shown in Table 23.
5. Medical Nutrition Therapy
As discussed in section III.E. of the preamble, section 105 of the BIPA amended the Act to authorize Medicare coverage under Part B of medical nutrition therapy (MNT) for beneficiaries who have diabetes or renal disease, effective for services furnished on or after January 1, 2002. We are implementing this provision in 42 CFR at part 410, in subpart G. Specifically, the final rule discusses the education, experience, and licensing requirements for dietitians or nutritionists furnishing the service. In addition, the final rule discusses a referral requirement and the manner by which the medical nutrition therapy and diabetes outpatient self-management training benefits will be coordinated to avoid duplicate payment. We are also establishing payment amounts for these services under the physician fee schedule.
We estimate that this new benefit will result in an increase in Medicare payments. These payments will be made to dietitians and nutrition professionals who will provide these diagnostic therapy and counseling services. Costs to the Medicare program associated with this provision are shown in Table 23.
6. Telehealth
We estimate that the cost of providing office or other outpatient visits, consultation services, individual psychotherapy, and pharmacologic management in accordance with section 223 of the BIPA will be approximately $20 million in FY 2002 and approximately $60 million by FY 2006, as indicated above in Table 23.
This final rule does not mandate that entities provide consultation, office or other outpatient visits, individual psychotherapy or pharmacological management services via a telecommunications system. Thus, this final rule will not require entities to purchase telehealth equipment or to acquire the telecommunications infrastructure necessary to deliver these services via a telecommunications system. Therefore, this final rule does not impose costs associated with starting and operating a telehealth network.
7. Indian Health Services
As discussed in section III.G. of the preamble, section 432 of the BIPA authorizes payment under the physician fee schedule to physicians and certain practitioners for services furnished in a hospital and an ambulatory care clinic, whether provider-based or free-standing, of the Indian Health Service effective for services furnished on or after July 1, 2001. We are adding a new § 410.46 to conform our regulations to the statute. Costs to the Medicare program for this BIPA provision are shown in Table 23.
8. Pathology Services
As discussed in section III.H. of the preamble, in the November 2, 1999 physician fee schedule final rule (64 FR 59381), we stated that we would implement a policy to pay only hospitals for the TC of physician pathology services furnished to hospital inpatients. Before the effective date of this proposal, any independent laboratory could bill the carrier under the physician fee schedule for the TC of physician pathology to a hospital inpatient. That regulation provided that for services furnished on or after January 1, 2001, the carriers would no longer pay claims to an independent laboratory under the physician fee schedule for the TC of physician pathology services furnished for hospital inpatients. Similar treatment was provided under the hospital outpatient prospective payment system for the TC of physician pathology services to hospital outpatients. We delayed implementation of this provision for one year; it was to take effect for services furnished on or after January 1, 2001. The delay was intended to allow independent laboratories and hospitals sufficient time to negotiate arrangements.
Section 542 of the BIPA requires Medicare to continue to pay for the TC of physician pathology services when an independent laboratory furnishes this service to an inpatient or outpatient of a covered hospital. This provision applies to TC services furnished during the 2-year period beginning on January 1, 2001.
In the November 2, 1999 final rule, we estimated that payment under the physician fee schedule for TC billings by independent laboratories would decrease by $6 million per year if the original proposal had been implemented on January 1, 2001. As a result of the BIPA, these savings are not realized for two years.
G. Update of the Codes for the Physician Self-Referral Prohibition
As discussed in section VI of this preamble, we are updating the list of codes used to define certain designated health services for the purposes of section 1877 of the Act. We are not making any substantive change to the description of any designated health service as set forth in the January 4, 2001 physician self-referral final rule (66 FR 856). Instead, we are merely updating our list of codes to conform to coding changes in the most recent publication of CPT and HCPCS codes. For this reason, we certify that the changes we are making will not have a significant economic effect on a substantial number of small entities or on the operations of a substantial number of small rural hospitals. For an in-depth discussion of the anticipated effects of the recent physician self-referral final rule, refer to the regulatory impact statement in that rule as published in the January 4, 2001 Federal Register (66 FR 856).
H. Budget-Neutrality
The increase in physician work RVUs will necessitate an adjustment to meet the statute's budget neutrality requirements. We are reducing the physician fee schedule CF by -0.46 percent (CF X 0.9954) to ensure that the increase in physician work RVUs remains budget neutral across all physician fee schedule services. Each year since the fee schedule has been implemented, our actuaries have determined any adjustments needed to meet the budget-neutrality requirement of the statute. A component of the actuarial determination of budget-neutrality involves estimating the impact of changes in the volume and intensity of physicians' services provided to Medicare beneficiaries as a result of the proposed changes to relative value units. Consistent with the provision in the November 1998 final rule, the actuaries would use a model that assumes a 30 percent volume-and-intensity response to price reductions. Based on the practice expense changes that will occur in 2002, the actuaries estimate that a -0.18 (CF X 0.9982) percent adjustment to the conversion factor is necessary to meet the budget neutrality requirements in the statute. If the assumed volume and intensity offset does not occur, the offset applied to the RVUs will be, in essence, returned because there will be a future year adjustment to the physician fee schedule update.
I. Impact on Beneficiaries
Although changes in physicians' payments when the physician fee schedule was implemented in 1992 were large, we detected no problems with beneficiary access to care. Furthermore, since beginning our transition to a resource-based practice expense system in 1999, we have not found that there are problems with beneficiary access to care.
J. Federalism
We have reviewed this proposed rule under the threshold criteria of EO 13132, Federalism, and we have determined that the proposed rule does not significantly affect the rights, roles, and responsibilities of States.
List of Subjects
42 CFR Part 405
Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.
42 CFR Part 410
Health facilities, Health professions, Kidney diseases, Laboratories, Medicare, Rural areas, X-rays.
42 CFR Part 411
Kidney diseases, Medicare, Reporting and recordkeeping requirements.
42 CFR Part 414
Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.
42 CFR Part 415
Health facilities, Health professions, Medicare, Reporting and recordkeeping requirements.
For the reasons set forth in the preamble, the Centers for Medicare and Medicaid amends 42 CFR chapter IV as follows:
PART 405-FEDERAL HEALTH INSURANCE FOR THE AGED AND DISABLED
1. The authority citation for part 405 continues to read as follows:
Authority:
Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).
2. In § 405.534, an introductory paragraph is added to read as follows:
§ 405.534 Limitation on payment for screening mammography services.
The provisions in paragraphs (a), (b), and (c) of this section apply for services provided from January 1, 1991 until December 31, 2001. Screening mammography services provided after December 31, 2001 are paid under the physician fee schedule in accordance with § 414.2 of this chapter.
3. In § 405.535, the section heading is revised and the introductory text is amended by adding two sentences to the beginning to read as follows:
§ 405.535 Special rule for nonparticipating physicians and suppliers furnishing screening mammography services before January 1, 2002.
The provisions in this section apply for screening mammography services provided from January 1, 1991 until December 31, 2001. Screening mammography services provided after December 31, 2001 are physician services pursuant to § 414.2 of this chapter paid under the physician fee schedule. * * *
PART 410-SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS
1. The authority citation for part 410 continues to read as follows:
Authority:
Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).
2. Section 410.3 is amended by revising paragraph (a)(1) to read as follows:
§ 410.3 Scope of benefits.
(a) * * *
(1) Medical and other health services such as physicians' services, outpatient services furnished by a hospital or a CAH, diagnostic tests, outpatient physical therapy and speech pathology services, rural health clinic services, Federally qualified health center services, IHS, Indian tribe, or tribal organization facility services, and outpatient renal dialysis services.
3. Section 410.10 is amended by adding paragraph (x) to read as follows:
§ 410.10 Medical and other health services: Included services.
(x) Services of physicians and other practitioners furnished in or at the direction of an IHS or Indian tribal hospital or clinic.
4. Section 410.22 is redesignated as § 410.21, § 410.23 is redesignated as § 410.22, and a new § 410.23 is added to read as follows:
§ 410.23 Screening for glaucoma: Conditions for and limitations on coverage.
(a) Definitions : As used in this section, the following definitions apply:
(1) Direct supervision in the office setting means the optometrist or the ophthalmologist must be present in the office suite and be immediately available to furnish assistance and direction throughout the performance of the procedure. It does not mean the physician must be present in the room when the procedure is performed.
(2) Eligible beneficiary means individuals in the following high risk categories:
(i) Individual with diabetes mellitus;
(ii) Individual with a family history of glaucoma; or
(iii) African-Americans age 50 and over.
(3) Screening for glaucoma means the following procedures furnished to an individual for the early detection of glaucoma:
(i) A dilated eye examination with an intraocular pressure measurement.
(ii) A direct ophthalmoscopy examination, or a slit-lamp biomicroscopic examination.
(b) Condition for coverage of screening for glaucoma.
Medicare Part B pays for glaucoma screening examinations provided to eligible beneficiaries as described in paragraph (a)(2) of this section if they are furnished by or under the direct supervision in the office setting of an optometrist or ophthalmologist who is legally authorized to perform these services under State law (or the State regulatory mechanism provided by State law) of the State in which the services are furnished, as would otherwise be covered if furnished by a physician or incident to a physician's professional service.
(c) Limitations on coverage of glaucoma screening examinations.
(1) Payment may not be made for a glaucoma screening examination that is performed for an individual who is not an eligible beneficiary as described in paragraph (a)(2) of this section.
(2) Payment may be made for a glaucoma screening examination that is performed on an individual who is an eligible beneficiary as described in paragraph (a)(2) of this section, after at least 11 months have passed following the month in which the last glaucoma screening examination was performed.
5. In § 410.26, paragraph (b) is redesignated as paragraph (c), paragraph (a) is redesignated as paragraph (b) and revised, a new paragraph (a) is added, and newly designated paragraph (c) is amended by adding a paragraph heading:
§ 410.26 Services and supplies incident to a physician's professional service: Conditions.
(a) Definitions . For purposes of this section, the following definitions apply:
(1) Auxiliary personnel means any individual who is acting under the supervision of a physician (or other practitioner), regardless of whether the individual is an employee, leased employee, or independent contractor of the physician (or other practitioner) or of the same entity that employs or contracts with the physician (or other practitioner).
(2) Direct supervision means the level of supervision by the physician (or other practitioner) of auxiliary personnel as defined in § 410.32(b)(3)(ii).
(3) Independent contractor means an individual who performs part-time or full-time work for which the individual receives an IRS-1099 form.
(4) Leased employment means an employment relationship that is recognized by applicable State law and that is established by two employers by a contract such that one employer hires the services of an employee of the other employer.
(5) Noninstitutional setting means all settings other than a hospital or skilled nursing facility.
(6) Practitioner means a non-physician practitioner who is authorized by the Act to receive payment for services incident to his or her own services.
(7) Services and supplies means any services or supplies (including drugs or biologicals that are not usually self-administered) that are included in section 1861(s)(2)(A) of the Act and are not specifically listed in the Act as a separate benefit included in the Medicare program.
(b) Medicare Part B pays for services and supplies incident to the service of a physician (or other practitioner).
(1) Services and supplies must be furnished in a noninstitutional setting to noninstitutional patients.
(2) Services and supplies must be an integral, though incidental, part of the service of a physician (or other practitioner) in the course of diagnosis or treatment of an injury or illness.
(3) Services and supplies must be commonly furnished without charge or included in the bill of a physician (or other practitioner).
(4) Services and supplies must be of a type that are commonly furnished in the office or clinic of a physician (or other practitioner).
(5) Services and supplies must be furnished under the direct supervision of the physician (or other practitioner). The physician (or other practitioner) directly supervising the auxiliary personnel need not be the same physician (or other practitioner) upon whose professional service the incident to service is based.
(6) Services and supplies must be furnished by the physician, practitioner with an incident to benefit, or auxiliary personnel.
(7) A physician (or other practitioner) may be an employee or an independent contractor.
(c) Limitation . * * *
6. In § 410.37, paragraphs (d), (e)(2), and (g) are revised and paragraph (e)(3) is added to read as follows:
§ 410.37 Colorectal cancer screening tests: Conditions for and limitations on coverage.
(d) Condition for coverage of flexible sigmoidoscopy screening. Medicare Part B pays for a flexible sigmoidoscopy screening service if it is performed by a doctor of medicine or osteopathy (as defined in section 1861(r)(1) of the Act), or by a physician assistant, nurse practitioner, or clinical nurse specialist (as defined in section 1861(aa)(5) of the Act and §§ 410.74, 410.75, and 410.76) who is authorized under State law to perform the examination.
(e) Limitations on coverage of screening flexible sigmoidoscopies. * * *
(2) For an individual 50 years of age or over, except as described in paragraph (e)(3) of this section, payment may be made for screening flexible sigmoidoscopy after at least 47 months have passed following the month in which the last screening flexible sigmoidoscopy or, as provided in paragraphs (h) and (i) of this section, the last screening barium enema was performed.
(3) In the case of an individual who is not at high risk for colorectal cancer as described in paragraph (a)(3) of this section but who has had a screening colonoscopy performed, payment may be made for a screening flexible sigmoidosocopy only after at least 119 months have passed following the month in which the last screening colonoscopy was performed.
(g) Limitations on coverage of screening colonoscopies. (1) Effective for services furnished on or after January 1, 1998 through June 30, 2001, payment may not be made for a screening colonoscopy for an individual who is not at high risk for colorectal cancer as described in paragraph (a)(3) of this section.
(2) Effective for services furnished on or after July 1, 2001, except as described in paragraph (g)(4) of this section, payment may be made for a screening colonoscopy performed for an individual who is not at high risk for colorectal cancer as described in paragraph (a)(3) of this section, after at least 119 months have passed following the month in which the last screening colonoscopy was performed.
(3) Payment may be made for a screening colonoscopy performed for an individual who is at high risk for colorectal cancer as described in paragraph (a)(3) of this section, after at least 23 months have passed following the month in which the last screening colonoscopy was performed, or, as provided in paragraphs (h) and (i) of this section, the last screening barium enema was performed.
(4) In the case of an individual who is not at high risk for colorectal cancer as described in paragraph (a)(3) of this section but who has had a screening flexible sigmoidoscopy performed, payment may be made for a screening colonoscopy only after at least 47 months have passed following the month in which the last screening flexible sigmoidoscopy was performed.
7. Section 410.46 is added to read as follows:
§ 410.46 Physician and other practitioner services furnished in or at the direction of an IHS or Indian tribal hospital or clinic: Scope and conditions.
(a) Medicare Part B pays, in accordance with the physician fee schedule, for services furnished in or at the direction of a hospital or outpatient clinic (provider-based or free-standing) that is operated by the Indian Health Service (IHS) or by an Indian tribe or tribal organization (as those terms are defined in section 4 of the Indian Health Care Improvement Act). These services are subject to the same situations, terms, and conditions that would apply if the services were furnished in or at the direction of a hospital or clinic that is not operated by IHS or by an Indian tribe or tribal organization. Payments include health professional shortage areas incentive payments when the requirements for these incentive payments in § 414.42 of this chapter are met.
(b) Payment is not made under this section to the extent that Medicare otherwise pays for the same services under other provisions.
(c) Payment is made under these provisions for the following services:
(1) Services for which payment is made under the physician fee schedule in accordance with part 414 of this chapter.
(2) Services furnished by non-physician practitioners for which payment under Part B is made under the physician fee schedule.
(3) Services furnished by a physical therapist or occupational therapist, for which payment under Part B is made under the physician fee schedule.
(d) Payments under these provisions will be paid to the IHS or tribal hospital or clinic.
8. In § 410.56, paragraphs (b)(1), the introductory text of (b)(2), and (b)(3) are revised to read as follows:
§ 410.56 Screening pelvic examinations.
(b) * * *
(1) General rule. Except as specified in paragraphs (b)(2) and (b)(3) of this section, payment may be made for a pelvic examination performed on an asymptomatic woman only if the individual has not had a pelvic examination paid for by Medicare during the preceding 23 months following the month in which her last Medicare-covered screening pelvic examination was performed.
(2) More frequent screening based on high-risk factors. Subject to the limitation as specified in paragraph (b)(4) of this section, payment may be made for a screening pelvic examination performed more frequently than once every 24 months if the test is performed by a physician or other practitioner specified in paragraph (a) of this section, and there is evidence that the woman is at high risk (on the basis of her medical history or other findings) of developing cervical cancer or vaginal cancer, as determined in accordance with the following risk factors:
(3) More frequent screening for women of childbearing age. Subject to the limitation as specified in paragraph (b)(4) of this section, payment may be made for a screening pelvic examination performed more frequently than once every 24 months if the test is performed by a physician or other practitioner as specified in paragraph (a) of this section for a woman of childbearing age who has had an examination that indicated the presence of cervical or vaginal cancer or other abnormality during any of the preceding 3 years. The term "woman of childbearing age" means a woman who is premenopausal, and has been determined by a physician, or a qualified practitioner, as specified in paragraph (a) of this section, to be of childbearing age, based on her medical history or other findings.
9. Section 410.78 is revised to read as follows:
§ 410.78 Office and other outpatient visits, consultation, individual psychotherapy and pharmacologic management via an interactive telecommunications system.
(a) Definitions. For the purposes of this section the following definitions apply:
(1) Asynchronous store and forward technologies means the transmission of a patient's medical information from an originating site to the physician or practitioner at the distant site. The physician or practitioner at the distant site can review the medical case without the patient being present. An asynchronous telecommunications system in single media format does not include telephone calls, images transmitted via facsimile machines and text messages without visualization of the patient (electronic mail). Photographs visualized by a telecommunications system must be specific to the patient's medical condition and adequate for furnishing or confirming a diagnosis and or treatment plan. Dermatological photographs, for example, a photograph of a skin lesion, may be considered to meet the requirement of a single media format under this provision.
(2) Distant site means the site at which the physician or practitioner delivering the service is located at the time the service is provided via a telecommunications system.
(3) Interactive telecommunications system means multimedia communications equipment that includes, at a minimum, audio and video equipment permitting two-way, real-time interactive communication between the patient and distant site physician or practitioner. Telephones, facsimile machines, and electronic mail systems do not meet the definition of an interactive telecommunications system.
(4) Originating site means, for purposes of a consultation, office or other outpatient visit, individual psychotherapy, or pharmacologic management via an interactive telecommunications system, the location of an eligible Medicare beneficiary at the time the service being furnished via a telecommunications system occurs. For asynchronous store and forward telecommunications technologies, the only originating sites are Federal telemedicine demonstration programs conducted in Alaska or Hawaii.
(b) General rule. Medicare Part B pays for office and other outpatient visits, professional consultation, individual psychotherapy, and pharmacologic management furnished by means of an interactive telecommunications system if the following conditions are met:
(1) The physician or practitioner at the distant site must be licensed to provide the service under State law. When the physician or practitioner at the distant site is licensed under State law to provide a covered telehealth service (that is, professional consultations, office and other outpatient visits, individual psychotherapy, and pharmacologic management), he or she may bill for, and receive payment for, this service when delivered via a telecommunications system.
(2) The practitioner at the distant site is one of the following:
(i) A physician as described in § 410.20.
(ii) A physician assistant as described § 410.74.
(iii) A nurse practitioner as described in § 410.75.
(iv) A clinical nurse specialist as described in § 410.76.
(v) A nurse-midwife as described in § 410.77.
(vi) A clinical psychologist as described in § 410.71.
(vii) A clinical social worker as described in § 410.73.
(3) The services are furnished to a beneficiary at an originating site, which is one of the following:
(i) The office of a physician or practitioner.
(ii) A critical access hospital (as described in section 1861(mm)(1) of the Act).
(iii) A rural health clinic (as described in section 1861(aa)(2) of the Act).
(iv) A Federally qualified health center (as defined in section 1861(aa)(4) of the Act).
(v) A hospital (as defined in section 1861(e) of the Act).
(4) Originating sites must be located in either a rural health professional shortage area as defined under section 332(a)(1)(A) of the Public Health Service Act (42 U.S.C. 254e(a)(1)(A)) or in a county that is not included in a Metropolitan Statistical Area as defined in section 1886(d)(2)(D) of the Act. Entities participating in a Federal telemedicine demonstration project that have been approved by, or receive funding from, the Secretary as of December 31, 2000 qualify as an eligible originating site regardless of geographic location.
(5) The medical examination of the patient is under the control of the physician or practitioner at the distant site.
(c) Telepresenter not required. A telepresenter is not required as a condition of payment unless a telepresenter is medically necessary as determined by the physician or practitioner at the distant site.
(d) Exception to the interactive telecommunications system requirement. For Federal telemedicine demonstration programs conducted in Alaska or Hawaii only, Medicare payment is permitted for telehealth when asynchronous store and forward technologies, in single or multimedia formats, are used as a substitute for an interactive telecommunications system.
(e) Limitation. A clinical psychologist and a clinical social worker may bill and receive payment for individual psychotherapy via a telecommunications system, but may not seek payment for medical evaluation and management services.
10. A new subpart G is added to read as follows:
Subpart G-Medical Nutrition Therapy
Sec. 410.130 Definitions.410.132 Medical nutrition therapy.410.134 Provider qualifications.
Subpart G-Medical Nutrition Therapy
§ 410.130 Definitions.
For the purposes of this subpart, the following definitions apply:
Chronic renal insufficiency means the stage of renal disease associated with a reduction in renal function not severe enough to require dialysis or transplantation (glomerular filtration rate [GFR] 13-50 ml/min/1.73m2 ).
Diabetes means diabetes mellitus consisting of two types. Type 1 is an autoimmune disease that destroys the beta cells of the pancreas, leading to insulin deficiency. Type 2 is familial hyperglycemia that occurs primarily in adults but can also occur in children and adolescents. It is caused by an insulin resistance whose etiology is multiple and not totally understood. Gestational diabetes is any degree of glucose intolerance with onset or first recognition during pregnancy. The diagnostic criterion for a diagnosis of diabetes for a fasting glucose tolerance test is greater than or equal to 126 mg/dL.
Episode of care means services covered in a 12-month time period when coordinated with initial diabetes self-management training (DSMT) and one calendar year for each year thereafter, starting with the assessment and including all covered interventions based on referral(s) from a physician as specified in § 410.132(c). The time period covered for gestational diabetes extends only until the pregnancy ends.
Medical nutrition therapy services means nutritional diagnostic, therapeutic, and counseling services provided by a registered dietitian or nutrition professional for the purpose of managing diabetes or a renal disease.
Physician means a doctor of medicine or osteopathy legally authorized to practice medicine and surgery by the State in which he or she performs such function or action (including a physician within the meaning of section of 1101(a)(7) of the Act).
Renal disease means chronic renal insufficiency, end-stage renal disease when dialysis is not received, or the medical condition of a beneficiary for 36 months after kidney transplant.
Treating physician means the primary care physician or specialist coordinating care for the beneficiary with diabetes or renal disease.
§ 410.132 Medical nutrition therapy.
(a) Conditions for coverage of MNT services. Medicare Part B pays for MNT services provided by a registered dietitian or nutrition professional as defined in § 410.134 when the beneficiary is referred for the service by the treating physician. Services covered consist of face-to-face nutritional assessments and interventions in accordance with nationally accepted dietary or nutritional protocols.
(b) Limitations on coverage of MNT services.
(1) MNT services based on a diagnosis of renal disease as described in this subpart are not covered for beneficiaries receiving maintenance dialysis for which payment is made under section 1881 of the Act.
(2) A beneficiary may only receive the maximum number of hours covered under the DSMT benefit for both DSMT and MNT during the initial DSMT training period unless additional hours are determined to be medically necessary under the national coverage determination process.
(3) In years when the beneficiary is eligible for MNT and follow-up DSMT, the beneficiary may only receive the maximum number of hours covered under MNT unless additional hours are determined to be medically necessary under the national coverage determination process.
(4) If a beneficiary has both diabetes and renal disease, the beneficiary may only receive the maximum number of hours covered under the renal MNT benefit in one episode of care unless he or she is receiving initial DSMT services, in which case the beneficiary would receive whichever is greater.
(5) An exception to the maximum number of hours in (b)(2), (3), and (4) of this section may be made when the treating physician determines that there is a change of diagnosis, medical condition, or treatment regimen related to diabetes or renal disease that requires a change in MNT during an episode of care.
(c) Referrals. Referral may only be made by the treating physician when the beneficiary has been diagnosed with diabetes or renal disease as defined in this subpart with documentation maintained by the referring physician in the beneficiary's medical record. Referrals must be made for each episode of care and any additional assessments or interventions required by a change of diagnosis, medical condition, or treatment regimen during an episode of care.
§ 410.134 Provider qualifications.
For Medicare Part B coverage of MNT, only a registered dietitian or nutrition professional may provide the services. "Registered dietitian or nutrition professional" means an individual who, on or after December 22, 2000:
(a) Holds a bachelor's or higher degree granted by a regionally accredited college or university in the United States (or an equivalent foreign degree) with completion of the academic requirements of a program in nutrition or dietetics accredited by an appropriate national accreditation organization recognized for this purpose.
(b) Has completed at least 900 hours of supervised dietetics practice under the supervision of a registered dietitian or nutrition professional.
(c) Is licensed or certified as a dietitian or nutrition professional by the State in which the services are performed. In a State that does not provide for licensure or certification, the individual will be deemed to have met this requirement if he or she is recognized as a "registered dietitian" by the Commission on Dietetic Registration or its successor organization, or meets the requirements of paragraphs (a) and (b) of this section.
(d) Exceptions .
(i) A dietitian or nutritionist licensed or certified in a State as of December 21, 2000 is not required to meet the requirements of (a) and (b) of this section.
(ii) A "registered dietician" in good standing, as recognized by the Commission of Dietetic Registration or its successor organization, is deemed to have met the requirements of (a) and (b) of this section.
PART 411-EXCLUSIONS FROM MEDICARE AND LIMITATIONS ON MEDICARE PAYMENT
1. The authority citation for part 411 continues to read as follows:
Authority:
Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).
2. In § 411.15, paragraph (a)(1) is revised, and a new paragraph (k)(10) is added to read as follows:
§ 411.15 Particular services excluded from coverage.
(a) * * *
(1) Examinations performed for a purpose other than treatment or diagnosis of a specific illness, symptoms, complaint, or injury, except for screening mammography, colorectal cancer screening tests, screening pelvic examinations, prostate cancer screening tests, or glaucoma screening exams that meet the criteria specified in paragraphs (k)(6) through (k)(10) of this section.
(k) * * *
(10) In the case of screening exams for glaucoma, for the purpose of early detection of glaucoma, subject to the conditions and limitations specified in § 410.23 of this chapter.
PART 414-PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES
1. The authority citation for part 414 continues to read as follows:
Authority:
Secs. 1102, 1871, and 1881(b)(1) of the Social Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(1)).
2. In 414.2, the definition of "Physician services" is amended by adding a new paragraph (8) to read as follows:
§ 414.2 Definitions.
Physician Services * * *
(8) Screening mammography services.
3. A new § 414.64 is added to read as follows:
§ 414.64 Payment for medical nutrition therapy.
(a) Payment under the physician fee schedule . Medicare payment for medical nutrition therapy is made under the physician fee schedule in accordance with subpart B of this part. Payment to non-physician professionals, as specified in paragraph (b) of this section, is the lesser of the actual charges or 80 percent of 85 percent of the physician fee schedule amount.
(b) To whom payment may be made . Payment may be made to a registered dietician or nutrition professional qualified to furnish medical nutrition therapy in accordance with part 410, subpart G of this chapter.
(c) Effective date of payment . Medicare pays suppliers of medical nutrition therapy on or after the effective date of enrollment of the supplier at the carrier.
(d) Limitation on payment . Payment is made only for documented nutritional therapy sessions actually attended by the beneficiary.
(e) Other conditions for fee-for-service payment . Payment is made only if the beneficiary:
(1) Is not an inpatient of a hospital, SNF, nursing home, or hospice.
(2) Is not receiving services in an RHC, FQHC or ESRD dialysis facility.
4. Section 414.65 is revised to read as follows:
§ 414.65 Payment for office or other outpatient visits, consultation, individual psychotherapy, and pharmacologic management via interactive telecommunications systems.
(a) Professional service . Medicare payment for the professional service via an interactive telecommunications system is made according to the following limitations:
(1) The Medicare payment amount for office or other outpatient visits, consultation, individual psychotherapy, and pharmacologic management via an interactive telecommunications system is equal to the current fee schedule amount applicable to services of the physician or practitioner.
(2) Only the physician or practitioner at the distant site may bill and receive payment for the professional service via an interactive telecommunications system.
(3) Payments made to the physician or practitioner at the distant site, including deductible and coinsurance, for the professional service may not be shared with the referring practitioner or telepresenter.
(b) Originating site facility fee . For office or other outpatient visits, consultation, individual psychotherapy, or pharmacologic management services delivered via an interactive telecommunications system furnished on or after October 1, 2001:
(1) For services furnished on or after October 1, 2001 through December 31, 2002, the payment amount to the originating site is the lesser of the actual charge or the originating site facility fee of $20. For services furnished on or after January 1 of each subsequent year, the facility fee for the originating site will be updated by the Medicare Economic Index (MEI) as defined in section 1842(i)(3) of the Act.
(2) Only the originating site may bill for the originating site facility fee and only on an assignment-related basis. The distant site physician or practitioner may not bill for or receive payment for facility fees associated with the professional service furnished via an interactive telecommunications system.
(c) Deductible and coinsurance apply . The payment for the professional service and originating site facility fee is subject to the coinsurance and deductible requirements of sections 1833(a)(1) and (b) of the Act.
(d) Assignment required for physicians, practitioners, and originating sites . Payment to physicians, practitioners, and originating sites is made only on an assignment-related basis.
(e) Sanctions . A distant site practitioner or originating site facility may be subject to the applicable sanctions provided for in chapter IV, part 402 and chapter V, parts 1001, 1002, and 1003 of this title if he or she does any of the following:
(1) Knowingly and willfully bills or collects for services in violation of the limitation of this section.
(2) Fails to timely correct excess charges by reducing the actual charge billed for the service in an amount that does not exceed the limiting charge for the service or fails to timely refund excess collections.
(3) Fails to submit a claim on a standard form for services provided for which payment is made on a fee schedule basis.
(4) Imposes a charge for completing and submitting the standard claims form.
PART 415-SERVICES FURNISHED BY PHYSICIANS IN PROVIDERS, SUPERVISING PHYSICIANS IN TEACHING SETTINGS, AND RESIDENTS IN CERTAIN SETTINGS
1. The authority citation for part 415 continues to read as follows:
Authority:
Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).
2. Section 415.130 is amended by:
A. Redesignating paragraphs (a), (b), and (c) as paragraphs (b), (c), and (d).
B. Adding a new paragraph (a).
C. Amending newly designated paragraph (b)(3) by removing the reference "paragraph (b)" and adding "paragraph (c)" in its place.
D. Amending newly designated paragraph (b)(4) by removing the reference "paragraphs (b)(1), (b)(3), and (b)(4)" and adding "paragraphs (c)(1), (c)(3), and (c)(4)" in their place.
E. Revising newly designated paragraph (d).
§ 415.130 Conditions for payment: Physician pathology services.
(a) Definitions . The following definitions are used in this section.
(1) Covered hospital means, with respect to an inpatient or an outpatient, a hospital that had an arrangement with an independent laboratory that was in effect as of July 22, 1999, under which a laboratory furnished the technical component of physician pathology services to fee-for-service Medicare beneficiaries who were hospital inpatients or outpatients, and submitted claims for payment for this technical component directly to a Medicare carrier.
(2) Fee-for-service Medicare beneficiaries means those beneficiaries who are entitled to benefits under Part A or are enrolled under Part B of Title XVIII of the Act or both and are not enrolled in any of the following:
(i) A Medicare+Choice plan under Part C of Title XVIII of the Act.
(ii) A plan offered by an eligible organization under section 1876 of the Act;
(iii) A program of all-inclusive care for the elderly (PACE) under 1894 of the Act; or
(iv) A social health maintenance organization (SHMO) demonstration project established under section 4018(b) of the Omnibus Budget Reconciliation Act of 1987.
(d) Physician pathology services furnished by an independent laboratory . The technical component of physician pathology services furnished by an independent laboratory to a hospital inpatient or outpatient before January 1, 2001 may be paid to the laboratory on a fee schedule basis. After December 31, 2000 but before January 1, 2003, if an independent laboratory furnishes the technical component of a physician pathology service to a fee-for-service Medicare beneficiary who is an inpatient or outpatient of a covered hospital, the carrier will treat the technical component as a service for which payment will be made to the laboratory under the physician fee schedule. For these two years the service will not be treated as an inpatient hospital service for which payment is made to the hospital under section 1886(d) of the Act or as an outpatient hospital service for which payment is made to the hospital under section 1833(t) of the Act. After December 31, 2002, the technical component for physician pathology services furnished by an independent laboratory to a hospital inpatient or outpatient is paid only to the hospital.
(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare-Supplementary Medical Insurance Program)
Dated: October 22, 2001.
Thomas A. Scully,
Administrator, Centers for Medicare Medicaid Services.
Approved: October 24, 2001.
Tommy G. Thompson,
Secretary.
Note:
These addenda will not appear in the Code of Federal Regulations.
Addendum A-Explanation and Use of Addenda B
The addenda on the following pages provide various data pertaining to the Medicare fee schedule for physicians' services furnished in 2002. Addendum B contains the RVUs for work, non-facility practice expense, facility practice expense, and malpractice expense, and other information for all services included in the physician fee schedule.
Addendum B-2002 Relative Value Units and Related Information Used in Determining Medicare Payments for 2002
This addendum contains the following information for each CPT code and alphanumeric HCPCS code, except for alphanumeric codes beginning with B (enteral and parenteral therapy), E (durable medical equipment), K (temporary codes for nonphysicians' services or items), or L (orthotics), and codes for anesthesiology.
1. CPT/HCPCS code. This is the CPT or alphanumeric HCPCS number for the service. Alphanumeric HCPCS codes are included at the end of this addendum.
2. Modifier. A modifier is shown if there is a technical component (modifier TC) and a professional component (PC) (modifier -26) for the service. If there is a PC and a TC for the service, Addendum B contains three entries for the code: One for the global values (both professional and technical); one for modifier -26 (PC); and one for modifier TC. The global service is not designated by a modifier, and physicians must bill using the code without a modifier if the physician furnishes both the PC and the TC of the service.
Modifier -53 is shown for a discontinued procedure. There will be RVUs for the code (CPT code 45378) with this modifier.
3. Status indicator. This indicator shows whether the CPT/HCPCS code is in the physician fee schedule and whether it is separately payable if the service is covered.
A = Active code. These codes are separately payable under the fee schedule if covered. There will be RVUs for codes with this status. The presence of an "A" indicator does not mean that Medicare has made a national decision regarding the coverage of the service. Carriers remain responsible for coverage decisions in the absence of a national Medicare policy.
B = Bundled code. Payment for covered services is always bundled into payment for other services not specified. If RVUs are shown, they are not used for Medicare payment. If these services are covered, payment for them is subsumed by the payment for the services to which they are incident. (An example is a telephone call from a hospital nurse regarding care of a patient.)
C = Carrier-priced code. Carriers will establish RVUs and payment amounts for these services, generally on a case-by-case basis following review of documentation, such as an operative report.
D = Deleted code. These codes are deleted effective with the beginning of the calendar year.
E = Excluded from physician fee schedule by regulation. These codes are for items or services that we chose to exclude from the physician fee schedule payment by regulation. No RVUs are shown, and no payment may be made under the physician fee schedule for these codes. Payment for them, if they are covered, continues under reasonable charge or other payment procedures.
G = Code not valid for Medicare purposes. Medicare does not recognize codes assigned this status. Medicare uses another code for reporting of, and payment for, these services.
H = Deleted modifier (code used to have modifier of TC and PC).
I = Code not valid for Medicare purposes. Medicare does not recognize codes assigned this status. Medicare uses another code for the reporting of, and payment for, these services. This indicator is treated in the same manner as status indicator "G". It's use allows for more efficient processing of Medicare claims.
N = Noncovered service. These codes are noncovered services. Medicare payment may not be made for these codes. If RVUs are shown, they are not used for Medicare payment.
P = Bundled or excluded code. There are no RVUs for these services. No separate payment should be made for them under the physician fee schedule.
-If the item or service is covered as incident to a physician's service and is furnished on the same day as a physician's service, payment for it is bundled into the payment for the physician's service to which it is incident (an example is an elastic bandage furnished by a physician incident to a physician's service).
-If the item or service is covered as other than incident to a physician's service, it is excluded from the physician fee schedule (for example, colostomy supplies) and is paid under the other payment provisions of the Act.
R = Restricted coverage. Special coverage instructions apply. If the service is covered and no RVUs are shown, it is carrier-priced.
T = There are RVUs for these services, but they are only paid if there are no other services payable under the physician fee schedule billed on the same date by the same provider. If any other services payable under the physician fee schedule are billed on the same date by the same provider, these services are bundled into the service(s) for which payment is made.
X = Exclusion by law. These codes represent an item or service that is not within the definition of "physicians' services" for physician fee schedule payment purposes. No RVUs are shown for these codes, and no payment may be made under the physician fee schedule. (Examples are ambulance services and clinical diagnostic laboratory services.)
4. Description of code. This is an abbreviated version of the narrative description of the code.
5. Physician work RVUs. These are the RVUs for the physician work for this service in 2000. Codes that are not used for Medicare payment are identified with a "+."
6. Facility practice expense RVUs. These are the fully implemented resource-based practice expense RVUs for facility settings.
7. Non-facility practice expense RVUs. These are the fully implemented resource-based practice expense RVUs for non-facility settings.
8. Malpractice expense RVUs. These are the RVUs for the malpractice expense for the service for 2000.
9. Facility total. This is the sum of the work, fully implemented facility practice expense, and malpractice expense RVUs.
10. Non-facility total. This is the sum of the work, fully implemented non-facility practice expense, and malpractice expense RVUs.
11. Global period. This indicator shows the number of days in the global period for the code (0, 10, or 90 days). An explanation of the alpha codes follows:
MMM = The code describes a service furnished in uncomplicated maternity cases including antepartum care, delivery, and postpartum care. The usual global surgical concept does not apply. See the 1999 Physicians' Current Procedural Terminology for specific definitions.
XXX = The global concept does not apply.
YYY = The global period is to be set by the carrier (for example, unlisted surgery codes).
ZZZ = The code is part of another service and falls within the global period for the other service.
----------
1 CPT codes and descriptions only are copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.2 Copyright 1994 American Dental Association. All rights reserved.3 +Indicates RVUs are not used for Medicare payment.
| CPT1 /HCPCS2 | MOD | Status | Description | Physician work RVUs3 | Fully implemented non-facility PE RVUs | Fully implemented facility PE RVUs | Mal- practice RVUs | Fully implemented non-facility total | Fully implemented facility total | Global | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0001T | C | Endovas repr abdo ao aneurys | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0002T | C | Endovas repr abdo ao aneurys | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0003T | C | Cervicography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0005T | C | Perc cath stent/brain cv art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0006T | C | Perc cath stent/brain cv art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0007T | C | Perc cath stent/brain cv art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0008T | C | Upper gi endoscopy w/suture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0009T | C | Endometrial cryoablation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0010T | C | Tb test, gamma interferon | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0012T | C | Osteochondral knee autograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0013T | C | Osteochondral knee allograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0014T | C | Meniscal transplant, knee | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0016T | C | Thermotx choroid vasc lesion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0017T | C | Photocoagulat macular drusen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0018T | C | Transcranial magnetic stimul | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0019T | C | Extracorp shock wave tx, ms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0020T | C | Extracorp shock wave tx, ft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0021T | C | Fetal oximetry, trnsvag/cerv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0023T | C | Phenotype drug test, hiv 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0024T | C | Transcath cardiac reduction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0025T | C | Ultrasonic pachymetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 0026T | C | Measure remnant lipoproteins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 10021 | A | Fna w/o image | 1.27 | 1.02 | NA | 0.10 | 2.39 | NA | XXX | ||||||||||||
| 10021 | 26 | A | Fna w/o image | 1.27 | 0.55 | 0.55 | 0.07 | 1.89 | 1.89 | XXX | |||||||||||
| 10021 | TC | A | Fna w/o image | 0.00 | 0.47 | NA | 0.03 | 0.50 | NA | XXX | |||||||||||
| 10022 | A | Fna w/image | 1.27 | 1.11 | NA | 0.08 | 2.46 | NA | XXX | ||||||||||||
| 10022 | 26 | A | Fna w/image | 1.27 | 0.48 | 0.48 | 0.05 | 1.80 | 1.80 | XXX | |||||||||||
| 10022 | TC | A | Fna w/image | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 10040 | A | Acne surgery | 1.18 | 1.00 | 0.54 | 0.05 | 2.23 | 1.77 | 010 | ||||||||||||
| 10060 | A | Drainage of skin abscess | 1.17 | 1.51 | 0.70 | 0.08 | 2.76 | 1.95 | 010 | ||||||||||||
| 10061 | A | Drainage of skin abscess | 2.40 | 1.88 | 1.48 | 0.17 | 4.45 | 4.05 | 010 | ||||||||||||
| 10080 | A | Drainage of pilonidal cyst | 1.17 | 2.18 | 0.75 | 0.09 | 3.44 | 2.01 | 010 | ||||||||||||
| 10081 | A | Drainage of pilonidal cyst | 2.45 | 3.02 | 1.61 | 0.19 | 5.66 | 4.25 | 010 | ||||||||||||
| 10120 | A | Remove foreign body | 1.22 | 1.52 | 0.36 | 0.10 | 2.84 | 1.68 | 010 | ||||||||||||
| 10121 | A | Remove foreign body | 2.69 | 2.99 | 1.83 | 0.25 | 5.93 | 4.77 | 010 | ||||||||||||
| 10140 | A | Drainage of hematoma/fluid | 1.53 | 1.54 | 0.90 | 0.15 | 3.22 | 2.58 | 010 | ||||||||||||
| 10160 | A | Puncture drainage of lesion | 1.20 | 0.74 | 0.43 | 0.11 | 2.05 | 1.74 | 010 | ||||||||||||
| 10180 | A | Complex drainage, wound | 2.25 | 1.51 | 1.33 | 0.25 | 4.01 | 3.83 | 010 | ||||||||||||
| 11000 | A | Debride infected skin | 0.60 | 0.66 | 0.24 | 0.05 | 1.31 | 0.89 | 000 | ||||||||||||
| 11001 | A | Debride infected skin add-on | 0.30 | 0.37 | 0.11 | 0.02 | 0.69 | 0.43 | ZZZ | ||||||||||||
| 11010 | A | Debride skin, fx | 4.20 | 2.53 | 2.10 | 0.45 | 7.18 | 6.75 | 010 | ||||||||||||
| 11011 | A | Debride skin/muscle, fx | 4.95 | 3.90 | 2.69 | 0.53 | 9.38 | 8.17 | 000 | ||||||||||||
| 11012 | A | Debride skin/muscle/bone, fx | 6.88 | 5.52 | 4.35 | 0.89 | 13.29 | 12.12 | 000 | ||||||||||||
| 11040 | A | Debride skin, partial | 0.50 | 0.55 | 0.22 | 0.05 | 1.10 | 0.77 | 000 | ||||||||||||
| 11041 | A | Debride skin, full | 0.82 | 0.69 | 0.34 | 0.08 | 1.59 | 1.24 | 000 | ||||||||||||
| 11042 | A | Debride skin/tissue | 1.12 | 1.04 | 0.47 | 0.11 | 2.27 | 1.70 | 000 | ||||||||||||
| 11043 | A | Debride tissue/muscle | 2.38 | 2.72 | 1.42 | 0.24 | 5.34 | 4.04 | 010 | ||||||||||||
| 11044 | A | Debride tissue/muscle/bone | 3.06 | 3.30 | 1.86 | 0.34 | 6.70 | 5.26 | 010 | ||||||||||||
| 11055 | R | Trim skin lesion | 0.43 | 0.52 | 0.19 | 0.02 | 0.97 | 0.64 | 000 | ||||||||||||
| 11056 | R | Trim skin lesions, 2 to 4 | 0.61 | 0.59 | 0.26 | 0.03 | 1.23 | 0.90 | 000 | ||||||||||||
| 11057 | R | Trim skin lesions, over 4 | 0.79 | 0.66 | 0.34 | 0.04 | 1.49 | 1.17 | 000 | ||||||||||||
| 11100 | A | Biopsy of skin lesion | 0.81 | 1.49 | 0.38 | 0.04 | 2.34 | 1.23 | 000 | ||||||||||||
| 11101 | A | Biopsy, skin add-on | 0.41 | 0.71 | 0.20 | 0.02 | 1.14 | 0.63 | ZZZ | ||||||||||||
| 11200 | A | Removal of skin tags | 0.77 | 1.20 | 0.32 | 0.04 | 2.01 | 1.13 | 010 | ||||||||||||
| 11201 | A | Remove skin tags add-on | 0.29 | 0.53 | 0.12 | 0.02 | 0.84 | 0.43 | ZZZ | ||||||||||||
| 11300 | A | Shave skin lesion | 0.51 | 1.05 | 0.22 | 0.03 | 1.59 | 0.76 | 000 | ||||||||||||
| 11301 | A | Shave skin lesion | 0.85 | 1.12 | 0.39 | 0.04 | 2.01 | 1.28 | 000 | ||||||||||||
| 11302 | A | Shave skin lesion | 1.05 | 1.21 | 0.49 | 0.05 | 2.31 | 1.59 | 000 | ||||||||||||
| 11303 | A | Shave skin lesion | 1.24 | 1.36 | 0.55 | 0.06 | 2.66 | 1.85 | 000 | ||||||||||||
| 11305 | A | Shave skin lesion | 0.67 | 0.77 | 0.29 | 0.04 | 1.48 | 1.00 | 000 | ||||||||||||
| 11306 | A | Shave skin lesion | 0.99 | 1.02 | 0.44 | 0.05 | 2.06 | 1.48 | 000 | ||||||||||||
| 11307 | A | Shave skin lesion | 1.14 | 1.15 | 0.51 | 0.05 | 2.34 | 1.70 | 000 | ||||||||||||
| 11308 | A | Shave skin lesion | 1.41 | 1.29 | 0.62 | 0.07 | 2.77 | 2.10 | 000 | ||||||||||||
| 11310 | A | Shave skin lesion | 0.73 | 1.15 | 0.34 | 0.04 | 1.92 | 1.11 | 000 | ||||||||||||
| 11311 | A | Shave skin lesion | 1.05 | 1.24 | 0.51 | 0.05 | 2.34 | 1.61 | 000 | ||||||||||||
| 11312 | A | Shave skin lesion | 1.20 | 1.32 | 0.58 | 0.06 | 2.58 | 1.84 | 000 | ||||||||||||
| 11313 | A | Shave skin lesion | 1.62 | 1.63 | 0.74 | 0.09 | 3.34 | 2.45 | 000 | ||||||||||||
| 11400 | A | Removal of skin lesion | 0.91 | 1.68 | 0.36 | 0.06 | 2.65 | 1.33 | 010 | ||||||||||||
| 11401 | A | Removal of skin lesion | 1.32 | 1.83 | 0.53 | 0.09 | 3.24 | 1.94 | 010 | ||||||||||||
| 11402 | A | Removal of skin lesion | 1.61 | 2.61 | 0.98 | 0.12 | 4.34 | 2.71 | 010 | ||||||||||||
| 11403 | A | Removal of skin lesion | 1.92 | 2.84 | 1.12 | 0.16 | 4.92 | 3.20 | 010 | ||||||||||||
| 11404 | A | Removal of skin lesion | 2.20 | 3.02 | 1.19 | 0.18 | 5.40 | 3.57 | 010 | ||||||||||||
| 11406 | A | Removal of skin lesion | 2.76 | 3.33 | 1.41 | 0.25 | 6.34 | 4.42 | 010 | ||||||||||||
| 11420 | A | Removal of skin lesion | 1.06 | 1.52 | 0.44 | 0.08 | 2.66 | 1.58 | 010 | ||||||||||||
| 11421 | A | Removal of skin lesion | 1.53 | 1.84 | 0.64 | 0.11 | 3.48 | 2.28 | 010 | ||||||||||||
| 11422 | A | Removal of skin lesion | 1.76 | 2.60 | 1.08 | 0.14 | 4.50 | 2.98 | 010 | ||||||||||||
| 11423 | A | Removal of skin lesion | 2.17 | 3.02 | 1.26 | 0.17 | 5.36 | 3.60 | 010 | ||||||||||||
| 11424 | A | Removal of skin lesion | 2.62 | 3.20 | 1.43 | 0.21 | 6.03 | 4.26 | 010 | ||||||||||||
| 11426 | A | Removal of skin lesion | 3.78 | 3.81 | 1.89 | 0.34 | 7.93 | 6.01 | 010 | ||||||||||||
| 11440 | A | Removal of skin lesion | 1.15 | 2.26 | 0.53 | 0.08 | 3.49 | 1.76 | 010 | ||||||||||||
| 11441 | A | Removal of skin lesion | 1.61 | 2.48 | 0.74 | 0.11 | 4.20 | 2.46 | 010 | ||||||||||||
| 11442 | A | Removal of skin lesion | 1.87 | 2.91 | 1.30 | 0.14 | 4.92 | 3.31 | 010 | ||||||||||||
| 11443 | A | Removal of skin lesion | 2.49 | 3.41 | 1.64 | 0.18 | 6.08 | 4.31 | 010 | ||||||||||||
| 11444 | A | Removal of skin lesion | 3.42 | 3.92 | 2.08 | 0.25 | 7.59 | 5.75 | 010 | ||||||||||||
| 11446 | A | Removal of skin lesion | 4.49 | 4.37 | 2.58 | 0.30 | 9.16 | 7.37 | 010 | ||||||||||||
| 11450 | A | Removal, sweat gland lesion | 2.73 | 4.20 | 1.03 | 0.26 | 7.19 | 4.02 | 090 | ||||||||||||
| 11451 | A | Removal, sweat gland lesion | 3.95 | 5.23 | 1.33 | 0.39 | 9.57 | 5.67 | 090 | ||||||||||||
| 11462 | A | Removal, sweat gland lesion | 2.51 | 4.32 | 0.98 | 0.23 | 7.06 | 3.72 | 090 | ||||||||||||
| 11463 | A | Removal, sweat gland lesion | 3.95 | 5.67 | 1.67 | 0.40 | 10.02 | 6.02 | 090 | ||||||||||||
| 11470 | A | Removal, sweat gland lesion | 3.25 | 4.97 | 1.26 | 0.30 | 8.52 | 4.81 | 090 | ||||||||||||
| 11471 | A | Removal, sweat gland lesion | 4.41 | 5.54 | 1.74 | 0.40 | 10.35 | 6.55 | 090 | ||||||||||||
| 11600 | A | Removal of skin lesion | 1.41 | 2.48 | 1.08 | 0.09 | 3.98 | 2.58 | 010 | ||||||||||||
| 11601 | A | Removal of skin lesion | 1.93 | 2.52 | 1.36 | 0.12 | 4.57 | 3.41 | 010 | ||||||||||||
| 11602 | A | Removal of skin lesion | 2.09 | 2.66 | 1.40 | 0.13 | 4.88 | 3.62 | 010 | ||||||||||||
| 11603 | A | Removal of skin lesion | 2.35 | 2.93 | 1.49 | 0.16 | 5.44 | 4.00 | 010 | ||||||||||||
| 11604 | A | Removal of skin lesion | 2.58 | 3.27 | 1.56 | 0.18 | 6.03 | 4.32 | 010 | ||||||||||||
| 11606 | A | Removal of skin lesion | 3.43 | 3.88 | 1.85 | 0.28 | 7.59 | 5.56 | 010 | ||||||||||||
| 11620 | A | Removal of skin lesion | 1.34 | 2.47 | 1.09 | 0.09 | 3.90 | 2.52 | 010 | ||||||||||||
| 11621 | A | Removal of skin lesion | 1.97 | 2.56 | 1.41 | 0.12 | 4.65 | 3.50 | 010 | ||||||||||||
| 11622 | A | Removal of skin lesion | 2.34 | 2.87 | 1.60 | 0.15 | 5.36 | 4.09 | 010 | ||||||||||||
| 11623 | A | Removal of skin lesion | 2.93 | 3.30 | 1.86 | 0.20 | 6.43 | 4.99 | 010 | ||||||||||||
| 11624 | A | Removal of skin lesion | 3.43 | 3.72 | 2.08 | 0.25 | 7.40 | 5.76 | 010 | ||||||||||||
| 11626 | A | Removal of skin lesion | 4.30 | 4.48 | 2.57 | 0.35 | 9.13 | 7.22 | 010 | ||||||||||||
| 11640 | A | Removal of skin lesion | 1.53 | 2.51 | 1.29 | 0.10 | 4.14 | 2.92 | 010 | ||||||||||||
| 11641 | A | Removal of skin lesion | 2.44 | 2.94 | 1.78 | 0.15 | 5.53 | 4.37 | 010 | ||||||||||||
| 11642 | A | Removal of skin lesion | 2.93 | 3.37 | 2.03 | 0.18 | 6.48 | 5.14 | 010 | ||||||||||||
| 11643 | A | Removal of skin lesion | 3.50 | 3.83 | 2.32 | 0.24 | 7.57 | 6.06 | 010 | ||||||||||||
| 11644 | A | Removal of skin lesion | 4.55 | 4.81 | 2.95 | 0.33 | 9.69 | 7.83 | 010 | ||||||||||||
| 11646 | A | Removal of skin lesion | 5.95 | 5.68 | 3.77 | 0.46 | 12.09 | 10.18 | 010 | ||||||||||||
| 11719 | R | Trim nail(s) | 0.17 | 0.25 | 0.07 | 0.01 | 0.43 | 0.25 | 000 | ||||||||||||
| 11720 | A | Debride nail, 1-5 | 0.32 | 0.34 | 0.13 | 0.02 | 0.68 | 0.47 | 000 | ||||||||||||
| 11721 | A | Debride nail, 6 or more | 0.54 | 0.44 | 0.22 | 0.04 | 1.02 | 0.80 | 000 | ||||||||||||
| 11730 | A | Removal of nail plate | 1.13 | 0.83 | 0.46 | 0.09 | 2.05 | 1.68 | 000 | ||||||||||||
| 11732 | A | Remove nail plate, add-on | 0.57 | 0.30 | 0.24 | 0.05 | 0.92 | 0.86 | ZZZ | ||||||||||||
| 11740 | A | Drain blood from under nail | 0.37 | 0.81 | 0.14 | 0.03 | 1.21 | 0.54 | 000 | ||||||||||||
| 11750 | A | Removal of nail bed | 1.86 | 1.75 | 0.78 | 0.16 | 3.77 | 2.80 | 010 | ||||||||||||
| 11752 | A | Remove nail bed/finger tip | 2.67 | 2.20 | 1.77 | 0.33 | 5.20 | 4.77 | 010 | ||||||||||||
| 11755 | A | Biopsy, nail unit | 1.31 | 1.10 | 0.60 | 0.06 | 2.47 | 1.97 | 000 | ||||||||||||
| 11760 | A | Repair of nail bed | 1.58 | 1.80 | 1.28 | 0.17 | 3.55 | 3.03 | 010 | ||||||||||||
| 11762 | A | Reconstruction of nail bed | 2.89 | 2.28 | 1.95 | 0.32 | 5.49 | 5.16 | 010 | ||||||||||||
| 11765 | A | Excision of nail fold, toe | 0.69 | 1.14 | 0.51 | 0.05 | 1.88 | 1.25 | 010 | ||||||||||||
| 11770 | A | Removal of pilonidal lesion | 2.61 | 3.11 | 1.26 | 0.24 | 5.96 | 4.11 | 010 | ||||||||||||
| 11771 | A | Removal of pilonidal lesion | 5.74 | 5.80 | 4.01 | 0.56 | 12.10 | 10.31 | 090 | ||||||||||||
| 11772 | A | Removal of pilonidal lesion | 6.98 | 6.95 | 4.44 | 0.68 | 14.61 | 12.10 | 090 | ||||||||||||
| 11900 | A | Injection into skin lesions | 0.52 | 0.77 | 0.23 | 0.02 | 1.31 | 0.77 | 000 | ||||||||||||
| 11901 | A | Added skin lesions injection | 0.80 | 0.89 | 0.38 | 0.03 | 1.72 | 1.21 | 000 | ||||||||||||
| 11920 | R | Correct skin color defects | 1.61 | 2.25 | 0.81 | 0.17 | 4.03 | 2.59 | 000 | ||||||||||||
| 11921 | R | Correct skin color defects | 1.93 | 2.78 | 1.02 | 0.21 | 4.92 | 3.16 | 000 | ||||||||||||
| 11922 | R | Correct skin color defects | 0.49 | 0.40 | 0.26 | 0.05 | 0.94 | 0.80 | ZZZ | ||||||||||||
| 11950 | R | Therapy for contour defects | 0.84 | 1.23 | 0.47 | 0.06 | 2.13 | 1.37 | 000 | ||||||||||||
| 11951 | R | Therapy for contour defects | 1.19 | 1.47 | 0.49 | 0.10 | 2.76 | 1.78 | 000 | ||||||||||||
| 11952 | R | Therapy for contour defects | 1.69 | 1.65 | 0.64 | 0.17 | 3.51 | 2.50 | 000 | ||||||||||||
| 11954 | R | Therapy for contour defects | 1.85 | 2.62 | 0.97 | 0.19 | 4.66 | 3.01 | 000 | ||||||||||||
| 11960 | A | Insert tissue expander(s) | 9.08 | NA | 11.54 | 0.88 | NA | 21.50 | 090 | ||||||||||||
| 11970 | A | Replace tissue expander | 7.06 | NA | 5.15 | 0.77 | NA | 12.98 | 090 | ||||||||||||
| 11971 | A | Remove tissue expander(s) | 2.13 | 6.10 | 4.07 | 0.21 | 8.44 | 6.41 | 090 | ||||||||||||
| 11975 | N | Insert contraceptive cap | +1.48 | 1.58 | 0.59 | 0.14 | 3.20 | 2.21 | XXX | ||||||||||||
| 11976 | R | Removal of contraceptive cap | 1.78 | 1.72 | 0.69 | 0.17 | 3.67 | 2.64 | 000 | ||||||||||||
| 11977 | N | Removal/reinsert contra cap | +3.30 | 2.31 | 1.32 | 0.31 | 5.92 | 4.93 | XXX | ||||||||||||
| 11980 | A | Implant hormone pellet(s) | 1.48 | 1.14 | 0.58 | 0.10 | 2.72 | 2.16 | 000 | ||||||||||||
| 11981 | A | Insert drug implant device | 1.48 | 1.58 | 0.59 | 0.14 | 3.20 | 2.21 | XXX | ||||||||||||
| 11982 | A | Remove drug implant device | 1.78 | 1.70 | 0.71 | 0.17 | 3.65 | 2.66 | XXX | ||||||||||||
| 11983 | A | Remove/insert drug implant | 3.30 | 2.31 | 1.32 | 0.31 | 5.92 | 4.93 | XXX | ||||||||||||
| 12001 | A | Repair superficial wound(s) | 1.70 | 2.13 | 0.44 | 0.13 | 3.96 | 2.27 | 010 | ||||||||||||
| 12002 | A | Repair superficial wound(s) | 1.86 | 2.21 | 0.95 | 0.15 | 4.22 | 2.96 | 010 | ||||||||||||
| 12004 | A | Repair superficial wound(s) | 2.24 | 2.47 | 1.07 | 0.17 | 4.88 | 3.48 | 010 | ||||||||||||
| 12005 | A | Repair superficial wound(s) | 2.86 | 3.04 | 1.25 | 0.23 | 6.13 | 4.34 | 010 | ||||||||||||
| 12006 | A | Repair superficial wound(s) | 3.67 | 3.59 | 1.59 | 0.31 | 7.57 | 5.57 | 010 | ||||||||||||
| 12007 | A | Repair superficial wound(s) | 4.12 | 4.26 | 1.85 | 0.37 | 8.75 | 6.34 | 010 | ||||||||||||
| 12011 | A | Repair superficial wound(s) | 1.76 | 2.30 | 0.45 | 0.14 | 4.20 | 2.35 | 010 | ||||||||||||
| 12013 | A | Repair superficial wound(s) | 1.99 | 2.45 | 0.99 | 0.16 | 4.60 | 3.14 | 010 | ||||||||||||
| 12014 | A | Repair superficial wound(s) | 2.46 | 2.72 | 1.11 | 0.18 | 5.36 | 3.75 | 010 | ||||||||||||
| 12015 | A | Repair superficial wound(s) | 3.19 | 3.38 | 1.31 | 0.24 | 6.81 | 4.74 | 010 | ||||||||||||
| 12016 | A | Repair superficial wound(s) | 3.93 | 3.89 | 1.58 | 0.32 | 8.14 | 5.83 | 010 | ||||||||||||
| 12017 | A | Repair superficial wound(s) | 4.71 | NA | 1.93 | 0.39 | NA | 7.03 | 010 | ||||||||||||
| 12018 | A | Repair superficial wound(s) | 5.53 | NA | 2.18 | 0.46 | NA | 8.17 | 010 | ||||||||||||
| 12020 | A | Closure of split wound | 2.62 | 2.51 | 1.44 | 0.24 | 5.37 | 4.30 | 010 | ||||||||||||
| 12021 | A | Closure of split wound | 1.84 | 1.65 | 1.02 | 0.19 | 3.68 | 3.05 | 010 | ||||||||||||
| 12031 | A | Layer closure of wound(s) | 2.15 | 2.21 | 0.81 | 0.15 | 4.51 | 3.11 | 010 | ||||||||||||
| 12032 | A | Layer closure of wound(s) | 2.47 | 2.84 | 1.36 | 0.15 | 5.46 | 3.98 | 010 | ||||||||||||
| 12034 | A | Layer closure of wound(s) | 2.92 | 3.12 | 1.51 | 0.21 | 6.25 | 4.64 | 010 | ||||||||||||
| 12035 | A | Layer closure of wound(s) | 3.43 | 3.20 | 1.73 | 0.30 | 6.93 | 5.46 | 010 | ||||||||||||
| 12036 | A | Layer closure of wound(s) | 4.05 | 5.33 | 2.50 | 0.41 | 9.79 | 6.96 | 010 | ||||||||||||
| 12037 | A | Layer closure of wound(s) | 4.67 | 5.57 | 2.86 | 0.49 | 10.73 | 8.02 | 010 | ||||||||||||
| 12041 | A | Layer closure of wound(s) | 2.37 | 2.41 | 0.87 | 0.17 | 4.95 | 3.41 | 010 | ||||||||||||
| 12042 | A | Layer closure of wound(s) | 2.74 | 3.03 | 1.49 | 0.17 | 5.94 | 4.40 | 010 | ||||||||||||
| 12044 | A | Layer closure of wound(s) | 3.14 | 3.22 | 1.67 | 0.24 | 6.60 | 5.05 | 010 | ||||||||||||
| 12045 | A | Layer closure of wound(s) | 3.64 | 3.54 | 1.93 | 0.34 | 7.52 | 5.91 | 010 | ||||||||||||
| 12046 | A | Layer closure of wound(s) | 4.25 | 6.24 | 2.62 | 0.40 | 10.89 | 7.27 | 010 | ||||||||||||
| 12047 | A | Layer closure of wound(s) | 4.65 | 7.21 | 2.86 | 0.41 | 12.27 | 7.92 | 010 | ||||||||||||
| 12051 | A | Layer closure of wound(s) | 2.47 | 3.11 | 1.49 | 0.16 | 5.74 | 4.12 | 010 | ||||||||||||
| 12052 | A | Layer closure of wound(s) | 2.77 | 3.00 | 1.47 | 0.17 | 5.94 | 4.41 | 010 | ||||||||||||
| 12053 | A | Layer closure of wound(s) | 3.12 | 3.20 | 1.63 | 0.20 | 6.52 | 4.95 | 010 | ||||||||||||
| 12054 | A | Layer closure of wound(s) | 3.46 | 3.52 | 1.72 | 0.25 | 7.23 | 5.43 | 010 | ||||||||||||
| 12055 | A | Layer closure of wound(s) | 4.43 | 4.49 | 2.27 | 0.35 | 9.27 | 7.05 | 010 | ||||||||||||
| 12056 | A | Layer closure of wound(s) | 5.24 | 7.31 | 3.26 | 0.43 | 12.98 | 8.93 | 010 | ||||||||||||
| 12057 | A | Layer closure of wound(s) | 5.96 | 6.31 | 3.66 | 0.50 | 12.77 | 10.12 | 010 | ||||||||||||
| 13100 | A | Repair of wound or lesion | 3.12 | 3.39 | 1.93 | 0.21 | 6.72 | 5.26 | 010 | ||||||||||||
| 13101 | A | Repair of wound or lesion | 3.92 | 3.59 | 2.39 | 0.22 | 7.73 | 6.53 | 010 | ||||||||||||
| 13102 | A | Repair wound/lesion add-on | 1.24 | 0.75 | 0.60 | 0.10 | 2.09 | 1.94 | ZZZ | ||||||||||||
| 13120 | A | Repair of wound or lesion | 3.30 | 3.48 | 1.95 | 0.23 | 7.01 | 5.48 | 010 | ||||||||||||
| 13121 | A | Repair of wound or lesion | 4.33 | 3.84 | 2.52 | 0.25 | 8.42 | 7.10 | 010 | ||||||||||||
| 13122 | A | Repair wound/lesion add-on | 1.44 | 0.89 | 0.67 | 0.12 | 2.45 | 2.23 | ZZZ | ||||||||||||
| 13131 | A | Repair of wound or lesion | 3.79 | 3.75 | 2.30 | 0.25 | 7.79 | 6.34 | 010 | ||||||||||||
| 13132 | A | Repair of wound or lesion | 5.95 | 4.57 | 3.38 | 0.32 | 10.84 | 9.65 | 010 | ||||||||||||
| 13133 | A | Repair wound/lesion add-on | 2.19 | 1.23 | 1.08 | 0.17 | 3.59 | 3.44 | ZZZ | ||||||||||||
| 13150 | A | Repair of wound or lesion | 3.81 | 5.19 | 2.75 | 0.29 | 9.29 | 6.85 | 010 | ||||||||||||
| 13151 | A | Repair of wound or lesion | 4.45 | 5.07 | 3.19 | 0.28 | 9.80 | 7.92 | 010 | ||||||||||||
| 13152 | A | Repair of wound or lesion | 6.33 | 5.78 | 4.14 | 0.38 | 12.49 | 10.85 | 010 | ||||||||||||
| 13153 | A | Repair wound/lesion add-on | 2.38 | 1.38 | 1.20 | 0.18 | 3.94 | 3.76 | ZZZ | ||||||||||||
| 13160 | A | Late closure of wound | 10.48 | NA | 6.47 | 1.19 | NA | 18.14 | 090 | ||||||||||||
| 14000 | A | Skin tissue rearrangement | 5.89 | 7.58 | 4.83 | 0.46 | 13.93 | 11.18 | 090 | ||||||||||||
| 14001 | A | Skin tissue rearrangement | 8.47 | 8.72 | 6.18 | 0.65 | 17.84 | 15.30 | 090 | ||||||||||||
| 14020 | A | Skin tissue rearrangement | 6.59 | 8.05 | 5.56 | 0.50 | 15.14 | 12.65 | 090 | ||||||||||||
| 14021 | A | Skin tissue rearrangement | 10.06 | 9.29 | 7.38 | 0.69 | 20.04 | 18.13 | 090 | ||||||||||||
| 14040 | A | Skin tissue rearrangement | 7.87 | 8.19 | 6.27 | 0.53 | 16.59 | 14.67 | 090 | ||||||||||||
| 14041 | A | Skin tissue rearrangement | 11.49 | 9.90 | 8.17 | 0.68 | 22.07 | 20.34 | 090 | ||||||||||||
| 14060 | A | Skin tissue rearrangement | 8.50 | 8.64 | 7.13 | 0.59 | 17.73 | 16.22 | 090 | ||||||||||||
| 14061 | A | Skin tissue rearrangement | 12.29 | 10.85 | 9.08 | 0.75 | 23.89 | 22.12 | 090 | ||||||||||||
| 14300 | A | Skin tissue rearrangement | 11.76 | 10.11 | 8.68 | 0.88 | 22.75 | 21.32 | 090 | ||||||||||||
| 14350 | A | Skin tissue rearrangement | 9.61 | NA | 6.48 | 1.09 | NA | 17.18 | 090 | ||||||||||||
| 15000 | A | Skin graft | 4.00 | 2.51 | 1.91 | 0.37 | 6.88 | 6.28 | 000 | ||||||||||||
| 15001 | A | Skin graft add-on | 1.00 | 0.64 | 0.43 | 0.11 | 1.75 | 1.54 | ZZZ | ||||||||||||
| 15050 | A | Skin pinch graft | 4.30 | 4.98 | 4.12 | 0.46 | 9.74 | 8.88 | 090 | ||||||||||||
| 15100 | A | Skin split graft | 9.05 | 6.27 | 6.26 | 0.94 | 16.26 | 16.25 | 090 | ||||||||||||
| 15101 | A | Skin split graft add-on | 1.72 | 1.40 | 0.76 | 0.18 | 3.30 | 2.66 | ZZZ | ||||||||||||
| 15120 | A | Skin split graft | 9.83 | 8.62 | 6.97 | 0.87 | 19.32 | 17.67 | 090 | ||||||||||||
| 15121 | A | Skin split graft add-on | 2.67 | 1.83 | 1.23 | 0.27 | 4.77 | 4.17 | ZZZ | ||||||||||||
| 15200 | A | Skin full graft | 8.03 | 9.90 | 5.64 | 0.73 | 18.66 | 14.40 | 090 | ||||||||||||
| 15201 | A | Skin full graft add-on | 1.32 | 1.00 | 0.68 | 0.14 | 2.46 | 2.14 | ZZZ | ||||||||||||
| 15220 | A | Skin full graft | 7.87 | 9.38 | 6.47 | 0.68 | 17.93 | 15.02 | 090 | ||||||||||||
| 15221 | A | Skin full graft add-on | 1.19 | 0.92 | 0.60 | 0.12 | 2.23 | 1.91 | ZZZ | ||||||||||||
| 15240 | A | Skin full graft | 9.04 | 9.01 | 7.27 | 0.77 | 18.82 | 17.08 | 090 | ||||||||||||
| 15241 | A | Skin full graft add-on | 1.86 | 1.47 | 0.95 | 0.17 | 3.50 | 2.98 | ZZZ | ||||||||||||
| 15260 | A | Skin full graft | 10.06 | 9.01 | 7.74 | 0.63 | 19.70 | 18.43 | 090 | ||||||||||||
| 15261 | A | Skin full graft add-on | 2.23 | 1.59 | 1.16 | 0.17 | 3.99 | 3.56 | ZZZ | ||||||||||||
| 15342 | A | Cultured skin graft, 25 cm | 1.00 | 2.18 | 1.04 | 0.09 | 3.27 | 2.13 | 010 | ||||||||||||
| 15343 | A | Cultured skin graft addl 25 cm | 0.25 | 0.42 | 0.10 | 0.02 | 0.69 | 0.37 | ZZZ | ||||||||||||
| 15350 | A | Skin homograft | 4.00 | 7.78 | 4.23 | 0.42 | 12.20 | 8.65 | 090 | ||||||||||||
| 15351 | A | Skin homograft add-on | 1.00 | 0.85 | 0.42 | 0.11 | 1.96 | 1.53 | ZZZ | ||||||||||||
| 15400 | A | Skin heterograft | 4.00 | 4.89 | 4.89 | 0.40 | 9.29 | 9.29 | 090 | ||||||||||||
| 15401 | A | Skin heterograft add-on | 1.00 | 1.59 | 0.47 | 0.11 | 2.70 | 1.58 | ZZZ | ||||||||||||
| 15570 | A | Form skin pedicle flap | 9.21 | 7.80 | 6.37 | 0.96 | 17.97 | 16.54 | 090 | ||||||||||||
| 15572 | A | Form skin pedicle flap | 9.27 | 8.08 | 6.34 | 0.93 | 18.28 | 16.54 | 090 | ||||||||||||
| 15574 | A | Form skin pedicle flap | 9.88 | 8.61 | 7.14 | 0.92 | 19.41 | 17.94 | 090 | ||||||||||||
| 15576 | A | Form skin pedicle flap | 8.69 | 8.89 | 6.55 | 0.72 | 18.30 | 15.96 | 090 | ||||||||||||
| 15600 | A | Skin graft | 1.91 | 6.66 | 2.51 | 0.19 | 8.76 | 4.61 | 090 | ||||||||||||
| 15610 | A | Skin graft | 2.42 | 5.90 | 2.67 | 0.25 | 8.57 | 5.34 | 090 | ||||||||||||
| 15620 | A | Skin graft | 2.94 | 7.04 | 3.54 | 0.28 | 10.26 | 6.76 | 090 | ||||||||||||
| 15630 | A | Skin graft | 3.27 | 6.09 | 3.83 | 0.28 | 9.64 | 7.38 | 090 | ||||||||||||
| 15650 | A | Transfer skin pedicle flap | 3.97 | 5.69 | 3.99 | 0.36 | 10.02 | 8.32 | 090 | ||||||||||||
| 15732 | A | Muscle-skin graft, head/neck | 17.84 | NA | 11.63 | 1.50 | NA | 30.97 | 090 | ||||||||||||
| 15734 | A | Muscle-skin graft, trunk | 17.79 | NA | 11.49 | 1.91 | NA | 31.19 | 090 | ||||||||||||
| 15736 | A | Muscle-skin graft, arm | 16.27 | NA | 11.14 | 1.78 | NA | 29.19 | 090 | ||||||||||||
| 15738 | A | Muscle-skin graft, leg | 17.92 | NA | 11.47 | 1.95 | NA | 31.34 | 090 | ||||||||||||
| 15740 | A | Island pedicle flap graft | 10.25 | 8.74 | 7.20 | 0.62 | 19.61 | 18.07 | 090 | ||||||||||||
| 15750 | A | Neurovascular pedicle graft | 11.41 | NA | 8.45 | 1.12 | NA | 20.98 | 090 | ||||||||||||
| 15756 | A | Free muscle flap, microvasc | 35.23 | NA | 22.50 | 3.11 | NA | 60.84 | 090 | ||||||||||||
| 15757 | A | Free skin flap, microvasc | 35.23 | NA | 22.54 | 3.37 | NA | 61.14 | 090 | ||||||||||||
| 15758 | A | Free fascial flap, microvasc | 35.10 | NA | 22.75 | 3.52 | NA | 61.37 | 090 | ||||||||||||
| 15760 | A | Composite skin graft | 8.74 | 9.27 | 6.93 | 0.72 | 18.73 | 16.39 | 090 | ||||||||||||
| 15770 | A | Derma-fat-fascia graft | 7.52 | NA | 6.14 | 0.78 | NA | 14.44 | 090 | ||||||||||||
| 15775 | R | Hair transplant punch grafts | 3.96 | 3.12 | 1.60 | 0.43 | 7.51 | 5.99 | 000 | ||||||||||||
| 15776 | R | Hair transplant punch grafts | 5.54 | 3.97 | 2.97 | 0.60 | 10.11 | 9.11 | 000 | ||||||||||||
| 15780 | A | Abrasion treatment of skin | 7.29 | 6.41 | 6.13 | 0.41 | 14.11 | 13.83 | 090 | ||||||||||||
| 15781 | A | Abrasion treatment of skin | 4.85 | 5.17 | 4.83 | 0.27 | 10.29 | 9.95 | 090 | ||||||||||||
| 15782 | A | Abrasion treatment of skin | 4.32 | 4.37 | 4.09 | 0.21 | 8.90 | 8.62 | 090 | ||||||||||||
| 15783 | A | Abrasion treatment of skin | 4.29 | 5.02 | 3.51 | 0.26 | 9.57 | 8.06 | 090 | ||||||||||||
| 15786 | A | Abrasion, lesion, single | 2.03 | 1.73 | 1.29 | 0.11 | 3.87 | 3.43 | 010 | ||||||||||||
| 15787 | A | Abrasion, lesions, add-on | 0.33 | 0.39 | 0.18 | 0.02 | 0.74 | 0.53 | ZZZ | ||||||||||||
| 15788 | R | Chemical peel, face, epiderm | 2.09 | 3.15 | 1.07 | 0.11 | 5.35 | 3.27 | 090 | ||||||||||||
| 15789 | R | Chemical peel, face, dermal | 4.92 | 5.65 | 3.32 | 0.27 | 10.84 | 8.51 | 090 | ||||||||||||
| 15792 | R | Chemical peel, nonfacial | 1.86 | 2.87 | 1.63 | 0.10 | 4.83 | 3.59 | 090 | ||||||||||||
| 15793 | A | Chemical peel, nonfacial | 3.74 | NA | 3.81 | 0.17 | NA | 7.72 | 090 | ||||||||||||
| 15810 | A | Salabrasion | 4.74 | 4.04 | 4.04 | 0.42 | 9.20 | 9.20 | 090 | ||||||||||||
| 15811 | A | Salabrasion | 5.39 | 5.85 | 5.06 | 0.52 | 11.76 | 10.97 | 090 | ||||||||||||
| 15819 | A | Plastic surgery, neck | 9.38 | NA | 6.24 | 0.77 | NA | 16.39 | 090 | ||||||||||||
| 15820 | A | Revision of lower eyelid | 5.15 | 10.34 | 7.13 | 0.30 | 15.79 | 12.58 | 090 | ||||||||||||
| 15821 | A | Revision of lower eyelid | 5.72 | 11.87 | 7.34 | 0.31 | 17.90 | 13.37 | 090 | ||||||||||||
| 15822 | A | Revision of upper eyelid | 4.45 | 10.58 | 6.58 | 0.22 | 15.25 | 11.25 | 090 | ||||||||||||
| 15823 | A | Revision of upper eyelid | 7.05 | 11.38 | 7.60 | 0.32 | 18.75 | 14.97 | 090 | ||||||||||||
| 15824 | R | Removal of forehead wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15825 | R | Removal of neck wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15826 | R | Removal of brow wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15828 | R | Removal of face wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15829 | R | Removal of skin wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15831 | A | Excise excessive skin tissue | 12.40 | NA | 8.14 | 1.30 | NA | 21.84 | 090 | ||||||||||||
| 15832 | A | Excise excessive skin tissue | 11.59 | NA | 8.04 | 1.21 | NA | 20.84 | 090 | ||||||||||||
| 15833 | A | Excise excessive skin tissue | 10.64 | NA | 7.34 | 1.17 | NA | 19.15 | 090 | ||||||||||||
| 15834 | A | Excise excessive skin tissue | 10.85 | NA | 7.59 | 1.18 | NA | 19.62 | 090 | ||||||||||||
| 15835 | A | Excise excessive skin tissue | 11.67 | NA | 7.94 | 1.13 | NA | 20.74 | 090 | ||||||||||||
| 15836 | A | Excise excessive skin tissue | 9.34 | NA | 6.51 | 0.95 | NA | 16.80 | 090 | ||||||||||||
| 15837 | A | Excise excessive skin tissue | 8.43 | 7.30 | 6.38 | 0.78 | 16.51 | 15.59 | 090 | ||||||||||||
| 15838 | A | Excise excessive skin tissue | 7.13 | NA | 5.70 | 0.58 | NA | 13.41 | 090 | ||||||||||||
| 15839 | A | Excise excessive skin tissue | 9.38 | 7.64 | 5.97 | 0.88 | 17.90 | 16.23 | 090 | ||||||||||||
| 15840 | A | Graft for face nerve palsy | 13.26 | NA | 10.10 | 1.15 | NA | 24.51 | 090 | ||||||||||||
| 15841 | A | Graft for face nerve palsy | 23.26 | NA | 14.68 | 2.65 | NA | 40.59 | 090 | ||||||||||||
| 15842 | A | Flap for face nerve palsy | 37.96 | NA | 22.81 | 3.99 | NA | 64.76 | 090 | ||||||||||||
| 15845 | A | Skin and muscle repair, face | 12.57 | NA | 8.81 | 0.80 | NA | 22.18 | 090 | ||||||||||||
| 15850 | B | Removal of sutures | +0.78 | 1.43 | 0.31 | 0.04 | 2.25 | 1.13 | XXX | ||||||||||||
| 15851 | A | Removal of sutures | 0.86 | 1.64 | 0.35 | 0.05 | 2.55 | 1.26 | 000 | ||||||||||||
| 15852 | A | Dressing change, not for burn | 0.86 | 1.93 | 0.36 | 0.07 | 2.86 | 1.29 | 000 | ||||||||||||
| 15860 | A | Test for blood flow in graft | 1.95 | 1.35 | 0.84 | 0.13 | 3.43 | 2.92 | 000 | ||||||||||||
| 15876 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15877 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15878 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15879 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 15920 | A | Removal of tail bone ulcer | 7.95 | NA | 5.90 | 0.83 | NA | 14.68 | 090 | ||||||||||||
| 15922 | A | Removal of tail bone ulcer | 9.90 | NA | 7.78 | 1.06 | NA | 18.74 | 090 | ||||||||||||
| 15931 | A | Remove sacrum pressure sore | 9.24 | NA | 5.89 | 0.95 | NA | 16.08 | 090 | ||||||||||||
| 15933 | A | Remove sacrum pressure sore | 10.85 | NA | 8.32 | 1.14 | NA | 20.31 | 090 | ||||||||||||
| 15934 | A | Remove sacrum pressure sore | 12.69 | NA | 8.48 | 1.35 | NA | 22.52 | 090 | ||||||||||||
| 15935 | A | Remove sacrum pressure sore | 14.57 | NA | 10.12 | 1.56 | NA | 26.25 | 090 | ||||||||||||
| 15936 | A | Remove sacrum pressure sore | 12.38 | NA | 8.81 | 1.32 | NA | 22.51 | 090 | ||||||||||||
| 15937 | A | Remove sacrum pressure sore | 14.21 | NA | 10.75 | 1.51 | NA | 26.47 | 090 | ||||||||||||
| 15940 | A | Remove hip pressure sore | 9.34 | NA | 6.17 | 0.98 | NA | 16.49 | 090 | ||||||||||||
| 15941 | A | Remove hip pressure sore | 11.43 | NA | 10.44 | 1.23 | NA | 23.10 | 090 | ||||||||||||
| 15944 | A | Remove hip pressure sore | 11.46 | NA | 8.77 | 1.21 | NA | 21.44 | 090 | ||||||||||||
| 15945 | A | Remove hip pressure sore | 12.69 | NA | 9.73 | 1.38 | NA | 23.80 | 090 | ||||||||||||
| 15946 | A | Remove hip pressure sore | 21.57 | NA | 14.65 | 2.32 | NA | 38.54 | 090 | ||||||||||||
| 15950 | A | Remove thigh pressure sore | 7.54 | NA | 5.43 | 0.80 | NA | 13.77 | 090 | ||||||||||||
| 15951 | A | Remove thigh pressure sore | 10.72 | NA | 8.07 | 1.14 | NA | 19.93 | 090 | ||||||||||||
| 15952 | A | Remove thigh pressure sore | 11.39 | NA | 7.86 | 1.19 | NA | 20.44 | 090 | ||||||||||||
| 15953 | A | Remove thigh pressure sore | 12.63 | NA | 9.24 | 1.38 | NA | 23.25 | 090 | ||||||||||||
| 15956 | A | Remove thigh pressure sore | 15.52 | NA | 10.71 | 1.64 | NA | 27.87 | 090 | ||||||||||||
| 15958 | A | Remove thigh pressure sore | 15.48 | NA | 11.20 | 1.66 | NA | 28.34 | 090 | ||||||||||||
| 15999 | C | Removal of pressure sore | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 16000 | A | Initial treatment of burn(s) | 0.89 | 1.09 | 0.27 | 0.06 | 2.04 | 1.22 | 000 | ||||||||||||
| 16010 | A | Treatment of burn(s) | 0.87 | 1.21 | 0.37 | 0.07 | 2.15 | 1.31 | 000 | ||||||||||||
| 16015 | A | Treatment of burn(s) | 2.35 | 2.01 | 1.03 | 0.22 | 4.58 | 3.60 | 000 | ||||||||||||
| 16020 | A | Treatment of burn(s) | 0.80 | 1.20 | 0.27 | 0.06 | 2.06 | 1.13 | 000 | ||||||||||||
| 16025 | A | Treatment of burn(s) | 1.85 | 1.94 | 0.69 | 0.16 | 3.95 | 2.70 | 000 | ||||||||||||
| 16030 | A | Treatment of burn(s) | 2.08 | 3.36 | 0.97 | 0.18 | 5.62 | 3.23 | 000 | ||||||||||||
| 16035 | A | Incision of burn scab, initi | 3.75 | NA | 1.56 | 0.36 | NA | 5.67 | 090 | ||||||||||||
| 16036 | A | Incise burn scab, addl incis | 1.50 | NA | 0.62 | 0.11 | NA | 2.23 | ZZZ | ||||||||||||
| 17000 | A | Detroy benign/premal lesion | 0.60 | 1.10 | 0.28 | 0.03 | 1.73 | 0.91 | 010 | ||||||||||||
| 17003 | A | Destroy lesions, 2-14 | 0.15 | 0.24 | 0.07 | 0.01 | 0.40 | 0.23 | ZZZ | ||||||||||||
| 17004 | A | Destroy lesions, 15 or more | 2.79 | 2.56 | 1.30 | 0.12 | 5.47 | 4.21 | 010 | ||||||||||||
| 17106 | A | Destruction of skin lesions | 4.59 | 4.88 | 2.88 | 0.28 | 9.75 | 7.75 | 090 | ||||||||||||
| 17107 | A | Destruction of skin lesions | 9.16 | 6.92 | 5.28 | 0.53 | 16.61 | 14.97 | 090 | ||||||||||||
| 17108 | A | Destruction of skin lesions | 13.20 | 8.87 | 7.26 | 0.89 | 22.96 | 21.35 | 090 | ||||||||||||
| 17110 | A | Destruct lesion, 1-14 | 0.65 | 1.11 | 0.26 | 0.04 | 1.80 | 0.95 | 010 | ||||||||||||
| 17111 | A | Destruct lesion, 15 or more | 0.92 | 1.13 | 0.41 | 0.04 | 2.09 | 1.37 | 010 | ||||||||||||
| 17250 | A | Chemical cautery, tissue | 0.50 | 0.76 | 0.21 | 0.04 | 1.30 | 0.75 | 000 | ||||||||||||
| 17260 | A | Destruction of skin lesions | 0.91 | 1.37 | 0.39 | 0.04 | 2.32 | 1.34 | 010 | ||||||||||||
| 17261 | A | Destruction of skin lesions | 1.17 | 1.48 | 0.56 | 0.05 | 2.70 | 1.78 | 010 | ||||||||||||
| 17262 | A | Destruction of skin lesions | 1.58 | 1.69 | 0.76 | 0.07 | 3.34 | 2.41 | 010 | ||||||||||||
| 17263 | A | Destruction of skin lesions | 1.79 | 1.80 | 0.83 | 0.08 | 3.67 | 2.70 | 010 | ||||||||||||
| 17264 | A | Destruction of skin lesions | 1.94 | 1.87 | 0.87 | 0.08 | 3.89 | 2.89 | 010 | ||||||||||||
| 17266 | A | Destruction of skin lesions | 2.34 | 2.08 | 1.05 | 0.11 | 4.53 | 3.50 | 010 | ||||||||||||
| 17270 | A | Destruction of skin lesions | 1.32 | 1.57 | 0.60 | 0.06 | 2.95 | 1.98 | 010 | ||||||||||||
| 17271 | A | Destruction of skin lesions | 1.49 | 1.65 | 0.72 | 0.06 | 3.20 | 2.27 | 010 | ||||||||||||
| 17272 | A | Destruction of skin lesions | 1.77 | 1.79 | 0.86 | 0.07 | 3.63 | 2.70 | 010 | ||||||||||||
| 17273 | A | Destruction of skin lesions | 2.05 | 1.93 | 0.97 | 0.09 | 4.07 | 3.11 | 010 | ||||||||||||
| 17274 | A | Destruction of skin lesions | 2.59 | 2.21 | 1.20 | 0.11 | 4.91 | 3.90 | 010 | ||||||||||||
| 17276 | A | Destruction of skin lesions | 3.20 | 2.52 | 1.84 | 0.15 | 5.87 | 5.19 | 010 | ||||||||||||
| 17280 | A | Destruction of skin lesions | 1.17 | 1.41 | 0.54 | 0.05 | 2.63 | 1.76 | 010 | ||||||||||||
| 17281 | A | Destruction of skin lesions | 1.72 | 1.77 | 0.83 | 0.07 | 3.56 | 2.62 | 010 | ||||||||||||
| 17282 | A | Destruction of skin lesions | 2.04 | 1.93 | 0.99 | 0.09 | 4.06 | 3.12 | 010 | ||||||||||||
| 17283 | A | Destruction of skin lesions | 2.64 | 2.23 | 1.24 | 0.11 | 4.98 | 3.99 | 010 | ||||||||||||
| 17284 | A | Destruction of skin lesions | 3.21 | 2.52 | 1.51 | 0.14 | 5.87 | 4.86 | 010 | ||||||||||||
| 17286 | A | Destruction of skin lesions | 4.44 | 3.23 | 2.52 | 0.22 | 7.89 | 7.18 | 010 | ||||||||||||
| 17304 | A | Chemosurgery of skin lesion | 7.60 | 7.76 | 3.74 | 0.31 | 15.67 | 11.65 | 000 | ||||||||||||
| 17305 | A | 2nd stage chemosurgery | 2.85 | 3.60 | 1.40 | 0.12 | 6.57 | 4.37 | 000 | ||||||||||||
| 17306 | A | 3rd stage chemosurgery | 2.85 | 3.64 | 1.41 | 0.12 | 6.61 | 4.38 | 000 | ||||||||||||
| 17307 | A | Followup skin lesion therapy | 2.85 | 3.62 | 1.43 | 0.12 | 6.59 | 4.40 | 000 | ||||||||||||
| 17310 | A | Extensive skin chemosurgery | 0.95 | 1.54 | 0.48 | 0.05 | 2.54 | 1.48 | 000 | ||||||||||||
| 17340 | A | Cryotherapy of skin | 0.76 | 0.39 | 0.27 | 0.04 | 1.19 | 1.07 | 010 | ||||||||||||
| 17360 | A | Skin peel therapy | 1.43 | 1.46 | 0.73 | 0.06 | 2.95 | 2.22 | 010 | ||||||||||||
| 17380 | R | Hair removal by electrolysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 17999 | C | Skin tissue procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 19000 | A | Drainage of breast lesion | 0.84 | 1.27 | 0.30 | 0.07 | 2.18 | 1.21 | 000 | ||||||||||||
| 19001 | A | Drain breast lesion add-on | 0.42 | 0.86 | 0.15 | 0.03 | 1.31 | 0.60 | ZZZ | ||||||||||||
| 19020 | A | Incision of breast lesion | 3.57 | 7.13 | 3.51 | 0.35 | 11.05 | 7.43 | 090 | ||||||||||||
| 19030 | A | Injection for breast x-ray | 1.53 | 3.70 | 0.54 | 0.07 | 5.30 | 2.14 | 000 | ||||||||||||
| 19100 | A | Bx breast percut w/o image | 1.27 | 1.50 | 0.45 | 0.10 | 2.87 | 1.82 | 000 | ||||||||||||
| 19101 | A | Biopsy of breast, open | 3.18 | 5.27 | 1.97 | 0.20 | 8.65 | 5.35 | 010 | ||||||||||||
| 19102 | A | Bx breast percut w/image | 2.00 | 5.13 | 0.71 | 0.13 | 7.26 | 2.84 | 000 | ||||||||||||
| 19103 | A | Bx breast percut w/device | 3.70 | 12.73 | 1.31 | 0.16 | 16.59 | 5.17 | 000 | ||||||||||||
| 19110 | A | Nipple exploration | 4.30 | 9.79 | 4.56 | 0.44 | 14.53 | 9.30 | 090 | ||||||||||||
| 19112 | A | Excise breast duct fistula | 3.67 | 10.91 | 3.19 | 0.38 | 14.96 | 7.24 | 090 | ||||||||||||
| 19120 | A | Removal of breast lesion | 5.56 | 5.18 | 3.20 | 0.56 | 11.30 | 9.32 | 090 | ||||||||||||
| 19125 | A | Excision, breast lesion | 6.06 | 5.36 | 3.36 | 0.61 | 12.03 | 10.03 | 090 | ||||||||||||
| 19126 | A | Excision, addl breast lesion | 2.93 | NA | 1.06 | 0.30 | NA | 4.29 | ZZZ | ||||||||||||
| 19140 | A | Removal of breast tissue | 5.14 | 10.26 | 3.79 | 0.52 | 15.92 | 9.45 | 090 | ||||||||||||
| 19160 | A | Removal of breast tissue | 5.99 | NA | 4.62 | 0.61 | NA | 11.22 | 090 | ||||||||||||
| 19162 | A | Remove breast tissue, nodes | 13.53 | NA | 8.07 | 1.38 | NA | 22.98 | 090 | ||||||||||||
| 19180 | A | Removal of breast | 8.80 | NA | 6.08 | 0.88 | NA | 15.76 | 090 | ||||||||||||
| 19182 | A | Removal of breast | 7.73 | NA | 5.06 | 0.79 | NA | 13.58 | 090 | ||||||||||||
| 19200 | A | Removal of breast | 15.49 | NA | 9.33 | 1.51 | NA | 26.33 | 090 | ||||||||||||
| 19220 | A | Removal of breast | 15.72 | NA | 9.52 | 1.56 | NA | 26.80 | 090 | ||||||||||||
| 19240 | A | Removal of breast | 16.00 | NA | 8.94 | 1.62 | NA | 26.56 | 090 | ||||||||||||
| 19260 | A | Removal of chest wall lesion | 15.44 | NA | 9.12 | 1.64 | NA | 26.20 | 090 | ||||||||||||
| 19271 | A | Revision of chest wall | 18.90 | NA | 11.13 | 2.27 | NA | 32.30 | 090 | ||||||||||||
| 19272 | A | Extensive chest wall surgery | 21.55 | NA | 12.36 | 2.54 | NA | 36.45 | 090 | ||||||||||||
| 19290 | A | Place needle wire, breast | 1.27 | 2.95 | 0.45 | 0.06 | 4.28 | 1.78 | 000 | ||||||||||||
| 19291 | A | Place needle wire, breast | 0.63 | 1.74 | 0.22 | 0.03 | 2.40 | 0.88 | ZZZ | ||||||||||||
| 19295 | A | Place breast clip, percut | 0.00 | 2.83 | NA | 0.01 | 2.84 | NA | ZZZ | ||||||||||||
| 19316 | A | Suspension of breast | 10.69 | NA | 8.00 | 1.15 | NA | 19.84 | 090 | ||||||||||||
| 19318 | A | Reduction of large breast | 15.62 | NA | 10.64 | 1.69 | NA | 27.95 | 090 | ||||||||||||
| 19324 | A | Enlarge breast | 5.85 | NA | 4.41 | 0.63 | NA | 10.89 | 090 | ||||||||||||
| 19325 | A | Enlarge breast with implant | 8.45 | NA | 7.00 | 0.90 | NA | 16.35 | 090 | ||||||||||||
| 19328 | A | Removal of breast implant | 5.68 | NA | 4.73 | 0.61 | NA | 11.02 | 090 | ||||||||||||
| 19330 | A | Removal of implant material | 7.59 | NA | 5.41 | 0.81 | NA | 13.81 | 090 | ||||||||||||
| 19340 | A | Immediate breast prosthesis | 6.33 | NA | 3.30 | 0.68 | NA | 10.31 | ZZZ | ||||||||||||
| 19342 | A | Delayed breast prosthesis | 11.20 | NA | 8.15 | 1.21 | NA | 20.56 | 090 | ||||||||||||
| 19350 | A | Breast reconstruction | 8.92 | 14.55 | 7.09 | 0.95 | 24.42 | 16.96 | 090 | ||||||||||||
| 19355 | A | Correct inverted nipple(s) | 7.57 | 12.42 | 5.93 | 0.80 | 20.79 | 14.30 | 090 | ||||||||||||
| 19357 | A | Breast reconstruction | 18.16 | NA | 14.40 | 1.96 | NA | 34.52 | 090 | ||||||||||||
| 19361 | A | Breast reconstruction | 19.26 | NA | 12.45 | 2.08 | NA | 33.79 | 090 | ||||||||||||
| 19364 | A | Breast reconstruction | 41.00 | NA | 25.45 | 3.91 | NA | 70.36 | 090 | ||||||||||||
| 19366 | A | Breast reconstruction | 21.28 | NA | 12.02 | 2.27 | NA | 35.57 | 090 | ||||||||||||
| 19367 | A | Breast reconstruction | 25.73 | NA | 15.77 | 2.78 | NA | 44.28 | 090 | ||||||||||||
| 19368 | A | Breast reconstruction | 32.42 | NA | 19.04 | 3.51 | NA | 54.97 | 090 | ||||||||||||
| 19369 | A | Breast reconstruction | 29.82 | NA | 18.29 | 3.24 | NA | 51.35 | 090 | ||||||||||||
| 19370 | A | Surgery of breast capsule | 8.05 | NA | 6.39 | 0.86 | NA | 15.30 | 090 | ||||||||||||
| 19371 | A | Removal of breast capsule | 9.35 | NA | 7.46 | 1.01 | NA | 17.82 | 090 | ||||||||||||
| 19380 | A | Revise breast reconstruction | 9.14 | NA | 7.35 | 0.98 | NA | 17.47 | 090 | ||||||||||||
| 19396 | A | Design custom breast implant | 2.17 | 7.08 | 0.87 | 0.23 | 9.48 | 3.27 | 000 | ||||||||||||
| 19499 | C | Breast surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 20000 | A | Incision of abscess | 2.12 | 2.23 | 1.20 | 0.17 | 4.52 | 3.49 | 010 | ||||||||||||
| 20005 | A | Incision of deep abscess | 3.42 | 3.07 | 2.22 | 0.34 | 6.83 | 5.98 | 010 | ||||||||||||
| 20100 | A | Explore wound, neck | 10.08 | 6.49 | 4.12 | 0.99 | 17.56 | 15.19 | 010 | ||||||||||||
| 20101 | A | Explore wound, chest | 3.22 | 3.03 | 1.64 | 0.24 | 6.49 | 5.10 | 010 | ||||||||||||
| 20102 | A | Explore wound, abdomen | 3.94 | 3.43 | 1.85 | 0.35 | 7.72 | 6.14 | 010 | ||||||||||||
| 20103 | A | Explore wound, extremity | 5.30 | 4.41 | 3.01 | 0.57 | 10.28 | 8.88 | 010 | ||||||||||||
| 20150 | A | Excise epiphyseal bar | 13.69 | NA | 9.72 | 0.96 | NA | 24.37 | 090 | ||||||||||||
| 20200 | A | Muscle biopsy | 1.46 | 1.72 | 0.62 | 0.17 | 3.35 | 2.25 | 000 | ||||||||||||
| 20205 | A | Deep muscle biopsy | 2.35 | 4.04 | 0.98 | 0.23 | 6.62 | 3.56 | 000 | ||||||||||||
| 20206 | A | Needle biopsy, muscle | 0.99 | 3.27 | 0.36 | 0.06 | 4.32 | 1.41 | 000 | ||||||||||||
| 20220 | A | Bone biopsy, trocar/needle | 1.27 | 4.96 | 2.98 | 0.06 | 6.29 | 4.31 | 000 | ||||||||||||
| 20225 | A | Bone biopsy, trocar/needle | 1.87 | 4.47 | 3.06 | 0.11 | 6.45 | 5.04 | 000 | ||||||||||||
| 20240 | A | Bone biopsy, excisional | 3.23 | NA | 4.15 | 0.33 | NA | 7.71 | 010 | ||||||||||||
| 20245 | A | Bone biopsy, excisional | 7.78 | NA | 6.91 | 0.44 | NA | 15.13 | 010 | ||||||||||||
| 20250 | A | Open bone biopsy | 5.03 | NA | 4.37 | 0.50 | NA | 9.90 | 010 | ||||||||||||
| 20251 | A | Open bone biopsy | 5.56 | NA | 4.86 | 0.79 | NA | 11.21 | 010 | ||||||||||||
| 20500 | A | Injection of sinus tract | 1.23 | 5.34 | 3.91 | 0.10 | 6.67 | 5.24 | 010 | ||||||||||||
| 20501 | A | Inject sinus tract for x-ray | 0.76 | 3.32 | 0.27 | 0.03 | 4.11 | 1.06 | 000 | ||||||||||||
| 20520 | A | Removal of foreign body | 1.85 | 5.62 | 3.62 | 0.17 | 7.64 | 5.64 | 010 | ||||||||||||
| 20525 | A | Removal of foreign body | 3.50 | 7.26 | 4.40 | 0.40 | 11.16 | 8.30 | 010 | ||||||||||||
| 20526 | A | Ther injection carpal tunnel | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | ||||||||||||
| 20550 | A | Inject tendon/ligament/cyst | 0.86 | 0.85 | 0.28 | 0.06 | 1.77 | 1.20 | 000 | ||||||||||||
| 20551 | A | Inject tendon origin/insert | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | ||||||||||||
| 20552 | A | Inject trigger point, 1 or 2 | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | ||||||||||||
| 20553 | A | Inject trigger points, 3 | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | ||||||||||||
| 20600 | A | Drain/inject, joint/bursa | 0.66 | 0.67 | 0.37 | 0.06 | 1.39 | 1.09 | 000 | ||||||||||||
| 20605 | A | Drain/inject, joint/bursa | 0.68 | 0.78 | 0.38 | 0.06 | 1.52 | 1.12 | 000 | ||||||||||||
| 20610 | A | Drain/inject, joint/bursa | 0.79 | 0.96 | 0.44 | 0.08 | 1.83 | 1.31 | 000 | ||||||||||||
| 20615 | A | Treatment of bone cyst | 2.28 | 4.89 | 2.52 | 0.19 | 7.36 | 4.99 | 010 | ||||||||||||
| 20650 | A | Insert and remove bone pin | 2.23 | 5.06 | 3.19 | 0.28 | 7.57 | 5.70 | 010 | ||||||||||||
| 20660 | A | Apply, remove fixation device | 2.51 | NA | 1.49 | 0.48 | NA | 4.48 | 000 | ||||||||||||
| 20661 | A | Application of head brace | 4.89 | NA | 6.74 | 0.92 | NA | 12.55 | 090 | ||||||||||||
| 20662 | A | Application of pelvis brace | 6.07 | NA | 5.12 | 0.81 | NA | 12.00 | 090 | ||||||||||||
| 20663 | A | Application of thigh brace | 5.43 | NA | 4.94 | 0.77 | NA | 11.14 | 090 | ||||||||||||
| 20664 | A | Halo brace application | 8.06 | NA | 8.55 | 1.49 | NA | 18.10 | 090 | ||||||||||||
| 20665 | A | Removal of fixation device | 1.31 | 2.33 | 1.25 | 0.17 | 3.81 | 2.73 | 010 | ||||||||||||
| 20670 | A | Removal of support implant | 1.74 | 5.73 | 3.42 | 0.23 | 7.70 | 5.39 | 010 | ||||||||||||
| 20680 | A | Removal of support implant | 3.35 | 5.04 | 5.04 | 0.46 | 8.85 | 8.85 | 090 | ||||||||||||
| 20690 | A | Apply bone fixation device | 3.52 | NA | 1.91 | 0.47 | NA | 5.90 | 090 | ||||||||||||
| 20692 | A | Apply bone fixation device | 6.41 | NA | 3.57 | 0.60 | NA | 10.58 | 090 | ||||||||||||
| 20693 | A | Adjust bone fixation device | 5.86 | NA | 12.98 | 0.85 | NA | 19.69 | 090 | ||||||||||||
| 20694 | A | Remove bone fixation device | 4.16 | 8.96 | 6.30 | 0.57 | 13.69 | 11.03 | 090 | ||||||||||||
| 20802 | A | Replantation, arm, complete | 41.15 | NA | 28.95 | 5.81 | NA | 75.91 | 090 | ||||||||||||
| 20805 | A | Replant, forearm, complete | 50.00 | NA | 38.72 | 3.95 | NA | 92.67 | 090 | ||||||||||||
| 20808 | A | Replantation hand, complete | 61.65 | NA | 56.41 | 6.49 | NA | 124.55 | 090 | ||||||||||||
| 20816 | A | Replantation digit, complete | 30.94 | NA | 49.50 | 3.01 | NA | 83.45 | 090 | ||||||||||||
| 20822 | A | Replantation digit, complete | 25.59 | NA | 45.97 | 3.07 | NA | 74.63 | 090 | ||||||||||||
| 20824 | A | Replantation thumb, complete | 30.94 | NA | 49.10 | 3.48 | NA | 83.52 | 090 | ||||||||||||
| 20827 | A | Replantation thumb, complete | 26.41 | NA | 45.65 | 3.21 | NA | 75.27 | 090 | ||||||||||||
| 20838 | A | Replantation foot, complete | 41.41 | NA | 25.82 | 5.85 | NA | 73.08 | 090 | ||||||||||||
| 20900 | A | Removal of bone for graft | 5.58 | 5.97 | 5.97 | 0.77 | 12.32 | 12.32 | 090 | ||||||||||||
| 20902 | A | Removal of bone for graft | 7.55 | NA | 8.91 | 1.06 | NA | 17.52 | 090 | ||||||||||||
| 20910 | A | Remove cartilage for graft | 5.34 | 9.09 | 6.94 | 0.50 | 14.93 | 12.78 | 090 | ||||||||||||
| 20912 | A | Remove cartilage for graft | 6.35 | NA | 7.68 | 0.55 | NA | 14.58 | 090 | ||||||||||||
| 20920 | A | Removal of fascia for graft | 5.31 | NA | 5.44 | 0.54 | NA | 11.29 | 090 | ||||||||||||
| 20922 | A | Removal of fascia for graft | 6.61 | 8.50 | 6.28 | 0.88 | 15.99 | 13.77 | 090 | ||||||||||||
| 20924 | A | Removal of tendon for graft | 6.48 | NA | 7.03 | 0.82 | NA | 14.33 | 090 | ||||||||||||
| 20926 | A | Removal of tissue for graft | 5.53 | NA | 6.54 | 0.73 | NA | 12.80 | 090 | ||||||||||||
| 20930 | B | Spinal bone allograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 20931 | A | Spinal bone allograft | 1.81 | NA | 0.98 | 0.34 | NA | 3.13 | ZZZ | ||||||||||||
| 20936 | B | Spinal bone autograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 20937 | A | Spinal bone autograft | 2.79 | NA | 1.54 | 0.43 | NA | 4.76 | ZZZ | ||||||||||||
| 20938 | A | Spinal bone autograft | 3.02 | NA | 1.64 | 0.52 | NA | 5.18 | ZZZ | ||||||||||||
| 20950 | A | Fluid pressure, muscle | 1.26 | NA | 2.15 | 0.16 | NA | 3.57 | 000 | ||||||||||||
| 20955 | A | Fibula bone graft, microvasc | 39.21 | NA | 30.52 | 4.35 | NA | 74.08 | 090 | ||||||||||||
| 20956 | A | Iliac bone graft, microvasc | 39.27 | NA | 28.18 | 5.77 | NA | 73.22 | 090 | ||||||||||||
| 20957 | A | Mt bone graft, microvasc | 40.65 | NA | 21.71 | 5.74 | NA | 68.10 | 090 | ||||||||||||
| 20962 | A | Other bone graft, microvasc | 39.27 | NA | 28.54 | 5.19 | NA | 73.00 | 090 | ||||||||||||
| 20969 | A | Bone/skin graft, microvasc | 43.92 | NA | 33.31 | 4.34 | NA | 81.57 | 090 | ||||||||||||
| 20970 | A | Bone/skin graft, iliac crest | 43.06 | NA | 30.08 | 4.64 | NA | 77.78 | 090 | ||||||||||||
| 20972 | A | Bone/skin graft, metatarsal | 42.99 | NA | 18.23 | 6.07 | NA | 67.29 | 090 | ||||||||||||
| 20973 | A | Bone/skin graft, great toe | 45.76 | NA | 30.52 | 4.65 | NA | 80.93 | 090 | ||||||||||||
| 20974 | A | Electrical bone stimulation | 0.62 | 0.47 | 0.34 | 0.09 | 1.18 | 1.05 | 000 | ||||||||||||
| 20975 | A | Electrical bone stimulation | 2.60 | NA | 1.42 | 0.42 | NA | 4.44 | 000 | ||||||||||||
| 20979 | A | Us bone stimulation | 0.62 | 0.58 | 0.25 | 0.04 | 1.24 | 0.91 | 000 | ||||||||||||
| 20999 | C | Musculoskeletal surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 21010 | A | Incision of jaw joint | 10.14 | NA | 7.24 | 0.54 | NA | 17.92 | 090 | ||||||||||||
| 21015 | A | Resection of facial tumor | 5.29 | NA | 7.38 | 0.52 | NA | 13.19 | 090 | ||||||||||||
| 21025 | A | Excision of bone, lower jaw | 10.06 | 7.40 | 7.00 | 0.79 | 18.25 | 17.85 | 090 | ||||||||||||
| 21026 | A | Excision of facial bone(s) | 4.85 | 5.23 | 5.12 | 0.40 | 10.48 | 10.37 | 090 | ||||||||||||
| 21029 | A | Contour of face bone lesion | 7.71 | 7.18 | 6.73 | 0.74 | 15.63 | 15.18 | 090 | ||||||||||||
| 21030 | A | Removal of face bone lesion | 6.46 | 5.47 | 4.94 | 0.60 | 12.53 | 12.00 | 090 | ||||||||||||
| 21031 | A | Remove exostosis, mandible | 3.24 | 3.39 | 2.19 | 0.28 | 6.91 | 5.71 | 090 | ||||||||||||
| 21032 | A | Remove exostosis, maxilla | 3.24 | 3.38 | 2.47 | 0.27 | 6.89 | 5.98 | 090 | ||||||||||||
| 21034 | A | Removal of face bone lesion | 16.17 | 10.59 | 10.59 | 1.37 | 28.13 | 28.13 | 090 | ||||||||||||
| 21040 | A | Removal of jaw bone lesion | 2.11 | 3.03 | 1.81 | 0.19 | 5.33 | 4.11 | 090 | ||||||||||||
| 21041 | A | Removal of jaw bone lesion | 6.71 | 5.68 | 4.46 | 0.56 | 12.95 | 11.73 | 090 | ||||||||||||
| 21044 | A | Removal of jaw bone lesion | 11.86 | NA | 8.33 | 0.87 | NA | 21.06 | 090 | ||||||||||||
| 21045 | A | Extensive jaw surgery | 16.17 | NA | 10.63 | 1.20 | NA | 28.00 | 090 | ||||||||||||
| 21050 | A | Removal of jaw joint | 10.77 | NA | 11.93 | 0.84 | NA | 23.54 | 090 | ||||||||||||
| 21060 | A | Remove jaw joint cartilage | 10.23 | NA | 10.59 | 1.16 | NA | 21.98 | 090 | ||||||||||||
| 21070 | A | Remove coronoid process | 8.20 | NA | 6.36 | 0.67 | NA | 15.23 | 090 | ||||||||||||
| 21076 | A | Prepare face/oral prosthesis | 13.42 | 9.87 | 7.41 | 1.36 | 24.65 | 22.19 | 010 | ||||||||||||
| 21077 | A | Prepare face/oral prosthesis | 33.75 | 24.83 | 18.64 | 3.43 | 62.01 | 55.82 | 090 | ||||||||||||
| 21079 | A | Prepare face/oral prosthesis | 22.34 | 17.55 | 12.90 | 1.59 | 41.48 | 36.83 | 090 | ||||||||||||
| 21080 | A | Prepare face/oral prosthesis | 25.10 | 19.72 | 14.49 | 2.55 | 47.37 | 42.14 | 090 | ||||||||||||
| 21081 | A | Prepare face/oral prosthesis | 22.88 | 17.97 | 13.21 | 1.87 | 42.72 | 37.96 | 090 | ||||||||||||
| 21082 | A | Prepare face/oral prosthesis | 20.87 | 15.35 | 11.53 | 1.46 | 37.68 | 33.86 | 090 | ||||||||||||
| 21083 | A | Prepare face/oral prosthesis | 19.30 | 15.16 | 11.14 | 1.96 | 36.42 | 32.40 | 090 | ||||||||||||
| 21084 | A | Prepare face/oral prosthesis | 22.51 | 17.68 | 12.99 | 1.57 | 41.76 | 37.07 | 090 | ||||||||||||
| 21085 | A | Prepare face/oral prosthesis | 9.00 | 6.62 | 4.97 | 0.65 | 16.27 | 14.62 | 010 | ||||||||||||
| 21086 | A | Prepare face/oral prosthesis | 24.92 | 19.58 | 14.39 | 1.86 | 46.36 | 41.17 | 090 | ||||||||||||
| 21087 | A | Prepare face/oral prosthesis | 24.92 | 18.33 | 13.76 | 2.22 | 45.47 | 40.90 | 090 | ||||||||||||
| 21088 | C | Prepare face/oral prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 21089 | C | Prepare face/oral prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 21100 | A | Maxillofacial fixation | 4.22 | 5.66 | 3.70 | 0.18 | 10.06 | 8.10 | 090 | ||||||||||||
| 21110 | A | Interdental fixation | 5.21 | 5.25 | 4.48 | 0.28 | 10.74 | 9.97 | 090 | ||||||||||||
| 21116 | A | Injection, jaw joint x-ray | 0.81 | 7.88 | 0.30 | 0.05 | 8.74 | 1.16 | 000 | ||||||||||||
| 21120 | A | Reconstruction of chin | 4.93 | 7.96 | 4.98 | 0.29 | 13.18 | 10.20 | 090 | ||||||||||||
| 21121 | A | Reconstruction of chin | 7.64 | 7.68 | 6.65 | 0.56 | 15.88 | 14.85 | 090 | ||||||||||||
| 21122 | A | Reconstruction of chin | 8.52 | NA | 7.95 | 0.59 | NA | 17.06 | 090 | ||||||||||||
| 21123 | A | Reconstruction of chin | 11.16 | NA | 7.68 | 1.16 | NA | 20.00 | 090 | ||||||||||||
| 21125 | A | Augmentation, lower jaw bone | 10.62 | 9.56 | 7.84 | 0.72 | 20.90 | 19.18 | 090 | ||||||||||||
| 21127 | A | Augmentation, lower jaw bone | 11.12 | 10.66 | 7.33 | 0.76 | 22.54 | 19.21 | 090 | ||||||||||||
| 21137 | A | Reduction of forehead | 9.82 | NA | 8.20 | 0.53 | NA | 18.55 | 090 | ||||||||||||
| 21138 | A | Reduction of forehead | 12.19 | NA | 8.82 | 1.47 | NA | 22.48 | 090 | ||||||||||||
| 21139 | A | Reduction of forehead | 14.61 | NA | 8.23 | 1.02 | NA | 23.86 | 090 | ||||||||||||
| 21141 | A | Reconstruct midface, lefort | 18.10 | NA | 10.69 | 1.63 | NA | 30.42 | 090 | ||||||||||||
| 21142 | A | Reconstruct midface, lefort | 18.81 | NA | 13.80 | 1.16 | NA | 33.77 | 090 | ||||||||||||
| 21143 | A | Reconstruct midface, lefort | 19.58 | NA | 11.21 | 0.90 | NA | 31.69 | 090 | ||||||||||||
| 21145 | A | Reconstruct midface, lefort | 19.94 | NA | 11.69 | 2.09 | NA | 33.72 | 090 | ||||||||||||
| 21146 | A | Reconstruct midface, lefort | 20.71 | NA | 11.61 | 2.13 | NA | 34.45 | 090 | ||||||||||||
| 21147 | A | Reconstruct midface, lefort | 21.77 | NA | 12.07 | 1.52 | NA | 35.36 | 090 | ||||||||||||
| 21150 | A | Reconstruct midface, lefort | 25.24 | NA | 17.20 | 1.09 | NA | 43.53 | 090 | ||||||||||||
| 21151 | A | Reconstruct midface, lefort | 28.30 | NA | 21.35 | 1.98 | NA | 51.63 | 090 | ||||||||||||
| 21154 | A | Reconstruct midface, lefort | 30.52 | NA | 21.03 | 4.86 | NA | 56.41 | 090 | ||||||||||||
| 21155 | A | Reconstruct midface, lefort | 34.45 | NA | 23.20 | 5.48 | NA | 63.13 | 090 | ||||||||||||
| 21159 | A | Reconstruct midface, lefort | 42.38 | NA | 21.72 | 6.74 | NA | 70.84 | 090 | ||||||||||||
| 21160 | A | Reconstruct midface, lefort | 46.44 | NA | 30.39 | 4.39 | NA | 81.22 | 090 | ||||||||||||
| 21172 | A | Reconstruct orbit/forehead | 27.80 | NA | 16.39 | 1.91 | NA | 46.10 | 090 | ||||||||||||
| 21175 | A | Reconstruct orbit/forehead | 33.17 | NA | 19.79 | 5.16 | NA | 58.12 | 090 | ||||||||||||
| 21179 | A | Reconstruct entire forehead | 22.25 | NA | 18.94 | 2.48 | NA | 43.67 | 090 | ||||||||||||
| 21180 | A | Reconstruct entire forehead | 25.19 | NA | 18.33 | 2.15 | NA | 45.67 | 090 | ||||||||||||
| 21181 | A | Contour cranial bone lesion | 9.90 | NA | 8.46 | 0.97 | NA | 19.33 | 090 | ||||||||||||
| 21182 | A | Reconstruct cranial bone | 32.19 | NA | 21.97 | 2.53 | NA | 56.69 | 090 | ||||||||||||
| 21183 | A | Reconstruct cranial bone | 35.31 | NA | 22.93 | 2.75 | NA | 60.99 | 090 | ||||||||||||
| 21184 | A | Reconstruct cranial bone | 38.24 | NA | 19.54 | 4.12 | NA | 61.90 | 090 | ||||||||||||
| 21188 | A | Reconstruction of midface | 22.46 | NA | 15.86 | 1.85 | NA | 40.17 | 090 | ||||||||||||
| 21193 | A | Reconst lwr jaw w/o graft | 17.15 | NA | 10.77 | 1.53 | NA | 29.45 | 090 | ||||||||||||
| 21194 | A | Reconst lwr jaw w/graft | 19.84 | NA | 12.44 | 1.39 | NA | 33.67 | 090 | ||||||||||||
| 21195 | A | Reconst lwr jaw w/o fixation | 17.24 | NA | 12.36 | 1.20 | NA | 30.80 | 090 | ||||||||||||
| 21196 | A | Reconst lwr jaw w/fixation | 18.91 | NA | 12.83 | 1.62 | NA | 33.36 | 090 | ||||||||||||
| 21198 | A | Reconstr lwr jaw segment | 14.16 | NA | 12.30 | 1.05 | NA | 27.51 | 090 | ||||||||||||
| 21199 | A | Reconstr lwr jaw w/advance | 16.00 | NA | 10.85 | 1.26 | NA | 28.11 | 090 | ||||||||||||
| 21206 | A | Reconstruct upper jaw bone | 14.10 | NA | 9.39 | 1.01 | NA | 24.50 | 090 | ||||||||||||
| 21208 | A | Augmentation of facial bones | 10.23 | 8.95 | 8.62 | 0.92 | 20.10 | 19.77 | 090 | ||||||||||||
| 21209 | A | Reduction of facial bones | 6.72 | 8.05 | 6.54 | 0.60 | 15.37 | 13.86 | 090 | ||||||||||||
| 21210 | A | Face bone graft | 10.23 | 8.82 | 8.28 | 0.88 | 19.93 | 19.39 | 090 | ||||||||||||
| 21215 | A | Lower jaw bone graft | 10.77 | 8.95 | 7.48 | 1.04 | 20.76 | 19.29 | 090 | ||||||||||||
| 21230 | A | Rib cartilage graft | 10.77 | NA | 10.85 | 0.96 | NA | 22.58 | 090 | ||||||||||||
| 21235 | A | Ear cartilage graft | 6.72 | 11.90 | 8.36 | 0.52 | 19.14 | 15.60 | 090 | ||||||||||||
| 21240 | A | Reconstruction of jaw joint | 14.05 | NA | 11.79 | 1.15 | NA | 26.99 | 090 | ||||||||||||
| 21242 | A | Reconstruction of jaw joint | 12.95 | NA | 10.85 | 1.40 | NA | 25.20 | 090 | ||||||||||||
| 21243 | A | Reconstruction of jaw joint | 20.79 | NA | 13.97 | 1.85 | NA | 36.61 | 090 | ||||||||||||
| 21244 | A | Reconstruction of lower jaw | 11.86 | NA | 9.56 | 0.95 | NA | 22.37 | 090 | ||||||||||||
| 21245 | A | Reconstruction of jaw | 11.86 | 24.85 | 10.25 | 0.88 | 37.59 | 22.99 | 090 | ||||||||||||
| 21246 | A | Reconstruction of jaw | 12.47 | 10.20 | 10.20 | 1.21 | 23.88 | 23.88 | 090 | ||||||||||||
| 21247 | A | Reconstruct lower jaw bone | 22.63 | NA | 20.17 | 2.21 | NA | 45.01 | 090 | ||||||||||||
| 21248 | A | Reconstruction of jaw | 11.48 | 8.91 | 7.86 | 1.01 | 21.40 | 20.35 | 090 | ||||||||||||
| 21249 | A | Reconstruction of jaw | 17.52 | 11.44 | 10.35 | 1.39 | 30.35 | 29.26 | 090 | ||||||||||||
| 21255 | A | Reconstruct lower jaw bone | 16.72 | NA | 13.16 | 1.13 | NA | 31.01 | 090 | ||||||||||||
| 21256 | A | Reconstruction of orbit | 16.19 | NA | 13.87 | 1.04 | NA | 31.10 | 090 | ||||||||||||
| 21260 | A | Revise eye sockets | 16.52 | NA | 13.54 | 1.25 | NA | 31.31 | 090 | ||||||||||||
| 21261 | A | Revise eye sockets | 31.49 | NA | 20.04 | 2.20 | NA | 53.73 | 090 | ||||||||||||
| 21263 | A | Revise eye sockets | 28.42 | NA | 15.09 | 2.16 | NA | 45.67 | 090 | ||||||||||||
| 21267 | A | Revise eye sockets | 18.90 | NA | 14.75 | 1.35 | NA | 35.00 | 090 | ||||||||||||
| 21268 | A | Revise eye sockets | 24.48 | NA | 15.15 | 0.79 | NA | 40.42 | 090 | ||||||||||||
| 21270 | A | Augmentation, cheek bone | 10.23 | 10.39 | 9.99 | 0.73 | 21.35 | 20.95 | 090 | ||||||||||||
| 21275 | A | Revision, orbitofacial bones | 11.24 | NA | 11.02 | 1.03 | NA | 23.29 | 090 | ||||||||||||
| 21280 | A | Revision of eyelid | 6.03 | NA | 6.27 | 0.27 | NA | 12.57 | 090 | ||||||||||||
| 21282 | A | Revision of eyelid | 3.49 | NA | 5.38 | 0.21 | NA | 9.08 | 090 | ||||||||||||
| 21295 | A | Revision of jaw muscle/bone | 1.53 | NA | 4.34 | 0.13 | NA | 6.00 | 090 | ||||||||||||
| 21296 | A | Revision of jaw muscle/bone | 4.25 | NA | 4.09 | 0.30 | NA | 8.64 | 090 | ||||||||||||
| 21299 | C | Cranio/maxillofacial surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 21300 | A | Treatment of skull fracture | 0.72 | 2.77 | 0.30 | 0.09 | 3.58 | 1.11 | 000 | ||||||||||||
| 21310 | A | Treatment of nose fracture | 0.58 | 2.70 | 0.15 | 0.05 | 3.33 | 0.78 | 000 | ||||||||||||
| 21315 | A | Treatment of nose fracture | 1.51 | 3.49 | 1.27 | 0.12 | 5.12 | 2.90 | 010 | ||||||||||||
| 21320 | A | Treatment of nose fracture | 1.85 | 4.96 | 2.10 | 0.15 | 6.96 | 4.10 | 010 | ||||||||||||
| 21325 | A | Treatment of nose fracture | 3.77 | NA | 3.73 | 0.31 | NA | 7.81 | 090 | ||||||||||||
| 21330 | A | Treatment of nose fracture | 5.38 | NA | 5.67 | 0.48 | NA | 11.53 | 090 | ||||||||||||
| 21335 | A | Treatment of nose fracture | 8.61 | NA | 7.34 | 0.64 | NA | 16.59 | 090 | ||||||||||||
| 21336 | A | Treat nasal septal fracture | 5.72 | NA | 5.74 | 0.45 | NA | 11.91 | 090 | ||||||||||||
| 21337 | A | Treat nasal septal fracture | 2.70 | 5.24 | 3.42 | 0.22 | 8.16 | 6.34 | 090 | ||||||||||||
| 21338 | A | Treat nasoethmoid fracture | 6.46 | NA | 5.75 | 0.53 | NA | 12.74 | 090 | ||||||||||||
| 21339 | A | Treat nasoethmoid fracture | 8.09 | NA | 6.97 | 0.76 | NA | 15.82 | 090 | ||||||||||||
| 21340 | A | Treatment of nose fracture | 10.77 | NA | 8.78 | 0.85 | NA | 20.40 | 090 | ||||||||||||
| 21343 | A | Treatment of sinus fracture | 12.95 | NA | 9.48 | 1.06 | NA | 23.49 | 090 | ||||||||||||
| 21344 | A | Treatment of sinus fracture | 19.72 | NA | 13.82 | 1.72 | NA | 35.26 | 090 | ||||||||||||
| 21345 | A | Treat nose/jaw fracture | 8.16 | 10.36 | 7.91 | 0.60 | 19.12 | 16.67 | 090 | ||||||||||||
| 21346 | A | Treat nose/jaw fracture | 10.61 | NA | 10.12 | 0.85 | NA | 21.58 | 090 | ||||||||||||
| 21347 | A | Treat nose/jaw fracture | 12.69 | NA | 9.68 | 1.14 | NA | 23.51 | 090 | ||||||||||||
| 21348 | A | Treat nose/jaw fracture | 16.69 | NA | 11.57 | 1.50 | NA | 29.76 | 090 | ||||||||||||
| 21355 | A | Treat cheek bone fracture | 3.77 | 3.89 | 2.54 | 0.29 | 7.95 | 6.60 | 010 | ||||||||||||
| 21356 | A | Treat cheek bone fracture | 4.15 | NA | 3.31 | 0.36 | NA | 7.82 | 010 | ||||||||||||
| 21360 | A | Treat cheek bone fracture | 6.46 | NA | 5.74 | 0.52 | NA | 12.72 | 090 | ||||||||||||
| 21365 | A | Treat cheek bone fracture | 14.95 | NA | 11.72 | 1.30 | NA | 27.97 | 090 | ||||||||||||
| 21366 | A | Treat cheek bone fracture | 17.77 | NA | 14.28 | 1.41 | NA | 33.46 | 090 | ||||||||||||
| 21385 | A | Treat eye socket fracture | 9.16 | NA | 8.04 | 0.64 | NA | 17.84 | 090 | ||||||||||||
| 21386 | A | Treat eye socket fracture | 9.16 | NA | 8.43 | 0.76 | NA | 18.35 | 090 | ||||||||||||
| 21387 | A | Treat eye socket fracture | 9.70 | NA | 8.55 | 0.78 | NA | 19.03 | 090 | ||||||||||||
| 21390 | A | Treat eye socket fracture | 10.13 | NA | 8.73 | 0.70 | NA | 19.56 | 090 | ||||||||||||
| 21395 | A | Treat eye socket fracture | 12.68 | NA | 9.24 | 1.09 | NA | 23.01 | 090 | ||||||||||||
| 21400 | A | Treat eye socket fracture | 1.40 | 3.29 | 1.05 | 0.12 | 4.81 | 2.57 | 090 | ||||||||||||
| 21401 | A | Treat eye socket fracture | 3.26 | 4.34 | 3.65 | 0.34 | 7.94 | 7.25 | 090 | ||||||||||||
| 21406 | A | Treat eye socket fracture | 7.01 | NA | 7.20 | 0.59 | NA | 14.80 | 090 | ||||||||||||
| 21407 | A | Treat eye socket fracture | 8.61 | NA | 7.99 | 0.67 | NA | 17.27 | 090 | ||||||||||||
| 21408 | A | Treat eye socket fracture | 12.38 | NA | 10.29 | 1.24 | NA | 23.91 | 090 | ||||||||||||
| 21421 | A | Treat mouth roof fracture | 5.14 | 7.23 | 6.84 | 0.42 | 12.79 | 12.40 | 090 | ||||||||||||
| 21422 | A | Treat mouth roof fracture | 8.32 | NA | 7.93 | 0.69 | NA | 16.94 | 090 | ||||||||||||
| 21423 | A | Treat mouth roof fracture | 10.40 | NA | 8.63 | 0.95 | NA | 19.98 | 090 | ||||||||||||
| 21431 | A | Treat craniofacial fracture | 7.05 | NA | 8.44 | 0.58 | NA | 16.07 | 090 | ||||||||||||
| 21432 | A | Treat craniofacial fracture | 8.61 | NA | 8.06 | 0.55 | NA | 17.22 | 090 | ||||||||||||
| 21433 | A | Treat craniofacial fracture | 25.35 | NA | 17.29 | 2.46 | NA | 45.10 | 090 | ||||||||||||
| 21435 | A | Treat craniofacial fracture | 17.25 | NA | 12.97 | 1.66 | NA | 31.88 | 090 | ||||||||||||
| 21436 | A | Treat craniofacial fracture | 28.04 | NA | 16.02 | 2.32 | NA | 46.38 | 090 | ||||||||||||
| 21440 | A | Treat dental ridge fracture | 2.70 | 5.44 | 3.73 | 0.22 | 8.36 | 6.65 | 090 | ||||||||||||
| 21445 | A | Treat dental ridge fracture | 5.38 | 7.14 | 5.04 | 0.55 | 13.07 | 10.97 | 090 | ||||||||||||
| 21450 | A | Treat lower jaw fracture | 2.97 | 6.45 | 2.90 | 0.23 | 9.65 | 6.10 | 090 | ||||||||||||
| 21451 | A | Treat lower jaw fracture | 4.87 | 6.46 | 6.11 | 0.39 | 11.72 | 11.37 | 090 | ||||||||||||
| 21452 | A | Treat lower jaw fracture | 1.98 | 13.44 | 4.35 | 0.14 | 15.56 | 6.47 | 090 | ||||||||||||
| 21453 | A | Treat lower jaw fracture | 5.54 | 7.32 | 6.69 | 0.49 | 13.35 | 12.72 | 090 | ||||||||||||
| 21454 | A | Treat lower jaw fracture | 6.46 | NA | 5.72 | 0.55 | NA | 12.73 | 090 | ||||||||||||
| 21461 | A | Treat lower jaw fracture | 8.09 | 8.40 | 8.26 | 0.73 | 17.22 | 17.08 | 090 | ||||||||||||
| 21462 | A | Treat lower jaw fracture | 9.79 | 10.06 | 8.18 | 0.80 | 20.65 | 18.77 | 090 | ||||||||||||
| 21465 | A | Treat lower jaw fracture | 11.91 | NA | 8.42 | 0.84 | NA | 21.17 | 090 | ||||||||||||
| 21470 | A | Treat lower jaw fracture | 15.34 | NA | 10.31 | 1.36 | NA | 27.01 | 090 | ||||||||||||
| 21480 | A | Reset dislocated jaw | 0.61 | 1.62 | 0.18 | 0.05 | 2.28 | 0.84 | 000 | ||||||||||||
| 21485 | A | Reset dislocated jaw | 3.99 | 3.82 | 3.34 | 0.31 | 8.12 | 7.64 | 090 | ||||||||||||
| 21490 | A | Repair dislocated jaw | 11.86 | NA | 7.69 | 1.31 | NA | 20.86 | 090 | ||||||||||||
| 21493 | A | Treat hyoid bone fracture | 1.27 | NA | 3.68 | 0.10 | NA | 5.05 | 090 | ||||||||||||
| 21494 | A | Treat hyoid bone fracture | 6.28 | NA | 4.21 | 0.44 | NA | 10.93 | 090 | ||||||||||||
| 21495 | A | Treat hyoid bone fracture | 5.69 | NA | 5.28 | 0.41 | NA | 11.38 | 090 | ||||||||||||
| 21497 | A | Interdental wiring | 3.86 | 4.68 | 3.81 | 0.31 | 8.85 | 7.98 | 090 | ||||||||||||
| 21499 | C | Head surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 21501 | A | Drain neck/chest lesion | 3.81 | 4.50 | 3.64 | 0.36 | 8.67 | 7.81 | 090 | ||||||||||||
| 21502 | A | Drain chest lesion | 7.12 | NA | 7.05 | 0.79 | NA | 14.96 | 090 | ||||||||||||
| 21510 | A | Drainage of bone lesion | 5.74 | NA | 7.47 | 0.67 | NA | 13.88 | 090 | ||||||||||||
| 21550 | A | Biopsy of neck/chest | 2.06 | 2.32 | 1.25 | 0.13 | 4.51 | 3.44 | 010 | ||||||||||||
| 21555 | A | Remove lesion, neck/chest | 4.35 | 4.25 | 2.43 | 0.41 | 9.01 | 7.19 | 090 | ||||||||||||
| 21556 | A | Remove lesion, neck/chest | 5.57 | NA | 3.29 | 0.51 | NA | 9.37 | 090 | ||||||||||||
| 21557 | A | Remove tumor, neck/chest | 8.88 | NA | 7.87 | 0.85 | NA | 17.60 | 090 | ||||||||||||
| 21600 | A | Partial removal of rib | 6.89 | NA | 7.80 | 0.81 | NA | 15.50 | 090 | ||||||||||||
| 21610 | A | Partial removal of rib | 14.61 | NA | 11.26 | 1.85 | NA | 27.72 | 090 | ||||||||||||
| 21615 | A | Removal of rib | 9.87 | NA | 7.90 | 1.20 | NA | 18.97 | 090 | ||||||||||||
| 21616 | A | Removal of rib and nerves | 12.04 | NA | 8.94 | 1.31 | NA | 22.29 | 090 | ||||||||||||
| 21620 | A | Partial removal of sternum | 6.79 | NA | 8.13 | 0.77 | NA | 15.69 | 090 | ||||||||||||
| 21627 | A | Sternal debridement | 6.81 | NA | 12.16 | 0.82 | NA | 19.79 | 090 | ||||||||||||
| 21630 | A | Extensive sternum surgery | 17.38 | NA | 14.03 | 1.95 | NA | 33.36 | 090 | ||||||||||||
| 21632 | A | Extensive sternum surgery | 18.14 | NA | 12.35 | 2.16 | NA | 32.65 | 090 | ||||||||||||
| 21700 | A | Revision of neck muscle | 6.19 | 8.63 | 7.19 | 0.31 | 15.13 | 13.69 | 090 | ||||||||||||
| 21705 | A | Revision of neck muscle/rib | 9.60 | NA | 7.87 | 0.92 | NA | 18.39 | 090 | ||||||||||||
| 21720 | A | Revision of neck muscle | 5.68 | 8.71 | 5.93 | 0.80 | 15.19 | 12.41 | 090 | ||||||||||||
| 21725 | A | Revision of neck muscle | 6.99 | NA | 7.28 | 0.90 | NA | 15.17 | 090 | ||||||||||||
| 21740 | A | Reconstruction of sternum | 16.50 | NA | 12.85 | 2.03 | NA | 31.38 | 090 | ||||||||||||
| 21750 | A | Repair of sternum separation | 10.77 | NA | 9.41 | 1.35 | NA | 21.53 | 090 | ||||||||||||
| 21800 | A | Treatment of rib fracture | 0.96 | 2.31 | 1.11 | 0.09 | 3.36 | 2.16 | 090 | ||||||||||||
| 21805 | A | Treatment of rib fracture | 2.75 | NA | 4.08 | 0.29 | NA | 7.12 | 090 | ||||||||||||
| 21810 | A | Treatment of rib fracture(s) | 6.86 | NA | 7.49 | 0.60 | NA | 14.95 | 090 | ||||||||||||
| 21820 | A | Treat sternum fracture | 1.28 | 2.80 | 1.58 | 0.15 | 4.23 | 3.01 | 090 | ||||||||||||
| 21825 | A | Treat sternum fracture | 7.41 | NA | 9.90 | 0.84 | NA | 18.15 | 090 | ||||||||||||
| 21899 | C | Neck/chest surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 21920 | A | Biopsy soft tissue of back | 2.06 | 2.40 | 0.77 | 0.12 | 4.58 | 2.95 | 010 | ||||||||||||
| 21925 | A | Biopsy soft tissue of back | 4.49 | 10.19 | 4.79 | 0.44 | 15.12 | 9.72 | 090 | ||||||||||||
| 21930 | A | Remove lesion, back or flank | 5.00 | 4.55 | 2.66 | 0.49 | 10.04 | 8.15 | 090 | ||||||||||||
| 21935 | A | Remove tumor, back | 17.96 | NA | 13.53 | 1.87 | NA | 33.36 | 090 | ||||||||||||
| 22100 | A | Remove part of neck vertebra | 9.73 | NA | 8.36 | 1.55 | NA | 19.64 | 090 | ||||||||||||
| 22101 | A | Remove part, thorax vertebra | 9.81 | NA | 9.04 | 1.51 | NA | 20.36 | 090 | ||||||||||||
| 22102 | A | Remove part, lumbar vertebra | 9.81 | NA | 9.18 | 1.46 | NA | 20.45 | 090 | ||||||||||||
| 22103 | A | Remove extra spine segment | 2.34 | NA | 1.27 | 0.37 | NA | 3.98 | ZZZ | ||||||||||||
| 22110 | A | Remove part of neck vertebra | 12.74 | NA | 11.06 | 2.20 | NA | 26.00 | 090 | ||||||||||||
| 22112 | A | Remove part, thorax vertebra | 12.81 | NA | 10.95 | 1.96 | NA | 25.72 | 090 | ||||||||||||
| 22114 | A | Remove part, lumbar vertebra | 12.81 | NA | 10.71 | 1.98 | NA | 25.50 | 090 | ||||||||||||
| 22116 | A | Remove extra spine segment | 2.32 | NA | 1.26 | 0.40 | NA | 3.98 | ZZZ | ||||||||||||
| 22210 | A | Revision of neck spine | 23.82 | NA | 17.42 | 4.23 | NA | 45.47 | 090 | ||||||||||||
| 22212 | A | Revision of thorax spine | 19.42 | NA | 14.60 | 2.78 | NA | 36.80 | 090 | ||||||||||||
| 22214 | A | Revision of lumbar spine | 19.45 | NA | 15.32 | 2.78 | NA | 37.55 | 090 | ||||||||||||
| 22216 | A | Revise, extra spine segment | 6.04 | NA | 3.31 | 0.98 | NA | 10.33 | ZZZ | ||||||||||||
| 22220 | A | Revision of neck spine | 21.37 | NA | 15.61 | 3.65 | NA | 40.63 | 090 | ||||||||||||
| 22222 | A | Revision of thorax spine | 21.52 | NA | 15.08 | 3.08 | NA | 39.68 | 090 | ||||||||||||
| 22224 | A | Revision of lumbar spine | 21.52 | NA | 15.70 | 3.20 | NA | 40.42 | 090 | ||||||||||||
| 22226 | A | Revise, extra spine segment | 6.04 | NA | 3.22 | 1.01 | NA | 10.27 | ZZZ | ||||||||||||
| 22305 | A | Treat spine process fracture | 2.05 | 3.25 | 2.01 | 0.29 | 5.59 | 4.35 | 090 | ||||||||||||
| 22310 | A | Treat spine fracture | 2.61 | 4.77 | 3.54 | 0.37 | 7.75 | 6.52 | 090 | ||||||||||||
| 22315 | A | Treat spine fracture | 8.84 | NA | 9.32 | 1.37 | NA | 19.53 | 090 | ||||||||||||
| 22318 | A | Treat odontoid fx w/o graft | 21.50 | NA | 15.02 | 4.26 | NA | 40.78 | 090 | ||||||||||||
| 22319 | A | Treat odontoid fx w/graft | 24.00 | NA | 17.42 | 4.76 | NA | 46.18 | 090 | ||||||||||||
| 22325 | A | Treat spine fracture | 18.30 | NA | 14.94 | 2.61 | NA | 35.85 | 090 | ||||||||||||
| 22326 | A | Treat neck spine fracture | 19.59 | NA | 15.67 | 3.54 | NA | 38.80 | 090 | ||||||||||||
| 22327 | A | Treat thorax spine fracture | 19.20 | NA | 15.43 | 2.75 | NA | 37.38 | 090 | ||||||||||||
| 22328 | A | Treat each add spine fx | 4.61 | NA | 2.43 | 0.66 | NA | 7.70 | ZZZ | ||||||||||||
| 22505 | A | Manipulation of spine | 1.87 | 4.58 | 3.20 | 0.27 | 6.72 | 5.34 | 010 | ||||||||||||
| 22520 | A | Percut vertebroplasty thor | 8.91 | NA | 4.15 | 0.99 | NA | 14.05 | 010 | ||||||||||||
| 22521 | A | Percut vertebroplasty lumb | 8.34 | NA | 3.92 | 0.93 | NA | 13.19 | 010 | ||||||||||||
| 22522 | A | Percut vertebroplasty addl | 4.31 | NA | 1.75 | 0.33 | NA | 6.39 | ZZZ | ||||||||||||
| 22548 | A | Neck spine fusion | 25.82 | NA | 18.08 | 4.98 | NA | 48.88 | 090 | ||||||||||||
| 22554 | A | Neck spine fusion | 18.62 | NA | 13.94 | 3.51 | NA | 36.07 | 090 | ||||||||||||
| 22556 | A | Thorax spine fusion | 23.46 | NA | 16.80 | 3.78 | NA | 44.04 | 090 | ||||||||||||
| 22558 | A | Lumbar spine fusion | 22.28 | NA | 15.27 | 3.18 | NA | 40.73 | 090 | ||||||||||||
| 22585 | A | Additional spinal fusion | 5.53 | NA | 2.94 | 0.98 | NA | 9.45 | ZZZ | ||||||||||||
| 22590 | A | Spine skull spinal fusion | 20.51 | NA | 15.56 | 3.81 | NA | 39.88 | 090 | ||||||||||||
| 22595 | A | Neck spinal fusion | 19.39 | NA | 14.58 | 3.62 | NA | 37.59 | 090 | ||||||||||||
| 22600 | A | Neck spine fusion | 16.14 | NA | 12.66 | 2.89 | NA | 31.69 | 090 | ||||||||||||
| 22610 | A | Thorax spine fusion | 16.02 | NA | 12.98 | 2.66 | NA | 31.66 | 090 | ||||||||||||
| 22612 | A | Lumbar spine fusion | 21.00 | NA | 15.75 | 3.28 | NA | 40.03 | 090 | ||||||||||||
| 22614 | A | Spine fusion, extra segment | 6.44 | NA | 3.54 | 1.04 | NA | 11.02 | ZZZ | ||||||||||||
| 22630 | A | Lumbar spine fusion | 20.84 | NA | 16.01 | 3.79 | NA | 40.64 | 090 | ||||||||||||
| 22632 | A | Spine fusion, extra segment | 5.23 | NA | 2.75 | 0.90 | NA | 8.88 | ZZZ | ||||||||||||
| 22800 | A | Fusion of spine | 18.25 | NA | 14.30 | 2.71 | NA | 35.26 | 090 | ||||||||||||
| 22802 | A | Fusion of spine | 30.88 | NA | 21.88 | 4.42 | NA | 57.18 | 090 | ||||||||||||
| 22804 | A | Fusion of spine | 36.27 | NA | 24.48 | 5.23 | NA | 65.98 | 090 | ||||||||||||
| 22808 | A | Fusion of spine | 26.27 | NA | 18.27 | 4.36 | NA | 48.90 | 090 | ||||||||||||
| 22810 | A | Fusion of spine | 30.27 | NA | 19.63 | 4.49 | NA | 54.39 | 090 | ||||||||||||
| 22812 | A | Fusion of spine | 32.70 | NA | 21.89 | 4.67 | NA | 59.26 | 090 | ||||||||||||
| 22818 | A | Kyphectomy, 1-2 segments | 31.83 | NA | 21.69 | 5.01 | NA | 58.53 | 090 | ||||||||||||
| 22819 | A | Kyphectomy, 3 or more | 36.44 | NA | 22.19 | 5.20 | NA | 63.83 | 090 | ||||||||||||
| 22830 | A | Exploration of spinal fusion | 10.85 | NA | 10.05 | 1.73 | NA | 22.63 | 090 | ||||||||||||
| 22840 | A | Insert spine fixation device | 12.54 | NA | 6.84 | 2.03 | NA | 21.41 | ZZZ | ||||||||||||
| 22841 | B | Insert spine fixation device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 22842 | A | Insert spine fixation device | 12.58 | NA | 6.83 | 2.04 | NA | 21.45 | ZZZ | ||||||||||||
| 22843 | A | Insert spine fixation device | 13.46 | NA | 7.39 | 2.10 | NA | 22.95 | ZZZ | ||||||||||||
| 22844 | A | Insert spine fixation device | 16.44 | NA | 9.26 | 2.42 | NA | 28.12 | ZZZ | ||||||||||||
| 22845 | A | Insert spine fixation device | 11.96 | NA | 6.38 | 2.22 | NA | 20.56 | ZZZ | ||||||||||||
| 22846 | A | Insert spine fixation device | 12.42 | NA | 6.70 | 2.26 | NA | 21.38 | ZZZ | ||||||||||||
| 22847 | A | Insert spine fixation device | 13.80 | NA | 7.08 | 2.36 | NA | 23.24 | ZZZ | ||||||||||||
| 22848 | A | Insert pelv fixation device | 6.00 | NA | 3.38 | 0.88 | NA | 10.26 | ZZZ | ||||||||||||
| 22849 | A | Reinsert spinal fixation | 18.51 | NA | 14.22 | 2.87 | NA | 35.60 | 090 | ||||||||||||
| 22850 | A | Remove spine fixation device | 9.52 | NA | 8.89 | 1.51 | NA | 19.92 | 090 | ||||||||||||
| 22851 | A | Apply spine prosth device | 6.71 | NA | 3.54 | 1.11 | NA | 11.36 | ZZZ | ||||||||||||
| 22852 | A | Remove spine fixation device | 9.01 | NA | 8.60 | 1.40 | NA | 19.01 | 090 | ||||||||||||
| 22855 | A | Remove spine fixation device | 15.13 | NA | 11.67 | 2.74 | NA | 29.54 | 090 | ||||||||||||
| 22899 | C | Spine surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 22900 | A | Remove abdominal wall lesion | 5.80 | NA | 4.42 | 0.58 | NA | 10.80 | 090 | ||||||||||||
| 22999 | C | Abdomen surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 23000 | A | Removal of calcium deposits | 4.36 | 9.04 | 6.97 | 0.50 | 13.90 | 11.83 | 090 | ||||||||||||
| 23020 | A | Release shoulder joint | 8.93 | NA | 10.53 | 1.23 | NA | 20.69 | 090 | ||||||||||||
| 23030 | A | Drain shoulder lesion | 3.43 | 6.40 | 4.44 | 0.42 | 10.25 | 8.29 | 010 | ||||||||||||
| 23031 | A | Drain shoulder bursa | 2.74 | 5.80 | 4.16 | 0.33 | 8.87 | 7.23 | 010 | ||||||||||||
| 23035 | A | Drain shoulder bone lesion | 8.61 | NA | 16.13 | 1.19 | NA | 25.93 | 090 | ||||||||||||
| 23040 | A | Exploratory shoulder surgery | 9.20 | NA | 11.71 | 1.28 | NA | 22.19 | 090 | ||||||||||||
| 23044 | A | Exploratory shoulder surgery | 7.12 | NA | 10.73 | 0.97 | NA | 18.82 | 090 | ||||||||||||
| 23065 | A | Biopsy shoulder tissues | 2.27 | 2.61 | 1.34 | 0.14 | 5.02 | 3.75 | 010 | ||||||||||||
| 23066 | A | Biopsy shoulder tissues | 4.16 | 8.34 | 6.16 | 0.50 | 13.00 | 10.82 | 090 | ||||||||||||
| 23075 | A | Removal of shoulder lesion | 2.39 | 5.40 | 3.17 | 0.25 | 8.04 | 5.81 | 010 | ||||||||||||
| 23076 | A | Removal of shoulder lesion | 7.63 | NA | 8.36 | 0.87 | NA | 16.86 | 090 | ||||||||||||
| 23077 | A | Remove tumor of shoulder | 16.09 | NA | 14.41 | 1.81 | NA | 32.31 | 090 | ||||||||||||
| 23100 | A | Biopsy of shoulder joint | 6.03 | NA | 8.73 | 0.81 | NA | 15.57 | 090 | ||||||||||||
| 23101 | A | Shoulder joint surgery | 5.58 | NA | 8.63 | 0.77 | NA | 14.98 | 090 | ||||||||||||
| 23105 | A | Remove shoulder joint lining | 8.23 | NA | 10.18 | 1.13 | NA | 19.54 | 090 | ||||||||||||
| 23106 | A | Incision of collarbone joint | 5.96 | NA | 9.27 | 0.82 | NA | 16.05 | 090 | ||||||||||||
| 23107 | A | Explore treat shoulder joint | 8.62 | NA | 10.41 | 1.19 | NA | 20.22 | 090 | ||||||||||||
| 23120 | A | Partial removal, collar bone | 7.11 | NA | 9.55 | 0.99 | NA | 17.65 | 090 | ||||||||||||
| 23125 | A | Removal of collar bone | 9.39 | NA | 10.78 | 1.27 | NA | 21.44 | 090 | ||||||||||||
| 23130 | A | Remove shoulder bone, part | 7.55 | NA | 9.82 | 1.06 | NA | 18.43 | 090 | ||||||||||||
| 23140 | A | Removal of bone lesion | 6.89 | NA | 8.31 | 0.82 | NA | 16.02 | 090 | ||||||||||||
| 23145 | A | Removal of bone lesion | 9.09 | NA | 10.87 | 1.24 | NA | 21.20 | 090 | ||||||||||||
| 23146 | A | Removal of bone lesion | 7.83 | NA | 10.70 | 1.11 | NA | 19.64 | 090 | ||||||||||||
| 23150 | A | Removal of humerus lesion | 8.48 | NA | 10.14 | 1.14 | NA | 19.76 | 090 | ||||||||||||
| 23155 | A | Removal of humerus lesion | 10.35 | NA | 12.33 | 1.20 | NA | 23.88 | 090 | ||||||||||||
| 23156 | A | Removal of humerus lesion | 8.68 | NA | 10.45 | 1.18 | NA | 20.31 | 090 | ||||||||||||
| 23170 | A | Remove collar bone lesion | 6.86 | NA | 11.33 | 0.84 | NA | 19.03 | 090 | ||||||||||||
| 23172 | A | Remove shoulder blade lesion | 6.90 | NA | 9.59 | 0.95 | NA | 17.44 | 090 | ||||||||||||
| 23174 | A | Remove humerus lesion | 9.51 | NA | 11.74 | 1.30 | NA | 22.55 | 090 | ||||||||||||
| 23180 | A | Remove collar bone lesion | 8.53 | NA | 16.16 | 1.18 | NA | 25.87 | 090 | ||||||||||||
| 23182 | A | Remove shoulder blade lesion | 8.15 | NA | 16.18 | 1.08 | NA | 25.41 | 090 | ||||||||||||
| 23184 | A | Remove humerus lesion | 9.38 | NA | 16.43 | 1.24 | NA | 27.05 | 090 | ||||||||||||
| 23190 | A | Partial removal of scapula | 7.24 | NA | 8.74 | 0.97 | NA | 16.95 | 090 | ||||||||||||
| 23195 | A | Removal of head of humerus | 9.81 | NA | 10.03 | 1.38 | NA | 21.22 | 090 | ||||||||||||
| 23200 | A | Removal of collar bone | 12.08 | NA | 14.39 | 1.48 | NA | 27.95 | 090 | ||||||||||||
| 23210 | A | Removal of shoulder blade | 12.49 | NA | 13.96 | 1.61 | NA | 28.06 | 090 | ||||||||||||
| 23220 | A | Partial removal of humerus | 14.56 | NA | 15.57 | 2.03 | NA | 32.16 | 090 | ||||||||||||
| 23221 | A | Partial removal of humerus | 17.74 | NA | 16.93 | 2.51 | NA | 37.18 | 090 | ||||||||||||
| 23222 | A | Partial removal of humerus | 23.92 | NA | 20.66 | 3.37 | NA | 47.95 | 090 | ||||||||||||
| 23330 | A | Remove shoulder foreign body | 1.85 | 6.15 | 3.49 | 0.18 | 8.18 | 5.52 | 010 | ||||||||||||
| 23331 | A | Remove shoulder foreign body | 7.38 | NA | 9.70 | 1.02 | NA | 18.10 | 090 | ||||||||||||
| 23332 | A | Remove shoulder foreign body | 11.62 | NA | 12.12 | 1.62 | NA | 25.36 | 090 | ||||||||||||
| 23350 | A | Injection for shoulder x-ray | 1.00 | 7.22 | 0.35 | 0.05 | 8.27 | 1.40 | 000 | ||||||||||||
| 23395 | A | Muscle transfer, shoulder/arm | 16.85 | NA | 14.09 | 2.29 | NA | 33.23 | 090 | ||||||||||||
| 23397 | A | Muscle transfers | 16.13 | NA | 13.86 | 2.24 | NA | 32.23 | 090 | ||||||||||||
| 23400 | A | Fixation of shoulder blade | 13.54 | NA | 14.52 | 1.91 | NA | 29.97 | 090 | ||||||||||||
| 23405 | A | Incision of tendon muscle | 8.37 | NA | 9.66 | 1.12 | NA | 19.15 | 090 | ||||||||||||
| 23406 | A | Incise tendon(s) muscle(s) | 10.79 | NA | 11.55 | 1.48 | NA | 23.82 | 090 | ||||||||||||
| 23410 | A | Repair of tendon(s) | 12.45 | NA | 12.55 | 1.72 | NA | 26.72 | 090 | ||||||||||||
| 23412 | A | Repair of tendon(s) | 13.31 | NA | 13.05 | 1.86 | NA | 28.22 | 090 | ||||||||||||
| 23415 | A | Release of shoulder ligament | 9.97 | NA | 10.22 | 1.39 | NA | 21.58 | 090 | ||||||||||||
| 23420 | A | Repair of shoulder | 13.30 | NA | 13.94 | 1.86 | NA | 29.10 | 090 | ||||||||||||
| 23430 | A | Repair biceps tendon | 9.98 | NA | 11.15 | 1.40 | NA | 22.53 | 090 | ||||||||||||
| 23440 | A | Remove/transplant tendon | 10.48 | NA | 11.54 | 1.47 | NA | 23.49 | 090 | ||||||||||||
| 23450 | A | Repair shoulder capsule | 13.40 | NA | 13.02 | 1.86 | NA | 28.28 | 090 | ||||||||||||
| 23455 | A | Repair shoulder capsule | 14.37 | NA | 13.62 | 2.01 | NA | 30.00 | 090 | ||||||||||||
| 23460 | A | Repair shoulder capsule | 15.37 | NA | 14.21 | 2.17 | NA | 31.75 | 090 | ||||||||||||
| 23462 | A | Repair shoulder capsule | 15.30 | NA | 13.68 | 2.16 | NA | 31.14 | 090 | ||||||||||||
| 23465 | A | Repair shoulder capsule | 15.85 | NA | 14.47 | 1.61 | NA | 31.93 | 090 | ||||||||||||
| 23466 | A | Repair shoulder capsule | 14.22 | NA | 13.63 | 2.00 | NA | 29.85 | 090 | ||||||||||||
| 23470 | A | Reconstruct shoulder joint | 17.15 | NA | 15.16 | 2.40 | NA | 34.71 | 090 | ||||||||||||
| 23472 | A | Reconstruct shoulder joint | 21.10 | NA | 17.40 | 2.37 | NA | 40.87 | 090 | ||||||||||||
| 23480 | A | Revision of collar bone | 11.18 | NA | 11.94 | 1.56 | NA | 24.68 | 090 | ||||||||||||
| 23485 | A | Revision of collar bone | 13.43 | NA | 13.10 | 1.84 | NA | 28.37 | 090 | ||||||||||||
| 23490 | A | Reinforce clavicle | 11.86 | NA | 13.74 | 1.11 | NA | 26.71 | 090 | ||||||||||||
| 23491 | A | Reinforce shoulder bones | 14.21 | NA | 13.54 | 2.00 | NA | 29.75 | 090 | ||||||||||||
| 23500 | A | Treat clavicle fracture | 2.08 | 3.87 | 2.60 | 0.26 | 6.21 | 4.94 | 090 | ||||||||||||
| 23505 | A | Treat clavicle fracture | 3.69 | 5.98 | 4.02 | 0.50 | 10.17 | 8.21 | 090 | ||||||||||||
| 23515 | A | Treat clavicle fracture | 7.41 | NA | 8.24 | 1.03 | NA | 16.68 | 090 | ||||||||||||
| 23520 | A | Treat clavicle dislocation | 2.16 | 3.91 | 2.67 | 0.26 | 6.33 | 5.09 | 090 | ||||||||||||
| 23525 | A | Treat clavicle dislocation | 3.60 | 7.16 | 4.08 | 0.44 | 11.20 | 8.12 | 090 | ||||||||||||
| 23530 | A | Treat clavicle dislocation | 7.31 | NA | 7.94 | 0.85 | NA | 16.10 | 090 | ||||||||||||
| 23532 | A | Treat clavicle dislocation | 8.01 | NA | 8.67 | 1.13 | NA | 17.81 | 090 | ||||||||||||
| 23540 | A | Treat clavicle dislocation | 2.23 | 4.56 | 2.63 | 0.24 | 7.03 | 5.10 | 090 | ||||||||||||
| 23545 | A | Treat clavicle dislocation | 3.25 | 4.99 | 3.65 | 0.39 | 8.63 | 7.29 | 090 | ||||||||||||
| 23550 | A | Treat clavicle dislocation | 7.24 | NA | 8.29 | 0.94 | NA | 16.47 | 090 | ||||||||||||
| 23552 | A | Treat clavicle dislocation | 8.45 | NA | 8.82 | 1.18 | NA | 18.45 | 090 | ||||||||||||
| 23570 | A | Treat shoulder blade fx | 2.23 | 3.84 | 2.70 | 0.29 | 6.36 | 5.22 | 090 | ||||||||||||
| 23575 | A | Treat shoulder blade fx | 4.06 | 6.22 | 4.18 | 0.53 | 10.81 | 8.77 | 090 | ||||||||||||
| 23585 | A | Treat scapula fracture | 8.96 | NA | 9.31 | 1.25 | NA | 19.52 | 090 | ||||||||||||
| 23600 | A | Treat humerus fracture | 2.93 | 5.65 | 3.71 | 0.39 | 8.97 | 7.03 | 090 | ||||||||||||
| 23605 | A | Treat humerus fracture | 4.87 | 8.32 | 6.55 | 0.67 | 13.86 | 12.09 | 090 | ||||||||||||
| 23615 | A | Treat humerus fracture | 9.35 | NA | 10.19 | 1.31 | NA | 20.85 | 090 | ||||||||||||
| 23616 | A | Treat humerus fracture | 21.27 | NA | 16.26 | 2.98 | NA | 40.51 | 090 | ||||||||||||
| 23620 | A | Treat humerus fracture | 2.40 | 5.35 | 3.43 | 0.32 | 8.07 | 6.15 | 090 | ||||||||||||
| 23625 | A | Treat humerus fracture | 3.93 | 7.35 | 5.57 | 0.53 | 11.81 | 10.03 | 090 | ||||||||||||
| 23630 | A | Treat humerus fracture | 7.35 | NA | 8.20 | 1.03 | NA | 16.58 | 090 | ||||||||||||
| 23650 | A | Treat shoulder dislocation | 3.39 | 5.58 | 3.67 | 0.31 | 9.28 | 7.37 | 090 | ||||||||||||
| 23655 | A | Treat shoulder dislocation | 4.57 | NA | 4.39 | 0.52 | NA | 9.48 | 090 | ||||||||||||
| 23660 | A | Treat shoulder dislocation | 7.49 | NA | 8.27 | 1.01 | NA | 16.77 | 090 | ||||||||||||
| 23665 | A | Treat dislocation/fracture | 4.47 | 7.68 | 5.81 | 0.60 | 12.75 | 10.88 | 090 | ||||||||||||
| 23670 | A | Treat dislocation/fracture | 7.90 | NA | 8.72 | 1.10 | NA | 17.72 | 090 | ||||||||||||
| 23675 | A | Treat dislocation/fracture | 6.05 | 8.22 | 6.71 | 0.83 | 15.10 | 13.59 | 090 | ||||||||||||
| 23680 | A | Treat dislocation/fracture | 10.06 | NA | 9.89 | 1.39 | NA | 21.34 | 090 | ||||||||||||
| 23700 | A | Fixation of shoulder | 2.52 | NA | 3.48 | 0.35 | NA | 6.35 | 010 | ||||||||||||
| 23800 | A | Fusion of shoulder joint | 14.16 | NA | 14.28 | 1.97 | NA | 30.41 | 090 | ||||||||||||
| 23802 | A | Fusion of shoulder joint | 16.60 | NA | 15.83 | 2.34 | NA | 34.77 | 090 | ||||||||||||
| 23900 | A | Amputation of arm girdle | 19.72 | NA | 16.35 | 2.47 | NA | 38.54 | 090 | ||||||||||||
| 23920 | A | Amputation at shoulder joint | 14.61 | NA | 13.70 | 1.92 | NA | 30.23 | 090 | ||||||||||||
| 23921 | A | Amputation follow-up surgery | 5.49 | NA | 6.67 | 0.78 | NA | 12.94 | 090 | ||||||||||||
| 23929 | C | Shoulder surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 23930 | A | Drainage of arm lesion | 2.94 | 6.10 | 4.01 | 0.32 | 9.36 | 7.27 | 010 | ||||||||||||
| 23931 | A | Drainage of arm bursa | 1.79 | 5.76 | 3.74 | 0.21 | 7.76 | 5.74 | 010 | ||||||||||||
| 23935 | A | Drain arm/elbow bone lesion | 6.09 | NA | 12.90 | 0.84 | NA | 19.83 | 090 | ||||||||||||
| 24000 | A | Exploratory elbow surgery | 5.82 | NA | 6.06 | 0.77 | NA | 12.65 | 090 | ||||||||||||
| 24006 | A | Release elbow joint | 9.31 | NA | 8.64 | 1.27 | NA | 19.22 | 090 | ||||||||||||
| 24065 | A | Biopsy arm/elbow soft tissue | 2.08 | 5.50 | 3.25 | 0.14 | 7.72 | 5.47 | 010 | ||||||||||||
| 24066 | A | Biopsy arm/elbow soft tissue | 5.21 | 8.48 | 6.40 | 0.61 | 14.30 | 12.22 | 090 | ||||||||||||
| 24075 | A | Remove arm/elbow lesion | 3.92 | 7.80 | 5.91 | 0.43 | 12.15 | 10.26 | 090 | ||||||||||||
| 24076 | A | Remove arm/elbow lesion | 6.30 | NA | 7.39 | 0.70 | NA | 14.39 | 090 | ||||||||||||
| 24077 | A | Remove tumor of arm/elbow | 11.76 | NA | 14.23 | 1.32 | NA | 27.31 | 090 | ||||||||||||
| 24100 | A | Biopsy elbow joint lining | 4.93 | NA | 5.83 | 0.62 | NA | 11.38 | 090 | ||||||||||||
| 24101 | A | Explore/treat elbow joint | 6.13 | NA | 6.82 | 0.84 | NA | 13.79 | 090 | ||||||||||||
| 24102 | A | Remove elbow joint lining | 8.03 | NA | 7.81 | 1.09 | NA | 16.93 | 090 | ||||||||||||
| 24105 | A | Removal of elbow bursa | 3.61 | NA | 5.26 | 0.49 | NA | 9.36 | 090 | ||||||||||||
| 24110 | A | Remove humerus lesion | 7.39 | NA | 9.75 | 0.99 | NA | 18.13 | 090 | ||||||||||||
| 24115 | A | Remove/graft bone lesion | 9.63 | NA | 10.80 | 1.15 | NA | 21.58 | 090 | ||||||||||||
| 24116 | A | Remove/graft bone lesion | 11.81 | NA | 12.20 | 1.66 | NA | 25.67 | 090 | ||||||||||||
| 24120 | A | Remove elbow lesion | 6.65 | NA | 6.96 | 0.87 | NA | 14.48 | 090 | ||||||||||||
| 24125 | A | Remove/graft bone lesion | 7.89 | NA | 6.67 | 0.88 | NA | 15.44 | 090 | ||||||||||||
| 24126 | A | Remove/graft bone lesion | 8.31 | NA | 7.79 | 0.90 | NA | 17.00 | 090 | ||||||||||||
| 24130 | A | Removal of head of radius | 6.25 | NA | 6.91 | 0.87 | NA | 14.03 | 090 | ||||||||||||
| 24134 | A | Removal of arm bone lesion | 9.73 | NA | 16.50 | 1.31 | NA | 27.54 | 090 | ||||||||||||
| 24136 | A | Remove radius bone lesion | 7.99 | NA | 7.09 | 0.85 | NA | 15.93 | 090 | ||||||||||||
| 24138 | A | Remove elbow bone lesion | 8.05 | NA | 8.06 | 1.12 | NA | 17.23 | 090 | ||||||||||||
| 24140 | A | Partial removal of arm bone | 9.18 | NA | 16.67 | 1.23 | NA | 27.08 | 090 | ||||||||||||
| 24145 | A | Partial removal of radius | 7.58 | NA | 11.43 | 1.01 | NA | 20.02 | 090 | ||||||||||||
| 24147 | A | Partial removal of elbow | 7.54 | NA | 11.40 | 1.04 | NA | 19.98 | 090 | ||||||||||||
| 24149 | A | Radical resection of elbow | 14.20 | NA | 11.28 | 1.90 | NA | 27.38 | 090 | ||||||||||||
| 24150 | A | Extensive humerus surgery | 13.27 | NA | 14.92 | 1.81 | NA | 30.00 | 090 | ||||||||||||
| 24151 | A | Extensive humerus surgery | 15.58 | NA | 16.64 | 2.19 | NA | 34.41 | 090 | ||||||||||||
| 24152 | A | Extensive radius surgery | 10.06 | NA | 9.96 | 1.19 | NA | 21.21 | 090 | ||||||||||||
| 24153 | A | Extensive radius surgery | 11.54 | NA | 7.55 | 0.64 | NA | 19.73 | 090 | ||||||||||||
| 24155 | A | Removal of elbow joint | 11.73 | NA | 9.66 | 1.42 | NA | 22.81 | 090 | ||||||||||||
| 24160 | A | Remove elbow joint implant | 7.83 | NA | 7.77 | 1.07 | NA | 16.67 | 090 | ||||||||||||
| 24164 | A | Remove radius head implant | 6.23 | NA | 6.93 | 0.84 | NA | 14.00 | 090 | ||||||||||||
| 24200 | A | Removal of arm foreign body | 1.76 | 5.80 | 3.25 | 0.15 | 7.71 | 5.16 | 010 | ||||||||||||
| 24201 | A | Removal of arm foreign body | 4.56 | 8.42 | 6.97 | 0.56 | 13.54 | 12.09 | 090 | ||||||||||||
| 24220 | A | Injection for elbow x-ray | 1.31 | 11.16 | 0.47 | 0.07 | 12.54 | 1.85 | 000 | ||||||||||||
| 24300 | A | Manipulate elbow w/anesth | 3.75 | NA | 5.46 | 0.52 | NA | 9.73 | 090 | ||||||||||||
| 24301 | A | Muscle/tendon transfer | 10.20 | NA | 9.11 | 1.30 | NA | 20.61 | 090 | ||||||||||||
| 24305 | A | Arm tendon lengthening | 7.45 | NA | 7.70 | 0.98 | NA | 16.13 | 090 | ||||||||||||
| 24310 | A | Revision of arm tendon | 5.98 | NA | 8.43 | 0.74 | NA | 15.15 | 090 | ||||||||||||
| 24320 | A | Repair of arm tendon | 10.56 | NA | 11.29 | 1.00 | NA | 22.85 | 090 | ||||||||||||
| 24330 | A | Revision of arm muscles | 9.60 | NA | 8.79 | 1.21 | NA | 19.60 | 090 | ||||||||||||
| 24331 | A | Revision of arm muscles | 10.65 | NA | 9.25 | 1.41 | NA | 21.31 | 090 | ||||||||||||
| 24332 | A | Tenolysis, triceps | 7.45 | NA | 5.23 | 0.77 | NA | 13.45 | 090 | ||||||||||||
| 24340 | A | Repair of biceps tendon | 7.89 | NA | 7.74 | 1.08 | NA | 16.71 | 090 | ||||||||||||
| 24341 | A | Repair arm tendon/muscle | 7.90 | NA | 7.85 | 1.08 | NA | 16.83 | 090 | ||||||||||||
| 24342 | A | Repair of ruptured tendon | 10.62 | NA | 9.37 | 1.48 | NA | 21.47 | 090 | ||||||||||||
| 24343 | A | Repr elbow lat ligmnt w/tiss | 8.65 | NA | 7.91 | 1.21 | NA | 17.77 | 090 | ||||||||||||
| 24344 | A | Reconstruct elbow lat ligmnt | 14.00 | NA | 10.87 | 1.95 | NA | 26.82 | 090 | ||||||||||||
| 24345 | A | Repr elbw med ligmnt w/tiss | 8.65 | NA | 7.91 | 1.21 | NA | 17.77 | 090 | ||||||||||||
| 24346 | A | Reconstruct elbow med ligmnt | 14.00 | NA | 10.87 | 1.95 | NA | 26.82 | 090 | ||||||||||||
| 24350 | A | Repair of tennis elbow | 5.25 | NA | 6.25 | 0.72 | NA | 12.22 | 090 | ||||||||||||
| 24351 | A | Repair of tennis elbow | 5.91 | NA | 6.72 | 0.82 | NA | 13.45 | 090 | ||||||||||||
| 24352 | A | Repair of tennis elbow | 6.43 | NA | 7.01 | 0.90 | NA | 14.34 | 090 | ||||||||||||
| 24354 | A | Repair of tennis elbow | 6.48 | NA | 6.85 | 0.88 | NA | 14.21 | 090 | ||||||||||||
| 24356 | A | Revision of tennis elbow | 6.68 | NA | 7.21 | 0.90 | NA | 14.79 | 090 | ||||||||||||
| 24360 | A | Reconstruct elbow joint | 12.34 | NA | 10.26 | 1.69 | NA | 24.29 | 090 | ||||||||||||
| 24361 | A | Reconstruct elbow joint | 14.08 | NA | 11.30 | 1.95 | NA | 27.33 | 090 | ||||||||||||
| 24362 | A | Reconstruct elbow joint | 14.99 | NA | 11.30 | 1.92 | NA | 28.21 | 090 | ||||||||||||
| 24363 | A | Replace elbow joint | 18.49 | NA | 13.80 | 2.52 | NA | 34.81 | 090 | ||||||||||||
| 24365 | A | Reconstruct head of radius | 8.39 | NA | 7.96 | 1.11 | NA | 17.46 | 090 | ||||||||||||
| 24366 | A | Reconstruct head of radius | 9.13 | NA | 8.48 | 1.28 | NA | 18.89 | 090 | ||||||||||||
| 24400 | A | Revision of humerus | 11.06 | NA | 12.48 | 1.53 | NA | 25.07 | 090 | ||||||||||||
| 24410 | A | Revision of humerus | 14.82 | NA | 13.75 | 1.89 | NA | 30.46 | 090 | ||||||||||||
| 24420 | A | Revision of humerus | 13.44 | NA | 16.08 | 1.82 | NA | 31.34 | 090 | ||||||||||||
| 24430 | A | Repair of humerus | 12.81 | NA | 12.88 | 1.80 | NA | 27.49 | 090 | ||||||||||||
| 24435 | A | Repair humerus with graft | 13.17 | NA | 13.98 | 1.84 | NA | 28.99 | 090 | ||||||||||||
| 24470 | A | Revision of elbow joint | 8.74 | NA | 6.59 | 1.23 | NA | 16.56 | 090 | ||||||||||||
| 24495 | A | Decompression of forearm | 8.12 | NA | 10.33 | 0.92 | NA | 19.37 | 090 | ||||||||||||
| 24498 | A | Reinforce humerus | 11.92 | NA | 12.31 | 1.67 | NA | 25.90 | 090 | ||||||||||||
| 24500 | A | Treat humerus fracture | 3.21 | 5.09 | 3.38 | 0.41 | 8.71 | 7.00 | 090 | ||||||||||||
| 24505 | A | Treat humerus fracture | 5.17 | 8.88 | 6.81 | 0.72 | 14.77 | 12.70 | 090 | ||||||||||||
| 24515 | A | Treat humerus fracture | 11.65 | NA | 11.40 | 1.63 | NA | 24.68 | 090 | ||||||||||||
| 24516 | A | Treat humerus fracture | 11.65 | NA | 11.85 | 1.63 | NA | 25.13 | 090 | ||||||||||||
| 24530 | A | Treat humerus fracture | 3.50 | 6.19 | 4.86 | 0.47 | 10.16 | 8.83 | 090 | ||||||||||||
| 24535 | A | Treat humerus fracture | 6.87 | 8.81 | 6.72 | 0.96 | 16.64 | 14.55 | 090 | ||||||||||||
| 24538 | A | Treat humerus fracture | 9.43 | NA | 10.61 | 1.25 | NA | 21.29 | 090 | ||||||||||||
| 24545 | A | Treat humerus fracture | 10.46 | NA | 10.18 | 1.47 | NA | 22.11 | 090 | ||||||||||||
| 24546 | A | Treat humerus fracture | 15.69 | NA | 13.69 | 2.18 | NA | 31.56 | 090 | ||||||||||||
| 24560 | A | Treat humerus fracture | 2.80 | 4.87 | 3.23 | 0.35 | 8.02 | 6.38 | 090 | ||||||||||||
| 24565 | A | Treat humerus fracture | 5.56 | 8.09 | 5.82 | 0.74 | 14.39 | 12.12 | 090 | ||||||||||||
| 24566 | A | Treat humerus fracture | 7.79 | NA | 9.96 | 1.10 | NA | 18.85 | 090 | ||||||||||||
| 24575 | A | Treat humerus fracture | 10.66 | NA | 8.49 | 1.44 | NA | 20.59 | 090 | ||||||||||||
| 24576 | A | Treat humerus fracture | 2.86 | 4.62 | 3.26 | 0.38 | 7.86 | 6.50 | 090 | ||||||||||||
| 24577 | A | Treat humerus fracture | 5.79 | 8.22 | 6.13 | 0.81 | 14.82 | 12.73 | 090 | ||||||||||||
| 24579 | A | Treat humerus fracture | 11.60 | NA | 11.32 | 1.62 | NA | 24.54 | 090 | ||||||||||||
| 24582 | A | Treat humerus fracture | 8.55 | NA | 10.46 | 1.20 | NA | 20.21 | 090 | ||||||||||||
| 24586 | A | Treat elbow fracture | 15.21 | NA | 11.23 | 2.12 | NA | 28.56 | 090 | ||||||||||||
| 24587 | A | Treat elbow fracture | 15.16 | NA | 11.13 | 2.14 | NA | 28.43 | 090 | ||||||||||||
| 24600 | A | Treat elbow dislocation | 4.23 | 6.82 | 5.12 | 0.49 | 11.54 | 9.84 | 090 | ||||||||||||
| 24605 | A | Treat elbow dislocation | 5.42 | NA | 5.02 | 0.72 | NA | 11.16 | 090 | ||||||||||||
| 24615 | A | Treat elbow dislocation | 9.42 | NA | 7.94 | 1.31 | NA | 18.67 | 090 | ||||||||||||
| 24620 | A | Treat elbow fracture | 6.98 | NA | 6.63 | 0.90 | NA | 14.51 | 090 | ||||||||||||
| 24635 | A | Treat elbow fracture | 13.19 | NA | 16.55 | 1.84 | NA | 31.58 | 090 | ||||||||||||
| 24640 | A | Treat elbow dislocation | 1.20 | 3.35 | 1.88 | 0.11 | 4.66 | 3.19 | 010 | ||||||||||||
| 24650 | A | Treat radius fracture | 2.16 | 4.55 | 2.92 | 0.28 | 6.99 | 5.36 | 090 | ||||||||||||
| 24655 | A | Treat radius fracture | 4.40 | 7.33 | 5.22 | 0.58 | 12.31 | 10.20 | 090 | ||||||||||||
| 24665 | A | Treat radius fracture | 8.14 | NA | 9.40 | 1.13 | NA | 18.67 | 090 | ||||||||||||
| 24666 | A | Treat radius fracture | 9.49 | NA | 10.18 | 1.32 | NA | 20.99 | 090 | ||||||||||||
| 24670 | A | Treat ulnar fracture | 2.54 | 4.49 | 3.10 | 0.33 | 7.36 | 5.97 | 090 | ||||||||||||
| 24675 | A | Treat ulnar fracture | 4.72 | 7.55 | 5.49 | 0.65 | 12.92 | 10.86 | 090 | ||||||||||||
| 24685 | A | Treat ulnar fracture | 8.80 | NA | 9.79 | 1.23 | NA | 19.82 | 090 | ||||||||||||
| 24800 | A | Fusion of elbow joint | 11.20 | NA | 9.90 | 1.41 | NA | 22.51 | 090 | ||||||||||||
| 24802 | A | Fusion/graft of elbow joint | 13.69 | NA | 11.50 | 1.89 | NA | 27.08 | 090 | ||||||||||||
| 24900 | A | Amputation of upper arm | 9.60 | NA | 11.37 | 1.18 | NA | 22.15 | 090 | ||||||||||||
| 24920 | A | Amputation of upper arm | 9.54 | NA | 13.96 | 1.22 | NA | 24.72 | 090 | ||||||||||||
| 24925 | A | Amputation follow-up surgery | 7.07 | NA | 9.64 | 0.95 | NA | 17.66 | 090 | ||||||||||||
| 24930 | A | Amputation follow-up surgery | 10.25 | NA | 10.86 | 1.23 | NA | 22.34 | 090 | ||||||||||||
| 24931 | A | Amputate upper arm implant | 12.72 | NA | 11.63 | 1.56 | NA | 25.91 | 090 | ||||||||||||
| 24935 | A | Revision of amputation | 15.56 | NA | 13.22 | 1.58 | NA | 30.36 | 090 | ||||||||||||
| 24940 | C | Revision of upper arm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 24999 | C | Upper arm/elbow surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 25000 | A | Incision of tendon sheath | 3.38 | NA | 7.49 | 0.45 | NA | 11.32 | 090 | ||||||||||||
| 25001 | A | Incise flexor carpi radialis | 3.38 | NA | 4.30 | 0.45 | NA | 8.13 | 090 | ||||||||||||
| 25020 | A | Decompress forearm 1 space | 5.92 | NA | 11.49 | 0.75 | NA | 18.16 | 090 | ||||||||||||
| 25023 | A | Decompress forearm 1 space | 12.96 | NA | 17.50 | 1.50 | NA | 31.96 | 090 | ||||||||||||
| 25024 | A | Decompress forearm 2 spaces | 9.50 | NA | 8.17 | 1.20 | NA | 18.87 | 090 | ||||||||||||
| 25025 | A | Decompress forearm 2 spaces | 16.54 | NA | 12.05 | 1.91 | NA | 30.50 | 090 | ||||||||||||
| 25028 | A | Drainage of forearm lesion | 5.25 | NA | 10.20 | 0.61 | NA | 16.06 | 090 | ||||||||||||
| 25031 | A | Drainage of forearm bursa | 4.14 | NA | 10.24 | 0.50 | NA | 14.88 | 090 | ||||||||||||
| 25035 | A | Treat forearm bone lesion | 7.36 | NA | 16.18 | 0.98 | NA | 24.52 | 090 | ||||||||||||
| 25040 | A | Explore/treat wrist joint | 7.18 | NA | 9.40 | 0.96 | NA | 17.54 | 090 | ||||||||||||
| 25065 | A | Biopsy forearm soft tissues | 1.99 | 2.53 | 2.53 | 0.12 | 4.64 | 4.64 | 010 | ||||||||||||
| 25066 | A | Biopsy forearm soft tissues | 4.13 | NA | 8.40 | 0.49 | NA | 13.02 | 090 | ||||||||||||
| 25075 | A | Remove forearm lesion subcut | 3.74 | NA | 7.13 | 0.40 | NA | 11.27 | 090 | ||||||||||||
| 25076 | A | Remove forearm lesion deep | 4.92 | NA | 12.68 | 0.59 | NA | 18.19 | 090 | ||||||||||||
| 25077 | A | Remove tumor, forearm/wrist | 9.76 | NA | 15.66 | 1.10 | NA | 26.52 | 090 | ||||||||||||
| 25085 | A | Incision of wrist capsule | 5.50 | NA | 11.29 | 0.71 | NA | 17.50 | 090 | ||||||||||||
| 25100 | A | Biopsy of wrist joint | 3.90 | NA | 7.99 | 0.50 | NA | 12.39 | 090 | ||||||||||||
| 25101 | A | Explore/treat wrist joint | 4.69 | NA | 7.75 | 0.60 | NA | 13.04 | 090 | ||||||||||||
| 25105 | A | Remove wrist joint lining | 5.85 | NA | 11.22 | 0.77 | NA | 17.84 | 090 | ||||||||||||
| 25107 | A | Remove wrist joint cartilage | 6.43 | NA | 11.41 | 0.82 | NA | 18.66 | 090 | ||||||||||||
| 25110 | A | Remove wrist tendon lesion | 3.92 | NA | 8.94 | 0.48 | NA | 13.34 | 090 | ||||||||||||
| 25111 | A | Remove wrist tendon lesion | 3.39 | NA | 6.70 | 0.42 | NA | 10.51 | 090 | ||||||||||||
| 25112 | A | Reremove wrist tendon lesion | 4.53 | NA | 7.43 | 0.54 | NA | 12.50 | 090 | ||||||||||||
| 25115 | A | Remove wrist/forearm lesion | 8.82 | NA | 17.19 | 1.11 | NA | 27.12 | 090 | ||||||||||||
| 25116 | A | Remove wrist/forearm lesion | 7.11 | NA | 16.20 | 0.90 | NA | 24.21 | 090 | ||||||||||||
| 25118 | A | Excise wrist tendon sheath | 4.37 | NA | 7.93 | 0.55 | NA | 12.85 | 090 | ||||||||||||
| 25119 | A | Partial removal of ulna | 6.04 | NA | 11.45 | 0.80 | NA | 18.29 | 090 | ||||||||||||
| 25120 | A | Removal of forearm lesion | 6.10 | NA | 14.87 | 0.81 | NA | 21.78 | 090 | ||||||||||||
| 25125 | A | Remove/graft forearm lesion | 7.48 | NA | 16.11 | 1.02 | NA | 24.61 | 090 | ||||||||||||
| 25126 | A | Remove/graft forearm lesion | 7.55 | NA | 15.76 | 1.00 | NA | 24.31 | 090 | ||||||||||||
| 25130 | A | Removal of wrist lesion | 5.26 | NA | 8.33 | 0.66 | NA | 14.25 | 090 | ||||||||||||
| 25135 | A | Remove graft wrist lesion | 6.89 | NA | 9.00 | 0.89 | NA | 16.78 | 090 | ||||||||||||
| 25136 | A | Remove graft wrist lesion | 5.97 | NA | 9.26 | 0.58 | NA | 15.81 | 090 | ||||||||||||
| 25145 | A | Remove forearm bone lesion | 6.37 | NA | 15.43 | 0.82 | NA | 22.62 | 090 | ||||||||||||
| 25150 | A | Partial removal of ulna | 7.09 | NA | 12.00 | 0.96 | NA | 20.05 | 090 | ||||||||||||
| 25151 | A | Partial removal of radius | 7.39 | NA | 16.22 | 0.93 | NA | 24.54 | 090 | ||||||||||||
| 25170 | A | Extensive forearm surgery | 11.09 | NA | 17.56 | 1.52 | NA | 30.17 | 090 | ||||||||||||
| 25210 | A | Removal of wrist bone | 5.95 | NA | 8.71 | 0.73 | NA | 15.39 | 090 | ||||||||||||
| 25215 | A | Removal of wrist bones | 7.89 | NA | 12.27 | 1.02 | NA | 21.18 | 090 | ||||||||||||
| 25230 | A | Partial removal of radius | 5.23 | NA | 8.23 | 0.66 | NA | 14.12 | 090 | ||||||||||||
| 25240 | A | Partial removal of ulna | 5.17 | NA | 10.78 | 0.69 | NA | 16.64 | 090 | ||||||||||||
| 25246 | A | Injection for wrist x-ray | 1.45 | 10.20 | 0.52 | 0.07 | 11.72 | 2.04 | 000 | ||||||||||||
| 25248 | A | Remove forearm foreign body | 5.14 | NA | 10.66 | 0.54 | NA | 16.34 | 090 | ||||||||||||
| 25250 | A | Removal of wrist prosthesis | 6.60 | NA | 8.91 | 0.84 | NA | 16.35 | 090 | ||||||||||||
| 25251 | A | Removal of wrist prosthesis | 9.57 | NA | 12.52 | 1.15 | NA | 23.24 | 090 | ||||||||||||
| 25259 | A | Manipulate wrist w/anesthes | 3.75 | NA | 5.35 | 0.52 | NA | 9.62 | 090 | ||||||||||||
| 25260 | A | Repair forearm tendon/muscle | 7.80 | NA | 17.11 | 0.97 | NA | 25.88 | 090 | ||||||||||||
| 25263 | A | Repair forearm tendon/muscle | 7.82 | NA | 15.65 | 0.94 | NA | 24.41 | 090 | ||||||||||||
| 25265 | A | Repair forearm tendon/muscle | 9.88 | NA | 17.11 | 1.19 | NA | 28.18 | 090 | ||||||||||||
| 25270 | A | Repair forearm tendon/muscle | 6.00 | NA | 16.04 | 0.76 | NA | 22.80 | 090 | ||||||||||||
| 25272 | A | Repair forearm tendon/muscle | 7.04 | NA | 16.50 | 0.89 | NA | 24.43 | 090 | ||||||||||||
| 25274 | A | Repair forearm tendon/muscle | 8.75 | NA | 17.36 | 1.11 | NA | 27.22 | 090 | ||||||||||||
| 25275 | A | Repair forearm tendon sheath | 8.50 | NA | 7.53 | 1.11 | NA | 17.14 | 090 | ||||||||||||
| 25280 | A | Revise wrist/forearm tendon | 7.22 | NA | 15.80 | 0.91 | NA | 23.93 | 090 | ||||||||||||
| 25290 | A | Incise wrist/forearm tendon | 5.29 | NA | 18.17 | 0.66 | NA | 24.12 | 090 | ||||||||||||
| 25295 | A | Release wrist/forearm tendon | 6.55 | NA | 15.16 | 0.84 | NA | 22.55 | 090 | ||||||||||||
| 25300 | A | Fusion of tendons at wrist | 8.80 | NA | 10.02 | 1.07 | NA | 19.89 | 090 | ||||||||||||
| 25301 | A | Fusion of tendons at wrist | 8.40 | NA | 10.15 | 1.08 | NA | 19.63 | 090 | ||||||||||||
| 25310 | A | Transplant forearm tendon | 8.14 | NA | 16.47 | 1.01 | NA | 25.62 | 090 | ||||||||||||
| 25312 | A | Transplant forearm tendon | 9.57 | NA | 17.24 | 1.22 | NA | 28.03 | 090 | ||||||||||||
| 25315 | A | Revise palsy hand tendon(s) | 10.20 | NA | 18.59 | 1.26 | NA | 30.05 | 090 | ||||||||||||
| 25316 | A | Revise palsy hand tendon(s) | 12.33 | NA | 18.40 | 1.74 | NA | 32.47 | 090 | ||||||||||||
| 25320 | A | Repair/revise wrist joint | 10.77 | NA | 11.53 | 1.32 | NA | 23.62 | 090 | ||||||||||||
| 25332 | A | Revise wrist joint | 11.41 | NA | 11.89 | 1.46 | NA | 24.76 | 090 | ||||||||||||
| 25335 | A | Realignment of hand | 12.88 | NA | 13.60 | 1.66 | NA | 28.14 | 090 | ||||||||||||
| 25337 | A | Reconstruct ulna/radioulnar | 10.17 | NA | 13.80 | 1.31 | NA | 25.28 | 090 | ||||||||||||
| 25350 | A | Revision of radius | 8.78 | NA | 16.68 | 1.17 | NA | 26.63 | 090 | ||||||||||||
| 25355 | A | Revision of radius | 10.17 | NA | 17.17 | 1.44 | NA | 28.78 | 090 | ||||||||||||
| 25360 | A | Revision of ulna | 8.43 | NA | 16.86 | 1.17 | NA | 26.46 | 090 | ||||||||||||
| 25365 | A | Revise radius ulna | 12.40 | NA | 18.74 | 1.67 | NA | 32.81 | 090 | ||||||||||||
| 25370 | A | Revise radius or ulna | 13.36 | NA | 17.84 | 1.88 | NA | 33.08 | 090 | ||||||||||||
| 25375 | A | Revise radius ulna | 13.04 | NA | 16.44 | 1.84 | NA | 31.32 | 090 | ||||||||||||
| 25390 | A | Shorten radius or ulna | 10.40 | NA | 17.38 | 1.38 | NA | 29.16 | 090 | ||||||||||||
| 25391 | A | Lengthen radius or ulna | 13.65 | NA | 19.01 | 1.73 | NA | 34.39 | 090 | ||||||||||||
| 25392 | A | Shorten radius ulna | 13.95 | NA | 15.59 | 1.73 | NA | 31.27 | 090 | ||||||||||||
| 25393 | A | Lengthen radius ulna | 15.87 | NA | 21.72 | 1.87 | NA | 39.46 | 090 | ||||||||||||
| 25394 | A | Repair carpal bone, shorten | 10.40 | NA | 8.43 | 1.15 | NA | 19.98 | 090 | ||||||||||||
| 25400 | A | Repair radius or ulna | 10.92 | NA | 17.98 | 1.50 | NA | 30.40 | 090 | ||||||||||||
| 25405 | A | Repair/graft radius or ulna | 14.38 | NA | 20.38 | 1.95 | NA | 36.71 | 090 | ||||||||||||
| 25415 | A | Repair radius ulna | 13.35 | NA | 19.14 | 1.87 | NA | 34.36 | 090 | ||||||||||||
| 25420 | A | Repair/graft radius ulna | 16.33 | NA | 21.72 | 2.20 | NA | 40.25 | 090 | ||||||||||||
| 25425 | A | Repair/graft radius or ulna | 13.21 | NA | 24.75 | 1.61 | NA | 39.57 | 090 | ||||||||||||
| 25426 | A | Repair/graft radius ulna | 15.82 | NA | 18.15 | 2.23 | NA | 36.20 | 090 | ||||||||||||
| 25430 | A | Vasc graft into carpal bone | 9.25 | NA | 7.82 | 0.56 | NA | 17.63 | 090 | ||||||||||||
| 25431 | A | Repair nonunion carpal bone | 10.44 | NA | 6.42 | 0.56 | NA | 17.42 | 090 | ||||||||||||
| 25440 | A | Repair/graft wrist bone | 10.44 | NA | 11.05 | 1.41 | NA | 22.90 | 090 | ||||||||||||
| 25441 | A | Reconstruct wrist joint | 12.90 | NA | 12.24 | 1.83 | NA | 26.97 | 090 | ||||||||||||
| 25442 | A | Reconstruct wrist joint | 10.85 | NA | 11.46 | 1.24 | NA | 23.55 | 090 | ||||||||||||
| 25443 | A | Reconstruct wrist joint | 10.39 | NA | 13.29 | 1.30 | NA | 24.98 | 090 | ||||||||||||
| 25444 | A | Reconstruct wrist joint | 11.15 | NA | 14.29 | 1.43 | NA | 26.87 | 090 | ||||||||||||
| 25445 | A | Reconstruct wrist joint | 9.69 | NA | 13.50 | 1.26 | NA | 24.45 | 090 | ||||||||||||
| 25446 | A | Wrist replacement | 16.55 | NA | 14.45 | 2.20 | NA | 33.20 | 090 | ||||||||||||
| 25447 | A | Repair wrist joint(s) | 10.37 | NA | 11.27 | 1.34 | NA | 22.98 | 090 | ||||||||||||
| 25449 | A | Remove wrist joint implant | 14.49 | NA | 16.20 | 1.77 | NA | 32.46 | 090 | ||||||||||||
| 25450 | A | Revision of wrist joint | 7.87 | NA | 13.91 | 0.88 | NA | 22.66 | 090 | ||||||||||||
| 25455 | A | Revision of wrist joint | 9.49 | NA | 15.22 | 1.07 | NA | 25.78 | 090 | ||||||||||||
| 25490 | A | Reinforce radius | 9.54 | NA | 16.70 | 1.19 | NA | 27.43 | 090 | ||||||||||||
| 25491 | A | Reinforce ulna | 9.96 | NA | 16.98 | 1.41 | NA | 28.35 | 090 | ||||||||||||
| 25492 | A | Reinforce radius and ulna | 12.33 | NA | 16.09 | 1.62 | NA | 30.04 | 090 | ||||||||||||
| 25500 | A | Treat fracture of radius | 2.45 | 4.27 | 2.94 | 0.28 | 7.00 | 5.67 | 090 | ||||||||||||
| 25505 | A | Treat fracture of radius | 5.21 | 7.87 | 5.65 | 0.69 | 13.77 | 11.55 | 090 | ||||||||||||
| 25515 | A | Treat fracture of radius | 9.18 | NA | 10.00 | 1.22 | NA | 20.40 | 090 | ||||||||||||
| 25520 | A | Treat fracture of radius | 6.26 | 8.00 | 6.28 | 0.85 | 15.11 | 13.39 | 090 | ||||||||||||
| 25525 | A | Treat fracture of radius | 12.24 | NA | 11.65 | 1.68 | NA | 25.57 | 090 | ||||||||||||
| 25526 | A | Treat fracture of radius | 12.98 | NA | 15.01 | 1.80 | NA | 29.79 | 090 | ||||||||||||
| 25530 | A | Treat fracture of ulna | 2.09 | 4.21 | 2.87 | 0.27 | 6.57 | 5.23 | 090 | ||||||||||||
| 25535 | A | Treat fracture of ulna | 5.14 | 7.74 | 5.72 | 0.68 | 13.56 | 11.54 | 090 | ||||||||||||
| 25545 | A | Treat fracture of ulna | 8.90 | NA | 9.88 | 1.23 | NA | 20.01 | 090 | ||||||||||||
| 25560 | A | Treat fracture radius ulna | 2.44 | 4.28 | 2.93 | 0.27 | 6.99 | 5.64 | 090 | ||||||||||||
| 25565 | A | Treat fracture radius ulna | 5.63 | 8.02 | 5.94 | 0.76 | 14.41 | 12.33 | 090 | ||||||||||||
| 25574 | A | Treat fracture radius ulna | 7.01 | NA | 8.72 | 0.96 | NA | 16.69 | 090 | ||||||||||||
| 25575 | A | Treat fracture radius/ulna | 10.45 | NA | 10.74 | 1.46 | NA | 22.65 | 090 | ||||||||||||
| 25600 | A | Treat fracture radius/ulna | 2.63 | 4.53 | 3.10 | 0.34 | 7.50 | 6.07 | 090 | ||||||||||||
| 25605 | A | Treat fracture radius/ulna | 5.81 | 8.18 | 6.11 | 0.81 | 14.80 | 12.73 | 090 | ||||||||||||
| 25611 | A | Treat fracture radius/ulna | 7.77 | NA | 10.04 | 1.08 | NA | 18.89 | 090 | ||||||||||||
| 25620 | A | Treat fracture radius/ulna | 8.55 | NA | 9.67 | 1.17 | NA | 19.39 | 090 | ||||||||||||
| 25622 | A | Treat wrist bone fracture | 2.61 | 4.48 | 3.10 | 0.33 | 7.42 | 6.04 | 090 | ||||||||||||
| 25624 | A | Treat wrist bone fracture | 4.53 | 7.40 | 5.34 | 0.61 | 12.54 | 10.48 | 090 | ||||||||||||
| 25628 | A | Treat wrist bone fracture | 8.43 | NA | 9.68 | 1.14 | NA | 19.25 | 090 | ||||||||||||
| 25630 | A | Treat wrist bone fracture | 2.88 | 4.66 | 3.20 | 0.37 | 7.91 | 6.45 | 090 | ||||||||||||
| 25635 | A | Treat wrist bone fracture | 4.39 | 7.45 | 5.11 | 0.39 | 12.23 | 9.89 | 090 | ||||||||||||
| 25645 | A | Treat wrist bone fracture | 7.25 | NA | 9.56 | 0.93 | NA | 17.74 | 090 | ||||||||||||
| 25650 | A | Treat wrist bone fracture | 3.05 | 4.75 | 3.24 | 0.37 | 8.17 | 6.66 | 090 | ||||||||||||
| 25651 | A | Pin ulnar styloid fracture | 5.36 | NA | 4.39 | 0.73 | NA | 10.48 | 090 | ||||||||||||
| 25652 | A | Treat fracture ulnar styloid | 7.60 | NA | 6.90 | 0.97 | NA | 15.47 | 090 | ||||||||||||
| 25660 | A | Treat wrist dislocation | 4.76 | NA | 5.45 | 0.59 | NA | 10.80 | 090 | ||||||||||||
| 25670 | A | Treat wrist dislocation | 7.92 | NA | 9.54 | 1.07 | NA | 18.53 | 090 | ||||||||||||
| 25671 | A | Pin radioulnar dislocation | 6.00 | NA | 6.02 | 0.75 | NA | 12.77 | 090 | ||||||||||||
| 25675 | A | Treat wrist dislocation | 4.67 | 7.57 | 5.39 | 0.57 | 12.81 | 10.63 | 090 | ||||||||||||
| 25676 | A | Treat wrist dislocation | 8.04 | NA | 9.52 | 1.10 | NA | 18.66 | 090 | ||||||||||||
| 25680 | A | Treat wrist fracture | 5.99 | NA | 6.45 | 0.61 | NA | 13.05 | 090 | ||||||||||||
| 25685 | A | Treat wrist fracture | 9.78 | NA | 10.20 | 1.25 | NA | 21.23 | 090 | ||||||||||||
| 25690 | A | Treat wrist dislocation | 5.50 | NA | 7.00 | 0.78 | NA | 13.28 | 090 | ||||||||||||
| 25695 | A | Treat wrist dislocation | 8.34 | NA | 9.68 | 1.07 | NA | 19.09 | 090 | ||||||||||||
| 25800 | A | Fusion of wrist joint | 9.76 | NA | 10.87 | 1.30 | NA | 21.93 | 090 | ||||||||||||
| 25805 | A | Fusion/graft of wrist joint | 11.28 | NA | 11.61 | 1.51 | NA | 24.40 | 090 | ||||||||||||
| 25810 | A | Fusion/graft of wrist joint | 10.57 | NA | 11.33 | 1.37 | NA | 23.27 | 090 | ||||||||||||
| 25820 | A | Fusion of hand bones | 7.45 | NA | 9.54 | 0.96 | NA | 17.95 | 090 | ||||||||||||
| 25825 | A | Fuse hand bones with graft | 9.27 | NA | 10.51 | 1.20 | NA | 20.98 | 090 | ||||||||||||
| 25830 | A | Fusion, radioulnar jnt/ulna | 10.06 | NA | 16.99 | 1.27 | NA | 28.32 | 090 | ||||||||||||
| 25900 | A | Amputation of forearm | 9.01 | NA | 15.04 | 1.08 | NA | 25.13 | 090 | ||||||||||||
| 25905 | A | Amputation of forearm | 9.12 | NA | 14.25 | 1.06 | NA | 24.43 | 090 | ||||||||||||
| 25907 | A | Amputation follow-up surgery | 7.80 | NA | 15.26 | 1.01 | NA | 24.07 | 090 | ||||||||||||
| 25909 | A | Amputation follow-up surgery | 8.96 | NA | 14.51 | 1.07 | NA | 24.54 | 090 | ||||||||||||
| 25915 | A | Amputation of forearm | 17.08 | NA | 15.11 | 2.41 | NA | 34.60 | 090 | ||||||||||||
| 25920 | A | Amputate hand at wrist | 8.68 | NA | 10.12 | 1.06 | NA | 19.86 | 090 | ||||||||||||
| 25922 | A | Amputate hand at wrist | 7.42 | NA | 7.58 | 0.93 | NA | 15.93 | 090 | ||||||||||||
| 25924 | A | Amputation follow-up surgery | 8.46 | NA | 10.19 | 1.07 | NA | 19.72 | 090 | ||||||||||||
| 25927 | A | Amputation of hand | 8.80 | NA | 14.11 | 1.02 | NA | 23.93 | 090 | ||||||||||||
| 25929 | A | Amputation follow-up surgery | 7.59 | NA | 7.42 | 0.89 | NA | 15.90 | 090 | ||||||||||||
| 25931 | A | Amputation follow-up surgery | 7.81 | NA | 15.79 | 0.88 | NA | 24.48 | 090 | ||||||||||||
| 25999 | C | Forearm or wrist surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 26010 | A | Drainage of finger abscess | 1.54 | 5.24 | 3.94 | 0.14 | 6.92 | 5.62 | 010 | ||||||||||||
| 26011 | A | Drainage of finger abscess | 2.19 | 7.48 | 6.50 | 0.25 | 9.92 | 8.94 | 010 | ||||||||||||
| 26020 | A | Drain hand tendon sheath | 4.67 | NA | 13.10 | 0.59 | NA | 18.36 | 090 | ||||||||||||
| 26025 | A | Drainage of palm bursa | 4.82 | NA | 13.26 | 0.60 | NA | 18.68 | 090 | ||||||||||||
| 26030 | A | Drainage of palm bursa(s) | 5.93 | NA | 14.02 | 0.72 | NA | 20.67 | 090 | ||||||||||||
| 26034 | A | Treat hand bone lesion | 6.23 | NA | 14.84 | 0.79 | NA | 21.86 | 090 | ||||||||||||
| 26035 | A | Decompress fingers/hand | 9.51 | NA | 15.17 | 1.12 | NA | 25.80 | 090 | ||||||||||||
| 26037 | A | Decompress fingers/hand | 7.25 | NA | 12.67 | 0.87 | NA | 20.79 | 090 | ||||||||||||
| 26040 | A | Release palm contracture | 3.33 | NA | 12.87 | 0.45 | NA | 16.65 | 090 | ||||||||||||
| 26045 | A | Release palm contracture | 5.56 | NA | 14.17 | 0.74 | NA | 20.47 | 090 | ||||||||||||
| 26055 | A | Incise finger tendon sheath | 2.69 | 8.12 | 7.69 | 0.36 | 11.17 | 10.74 | 090 | ||||||||||||
| 26060 | A | Incision of finger tendon | 2.81 | NA | 7.57 | 0.35 | NA | 10.73 | 090 | ||||||||||||
| 26070 | A | Explore/treat hand joint | 3.69 | NA | 11.69 | 0.35 | NA | 15.73 | 090 | ||||||||||||
| 26075 | A | Explore/treat finger joint | 3.79 | NA | 12.47 | 0.40 | NA | 16.66 | 090 | ||||||||||||
| 26080 | A | Explore/treat finger joint | 4.24 | NA | 13.09 | 0.52 | NA | 17.85 | 090 | ||||||||||||
| 26100 | A | Biopsy hand joint lining | 3.67 | NA | 8.43 | 0.45 | NA | 12.55 | 090 | ||||||||||||
| 26105 | A | Biopsy finger joint lining | 3.71 | NA | 12.95 | 0.45 | NA | 17.11 | 090 | ||||||||||||
| 26110 | A | Biopsy finger joint lining | 3.53 | NA | 12.46 | 0.44 | NA | 16.43 | 090 | ||||||||||||
| 26115 | A | Remove hand lesion subcut | 3.86 | 7.66 | 7.66 | 0.48 | 12.00 | 12.00 | 090 | ||||||||||||
| 26116 | A | Remove hand lesion, deep | 5.53 | NA | 13.91 | 0.69 | NA | 20.13 | 090 | ||||||||||||
| 26117 | A | Remove tumor, hand/finger | 8.55 | NA | 15.41 | 1.01 | NA | 24.97 | 090 | ||||||||||||
| 26121 | A | Release palm contracture | 7.54 | NA | 15.80 | 0.94 | NA | 24.28 | 090 | ||||||||||||
| 26123 | A | Release palm contracture | 9.29 | NA | 16.73 | 1.17 | NA | 27.19 | 090 | ||||||||||||
| 26125 | A | Release palm contracture | 4.61 | NA | 2.60 | 0.57 | NA | 7.78 | ZZZ | ||||||||||||
| 26130 | A | Remove wrist joint lining | 5.42 | NA | 15.62 | 0.65 | NA | 21.69 | 090 | ||||||||||||
| 26135 | A | Revise finger joint, each | 6.96 | NA | 17.04 | 0.87 | NA | 24.87 | 090 | ||||||||||||
| 26140 | A | Revise finger joint, each | 6.17 | NA | 16.33 | 0.76 | NA | 23.26 | 090 | ||||||||||||
| 26145 | A | Tendon excision, palm/finger | 6.32 | NA | 16.86 | 0.77 | NA | 23.95 | 090 | ||||||||||||
| 26160 | A | Remove tendon sheath lesion | 3.15 | 7.93 | 7.88 | 0.39 | 11.47 | 11.42 | 090 | ||||||||||||
| 26170 | A | Removal of palm tendon, each | 4.77 | NA | 8.53 | 0.60 | NA | 13.90 | 090 | ||||||||||||
| 26180 | A | Removal of finger tendon | 5.18 | NA | 9.19 | 0.64 | NA | 15.01 | 090 | ||||||||||||
| 26185 | A | Remove finger bone | 5.25 | NA | 8.76 | 0.67 | NA | 14.68 | 090 | ||||||||||||
| 26200 | A | Remove hand bone lesion | 5.51 | NA | 13.97 | 0.71 | NA | 20.19 | 090 | ||||||||||||
| 26205 | A | Remove/graft bone lesion | 7.70 | NA | 15.35 | 0.95 | NA | 24.00 | 090 | ||||||||||||
| 26210 | A | Removal of finger lesion | 5.15 | NA | 14.32 | 0.64 | NA | 20.11 | 090 | ||||||||||||
| 26215 | A | Remove/graft finger lesion | 7.10 | NA | 14.89 | 0.77 | NA | 22.76 | 090 | ||||||||||||
| 26230 | A | Partial removal of hand bone | 6.33 | NA | 12.87 | 0.84 | NA | 20.04 | 090 | ||||||||||||
| 26235 | A | Partial removal, finger bone | 6.19 | NA | 12.56 | 0.78 | NA | 19.53 | 090 | ||||||||||||
| 26236 | A | Partial removal, finger bone | 5.32 | NA | 12.62 | 0.66 | NA | 18.60 | 090 | ||||||||||||
| 26250 | A | Extensive hand surgery | 7.55 | NA | 17.33 | 0.92 | NA | 25.80 | 090 | ||||||||||||
| 26255 | A | Extensive hand surgery | 12.43 | NA | 18.74 | 1.05 | NA | 32.22 | 090 | ||||||||||||
| 26260 | A | Extensive finger surgery | 7.03 | NA | 16.39 | 0.83 | NA | 24.25 | 090 | ||||||||||||
| 26261 | A | Extensive finger surgery | 9.09 | NA | 16.10 | 0.84 | NA | 26.03 | 090 | ||||||||||||
| 26262 | A | Partial removal of finger | 5.67 | NA | 14.81 | 0.70 | NA | 21.18 | 090 | ||||||||||||
| 26320 | A | Removal of implant from hand | 3.98 | NA | 13.08 | 0.49 | NA | 17.55 | 090 | ||||||||||||
| 26340 | A | Manipulate finger w/anesth | 2.50 | NA | 4.53 | 0.32 | NA | 7.35 | 090 | ||||||||||||
| 26350 | A | Repair finger/hand tendon | 5.99 | NA | 20.24 | 0.73 | NA | 26.96 | 090 | ||||||||||||
| 26352 | A | Repair/graft hand tendon | 7.68 | NA | 19.74 | 0.93 | NA | 28.35 | 090 | ||||||||||||
| 26356 | A | Repair finger/hand tendon | 8.07 | NA | 21.55 | 0.99 | NA | 30.61 | 090 | ||||||||||||
| 26357 | A | Repair finger/hand tendon | 8.58 | NA | 21.30 | 1.02 | NA | 30.90 | 090 | ||||||||||||
| 26358 | A | Repair/graft hand tendon | 9.14 | NA | 22.43 | 1.07 | NA | 32.64 | 090 | ||||||||||||
| 26370 | A | Repair finger/hand tendon | 7.11 | NA | 20.61 | 0.90 | NA | 28.62 | 090 | ||||||||||||
| 26372 | A | Repair/graft hand tendon | 8.76 | NA | 20.46 | 1.06 | NA | 30.28 | 090 | ||||||||||||
| 26373 | A | Repair finger/hand tendon | 8.16 | NA | 22.61 | 0.98 | NA | 31.75 | 090 | ||||||||||||
| 26390 | A | Revise hand/finger tendon | 9.19 | NA | 16.93 | 1.09 | NA | 27.21 | 090 | ||||||||||||
| 26392 | A | Repair/graft hand tendon | 10.26 | NA | 23.05 | 1.26 | NA | 34.57 | 090 | ||||||||||||
| 26410 | A | Repair hand tendon | 4.63 | NA | 16.26 | 0.57 | NA | 21.46 | 090 | ||||||||||||
| 26412 | A | Repair/graft hand tendon | 6.31 | NA | 16.83 | 0.80 | NA | 23.94 | 090 | ||||||||||||
| 26415 | A | Excision, hand/finger tendon | 8.34 | NA | 18.14 | 0.77 | NA | 27.25 | 090 | ||||||||||||
| 26416 | A | Graft hand or finger tendon | 9.37 | NA | 18.95 | 1.20 | NA | 29.52 | 090 | ||||||||||||
| 26418 | A | Repair finger tendon | 4.25 | NA | 16.34 | 0.50 | NA | 21.09 | 090 | ||||||||||||
| 26420 | A | Repair/graft finger tendon | 6.77 | NA | 17.92 | 0.83 | NA | 25.52 | 090 | ||||||||||||
| 26426 | A | Repair finger/hand tendon | 6.15 | NA | 17.05 | 0.77 | NA | 23.97 | 090 | ||||||||||||
| 26428 | A | Repair/graft finger tendon | 7.21 | NA | 16.05 | 0.84 | NA | 24.10 | 090 | ||||||||||||
| 26432 | A | Repair finger tendon | 4.02 | NA | 13.49 | 0.48 | NA | 17.99 | 090 | ||||||||||||
| 26433 | A | Repair finger tendon | 4.56 | NA | 14.42 | 0.56 | NA | 19.54 | 090 | ||||||||||||
| 26434 | A | Repair/graft finger tendon | 6.09 | NA | 15.34 | 0.71 | NA | 22.14 | 090 | ||||||||||||
| 26437 | A | Realignment of tendons | 5.82 | NA | 14.16 | 0.74 | NA | 20.72 | 090 | ||||||||||||
| 26440 | A | Release palm/finger tendon | 5.02 | NA | 18.48 | 0.62 | NA | 24.12 | 090 | ||||||||||||
| 26442 | A | Release palm finger tendon | 8.16 | NA | 19.40 | 0.94 | NA | 28.50 | 090 | ||||||||||||
| 26445 | A | Release hand/finger tendon | 4.31 | NA | 18.27 | 0.54 | NA | 23.12 | 090 | ||||||||||||
| 26449 | A | Release forearm/hand tendon | 7.00 | NA | 20.16 | 0.84 | NA | 28.00 | 090 | ||||||||||||
| 26450 | A | Incision of palm tendon | 3.67 | NA | 8.71 | 0.46 | NA | 12.84 | 090 | ||||||||||||
| 26455 | A | Incision of finger tendon | 3.64 | NA | 8.38 | 0.47 | NA | 12.49 | 090 | ||||||||||||
| 26460 | A | Incise hand/finger tendon | 3.46 | NA | 8.06 | 0.44 | NA | 11.96 | 090 | ||||||||||||
| 26471 | A | Fusion of finger tendons | 5.73 | NA | 13.93 | 0.73 | NA | 20.39 | 090 | ||||||||||||
| 26474 | A | Fusion of finger tendons | 5.32 | NA | 13.30 | 0.69 | NA | 19.31 | 090 | ||||||||||||
| 26476 | A | Tendon lengthening | 5.18 | NA | 12.72 | 0.62 | NA | 18.52 | 090 | ||||||||||||
| 26477 | A | Tendon shortening | 5.15 | NA | 13.73 | 0.60 | NA | 19.48 | 090 | ||||||||||||
| 26478 | A | Lengthening of hand tendon | 5.80 | NA | 14.73 | 0.77 | NA | 21.30 | 090 | ||||||||||||
| 26479 | A | Shortening of hand tendon | 5.74 | NA | 13.71 | 0.76 | NA | 20.21 | 090 | ||||||||||||
| 26480 | A | Transplant hand tendon | 6.69 | NA | 19.63 | 0.84 | NA | 27.16 | 090 | ||||||||||||
| 26483 | A | Transplant/graft hand tendon | 8.29 | NA | 19.79 | 1.03 | NA | 29.11 | 090 | ||||||||||||
| 26485 | A | Transplant palm tendon | 7.70 | NA | 20.08 | 0.94 | NA | 28.72 | 090 | ||||||||||||
| 26489 | A | Transplant/graft palm tendon | 9.55 | NA | 17.34 | 0.98 | NA | 27.87 | 090 | ||||||||||||
| 26490 | A | Revise thumb tendon | 8.41 | NA | 14.87 | 1.05 | NA | 24.33 | 090 | ||||||||||||
| 26492 | A | Tendon transfer with graft | 9.62 | NA | 15.84 | 1.19 | NA | 26.65 | 090 | ||||||||||||
| 26494 | A | Hand tendon/muscle transfer | 8.47 | NA | 13.52 | 1.13 | NA | 23.12 | 090 | ||||||||||||
| 26496 | A | Revise thumb tendon | 9.59 | NA | 15.53 | 1.17 | NA | 26.29 | 090 | ||||||||||||
| 26497 | A | Finger tendon transfer | 9.57 | NA | 16.42 | 1.17 | NA | 27.16 | 090 | ||||||||||||
| 26498 | A | Finger tendon transfer | 14.00 | NA | 18.19 | 1.74 | NA | 33.93 | 090 | ||||||||||||
| 26499 | A | Revision of finger | 8.98 | NA | 14.61 | 0.94 | NA | 24.53 | 090 | ||||||||||||
| 26500 | A | Hand tendon reconstruction | 5.96 | NA | 15.16 | 0.66 | NA | 21.78 | 090 | ||||||||||||
| 26502 | A | Hand tendon reconstruction | 7.14 | NA | 15.14 | 0.87 | NA | 23.15 | 090 | ||||||||||||
| 26504 | A | Hand tendon reconstruction | 7.47 | NA | 14.31 | 0.84 | NA | 22.62 | 090 | ||||||||||||
| 26508 | A | Release thumb contracture | 6.01 | NA | 14.11 | 0.76 | NA | 20.88 | 090 | ||||||||||||
| 26510 | A | Thumb tendon transfer | 5.43 | NA | 14.18 | 0.71 | NA | 20.32 | 090 | ||||||||||||
| 26516 | A | Fusion of knuckle joint | 7.15 | NA | 15.06 | 0.90 | NA | 23.11 | 090 | ||||||||||||
| 26517 | A | Fusion of knuckle joints | 8.83 | NA | 15.89 | 0.96 | NA | 25.68 | 090 | ||||||||||||
| 26518 | A | Fusion of knuckle joints | 9.02 | NA | 15.91 | 1.13 | NA | 26.06 | 090 | ||||||||||||
| 26520 | A | Release knuckle contracture | 5.30 | NA | 18.59 | 0.65 | NA | 24.54 | 090 | ||||||||||||
| 26525 | A | Release finger contracture | 5.33 | NA | 18.67 | 0.66 | NA | 24.66 | 090 | ||||||||||||
| 26530 | A | Revise knuckle joint | 6.69 | NA | 19.35 | 0.86 | NA | 26.90 | 090 | ||||||||||||
| 26531 | A | Revise knuckle with implant | 7.91 | NA | 19.41 | 1.01 | NA | 28.33 | 090 | ||||||||||||
| 26535 | A | Revise finger joint | 5.24 | NA | 11.10 | 0.66 | NA | 17.00 | 090 | ||||||||||||
| 26536 | A | Revise/implant finger joint | 6.37 | NA | 17.97 | 0.80 | NA | 25.14 | 090 | ||||||||||||
| 26540 | A | Repair hand joint | 6.43 | NA | 14.54 | 0.81 | NA | 21.78 | 090 | ||||||||||||
| 26541 | A | Repair hand joint with graft | 8.62 | NA | 16.36 | 1.12 | NA | 26.10 | 090 | ||||||||||||
| 26542 | A | Repair hand joint with graft | 6.78 | NA | 14.51 | 0.87 | NA | 22.16 | 090 | ||||||||||||
| 26545 | A | Reconstruct finger joint | 6.92 | NA | 16.16 | 0.79 | NA | 23.87 | 090 | ||||||||||||
| 26546 | A | Repair nonunion hand | 8.92 | NA | 15.95 | 1.14 | NA | 26.01 | 090 | ||||||||||||
| 26548 | A | Reconstruct finger joint | 8.03 | NA | 16.13 | 0.98 | NA | 25.14 | 090 | ||||||||||||
| 26550 | A | Construct thumb replacement | 21.24 | NA | 30.36 | 1.80 | NA | 53.40 | 090 | ||||||||||||
| 26551 | A | Great toe-hand transfer | 46.58 | NA | 29.35 | 6.57 | NA | 82.50 | 090 | ||||||||||||
| 26553 | A | Single transfer, toe-hand | 46.27 | NA | 29.23 | 1.99 | NA | 77.49 | 090 | ||||||||||||
| 26554 | A | Double transfer, toe-hand | 54.95 | NA | 32.69 | 7.76 | NA | 95.40 | 090 | ||||||||||||
| 26555 | A | Positional change of finger | 16.63 | NA | 24.00 | 2.13 | NA | 42.76 | 090 | ||||||||||||
| 26556 | A | Toe joint transfer | 47.26 | NA | 29.62 | 6.67 | NA | 83.55 | 090 | ||||||||||||
| 26560 | A | Repair of web finger | 5.38 | NA | 12.55 | 0.60 | NA | 18.53 | 090 | ||||||||||||
| 26561 | A | Repair of web finger | 10.92 | NA | 18.61 | 0.69 | NA | 30.22 | 090 | ||||||||||||
| 26562 | A | Repair of web finger | 15.00 | NA | 13.44 | 0.98 | NA | 29.42 | 090 | ||||||||||||
| 26565 | A | Correct metacarpal flaw | 6.74 | NA | 14.77 | 0.84 | NA | 22.35 | 090 | ||||||||||||
| 26567 | A | Correct finger deformity | 6.82 | NA | 15.10 | 0.84 | NA | 22.76 | 090 | ||||||||||||
| 26568 | A | Lengthen metacarpal/finger | 9.08 | NA | 19.48 | 1.10 | NA | 29.66 | 090 | ||||||||||||
| 26580 | A | Repair hand deformity | 18.18 | NA | 17.22 | 1.46 | NA | 36.86 | 090 | ||||||||||||
| 26585 | D | Repair finger deformity | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 26587 | A | Reconstruct extra finger | 14.05 | 4.67 | NA | 1.08 | 19.80 | NA | 090 | ||||||||||||
| 26590 | A | Repair finger deformity | 17.96 | NA | 14.62 | 1.32 | NA | 33.90 | 090 | ||||||||||||
| 26591 | A | Repair muscles of hand | 3.25 | NA | 14.22 | 0.37 | NA | 17.84 | 090 | ||||||||||||
| 26593 | A | Release muscles of hand | 5.31 | NA | 13.33 | 0.64 | NA | 19.28 | 090 | ||||||||||||
| 26596 | A | Excision constricting tissue | 8.95 | NA | 10.26 | 0.87 | NA | 20.08 | 090 | ||||||||||||
| 26597 | D | Release of scar contracture | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 26600 | A | Treat metacarpal fracture | 1.96 | 4.15 | 2.83 | 0.25 | 6.36 | 5.04 | 090 | ||||||||||||
| 26605 | A | Treat metacarpal fracture | 2.85 | 6.05 | 4.29 | 0.38 | 9.28 | 7.52 | 090 | ||||||||||||
| 26607 | A | Treat metacarpal fracture | 5.36 | NA | 8.33 | 0.70 | NA | 14.39 | 090 | ||||||||||||
| 26608 | A | Treat metacarpal fracture | 5.36 | NA | 8.85 | 0.73 | NA | 14.94 | 090 | ||||||||||||
| 26615 | A | Treat metacarpal fracture | 5.33 | NA | 8.43 | 0.70 | NA | 14.46 | 090 | ||||||||||||
| 26641 | A | Treat thumb dislocation | 3.94 | 6.58 | 4.99 | 0.42 | 10.94 | 9.35 | 090 | ||||||||||||
| 26645 | A | Treat thumb fracture | 4.41 | 7.33 | 5.30 | 0.54 | 12.28 | 10.25 | 090 | ||||||||||||
| 26650 | A | Treat thumb fracture | 5.72 | NA | 9.02 | 0.77 | NA | 15.51 | 090 | ||||||||||||
| 26665 | A | Treat thumb fracture | 7.60 | NA | 9.24 | 0.97 | NA | 17.81 | 090 | ||||||||||||
| 26670 | A | Treat hand dislocation | 3.69 | 6.46 | 4.93 | 0.36 | 10.51 | 8.98 | 090 | ||||||||||||
| 26675 | A | Treat hand dislocation | 4.64 | 6.82 | 4.71 | 0.56 | 12.02 | 9.91 | 090 | ||||||||||||
| 26676 | A | Pin hand dislocation | 5.52 | NA | 9.36 | 0.76 | NA | 15.64 | 090 | ||||||||||||
| 26685 | A | Treat hand dislocation | 6.98 | NA | 8.88 | 0.95 | NA | 16.81 | 090 | ||||||||||||
| 26686 | A | Treat hand dislocation | 7.94 | NA | 9.84 | 1.05 | NA | 18.83 | 090 | ||||||||||||
| 26700 | A | Treat knuckle dislocation | 3.69 | 5.01 | 3.02 | 0.35 | 9.05 | 7.06 | 090 | ||||||||||||
| 26705 | A | Treat knuckle dislocation | 4.19 | 6.26 | 4.33 | 0.50 | 10.95 | 9.02 | 090 | ||||||||||||
| 26706 | A | Pin knuckle dislocation | 5.12 | NA | 5.87 | 0.64 | NA | 11.63 | 090 | ||||||||||||
| 26715 | A | Treat knuckle dislocation | 5.74 | NA | 8.62 | 0.75 | NA | 15.11 | 090 | ||||||||||||
| 26720 | A | Treat finger fracture, each | 1.66 | 3.06 | 1.72 | 0.20 | 4.92 | 3.58 | 090 | ||||||||||||
| 26725 | A | Treat finger fracture, each | 3.33 | 5.27 | 3.26 | 0.43 | 9.03 | 7.02 | 090 | ||||||||||||
| 26727 | A | Treat finger fracture, each | 5.23 | NA | 8.88 | 0.69 | NA | 14.80 | 090 | ||||||||||||
| 26735 | A | Treat finger fracture, each | 5.98 | NA | 8.99 | 0.77 | NA | 15.74 | 090 | ||||||||||||
| 26740 | A | Treat finger fracture, each | 1.94 | 3.86 | 2.67 | 0.24 | 6.04 | 4.85 | 090 | ||||||||||||
| 26742 | A | Treat finger fracture, each | 3.85 | 7.21 | 5.13 | 0.49 | 11.55 | 9.47 | 090 | ||||||||||||
| 26746 | A | Treat finger fracture, each | 5.81 | NA | 8.93 | 0.74 | NA | 15.48 | 090 | ||||||||||||
| 26750 | A | Treat finger fracture, each | 1.70 | 3.66 | 2.47 | 0.19 | 5.55 | 4.36 | 090 | ||||||||||||
| 26755 | A | Treat finger fracture, each | 3.10 | 5.08 | 3.27 | 0.37 | 8.55 | 6.74 | 090 | ||||||||||||
| 26756 | A | Pin finger fracture, each | 4.39 | NA | 8.74 | 0.56 | NA | 13.69 | 090 | ||||||||||||
| 26765 | A | Treat finger fracture, each | 4.17 | NA | 8.02 | 0.51 | NA | 12.70 | 090 | ||||||||||||
| 26770 | A | Treat finger dislocation | 3.02 | 4.87 | 2.80 | 0.27 | 8.16 | 6.09 | 090 | ||||||||||||
| 26775 | A | Treat finger dislocation | 3.71 | 6.07 | 4.09 | 0.43 | 10.21 | 8.23 | 090 | ||||||||||||
| 26776 | A | Pin finger dislocation | 4.80 | NA | 8.61 | 0.63 | NA | 14.04 | 090 | ||||||||||||
| 26785 | A | Treat finger dislocation | 4.21 | NA | 7.95 | 0.54 | NA | 12.70 | 090 | ||||||||||||
| 26820 | A | Thumb fusion with graft | 8.26 | NA | 15.80 | 1.11 | NA | 25.17 | 090 | ||||||||||||
| 26841 | A | Fusion of thumb | 7.13 | NA | 15.37 | 0.97 | NA | 23.47 | 090 | ||||||||||||
| 26842 | A | Thumb fusion with graft | 8.24 | NA | 15.49 | 1.10 | NA | 24.83 | 090 | ||||||||||||
| 26843 | A | Fusion of hand joint | 7.61 | NA | 13.91 | 0.99 | NA | 22.51 | 090 | ||||||||||||
| 26844 | A | Fusion/graft of hand joint | 8.73 | NA | 15.63 | 1.12 | NA | 25.48 | 090 | ||||||||||||
| 26850 | A | Fusion of knuckle | 6.97 | NA | 14.63 | 0.89 | NA | 22.49 | 090 | ||||||||||||
| 26852 | A | Fusion of knuckle with graft | 8.46 | NA | 15.19 | 1.05 | NA | 24.70 | 090 | ||||||||||||
| 26860 | A | Fusion of finger joint | 4.69 | NA | 13.45 | 0.60 | NA | 18.74 | 090 | ||||||||||||
| 26861 | A | Fusion of finger jnt, add-on | 1.74 | NA | 0.99 | 0.22 | NA | 2.95 | ZZZ | ||||||||||||
| 26862 | A | Fusion/graft of finger joint | 7.37 | NA | 15.18 | 0.92 | NA | 23.47 | 090 | ||||||||||||
| 26863 | A | Fuse/graft added joint | 3.90 | NA | 2.25 | 0.51 | NA | 6.66 | ZZZ | ||||||||||||
| 26910 | A | Amputate metacarpal bone | 7.60 | NA | 13.98 | 0.90 | NA | 22.48 | 090 | ||||||||||||
| 26951 | A | Amputation of finger/thumb | 4.59 | NA | 13.06 | 0.56 | NA | 18.21 | 090 | ||||||||||||
| 26952 | A | Amputation of finger/thumb | 6.31 | NA | 14.47 | 0.74 | NA | 21.52 | 090 | ||||||||||||
| 26989 | C | Hand/finger surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 26990 | A | Drainage of pelvis lesion | 7.48 | NA | 15.92 | 0.92 | NA | 24.32 | 090 | ||||||||||||
| 26991 | A | Drainage of pelvis bursa | 6.68 | 11.32 | 9.39 | 0.85 | 18.85 | 16.92 | 090 | ||||||||||||
| 26992 | A | Drainage of bone lesion | 13.02 | NA | 19.95 | 1.75 | NA | 34.72 | 090 | ||||||||||||
| 27000 | A | Incision of hip tendon | 5.62 | NA | 7.48 | 0.76 | NA | 13.86 | 090 | ||||||||||||
| 27001 | A | Incision of hip tendon | 6.94 | NA | 8.42 | 0.95 | NA | 16.31 | 090 | ||||||||||||
| 27003 | A | Incision of hip tendon | 7.34 | NA | 9.01 | 0.93 | NA | 17.28 | 090 | ||||||||||||
| 27005 | A | Incision of hip tendon | 9.66 | NA | 10.50 | 1.36 | NA | 21.52 | 090 | ||||||||||||
| 27006 | A | Incision of hip tendons | 9.68 | NA | 10.59 | 1.33 | NA | 21.60 | 090 | ||||||||||||
| 27025 | A | Incision of hip/thigh fascia | 11.16 | NA | 10.53 | 1.38 | NA | 23.07 | 090 | ||||||||||||
| 27030 | A | Drainage of hip joint | 13.01 | NA | 12.45 | 1.81 | NA | 27.27 | 090 | ||||||||||||
| 27033 | A | Exploration of hip joint | 13.39 | NA | 12.62 | 1.87 | NA | 27.88 | 090 | ||||||||||||
| 27035 | A | Denervation of hip joint | 16.69 | NA | 19.67 | 1.70 | NA | 38.06 | 090 | ||||||||||||
| 27036 | A | Excision of hip joint/muscle | 12.88 | NA | 14.03 | 1.80 | NA | 28.71 | 090 | ||||||||||||
| 27040 | A | Biopsy of soft tissues | 2.87 | 6.23 | 4.00 | 0.21 | 9.31 | 7.08 | 010 | ||||||||||||
| 27041 | A | Biopsy of soft tissues | 9.89 | NA | 8.60 | 1.01 | NA | 19.50 | 090 | ||||||||||||
| 27047 | A | Remove hip/pelvis lesion | 7.45 | 9.26 | 7.03 | 0.79 | 17.50 | 15.27 | 090 | ||||||||||||
| 27048 | A | Remove hip/pelvis lesion | 6.25 | NA | 7.94 | 0.73 | NA | 14.92 | 090 | ||||||||||||
| 27049 | A | Remove tumor, hip/pelvis | 13.66 | NA | 13.77 | 1.60 | NA | 29.03 | 090 | ||||||||||||
| 27050 | A | Biopsy of sacroiliac joint | 4.36 | NA | 7.52 | 0.53 | NA | 12.41 | 090 | ||||||||||||
| 27052 | A | Biopsy of hip joint | 6.23 | NA | 8.24 | 0.85 | NA | 15.32 | 090 | ||||||||||||
| 27054 | A | Removal of hip joint lining | 8.54 | NA | 10.67 | 1.17 | NA | 20.38 | 090 | ||||||||||||
| 27060 | A | Removal of ischial bursa | 5.43 | NA | 7.21 | 0.60 | NA | 13.24 | 090 | ||||||||||||
| 27062 | A | Remove femur lesion/bursa | 5.37 | NA | 7.32 | 0.74 | NA | 13.43 | 090 | ||||||||||||
| 27065 | A | Removal of hip bone lesion | 5.90 | NA | 8.65 | 0.76 | NA | 15.31 | 090 | ||||||||||||
| 27066 | A | Removal of hip bone lesion | 10.33 | NA | 12.53 | 1.42 | NA | 24.28 | 090 | ||||||||||||
| 27067 | A | Remove/graft hip bone lesion | 13.83 | NA | 14.54 | 1.95 | NA | 30.32 | 090 | ||||||||||||
| 27070 | A | Partial removal of hip bone | 10.72 | NA | 17.71 | 1.36 | NA | 29.79 | 090 | ||||||||||||
| 27071 | A | Partial removal of hip bone | 11.46 | NA | 18.67 | 1.51 | NA | 31.64 | 090 | ||||||||||||
| 27075 | A | Extensive hip surgery | 35.00 | NA | 25.75 | 2.22 | NA | 62.97 | 090 | ||||||||||||
| 27076 | A | Extensive hip surgery | 22.12 | NA | 20.08 | 2.86 | NA | 45.06 | 090 | ||||||||||||
| 27077 | A | Extensive hip surgery | 40.00 | NA | 30.55 | 3.18 | NA | 73.73 | 090 | ||||||||||||
| 27078 | A | Extensive hip surgery | 13.44 | NA | 16.30 | 1.67 | NA | 31.41 | 090 | ||||||||||||
| 27079 | A | Extensive hip surgery | 13.75 | NA | 13.43 | 1.86 | NA | 29.04 | 090 | ||||||||||||
| 27080 | A | Removal of tail bone | 6.39 | NA | 7.64 | 0.80 | NA | 14.83 | 090 | ||||||||||||
| 27086 | A | Remove hip foreign body | 1.87 | 5.85 | 3.70 | 0.17 | 7.89 | 5.74 | 010 | ||||||||||||
| 27087 | A | Remove hip foreign body | 8.54 | NA | 9.04 | 1.09 | NA | 18.67 | 090 | ||||||||||||
| 27090 | A | Removal of hip prosthesis | 11.15 | NA | 11.37 | 1.55 | NA | 24.07 | 090 | ||||||||||||
| 27091 | A | Removal of hip prosthesis | 22.14 | NA | 15.14 | 3.11 | NA | 40.39 | 090 | ||||||||||||
| 27093 | A | Injection for hip x-ray | 1.30 | 13.59 | 0.53 | 0.09 | 14.98 | 1.92 | 000 | ||||||||||||
| 27095 | A | Injection for hip x-ray | 1.50 | 11.00 | 0.60 | 0.10 | 12.60 | 2.20 | 000 | ||||||||||||
| 27096 | A | Inject sacroiliac joint | 1.40 | 8.86 | 0.35 | 0.08 | 10.34 | 1.83 | 000 | ||||||||||||
| 27097 | A | Revision of hip tendon | 8.80 | NA | 8.13 | 1.22 | NA | 18.15 | 090 | ||||||||||||
| 27098 | A | Transfer tendon to pelvis | 8.83 | NA | 9.18 | 1.24 | NA | 19.25 | 090 | ||||||||||||
| 27100 | A | Transfer of abdominal muscle | 11.08 | NA | 13.03 | 1.57 | NA | 25.68 | 090 | ||||||||||||
| 27105 | A | Transfer of spinal muscle | 11.77 | NA | 12.14 | 1.66 | NA | 25.57 | 090 | ||||||||||||
| 27110 | A | Transfer of iliopsoas muscle | 13.26 | NA | 12.99 | 1.38 | NA | 27.63 | 090 | ||||||||||||
| 27111 | A | Transfer of iliopsoas muscle | 12.15 | NA | 11.77 | 1.48 | NA | 25.40 | 090 | ||||||||||||
| 27120 | A | Reconstruction of hip socket | 18.01 | NA | 14.28 | 2.45 | NA | 34.74 | 090 | ||||||||||||
| 27122 | A | Reconstruction of hip socket | 14.98 | NA | 14.48 | 2.08 | NA | 31.54 | 090 | ||||||||||||
| 27125 | A | Partial hip replacement | 14.69 | NA | 14.02 | 2.05 | NA | 30.76 | 090 | ||||||||||||
| 27130 | A | Total hip arthroplasty | 20.12 | NA | 17.18 | 2.82 | NA | 40.12 | 090 | ||||||||||||
| 27132 | A | Total hip arthroplasty | 23.30 | NA | 19.00 | 3.26 | NA | 45.56 | 090 | ||||||||||||
| 27134 | A | Revise hip joint replacement | 28.52 | NA | 21.82 | 3.97 | NA | 54.31 | 090 | ||||||||||||
| 27137 | A | Revise hip joint replacement | 21.17 | NA | 17.54 | 2.97 | NA | 41.68 | 090 | ||||||||||||
| 27138 | A | Revise hip joint replacement | 22.17 | NA | 17.94 | 3.11 | NA | 43.22 | 090 | ||||||||||||
| 27140 | A | Transplant femur ridge | 12.24 | NA | 11.98 | 1.67 | NA | 25.89 | 090 | ||||||||||||
| 27146 | A | Incision of hip bone | 17.43 | NA | 15.87 | 2.27 | NA | 35.57 | 090 | ||||||||||||
| 27147 | A | Revision of hip bone | 20.58 | NA | 17.87 | 2.61 | NA | 41.06 | 090 | ||||||||||||
| 27151 | A | Incision of hip bones | 22.51 | NA | 18.97 | 3.12 | NA | 44.60 | 090 | ||||||||||||
| 27156 | A | Revision of hip bones | 24.63 | NA | 19.84 | 3.48 | NA | 47.95 | 090 | ||||||||||||
| 27158 | A | Revision of pelvis | 19.74 | NA | 15.58 | 2.60 | NA | 37.92 | 090 | ||||||||||||
| 27161 | A | Incision of neck of femur | 16.71 | NA | 14.47 | 2.32 | NA | 33.50 | 090 | ||||||||||||
| 27165 | A | Incision/fixation of femur | 17.91 | NA | 14.92 | 2.51 | NA | 35.34 | 090 | ||||||||||||
| 27170 | A | Repair/graft femur head/neck | 16.07 | NA | 14.16 | 2.20 | NA | 32.43 | 090 | ||||||||||||
| 27175 | A | Treat slipped epiphysis | 8.46 | NA | 7.26 | 1.19 | NA | 16.91 | 090 | ||||||||||||
| 27176 | A | Treat slipped epiphysis | 12.05 | NA | 10.23 | 1.68 | NA | 23.96 | 090 | ||||||||||||
| 27177 | A | Treat slipped epiphysis | 15.08 | NA | 12.22 | 2.11 | NA | 29.41 | 090 | ||||||||||||
| 27178 | A | Treat slipped epiphysis | 11.99 | NA | 10.13 | 1.68 | NA | 23.80 | 090 | ||||||||||||
| 27179 | A | Revise head/neck of femur | 12.98 | NA | 10.90 | 1.84 | NA | 25.72 | 090 | ||||||||||||
| 27181 | A | Treat slipped epiphysis | 14.68 | NA | 11.92 | 1.74 | NA | 28.34 | 090 | ||||||||||||
| 27185 | A | Revision of femur epiphysis | 9.18 | NA | 10.04 | 1.29 | NA | 20.51 | 090 | ||||||||||||
| 27187 | A | Reinforce hip bones | 13.54 | NA | 13.53 | 1.89 | NA | 28.96 | 090 | ||||||||||||
| 27193 | A | Treat pelvic ring fracture | 5.56 | 7.14 | 5.36 | 0.77 | 13.47 | 11.69 | 090 | ||||||||||||
| 27194 | A | Treat pelvic ring fracture | 9.65 | 9.20 | 7.69 | 1.32 | 20.17 | 18.66 | 090 | ||||||||||||
| 27200 | A | Treat tail bone fracture | 1.84 | 3.13 | 1.84 | 0.22 | 5.19 | 3.90 | 090 | ||||||||||||
| 27202 | A | Treat tail bone fracture | 7.04 | NA | 21.62 | 0.69 | NA | 29.35 | 090 | ||||||||||||
| 27215 | A | Treat pelvic fracture(s) | 10.05 | NA | 10.60 | 1.37 | NA | 22.02 | 090 | ||||||||||||
| 27216 | A | Treat pelvic ring fracture | 15.19 | NA | 15.51 | 2.15 | NA | 32.85 | 090 | ||||||||||||
| 27217 | A | Treat pelvic ring fracture | 14.11 | NA | 12.83 | 1.95 | NA | 28.89 | 090 | ||||||||||||
| 27218 | A | Treat pelvic ring fracture | 20.15 | NA | 16.68 | 2.85 | NA | 39.68 | 090 | ||||||||||||
| 27220 | A | Treat hip socket fracture | 6.18 | 7.48 | 5.72 | 0.85 | 14.51 | 12.75 | 090 | ||||||||||||
| 27222 | A | Treat hip socket fracture | 12.70 | NA | 10.37 | 1.77 | NA | 24.84 | 090 | ||||||||||||
| 27226 | A | Treat hip wall fracture | 14.91 | NA | 10.36 | 2.07 | NA | 27.34 | 090 | ||||||||||||
| 27227 | A | Treat hip fracture(s) | 23.45 | NA | 17.22 | 3.24 | NA | 43.91 | 090 | ||||||||||||
| 27228 | A | Treat hip fracture(s) | 27.16 | NA | 19.67 | 3.77 | NA | 50.60 | 090 | ||||||||||||
| 27230 | A | Treat thigh fracture | 5.50 | 7.62 | 6.30 | 0.73 | 13.85 | 12.53 | 090 | ||||||||||||
| 27232 | A | Treat thigh fracture | 10.68 | NA | 9.31 | 1.45 | NA | 21.44 | 090 | ||||||||||||
| 27235 | A | Treat thigh fracture | 12.16 | NA | 11.24 | 1.71 | NA | 25.11 | 090 | ||||||||||||
| 27236 | A | Treat thigh fracture | 15.60 | NA | 12.99 | 2.18 | NA | 30.77 | 090 | ||||||||||||
| 27238 | A | Treat thigh fracture | 5.52 | NA | 6.36 | 0.76 | NA | 12.64 | 090 | ||||||||||||
| 27240 | A | Treat thigh fracture | 12.50 | NA | 10.38 | 1.69 | NA | 24.57 | 090 | ||||||||||||
| 27244 | A | Treat thigh fracture | 15.94 | NA | 13.25 | 2.23 | NA | 31.42 | 090 | ||||||||||||
| 27245 | A | Treat thigh fracture | 20.31 | NA | 15.61 | 2.85 | NA | 38.77 | 090 | ||||||||||||
| 27246 | A | Treat thigh fracture | 4.71 | 7.31 | 5.93 | 0.66 | 12.68 | 11.30 | 090 | ||||||||||||
| 27248 | A | Treat thigh fracture | 10.45 | NA | 10.20 | 1.45 | NA | 22.10 | 090 | ||||||||||||
| 27250 | A | Treat hip dislocation | 6.95 | NA | 6.55 | 0.68 | NA | 14.18 | 090 | ||||||||||||
| 27252 | A | Treat hip dislocation | 10.39 | NA | 8.31 | 1.37 | NA | 20.07 | 090 | ||||||||||||
| 27253 | A | Treat hip dislocation | 12.92 | NA | 11.10 | 1.81 | NA | 25.83 | 090 | ||||||||||||
| 27254 | A | Treat hip dislocation | 18.26 | NA | 14.29 | 2.52 | NA | 35.07 | 090 | ||||||||||||
| 27256 | A | Treat hip dislocation | 4.12 | NA | 4.31 | 0.49 | NA | 8.92 | 010 | ||||||||||||
| 27257 | A | Treat hip dislocation | 5.22 | NA | 4.59 | 0.56 | NA | 10.37 | 010 | ||||||||||||
| 27258 | A | Treat hip dislocation | 15.43 | NA | 13.93 | 2.06 | NA | 31.42 | 090 | ||||||||||||
| 27259 | A | Treat hip dislocation | 21.55 | NA | 18.02 | 2.99 | NA | 42.56 | 090 | ||||||||||||
| 27265 | A | Treat hip dislocation | 5.05 | NA | 6.09 | 0.65 | NA | 11.79 | 090 | ||||||||||||
| 27266 | A | Treat hip dislocation | 7.49 | NA | 7.50 | 1.04 | NA | 16.03 | 090 | ||||||||||||
| 27275 | A | Manipulation of hip joint | 2.27 | NA | 3.62 | 0.31 | NA | 6.20 | 010 | ||||||||||||
| 27280 | A | Fusion of sacroiliac joint | 13.39 | NA | 13.95 | 1.98 | NA | 29.32 | 090 | ||||||||||||
| 27282 | A | Fusion of pubic bones | 11.34 | NA | 12.33 | 1.14 | NA | 24.81 | 090 | ||||||||||||
| 27284 | A | Fusion of hip joint | 23.45 | NA | 18.86 | 2.36 | NA | 44.67 | 090 | ||||||||||||
| 27286 | A | Fusion of hip joint | 23.45 | NA | 19.13 | 2.37 | NA | 44.95 | 090 | ||||||||||||
| 27290 | A | Amputation of leg at hip | 23.28 | NA | 17.37 | 2.94 | NA | 43.59 | 090 | ||||||||||||
| 27295 | A | Amputation of leg at hip | 18.65 | NA | 14.65 | 2.35 | NA | 35.65 | 090 | ||||||||||||
| 27299 | C | Pelvis/hip joint surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 27301 | A | Drain thigh/knee lesion | 6.49 | 15.30 | 14.04 | 0.80 | 22.59 | 21.33 | 090 | ||||||||||||
| 27303 | A | Drainage of bone lesion | 8.28 | NA | 14.63 | 1.14 | NA | 24.05 | 090 | ||||||||||||
| 27305 | A | Incise thigh tendon fascia | 5.92 | NA | 8.88 | 0.77 | NA | 15.57 | 090 | ||||||||||||
| 27306 | A | Incision of thigh tendon | 4.62 | NA | 7.54 | 0.62 | NA | 12.78 | 090 | ||||||||||||
| 27307 | A | Incision of thigh tendons | 5.80 | NA | 8.15 | 0.78 | NA | 14.73 | 090 | ||||||||||||
| 27310 | A | Exploration of knee joint | 9.27 | NA | 10.14 | 1.29 | NA | 20.70 | 090 | ||||||||||||
| 27315 | A | Partial removal, thigh nerve | 6.97 | NA | 4.04 | 0.79 | NA | 11.80 | 090 | ||||||||||||
| 27320 | A | Partial removal, thigh nerve | 6.30 | NA | 5.07 | 0.78 | NA | 12.15 | 090 | ||||||||||||
| 27323 | A | Biopsy, thigh soft tissues | 2.28 | 5.57 | 3.49 | 0.17 | 8.02 | 5.94 | 010 | ||||||||||||
| 27324 | A | Biopsy, thigh soft tissues | 4.90 | NA | 6.79 | 0.59 | NA | 12.28 | 090 | ||||||||||||
| 27327 | A | Removal of thigh lesion | 4.47 | 8.47 | 6.35 | 0.50 | 13.44 | 11.32 | 090 | ||||||||||||
| 27328 | A | Removal of thigh lesion | 5.57 | NA | 7.19 | 0.66 | NA | 13.42 | 090 | ||||||||||||
| 27329 | A | Remove tumor, thigh/knee | 14.14 | NA | 15.02 | 1.68 | NA | 30.84 | 090 | ||||||||||||
| 27330 | A | Biopsy, knee joint lining | 4.97 | NA | 6.42 | 0.66 | NA | 12.05 | 090 | ||||||||||||
| 27331 | A | Explore/treat knee joint | 5.88 | NA | 7.56 | 0.81 | NA | 14.25 | 090 | ||||||||||||
| 27332 | A | Removal of knee cartilage | 8.27 | NA | 8.84 | 1.15 | NA | 18.26 | 090 | ||||||||||||
| 27333 | A | Removal of knee cartilage | 7.30 | NA | 8.49 | 1.03 | NA | 16.82 | 090 | ||||||||||||
| 27334 | A | Remove knee joint lining | 8.70 | NA | 9.80 | 1.21 | NA | 19.71 | 090 | ||||||||||||
| 27335 | A | Remove knee joint lining | 10.00 | NA | 10.58 | 1.41 | NA | 21.99 | 090 | ||||||||||||
| 27340 | A | Removal of kneecap bursa | 4.18 | NA | 6.03 | 0.58 | NA | 10.79 | 090 | ||||||||||||
| 27345 | A | Removal of knee cyst | 5.92 | NA | 7.49 | 0.81 | NA | 14.22 | 090 | ||||||||||||
| 27347 | A | Remove knee cyst | 5.78 | 2.64 | 2.64 | 0.76 | 9.18 | 9.18 | 090 | ||||||||||||
| 27350 | A | Removal of kneecap | 8.17 | NA | 8.95 | 1.15 | NA | 18.27 | 090 | ||||||||||||
| 27355 | A | Remove femur lesion | 7.65 | NA | 10.36 | 1.07 | NA | 19.08 | 090 | ||||||||||||
| 27356 | A | Remove femur lesion/graft | 9.48 | NA | 11.32 | 1.29 | NA | 22.09 | 090 | ||||||||||||
| 27357 | A | Remove femur lesion/graft | 10.53 | NA | 11.75 | 1.48 | NA | 23.76 | 090 | ||||||||||||
| 27358 | A | Remove femur lesion/fixation | 4.74 | NA | 2.69 | 0.67 | NA | 8.10 | ZZZ | ||||||||||||
| 27360 | A | Partial removal, leg bone(s) | 10.50 | NA | 18.43 | 1.42 | NA | 30.35 | 090 | ||||||||||||
| 27365 | A | Extensive leg surgery | 16.27 | NA | 14.69 | 2.26 | NA | 33.22 | 090 | ||||||||||||
| 27370 | A | Injection for knee x-ray | 0.96 | 11.10 | 0.35 | 0.06 | 12.12 | 1.37 | 000 | ||||||||||||
| 27372 | A | Removal of foreign body | 5.07 | 8.66 | 6.28 | 0.62 | 14.35 | 11.97 | 090 | ||||||||||||
| 27380 | A | Repair of kneecap tendon | 7.16 | NA | 8.57 | 1.00 | NA | 16.73 | 090 | ||||||||||||
| 27381 | A | Repair/graft kneecap tendon | 10.34 | NA | 10.34 | 1.44 | NA | 22.12 | 090 | ||||||||||||
| 27385 | A | Repair of thigh muscle | 7.76 | NA | 8.93 | 1.09 | NA | 17.78 | 090 | ||||||||||||
| 27386 | A | Repair/graft of thigh muscle | 10.56 | NA | 11.12 | 1.49 | NA | 23.17 | 090 | ||||||||||||
| 27390 | A | Incision of thigh tendon | 5.33 | NA | 8.22 | 0.69 | NA | 14.24 | 090 | ||||||||||||
| 27391 | A | Incision of thigh tendons | 7.20 | NA | 9.08 | 0.99 | NA | 17.27 | 090 | ||||||||||||
| 27392 | A | Incision of thigh tendons | 9.20 | NA | 11.15 | 1.23 | NA | 21.58 | 090 | ||||||||||||
| 27393 | A | Lengthening of thigh tendon | 6.39 | NA | 8.45 | 0.90 | NA | 15.74 | 090 | ||||||||||||
| 27394 | A | Lengthening of thigh tendons | 8.50 | NA | 10.51 | 1.17 | NA | 20.18 | 090 | ||||||||||||
| 27395 | A | Lengthening of thigh tendons | 11.73 | NA | 13.19 | 1.63 | NA | 26.55 | 090 | ||||||||||||
| 27396 | A | Transplant of thigh tendon | 7.86 | NA | 9.65 | 1.11 | NA | 18.62 | 090 | ||||||||||||
| 27397 | A | Transplants of thigh tendons | 11.28 | NA | 11.71 | 1.58 | NA | 24.57 | 090 | ||||||||||||
| 27400 | A | Revise thigh muscles/tendons | 9.02 | NA | 10.67 | 1.18 | NA | 20.87 | 090 | ||||||||||||
| 27403 | A | Repair of knee cartilage | 8.33 | NA | 8.88 | 1.16 | NA | 18.37 | 090 | ||||||||||||
| 27405 | A | Repair of knee ligament | 8.65 | NA | 9.81 | 1.21 | NA | 19.67 | 090 | ||||||||||||
| 27407 | A | Repair of knee ligament | 10.28 | NA | 10.67 | 1.38 | NA | 22.33 | 090 | ||||||||||||
| 27409 | A | Repair of knee ligaments | 12.90 | NA | 12.11 | 1.75 | NA | 26.76 | 090 | ||||||||||||
| 27418 | A | Repair degenerated kneecap | 10.85 | NA | 10.99 | 1.51 | NA | 23.35 | 090 | ||||||||||||
| 27420 | A | Revision of unstable kneecap | 9.83 | NA | 9.87 | 1.38 | NA | 21.08 | 090 | ||||||||||||
| 27422 | A | Revision of unstable kneecap | 9.78 | NA | 9.83 | 1.37 | NA | 20.98 | 090 | ||||||||||||
| 27424 | A | Revision/removal of kneecap | 9.81 | NA | 9.75 | 1.38 | NA | 20.94 | 090 | ||||||||||||
| 27425 | A | Lateral retinacular release | 5.22 | NA | 7.29 | 0.73 | NA | 13.24 | 090 | ||||||||||||
| 27427 | A | Reconstruction, knee | 9.36 | NA | 9.57 | 1.29 | NA | 20.22 | 090 | ||||||||||||
| 27428 | A | Reconstruction, knee | 14.00 | NA | 12.85 | 1.95 | NA | 28.80 | 090 | ||||||||||||
| 27429 | A | Reconstruction, knee | 15.52 | NA | 13.69 | 2.18 | NA | 31.39 | 090 | ||||||||||||
| 27430 | A | Revision of thigh muscles | 9.67 | NA | 9.90 | 1.35 | NA | 20.92 | 090 | ||||||||||||
| 27435 | A | Incision of knee joint | 9.49 | NA | 9.68 | 1.33 | NA | 20.50 | 090 | ||||||||||||
| 27437 | A | Revise kneecap | 8.46 | NA | 10.06 | 1.18 | NA | 19.70 | 090 | ||||||||||||
| 27438 | A | Revise kneecap with implant | 11.23 | NA | 11.34 | 1.56 | NA | 24.13 | 090 | ||||||||||||
| 27440 | A | Revision of knee joint | 10.43 | NA | 10.92 | 1.42 | NA | 22.77 | 090 | ||||||||||||
| 27441 | A | Revision of knee joint | 10.82 | NA | 11.24 | 1.49 | NA | 23.55 | 090 | ||||||||||||
| 27442 | A | Revision of knee joint | 11.89 | NA | 11.77 | 1.68 | NA | 25.34 | 090 | ||||||||||||
| 27443 | A | Revision of knee joint | 10.93 | NA | 11.56 | 1.52 | NA | 24.01 | 090 | ||||||||||||
| 27445 | A | Revision of knee joint | 17.68 | NA | 14.98 | 2.49 | NA | 35.15 | 090 | ||||||||||||
| 27446 | A | Revision of knee joint | 15.84 | NA | 14.26 | 2.22 | NA | 32.32 | 090 | ||||||||||||
| 27447 | A | Total knee arthroplasty | 21.48 | NA | 17.35 | 3.00 | NA | 41.83 | 090 | ||||||||||||
| 27448 | A | Incision of thigh | 11.06 | NA | 11.98 | 1.51 | NA | 24.55 | 090 | ||||||||||||
| 27450 | A | Incision of thigh | 13.98 | NA | 13.83 | 1.96 | NA | 29.77 | 090 | ||||||||||||
| 27454 | A | Realignment of thigh bone | 17.56 | NA | 15.83 | 2.46 | NA | 35.85 | 090 | ||||||||||||
| 27455 | A | Realignment of knee | 12.82 | NA | 12.57 | 1.78 | NA | 27.17 | 090 | ||||||||||||
| 27457 | A | Realignment of knee | 13.45 | NA | 11.73 | 1.88 | NA | 27.06 | 090 | ||||||||||||
| 27465 | A | Shortening of thigh bone | 13.87 | NA | 14.09 | 1.86 | NA | 29.82 | 090 | ||||||||||||
| 27466 | A | Lengthening of thigh bone | 16.33 | NA | 16.19 | 1.92 | NA | 34.44 | 090 | ||||||||||||
| 27468 | A | Shorten/lengthen thighs | 18.97 | NA | 14.57 | 2.68 | NA | 36.22 | 090 | ||||||||||||
| 27470 | A | Repair of thigh | 16.07 | NA | 16.07 | 2.24 | NA | 34.38 | 090 | ||||||||||||
| 27472 | A | Repair/graft of thigh | 17.72 | NA | 16.98 | 2.49 | NA | 37.19 | 090 | ||||||||||||
| 27475 | A | Surgery to stop leg growth | 8.64 | NA | 9.51 | 1.13 | NA | 19.28 | 090 | ||||||||||||
| 27477 | A | Surgery to stop leg growth | 9.85 | NA | 10.10 | 1.31 | NA | 21.26 | 090 | ||||||||||||
| 27479 | A | Surgery to stop leg growth | 12.80 | NA | 12.09 | 1.81 | NA | 26.70 | 090 | ||||||||||||
| 27485 | A | Surgery to stop leg growth | 8.84 | NA | 9.40 | 1.24 | NA | 19.48 | 090 | ||||||||||||
| 27486 | A | Revise/replace knee joint | 19.27 | NA | 16.13 | 2.70 | NA | 38.10 | 090 | ||||||||||||
| 27487 | A | Revise/replace knee joint | 25.27 | NA | 19.26 | 3.54 | NA | 48.07 | 090 | ||||||||||||
| 27488 | A | Removal of knee prosthesis | 15.74 | NA | 14.21 | 2.21 | NA | 32.16 | 090 | ||||||||||||
| 27495 | A | Reinforce thigh | 15.55 | NA | 15.78 | 2.18 | NA | 33.51 | 090 | ||||||||||||
| 27496 | A | Decompression of thigh/knee | 6.11 | NA | 7.96 | 0.77 | NA | 14.84 | 090 | ||||||||||||
| 27497 | A | Decompression of thigh/knee | 7.17 | NA | 8.16 | 0.84 | NA | 16.17 | 090 | ||||||||||||
| 27498 | A | Decompression of thigh/knee | 7.99 | NA | 8.37 | 0.97 | NA | 17.33 | 090 | ||||||||||||
| 27499 | A | Decompression of thigh/knee | 9.00 | NA | 9.42 | 1.18 | NA | 19.60 | 090 | ||||||||||||
| 27500 | A | Treatment of thigh fracture | 5.92 | 9.84 | 7.57 | 0.80 | 16.56 | 14.29 | 090 | ||||||||||||
| 27501 | A | Treatment of thigh fracture | 5.92 | 10.92 | 8.62 | 0.83 | 17.67 | 15.37 | 090 | ||||||||||||
| 27502 | A | Treatment of thigh fracture | 10.58 | NA | 11.27 | 1.49 | NA | 23.34 | 090 | ||||||||||||
| 27503 | A | Treatment of thigh fracture | 10.58 | NA | 11.26 | 1.49 | NA | 23.33 | 090 | ||||||||||||
| 27506 | A | Treatment of thigh fracture | 17.45 | NA | 14.57 | 2.33 | NA | 34.35 | 090 | ||||||||||||
| 27507 | A | Treatment of thigh fracture | 13.99 | NA | 12.58 | 1.95 | NA | 28.52 | 090 | ||||||||||||
| 27508 | A | Treatment of thigh fracture | 5.83 | 7.17 | 5.43 | 0.80 | 13.80 | 12.06 | 090 | ||||||||||||
| 27509 | A | Treatment of thigh fracture | 7.71 | NA | 9.44 | 1.08 | NA | 18.23 | 090 | ||||||||||||
| 27510 | A | Treatment of thigh fracture | 9.13 | NA | 7.37 | 1.26 | NA | 17.76 | 090 | ||||||||||||
| 27511 | A | Treatment of thigh fracture | 13.64 | NA | 13.38 | 1.91 | NA | 28.93 | 090 | ||||||||||||
| 27513 | A | Treatment of thigh fracture | 17.92 | NA | 15.80 | 2.51 | NA | 36.23 | 090 | ||||||||||||
| 27514 | A | Treatment of thigh fracture | 17.30 | NA | 14.55 | 2.41 | NA | 34.26 | 090 | ||||||||||||
| 27516 | A | Treat thigh fx growth plate | 5.37 | 7.98 | 5.85 | 0.74 | 14.09 | 11.96 | 090 | ||||||||||||
| 27517 | A | Treat thigh fx growth plate | 8.78 | 9.94 | 7.90 | 1.22 | 19.94 | 17.90 | 090 | ||||||||||||
| 27519 | A | Treat thigh fx growth plate | 15.02 | NA | 13.11 | 2.09 | NA | 30.22 | 090 | ||||||||||||
| 27520 | A | Treat kneecap fracture | 2.86 | 5.48 | 3.82 | 0.38 | 8.72 | 7.06 | 090 | ||||||||||||
| 27524 | A | Treat kneecap fracture | 10.00 | NA | 8.98 | 1.40 | NA | 20.38 | 090 | ||||||||||||
| 27530 | A | Treat knee fracture | 3.78 | 6.00 | 4.33 | 0.51 | 10.29 | 8.62 | 090 | ||||||||||||
| 27532 | A | Treat knee fracture | 7.30 | 7.65 | 5.84 | 1.02 | 15.97 | 14.16 | 090 | ||||||||||||
| 27535 | A | Treat knee fracture | 11.50 | NA | 12.15 | 1.61 | NA | 25.26 | 090 | ||||||||||||
| 27536 | A | Treat knee fracture | 15.65 | NA | 12.16 | 2.19 | NA | 30.00 | 090 | ||||||||||||
| 27538 | A | Treat knee fracture(s) | 4.87 | 7.64 | 5.60 | 0.67 | 13.18 | 11.14 | 090 | ||||||||||||
| 27540 | A | Treat knee fracture | 13.10 | NA | 10.75 | 1.80 | NA | 25.65 | 090 | ||||||||||||
| 27550 | A | Treat knee dislocation | 5.76 | 7.60 | 5.79 | 0.68 | 14.04 | 12.23 | 090 | ||||||||||||
| 27552 | A | Treat knee dislocation | 7.90 | NA | 8.04 | 1.10 | NA | 17.04 | 090 | ||||||||||||
| 27556 | A | Treat knee dislocation | 14.41 | NA | 14.45 | 2.01 | NA | 30.87 | 090 | ||||||||||||
| 27557 | A | Treat knee dislocation | 16.77 | NA | 15.78 | 2.37 | NA | 34.92 | 090 | ||||||||||||
| 27558 | A | Treat knee dislocation | 17.72 | NA | 15.91 | 2.51 | NA | 36.14 | 090 | ||||||||||||
| 27560 | A | Treat kneecap dislocation | 3.82 | 5.89 | 4.04 | 0.40 | 10.11 | 8.26 | 090 | ||||||||||||
| 27562 | A | Treat kneecap dislocation | 5.79 | NA | 5.67 | 0.69 | NA | 12.15 | 090 | ||||||||||||
| 27566 | A | Treat kneecap dislocation | 12.23 | NA | 10.09 | 1.73 | NA | 24.05 | 090 | ||||||||||||
| 27570 | A | Fixation of knee joint | 1.74 | NA | 3.24 | 0.24 | NA | 5.22 | 010 | ||||||||||||
| 27580 | A | Fusion of knee | 19.37 | NA | 16.63 | 2.70 | NA | 38.70 | 090 | ||||||||||||
| 27590 | A | Amputate leg at thigh | 12.03 | NA | 12.67 | 1.35 | NA | 26.05 | 090 | ||||||||||||
| 27591 | A | Amputate leg at thigh | 12.68 | NA | 14.01 | 1.63 | NA | 28.32 | 090 | ||||||||||||
| 27592 | A | Amputate leg at thigh | 10.02 | NA | 12.55 | 1.17 | NA | 23.74 | 090 | ||||||||||||
| 27594 | A | Amputation follow-up surgery | 6.92 | NA | 9.05 | 0.82 | NA | 16.79 | 090 | ||||||||||||
| 27596 | A | Amputation follow-up surgery | 10.60 | NA | 12.64 | 1.24 | NA | 24.48 | 090 | ||||||||||||
| 27598 | A | Amputate lower leg at knee | 10.53 | NA | 11.69 | 1.24 | NA | 23.46 | 090 | ||||||||||||
| 27599 | C | Leg surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 27600 | A | Decompression of lower leg | 5.65 | NA | 7.67 | 0.68 | NA | 14.00 | 090 | ||||||||||||
| 27601 | A | Decompression of lower leg | 5.64 | NA | 7.68 | 0.69 | NA | 14.01 | 090 | ||||||||||||
| 27602 | A | Decompression of lower leg | 7.35 | NA | 8.08 | 0.85 | NA | 16.28 | 090 | ||||||||||||
| 27603 | A | Drain lower leg lesion | 4.94 | 16.03 | 10.54 | 0.56 | 21.53 | 16.04 | 090 | ||||||||||||
| 27604 | A | Drain lower leg bursa | 4.47 | 11.01 | 8.47 | 0.54 | 16.02 | 13.48 | 090 | ||||||||||||
| 27605 | A | Incision of achilles tendon | 2.87 | 9.81 | 3.67 | 0.38 | 13.06 | 6.92 | 010 | ||||||||||||
| 27606 | A | Incision of achilles tendon | 4.14 | 13.19 | 5.08 | 0.57 | 17.90 | 9.79 | 010 | ||||||||||||
| 27607 | A | Treat lower leg bone lesion | 7.97 | NA | 12.78 | 1.08 | NA | 21.83 | 090 | ||||||||||||
| 27610 | A | Explore/treat ankle joint | 8.34 | NA | 10.43 | 1.15 | NA | 19.92 | 090 | ||||||||||||
| 27612 | A | Exploration of ankle joint | 7.33 | NA | 8.32 | 1.01 | NA | 16.66 | 090 | ||||||||||||
| 27613 | A | Biopsy lower leg soft tissue | 2.17 | 5.38 | 2.96 | 0.16 | 7.71 | 5.29 | 010 | ||||||||||||
| 27614 | A | Biopsy lower leg soft tissue | 5.66 | 10.88 | 7.17 | 0.62 | 17.16 | 13.45 | 090 | ||||||||||||
| 27615 | A | Remove tumor, lower leg | 12.56 | NA | 17.07 | 1.39 | NA | 31.02 | 090 | ||||||||||||
| 27618 | A | Remove lower leg lesion | 5.09 | 11.72 | 6.72 | 0.54 | 17.35 | 12.35 | 090 | ||||||||||||
| 27619 | A | Remove lower leg lesion | 8.40 | 12.63 | 9.55 | 1.01 | 22.04 | 18.96 | 090 | ||||||||||||
| 27620 | A | Explore/treat ankle joint | 5.98 | NA | 8.20 | 0.83 | NA | 15.01 | 090 | ||||||||||||
| 27625 | A | Remove ankle joint lining | 8.30 | NA | 9.57 | 1.16 | NA | 19.03 | 090 | ||||||||||||
| 27626 | A | Remove ankle joint lining | 8.91 | NA | 10.39 | 1.23 | NA | 20.53 | 090 | ||||||||||||
| 27630 | A | Removal of tendon lesion | 4.80 | 10.70 | 6.87 | 0.60 | 16.10 | 12.27 | 090 | ||||||||||||
| 27635 | A | Remove lower leg bone lesion | 7.78 | NA | 11.13 | 1.06 | NA | 19.97 | 090 | ||||||||||||
| 27637 | A | Remove/graft leg bone lesion | 9.85 | NA | 12.36 | 1.38 | NA | 23.59 | 090 | ||||||||||||
| 27638 | A | Remove/graft leg bone lesion | 10.57 | NA | 12.55 | 1.47 | NA | 24.59 | 090 | ||||||||||||
| 27640 | A | Partial removal of tibia | 11.37 | NA | 18.46 | 1.54 | NA | 31.37 | 090 | ||||||||||||
| 27641 | A | Partial removal of fibula | 9.24 | NA | 16.52 | 1.22 | NA | 26.98 | 090 | ||||||||||||
| 27645 | A | Extensive lower leg surgery | 14.17 | NA | 18.78 | 1.98 | NA | 34.93 | 090 | ||||||||||||
| 27646 | A | Extensive lower leg surgery | 12.66 | NA | 18.50 | 1.55 | NA | 32.71 | 090 | ||||||||||||
| 27647 | A | Extensive ankle/heel surgery | 12.24 | NA | 11.31 | 1.64 | NA | 25.19 | 090 | ||||||||||||
| 27648 | A | Injection for ankle x-ray | 0.96 | 9.49 | 0.36 | 0.05 | 10.50 | 1.37 | 000 | ||||||||||||
| 27650 | A | Repair achilles tendon | 9.69 | NA | 9.60 | 1.35 | NA | 20.64 | 090 | ||||||||||||
| 27652 | A | Repair/graft achilles tendon | 10.33 | NA | 9.90 | 1.45 | NA | 21.68 | 090 | ||||||||||||
| 27654 | A | Repair of achilles tendon | 10.02 | NA | 10.34 | 1.41 | NA | 21.77 | 090 | ||||||||||||
| 27656 | A | Repair leg fascia defect | 4.57 | 11.38 | 7.06 | 0.48 | 16.43 | 12.11 | 090 | ||||||||||||
| 27658 | A | Repair of leg tendon, each | 4.98 | 10.63 | 9.14 | 0.68 | 16.29 | 14.80 | 090 | ||||||||||||
| 27659 | A | Repair of leg tendon, each | 6.81 | 12.77 | 9.97 | 0.96 | 20.54 | 17.74 | 090 | ||||||||||||
| 27664 | A | Repair of leg tendon, each | 4.59 | 17.85 | 9.17 | 0.63 | 23.07 | 14.39 | 090 | ||||||||||||
| 27665 | A | Repair of leg tendon, each | 5.40 | 8.95 | 8.95 | 0.75 | 15.10 | 15.10 | 090 | ||||||||||||
| 27675 | A | Repair lower leg tendons | 7.18 | NA | 8.48 | 1.01 | NA | 16.67 | 090 | ||||||||||||
| 27676 | A | Repair lower leg tendons | 8.42 | NA | 9.72 | 1.15 | NA | 19.29 | 090 | ||||||||||||
| 27680 | A | Release of lower leg tendon | 5.74 | NA | 8.27 | 0.80 | NA | 14.81 | 090 | ||||||||||||
| 27681 | A | Release of lower leg tendons | 6.82 | NA | 8.88 | 0.92 | NA | 16.62 | 090 | ||||||||||||
| 27685 | A | Revision of lower leg tendon | 6.50 | 10.37 | 8.45 | 0.91 | 17.78 | 15.86 | 090 | ||||||||||||
| 27686 | A | Revise lower leg tendons | 7.46 | 15.30 | 9.89 | 1.05 | 23.81 | 18.40 | 090 | ||||||||||||
| 27687 | A | Revision of calf tendon | 6.24 | NA | 8.70 | 0.88 | NA | 15.82 | 090 | ||||||||||||
| 27690 | A | Revise lower leg tendon | 8.71 | NA | 9.61 | 1.22 | NA | 19.54 | 090 | ||||||||||||
| 27691 | A | Revise lower leg tendon | 9.96 | NA | 11.10 | 1.40 | NA | 22.46 | 090 | ||||||||||||
| 27692 | A | Revise additional leg tendon | 1.87 | NA | 0.99 | 0.26 | NA | 3.12 | ZZZ | ||||||||||||
| 27695 | A | Repair of ankle ligament | 6.51 | NA | 9.20 | 0.90 | NA | 16.61 | 090 | ||||||||||||
| 27696 | A | Repair of ankle ligaments | 8.27 | NA | 9.54 | 1.16 | NA | 18.97 | 090 | ||||||||||||
| 27698 | A | Repair of ankle ligament | 9.36 | NA | 9.72 | 1.31 | NA | 20.39 | 090 | ||||||||||||
| 27700 | A | Revision of ankle joint | 9.29 | NA | 7.95 | 1.24 | NA | 18.48 | 090 | ||||||||||||
| 27702 | A | Reconstruct ankle joint | 13.67 | NA | 13.02 | 1.92 | NA | 28.61 | 090 | ||||||||||||
| 27703 | A | Reconstruction, ankle joint | 15.87 | NA | 13.31 | 2.24 | NA | 31.42 | 090 | ||||||||||||
| 27704 | A | Removal of ankle implant | 7.62 | NA | 9.40 | 0.61 | NA | 17.63 | 090 | ||||||||||||
| 27705 | A | Incision of tibia | 10.38 | NA | 11.55 | 1.44 | NA | 23.37 | 090 | ||||||||||||
| 27707 | A | Incision of fibula | 4.37 | NA | 8.48 | 0.60 | NA | 13.45 | 090 | ||||||||||||
| 27709 | A | Incision of tibia fibula | 9.95 | NA | 11.48 | 1.39 | NA | 22.82 | 090 | ||||||||||||
| 27712 | A | Realignment of lower leg | 14.25 | NA | 13.92 | 2.00 | NA | 30.17 | 090 | ||||||||||||
| 27715 | A | Revision of lower leg | 14.39 | NA | 15.22 | 2.00 | NA | 31.61 | 090 | ||||||||||||
| 27720 | A | Repair of tibia | 11.79 | NA | 13.67 | 1.66 | NA | 27.12 | 090 | ||||||||||||
| 27722 | A | Repair/graft of tibia | 11.82 | NA | 13.46 | 1.65 | NA | 26.93 | 090 | ||||||||||||
| 27724 | A | Repair/graft of tibia | 18.20 | NA | 17.28 | 2.10 | NA | 37.58 | 090 | ||||||||||||
| 27725 | A | Repair of lower leg | 15.59 | NA | 15.62 | 2.20 | NA | 33.41 | 090 | ||||||||||||
| 27727 | A | Repair of lower leg | 14.01 | NA | 14.43 | 1.84 | NA | 30.28 | 090 | ||||||||||||
| 27730 | A | Repair of tibia epiphysis | 7.41 | 21.54 | 10.22 | 0.75 | 29.70 | 18.38 | 090 | ||||||||||||
| 27732 | A | Repair of fibula epiphysis | 5.32 | 14.45 | 7.22 | 0.63 | 20.40 | 13.17 | 090 | ||||||||||||
| 27734 | A | Repair lower leg epiphyses | 8.48 | NA | 10.84 | 0.85 | NA | 20.17 | 090 | ||||||||||||
| 27740 | A | Repair of leg epiphyses | 9.30 | 16.04 | 9.72 | 1.31 | 26.65 | 20.33 | 090 | ||||||||||||
| 27742 | A | Repair of leg epiphyses | 10.30 | 16.44 | 9.27 | 1.55 | 28.29 | 21.12 | 090 | ||||||||||||
| 27745 | A | Reinforce tibia | 10.07 | NA | 11.60 | 1.38 | NA | 23.05 | 090 | ||||||||||||
| 27750 | A | Treatment of tibia fracture | 3.19 | 5.65 | 4.00 | 0.43 | 9.27 | 7.62 | 090 | ||||||||||||
| 27752 | A | Treatment of tibia fracture | 5.84 | 8.20 | 6.17 | 0.82 | 14.86 | 12.83 | 090 | ||||||||||||
| 27756 | A | Treatment of tibia fracture | 6.78 | NA | 10.84 | 0.94 | NA | 18.56 | 090 | ||||||||||||
| 27758 | A | Treatment of tibia fracture | 11.67 | NA | 12.22 | 1.52 | NA | 25.41 | 090 | ||||||||||||
| 27759 | A | Treatment of tibia fracture | 13.76 | NA | 13.46 | 1.93 | NA | 29.15 | 090 | ||||||||||||
| 27760 | A | Treatment of ankle fracture | 3.01 | 5.42 | 3.87 | 0.39 | 8.82 | 7.27 | 090 | ||||||||||||
| 27762 | A | Treatment of ankle fracture | 5.25 | 7.57 | 5.75 | 0.71 | 13.53 | 11.71 | 090 | ||||||||||||
| 27766 | A | Treatment of ankle fracture | 8.36 | NA | 8.26 | 1.17 | NA | 17.79 | 090 | ||||||||||||
| 27780 | A | Treatment of fibula fracture | 2.65 | 5.37 | 3.69 | 0.33 | 8.35 | 6.67 | 090 | ||||||||||||
| 27781 | A | Treatment of fibula fracture | 4.40 | 6.38 | 4.62 | 0.57 | 11.35 | 9.59 | 090 | ||||||||||||
| 27784 | A | Treatment of fibula fracture | 7.11 | NA | 8.63 | 0.98 | NA | 16.72 | 090 | ||||||||||||
| 27786 | A | Treatment of ankle fracture | 2.84 | 5.38 | 3.78 | 0.37 | 8.59 | 6.99 | 090 | ||||||||||||
| 27788 | A | Treatment of ankle fracture | 4.45 | 6.65 | 4.62 | 0.61 | 11.71 | 9.68 | 090 | ||||||||||||
| 27792 | A | Treatment of ankle fracture | 7.66 | NA | 8.18 | 1.07 | NA | 16.91 | 090 | ||||||||||||
| 27808 | A | Treatment of ankle fracture | 2.83 | 6.44 | 4.50 | 0.38 | 9.65 | 7.71 | 090 | ||||||||||||
| 27810 | A | Treatment of ankle fracture | 5.13 | 7.77 | 5.71 | 0.71 | 13.61 | 11.55 | 090 | ||||||||||||
| 27814 | A | Treatment of ankle fracture | 10.68 | NA | 10.93 | 1.50 | NA | 23.11 | 090 | ||||||||||||
| 27816 | A | Treatment of ankle fracture | 2.89 | 5.97 | 4.55 | 0.37 | 9.23 | 7.81 | 090 | ||||||||||||
| 27818 | A | Treatment of ankle fracture | 5.50 | 7.89 | 5.88 | 0.74 | 14.13 | 12.12 | 090 | ||||||||||||
| 27822 | A | Treatment of ankle fracture | 11.00 | NA | 13.18 | 1.29 | NA | 25.47 | 090 | ||||||||||||
| 27823 | A | Treatment of ankle fracture | 13.00 | NA | 14.39 | 1.65 | NA | 29.04 | 090 | ||||||||||||
| 27824 | A | Treat lower leg fracture | 2.89 | 6.43 | 4.50 | 0.39 | 9.71 | 7.78 | 090 | ||||||||||||
| 27825 | A | Treat lower leg fracture | 6.19 | 8.30 | 6.32 | 0.85 | 15.34 | 13.36 | 090 | ||||||||||||
| 27826 | A | Treat lower leg fracture | 8.54 | NA | 11.88 | 1.19 | NA | 21.61 | 090 | ||||||||||||
| 27827 | A | Treat lower leg fracture | 14.06 | NA | 15.00 | 1.96 | NA | 31.02 | 090 | ||||||||||||
| 27828 | A | Treat lower leg fracture | 16.23 | NA | 15.03 | 2.27 | NA | 33.53 | 090 | ||||||||||||
| 27829 | A | Treat lower leg joint | 5.49 | NA | 8.67 | 0.77 | NA | 14.93 | 090 | ||||||||||||
| 27830 | A | Treat lower leg dislocation | 3.79 | 5.82 | 4.36 | 0.44 | 10.05 | 8.59 | 090 | ||||||||||||
| 27831 | A | Treat lower leg dislocation | 4.56 | NA | 4.94 | 0.61 | NA | 10.11 | 090 | ||||||||||||
| 27832 | A | Treat lower leg dislocation | 6.49 | NA | 8.06 | 0.91 | NA | 15.46 | 090 | ||||||||||||
| 27840 | A | Treat ankle dislocation | 4.58 | NA | 6.21 | 0.47 | NA | 11.26 | 090 | ||||||||||||
| 27842 | A | Treat ankle dislocation | 6.21 | NA | 5.25 | 0.76 | NA | 12.22 | 090 | ||||||||||||
| 27846 | A | Treat ankle dislocation | 9.79 | NA | 10.46 | 1.36 | NA | 21.61 | 090 | ||||||||||||
| 27848 | A | Treat ankle dislocation | 11.20 | NA | 11.70 | 1.55 | NA | 24.45 | 090 | ||||||||||||
| 27860 | A | Fixation of ankle joint | 2.34 | NA | 3.78 | 0.31 | NA | 6.43 | 010 | ||||||||||||
| 27870 | A | Fusion of ankle joint | 13.91 | NA | 13.76 | 1.95 | NA | 29.62 | 090 | ||||||||||||
| 27871 | A | Fusion of tibiofibular joint | 9.17 | NA | 11.03 | 1.29 | NA | 21.49 | 090 | ||||||||||||
| 27880 | A | Amputation of lower leg | 11.85 | NA | 11.95 | 1.38 | NA | 25.18 | 090 | ||||||||||||
| 27881 | A | Amputation of lower leg | 12.34 | NA | 13.44 | 1.59 | NA | 27.37 | 090 | ||||||||||||
| 27882 | A | Amputation of lower leg | 8.94 | NA | 13.13 | 1.03 | NA | 23.10 | 090 | ||||||||||||
| 27884 | A | Amputation follow-up surgery | 8.21 | NA | 10.78 | 0.95 | NA | 19.94 | 090 | ||||||||||||
| 27886 | A | Amputation follow-up surgery | 9.32 | NA | 11.26 | 1.13 | NA | 21.71 | 090 | ||||||||||||
| 27888 | A | Amputation of foot at ankle | 9.67 | NA | 11.11 | 1.26 | NA | 22.04 | 090 | ||||||||||||
| 27889 | A | Amputation of foot at ankle | 9.98 | NA | 10.45 | 1.19 | NA | 21.62 | 090 | ||||||||||||
| 27892 | A | Decompression of leg | 7.39 | NA | 8.41 | 0.86 | NA | 16.66 | 090 | ||||||||||||
| 27893 | A | Decompression of leg | 7.35 | NA | 8.58 | 0.90 | NA | 16.83 | 090 | ||||||||||||
| 27894 | A | Decompression of leg | 10.49 | NA | 10.09 | 1.25 | NA | 21.83 | 090 | ||||||||||||
| 27899 | C | Leg/ankle surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 28001 | A | Drainage of bursa of foot | 2.73 | 5.62 | 3.09 | 0.31 | 8.66 | 6.13 | 010 | ||||||||||||
| 28002 | A | Treatment of foot infection | 4.62 | 6.78 | 4.22 | 0.56 | 11.96 | 9.40 | 010 | ||||||||||||
| 28003 | A | Treatment of foot infection | 8.41 | 11.40 | 10.63 | 1.03 | 20.84 | 20.07 | 090 | ||||||||||||
| 28005 | A | Treat foot bone lesion | 8.68 | NA | 10.26 | 1.14 | NA | 20.08 | 090 | ||||||||||||
| 28008 | A | Incision of foot fascia | 4.45 | 8.17 | 6.38 | 0.56 | 13.18 | 11.39 | 090 | ||||||||||||
| 28010 | A | Incision of toe tendon | 2.84 | 7.64 | 5.37 | 0.39 | 10.87 | 8.60 | 090 | ||||||||||||
| 28011 | A | Incision of toe tendons | 4.14 | 9.36 | 6.79 | 0.58 | 14.08 | 11.51 | 090 | ||||||||||||
| 28020 | A | Exploration of foot joint | 5.01 | 8.12 | 6.81 | 0.64 | 13.77 | 12.46 | 090 | ||||||||||||
| 28022 | A | Exploration of foot joint | 4.67 | 7.90 | 6.26 | 0.62 | 13.19 | 11.55 | 090 | ||||||||||||
| 28024 | A | Exploration of toe joint | 4.38 | 8.55 | 6.64 | 0.50 | 13.43 | 11.52 | 090 | ||||||||||||
| 28030 | A | Removal of foot nerve | 6.15 | NA | 3.50 | 0.85 | NA | 10.50 | 090 | ||||||||||||
| 28035 | A | Decompression of tibia nerve | 5.09 | 8.80 | 5.35 | 0.71 | 14.60 | 11.15 | 090 | ||||||||||||
| 28043 | A | Excision of foot lesion | 3.54 | 7.47 | 4.96 | 0.45 | 11.46 | 8.95 | 090 | ||||||||||||
| 28045 | A | Excision of foot lesion | 4.72 | 8.18 | 5.81 | 0.62 | 13.52 | 11.15 | 090 | ||||||||||||
| 28046 | A | Resection of tumor, foot | 10.18 | 13.58 | 11.38 | 1.13 | 24.89 | 22.69 | 090 | ||||||||||||
| 28050 | A | Biopsy of foot joint lining | 4.25 | 9.52 | 6.11 | 0.55 | 14.32 | 10.91 | 090 | ||||||||||||
| 28052 | A | Biopsy of foot joint lining | 3.94 | 8.01 | 5.76 | 0.51 | 12.46 | 10.21 | 090 | ||||||||||||
| 28054 | A | Biopsy of toe joint lining | 3.45 | 7.70 | 5.50 | 0.45 | 11.60 | 9.40 | 090 | ||||||||||||
| 28060 | A | Partial removal, foot fascia | 5.23 | 8.72 | 6.51 | 0.69 | 14.64 | 12.43 | 090 | ||||||||||||
| 28062 | A | Removal of foot fascia | 6.52 | 9.27 | 6.87 | 0.85 | 16.64 | 14.24 | 090 | ||||||||||||
| 28070 | A | Removal of foot joint lining | 5.10 | 7.98 | 6.12 | 0.68 | 13.76 | 11.90 | 090 | ||||||||||||
| 28072 | A | Removal of foot joint lining | 4.58 | 8.84 | 6.67 | 0.64 | 14.06 | 11.89 | 090 | ||||||||||||
| 28080 | A | Removal of foot lesion | 3.58 | 7.82 | 5.51 | 0.50 | 11.90 | 9.59 | 090 | ||||||||||||
| 28086 | A | Excise foot tendon sheath | 4.78 | 11.87 | 7.11 | 0.66 | 17.31 | 12.55 | 090 | ||||||||||||
| 28088 | A | Excise foot tendon sheath | 3.86 | 9.97 | 6.62 | 0.52 | 14.35 | 11.00 | 090 | ||||||||||||
| 28090 | A | Removal of foot lesion | 4.41 | 8.12 | 5.64 | 0.57 | 13.10 | 10.62 | 090 | ||||||||||||
| 28092 | A | Removal of toe lesions | 3.64 | 8.17 | 6.08 | 0.46 | 12.27 | 10.18 | 090 | ||||||||||||
| 28100 | A | Removal of ankle/heel lesion | 5.66 | 13.07 | 7.70 | 0.76 | 19.49 | 14.12 | 090 | ||||||||||||
| 28102 | A | Remove/graft foot lesion | 7.73 | NA | 9.00 | 0.97 | NA | 17.70 | 090 | ||||||||||||
| 28103 | A | Remove/graft foot lesion | 6.50 | 8.76 | 6.93 | 0.89 | 16.15 | 14.32 | 090 | ||||||||||||
| 28104 | A | Removal of foot lesion | 5.12 | 8.49 | 6.76 | 0.69 | 14.30 | 12.57 | 090 | ||||||||||||
| 28106 | A | Remove/graft foot lesion | 7.16 | NA | 6.97 | 1.01 | NA | 15.14 | 090 | ||||||||||||
| 28107 | A | Remove/graft foot lesion | 5.56 | 9.96 | 7.13 | 0.74 | 16.26 | 13.43 | 090 | ||||||||||||
| 28108 | A | Removal of toe lesions | 4.16 | 7.49 | 5.36 | 0.52 | 12.17 | 10.04 | 090 | ||||||||||||
| 28110 | A | Part removal of metatarsal | 4.08 | 8.80 | 6.87 | 0.49 | 13.37 | 11.44 | 090 | ||||||||||||
| 28111 | A | Part removal of metatarsal | 5.01 | 9.09 | 7.69 | 0.63 | 14.73 | 13.33 | 090 | ||||||||||||
| 28112 | A | Part removal of metatarsal | 4.49 | 8.89 | 7.47 | 0.60 | 13.98 | 12.56 | 090 | ||||||||||||
| 28113 | A | Part removal of metatarsal | 4.79 | 8.92 | 7.13 | 0.63 | 14.34 | 12.55 | 090 | ||||||||||||
| 28114 | A | Removal of metatarsal heads | 9.79 | 12.36 | 10.85 | 1.36 | 23.51 | 22.00 | 090 | ||||||||||||
| 28116 | A | Revision of foot | 7.75 | 9.27 | 6.38 | 1.03 | 18.05 | 15.16 | 090 | ||||||||||||
| 28118 | A | Removal of heel bone | 5.96 | 9.37 | 7.24 | 0.79 | 16.12 | 13.99 | 090 | ||||||||||||
| 28119 | A | Removal of heel spur | 5.39 | 8.58 | 6.15 | 0.74 | 14.71 | 12.28 | 090 | ||||||||||||
| 28120 | A | Part removal of ankle/heel | 5.40 | 11.28 | 9.83 | 0.69 | 17.37 | 15.92 | 090 | ||||||||||||
| 28122 | A | Partial removal of foot bone | 7.29 | 10.94 | 9.50 | 0.96 | 19.19 | 17.75 | 090 | ||||||||||||
| 28124 | A | Partial removal of toe | 4.81 | 9.61 | 7.61 | 0.65 | 15.07 | 13.07 | 090 | ||||||||||||
| 28126 | A | Partial removal of toe | 3.52 | 8.37 | 6.76 | 0.49 | 12.38 | 10.77 | 090 | ||||||||||||
| 28130 | A | Removal of ankle bone | 8.11 | NA | 8.77 | 1.11 | NA | 17.99 | 090 | ||||||||||||
| 28140 | A | Removal of metatarsal | 6.91 | 10.40 | 7.92 | 0.84 | 18.15 | 15.67 | 090 | ||||||||||||
| 28150 | A | Removal of toe | 4.09 | 8.75 | 7.07 | 0.52 | 13.36 | 11.68 | 090 | ||||||||||||
| 28153 | A | Partial removal of toe | 3.66 | 8.39 | 6.22 | 0.49 | 12.54 | 10.37 | 090 | ||||||||||||
| 28160 | A | Partial removal of toe | 3.74 | 8.55 | 7.22 | 0.51 | 12.80 | 11.47 | 090 | ||||||||||||
| 28171 | A | Extensive foot surgery | 9.60 | NA | 8.27 | 1.13 | NA | 19.00 | 090 | ||||||||||||
| 28173 | A | Extensive foot surgery | 8.80 | 10.83 | 8.88 | 1.04 | 20.67 | 18.72 | 090 | ||||||||||||
| 28175 | A | Extensive foot surgery | 6.05 | 9.54 | 6.99 | 0.75 | 16.34 | 13.79 | 090 | ||||||||||||
| 28190 | A | Removal of foot foreign body | 1.96 | 6.54 | 3.53 | 0.16 | 8.66 | 5.65 | 010 | ||||||||||||
| 28192 | A | Removal of foot foreign body | 4.64 | 8.20 | 5.44 | 0.52 | 13.36 | 10.60 | 090 | ||||||||||||
| 28193 | A | Removal of foot foreign body | 5.73 | 8.94 | 6.67 | 0.63 | 15.30 | 13.03 | 090 | ||||||||||||
| 28200 | A | Repair of foot tendon | 4.60 | 8.47 | 6.32 | 0.59 | 13.66 | 11.51 | 090 | ||||||||||||
| 28202 | A | Repair/graft of foot tendon | 6.84 | 12.63 | 6.83 | 0.86 | 20.33 | 14.53 | 090 | ||||||||||||
| 28208 | A | Repair of foot tendon | 4.37 | 8.17 | 6.03 | 0.59 | 13.13 | 10.99 | 090 | ||||||||||||
| 28210 | A | Repair/graft of foot tendon | 6.35 | 9.83 | 6.38 | 0.77 | 16.95 | 13.50 | 090 | ||||||||||||
| 28220 | A | Release of foot tendon | 4.53 | 8.12 | 6.41 | 0.63 | 13.28 | 11.57 | 090 | ||||||||||||
| 28222 | A | Release of foot tendons | 5.62 | 8.40 | 6.77 | 0.77 | 14.79 | 13.16 | 090 | ||||||||||||
| 28225 | A | Release of foot tendon | 3.66 | 7.76 | 5.57 | 0.50 | 11.92 | 9.73 | 090 | ||||||||||||
| 28226 | A | Release of foot tendons | 4.53 | 8.30 | 6.66 | 0.62 | 13.45 | 11.81 | 090 | ||||||||||||
| 28230 | A | Incision of foot tendon(s) | 4.24 | 8.26 | 6.83 | 0.59 | 13.09 | 11.66 | 090 | ||||||||||||
| 28232 | A | Incision of toe tendon | 3.39 | 8.12 | 6.53 | 0.48 | 11.99 | 10.40 | 090 | ||||||||||||
| 28234 | A | Incision of foot tendon | 3.37 | 7.98 | 6.11 | 0.46 | 11.81 | 9.94 | 090 | ||||||||||||
| 28238 | A | Revision of foot tendon | 7.73 | 9.77 | 7.60 | 1.08 | 18.58 | 16.41 | 090 | ||||||||||||
| 28240 | A | Release of big toe | 4.36 | 8.17 | 6.40 | 0.61 | 13.14 | 11.37 | 090 | ||||||||||||
| 28250 | A | Revision of foot fascia | 5.92 | 9.05 | 7.12 | 0.81 | 15.78 | 13.85 | 090 | ||||||||||||
| 28260 | A | Release of midfoot joint | 7.96 | 11.04 | 8.08 | 1.08 | 20.08 | 17.12 | 090 | ||||||||||||
| 28261 | A | Revision of foot tendon | 11.73 | 11.16 | 9.64 | 1.66 | 24.55 | 23.03 | 090 | ||||||||||||
| 28262 | A | Revision of foot and ankle | 15.83 | 15.66 | 15.09 | 2.22 | 33.71 | 33.14 | 090 | ||||||||||||
| 28264 | A | Release of midfoot joint | 10.35 | 10.98 | 10.98 | 1.46 | 22.79 | 22.79 | 090 | ||||||||||||
| 28270 | A | Release of foot contracture | 4.76 | 8.75 | 7.43 | 0.67 | 14.18 | 12.86 | 090 | ||||||||||||
| 28272 | A | Release of toe joint, each | 3.80 | 7.70 | 5.50 | 0.52 | 12.02 | 9.82 | 090 | ||||||||||||
| 28280 | A | Fusion of toes | 5.19 | 8.39 | 6.77 | 0.72 | 14.30 | 12.68 | 090 | ||||||||||||
| 28285 | A | Repair of hammertoe | 4.59 | 8.79 | 6.76 | 0.64 | 14.02 | 11.99 | 090 | ||||||||||||
| 28286 | A | Repair of hammertoe | 4.56 | 8.78 | 6.75 | 0.64 | 13.98 | 11.95 | 090 | ||||||||||||
| 28288 | A | Partial removal of foot bone | 4.74 | 9.00 | 8.02 | 0.65 | 14.39 | 13.41 | 090 | ||||||||||||
| 28289 | A | Repair hallux rigidus | 7.04 | 10.54 | 9.75 | 0.96 | 18.54 | 17.75 | 090 | ||||||||||||
| 28290 | A | Correction of bunion | 5.66 | 9.55 | 8.81 | 0.79 | 16.00 | 15.26 | 090 | ||||||||||||
| 28292 | A | Correction of bunion | 7.04 | 9.82 | 7.69 | 0.98 | 17.84 | 15.71 | 090 | ||||||||||||
| 28293 | A | Correction of bunion | 9.15 | 10.67 | 8.02 | 1.28 | 21.10 | 18.45 | 090 | ||||||||||||
| 28294 | A | Correction of bunion | 8.56 | 10.52 | 8.30 | 1.16 | 20.24 | 18.02 | 090 | ||||||||||||
| 28296 | A | Correction of bunion | 9.18 | 10.84 | 8.65 | 1.28 | 21.30 | 19.11 | 090 | ||||||||||||
| 28297 | A | Correction of bunion | 9.18 | 12.80 | 10.25 | 1.31 | 23.29 | 20.74 | 090 | ||||||||||||
| 28298 | A | Correction of bunion | 7.94 | 10.10 | 8.48 | 1.12 | 19.16 | 17.54 | 090 | ||||||||||||
| 28299 | A | Correction of bunion | 10.58 | 11.55 | 9.21 | 1.24 | 23.37 | 21.03 | 090 | ||||||||||||
| 28300 | A | Incision of heel bone | 9.54 | 14.15 | 9.43 | 1.31 | 25.00 | 20.28 | 090 | ||||||||||||
| 28302 | A | Incision of ankle bone | 9.55 | 9.55 | 9.22 | 1.15 | 20.25 | 19.92 | 090 | ||||||||||||
| 28304 | A | Incision of midfoot bones | 9.16 | 9.53 | 7.88 | 1.00 | 19.69 | 18.04 | 090 | ||||||||||||
| 28305 | A | Incise/graft midfoot bones | 10.50 | 14.52 | 10.07 | 0.55 | 25.57 | 21.12 | 090 | ||||||||||||
| 28306 | A | Incision of metatarsal | 5.86 | 8.84 | 6.51 | 0.81 | 15.51 | 13.18 | 090 | ||||||||||||
| 28307 | A | Incision of metatarsal | 6.33 | 13.70 | 7.74 | 0.71 | 20.74 | 14.78 | 090 | ||||||||||||
| 28308 | A | Incision of metatarsal | 5.29 | 7.97 | 5.60 | 0.74 | 14.00 | 11.63 | 090 | ||||||||||||
| 28309 | A | Incision of metatarsals | 12.78 | NA | 11.08 | 1.64 | NA | 25.50 | 090 | ||||||||||||
| 28310 | A | Revision of big toe | 5.43 | 9.00 | 6.93 | 0.76 | 15.19 | 13.12 | 090 | ||||||||||||
| 28312 | A | Revision of toe | 4.55 | 8.66 | 7.87 | 0.62 | 13.83 | 13.04 | 090 | ||||||||||||
| 28313 | A | Repair deformity of toe | 5.01 | 9.06 | 9.06 | 0.68 | 14.75 | 14.75 | 090 | ||||||||||||
| 28315 | A | Removal of sesamoid bone | 4.86 | 7.95 | 5.82 | 0.66 | 13.47 | 11.34 | 090 | ||||||||||||
| 28320 | A | Repair of foot bones | 9.18 | NA | 9.02 | 1.27 | NA | 19.47 | 090 | ||||||||||||
| 28322 | A | Repair of metatarsals | 8.34 | 11.71 | 8.38 | 1.17 | 21.22 | 17.89 | 090 | ||||||||||||
| 28340 | A | Resect enlarged toe tissue | 6.98 | 8.96 | 6.28 | 0.98 | 16.92 | 14.24 | 090 | ||||||||||||
| 28341 | A | Resect enlarged toe | 8.41 | 9.55 | 6.88 | 1.18 | 19.14 | 16.47 | 090 | ||||||||||||
| 28344 | A | Repair extra toe(s) | 4.26 | 7.38 | 4.86 | 0.60 | 12.24 | 9.72 | 090 | ||||||||||||
| 28345 | A | Repair webbed toe(s) | 5.92 | 9.48 | 7.58 | 0.84 | 16.24 | 14.34 | 090 | ||||||||||||
| 28360 | A | Reconstruct cleft foot | 13.34 | NA | 12.22 | 1.88 | NA | 27.44 | 090 | ||||||||||||
| 28400 | A | Treatment of heel fracture | 2.16 | 5.76 | 4.74 | 0.29 | 8.21 | 7.19 | 090 | ||||||||||||
| 28405 | A | Treatment of heel fracture | 4.57 | 6.66 | 5.87 | 0.63 | 11.86 | 11.07 | 090 | ||||||||||||
| 28406 | A | Treatment of heel fracture | 6.31 | NA | 8.69 | 0.87 | NA | 15.87 | 090 | ||||||||||||
| 28415 | A | Treat heel fracture | 15.97 | NA | 15.72 | 2.24 | NA | 33.93 | 090 | ||||||||||||
| 28420 | A | Treat/graft heel fracture | 16.64 | NA | 15.95 | 2.29 | NA | 34.88 | 090 | ||||||||||||
| 28430 | A | Treatment of ankle fracture | 2.09 | 5.25 | 4.26 | 0.27 | 7.61 | 6.62 | 090 | ||||||||||||
| 28435 | A | Treatment of ankle fracture | 3.40 | 5.41 | 4.57 | 0.47 | 9.28 | 8.44 | 090 | ||||||||||||
| 28436 | A | Treatment of ankle fracture | 4.71 | NA | 7.86 | 0.66 | NA | 13.23 | 090 | ||||||||||||
| 28445 | A | Treat ankle fracture | 15.62 | NA | 13.94 | 1.29 | NA | 30.85 | 090 | ||||||||||||
| 28450 | A | Treat midfoot fracture, each | 1.90 | 5.28 | 4.07 | 0.25 | 7.43 | 6.22 | 090 | ||||||||||||
| 28455 | A | Treat midfoot fracture, each | 3.09 | 5.51 | 4.94 | 0.43 | 9.03 | 8.46 | 090 | ||||||||||||
| 28456 | A | Treat midfoot fracture | 2.68 | NA | 6.27 | 0.36 | NA | 9.31 | 090 | ||||||||||||
| 28465 | A | Treat midfoot fracture, each | 7.01 | NA | 8.25 | 0.87 | NA | 16.13 | 090 | ||||||||||||
| 28470 | A | Treat metatarsal fracture | 1.99 | 4.52 | 3.41 | 0.26 | 6.77 | 5.66 | 090 | ||||||||||||
| 28475 | A | Treat metatarsal fracture | 2.97 | 5.18 | 4.38 | 0.41 | 8.56 | 7.76 | 090 | ||||||||||||
| 28476 | A | Treat metatarsal fracture | 3.38 | NA | 6.71 | 0.46 | NA | 10.55 | 090 | ||||||||||||
| 28485 | A | Treat metatarsal fracture | 5.71 | NA | 8.16 | 0.80 | NA | 14.67 | 090 | ||||||||||||
| 28490 | A | Treat big toe fracture | 1.09 | 2.76 | 2.21 | 0.13 | 3.98 | 3.43 | 090 | ||||||||||||
| 28495 | A | Treat big toe fracture | 1.58 | 2.82 | 2.31 | 0.19 | 4.59 | 4.08 | 090 | ||||||||||||
| 28496 | A | Treat big toe fracture | 2.33 | 11.10 | 4.58 | 0.32 | 13.75 | 7.23 | 090 | ||||||||||||
| 28505 | A | Treat big toe fracture | 3.81 | 11.46 | 6.74 | 0.50 | 15.77 | 11.05 | 090 | ||||||||||||
| 28510 | A | Treatment of toe fracture | 1.09 | 2.51 | 2.23 | 0.13 | 3.73 | 3.45 | 090 | ||||||||||||
| 28515 | A | Treatment of toe fracture | 1.46 | 2.83 | 2.30 | 0.17 | 4.46 | 3.93 | 090 | ||||||||||||
| 28525 | A | Treat toe fracture | 3.32 | 10.82 | 6.16 | 0.44 | 14.58 | 9.92 | 090 | ||||||||||||
| 28530 | A | Treat sesamoid bone fracture | 1.06 | 2.91 | 2.91 | 0.13 | 4.10 | 4.10 | 090 | ||||||||||||
| 28531 | A | Treat sesamoid bone fracture | 2.35 | 11.91 | 4.73 | 0.33 | 14.59 | 7.41 | 090 | ||||||||||||
| 28540 | A | Treat foot dislocation | 2.04 | 3.75 | 3.75 | 0.24 | 6.03 | 6.03 | 090 | ||||||||||||
| 28545 | A | Treat foot dislocation | 2.45 | 4.76 | 4.76 | 0.33 | 7.54 | 7.54 | 090 | ||||||||||||
| 28546 | A | Treat foot dislocation | 3.20 | 12.55 | 6.31 | 0.46 | 16.21 | 9.97 | 090 | ||||||||||||
| 28555 | A | Repair foot dislocation | 6.30 | 13.49 | 8.36 | 0.88 | 20.67 | 15.54 | 090 | ||||||||||||
| 28570 | A | Treat foot dislocation | 1.66 | 3.67 | 3.67 | 0.22 | 5.55 | 5.55 | 090 | ||||||||||||
| 28575 | A | Treat foot dislocation | 3.31 | 5.19 | 5.19 | 0.45 | 8.95 | 8.95 | 090 | ||||||||||||
| 28576 | A | Treat foot dislocation | 4.17 | 12.06 | 6.85 | 0.56 | 16.79 | 11.58 | 090 | ||||||||||||
| 28585 | A | Repair foot dislocation | 7.99 | 8.75 | 8.32 | 1.13 | 17.87 | 17.44 | 090 | ||||||||||||
| 28600 | A | Treat foot dislocation | 1.89 | 4.32 | 3.89 | 0.24 | 6.45 | 6.02 | 090 | ||||||||||||
| 28605 | A | Treat foot dislocation | 2.71 | 4.40 | 4.40 | 0.35 | 7.46 | 7.46 | 090 | ||||||||||||
| 28606 | A | Treat foot dislocation | 4.90 | 16.14 | 7.09 | 0.68 | 21.72 | 12.67 | 090 | ||||||||||||
| 28615 | A | Repair foot dislocation | 7.77 | NA | 9.45 | 1.09 | NA | 18.31 | 090 | ||||||||||||
| 28630 | A | Treat toe dislocation | 1.70 | 2.35 | 2.35 | 0.17 | 4.22 | 4.22 | 010 | ||||||||||||
| 28635 | A | Treat toe dislocation | 1.91 | 2.49 | 2.49 | 0.24 | 4.64 | 4.64 | 010 | ||||||||||||
| 28636 | A | Treat toe dislocation | 2.77 | 4.81 | 3.22 | 0.39 | 7.97 | 6.38 | 010 | ||||||||||||
| 28645 | A | Repair toe dislocation | 4.22 | 6.69 | 4.34 | 0.58 | 11.49 | 9.14 | 090 | ||||||||||||
| 28660 | A | Treat toe dislocation | 1.23 | 3.11 | 2.60 | 0.11 | 4.45 | 3.94 | 010 | ||||||||||||
| 28665 | A | Treat toe dislocation | 1.92 | 2.47 | 2.47 | 0.24 | 4.63 | 4.63 | 010 | ||||||||||||
| 28666 | A | Treat toe dislocation | 2.66 | 13.30 | 3.00 | 0.38 | 16.34 | 6.04 | 010 | ||||||||||||
| 28675 | A | Repair of toe dislocation | 2.92 | 9.48 | 4.90 | 0.41 | 12.81 | 8.23 | 090 | ||||||||||||
| 28705 | A | Fusion of foot bones | 18.80 | NA | 15.67 | 2.13 | NA | 36.60 | 090 | ||||||||||||
| 28715 | A | Fusion of foot bones | 13.10 | NA | 12.57 | 1.84 | NA | 27.51 | 090 | ||||||||||||
| 28725 | A | Fusion of foot bones | 11.61 | NA | 11.48 | 1.63 | NA | 24.72 | 090 | ||||||||||||
| 28730 | A | Fusion of foot bones | 10.76 | NA | 10.76 | 1.51 | NA | 23.03 | 090 | ||||||||||||
| 28735 | A | Fusion of foot bones | 10.85 | NA | 10.45 | 1.51 | NA | 22.81 | 090 | ||||||||||||
| 28737 | A | Revision of foot bones | 9.64 | NA | 9.04 | 1.36 | NA | 20.04 | 090 | ||||||||||||
| 28740 | A | Fusion of foot bones | 8.02 | 13.03 | 8.94 | 1.13 | 22.18 | 18.09 | 090 | ||||||||||||
| 28750 | A | Fusion of big toe joint | 7.30 | 12.48 | 9.13 | 1.03 | 20.81 | 17.46 | 090 | ||||||||||||
| 28755 | A | Fusion of big toe joint | 4.74 | 8.52 | 6.42 | 0.66 | 13.92 | 11.82 | 090 | ||||||||||||
| 28760 | A | Fusion of big toe joint | 7.75 | 10.39 | 7.82 | 1.07 | 19.21 | 16.64 | 090 | ||||||||||||
| 28800 | A | Amputation of midfoot | 8.21 | NA | 8.90 | 0.98 | NA | 18.09 | 090 | ||||||||||||
| 28805 | A | Amputation thru metatarsal | 8.39 | NA | 9.00 | 0.97 | NA | 18.36 | 090 | ||||||||||||
| 28810 | A | Amputation toe metatarsal | 6.21 | NA | 7.97 | 0.70 | NA | 14.88 | 090 | ||||||||||||
| 28820 | A | Amputation of toe | 4.41 | 9.91 | 7.16 | 0.51 | 14.83 | 12.08 | 090 | ||||||||||||
| 28825 | A | Partial amputation of toe | 3.59 | 10.12 | 6.95 | 0.43 | 14.14 | 10.97 | 090 | ||||||||||||
| 28899 | C | Foot/toes surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 29000 | A | Application of body cast | 2.25 | 2.71 | 1.67 | 0.30 | 5.26 | 4.22 | 000 | ||||||||||||
| 29010 | A | Application of body cast | 2.06 | 2.98 | 1.72 | 0.27 | 5.31 | 4.05 | 000 | ||||||||||||
| 29015 | A | Application of body cast | 2.41 | 3.17 | 1.93 | 0.21 | 5.79 | 4.55 | 000 | ||||||||||||
| 29020 | A | Application of body cast | 2.11 | 3.33 | 1.47 | 0.16 | 5.60 | 3.74 | 000 | ||||||||||||
| 29025 | A | Application of body cast | 2.40 | 3.32 | 1.86 | 0.26 | 5.98 | 4.52 | 000 | ||||||||||||
| 29035 | A | Application of body cast | 1.77 | 3.05 | 1.56 | 0.24 | 5.06 | 3.57 | 000 | ||||||||||||
| 29040 | A | Application of body cast | 2.22 | 2.54 | 1.49 | 0.35 | 5.11 | 4.06 | 000 | ||||||||||||
| 29044 | A | Application of body cast | 2.12 | 3.20 | 1.81 | 0.29 | 5.61 | 4.22 | 000 | ||||||||||||
| 29046 | A | Application of body cast | 2.41 | 3.31 | 2.04 | 0.34 | 6.06 | 4.79 | 000 | ||||||||||||
| 29049 | A | Application of figure eight | 0.89 | 1.07 | 0.57 | 0.12 | 2.08 | 1.58 | 000 | ||||||||||||
| 29055 | A | Application of shoulder cast | 1.78 | 2.40 | 1.42 | 0.24 | 4.42 | 3.44 | 000 | ||||||||||||
| 29058 | A | Application of shoulder cast | 1.31 | 1.33 | 0.73 | 0.14 | 2.78 | 2.18 | 000 | ||||||||||||
| 29065 | A | Application of long arm cast | 0.87 | 1.10 | 0.69 | 0.12 | 2.09 | 1.68 | 000 | ||||||||||||
| 29075 | A | Application of forearm cast | 0.77 | 1.05 | 0.63 | 0.11 | 1.93 | 1.51 | 000 | ||||||||||||
| 29085 | A | Apply hand/wrist cast | 0.87 | 1.10 | 0.62 | 0.11 | 2.08 | 1.60 | 000 | ||||||||||||
| 29086 | A | Apply finger cast | 0.62 | 0.81 | 0.50 | 0.07 | 1.50 | 1.19 | 000 | ||||||||||||
| 29105 | A | Apply long arm splint | 0.87 | 1.05 | 0.52 | 0.11 | 2.03 | 1.50 | 000 | ||||||||||||
| 29125 | A | Apply forearm splint | 0.59 | 0.88 | 0.41 | 0.06 | 1.53 | 1.06 | 000 | ||||||||||||
| 29126 | A | Apply forearm splint | 0.77 | 1.21 | 0.47 | 0.06 | 2.04 | 1.30 | 000 | ||||||||||||
| 29130 | A | Application of finger splint | 0.50 | 0.44 | 0.18 | 0.05 | 0.99 | 0.73 | 000 | ||||||||||||
| 29131 | A | Application of finger splint | 0.55 | 0.71 | 0.23 | 0.03 | 1.29 | 0.81 | 000 | ||||||||||||
| 29200 | A | Strapping of chest | 0.65 | 0.85 | 0.37 | 0.04 | 1.54 | 1.06 | 000 | ||||||||||||
| 29220 | A | Strapping of low back | 0.64 | 0.96 | 0.41 | 0.07 | 1.67 | 1.12 | 000 | ||||||||||||
| 29240 | A | Strapping of shoulder | 0.71 | 0.92 | 0.39 | 0.05 | 1.68 | 1.15 | 000 | ||||||||||||
| 29260 | A | Strapping of elbow or wrist | 0.55 | 0.85 | 0.35 | 0.04 | 1.44 | 0.94 | 000 | ||||||||||||
| 29280 | A | Strapping of hand or finger | 0.51 | 0.91 | 0.39 | 0.04 | 1.46 | 0.94 | 000 | ||||||||||||
| 29305 | A | Application of hip cast | 2.03 | 2.74 | 1.60 | 0.29 | 5.06 | 3.92 | 000 | ||||||||||||
| 29325 | A | Application of hip casts | 2.32 | 3.05 | 1.79 | 0.31 | 5.68 | 4.42 | 000 | ||||||||||||
| 29345 | A | Application of long leg cast | 1.40 | 1.51 | 1.02 | 0.19 | 3.10 | 2.61 | 000 | ||||||||||||
| 29355 | A | Application of long leg cast | 1.53 | 1.47 | 1.11 | 0.20 | 3.20 | 2.84 | 000 | ||||||||||||
| 29358 | A | Apply long leg cast brace | 1.43 | 1.72 | 1.07 | 0.19 | 3.34 | 2.69 | 000 | ||||||||||||
| 29365 | A | Application of long leg cast | 1.18 | 1.38 | 0.90 | 0.17 | 2.73 | 2.25 | 000 | ||||||||||||
| 29405 | A | Apply short leg cast | 0.86 | 1.03 | 0.66 | 0.12 | 2.01 | 1.64 | 000 | ||||||||||||
| 29425 | A | Apply short leg cast | 1.01 | 1.05 | 0.68 | 0.14 | 2.20 | 1.83 | 000 | ||||||||||||
| 29435 | A | Apply short leg cast | 1.18 | 1.35 | 0.88 | 0.17 | 2.70 | 2.23 | 000 | ||||||||||||
| 29440 | A | Addition of walker to cast | 0.57 | 0.61 | 0.26 | 0.07 | 1.25 | 0.90 | 000 | ||||||||||||
| 29445 | A | Apply rigid leg cast | 1.78 | 1.58 | 0.96 | 0.24 | 3.60 | 2.98 | 000 | ||||||||||||
| 29450 | A | Application of leg cast | 2.08 | 1.40 | 1.11 | 0.13 | 3.61 | 3.32 | 000 | ||||||||||||
| 29505 | A | Application, long leg splint | 0.69 | 1.10 | 0.48 | 0.06 | 1.85 | 1.23 | 000 | ||||||||||||
| 29515 | A | Application lower leg splint | 0.73 | 0.78 | 0.48 | 0.07 | 1.58 | 1.28 | 000 | ||||||||||||
| 29520 | A | Strapping of hip | 0.54 | 0.93 | 0.44 | 0.02 | 1.49 | 1.00 | 000 | ||||||||||||
| 29530 | A | Strapping of knee | 0.57 | 0.83 | 0.36 | 0.04 | 1.44 | 0.97 | 000 | ||||||||||||
| 29540 | A | Strapping of ankle | 0.51 | 0.40 | 0.32 | 0.04 | 0.95 | 0.87 | 000 | ||||||||||||
| 29550 | A | Strapping of toes | 0.47 | 0.40 | 0.29 | 0.05 | 0.92 | 0.81 | 000 | ||||||||||||
| 29580 | A | Application of paste boot | 0.57 | 0.61 | 0.36 | 0.05 | 1.23 | 0.98 | 000 | ||||||||||||
| 29590 | A | Application of foot splint | 0.76 | 0.50 | 0.30 | 0.06 | 1.32 | 1.12 | 000 | ||||||||||||
| 29700 | A | Removal/revision of cast | 0.57 | 0.81 | 0.28 | 0.07 | 1.45 | 0.92 | 000 | ||||||||||||
| 29705 | A | Removal/revision of cast | 0.76 | 0.73 | 0.39 | 0.10 | 1.59 | 1.25 | 000 | ||||||||||||
| 29710 | A | Removal/revision of cast | 1.34 | 1.50 | 0.66 | 0.17 | 3.01 | 2.17 | 000 | ||||||||||||
| 29715 | A | Removal/revision of cast | 0.94 | 0.98 | 0.29 | 0.08 | 2.00 | 1.31 | 000 | ||||||||||||
| 29720 | A | Repair of body cast | 0.68 | 0.95 | 0.36 | 0.10 | 1.73 | 1.14 | 000 | ||||||||||||
| 29730 | A | Windowing of cast | 0.75 | 0.71 | 0.36 | 0.10 | 1.56 | 1.21 | 000 | ||||||||||||
| 29740 | A | Wedging of cast | 1.12 | 1.02 | 0.46 | 0.15 | 2.29 | 1.73 | 000 | ||||||||||||
| 29750 | A | Wedging of clubfoot cast | 1.26 | 1.13 | 0.62 | 0.16 | 2.55 | 2.04 | 000 | ||||||||||||
| 29799 | C | Casting/strapping procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 29800 | A | Jaw arthroscopy/surgery | 6.43 | NA | 9.15 | 0.84 | NA | 16.42 | 090 | ||||||||||||
| 29804 | A | Jaw arthroscopy/surgery | 8.14 | NA | 8.73 | 0.66 | NA | 17.53 | 090 | ||||||||||||
| 29805 | A | Shoulder arthroscopy, dx | 5.89 | 3.23 | 3.23 | 0.83 | 9.95 | 9.95 | 090 | ||||||||||||
| 29806 | A | Shoulder arthroscopy/surgery | 14.37 | NA | 11.33 | 2.01 | NA | 27.71 | 090 | ||||||||||||
| 29807 | A | Shoulder arthroscopy/surgery | 13.90 | NA | 11.06 | 2.01 | NA | 26.97 | 090 | ||||||||||||
| 29815 | D | Shoulder arthroscopy | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 29819 | A | Shoulder arthroscopy/surgery | 7.62 | NA | 9.82 | 1.07 | NA | 18.51 | 090 | ||||||||||||
| 29820 | A | Shoulder arthroscopy/surgery | 7.07 | NA | 9.55 | 0.99 | NA | 17.61 | 090 | ||||||||||||
| 29821 | A | Shoulder arthroscopy/surgery | 7.72 | NA | 9.84 | 1.08 | NA | 18.64 | 090 | ||||||||||||
| 29822 | A | Shoulder arthroscopy/surgery | 7.43 | NA | 9.75 | 1.04 | NA | 18.22 | 090 | ||||||||||||
| 29823 | A | Shoulder arthroscopy/surgery | 8.17 | NA | 10.14 | 1.15 | NA | 19.46 | 090 | ||||||||||||
| 29824 | A | Shoulder arthroscopy/surgery | 8.25 | NA | 7.48 | 1.16 | NA | 16.89 | 090 | ||||||||||||
| 29825 | A | Shoulder arthroscopy/surgery | 7.62 | NA | 9.80 | 1.06 | NA | 18.48 | 090 | ||||||||||||
| 29826 | A | Shoulder arthroscopy/surgery | 8.99 | NA | 10.65 | 1.26 | NA | 20.90 | 090 | ||||||||||||
| 29830 | A | Elbow arthroscopy | 5.76 | NA | 6.14 | 0.79 | NA | 12.69 | 090 | ||||||||||||
| 29834 | A | Elbow arthroscopy/surgery | 6.28 | NA | 6.94 | 0.86 | NA | 14.08 | 090 | ||||||||||||
| 29835 | A | Elbow arthroscopy/surgery | 6.48 | NA | 6.95 | 0.88 | NA | 14.31 | 090 | ||||||||||||
| 29836 | A | Elbow arthroscopy/surgery | 7.55 | NA | 7.62 | 1.06 | NA | 16.23 | 090 | ||||||||||||
| 29837 | A | Elbow arthroscopy/surgery | 6.87 | NA | 7.30 | 0.96 | NA | 15.13 | 090 | ||||||||||||
| 29838 | A | Elbow arthroscopy/surgery | 7.71 | NA | 7.73 | 1.07 | NA | 16.51 | 090 | ||||||||||||
| 29840 | A | Wrist arthroscopy | 5.54 | NA | 8.38 | 0.69 | NA | 14.61 | 090 | ||||||||||||
| 29843 | A | Wrist arthroscopy/surgery | 6.01 | NA | 8.70 | 0.82 | NA | 15.53 | 090 | ||||||||||||
| 29844 | A | Wrist arthroscopy/surgery | 6.37 | NA | 8.96 | 0.86 | NA | 16.19 | 090 | ||||||||||||
| 29845 | A | Wrist arthroscopy/surgery | 7.52 | NA | 9.56 | 0.84 | NA | 17.92 | 090 | ||||||||||||
| 29846 | A | Wrist arthroscopy/surgery | 6.75 | NA | 11.67 | 0.89 | NA | 19.31 | 090 | ||||||||||||
| 29847 | A | Wrist arthroscopy/surgery | 7.08 | NA | 11.85 | 0.91 | NA | 19.84 | 090 | ||||||||||||
| 29848 | A | Wrist endoscopy/surgery | 5.44 | NA | 8.46 | 0.72 | NA | 14.62 | 090 | ||||||||||||
| 29850 | A | Knee arthroscopy/surgery | 8.19 | NA | 7.49 | 0.74 | NA | 16.42 | 090 | ||||||||||||
| 29851 | A | Knee arthroscopy/surgery | 13.10 | NA | 12.00 | 1.81 | NA | 26.91 | 090 | ||||||||||||
| 29855 | A | Tibial arthroscopy/surgery | 10.62 | NA | 10.55 | 1.50 | NA | 22.67 | 090 | ||||||||||||
| 29856 | A | Tibial arthroscopy/surgery | 14.14 | NA | 12.49 | 2.00 | NA | 28.63 | 090 | ||||||||||||
| 29860 | A | Hip arthroscopy, dx | 8.05 | NA | 8.05 | 1.14 | NA | 17.24 | 090 | ||||||||||||
| 29861 | A | Hip arthroscopy/surgery | 9.15 | NA | 8.71 | 1.29 | NA | 19.15 | 090 | ||||||||||||
| 29862 | A | Hip arthroscopy/surgery | 9.90 | NA | 9.75 | 1.39 | NA | 21.04 | 090 | ||||||||||||
| 29863 | A | Hip arthroscopy/surgery | 9.90 | NA | 10.31 | 1.40 | NA | 21.61 | 090 | ||||||||||||
| 29870 | A | Knee arthroscopy, dx | 5.07 | NA | 6.27 | 0.67 | NA | 12.01 | 090 | ||||||||||||
| 29871 | A | Knee arthroscopy/drainage | 6.55 | NA | 8.38 | 0.88 | NA | 15.81 | 090 | ||||||||||||
| 29874 | A | Knee arthroscopy/surgery | 7.05 | NA | 8.15 | 0.87 | NA | 16.07 | 090 | ||||||||||||
| 29875 | A | Knee arthroscopy/surgery | 6.31 | NA | 7.69 | 0.88 | NA | 14.88 | 090 | ||||||||||||
| 29876 | A | Knee arthroscopy/surgery | 7.92 | NA | 9.19 | 1.11 | NA | 18.22 | 090 | ||||||||||||
| 29877 | A | Knee arthroscopy/surgery | 7.35 | NA | 8.29 | 1.03 | NA | 16.67 | 090 | ||||||||||||
| 29879 | A | Knee arthroscopy/surgery | 8.04 | NA | 8.68 | 1.13 | NA | 17.85 | 090 | ||||||||||||
| 29880 | A | Knee arthroscopy/surgery | 8.50 | NA | 8.95 | 1.19 | NA | 18.64 | 090 | ||||||||||||
| 29881 | A | Knee arthroscopy/surgery | 7.76 | NA | 8.53 | 1.09 | NA | 17.38 | 090 | ||||||||||||
| 29882 | A | Knee arthroscopy/surgery | 8.65 | NA | 9.01 | 1.09 | NA | 18.75 | 090 | ||||||||||||
| 29883 | A | Knee arthroscopy/surgery | 11.05 | NA | 10.41 | 1.33 | NA | 22.79 | 090 | ||||||||||||
| 29884 | A | Knee arthroscopy/surgery | 7.33 | NA | 8.87 | 1.03 | NA | 17.23 | 090 | ||||||||||||
| 29885 | A | Knee arthroscopy/surgery | 9.09 | NA | 9.85 | 1.27 | NA | 20.21 | 090 | ||||||||||||
| 29886 | A | Knee arthroscopy/surgery | 7.54 | NA | 8.99 | 1.06 | NA | 17.59 | 090 | ||||||||||||
| 29887 | A | Knee arthroscopy/surgery | 9.04 | NA | 9.83 | 1.27 | NA | 20.14 | 090 | ||||||||||||
| 29888 | A | Knee arthroscopy/surgery | 13.90 | NA | 12.50 | 1.95 | NA | 28.35 | 090 | ||||||||||||
| 29889 | A | Knee arthroscopy/surgery | 16.00 | NA | 13.71 | 2.11 | NA | 31.82 | 090 | ||||||||||||
| 29891 | A | Ankle arthroscopy/surgery | 8.40 | NA | 8.92 | 1.17 | NA | 18.49 | 090 | ||||||||||||
| 29892 | A | Ankle arthroscopy/surgery | 9.00 | NA | 9.04 | 1.26 | NA | 19.30 | 090 | ||||||||||||
| 29893 | A | Scope, plantar fasciotomy | 5.22 | NA | 5.56 | 0.74 | NA | 11.52 | 090 | ||||||||||||
| 29894 | A | Ankle arthroscopy/surgery | 7.21 | NA | 8.04 | 1.01 | NA | 16.26 | 090 | ||||||||||||
| 29895 | A | Ankle arthroscopy/surgery | 6.99 | NA | 8.01 | 0.97 | NA | 15.97 | 090 | ||||||||||||
| 29897 | A | Ankle arthroscopy/surgery | 7.18 | NA | 8.73 | 1.01 | NA | 16.92 | 090 | ||||||||||||
| 29898 | A | Ankle arthroscopy/surgery | 8.32 | NA | 8.79 | 1.14 | NA | 18.25 | 090 | ||||||||||||
| 29900 | A | Mcp joint arthroscopy, dx | 5.42 | NA | 5.88 | 0.69 | NA | 11.99 | 090 | ||||||||||||
| 29901 | A | Mcp joint arthroscopy, surg | 6.13 | NA | 6.28 | 0.81 | NA | 13.22 | 090 | ||||||||||||
| 29902 | A | Mcp joint arthroscopy, surg | 6.70 | NA | 6.60 | 0.89 | NA | 14.19 | 090 | ||||||||||||
| 29909 | D | Arthroscopy of joint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 29999 | C | Arthroscopy of joint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 30000 | A | Drainage of nose lesion | 1.43 | 2.53 | 1.51 | 0.10 | 4.06 | 3.04 | 010 | ||||||||||||
| 30020 | A | Drainage of nose lesion | 1.43 | 2.64 | 1.57 | 0.08 | 4.15 | 3.08 | 010 | ||||||||||||
| 30100 | A | Intranasal biopsy | 0.94 | 1.34 | 0.53 | 0.06 | 2.34 | 1.53 | 000 | ||||||||||||
| 30110 | A | Removal of nose polyp(s) | 1.63 | 2.80 | 0.88 | 0.12 | 4.55 | 2.63 | 010 | ||||||||||||
| 30115 | A | Removal of nose polyp(s) | 4.35 | NA | 4.54 | 0.31 | NA | 9.20 | 090 | ||||||||||||
| 30117 | A | Removal of intranasal lesion | 3.16 | 4.95 | 3.20 | 0.22 | 8.33 | 6.58 | 090 | ||||||||||||
| 30118 | A | Removal of intranasal lesion | 9.69 | NA | 8.55 | 0.66 | NA | 18.90 | 090 | ||||||||||||
| 30120 | A | Revision of nose | 5.27 | 5.71 | 5.71 | 0.41 | 11.39 | 11.39 | 090 | ||||||||||||
| 30124 | A | Removal of nose lesion | 3.10 | NA | 3.31 | 0.20 | NA | 6.61 | 090 | ||||||||||||
| 30125 | A | Removal of nose lesion | 7.16 | NA | 6.61 | 0.54 | NA | 14.31 | 090 | ||||||||||||
| 30130 | A | Removal of turbinate bones | 3.38 | NA | 3.99 | 0.22 | NA | 7.59 | 090 | ||||||||||||
| 30140 | A | Removal of turbinate bones | 3.43 | NA | 4.61 | 0.24 | NA | 8.28 | 090 | ||||||||||||
| 30150 | A | Partial removal of nose | 9.14 | NA | 8.83 | 0.76 | NA | 18.73 | 090 | ||||||||||||
| 30160 | A | Removal of nose | 9.58 | NA | 8.79 | 0.78 | NA | 19.15 | 090 | ||||||||||||
| 30200 | A | Injection treatment of nose | 0.78 | 1.23 | 0.46 | 0.06 | 2.07 | 1.30 | 000 | ||||||||||||
| 30210 | A | Nasal sinus therapy | 1.08 | 2.15 | 0.61 | 0.08 | 3.31 | 1.77 | 010 | ||||||||||||
| 30220 | A | Insert nasal septal button | 1.54 | 2.52 | 0.84 | 0.11 | 4.17 | 2.49 | 010 | ||||||||||||
| 30300 | A | Remove nasal foreign body | 1.04 | 2.62 | 0.37 | 0.07 | 3.73 | 1.48 | 010 | ||||||||||||
| 30310 | A | Remove nasal foreign body | 1.96 | NA | 1.92 | 0.14 | NA | 4.02 | 010 | ||||||||||||
| 30320 | A | Remove nasal foreign body | 4.52 | NA | 5.26 | 0.36 | NA | 10.14 | 090 | ||||||||||||
| 30400 | R | Reconstruction of nose | 9.83 | NA | 8.95 | 0.80 | NA | 19.58 | 090 | ||||||||||||
| 30410 | R | Reconstruction of nose | 12.98 | NA | 10.45 | 1.08 | NA | 24.51 | 090 | ||||||||||||
| 30420 | R | Reconstruction of nose | 15.88 | NA | 12.50 | 1.24 | NA | 29.62 | 090 | ||||||||||||
| 30430 | R | Revision of nose | 7.21 | NA | 7.40 | 0.62 | NA | 15.23 | 090 | ||||||||||||
| 30435 | R | Revision of nose | 11.71 | NA | 10.68 | 1.10 | NA | 23.49 | 090 | ||||||||||||
| 30450 | R | Revision of nose | 18.65 | NA | 14.37 | 1.53 | NA | 34.55 | 090 | ||||||||||||
| 30460 | A | Revision of nose | 9.96 | NA | 9.16 | 0.85 | NA | 19.97 | 090 | ||||||||||||
| 30462 | A | Revision of nose | 19.57 | NA | 14.30 | 1.92 | NA | 35.79 | 090 | ||||||||||||
| 30465 | A | Repair nasal stenosis | 11.64 | NA | 9.58 | 0.97 | NA | 22.19 | 090 | ||||||||||||
| 30520 | A | Repair of nasal septum | 5.70 | NA | 5.93 | 0.41 | NA | 12.04 | 090 | ||||||||||||
| 30540 | A | Repair nasal defect | 7.75 | NA | 6.71 | 0.53 | NA | 14.99 | 090 | ||||||||||||
| 30545 | A | Repair nasal defect | 11.38 | NA | 9.19 | 0.80 | NA | 21.37 | 090 | ||||||||||||
| 30560 | A | Release of nasal adhesions | 1.26 | 2.37 | 1.52 | 0.09 | 3.72 | 2.87 | 010 | ||||||||||||
| 30580 | A | Repair upper jaw fistula | 6.69 | 5.00 | 5.00 | 0.50 | 12.19 | 12.19 | 090 | ||||||||||||
| 30600 | A | Repair mouth/nose fistula | 6.02 | 4.90 | 4.90 | 0.70 | 11.62 | 11.62 | 090 | ||||||||||||
| 30620 | A | Intranasal reconstruction | 5.97 | NA | 6.69 | 0.45 | NA | 13.11 | 090 | ||||||||||||
| 30630 | A | Repair nasal septum defect | 7.12 | NA | 7.23 | 0.51 | NA | 14.86 | 090 | ||||||||||||
| 30801 | A | Cauterization, inner nose | 1.09 | 2.57 | 2.31 | 0.08 | 3.74 | 3.48 | 010 | ||||||||||||
| 30802 | A | Cauterization, inner nose | 2.03 | 3.14 | 2.87 | 0.15 | 5.32 | 5.05 | 010 | ||||||||||||
| 30901 | A | Control of nosebleed | 1.21 | 1.43 | 0.34 | 0.09 | 2.73 | 1.64 | 000 | ||||||||||||
| 30903 | A | Control of nosebleed | 1.54 | 3.20 | 0.53 | 0.12 | 4.86 | 2.19 | 000 | ||||||||||||
| 30905 | A | Control of nosebleed | 1.97 | 3.85 | 0.80 | 0.15 | 5.97 | 2.92 | 000 | ||||||||||||
| 30906 | A | Repeat control of nosebleed | 2.45 | 4.27 | 1.27 | 0.17 | 6.89 | 3.89 | 000 | ||||||||||||
| 30915 | A | Ligation, nasal sinus artery | 7.20 | NA | 7.13 | 0.50 | NA | 14.83 | 090 | ||||||||||||
| 30920 | A | Ligation, upper jaw artery | 9.83 | NA | 8.64 | 0.69 | NA | 19.16 | 090 | ||||||||||||
| 30930 | A | Therapy, fracture of nose | 1.26 | NA | 2.17 | 0.09 | NA | 3.52 | 010 | ||||||||||||
| 30999 | C | Nasal surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 31000 | A | Irrigation, maxillary sinus | 1.15 | 2.43 | 0.66 | 0.08 | 3.66 | 1.89 | 010 | ||||||||||||
| 31002 | A | Irrigation, sphenoid sinus | 1.91 | NA | 2.07 | 0.14 | NA | 4.12 | 010 | ||||||||||||
| 31020 | A | Exploration, maxillary sinus | 2.94 | 4.20 | 3.68 | 0.20 | 7.34 | 6.82 | 090 | ||||||||||||
| 31030 | A | Exploration, maxillary sinus | 5.92 | 4.85 | 4.68 | 0.42 | 11.19 | 11.02 | 090 | ||||||||||||
| 31032 | A | Explore sinus,remove polyps | 6.57 | NA | 6.16 | 0.47 | NA | 13.20 | 090 | ||||||||||||
| 31040 | A | Exploration behind upper jaw | 9.42 | NA | 7.34 | 0.71 | NA | 17.47 | 090 | ||||||||||||
| 31050 | A | Exploration, sphenoid sinus | 5.28 | NA | 5.12 | 0.39 | NA | 10.79 | 090 | ||||||||||||
| 31051 | A | Sphenoid sinus surgery | 7.11 | NA | 6.66 | 0.55 | NA | 14.32 | 090 | ||||||||||||
| 31070 | A | Exploration of frontal sinus | 4.28 | NA | 5.04 | 0.30 | NA | 9.62 | 090 | ||||||||||||
| 31075 | A | Exploration of frontal sinus | 9.16 | NA | 8.38 | 0.64 | NA | 18.18 | 090 | ||||||||||||
| 31080 | A | Removal of frontal sinus | 11.42 | NA | 9.13 | 0.78 | NA | 21.33 | 090 | ||||||||||||
| 31081 | A | Removal of frontal sinus | 12.75 | NA | 9.97 | 1.84 | NA | 24.56 | 090 | ||||||||||||
| 31084 | A | Removal of frontal sinus | 13.51 | NA | 10.76 | 0.96 | NA | 25.23 | 090 | ||||||||||||
| 31085 | A | Removal of frontal sinus | 14.20 | NA | 11.12 | 1.18 | NA | 26.50 | 090 | ||||||||||||
| 31086 | A | Removal of frontal sinus | 12.86 | NA | 10.50 | 0.90 | NA | 24.26 | 090 | ||||||||||||
| 31087 | A | Removal of frontal sinus | 13.10 | NA | 10.32 | 1.15 | NA | 24.57 | 090 | ||||||||||||
| 31090 | A | Exploration of sinuses | 9.53 | NA | 9.05 | 0.66 | NA | 19.24 | 090 | ||||||||||||
| 31200 | A | Removal of ethmoid sinus | 4.97 | NA | 5.86 | 0.25 | NA | 11.08 | 090 | ||||||||||||
| 31201 | A | Removal of ethmoid sinus | 8.37 | NA | 7.91 | 0.58 | NA | 16.86 | 090 | ||||||||||||
| 31205 | A | Removal of ethmoid sinus | 10.24 | NA | 8.66 | 0.58 | NA | 19.48 | 090 | ||||||||||||
| 31225 | A | Removal of upper jaw | 19.23 | NA | 15.42 | 1.38 | NA | 36.03 | 090 | ||||||||||||
| 31230 | A | Removal of upper jaw | 21.94 | NA | 17.21 | 1.57 | NA | 40.72 | 090 | ||||||||||||
| 31231 | A | Nasal endoscopy, dx | 1.10 | 2.01 | 0.61 | 0.08 | 3.19 | 1.79 | 000 | ||||||||||||
| 31233 | A | Nasal/sinus endoscopy, dx | 2.18 | 2.66 | 1.24 | 0.16 | 5.00 | 3.58 | 000 | ||||||||||||
| 31235 | A | Nasal/sinus endoscopy, dx | 2.64 | 2.93 | 1.49 | 0.18 | 5.75 | 4.31 | 000 | ||||||||||||
| 31237 | A | Nasal/sinus endoscopy, surg | 2.98 | 3.22 | 1.66 | 0.21 | 6.41 | 4.85 | 000 | ||||||||||||
| 31238 | A | Nasal/sinus endoscopy, surg | 3.26 | 3.75 | 1.89 | 0.23 | 7.24 | 5.38 | 000 | ||||||||||||
| 31239 | A | Nasal/sinus endoscopy, surg | 8.70 | NA | 6.72 | 0.46 | NA | 15.88 | 010 | ||||||||||||
| 31240 | A | Nasal/sinus endoscopy, surg | 2.61 | NA | 1.62 | 0.18 | NA | 4.41 | 000 | ||||||||||||
| 31254 | A | Revision of ethmoid sinus | 4.65 | NA | 2.79 | 0.32 | NA | 7.76 | 000 | ||||||||||||
| 31255 | A | Removal of ethmoid sinus | 6.96 | NA | 4.14 | 0.49 | NA | 11.59 | 000 | ||||||||||||
| 31256 | A | Exploration maxillary sinus | 3.29 | NA | 2.01 | 0.23 | NA | 5.53 | 000 | ||||||||||||
| 31267 | A | Endoscopy, maxillary sinus | 5.46 | NA | 3.27 | 0.38 | NA | 9.11 | 000 | ||||||||||||
| 31276 | A | Sinus endoscopy, surgical | 8.85 | NA | 5.24 | 0.62 | NA | 14.71 | 000 | ||||||||||||
| 31287 | A | Nasal/sinus endoscopy, surg | 3.92 | NA | 2.37 | 0.27 | NA | 6.56 | 000 | ||||||||||||
| 31288 | A | Nasal/sinus endoscopy, surg | 4.58 | NA | 2.75 | 0.32 | NA | 7.65 | 000 | ||||||||||||
| 31290 | A | Nasal/sinus endoscopy, surg | 17.24 | NA | 11.86 | 1.20 | NA | 30.30 | 010 | ||||||||||||
| 31291 | A | Nasal/sinus endoscopy, surg | 18.19 | NA | 12.28 | 1.73 | NA | 32.20 | 010 | ||||||||||||
| 31292 | A | Nasal/sinus endoscopy, surg | 14.76 | NA | 10.36 | 0.99 | NA | 26.11 | 010 | ||||||||||||
| 31293 | A | Nasal/sinus endoscopy, surg | 16.21 | NA | 11.16 | 0.97 | NA | 28.34 | 010 | ||||||||||||
| 31294 | A | Nasal/sinus endoscopy, surg | 19.06 | NA | 12.46 | 1.04 | NA | 32.56 | 010 | ||||||||||||
| 31299 | C | Sinus surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 31300 | A | Removal of larynx lesion | 14.29 | NA | 17.46 | 0.99 | NA | 32.74 | 090 | ||||||||||||
| 31320 | A | Diagnostic incision, larynx | 5.26 | NA | 12.54 | 0.40 | NA | 18.20 | 090 | ||||||||||||
| 31360 | A | Removal of larynx | 17.08 | NA | 19.24 | 1.20 | NA | 37.52 | 090 | ||||||||||||
| 31365 | A | Removal of larynx | 24.16 | NA | 23.20 | 1.72 | NA | 49.08 | 090 | ||||||||||||
| 31367 | A | Partial removal of larynx | 21.86 | NA | 23.92 | 1.57 | NA | 47.35 | 090 | ||||||||||||
| 31368 | A | Partial removal of larynx | 27.09 | NA | 28.64 | 1.90 | NA | 57.63 | 090 | ||||||||||||
| 31370 | A | Partial removal of larynx | 21.38 | NA | 23.46 | 1.51 | NA | 46.35 | 090 | ||||||||||||
| 31375 | A | Partial removal of larynx | 20.21 | NA | 21.16 | 1.43 | NA | 42.80 | 090 | ||||||||||||
| 31380 | A | Partial removal of larynx | 20.21 | NA | 21.41 | 1.40 | NA | 43.02 | 090 | ||||||||||||
| 31382 | A | Partial removal of larynx | 20.52 | NA | 23.06 | 1.44 | NA | 45.02 | 090 | ||||||||||||
| 31390 | A | Removal of larynx pharynx | 27.53 | NA | 28.90 | 1.95 | NA | 58.38 | 090 | ||||||||||||
| 31395 | A | Reconstruct larynx pharynx | 31.09 | NA | 35.02 | 2.27 | NA | 68.38 | 090 | ||||||||||||
| 31400 | A | Revision of larynx | 10.31 | NA | 15.75 | 0.72 | NA | 26.78 | 090 | ||||||||||||
| 31420 | A | Removal of epiglottis | 10.22 | NA | 15.60 | 0.71 | NA | 26.53 | 090 | ||||||||||||
| 31500 | A | Insert emergency airway | 2.33 | NA | 0.69 | 0.15 | NA | 3.17 | 000 | ||||||||||||
| 31502 | A | Change of windpipe airway | 0.65 | 1.97 | 0.27 | 0.04 | 2.66 | 0.96 | 000 | ||||||||||||
| 31505 | A | Diagnostic laryngoscopy | 0.61 | 1.85 | 0.35 | 0.04 | 2.50 | 1.00 | 000 | ||||||||||||
| 31510 | A | Laryngoscopy with biopsy | 1.92 | 2.86 | 1.04 | 0.15 | 4.93 | 3.11 | 000 | ||||||||||||
| 31511 | A | Remove foreign body, larynx | 2.16 | 3.15 | 0.75 | 0.16 | 5.47 | 3.07 | 000 | ||||||||||||
| 31512 | A | Removal of larynx lesion | 2.07 | 3.00 | 1.10 | 0.16 | 5.23 | 3.33 | 000 | ||||||||||||
| 31513 | A | Injection into vocal cord | 2.10 | NA | 1.32 | 0.15 | NA | 3.57 | 000 | ||||||||||||
| 31515 | A | Laryngoscopy for aspiration | 1.80 | 2.30 | 0.90 | 0.12 | 4.22 | 2.82 | 000 | ||||||||||||
| 31520 | A | Diagnostic laryngoscopy | 2.56 | NA | 1.41 | 0.17 | NA | 4.14 | 000 | ||||||||||||
| 31525 | A | Diagnostic laryngoscopy | 2.63 | 2.94 | 1.53 | 0.18 | 5.75 | 4.34 | 000 | ||||||||||||
| 31526 | A | Diagnostic laryngoscopy | 2.57 | NA | 1.59 | 0.18 | NA | 4.34 | 000 | ||||||||||||
| 31527 | A | Laryngoscopy for treatment | 3.27 | NA | 1.77 | 0.21 | NA | 5.25 | 000 | ||||||||||||
| 31528 | A | Laryngoscopy and dilation | 2.37 | NA | 1.24 | 0.16 | NA | 3.77 | 000 | ||||||||||||
| 31529 | A | Laryngoscopy and dilation | 2.68 | NA | 1.62 | 0.18 | NA | 4.48 | 000 | ||||||||||||
| 31530 | A | Operative laryngoscopy | 3.39 | NA | 1.89 | 0.24 | NA | 5.52 | 000 | ||||||||||||
| 31531 | A | Operative laryngoscopy | 3.59 | NA | 2.18 | 0.25 | NA | 6.02 | 000 | ||||||||||||
| 31535 | A | Operative laryngoscopy | 3.16 | NA | 1.88 | 0.22 | NA | 5.26 | 000 | ||||||||||||
| 31536 | A | Operative laryngoscopy | 3.56 | NA | 2.16 | 0.25 | NA | 5.97 | 000 | ||||||||||||
| 31540 | A | Operative laryngoscopy | 4.13 | NA | 2.48 | 0.29 | NA | 6.90 | 000 | ||||||||||||
| 31541 | A | Operative laryngoscopy | 4.53 | NA | 2.72 | 0.32 | NA | 7.57 | 000 | ||||||||||||
| 31560 | A | Operative laryngoscopy | 5.46 | NA | 3.11 | 0.38 | NA | 8.95 | 000 | ||||||||||||
| 31561 | A | Operative laryngoscopy | 6.00 | NA | 2.96 | 0.42 | NA | 9.38 | 000 | ||||||||||||
| 31570 | A | Laryngoscopy with injection | 3.87 | 3.97 | 2.31 | 0.24 | 8.08 | 6.42 | 000 | ||||||||||||
| 31571 | A | Laryngoscopy with injection | 4.27 | NA | 2.46 | 0.30 | NA | 7.03 | 000 | ||||||||||||
| 31575 | A | Diagnostic laryngoscopy | 1.10 | 2.08 | 0.59 | 0.08 | 3.26 | 1.77 | 000 | ||||||||||||
| 31576 | A | Laryngoscopy with biopsy | 1.97 | 2.26 | 1.08 | 0.13 | 4.36 | 3.18 | 000 | ||||||||||||
| 31577 | A | Remove foreign body, larynx | 2.47 | 2.90 | 1.31 | 0.17 | 5.54 | 3.95 | 000 | ||||||||||||
| 31578 | A | Removal of larynx lesion | 2.84 | 3.13 | 1.62 | 0.20 | 6.17 | 4.66 | 000 | ||||||||||||
| 31579 | A | Diagnostic laryngoscopy | 2.26 | 2.97 | 1.27 | 0.16 | 5.39 | 3.69 | 000 | ||||||||||||
| 31580 | A | Revision of larynx | 12.38 | NA | 16.85 | 0.87 | NA | 30.10 | 090 | ||||||||||||
| 31582 | A | Revision of larynx | 21.62 | NA | 22.06 | 1.52 | NA | 45.20 | 090 | ||||||||||||
| 31584 | A | Treat larynx fracture | 19.64 | NA | 19.05 | 1.42 | NA | 40.11 | 090 | ||||||||||||
| 31585 | A | Treat larynx fracture | 4.64 | NA | 8.92 | 0.30 | NA | 13.86 | 090 | ||||||||||||
| 31586 | A | Treat larynx fracture | 8.03 | NA | 12.71 | 0.56 | NA | 21.30 | 090 | ||||||||||||
| 31587 | A | Revision of larynx | 11.99 | NA | 14.77 | 0.88 | NA | 27.64 | 090 | ||||||||||||
| 31588 | A | Revision of larynx | 13.11 | NA | 17.21 | 0.92 | NA | 31.24 | 090 | ||||||||||||
| 31590 | A | Reinnervate larynx | 6.97 | NA | 12.63 | 0.50 | NA | 20.10 | 090 | ||||||||||||
| 31595 | A | Larynx nerve surgery | 8.34 | NA | 11.90 | 0.62 | NA | 20.86 | 090 | ||||||||||||
| 31599 | C | Larynx surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 31600 | A | Incision of windpipe | 7.18 | NA | 3.15 | 0.34 | NA | 10.67 | 000 | ||||||||||||
| 31601 | A | Incision of windpipe | 4.45 | NA | 2.20 | 0.39 | NA | 7.04 | 000 | ||||||||||||
| 31603 | A | Incision of windpipe | 4.15 | NA | 1.88 | 0.35 | NA | 6.38 | 000 | ||||||||||||
| 31605 | A | Incision of windpipe | 3.58 | NA | 1.24 | 0.33 | NA | 5.15 | 000 | ||||||||||||
| 31610 | A | Incision of windpipe | 8.76 | NA | 10.98 | 0.69 | NA | 20.43 | 090 | ||||||||||||
| 31611 | A | Surgery/speech prosthesis | 5.64 | NA | 10.28 | 0.40 | NA | 16.32 | 090 | ||||||||||||
| 31612 | A | Puncture/clear windpipe | 0.91 | 1.53 | 0.48 | 0.06 | 2.50 | 1.45 | 000 | ||||||||||||
| 31613 | A | Repair windpipe opening | 4.59 | NA | 8.94 | 0.37 | NA | 13.90 | 090 | ||||||||||||
| 31614 | A | Repair windpipe opening | 7.12 | NA | 12.47 | 0.51 | NA | 20.10 | 090 | ||||||||||||
| 31615 | A | Visualization of windpipe | 2.09 | 3.76 | 1.20 | 0.14 | 5.99 | 3.43 | 000 | ||||||||||||
| 31622 | A | Dx bronchoscope/wash | 2.78 | 3.69 | 1.20 | 0.14 | 6.61 | 4.12 | 000 | ||||||||||||
| 31623 | A | Dx bronchoscope/brush | 2.88 | 2.97 | 1.17 | 0.14 | 5.99 | 4.19 | 000 | ||||||||||||
| 31624 | A | Dx bronchoscope/lavage | 2.88 | 2.75 | 1.17 | 0.13 | 5.76 | 4.18 | 000 | ||||||||||||
| 31625 | A | Bronchoscopy with biopsy | 3.37 | 2.96 | 1.34 | 0.16 | 6.49 | 4.87 | 000 | ||||||||||||
| 31628 | A | Bronchoscopy with biopsy | 3.81 | 3.38 | 1.45 | 0.14 | 7.33 | 5.40 | 000 | ||||||||||||
| 31629 | A | Bronchoscopy with biopsy | 3.37 | NA | 1.32 | 0.13 | NA | 4.82 | 000 | ||||||||||||
| 31630 | A | Bronchoscopy with repair | 3.82 | NA | 1.99 | 0.30 | NA | 6.11 | 000 | ||||||||||||
| 31631 | A | Bronchoscopy with dilation | 4.37 | NA | 2.04 | 0.31 | NA | 6.72 | 000 | ||||||||||||
| 31635 | A | Remove foreign body, airway | 3.68 | NA | 1.70 | 0.21 | NA | 5.59 | 000 | ||||||||||||
| 31640 | A | Bronchoscopy remove lesion | 4.94 | NA | 2.36 | 0.37 | NA | 7.67 | 000 | ||||||||||||
| 31641 | A | Bronchoscopy, treat blockage | 5.03 | NA | 2.20 | 0.30 | NA | 7.53 | 000 | ||||||||||||
| 31643 | A | Diag bronchoscope/catheter | 3.50 | 1.17 | 1.17 | 0.15 | 4.82 | 4.82 | 000 | ||||||||||||
| 31645 | A | Bronchoscopy, clear airways | 3.16 | NA | 1.27 | 0.13 | NA | 4.56 | 000 | ||||||||||||
| 31646 | A | Bronchoscopy, reclear airway | 2.72 | NA | 1.12 | 0.12 | NA | 3.96 | 000 | ||||||||||||
| 31656 | A | Bronchoscopy, inj for xray | 2.17 | NA | 1.05 | 0.10 | NA | 3.32 | 000 | ||||||||||||
| 31700 | A | Insertion of airway catheter | 1.34 | 3.44 | 0.68 | 0.07 | 4.85 | 2.09 | 000 | ||||||||||||
| 31708 | A | Instill airway contrast dye | 1.41 | NA | 0.64 | 0.06 | NA | 2.11 | 000 | ||||||||||||
| 31710 | A | Insertion of airway catheter | 1.30 | NA | 0.75 | 0.06 | NA | 2.11 | 000 | ||||||||||||
| 31715 | A | Injection for bronchus x-ray | 1.11 | NA | 0.73 | 0.06 | NA | 1.90 | 000 | ||||||||||||
| 31717 | A | Bronchial brush biopsy | 2.12 | 3.25 | 0.89 | 0.09 | 5.46 | 3.10 | 000 | ||||||||||||
| 31720 | A | Clearance of airways | 1.06 | 1.90 | 0.35 | 0.06 | 3.02 | 1.47 | 000 | ||||||||||||
| 31725 | A | Clearance of airways | 1.96 | NA | 0.61 | 0.10 | NA | 2.67 | 000 | ||||||||||||
| 31730 | A | Intro, windpipe wire/tube | 2.85 | 2.54 | 1.13 | 0.15 | 5.54 | 4.13 | 000 | ||||||||||||
| 31750 | A | Repair of windpipe | 13.02 | NA | 16.22 | 1.02 | NA | 30.26 | 090 | ||||||||||||
| 31755 | A | Repair of windpipe | 15.93 | NA | 19.27 | 1.15 | NA | 36.35 | 090 | ||||||||||||
| 31760 | A | Repair of windpipe | 22.35 | NA | 12.79 | 1.48 | NA | 36.62 | 090 | ||||||||||||
| 31766 | A | Reconstruction of windpipe | 30.43 | NA | 15.03 | 3.16 | NA | 48.62 | 090 | ||||||||||||
| 31770 | A | Repair/graft of bronchus | 22.51 | NA | 15.67 | 2.27 | NA | 40.45 | 090 | ||||||||||||
| 31775 | A | Reconstruct bronchus | 23.54 | NA | 15.14 | 2.91 | NA | 41.59 | 090 | ||||||||||||
| 31780 | A | Reconstruct windpipe | 17.72 | NA | 12.97 | 1.55 | NA | 32.24 | 090 | ||||||||||||
| 31781 | A | Reconstruct windpipe | 23.53 | NA | 15.49 | 2.04 | NA | 41.06 | 090 | ||||||||||||
| 31785 | A | Remove windpipe lesion | 17.23 | NA | 13.05 | 1.36 | NA | 31.64 | 090 | ||||||||||||
| 31786 | A | Remove windpipe lesion | 23.98 | NA | 14.41 | 2.20 | NA | 40.59 | 090 | ||||||||||||
| 31800 | A | Repair of windpipe injury | 7.43 | NA | 6.81 | 0.67 | NA | 14.91 | 090 | ||||||||||||
| 31805 | A | Repair of windpipe injury | 13.13 | NA | 10.72 | 1.45 | NA | 25.30 | 090 | ||||||||||||
| 31820 | A | Closure of windpipe lesion | 4.49 | 8.24 | 8.07 | 0.35 | 13.08 | 12.91 | 090 | ||||||||||||
| 31825 | A | Repair of windpipe defect | 6.81 | 10.86 | 10.86 | 0.50 | 18.17 | 18.17 | 090 | ||||||||||||
| 31830 | A | Revise windpipe scar | 4.50 | 7.82 | 7.82 | 0.36 | 12.68 | 12.68 | 090 | ||||||||||||
| 31899 | C | Airways surgical procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 32000 | A | Drainage of chest | 1.54 | 3.10 | 0.51 | 0.07 | 4.71 | 2.12 | 000 | ||||||||||||
| 32002 | A | Treatment of collapsed lung | 2.19 | NA | 0.87 | 0.11 | NA | 3.17 | 000 | ||||||||||||
| 32005 | A | Treat lung lining chemically | 2.19 | NA | 0.88 | 0.17 | NA | 3.24 | 000 | ||||||||||||
| 32020 | A | Insertion of chest tube | 3.98 | NA | 1.48 | 0.36 | NA | 5.82 | 000 | ||||||||||||
| 32035 | A | Exploration of chest | 8.67 | NA | 7.83 | 1.02 | NA | 17.52 | 090 | ||||||||||||
| 32036 | A | Exploration of chest | 9.68 | NA | 8.39 | 1.20 | NA | 19.27 | 090 | ||||||||||||
| 32095 | A | Biopsy through chest wall | 8.36 | NA | 8.05 | 0.99 | NA | 17.40 | 090 | ||||||||||||
| 32100 | A | Exploration/biopsy of chest | 15.24 | NA | 10.30 | 1.45 | NA | 26.99 | 090 | ||||||||||||
| 32110 | A | Explore/repair chest | 23.00 | NA | 12.72 | 1.63 | NA | 37.35 | 090 | ||||||||||||
| 32120 | A | Re-exploration of chest | 11.54 | NA | 9.34 | 1.42 | NA | 22.30 | 090 | ||||||||||||
| 32124 | A | Explore chest free adhesions | 12.72 | NA | 9.53 | 1.51 | NA | 23.76 | 090 | ||||||||||||
| 32140 | A | Removal of lung lesion(s) | 13.93 | NA | 9.79 | 1.68 | NA | 25.40 | 090 | ||||||||||||
| 32141 | A | Remove/treat lung lesions | 14.00 | NA | 9.98 | 1.72 | NA | 25.70 | 090 | ||||||||||||
| 32150 | A | Removal of lung lesion(s) | 14.15 | NA | 9.70 | 1.60 | NA | 25.45 | 090 | ||||||||||||
| 32151 | A | Remove lung foreign body | 14.21 | NA | 10.20 | 1.49 | NA | 25.90 | 090 | ||||||||||||
| 32160 | A | Open chest heart massage | 9.30 | NA | 6.34 | 1.01 | NA | 16.65 | 090 | ||||||||||||
| 32200 | A | Drain, open, lung lesion | 15.29 | NA | 10.08 | 1.46 | NA | 26.83 | 090 | ||||||||||||
| 32201 | A | Drain, percut, lung lesion | 4.00 | NA | 5.67 | 0.18 | NA | 9.85 | 000 | ||||||||||||
| 32215 | A | Treat chest lining | 11.33 | NA | 9.16 | 1.34 | NA | 21.83 | 090 | ||||||||||||
| 32220 | A | Release of lung | 24.00 | NA | 13.56 | 2.39 | NA | 39.95 | 090 | ||||||||||||
| 32225 | A | Partial release of lung | 13.96 | NA | 9.95 | 1.70 | NA | 25.61 | 090 | ||||||||||||
| 32310 | A | Removal of chest lining | 13.44 | NA | 9.86 | 1.65 | NA | 24.95 | 090 | ||||||||||||
| 32320 | A | Free/remove chest lining | 24.00 | NA | 13.21 | 2.50 | NA | 39.71 | 090 | ||||||||||||
| 32400 | A | Needle biopsy chest lining | 1.76 | 1.89 | 0.59 | 0.07 | 3.72 | 2.42 | 000 | ||||||||||||
| 32402 | A | Open biopsy chest lining | 7.56 | NA | 7.76 | 0.91 | NA | 16.23 | 090 | ||||||||||||
| 32405 | A | Biopsy, lung or mediastinum | 1.93 | 2.33 | 0.67 | 0.09 | 4.35 | 2.69 | 000 | ||||||||||||
| 32420 | A | Puncture/clear lung | 2.18 | NA | 0.88 | 0.11 | NA | 3.17 | 000 | ||||||||||||
| 32440 | A | Removal of lung | 25.00 | NA | 13.57 | 2.56 | NA | 41.13 | 090 | ||||||||||||
| 32442 | A | Sleeve pneumonectomy | 26.24 | NA | 14.35 | 3.12 | NA | 43.71 | 090 | ||||||||||||
| 32445 | A | Removal of lung | 25.09 | NA | 13.83 | 3.11 | NA | 42.03 | 090 | ||||||||||||
| 32480 | A | Partial removal of lung | 23.75 | NA | 12.78 | 2.24 | NA | 38.77 | 090 | ||||||||||||
| 32482 | A | Bilobectomy | 25.00 | NA | 13.39 | 2.35 | NA | 40.74 | 090 | ||||||||||||
| 32484 | A | Segmentectomy | 20.69 | NA | 11.97 | 2.54 | NA | 35.20 | 090 | ||||||||||||
| 32486 | A | Sleeve lobectomy | 23.92 | NA | 13.32 | 3.00 | NA | 40.24 | 090 | ||||||||||||
| 32488 | A | Completion pneumonectomy | 25.71 | NA | 13.89 | 3.18 | NA | 42.78 | 090 | ||||||||||||
| 32491 | R | Lung volume reduction | 21.25 | NA | 12.67 | 2.66 | NA | 36.58 | 090 | ||||||||||||
| 32500 | A | Partial removal of lung | 22.00 | NA | 12.70 | 1.77 | NA | 36.47 | 090 | ||||||||||||
| 32501 | A | Repair bronchus add-on | 4.69 | NA | 1.59 | 0.56 | NA | 6.84 | ZZZ | ||||||||||||
| 32520 | A | Remove lung revise chest | 21.68 | NA | 12.56 | 2.71 | NA | 36.95 | 090 | ||||||||||||
| 32522 | A | Remove lung revise chest | 24.20 | NA | 13.63 | 2.84 | NA | 40.67 | 090 | ||||||||||||
| 32525 | A | Remove lung revise chest | 26.50 | NA | 14.22 | 3.25 | NA | 43.97 | 090 | ||||||||||||
| 32540 | A | Removal of lung lesion | 14.64 | NA | 9.99 | 1.84 | NA | 26.47 | 090 | ||||||||||||
| 32601 | A | Thoracoscopy, diagnostic | 5.46 | NA | 3.60 | 0.63 | NA | 9.69 | 000 | ||||||||||||
| 32602 | A | Thoracoscopy, diagnostic | 5.96 | NA | 3.72 | 0.70 | NA | 10.38 | 000 | ||||||||||||
| 32603 | A | Thoracoscopy, diagnostic | 7.81 | NA | 4.33 | 0.76 | NA | 12.90 | 000 | ||||||||||||
| 32604 | A | Thoracoscopy, diagnostic | 8.78 | NA | 4.79 | 0.97 | NA | 14.54 | 000 | ||||||||||||
| 32605 | A | Thoracoscopy, diagnostic | 6.93 | NA | 4.19 | 0.86 | NA | 11.98 | 000 | ||||||||||||
| 32606 | A | Thoracoscopy, diagnostic | 8.40 | NA | 4.55 | 0.99 | NA | 13.94 | 000 | ||||||||||||
| 32650 | A | Thoracoscopy, surgical | 10.75 | NA | 8.47 | 1.25 | NA | 20.47 | 090 | ||||||||||||
| 32651 | A | Thoracoscopy, surgical | 12.91 | NA | 8.84 | 1.50 | NA | 23.25 | 090 | ||||||||||||
| 32652 | A | Thoracoscopy, surgical | 18.66 | NA | 11.16 | 2.30 | NA | 32.12 | 090 | ||||||||||||
| 32653 | A | Thoracoscopy, surgical | 12.87 | NA | 9.15 | 1.55 | NA | 23.57 | 090 | ||||||||||||
| 32654 | A | Thoracoscopy, surgical | 12.44 | NA | 7.53 | 1.51 | NA | 21.48 | 090 | ||||||||||||
| 32655 | A | Thoracoscopy, surgical | 13.10 | NA | 8.86 | 1.53 | NA | 23.49 | 090 | ||||||||||||
| 32656 | A | Thoracoscopy, surgical | 12.91 | NA | 9.53 | 1.61 | NA | 24.05 | 090 | ||||||||||||
| 32657 | A | Thoracoscopy, surgical | 13.65 | NA | 9.36 | 1.64 | NA | 24.65 | 090 | ||||||||||||
| 32658 | A | Thoracoscopy, surgical | 11.63 | NA | 9.05 | 1.47 | NA | 22.15 | 090 | ||||||||||||
| 32659 | A | Thoracoscopy, surgical | 11.59 | NA | 9.10 | 1.39 | NA | 22.08 | 090 | ||||||||||||
| 32660 | A | Thoracoscopy, surgical | 17.43 | NA | 10.53 | 2.09 | NA | 30.05 | 090 | ||||||||||||
| 32661 | A | Thoracoscopy, surgical | 13.25 | NA | 9.15 | 1.66 | NA | 24.06 | 090 | ||||||||||||
| 32662 | A | Thoracoscopy, surgical | 16.44 | NA | 10.59 | 2.01 | NA | 29.04 | 090 | ||||||||||||
| 32663 | A | Thoracoscopy, surgical | 18.47 | NA | 11.22 | 2.28 | NA | 31.97 | 090 | ||||||||||||
| 32664 | A | Thoracoscopy, surgical | 14.20 | NA | 9.43 | 1.70 | NA | 25.33 | 090 | ||||||||||||
| 32665 | A | Thoracoscopy, surgical | 15.54 | NA | 9.18 | 1.79 | NA | 26.51 | 090 | ||||||||||||
| 32800 | A | Repair lung hernia | 13.69 | NA | 10.05 | 1.51 | NA | 25.25 | 090 | ||||||||||||
| 32810 | A | Close chest after drainage | 13.05 | NA | 10.05 | 1.55 | NA | 24.65 | 090 | ||||||||||||
| 32815 | A | Close bronchial fistula | 23.15 | NA | 13.32 | 2.84 | NA | 39.31 | 090 | ||||||||||||
| 32820 | A | Reconstruct injured chest | 21.48 | NA | 13.99 | 2.31 | NA | 37.78 | 090 | ||||||||||||
| 32850 | X | Donor pneumonectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 32851 | A | Lung transplant, single | 38.63 | NA | 19.94 | 4.90 | NA | 63.47 | 090 | ||||||||||||
| 32852 | A | Lung transplant with bypass | 41.80 | NA | 21.40 | 5.17 | NA | 68.37 | 090 | ||||||||||||
| 32853 | A | Lung transplant, double | 47.81 | NA | 23.49 | 6.13 | NA | 77.43 | 090 | ||||||||||||
| 32854 | A | Lung transplant with bypass | 50.98 | NA | 24.35 | 6.41 | NA | 81.74 | 090 | ||||||||||||
| 32900 | A | Removal of rib(s) | 20.27 | NA | 12.27 | 2.42 | NA | 34.96 | 090 | ||||||||||||
| 32905 | A | Revise repair chest wall | 20.75 | NA | 12.77 | 2.54 | NA | 36.06 | 090 | ||||||||||||
| 32906 | A | Revise repair chest wall | 26.77 | NA | 14.12 | 3.30 | NA | 44.19 | 090 | ||||||||||||
| 32940 | A | Revision of lung | 19.43 | NA | 11.96 | 2.47 | NA | 33.86 | 090 | ||||||||||||
| 32960 | A | Therapeutic pneumothorax | 1.84 | 2.16 | 0.70 | 0.12 | 4.12 | 2.66 | 000 | ||||||||||||
| 32997 | A | Total lung lavage | 6.00 | NA | 2.00 | 0.55 | NA | 8.55 | 000 | ||||||||||||
| 32999 | C | Chest surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 33010 | A | Drainage of heart sac | 2.24 | NA | 1.01 | 0.13 | NA | 3.38 | 000 | ||||||||||||
| 33011 | A | Repeat drainage of heart sac | 2.24 | NA | 1.05 | 0.13 | NA | 3.42 | 000 | ||||||||||||
| 33015 | A | Incision of heart sac | 6.80 | NA | 4.41 | 0.64 | NA | 11.85 | 090 | ||||||||||||
| 33020 | A | Incision of heart sac | 12.61 | NA | 7.91 | 1.50 | NA | 22.02 | 090 | ||||||||||||
| 33025 | A | Incision of heart sac | 12.09 | NA | 7.77 | 1.50 | NA | 21.36 | 090 | ||||||||||||
| 33030 | A | Partial removal of heart sac | 18.71 | NA | 12.12 | 2.40 | NA | 33.23 | 090 | ||||||||||||
| 33031 | A | Partial removal of heart sac | 21.79 | NA | 13.20 | 2.78 | NA | 37.77 | 090 | ||||||||||||
| 33050 | A | Removal of heart sac lesion | 14.36 | NA | 10.24 | 1.73 | NA | 26.33 | 090 | ||||||||||||
| 33120 | A | Removal of heart lesion | 24.56 | NA | 15.68 | 3.06 | NA | 43.30 | 090 | ||||||||||||
| 33130 | A | Removal of heart lesion | 21.39 | NA | 12.40 | 2.51 | NA | 36.30 | 090 | ||||||||||||
| 33140 | A | Heart revascularize (tmr) | 20.00 | NA | 10.57 | 2.27 | NA | 32.84 | 090 | ||||||||||||
| 33141 | A | Heart tmr w/other procedure | 4.84 | NA | 1.63 | 0.55 | NA | 7.02 | ZZZ | ||||||||||||
| 33200 | A | Insertion of heart pacemaker | 12.48 | NA | 9.59 | 1.17 | NA | 23.24 | 090 | ||||||||||||
| 33201 | A | Insertion of heart pacemaker | 10.18 | NA | 9.39 | 1.21 | NA | 20.78 | 090 | ||||||||||||
| 33206 | A | Insertion of heart pacemaker | 6.67 | NA | 5.35 | 0.50 | NA | 12.52 | 090 | ||||||||||||
| 33207 | A | Insertion of heart pacemaker | 8.04 | NA | 6.00 | 0.57 | NA | 14.61 | 090 | ||||||||||||
| 33208 | A | Insertion of heart pacemaker | 8.13 | NA | 6.14 | 0.54 | NA | 14.81 | 090 | ||||||||||||
| 33210 | A | Insertion of heart electrode | 3.30 | NA | 1.34 | 0.17 | NA | 4.81 | 000 | ||||||||||||
| 33211 | A | Insertion of heart electrode | 3.40 | NA | 1.41 | 0.17 | NA | 4.98 | 000 | ||||||||||||
| 33212 | A | Insertion of pulse generator | 5.52 | NA | 4.44 | 0.44 | NA | 10.40 | 090 | ||||||||||||
| 33213 | A | Insertion of pulse generator | 6.37 | NA | 4.85 | 0.46 | NA | 11.68 | 090 | ||||||||||||
| 33214 | A | Upgrade of pacemaker system | 7.75 | NA | 5.95 | 0.52 | NA | 14.22 | 090 | ||||||||||||
| 33216 | A | Revise eltrd pacing-defib | 5.39 | NA | 4.95 | 0.36 | NA | 10.70 | 090 | ||||||||||||
| 33217 | A | Revise eltrd pacing-defib | 5.75 | NA | 5.26 | 0.36 | NA | 11.37 | 090 | ||||||||||||
| 33218 | A | Revise eltrd pacing-defib | 5.44 | NA | 4.51 | 0.40 | NA | 10.35 | 090 | ||||||||||||
| 33220 | A | Revise eltrd pacing-defib | 5.52 | NA | 4.45 | 0.39 | NA | 10.36 | 090 | ||||||||||||
| 33222 | A | Revise pocket, pacemaker | 4.96 | NA | 3.93 | 0.39 | NA | 9.28 | 090 | ||||||||||||
| 33223 | A | Revise pocket, pacing-defib | 6.46 | NA | 5.06 | 0.44 | NA | 11.96 | 090 | ||||||||||||
| 33233 | A | Removal of pacemaker system | 3.29 | NA | 3.80 | 0.22 | NA | 7.31 | 090 | ||||||||||||
| 33234 | A | Removal of pacemaker system | 7.82 | NA | 5.03 | 0.56 | NA | 13.41 | 090 | ||||||||||||
| 33235 | A | Removal pacemaker electrode | 9.40 | NA | 6.26 | 0.68 | NA | 16.34 | 090 | ||||||||||||
| 33236 | A | Remove electrode/thoracotomy | 12.60 | NA | 9.35 | 1.49 | NA | 23.44 | 090 | ||||||||||||
| 33237 | A | Remove electrode/thoracotomy | 13.71 | NA | 9.51 | 1.57 | NA | 24.79 | 090 | ||||||||||||
| 33238 | A | Remove electrode/thoracotomy | 15.22 | NA | 9.24 | 1.56 | NA | 26.02 | 090 | ||||||||||||
| 33240 | A | Insert pulse generator | 7.60 | NA | 5.49 | 0.53 | NA | 13.62 | 090 | ||||||||||||
| 33241 | A | Remove pulse generator | 3.24 | NA | 3.39 | 0.21 | NA | 6.84 | 090 | ||||||||||||
| 33243 | A | Remove eltrd/thoracotomy | 22.64 | NA | 10.88 | 2.53 | NA | 36.05 | 090 | ||||||||||||
| 33244 | A | Remove eltrd, transven | 13.76 | NA | 8.22 | 1.05 | NA | 23.03 | 090 | ||||||||||||
| 33245 | A | Insert epic eltrd pace-defib | 14.30 | NA | 10.79 | 1.28 | NA | 26.37 | 090 | ||||||||||||
| 33246 | A | Insert epic eltrd/generator | 20.71 | NA | 14.16 | 2.22 | NA | 37.09 | 090 | ||||||||||||
| 33249 | A | Eltrd/insert pace-defib | 14.23 | NA | 8.98 | 0.80 | NA | 24.01 | 090 | ||||||||||||
| 33250 | A | Ablate heart dysrhythm focus | 21.85 | NA | 13.65 | 1.01 | NA | 36.51 | 090 | ||||||||||||
| 33251 | A | Ablate heart dysrhythm focus | 24.88 | NA | 14.06 | 2.41 | NA | 41.35 | 090 | ||||||||||||
| 33253 | A | Reconstruct atria | 31.06 | NA | 16.58 | 3.68 | NA | 51.32 | 090 | ||||||||||||
| 33261 | A | Ablate heart dysrhythm focus | 24.88 | NA | 14.47 | 2.82 | NA | 42.17 | 090 | ||||||||||||
| 33282 | A | Implant pat-active ht record | 4.17 | NA | 4.42 | 0.39 | NA | 8.98 | 090 | ||||||||||||
| 33284 | A | Remove pat-active ht record | 2.50 | NA | 3.94 | 0.23 | NA | 6.67 | 090 | ||||||||||||
| 33300 | A | Repair of heart wound | 17.92 | NA | 11.56 | 1.91 | NA | 31.39 | 090 | ||||||||||||
| 33305 | A | Repair of heart wound | 21.44 | NA | 13.24 | 2.68 | NA | 37.36 | 090 | ||||||||||||
| 33310 | A | Exploratory heart surgery | 18.51 | NA | 11.85 | 2.26 | NA | 32.62 | 090 | ||||||||||||
| 33315 | A | Exploratory heart surgery | 22.37 | NA | 13.43 | 2.90 | NA | 38.70 | 090 | ||||||||||||
| 33320 | A | Repair major blood vessel(s) | 16.79 | NA | 11.06 | 1.66 | NA | 29.51 | 090 | ||||||||||||
| 33321 | A | Repair major vessel | 20.20 | NA | 13.15 | 2.70 | NA | 36.05 | 090 | ||||||||||||
| 33322 | A | Repair major blood vessel(s) | 20.62 | NA | 13.02 | 2.51 | NA | 36.15 | 090 | ||||||||||||
| 33330 | A | Insert major vessel graft | 21.43 | NA | 12.35 | 2.49 | NA | 36.27 | 090 | ||||||||||||
| 33332 | A | Insert major vessel graft | 23.96 | NA | 12.94 | 2.45 | NA | 39.35 | 090 | ||||||||||||
| 33335 | A | Insert major vessel graft | 30.01 | NA | 16.15 | 3.79 | NA | 49.95 | 090 | ||||||||||||
| 33400 | A | Repair of aortic valve | 28.50 | NA | 17.04 | 3.09 | NA | 48.63 | 090 | ||||||||||||
| 33401 | A | Valvuloplasty, open | 23.91 | NA | 14.85 | 2.71 | NA | 41.47 | 090 | ||||||||||||
| 33403 | A | Valvuloplasty, w/cp bypass | 24.89 | NA | 15.99 | 2.48 | NA | 43.36 | 090 | ||||||||||||
| 33404 | A | Prepare heart-aorta conduit | 28.54 | NA | 17.22 | 3.31 | NA | 49.07 | 090 | ||||||||||||
| 33405 | A | Replacement of aortic valve | 35.00 | NA | 17.69 | 3.86 | NA | 56.55 | 090 | ||||||||||||
| 33406 | A | Replacement of aortic valve | 37.50 | NA | 18.53 | 4.07 | NA | 60.10 | 090 | ||||||||||||
| 33410 | A | Replacement of aortic valve | 32.46 | NA | 16.93 | 4.11 | NA | 53.50 | 090 | ||||||||||||
| 33411 | A | Replacement of aortic valve | 36.25 | NA | 18.07 | 4.16 | NA | 58.48 | 090 | ||||||||||||
| 33412 | A | Replacement of aortic valve | 42.00 | NA | 21.90 | 4.66 | NA | 68.56 | 090 | ||||||||||||
| 33413 | A | Replacement of aortic valve | 43.50 | NA | 23.05 | 4.26 | NA | 70.81 | 090 | ||||||||||||
| 33414 | A | Repair of aortic valve | 30.35 | NA | 17.67 | 3.79 | NA | 51.81 | 090 | ||||||||||||
| 33415 | A | Revision, subvalvular tissue | 27.15 | NA | 16.53 | 3.25 | NA | 46.93 | 090 | ||||||||||||
| 33416 | A | Revise ventricle muscle | 30.35 | NA | 16.06 | 3.85 | NA | 50.26 | 090 | ||||||||||||
| 33417 | A | Repair of aortic valve | 28.53 | NA | 17.09 | 3.58 | NA | 49.20 | 090 | ||||||||||||
| 33420 | A | Revision of mitral valve | 22.70 | NA | 11.77 | 1.48 | NA | 35.95 | 090 | ||||||||||||
| 33422 | A | Revision of mitral valve | 25.94 | NA | 14.74 | 3.30 | NA | 43.98 | 090 | ||||||||||||
| 33425 | A | Repair of mitral valve | 27.00 | NA | 14.98 | 3.00 | NA | 44.98 | 090 | ||||||||||||
| 33426 | A | Repair of mitral valve | 33.00 | NA | 17.14 | 3.87 | NA | 54.01 | 090 | ||||||||||||
| 33427 | A | Repair of mitral valve | 40.00 | NA | 19.42 | 4.30 | NA | 63.72 | 090 | ||||||||||||
| 33430 | A | Replacement of mitral valve | 33.50 | NA | 17.26 | 3.95 | NA | 54.71 | 090 | ||||||||||||
| 33460 | A | Revision of tricuspid valve | 23.60 | NA | 13.83 | 3.02 | NA | 40.45 | 090 | ||||||||||||
| 33463 | A | Valvuloplasty, tricuspid | 25.62 | NA | 14.60 | 3.17 | NA | 43.39 | 090 | ||||||||||||
| 33464 | A | Valvuloplasty, tricuspid | 27.33 | NA | 15.22 | 3.47 | NA | 46.02 | 090 | ||||||||||||
| 33465 | A | Replace tricuspid valve | 28.79 | NA | 15.67 | 3.61 | NA | 48.07 | 090 | ||||||||||||
| 33468 | A | Revision of tricuspid valve | 30.12 | NA | 19.06 | 4.00 | NA | 53.18 | 090 | ||||||||||||
| 33470 | A | Revision of pulmonary valve | 20.81 | NA | 14.20 | 2.81 | NA | 37.82 | 090 | ||||||||||||
| 33471 | A | Valvotomy, pulmonary valve | 22.25 | NA | 13.13 | 3.00 | NA | 38.38 | 090 | ||||||||||||
| 33472 | A | Revision of pulmonary valve | 22.25 | NA | 13.13 | 2.92 | NA | 38.30 | 090 | ||||||||||||
| 33474 | A | Revision of pulmonary valve | 23.04 | NA | 13.45 | 2.84 | NA | 39.33 | 090 | ||||||||||||
| 33475 | A | Replacement, pulmonary valve | 33.00 | NA | 18.28 | 2.64 | NA | 53.92 | 090 | ||||||||||||
| 33476 | A | Revision of heart chamber | 25.77 | NA | 14.23 | 2.40 | NA | 42.40 | 090 | ||||||||||||
| 33478 | A | Revision of heart chamber | 26.74 | NA | 14.43 | 3.56 | NA | 44.73 | 090 | ||||||||||||
| 33496 | A | Repair, prosth valve clot | 27.25 | NA | 16.84 | 3.44 | NA | 47.53 | 090 | ||||||||||||
| 33500 | A | Repair heart vessel fistula | 25.55 | NA | 13.99 | 2.80 | NA | 42.34 | 090 | ||||||||||||
| 33501 | A | Repair heart vessel fistula | 17.78 | NA | 10.24 | 2.05 | NA | 30.07 | 090 | ||||||||||||
| 33502 | A | Coronary artery correction | 21.04 | NA | 16.64 | 2.51 | NA | 40.19 | 090 | ||||||||||||
| 33503 | A | Coronary artery graft | 21.78 | NA | 13.90 | 1.42 | NA | 37.10 | 090 | ||||||||||||
| 33504 | A | Coronary artery graft | 24.66 | NA | 16.55 | 3.04 | NA | 44.25 | 090 | ||||||||||||
| 33505 | A | Repair artery w/tunnel | 26.84 | NA | 18.16 | 1.52 | NA | 46.52 | 090 | ||||||||||||
| 33506 | A | Repair artery, translocation | 35.50 | NA | 19.27 | 3.19 | NA | 57.96 | 090 | ||||||||||||
| 33510 | A | CABG, vein, single | 29.00 | NA | 15.53 | 3.13 | NA | 47.66 | 090 | ||||||||||||
| 33511 | A | CABG, vein, two | 30.00 | NA | 16.05 | 3.34 | NA | 49.39 | 090 | ||||||||||||
| 33512 | A | CABG, vein, three | 31.80 | NA | 16.65 | 3.70 | NA | 52.15 | 090 | ||||||||||||
| 33513 | A | CABG, vein, four | 32.00 | NA | 16.77 | 3.99 | NA | 52.76 | 090 | ||||||||||||
| 33514 | A | CABG, vein, five | 32.75 | NA | 17.00 | 4.37 | NA | 54.12 | 090 | ||||||||||||
| 33516 | A | Cabg, vein, six or more | 35.00 | NA | 17.74 | 4.62 | NA | 57.36 | 090 | ||||||||||||
| 33517 | A | CABG, artery-vein, single | 2.57 | NA | 0.86 | 0.32 | NA | 3.75 | ZZZ | ||||||||||||
| 33518 | A | CABG, artery-vein, two | 4.85 | NA | 1.62 | 0.61 | NA | 7.08 | ZZZ | ||||||||||||
| 33519 | A | CABG, artery-vein, three | 7.12 | NA | 2.38 | 0.89 | NA | 10.39 | ZZZ | ||||||||||||
| 33521 | A | CABG, artery-vein, four | 9.40 | NA | 3.15 | 1.18 | NA | 13.73 | ZZZ | ||||||||||||
| 33522 | A | CABG, artery-vein, five | 11.67 | NA | 3.91 | 1.48 | NA | 17.06 | ZZZ | ||||||||||||
| 33523 | A | Cabg, art-vein, six or more | 13.95 | NA | 4.63 | 1.78 | NA | 20.36 | ZZZ | 33530 | A | Coronary artery, bypass/reop | 5.86 | NA | 1.96 | 0.73 | NA | 8.55 | ZZZ | ||
| 33533 | A | CABG, arterial, single | 30.00 | NA | 17.24 | 3.24 | NA | 50.48 | 090 | ||||||||||||
| 33534 | A | CABG, arterial, two | 32.20 | NA | 17.45 | 3.63 | NA | 53.28 | 090 | ||||||||||||
| 33535 | A | CABG, arterial, three | 34.50 | NA | 17.77 | 3.97 | NA | 56.24 | 090 | ||||||||||||
| 33536 | A | Cabg, arterial, four or more | 37.50 | NA | 19.27 | 3.29 | NA | 60.06 | 090 | ||||||||||||
| 33542 | A | Removal of heart lesion | 28.85 | NA | 17.05 | 3.61 | NA | 49.51 | 090 | ||||||||||||
| 33545 | A | Repair of heart damage | 36.78 | NA | 19.79 | 4.40 | NA | 60.97 | 090 | ||||||||||||
| 33572 | A | Open coronary endarterectomy | 4.45 | NA | 1.48 | 0.55 | NA | 6.48 | ZZZ | ||||||||||||
| 33600 | A | Closure of valve | 29.51 | NA | 17.79 | 2.30 | NA | 49.60 | 090 | ||||||||||||
| 33602 | A | Closure of valve | 28.54 | NA | 16.65 | 2.90 | NA | 48.09 | 090 | ||||||||||||
| 33606 | A | Anastomosis/artery-aorta | 30.74 | NA | 17.53 | 3.59 | NA | 51.86 | 090 | ||||||||||||
| 33608 | A | Repair anomaly w/conduit | 31.09 | NA | 16.38 | 4.17 | NA | 51.64 | 090 | ||||||||||||
| 33610 | A | Repair by enlargement | 30.61 | NA | 18.89 | 4.02 | NA | 53.52 | 090 | ||||||||||||
| 33611 | A | Repair double ventricle | 34.00 | NA | 19.08 | 3.28 | NA | 56.36 | 090 | ||||||||||||
| 33612 | A | Repair double ventricle | 35.00 | NA | 20.17 | 4.44 | NA | 59.61 | 090 | ||||||||||||
| 33615 | A | Repair, modified fontan | 34.00 | NA | 19.33 | 3.15 | NA | 56.48 | 090 | ||||||||||||
| 33617 | A | Repair single ventricle | 37.00 | NA | 21.25 | 4.09 | NA | 62.34 | 090 | ||||||||||||
| 33619 | A | Repair single ventricle | 45.00 | NA | 26.49 | 4.71 | NA | 76.20 | 090 | ||||||||||||
| 33641 | A | Repair heart septum defect | 21.39 | NA | 11.82 | 2.67 | NA | 35.88 | 090 | ||||||||||||
| 33645 | A | Revision of heart veins | 24.82 | NA | 13.92 | 3.27 | NA | 42.01 | 090 | ||||||||||||
| 33647 | A | Repair heart septum defects | 28.73 | NA | 17.08 | 3.37 | NA | 49.18 | 090 | ||||||||||||
| 33660 | A | Repair of heart defects | 30.00 | NA | 17.09 | 2.82 | NA | 49.91 | 090 | ||||||||||||
| 33665 | A | Repair of heart defects | 28.60 | NA | 16.87 | 3.81 | NA | 49.28 | 090 | ||||||||||||
| 33670 | A | Repair of heart chambers | 35.00 | NA | 16.68 | 2.18 | NA | 53.86 | 090 | ||||||||||||
| 33681 | A | Repair heart septum defect | 30.61 | NA | 17.83 | 3.53 | NA | 51.97 | 090 | ||||||||||||
| 33684 | A | Repair heart septum defect | 29.65 | NA | 17.82 | 3.77 | NA | 51.24 | 090 | ||||||||||||
| 33688 | A | Repair heart septum defect | 30.62 | NA | 16.70 | 3.89 | NA | 51.21 | 090 | ||||||||||||
| 33690 | A | Reinforce pulmonary artery | 19.55 | NA | 13.55 | 2.56 | NA | 35.66 | 090 | ||||||||||||
| 33692 | A | Repair of heart defects | 30.75 | NA | 17.52 | 3.77 | NA | 52.04 | 090 | ||||||||||||
| 33694 | A | Repair of heart defects | 34.00 | NA | 17.82 | 4.27 | NA | 56.09 | 090 | ||||||||||||
| 33697 | A | Repair of heart defects | 36.00 | NA | 18.62 | 4.54 | NA | 59.16 | 090 | ||||||||||||
| 33702 | A | Repair of heart defects | 26.54 | NA | 16.53 | 3.45 | NA | 46.52 | 090 | ||||||||||||
| 33710 | A | Repair of heart defects | 29.71 | NA | 16.82 | 3.85 | NA | 50.38 | 090 | ||||||||||||
| 33720 | A | Repair of heart defect | 26.56 | NA | 16.51 | 3.21 | NA | 46.28 | 090 | ||||||||||||
| 33722 | A | Repair of heart defect | 28.41 | NA | 17.05 | 3.80 | NA | 49.26 | 090 | ||||||||||||
| 33730 | A | Repair heart-vein defect(s) | 34.25 | NA | 18.35 | 2.85 | NA | 55.45 | 090 | ||||||||||||
| 33732 | A | Repair heart-vein defect | 28.16 | NA | 17.95 | 2.78 | NA | 48.89 | 090 | ||||||||||||
| 33735 | A | Revision of heart chamber | 21.39 | NA | 13.00 | 1.12 | NA | 35.51 | 090 | ||||||||||||
| 33736 | A | Revision of heart chamber | 23.52 | NA | 14.06 | 2.70 | NA | 40.28 | 090 | ||||||||||||
| 33737 | A | Revision of heart chamber | 21.76 | NA | 15.22 | 2.93 | NA | 39.91 | 090 | ||||||||||||
| 33750 | A | Major vessel shunt | 21.41 | NA | 12.83 | 1.74 | NA | 35.98 | 090 | ||||||||||||
| 33755 | A | Major vessel shunt | 21.79 | NA | 12.94 | 2.93 | NA | 37.66 | 090 | ||||||||||||
| 33762 | A | Major vessel shunt | 21.79 | NA | 13.32 | 1.59 | NA | 36.70 | 090 | ||||||||||||
| 33764 | A | Major vessel shunt graft | 21.79 | NA | 14.22 | 1.93 | NA | 37.94 | 090 | ||||||||||||
| 33766 | A | Major vessel shunt | 22.76 | NA | 15.16 | 3.04 | NA | 40.96 | 090 | ||||||||||||
| 33767 | A | Major vessel shunt | 24.50 | NA | 14.92 | 3.14 | NA | 42.56 | 090 | ||||||||||||
| 33770 | A | Repair great vessels defect | 37.00 | NA | 19.01 | 4.49 | NA | 60.50 | 090 | ||||||||||||
| 33771 | A | Repair great vessels defect | 34.65 | NA | 18.08 | 4.67 | NA | 57.40 | 090 | ||||||||||||
| 33774 | A | Repair great vessels defect | 30.98 | NA | 16.61 | 4.18 | NA | 51.77 | 090 | ||||||||||||
| 33775 | A | Repair great vessels defect | 32.20 | NA | 17.10 | 4.34 | NA | 53.64 | 090 | ||||||||||||
| 33776 | A | Repair great vessels defect | 34.04 | NA | 17.83 | 4.58 | NA | 56.45 | 090 | ||||||||||||
| 33777 | A | Repair great vessels defect | 33.46 | NA | 17.60 | 4.51 | NA | 55.57 | 090 | ||||||||||||
| 33778 | A | Repair great vessels defect | 40.00 | NA | 20.21 | 4.83 | NA | 65.04 | 090 | ||||||||||||
| 33779 | A | Repair great vessels defect | 36.21 | NA | 17.93 | 2.40 | NA | 56.54 | 090 | ||||||||||||
| 33780 | A | Repair great vessels defect | 41.75 | NA | 20.98 | 5.21 | NA | 67.94 | 090 | ||||||||||||
| 33781 | A | Repair great vessels defect | 36.45 | NA | 18.80 | 4.91 | NA | 60.16 | 090 | ||||||||||||
| 33786 | A | Repair arterial trunk | 39.00 | NA | 19.81 | 4.69 | NA | 63.50 | 090 | ||||||||||||
| 33788 | A | Revision of pulmonary artery | 26.62 | NA | 14.87 | 3.32 | NA | 44.81 | 090 | ||||||||||||
| 33800 | A | Aortic suspension | 16.24 | NA | 13.12 | 1.11 | NA | 30.47 | 090 | ||||||||||||
| 33802 | A | Repair vessel defect | 17.66 | NA | 12.22 | 1.56 | NA | 31.44 | 090 | ||||||||||||
| 33803 | A | Repair vessel defect | 19.60 | NA | 13.53 | 2.63 | NA | 35.76 | 090 | ||||||||||||
| 33813 | A | Repair septal defect | 20.65 | NA | 14.12 | 2.78 | NA | 37.55 | 090 | ||||||||||||
| 33814 | A | Repair septal defect | 25.77 | NA | 15.61 | 2.52 | NA | 43.90 | 090 | ||||||||||||
| 33820 | A | Revise major vessel | 16.29 | NA | 10.95 | 2.10 | NA | 29.34 | 090 | ||||||||||||
| 33822 | A | Revise major vessel | 17.32 | NA | 11.16 | 2.33 | NA | 30.81 | 090 | ||||||||||||
| 33824 | A | Revise major vessel | 19.52 | NA | 11.97 | 2.61 | NA | 34.10 | 090 | ||||||||||||
| 33840 | A | Remove aorta constriction | 20.63 | NA | 14.11 | 2.36 | NA | 37.10 | 090 | ||||||||||||
| 33845 | A | Remove aorta constriction | 22.12 | NA | 14.85 | 2.90 | NA | 39.87 | 090 | ||||||||||||
| 33851 | A | Remove aorta constriction | 21.27 | NA | 12.98 | 2.86 | NA | 37.11 | 090 | ||||||||||||
| 33852 | A | Repair septal defect | 23.71 | NA | 14.14 | 3.19 | NA | 41.04 | 090 | ||||||||||||
| 33853 | A | Repair septal defect | 31.72 | NA | 18.25 | 4.23 | NA | 54.20 | 090 | ||||||||||||
| 33860 | A | Ascending aortic graft | 38.00 | NA | 18.74 | 4.30 | NA | 61.04 | 090 | ||||||||||||
| 33861 | A | Ascending aortic graft | 42.00 | NA | 20.15 | 4.24 | NA | 66.39 | 090 | ||||||||||||
| 33863 | A | Ascending aortic graft | 45.00 | NA | 21.10 | 4.60 | NA | 70.70 | 090 | ||||||||||||
| 33870 | A | Transverse aortic arch graft | 44.00 | NA | 20.69 | 5.09 | NA | 69.78 | 090 | ||||||||||||
| 33875 | A | Thoracic aortic graft | 33.06 | NA | 17.01 | 4.08 | NA | 54.15 | 090 | ||||||||||||
| 33877 | A | Thoracoabdominal graft | 42.60 | NA | 19.96 | 5.07 | NA | 67.63 | 090 | ||||||||||||
| 33910 | A | Remove lung artery emboli | 24.59 | NA | 14.16 | 3.06 | NA | 41.81 | 090 | ||||||||||||
| 33915 | A | Remove lung artery emboli | 21.02 | NA | 12.31 | 1.20 | NA | 34.53 | 090 | ||||||||||||
| 33916 | A | Surgery of great vessel | 25.83 | NA | 15.49 | 3.04 | NA | 44.36 | 090 | ||||||||||||
| 33917 | A | Repair pulmonary artery | 24.50 | NA | 15.36 | 3.17 | NA | 43.03 | 090 | ||||||||||||
| 33918 | A | Repair pulmonary atresia | 26.45 | NA | 14.80 | 3.42 | NA | 44.67 | 090 | ||||||||||||
| 33919 | A | Repair pulmonary atresia | 40.00 | NA | 21.02 | 3.48 | NA | 64.50 | 090 | ||||||||||||
| 33920 | A | Repair pulmonary atresia | 31.95 | NA | 17.28 | 3.61 | NA | 52.84 | 090 | ||||||||||||
| 33922 | A | Transect pulmonary artery | 23.52 | NA | 13.79 | 2.30 | NA | 39.61 | 090 | ||||||||||||
| 33924 | A | Remove pulmonary shunt | 5.50 | NA | 2.05 | 0.74 | NA | 8.29 | ZZZ | ||||||||||||
| 33930 | X | Removal of donor heart/lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 33935 | R | Transplantation, heart/lung | 60.96 | NA | 27.93 | 8.15 | NA | 97.04 | 090 | ||||||||||||
| 33940 | X | Removal of donor heart | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 33945 | R | Transplantation of heart | 42.10 | NA | 21.67 | 5.42 | NA | 69.19 | 090 | ||||||||||||
| 33960 | A | External circulation assist | 19.36 | NA | 6.06 | 2.14 | NA | 27.56 | 000 | ||||||||||||
| 33961 | A | External circulation assist | 10.93 | NA | 3.79 | 1.47 | NA | 16.19 | ZZZ | ||||||||||||
| 33967 | A | Insert ia percut device | 4.85 | 2.01 | 1.96 | 0.27 | 7.13 | 7.08 | 000 | ||||||||||||
| 33968 | A | Remove aortic assist device | 0.64 | NA | 0.24 | 0.07 | NA | 0.95 | 000 | ||||||||||||
| 33970 | A | Aortic circulation assist | 6.75 | NA | 2.37 | 0.70 | NA | 9.82 | 000 | ||||||||||||
| 33971 | A | Aortic circulation assist | 9.69 | NA | 7.82 | 0.97 | NA | 18.48 | 090 | ||||||||||||
| 33973 | A | Insert balloon device | 9.76 | NA | 3.44 | 1.01 | NA | 14.21 | 000 | ||||||||||||
| 33974 | A | Remove intra-aortic balloon | 14.41 | NA | 10.69 | 1.48 | NA | 26.58 | 090 | ||||||||||||
| 33975 | A | Implant ventricular device | 21.00 | NA | 7.04 | 1.72 | NA | 29.76 | XXX | ||||||||||||
| 33976 | A | Implant ventricular device | 23.00 | NA | 7.78 | 2.82 | NA | 33.60 | XXX | ||||||||||||
| 33977 | A | Remove ventricular device | 19.29 | NA | 10.46 | 2.44 | NA | 32.19 | 090 | ||||||||||||
| 33978 | A | Remove ventricular device | 21.73 | NA | 11.27 | 2.66 | NA | 35.66 | 090 | ||||||||||||
| 33979 | C | Insert intracorporeal device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 33980 | C | Remove intracorporeal device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 33999 | C | Cardiac surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 34001 | A | Removal of artery clot | 12.91 | NA | 5.97 | 1.46 | NA | 20.34 | 090 | ||||||||||||
| 34051 | A | Removal of artery clot | 15.21 | NA | 7.07 | 1.90 | NA | 24.18 | 090 | ||||||||||||
| 34101 | A | Removal of artery clot | 10.00 | NA | 4.84 | 1.11 | NA | 15.95 | 090 | ||||||||||||
| 34111 | A | Removal of arm artery clot | 10.00 | NA | 4.88 | 0.85 | NA | 15.73 | 090 | ||||||||||||
| 34151 | A | Removal of artery clot | 25.00 | NA | 10.54 | 1.84 | NA | 37.38 | 090 | ||||||||||||
| 34201 | A | Removal of artery clot | 10.03 | NA | 5.12 | 1.02 | NA | 16.17 | 090 | ||||||||||||
| 34203 | A | Removal of leg artery clot | 16.50 | NA | 7.65 | 1.37 | NA | 25.52 | 090 | ||||||||||||
| 34401 | A | Removal of vein clot | 25.00 | NA | 10.47 | 1.20 | NA | 36.67 | 090 | ||||||||||||
| 34421 | A | Removal of vein clot | 12.00 | NA | 6.01 | 0.95 | NA | 18.96 | 090 | ||||||||||||
| 34451 | A | Removal of vein clot | 27.00 | NA | 11.08 | 1.59 | NA | 39.67 | 090 | ||||||||||||
| 34471 | A | Removal of vein clot | 10.18 | NA | 5.18 | 0.90 | NA | 16.26 | 090 | ||||||||||||
| 34490 | A | Removal of vein clot | 9.86 | NA | 6.26 | 0.73 | NA | 16.85 | 090 | ||||||||||||
| 34501 | A | Repair valve, femoral vein | 16.00 | NA | 8.98 | 1.37 | NA | 26.35 | 090 | ||||||||||||
| 34502 | A | Reconstruct vena cava | 26.95 | NA | 11.34 | 2.99 | NA | 41.28 | 090 | ||||||||||||
| 34510 | A | Transposition of vein valve | 18.95 | NA | 10.23 | 1.60 | NA | 30.78 | 090 | ||||||||||||
| 34520 | A | Cross-over vein graft | 17.95 | NA | 9.59 | 1.41 | NA | 28.95 | 090 | ||||||||||||
| 34530 | A | Leg vein fusion | 16.64 | NA | 8.48 | 2.06 | NA | 27.18 | 090 | ||||||||||||
| 34800 | A | Endovasc abdo repair w/tube | 20.75 | NA | 9.79 | 1.49 | NA | 32.03 | 090 | ||||||||||||
| 34802 | A | Endovasc abdo repr w/device | 23.00 | NA | 10.69 | 1.65 | NA | 35.34 | 090 | ||||||||||||
| 34804 | A | Endovasc abdo repr w/device | 23.00 | NA | 10.69 | 1.65 | NA | 35.34 | 090 | ||||||||||||
| 34808 | A | Endovasc abdo occlud device | 4.13 | NA | 1.65 | 0.29 | NA | 6.07 | ZZZ | ||||||||||||
| 34812 | A | Xpose for endoprosth, aortic | 6.75 | NA | 2.69 | 0.49 | NA | 9.93 | 000 | ||||||||||||
| 34813 | A | Xpose for endoprosth, femorl | 4.80 | NA | 1.92 | 0.34 | NA | 7.06 | ZZZ | ||||||||||||
| 34820 | A | Xpose for endoprosth, iliac | 9.75 | NA | 3.89 | 0.70 | NA | 14.34 | 000 | ||||||||||||
| 34825 | A | Endovasc extend prosth, init | 12.00 | NA | 6.30 | 0.86 | NA | 19.16 | 090 | ||||||||||||
| 34826 | A | Endovasc exten prosth, addl | 4.13 | NA | 1.65 | 0.29 | NA | 6.07 | ZZZ | ||||||||||||
| 34830 | A | Open aortic tube prosth repr | 32.59 | NA | 14.89 | 2.34 | NA | 49.82 | 090 | ||||||||||||
| 34831 | A | Open aortoiliac prosth repr | 35.34 | NA | 15.99 | 2.53 | NA | 53.86 | 090 | ||||||||||||
| 34832 | A | Open aortofemor prosth repr | 35.34 | NA | 15.99 | 2.53 | NA | 53.86 | 090 | ||||||||||||
| 35001 | A | Repair defect of artery | 19.64 | NA | 8.41 | 2.44 | NA | 30.49 | 090 | ||||||||||||
| 35002 | A | Repair artery rupture, neck | 21.00 | NA | 9.12 | 1.82 | NA | 31.94 | 090 | ||||||||||||
| 35005 | A | Repair defect of artery | 18.12 | NA | 8.04 | 1.35 | NA | 27.51 | 090 | ||||||||||||
| 35011 | A | Repair defect of artery | 18.00 | NA | 7.59 | 1.30 | NA | 26.89 | 090 | ||||||||||||
| 35013 | A | Repair artery rupture, arm | 22.00 | NA | 8.98 | 1.91 | NA | 32.89 | 090 | ||||||||||||
| 35021 | A | Repair defect of artery | 19.65 | NA | 8.64 | 1.93 | NA | 30.22 | 090 | ||||||||||||
| 35022 | A | Repair artery rupture, chest | 23.18 | NA | 9.57 | 1.99 | NA | 34.74 | 090 | ||||||||||||
| 35045 | A | Repair defect of arm artery | 17.57 | NA | 7.99 | 1.25 | NA | 26.81 | 090 | ||||||||||||
| 35081 | A | Repair defect of artery | 28.01 | NA | 11.69 | 3.20 | NA | 42.90 | 090 | ||||||||||||
| 35082 | A | Repair artery rupture, aorta | 38.50 | NA | 15.08 | 4.07 | NA | 57.65 | 090 | ||||||||||||
| 35091 | A | Repair defect of artery | 35.40 | NA | 14.22 | 4.09 | NA | 53.71 | 090 | ||||||||||||
| 35092 | A | Repair artery rupture, aorta | 45.00 | NA | 17.35 | 4.31 | NA | 66.66 | 090 | ||||||||||||
| 35102 | A | Repair defect of artery | 30.76 | NA | 12.67 | 3.44 | NA | 46.87 | 090 | ||||||||||||
| 35103 | A | Repair artery rupture, groin | 40.50 | NA | 15.81 | 3.79 | NA | 60.10 | 090 | ||||||||||||
| 35111 | A | Repair defect of artery | 25.00 | NA | 10.43 | 1.81 | NA | 37.24 | 090 | ||||||||||||
| 35112 | A | Repair artery rupture,spleen | 30.00 | NA | 12.06 | 1.95 | NA | 44.01 | 090 | ||||||||||||
| 35121 | A | Repair defect of artery | 30.00 | NA | 12.39 | 2.93 | NA | 45.32 | 090 | ||||||||||||
| 35122 | A | Repair artery rupture, belly | 35.00 | NA | 13.73 | 3.54 | NA | 52.27 | 090 | ||||||||||||
| 35131 | A | Repair defect of artery | 25.00 | NA | 10.64 | 2.11 | NA | 37.75 | 090 | ||||||||||||
| 35132 | A | Repair artery rupture, groin | 30.00 | NA | 12.14 | 2.48 | NA | 44.62 | 090 | ||||||||||||
| 35141 | A | Repair defect of artery | 20.00 | NA | 8.66 | 1.65 | NA | 30.31 | 090 | ||||||||||||
| 35142 | A | Repair artery rupture, thigh | 23.30 | NA | 9.76 | 1.75 | NA | 34.81 | 090 | ||||||||||||
| 35151 | A | Repair defect of artery | 22.64 | NA | 9.72 | 1.93 | NA | 34.29 | 090 | ||||||||||||
| 35152 | A | Repair artery rupture, knee | 25.62 | NA | 10.50 | 1.93 | NA | 38.05 | 090 | ||||||||||||
| 35161 | A | Repair defect of artery | 18.76 | NA | 8.96 | 2.21 | NA | 29.93 | 090 | ||||||||||||
| 35162 | A | Repair artery rupture | 19.78 | NA | 9.05 | 2.21 | NA | 31.04 | 090 | ||||||||||||
| 35180 | A | Repair blood vessel lesion | 13.62 | NA | 6.49 | 1.44 | NA | 21.55 | 090 | ||||||||||||
| 35182 | A | Repair blood vessel lesion | 30.00 | NA | 12.39 | 1.88 | NA | 44.27 | 090 | ||||||||||||
| 35184 | A | Repair blood vessel lesion | 18.00 | NA | 7.92 | 1.34 | NA | 27.26 | 090 | ||||||||||||
| 35188 | A | Repair blood vessel lesion | 14.28 | NA | 6.70 | 1.53 | NA | 22.51 | 090 | ||||||||||||
| 35189 | A | Repair blood vessel lesion | 28.00 | NA | 11.71 | 2.12 | NA | 41.83 | 090 | ||||||||||||
| 35190 | A | Repair blood vessel lesion | 12.75 | NA | 6.03 | 1.33 | NA | 20.11 | 090 | ||||||||||||
| 35201 | A | Repair blood vessel lesion | 16.14 | NA | 7.18 | 1.17 | NA | 24.49 | 090 | ||||||||||||
| 35206 | A | Repair blood vessel lesion | 13.25 | NA | 7.60 | 1.04 | NA | 21.89 | 090 | ||||||||||||
| 35207 | A | Repair blood vessel lesion | 10.15 | NA | 9.91 | 1.15 | NA | 21.21 | 090 | ||||||||||||
| 35211 | A | Repair blood vessel lesion | 22.12 | NA | 13.55 | 2.83 | NA | 38.50 | 090 | ||||||||||||
| 35216 | A | Repair blood vessel lesion | 18.75 | NA | 11.83 | 2.17 | NA | 32.75 | 090 | ||||||||||||
| 35221 | A | Repair blood vessel lesion | 24.39 | NA | 10.31 | 1.79 | NA | 36.49 | 090 | ||||||||||||
| 35226 | A | Repair blood vessel lesion | 14.50 | NA | 8.54 | 0.84 | NA | 23.88 | 090 | ||||||||||||
| 35231 | A | Repair blood vessel lesion | 20.00 | NA | 9.45 | 1.32 | NA | 30.77 | 090 | ||||||||||||
| 35236 | A | Repair blood vessel lesion | 17.11 | NA | 8.97 | 1.19 | NA | 27.27 | 090 | ||||||||||||
| 35241 | A | Repair blood vessel lesion | 23.12 | NA | 14.09 | 2.90 | NA | 40.11 | 090 | ||||||||||||
| 35246 | A | Repair blood vessel lesion | 26.45 | NA | 14.32 | 2.22 | NA | 42.99 | 090 | ||||||||||||
| 35251 | A | Repair blood vessel lesion | 30.20 | NA | 12.39 | 1.87 | NA | 44.46 | 090 | ||||||||||||
| 35256 | A | Repair blood vessel lesion | 18.36 | NA | 9.63 | 1.32 | NA | 29.31 | 090 | ||||||||||||
| 35261 | A | Repair blood vessel lesion | 17.80 | NA | 7.56 | 1.34 | NA | 26.70 | 090 | ||||||||||||
| 35266 | A | Repair blood vessel lesion | 14.91 | NA | 8.12 | 1.16 | NA | 24.19 | 090 | ||||||||||||
| 35271 | A | Repair blood vessel lesion | 22.12 | NA | 13.43 | 2.77 | NA | 38.32 | 090 | ||||||||||||
| 35276 | A | Repair blood vessel lesion | 24.25 | NA | 13.56 | 2.37 | NA | 40.18 | 090 | ||||||||||||
| 35281 | A | Repair blood vessel lesion | 28.00 | NA | 11.66 | 1.82 | NA | 41.48 | 090 | ||||||||||||
| 35286 | A | Repair blood vessel lesion | 16.16 | NA | 8.88 | 1.36 | NA | 26.40 | 090 | ||||||||||||
| 35301 | A | Rechanneling of artery | 18.70 | NA | 8.39 | 2.23 | NA | 29.32 | 090 | ||||||||||||
| 35311 | A | Rechanneling of artery | 27.00 | NA | 11.10 | 2.75 | NA | 40.85 | 090 | ||||||||||||
| 35321 | A | Rechanneling of artery | 16.00 | NA | 6.87 | 1.36 | NA | 24.23 | 090 | ||||||||||||
| 35331 | A | Rechanneling of artery | 26.20 | NA | 11.11 | 2.71 | NA | 40.02 | 090 | ||||||||||||
| 35341 | A | Rechanneling of artery | 25.11 | NA | 10.70 | 2.87 | NA | 38.68 | 090 | ||||||||||||
| 35351 | A | Rechanneling of artery | 23.00 | NA | 9.84 | 2.29 | NA | 35.13 | 090 | ||||||||||||
| 35355 | A | Rechanneling of artery | 18.50 | NA | 8.33 | 1.80 | NA | 28.63 | 090 | ||||||||||||
| 35361 | A | Rechanneling of artery | 28.20 | NA | 11.60 | 2.66 | NA | 42.46 | 090 | ||||||||||||
| 35363 | A | Rechanneling of artery | 30.20 | NA | 12.54 | 2.77 | NA | 45.51 | 090 | ||||||||||||
| 35371 | A | Rechanneling of artery | 14.72 | NA | 6.75 | 1.32 | NA | 22.79 | 090 | ||||||||||||
| 35372 | A | Rechanneling of artery | 18.00 | NA | 7.91 | 1.53 | NA | 27.44 | 090 | ||||||||||||
| 35381 | A | Rechanneling of artery | 15.81 | NA | 7.35 | 1.80 | NA | 24.96 | 090 | ||||||||||||
| 35390 | A | Reoperation, carotid add-on | 3.19 | NA | 1.11 | 0.38 | NA | 4.68 | ZZZ | ||||||||||||
| 35400 | A | Angioscopy | 3.00 | NA | 1.05 | 0.34 | NA | 4.39 | ZZZ | ||||||||||||
| 35450 | A | Repair arterial blockage | 10.07 | NA | 4.22 | 0.84 | NA | 15.13 | 000 | ||||||||||||
| 35452 | A | Repair arterial blockage | 6.91 | NA | 3.11 | 0.76 | NA | 10.78 | 000 | ||||||||||||
| 35454 | A | Repair arterial blockage | 6.04 | NA | 2.83 | 0.67 | NA | 9.54 | 000 | ||||||||||||
| 35456 | A | Repair arterial blockage | 7.35 | NA | 3.27 | 0.82 | NA | 11.44 | 000 | ||||||||||||
| 35458 | A | Repair arterial blockage | 9.49 | NA | 4.03 | 1.09 | NA | 14.61 | 000 | ||||||||||||
| 35459 | A | Repair arterial blockage | 8.63 | NA | 3.69 | 0.96 | NA | 13.28 | 000 | ||||||||||||
| 35460 | A | Repair venous blockage | 6.04 | NA | 2.70 | 0.66 | NA | 9.40 | 000 | ||||||||||||
| 35470 | A | Repair arterial blockage | 8.63 | NA | 3.98 | 0.50 | NA | 13.11 | 000 | ||||||||||||
| 35471 | A | Repair arterial blockage | 10.07 | NA | 4.67 | 0.50 | NA | 15.24 | 000 | ||||||||||||
| 35472 | A | Repair arterial blockage | 6.91 | NA | 3.32 | 0.39 | NA | 10.62 | 000 | ||||||||||||
| 35473 | A | Repair arterial blockage | 6.04 | NA | 3.01 | 0.34 | NA | 9.39 | 000 | ||||||||||||
| 35474 | A | Repair arterial blockage | 7.36 | NA | 3.52 | 0.40 | NA | 11.28 | 000 | ||||||||||||
| 35475 | R | Repair arterial blockage | 9.49 | NA | 4.23 | 0.47 | NA | 14.19 | 000 | ||||||||||||
| 35476 | A | Repair venous blockage | 6.04 | NA | 2.94 | 0.27 | NA | 9.25 | 000 | ||||||||||||
| 35480 | A | Atherectomy, open | 11.08 | NA | 4.58 | 1.13 | NA | 16.79 | 000 | ||||||||||||
| 35481 | A | Atherectomy, open | 7.61 | NA | 3.54 | 0.84 | NA | 11.99 | 000 | ||||||||||||
| 35482 | A | Atherectomy, open | 6.65 | NA | 3.16 | 0.75 | NA | 10.56 | 000 | ||||||||||||
| 35483 | A | Atherectomy, open | 8.10 | NA | 3.52 | 0.81 | NA | 12.43 | 000 | ||||||||||||
| 35484 | A | Atherectomy, open | 10.44 | NA | 4.21 | 1.13 | NA | 15.78 | 000 | ||||||||||||
| 35485 | A | Atherectomy, open | 9.49 | NA | 4.05 | 1.06 | NA | 14.60 | 000 | ||||||||||||
| 35490 | A | Atherectomy, percutaneous | 11.08 | NA | 4.83 | 0.55 | NA | 16.46 | 000 | ||||||||||||
| 35491 | A | Atherectomy, percutaneous | 7.61 | NA | 3.59 | 0.49 | NA | 11.69 | 000 | ||||||||||||
| 35492 | A | Atherectomy, percutaneous | 6.65 | NA | 3.22 | 0.43 | NA | 10.30 | 000 | ||||||||||||
| 35493 | A | Atherectomy, percutaneous | 8.10 | NA | 3.90 | 0.47 | NA | 12.47 | 000 | ||||||||||||
| 35494 | A | Atherectomy, percutaneous | 10.44 | NA | 4.57 | 0.48 | NA | 15.49 | 000 | ||||||||||||
| 35495 | A | Atherectomy, percutaneous | 9.49 | NA | 4.52 | 0.51 | NA | 14.52 | 000 | ||||||||||||
| 35500 | A | Harvest vein for bypass | 6.45 | NA | 2.25 | 0.63 | NA | 9.33 | ZZZ | ||||||||||||
| 35501 | A | Artery bypass graft | 19.19 | NA | 8.14 | 2.33 | NA | 29.66 | 090 | ||||||||||||
| 35506 | A | Artery bypass graft | 19.67 | NA | 8.32 | 2.33 | NA | 30.32 | 090 | ||||||||||||
| 35507 | A | Artery bypass graft | 19.67 | NA | 8.29 | 2.27 | NA | 30.23 | 090 | ||||||||||||
| 35508 | A | Artery bypass graft | 18.65 | NA | 7.91 | 2.34 | NA | 28.90 | 090 | ||||||||||||
| 35509 | A | Artery bypass graft | 18.07 | NA | 7.70 | 2.12 | NA | 27.89 | 090 | ||||||||||||
| 35511 | A | Artery bypass graft | 21.20 | NA | 8.80 | 1.74 | NA | 31.74 | 090 | ||||||||||||
| 35515 | A | Artery bypass graft | 18.65 | NA | 7.80 | 2.26 | NA | 28.71 | 090 | ||||||||||||
| 35516 | A | Artery bypass graft | 16.32 | NA | 4.94 | 1.88 | NA | 23.14 | 090 | ||||||||||||
| 35518 | A | Artery bypass graft | 21.20 | NA | 8.80 | 1.78 | NA | 31.78 | 090 | ||||||||||||
| 35521 | A | Artery bypass graft | 22.20 | NA | 9.53 | 1.82 | NA | 33.55 | 090 | ||||||||||||
| 35526 | A | Artery bypass graft | 29.95 | NA | 12.19 | 2.18 | NA | 44.32 | 090 | ||||||||||||
| 35531 | A | Artery bypass graft | 36.20 | NA | 14.53 | 2.91 | NA | 53.64 | 090 | ||||||||||||
| 35533 | A | Artery bypass graft | 28.00 | NA | 11.74 | 2.35 | NA | 42.09 | 090 | ||||||||||||
| 35536 | A | Artery bypass graft | 31.70 | NA | 12.85 | 2.62 | NA | 47.17 | 090 | ||||||||||||
| 35541 | A | Artery bypass graft | 25.80 | NA | 10.98 | 2.74 | NA | 39.52 | 090 | ||||||||||||
| 35546 | A | Artery bypass graft | 25.54 | NA | 10.75 | 2.84 | NA | 39.13 | 090 | ||||||||||||
| 35548 | A | Artery bypass graft | 21.57 | NA | 9.45 | 2.45 | NA | 33.47 | 090 | ||||||||||||
| 35549 | A | Artery bypass graft | 23.35 | NA | 9.88 | 2.77 | NA | 36.00 | 090 | ||||||||||||
| 35551 | A | Artery bypass graft | 26.67 | NA | 11.20 | 3.19 | NA | 41.06 | 090 | ||||||||||||
| 35556 | A | Artery bypass graft | 21.76 | NA | 9.45 | 2.48 | NA | 33.69 | 090 | ||||||||||||
| 35558 | A | Artery bypass graft | 21.20 | NA | 9.11 | 1.58 | NA | 31.89 | 090 | ||||||||||||
| 35560 | A | Artery bypass graft | 32.00 | NA | 13.12 | 2.73 | NA | 47.85 | 090 | ||||||||||||
| 35563 | A | Artery bypass graft | 24.20 | NA | 10.42 | 1.68 | NA | 36.30 | 090 | ||||||||||||
| 35565 | A | Artery bypass graft | 23.20 | NA | 9.99 | 1.71 | NA | 34.90 | 090 | ||||||||||||
| 35566 | A | Artery bypass graft | 26.92 | NA | 11.77 | 3.02 | NA | 41.71 | 090 | ||||||||||||
| 35571 | A | Artery bypass graft | 24.06 | NA | 12.13 | 2.14 | NA | 38.33 | 090 | ||||||||||||
| 35582 | A | Vein bypass graft | 27.13 | NA | 11.35 | 3.11 | NA | 41.59 | 090 | ||||||||||||
| 35583 | A | Vein bypass graft | 22.37 | NA | 10.62 | 2.53 | NA | 35.52 | 090 | ||||||||||||
| 35585 | A | Vein bypass graft | 28.39 | NA | 14.53 | 3.21 | NA | 46.13 | 090 | ||||||||||||
| 35587 | A | Vein bypass graft | 24.75 | NA | 12.79 | 2.17 | NA | 39.71 | 090 | ||||||||||||
| 35600 | A | Harvest artery for cabg | 4.95 | NA | 1.98 | 0.60 | NA | 7.53 | ZZZ | ||||||||||||
| 35601 | A | Artery bypass graft | 17.50 | NA | 7.49 | 2.08 | NA | 27.07 | 090 | ||||||||||||
| 35606 | A | Artery bypass graft | 18.71 | NA | 7.93 | 2.17 | NA | 28.81 | 090 | ||||||||||||
| 35612 | A | Artery bypass graft | 15.76 | NA | 6.70 | 1.72 | NA | 24.18 | 090 | ||||||||||||
| 35616 | A | Artery bypass graft | 15.70 | NA | 7.05 | 1.84 | NA | 24.59 | 090 | ||||||||||||
| 35621 | A | Artery bypass graft | 20.00 | NA | 8.79 | 1.68 | NA | 30.47 | 090 | ||||||||||||
| 35623 | A | Bypass graft, not vein | 24.00 | NA | 10.22 | 1.91 | NA | 36.13 | 090 | ||||||||||||
| 35626 | A | Artery bypass graft | 27.75 | NA | 11.08 | 2.89 | NA | 41.72 | 090 | ||||||||||||
| 35631 | A | Artery bypass graft | 34.00 | NA | 13.74 | 2.83 | NA | 50.57 | 090 | ||||||||||||
| 35636 | A | Artery bypass graft | 29.50 | NA | 12.26 | 2.37 | NA | 44.13 | 090 | ||||||||||||
| 35641 | A | Artery bypass graft | 24.57 | NA | 10.47 | 2.83 | NA | 37.87 | 090 | ||||||||||||
| 35642 | A | Artery bypass graft | 17.98 | NA | 7.92 | 1.84 | NA | 27.74 | 090 | ||||||||||||
| 35645 | A | Artery bypass graft | 17.47 | NA | 8.36 | 1.91 | NA | 27.74 | 090 | ||||||||||||
| 35646 | A | Artery bypass graft | 31.00 | NA | 13.26 | 2.98 | NA | 47.24 | 090 | ||||||||||||
| 35647 | A | Artery bypass graft | 28.00 | NA | 11.97 | 2.98 | NA | 42.95 | 090 | ||||||||||||
| 35650 | A | Artery bypass graft | 19.00 | NA | 7.93 | 1.64 | NA | 28.57 | 090 | ||||||||||||
| 35651 | A | Artery bypass graft | 25.04 | NA | 10.70 | 2.53 | NA | 38.27 | 090 | ||||||||||||
| 35654 | A | Artery bypass graft | 25.00 | NA | 10.60 | 2.10 | NA | 37.70 | 090 | ||||||||||||
| 35656 | A | Artery bypass graft | 19.53 | NA | 8.44 | 2.21 | NA | 30.18 | 090 | ||||||||||||
| 35661 | A | Artery bypass graft | 19.00 | NA | 8.26 | 1.50 | NA | 28.76 | 090 | ||||||||||||
| 35663 | A | Artery bypass graft | 22.00 | NA | 9.65 | 1.55 | NA | 33.20 | 090 | ||||||||||||
| 35665 | A | Artery bypass graft | 21.00 | NA | 9.18 | 1.76 | NA | 31.94 | 090 | ||||||||||||
| 35666 | A | Artery bypass graft | 22.19 | NA | 11.93 | 2.19 | NA | 36.31 | 090 | ||||||||||||
| 35671 | A | Artery bypass graft | 19.33 | NA | 10.53 | 1.68 | NA | 31.54 | 090 | ||||||||||||
| 35681 | A | Composite bypass graft | 1.60 | NA | 0.56 | 0.18 | NA | 2.34 | ZZZ | ||||||||||||
| 35682 | A | Composite bypass graft | 7.20 | NA | 2.51 | 0.83 | NA | 10.54 | ZZZ | ||||||||||||
| 35683 | A | Composite bypass graft | 8.50 | NA | 2.99 | 0.98 | NA | 12.47 | ZZZ | ||||||||||||
| 35685 | A | Bypass graft patency/patch | 4.05 | NA | 1.50 | 0.41 | NA | 5.96 | ZZZ | ||||||||||||
| 35686 | A | Bypass graft/av fist patency | 3.35 | NA | 1.24 | 0.34 | NA | 4.93 | ZZZ | ||||||||||||
| 35691 | A | Arterial transposition | 18.05 | NA | 7.65 | 2.06 | NA | 27.76 | 090 | ||||||||||||
| 35693 | A | Arterial transposition | 15.36 | NA | 6.66 | 1.80 | NA | 23.82 | 090 | ||||||||||||
| 35694 | A | Arterial transposition | 19.16 | NA | 8.02 | 2.13 | NA | 29.31 | 090 | ||||||||||||
| 35695 | A | Arterial transposition | 19.16 | NA | 7.92 | 2.19 | NA | 29.27 | 090 | ||||||||||||
| 35700 | A | Reoperation, bypass graft | 3.08 | NA | 1.07 | 0.36 | NA | 4.51 | ZZZ | ||||||||||||
| 35701 | A | Exploration, carotid artery | 8.50 | NA | 4.70 | 0.64 | NA | 13.84 | 090 | ||||||||||||
| 35721 | A | Exploration, femoral artery | 7.18 | NA | 5.10 | 0.59 | NA | 12.87 | 090 | ||||||||||||
| 35741 | A | Exploration popliteal artery | 8.00 | NA | 5.47 | 0.60 | NA | 14.07 | 090 | ||||||||||||
| 35761 | A | Exploration of artery/vein | 5.37 | NA | 4.47 | 0.60 | NA | 10.44 | 090 | ||||||||||||
| 35800 | A | Explore neck vessels | 7.02 | NA | 3.95 | 0.79 | NA | 11.76 | 090 | ||||||||||||
| 35820 | A | Explore chest vessels | 12.88 | NA | 4.32 | 1.61 | NA | 18.81 | 090 | ||||||||||||
| 35840 | A | Explore abdominal vessels | 9.77 | NA | 5.21 | 1.06 | NA | 16.04 | 090 | ||||||||||||
| 35860 | A | Explore limb vessels | 5.55 | NA | 3.62 | 0.63 | NA | 9.80 | 090 | ||||||||||||
| 35870 | A | Repair vessel graft defect | 22.17 | NA | 10.21 | 2.47 | NA | 34.85 | 090 | ||||||||||||
| 35875 | A | Removal of clot in graft | 10.13 | NA | 6.63 | 0.97 | NA | 17.73 | 090 | ||||||||||||
| 35876 | A | Removal of clot in graft | 17.00 | NA | 9.16 | 1.88 | NA | 28.04 | 090 | ||||||||||||
| 35879 | A | Revise graft w/vein | 16.00 | NA | 7.77 | 1.35 | NA | 25.12 | 090 | ||||||||||||
| 35881 | A | Revise graft w/vein | 18.00 | NA | 8.65 | 1.44 | NA | 28.09 | 090 | ||||||||||||
| 35901 | A | Excision, graft, neck | 8.19 | NA | 5.85 | 0.90 | NA | 14.94 | 090 | ||||||||||||
| 35903 | A | Excision, graft, extremity | 9.39 | NA | 8.20 | 1.03 | NA | 18.62 | 090 | ||||||||||||
| 35905 | A | Excision, graft, thorax | 31.25 | NA | 15.39 | 2.15 | NA | 48.79 | 090 | ||||||||||||
| 35907 | A | Excision, graft, abdomen | 35.00 | NA | 14.97 | 2.17 | NA | 52.14 | 090 | ||||||||||||
| 36000 | A | Place needle in vein | 0.18 | 0.65 | 0.05 | 0.01 | 0.84 | 0.24 | XXX | ||||||||||||
| 36002 | A | Pseudoaneurysm injection trt | 1.96 | 2.95 | 1.03 | 0.08 | 4.99 | 3.07 | 000 | ||||||||||||
| 36005 | A | Injection ext venography | 0.95 | 7.29 | 0.34 | 0.04 | 8.28 | 1.33 | 000 | ||||||||||||
| 36010 | A | Place catheter in vein | 2.43 | NA | 0.84 | 0.16 | NA | 3.43 | XXX | ||||||||||||
| 36011 | A | Place catheter in vein | 3.14 | NA | 1.10 | 0.17 | NA | 4.41 | XXX | ||||||||||||
| 36012 | A | Place catheter in vein | 3.52 | NA | 1.23 | 0.17 | NA | 4.92 | XXX | ||||||||||||
| 36013 | A | Place catheter in artery | 2.52 | NA | 0.61 | 0.17 | NA | 3.30 | XXX | ||||||||||||
| 36014 | A | Place catheter in artery | 3.02 | NA | 1.06 | 0.14 | NA | 4.22 | XXX | ||||||||||||
| 36015 | A | Place catheter in artery | 3.52 | NA | 1.24 | 0.16 | NA | 4.92 | XXX | ||||||||||||
| 36100 | A | Establish access to artery | 3.02 | NA | 1.16 | 0.18 | NA | 4.36 | XXX | ||||||||||||
| 36120 | A | Establish access to artery | 2.01 | NA | 0.69 | 0.11 | NA | 2.81 | XXX | ||||||||||||
| 36140 | A | Establish access to artery | 2.01 | NA | 0.69 | 0.12 | NA | 2.82 | XXX | ||||||||||||
| 36145 | A | Artery to vein shunt | 2.01 | NA | 0.70 | 0.10 | NA | 2.81 | XXX | ||||||||||||
| 36160 | A | Establish access to aorta | 2.52 | NA | 0.90 | 0.20 | NA | 3.62 | XXX | ||||||||||||
| 36200 | A | Place catheter in aorta | 3.02 | NA | 1.09 | 0.15 | NA | 4.26 | XXX | ||||||||||||
| 36215 | A | Place catheter in artery | 4.68 | NA | 1.68 | 0.22 | NA | 6.58 | XXX | ||||||||||||
| 36216 | A | Place catheter in artery | 5.28 | NA | 1.89 | 0.24 | NA | 7.41 | XXX | ||||||||||||
| 36217 | A | Place catheter in artery | 6.30 | NA | 2.29 | 0.32 | NA | 8.91 | XXX | ||||||||||||
| 36218 | A | Place catheter in artery | 1.01 | NA | 0.37 | 0.05 | NA | 1.43 | ZZZ | ||||||||||||
| 36245 | A | Place catheter in artery | 4.68 | NA | 1.78 | 0.23 | NA | 6.69 | XXX | ||||||||||||
| 36246 | A | Place catheter in artery | 5.28 | NA | 1.91 | 0.26 | NA | 7.45 | XXX | ||||||||||||
| 36247 | A | Place catheter in artery | 6.30 | NA | 2.25 | 0.32 | NA | 8.87 | XXX | ||||||||||||
| 36248 | A | Place catheter in artery | 1.01 | NA | 0.37 | 0.06 | NA | 1.44 | ZZZ | ||||||||||||
| 36260 | A | Insertion of infusion pump | 9.71 | NA | 5.63 | 1.00 | NA | 16.34 | 090 | ||||||||||||
| 36261 | A | Revision of infusion pump | 5.45 | NA | 3.47 | 0.50 | NA | 9.42 | 090 | ||||||||||||
| 36262 | A | Removal of infusion pump | 4.02 | NA | 2.59 | 0.43 | NA | 7.04 | 090 | ||||||||||||
| 36299 | C | Vessel injection procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 36400 | A | Drawing blood | 0.38 | 0.72 | 0.10 | 0.01 | 1.11 | 0.49 | XXX | ||||||||||||
| 36405 | A | Drawing blood | 0.31 | 0.58 | 0.09 | 0.01 | 0.90 | 0.41 | XXX | ||||||||||||
| 36406 | A | Drawing blood | 0.18 | 0.94 | 0.06 | 0.01 | 1.13 | 0.25 | XXX | ||||||||||||
| 36410 | A | Drawing blood | 0.18 | 0.50 | 0.05 | 0.01 | 0.69 | 0.24 | XXX | ||||||||||||
| 36415 | I | Drawing blood | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 36420 | A | Establish access to vein | 1.01 | NA | 0.33 | 0.09 | NA | 1.43 | XXX | ||||||||||||
| 36425 | A | Establish access to vein | 0.76 | 3.44 | 0.17 | 0.05 | 4.25 | 0.98 | XXX | ||||||||||||
| 36430 | A | Blood transfusion service | 0.00 | 0.95 | NA | 0.05 | 1.00 | NA | XXX | ||||||||||||
| 36440 | A | Blood transfusion service | 1.03 | NA | 0.31 | 0.08 | NA | 1.42 | XXX | ||||||||||||
| 36450 | A | Exchange transfusion service | 2.23 | NA | 0.71 | 0.16 | NA | 3.10 | XXX | ||||||||||||
| 36455 | A | Exchange transfusion service | 2.43 | NA | 0.97 | 0.10 | NA | 3.50 | XXX | ||||||||||||
| 36460 | A | Transfusion service, fetal | 6.59 | NA | 2.55 | 0.56 | NA | 9.70 | XXX | ||||||||||||
| 36468 | R | Injection(s), spider veins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 36469 | R | Injection(s), spider veins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 36470 | A | Injection therapy of vein | 1.09 | 2.60 | 0.40 | 0.10 | 3.79 | 1.59 | 010 | ||||||||||||
| 36471 | A | Injection therapy of veins | 1.57 | 2.65 | 0.58 | 0.15 | 4.37 | 2.30 | 010 | ||||||||||||
| 36481 | A | Insertion of catheter, vein | 6.99 | NA | 2.86 | 0.40 | NA | 10.25 | 000 | ||||||||||||
| 36488 | A | Insertion of catheter, vein | 1.35 | NA | 0.76 | 0.09 | NA | 2.20 | 000 | ||||||||||||
| 36489 | A | Insertion of catheter, vein | 2.50 | 4.70 | 1.08 | 0.08 | 7.28 | 3.66 | 000 | ||||||||||||
| 36490 | A | Insertion of catheter, vein | 1.67 | NA | 0.86 | 0.17 | NA | 2.70 | 000 | ||||||||||||
| 36491 | A | Insertion of catheter, vein | 1.43 | NA | 0.75 | 0.13 | NA | 2.31 | 000 | ||||||||||||
| 36493 | A | Repositioning of cvc | 1.21 | NA | 0.88 | 0.06 | NA | 2.15 | 000 | ||||||||||||
| 36500 | A | Insertion of catheter, vein | 3.52 | NA | 1.31 | 0.14 | NA | 4.97 | 000 | ||||||||||||
| 36510 | A | Insertion of catheter, vein | 1.09 | NA | 0.73 | 0.06 | NA | 1.88 | 000 | ||||||||||||
| 36520 | A | Plasma and/or cell exchange | 1.74 | NA | 1.07 | 0.06 | NA | 2.87 | 000 | ||||||||||||
| 36521 | A | Apheresis w/ adsorp/reinfuse | 1.74 | NA | 1.07 | 0.06 | NA | 2.87 | 000 | ||||||||||||
| 36522 | A | Photopheresis | 1.67 | 6.03 | 1.16 | 0.07 | 7.77 | 2.90 | 000 | ||||||||||||
| 36530 | R | Insertion of infusion pump | 6.20 | NA | 4.17 | 0.56 | NA | 10.93 | 010 | ||||||||||||
| 36531 | R | Revision of infusion pump | 4.87 | NA | 3.32 | 0.44 | NA | 8.63 | 010 | ||||||||||||
| 36532 | R | Removal of infusion pump | 3.30 | NA | 1.57 | 0.34 | NA | 5.21 | 010 | ||||||||||||
| 36533 | A | Insertion of access device | 5.32 | 4.67 | 3.50 | 0.49 | 10.48 | 9.31 | 010 | ||||||||||||
| 36534 | A | Revision of access device | 2.80 | NA | 1.55 | 0.19 | NA | 4.54 | 010 | ||||||||||||
| 36535 | A | Removal of access device | 2.27 | 2.95 | 1.89 | 0.21 | 5.43 | 4.37 | 010 | ||||||||||||
| 36540 | B | Collect blood venous device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 36550 | A | Declot vascular device | 0.00 | 0.38 | NA | 0.31 | 0.69 | NA | XXX | ||||||||||||
| 36600 | A | Withdrawal of arterial blood | 0.32 | 0.43 | 0.09 | 0.02 | 0.77 | 0.43 | XXX | ||||||||||||
| 36620 | A | Insertion catheter, artery | 1.15 | NA | 0.25 | 0.06 | NA | 1.46 | 000 | ||||||||||||
| 36625 | A | Insertion catheter, artery | 2.11 | NA | 0.61 | 0.16 | NA | 2.88 | 000 | ||||||||||||
| 36640 | A | Insertion catheter, artery | 2.10 | NA | 0.75 | 0.18 | NA | 3.03 | 000 | ||||||||||||
| 36660 | A | Insertion catheter, artery | 1.40 | NA | 0.38 | 0.08 | NA | 1.86 | 000 | ||||||||||||
| 36680 | A | Insert needle, bone cavity | 1.20 | NA | 0.66 | 0.08 | NA | 1.94 | 000 | ||||||||||||
| 36800 | A | Insertion of cannula | 2.43 | NA | 1.59 | 0.17 | NA | 4.19 | 000 | ||||||||||||
| 36810 | A | Insertion of cannula | 3.97 | NA | 2.22 | 0.40 | NA | 6.59 | 000 | ||||||||||||
| 36815 | A | Insertion of cannula | 2.62 | NA | 1.28 | 0.26 | NA | 4.16 | 000 | ||||||||||||
| 36819 | A | Av fusion/uppr arm vein | 14.00 | NA | 6.56 | 1.53 | NA | 22.09 | 090 | ||||||||||||
| 36820 | A | Av fusion/forearm vein | 14.00 | NA | 6.56 | 1.53 | NA | 22.09 | 090 | ||||||||||||
| 36821 | A | Av fusion direct any site | 8.93 | NA | 5.03 | 0.97 | NA | 14.93 | 090 | ||||||||||||
| 36822 | A | Insertion of cannula(s) | 5.42 | NA | 6.81 | 0.63 | NA | 12.86 | 090 | ||||||||||||
| 36823 | A | Insertion of cannula(s) | 21.00 | NA | 10.63 | 2.18 | NA | 33.81 | 090 | ||||||||||||
| 36825 | A | Artery-vein graft | 9.84 | NA | 5.58 | 1.09 | NA | 16.51 | 090 | ||||||||||||
| 36830 | A | Artery-vein graft | 12.00 | NA | 6.14 | 1.32 | NA | 19.46 | 090 | ||||||||||||
| 36831 | A | Open thrombect av fistula | 8.00 | NA | 3.99 | 0.79 | NA | 12.78 | 090 | ||||||||||||
| 36832 | A | Av fistula revision, open | 10.50 | NA | 5.59 | 1.13 | NA | 17.22 | 090 | ||||||||||||
| 36833 | A | Av fistula revision | 11.95 | NA | 6.11 | 1.29 | NA | 19.35 | 090 | ||||||||||||
| 36834 | A | Repair A-V aneurysm | 9.93 | NA | 3.93 | 1.06 | NA | 14.92 | 090 | ||||||||||||
| 36835 | A | Artery to vein shunt | 7.15 | NA | 4.50 | 0.80 | NA | 12.45 | 090 | ||||||||||||
| 36860 | A | External cannula declotting | 2.01 | 2.52 | 1.33 | 0.10 | 4.63 | 3.44 | 000 | ||||||||||||
| 36861 | A | Cannula declotting | 2.52 | NA | 1.50 | 0.14 | NA | 4.16 | 000 | ||||||||||||
| 36870 | A | Percut thrombect av fistula | 5.16 | 41.63 | 2.45 | 0.23 | 47.02 | 7.84 | 090 | ||||||||||||
| 37140 | A | Revision of circulation | 23.60 | NA | 10.56 | 1.21 | NA | 35.37 | 090 | ||||||||||||
| 37145 | A | Revision of circulation | 24.61 | NA | 12.97 | 2.48 | NA | 40.06 | 090 | ||||||||||||
| 37160 | A | Revision of circulation | 21.60 | NA | 9.43 | 2.16 | NA | 33.19 | 090 | ||||||||||||
| 37180 | A | Revision of circulation | 24.61 | NA | 10.66 | 2.63 | NA | 37.90 | 090 | ||||||||||||
| 37181 | A | Splice spleen/kidney veins | 26.68 | NA | 11.02 | 2.67 | NA | 40.37 | 090 | ||||||||||||
| 37195 | A | Thrombolytic therapy, stroke | 0.00 | 7.65 | NA | 0.38 | 8.03 | NA | XXX | ||||||||||||
| 37200 | A | Transcatheter biopsy | 4.56 | NA | 1.60 | 0.19 | NA | 6.35 | 000 | ||||||||||||
| 37201 | A | Transcatheter therapy infuse | 5.00 | NA | 2.59 | 0.24 | NA | 7.83 | 000 | ||||||||||||
| 37202 | A | Transcatheter therapy infuse | 5.68 | NA | 3.33 | 0.38 | NA | 9.39 | 000 | ||||||||||||
| 37203 | A | Transcatheter retrieval | 5.03 | NA | 2.62 | 0.23 | NA | 7.88 | 000 | ||||||||||||
| 37204 | A | Transcatheter occlusion | 18.14 | NA | 6.36 | 0.85 | NA | 25.35 | 000 | ||||||||||||
| 37205 | A | Transcatheter stent | 8.28 | NA | 3.90 | 0.43 | NA | 12.61 | 000 | ||||||||||||
| 37206 | A | Transcatheter stent add-on | 4.13 | NA | 1.54 | 0.22 | NA | 5.89 | ZZZ | ||||||||||||
| 37207 | A | Transcatheter stent | 8.28 | NA | 3.61 | 0.89 | NA | 12.78 | 000 | ||||||||||||
| 37208 | A | Transcatheter stent add-on | 4.13 | NA | 1.45 | 0.44 | NA | 6.02 | ZZZ | ||||||||||||
| 37209 | A | Exchange arterial catheter | 2.27 | NA | 0.80 | 0.11 | NA | 3.18 | 000 | ||||||||||||
| 37250 | A | Iv us first vessel add-on | 2.10 | NA | 0.79 | 0.17 | NA | 3.06 | ZZZ | ||||||||||||
| 37251 | A | Iv us each add vessel add-on | 1.60 | NA | 0.58 | 0.14 | NA | 2.32 | ZZZ | ||||||||||||
| 37565 | A | Ligation of neck vein | 10.88 | NA | 5.34 | 0.45 | NA | 16.67 | 090 | ||||||||||||
| 37600 | A | Ligation of neck artery | 11.25 | NA | 6.51 | 0.40 | NA | 18.16 | 090 | ||||||||||||
| 37605 | A | Ligation of neck artery | 13.11 | NA | 6.63 | 0.77 | NA | 20.51 | 090 | ||||||||||||
| 37606 | A | Ligation of neck artery | 6.28 | NA | 3.85 | 0.79 | NA | 10.92 | 090 | ||||||||||||
| 37607 | A | Ligation of a-v fistula | 6.16 | NA | 3.71 | 0.67 | NA | 10.54 | 090 | ||||||||||||
| 37609 | A | Temporal artery procedure | 3.00 | 7.25 | 2.58 | 0.21 | 10.46 | 5.79 | 010 | ||||||||||||
| 37615 | A | Ligation of neck artery | 5.73 | NA | 3.61 | 0.57 | NA | 9.91 | 090 | ||||||||||||
| 37616 | A | Ligation of chest artery | 16.49 | NA | 10.54 | 1.93 | NA | 28.96 | 090 | ||||||||||||
| 37617 | A | Ligation of abdomen artery | 22.06 | NA | 9.81 | 1.69 | NA | 33.56 | 090 | ||||||||||||
| 37618 | A | Ligation of extremity artery | 4.84 | NA | 3.56 | 0.54 | NA | 8.94 | 090 | ||||||||||||
| 37620 | A | Revision of major vein | 10.56 | NA | 5.53 | 0.75 | NA | 16.84 | 090 | ||||||||||||
| 37650 | A | Revision of major vein | 7.80 | NA | 4.64 | 0.56 | NA | 13.00 | 090 | ||||||||||||
| 37660 | A | Revision of major vein | 21.00 | NA | 9.44 | 1.17 | NA | 31.61 | 090 | ||||||||||||
| 37700 | A | Revise leg vein | 3.73 | NA | 3.20 | 0.40 | NA | 7.33 | 090 | ||||||||||||
| 37720 | A | Removal of leg vein | 5.66 | NA | 3.72 | 0.61 | NA | 9.99 | 090 | ||||||||||||
| 37730 | A | Removal of leg veins | 7.33 | NA | 4.59 | 0.77 | NA | 12.69 | 090 | ||||||||||||
| 37735 | A | Removal of leg veins/lesion | 10.53 | NA | 5.94 | 1.17 | NA | 17.64 | 090 | ||||||||||||
| 37760 | A | Revision of leg veins | 10.47 | NA | 5.78 | 1.11 | NA | 17.36 | 090 | ||||||||||||
| 37780 | A | Revision of leg vein | 3.84 | NA | 2.89 | 0.41 | NA | 7.14 | 090 | ||||||||||||
| 37785 | A | Revise secondary varicosity | 3.84 | 7.18 | 2.91 | 0.41 | 11.43 | 7.16 | 090 | ||||||||||||
| 37788 | A | Revascularization, penis | 22.01 | NA | 14.08 | 1.35 | NA | 37.44 | 090 | ||||||||||||
| 37790 | A | Penile venous occlusion | 8.34 | NA | 6.78 | 0.63 | NA | 15.75 | 090 | ||||||||||||
| 37799 | C | Vascular surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 38100 | A | Removal of spleen, total | 14.50 | NA | 6.73 | 1.30 | NA | 22.53 | 090 | ||||||||||||
| 38101 | A | Removal of spleen, partial | 15.31 | NA | 7.27 | 1.38 | NA | 23.96 | 090 | ||||||||||||
| 38102 | A | Removal of spleen, total | 4.80 | NA | 1.73 | 0.49 | NA | 7.02 | ZZZ | ||||||||||||
| 38115 | A | Repair of ruptured spleen | 15.82 | NA | 7.23 | 1.40 | NA | 24.45 | 090 | ||||||||||||
| 38120 | A | Laparoscopy, splenectomy | 17.00 | NA | 7.58 | 1.73 | NA | 26.31 | 090 | ||||||||||||
| 38129 | C | Laparoscope proc, spleen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 38200 | A | Injection for spleen x-ray | 2.64 | NA | 0.93 | 0.12 | NA | 3.69 | 000 | ||||||||||||
| 38220 | A | Bone marrow aspiration | 1.08 | 4.64 | 0.44 | 0.03 | 5.75 | 1.55 | XXX | ||||||||||||
| 38221 | A | Bone marrow biopsy | 1.37 | 4.74 | 0.56 | 0.04 | 6.15 | 1.97 | XXX | ||||||||||||
| 38230 | R | Bone marrow collection | 4.54 | NA | 2.45 | 0.25 | NA | 7.24 | 010 | ||||||||||||
| 38231 | R | Stem cell collection | 1.50 | NA | 0.61 | 0.05 | NA | 2.16 | 000 | ||||||||||||
| 38240 | R | Bone marrow/stem transplant | 2.24 | NA | 0.88 | 0.08 | NA | 3.20 | XXX | ||||||||||||
| 38241 | R | Bone marrow/stem transplant | 2.24 | NA | 0.86 | 0.08 | NA | 3.18 | XXX | ||||||||||||
| 38300 | A | Drainage, lymph node lesion | 1.99 | 4.88 | 2.65 | 0.15 | 7.02 | 4.79 | 010 | ||||||||||||
| 38305 | A | Drainage, lymph node lesion | 6.00 | 7.99 | 6.41 | 0.36 | 14.35 | 12.77 | 090 | ||||||||||||
| 38308 | A | Incision of lymph channels | 6.45 | NA | 5.40 | 0.51 | NA | 12.36 | 090 | ||||||||||||
| 38380 | A | Thoracic duct procedure | 7.46 | NA | 7.61 | 0.68 | NA | 15.75 | 090 | ||||||||||||
| 38381 | A | Thoracic duct procedure | 12.88 | NA | 9.72 | 1.58 | NA | 24.18 | 090 | ||||||||||||
| 38382 | A | Thoracic duct procedure | 10.08 | NA | 8.81 | 1.08 | NA | 19.97 | 090 | ||||||||||||
| 38500 | A | Biopsy/removal, lymph nodes | 3.75 | 3.15 | 2.63 | 0.28 | 7.18 | 6.66 | 010 | ||||||||||||
| 38505 | A | Needle biopsy, lymph nodes | 1.14 | 3.21 | 1.13 | 0.09 | 4.44 | 2.36 | 000 | ||||||||||||
| 38510 | A | Biopsy/removal, lymph nodes | 6.43 | NA | 5.55 | 0.38 | NA | 12.36 | 010 | ||||||||||||
| 38520 | A | Biopsy/removal, lymph nodes | 6.67 | NA | 5.67 | 0.52 | NA | 12.86 | 090 | ||||||||||||
| 38525 | A | Biopsy/removal, lymph nodes | 6.07 | NA | 4.51 | 0.48 | NA | 11.06 | 090 | ||||||||||||
| 38530 | A | Biopsy/removal, lymph nodes | 7.98 | NA | 5.78 | 0.63 | NA | 14.39 | 090 | ||||||||||||
| 38542 | A | Explore deep node(s), neck | 5.91 | NA | 6.09 | 0.50 | NA | 12.50 | 090 | ||||||||||||
| 38550 | A | Removal, neck/armpit lesion | 6.92 | NA | 5.01 | 0.69 | NA | 12.62 | 090 | ||||||||||||
| 38555 | A | Removal, neck/armpit lesion | 14.14 | NA | 9.47 | 1.46 | NA | 25.07 | 090 | ||||||||||||
| 38562 | A | Removal, pelvic lymph nodes | 10.49 | NA | 6.79 | 0.97 | NA | 18.25 | 090 | ||||||||||||
| 38564 | A | Removal, abdomen lymph nodes | 10.83 | NA | 6.54 | 1.06 | NA | 18.43 | 090 | ||||||||||||
| 38570 | A | Laparoscopy, lymph node biop | 9.25 | NA | 4.63 | 0.89 | NA | 14.77 | 010 | ||||||||||||
| 38571 | A | Laparoscopy, lymphadenectomy | 14.68 | NA | 6.50 | 0.80 | NA | 21.98 | 010 | ||||||||||||
| 38572 | A | Laparoscopy, lymphadenectomy | 16.59 | NA | 7.71 | 1.32 | NA | 25.62 | 010 | ||||||||||||
| 38589 | C | Laparoscope proc, lymphatic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 38700 | A | Removal of lymph nodes, neck | 8.24 | NA | 13.61 | 0.60 | NA | 22.45 | 090 | ||||||||||||
| 38720 | A | Removal of lymph nodes, neck | 13.61 | NA | 16.25 | 1.03 | NA | 30.89 | 090 | ||||||||||||
| 38724 | A | Removal of lymph nodes, neck | 14.54 | NA | 16.82 | 1.10 | NA | 32.46 | 090 | ||||||||||||
| 38740 | A | Remove armpit lymph nodes | 10.03 | NA | 5.89 | 0.69 | NA | 16.61 | 090 | ||||||||||||
| 38745 | A | Remove armpit lymph nodes | 13.10 | NA | 8.47 | 0.90 | NA | 22.47 | 090 | ||||||||||||
| 38746 | A | Remove thoracic lymph nodes | 4.89 | NA | 1.65 | 0.55 | NA | 7.09 | ZZZ | ||||||||||||
| 38747 | A | Remove abdominal lymph nodes | 4.89 | NA | 1.75 | 0.50 | NA | 7.14 | ZZZ | ||||||||||||
| 38760 | A | Remove groin lymph nodes | 12.95 | NA | 7.36 | 0.88 | NA | 21.19 | 090 | ||||||||||||
| 38765 | A | Remove groin lymph nodes | 19.98 | NA | 11.57 | 1.50 | NA | 33.05 | 090 | ||||||||||||
| 38770 | A | Remove pelvis lymph nodes | 13.23 | NA | 7.18 | 0.94 | NA | 21.35 | 090 | ||||||||||||
| 38780 | A | Remove abdomen lymph nodes | 16.59 | NA | 9.67 | 1.60 | NA | 27.86 | 090 | ||||||||||||
| 38790 | A | Inject for lymphatic x-ray | 1.29 | 14.77 | 0.46 | 0.09 | 16.15 | 1.84 | 000 | ||||||||||||
| 38792 | A | Identify sentinel node | 0.52 | NA | 0.19 | 0.04 | NA | 0.75 | 000 | ||||||||||||
| 38794 | A | Access thoracic lymph duct | 4.45 | NA | 1.57 | 0.17 | NA | 6.19 | 090 | ||||||||||||
| 38999 | C | Blood/lymph system procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 39000 | A | Exploration of chest | 6.10 | NA | 7.41 | 0.73 | NA | 14.24 | 090 | ||||||||||||
| 39010 | A | Exploration of chest | 11.79 | NA | 9.31 | 1.46 | NA | 22.56 | 090 | ||||||||||||
| 39200 | A | Removal chest lesion | 13.62 | NA | 10.10 | 1.65 | NA | 25.37 | 090 | ||||||||||||
| 39220 | A | Removal chest lesion | 17.42 | NA | 11.29 | 2.10 | NA | 30.81 | 090 | ||||||||||||
| 39400 | A | Visualization of chest | 5.61 | NA | 7.01 | 0.69 | NA | 13.31 | 010 | ||||||||||||
| 39499 | C | Chest procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 39501 | A | Repair diaphragm laceration | 13.19 | NA | 7.82 | 1.38 | NA | 22.39 | 090 | ||||||||||||
| 39502 | A | Repair paraesophageal hernia | 16.33 | NA | 8.41 | 1.68 | NA | 26.42 | 090 | ||||||||||||
| 39503 | A | Repair of diaphragm hernia | 95.00 | NA | 37.24 | 3.52 | NA | 135.76 | 090 | ||||||||||||
| 39520 | A | Repair of diaphragm hernia | 16.10 | NA | 9.59 | 1.83 | NA | 27.52 | 090 | ||||||||||||
| 39530 | A | Repair of diaphragm hernia | 15.41 | NA | 8.69 | 1.66 | NA | 25.76 | 090 | ||||||||||||
| 39531 | A | Repair of diaphragm hernia | 16.42 | NA | 8.45 | 1.83 | NA | 26.70 | 090 | ||||||||||||
| 39540 | A | Repair of diaphragm hernia | 13.32 | NA | 7.79 | 1.38 | NA | 22.49 | 090 | ||||||||||||
| 39541 | A | Repair of diaphragm hernia | 14.41 | NA | 7.97 | 1.52 | NA | 23.90 | 090 | ||||||||||||
| 39545 | A | Revision of diaphragm | 13.37 | NA | 9.32 | 1.55 | NA | 24.24 | 090 | ||||||||||||
| 39560 | A | Resect diaphragm, simple | 12.00 | NA | 7.62 | 1.35 | NA | 20.97 | 090 | ||||||||||||
| 39561 | A | Resect diaphragm, complex | 17.50 | NA | 9.84 | 1.97 | NA | 29.31 | 090 | ||||||||||||
| 39599 | C | Diaphragm surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 40490 | A | Biopsy of lip | 1.22 | 1.63 | 0.63 | 0.06 | 2.91 | 1.91 | 000 | ||||||||||||
| 40500 | A | Partial excision of lip | 4.28 | 5.72 | 5.72 | 0.31 | 10.31 | 10.31 | 090 | ||||||||||||
| 40510 | A | Partial excision of lip | 4.70 | 6.75 | 6.52 | 0.38 | 11.83 | 11.60 | 090 | ||||||||||||
| 40520 | A | Partial excision of lip | 4.67 | 7.97 | 7.15 | 0.42 | 13.06 | 12.24 | 090 | ||||||||||||
| 40525 | A | Reconstruct lip with flap | 7.55 | NA | 8.84 | 0.68 | NA | 17.07 | 090 | ||||||||||||
| 40527 | A | Reconstruct lip with flap | 9.13 | NA | 9.60 | 0.82 | NA | 19.55 | 090 | ||||||||||||
| 40530 | A | Partial removal of lip | 5.40 | 7.35 | 6.56 | 0.47 | 13.22 | 12.43 | 090 | ||||||||||||
| 40650 | A | Repair lip | 3.64 | 5.78 | 5.18 | 0.31 | 9.73 | 9.13 | 090 | ||||||||||||
| 40652 | A | Repair lip | 4.26 | 7.08 | 7.04 | 0.39 | 11.73 | 11.69 | 090 | ||||||||||||
| 40654 | A | Repair lip | 5.31 | 7.95 | 7.95 | 0.48 | 13.74 | 13.74 | 090 | ||||||||||||
| 40700 | A | Repair cleft lip/nasal | 12.79 | NA | 10.88 | 0.93 | NA | 24.60 | 090 | ||||||||||||
| 40701 | A | Repair cleft lip/nasal | 15.85 | NA | 14.66 | 1.36 | NA | 31.87 | 090 | ||||||||||||
| 40702 | A | Repair cleft lip/nasal | 13.04 | NA | 8.99 | 1.01 | NA | 23.04 | 090 | ||||||||||||
| 40720 | A | Repair cleft lip/nasal | 13.55 | NA | 12.89 | 1.31 | NA | 27.75 | 090 | ||||||||||||
| 40761 | A | Repair cleft lip/nasal | 14.72 | NA | 12.76 | 1.41 | NA | 28.89 | 090 | ||||||||||||
| 40799 | C | Lip surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 40800 | A | Drainage of mouth lesion | 1.17 | 2.01 | 0.48 | 0.09 | 3.27 | 1.74 | 010 | ||||||||||||
| 40801 | A | Drainage of mouth lesion | 2.53 | 2.52 | 1.98 | 0.18 | 5.23 | 4.69 | 010 | ||||||||||||
| 40804 | A | Removal, foreign body, mouth | 1.24 | 2.59 | 2.03 | 0.09 | 3.92 | 3.36 | 010 | ||||||||||||
| 40805 | A | Removal, foreign body, mouth | 2.69 | 3.27 | 2.85 | 0.17 | 6.13 | 5.71 | 010 | ||||||||||||
| 40806 | A | Incision of lip fold | 0.31 | 0.89 | 0.89 | 0.02 | 1.22 | 1.22 | 000 | ||||||||||||
| 40808 | A | Biopsy of mouth lesion | 0.96 | 2.11 | 2.11 | 0.07 | 3.14 | 3.14 | 010 | ||||||||||||
| 40810 | A | Excision of mouth lesion | 1.31 | 2.70 | 2.47 | 0.09 | 4.10 | 3.87 | 010 | ||||||||||||
| 40812 | A | Excise/repair mouth lesion | 2.31 | 2.95 | 2.93 | 0.17 | 5.43 | 5.41 | 010 | ||||||||||||
| 40814 | A | Excise/repair mouth lesion | 3.42 | 4.08 | 4.08 | 0.26 | 7.76 | 7.76 | 090 | ||||||||||||
| 40816 | A | Excision of mouth lesion | 3.67 | 4.32 | 4.32 | 0.27 | 8.26 | 8.26 | 090 | ||||||||||||
| 40818 | A | Excise oral mucosa for graft | 2.41 | 4.05 | 4.05 | 0.14 | 6.60 | 6.60 | 090 | ||||||||||||
| 40819 | A | Excise lip or cheek fold | 2.41 | 3.67 | 3.48 | 0.17 | 6.25 | 6.06 | 090 | ||||||||||||
| 40820 | A | Treatment of mouth lesion | 1.28 | 2.38 | 2.30 | 0.08 | 3.74 | 3.66 | 010 | ||||||||||||
| 40830 | A | Repair mouth laceration | 1.76 | 2.48 | 2.48 | 0.14 | 4.38 | 4.38 | 010 | ||||||||||||
| 40831 | A | Repair mouth laceration | 2.46 | 2.72 | 2.72 | 0.21 | 5.39 | 5.39 | 010 | ||||||||||||
| 40840 | R | Reconstruction of mouth | 8.73 | 5.93 | 5.93 | 0.79 | 15.45 | 15.45 | 090 | ||||||||||||
| 40842 | R | Reconstruction of mouth | 8.73 | 5.90 | 5.90 | 0.65 | 15.28 | 15.28 | 090 | ||||||||||||
| 40843 | R | Reconstruction of mouth | 12.10 | 7.35 | 7.35 | 0.84 | 20.29 | 20.29 | 090 | ||||||||||||
| 40844 | R | Reconstruction of mouth | 16.01 | 9.01 | 9.01 | 1.63 | 26.65 | 26.65 | 090 | ||||||||||||
| 40845 | R | Reconstruction of mouth | 18.58 | 12.25 | 12.25 | 1.47 | 32.30 | 32.30 | 090 | ||||||||||||
| 40899 | C | Mouth surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 41000 | A | Drainage of mouth lesion | 1.30 | 2.40 | 1.55 | 0.09 | 3.79 | 2.94 | 010 | ||||||||||||
| 41005 | A | Drainage of mouth lesion | 1.26 | 2.33 | 1.62 | 0.09 | 3.68 | 2.97 | 010 | ||||||||||||
| 41006 | A | Drainage of mouth lesion | 3.24 | 3.58 | 3.28 | 0.25 | 7.07 | 6.77 | 090 | ||||||||||||
| 41007 | A | Drainage of mouth lesion | 3.10 | 3.78 | 3.33 | 0.22 | 7.10 | 6.65 | 090 | ||||||||||||
| 41008 | A | Drainage of mouth lesion | 3.37 | 3.69 | 3.22 | 0.24 | 7.30 | 6.83 | 090 | ||||||||||||
| 41009 | A | Drainage of mouth lesion | 3.59 | 3.65 | 3.42 | 0.25 | 7.49 | 7.26 | 090 | ||||||||||||
| 41010 | A | Incision of tongue fold | 1.06 | 3.57 | 3.57 | 0.06 | 4.69 | 4.69 | 010 | ||||||||||||
| 41015 | A | Drainage of mouth lesion | 3.96 | 4.05 | 3.39 | 0.29 | 8.30 | 7.64 | 090 | ||||||||||||
| 41016 | A | Drainage of mouth lesion | 4.07 | 4.31 | 3.61 | 0.28 | 8.66 | 7.96 | 090 | ||||||||||||
| 41017 | A | Drainage of mouth lesion | 4.07 | 4.26 | 3.46 | 0.32 | 8.65 | 7.85 | 090 | ||||||||||||
| 41018 | A | Drainage of mouth lesion | 5.10 | 4.39 | 3.87 | 0.35 | 9.84 | 9.32 | 090 | ||||||||||||
| 41100 | A | Biopsy of tongue | 1.63 | 2.67 | 2.64 | 0.12 | 4.42 | 4.39 | 010 | ||||||||||||
| 41105 | A | Biopsy of tongue | 1.42 | 2.42 | 2.42 | 0.10 | 3.94 | 3.94 | 010 | ||||||||||||
| 41108 | A | Biopsy of floor of mouth | 1.05 | 2.38 | 2.38 | 0.08 | 3.51 | 3.51 | 010 | ||||||||||||
| 41110 | A | Excision of tongue lesion | 1.51 | 3.19 | 2.63 | 0.11 | 4.81 | 4.25 | 010 | ||||||||||||
| 41112 | A | Excision of tongue lesion | 2.73 | 3.56 | 3.56 | 0.20 | 6.49 | 6.49 | 090 | ||||||||||||
| 41113 | A | Excision of tongue lesion | 3.19 | 3.50 | 3.50 | 0.23 | 6.92 | 6.92 | 090 | ||||||||||||
| 41114 | A | Excision of tongue lesion | 8.47 | NA | 6.59 | 0.64 | NA | 15.70 | 090 | ||||||||||||
| 41115 | A | Excision of tongue fold | 1.74 | 2.69 | 2.53 | 0.13 | 4.56 | 4.40 | 010 | ||||||||||||
| 41116 | A | Excision of mouth lesion | 2.44 | 3.37 | 3.37 | 0.17 | 5.98 | 5.98 | 090 | ||||||||||||
| 41120 | A | Partial removal of tongue | 9.77 | NA | 9.12 | 0.70 | NA | 19.59 | 090 | ||||||||||||
| 41130 | A | Partial removal of tongue | 11.15 | NA | 9.76 | 0.81 | NA | 21.72 | 090 | ||||||||||||
| 41135 | A | Tongue and neck surgery | 23.09 | NA | 16.63 | 1.66 | NA | 41.38 | 090 | ||||||||||||
| 41140 | A | Removal of tongue | 25.50 | NA | 17.39 | 1.85 | NA | 44.74 | 090 | ||||||||||||
| 41145 | A | Tongue removal, neck surgery | 30.06 | NA | 21.36 | 2.11 | NA | 53.53 | 090 | ||||||||||||
| 41150 | A | Tongue, mouth, jaw surgery | 23.04 | NA | 17.64 | 1.67 | NA | 42.35 | 090 | ||||||||||||
| 41153 | A | Tongue, mouth, neck surgery | 23.77 | NA | 18.04 | 1.71 | NA | 43.52 | 090 | ||||||||||||
| 41155 | A | Tongue, jaw, neck surgery | 27.72 | NA | 20.44 | 2.02 | NA | 50.18 | 090 | ||||||||||||
| 41250 | A | Repair tongue laceration | 1.91 | 2.98 | 1.77 | 0.15 | 5.04 | 3.83 | 010 | ||||||||||||
| 41251 | A | Repair tongue laceration | 2.27 | 3.12 | 1.88 | 0.18 | 5.57 | 4.33 | 010 | ||||||||||||
| 41252 | A | Repair tongue laceration | 2.97 | 3.23 | 2.33 | 0.23 | 6.43 | 5.53 | 010 | ||||||||||||
| 41500 | A | Fixation of tongue | 3.71 | NA | 4.43 | 0.26 | NA | 8.40 | 090 | ||||||||||||
| 41510 | A | Tongue to lip surgery | 3.42 | NA | 5.39 | 0.24 | NA | 9.05 | 090 | ||||||||||||
| 41520 | A | Reconstruction, tongue fold | 2.73 | 3.06 | 3.06 | 0.19 | 5.98 | 5.98 | 090 | ||||||||||||
| 41599 | C | Tongue and mouth surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 41800 | A | Drainage of gum lesion | 1.17 | 1.96 | 1.43 | 0.09 | 3.22 | 2.69 | 010 | ||||||||||||
| 41805 | A | Removal foreign body, gum | 1.24 | 2.08 | 2.08 | 0.09 | 3.41 | 3.41 | 010 | ||||||||||||
| 41806 | A | Removal foreign body, jawbone | 2.69 | 2.54 | 2.54 | 0.22 | 5.45 | 5.45 | 010 | ||||||||||||
| 41820 | R | Excision, gum, each quadrant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 41821 | R | Excision of gum flap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 41822 | R | Excision of gum lesion | 2.31 | 2.82 | 0.98 | 0.24 | 5.37 | 3.53 | 010 | ||||||||||||
| 41823 | R | Excision of gum lesion | 3.30 | 3.54 | 3.23 | 0.29 | 7.13 | 6.82 | 090 | ||||||||||||
| 41825 | A | Excision of gum lesion | 1.31 | 2.43 | 2.41 | 0.10 | 3.84 | 3.82 | 010 | ||||||||||||
| 41826 | A | Excision of gum lesion | 2.31 | 2.66 | 2.66 | 0.17 | 5.14 | 5.14 | 010 | ||||||||||||
| 41827 | A | Excision of gum lesion | 3.42 | 3.63 | 3.63 | 0.25 | 7.30 | 7.30 | 090 | ||||||||||||
| 41828 | R | Excision of gum lesion | 3.09 | 3.07 | 2.47 | 0.22 | 6.38 | 5.78 | 010 | ||||||||||||
| 41830 | R | Removal of gum tissue | 3.35 | 3.39 | 2.98 | 0.23 | 6.97 | 6.56 | 010 | ||||||||||||
| 41850 | R | Treatment of gum lesion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 41870 | R | Gum graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 41872 | R | Repair gum | 2.59 | 2.93 | 2.93 | 0.18 | 5.70 | 5.70 | 090 | ||||||||||||
| 41874 | R | Repair tooth socket | 3.09 | 2.86 | 2.45 | 0.23 | 6.18 | 5.77 | 090 | ||||||||||||
| 41899 | C | Dental surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 42000 | A | Drainage mouth roof lesion | 1.23 | 2.52 | 1.51 | 0.10 | 3.85 | 2.84 | 010 | ||||||||||||
| 42100 | A | Biopsy roof of mouth | 1.31 | 2.47 | 2.47 | 0.10 | 3.88 | 3.88 | 010 | ||||||||||||
| 42104 | A | Excision lesion, mouth roof | 1.64 | 2.58 | 2.58 | 0.12 | 4.34 | 4.34 | 010 | ||||||||||||
| 42106 | A | Excision lesion, mouth roof | 2.10 | 2.66 | 2.66 | 0.16 | 4.92 | 4.92 | 010 | ||||||||||||
| 42107 | A | Excision lesion, mouth roof | 4.44 | 4.26 | 4.26 | 0.32 | 9.02 | 9.02 | 090 | ||||||||||||
| 42120 | A | Remove palate/lesion | 6.17 | NA | 6.19 | 0.44 | NA | 12.80 | 090 | ||||||||||||
| 42140 | A | Excision of uvula | 1.62 | 3.91 | 3.36 | 0.12 | 5.65 | 5.10 | 090 | ||||||||||||
| 42145 | A | Repair palate, pharynx/uvula | 8.05 | NA | 7.59 | 0.56 | NA | 16.20 | 090 | ||||||||||||
| 42160 | A | Treatment mouth roof lesion | 1.80 | 3.25 | 2.72 | 0.13 | 5.18 | 4.65 | 010 | ||||||||||||
| 42180 | A | Repair palate | 2.50 | 3.29 | 2.25 | 0.19 | 5.98 | 4.94 | 010 | ||||||||||||
| 42182 | A | Repair palate | 3.83 | 3.10 | 3.10 | 0.27 | 7.20 | 7.20 | 010 | ||||||||||||
| 42200 | A | Reconstruct cleft palate | 12.00 | NA | 9.78 | 0.97 | NA | 22.75 | 090 | ||||||||||||
| 42205 | A | Reconstruct cleft palate | 13.29 | NA | 9.76 | 0.82 | NA | 23.87 | 090 | ||||||||||||
| 42210 | A | Reconstruct cleft palate | 14.50 | NA | 11.47 | 1.24 | NA | 27.21 | 090 | ||||||||||||
| 42215 | A | Reconstruct cleft palate | 8.82 | NA | 9.72 | 0.96 | NA | 19.50 | 090 | ||||||||||||
| 42220 | A | Reconstruct cleft palate | 7.02 | NA | 6.85 | 0.41 | NA | 14.28 | 090 | ||||||||||||
| 42225 | A | Reconstruct cleft palate | 9.54 | NA | 9.16 | 0.75 | NA | 19.45 | 090 | ||||||||||||
| 42226 | A | Lengthening of palate | 10.01 | NA | 9.96 | 0.73 | NA | 20.70 | 090 | ||||||||||||
| 42227 | A | Lengthening of palate | 9.52 | NA | 9.09 | 0.70 | NA | 19.31 | 090 | ||||||||||||
| 42235 | A | Repair palate | 7.87 | NA | 5.93 | 0.49 | NA | 14.29 | 090 | ||||||||||||
| 42260 | A | Repair nose to lip fistula | 9.80 | 6.43 | 6.43 | 0.85 | 17.08 | 17.08 | 090 | ||||||||||||
| 42280 | A | Preparation, palate mold | 1.54 | 1.44 | 0.60 | 0.12 | 3.10 | 2.26 | 010 | ||||||||||||
| 42281 | A | Insertion, palate prosthesis | 1.93 | 1.57 | 0.92 | 0.14 | 3.64 | 2.99 | 010 | ||||||||||||
| 42299 | C | Palate/uvula surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 42300 | A | Drainage of salivary gland | 1.93 | 2.65 | 1.98 | 0.15 | 4.73 | 4.06 | 010 | ||||||||||||
| 42305 | A | Drainage of salivary gland | 6.07 | NA | 5.38 | 0.46 | NA | 11.91 | 090 | ||||||||||||
| 42310 | A | Drainage of salivary gland | 1.56 | 2.32 | 1.82 | 0.11 | 3.99 | 3.49 | 010 | ||||||||||||
| 42320 | A | Drainage of salivary gland | 2.35 | 2.79 | 2.15 | 0.17 | 5.31 | 4.67 | 010 | ||||||||||||
| 42325 | A | Create salivary cyst drain | 2.75 | 3.85 | 1.26 | 0.17 | 6.77 | 4.18 | 090 | ||||||||||||
| 42326 | A | Create salivary cyst drain | 3.78 | 3.33 | 1.51 | 0.34 | 7.45 | 5.63 | 090 | ||||||||||||
| 42330 | A | Removal of salivary stone | 2.21 | 2.81 | 1.20 | 0.16 | 5.18 | 3.57 | 010 | ||||||||||||
| 42335 | A | Removal of salivary stone | 3.31 | 3.71 | 3.71 | 0.23 | 7.25 | 7.25 | 090 | ||||||||||||
| 42340 | A | Removal of salivary stone | 4.60 | 5.07 | 5.07 | 0.34 | 10.01 | 10.01 | 090 | ||||||||||||
| 42400 | A | Biopsy of salivary gland | 0.78 | 2.52 | 0.40 | 0.06 | 3.36 | 1.24 | 000 | ||||||||||||
| 42405 | A | Biopsy of salivary gland | 3.29 | 3.44 | 3.44 | 0.24 | 6.97 | 6.97 | 010 | ||||||||||||
| 42408 | A | Excision of salivary cyst | 4.54 | 4.71 | 4.71 | 0.34 | 9.59 | 9.59 | 090 | ||||||||||||
| 42409 | A | Drainage of salivary cyst | 2.81 | 3.34 | 3.34 | 0.20 | 6.35 | 6.35 | 090 | ||||||||||||
| 42410 | A | Excise parotid gland/lesion | 9.34 | NA | 8.20 | 0.77 | NA | 18.31 | 090 | ||||||||||||
| 42415 | A | Excise parotid gland/lesion | 16.89 | NA | 12.82 | 1.26 | NA | 30.97 | 090 | ||||||||||||
| 42420 | A | Excise parotid gland/lesion | 19.59 | NA | 14.46 | 1.45 | NA | 35.50 | 090 | ||||||||||||
| 42425 | A | Excise parotid gland/lesion | 13.02 | NA | 10.70 | 0.98 | NA | 24.70 | 090 | ||||||||||||
| 42426 | A | Excise parotid gland/lesion | 21.26 | NA | 15.44 | 1.57 | NA | 38.27 | 090 | ||||||||||||
| 42440 | A | Excise submaxillary gland | 6.97 | NA | 6.13 | 0.51 | NA | 13.61 | 090 | ||||||||||||
| 42450 | A | Excise sublingual gland | 4.62 | 4.38 | 4.38 | 0.34 | 9.34 | 9.34 | 090 | ||||||||||||
| 42500 | A | Repair salivary duct | 4.30 | 5.14 | 5.10 | 0.30 | 9.74 | 9.70 | 090 | ||||||||||||
| 42505 | A | Repair salivary duct | 6.18 | 6.02 | 6.02 | 0.44 | 12.64 | 12.64 | 090 | ||||||||||||
| 42507 | A | Parotid duct diversion | 6.11 | NA | 5.44 | 0.66 | NA | 12.21 | 090 | ||||||||||||
| 42508 | A | Parotid duct diversion | 9.10 | NA | 8.40 | 0.64 | NA | 18.14 | 090 | ||||||||||||
| 42509 | A | Parotid duct diversion | 11.54 | NA | 9.25 | 1.24 | NA | 22.03 | 090 | ||||||||||||
| 42510 | A | Parotid duct diversion | 8.15 | NA | 7.27 | 0.57 | NA | 15.99 | 090 | ||||||||||||
| 42550 | A | Injection for salivary x-ray | 1.25 | 12.45 | 0.44 | 0.06 | 13.76 | 1.75 | 000 | ||||||||||||
| 42600 | A | Closure of salivary fistula | 4.82 | 7.89 | 5.61 | 0.34 | 13.05 | 10.77 | 090 | ||||||||||||
| 42650 | A | Dilation of salivary duct | 0.77 | 1.13 | 0.41 | 0.06 | 1.96 | 1.24 | 000 | ||||||||||||
| 42660 | A | Dilation of salivary duct | 1.13 | 1.15 | 1.15 | 0.07 | 2.35 | 2.35 | 000 | ||||||||||||
| 42665 | A | Ligation of salivary duct | 2.53 | 3.03 | 3.03 | 0.17 | 5.73 | 5.73 | 090 | ||||||||||||
| 42699 | C | Salivary surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 42700 | A | Drainage of tonsil abscess | 1.62 | 3.30 | 1.93 | 0.12 | 5.04 | 3.67 | 010 | ||||||||||||
| 42720 | A | Drainage of throat abscess | 5.42 | 4.77 | 4.77 | 0.39 | 10.58 | 10.58 | 010 | ||||||||||||
| 42725 | A | Drainage of throat abscess | 10.72 | NA | 8.70 | 0.80 | NA | 20.22 | 090 | ||||||||||||
| 42800 | A | Biopsy of throat | 1.39 | 3.09 | 2.63 | 0.10 | 4.58 | 4.12 | 010 | ||||||||||||
| 42802 | A | Biopsy of throat | 1.54 | 3.24 | 2.72 | 0.11 | 4.89 | 4.37 | 010 | ||||||||||||
| 42804 | A | Biopsy of upper nose/throat | 1.24 | 3.04 | 2.56 | 0.09 | 4.37 | 3.89 | 010 | ||||||||||||
| 42806 | A | Biopsy of upper nose/throat | 1.58 | 3.53 | 2.76 | 0.12 | 5.23 | 4.46 | 010 | ||||||||||||
| 42808 | A | Excise pharynx lesion | 2.30 | 5.00 | 3.17 | 0.17 | 7.47 | 5.64 | 010 | ||||||||||||
| 42809 | A | Remove pharynx foreign body | 1.81 | 3.48 | 1.77 | 0.13 | 5.42 | 3.71 | 010 | ||||||||||||
| 42810 | A | Excision of neck cyst | 3.25 | 5.66 | 4.61 | 0.25 | 9.16 | 8.11 | 090 | ||||||||||||
| 42815 | A | Excision of neck cyst | 7.07 | NA | 6.67 | 0.53 | NA | 14.27 | 090 | ||||||||||||
| 42820 | A | Remove tonsils and adenoids | 3.91 | NA | 4.02 | 0.28 | NA | 8.21 | 090 | ||||||||||||
| 42821 | A | Remove tonsils and adenoids | 4.29 | NA | 4.30 | 0.30 | NA | 8.89 | 090 | ||||||||||||
| 42825 | A | Removal of tonsils | 3.42 | NA | 3.74 | 0.24 | NA | 7.40 | 090 | ||||||||||||
| 42826 | A | Removal of tonsils | 3.38 | NA | 3.81 | 0.23 | NA | 7.42 | 090 | ||||||||||||
| 42830 | A | Removal of adenoids | 2.57 | NA | 2.51 | 0.18 | NA | 5.26 | 090 | ||||||||||||
| 42831 | A | Removal of adenoids | 2.71 | NA | 2.59 | 0.19 | NA | 5.49 | 090 | ||||||||||||
| 42835 | A | Removal of adenoids | 2.30 | NA | 3.20 | 0.17 | NA | 5.67 | 090 | ||||||||||||
| 42836 | A | Removal of adenoids | 3.18 | NA | 3.69 | 0.22 | NA | 7.09 | 090 | ||||||||||||
| 42842 | A | Extensive surgery of throat | 8.76 | NA | 7.96 | 0.61 | NA | 17.33 | 090 | ||||||||||||
| 42844 | A | Extensive surgery of throat | 14.31 | NA | 11.57 | 1.04 | NA | 26.92 | 090 | ||||||||||||
| 42845 | A | Extensive surgery of throat | 24.29 | NA | 18.00 | 1.76 | NA | 44.05 | 090 | ||||||||||||
| 42860 | A | Excision of tonsil tags | 2.22 | NA | 3.08 | 0.16 | NA | 5.46 | 090 | ||||||||||||
| 42870 | A | Excision of lingual tonsil | 5.40 | NA | 6.18 | 0.38 | NA | 11.96 | 090 | ||||||||||||
| 42890 | A | Partial removal of pharynx | 12.94 | NA | 11.03 | 0.91 | NA | 24.88 | 090 | ||||||||||||
| 42892 | A | Revision of pharyngeal walls | 15.83 | NA | 12.68 | 1.14 | NA | 29.65 | 090 | ||||||||||||
| 42894 | A | Revision of pharyngeal walls | 22.88 | NA | 17.38 | 1.64 | NA | 41.90 | 090 | ||||||||||||
| 42900 | A | Repair throat wound | 5.25 | NA | 3.93 | 0.39 | NA | 9.57 | 010 | ||||||||||||
| 42950 | A | Reconstruction of throat | 8.10 | NA | 7.60 | 0.58 | NA | 16.28 | 090 | ||||||||||||
| 42953 | A | Repair throat, esophagus | 8.96 | NA | 9.14 | 0.73 | NA | 18.83 | 090 | ||||||||||||
| 42955 | A | Surgical opening of throat | 7.39 | NA | 6.55 | 0.63 | NA | 14.57 | 090 | ||||||||||||
| 42960 | A | Control throat bleeding | 2.33 | NA | 2.13 | 0.17 | NA | 4.63 | 010 | ||||||||||||
| 42961 | A | Control throat bleeding | 5.59 | NA | 5.30 | 0.40 | NA | 11.29 | 090 | ||||||||||||
| 42962 | A | Control throat bleeding | 7.14 | NA | 6.35 | 0.51 | NA | 14.00 | 090 | ||||||||||||
| 42970 | A | Control nose/throat bleeding | 5.43 | NA | 3.99 | 0.37 | NA | 9.79 | 090 | ||||||||||||
| 42971 | A | Control nose/throat bleeding | 6.21 | NA | 5.99 | 0.45 | NA | 12.65 | 090 | ||||||||||||
| 42972 | A | Control nose/throat bleeding | 7.20 | NA | 5.73 | 0.54 | NA | 13.47 | 090 | ||||||||||||
| 42999 | C | Throat surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 43020 | A | Incision of esophagus | 8.09 | NA | 6.77 | 0.70 | NA | 15.56 | 090 | ||||||||||||
| 43030 | A | Throat muscle surgery | 7.69 | NA | 7.00 | 0.60 | NA | 15.29 | 090 | ||||||||||||
| 43045 | A | Incision of esophagus | 20.12 | NA | 11.14 | 2.15 | NA | 33.41 | 090 | ||||||||||||
| 43100 | A | Excision of esophagus lesion | 9.19 | NA | 7.58 | 0.79 | NA | 17.56 | 090 | ||||||||||||
| 43101 | A | Excision of esophagus lesion | 16.24 | NA | 8.84 | 1.81 | NA | 26.89 | 090 | ||||||||||||
| 43107 | A | Removal of esophagus | 40.00 | NA | 18.49 | 3.29 | NA | 61.78 | 090 | ||||||||||||
| 43108 | A | Removal of esophagus | 34.19 | NA | 16.39 | 3.78 | NA | 54.36 | 090 | ||||||||||||
| 43112 | A | Removal of esophagus | 43.50 | NA | 20.06 | 3.67 | NA | 67.23 | 090 | ||||||||||||
| 43113 | A | Removal of esophagus | 35.27 | NA | 16.38 | 4.33 | NA | 55.98 | 090 | ||||||||||||
| 43116 | A | Partial removal of esophagus | 31.22 | NA | 18.49 | 2.62 | NA | 52.33 | 090 | ||||||||||||
| 43117 | A | Partial removal of esophagus | 40.00 | NA | 18.51 | 3.51 | NA | 62.02 | 090 | ||||||||||||
| 43118 | A | Partial removal of esophagus | 33.20 | NA | 15.76 | 3.56 | NA | 52.52 | 090 | ||||||||||||
| 43121 | A | Partial removal of esophagus | 29.19 | NA | 15.08 | 3.44 | NA | 47.71 | 090 | ||||||||||||
| 43122 | A | Parital removal of esophagus | 40.00 | NA | 18.05 | 3.27 | NA | 61.32 | 090 | ||||||||||||
| 43123 | A | Partial removal of esophagus | 33.20 | NA | 15.58 | 3.96 | NA | 52.74 | 090 | ||||||||||||
| 43124 | A | Removal of esophagus | 27.32 | NA | 15.15 | 2.95 | NA | 45.42 | 090 | ||||||||||||
| 43130 | A | Removal of esophagus pouch | 11.75 | NA | 9.05 | 1.06 | NA | 21.86 | 090 | ||||||||||||
| 43135 | A | Removal of esophagus pouch | 16.10 | NA | 10.09 | 1.85 | NA | 28.04 | 090 | ||||||||||||
| 43200 | A | Esophagus endoscopy | 1.59 | 7.92 | 1.22 | 0.11 | 9.62 | 2.92 | 000 | ||||||||||||
| 43202 | A | Esophagus endoscopy, biopsy | 1.89 | 6.46 | 1.15 | 0.12 | 8.47 | 3.16 | 000 | ||||||||||||
| 43204 | A | Esophagus endoscopy inject | 3.77 | NA | 1.71 | 0.18 | NA | 5.66 | 000 | ||||||||||||
| 43205 | A | Esophagus endoscopy/ligation | 3.79 | NA | 1.71 | 0.17 | NA | 5.67 | 000 | ||||||||||||
| 43215 | A | Esophagus endoscopy | 2.60 | NA | 1.26 | 0.17 | NA | 4.03 | 000 | ||||||||||||
| 43216 | A | Esophagus endoscopy/lesion | 2.40 | NA | 1.20 | 0.15 | NA | 3.75 | 000 | ||||||||||||
| 43217 | A | Esophagus endoscopy | 2.90 | NA | 1.35 | 0.17 | NA | 4.42 | 000 | ||||||||||||
| 43219 | A | Esophagus endoscopy | 2.80 | NA | 1.43 | 0.16 | NA | 4.39 | 000 | ||||||||||||
| 43220 | A | Esoph endoscopy, dilation | 2.10 | NA | 1.14 | 0.12 | NA | 3.36 | 000 | ||||||||||||
| 43226 | A | Esoph endoscopy, dilation | 2.34 | NA | 1.21 | 0.12 | NA | 3.67 | 000 | ||||||||||||
| 43227 | A | Esoph endoscopy, repair | 3.60 | NA | 1.64 | 0.18 | NA | 5.42 | 000 | ||||||||||||
| 43228 | A | Esoph endoscopy, ablation | 3.77 | NA | 1.77 | 0.25 | NA | 5.79 | 000 | ||||||||||||
| 43231 | A | Esoph endoscopy w/us exam | 3.19 | NA | 1.60 | 0.20 | NA | 4.99 | 000 | ||||||||||||
| 43232 | A | Esoph endoscopy w/us fn bx | 4.48 | NA | 2.15 | 0.26 | NA | 6.89 | 000 | ||||||||||||
| 43234 | A | Upper GI endoscopy, exam | 2.01 | 4.58 | 1.06 | 0.13 | 6.72 | 3.20 | 000 | ||||||||||||
| 43235 | A | Uppr GI endoscopy, diagnosis | 2.39 | 6.38 | 1.23 | 0.13 | 8.90 | 3.75 | 000 | ||||||||||||
| 43239 | A | Upper GI endoscopy, biopsy | 2.87 | 6.79 | 1.27 | 0.14 | 9.80 | 4.28 | 000 | ||||||||||||
| 43240 | A | Esoph endoscope w/drain cyst | 6.86 | NA | 2.97 | 0.36 | NA | 10.19 | 000 | ||||||||||||
| 43241 | A | Upper GI endoscopy with tube | 2.59 | NA | 1.27 | 0.14 | NA | 4.00 | 000 | ||||||||||||
| 43242 | A | Uppr GI endoscopy w/us fn bx | 7.31 | 2.64 | 2.64 | 0.29 | 10.24 | 10.24 | 000 | ||||||||||||
| 43243 | A | Upper GI endoscopy inject | 4.57 | NA | 2.00 | 0.21 | NA | 6.78 | 000 | ||||||||||||
| 43244 | A | Upper GI endoscopy/ligation | 5.05 | NA | 2.18 | 0.21 | NA | 7.44 | 000 | ||||||||||||
| 43245 | A | Operative upper GI endoscopy | 3.39 | NA | 1.55 | 0.18 | NA | 5.12 | 000 | ||||||||||||
| 43246 | A | Place gastrostomy tube | 4.33 | NA | 1.84 | 0.24 | NA | 6.41 | 000 | ||||||||||||
| 43247 | A | Operative upper GI endoscopy | 3.39 | NA | 1.56 | 0.17 | NA | 5.12 | 000 | ||||||||||||
| 43248 | A | Uppr GI endoscopy/guide wire | 3.15 | NA | 1.49 | 0.15 | NA | 4.79 | 000 | ||||||||||||
| 43249 | A | Esoph endoscopy, dilation | 2.90 | NA | 1.39 | 0.15 | NA | 4.44 | 000 | ||||||||||||
| 43250 | A | Upper GI endoscopy/tumor | 3.20 | NA | 1.48 | 0.17 | NA | 4.85 | 000 | ||||||||||||
| 43251 | A | Operative upper GI endoscopy | 3.70 | NA | 1.67 | 0.19 | NA | 5.56 | 000 | ||||||||||||
| 43255 | A | Operative upper GI endoscopy | 4.82 | NA | 1.97 | 0.20 | NA | 6.99 | 000 | ||||||||||||
| 43256 | A | Uppr GI endoscopy w stent | 4.60 | 1.66 | 1.66 | 0.23 | 6.49 | 6.49 | 000 | ||||||||||||
| 43258 | A | Operative upper GI endoscopy | 4.55 | NA | 1.99 | 0.22 | NA | 6.76 | 000 | ||||||||||||
| 43259 | A | Endoscopic ultrasound exam | 4.89 | NA | 2.22 | 0.22 | NA | 7.33 | 000 | ||||||||||||
| 43260 | A | Endo cholangiopancreatograph | 5.96 | NA | 2.50 | 0.27 | NA | 8.73 | 000 | ||||||||||||
| 43261 | A | Endo cholangiopancreatograph | 6.27 | NA | 2.62 | 0.29 | NA | 9.18 | 000 | ||||||||||||
| 43262 | A | Endo cholangiopancreatograph | 7.39 | NA | 3.03 | 0.34 | NA | 10.76 | 000 | ||||||||||||
| 43263 | A | Endo cholangiopancreatograph | 7.29 | NA | 3.00 | 0.28 | NA | 10.57 | 000 | ||||||||||||
| 43264 | A | Endo cholangiopancreatograph | 8.90 | NA | 3.58 | 0.41 | NA | 12.89 | 000 | ||||||||||||
| 43265 | A | Endo cholangiopancreatograph | 10.02 | NA | 3.99 | 0.42 | NA | 14.43 | 000 | ||||||||||||
| 43267 | A | Endo cholangiopancreatograph | 7.39 | NA | 3.04 | 0.34 | NA | 10.77 | 000 | ||||||||||||
| 43268 | A | Endo cholangiopancreatograph | 7.39 | NA | 3.03 | 0.34 | NA | 10.76 | 000 | ||||||||||||
| 43269 | A | Endo cholangiopancreatograph | 8.21 | NA | 3.33 | 0.28 | NA | 11.82 | 000 | ||||||||||||
| 43271 | A | Endo cholangiopancreatograph | 7.39 | NA | 3.02 | 0.34 | NA | 10.75 | 000 | ||||||||||||
| 43272 | A | Endo cholangiopancreatograph | 7.39 | NA | 3.04 | 0.34 | NA | 10.77 | 000 | ||||||||||||
| 43280 | A | Laparoscopy, fundoplasty | 17.25 | NA | 8.43 | 1.76 | NA | 27.44 | 090 | ||||||||||||
| 43289 | C | Laparoscope proc, esoph | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 43300 | A | Repair of esophagus | 9.14 | NA | 7.31 | 0.85 | NA | 17.30 | 090 | ||||||||||||
| 43305 | A | Repair esophagus and fistula | 17.39 | NA | 12.84 | 1.36 | NA | 31.59 | 090 | ||||||||||||
| 43310 | A | Repair of esophagus | 25.39 | NA | 14.51 | 3.18 | NA | 43.08 | 090 | ||||||||||||
| 43312 | A | Repair esophagus and fistula | 28.42 | NA | 17.45 | 3.38 | NA | 49.25 | 090 | ||||||||||||
| 43313 | A | Esophagoplasty congential | 45.28 | NA | 22.01 | 5.43 | NA | 72.72 | 090 | ||||||||||||
| 43314 | A | Tracheo-esophagoplasty cong | 50.27 | NA | 24.07 | 5.53 | NA | 79.87 | 090 | ||||||||||||
| 43320 | A | Fuse esophagus stomach | 19.93 | NA | 10.67 | 1.59 | NA | 32.19 | 090 | ||||||||||||
| 43324 | A | Revise esophagus stomach | 20.57 | NA | 9.79 | 1.72 | NA | 32.08 | 090 | ||||||||||||
| 43325 | A | Revise esophagus stomach | 20.06 | NA | 10.08 | 1.65 | NA | 31.79 | 090 | ||||||||||||
| 43326 | A | Revise esophagus stomach | 19.74 | NA | 10.33 | 1.84 | NA | 31.91 | 090 | ||||||||||||
| 43330 | A | Repair of esophagus | 19.77 | NA | 9.78 | 1.52 | NA | 31.07 | 090 | ||||||||||||
| 43331 | A | Repair of esophagus | 20.13 | NA | 11.41 | 1.93 | NA | 33.47 | 090 | ||||||||||||
| 43340 | A | Fuse esophagus intestine | 19.61 | NA | 10.31 | 1.53 | NA | 31.45 | 090 | ||||||||||||
| 43341 | A | Fuse esophagus intestine | 20.85 | NA | 11.17 | 2.14 | NA | 34.16 | 090 | ||||||||||||
| 43350 | A | Surgical opening, esophagus | 15.78 | NA | 10.50 | 1.15 | NA | 27.43 | 090 | ||||||||||||
| 43351 | A | Surgical opening, esophagus | 18.35 | NA | 10.91 | 1.51 | NA | 30.77 | 090 | ||||||||||||
| 43352 | A | Surgical opening, esophagus | 15.26 | NA | 9.59 | 1.28 | NA | 26.13 | 090 | ||||||||||||
| 43360 | A | Gastrointestinal repair | 35.70 | NA | 17.43 | 3.00 | NA | 56.13 | 090 | ||||||||||||
| 43361 | A | Gastrointestinal repair | 40.50 | NA | 17.93 | 3.52 | NA | 61.95 | 090 | ||||||||||||
| 43400 | A | Ligate esophagus veins | 21.20 | NA | 10.46 | 0.99 | NA | 32.65 | 090 | ||||||||||||
| 43401 | A | Esophagus surgery for veins | 22.09 | NA | 10.34 | 1.73 | NA | 34.16 | 090 | ||||||||||||
| 43405 | A | Ligate/staple esophagus | 20.01 | NA | 9.45 | 1.63 | NA | 31.09 | 090 | ||||||||||||
| 43410 | A | Repair esophagus wound | 13.47 | NA | 9.35 | 1.15 | NA | 23.97 | 090 | ||||||||||||
| 43415 | A | Repair esophagus wound | 25.00 | NA | 12.50 | 1.92 | NA | 39.42 | 090 | ||||||||||||
| 43420 | A | Repair esophagus opening | 14.35 | NA | 9.15 | 0.86 | NA | 24.36 | 090 | ||||||||||||
| 43425 | A | Repair esophagus opening | 21.03 | NA | 11.00 | 2.03 | NA | 34.06 | 090 | ||||||||||||
| 43450 | A | Dilate esophagus | 1.38 | 1.47 | 0.63 | 0.07 | 2.92 | 2.08 | 000 | ||||||||||||
| 43453 | A | Dilate esophagus | 1.51 | NA | 0.68 | 0.08 | NA | 2.27 | 000 | ||||||||||||
| 43456 | A | Dilate esophagus | 2.57 | NA | 1.07 | 0.14 | NA | 3.78 | 000 | ||||||||||||
| 43458 | A | Dilate esophagus | 3.06 | NA | 1.26 | 0.17 | NA | 4.49 | 000 | ||||||||||||
| 43460 | A | Pressure treatment esophagus | 3.80 | NA | 1.54 | 0.21 | NA | 5.55 | 000 | ||||||||||||
| 43496 | C | Free jejunum flap, microvasc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 43499 | C | Esophagus surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 43500 | A | Surgical opening of stomach | 11.05 | NA | 5.23 | 0.84 | NA | 17.12 | 090 | ||||||||||||
| 43501 | A | Surgical repair of stomach | 20.04 | NA | 8.86 | 1.55 | NA | 30.45 | 090 | ||||||||||||
| 43502 | A | Surgical repair of stomach | 23.13 | NA | 10.16 | 1.83 | NA | 35.12 | 090 | ||||||||||||
| 43510 | A | Surgical opening of stomach | 13.08 | NA | 7.50 | 0.90 | NA | 21.48 | 090 | ||||||||||||
| 43520 | A | Incision of pyloric muscle | 9.99 | NA | 5.73 | 0.84 | NA | 16.56 | 090 | ||||||||||||
| 43600 | A | Biopsy of stomach | 1.91 | NA | 1.05 | 0.11 | NA | 3.07 | 000 | ||||||||||||
| 43605 | A | Biopsy of stomach | 11.98 | NA | 5.55 | 0.93 | NA | 18.46 | 090 | ||||||||||||
| 43610 | A | Excision of stomach lesion | 14.60 | NA | 6.85 | 1.14 | NA | 22.59 | 090 | ||||||||||||
| 43611 | A | Excision of stomach lesion | 17.84 | NA | 8.12 | 1.38 | NA | 27.34 | 090 | ||||||||||||
| 43620 | A | Removal of stomach | 30.04 | NA | 12.89 | 2.29 | NA | 45.22 | 090 | ||||||||||||
| 43621 | A | Removal of stomach | 30.73 | NA | 13.21 | 2.36 | NA | 46.30 | 090 | ||||||||||||
| 43622 | A | Removal of stomach | 32.53 | NA | 13.79 | 2.48 | NA | 48.80 | 090 | ||||||||||||
| 43631 | A | Removal of stomach, partial | 22.59 | NA | 9.72 | 1.99 | NA | 34.30 | 090 | ||||||||||||
| 43632 | A | Removal of stomach, partial | 22.59 | NA | 9.73 | 2.00 | NA | 34.32 | 090 | ||||||||||||
| 43633 | A | Removal of stomach, partial | 23.10 | NA | 9.87 | 2.05 | NA | 35.02 | 090 | ||||||||||||
| 43634 | A | Removal of stomach, partial | 25.12 | NA | 10.84 | 2.18 | NA | 38.14 | 090 | ||||||||||||
| 43635 | A | Removal of stomach, partial | 2.06 | NA | 0.74 | 0.21 | NA | 3.01 | ZZZ | ||||||||||||
| 43638 | A | Removal of stomach, partial | 29.00 | NA | 12.13 | 2.24 | NA | 43.37 | 090 | ||||||||||||
| 43639 | A | Removal of stomach, partial | 29.65 | NA | 12.30 | 2.31 | NA | 44.26 | 090 | ||||||||||||
| 43640 | A | Vagotomy pylorus repair | 17.02 | NA | 7.72 | 1.51 | NA | 26.25 | 090 | ||||||||||||
| 43641 | A | Vagotomy pylorus repair | 17.27 | NA | 7.82 | 1.53 | NA | 26.62 | 090 | ||||||||||||
| 43651 | A | Laparoscopy, vagus nerve | 10.15 | NA | 4.71 | 1.03 | NA | 15.89 | 090 | ||||||||||||
| 43652 | A | Laparoscopy, vagus nerve | 12.15 | NA | 5.53 | 1.25 | NA | 18.93 | 090 | ||||||||||||
| 43653 | A | Laparoscopy, gastrostomy | 7.73 | NA | 4.37 | 0.78 | NA | 12.88 | 090 | ||||||||||||
| 43659 | C | Laparoscope proc, stom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 43750 | A | Place gastrostomy tube | 4.49 | NA | 2.72 | 0.33 | NA | 7.54 | 010 | ||||||||||||
| 43752 | B | Nasal/orogastric w/stent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 43760 | A | Change gastrostomy tube | 1.10 | 1.47 | 0.46 | 0.07 | 2.64 | 1.63 | 000 | ||||||||||||
| 43761 | A | Reposition gastrostomy tube | 2.01 | NA | 0.83 | 0.10 | NA | 2.94 | 000 | ||||||||||||
| 43800 | A | Reconstruction of pylorus | 13.69 | NA | 6.60 | 1.07 | NA | 21.36 | 090 | ||||||||||||
| 43810 | A | Fusion of stomach and bowel | 14.65 | NA | 6.94 | 1.10 | NA | 22.69 | 090 | ||||||||||||
| 43820 | A | Fusion of stomach and bowel | 15.37 | NA | 7.15 | 1.18 | NA | 23.70 | 090 | ||||||||||||
| 43825 | A | Fusion of stomach and bowel | 19.22 | NA | 8.56 | 1.50 | NA | 29.28 | 090 | ||||||||||||
| 43830 | A | Place gastrostomy tube | 9.53 | NA | 5.06 | 0.69 | NA | 15.28 | 090 | ||||||||||||
| 43831 | A | Place gastrostomy tube | 7.84 | NA | 4.67 | 0.81 | NA | 13.32 | 090 | ||||||||||||
| 43832 | A | Place gastrostomy tube | 15.60 | NA | 7.66 | 1.13 | NA | 24.39 | 090 | ||||||||||||
| 43840 | A | Repair of stomach lesion | 15.56 | NA | 7.21 | 1.20 | NA | 23.97 | 090 | ||||||||||||
| 43842 | A | Gastroplasty for obesity | 18.47 | NA | 11.24 | 1.51 | NA | 31.22 | 090 | ||||||||||||
| 43843 | A | Gastroplasty for obesity | 18.65 | NA | 11.25 | 1.53 | NA | 31.43 | 090 | ||||||||||||
| 43846 | A | Gastric bypass for obesity | 24.05 | NA | 13.68 | 1.96 | NA | 39.69 | 090 | ||||||||||||
| 43847 | A | Gastric bypass for obesity | 26.92 | NA | 15.28 | 2.14 | NA | 44.34 | 090 | ||||||||||||
| 43848 | A | Revision gastroplasty | 29.39 | NA | 16.54 | 2.39 | NA | 48.32 | 090 | ||||||||||||
| 43850 | A | Revise stomach-bowel fusion | 24.72 | NA | 10.42 | 1.97 | NA | 37.11 | 090 | ||||||||||||
| 43855 | A | Revise stomach-bowel fusion | 26.16 | NA | 11.12 | 2.01 | NA | 39.29 | 090 | ||||||||||||
| 43860 | A | Revise stomach-bowel fusion | 25.00 | NA | 10.58 | 2.03 | NA | 37.61 | 090 | ||||||||||||
| 43865 | A | Revise stomach-bowel fusion | 26.52 | NA | 11.21 | 2.15 | NA | 39.88 | 090 | ||||||||||||
| 43870 | A | Repair stomach opening | 9.69 | NA | 5.22 | 0.71 | NA | 15.62 | 090 | ||||||||||||
| 43880 | A | Repair stomach-bowel fistula | 24.65 | NA | 10.87 | 1.94 | NA | 37.46 | 090 | ||||||||||||
| 43999 | C | Stomach surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 44005 | A | Freeing of bowel adhesion | 16.23 | NA | 7.40 | 1.39 | NA | 25.02 | 090 | ||||||||||||
| 44010 | A | Incision of small bowel | 12.52 | NA | 6.48 | 1.05 | NA | 20.05 | 090 | ||||||||||||
| 44015 | A | Insert needle cath bowel | 2.62 | NA | 0.93 | 0.25 | NA | 3.80 | ZZZ | ||||||||||||
| 44020 | A | Explore small intestine | 13.99 | NA | 6.56 | 1.20 | NA | 21.75 | 090 | ||||||||||||
| 44021 | A | Decompress small bowel | 14.08 | NA | 7.02 | 1.18 | NA | 22.28 | 090 | ||||||||||||
| 44025 | A | Incision of large bowel | 14.28 | NA | 6.65 | 1.21 | NA | 22.14 | 090 | ||||||||||||
| 44050 | A | Reduce bowel obstruction | 14.03 | NA | 6.60 | 1.15 | NA | 21.78 | 090 | ||||||||||||
| 44055 | A | Correct malrotation of bowel | 22.00 | NA | 9.51 | 1.32 | NA | 32.83 | 090 | ||||||||||||
| 44100 | A | Biopsy of bowel | 2.01 | NA | 1.09 | 0.12 | NA | 3.22 | 000 | ||||||||||||
| 44110 | A | Excise intestine lesion(s) | 11.81 | NA | 5.84 | 1.00 | NA | 18.65 | 090 | ||||||||||||
| 44111 | A | Excision of bowel lesion(s) | 14.29 | NA | 7.10 | 1.22 | NA | 22.61 | 090 | ||||||||||||
| 44120 | A | Removal of small intestine | 17.00 | NA | 7.67 | 1.46 | NA | 26.13 | 090 | ||||||||||||
| 44121 | A | Removal of small intestine | 4.45 | NA | 1.60 | 0.45 | NA | 6.50 | ZZZ | ||||||||||||
| 44125 | A | Removal of small intestine | 17.54 | NA | 7.86 | 1.49 | NA | 26.89 | 090 | ||||||||||||
| 44126 | A | Enterectomy w/taper, cong | 35.50 | NA | 18.03 | 0.36 | NA | 53.89 | 090 | ||||||||||||
| 44127 | A | Enterectomy w/o taper, cong | 41.00 | NA | 20.56 | 0.41 | NA | 61.97 | 090 | ||||||||||||
| 44128 | A | Enterectomy cong, add-on | 4.45 | NA | 1.78 | 0.45 | NA | 6.68 | ZZZ | ||||||||||||
| 44130 | A | Bowel to bowel fusion | 14.49 | NA | 6.78 | 1.23 | NA | 22.50 | 090 | ||||||||||||
| 44132 | R | Enterectomy, cadaver donor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 44133 | R | Enterectomy, live donor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 44135 | R | Intestine transplant, cadaver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 44136 | R | Intestine transplant, live | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 44139 | A | Mobilization of colon | 2.23 | NA | 0.80 | 0.21 | NA | 3.24 | ZZZ | ||||||||||||
| 44140 | A | Partial removal of colon | 21.00 | NA | 9.53 | 1.83 | NA | 32.36 | 090 | ||||||||||||
| 44141 | A | Partial removal of colon | 19.51 | NA | 11.93 | 1.95 | NA | 33.39 | 090 | ||||||||||||
| 44143 | A | Partial removal of colon | 22.99 | NA | 13.14 | 2.02 | NA | 38.15 | 090 | ||||||||||||
| 44144 | A | Partial removal of colon | 21.53 | NA | 11.75 | 1.89 | NA | 35.17 | 090 | ||||||||||||
| 44145 | A | Partial removal of colon | 26.42 | NA | 11.90 | 2.22 | NA | 40.54 | 090 | ||||||||||||
| 44146 | A | Partial removal of colon | 27.54 | NA | 15.41 | 2.20 | NA | 45.15 | 090 | ||||||||||||
| 44147 | A | Partial removal of colon | 20.71 | NA | 10.15 | 1.74 | NA | 32.60 | 090 | ||||||||||||
| 44150 | A | Removal of colon | 23.95 | NA | 14.08 | 2.05 | NA | 40.08 | 090 | ||||||||||||
| 44151 | A | Removal of colon/ileostomy | 26.88 | NA | 15.74 | 1.97 | NA | 44.59 | 090 | ||||||||||||
| 44152 | A | Removal of colon/ileostomy | 27.83 | NA | 17.01 | 2.36 | NA | 47.20 | 090 | ||||||||||||
| 44153 | A | Removal of colon/ileostomy | 30.59 | NA | 16.64 | 2.33 | NA | 49.56 | 090 | ||||||||||||
| 44155 | A | Removal of colon/ileostomy | 27.86 | NA | 15.28 | 2.26 | NA | 45.40 | 090 | ||||||||||||
| 44156 | A | Removal of colon/ileostomy | 30.79 | NA | 17.86 | 2.19 | NA | 50.84 | 090 | ||||||||||||
| 44160 | A | Removal of colon | 18.62 | NA | 8.65 | 1.55 | NA | 28.82 | 090 | ||||||||||||
| 44200 | A | Laparoscopy, enterolysis | 14.44 | NA | 6.79 | 1.46 | NA | 22.69 | 090 | ||||||||||||
| 44201 | A | Laparoscopy, jejunostomy | 9.78 | NA | 5.16 | 0.97 | NA | 15.91 | 090 | ||||||||||||
| 44202 | A | Lap resect s/intestine singl | 22.04 | NA | 9.82 | 2.16 | NA | 34.02 | 090 | ||||||||||||
| 44203 | A | Lap resect s/intestine, addl | 4.45 | NA | 1.60 | 0.45 | NA | 6.50 | ZZZ | ||||||||||||
| 44204 | A | Laparo partial colectomy | 25.08 | NA | 10.46 | 1.83 | NA | 37.37 | 090 | ||||||||||||
| 44205 | A | Lap colectomy part w/ileum | 22.23 | NA | 9.31 | 1.55 | NA | 33.09 | 090 | ||||||||||||
| 44209 | C | Laparoscope proc, intestine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 44300 | A | Open bowel to skin | 12.11 | NA | 6.79 | 0.88 | NA | 19.78 | 090 | ||||||||||||
| 44310 | A | Ileostomy/jejunostomy | 15.95 | NA | 10.50 | 1.13 | NA | 27.58 | 090 | ||||||||||||
| 44312 | A | Revision of ileostomy | 8.02 | NA | 5.25 | 0.54 | NA | 13.81 | 090 | ||||||||||||
| 44314 | A | Revision of ileostomy | 15.05 | NA | 10.37 | 0.99 | NA | 26.41 | 090 | ||||||||||||
| 44316 | A | Devise bowel pouch | 21.09 | NA | 13.77 | 1.41 | NA | 36.27 | 090 | ||||||||||||
| 44320 | A | Colostomy | 17.64 | NA | 12.13 | 1.28 | NA | 31.05 | 090 | ||||||||||||
| 44322 | A | Colostomy with biopsies | 11.98 | NA | 10.41 | 1.18 | NA | 23.57 | 090 | ||||||||||||
| 44340 | A | Revision of colostomy | 7.72 | NA | 4.86 | 0.56 | NA | 13.14 | 090 | ||||||||||||
| 44345 | A | Revision of colostomy | 15.43 | NA | 8.34 | 1.11 | NA | 24.88 | 090 | ||||||||||||
| 44346 | A | Revision of colostomy | 16.99 | NA | 8.91 | 1.20 | NA | 27.10 | 090 | ||||||||||||
| 44360 | A | Small bowel endoscopy | 2.59 | NA | 1.39 | 0.14 | NA | 4.12 | 000 | ||||||||||||
| 44361 | A | Small bowel endoscopy/biopsy | 2.87 | NA | 1.50 | 0.15 | NA | 4.52 | 000 | ||||||||||||
| 44363 | A | Small bowel endoscopy | 3.50 | NA | 1.71 | 0.19 | NA | 5.40 | 000 | ||||||||||||
| 44364 | A | Small bowel endoscopy | 3.74 | NA | 1.80 | 0.21 | NA | 5.75 | 000 | ||||||||||||
| 44365 | A | Small bowel endoscopy | 3.31 | NA | 1.68 | 0.18 | NA | 5.17 | 000 | ||||||||||||
| 44366 | A | Small bowel endoscopy | 4.41 | NA | 2.05 | 0.22 | NA | 6.68 | 000 | ||||||||||||
| 44369 | A | Small bowel endoscopy | 4.52 | NA | 2.05 | 0.23 | NA | 6.80 | 000 | ||||||||||||
| 44370 | A | Small bowel endoscopy/stent | 4.80 | 1.74 | 1.74 | 0.21 | 6.75 | 6.75 | 000 | ||||||||||||
| 44372 | A | Small bowel endoscopy | 4.41 | NA | 2.04 | 0.27 | NA | 6.72 | 000 | ||||||||||||
| 44373 | A | Small bowel endoscopy | 3.50 | NA | 1.80 | 0.19 | NA | 5.49 | 000 | ||||||||||||
| 44376 | A | Small bowel endoscopy | 5.26 | NA | 2.36 | 0.29 | NA | 7.91 | 000 | ||||||||||||
| 44377 | A | Small bowel endoscopy/biopsy | 5.53 | NA | 2.47 | 0.28 | NA | 8.28 | 000 | ||||||||||||
| 44378 | A | Small bowel endoscopy | 7.13 | NA | 3.06 | 0.37 | NA | 10.56 | 000 | ||||||||||||
| 44379 | A | S bowel endoscope w/stent | 7.47 | 2.67 | 2.67 | 0.38 | 10.52 | 10.52 | 000 | ||||||||||||
| 44380 | A | Small bowel endoscopy | 1.05 | NA | 0.79 | 0.08 | NA | 1.92 | 000 | ||||||||||||
| 44382 | A | Small bowel endoscopy | 1.27 | NA | 0.90 | 0.09 | NA | 2.26 | 000 | ||||||||||||
| 44383 | A | Ileoscopy w/stent | 3.26 | 1.16 | 1.16 | 0.13 | 4.55 | 4.55 | 000 | ||||||||||||
| 44385 | A | Endoscopy of bowel pouch | 1.82 | 5.26 | 0.95 | 0.12 | 7.20 | 2.89 | 000 | ||||||||||||
| 44386 | A | Endoscopy, bowel pouch/biop | 2.12 | 6.98 | 1.09 | 0.15 | 9.25 | 3.36 | 000 | ||||||||||||
| 44388 | A | Colon endoscopy | 2.82 | 6.91 | 1.42 | 0.18 | 9.91 | 4.42 | 000 | ||||||||||||
| 44389 | A | Colonoscopy with biopsy | 3.13 | 7.62 | 1.55 | 0.18 | 10.93 | 4.86 | 000 | ||||||||||||
| 44390 | A | Colonoscopy for foreign body | 3.83 | 6.68 | 1.80 | 0.22 | 10.73 | 5.85 | 000 | ||||||||||||
| 44391 | A | Colonoscopy for bleeding | 4.32 | 6.04 | 1.78 | 0.23 | 10.59 | 6.33 | 000 | ||||||||||||
| 44392 | A | Colonoscopy polypectomy | 3.82 | 8.21 | 1.79 | 0.23 | 12.26 | 5.84 | 000 | ||||||||||||
| 44393 | A | Colonoscopy, lesion removal | 4.84 | 8.45 | 2.19 | 0.27 | 13.56 | 7.30 | 000 | ||||||||||||
| 44394 | A | Colonoscopy w/snare | 4.43 | 7.71 | 2.04 | 0.26 | 12.40 | 6.73 | 000 | ||||||||||||
| 44397 | A | Colonoscopy w stent | 4.71 | NA | 2.10 | 0.28 | NA | 7.09 | 000 | ||||||||||||
| 44500 | A | Intro, gastrointestinal tube | 0.49 | NA | 0.37 | 0.02 | NA | 0.88 | 000 | ||||||||||||
| 44602 | A | Suture, small intestine | 16.03 | NA | 7.34 | 1.07 | NA | 24.44 | 090 | ||||||||||||
| 44603 | A | Suture, small intestine | 18.66 | NA | 8.25 | 1.39 | NA | 28.30 | 090 | ||||||||||||
| 44604 | A | Suture, large intestine | 16.03 | NA | 7.35 | 1.42 | NA | 24.80 | 090 | ||||||||||||
| 44605 | A | Repair of bowel lesion | 19.53 | NA | 8.94 | 1.54 | NA | 30.01 | 090 | ||||||||||||
| 44615 | A | Intestinal stricturoplasty | 15.93 | NA | 7.32 | 1.39 | NA | 24.64 | 090 | ||||||||||||
| 44620 | A | Repair bowel opening | 12.20 | NA | 5.81 | 1.05 | NA | 19.06 | 090 | ||||||||||||
| 44625 | A | Repair bowel opening | 15.05 | NA | 6.86 | 1.30 | NA | 23.21 | 090 | ||||||||||||
| 44626 | A | Repair bowel opening | 25.36 | NA | 10.60 | 2.19 | NA | 38.15 | 090 | ||||||||||||
| 44640 | A | Repair bowel-skin fistula | 21.65 | NA | 9.70 | 1.46 | NA | 32.81 | 090 | ||||||||||||
| 44650 | A | Repair bowel fistula | 22.57 | NA | 10.01 | 1.49 | NA | 34.07 | 090 | ||||||||||||
| 44660 | A | Repair bowel-bladder fistula | 21.36 | NA | 9.51 | 1.14 | NA | 32.01 | 090 | ||||||||||||
| 44661 | A | Repair bowel-bladder fistula | 24.81 | NA | 10.73 | 1.53 | NA | 37.07 | 090 | ||||||||||||
| 44680 | A | Surgical revision, intestine | 15.40 | NA | 7.47 | 1.37 | NA | 24.24 | 090 | ||||||||||||
| 44700 | A | Suspend bowel w/prosthesis | 16.11 | NA | 7.57 | 1.21 | NA | 24.89 | 090 | ||||||||||||
| 44799 | C | Intestine surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 44800 | A | Excision of bowel pouch | 11.23 | NA | 5.61 | 1.11 | NA | 17.95 | 090 | ||||||||||||
| 44820 | A | Excision of mesentery lesion | 12.09 | NA | 5.98 | 1.03 | NA | 19.10 | 090 | ||||||||||||
| 44850 | A | Repair of mesentery | 10.74 | NA | 5.41 | 0.99 | NA | 17.14 | 090 | ||||||||||||
| 44899 | C | Bowel surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 44900 | A | Drain app abscess, open | 10.14 | NA | 5.96 | 0.84 | NA | 16.94 | 090 | ||||||||||||
| 44901 | A | Drain app abscess, percut | 3.38 | NA | 5.01 | 0.17 | NA | 8.56 | 000 | ||||||||||||
| 44950 | A | Appendectomy | 10.00 | NA | 5.31 | 0.88 | NA | 16.19 | 090 | ||||||||||||
| 44955 | A | Appendectomy add-on | 1.53 | NA | 0.57 | 0.16 | NA | 2.26 | ZZZ | ||||||||||||
| 44960 | A | Appendectomy | 12.34 | NA | 6.50 | 1.09 | NA | 19.93 | 090 | ||||||||||||
| 44970 | A | Laparoscopy, appendectomy | 8.70 | NA | 4.21 | 0.88 | NA | 13.79 | 090 | ||||||||||||
| 44979 | C | Laparoscope proc, app | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 45000 | A | Drainage of pelvic abscess | 4.52 | NA | 3.80 | 0.37 | NA | 8.69 | 090 | ||||||||||||
| 45005 | A | Drainage of rectal abscess | 1.99 | 4.58 | 1.62 | 0.18 | 6.75 | 3.79 | 010 | ||||||||||||
| 45020 | A | Drainage of rectal abscess | 4.72 | NA | 4.21 | 0.41 | NA | 9.34 | 090 | ||||||||||||
| 45100 | A | Biopsy of rectum | 3.68 | 4.86 | 2.12 | 0.33 | 8.87 | 6.13 | 090 | ||||||||||||
| 45108 | A | Removal of anorectal lesion | 4.76 | 6.40 | 2.95 | 0.46 | 11.62 | 8.17 | 090 | ||||||||||||
| 45110 | A | Removal of rectum | 28.00 | NA | 13.26 | 2.26 | NA | 43.52 | 090 | ||||||||||||
| 45111 | A | Partial removal of rectum | 16.48 | NA | 8.78 | 1.60 | NA | 26.86 | 090 | ||||||||||||
| 45112 | A | Removal of rectum | 30.54 | NA | 13.70 | 2.35 | NA | 46.59 | 090 | ||||||||||||
| 45113 | A | Partial proctectomy | 30.58 | NA | 13.39 | 2.13 | NA | 46.10 | 090 | ||||||||||||
| 45114 | A | Partial removal of rectum | 27.32 | NA | 12.61 | 2.28 | NA | 42.21 | 090 | ||||||||||||
| 45116 | A | Partial removal of rectum | 24.58 | NA | 11.58 | 2.00 | NA | 38.16 | 090 | ||||||||||||
| 45119 | A | Remove rectum w/reservoir | 30.84 | NA | 13.25 | 2.13 | NA | 46.22 | 090 | ||||||||||||
| 45120 | A | Removal of rectum | 24.60 | NA | 11.63 | 2.28 | NA | 38.51 | 090 | ||||||||||||
| 45121 | A | Removal of rectum and colon | 27.04 | NA | 12.53 | 2.66 | NA | 42.23 | 090 | ||||||||||||
| 45123 | A | Partial proctectomy | 16.71 | NA | 8.21 | 1.04 | NA | 25.96 | 090 | ||||||||||||
| 45126 | A | Pelvic exenteration | 45.16 | NA | 19.12 | 3.23 | NA | 67.51 | 090 | ||||||||||||
| 45130 | A | Excision of rectal prolapse | 16.44 | NA | 7.80 | 1.12 | NA | 25.36 | 090 | ||||||||||||
| 45135 | A | Excision of rectal prolapse | 19.28 | NA | 9.10 | 1.52 | NA | 29.90 | 090 | ||||||||||||
| 45136 | A | Excise ileoanal reservoir | 27.30 | NA | 12.66 | 2.19 | NA | 42.15 | 090 | ||||||||||||
| 45150 | A | Excision of rectal stricture | 5.67 | 5.89 | 3.19 | 0.46 | 12.02 | 9.32 | 090 | ||||||||||||
| 45160 | A | Excision of rectal lesion | 15.32 | NA | 7.14 | 1.07 | NA | 23.53 | 090 | ||||||||||||
| 45170 | A | Excision of rectal lesion | 11.49 | NA | 5.89 | 0.89 | NA | 18.27 | 090 | ||||||||||||
| 45190 | A | Destruction, rectal tumor | 9.74 | NA | 5.33 | 0.76 | NA | 15.83 | 090 | ||||||||||||
| 45300 | A | Proctosigmoidoscopy dx | 0.38 | 1.34 | 0.23 | 0.05 | 1.77 | 0.66 | 000 | ||||||||||||
| 45303 | A | Proctosigmoidoscopy dilate | 0.44 | 1.55 | 0.27 | 0.06 | 2.05 | 0.77 | 000 | ||||||||||||
| 45305 | A | Protosigmoidoscopy w/bx | 1.01 | 1.64 | 0.46 | 0.09 | 2.74 | 1.56 | 000 | ||||||||||||
| 45307 | A | Protosigmoidoscopy fb | 0.94 | 2.68 | 0.44 | 0.15 | 3.77 | 1.53 | 000 | ||||||||||||
| 45308 | A | Protosigmoidoscopy removal | 0.83 | 1.59 | 0.39 | 0.13 | 2.55 | 1.35 | 000 | ||||||||||||
| 45309 | A | Protosigmoidoscopy removal | 2.01 | 2.43 | 0.81 | 0.17 | 4.61 | 2.99 | 000 | ||||||||||||
| 45315 | A | Protosigmoidoscopy removal | 1.40 | 2.84 | 0.60 | 0.20 | 4.44 | 2.20 | 000 | ||||||||||||
| 45317 | A | Protosigmoidoscopy bleed | 1.50 | 1.94 | 0.63 | 0.20 | 3.64 | 2.33 | 000 | ||||||||||||
| 45320 | A | Protosigmoidoscopy ablate | 1.58 | 1.88 | 0.68 | 0.20 | 3.66 | 2.46 | 000 | ||||||||||||
| 45321 | A | Protosigmoidoscopy volvul | 1.17 | NA | 0.52 | 0.17 | NA | 1.86 | 000 | ||||||||||||
| 45327 | A | Proctosigmoidoscopy w/stent | 1.65 | NA | 0.89 | 0.10 | NA | 2.64 | 000 | ||||||||||||
| 45330 | A | Diagnostic sigmoidoscopy | 0.96 | 1.92 | 0.53 | 0.05 | 2.93 | 1.54 | 000 | ||||||||||||
| 45331 | A | Sigmoidoscopy and biopsy | 1.15 | 2.38 | 0.54 | 0.07 | 3.60 | 1.76 | 000 | ||||||||||||
| 45332 | A | Sigmoidoscopy w/fb removal | 1.79 | 4.36 | 0.76 | 0.11 | 6.26 | 2.66 | 000 | ||||||||||||
| 45333 | A | Sigmoidoscopy polypectomy | 1.79 | 3.93 | 0.77 | 0.12 | 5.84 | 2.68 | 000 | ||||||||||||
| 45334 | A | Sigmoidoscopy for bleeding | 2.73 | NA | 1.12 | 0.16 | NA | 4.01 | 000 | ||||||||||||
| 45337 | A | Sigmoidoscopy decompress | 2.36 | NA | 0.97 | 0.15 | NA | 3.48 | 000 | ||||||||||||
| 45338 | A | Sigmoidoscpy w/tumr remove | 2.34 | 4.75 | 0.97 | 0.15 | 7.24 | 3.46 | 000 | ||||||||||||
| 45339 | A | Sigmoidoscopy w/ablate tumr | 3.14 | 3.62 | 1.27 | 0.17 | 6.93 | 4.58 | 000 | ||||||||||||
| 45341 | A | Sigmoidoscopy w/ultrasound | 2.60 | NA | 1.40 | 0.20 | NA | 4.20 | 000 | ||||||||||||
| 45342 | A | Sigmoidoscopy w/us guide bx | 4.06 | NA | 1.85 | 0.23 | NA | 6.14 | 000 | ||||||||||||
| 45345 | A | Sigmodoscopy w/stent | 2.92 | NA | 1.44 | 0.15 | NA | 4.51 | 000 | ||||||||||||
| 45355 | A | Surgical colonoscopy | 3.52 | NA | 1.28 | 0.26 | NA | 5.06 | 000 | ||||||||||||
| 45378 | A | Diagnostic colonoscopy | 3.70 | 8.79 | 1.77 | 0.20 | 12.69 | 5.67 | 000 | ||||||||||||
| 45378 | 53 | A | Diagnostic colonoscopy | 0.96 | 1.92 | 0.53 | 0.05 | 2.93 | 1.54 | 000 | |||||||||||
| 45379 | A | Colonoscopy w/fb removal | 4.69 | 8.25 | 2.13 | 0.25 | 13.19 | 7.07 | 000 | ||||||||||||
| 45380 | A | Colonoscopy and biopsy | 4.44 | 9.28 | 2.05 | 0.21 | 13.93 | 6.70 | 000 | ||||||||||||
| 45382 | A | Colonoscopy/control bleeding | 5.69 | 10.32 | 2.29 | 0.27 | 16.28 | 8.25 | 000 | ||||||||||||
| 45383 | A | Lesion removal colonoscopy | 5.87 | 10.01 | 2.56 | 0.32 | 16.20 | 8.75 | 000 | ||||||||||||
| 45384 | A | Lesion remove colonoscopy | 4.70 | 9.74 | 2.14 | 0.24 | 14.68 | 7.08 | 000 | ||||||||||||
| 45385 | A | Lesion removal colonoscopy | 5.31 | 10.19 | 2.36 | 0.28 | 15.78 | 7.95 | 000 | ||||||||||||
| 45387 | A | Colonoscopy w/stent | 5.91 | NA | 2.57 | 0.33 | NA | 8.81 | 000 | ||||||||||||
| 45500 | A | Repair of rectum | 7.29 | NA | 4.24 | 0.56 | NA | 12.09 | 090 | ||||||||||||
| 45505 | A | Repair of rectum | 7.58 | NA | 3.86 | 0.50 | NA | 11.94 | 090 | ||||||||||||
| 45520 | A | Treatment of rectal prolapse | 0.55 | 0.77 | 0.20 | 0.04 | 1.36 | 0.79 | 000 | ||||||||||||
| 45540 | A | Correct rectal prolapse | 16.27 | NA | 8.18 | 1.17 | NA | 25.62 | 090 | ||||||||||||
| 45541 | A | Correct rectal prolapse | 13.40 | NA | 7.03 | 0.88 | NA | 21.31 | 090 | ||||||||||||
| 45550 | A | Repair rectum/remove sigmoid | 23.00 | NA | 10.40 | 1.58 | NA | 34.98 | 090 | ||||||||||||
| 45560 | A | Repair of rectocele | 10.58 | NA | 6.12 | 0.73 | NA | 17.43 | 090 | ||||||||||||
| 45562 | A | Exploration/repair of rectum | 15.38 | NA | 7.52 | 1.15 | NA | 24.05 | 090 | ||||||||||||
| 45563 | A | Exploration/repair of rectum | 23.47 | NA | 11.34 | 1.84 | NA | 36.65 | 090 | ||||||||||||
| 45800 | A | Repair rect/bladder fistula | 17.77 | NA | 8.23 | 1.14 | NA | 27.14 | 090 | ||||||||||||
| 45805 | A | Repair fistula w/colostomy | 20.78 | NA | 10.72 | 1.47 | NA | 32.97 | 090 | ||||||||||||
| 45820 | A | Repair rectourethral fistula | 18.48 | NA | 8.55 | 1.17 | NA | 28.20 | 090 | ||||||||||||
| 45825 | A | Repair fistula w/colostomy | 21.25 | NA | 10.57 | 0.97 | NA | 32.79 | 090 | ||||||||||||
| 45900 | A | Reduction of rectal prolapse | 2.61 | NA | 1.04 | 0.17 | NA | 3.82 | 010 | ||||||||||||
| 45905 | A | Dilation of anal sphincter | 2.30 | 12.19 | 0.96 | 0.14 | 14.63 | 3.40 | 010 | ||||||||||||
| 45910 | A | Dilation of rectal narrowing | 2.80 | 17.62 | 1.15 | 0.14 | 20.56 | 4.09 | 010 | ||||||||||||
| 45915 | A | Remove rectal obstruction | 3.14 | 4.89 | 1.16 | 0.17 | 8.20 | 4.47 | 010 | ||||||||||||
| 45999 | C | Rectum surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 46020 | A | Placement of seton | 2.90 | 3.09 | 2.36 | 0.22 | 6.21 | 5.48 | 010 | ||||||||||||
| 46030 | A | Removal of rectal marker | 1.23 | 2.90 | 1.22 | 0.11 | 4.24 | 2.56 | 010 | ||||||||||||
| 46040 | A | Incision of rectal abscess | 4.96 | 5.57 | 3.15 | 0.48 | 11.01 | 8.59 | 090 | ||||||||||||
| 46045 | A | Incision of rectal abscess | 4.32 | NA | 2.88 | 0.40 | NA | 7.60 | 090 | ||||||||||||
| 46050 | A | Incision of anal abscess | 1.19 | 3.68 | 1.37 | 0.11 | 4.98 | 2.67 | 010 | ||||||||||||
| 46060 | A | Incision of rectal abscess | 5.69 | NA | 3.83 | 0.52 | NA | 10.04 | 090 | ||||||||||||
| 46070 | A | Incision of anal septum | 2.71 | NA | 2.54 | 0.27 | NA | 5.52 | 090 | ||||||||||||
| 46080 | A | Incision of anal sphincter | 2.49 | 3.81 | 1.65 | 0.23 | 6.53 | 4.37 | 010 | ||||||||||||
| 46083 | A | Incise external hemorrhoid | 1.40 | 4.78 | 1.59 | 0.12 | 6.30 | 3.11 | 010 | ||||||||||||
| 46200 | A | Removal of anal fissure | 3.42 | 4.01 | 2.42 | 0.30 | 7.73 | 6.14 | 090 | ||||||||||||
| 46210 | A | Removal of anal crypt | 2.67 | 5.12 | 2.17 | 0.26 | 8.05 | 5.10 | 090 | ||||||||||||
| 46211 | A | Removal of anal crypts | 4.25 | 4.97 | 3.10 | 0.37 | 9.59 | 7.72 | 090 | ||||||||||||
| 46220 | A | Removal of anal tab | 1.56 | 1.32 | 0.56 | 0.14 | 3.02 | 2.26 | 010 | ||||||||||||
| 46221 | A | Ligation of hemorrhoid(s) | 2.04 | 1.80 | 1.12 | 0.12 | 3.96 | 3.28 | 010 | ||||||||||||
| 46230 | A | Removal of anal tabs | 2.57 | 4.38 | 1.69 | 0.22 | 7.17 | 4.48 | 010 | ||||||||||||
| 46250 | A | Hemorrhoidectomy | 3.89 | 5.59 | 2.71 | 0.43 | 9.91 | 7.03 | 090 | ||||||||||||
| 46255 | A | Hemorrhoidectomy | 4.60 | 6.45 | 2.96 | 0.51 | 11.56 | 8.07 | 090 | ||||||||||||
| 46257 | A | Remove hemorrhoids fissure | 5.40 | NA | 3.12 | 0.59 | NA | 9.11 | 090 | ||||||||||||
| 46258 | A | Remove hemorrhoids fistula | 5.73 | NA | 3.30 | 0.64 | NA | 9.67 | 090 | ||||||||||||
| 46260 | A | Hemorrhoidectomy | 6.37 | NA | 4.04 | 0.68 | NA | 11.09 | 090 | ||||||||||||
| 46261 | A | Remove hemorrhoids fissure | 7.08 | NA | 4.19 | 0.70 | NA | 11.97 | 090 | ||||||||||||
| 46262 | A | Remove hemorrhoids fistula | 7.50 | NA | 4.35 | 0.76 | NA | 12.61 | 090 | ||||||||||||
| 46270 | A | Removal of anal fistula | 3.72 | 5.23 | 2.65 | 0.36 | 9.31 | 6.73 | 090 | ||||||||||||
| 46275 | A | Removal of anal fistula | 4.56 | 4.65 | 2.85 | 0.40 | 9.61 | 7.81 | 090 | ||||||||||||
| 46280 | A | Removal of anal fistula | 5.98 | NA | 3.83 | 0.50 | NA | 10.31 | 090 | ||||||||||||
| 46285 | A | Removal of anal fistula | 4.09 | 4.28 | 2.69 | 0.34 | 8.71 | 7.12 | 090 | ||||||||||||
| 46288 | A | Repair anal fistula | 7.13 | NA | 4.25 | 0.60 | NA | 11.98 | 090 | ||||||||||||
| 46320 | A | Removal of hemorrhoid clot | 1.61 | 4.00 | 1.57 | 0.14 | 5.75 | 3.32 | 010 | ||||||||||||
| 46500 | A | Injection into hemorrhoid(s) | 1.61 | 2.89 | 0.58 | 0.12 | 4.62 | 2.31 | 010 | ||||||||||||
| 46600 | A | Diagnostic anoscopy | 0.50 | 0.82 | 0.15 | 0.04 | 1.36 | 0.69 | 000 | ||||||||||||
| 46604 | A | Anoscopy and dilation | 1.31 | 0.99 | 0.47 | 0.09 | 2.39 | 1.87 | 000 | ||||||||||||
| 46606 | A | Anoscopy and biopsy | 0.81 | 0.87 | 0.29 | 0.07 | 1.75 | 1.17 | 000 | ||||||||||||
| 46608 | A | Anoscopy/remove for body | 1.51 | 1.81 | 0.49 | 0.13 | 3.45 | 2.13 | 000 | ||||||||||||
| 46610 | A | Anoscopy/remove lesion | 1.32 | 1.46 | 0.48 | 0.12 | 2.90 | 1.92 | 000 | ||||||||||||
| 46611 | A | Anoscopy | 1.81 | 2.07 | 0.65 | 0.15 | 4.03 | 2.61 | 000 | ||||||||||||
| 46612 | A | Anoscopy/ remove lesions | 2.34 | 2.65 | 0.85 | 0.18 | 5.17 | 3.37 | 000 | ||||||||||||
| 46614 | A | Anoscopy/control bleeding | 2.01 | 1.90 | 0.71 | 0.14 | 4.05 | 2.86 | 000 | ||||||||||||
| 46615 | A | Anoscopy | 2.68 | 1.76 | 0.96 | 0.23 | 4.67 | 3.87 | 000 | ||||||||||||
| 46700 | A | Repair of anal stricture | 9.13 | NA | 4.78 | 0.56 | NA | 14.47 | 090 | ||||||||||||
| 46705 | A | Repair of anal stricture | 6.90 | NA | 4.53 | 0.73 | NA | 12.16 | 090 | ||||||||||||
| 46715 | A | Repair of anovaginal fistula | 7.20 | NA | 4.46 | 0.76 | NA | 12.42 | 090 | ||||||||||||
| 46716 | A | Repair of anovaginal fistula | 15.07 | NA | 8.05 | 1.30 | NA | 24.42 | 090 | ||||||||||||
| 46730 | A | Construction of absent anus | 26.75 | NA | 12.25 | 2.03 | NA | 41.03 | 090 | ||||||||||||
| 46735 | A | Construction of absent anus | 32.17 | NA | 15.49 | 2.64 | NA | 50.30 | 090 | ||||||||||||
| 46740 | A | Construction of absent anus | 30.00 | NA | 14.61 | 1.99 | NA | 46.60 | 090 | ||||||||||||
| 46742 | A | Repair of imperforated anus | 35.80 | NA | 18.31 | 2.63 | NA | 56.74 | 090 | ||||||||||||
| 46744 | A | Repair of cloacal anomaly | 52.63 | NA | 22.78 | 2.27 | NA | 77.68 | 090 | ||||||||||||
| 46746 | A | Repair of cloacal anomaly | 58.22 | NA | 27.19 | 2.51 | NA | 87.92 | 090 | ||||||||||||
| 46748 | A | Repair of cloacal anomaly | 64.21 | NA | 29.58 | 2.77 | NA | 96.56 | 090 | ||||||||||||
| 46750 | A | Repair of anal sphincter | 10.25 | NA | 5.79 | 0.69 | NA | 16.73 | 090 | ||||||||||||
| 46751 | A | Repair of anal sphincter | 8.77 | NA | 6.14 | 0.78 | NA | 15.69 | 090 | ||||||||||||
| 46753 | A | Reconstruction of anus | 8.29 | NA | 4.13 | 0.58 | NA | 13.00 | 090 | ||||||||||||
| 46754 | A | Removal of suture from anus | 2.20 | 5.36 | 1.43 | 0.12 | 7.68 | 3.75 | 010 | ||||||||||||
| 46760 | A | Repair of anal sphincter | 14.43 | NA | 7.07 | 0.86 | NA | 22.36 | 090 | ||||||||||||
| 46761 | A | Repair of anal sphincter | 13.84 | NA | 6.87 | 0.84 | NA | 21.55 | 090 | ||||||||||||
| 46762 | A | Implant artificial sphincter | 12.71 | NA | 6.08 | 0.71 | NA | 19.50 | 090 | ||||||||||||
| 46900 | A | Destruction, anal lesion(s) | 1.91 | 3.52 | 0.74 | 0.13 | 5.56 | 2.78 | 010 | ||||||||||||
| 46910 | A | Destruction, anal lesion(s) | 1.86 | 3.81 | 1.48 | 0.14 | 5.81 | 3.48 | 010 | ||||||||||||
| 46916 | A | Cryosurgery, anal lesion(s) | 1.86 | 3.24 | 1.68 | 0.09 | 5.19 | 3.63 | 010 | ||||||||||||
| 46917 | A | Laser surgery, anal lesions | 1.86 | 5.32 | 1.62 | 0.16 | 7.34 | 3.64 | 010 | ||||||||||||
| 46922 | A | Excision of anal lesion(s) | 1.86 | 3.96 | 1.46 | 0.17 | 5.99 | 3.49 | 010 | ||||||||||||
| 46924 | A | Destruction, anal lesion(s) | 2.76 | 4.81 | 1.77 | 0.20 | 7.77 | 4.73 | 010 | ||||||||||||
| 46934 | A | Destruction of hemorrhoids | 3.51 | 6.62 | 3.77 | 0.26 | 10.39 | 7.54 | 090 | ||||||||||||
| 46935 | A | Destruction of hemorrhoids | 2.43 | 4.60 | 0.87 | 0.17 | 7.20 | 3.47 | 010 | ||||||||||||
| 46936 | A | Destruction of hemorrhoids | 3.69 | 6.67 | 3.58 | 0.30 | 10.66 | 7.57 | 090 | ||||||||||||
| 46937 | A | Cryotherapy of rectal lesion | 2.69 | 4.51 | 1.72 | 0.12 | 7.32 | 4.53 | 010 | ||||||||||||
| 46938 | A | Cryotherapy of rectal lesion | 4.66 | 6.22 | 3.27 | 0.40 | 11.28 | 8.33 | 090 | ||||||||||||
| 46940 | A | Treatment of anal fissure | 2.32 | 3.47 | 0.83 | 0.17 | 5.96 | 3.32 | 010 | ||||||||||||
| 46942 | A | Treatment of anal fissure | 2.04 | 2.84 | 0.71 | 0.14 | 5.02 | 2.89 | 010 | ||||||||||||
| 46945 | A | Ligation of hemorrhoids | 1.84 | 4.04 | 2.29 | 0.17 | 6.05 | 4.30 | 090 | ||||||||||||
| 46946 | A | Ligation of hemorrhoids | 2.58 | 5.40 | 2.61 | 0.22 | 8.20 | 5.41 | 090 | ||||||||||||
| 46999 | C | Anus surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 47000 | A | Needle biopsy of liver | 1.90 | 8.36 | 0.67 | 0.09 | 10.35 | 2.66 | 000 | ||||||||||||
| 47001 | A | Needle biopsy, liver add-on | 1.90 | NA | 0.68 | 0.18 | NA | 2.76 | ZZZ | ||||||||||||
| 47010 | A | Open drainage, liver lesion | 16.01 | NA | 9.60 | 0.65 | NA | 26.26 | 090 | ||||||||||||
| 47011 | A | Percut drain, liver lesion | 3.70 | NA | 4.61 | 0.17 | NA | 8.48 | 000 | ||||||||||||
| 47015 | A | Inject/aspirate liver cyst | 15.11 | NA | 8.23 | 0.86 | NA | 24.20 | 090 | ||||||||||||
| 47100 | A | Wedge biopsy of liver | 11.67 | NA | 6.50 | 0.75 | NA | 18.92 | 090 | ||||||||||||
| 47120 | A | Partial removal of liver | 35.50 | NA | 17.02 | 2.29 | NA | 54.81 | 090 | ||||||||||||
| 47122 | A | Extensive removal of liver | 55.13 | NA | 24.11 | 3.60 | NA | 82.84 | 090 | ||||||||||||
| 47125 | A | Partial removal of liver | 49.19 | NA | 22.12 | 3.18 | NA | 74.49 | 090 | ||||||||||||
| 47130 | A | Partial removal of liver | 53.35 | NA | 23.49 | 3.47 | NA | 80.31 | 090 | ||||||||||||
| 47133 | X | Removal of donor liver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 47134 | R | Partial removal, donor liver | 39.15 | NA | 13.91 | 3.98 | NA | 57.04 | XXX | ||||||||||||
| 47135 | R | Transplantation of liver | 81.52 | NA | 43.28 | 8.13 | NA | 132.93 | 090 | ||||||||||||
| 47136 | R | Transplantation of liver | 68.60 | NA | 47.00 | 6.93 | NA | 122.53 | 090 | ||||||||||||
| 47300 | A | Surgery for liver lesion | 15.08 | NA | 7.75 | 0.97 | NA | 23.80 | 090 | ||||||||||||
| 47350 | A | Repair liver wound | 19.56 | NA | 9.45 | 1.25 | NA | 30.26 | 090 | ||||||||||||
| 47360 | A | Repair liver wound | 26.92 | NA | 12.96 | 1.71 | NA | 41.59 | 090 | ||||||||||||
| 47361 | A | Repair liver wound | 47.12 | NA | 19.94 | 3.11 | NA | 70.17 | 090 | ||||||||||||
| 47362 | A | Repair liver wound | 18.51 | NA | 9.77 | 1.22 | NA | 29.50 | 090 | ||||||||||||
| 47370 | A | Laparo ablate liver tumor rf | 18.00 | 7.19 | 7.19 | 0.85 | 26.04 | 26.04 | 090 | ||||||||||||
| 47371 | A | Laparo ablate liver cryosug | 16.94 | 6.76 | 6.76 | 0.85 | 24.55 | 24.55 | 090 | ||||||||||||
| 47379 | C | Laparoscope procedure, liver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 47380 | A | Open ablate liver tumor rf | 21.25 | 8.48 | 8.48 | 0.85 | 30.58 | 30.58 | 090 | ||||||||||||
| 47381 | A | Open ablate liver tumor cryo | 21.00 | 8.38 | 8.38 | 0.85 | 30.23 | 30.23 | 090 | ||||||||||||
| 47382 | A | Percut ablate liver rf | 12.00 | NA | 5.37 | 0.85 | NA | 18.22 | 010 | ||||||||||||
| 47399 | C | Liver surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 47400 | A | Incision of liver duct | 32.49 | NA | 14.99 | 1.82 | NA | 49.30 | 090 | ||||||||||||
| 47420 | A | Incision of bile duct | 19.88 | NA | 9.46 | 1.70 | NA | 31.04 | 090 | ||||||||||||
| 47425 | A | Incision of bile duct | 19.83 | NA | 9.38 | 1.60 | NA | 30.81 | 090 | ||||||||||||
| 47460 | A | Incise bile duct sphincter | 18.04 | NA | 9.26 | 1.24 | NA | 28.54 | 090 | ||||||||||||
| 47480 | A | Incision of gallbladder | 10.82 | NA | 6.80 | 0.85 | NA | 18.47 | 090 | ||||||||||||
| 47490 | A | Incision of gallbladder | 7.23 | NA | 7.67 | 0.33 | NA | 15.23 | 090 | ||||||||||||
| 47500 | A | Injection for liver x-rays | 1.96 | NA | 0.68 | 0.09 | NA | 2.73 | 000 | ||||||||||||
| 47505 | A | Injection for liver x-rays | 0.76 | 2.88 | 0.26 | 0.03 | 3.67 | 1.05 | 000 | ||||||||||||
| 47510 | A | Insert catheter, bile duct | 7.83 | NA | 9.46 | 0.36 | NA | 17.65 | 090 | ||||||||||||
| 47511 | A | Insert bile duct drain | 10.50 | NA | 10.57 | 0.47 | NA | 21.54 | 090 | ||||||||||||
| 47525 | A | Change bile duct catheter | 5.55 | NA | 3.34 | 0.24 | NA | 9.13 | 010 | ||||||||||||
| 47530 | A | Revise/reinsert bile tube | 5.85 | NA | 5.07 | 0.29 | NA | 11.21 | 090 | ||||||||||||
| 47550 | A | Bile duct endoscopy add-on | 3.02 | NA | 1.08 | 0.30 | NA | 4.40 | ZZZ | ||||||||||||
| 47552 | A | Biliary endoscopy thru skin | 6.04 | NA | 2.52 | 0.42 | NA | 8.98 | 000 | ||||||||||||
| 47553 | A | Biliary endoscopy thru skin | 6.35 | NA | 2.70 | 0.30 | NA | 9.35 | 000 | ||||||||||||
| 47554 | A | Biliary endoscopy thru skin | 9.06 | NA | 3.55 | 0.74 | NA | 13.35 | 000 | ||||||||||||
| 47555 | A | Biliary endoscopy thru skin | 7.56 | NA | 3.15 | 0.35 | NA | 11.06 | 000 | ||||||||||||
| 47556 | A | Biliary endoscopy thru skin | 8.56 | NA | 3.49 | 0.38 | NA | 12.43 | 000 | ||||||||||||
| 47560 | A | Laparoscopy w/cholangio | 4.89 | NA | 1.89 | 0.49 | NA | 7.27 | 000 | ||||||||||||
| 47561 | A | Laparo w/cholangio/biopsy | 5.18 | NA | 2.19 | 0.49 | NA | 7.86 | 000 | ||||||||||||
| 47562 | A | Laparoscopic cholecystectomy | 11.09 | NA | 5.15 | 1.13 | NA | 17.37 | 090 | ||||||||||||
| 47563 | A | Laparo cholecystectomy/graph | 11.94 | NA | 5.43 | 1.21 | NA | 18.58 | 090 | ||||||||||||
| 47564 | A | Laparo cholecystectomy/explr | 14.23 | NA | 6.26 | 1.44 | NA | 21.93 | 090 | ||||||||||||
| 47570 | A | Laparo cholecystoenterostomy | 12.58 | NA | 5.67 | 1.28 | NA | 19.53 | 090 | ||||||||||||
| 47579 | C | Laparoscope proc, biliary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 47600 | A | Removal of gallbladder | 13.58 | NA | 6.86 | 1.16 | NA | 21.60 | 090 | ||||||||||||
| 47605 | A | Removal of gallbladder | 14.69 | NA | 7.23 | 1.25 | NA | 23.17 | 090 | ||||||||||||
| 47610 | A | Removal of gallbladder | 18.82 | NA | 8.80 | 1.61 | NA | 29.23 | 090 | ||||||||||||
| 47612 | A | Removal of gallbladder | 18.78 | NA | 8.70 | 1.60 | NA | 29.08 | 090 | ||||||||||||
| 47620 | A | Removal of gallbladder | 20.64 | NA | 9.35 | 1.77 | NA | 31.76 | 090 | ||||||||||||
| 47630 | A | Remove bile duct stone | 9.11 | NA | 3.20 | 0.46 | NA | 12.77 | 090 | ||||||||||||
| 47700 | A | Exploration of bile ducts | 15.62 | NA | 8.79 | 1.40 | NA | 25.81 | 090 | ||||||||||||
| 47701 | A | Bile duct revision | 27.81 | NA | 13.60 | 3.00 | NA | 44.41 | 090 | ||||||||||||
| 47711 | A | Excision of bile duct tumor | 23.03 | NA | 11.34 | 1.98 | NA | 36.35 | 090 | ||||||||||||
| 47712 | A | Excision of bile duct tumor | 30.24 | NA | 14.00 | 2.67 | NA | 46.91 | 090 | ||||||||||||
| 47715 | A | Excision of bile duct cyst | 18.80 | NA | 8.95 | 1.59 | NA | 29.34 | 090 | ||||||||||||
| 47716 | A | Fusion of bile duct cyst | 16.44 | NA | 8.19 | 1.41 | NA | 26.04 | 090 | ||||||||||||
| 47720 | A | Fuse gallbladder bowel | 15.91 | NA | 8.66 | 1.37 | NA | 25.94 | 090 | ||||||||||||
| 47721 | A | Fuse upper gi structures | 19.12 | NA | 9.90 | 1.63 | NA | 30.65 | 090 | ||||||||||||
| 47740 | A | Fuse gallbladder bowel | 18.48 | NA | 9.64 | 1.59 | NA | 29.71 | 090 | ||||||||||||
| 47741 | A | Fuse gallbladder bowel | 21.34 | NA | 10.62 | 1.82 | NA | 33.78 | 090 | ||||||||||||
| 47760 | A | Fuse bile ducts and bowel | 25.85 | NA | 12.28 | 2.21 | NA | 40.34 | 090 | ||||||||||||
| 47765 | A | Fuse liver ducts bowel | 24.88 | NA | 12.73 | 2.18 | NA | 39.79 | 090 | ||||||||||||
| 47780 | A | Fuse bile ducts and bowel | 26.50 | NA | 12.49 | 2.27 | NA | 41.26 | 090 | ||||||||||||
| 47785 | A | Fuse bile ducts and bowel | 31.18 | NA | 14.97 | 2.69 | NA | 48.84 | 090 | ||||||||||||
| 47800 | A | Reconstruction of bile ducts | 23.30 | NA | 11.57 | 1.95 | NA | 36.82 | 090 | ||||||||||||
| 47801 | A | Placement, bile duct support | 15.17 | NA | 10.21 | 0.69 | NA | 26.07 | 090 | ||||||||||||
| 47802 | A | Fuse liver duct intestine | 21.55 | NA | 11.60 | 1.84 | NA | 34.99 | 090 | ||||||||||||
| 47900 | A | Suture bile duct injury | 19.90 | NA | 10.25 | 1.65 | NA | 31.80 | 090 | ||||||||||||
| 47999 | C | Bile tract surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 48000 | A | Drainage of abdomen | 28.07 | NA | 12.59 | 1.32 | NA | 41.98 | 090 | ||||||||||||
| 48001 | A | Placement of drain, pancreas | 35.45 | NA | 15.04 | 1.90 | NA | 52.39 | 090 | ||||||||||||
| 48005 | A | Resect/debride pancreas | 42.17 | NA | 17.39 | 2.26 | NA | 61.82 | 090 | ||||||||||||
| 48020 | A | Removal of pancreatic stone | 15.70 | NA | 7.44 | 1.36 | NA | 24.50 | 090 | ||||||||||||
| 48100 | A | Biopsy of pancreas, open | 12.23 | NA | 7.03 | 1.08 | NA | 20.34 | 090 | ||||||||||||
| 48102 | A | Needle biopsy, pancreas | 4.68 | 8.96 | 2.45 | 0.20 | 13.84 | 7.33 | 010 | ||||||||||||
| 48120 | A | Removal of pancreas lesion | 15.85 | NA | 7.69 | 1.35 | NA | 24.89 | 090 | ||||||||||||
| 48140 | A | Partial removal of pancreas | 22.94 | NA | 10.78 | 2.12 | NA | 35.84 | 090 | ||||||||||||
| 48145 | A | Partial removal of pancreas | 24.02 | NA | 11.48 | 2.25 | NA | 37.75 | 090 | ||||||||||||
| 48146 | A | Pancreatectomy | 26.40 | NA | 13.96 | 2.43 | NA | 42.79 | 090 | ||||||||||||
| 48148 | A | Removal of pancreatic duct | 17.34 | NA | 9.15 | 1.61 | NA | 28.10 | 090 | ||||||||||||
| 48150 | A | Partial removal of pancreas | 48.00 | NA | 21.29 | 4.43 | NA | 73.72 | 090 | ||||||||||||
| 48152 | A | Pancreatectomy | 43.75 | NA | 20.74 | 4.07 | NA | 68.56 | 090 | ||||||||||||
| 48153 | A | Pancreatectomy | 47.89 | NA | 22.18 | 4.40 | NA | 74.47 | 090 | ||||||||||||
| 48154 | A | Pancreatectomy | 44.10 | NA | 20.82 | 4.10 | NA | 69.02 | 090 | ||||||||||||
| 48155 | A | Removal of pancreas | 24.64 | NA | 13.89 | 2.30 | NA | 40.83 | 090 | ||||||||||||
| 48160 | N | Pancreas removal/transplant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 48180 | A | Fuse pancreas and bowel | 24.72 | NA | 11.16 | 2.24 | NA | 38.12 | 090 | ||||||||||||
| 48400 | A | Injection, intraop add-on | 1.95 | NA | 0.69 | 0.10 | NA | 2.74 | ZZZ | ||||||||||||
| 48500 | A | Surgery of pancreatic cyst | 15.28 | NA | 7.74 | 1.35 | NA | 24.37 | 090 | ||||||||||||
| 48510 | A | Drain pancreatic pseudocyst | 14.31 | NA | 7.45 | 1.07 | NA | 22.83 | 090 | ||||||||||||
| 48511 | A | Drain pancreatic pseudocyst | 4.00 | NA | 3.95 | 0.17 | NA | 8.12 | 000 | ||||||||||||
| 48520 | A | Fuse pancreas cyst and bowel | 15.59 | NA | 7.49 | 1.41 | NA | 24.49 | 090 | ||||||||||||
| 48540 | A | Fuse pancreas cyst and bowel | 19.72 | NA | 8.84 | 1.82 | NA | 30.38 | 090 | ||||||||||||
| 48545 | A | Pancreatorrhaphy | 18.18 | NA | 8.88 | 1.61 | NA | 28.67 | 090 | ||||||||||||
| 48547 | A | Duodenal exclusion | 25.83 | NA | 11.04 | 2.30 | NA | 39.17 | 090 | ||||||||||||
| 48550 | X | Donor pancreatectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 48554 | R | Transpl allograft pancreas | 34.17 | NA | 12.27 | 3.30 | NA | 49.74 | 090 | ||||||||||||
| 48556 | A | Removal, allograft pancreas | 15.71 | NA | 8.71 | 1.52 | NA | 25.94 | 090 | ||||||||||||
| 48999 | C | Pancreas surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 49000 | A | Exploration of abdomen | 11.68 | NA | 6.22 | 1.17 | NA | 19.07 | 090 | ||||||||||||
| 49002 | A | Reopening of abdomen | 10.49 | NA | 6.10 | 1.06 | NA | 17.65 | 090 | ||||||||||||
| 49010 | A | Exploration behind abdomen | 12.28 | NA | 7.05 | 1.22 | NA | 20.55 | 090 | ||||||||||||
| 49020 | A | Drain abdominal abscess | 22.84 | NA | 11.41 | 1.31 | NA | 35.56 | 090 | ||||||||||||
| 49021 | A | Drain abdominal abscess | 3.38 | NA | 5.84 | 0.16 | NA | 9.38 | 000 | ||||||||||||
| 49040 | A | Drain, open, abdom abscess | 13.52 | NA | 8.02 | 0.84 | NA | 22.38 | 090 | ||||||||||||
| 49041 | A | Drain, percut, abdom abscess | 4.00 | NA | 6.07 | 0.18 | NA | 10.25 | 000 | ||||||||||||
| 49060 | A | Drain, open, retrop abscess | 15.86 | NA | 9.62 | 0.77 | NA | 26.25 | 090 | ||||||||||||
| 49061 | A | Drain, percut, retroper absc | 3.70 | NA | 5.99 | 0.17 | NA | 9.86 | 000 | ||||||||||||
| 49062 | A | Drain to peritoneal cavity | 11.36 | NA | 7.06 | 1.08 | NA | 19.50 | 090 | ||||||||||||
| 49080 | A | Puncture, peritoneal cavity | 1.35 | 4.56 | 0.48 | 0.07 | 5.98 | 1.90 | 000 | ||||||||||||
| 49081 | A | Removal of abdominal fluid | 1.26 | 3.14 | 0.60 | 0.06 | 4.46 | 1.92 | 000 | ||||||||||||
| 49085 | A | Remove abdomen foreign body | 12.14 | NA | 6.72 | 0.88 | NA | 19.74 | 090 | ||||||||||||
| 49180 | A | Biopsy, abdominal mass | 1.73 | 8.50 | 0.60 | 0.08 | 10.31 | 2.41 | 000 | ||||||||||||
| 49200 | A | Removal of abdominal lesion | 10.25 | NA | 6.59 | 0.89 | NA | 17.73 | 090 | ||||||||||||
| 49201 | A | Removal of abdominal lesion | 14.84 | NA | 8.90 | 1.44 | NA | 25.18 | 090 | ||||||||||||
| 49215 | A | Excise sacral spine tumor | 33.50 | NA | 15.52 | 2.48 | NA | 51.50 | 090 | ||||||||||||
| 49220 | A | Multiple surgery, abdomen | 14.88 | NA | 7.94 | 1.51 | NA | 24.33 | 090 | ||||||||||||
| 49250 | A | Excision of umbilicus | 8.35 | NA | 5.26 | 0.84 | NA | 14.45 | 090 | ||||||||||||
| 49255 | A | Removal of omentum | 11.14 | NA | 6.66 | 1.12 | NA | 18.92 | 090 | ||||||||||||
| 49320 | A | Diag laparo separate proc | 5.10 | NA | 3.08 | 0.50 | NA | 8.68 | 010 | ||||||||||||
| 49321 | A | Laparoscopy, biopsy | 5.40 | NA | 3.07 | 0.53 | NA | 9.00 | 010 | ||||||||||||
| 49322 | A | Laparoscopy, aspiration | 5.70 | NA | 3.53 | 0.57 | NA | 9.80 | 010 | ||||||||||||
| 49323 | A | Laparo drain lymphocele | 9.48 | NA | 4.18 | 0.88 | NA | 14.54 | 090 | ||||||||||||
| 49329 | C | Laparo proc, abdm/per/oment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 49400 | A | Air injection into abdomen | 1.88 | NA | 0.82 | 0.11 | NA | 2.81 | 000 | ||||||||||||
| 49420 | A | Insert abdominal drain | 2.22 | NA | 0.98 | 0.13 | NA | 3.33 | 000 | ||||||||||||
| 49421 | A | Insert abdominal drain | 5.54 | NA | 4.08 | 0.55 | NA | 10.17 | 090 | ||||||||||||
| 49422 | A | Remove perm cannula/catheter | 6.25 | NA | 3.01 | 0.63 | NA | 9.89 | 010 | ||||||||||||
| 49423 | A | Exchange drainage catheter | 1.46 | NA | 0.70 | 0.07 | NA | 2.23 | 000 | ||||||||||||
| 49424 | A | Assess cyst, contrast inject | 0.76 | NA | 0.45 | 0.03 | NA | 1.24 | 000 | ||||||||||||
| 49425 | A | Insert abdomen-venous drain | 11.37 | NA | 6.79 | 1.21 | NA | 19.37 | 090 | ||||||||||||
| 49426 | A | Revise abdomen-venous shunt | 9.63 | NA | 6.17 | 0.93 | NA | 16.73 | 090 | ||||||||||||
| 49427 | A | Injection, abdominal shunt | 0.89 | NA | 0.50 | 0.05 | NA | 1.44 | 000 | ||||||||||||
| 49428 | A | Ligation of shunt | 6.06 | NA | 3.19 | 0.31 | NA | 9.56 | 010 | ||||||||||||
| 49429 | A | Removal of shunt | 7.40 | NA | 3.55 | 0.81 | NA | 11.76 | 010 | ||||||||||||
| 49491 | A | Repairing hern premie reduc | 11.13 | NA | 5.65 | 1.00 | NA | 17.78 | 090 | ||||||||||||
| 49492 | A | Rpr ing hern premie, blocked | 14.03 | NA | 6.40 | 1.42 | NA | 21.85 | 090 | ||||||||||||
| 49495 | A | Rpr ing hernia baby, reduc | 5.89 | NA | 3.72 | 0.55 | NA | 10.16 | 090 | ||||||||||||
| 49496 | A | Rpr ing hernia baby, blocked | 8.79 | NA | 5.94 | 0.89 | NA | 15.62 | 090 | ||||||||||||
| 49500 | A | Rpr ing hernia, init, reduce | 5.48 | NA | 3.48 | 0.46 | NA | 9.42 | 090 | ||||||||||||
| 49501 | A | Rpr ing hernia, init blocked | 8.88 | NA | 4.62 | 0.76 | NA | 14.26 | 090 | ||||||||||||
| 49505 | A | Rpr i/hern init reduc5 yr | 7.60 | 4.58 | 4.13 | 0.65 | 12.83 | 12.38 | 090 | ||||||||||||
| 49507 | A | Rpr i/hern init block5 yr | 9.57 | NA | 6.17 | 0.83 | NA | 16.57 | 090 | ||||||||||||
| 49520 | A | Rerepair ing hernia, reduce | 9.63 | NA | 5.49 | 0.84 | NA | 15.96 | 090 | ||||||||||||
| 49521 | A | Rerepair ing hernia, blocked | 11.97 | NA | 5.85 | 1.04 | NA | 18.86 | 090 | ||||||||||||
| 49525 | A | Repair ing hernia, sliding | 8.57 | NA | 4.97 | 0.74 | NA | 14.28 | 090 | ||||||||||||
| 49540 | A | Repair lumbar hernia | 10.39 | NA | 5.65 | 0.90 | NA | 16.94 | 090 | ||||||||||||
| 49550 | A | Rpr fem hernia, init, reduce | 8.63 | NA | 4.55 | 0.75 | NA | 13.93 | 090 | ||||||||||||
| 49553 | A | Rpr fem hernia, init blocked | 9.44 | NA | 4.95 | 0.83 | NA | 15.22 | 090 | ||||||||||||
| 49555 | A | Rerepair fem hernia, reduce | 9.03 | NA | 5.30 | 0.79 | NA | 15.12 | 090 | ||||||||||||
| 49557 | A | Rerepair fem hernia, blocked | 11.15 | NA | 5.59 | 0.97 | NA | 17.71 | 090 | ||||||||||||
| 49560 | A | Rpr ventral hern init, reduc | 11.57 | NA | 6.11 | 1.00 | NA | 18.68 | 090 | ||||||||||||
| 49561 | A | Rpr ventral hern init, block | 14.25 | NA | 6.71 | 1.23 | NA | 22.19 | 090 | ||||||||||||
| 49565 | A | Rerepair ventrl hern, reduce | 11.57 | NA | 6.27 | 1.00 | NA | 18.84 | 090 | ||||||||||||
| 49566 | A | Rerepair ventrl hern, block | 14.40 | NA | 6.79 | 1.24 | NA | 22.43 | 090 | ||||||||||||
| 49568 | A | Hernia repair w/mesh | 4.89 | NA | 1.76 | 0.50 | NA | 7.15 | ZZZ | ||||||||||||
| 49570 | A | Rpr epigastric hern, reduce | 5.69 | NA | 3.54 | 0.50 | NA | 9.73 | 090 | ||||||||||||
| 49572 | A | Rpr epigastric hern, blocked | 6.73 | NA | 4.00 | 0.58 | NA | 11.31 | 090 | ||||||||||||
| 49580 | A | Rpr umbil hern, reduc 5 yr | 4.11 | NA | 3.03 | 0.34 | NA | 7.48 | 090 | ||||||||||||
| 49582 | A | Rpr umbil hern, block 5 yr | 6.65 | NA | 5.02 | 0.57 | NA | 12.24 | 090 | ||||||||||||
| 49585 | A | Rpr umbil hern, reduc 5 yr | 6.23 | NA | 4.15 | 0.53 | NA | 10.91 | 090 | ||||||||||||
| 49587 | A | Rpr umbil hern, block 5 yr | 7.56 | NA | 4.27 | 0.65 | NA | 12.48 | 090 | ||||||||||||
| 49590 | A | Repair spigelian hernia | 8.54 | NA | 4.96 | 0.74 | NA | 14.24 | 090 | ||||||||||||
| 49600 | A | Repair umbilical lesion | 10.96 | NA | 6.30 | 1.13 | NA | 18.39 | 090 | ||||||||||||
| 49605 | A | Repair umbilical lesion | 76.00 | NA | 30.79 | 2.57 | NA | 109.36 | 090 | ||||||||||||
| 49606 | A | Repair umbilical lesion | 18.60 | NA | 9.61 | 2.22 | NA | 30.43 | 090 | ||||||||||||
| 49610 | A | Repair umbilical lesion | 10.50 | NA | 6.87 | 0.77 | NA | 18.14 | 090 | ||||||||||||
| 49611 | A | Repair umbilical lesion | 8.92 | NA | 6.56 | 0.65 | NA | 16.13 | 090 | ||||||||||||
| 49650 | A | Laparo hernia repair initial | 6.27 | NA | 3.33 | 0.64 | NA | 10.24 | 090 | ||||||||||||
| 49651 | A | Laparo hernia repair recur | 8.24 | NA | 4.40 | 0.84 | NA | 13.48 | 090 | ||||||||||||
| 49659 | C | Laparo proc, hernia repair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 49900 | A | Repair of abdominal wall | 12.28 | NA | 6.80 | 1.23 | NA | 20.31 | 090 | ||||||||||||
| 49905 | A | Omental flap | 6.55 | NA | 2.44 | 0.61 | NA | 9.60 | ZZZ | ||||||||||||
| 49906 | C | Free omental flap, microvasc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 49999 | C | Abdomen surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 50010 | A | Exploration of kidney | 10.98 | NA | 7.07 | 0.79 | NA | 18.84 | 090 | ||||||||||||
| 50020 | A | Renal abscess, open drain | 14.66 | NA | 13.72 | 0.80 | NA | 29.18 | 090 | ||||||||||||
| 50021 | A | Renal abscess, percut drain | 3.38 | NA | 10.46 | 0.15 | NA | 13.99 | 000 | ||||||||||||
| 50040 | A | Drainage of kidney | 14.94 | NA | 11.56 | 0.82 | NA | 27.32 | 090 | ||||||||||||
| 50045 | A | Exploration of kidney | 15.46 | NA | 8.55 | 1.06 | NA | 25.07 | 090 | ||||||||||||
| 50060 | A | Removal of kidney stone | 19.30 | NA | 10.03 | 1.14 | NA | 30.47 | 090 | ||||||||||||
| 50065 | A | Incision of kidney | 20.79 | NA | 10.56 | 1.13 | NA | 32.48 | 090 | ||||||||||||
| 50070 | A | Incision of kidney | 20.32 | NA | 10.70 | 1.20 | NA | 32.22 | 090 | ||||||||||||
| 50075 | A | Removal of kidney stone | 25.34 | NA | 12.65 | 1.51 | NA | 39.50 | 090 | ||||||||||||
| 50080 | A | Removal of kidney stone | 14.71 | NA | 11.03 | 0.86 | NA | 26.60 | 090 | ||||||||||||
| 50081 | A | Removal of kidney stone | 21.80 | NA | 13.27 | 1.30 | NA | 36.37 | 090 | ||||||||||||
| 50100 | A | Revise kidney blood vessels | 16.09 | NA | 9.34 | 1.64 | NA | 27.07 | 090 | ||||||||||||
| 50120 | A | Exploration of kidney | 15.91 | NA | 8.93 | 1.04 | NA | 25.88 | 090 | ||||||||||||
| 50125 | A | Explore and drain kidney | 16.52 | NA | 9.48 | 1.07 | NA | 27.07 | 090 | ||||||||||||
| 50130 | A | Removal of kidney stone | 17.29 | NA | 9.24 | 1.04 | NA | 27.57 | 090 | ||||||||||||
| 50135 | A | Exploration of kidney | 19.18 | NA | 9.93 | 1.18 | NA | 30.29 | 090 | ||||||||||||
| 50200 | A | Biopsy of kidney | 2.63 | NA | 0.96 | 0.12 | NA | 3.71 | 000 | ||||||||||||
| 50205 | A | Biopsy of kidney | 11.31 | NA | 6.52 | 0.94 | NA | 18.77 | 090 | ||||||||||||
| 50220 | A | Remove kidney, open | 17.15 | NA | 9.29 | 1.16 | NA | 27.60 | 090 | ||||||||||||
| 50225 | A | Removal kidney open, complex | 20.23 | NA | 10.30 | 1.26 | NA | 31.79 | 090 | ||||||||||||
| 50230 | A | Removal kidney open, radical | 22.07 | NA | 10.92 | 1.35 | NA | 34.34 | 090 | ||||||||||||
| 50234 | A | Removal of kidney ureter | 22.40 | NA | 11.05 | 1.37 | NA | 34.82 | 090 | ||||||||||||
| 50236 | A | Removal of kidney ureter | 24.86 | NA | 14.27 | 1.50 | NA | 40.63 | 090 | ||||||||||||
| 50240 | A | Partial removal of kidney | 22.00 | NA | 13.32 | 1.36 | NA | 36.68 | 090 | ||||||||||||
| 50280 | A | Removal of kidney lesion | 15.67 | NA | 8.69 | 0.99 | NA | 25.35 | 090 | ||||||||||||
| 50290 | A | Removal of kidney lesion | 14.73 | NA | 8.49 | 1.11 | NA | 24.33 | 090 | ||||||||||||
| 50300 | X | Removal of donor kidney | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 50320 | A | Removal of donor kidney | 22.21 | NA | 10.98 | 1.78 | NA | 34.97 | 090 | ||||||||||||
| 50340 | A | Removal of kidney | 12.15 | NA | 9.31 | 1.15 | NA | 22.61 | 090 | ||||||||||||
| 50360 | A | Transplantation of kidney | 31.53 | NA | 17.87 | 2.97 | NA | 52.37 | 090 | ||||||||||||
| 50365 | A | Transplantation of kidney | 36.81 | NA | 21.29 | 3.51 | NA | 61.61 | 090 | ||||||||||||
| 50370 | A | Remove transplanted kidney | 13.72 | NA | 9.88 | 1.26 | NA | 24.86 | 090 | ||||||||||||
| 50380 | A | Reimplantation of kidney | 20.76 | NA | 13.52 | 1.80 | NA | 36.08 | 090 | ||||||||||||
| 50390 | A | Drainage of kidney lesion | 1.96 | NA | 0.68 | 0.09 | NA | 2.73 | 000 | ||||||||||||
| 50392 | A | Insert kidney drain | 3.38 | NA | 1.18 | 0.15 | NA | 4.71 | 000 | ||||||||||||
| 50393 | A | Insert ureteral tube | 4.16 | NA | 1.44 | 0.18 | NA | 5.78 | 000 | ||||||||||||
| 50394 | A | Injection for kidney x-ray | 0.76 | 2.60 | 0.26 | 0.04 | 3.40 | 1.06 | 000 | ||||||||||||
| 50395 | A | Create passage to kidney | 3.38 | NA | 1.17 | 0.16 | NA | 4.71 | 000 | ||||||||||||
| 50396 | A | Measure kidney pressure | 2.09 | NA | 0.89 | 0.10 | NA | 3.08 | 000 | ||||||||||||
| 50398 | A | Change kidney tube | 1.46 | 1.06 | 0.51 | 0.07 | 2.59 | 2.04 | 000 | ||||||||||||
| 50400 | A | Revision of kidney/ureter | 19.50 | NA | 10.06 | 1.21 | NA | 30.77 | 090 | ||||||||||||
| 50405 | A | Revision of kidney/ureter | 23.93 | NA | 11.84 | 1.45 | NA | 37.22 | 090 | ||||||||||||
| 50500 | A | Repair of kidney wound | 19.57 | NA | 11.37 | 1.45 | NA | 32.39 | 090 | ||||||||||||
| 50520 | A | Close kidney-skin fistula | 17.23 | NA | 11.80 | 1.26 | NA | 30.29 | 090 | ||||||||||||
| 50525 | A | Repair renal-abdomen fistula | 22.27 | NA | 13.30 | 1.51 | NA | 37.08 | 090 | ||||||||||||
| 50526 | A | Repair renal-abdomen fistula | 24.02 | NA | 14.86 | 1.62 | NA | 40.50 | 090 | ||||||||||||
| 50540 | A | Revision of horseshoe kidney | 19.93 | NA | 10.42 | 1.28 | NA | 31.63 | 090 | ||||||||||||
| 50541 | A | Laparo ablate renal cyst | 16.00 | NA | 6.79 | 0.99 | NA | 23.78 | 090 | ||||||||||||
| 50544 | A | Laparoscopy, pyeloplasty | 22.40 | NA | 9.04 | 1.41 | NA | 32.85 | 090 | ||||||||||||
| 50545 | A | Laparo radical nephrectomy | 24.00 | NA | 9.65 | 1.53 | NA | 35.18 | 090 | ||||||||||||
| 50546 | A | Laparoscopic nephrectomy | 20.48 | NA | 8.40 | 1.37 | NA | 30.25 | 090 | ||||||||||||
| 50547 | A | Laparo removal donor kidney | 25.50 | NA | 11.27 | 2.04 | NA | 38.81 | 090 | ||||||||||||
| 50548 | A | Laparo remove k/ureter | 24.40 | NA | 9.70 | 1.49 | NA | 35.59 | 090 | ||||||||||||
| 50549 | C | Laparoscope proc, renal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 50551 | A | Kidney endoscopy | 5.60 | 4.93 | 1.90 | 0.33 | 10.86 | 7.83 | 000 | ||||||||||||
| 50553 | A | Kidney endoscopy | 5.99 | 16.25 | 2.05 | 0.35 | 22.59 | 8.39 | 000 | ||||||||||||
| 50555 | A | Kidney endoscopy biopsy | 6.53 | 20.11 | 2.25 | 0.38 | 27.02 | 9.16 | 000 | ||||||||||||
| 50557 | A | Kidney endoscopy treatment | 6.62 | 20.23 | 2.25 | 0.39 | 27.24 | 9.26 | 000 | ||||||||||||
| 50559 | A | Renal endoscopy/radiotracer | 6.78 | NA | 2.42 | 0.27 | NA | 9.47 | 000 | ||||||||||||
| 50561 | A | Kidney endoscopy treatment | 7.59 | 18.31 | 2.58 | 0.44 | 26.34 | 10.61 | 000 | ||||||||||||
| 50570 | A | Kidney endoscopy | 9.54 | NA | 3.24 | 0.56 | NA | 13.34 | 000 | ||||||||||||
| 50572 | A | Kidney endoscopy | 10.35 | NA | 3.52 | 0.64 | NA | 14.51 | 000 | ||||||||||||
| 50574 | A | Kidney endoscopy biopsy | 11.02 | NA | 3.87 | 0.65 | NA | 15.54 | 000 | ||||||||||||
| 50575 | A | Kidney endoscopy | 13.98 | NA | 4.73 | 0.84 | NA | 19.55 | 000 | ||||||||||||
| 50576 | A | Kidney endoscopy treatment | 10.99 | NA | 3.74 | 0.66 | NA | 15.39 | 000 | ||||||||||||
| 50578 | A | Renal endoscopy/radiotracer | 11.35 | NA | 4.01 | 0.67 | NA | 16.03 | 000 | ||||||||||||
| 50580 | A | Kidney endoscopy treatment | 11.86 | NA | 4.03 | 0.70 | NA | 16.59 | 000 | ||||||||||||
| 50590 | A | Fragmenting of kidney stone | 9.09 | 10.78 | 5.35 | 0.54 | 20.41 | 14.98 | 090 | ||||||||||||
| 50600 | A | Exploration of ureter | 15.84 | NA | 9.07 | 0.99 | NA | 25.90 | 090 | ||||||||||||
| 50605 | A | Insert ureteral support | 15.46 | NA | 8.88 | 1.13 | NA | 25.47 | 090 | ||||||||||||
| 50610 | A | Removal of ureter stone | 15.92 | NA | 9.09 | 1.08 | NA | 26.09 | 090 | ||||||||||||
| 50620 | A | Removal of ureter stone | 15.16 | NA | 8.55 | 0.91 | NA | 24.62 | 090 | ||||||||||||
| 50630 | A | Removal of ureter stone | 14.94 | NA | 8.48 | 0.90 | NA | 24.32 | 090 | ||||||||||||
| 50650 | A | Removal of ureter | 17.41 | NA | 9.71 | 1.07 | NA | 28.19 | 090 | ||||||||||||
| 50660 | A | Removal of ureter | 19.55 | NA | 10.43 | 1.19 | NA | 31.17 | 090 | ||||||||||||
| 50684 | A | Injection for ureter x-ray | 0.76 | 15.02 | 0.26 | 0.04 | 15.82 | 1.06 | 000 | ||||||||||||
| 50686 | A | Measure ureter pressure | 1.51 | 5.08 | 0.65 | 0.09 | 6.68 | 2.25 | 000 | ||||||||||||
| 50688 | A | Change of ureter tube | 1.17 | NA | 1.76 | 0.06 | NA | 2.99 | 010 | ||||||||||||
| 50690 | A | Injection for ureter x-ray | 1.16 | 15.40 | 0.40 | 0.06 | 16.62 | 1.62 | 000 | ||||||||||||
| 50700 | A | Revision of ureter | 15.21 | NA | 9.09 | 0.86 | NA | 25.16 | 090 | ||||||||||||
| 50715 | A | Release of ureter | 18.90 | NA | 12.37 | 1.68 | NA | 32.95 | 090 | ||||||||||||
| 50722 | A | Release of ureter | 16.35 | NA | 10.42 | 1.41 | NA | 28.18 | 090 | ||||||||||||
| 50725 | A | Release/revise ureter | 18.49 | NA | 10.61 | 1.44 | NA | 30.54 | 090 | ||||||||||||
| 50727 | A | Revise ureter | 8.18 | NA | 6.54 | 0.51 | NA | 15.23 | 090 | ||||||||||||
| 50728 | A | Revise ureter | 12.02 | NA | 8.18 | 0.88 | NA | 21.08 | 090 | ||||||||||||
| 50740 | A | Fusion of ureter kidney | 18.42 | NA | 9.66 | 1.49 | NA | 29.57 | 090 | ||||||||||||
| 50750 | A | Fusion of ureter kidney | 19.51 | NA | 10.48 | 1.24 | NA | 31.23 | 090 | ||||||||||||
| 50760 | A | Fusion of ureters | 18.42 | NA | 10.11 | 1.25 | NA | 29.78 | 090 | ||||||||||||
| 50770 | A | Splicing of ureters | 19.51 | NA | 10.43 | 1.25 | NA | 31.19 | 090 | ||||||||||||
| 50780 | A | Reimplant ureter in bladder | 18.36 | NA | 10.01 | 1.20 | NA | 29.57 | 090 | ||||||||||||
| 50782 | A | Reimplant ureter in bladder | 19.54 | NA | 11.91 | 1.13 | NA | 32.58 | 090 | ||||||||||||
| 50783 | A | Reimplant ureter in bladder | 20.55 | NA | 11.22 | 1.35 | NA | 33.12 | 090 | ||||||||||||
| 50785 | A | Reimplant ureter in bladder | 20.52 | NA | 10.83 | 1.30 | NA | 32.65 | 090 | ||||||||||||
| 50800 | A | Implant ureter in bowel | 14.52 | NA | 10.02 | 0.92 | NA | 25.46 | 090 | ||||||||||||
| 50810 | A | Fusion of ureter bowel | 20.05 | NA | 12.23 | 1.78 | NA | 34.06 | 090 | ||||||||||||
| 50815 | A | Urine shunt to intestine | 19.93 | NA | 11.71 | 1.31 | NA | 32.95 | 090 | ||||||||||||
| 50820 | A | Construct bowel bladder | 21.89 | NA | 12.38 | 1.38 | NA | 35.65 | 090 | ||||||||||||
| 50825 | A | Construct bowel bladder | 28.18 | NA | 15.30 | 1.81 | NA | 45.29 | 090 | ||||||||||||
| 50830 | A | Revise urine flow | 31.28 | NA | 15.96 | 2.20 | NA | 49.44 | 090 | ||||||||||||
| 50840 | A | Replace ureter by bowel | 20.00 | NA | 11.83 | 1.26 | NA | 33.09 | 090 | ||||||||||||
| 50845 | A | Appendico-vesicostomy | 20.89 | NA | 10.20 | 1.26 | NA | 32.35 | 090 | ||||||||||||
| 50860 | A | Transplant ureter to skin | 15.36 | NA | 8.93 | 1.01 | NA | 25.30 | 090 | ||||||||||||
| 50900 | A | Repair of ureter | 13.62 | NA | 8.08 | 0.98 | NA | 22.68 | 090 | ||||||||||||
| 50920 | A | Closure ureter/skin fistula | 14.33 | NA | 8.37 | 0.84 | NA | 23.54 | 090 | ||||||||||||
| 50930 | A | Closure ureter/bowel fistula | 18.72 | NA | 10.80 | 1.57 | NA | 31.09 | 090 | ||||||||||||
| 50940 | A | Release of ureter | 14.51 | NA | 8.44 | 1.04 | NA | 23.99 | 090 | ||||||||||||
| 50945 | A | Laparoscopy ureterolithotomy | 17.00 | NA | 7.42 | 1.15 | NA | 25.57 | 090 | ||||||||||||
| 50947 | A | Laparo new ureter/bladder | 24.50 | NA | 11.74 | 1.99 | NA | 38.23 | 090 | ||||||||||||
| 50948 | A | Laparo new ureter/bladder | 22.50 | NA | 10.61 | 1.83 | NA | 34.94 | 090 | ||||||||||||
| 50949 | C | Laparoscope proc, ureter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 50951 | A | Endoscopy of ureter | 5.84 | 5.28 | 1.98 | 0.35 | 11.47 | 8.17 | 000 | ||||||||||||
| 50953 | A | Endoscopy of ureter | 6.24 | 16.55 | 2.12 | 0.37 | 23.16 | 8.73 | 000 | ||||||||||||
| 50955 | A | Ureter endoscopy biopsy | 6.75 | 21.11 | 2.38 | 0.38 | 28.24 | 9.51 | 000 | ||||||||||||
| 50957 | A | Ureter endoscopy treatment | 6.79 | 19.64 | 2.28 | 0.40 | 26.83 | 9.47 | 000 | ||||||||||||
| 50959 | A | Ureter endoscopy tracer | 4.40 | NA | 1.58 | 0.18 | NA | 6.16 | 000 | ||||||||||||
| 50961 | A | Ureter endoscopy treatment | 6.05 | 23.38 | 2.04 | 0.35 | 29.78 | 8.44 | 000 | ||||||||||||
| 50970 | A | Ureter endoscopy | 7.14 | NA | 2.43 | 0.43 | NA | 10.00 | 000 | ||||||||||||
| 50972 | A | Ureter endoscopy catheter | 6.89 | NA | 2.52 | 0.39 | NA | 9.80 | 000 | ||||||||||||
| 50974 | A | Ureter endoscopy biopsy | 9.17 | NA | 3.16 | 0.53 | NA | 12.86 | 000 | ||||||||||||
| 50976 | A | Ureter endoscopy treatment | 9.04 | NA | 3.09 | 0.53 | NA | 12.66 | 000 | ||||||||||||
| 50978 | A | Ureter endoscopy tracer | 5.10 | NA | 1.88 | 0.30 | NA | 7.28 | 000 | ||||||||||||
| 50980 | A | Ureter endoscopy treatment | 6.85 | NA | 2.34 | 0.41 | NA | 9.60 | 000 | ||||||||||||
| 51000 | A | Drainage of bladder | 0.78 | 2.03 | 0.25 | 0.05 | 2.86 | 1.08 | 000 | ||||||||||||
| 51005 | A | Drainage of bladder | 1.02 | 3.37 | 0.35 | 0.08 | 4.47 | 1.45 | 000 | ||||||||||||
| 51010 | A | Drainage of bladder | 3.53 | 4.42 | 2.37 | 0.23 | 8.18 | 6.13 | 010 | ||||||||||||
| 51020 | A | Incise treat bladder | 6.71 | NA | 5.72 | 0.42 | NA | 12.85 | 090 | ||||||||||||
| 51030 | A | Incise treat bladder | 6.77 | NA | 6.01 | 0.42 | NA | 13.20 | 090 | ||||||||||||
| 51040 | A | Incise drain bladder | 4.40 | NA | 4.47 | 0.27 | NA | 9.14 | 090 | ||||||||||||
| 51045 | A | Incise bladder/drain ureter | 6.77 | NA | 6.01 | 0.47 | NA | 13.25 | 090 | ||||||||||||
| 51050 | A | Removal of bladder stone | 6.92 | NA | 5.27 | 0.42 | NA | 12.61 | 090 | ||||||||||||
| 51060 | A | Removal of ureter stone | 8.85 | NA | 6.53 | 0.54 | NA | 15.92 | 090 | ||||||||||||
| 51065 | A | Remove ureter calculus | 8.85 | NA | 6.06 | 0.53 | NA | 15.44 | 090 | ||||||||||||
| 51080 | A | Drainage of bladder abscess | 5.96 | NA | 5.67 | 0.35 | NA | 11.98 | 090 | ||||||||||||
| 51500 | A | Removal of bladder cyst | 10.14 | NA | 6.13 | 0.88 | NA | 17.15 | 090 | ||||||||||||
| 51520 | A | Removal of bladder lesion | 9.29 | NA | 6.66 | 0.58 | NA | 16.53 | 090 | ||||||||||||
| 51525 | A | Removal of bladder lesion | 13.97 | NA | 8.15 | 0.85 | NA | 22.97 | 090 | ||||||||||||
| 51530 | A | Removal of bladder lesion | 12.38 | NA | 7.81 | 0.82 | NA | 21.01 | 090 | ||||||||||||
| 51535 | A | Repair of ureter lesion | 12.57 | NA | 8.23 | 0.90 | NA | 21.70 | 090 | ||||||||||||
| 51550 | A | Partial removal of bladder | 15.66 | NA | 8.68 | 1.05 | NA | 25.39 | 090 | ||||||||||||
| 51555 | A | Partial removal of bladder | 21.23 | NA | 11.00 | 1.37 | NA | 33.60 | 090 | ||||||||||||
| 51565 | A | Revise bladder ureter(s) | 21.62 | NA | 11.62 | 1.40 | NA | 34.64 | 090 | ||||||||||||
| 51570 | A | Removal of bladder | 24.24 | NA | 12.60 | 1.59 | NA | 38.43 | 090 | ||||||||||||
| 51575 | A | Removal of bladder nodes | 30.45 | NA | 15.35 | 1.88 | NA | 47.68 | 090 | ||||||||||||
| 51580 | A | Remove bladder/revise tract | 31.08 | NA | 16.01 | 1.94 | NA | 49.03 | 090 | ||||||||||||
| 51585 | A | Removal of bladder nodes | 35.23 | NA | 17.34 | 2.18 | NA | 54.75 | 090 | ||||||||||||
| 51590 | A | Remove bladder/revise tract | 32.66 | NA | 16.01 | 2.01 | NA | 50.68 | 090 | ||||||||||||
| 51595 | A | Remove bladder/revise tract | 37.14 | NA | 17.55 | 2.23 | NA | 56.92 | 090 | ||||||||||||
| 51596 | A | Remove bladder/create pouch | 39.52 | NA | 18.94 | 2.39 | NA | 60.85 | 090 | ||||||||||||
| 51597 | A | Removal of pelvic structures | 38.35 | NA | 18.06 | 2.49 | NA | 58.90 | 090 | ||||||||||||
| 51600 | A | Injection for bladder x-ray | 0.88 | 5.51 | 0.30 | 0.04 | 6.43 | 1.22 | 000 | ||||||||||||
| 51605 | A | Preparation for bladder x-ray | 0.64 | 16.73 | 0.22 | 0.04 | 17.41 | 0.90 | 000 | ||||||||||||
| 51610 | A | Injection for bladder x-ray | 1.05 | 16.20 | 0.36 | 0.05 | 17.30 | 1.46 | 000 | ||||||||||||
| 51700 | A | Irrigation of bladder | 0.88 | 1.32 | 0.30 | 0.05 | 2.25 | 1.23 | 000 | ||||||||||||
| 51705 | A | Change of bladder tube | 1.02 | 2.15 | 0.65 | 0.06 | 3.23 | 1.73 | 010 | ||||||||||||
| 51710 | A | Change of bladder tube | 1.49 | 5.11 | 1.47 | 0.09 | 6.69 | 3.05 | 010 | ||||||||||||
| 51715 | A | Endoscopic injection/implant | 3.74 | 4.44 | 1.29 | 0.24 | 8.42 | 5.27 | 000 | ||||||||||||
| 51720 | A | Treatment of bladder lesion | 1.96 | 1.68 | 0.74 | 0.12 | 3.76 | 2.82 | 000 | ||||||||||||
| 51725 | A | Simple cystometrogram | 1.51 | 5.92 | NA | 0.13 | 7.56 | NA | 000 | ||||||||||||
| 51725 | 26 | A | Simple cystometrogram | 1.51 | 0.52 | 0.52 | 0.10 | 2.13 | 2.13 | 000 | |||||||||||
| 51725 | TC | A | Simple cystometrogram | 0.00 | 5.40 | NA | 0.03 | 5.43 | NA | 000 | |||||||||||
| 51726 | A | Complex cystometrogram | 1.71 | 4.65 | NA | 0.15 | 6.51 | NA | 000 | ||||||||||||
| 51726 | 26 | A | Complex cystometrogram | 1.71 | 0.59 | 0.59 | 0.11 | 2.41 | 2.41 | 000 | |||||||||||
| 51726 | TC | A | Complex cystometrogram | 0.00 | 4.06 | NA | 0.04 | 4.10 | NA | 000 | |||||||||||
| 51736 | A | Urine flow measurement | 0.61 | 1.07 | NA | 0.05 | 1.73 | NA | 000 | ||||||||||||
| 51736 | 26 | A | Urine flow measurement | 0.61 | 0.21 | 0.21 | 0.04 | 0.86 | 0.86 | 000 | |||||||||||
| 51736 | TC | A | Urine flow measurement | 0.00 | 0.86 | NA | 0.01 | 0.87 | NA | 000 | |||||||||||
| 51741 | A | Electro-uroflowmetry, first | 1.14 | 1.93 | NA | 0.09 | 3.16 | NA | 000 | ||||||||||||
| 51741 | 26 | A | Electro-uroflowmetry, first | 1.14 | 0.40 | 0.40 | 0.07 | 1.61 | 1.61 | 000 | |||||||||||
| 51741 | TC | A | Electro-uroflowmetry, first | 0.00 | 1.53 | NA | 0.02 | 1.55 | NA | 000 | |||||||||||
| 51772 | A | Urethra pressure profile | 1.61 | 4.73 | NA | 0.16 | 6.50 | NA | 000 | ||||||||||||
| 51772 | 26 | A | Urethra pressure profile | 1.61 | 0.59 | 0.59 | 0.12 | 2.32 | 2.32 | 000 | |||||||||||
| 51772 | TC | A | Urethra pressure profile | 0.00 | 4.14 | NA | 0.04 | 4.18 | NA | 000 | |||||||||||
| 51784 | A | Anal/urinary muscle study | 1.53 | 3.36 | NA | 0.13 | 5.02 | NA | 000 | ||||||||||||
| 51784 | 26 | A | Anal/urinary muscle study | 1.53 | 0.53 | 0.53 | 0.10 | 2.16 | 2.16 | 000 | |||||||||||
| 51784 | TC | A | Anal/urinary muscle study | 0.00 | 2.83 | NA | 0.03 | 2.86 | NA | 000 | |||||||||||
| 51785 | A | Anal/urinary muscle study | 1.53 | 3.46 | NA | 0.12 | 5.11 | NA | 000 | ||||||||||||
| 51785 | 26 | A | Anal/urinary muscle study | 1.53 | 0.53 | 0.53 | 0.09 | 2.15 | 2.15 | 000 | |||||||||||
| 51785 | TC | A | Anal/urinary muscle study | 0.00 | 2.93 | NA | 0.03 | 2.96 | NA | 000 | |||||||||||
| 51792 | A | Urinary reflex study | 1.10 | 3.33 | NA | 0.20 | 4.63 | NA | 000 | ||||||||||||
| 51792 | 26 | A | Urinary reflex study | 1.10 | 0.43 | 0.43 | 0.09 | 1.62 | 1.62 | 000 | |||||||||||
| 51792 | TC | A | Urinary reflex study | 0.00 | 2.90 | NA | 0.11 | 3.01 | NA | 000 | |||||||||||
| 51795 | A | Urine voiding pressure study | 1.53 | 4.84 | NA | 0.18 | 6.55 | NA | 000 | ||||||||||||
| 51795 | 26 | A | Urine voiding pressure study | 1.53 | 0.53 | 0.53 | 0.10 | 2.16 | 2.16 | 000 | |||||||||||
| 51795 | TC | A | Urine voiding pressure study | 0.00 | 4.31 | NA | 0.08 | 4.39 | NA | 000 | |||||||||||
| 51797 | A | Intraabdominal pressure test | 1.60 | 4.87 | NA | 0.14 | 6.61 | NA | 000 | ||||||||||||
| 51797 | 26 | A | Intraabdominal pressure test | 1.60 | 0.56 | 0.56 | 0.10 | 2.26 | 2.26 | 000 | |||||||||||
| 51797 | TC | A | Intraabdominal pressure test | 0.00 | 4.31 | NA | 0.04 | 4.35 | NA | 000 | |||||||||||
| 51800 | A | Revision of bladder/urethra | 17.42 | NA | 9.59 | 1.17 | NA | 28.18 | 090 | ||||||||||||
| 51820 | A | Revision of urinary tract | 17.89 | NA | 10.91 | 1.45 | NA | 30.25 | 090 | ||||||||||||
| 51840 | A | Attach bladder/urethra | 10.71 | NA | 6.88 | 0.87 | NA | 18.46 | 090 | ||||||||||||
| 51841 | A | Attach bladder/urethra | 13.03 | NA | 8.57 | 1.04 | NA | 22.64 | 090 | ||||||||||||
| 51845 | A | Repair bladder neck | 9.73 | NA | 6.90 | 0.62 | NA | 17.25 | 090 | ||||||||||||
| 51860 | A | Repair of bladder wound | 12.02 | NA | 7.90 | 0.89 | NA | 20.81 | 090 | ||||||||||||
| 51865 | A | Repair of bladder wound | 15.04 | NA | 8.93 | 1.01 | NA | 24.98 | 090 | ||||||||||||
| 51880 | A | Repair of bladder opening | 7.66 | NA | 5.98 | 0.54 | NA | 14.18 | 090 | ||||||||||||
| 51900 | A | Repair bladder/vagina lesion | 12.97 | NA | 8.29 | 0.87 | NA | 22.13 | 090 | ||||||||||||
| 51920 | A | Close bladder-uterus fistula | 11.81 | NA | 7.65 | 0.86 | NA | 20.32 | 090 | ||||||||||||
| 51925 | A | Hysterectomy/bladder repair | 15.58 | NA | 9.65 | 1.48 | NA | 26.71 | 090 | ||||||||||||
| 51940 | A | Correction of bladder defect | 28.43 | NA | 16.41 | 1.97 | NA | 46.81 | 090 | ||||||||||||
| 51960 | A | Revision of bladder bowel | 23.01 | NA | 13.39 | 1.41 | NA | 37.81 | 090 | ||||||||||||
| 51980 | A | Construct bladder opening | 11.36 | NA | 7.30 | 0.74 | NA | 19.40 | 090 | ||||||||||||
| 51990 | A | Laparo urethral suspension | 12.50 | NA | 6.79 | 1.02 | NA | 20.31 | 090 | ||||||||||||
| 51992 | A | Laparo sling operation | 14.01 | NA | 6.81 | 0.93 | NA | 21.75 | 090 | ||||||||||||
| 52000 | A | Cystoscopy | 2.01 | 3.45 | 0.69 | 0.12 | 5.58 | 2.82 | 000 | ||||||||||||
| 52001 | A | Cystoscopy, removal of clots | 2.37 | NA | 0.98 | 0.32 | NA | 3.67 | 000 | ||||||||||||
| 52005 | A | Cystoscopy ureter catheter | 2.37 | 13.40 | 0.91 | 0.15 | 15.92 | 3.43 | 000 | ||||||||||||
| 52007 | A | Cystoscopy and biopsy | 3.02 | NA | 1.02 | 0.18 | NA | 4.22 | 000 | ||||||||||||
| 52010 | A | Cystoscopy duct catheter | 3.02 | 5.91 | 1.02 | 0.18 | 9.11 | 4.22 | 000 | ||||||||||||
| 52204 | A | Cystoscopy | 2.37 | 6.17 | 0.80 | 0.15 | 8.69 | 3.32 | 000 | ||||||||||||
| 52214 | A | Cystoscopy and treatment | 3.71 | 6.53 | 1.26 | 0.22 | 10.46 | 5.19 | 000 | ||||||||||||
| 52224 | A | Cystoscopy and treatment | 3.14 | 6.41 | 1.07 | 0.18 | 9.73 | 4.39 | 000 | ||||||||||||
| 52234 | A | Cystoscopy and treatment | 4.63 | NA | 1.68 | 0.27 | NA | 6.58 | 000 | ||||||||||||
| 52235 | A | Cystoscopy and treatment | 5.45 | NA | 1.97 | 0.32 | NA | 7.74 | 000 | ||||||||||||
| 52240 | A | Cystoscopy and treatment | 9.72 | NA | 3.43 | 0.58 | NA | 13.73 | 000 | ||||||||||||
| 52250 | A | Cystoscopy and radiotracer | 4.50 | NA | 1.53 | 0.27 | NA | 6.30 | 000 | ||||||||||||
| 52260 | A | Cystoscopy and treatment | 3.92 | NA | 1.34 | 0.23 | NA | 5.49 | 000 | ||||||||||||
| 52265 | A | Cystoscopy and treatment | 2.94 | 3.77 | 1.00 | 0.18 | 6.89 | 4.12 | 000 | ||||||||||||
| 52270 | A | Cystoscopy revise urethra | 3.37 | 6.88 | 1.14 | 0.20 | 10.45 | 4.71 | 000 | ||||||||||||
| 52275 | A | Cystoscopy revise urethra | 4.70 | 7.42 | 1.59 | 0.28 | 12.40 | 6.57 | 000 | ||||||||||||
| 52276 | A | Cystoscopy and treatment | 5.00 | 7.55 | 1.70 | 0.30 | 12.85 | 7.00 | 000 | ||||||||||||
| 52277 | A | Cystoscopy and treatment | 6.17 | NA | 2.12 | 0.38 | NA | 8.67 | 000 | ||||||||||||
| 52281 | A | Cystoscopy and treatment | 2.80 | 14.54 | 1.08 | 0.17 | 17.51 | 4.05 | 000 | ||||||||||||
| 52282 | A | Cystoscopy, implant stent | 6.40 | 15.36 | 2.18 | 0.38 | 22.14 | 8.96 | 000 | ||||||||||||
| 52283 | A | Cystoscopy and treatment | 3.74 | 6.58 | 1.27 | 0.22 | 10.54 | 5.23 | 000 | ||||||||||||
| 52285 | A | Cystoscopy and treatment | 3.61 | 7.06 | 1.23 | 0.22 | 10.89 | 5.06 | 000 | ||||||||||||
| 52290 | A | Cystoscopy and treatment | 4.59 | NA | 1.56 | 0.27 | NA | 6.42 | 000 | ||||||||||||
| 52300 | A | Cystoscopy and treatment | 5.31 | NA | 1.80 | 0.32 | NA | 7.43 | 000 | ||||||||||||
| 52301 | A | Cystoscopy and treatment | 5.51 | NA | 1.82 | 0.39 | NA | 7.72 | 000 | ||||||||||||
| 52305 | A | Cystoscopy and treatment | 5.31 | NA | 1.80 | 0.31 | NA | 7.42 | 000 | ||||||||||||
| 52310 | A | Cystoscopy and treatment | 2.81 | 3.85 | 1.02 | 0.17 | 6.83 | 4.00 | 000 | ||||||||||||
| 52315 | A | Cystoscopy and treatment | 5.21 | 16.43 | 1.76 | 0.31 | 21.95 | 7.28 | 000 | ||||||||||||
| 52317 | A | Remove bladder stone | 6.72 | 26.09 | 2.28 | 0.40 | 33.21 | 9.40 | 000 | ||||||||||||
| 52318 | A | Remove bladder stone | 9.19 | NA | 3.11 | 0.54 | NA | 12.84 | 000 | ||||||||||||
| 52320 | A | Cystoscopy and treatment | 4.70 | NA | 1.59 | 0.28 | NA | 6.57 | 000 | ||||||||||||
| 52325 | A | Cystoscopy, stone removal | 6.16 | NA | 2.08 | 0.37 | NA | 8.61 | 000 | ||||||||||||
| 52327 | A | Cystoscopy, inject material | 5.19 | NA | 1.77 | 0.32 | NA | 7.28 | 000 | ||||||||||||
| 52330 | A | Cystoscopy and treatment | 5.04 | 20.79 | 1.71 | 0.30 | 26.13 | 7.05 | 000 | ||||||||||||
| 52332 | A | Cystoscopy and treatment | 2.83 | 18.84 | 1.07 | 0.17 | 21.84 | 4.07 | 000 | ||||||||||||
| 52334 | A | Create passage to kidney | 4.83 | NA | 1.63 | 0.28 | NA | 6.74 | 000 | ||||||||||||
| 52341 | A | Cysto w/ureter stricture tx | 6.00 | NA | 2.40 | 0.37 | NA | 8.77 | 000 | ||||||||||||
| 52342 | A | Cysto w/up stricture tx | 6.50 | NA | 2.59 | 0.40 | NA | 9.49 | 000 | ||||||||||||
| 52343 | A | Cysto w/renal stricture tx | 7.20 | NA | 2.87 | 0.44 | NA | 10.51 | 000 | ||||||||||||
| 52344 | A | Cysto/uretero, stone remove | 7.70 | NA | 3.07 | 0.47 | NA | 11.24 | 000 | ||||||||||||
| 52345 | A | Cysto/uretero w/up stricture | 8.20 | NA | 3.27 | 0.50 | NA | 11.97 | 000 | ||||||||||||
| 52346 | A | Cystouretero w/renal strict | 9.23 | NA | 3.68 | 0.57 | NA | 13.48 | 000 | ||||||||||||
| 52347 | A | Cystoscopy, resect ducts | 5.28 | NA | 2.14 | 0.33 | NA | 7.75 | 000 | ||||||||||||
| 52351 | A | Cystouretro or pyeloscope | 5.86 | NA | 1.99 | 0.36 | NA | 8.21 | 000 | ||||||||||||
| 52352 | A | Cystouretro w/stone remove | 6.88 | NA | 2.33 | 0.42 | NA | 9.63 | 000 | ||||||||||||
| 52353 | A | Cystouretero w/lithotripsy | 7.97 | NA | 2.69 | 0.49 | NA | 11.15 | 000 | ||||||||||||
| 52354 | A | Cystouretero w/biopsy | 7.34 | NA | 2.49 | 0.45 | NA | 10.28 | 000 | ||||||||||||
| 52355 | A | Cystouretero w/excise tumor | 8.82 | NA | 2.99 | 0.55 | NA | 12.36 | 000 | ||||||||||||
| 52400 | A | Cystouretero w/congen repr | 9.68 | NA | 5.75 | 0.60 | NA | 16.03 | 090 | ||||||||||||
| 52450 | A | Incision of prostate | 7.64 | NA | 6.56 | 0.46 | NA | 14.66 | 090 | ||||||||||||
| 52500 | A | Revision of bladder neck | 8.47 | NA | 6.81 | 0.50 | NA | 15.78 | 090 | ||||||||||||
| 52510 | A | Dilation prostatic urethra | 6.72 | NA | 5.80 | 0.40 | NA | 12.92 | 090 | ||||||||||||
| 52601 | A | Prostatectomy (TURP) | 12.37 | NA | 8.16 | 0.74 | NA | 21.27 | 090 | ||||||||||||
| 52606 | A | Control postop bleeding | 8.13 | NA | 6.27 | 0.49 | NA | 14.89 | 090 | ||||||||||||
| 52612 | A | Prostatectomy, first stage | 7.98 | NA | 6.72 | 0.48 | NA | 15.18 | 090 | ||||||||||||
| 52614 | A | Prostatectomy, second stage | 6.84 | NA | 6.30 | 0.41 | NA | 13.55 | 090 | ||||||||||||
| 52620 | A | Remove residual prostate | 6.61 | NA | 6.22 | 0.39 | NA | 13.22 | 090 | ||||||||||||
| 52630 | A | Remove prostate regrowth | 7.26 | NA | 6.44 | 0.43 | NA | 14.13 | 090 | ||||||||||||
| 52640 | A | Relieve bladder contracture | 6.62 | NA | 5.73 | 0.39 | NA | 12.74 | 090 | ||||||||||||
| 52647 | A | Laser surgery of prostate | 10.36 | 59.33 | 4.85 | 0.61 | 70.30 | 15.82 | 090 | ||||||||||||
| 52648 | A | Laser surgery of prostate | 11.21 | NA | 7.63 | 0.66 | NA | 19.50 | 090 | ||||||||||||
| 52700 | A | Drainage of prostate abscess | 6.80 | NA | 6.32 | 0.41 | NA | 13.53 | 090 | ||||||||||||
| 53000 | A | Incision of urethra | 2.28 | 7.47 | 2.63 | 0.13 | 9.88 | 5.04 | 010 | ||||||||||||
| 53010 | A | Incision of urethra | 3.64 | NA | 4.12 | 0.20 | NA | 7.96 | 090 | ||||||||||||
| 53020 | A | Incision of urethra | 1.77 | 4.43 | 0.67 | 0.11 | 6.31 | 2.55 | 000 | ||||||||||||
| 53025 | A | Incision of urethra | 1.13 | 4.81 | 0.45 | 0.07 | 6.01 | 1.65 | 000 | ||||||||||||
| 53040 | A | Drainage of urethra abscess | 6.40 | 14.74 | 8.33 | 0.41 | 21.55 | 15.14 | 090 | ||||||||||||
| 53060 | A | Drainage of urethra abscess | 2.63 | 6.21 | 2.91 | 0.23 | 9.07 | 5.77 | 010 | ||||||||||||
| 53080 | A | Drainage of urinary leakage | 6.29 | NA | 8.37 | 0.42 | NA | 15.08 | 090 | ||||||||||||
| 53085 | A | Drainage of urinary leakage | 10.27 | NA | 10.29 | 0.67 | NA | 21.23 | 090 | ||||||||||||
| 53200 | A | Biopsy of urethra | 2.59 | 5.63 | 0.97 | 0.17 | 8.39 | 3.73 | 000 | ||||||||||||
| 53210 | A | Removal of urethra | 12.57 | NA | 8.00 | 0.81 | NA | 21.38 | 090 | ||||||||||||
| 53215 | A | Removal of urethra | 15.58 | NA | 8.81 | 0.93 | NA | 25.32 | 090 | ||||||||||||
| 53220 | A | Treatment of urethra lesion | 7.00 | NA | 5.71 | 0.44 | NA | 13.15 | 090 | ||||||||||||
| 53230 | A | Removal of urethra lesion | 9.58 | NA | 6.36 | 0.60 | NA | 16.54 | 090 | ||||||||||||
| 53235 | A | Removal of urethra lesion | 10.14 | NA | 6.49 | 0.60 | NA | 17.23 | 090 | ||||||||||||
| 53240 | A | Surgery for urethra pouch | 6.45 | NA | 5.32 | 0.42 | NA | 12.19 | 090 | ||||||||||||
| 53250 | A | Removal of urethra gland | 5.89 | NA | 4.74 | 0.35 | NA | 10.98 | 090 | ||||||||||||
| 53260 | A | Treatment of urethra lesion | 2.98 | 6.11 | 2.44 | 0.23 | 9.32 | 5.65 | 010 | ||||||||||||
| 53265 | A | Treatment of urethra lesion | 3.12 | 6.60 | 2.42 | 0.20 | 9.92 | 5.74 | 010 | ||||||||||||
| 53270 | A | Removal of urethra gland | 3.09 | 7.03 | 2.83 | 0.21 | 10.33 | 6.13 | 010 | ||||||||||||
| 53275 | A | Repair of urethra defect | 4.53 | NA | 3.43 | 0.28 | NA | 8.24 | 010 | ||||||||||||
| 53400 | A | Revise urethra, stage 1 | 12.77 | NA | 8.31 | 0.85 | NA | 21.93 | 090 | ||||||||||||
| 53405 | A | Revise urethra, stage 2 | 14.48 | NA | 8.61 | 0.91 | NA | 24.00 | 090 | ||||||||||||
| 53410 | A | Reconstruction of urethra | 16.44 | NA | 9.21 | 0.99 | NA | 26.64 | 090 | ||||||||||||
| 53415 | A | Reconstruction of urethra | 19.41 | NA | 10.16 | 1.16 | NA | 30.73 | 090 | ||||||||||||
| 53420 | A | Reconstruct urethra, stage 1 | 14.08 | NA | 8.82 | 0.90 | NA | 23.80 | 090 | ||||||||||||
| 53425 | A | Reconstruct urethra, stage 2 | 15.98 | NA | 9.02 | 0.97 | NA | 25.97 | 090 | ||||||||||||
| 53430 | A | Reconstruction of urethra | 16.34 | NA | 9.34 | 1.01 | NA | 26.69 | 090 | ||||||||||||
| 53431 | A | Reconstruct urethra/bladder | 19.89 | 7.94 | 7.94 | 1.25 | 29.08 | 29.08 | 090 | ||||||||||||
| 53440 | A | Correct bladder function | 12.34 | NA | 8.09 | 0.73 | NA | 21.16 | 090 | ||||||||||||
| 53442 | A | Remove perineal prosthesis | 8.27 | NA | 6.08 | 0.55 | NA | 14.90 | 090 | ||||||||||||
| 53443 | D | Reconstruction of urethra | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 53444 | A | Insert tandem cuff | 13.40 | NA | 6.66 | 0.79 | NA | 20.85 | 090 | ||||||||||||
| 53445 | A | Insert uro/ves nck sphincter | 14.06 | NA | 8.72 | 0.84 | NA | 23.62 | 090 | ||||||||||||
| 53446 | A | Remove uro sphincter | 10.23 | NA | 8.46 | 0.61 | NA | 19.30 | 090 | ||||||||||||
| 53447 | A | Remove/replace ur sphincter | 13.49 | NA | 7.90 | 0.79 | NA | 22.18 | 090 | ||||||||||||
| 53448 | A | Remov/replc ur sphinctr comp | 21.15 | NA | 12.35 | 1.27 | NA | 34.77 | 090 | ||||||||||||
| 53449 | A | Repair uro sphincter | 9.70 | NA | 6.73 | 0.57 | NA | 17.00 | 090 | ||||||||||||
| 53450 | A | Revision of urethra | 6.14 | NA | 5.16 | 0.37 | NA | 11.67 | 090 | ||||||||||||
| 53460 | A | Revision of urethra | 7.12 | NA | 5.50 | 0.43 | NA | 13.05 | 090 | ||||||||||||
| 53502 | A | Repair of urethra injury | 7.63 | NA | 5.80 | 0.50 | NA | 13.93 | 090 | ||||||||||||
| 53505 | A | Repair of urethra injury | 7.63 | NA | 5.62 | 0.46 | NA | 13.71 | 090 | ||||||||||||
| 53510 | A | Repair of urethra injury | 10.11 | NA | 6.58 | 0.60 | NA | 17.29 | 090 | ||||||||||||
| 53515 | A | Repair of urethra injury | 13.31 | NA | 7.81 | 0.83 | NA | 21.95 | 090 | ||||||||||||
| 53520 | A | Repair of urethra defect | 8.68 | NA | 6.12 | 0.53 | NA | 15.33 | 090 | ||||||||||||
| 53600 | A | Dilate urethra stricture | 1.21 | 1.19 | 0.46 | 0.07 | 2.47 | 1.74 | 000 | ||||||||||||
| 53601 | A | Dilate urethra stricture | 0.98 | 1.31 | 0.40 | 0.06 | 2.35 | 1.44 | 000 | ||||||||||||
| 53605 | A | Dilate urethra stricture | 1.28 | NA | 0.44 | 0.08 | NA | 1.80 | 000 | ||||||||||||
| 53620 | A | Dilate urethra stricture | 1.62 | 1.91 | 0.63 | 0.10 | 3.63 | 2.35 | 000 | ||||||||||||
| 53621 | A | Dilate urethra stricture | 1.35 | 2.00 | 0.52 | 0.08 | 3.43 | 1.95 | 000 | ||||||||||||
| 53660 | A | Dilation of urethra | 0.71 | 1.22 | 0.33 | 0.04 | 1.97 | 1.08 | 000 | ||||||||||||
| 53661 | A | Dilation of urethra | 0.72 | 1.21 | 0.31 | 0.04 | 1.97 | 1.07 | 000 | ||||||||||||
| 53665 | A | Dilation of urethra | 0.76 | NA | 0.27 | 0.05 | NA | 1.08 | 000 | ||||||||||||
| 53670 | A | Insert urinary catheter | 0.50 | 1.74 | 0.18 | 0.03 | 2.27 | 0.71 | 000 | ||||||||||||
| 53675 | A | Insert urinary catheter | 1.47 | 2.63 | 0.58 | 0.09 | 4.19 | 2.14 | 000 | ||||||||||||
| 53850 | A | Prostatic microwave thermotx | 9.45 | 87.54 | 4.50 | 0.56 | 97.55 | 14.51 | 090 | ||||||||||||
| 53852 | A | Prostatic rf thermotx | 9.88 | 75.53 | 4.68 | 0.58 | 85.99 | 15.14 | 090 | ||||||||||||
| 53853 | A | Prostatic water thermother | 4.14 | 52.75 | 2.55 | 0.38 | 57.27 | 7.07 | 090 | ||||||||||||
| 53899 | C | Urology surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 54000 | A | Slitting of prepuce | 1.54 | 5.66 | 1.51 | 0.10 | 7.30 | 3.15 | 010 | ||||||||||||
| 54001 | A | Slitting of prepuce | 2.19 | 6.56 | 2.15 | 0.14 | 8.89 | 4.48 | 010 | ||||||||||||
| 54015 | A | Drain penis lesion | 5.32 | 7.95 | 3.21 | 0.33 | 13.60 | 8.86 | 010 | ||||||||||||
| 54050 | A | Destruction, penis lesion(s) | 1.24 | 2.85 | 0.47 | 0.07 | 4.16 | 1.78 | 010 | ||||||||||||
| 54055 | A | Destruction, penis lesion(s) | 1.22 | 6.64 | 1.42 | 0.07 | 7.93 | 2.71 | 010 | ||||||||||||
| 54056 | A | Cryosurgery, penis lesion(s) | 1.24 | 2.96 | 0.58 | 0.06 | 4.26 | 1.88 | 010 | ||||||||||||
| 54057 | A | Laser surg, penis lesion(s) | 1.24 | 2.97 | 1.41 | 0.08 | 4.29 | 2.73 | 010 | ||||||||||||
| 54060 | A | Excision of penis lesion(s) | 1.93 | 5.65 | 1.66 | 0.12 | 7.70 | 3.71 | 010 | ||||||||||||
| 54065 | A | Destruction, penis lesion(s) | 2.42 | 5.38 | 2.24 | 0.13 | 7.93 | 4.79 | 010 | ||||||||||||
| 54100 | A | Biopsy of penis | 1.90 | 3.54 | 0.77 | 0.10 | 5.54 | 2.77 | 000 | ||||||||||||
| 54105 | A | Biopsy of penis | 3.50 | 6.75 | 2.19 | 0.21 | 10.46 | 5.90 | 010 | ||||||||||||
| 54110 | A | Treatment of penis lesion | 10.13 | NA | 8.20 | 0.60 | NA | 18.93 | 090 | ||||||||||||
| 54111 | A | Treat penis lesion, graft | 13.57 | NA | 9.37 | 0.79 | NA | 23.73 | 090 | ||||||||||||
| 54112 | A | Treat penis lesion, graft | 15.86 | NA | 10.08 | 0.94 | NA | 26.88 | 090 | ||||||||||||
| 54115 | A | Treatment of penis lesion | 6.15 | 11.63 | 6.77 | 0.39 | 18.17 | 13.31 | 090 | ||||||||||||
| 54120 | A | Partial removal of penis | 9.97 | NA | 8.14 | 0.60 | NA | 18.71 | 090 | ||||||||||||
| 54125 | A | Removal of penis | 13.53 | NA | 9.37 | 0.81 | NA | 23.71 | 090 | ||||||||||||
| 54130 | A | Remove penis nodes | 20.14 | NA | 12.00 | 1.19 | NA | 33.33 | 090 | ||||||||||||
| 54135 | A | Remove penis nodes | 26.36 | NA | 14.68 | 1.58 | NA | 42.62 | 090 | ||||||||||||
| 54150 | A | Circumcision | 1.81 | 6.04 | 1.87 | 0.17 | 8.02 | 3.85 | 010 | ||||||||||||
| 54152 | A | Circumcision | 2.31 | NA | 1.76 | 0.16 | NA | 4.23 | 010 | ||||||||||||
| 54160 | A | Circumcision | 2.48 | 5.04 | 1.82 | 0.16 | 7.68 | 4.46 | 010 | ||||||||||||
| 54161 | A | Circumcision | 3.27 | NA | 2.10 | 0.20 | NA | 5.57 | 010 | ||||||||||||
| 54162 | A | Lysis penil circumcis lesion | 3.00 | NA | 2.91 | 0.18 | NA | 6.09 | 010 | ||||||||||||
| 54163 | A | Repair of circumcision | 3.00 | NA | 2.54 | 0.18 | NA | 5.72 | 010 | ||||||||||||
| 54164 | A | Frenulotomy of penis | 2.50 | NA | 2.37 | 0.15 | NA | 5.02 | 010 | ||||||||||||
| 54200 | A | Treatment of penis lesion | 1.06 | 2.87 | 0.38 | 0.06 | 3.99 | 1.50 | 010 | ||||||||||||
| 54205 | A | Treatment of penis lesion | 7.93 | NA | 7.50 | 0.47 | NA | 15.90 | 090 | ||||||||||||
| 54220 | A | Treatment of penis lesion | 2.42 | 2.08 | 1.04 | 0.15 | 4.65 | 3.61 | 000 | ||||||||||||
| 54230 | A | Prepare penis study | 1.34 | NA | 0.46 | 0.08 | NA | 1.88 | 000 | ||||||||||||
| 54231 | A | Dynamic cavernosometry | 2.04 | 2.26 | 0.83 | 0.14 | 4.44 | 3.01 | 000 | ||||||||||||
| 54235 | A | Penile injection | 1.19 | 1.19 | 0.41 | 0.07 | 2.45 | 1.67 | 000 | ||||||||||||
| 54240 | A | Penis study | 1.31 | 1.59 | NA | 0.13 | 3.03 | NA | 000 | ||||||||||||
| 54240 | 26 | A | Penis study | 1.31 | 0.45 | 0.45 | 0.08 | 1.84 | 1.84 | 000 | |||||||||||
| 54240 | TC | A | Penis study | 0.00 | 1.14 | NA | 0.05 | 1.19 | NA | 000 | |||||||||||
| 54250 | A | Penis study | 2.22 | 2.90 | NA | 0.16 | 5.28 | NA | 000 | ||||||||||||
| 54250 | 26 | A | Penis study | 2.22 | 0.75 | 0.75 | 0.14 | 3.11 | 3.11 | 000 | |||||||||||
| 54250 | TC | A | Penis study | 0.00 | 2.15 | NA | 0.02 | 2.17 | NA | 000 | |||||||||||
| 54300 | A | Revision of penis | 10.41 | NA | 8.89 | 0.64 | NA | 19.94 | 090 | ||||||||||||
| 54304 | A | Revision of penis | 12.49 | NA | 10.04 | 0.74 | NA | 23.27 | 090 | ||||||||||||
| 54308 | A | Reconstruction of urethra | 11.83 | NA | 9.94 | 0.70 | NA | 22.47 | 090 | ||||||||||||
| 54312 | A | Reconstruction of urethra | 13.57 | NA | 10.73 | 0.81 | NA | 25.11 | 090 | ||||||||||||
| 54316 | A | Reconstruction of urethra | 16.82 | NA | 11.67 | 1.00 | NA | 29.49 | 090 | ||||||||||||
| 54318 | A | Reconstruction of urethra | 11.25 | NA | 10.06 | 1.15 | NA | 22.46 | 090 | ||||||||||||
| 54322 | A | Reconstruction of urethra | 13.01 | NA | 9.56 | 0.77 | NA | 23.34 | 090 | ||||||||||||
| 54324 | A | Reconstruction of urethra | 16.31 | NA | 12.02 | 1.03 | NA | 29.36 | 090 | ||||||||||||
| 54326 | A | Reconstruction of urethra | 15.72 | NA | 11.17 | 0.93 | NA | 27.82 | 090 | ||||||||||||
| 54328 | A | Revise penis/urethra | 15.65 | NA | 11.59 | 0.92 | NA | 28.16 | 090 | ||||||||||||
| 54332 | A | Revise penis/urethra | 17.08 | NA | 11.87 | 1.01 | NA | 29.96 | 090 | ||||||||||||
| 54336 | A | Revise penis/urethra | 20.04 | NA | 13.59 | 1.90 | NA | 35.53 | 090 | ||||||||||||
| 54340 | A | Secondary urethral surgery | 8.91 | NA | 9.80 | 0.72 | NA | 19.43 | 090 | ||||||||||||
| 54344 | A | Secondary urethral surgery | 15.94 | NA | 10.91 | 1.10 | NA | 27.95 | 090 | ||||||||||||
| 54348 | A | Secondary urethral surgery | 17.15 | NA | 12.10 | 1.02 | NA | 30.27 | 090 | ||||||||||||
| 54352 | A | Reconstruct urethra/penis | 24.74 | NA | 16.53 | 1.62 | NA | 42.89 | 090 | ||||||||||||
| 54360 | A | Penis plastic surgery | 11.93 | NA | 8.82 | 0.72 | NA | 21.47 | 090 | ||||||||||||
| 54380 | A | Repair penis | 13.18 | NA | 10.79 | 1.16 | NA | 25.13 | 090 | ||||||||||||
| 54385 | A | Repair penis | 15.39 | NA | 12.20 | 0.71 | NA | 28.30 | 090 | ||||||||||||
| 54390 | A | Repair penis and bladder | 21.61 | NA | 14.69 | 1.28 | NA | 37.58 | 090 | ||||||||||||
| 54400 | A | Insert semi-rigid prosthesis | 8.99 | NA | 6.53 | 0.53 | NA | 16.05 | 090 | ||||||||||||
| 54401 | A | Insert self-contd prosthesis | 10.28 | NA | 7.37 | 0.61 | NA | 18.26 | 090 | ||||||||||||
| 54402 | D | Remove penis prosthesis | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 54405 | A | Insert multi-comp penis pros | 13.43 | NA | 8.45 | 0.80 | NA | 22.68 | 090 | ||||||||||||
| 54406 | A | Remove multi-comp penis pros | 12.10 | NA | 6.09 | 0.80 | NA | 18.99 | 090 | ||||||||||||
| 54407 | D | Remove multi-comp prosthesis | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 54408 | A | Repair multi-comp penis pros | 12.75 | NA | 6.46 | 0.80 | NA | 20.01 | 090 | ||||||||||||
| 54409 | D | Revise penis prosthesis | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 54410 | A | Remove/replace penis prosth | 15.50 | NA | 7.36 | 0.80 | NA | 23.66 | 090 | ||||||||||||
| 54411 | A | Remv/replc penis pros, comp | 16.00 | NA | 8.98 | 0.80 | NA | 25.78 | 090 | ||||||||||||
| 54415 | A | Remove self-contd penis pros | 8.20 | NA | 5.35 | 0.55 | NA | 14.10 | 090 | ||||||||||||
| 54416 | A | Remv/repl penis contain pros | 10.87 | NA | 6.94 | 0.55 | NA | 18.36 | 090 | ||||||||||||
| 54417 | A | Remv/replc penis pros, compl | 14.19 | NA | 7.89 | 0.55 | NA | 22.63 | 090 | ||||||||||||
| 54420 | A | Revision of penis | 11.42 | NA | 8.70 | 0.72 | NA | 20.84 | 090 | ||||||||||||
| 54430 | A | Revision of penis | 10.15 | NA | 8.17 | 0.60 | NA | 18.92 | 090 | ||||||||||||
| 54435 | A | Revision of penis | 6.12 | NA | 6.30 | 0.36 | NA | 12.78 | 090 | ||||||||||||
| 54440 | C | Repair of penis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 54450 | A | Preputial stretching | 1.12 | 1.10 | 0.49 | 0.07 | 2.29 | 1.68 | 000 | ||||||||||||
| 54500 | A | Biopsy of testis | 1.31 | 6.26 | 0.45 | 0.08 | 7.65 | 1.84 | 000 | ||||||||||||
| 54505 | A | Biopsy of testis | 3.46 | NA | 2.75 | 0.21 | NA | 6.42 | 010 | ||||||||||||
| 54510 | D | Removal of testis lesion | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 090 | ||||||||||||
| 54512 | A | Excise lesion testis | 8.58 | NA | 5.19 | 0.56 | NA | 14.33 | 090 | ||||||||||||
| 54520 | A | Removal of testis | 5.23 | NA | 3.75 | 0.33 | NA | 9.31 | 090 | ||||||||||||
| 54522 | A | Orchiectomy, partial | 9.50 | NA | 6.15 | 0.62 | NA | 16.27 | 090 | ||||||||||||
| 54530 | A | Removal of testis | 8.58 | NA | 5.46 | 0.53 | NA | 14.57 | 090 | ||||||||||||
| 54535 | A | Extensive testis surgery | 12.16 | NA | 7.62 | 0.83 | NA | 20.61 | 090 | ||||||||||||
| 54550 | A | Exploration for testis | 7.78 | NA | 4.97 | 0.49 | NA | 13.24 | 090 | ||||||||||||
| 54560 | A | Exploration for testis | 11.13 | NA | 7.10 | 0.79 | NA | 19.02 | 090 | ||||||||||||
| 54600 | A | Reduce testis torsion | 7.01 | NA | 4.38 | 0.45 | NA | 11.84 | 090 | ||||||||||||
| 54620 | A | Suspension of testis | 4.90 | NA | 3.26 | 0.31 | NA | 8.47 | 010 | ||||||||||||
| 54640 | A | Suspension of testis | 6.90 | NA | 4.40 | 0.49 | NA | 11.79 | 090 | ||||||||||||
| 54650 | A | Orchiopexy (Fowler-Stephens) | 11.45 | NA | 7.29 | 0.81 | NA | 19.55 | 090 | ||||||||||||
| 54660 | A | Revision of testis | 5.11 | NA | 3.65 | 0.35 | NA | 9.11 | 090 | ||||||||||||
| 54670 | A | Repair testis injury | 6.41 | NA | 4.30 | 0.41 | NA | 11.12 | 090 | ||||||||||||
| 54680 | A | Relocation of testis(es) | 12.65 | NA | 7.65 | 0.94 | NA | 21.24 | 090 | ||||||||||||
| 54690 | A | Laparoscopy, orchiectomy | 10.96 | NA | 7.08 | 0.99 | NA | 19.03 | 090 | ||||||||||||
| 54692 | A | Laparoscopy, orchiopexy | 12.88 | NA | 5.84 | 0.87 | NA | 19.59 | 090 | ||||||||||||
| 54699 | C | Laparoscope proc, testis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 54700 | A | Drainage of scrotum | 3.43 | 8.80 | 3.53 | 0.23 | 12.46 | 7.19 | 010 | ||||||||||||
| 54800 | A | Biopsy of epididymis | 2.33 | 6.45 | 0.79 | 0.14 | 8.92 | 3.26 | 000 | ||||||||||||
| 54820 | A | Exploration of epididymis | 5.14 | NA | 3.61 | 0.33 | NA | 9.08 | 090 | ||||||||||||
| 54830 | A | Remove epididymis lesion | 5.38 | NA | 3.85 | 0.34 | NA | 9.57 | 090 | ||||||||||||
| 54840 | A | Remove epididymis lesion | 5.20 | NA | 3.79 | 0.31 | NA | 9.30 | 090 | ||||||||||||
| 54860 | A | Removal of epididymis | 6.32 | NA | 4.40 | 0.38 | NA | 11.10 | 090 | ||||||||||||
| 54861 | A | Removal of epididymis | 8.90 | NA | 5.28 | 0.52 | NA | 14.70 | 090 | ||||||||||||
| 54900 | A | Fusion of spermatic ducts | 13.20 | NA | 6.99 | 1.34 | NA | 21.53 | 090 | ||||||||||||
| 54901 | A | Fusion of spermatic ducts | 17.94 | NA | 9.27 | 1.83 | NA | 29.04 | 090 | ||||||||||||
| 55000 | A | Drainage of hydrocele | 1.43 | 2.24 | 0.49 | 0.10 | 3.77 | 2.02 | 000 | ||||||||||||
| 55040 | A | Removal of hydrocele | 5.36 | NA | 3.56 | 0.35 | NA | 9.27 | 090 | ||||||||||||
| 55041 | A | Removal of hydroceles | 7.74 | NA | 4.63 | 0.50 | NA | 12.87 | 090 | ||||||||||||
| 55060 | A | Repair of hydrocele | 5.52 | NA | 3.64 | 0.37 | NA | 9.53 | 090 | ||||||||||||
| 55100 | A | Drainage of scrotum abscess | 2.13 | 10.06 | 3.63 | 0.15 | 12.34 | 5.91 | 010 | ||||||||||||
| 55110 | A | Explore scrotum | 5.70 | NA | 3.71 | 0.36 | NA | 9.77 | 090 | ||||||||||||
| 55120 | A | Removal of scrotum lesion | 5.09 | NA | 3.52 | 0.33 | NA | 8.94 | 090 | ||||||||||||
| 55150 | A | Removal of scrotum | 7.22 | NA | 4.76 | 0.47 | NA | 12.45 | 090 | ||||||||||||
| 55175 | A | Revision of scrotum | 5.24 | NA | 3.88 | 0.33 | NA | 9.45 | 090 | ||||||||||||
| 55180 | A | Revision of scrotum | 10.72 | NA | 6.38 | 0.72 | NA | 17.82 | 090 | ||||||||||||
| 55200 | A | Incision of sperm duct | 4.24 | NA | 3.10 | 0.25 | NA | 7.59 | 090 | ||||||||||||
| 55250 | A | Removal of sperm duct(s) | 3.29 | 9.72 | 3.28 | 0.21 | 13.22 | 6.78 | 090 | ||||||||||||
| 55300 | A | Prepare, sperm duct x-ray | 3.51 | NA | 1.56 | 0.20 | NA | 5.27 | 000 | ||||||||||||
| 55400 | A | Repair of sperm duct | 8.49 | NA | 5.32 | 0.50 | NA | 14.31 | 090 | ||||||||||||
| 55450 | A | Ligation of sperm duct | 4.12 | 8.08 | 2.62 | 0.24 | 12.44 | 6.98 | 010 | ||||||||||||
| 55500 | A | Removal of hydrocele | 5.59 | NA | 3.76 | 0.43 | NA | 9.78 | 090 | ||||||||||||
| 55520 | A | Removal of sperm cord lesion | 6.03 | NA | 3.82 | 0.56 | NA | 10.41 | 090 | ||||||||||||
| 55530 | A | Revise spermatic cord veins | 5.66 | NA | 3.92 | 0.36 | NA | 9.94 | 090 | ||||||||||||
| 55535 | A | Revise spermatic cord veins | 6.56 | NA | 4.23 | 0.42 | NA | 11.21 | 090 | ||||||||||||
| 55540 | A | Revise hernia sperm veins | 7.67 | NA | 4.37 | 0.74 | NA | 12.78 | 090 | ||||||||||||
| 55550 | A | Laparo ligate spermatic vein | 6.57 | NA | 3.67 | 0.47 | NA | 10.71 | 090 | ||||||||||||
| 55559 | C | Laparo proc, spermatic cord | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 55600 | A | Incise sperm duct pouch | 6.38 | NA | 4.41 | 0.38 | NA | 11.17 | 090 | ||||||||||||
| 55605 | A | Incise sperm duct pouch | 7.96 | NA | 5.39 | 0.54 | NA | 13.89 | 090 | ||||||||||||
| 55650 | A | Remove sperm duct pouch | 11.80 | NA | 6.44 | 0.72 | NA | 18.96 | 090 | ||||||||||||
| 55680 | A | Remove sperm pouch lesion | 5.19 | NA | 3.77 | 0.31 | NA | 9.27 | 090 | ||||||||||||
| 55700 | A | Biopsy of prostate | 1.57 | 4.68 | 0.73 | 0.10 | 6.35 | 2.40 | 000 | ||||||||||||
| 55705 | A | Biopsy of prostate | 4.57 | NA | 3.92 | 0.26 | NA | 8.75 | 010 | ||||||||||||
| 55720 | A | Drainage of prostate abscess | 7.64 | NA | 5.88 | 0.44 | NA | 13.96 | 090 | ||||||||||||
| 55725 | A | Drainage of prostate abscess | 8.68 | NA | 6.58 | 0.51 | NA | 15.77 | 090 | ||||||||||||
| 55801 | A | Removal of prostate | 17.80 | NA | 9.78 | 1.08 | NA | 28.66 | 090 | ||||||||||||
| 55810 | A | Extensive prostate surgery | 22.58 | NA | 11.85 | 1.35 | NA | 35.78 | 090 | ||||||||||||
| 55812 | A | Extensive prostate surgery | 27.51 | NA | 13.91 | 1.69 | NA | 43.11 | 090 | ||||||||||||
| 55815 | A | Extensive prostate surgery | 30.46 | NA | 15.01 | 1.84 | NA | 47.31 | 090 | ||||||||||||
| 55821 | A | Removal of prostate | 14.25 | NA | 8.20 | 0.85 | NA | 23.30 | 090 | ||||||||||||
| 55831 | A | Removal of prostate | 15.62 | NA | 8.67 | 0.94 | NA | 25.23 | 090 | ||||||||||||
| 55840 | A | Extensive prostate surgery | 22.69 | NA | 12.32 | 1.37 | NA | 36.38 | 090 | ||||||||||||
| 55842 | A | Extensive prostate surgery | 24.38 | NA | 12.86 | 1.48 | NA | 38.72 | 090 | ||||||||||||
| 55845 | A | Extensive prostate surgery | 28.55 | NA | 14.26 | 1.71 | NA | 44.52 | 090 | ||||||||||||
| 55859 | A | Percut/needle insert, pros | 12.52 | NA | 7.71 | 0.74 | NA | 20.97 | 090 | ||||||||||||
| 55860 | A | Surgical exposure, prostate | 14.45 | NA | 7.93 | 0.82 | NA | 23.20 | 090 | ||||||||||||
| 55862 | A | Extensive prostate surgery | 18.39 | NA | 9.69 | 1.14 | NA | 29.22 | 090 | ||||||||||||
| 55865 | A | Extensive prostate surgery | 22.87 | NA | 11.49 | 1.37 | NA | 35.73 | 090 | ||||||||||||
| 55870 | A | Electroejaculation | 2.58 | 1.96 | 0.98 | 0.14 | 4.68 | 3.70 | 000 | ||||||||||||
| 55873 | A | Cryoablate prostate | 19.47 | NA | 10.65 | 1.02 | NA | 31.14 | 090 | ||||||||||||
| 55899 | C | Genital surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 55970 | N | Sex transformation, M to F | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 55980 | N | Sex transformation, F to M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 56405 | A | I D of vulva/perineum | 1.44 | 2.50 | 1.33 | 0.14 | 4.08 | 2.91 | 010 | ||||||||||||
| 56420 | A | Drainage of gland abscess | 1.39 | 2.48 | 1.33 | 0.13 | 4.00 | 2.85 | 010 | ||||||||||||
| 56440 | A | Surgery for vulva lesion | 2.84 | 3.83 | 2.40 | 0.28 | 6.95 | 5.52 | 010 | ||||||||||||
| 56441 | A | Lysis of labial lesion(s) | 1.97 | 2.74 | 2.11 | 0.17 | 4.88 | 4.25 | 010 | ||||||||||||
| 56501 | A | Destroy, vulva lesions, simp | 1.53 | 2.42 | 1.42 | 0.15 | 4.10 | 3.10 | 010 | ||||||||||||
| 56515 | A | Destroy vulva lesion/s compl | 2.76 | 3.20 | 2.46 | 0.18 | 6.14 | 5.40 | 010 | ||||||||||||
| 56605 | A | Biopsy of vulva/perineum | 1.10 | 1.90 | 0.50 | 0.11 | 3.11 | 1.71 | 000 | ||||||||||||
| 56606 | A | Biopsy of vulva/perineum | 0.55 | 1.69 | 0.23 | 0.06 | 2.30 | 0.84 | ZZZ | ||||||||||||
| 56620 | A | Partial removal of vulva | 7.47 | NA | 5.13 | 0.76 | NA | 13.36 | 090 | ||||||||||||
| 56625 | A | Complete removal of vulva | 8.40 | NA | 6.20 | 0.84 | NA | 15.44 | 090 | ||||||||||||
| 56630 | A | Extensive vulva surgery | 12.36 | NA | 7.93 | 1.23 | NA | 21.52 | 090 | ||||||||||||
| 56631 | A | Extensive vulva surgery | 16.20 | NA | 10.80 | 1.63 | NA | 28.63 | 090 | ||||||||||||
| 56632 | A | Extensive vulva surgery | 20.29 | NA | 12.42 | 2.03 | NA | 34.74 | 090 | ||||||||||||
| 56633 | A | Extensive vulva surgery | 16.47 | NA | 9.70 | 1.66 | NA | 27.83 | 090 | ||||||||||||
| 56634 | A | Extensive vulva surgery | 17.88 | NA | 11.25 | 1.78 | NA | 30.91 | 090 | ||||||||||||
| 56637 | A | Extensive vulva surgery | 21.97 | NA | 13.16 | 2.18 | NA | 37.31 | 090 | ||||||||||||
| 56640 | A | Extensive vulva surgery | 22.17 | NA | 12.58 | 2.26 | NA | 37.01 | 090 | ||||||||||||
| 56700 | A | Partial removal of hymen | 2.52 | 3.18 | 2.16 | 0.24 | 5.94 | 4.92 | 010 | ||||||||||||
| 56720 | A | Incision of hymen | 0.68 | 1.79 | 0.57 | 0.07 | 2.54 | 1.32 | 000 | ||||||||||||
| 56740 | A | Remove vagina gland lesion | 4.57 | 4.08 | 3.08 | 0.37 | 9.02 | 8.02 | 010 | ||||||||||||
| 56800 | A | Repair of vagina | 3.89 | NA | 2.86 | 0.37 | NA | 7.12 | 010 | ||||||||||||
| 56805 | A | Repair clitoris | 18.86 | NA | 9.69 | 1.82 | NA | 30.37 | 090 | ||||||||||||
| 56810 | A | Repair of perineum | 4.13 | NA | 2.91 | 0.41 | NA | 7.45 | 010 | ||||||||||||
| 57000 | A | Exploration of vagina | 2.97 | NA | 2.49 | 0.28 | NA | 5.74 | 010 | ||||||||||||
| 57010 | A | Drainage of pelvic abscess | 6.03 | NA | 4.08 | 0.57 | NA | 10.68 | 090 | ||||||||||||
| 57020 | A | Drainage of pelvic fluid | 1.50 | 1.63 | 0.66 | 0.15 | 3.28 | 2.31 | 000 | ||||||||||||
| 57022 | A | I d vaginal hematoma, pp | 2.56 | NA | 2.14 | 0.24 | NA | 4.94 | 010 | ||||||||||||
| 57023 | A | I d vag hematoma, non-ob | 4.75 | NA | 3.01 | 0.24 | NA | 8.00 | 010 | ||||||||||||
| 57061 | A | Destroy vag lesions, simple | 1.25 | 2.37 | 1.33 | 0.13 | 3.75 | 2.71 | 010 | ||||||||||||
| 57065 | A | Destroy vag lesions, complex | 2.61 | 3.09 | 2.41 | 0.26 | 5.96 | 5.28 | 010 | ||||||||||||
| 57100 | A | Biopsy of vagina | 1.20 | 1.64 | 0.53 | 0.10 | 2.94 | 1.83 | 000 | ||||||||||||
| 57105 | A | Biopsy of vagina | 1.69 | 2.35 | 2.34 | 0.17 | 4.21 | 4.20 | 010 | ||||||||||||
| 57106 | A | Remove vagina wall, partial | 6.36 | 2.67 | 2.67 | 0.58 | 9.61 | 9.61 | 090 | ||||||||||||
| 57107 | A | Remove vagina tissue, part | 23.00 | NA | 10.65 | 2.17 | NA | 35.82 | 090 | ||||||||||||
| 57109 | A | Vaginectomy partial w/nodes | 27.00 | NA | 13.89 | 1.97 | NA | 42.86 | 090 | ||||||||||||
| 57110 | A | Remove vagina wall, complete | 14.29 | NA | 7.56 | 1.43 | NA | 23.28 | 090 | ||||||||||||
| 57111 | A | Remove vagina tissue, compl | 27.00 | NA | 12.85 | 2.71 | NA | 42.56 | 090 | ||||||||||||
| 57112 | A | Vaginectomy w/nodes, compl | 29.00 | NA | 14.38 | 2.19 | NA | 45.57 | 090 | ||||||||||||
| 57120 | A | Closure of vagina | 7.41 | NA | 4.85 | 0.75 | NA | 13.01 | 090 | ||||||||||||
| 57130 | A | Remove vagina lesion | 2.43 | NA | 2.25 | 0.23 | NA | 4.91 | 010 | ||||||||||||
| 57135 | A | Remove vagina lesion | 2.67 | 3.09 | 2.35 | 0.26 | 6.02 | 5.28 | 010 | ||||||||||||
| 57150 | A | Treat vagina infection | 0.55 | 1.04 | 0.22 | 0.06 | 1.65 | 0.83 | 000 | ||||||||||||
| 57155 | A | Insert uteri tandems/ovoids | 6.27 | NA | 3.67 | 0.63 | NA | 10.57 | 090 | ||||||||||||
| 57160 | A | Insert pessary/other device | 0.89 | 1.12 | 0.41 | 0.09 | 2.10 | 1.39 | 000 | ||||||||||||
| 57170 | A | Fitting of diaphragm/cap | 0.91 | 1.46 | 0.36 | 0.09 | 2.46 | 1.36 | 000 | ||||||||||||
| 57180 | A | Treat vaginal bleeding | 1.58 | 2.37 | 1.55 | 0.16 | 4.11 | 3.29 | 010 | ||||||||||||
| 57200 | A | Repair of vagina | 3.94 | NA | 3.14 | 0.38 | NA | 7.46 | 090 | ||||||||||||
| 57210 | A | Repair vagina/perineum | 5.17 | NA | 3.69 | 0.50 | NA | 9.36 | 090 | ||||||||||||
| 57220 | A | Revision of urethra | 4.31 | NA | 3.52 | 0.42 | NA | 8.25 | 090 | ||||||||||||
| 57230 | A | Repair of urethral lesion | 5.64 | NA | 4.49 | 0.50 | NA | 10.63 | 090 | ||||||||||||
| 57240 | A | Repair bladder vagina | 6.07 | NA | 4.62 | 0.53 | NA | 11.22 | 090 | ||||||||||||
| 57250 | A | Repair rectum vagina | 5.53 | NA | 4.01 | 0.54 | NA | 10.08 | 090 | ||||||||||||
| 57260 | A | Repair of vagina | 8.27 | NA | 5.17 | 0.83 | NA | 14.27 | 090 | ||||||||||||
| 57265 | A | Extensive repair of vagina | 11.34 | NA | 7.22 | 1.14 | NA | 19.70 | 090 | ||||||||||||
| 57268 | A | Repair of bowel bulge | 6.76 | NA | 4.54 | 0.66 | NA | 11.96 | 090 | ||||||||||||
| 57270 | A | Repair of bowel pouch | 12.11 | NA | 6.58 | 1.17 | NA | 19.86 | 090 | ||||||||||||
| 57280 | A | Suspension of vagina | 15.04 | NA | 7.74 | 1.44 | NA | 24.22 | 090 | ||||||||||||
| 57282 | A | Repair of vaginal prolapse | 8.86 | NA | 5.44 | 0.86 | NA | 15.16 | 090 | ||||||||||||
| 57284 | A | Repair paravaginal defect | 12.70 | NA | 7.45 | 1.17 | NA | 21.32 | 090 | ||||||||||||
| 57287 | A | Revise/remove sling repair | 10.71 | NA | 7.47 | 0.74 | NA | 18.92 | 090 | ||||||||||||
| 57288 | A | Repair bladder defect | 13.02 | NA | 7.24 | 0.86 | NA | 21.12 | 090 | ||||||||||||
| 57289 | A | Repair bladder vagina | 11.58 | NA | 7.12 | 0.95 | NA | 19.65 | 090 | ||||||||||||
| 57291 | A | Construction of vagina | 7.95 | NA | 5.93 | 0.78 | NA | 14.66 | 090 | ||||||||||||
| 57292 | A | Construct vagina with graft | 13.09 | NA | 7.20 | 1.29 | NA | 21.58 | 090 | ||||||||||||
| 57300 | A | Repair rectum-vagina fistula | 7.61 | NA | 4.82 | 0.70 | NA | 13.13 | 090 | ||||||||||||
| 57305 | A | Repair rectum-vagina fistula | 13.77 | NA | 7.00 | 1.33 | NA | 22.10 | 090 | ||||||||||||
| 57307 | A | Fistula repair colostomy | 15.93 | NA | 7.72 | 1.59 | NA | 25.24 | 090 | ||||||||||||
| 57308 | A | Fistula repair, transperine | 9.94 | NA | 5.96 | 0.91 | NA | 16.81 | 090 | ||||||||||||
| 57310 | A | Repair urethrovaginal lesion | 6.78 | NA | 4.95 | 0.45 | NA | 12.18 | 090 | ||||||||||||
| 57311 | A | Repair urethrovaginal lesion | 7.98 | NA | 5.45 | 0.51 | NA | 13.94 | 090 | ||||||||||||
| 57320 | A | Repair bladder-vagina lesion | 8.01 | NA | 5.68 | 0.60 | NA | 14.29 | 090 | ||||||||||||
| 57330 | A | Repair bladder-vagina lesion | 12.35 | NA | 6.96 | 0.86 | NA | 20.17 | 090 | ||||||||||||
| 57335 | A | Repair vagina | 18.73 | NA | 9.84 | 1.66 | NA | 30.23 | 090 | ||||||||||||
| 57400 | A | Dilation of vagina | 2.27 | NA | 1.18 | 0.22 | NA | 3.67 | 000 | ||||||||||||
| 57410 | A | Pelvic examination | 1.75 | 2.75 | 1.12 | 0.14 | 4.64 | 3.01 | 000 | ||||||||||||
| 57415 | A | Remove vaginal foreign body | 2.17 | 3.71 | 2.18 | 0.19 | 6.07 | 4.54 | 010 | ||||||||||||
| 57452 | A | Examination of vagina | 0.99 | 1.69 | 0.46 | 0.10 | 2.78 | 1.55 | 000 | ||||||||||||
| 57454 | A | Vagina examination biopsy | 1.27 | 1.88 | 0.62 | 0.13 | 3.28 | 2.02 | 000 | ||||||||||||
| 57460 | A | Cervix excision | 2.83 | 2.17 | 1.19 | 0.28 | 5.28 | 4.30 | 000 | ||||||||||||
| 57500 | A | Biopsy of cervix | 0.97 | 2.29 | 0.50 | 0.10 | 3.36 | 1.57 | 000 | ||||||||||||
| 57505 | A | Endocervical curettage | 1.14 | 2.05 | 1.36 | 0.12 | 3.31 | 2.62 | 010 | ||||||||||||
| 57510 | A | Cauterization of cervix | 1.90 | 3.39 | 1.66 | 0.18 | 5.47 | 3.74 | 010 | ||||||||||||
| 57511 | A | Cryocautery of cervix | 1.90 | 2.54 | 0.77 | 0.18 | 4.62 | 2.85 | 010 | ||||||||||||
| 57513 | A | Laser surgery of cervix | 1.90 | 2.72 | 1.66 | 0.19 | 4.81 | 3.75 | 010 | ||||||||||||
| 57520 | A | Conization of cervix | 4.04 | 4.43 | 2.93 | 0.41 | 8.88 | 7.38 | 090 | ||||||||||||
| 57522 | A | Conization of cervix | 3.36 | 4.02 | 2.68 | 0.34 | 7.72 | 6.38 | 090 | ||||||||||||
| 57530 | A | Removal of cervix | 4.79 | NA | 3.78 | 0.48 | NA | 9.05 | 090 | ||||||||||||
| 57531 | A | Removal of cervix, radical | 28.00 | NA | 14.44 | 2.46 | NA | 44.90 | 090 | ||||||||||||
| 57540 | A | Removal of residual cervix | 12.22 | NA | 6.49 | 1.21 | NA | 19.92 | 090 | ||||||||||||
| 57545 | A | Remove cervix/repair pelvis | 13.03 | NA | 6.95 | 1.30 | NA | 21.28 | 090 | ||||||||||||
| 57550 | A | Removal of residual cervix | 5.53 | NA | 3.98 | 0.55 | NA | 10.06 | 090 | ||||||||||||
| 57555 | A | Remove cervix/repair vagina | 8.95 | NA | 5.90 | 0.89 | NA | 15.74 | 090 | ||||||||||||
| 57556 | A | Remove cervix, repair bowel | 8.37 | NA | 5.14 | 0.80 | NA | 14.31 | 090 | ||||||||||||
| 57700 | A | Revision of cervix | 3.55 | NA | 2.71 | 0.33 | NA | 6.59 | 090 | ||||||||||||
| 57720 | A | Revision of cervix | 4.13 | NA | 3.41 | 0.41 | NA | 7.95 | 090 | ||||||||||||
| 57800 | A | Dilation of cervical canal | 0.77 | 1.22 | 0.36 | 0.08 | 2.07 | 1.21 | 000 | ||||||||||||
| 57820 | A | D C of residual cervix | 1.67 | 2.70 | 2.40 | 0.17 | 4.54 | 4.24 | 010 | ||||||||||||
| 58100 | A | Biopsy of uterus lining | 1.53 | 1.56 | 0.76 | 0.07 | 3.16 | 2.36 | 000 | ||||||||||||
| 58120 | A | Dilation and curettage | 3.27 | 4.01 | 2.55 | 0.33 | 7.61 | 6.15 | 010 | ||||||||||||
| 58140 | A | Removal of uterus lesion | 14.60 | NA | 7.38 | 1.46 | NA | 23.44 | 090 | ||||||||||||
| 58145 | A | Removal of uterus lesion | 8.04 | NA | 5.11 | 0.80 | NA | 13.95 | 090 | ||||||||||||
| 58150 | A | Total hysterectomy | 15.24 | NA | 7.90 | 1.53 | NA | 24.67 | 090 | ||||||||||||
| 58152 | A | Total hysterectomy | 20.60 | NA | 10.17 | 1.52 | NA | 32.29 | 090 | ||||||||||||
| 58180 | A | Partial hysterectomy | 15.29 | NA | 7.90 | 1.54 | NA | 24.73 | 090 | ||||||||||||
| 58200 | A | Extensive hysterectomy | 21.59 | NA | 11.62 | 2.15 | NA | 35.36 | 090 | ||||||||||||
| 58210 | A | Extensive hysterectomy | 28.85 | NA | 14.67 | 2.91 | NA | 46.43 | 090 | ||||||||||||
| 58240 | A | Removal of pelvis contents | 38.39 | NA | 19.71 | 3.76 | NA | 61.86 | 090 | ||||||||||||
| 58260 | A | Vaginal hysterectomy | 12.98 | NA | 6.90 | 1.23 | NA | 21.11 | 090 | ||||||||||||
| 58262 | A | Vaginal hysterectomy | 14.77 | NA | 7.66 | 1.42 | NA | 23.85 | 090 | ||||||||||||
| 58263 | A | Vaginal hysterectomy | 16.06 | NA | 8.22 | 1.55 | NA | 25.83 | 090 | ||||||||||||
| 58267 | A | Hysterectomy vagina repair | 17.04 | NA | 8.81 | 1.51 | NA | 27.36 | 090 | ||||||||||||
| 58270 | A | Hysterectomy vagina repair | 14.26 | NA | 7.43 | 1.37 | NA | 23.06 | 090 | ||||||||||||
| 58275 | A | Hysterectomy/revise vagina | 15.76 | NA | 7.94 | 1.51 | NA | 25.21 | 090 | ||||||||||||
| 58280 | A | Hysterectomy/revise vagina | 17.01 | NA | 8.46 | 1.54 | NA | 27.01 | 090 | ||||||||||||
| 58285 | A | Extensive hysterectomy | 22.26 | NA | 11.15 | 1.88 | NA | 35.29 | 090 | ||||||||||||
| 58300 | N | Insert intrauterine device | +1.01 | 1.42 | 0.40 | 0.10 | 2.53 | 1.51 | XXX | ||||||||||||
| 58301 | A | Remove intrauterine device | 1.27 | 1.62 | 0.51 | 0.13 | 3.02 | 1.91 | 000 | ||||||||||||
| 58321 | A | Artificial insemination | 0.92 | 1.03 | 0.37 | 0.10 | 2.05 | 1.39 | 000 | ||||||||||||
| 58322 | A | Artificial insemination | 1.10 | 1.05 | 0.42 | 0.11 | 2.26 | 1.63 | 000 | ||||||||||||
| 58323 | A | Sperm washing | 0.23 | 0.53 | 0.10 | 0.02 | 0.78 | 0.35 | 000 | ||||||||||||
| 58340 | A | Catheter for hysterography | 0.88 | 12.42 | 0.33 | 0.08 | 13.38 | 1.29 | 000 | ||||||||||||
| 58345 | A | Reopen fallopian tube | 4.66 | NA | 1.73 | 0.36 | NA | 6.75 | 010 | ||||||||||||
| 58346 | A | Insert heyman uteri capsule | 6.75 | NA | 3.84 | 0.68 | NA | 11.27 | 090 | ||||||||||||
| 58350 | A | Reopen fallopian tube | 1.01 | 2.15 | 1.17 | 0.10 | 3.26 | 2.28 | 010 | ||||||||||||
| 58353 | A | Endometr ablate, thermal | 3.56 | NA | 2.28 | 0.37 | NA | 6.21 | 010 | ||||||||||||
| 58400 | A | Suspension of uterus | 6.36 | NA | 4.17 | 0.62 | NA | 11.15 | 090 | ||||||||||||
| 58410 | A | Suspension of uterus | 12.73 | NA | 6.84 | 1.09 | NA | 20.66 | 090 | ||||||||||||
| 58520 | A | Repair of ruptured uterus | 11.92 | NA | 6.24 | 1.17 | NA | 19.33 | 090 | ||||||||||||
| 58540 | A | Revision of uterus | 14.64 | NA | 6.96 | 1.28 | NA | 22.88 | 090 | ||||||||||||
| 58550 | A | Laparo-asst vag hysterectomy | 14.19 | NA | 7.11 | 1.44 | NA | 22.74 | 010 | ||||||||||||
| 58551 | A | Laparoscopy, remove myoma | 14.21 | NA | 7.09 | 1.45 | NA | 22.75 | 010 | ||||||||||||
| 58555 | A | Hysteroscopy, dx, sep proc | 3.33 | 2.95 | 1.49 | 0.34 | 6.62 | 5.16 | 000 | ||||||||||||
| 58558 | A | Hysteroscopy, biopsy | 4.75 | 3.55 | 2.13 | 0.49 | 8.79 | 7.37 | 000 | ||||||||||||
| 58559 | A | Hysteroscopy, lysis | 6.17 | 2.59 | 2.59 | 0.62 | 9.38 | 9.38 | 000 | ||||||||||||
| 58560 | A | Hysteroscopy, resect septum | 7.00 | 3.01 | 3.01 | 0.71 | 10.72 | 10.72 | 000 | ||||||||||||
| 58561 | A | Hysteroscopy, remove myoma | 10.00 | 3.78 | 3.78 | 1.02 | 14.80 | 14.80 | 000 | ||||||||||||
| 58562 | A | Hysteroscopy, remove fb | 5.21 | NA | 2.34 | 0.52 | NA | 8.07 | 000 | ||||||||||||
| 58563 | A | Hysteroscopy, ablation | 6.17 | 2.62 | 2.62 | 0.62 | 9.41 | 9.41 | 000 | ||||||||||||
| 58578 | C | Laparo proc, uterus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 58579 | C | Hysteroscope procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 58600 | A | Division of fallopian tube | 5.60 | NA | 3.51 | 0.39 | NA | 9.50 | 090 | ||||||||||||
| 58605 | A | Division of fallopian tube | 5.00 | NA | 3.32 | 0.33 | NA | 8.65 | 090 | ||||||||||||
| 58611 | A | Ligate oviduct(s) add-on | 1.45 | NA | 0.61 | 0.07 | NA | 2.13 | ZZZ | ||||||||||||
| 58615 | A | Occlude fallopian tube(s) | 3.90 | NA | 3.35 | 0.40 | NA | 7.65 | 010 | ||||||||||||
| 58660 | A | Laparoscopy, lysis | 11.29 | NA | 5.78 | 1.14 | NA | 18.21 | 090 | ||||||||||||
| 58661 | A | Laparoscopy, remove adnexa | 11.05 | NA | 5.47 | 1.12 | NA | 17.64 | 010 | ||||||||||||
| 58662 | A | Laparoscopy, excise lesions | 11.79 | NA | 5.75 | 1.18 | NA | 18.72 | 090 | ||||||||||||
| 58670 | A | Laparoscopy, tubal cautery | 5.60 | NA | 3.73 | 0.55 | NA | 9.88 | 090 | ||||||||||||
| 58671 | A | Laparoscopy, tubal block | 5.60 | NA | 3.74 | 0.56 | NA | 9.90 | 090 | ||||||||||||
| 58672 | A | Laparoscopy, fimbrioplasty | 12.88 | NA | 6.81 | 1.22 | NA | 20.91 | 090 | ||||||||||||
| 58673 | A | Laparoscopy, salpingostomy | 13.74 | NA | 7.16 | 1.40 | NA | 22.30 | 090 | ||||||||||||
| 58679 | C | Laparo proc, oviduct-ovary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 58700 | A | Removal of fallopian tube | 12.05 | NA | 6.05 | 0.64 | NA | 18.74 | 090 | ||||||||||||
| 58720 | A | Removal of ovary/tube(s) | 11.36 | NA | 6.05 | 1.14 | NA | 18.55 | 090 | ||||||||||||
| 58740 | A | Revise fallopian tube(s) | 14.00 | NA | 7.34 | 0.59 | NA | 21.93 | 090 | ||||||||||||
| 58750 | A | Repair oviduct | 14.84 | NA | 7.60 | 1.52 | NA | 23.96 | 090 | ||||||||||||
| 58752 | A | Revise ovarian tube(s) | 14.84 | NA | 7.92 | 1.51 | NA | 24.27 | 090 | ||||||||||||
| 58760 | A | Remove tubal obstruction | 13.13 | NA | 7.00 | 1.34 | NA | 21.47 | 090 | ||||||||||||
| 58770 | A | Create new tubal opening | 13.97 | NA | 7.24 | 1.42 | NA | 22.63 | 090 | ||||||||||||
| 58800 | A | Drainage of ovarian cyst(s) | 4.14 | 4.43 | 4.36 | 0.36 | 8.93 | 8.86 | 090 | ||||||||||||
| 58805 | A | Drainage of ovarian cyst(s) | 5.88 | NA | 3.66 | 0.56 | NA | 10.10 | 090 | ||||||||||||
| 58820 | A | Drain ovary abscess, open | 4.22 | NA | 3.38 | 0.29 | NA | 7.89 | 090 | ||||||||||||
| 58822 | A | Drain ovary abscess, percut | 10.13 | NA | 5.20 | 0.92 | NA | 16.25 | 090 | ||||||||||||
| 58823 | A | Drain pelvic abscess, percut | 3.38 | NA | 2.38 | 0.18 | NA | 5.94 | 000 | ||||||||||||
| 58825 | A | Transposition, ovary(s) | 10.98 | NA | 5.95 | 0.62 | NA | 17.55 | 090 | ||||||||||||
| 58900 | A | Biopsy of ovary(s) | 5.99 | NA | 3.64 | 0.56 | NA | 10.19 | 090 | ||||||||||||
| 58920 | A | Partial removal of ovary(s) | 11.36 | NA | 5.85 | 0.68 | NA | 17.89 | 090 | ||||||||||||
| 58925 | A | Removal of ovarian cyst(s) | 11.36 | NA | 5.79 | 1.14 | NA | 18.29 | 090 | ||||||||||||
| 58940 | A | Removal of ovary(s) | 7.29 | NA | 4.18 | 0.73 | NA | 12.20 | 090 | ||||||||||||
| 58943 | A | Removal of ovary(s) | 18.43 | NA | 9.92 | 1.86 | NA | 30.21 | 090 | ||||||||||||
| 58950 | A | Resect ovarian malignancy | 16.93 | NA | 9.41 | 1.55 | NA | 27.89 | 090 | ||||||||||||
| 58951 | A | Resect ovarian malignancy | 22.38 | NA | 11.81 | 2.20 | NA | 36.39 | 090 | ||||||||||||
| 58952 | A | Resect ovarian malignancy | 25.01 | NA | 12.99 | 2.50 | NA | 40.50 | 090 | ||||||||||||
| 58953 | A | Tah, rad dissect for debulk | 32.00 | NA | 15.59 | 3.20 | NA | 50.79 | 090 | ||||||||||||
| 58954 | A | Tah rad debulk/lymph remove | 35.00 | NA | 16.71 | 3.50 | NA | 55.21 | 090 | ||||||||||||
| 58960 | A | Exploration of abdomen | 14.65 | NA | 8.52 | 1.47 | NA | 24.64 | 090 | ||||||||||||
| 58970 | A | Retrieval of oocyte | 3.53 | 8.56 | 1.92 | 0.36 | 12.45 | 5.81 | 000 | ||||||||||||
| 58974 | C | Transfer of embryo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 58976 | A | Transfer of embryo | 3.83 | 2.30 | 1.53 | 0.39 | 6.52 | 5.75 | 000 | ||||||||||||
| 58999 | C | Genital surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 59000 | A | Amniocentesis, diagnostic | 1.30 | 2.05 | 0.72 | 0.23 | 3.58 | 2.25 | 000 | ||||||||||||
| 59001 | A | Amniocentesis, therapeutic | 3.00 | NA | 1.37 | 0.23 | NA | 4.60 | 000 | ||||||||||||
| 59012 | A | Fetal cord puncture, prenatal | 3.45 | NA | 1.71 | 0.62 | NA | 5.78 | 000 | ||||||||||||
| 59015 | A | Chorion biopsy | 2.20 | 1.64 | 1.11 | 0.40 | 4.24 | 3.71 | 000 | ||||||||||||
| 59020 | A | Fetal contract stress test | 0.66 | 0.78 | NA | 0.20 | 1.64 | NA | 000 | ||||||||||||
| 59020 | 26 | A | Fetal contract stress test | 0.66 | 0.28 | 0.28 | 0.12 | 1.06 | 1.06 | 000 | |||||||||||
| 59020 | TC | A | Fetal contract stress test | 0.00 | 0.50 | NA | 0.08 | 0.58 | NA | 000 | |||||||||||
| 59025 | A | Fetal non-stress test | 0.53 | 0.44 | NA | 0.12 | 1.09 | NA | 000 | ||||||||||||
| 59025 | 26 | A | Fetal non-stress test | 0.53 | 0.22 | 0.22 | 0.10 | 0.85 | 0.85 | 000 | |||||||||||
| 59025 | TC | A | Fetal non-stress test | 0.00 | 0.22 | NA | 0.02 | 0.24 | NA | 000 | |||||||||||
| 59030 | A | Fetal scalp blood sample | 1.99 | NA | 1.14 | 0.36 | NA | 3.49 | 000 | ||||||||||||
| 59050 | A | Fetal monitor w/report | 0.89 | NA | 0.38 | 0.16 | NA | 1.43 | XXX | ||||||||||||
| 59051 | A | Fetal monitor/interpret only | 0.74 | NA | 0.31 | 0.14 | NA | 1.19 | XXX | ||||||||||||
| 59100 | A | Remove uterus lesion | 12.35 | NA | 6.61 | 2.21 | NA | 21.17 | 090 | ||||||||||||
| 59120 | A | Treat ectopic pregnancy | 11.49 | NA | 6.35 | 2.06 | NA | 19.90 | 090 | ||||||||||||
| 59121 | A | Treat ectopic pregnancy | 11.67 | NA | 6.39 | 2.09 | NA | 20.15 | 090 | ||||||||||||
| 59130 | A | Treat ectopic pregnancy | 14.22 | NA | 7.16 | 2.54 | NA | 23.92 | 090 | ||||||||||||
| 59135 | A | Treat ectopic pregnancy | 13.88 | NA | 7.27 | 2.49 | NA | 23.64 | 090 | ||||||||||||
| 59136 | A | Treat ectopic pregnancy | 13.18 | NA | 6.36 | 2.36 | NA | 21.90 | 090 | ||||||||||||
| 59140 | A | Treat ectopic pregnancy | 5.46 | NA | 3.70 | 0.98 | NA | 10.14 | 090 | ||||||||||||
| 59150 | A | Treat ectopic pregnancy | 11.67 | NA | 6.69 | 1.23 | NA | 19.59 | 090 | ||||||||||||
| 59151 | A | Treat ectopic pregnancy | 11.49 | NA | 6.12 | 1.41 | NA | 19.02 | 090 | ||||||||||||
| 59160 | A | D C after delivery | 2.71 | 3.73 | 2.29 | 0.49 | 6.93 | 5.49 | 010 | ||||||||||||
| 59200 | A | Insert cervical dilator | 0.79 | 1.41 | 0.32 | 0.15 | 2.35 | 1.26 | 000 | ||||||||||||
| 59300 | A | Episiotomy or vaginal repair | 2.41 | 2.01 | 1.01 | 0.43 | 4.85 | 3.85 | 000 | ||||||||||||
| 59320 | A | Revision of cervix | 2.48 | NA | 1.31 | 0.45 | NA | 4.24 | 000 | ||||||||||||
| 59325 | A | Revision of cervix | 4.07 | NA | 1.97 | 0.73 | NA | 6.77 | 000 | ||||||||||||
| 59350 | A | Repair of uterus | 4.95 | NA | 2.19 | 0.88 | NA | 8.02 | 000 | ||||||||||||
| 59400 | A | Obstetrical care | 23.06 | NA | 15.41 | 4.14 | NA | 42.61 | MMM | ||||||||||||
| 59409 | A | Obstetrical care | 13.50 | NA | 5.57 | 2.42 | NA | 21.49 | MMM | ||||||||||||
| 59410 | A | Obstetrical care | 14.78 | NA | 6.98 | 2.65 | NA | 24.41 | MMM | ||||||||||||
| 59412 | A | Antepartum manipulation | 1.71 | 1.38 | 0.72 | 0.31 | 3.40 | 2.74 | MMM | ||||||||||||
| 59414 | A | Deliver placenta | 1.61 | NA | 1.34 | 0.29 | NA | 3.24 | MMM | ||||||||||||
| 59425 | A | Antepartum care only | 4.81 | 5.36 | 5.32 | 0.86 | 11.03 | 10.99 | MMM | ||||||||||||
| 59426 | A | Antepartum care only | 8.28 | 9.14 | 9.14 | 1.49 | 18.91 | 18.91 | MMM | ||||||||||||
| 59430 | A | Care after delivery | 2.13 | 1.29 | 1.29 | 0.38 | 3.80 | 3.80 | MMM | ||||||||||||
| 59510 | A | Cesarean delivery | 26.22 | NA | 17.61 | 4.70 | NA | 48.53 | MMM | ||||||||||||
| 59514 | A | Cesarean delivery only | 15.97 | NA | 6.57 | 2.86 | NA | 25.40 | MMM | ||||||||||||
| 59515 | A | Cesarean delivery | 17.37 | NA | 8.52 | 3.12 | NA | 29.01 | MMM | ||||||||||||
| 59525 | A | Remove uterus after cesarean | 8.54 | NA | 3.52 | 1.53 | NA | 13.59 | ZZZ | ||||||||||||
| 59610 | A | Vbac delivery | 24.62 | NA | 16.29 | 4.41 | NA | 45.32 | MMM | ||||||||||||
| 59612 | A | Vbac delivery only | 15.06 | NA | 6.43 | 2.70 | NA | 24.19 | MMM | ||||||||||||
| 59614 | A | Vbac care after delivery | 16.34 | NA | 7.70 | 2.93 | NA | 26.97 | MMM | ||||||||||||
| 59618 | A | Attempted vbac delivery | 27.78 | NA | 18.38 | 4.98 | NA | 51.14 | MMM | ||||||||||||
| 59620 | A | Attempted vbac delivery only | 17.53 | NA | 6.87 | 3.15 | NA | 27.55 | MMM | ||||||||||||
| 59622 | A | Attempted vbac after care | 18.93 | NA | 8.91 | 3.39 | NA | 31.23 | MMM | ||||||||||||
| 59812 | A | Treatment of miscarriage | 4.01 | 3.75 | 2.51 | 0.58 | 8.34 | 7.10 | 090 | ||||||||||||
| 59820 | A | Care of miscarriage | 4.01 | 3.79 | 2.85 | 0.72 | 8.52 | 7.58 | 090 | ||||||||||||
| 59821 | A | Treatment of miscarriage | 4.47 | 3.79 | 3.01 | 0.80 | 9.06 | 8.28 | 090 | ||||||||||||
| 59830 | A | Treat uterus infection | 6.11 | NA | 3.85 | 1.10 | NA | 11.06 | 090 | ||||||||||||
| 59840 | R | Abortion | 3.01 | 4.01 | 2.47 | 0.54 | 7.56 | 6.02 | 010 | ||||||||||||
| 59841 | R | Abortion | 5.24 | 5.78 | 3.72 | 0.94 | 11.96 | 9.90 | 010 | ||||||||||||
| 59850 | R | Abortion | 5.91 | NA | 2.75 | 1.06 | NA | 9.72 | 090 | ||||||||||||
| 59851 | R | Abortion | 5.93 | NA | 3.22 | 1.06 | NA | 10.21 | 090 | ||||||||||||
| 59852 | R | Abortion | 8.24 | NA | 4.58 | 1.48 | NA | 14.30 | 090 | ||||||||||||
| 59855 | R | Abortion | 6.12 | NA | 3.38 | 1.10 | NA | 10.60 | 090 | ||||||||||||
| 59856 | R | Abortion | 7.48 | NA | 3.74 | 1.34 | NA | 12.56 | 090 | ||||||||||||
| 59857 | R | Abortion | 9.29 | NA | 4.46 | 1.66 | NA | 15.41 | 090 | ||||||||||||
| 59866 | R | Abortion (mpr) | 4.00 | NA | 1.60 | 0.72 | NA | 6.32 | 000 | ||||||||||||
| 59870 | A | Evacuate mole of uterus | 6.01 | NA | 3.83 | 0.77 | NA | 10.61 | 090 | ||||||||||||
| 59871 | A | Remove cerclage suture | 2.13 | 2.19 | 0.93 | 0.38 | 4.70 | 3.44 | 000 | ||||||||||||
| 59898 | C | Laparo proc, ob care/deliver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 59899 | C | Maternity care procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 60000 | A | Drain thyroid/tongue cyst | 1.76 | 2.40 | 2.22 | 0.14 | 4.30 | 4.12 | 010 | ||||||||||||
| 60001 | A | Aspirate/inject thyriod cyst | 0.97 | 1.77 | 0.35 | 0.06 | 2.80 | 1.38 | 000 | ||||||||||||
| 60100 | A | Biopsy of thyroid | 1.56 | 2.70 | 0.56 | 0.05 | 4.31 | 2.17 | 000 | ||||||||||||
| 60200 | A | Remove thyroid lesion | 9.55 | NA | 6.88 | 0.84 | NA | 17.27 | 090 | ||||||||||||
| 60210 | A | Partial thyroid excision | 10.88 | NA | 6.63 | 1.01 | NA | 18.52 | 090 | ||||||||||||
| 60212 | A | Parital thyroid excision | 16.03 | NA | 8.62 | 1.51 | NA | 26.16 | 090 | ||||||||||||
| 60220 | A | Partial removal of thyroid | 11.90 | NA | 7.27 | 0.97 | NA | 20.14 | 090 | ||||||||||||
| 60225 | A | Partial removal of thyroid | 14.19 | NA | 8.05 | 1.31 | NA | 23.55 | 090 | ||||||||||||
| 60240 | A | Removal of thyroid | 16.06 | NA | 9.32 | 1.50 | NA | 26.88 | 090 | ||||||||||||
| 60252 | A | Removal of thyroid | 20.57 | NA | 11.64 | 1.63 | NA | 33.84 | 090 | ||||||||||||
| 60254 | A | Extensive thyroid surgery | 26.99 | NA | 16.39 | 1.96 | NA | 45.34 | 090 | ||||||||||||
| 60260 | A | Repeat thyroid surgery | 17.47 | NA | 10.66 | 1.39 | NA | 29.52 | 090 | ||||||||||||
| 60270 | A | Removal of thyroid | 20.27 | NA | 11.54 | 1.78 | NA | 33.59 | 090 | ||||||||||||
| 60271 | A | Removal of thyroid | 16.83 | NA | 10.20 | 1.35 | NA | 28.38 | 090 | ||||||||||||
| 60280 | A | Remove thyroid duct lesion | 5.87 | NA | 5.29 | 0.45 | NA | 11.61 | 090 | ||||||||||||
| 60281 | A | Remove thyroid duct lesion | 8.53 | NA | 6.27 | 0.67 | NA | 15.47 | 090 | ||||||||||||
| 60500 | A | Explore parathyroid glands | 16.23 | NA | 7.99 | 1.61 | NA | 25.83 | 090 | ||||||||||||
| 60502 | A | Re-explore parathyroids | 20.35 | NA | 9.97 | 2.00 | NA | 32.32 | 090 | ||||||||||||
| 60505 | A | Explore parathyroid glands | 21.49 | NA | 11.53 | 2.14 | NA | 35.16 | 090 | ||||||||||||
| 60512 | A | Autotransplant parathyroid | 4.45 | NA | 1.72 | 0.44 | NA | 6.61 | ZZZ | ||||||||||||
| 60520 | A | Removal of thymus gland | 16.81 | NA | 9.55 | 1.84 | NA | 28.20 | 090 | ||||||||||||
| 60521 | A | Removal of thymus gland | 18.87 | NA | 11.57 | 2.34 | NA | 32.78 | 090 | ||||||||||||
| 60522 | A | Removal of thymus gland | 23.09 | NA | 12.88 | 2.83 | NA | 38.80 | 090 | ||||||||||||
| 60540 | A | Explore adrenal gland | 17.03 | NA | 8.09 | 1.42 | NA | 26.54 | 090 | ||||||||||||
| 60545 | A | Explore adrenal gland | 19.88 | NA | 9.73 | 1.75 | NA | 31.36 | 090 | ||||||||||||
| 60600 | A | Remove carotid body lesion | 17.93 | NA | 13.43 | 1.87 | NA | 33.23 | 090 | ||||||||||||
| 60605 | A | Remove carotid body lesion | 20.24 | NA | 18.12 | 2.28 | NA | 40.64 | 090 | ||||||||||||
| 60650 | A | Laparoscopy adrenalectomy | 20.00 | NA | 8.34 | 1.98 | NA | 30.32 | 090 | ||||||||||||
| 60659 | C | Laparo proc, endocrine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 60699 | C | Endocrine surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 61000 | A | Remove cranial cavity fluid | 1.58 | 1.79 | 1.53 | 0.13 | 3.50 | 3.24 | 000 | ||||||||||||
| 61001 | A | Remove cranial cavity fluid | 1.49 | 2.08 | 1.47 | 0.15 | 3.72 | 3.11 | 000 | ||||||||||||
| 61020 | A | Remove brain cavity fluid | 1.51 | 2.52 | 1.51 | 0.26 | 4.29 | 3.28 | 000 | ||||||||||||
| 61026 | A | Injection into brain canal | 1.69 | 2.28 | 1.73 | 0.21 | 4.18 | 3.63 | 000 | ||||||||||||
| 61050 | A | Remove brain canal fluid | 1.51 | NA | 1.56 | 0.13 | NA | 3.20 | 000 | ||||||||||||
| 61055 | A | Injection into brain canal | 2.10 | NA | 1.80 | 0.13 | NA | 4.03 | 000 | ||||||||||||
| 61070 | A | Brain canal shunt procedure | 0.89 | 7.33 | 1.22 | 0.09 | 8.31 | 2.20 | 000 | ||||||||||||
| 61105 | A | Twist drill hole | 5.14 | NA | 3.67 | 1.05 | NA | 9.86 | 090 | ||||||||||||
| 61107 | A | Drill skull for implantation | 5.00 | NA | 3.12 | 1.02 | NA | 9.14 | 000 | ||||||||||||
| 61108 | A | Drill skull for drainage | 10.19 | NA | 7.09 | 2.04 | NA | 19.32 | 090 | ||||||||||||
| 61120 | A | Burr hole for puncture | 8.76 | NA | 5.88 | 1.81 | NA | 16.45 | 090 | ||||||||||||
| 61140 | A | Pierce skull for biopsy | 15.90 | NA | 10.00 | 3.15 | NA | 29.05 | 090 | ||||||||||||
| 61150 | A | Pierce skull for drainage | 17.57 | NA | 10.74 | 3.52 | NA | 31.83 | 090 | ||||||||||||
| 61151 | A | Pierce skull for drainage | 12.42 | NA | 8.16 | 2.45 | NA | 23.03 | 090 | ||||||||||||
| 61154 | A | Pierce skull remove clot | 14.99 | NA | 9.43 | 3.05 | NA | 27.47 | 090 | ||||||||||||
| 61156 | A | Pierce skull for drainage | 16.32 | NA | 10.30 | 3.42 | NA | 30.04 | 090 | ||||||||||||
| 61210 | A | Pierce skull, implant device | 5.84 | NA | 3.53 | 1.16 | NA | 10.53 | 000 | ||||||||||||
| 61215 | A | Insert brain-fluid device | 4.89 | NA | 4.24 | 0.99 | NA | 10.12 | 090 | ||||||||||||
| 61250 | A | Pierce skull explore | 10.42 | NA | 6.73 | 2.02 | NA | 19.17 | 090 | ||||||||||||
| 61253 | A | Pierce skull explore | 12.36 | NA | 7.65 | 2.26 | NA | 22.27 | 090 | ||||||||||||
| 61304 | A | Open skull for exploration | 21.96 | NA | 12.85 | 4.33 | NA | 39.14 | 090 | ||||||||||||
| 61305 | A | Open skull for exploration | 26.61 | NA | 15.31 | 5.25 | NA | 47.17 | 090 | ||||||||||||
| 61312 | A | Open skull for drainage | 24.57 | NA | 14.57 | 4.99 | NA | 44.13 | 090 | ||||||||||||
| 61313 | A | Open skull for drainage | 24.93 | NA | 14.76 | 5.07 | NA | 44.76 | 090 | ||||||||||||
| 61314 | A | Open skull for drainage | 24.23 | NA | 11.55 | 4.00 | NA | 39.78 | 090 | ||||||||||||
| 61315 | A | Open skull for drainage | 27.68 | NA | 16.22 | 5.62 | NA | 49.52 | 090 | ||||||||||||
| 61320 | A | Open skull for drainage | 25.62 | NA | 15.20 | 5.20 | NA | 46.02 | 090 | ||||||||||||
| 61321 | A | Open skull for drainage | 28.50 | NA | 16.09 | 5.35 | NA | 49.94 | 090 | ||||||||||||
| 61330 | A | Decompress eye socket | 23.32 | NA | 19.43 | 2.58 | NA | 45.33 | 090 | ||||||||||||
| 61332 | A | Explore/biopsy eye socket | 27.28 | NA | 20.43 | 4.15 | NA | 51.86 | 090 | ||||||||||||
| 61333 | A | Explore orbit/remove lesion | 27.95 | NA | 16.45 | 2.24 | NA | 46.64 | 090 | ||||||||||||
| 61334 | A | Explore orbit/remove object | 18.27 | NA | 10.08 | 3.02 | NA | 31.37 | 090 | ||||||||||||
| 61340 | A | Relieve cranial pressure | 18.66 | NA | 11.75 | 3.66 | NA | 34.07 | 090 | ||||||||||||
| 61343 | A | Incise skull (press relief) | 29.77 | NA | 17.96 | 6.04 | NA | 53.77 | 090 | ||||||||||||
| 61345 | A | Relieve cranial pressure | 27.20 | NA | 16.17 | 5.23 | NA | 48.60 | 090 | ||||||||||||
| 61440 | A | Incise skull for surgery | 26.63 | NA | 12.14 | 5.57 | NA | 44.34 | 090 | ||||||||||||
| 61450 | A | Incise skull for surgery | 25.95 | NA | 14.46 | 5.11 | NA | 45.52 | 090 | ||||||||||||
| 61458 | A | Incise skull for brain wound | 27.29 | NA | 15.89 | 5.28 | NA | 48.46 | 090 | ||||||||||||
| 61460 | A | Incise skull for surgery | 28.39 | NA | 16.77 | 5.13 | NA | 50.29 | 090 | ||||||||||||
| 61470 | A | Incise skull for surgery | 26.06 | NA | 13.74 | 4.65 | NA | 44.45 | 090 | ||||||||||||
| 61480 | A | Incise skull for surgery | 26.49 | NA | 12.34 | 5.54 | NA | 44.37 | 090 | ||||||||||||
| 61490 | A | Incise skull for surgery | 25.66 | NA | 15.18 | 5.37 | NA | 46.21 | 090 | ||||||||||||
| 61500 | A | Removal of skull lesion | 17.92 | NA | 11.03 | 3.26 | NA | 32.21 | 090 | ||||||||||||
| 61501 | A | Remove infected skull bone | 14.84 | NA | 9.62 | 2.63 | NA | 27.09 | 090 | ||||||||||||
| 61510 | A | Removal of brain lesion | 28.45 | NA | 16.60 | 5.77 | NA | 50.82 | 090 | ||||||||||||
| 61512 | A | Remove brain lining lesion | 35.09 | NA | 20.18 | 7.14 | NA | 62.41 | 090 | ||||||||||||
| 61514 | A | Removal of brain abscess | 25.26 | NA | 14.91 | 5.12 | NA | 45.29 | 090 | ||||||||||||
| 61516 | A | Removal of brain lesion | 24.61 | NA | 15.01 | 4.94 | NA | 44.56 | 090 | ||||||||||||
| 61518 | A | Removal of brain lesion | 37.32 | NA | 22.34 | 7.53 | NA | 67.19 | 090 | ||||||||||||
| 61519 | A | Remove brain lining lesion | 41.39 | NA | 24.42 | 8.15 | NA | 73.96 | 090 | ||||||||||||
| 61520 | A | Removal of brain lesion | 54.84 | NA | 31.93 | 10.10 | NA | 96.87 | 090 | ||||||||||||
| 61521 | A | Removal of brain lesion | 44.48 | NA | 26.22 | 8.85 | NA | 79.55 | 090 | ||||||||||||
| 61522 | A | Removal of brain abscess | 29.45 | NA | 17.20 | 5.30 | NA | 51.95 | 090 | ||||||||||||
| 61524 | A | Removal of brain lesion | 27.86 | NA | 16.83 | 5.01 | NA | 49.70 | 090 | ||||||||||||
| 61526 | A | Removal of brain lesion | 52.17 | NA | 31.55 | 6.72 | NA | 90.44 | 090 | ||||||||||||
| 61530 | A | Removal of brain lesion | 43.86 | NA | 27.43 | 6.17 | NA | 77.46 | 090 | ||||||||||||
| 61531 | A | Implant brain electrodes | 14.63 | NA | 9.56 | 2.84 | NA | 27.03 | 090 | ||||||||||||
| 61533 | A | Implant brain electrodes | 19.71 | NA | 12.21 | 3.80 | NA | 35.72 | 090 | ||||||||||||
| 61534 | A | Removal of brain lesion | 20.97 | NA | 13.30 | 4.15 | NA | 38.42 | 090 | ||||||||||||
| 61535 | A | Remove brain electrodes | 11.63 | NA | 8.16 | 2.29 | NA | 22.08 | 090 | ||||||||||||
| 61536 | A | Removal of brain lesion | 35.52 | NA | 21.18 | 6.68 | NA | 63.38 | 090 | ||||||||||||
| 61538 | A | Removal of brain tissue | 26.81 | NA | 16.30 | 5.38 | NA | 48.49 | 090 | ||||||||||||
| 61539 | A | Removal of brain tissue | 32.08 | NA | 18.91 | 6.62 | NA | 57.61 | 090 | ||||||||||||
| 61541 | A | Incision of brain tissue | 28.85 | NA | 16.89 | 5.50 | NA | 51.24 | 090 | ||||||||||||
| 61542 | A | Removal of brain tissue | 31.02 | NA | 18.00 | 6.49 | NA | 55.51 | 090 | ||||||||||||
| 61543 | A | Removal of brain tissue | 29.22 | NA | 17.42 | 6.11 | NA | 52.75 | 090 | ||||||||||||
| 61544 | A | Remove treat brain lesion | 25.50 | NA | 15.21 | 4.91 | NA | 45.62 | 090 | ||||||||||||
| 61545 | A | Excision of brain tumor | 43.80 | NA | 25.09 | 8.88 | NA | 77.77 | 090 | ||||||||||||
| 61546 | A | Removal of pituitary gland | 31.30 | NA | 18.74 | 6.06 | NA | 56.10 | 090 | ||||||||||||
| 61548 | A | Removal of pituitary gland | 21.53 | NA | 13.74 | 3.63 | NA | 38.90 | 090 | ||||||||||||
| 61550 | A | Release of skull seams | 14.65 | NA | 4.89 | 1.14 | NA | 20.68 | 090 | ||||||||||||
| 61552 | A | Release of skull seams | 19.56 | NA | 9.87 | 0.88 | NA | 30.31 | 090 | ||||||||||||
| 61556 | A | Incise skull/sutures | 22.26 | NA | 11.74 | 3.57 | NA | 37.57 | 090 | ||||||||||||
| 61557 | A | Incise skull/sutures | 22.38 | NA | 13.41 | 4.68 | NA | 40.47 | 090 | ||||||||||||
| 61558 | A | Excision of skull/sutures | 25.58 | NA | 12.67 | 2.61 | NA | 40.86 | 090 | ||||||||||||
| 61559 | A | Excision of skull/sutures | 32.79 | NA | 18.89 | 6.86 | NA | 58.54 | 090 | ||||||||||||
| 61563 | A | Excision of skull tumor | 26.83 | NA | 16.25 | 4.46 | NA | 47.54 | 090 | ||||||||||||
| 61564 | A | Excision of skull tumor | 33.83 | NA | 18.73 | 7.08 | NA | 59.64 | 090 | ||||||||||||
| 61570 | A | Remove foreign body, brain | 24.60 | NA | 13.80 | 4.60 | NA | 43.00 | 090 | ||||||||||||
| 61571 | A | Incise skull for brain wound | 26.39 | NA | 15.43 | 5.23 | NA | 47.05 | 090 | ||||||||||||
| 61575 | A | Skull base/brainstem surgery | 34.36 | NA | 21.38 | 5.02 | NA | 60.76 | 090 | ||||||||||||
| 61576 | A | Skull base/brainstem surgery | 52.43 | NA | 28.89 | 4.68 | NA | 86.00 | 090 | ||||||||||||
| 61580 | A | Craniofacial approach, skull | 30.35 | NA | 19.96 | 2.75 | NA | 53.06 | 090 | ||||||||||||
| 61581 | A | Craniofacial approach, skull | 34.60 | NA | 22.57 | 3.37 | NA | 60.54 | 090 | ||||||||||||
| 61582 | A | Craniofacial approach, skull | 31.66 | NA | 19.56 | 6.30 | NA | 57.52 | 090 | ||||||||||||
| 61583 | A | Craniofacial approach, skull | 36.21 | NA | 22.71 | 6.94 | NA | 65.86 | 090 | ||||||||||||
| 61584 | A | Orbitocranial approach/skull | 34.65 | NA | 20.99 | 6.53 | NA | 62.17 | 090 | ||||||||||||
| 61585 | A | Orbitocranial approach/skull | 38.61 | NA | 22.21 | 6.19 | NA | 67.01 | 090 | ||||||||||||
| 61586 | A | Resect nasopharynx, skull | 25.10 | NA | 16.39 | 3.52 | NA | 45.01 | 090 | ||||||||||||
| 61590 | A | Infratemporal approach/skull | 41.78 | NA | 26.12 | 4.28 | NA | 72.18 | 090 | ||||||||||||
| 61591 | A | Infratemporal approach/skull | 43.68 | NA | 26.89 | 5.26 | NA | 75.83 | 090 | ||||||||||||
| 61592 | A | Orbitocranial approach/skull | 39.64 | NA | 23.59 | 7.55 | NA | 70.78 | 090 | ||||||||||||
| 61595 | A | Transtemporal approach/skull | 29.57 | NA | 19.74 | 3.05 | NA | 52.36 | 090 | ||||||||||||
| 61596 | A | Transcochlear approach/skull | 35.63 | NA | 21.88 | 4.25 | NA | 61.76 | 090 | ||||||||||||
| 61597 | A | Transcondylar approach/skull | 37.96 | NA | 22.41 | 6.65 | NA | 67.02 | 090 | ||||||||||||
| 61598 | A | Transpetrosal approach/skull | 33.41 | NA | 20.92 | 4.60 | NA | 58.93 | 090 | ||||||||||||
| 61600 | A | Resect/excise cranial lesion | 25.85 | NA | 15.01 | 3.12 | NA | 43.98 | 090 | ||||||||||||
| 61601 | A | Resect/excise cranial lesion | 27.89 | NA | 17.34 | 5.29 | NA | 50.52 | 090 | ||||||||||||
| 61605 | A | Resect/excise cranial lesion | 29.33 | NA | 18.97 | 2.51 | NA | 50.81 | 090 | ||||||||||||
| 61606 | A | Resect/excise cranial lesion | 38.83 | NA | 23.17 | 6.81 | NA | 68.81 | 090 | ||||||||||||
| 61607 | A | Resect/excise cranial lesion | 36.27 | NA | 22.17 | 5.69 | NA | 64.13 | 090 | ||||||||||||
| 61608 | A | Resect/excise cranial lesion | 42.10 | NA | 24.89 | 8.31 | NA | 75.30 | 090 | ||||||||||||
| 61609 | A | Transect artery, sinus | 9.89 | NA | 5.11 | 2.07 | NA | 17.07 | ZZZ | ||||||||||||
| 61610 | A | Transect artery, sinus | 29.67 | NA | 14.38 | 3.52 | NA | 47.57 | ZZZ | ||||||||||||
| 61611 | A | Transect artery, sinus | 7.42 | NA | 2.96 | 1.55 | NA | 11.93 | ZZZ | ||||||||||||
| 61612 | A | Transect artery, sinus | 27.88 | NA | 14.30 | 3.55 | NA | 45.73 | ZZZ | ||||||||||||
| 61613 | A | Remove aneurysm, sinus | 40.86 | NA | 23.34 | 8.32 | NA | 72.52 | 090 | ||||||||||||
| 61615 | A | Resect/excise lesion, skull | 32.07 | NA | 20.81 | 4.64 | NA | 57.52 | 090 | ||||||||||||
| 61616 | A | Resect/excise lesion, skull | 43.33 | NA | 26.97 | 7.02 | NA | 77.32 | 090 | ||||||||||||
| 61618 | A | Repair dura | 16.99 | NA | 11.43 | 2.92 | NA | 31.34 | 090 | ||||||||||||
| 61619 | A | Repair dura | 20.71 | NA | 13.67 | 3.42 | NA | 37.80 | 090 | ||||||||||||
| 61624 | A | Occlusion/embolization cath | 20.15 | NA | 7.46 | 1.15 | NA | 28.76 | 000 | ||||||||||||
| 61626 | A | Occlusion/embolization cath | 16.62 | NA | 5.88 | 0.84 | NA | 23.34 | 000 | ||||||||||||
| 61680 | A | Intracranial vessel surgery | 30.71 | NA | 18.38 | 6.04 | NA | 55.13 | 090 | ||||||||||||
| 61682 | A | Intracranial vessel surgery | 61.57 | NA | 34.65 | 12.69 | NA | 108.91 | 090 | ||||||||||||
| 61684 | A | Intracranial vessel surgery | 39.81 | NA | 22.60 | 7.87 | NA | 70.28 | 090 | ||||||||||||
| 61686 | A | Intracranial vessel surgery | 64.49 | NA | 36.70 | 13.20 | NA | 114.39 | 090 | ||||||||||||
| 61690 | A | Intracranial vessel surgery | 29.31 | NA | 17.64 | 5.51 | NA | 52.46 | 090 | ||||||||||||
| 61692 | A | Intracranial vessel surgery | 51.87 | NA | 29.51 | 10.17 | NA | 91.55 | 090 | ||||||||||||
| 61697 | A | Brain aneurysm repr, complx | 50.52 | NA | 28.42 | 10.31 | NA | 89.25 | 090 | ||||||||||||
| 61698 | A | Brain aneurysm repr, complx | 48.41 | NA | 27.31 | 9.99 | NA | 85.71 | 090 | ||||||||||||
| 61700 | A | Brain aneurysm repr , simple | 50.52 | NA | 28.42 | 10.18 | NA | 89.12 | 090 | ||||||||||||
| 61702 | A | Inner skull vessel surgery | 48.41 | NA | 27.31 | 9.75 | NA | 85.47 | 090 | ||||||||||||
| 61703 | A | Clamp neck artery | 17.47 | NA | 11.13 | 3.62 | NA | 32.22 | 090 | ||||||||||||
| 61705 | A | Revise circulation to head | 36.20 | NA | 19.89 | 6.67 | NA | 62.76 | 090 | ||||||||||||
| 61708 | A | Revise circulation to head | 35.30 | NA | 16.52 | 2.18 | NA | 54.00 | 090 | ||||||||||||
| 61710 | A | Revise circulation to head | 29.67 | NA | 14.68 | 2.42 | NA | 46.77 | 090 | ||||||||||||
| 61711 | A | Fusion of skull arteries | 36.33 | NA | 20.68 | 7.39 | NA | 64.40 | 090 | ||||||||||||
| 61720 | A | Incise skull/brain surgery | 16.77 | NA | 10.90 | 3.51 | NA | 31.18 | 090 | ||||||||||||
| 61735 | A | Incise skull/brain surgery | 20.43 | NA | 12.77 | 4.16 | NA | 37.36 | 090 | ||||||||||||
| 61750 | A | Incise skull/brain biopsy | 18.20 | NA | 11.08 | 3.71 | NA | 32.99 | 090 | ||||||||||||
| 61751 | A | Brain biopsy w/ ct/mr guide | 17.62 | NA | 10.92 | 3.57 | NA | 32.11 | 090 | ||||||||||||
| 61760 | A | Implant brain electrodes | 22.27 | NA | 12.85 | 4.59 | NA | 39.71 | 090 | ||||||||||||
| 61770 | A | Incise skull for treatment | 21.44 | NA | 13.26 | 4.09 | NA | 38.79 | 090 | ||||||||||||
| 61790 | A | Treat trigeminal nerve | 10.86 | NA | 6.92 | 1.82 | NA | 19.60 | 090 | ||||||||||||
| 61791 | A | Treat trigeminal tract | 14.61 | NA | 9.39 | 3.03 | NA | 27.03 | 090 | ||||||||||||
| 61793 | A | Focus radiation beam | 17.24 | NA | 11.07 | 3.51 | NA | 31.82 | 090 | ||||||||||||
| 61795 | A | Brain surgery using computer | 4.04 | NA | 2.14 | 0.81 | NA | 6.99 | ZZZ | ||||||||||||
| 61850 | A | Implant neuroelectrodes | 12.39 | NA | 8.13 | 2.23 | NA | 22.75 | 090 | ||||||||||||
| 61860 | A | Implant neuroelectrodes | 20.87 | NA | 12.59 | 4.04 | NA | 37.50 | 090 | ||||||||||||
| 61862 | A | Implant neurostimul, subcort | 19.34 | NA | 12.16 | 3.97 | NA | 35.47 | 090 | ||||||||||||
| 61870 | A | Implant neuroelectrodes | 14.94 | NA | 9.97 | 1.70 | NA | 26.61 | 090 | ||||||||||||
| 61875 | A | Implant neuroelectrodes | 15.06 | NA | 7.39 | 2.42 | NA | 24.87 | 090 | ||||||||||||
| 61880 | A | Revise/remove neuroelectrode | 6.29 | NA | 5.26 | 1.31 | NA | 12.86 | 090 | ||||||||||||
| 61885 | A | Implant neurostim one array | 5.85 | NA | 4.36 | 1.22 | NA | 11.43 | 090 | ||||||||||||
| 61886 | A | Implant neurostim arrays | 8.00 | NA | 6.13 | 1.64 | NA | 15.77 | 090 | ||||||||||||
| 61888 | A | Revise/remove neuroreceiver | 5.07 | NA | 3.90 | 1.04 | NA | 10.01 | 010 | ||||||||||||
| 62000 | A | Treat skull fracture | 12.53 | NA | 6.19 | 0.87 | NA | 19.59 | 090 | ||||||||||||
| 62005 | A | Treat skull fracture | 16.17 | NA | 9.35 | 2.33 | NA | 27.85 | 090 | ||||||||||||
| 62010 | A | Treatment of head injury | 19.81 | NA | 11.83 | 4.05 | NA | 35.69 | 090 | ||||||||||||
| 62100 | A | Repair brain fluid leakage | 22.03 | NA | 13.97 | 4.07 | NA | 40.07 | 090 | ||||||||||||
| 62115 | A | Reduction of skull defect | 21.66 | NA | 11.03 | 4.53 | NA | 37.22 | 090 | ||||||||||||
| 62116 | A | Reduction of skull defect | 23.59 | NA | 14.04 | 4.85 | NA | 42.48 | 090 | ||||||||||||
| 62117 | A | Reduction of skull defect | 26.60 | NA | 12.68 | 5.56 | NA | 44.84 | 090 | ||||||||||||
| 62120 | A | Repair skull cavity lesion | 23.35 | NA | 15.14 | 3.07 | NA | 41.56 | 090 | ||||||||||||
| 62121 | A | Incise skull repair | 21.58 | NA | 13.52 | 2.47 | NA | 37.57 | 090 | ||||||||||||
| 62140 | A | Repair of skull defect | 13.51 | NA | 8.72 | 2.60 | NA | 24.83 | 090 | ||||||||||||
| 62141 | A | Repair of skull defect | 14.91 | NA | 9.89 | 2.85 | NA | 27.65 | 090 | ||||||||||||
| 62142 | A | Remove skull plate/flap | 10.79 | NA | 7.31 | 2.10 | NA | 20.20 | 090 | ||||||||||||
| 62143 | A | Replace skull plate/flap | 13.05 | NA | 8.81 | 2.55 | NA | 24.41 | 090 | ||||||||||||
| 62145 | A | Repair of skull brain | 18.82 | NA | 11.77 | 3.81 | NA | 34.40 | 090 | ||||||||||||
| 62146 | A | Repair of skull with graft | 16.12 | NA | 10.63 | 2.94 | NA | 29.69 | 090 | ||||||||||||
| 62147 | A | Repair of skull with graft | 19.34 | NA | 12.38 | 3.64 | NA | 35.36 | 090 | ||||||||||||
| 62180 | A | Establish brain cavity shunt | 21.06 | NA | 13.08 | 4.32 | NA | 38.46 | 090 | ||||||||||||
| 62190 | A | Establish brain cavity shunt | 11.07 | NA | 7.77 | 2.18 | NA | 21.02 | 090 | ||||||||||||
| 62192 | A | Establish brain cavity shunt | 12.25 | NA | 8.25 | 2.46 | NA | 22.96 | 090 | ||||||||||||
| 62194 | A | Replace/irrigate catheter | 5.03 | NA | 2.25 | 0.50 | NA | 7.78 | 010 | ||||||||||||
| 62200 | A | Establish brain cavity shunt | 18.32 | NA | 11.72 | 3.70 | NA | 33.74 | 090 | ||||||||||||
| 62201 | A | Establish brain cavity shunt | 14.86 | NA | 9.76 | 2.52 | NA | 27.14 | 090 | ||||||||||||
| 62220 | A | Establish brain cavity shunt | 13.00 | NA | 8.60 | 2.53 | NA | 24.13 | 090 | ||||||||||||
| 62223 | A | Establish brain cavity shunt | 12.87 | NA | 8.54 | 2.58 | NA | 23.99 | 090 | ||||||||||||
| 62225 | A | Replace/irrigate catheter | 5.41 | NA | 4.11 | 1.09 | NA | 10.61 | 090 | ||||||||||||
| 62230 | A | Replace/revise brain shunt | 10.54 | NA | 6.42 | 2.10 | NA | 19.06 | 090 | ||||||||||||
| 62252 | A | Csf shunt reprogram | 0.74 | 1.35 | NA | 0.18 | 2.27 | NA | XXX | ||||||||||||
| 62252 | 26 | A | Csf shunt reprogram | 0.74 | 0.30 | 0.30 | 0.16 | 1.20 | 1.20 | XXX | |||||||||||
| 62252 | TC | A | Csf shunt reprogram | 0.00 | 1.05 | NA | 0.02 | 1.07 | NA | XXX | |||||||||||
| 62256 | A | Remove brain cavity shunt | 6.60 | NA | 5.40 | 1.34 | NA | 13.34 | 090 | ||||||||||||
| 62258 | A | Replace brain cavity shunt | 14.54 | NA | 8.82 | 2.91 | NA | 26.27 | 090 | ||||||||||||
| 62263 | A | Lysis epidural adhesions | 6.14 | 5.15 | 2.07 | 0.42 | 11.71 | 8.63 | 010 | ||||||||||||
| 62268 | A | Drain spinal cord cyst | 4.74 | NA | 2.74 | 0.29 | NA | 7.77 | 000 | ||||||||||||
| 62269 | A | Needle biopsy, spinal cord | 5.02 | NA | 2.40 | 0.29 | NA | 7.71 | 000 | ||||||||||||
| 62270 | A | Spinal fluid tap, diagnostic | 1.13 | 4.08 | 0.48 | 0.06 | 5.27 | 1.67 | 000 | ||||||||||||
| 62272 | A | Drain cerebro spinal fluid | 1.35 | 3.38 | 0.62 | 0.13 | 4.86 | 2.10 | 000 | ||||||||||||
| 62273 | A | Treat epidural spine lesion | 2.15 | 1.57 | 1.27 | 0.14 | 3.86 | 3.56 | 000 | ||||||||||||
| 62280 | A | Treat spinal cord lesion | 2.63 | 3.79 | 0.70 | 0.17 | 6.59 | 3.50 | 010 | ||||||||||||
| 62281 | A | Treat spinal cord lesion | 2.66 | 4.50 | 0.62 | 0.16 | 7.32 | 3.44 | 010 | ||||||||||||
| 62282 | A | Treat spinal canal lesion | 2.33 | 5.57 | 0.62 | 0.14 | 8.04 | 3.09 | 010 | ||||||||||||
| 62284 | A | Injection for myelogram | 1.54 | 5.53 | 0.55 | 0.10 | 7.17 | 2.19 | 000 | ||||||||||||
| 62287 | A | Percutaneous diskectomy | 8.08 | NA | 5.05 | 0.66 | NA | 13.79 | 090 | ||||||||||||
| 62290 | A | Inject for spine disk x-ray | 3.00 | 5.68 | 1.30 | 0.20 | 8.88 | 4.50 | 000 | ||||||||||||
| 62291 | A | Inject for spine disk x-ray | 2.91 | 6.24 | 1.20 | 0.17 | 9.32 | 4.28 | 000 | ||||||||||||
| 62292 | A | Injection into disk lesion | 7.86 | NA | 5.34 | 0.65 | NA | 13.85 | 090 | ||||||||||||
| 62294 | A | Injection into spinal artery | 11.83 | NA | 7.37 | 0.85 | NA | 20.05 | 090 | ||||||||||||
| 62310 | A | Inject spine c/t | 1.91 | 3.71 | 0.43 | 0.11 | 5.73 | 2.45 | 000 | ||||||||||||
| 62311 | A | Inject spine l/s (cd) | 1.54 | 4.22 | 0.37 | 0.09 | 5.85 | 2.00 | 000 | ||||||||||||
| 62318 | A | Inject spine w/cath, c/t | 2.04 | 3.83 | 0.44 | 0.12 | 5.99 | 2.60 | 000 | ||||||||||||
| 62319 | A | Inject spine w/cath l/s (cd) | 1.87 | 3.67 | 0.40 | 0.11 | 5.65 | 2.38 | 000 | ||||||||||||
| 62350 | A | Implant spinal canal cath | 6.87 | NA | 3.79 | 0.64 | NA | 11.30 | 090 | ||||||||||||
| 62351 | A | Implant spinal canal cath | 10.00 | NA | 6.90 | 1.79 | NA | 18.69 | 090 | ||||||||||||
| 62355 | A | Remove spinal canal catheter | 5.45 | NA | 3.02 | 0.47 | NA | 8.94 | 090 | ||||||||||||
| 62360 | A | Insert spine infusion device | 2.62 | NA | 2.46 | 0.21 | NA | 5.29 | 090 | ||||||||||||
| 62361 | A | Implant spine infusion pump | 5.42 | NA | 3.67 | 0.50 | NA | 9.59 | 090 | ||||||||||||
| 62362 | A | Implant spine infusion pump | 7.04 | NA | 4.06 | 0.86 | NA | 11.96 | 090 | ||||||||||||
| 62365 | A | Remove spine infusion device | 5.42 | NA | 3.99 | 0.58 | NA | 9.99 | 090 | ||||||||||||
| 62367 | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 62367 | 26 | A | Analyze spine infusion pump | 0.48 | 0.14 | 0.14 | 0.03 | 0.65 | 0.65 | XXX | |||||||||||
| 62367 | TC | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 62368 | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 62368 | 26 | A | Analyze spine infusion pump | 0.75 | 0.20 | 0.20 | 0.05 | 1.00 | 1.00 | XXX | |||||||||||
| 62368 | TC | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 63001 | A | Removal of spinal lamina | 15.82 | NA | 11.68 | 3.03 | NA | 30.53 | 090 | ||||||||||||
| 63003 | A | Removal of spinal lamina | 15.95 | NA | 11.95 | 2.98 | NA | 30.88 | 090 | ||||||||||||
| 63005 | A | Removal of spinal lamina | 14.92 | NA | 11.49 | 2.62 | NA | 29.03 | 090 | ||||||||||||
| 63011 | A | Removal of spinal lamina | 14.52 | NA | 11.29 | 1.43 | NA | 27.24 | 090 | ||||||||||||
| 63012 | A | Removal of spinal lamina | 15.40 | NA | 10.34 | 2.71 | NA | 28.45 | 090 | ||||||||||||
| 63015 | A | Removal of spinal lamina | 19.35 | NA | 13.68 | 3.84 | NA | 36.87 | 090 | ||||||||||||
| 63016 | A | Removal of spinal lamina | 19.20 | NA | 13.66 | 3.62 | NA | 36.48 | 090 | ||||||||||||
| 63017 | A | Removal of spinal lamina | 15.94 | NA | 12.00 | 2.91 | NA | 30.85 | 090 | ||||||||||||
| 63020 | A | Neck spine disk surgery | 14.81 | NA | 11.33 | 2.89 | NA | 29.03 | 090 | ||||||||||||
| 63030 | A | Low back disk surgery | 12.00 | NA | 9.92 | 2.21 | NA | 24.13 | 090 | ||||||||||||
| 63035 | A | Spinal disk surgery add-on | 3.15 | NA | 1.67 | 0.57 | NA | 5.39 | ZZZ | ||||||||||||
| 63040 | A | Laminotomy, single cervical | 18.81 | NA | 13.39 | 3.36 | NA | 35.56 | 090 | ||||||||||||
| 63042 | A | Laminotomy, single lumbar | 17.47 | NA | 12.95 | 3.11 | NA | 33.53 | 090 | ||||||||||||
| 63043 | C | Laminotomy, addl cervical | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 63044 | C | Laminotomy, addl lumbar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 63045 | A | Removal of spinal lamina | 16.50 | NA | 12.22 | 3.19 | NA | 31.91 | 090 | ||||||||||||
| 63046 | A | Removal of spinal lamina | 15.80 | NA | 12.02 | 2.89 | NA | 30.71 | 090 | ||||||||||||
| 63047 | A | Removal of spinal lamina | 14.61 | NA | 11.42 | 2.61 | NA | 28.64 | 090 | ||||||||||||
| 63048 | A | Remove spinal lamina add-on | 3.26 | NA | 1.75 | 0.58 | NA | 5.59 | ZZZ | ||||||||||||
| 63055 | A | Decompress spinal cord | 21.99 | NA | 15.11 | 4.09 | NA | 41.19 | 090 | ||||||||||||
| 63056 | A | Decompress spinal cord | 20.36 | NA | 14.44 | 3.34 | NA | 38.14 | 090 | ||||||||||||
| 63057 | A | Decompress spine cord add-on | 5.26 | NA | 2.82 | 0.81 | NA | 8.89 | ZZZ | ||||||||||||
| 63064 | A | Decompress spinal cord | 24.61 | NA | 17.12 | 4.72 | NA | 46.45 | 090 | ||||||||||||
| 63066 | A | Decompress spine cord add-on | 3.26 | NA | 1.76 | 0.63 | NA | 5.65 | ZZZ | ||||||||||||
| 63075 | A | Neck spine disk surgery | 19.41 | NA | 13.83 | 3.73 | NA | 36.97 | 090 | ||||||||||||
| 63076 | A | Neck spine disk surgery | 4.05 | NA | 2.16 | 0.78 | NA | 6.99 | ZZZ | ||||||||||||
| 63077 | A | Spine disk surgery, thorax | 21.44 | NA | 15.47 | 3.44 | NA | 40.35 | 090 | ||||||||||||
| 63078 | A | Spine disk surgery, thorax | 3.28 | NA | 1.72 | 0.50 | NA | 5.50 | ZZZ | ||||||||||||
| 63081 | A | Removal of vertebral body | 23.73 | NA | 16.68 | 4.46 | NA | 44.87 | 090 | ||||||||||||
| 63082 | A | Remove vertebral body add-on | 4.37 | NA | 2.34 | 0.82 | NA | 7.53 | ZZZ | ||||||||||||
| 63085 | A | Removal of vertebral body | 26.92 | NA | 17.89 | 4.70 | NA | 49.51 | 090 | ||||||||||||
| 63086 | A | Remove vertebral body add-on | 3.19 | NA | 1.66 | 0.55 | NA | 5.40 | ZZZ | ||||||||||||
| 63087 | A | Removal of vertebral body | 35.57 | NA | 22.45 | 5.87 | NA | 63.89 | 090 | ||||||||||||
| 63088 | A | Remove vertebral body add-on | 4.33 | NA | 2.30 | 0.77 | NA | 7.40 | ZZZ | ||||||||||||
| 63090 | A | Removal of vertebral body | 28.16 | NA | 18.12 | 4.27 | NA | 50.55 | 090 | ||||||||||||
| 63091 | A | Remove vertebral body add-on | 3.03 | NA | 1.48 | 0.45 | NA | 4.96 | ZZZ | ||||||||||||
| 63170 | A | Incise spinal cord tract(s) | 19.83 | NA | 13.54 | 3.89 | NA | 37.26 | 090 | ||||||||||||
| 63172 | A | Drainage of spinal cyst | 17.66 | NA | 13.37 | 3.46 | NA | 34.49 | 090 | ||||||||||||
| 63173 | A | Drainage of spinal cyst | 21.99 | NA | 15.54 | 4.14 | NA | 41.67 | 090 | ||||||||||||
| 63180 | A | Revise spinal cord ligaments | 18.27 | NA | 13.04 | 3.83 | NA | 35.14 | 090 | ||||||||||||
| 63182 | A | Revise spinal cord ligaments | 20.50 | NA | 13.61 | 3.48 | NA | 37.59 | 090 | ||||||||||||
| 63185 | A | Incise spinal column/nerves | 15.04 | NA | 9.70 | 2.08 | NA | 26.82 | 090 | ||||||||||||
| 63190 | A | Incise spinal column/nerves | 17.45 | NA | 11.68 | 2.88 | NA | 32.01 | 090 | ||||||||||||
| 63191 | A | Incise spinal column/nerves | 17.54 | NA | 10.65 | 3.50 | NA | 31.69 | 090 | ||||||||||||
| 63194 | A | Incise spinal column cord | 19.19 | NA | 13.48 | 4.01 | NA | 36.68 | 090 | ||||||||||||
| 63195 | A | Incise spinal column cord | 18.84 | NA | 13.02 | 3.44 | NA | 35.30 | 090 | ||||||||||||
| 63196 | A | Incise spinal column cord | 22.30 | NA | 14.03 | 4.66 | NA | 40.99 | 090 | ||||||||||||
| 63197 | A | Incise spinal column cord | 21.11 | NA | 13.49 | 4.42 | NA | 39.02 | 090 | ||||||||||||
| 63198 | A | Incise spinal column cord | 25.38 | NA | 12.70 | 5.31 | NA | 43.39 | 090 | ||||||||||||
| 63199 | A | Incise spinal column cord | 26.89 | NA | 14.38 | 5.62 | NA | 46.89 | 090 | ||||||||||||
| 63200 | A | Release of spinal cord | 19.18 | NA | 13.42 | 3.61 | NA | 36.21 | 090 | ||||||||||||
| 63250 | A | Revise spinal cord vessels | 40.76 | NA | 23.15 | 7.65 | NA | 71.56 | 090 | ||||||||||||
| 63251 | A | Revise spinal cord vessels | 41.20 | NA | 23.51 | 7.98 | NA | 72.69 | 090 | ||||||||||||
| 63252 | A | Revise spinal cord vessels | 41.19 | NA | 23.36 | 7.75 | NA | 72.30 | 090 | ||||||||||||
| 63265 | A | Excise intraspinal lesion | 21.56 | NA | 13.21 | 4.29 | NA | 39.06 | 090 | ||||||||||||
| 63266 | A | Excise intraspinal lesion | 22.30 | NA | 13.70 | 4.47 | NA | 40.47 | 090 | ||||||||||||
| 63267 | A | Excise intraspinal lesion | 17.95 | NA | 11.48 | 3.50 | NA | 32.93 | 090 | ||||||||||||
| 63268 | A | Excise intraspinal lesion | 18.52 | NA | 10.97 | 3.18 | NA | 32.67 | 090 | ||||||||||||
| 63270 | A | Excise intraspinal lesion | 26.80 | NA | 16.10 | 5.41 | NA | 48.31 | 090 | ||||||||||||
| 63271 | A | Excise intraspinal lesion | 26.92 | NA | 16.17 | 5.56 | NA | 48.65 | 090 | ||||||||||||
| 63272 | A | Excise intraspinal lesion | 25.32 | NA | 15.31 | 5.07 | NA | 45.70 | 090 | ||||||||||||
| 63273 | A | Excise intraspinal lesion | 24.29 | NA | 14.84 | 5.08 | NA | 44.21 | 090 | ||||||||||||
| 63275 | A | Biopsy/excise spinal tumor | 23.68 | NA | 14.47 | 4.68 | NA | 42.83 | 090 | ||||||||||||
| 63276 | A | Biopsy/excise spinal tumor | 23.45 | NA | 14.27 | 4.63 | NA | 42.35 | 090 | ||||||||||||
| 63277 | A | Biopsy/excise spinal tumor | 20.83 | NA | 12.99 | 4.03 | NA | 37.85 | 090 | ||||||||||||
| 63278 | A | Biopsy/excise spinal tumor | 20.56 | NA | 13.08 | 4.02 | NA | 37.66 | 090 | ||||||||||||
| 63280 | A | Biopsy/excise spinal tumor | 28.35 | NA | 16.76 | 5.80 | NA | 50.91 | 090 | ||||||||||||
| 63281 | A | Biopsy/excise spinal tumor | 28.05 | NA | 16.73 | 5.67 | NA | 50.45 | 090 | ||||||||||||
| 63282 | A | Biopsy/excise spinal tumor | 26.39 | NA | 15.79 | 5.33 | NA | 47.51 | 090 | ||||||||||||
| 63283 | A | Biopsy/excise spinal tumor | 25.00 | NA | 15.07 | 5.12 | NA | 45.19 | 090 | ||||||||||||
| 63285 | A | Biopsy/excise spinal tumor | 36.00 | NA | 20.82 | 7.31 | NA | 64.13 | 090 | ||||||||||||
| 63286 | A | Biopsy/excise spinal tumor | 35.63 | NA | 20.51 | 7.07 | NA | 63.21 | 090 | ||||||||||||
| 63287 | A | Biopsy/excise spinal tumor | 36.70 | NA | 21.03 | 7.48 | NA | 65.21 | 090 | ||||||||||||
| 63290 | A | Biopsy/excise spinal tumor | 37.38 | NA | 21.58 | 7.65 | NA | 66.61 | 090 | ||||||||||||
| 63300 | A | Removal of vertebral body | 24.43 | NA | 14.63 | 4.78 | NA | 43.84 | 090 | ||||||||||||
| 63301 | A | Removal of vertebral body | 27.60 | NA | 15.65 | 5.03 | NA | 48.28 | 090 | ||||||||||||
| 63302 | A | Removal of vertebral body | 27.81 | NA | 16.45 | 5.25 | NA | 49.51 | 090 | ||||||||||||
| 63303 | A | Removal of vertebral body | 30.50 | NA | 17.71 | 5.21 | NA | 53.42 | 090 | ||||||||||||
| 63304 | A | Removal of vertebral body | 30.33 | NA | 17.80 | 4.72 | NA | 52.85 | 090 | ||||||||||||
| 63305 | A | Removal of vertebral body | 32.03 | NA | 19.24 | 5.39 | NA | 56.66 | 090 | ||||||||||||
| 63306 | A | Removal of vertebral body | 32.22 | NA | 18.19 | 2.39 | NA | 52.80 | 090 | ||||||||||||
| 63307 | A | Removal of vertebral body | 31.63 | NA | 17.29 | 4.23 | NA | 53.15 | 090 | ||||||||||||
| 63308 | A | Remove vertebral body add-on | 5.25 | NA | 2.74 | 1.01 | NA | 9.00 | ZZZ | ||||||||||||
| 63600 | A | Remove spinal cord lesion | 14.02 | NA | 6.38 | 1.22 | NA | 21.62 | 090 | ||||||||||||
| 63610 | A | Stimulation of spinal cord | 8.73 | NA | 3.90 | 0.43 | NA | 13.06 | 000 | ||||||||||||
| 63615 | A | Remove lesion of spinal cord | 16.28 | NA | 9.50 | 2.85 | NA | 28.63 | 090 | ||||||||||||
| 63650 | A | Implant neuroelectrodes | 6.74 | NA | 2.97 | 0.48 | NA | 10.19 | 090 | ||||||||||||
| 63655 | A | Implant neuroelectrodes | 10.29 | NA | 7.26 | 1.85 | NA | 19.40 | 090 | ||||||||||||
| 63660 | A | Revise/remove neuroelectrode | 6.16 | NA | 3.67 | 0.65 | NA | 10.48 | 090 | ||||||||||||
| 63685 | A | Implant neuroreceiver | 7.04 | NA | 4.15 | 0.96 | NA | 12.15 | 090 | ||||||||||||
| 63688 | A | Revise/remove neuroreceiver | 5.39 | NA | 3.69 | 0.70 | NA | 9.78 | 090 | ||||||||||||
| 63700 | A | Repair of spinal herniation | 16.53 | NA | 10.47 | 2.69 | NA | 29.69 | 090 | ||||||||||||
| 63702 | A | Repair of spinal herniation | 18.48 | NA | 9.90 | 1.36 | NA | 29.74 | 090 | ||||||||||||
| 63704 | A | Repair of spinal herniation | 21.18 | NA | 12.37 | 3.84 | NA | 37.39 | 090 | ||||||||||||
| 63706 | A | Repair of spinal herniation | 24.11 | NA | 13.60 | 4.73 | NA | 42.44 | 090 | ||||||||||||
| 63707 | A | Repair spinal fluid leakage | 11.26 | NA | 8.06 | 1.96 | NA | 21.28 | 090 | ||||||||||||
| 63709 | A | Repair spinal fluid leakage | 14.32 | NA | 9.79 | 2.49 | NA | 26.60 | 090 | ||||||||||||
| 63710 | A | Graft repair of spine defect | 14.07 | NA | 9.54 | 2.61 | NA | 26.22 | 090 | ||||||||||||
| 63740 | A | Install spinal shunt | 11.36 | NA | 7.79 | 2.15 | NA | 21.30 | 090 | ||||||||||||
| 63741 | A | Install spinal shunt | 8.25 | NA | 4.72 | 1.05 | NA | 14.02 | 090 | ||||||||||||
| 63744 | A | Revision of spinal shunt | 8.10 | NA | 5.72 | 1.51 | NA | 15.33 | 090 | ||||||||||||
| 63746 | A | Removal of spinal shunt | 6.43 | NA | 4.96 | 1.15 | NA | 12.54 | 090 | ||||||||||||
| 64400 | A | Injection for nerve block | 1.11 | 2.70 | 0.29 | 0.06 | 3.87 | 1.46 | 000 | ||||||||||||
| 64402 | A | Injection for nerve block | 1.25 | 4.38 | 0.45 | 0.07 | 5.70 | 1.77 | 000 | ||||||||||||
| 64405 | A | Injection for nerve block | 1.32 | 1.34 | 0.37 | 0.08 | 2.74 | 1.77 | 000 | ||||||||||||
| 64408 | A | Injection for nerve block | 1.41 | 2.95 | 0.62 | 0.09 | 4.45 | 2.12 | 000 | ||||||||||||
| 64410 | A | Injection for nerve block | 1.43 | 3.27 | 0.35 | 0.08 | 4.78 | 1.86 | 000 | ||||||||||||
| 64412 | A | Injection for nerve block | 1.18 | 2.49 | 0.37 | 0.08 | 3.75 | 1.63 | 000 | ||||||||||||
| 64413 | A | Injection for nerve block | 1.40 | 2.81 | 0.34 | 0.09 | 4.30 | 1.83 | 000 | ||||||||||||
| 64415 | A | Injection for nerve block | 1.48 | 2.65 | 0.32 | 0.08 | 4.21 | 1.88 | 000 | ||||||||||||
| 64417 | A | Injection for nerve block | 1.44 | 3.21 | 0.38 | 0.09 | 4.74 | 1.91 | 000 | ||||||||||||
| 64418 | A | Injection for nerve block | 1.32 | 2.49 | 0.29 | 0.07 | 3.88 | 1.68 | 000 | ||||||||||||
| 64420 | A | Injection for nerve block | 1.18 | 2.37 | 0.27 | 0.07 | 3.62 | 1.52 | 000 | ||||||||||||
| 64421 | A | Injection for nerve block | 1.68 | 2.91 | 0.38 | 0.10 | 4.69 | 2.16 | 000 | ||||||||||||
| 64425 | A | Injection for nerve block | 1.75 | 2.33 | 0.41 | 0.11 | 4.19 | 2.27 | 000 | ||||||||||||
| 64430 | A | Injection for nerve block | 1.46 | 2.89 | 0.47 | 0.11 | 4.46 | 2.04 | 000 | ||||||||||||
| 64435 | A | Injection for nerve block | 1.45 | 2.96 | 0.60 | 0.15 | 4.56 | 2.20 | 000 | ||||||||||||
| 64445 | A | Injection for nerve block | 1.48 | 1.60 | 0.42 | 0.08 | 3.16 | 1.98 | 000 | ||||||||||||
| 64450 | A | Injection for nerve block | 1.27 | 1.79 | 0.33 | 0.08 | 3.14 | 1.68 | 000 | ||||||||||||
| 64470 | A | Inj paravertebral c/t | 1.85 | 4.02 | 0.48 | 0.12 | 5.99 | 2.45 | 000 | ||||||||||||
| 64472 | A | Inj paravertebral c/t add-on | 1.29 | 3.90 | 0.33 | 0.09 | 5.28 | 1.71 | ZZZ | ||||||||||||
| 64475 | A | Inj paravertebral l/s | 1.41 | 3.82 | 0.39 | 0.09 | 5.32 | 1.89 | 000 | ||||||||||||
| 64476 | A | Inj paravertebral l/s add-on | 0.98 | 3.86 | 0.26 | 0.06 | 4.90 | 1.30 | ZZZ | ||||||||||||
| 64479 | A | Inj foramen epidural c/t | 2.20 | 4.40 | 0.64 | 0.14 | 6.74 | 2.98 | 000 | ||||||||||||
| 64480 | A | Inj foramen epidural add-on | 1.54 | 4.07 | 0.50 | 0.09 | 5.70 | 2.13 | ZZZ | ||||||||||||
| 64483 | A | Inj foramen epidural l/s | 1.90 | 4.44 | 0.56 | 0.12 | 6.46 | 2.58 | 000 | ||||||||||||
| 64484 | A | Inj foramen epidural add-on | 1.33 | 4.05 | 0.40 | 0.08 | 5.46 | 1.81 | ZZZ | ||||||||||||
| 64505 | A | Injection for nerve block | 1.36 | 2.41 | 0.35 | 0.08 | 3.85 | 1.79 | 000 | ||||||||||||
| 64508 | A | Injection for nerve block | 1.12 | 2.32 | 0.48 | 0.06 | 3.50 | 1.66 | 000 | ||||||||||||
| 64510 | A | Injection for nerve block | 1.22 | 2.53 | 0.26 | 0.07 | 3.82 | 1.55 | 000 | ||||||||||||
| 64520 | A | Injection for nerve block | 1.35 | 3.49 | 0.31 | 0.08 | 4.92 | 1.74 | 000 | ||||||||||||
| 64530 | A | Injection for nerve block | 1.58 | 3.07 | 0.37 | 0.09 | 4.74 | 2.04 | 000 | ||||||||||||
| 64550 | A | Apply neurostimulator | 0.18 | 0.56 | 0.07 | 0.01 | 0.75 | 0.26 | 000 | ||||||||||||
| 64553 | A | Implant neuroelectrodes | 2.31 | 4.25 | 1.33 | 0.17 | 6.73 | 3.81 | 010 | ||||||||||||
| 64555 | A | Implant neuroelectrodes | 2.27 | 2.38 | 0.77 | 0.11 | 4.76 | 3.15 | 010 | ||||||||||||
| 64560 | A | Implant neuroelectrodes | 2.36 | 2.30 | 0.94 | 0.17 | 4.83 | 3.47 | 010 | ||||||||||||
| 64561 | A | Implant neuroelectrodes | 6.74 | 15.28 | 3.83 | 0.11 | 22.13 | 10.68 | 010 | ||||||||||||
| 64565 | A | Implant neuroelectrodes | 1.76 | 3.41 | 0.69 | 0.08 | 5.25 | 2.53 | 010 | ||||||||||||
| 64573 | A | Implant neuroelectrodes | 7.50 | NA | 5.40 | 1.48 | NA | 14.38 | 090 | ||||||||||||
| 64575 | A | Implant neuroelectrodes | 4.35 | NA | 3.03 | 0.37 | NA | 7.75 | 090 | ||||||||||||
| 64577 | A | Implant neuroelectrodes | 4.62 | NA | 3.44 | 0.50 | NA | 8.56 | 090 | ||||||||||||
| 64580 | A | Implant neuroelectrodes | 4.12 | NA | 3.94 | 0.21 | NA | 8.27 | 090 | ||||||||||||
| 64581 | A | Implant neuroelectrodes | 13.50 | NA | 6.72 | 0.37 | NA | 20.59 | 090 | ||||||||||||
| 64585 | A | Revise/remove neuroelectrode | 2.06 | 2.82 | 2.20 | 0.29 | 5.17 | 4.55 | 010 | ||||||||||||
| 64590 | A | Implant neuroreceiver | 2.40 | NA | 2.17 | 0.40 | NA | 4.97 | 010 | ||||||||||||
| 64595 | A | Revise/remove neuroreceiver | 1.73 | NA | 2.08 | 0.22 | NA | 4.03 | 010 | ||||||||||||
| 64600 | A | Injection treatment of nerve | 3.45 | 2.98 | 2.06 | 0.28 | 6.71 | 5.79 | 010 | ||||||||||||
| 64605 | A | Injection treatment of nerve | 5.61 | 3.62 | 2.90 | 0.53 | 9.76 | 9.04 | 010 | ||||||||||||
| 64610 | A | Injection treatment of nerve | 7.16 | NA | 4.18 | 1.12 | NA | 12.46 | 010 | ||||||||||||
| 64612 | A | Destroy nerve, face muscle | 1.96 | 3.00 | 1.65 | 0.09 | 5.05 | 3.70 | 010 | ||||||||||||
| 64613 | A | Destroy nerve, spine muscle | 1.96 | 1.82 | 1.48 | 0.10 | 3.88 | 3.54 | 010 | ||||||||||||
| 64614 | A | Destroy nerve, extrem musc | 2.20 | 3.23 | 0.82 | 0.09 | 5.52 | 3.11 | 010 | ||||||||||||
| 64620 | A | Injection treatment of nerve | 2.84 | 2.98 | 0.67 | 0.17 | 5.99 | 3.68 | 010 | ||||||||||||
| 64622 | A | Destr paravertebrl nerve l/s | 3.00 | 4.77 | 0.74 | 0.17 | 7.94 | 3.91 | 010 | ||||||||||||
| 64623 | A | Destr paravertebral n add-on | 0.99 | 3.85 | 0.24 | 0.06 | 4.90 | 1.29 | ZZZ | ||||||||||||
| 64626 | A | Destr paravertebrl nerve c/t | 3.28 | 4.34 | 0.80 | 0.22 | 7.84 | 4.30 | 010 | ||||||||||||
| 64627 | A | Destr paravertebral n add-on | 1.16 | 3.74 | 0.29 | 0.08 | 4.98 | 1.53 | ZZZ | ||||||||||||
| 64630 | A | Injection treatment of nerve | 3.00 | 3.66 | 0.88 | 0.16 | 6.82 | 4.04 | 010 | ||||||||||||
| 64640 | A | Injection treatment of nerve | 2.76 | 3.67 | 1.72 | 0.11 | 6.54 | 4.59 | 010 | ||||||||||||
| 64680 | A | Injection treatment of nerve | 2.62 | 2.89 | 0.76 | 0.15 | 5.66 | 3.53 | 010 | ||||||||||||
| 64702 | A | Revise finger/toe nerve | 4.23 | NA | 4.05 | 0.51 | NA | 8.79 | 090 | ||||||||||||
| 64704 | A | Revise hand/foot nerve | 4.57 | NA | 3.23 | 0.59 | NA | 8.39 | 090 | ||||||||||||
| 64708 | A | Revise arm/leg nerve | 6.12 | NA | 5.19 | 0.82 | NA | 12.13 | 090 | ||||||||||||
| 64712 | A | Revision of sciatic nerve | 7.75 | NA | 5.61 | 0.54 | NA | 13.90 | 090 | ||||||||||||
| 64713 | A | Revision of arm nerve(s) | 11.00 | NA | 6.66 | 1.01 | NA | 18.67 | 090 | ||||||||||||
| 64714 | A | Revise low back nerve(s) | 10.33 | NA | 4.25 | 0.64 | NA | 15.22 | 090 | ||||||||||||
| 64716 | A | Revision of cranial nerve | 6.31 | NA | 5.18 | 0.59 | NA | 12.08 | 090 | ||||||||||||
| 64718 | A | Revise ulnar nerve at elbow | 5.99 | NA | 5.29 | 0.87 | NA | 12.15 | 090 | ||||||||||||
| 64719 | A | Revise ulnar nerve at wrist | 4.85 | NA | 4.78 | 0.63 | NA | 10.26 | 090 | ||||||||||||
| 64721 | A | Carpal tunnel surgery | 4.29 | 6.59 | 6.14 | 0.59 | 11.47 | 11.02 | 090 | ||||||||||||
| 64722 | A | Relieve pressure on nerve(s) | 4.70 | NA | 3.49 | 0.32 | NA | 8.51 | 090 | ||||||||||||
| 64726 | A | Release foot/toe nerve | 4.18 | NA | 3.14 | 0.57 | NA | 7.89 | 090 | ||||||||||||
| 64727 | A | Internal nerve revision | 3.10 | NA | 1.68 | 0.40 | NA | 5.18 | ZZZ | ||||||||||||
| 64732 | A | Incision of brow nerve | 4.41 | NA | 3.69 | 0.77 | NA | 8.87 | 090 | ||||||||||||
| 64734 | A | Incision of cheek nerve | 4.92 | NA | 3.80 | 0.83 | NA | 9.55 | 090 | ||||||||||||
| 64736 | A | Incision of chin nerve | 4.60 | NA | 2.98 | 0.71 | NA | 8.29 | 090 | ||||||||||||
| 64738 | A | Incision of jaw nerve | 5.73 | NA | 3.92 | 0.84 | NA | 10.49 | 090 | ||||||||||||
| 64740 | A | Incision of tongue nerve | 5.59 | NA | 4.11 | 0.43 | NA | 10.13 | 090 | ||||||||||||
| 64742 | A | Incision of facial nerve | 6.22 | NA | 4.96 | 0.69 | NA | 11.87 | 090 | ||||||||||||
| 64744 | A | Incise nerve, back of head | 5.24 | NA | 3.94 | 0.98 | NA | 10.16 | 090 | ||||||||||||
| 64746 | A | Incise diaphragm nerve | 5.93 | NA | 4.58 | 0.75 | NA | 11.26 | 090 | ||||||||||||
| 64752 | A | Incision of vagus nerve | 7.06 | NA | 4.96 | 0.83 | NA | 12.85 | 090 | ||||||||||||
| 64755 | A | Incision of stomach nerves | 13.52 | NA | 6.40 | 1.16 | NA | 21.08 | 090 | ||||||||||||
| 64760 | A | Incision of vagus nerve | 6.96 | NA | 4.05 | 0.51 | NA | 11.52 | 090 | ||||||||||||
| 64761 | A | Incision of pelvis nerve | 6.41 | NA | 3.48 | 0.26 | NA | 10.15 | 090 | ||||||||||||
| 64763 | A | Incise hip/thigh nerve | 6.93 | NA | 6.21 | 0.77 | NA | 13.91 | 090 | ||||||||||||
| 64766 | A | Incise hip/thigh nerve | 8.67 | NA | 4.73 | 0.99 | NA | 14.39 | 090 | ||||||||||||
| 64771 | A | Sever cranial nerve | 7.35 | NA | 5.44 | 1.32 | NA | 14.11 | 090 | ||||||||||||
| 64772 | A | Incision of spinal nerve | 7.21 | NA | 4.88 | 1.20 | NA | 13.29 | 090 | ||||||||||||
| 64774 | A | Remove skin nerve lesion | 5.17 | NA | 3.92 | 0.60 | NA | 9.69 | 090 | ||||||||||||
| 64776 | A | Remove digit nerve lesion | 5.12 | NA | 3.89 | 0.63 | NA | 9.64 | 090 | ||||||||||||
| 64778 | A | Digit nerve surgery add-on | 3.11 | NA | 1.64 | 0.38 | NA | 5.13 | ZZZ | ||||||||||||
| 64782 | A | Remove limb nerve lesion | 6.23 | NA | 3.93 | 0.79 | NA | 10.95 | 090 | ||||||||||||
| 64783 | A | Limb nerve surgery add-on | 3.72 | NA | 1.95 | 0.48 | NA | 6.15 | ZZZ | ||||||||||||
| 64784 | A | Remove nerve lesion | 9.82 | NA | 6.99 | 1.17 | NA | 17.98 | 090 | ||||||||||||
| 64786 | A | Remove sciatic nerve lesion | 15.46 | NA | 10.41 | 2.22 | NA | 28.09 | 090 | ||||||||||||
| 64787 | A | Implant nerve end | 4.30 | NA | 2.28 | 0.56 | NA | 7.14 | ZZZ | ||||||||||||
| 64788 | A | Remove skin nerve lesion | 4.61 | NA | 3.50 | 0.54 | NA | 8.65 | 090 | ||||||||||||
| 64790 | A | Removal of nerve lesion | 11.31 | NA | 7.53 | 1.68 | NA | 20.52 | 090 | ||||||||||||
| 64792 | A | Removal of nerve lesion | 14.92 | NA | 9.13 | 1.88 | NA | 25.93 | 090 | ||||||||||||
| 64795 | A | Biopsy of nerve | 3.01 | NA | 1.81 | 0.40 | NA | 5.22 | 000 | ||||||||||||
| 64802 | A | Remove sympathetic nerves | 9.15 | NA | 5.17 | 0.87 | NA | 15.19 | 090 | ||||||||||||
| 64804 | A | Remove sympathetic nerves | 14.64 | NA | 6.83 | 1.79 | NA | 23.26 | 090 | ||||||||||||
| 64809 | A | Remove sympathetic nerves | 13.67 | NA | 6.04 | 0.96 | NA | 20.67 | 090 | ||||||||||||
| 64818 | A | Remove sympathetic nerves | 10.30 | NA | 5.76 | 1.08 | NA | 17.14 | 090 | ||||||||||||
| 64820 | A | Remove sympathetic nerves | 10.37 | NA | 6.48 | 1.17 | NA | 18.02 | 090 | ||||||||||||
| 64821 | A | Remove sympathetic nerves | 8.75 | NA | 7.09 | 0.99 | NA | 16.83 | 090 | ||||||||||||
| 64822 | A | Remove sympathetic nerves | 8.75 | NA | 7.09 | 0.99 | NA | 16.83 | 090 | ||||||||||||
| 64823 | A | Remove sympathetic nerves | 10.37 | NA | 7.89 | 1.17 | NA | 19.43 | 090 | ||||||||||||
| 64831 | A | Repair of digit nerve | 9.44 | NA | 7.44 | 1.14 | NA | 18.02 | 090 | ||||||||||||
| 64832 | A | Repair nerve add-on | 5.66 | NA | 3.11 | 0.68 | NA | 9.45 | ZZZ | ||||||||||||
| 64834 | A | Repair of hand or foot nerve | 10.19 | NA | 7.40 | 1.23 | NA | 18.82 | 090 | ||||||||||||
| 64835 | A | Repair of hand or foot nerve | 10.94 | NA | 8.06 | 1.36 | NA | 20.36 | 090 | ||||||||||||
| 64836 | A | Repair of hand or foot nerve | 10.94 | NA | 7.94 | 1.32 | NA | 20.20 | 090 | ||||||||||||
| 64837 | A | Repair nerve add-on | 6.26 | NA | 3.47 | 0.80 | NA | 10.53 | ZZZ | ||||||||||||
| 64840 | A | Repair of leg nerve | 13.02 | NA | 7.79 | 0.86 | NA | 21.67 | 090 | ||||||||||||
| 64856 | A | Repair/transpose nerve | 13.80 | NA | 9.66 | 1.71 | NA | 25.17 | 090 | ||||||||||||
| 64857 | A | Repair arm/leg nerve | 14.49 | NA | 10.21 | 1.76 | NA | 26.46 | 090 | ||||||||||||
| 64858 | A | Repair sciatic nerve | 16.49 | NA | 11.04 | 2.78 | NA | 30.31 | 090 | ||||||||||||
| 64859 | A | Nerve surgery | 4.26 | NA | 2.24 | 0.50 | NA | 7.00 | ZZZ | ||||||||||||
| 64861 | A | Repair of arm nerves | 19.24 | NA | 13.02 | 2.45 | NA | 34.71 | 090 | ||||||||||||
| 64862 | A | Repair of low back nerves | 19.44 | NA | 12.29 | 2.47 | NA | 34.20 | 090 | ||||||||||||
| 64864 | A | Repair of facial nerve | 12.55 | NA | 8.63 | 1.13 | NA | 22.31 | 090 | ||||||||||||
| 64865 | A | Repair of facial nerve | 15.24 | NA | 10.46 | 1.37 | NA | 27.07 | 090 | ||||||||||||
| 64866 | A | Fusion of facial/other nerve | 15.74 | NA | 9.84 | 1.06 | NA | 26.64 | 090 | ||||||||||||
| 64868 | A | Fusion of facial/other nerve | 14.04 | NA | 9.57 | 1.40 | NA | 25.01 | 090 | ||||||||||||
| 64870 | A | Fusion of facial/other nerve | 15.99 | NA | 9.65 | 1.08 | NA | 26.72 | 090 | ||||||||||||
| 64872 | A | Subsequent repair of nerve | 1.99 | NA | 1.08 | 0.24 | NA | 3.31 | ZZZ | ||||||||||||
| 64874 | A | Repair revise nerve add-on | 2.98 | NA | 1.64 | 0.34 | NA | 4.96 | ZZZ | ||||||||||||
| 64876 | A | Repair nerve/shorten bone | 3.38 | NA | 1.35 | 0.39 | NA | 5.12 | ZZZ | ||||||||||||
| 64885 | A | Nerve graft, head or neck | 17.53 | NA | 11.66 | 1.51 | NA | 30.70 | 090 | ||||||||||||
| 64886 | A | Nerve graft, head or neck | 20.75 | NA | 13.60 | 1.73 | NA | 36.08 | 090 | ||||||||||||
| 64890 | A | Nerve graft, hand or foot | 15.15 | NA | 10.27 | 1.74 | NA | 27.16 | 090 | ||||||||||||
| 64891 | A | Nerve graft, hand or foot | 16.14 | NA | 5.75 | 1.38 | NA | 23.27 | 090 | ||||||||||||
| 64892 | A | Nerve graft, arm or leg | 14.65 | NA | 8.96 | 1.65 | NA | 25.26 | 090 | ||||||||||||
| 64893 | A | Nerve graft, arm or leg | 15.60 | NA | 10.75 | 1.77 | NA | 28.12 | 090 | ||||||||||||
| 64895 | A | Nerve graft, hand or foot | 19.25 | NA | 8.62 | 2.04 | NA | 29.91 | 090 | ||||||||||||
| 64896 | A | Nerve graft, hand or foot | 20.49 | NA | 11.75 | 1.85 | NA | 34.09 | 090 | ||||||||||||
| 64897 | A | Nerve graft, arm or leg | 18.24 | NA | 10.92 | 2.64 | NA | 31.80 | 090 | ||||||||||||
| 64898 | A | Nerve graft, arm or leg | 19.50 | NA | 10.75 | 2.71 | NA | 32.96 | 090 | ||||||||||||
| 64901 | A | Nerve graft add-on | 10.22 | NA | 5.75 | 0.99 | NA | 16.96 | ZZZ | ||||||||||||
| 64902 | A | Nerve graft add-on | 11.83 | NA | 6.32 | 1.10 | NA | 19.25 | ZZZ | ||||||||||||
| 64905 | A | Nerve pedicle transfer | 14.02 | NA | 8.93 | 1.52 | NA | 24.47 | 090 | ||||||||||||
| 64907 | A | Nerve pedicle transfer | 18.83 | NA | 12.07 | 1.79 | NA | 32.69 | 090 | ||||||||||||
| 64999 | C | Nervous system surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 65091 | A | Revise eye | 6.46 | NA | 11.59 | 0.26 | NA | 18.31 | 090 | ||||||||||||
| 65093 | A | Revise eye with implant | 6.87 | NA | 11.83 | 0.28 | NA | 18.98 | 090 | ||||||||||||
| 65101 | A | Removal of eye | 7.03 | NA | 12.04 | 0.28 | NA | 19.35 | 090 | ||||||||||||
| 65103 | A | Remove eye/insert implant | 7.57 | NA | 12.17 | 0.30 | NA | 20.04 | 090 | ||||||||||||
| 65105 | A | Remove eye/attach implant | 8.49 | NA | 12.67 | 0.34 | NA | 21.50 | 090 | ||||||||||||
| 65110 | A | Removal of eye | 13.95 | NA | 15.90 | 0.68 | NA | 30.53 | 090 | ||||||||||||
| 65112 | A | Remove eye/revise socket | 16.38 | NA | 17.26 | 0.96 | NA | 34.60 | 090 | ||||||||||||
| 65114 | A | Remove eye/revise socket | 17.53 | NA | 18.54 | 0.94 | NA | 37.01 | 090 | ||||||||||||
| 65125 | A | Revise ocular implant | 3.12 | 6.23 | 1.48 | 0.15 | 9.50 | 4.75 | 090 | ||||||||||||
| 65130 | A | Insert ocular implant | 7.15 | NA | 11.46 | 0.28 | NA | 18.89 | 090 | ||||||||||||
| 65135 | A | Insert ocular implant | 7.33 | NA | 12.37 | 0.29 | NA | 19.99 | 090 | ||||||||||||
| 65140 | A | Attach ocular implant | 8.02 | NA | 12.36 | 0.31 | NA | 20.69 | 090 | ||||||||||||
| 65150 | A | Revise ocular implant | 6.26 | NA | 10.94 | 0.25 | NA | 17.45 | 090 | ||||||||||||
| 65155 | A | Reinsert ocular implant | 8.66 | NA | 12.59 | 0.40 | NA | 21.65 | 090 | ||||||||||||
| 65175 | A | Removal of ocular implant | 6.28 | NA | 11.35 | 0.26 | NA | 17.89 | 090 | ||||||||||||
| 65205 | A | Remove foreign body from eye | 0.71 | 0.63 | 0.20 | 0.03 | 1.37 | 0.94 | 000 | ||||||||||||
| 65210 | A | Remove foreign body from eye | 0.84 | 0.78 | 0.32 | 0.03 | 1.65 | 1.19 | 000 | ||||||||||||
| 65220 | A | Remove foreign body from eye | 0.71 | 8.23 | 0.19 | 0.05 | 8.99 | 0.95 | 000 | ||||||||||||
| 65222 | A | Remove foreign body from eye | 0.93 | 0.80 | 0.29 | 0.04 | 1.77 | 1.26 | 000 | ||||||||||||
| 65235 | A | Remove foreign body from eye | 7.57 | NA | 7.04 | 0.30 | NA | 14.91 | 090 | ||||||||||||
| 65260 | A | Remove foreign body from eye | 10.96 | NA | 12.66 | 0.43 | NA | 24.05 | 090 | ||||||||||||
| 65265 | A | Remove foreign body from eye | 12.59 | NA | 14.38 | 0.50 | NA | 27.47 | 090 | ||||||||||||
| 65270 | A | Repair of eye wound | 1.90 | 4.07 | 2.44 | 0.08 | 6.05 | 4.42 | 010 | ||||||||||||
| 65272 | A | Repair of eye wound | 3.82 | 5.76 | 4.75 | 0.16 | 9.74 | 8.73 | 090 | ||||||||||||
| 65273 | A | Repair of eye wound | 4.36 | NA | 5.15 | 0.17 | NA | 9.68 | 090 | ||||||||||||
| 65275 | A | Repair of eye wound | 5.34 | 5.50 | 5.32 | 0.27 | 11.11 | 10.93 | 090 | ||||||||||||
| 65280 | A | Repair of eye wound | 7.66 | NA | 7.88 | 0.30 | NA | 15.84 | 090 | ||||||||||||
| 65285 | A | Repair of eye wound | 12.90 | NA | 13.86 | 0.51 | NA | 27.27 | 090 | ||||||||||||
| 65286 | A | Repair of eye wound | 5.51 | 9.12 | 7.85 | 0.21 | 14.84 | 13.57 | 090 | ||||||||||||
| 65290 | A | Repair of eye socket wound | 5.41 | NA | 6.60 | 0.26 | NA | 12.27 | 090 | ||||||||||||
| 65400 | A | Removal of eye lesion | 6.06 | 8.61 | 7.13 | 0.24 | 14.91 | 13.43 | 090 | ||||||||||||
| 65410 | A | Biopsy of cornea | 1.47 | 1.76 | 0.71 | 0.06 | 3.29 | 2.24 | 000 | ||||||||||||
| 65420 | A | Removal of eye lesion | 4.17 | 8.36 | 7.22 | 0.17 | 12.70 | 11.56 | 090 | ||||||||||||
| 65426 | A | Removal of eye lesion | 5.25 | 8.01 | 6.75 | 0.20 | 13.46 | 12.20 | 090 | ||||||||||||
| 65430 | A | Corneal smear | 1.47 | 8.68 | 0.71 | 0.06 | 10.21 | 2.24 | 000 | ||||||||||||
| 65435 | A | Curette/treat cornea | 0.92 | 1.37 | 0.41 | 0.04 | 2.33 | 1.37 | 000 | ||||||||||||
| 65436 | A | Curette/treat cornea | 4.19 | 6.02 | 5.03 | 0.17 | 10.38 | 9.39 | 090 | ||||||||||||
| 65450 | A | Treatment of corneal lesion | 3.27 | 7.97 | 6.80 | 0.13 | 11.37 | 10.20 | 090 | ||||||||||||
| 65600 | A | Revision of cornea | 3.40 | 5.54 | 1.54 | 0.14 | 9.08 | 5.08 | 090 | ||||||||||||
| 65710 | A | Corneal transplant | 12.35 | NA | 13.25 | 0.49 | NA | 26.09 | 090 | ||||||||||||
| 65730 | A | Corneal transplant | 14.25 | NA | 12.16 | 0.56 | NA | 26.97 | 090 | ||||||||||||
| 65750 | A | Corneal transplant | 15.00 | NA | 14.54 | 0.59 | NA | 30.13 | 090 | ||||||||||||
| 65755 | A | Corneal transplant | 14.89 | NA | 14.48 | 0.58 | NA | 29.95 | 090 | ||||||||||||
| 65760 | N | Revision of cornea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 65765 | N | Revision of cornea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 65767 | N | Corneal tissue transplant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 65770 | A | Revise cornea with implant | 17.56 | NA | 15.48 | 0.69 | NA | 33.73 | 090 | ||||||||||||
| 65771 | N | Radial keratotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 65772 | A | Correction of astigmatism | 4.29 | 7.51 | 6.47 | 0.17 | 11.97 | 10.93 | 090 | ||||||||||||
| 65775 | A | Correction of astigmatism | 5.79 | NA | 8.63 | 0.22 | NA | 14.64 | 090 | ||||||||||||
| 65800 | A | Drainage of eye | 1.91 | 2.33 | 1.45 | 0.08 | 4.32 | 3.44 | 000 | ||||||||||||
| 65805 | A | Drainage of eye | 1.91 | 2.34 | 1.46 | 0.08 | 4.33 | 3.45 | 000 | ||||||||||||
| 65810 | A | Drainage of eye | 4.87 | NA | 8.95 | 0.19 | NA | 14.01 | 090 | ||||||||||||
| 65815 | A | Drainage of eye | 5.05 | 9.40 | 8.16 | 0.20 | 14.65 | 13.41 | 090 | ||||||||||||
| 65820 | A | Relieve inner eye pressure | 8.13 | NA | 10.99 | 0.32 | NA | 19.44 | 090 | ||||||||||||
| 65850 | A | Incision of eye | 10.52 | NA | 10.35 | 0.41 | NA | 21.28 | 090 | ||||||||||||
| 65855 | A | Laser surgery of eye | 3.85 | 5.17 | 3.70 | 0.17 | 9.19 | 7.72 | 010 | ||||||||||||
| 65860 | A | Incise inner eye adhesions | 3.55 | 4.15 | 3.18 | 0.14 | 7.84 | 6.87 | 090 | ||||||||||||
| 65865 | A | Incise inner eye adhesions | 5.60 | NA | 6.92 | 0.22 | NA | 12.74 | 090 | ||||||||||||
| 65870 | A | Incise inner eye adhesions | 6.27 | NA | 7.25 | 0.24 | NA | 13.76 | 090 | ||||||||||||
| 65875 | A | Incise inner eye adhesions | 6.54 | NA | 7.37 | 0.25 | NA | 14.16 | 090 | ||||||||||||
| 65880 | A | Incise inner eye adhesions | 7.09 | NA | 7.64 | 0.28 | NA | 15.01 | 090 | ||||||||||||
| 65900 | A | Remove eye lesion | 10.93 | NA | 12.75 | 0.46 | NA | 24.14 | 090 | ||||||||||||
| 65920 | A | Remove implant of eye | 8.40 | NA | 8.26 | 0.33 | NA | 16.99 | 090 | ||||||||||||
| 65930 | A | Remove blood clot from eye | 7.44 | NA | 8.83 | 0.29 | NA | 16.56 | 090 | ||||||||||||
| 66020 | A | Injection treatment of eye | 1.59 | 2.43 | 1.57 | 0.07 | 4.09 | 3.23 | 010 | ||||||||||||
| 66030 | A | Injection treatment of eye | 1.25 | 2.25 | 1.40 | 0.05 | 3.55 | 2.70 | 010 | ||||||||||||
| 66130 | A | Remove eye lesion | 7.69 | 7.63 | 6.71 | 0.31 | 15.63 | 14.71 | 090 | ||||||||||||
| 66150 | A | Glaucoma surgery | 8.30 | NA | 10.98 | 0.33 | NA | 19.61 | 090 | ||||||||||||
| 66155 | A | Glaucoma surgery | 8.29 | NA | 10.94 | 0.32 | NA | 19.55 | 090 | ||||||||||||
| 66160 | A | Glaucoma surgery | 10.17 | NA | 11.84 | 0.41 | NA | 22.42 | 090 | ||||||||||||
| 66165 | A | Glaucoma surgery | 8.01 | NA | 10.72 | 0.31 | NA | 19.04 | 090 | ||||||||||||
| 66170 | A | Glaucoma surgery | 12.16 | NA | 17.11 | 0.48 | NA | 29.75 | 090 | ||||||||||||
| 66172 | A | Incision of eye | 15.04 | NA | 15.67 | 0.59 | NA | 31.30 | 090 | ||||||||||||
| 66180 | A | Implant eye shunt | 14.55 | NA | 12.44 | 0.57 | NA | 27.56 | 090 | ||||||||||||
| 66185 | A | Revise eye shunt | 8.14 | NA | 8.47 | 0.32 | NA | 16.93 | 090 | ||||||||||||
| 66220 | A | Repair eye lesion | 7.77 | NA | 9.99 | 0.32 | NA | 18.08 | 090 | ||||||||||||
| 66225 | A | Repair/graft eye lesion | 11.05 | NA | 9.65 | 0.44 | NA | 21.14 | 090 | ||||||||||||
| 66250 | A | Follow-up surgery of eye | 5.98 | 8.08 | 6.48 | 0.23 | 14.29 | 12.69 | 090 | ||||||||||||
| 66500 | A | Incision of iris | 3.71 | NA | 4.82 | 0.15 | NA | 8.68 | 090 | ||||||||||||
| 66505 | A | Incision of iris | 4.08 | NA | 5.01 | 0.17 | NA | 9.26 | 090 | ||||||||||||
| 66600 | A | Remove iris and lesion | 8.68 | NA | 8.90 | 0.34 | NA | 17.92 | 090 | ||||||||||||
| 66605 | A | Removal of iris | 12.79 | NA | 12.54 | 0.61 | NA | 25.94 | 090 | ||||||||||||
| 66625 | A | Removal of iris | 5.13 | 7.90 | 6.81 | 0.20 | 13.23 | 12.14 | 090 | ||||||||||||
| 66630 | A | Removal of iris | 6.16 | NA | 7.76 | 0.24 | NA | 14.16 | 090 | ||||||||||||
| 66635 | A | Removal of iris | 6.25 | NA | 6.65 | 0.24 | NA | 13.14 | 090 | ||||||||||||
| 66680 | A | Repair iris ciliary body | 5.44 | NA | 6.30 | 0.21 | NA | 11.95 | 090 | ||||||||||||
| 66682 | A | Repair iris ciliary body | 6.21 | NA | 7.75 | 0.24 | NA | 14.20 | 090 | ||||||||||||
| 66700 | A | Destruction, ciliary body | 4.78 | 7.17 | 7.17 | 0.19 | 12.14 | 12.14 | 090 | ||||||||||||
| 66710 | A | Destruction, ciliary body | 4.78 | 8.92 | 7.53 | 0.18 | 13.88 | 12.49 | 090 | ||||||||||||
| 66720 | A | Destruction, ciliary body | 4.78 | 8.40 | 7.53 | 0.19 | 13.37 | 12.50 | 090 | ||||||||||||
| 66740 | A | Destruction, ciliary body | 4.78 | NA | 6.53 | 0.18 | NA | 11.49 | 090 | ||||||||||||
| 66761 | A | Revision of iris | 4.07 | 5.66 | 4.38 | 0.16 | 9.89 | 8.61 | 090 | ||||||||||||
| 66762 | A | Revision of iris | 4.58 | 5.65 | 4.45 | 0.18 | 10.41 | 9.21 | 090 | ||||||||||||
| 66770 | A | Removal of inner eye lesion | 5.18 | 5.94 | 4.68 | 0.20 | 11.32 | 10.06 | 090 | ||||||||||||
| 66820 | A | Incision, secondary cataract | 3.89 | NA | 8.50 | 0.16 | NA | 12.55 | 090 | ||||||||||||
| 66821 | A | After cataract laser surgery | 2.35 | 3.89 | 3.46 | 0.10 | 6.34 | 5.91 | 090 | ||||||||||||
| 66825 | A | Reposition intraocular lens | 8.23 | NA | 10.56 | 0.32 | NA | 19.11 | 090 | ||||||||||||
| 66830 | A | Removal of lens lesion | 8.20 | NA | 7.06 | 0.32 | NA | 15.58 | 090 | ||||||||||||
| 66840 | A | Removal of lens material | 7.91 | NA | 6.92 | 0.31 | NA | 15.14 | 090 | ||||||||||||
| 66850 | A | Removal of lens material | 9.11 | NA | 7.52 | 0.36 | NA | 16.99 | 090 | ||||||||||||
| 66852 | A | Removal of lens material | 9.97 | NA | 7.99 | 0.39 | NA | 18.35 | 090 | ||||||||||||
| 66920 | A | Extraction of lens | 8.86 | NA | 7.42 | 0.35 | NA | 16.63 | 090 | ||||||||||||
| 66930 | A | Extraction of lens | 10.18 | NA | 8.94 | 0.41 | NA | 19.53 | 090 | ||||||||||||
| 66940 | A | Extraction of lens | 8.93 | NA | 8.39 | 0.35 | NA | 17.67 | 090 | ||||||||||||
| 66982 | A | Cataract surgery, complex | 13.50 | NA | 9.31 | 0.56 | NA | 23.37 | 090 | ||||||||||||
| 66983 | A | Cataract surg w/iol, 1 stage | 8.99 | NA | 6.34 | 0.37 | NA | 15.70 | 090 | ||||||||||||
| 66984 | A | Cataract surg w/iol, 1 stage | 10.23 | NA | 7.85 | 0.41 | NA | 18.49 | 090 | ||||||||||||
| 66985 | A | Insert lens prosthesis | 8.39 | NA | 7.05 | 0.33 | NA | 15.77 | 090 | ||||||||||||
| 66986 | A | Exchange lens prosthesis | 12.28 | NA | 8.86 | 0.49 | NA | 21.63 | 090 | ||||||||||||
| 66999 | C | Eye surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 67005 | A | Partial removal of eye fluid | 5.70 | NA | 2.75 | 0.22 | NA | 8.67 | 090 | ||||||||||||
| 67010 | A | Partial removal of eye fluid | 6.87 | NA | 3.32 | 0.27 | NA | 10.46 | 090 | ||||||||||||
| 67015 | A | Release of eye fluid | 6.92 | NA | 8.38 | 0.27 | NA | 15.57 | 090 | ||||||||||||
| 67025 | A | Replace eye fluid | 6.84 | 18.23 | 7.77 | 0.27 | 25.34 | 14.88 | 090 | ||||||||||||
| 67027 | A | Implant eye drug system | 10.85 | 15.12 | 9.26 | 0.46 | 26.43 | 20.57 | 090 | ||||||||||||
| 67028 | A | Injection eye drug | 2.52 | 11.92 | 1.21 | 0.11 | 14.55 | 3.84 | 000 | ||||||||||||
| 67030 | A | Incise inner eye strands | 4.84 | NA | 6.96 | 0.19 | NA | 11.99 | 090 | ||||||||||||
| 67031 | A | Laser surgery, eye strands | 3.67 | 4.22 | 3.24 | 0.15 | 8.04 | 7.06 | 090 | ||||||||||||
| 67036 | A | Removal of inner eye fluid | 11.89 | NA | 9.30 | 0.47 | NA | 21.66 | 090 | ||||||||||||
| 67038 | A | Strip retinal membrane | 21.24 | NA | 16.01 | 0.84 | NA | 38.09 | 090 | ||||||||||||
| 67039 | A | Laser treatment of retina | 14.52 | NA | 12.74 | 0.57 | NA | 27.83 | 090 | ||||||||||||
| 67040 | A | Laser treatment of retina | 17.23 | NA | 14.08 | 0.68 | NA | 31.99 | 090 | ||||||||||||
| 67101 | A | Repair detached retina | 7.53 | 11.29 | 9.12 | 0.29 | 19.11 | 16.94 | 090 | ||||||||||||
| 67105 | A | Repair detached retina | 7.41 | 7.80 | 5.70 | 0.29 | 15.50 | 13.40 | 090 | ||||||||||||
| 67107 | A | Repair detached retina | 14.84 | NA | 13.63 | 0.58 | NA | 29.05 | 090 | ||||||||||||
| 67108 | A | Repair detached retina | 20.82 | NA | 18.30 | 0.82 | NA | 39.94 | 090 | ||||||||||||
| 67110 | A | Repair detached retina | 8.81 | 21.74 | 10.56 | 0.35 | 30.90 | 19.72 | 090 | ||||||||||||
| 67112 | A | Rerepair detached retina | 16.86 | NA | 15.66 | 0.66 | NA | 33.18 | 090 | ||||||||||||
| 67115 | A | Release encircling material | 4.99 | NA | 7.02 | 0.19 | NA | 12.20 | 090 | ||||||||||||
| 67120 | A | Remove eye implant material | 5.98 | 17.57 | 7.36 | 0.23 | 23.78 | 13.57 | 090 | ||||||||||||
| 67121 | A | Remove eye implant material | 10.67 | NA | 12.47 | 0.42 | NA | 23.56 | 090 | ||||||||||||
| 67141 | A | Treatment of retina | 5.20 | 8.29 | 7.16 | 0.20 | 13.69 | 12.56 | 090 | ||||||||||||
| 67145 | A | Treatment of retina | 5.37 | 5.43 | 4.28 | 0.21 | 11.01 | 9.86 | 090 | ||||||||||||
| 67208 | A | Treatment of retinal lesion | 6.70 | 8.62 | 7.26 | 0.26 | 15.58 | 14.22 | 090 | ||||||||||||
| 67210 | A | Treatment of retinal lesion | 8.82 | 7.49 | 5.93 | 0.35 | 16.66 | 15.10 | 090 | ||||||||||||
| 67218 | A | Treatment of retinal lesion | 18.53 | NA | 16.36 | 0.53 | NA | 35.42 | 090 | ||||||||||||
| 67220 | A | Treatment of choroid lesion | 13.13 | 11.18 | 9.94 | 0.51 | 24.82 | 23.58 | 090 | ||||||||||||
| 67221 | A | Ocular photodynamic ther | 4.01 | 4.80 | 1.95 | 0.16 | 8.97 | 6.12 | 000 | ||||||||||||
| 67225 | A | Eye photodynamic ther add-on | 0.47 | 0.24 | 0.19 | 0.50 | 1.21 | 1.16 | ZZZ | ||||||||||||
| 67227 | A | Treatment of retinal lesion | 6.58 | 9.29 | 7.40 | 0.26 | 16.13 | 14.24 | 090 | ||||||||||||
| 67228 | A | Treatment of retinal lesion | 12.74 | 10.17 | 7.47 | 0.50 | 23.41 | 20.71 | 090 | ||||||||||||
| 67250 | A | Reinforce eye wall | 8.66 | NA | 12.10 | 0.36 | NA | 21.12 | 090 | ||||||||||||
| 67255 | A | Reinforce/graft eye wall | 8.90 | NA | 12.11 | 0.35 | NA | 21.36 | 090 | ||||||||||||
| 67299 | C | Eye surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 67311 | A | Revise eye muscle | 6.65 | NA | 6.36 | 0.27 | NA | 13.28 | 090 | ||||||||||||
| 67312 | A | Revise two eye muscles | 8.54 | NA | 7.46 | 0.35 | NA | 16.35 | 090 | ||||||||||||
| 67314 | A | Revise eye muscle | 7.52 | NA | 6.94 | 0.30 | NA | 14.76 | 090 | ||||||||||||
| 67316 | A | Revise two eye muscles | 9.66 | NA | 7.99 | 0.40 | NA | 18.05 | 090 | ||||||||||||
| 67318 | A | Revise eye muscle(s) | 7.85 | NA | 7.37 | 0.31 | NA | 15.53 | 090 | ||||||||||||
| 67320 | A | Revise eye muscle(s) add-on | 4.33 | NA | 2.09 | 0.17 | NA | 6.59 | ZZZ | ||||||||||||
| 67331 | A | Eye surgery follow-up add-on | 4.06 | NA | 2.02 | 0.17 | NA | 6.25 | ZZZ | ||||||||||||
| 67332 | A | Rerevise eye muscles add-on | 4.49 | NA | 2.16 | 0.18 | NA | 6.83 | ZZZ | ||||||||||||
| 67334 | A | Revise eye muscle w/suture | 3.98 | NA | 1.90 | 0.16 | NA | 6.04 | ZZZ | ||||||||||||
| 67335 | A | Eye suture during surgery | 2.49 | NA | 1.20 | 0.10 | NA | 3.79 | ZZZ | ||||||||||||
| 67340 | A | Revise eye muscle add-on | 4.93 | NA | 2.41 | 0.19 | NA | 7.53 | ZZZ | ||||||||||||
| 67343 | A | Release eye tissue | 7.35 | NA | 7.26 | 0.30 | NA | 14.91 | 090 | ||||||||||||
| 67345 | A | Destroy nerve of eye muscle | 2.96 | 4.46 | 1.36 | 0.13 | 7.55 | 4.45 | 010 | ||||||||||||
| 67350 | A | Biopsy eye muscle | 2.87 | NA | 1.99 | 0.13 | NA | 4.99 | 000 | ||||||||||||
| 67399 | C | Eye muscle surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 67400 | A | Explore/biopsy eye socket | 9.76 | NA | 13.85 | 0.43 | NA | 24.04 | 090 | ||||||||||||
| 67405 | A | Explore/drain eye socket | 7.93 | NA | 12.56 | 0.36 | NA | 20.85 | 090 | ||||||||||||
| 67412 | A | Explore/treat eye socket | 9.50 | NA | 16.02 | 0.41 | NA | 25.93 | 090 | ||||||||||||
| 67413 | A | Explore/treat eye socket | 10.00 | NA | 13.80 | 0.43 | NA | 24.23 | 090 | ||||||||||||
| 67414 | A | Explr/decompress eye socket | 11.13 | NA | 16.90 | 0.48 | NA | 28.51 | 090 | ||||||||||||
| 67415 | A | Aspiration, orbital contents | 1.76 | NA | 0.80 | 0.09 | NA | 2.65 | 000 | ||||||||||||
| 67420 | A | Explore/treat eye socket | 20.06 | NA | 20.79 | 0.84 | NA | 41.69 | 090 | ||||||||||||
| 67430 | A | Explore/treat eye socket | 13.39 | NA | 18.38 | 0.97 | NA | 32.74 | 090 | ||||||||||||
| 67440 | A | Explore/drain eye socket | 13.09 | NA | 18.43 | 0.58 | NA | 32.10 | 090 | ||||||||||||
| 67445 | A | Explr/decompress eye socket | 14.42 | NA | 18.19 | 0.63 | NA | 33.24 | 090 | ||||||||||||
| 67450 | A | Explore/biopsy eye socket | 13.51 | NA | 17.51 | 0.56 | NA | 31.58 | 090 | ||||||||||||
| 67500 | A | Inject/treat eye socket | 0.79 | 0.95 | 0.20 | 0.04 | 1.78 | 1.03 | 000 | ||||||||||||
| 67505 | A | Inject/treat eye socket | 0.82 | 0.95 | 0.21 | 0.04 | 1.81 | 1.07 | 000 | ||||||||||||
| 67515 | A | Inject/treat eye socket | 0.61 | 0.86 | 0.29 | 0.02 | 1.49 | 0.92 | 000 | ||||||||||||
| 67550 | A | Insert eye socket implant | 10.19 | NA | 13.57 | 0.50 | NA | 24.26 | 090 | ||||||||||||
| 67560 | A | Revise eye socket implant | 10.60 | NA | 13.50 | 0.47 | NA | 24.57 | 090 | ||||||||||||
| 67570 | A | Decompress optic nerve | 13.58 | NA | 17.66 | 0.69 | NA | 31.93 | 090 | ||||||||||||
| 67599 | C | Orbit surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 67700 | A | Drainage of eyelid abscess | 1.35 | 7.80 | 0.60 | 0.06 | 9.21 | 2.01 | 010 | ||||||||||||
| 67710 | A | Incision of eyelid | 1.02 | 7.92 | 0.49 | 0.04 | 8.98 | 1.55 | 010 | ||||||||||||
| 67715 | A | Incision of eyelid fold | 1.22 | NA | 0.59 | 0.05 | NA | 1.86 | 010 | ||||||||||||
| 67800 | A | Remove eyelid lesion | 1.38 | 2.67 | 0.66 | 0.06 | 4.11 | 2.10 | 010 | ||||||||||||
| 67801 | A | Remove eyelid lesions | 1.88 | 8.23 | 0.91 | 0.08 | 10.19 | 2.87 | 010 | ||||||||||||
| 67805 | A | Remove eyelid lesions | 2.22 | 8.41 | 1.06 | 0.09 | 10.72 | 3.37 | 010 | ||||||||||||
| 67808 | A | Remove eyelid lesion(s) | 3.80 | NA | 4.34 | 0.17 | NA | 8.31 | 090 | ||||||||||||
| 67810 | A | Biopsy of eyelid | 1.48 | 5.26 | 0.72 | 0.06 | 6.80 | 2.26 | 000 | ||||||||||||
| 67820 | A | Revise eyelashes | 0.89 | 2.02 | 0.39 | 0.04 | 2.95 | 1.32 | 000 | ||||||||||||
| 67825 | A | Revise eyelashes | 1.38 | 5.70 | 1.07 | 0.06 | 7.14 | 2.51 | 010 | ||||||||||||
| 67830 | A | Revise eyelashes | 1.70 | 11.55 | 2.20 | 0.07 | 13.32 | 3.97 | 010 | ||||||||||||
| 67835 | A | Revise eyelashes | 5.56 | NA | 4.90 | 0.22 | NA | 10.68 | 090 | ||||||||||||
| 67840 | A | Remove eyelid lesion | 2.04 | 8.19 | 0.99 | 0.08 | 10.31 | 3.11 | 010 | ||||||||||||
| 67850 | A | Treat eyelid lesion | 1.69 | 8.79 | 2.07 | 0.07 | 10.55 | 3.83 | 010 | ||||||||||||
| 67875 | A | Closure of eyelid by suture | 1.35 | 11.62 | 2.16 | 0.06 | 13.03 | 3.57 | 000 | ||||||||||||
| 67880 | A | Revision of eyelid | 3.80 | 12.77 | 3.24 | 0.16 | 16.73 | 7.20 | 090 | ||||||||||||
| 67882 | A | Revision of eyelid | 5.07 | 15.42 | 4.84 | 0.21 | 20.70 | 10.12 | 090 | ||||||||||||
| 67900 | A | Repair brow defect | 6.14 | 11.29 | 6.69 | 0.30 | 17.73 | 13.13 | 090 | ||||||||||||
| 67901 | A | Repair eyelid defect | 6.97 | NA | 7.22 | 0.32 | NA | 14.51 | 090 | ||||||||||||
| 67902 | A | Repair eyelid defect | 7.03 | NA | 7.17 | 0.34 | NA | 14.54 | 090 | ||||||||||||
| 67903 | A | Repair eyelid defect | 6.37 | 10.72 | 6.80 | 0.39 | 17.48 | 13.56 | 090 | ||||||||||||
| 67904 | A | Repair eyelid defect | 6.26 | 14.97 | 8.57 | 0.26 | 21.49 | 15.09 | 090 | ||||||||||||
| 67906 | A | Repair eyelid defect | 6.79 | 9.91 | 6.30 | 0.42 | 17.12 | 13.51 | 090 | ||||||||||||
| 67908 | A | Repair eyelid defect | 5.13 | 9.65 | 6.36 | 0.20 | 14.98 | 11.69 | 090 | ||||||||||||
| 67909 | A | Revise eyelid defect | 5.40 | 10.20 | 6.87 | 0.25 | 15.85 | 12.52 | 090 | ||||||||||||
| 67911 | A | Revise eyelid defect | 5.27 | NA | 6.92 | 0.23 | NA | 12.42 | 090 | ||||||||||||
| 67914 | A | Repair eyelid defect | 3.68 | 13.22 | 3.70 | 0.16 | 17.06 | 7.54 | 090 | ||||||||||||
| 67915 | A | Repair eyelid defect | 3.18 | 11.73 | 1.52 | 0.13 | 15.04 | 4.83 | 090 | ||||||||||||
| 67916 | A | Repair eyelid defect | 5.31 | 17.26 | 5.52 | 0.22 | 22.79 | 11.05 | 090 | ||||||||||||
| 67917 | A | Repair eyelid defect | 6.02 | 10.63 | 6.86 | 0.25 | 16.90 | 13.13 | 090 | ||||||||||||
| 67921 | A | Repair eyelid defect | 3.40 | 12.94 | 3.47 | 0.14 | 16.48 | 7.01 | 090 | ||||||||||||
| 67922 | A | Repair eyelid defect | 3.06 | 11.73 | 3.31 | 0.13 | 14.92 | 6.50 | 090 | ||||||||||||
| 67923 | A | Repair eyelid defect | 5.88 | 16.33 | 5.62 | 0.24 | 22.45 | 11.74 | 090 | ||||||||||||
| 67924 | A | Repair eyelid defect | 5.79 | 9.97 | 6.20 | 0.23 | 15.99 | 12.22 | 090 | ||||||||||||
| 67930 | A | Repair eyelid wound | 3.61 | 12.50 | 3.15 | 0.17 | 16.28 | 6.93 | 010 | ||||||||||||
| 67935 | A | Repair eyelid wound | 6.22 | 16.12 | 5.60 | 0.29 | 22.63 | 12.11 | 090 | ||||||||||||
| 67938 | A | Remove eyelid foreign body | 1.33 | 9.65 | 0.53 | 0.06 | 11.04 | 1.92 | 010 | ||||||||||||
| 67950 | A | Revision of eyelid | 5.82 | 9.01 | 7.67 | 0.30 | 15.13 | 13.79 | 090 | ||||||||||||
| 67961 | A | Revision of eyelid | 5.69 | 9.39 | 6.03 | 0.26 | 15.34 | 11.98 | 090 | ||||||||||||
| 67966 | A | Revision of eyelid | 6.57 | 9.01 | 6.25 | 0.33 | 15.91 | 13.15 | 090 | ||||||||||||
| 67971 | A | Reconstruction of eyelid | 9.79 | NA | 7.85 | 0.42 | NA | 18.06 | 090 | ||||||||||||
| 67973 | A | Reconstruction of eyelid | 12.87 | NA | 9.95 | 0.59 | NA | 23.41 | 090 | ||||||||||||
| 67974 | A | Reconstruction of eyelid | 12.84 | NA | 9.87 | 0.54 | NA | 23.25 | 090 | ||||||||||||
| 67975 | A | Reconstruction of eyelid | 9.13 | NA | 7.51 | 0.38 | NA | 17.02 | 090 | ||||||||||||
| 67999 | C | Revision of eyelid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 68020 | A | Incise/drain eyelid lining | 1.37 | 7.79 | 0.65 | 0.06 | 9.22 | 2.08 | 010 | ||||||||||||
| 68040 | A | Treatment of eyelid lesions | 0.85 | 7.68 | 0.41 | 0.03 | 8.56 | 1.29 | 000 | ||||||||||||
| 68100 | A | Biopsy of eyelid lining | 1.35 | 7.93 | 0.65 | 0.06 | 9.34 | 2.06 | 000 | ||||||||||||
| 68110 | A | Remove eyelid lining lesion | 1.77 | 8.98 | 1.41 | 0.07 | 10.82 | 3.25 | 010 | ||||||||||||
| 68115 | A | Remove eyelid lining lesion | 2.36 | 8.47 | 1.14 | 0.10 | 10.93 | 3.60 | 010 | ||||||||||||
| 68130 | A | Remove eyelid lining lesion | 4.93 | NA | 2.38 | 0.19 | NA | 7.50 | 090 | ||||||||||||
| 68135 | A | Remove eyelid lining lesion | 1.84 | 8.23 | 0.89 | 0.07 | 10.14 | 2.80 | 010 | ||||||||||||
| 68200 | A | Treat eyelid by injection | 0.49 | 0.76 | 0.24 | 0.02 | 1.27 | 0.75 | 000 | ||||||||||||
| 68320 | A | Revise/graft eyelid lining | 5.37 | 5.75 | 5.34 | 0.21 | 11.33 | 10.92 | 090 | ||||||||||||
| 68325 | A | Revise/graft eyelid lining | 7.36 | NA | 6.33 | 0.30 | NA | 13.99 | 090 | ||||||||||||
| 68326 | A | Revise/graft eyelid lining | 7.15 | NA | 6.26 | 0.30 | NA | 13.71 | 090 | ||||||||||||
| 68328 | A | Revise/graft eyelid lining | 8.18 | NA | 7.07 | 0.40 | NA | 15.65 | 090 | ||||||||||||
| 68330 | A | Revise eyelid lining | 4.83 | 7.34 | 5.82 | 0.19 | 12.36 | 10.84 | 090 | ||||||||||||
| 68335 | A | Revise/graft eyelid lining | 7.19 | NA | 5.68 | 0.29 | NA | 13.16 | 090 | ||||||||||||
| 68340 | A | Separate eyelid adhesions | 4.17 | 15.87 | 4.33 | 0.17 | 20.21 | 8.67 | 090 | ||||||||||||
| 68360 | A | Revise eyelid lining | 4.37 | 6.77 | 5.42 | 0.17 | 11.31 | 9.96 | 090 | ||||||||||||
| 68362 | A | Revise eyelid lining | 7.34 | NA | 8.02 | 0.29 | NA | 15.65 | 090 | ||||||||||||
| 68399 | C | Eyelid lining surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 68400 | A | Incise/drain tear gland | 1.69 | 11.48 | 2.18 | 0.07 | 13.24 | 3.94 | 010 | ||||||||||||
| 68420 | A | Incise/drain tear sac | 2.30 | 11.89 | 2.52 | 0.10 | 14.29 | 4.92 | 010 | ||||||||||||
| 68440 | A | Incise tear duct opening | 0.94 | 7.86 | 0.45 | 0.04 | 8.84 | 1.43 | 010 | ||||||||||||
| 68500 | A | Removal of tear gland | 11.02 | NA | 9.13 | 0.60 | NA | 20.75 | 090 | ||||||||||||
| 68505 | A | Partial removal, tear gland | 10.94 | NA | 10.31 | 0.57 | NA | 21.82 | 090 | ||||||||||||
| 68510 | A | Biopsy of tear gland | 4.61 | 13.09 | 2.22 | 0.19 | 17.89 | 7.02 | 000 | ||||||||||||
| 68520 | A | Removal of tear sac | 7.51 | NA | 7.47 | 0.33 | NA | 15.31 | 090 | ||||||||||||
| 68525 | A | Biopsy of tear sac | 4.43 | NA | 2.15 | 0.18 | NA | 6.76 | 000 | ||||||||||||
| 68530 | A | Clearance of tear duct | 3.66 | 15.33 | 3.18 | 0.16 | 19.15 | 7.00 | 010 | ||||||||||||
| 68540 | A | Remove tear gland lesion | 10.60 | NA | 9.73 | 0.46 | NA | 20.79 | 090 | ||||||||||||
| 68550 | A | Remove tear gland lesion | 13.26 | NA | 10.50 | 0.66 | NA | 24.42 | 090 | ||||||||||||
| 68700 | A | Repair tear ducts | 6.60 | NA | 6.87 | 0.27 | NA | 13.74 | 090 | ||||||||||||
| 68705 | A | Revise tear duct opening | 2.06 | 8.33 | 1.00 | 0.08 | 10.47 | 3.14 | 010 | ||||||||||||
| 68720 | A | Create tear sac drain | 8.96 | NA | 8.04 | 0.38 | NA | 17.38 | 090 | ||||||||||||
| 68745 | A | Create tear duct drain | 8.63 | NA | 7.82 | 0.38 | NA | 16.83 | 090 | ||||||||||||
| 68750 | A | Create tear duct drain | 8.66 | NA | 8.46 | 0.37 | NA | 17.49 | 090 | ||||||||||||
| 68760 | A | Close tear duct opening | 1.73 | 6.77 | 1.25 | 0.07 | 8.57 | 3.05 | 010 | ||||||||||||
| 68761 | A | Close tear duct opening | 1.36 | 3.09 | 1.03 | 0.06 | 4.51 | 2.45 | 010 | ||||||||||||
| 68770 | A | Close tear system fistula | 7.02 | 17.74 | 6.15 | 0.28 | 25.04 | 13.45 | 090 | ||||||||||||
| 68801 | A | Dilate tear duct opening | 0.94 | 0.88 | 0.57 | 0.04 | 1.86 | 1.55 | 010 | ||||||||||||
| 68810 | A | Probe nasolacrimal duct | 1.90 | 2.48 | 0.91 | 0.08 | 4.46 | 2.89 | 010 | ||||||||||||
| 68811 | A | Probe nasolacrimal duct | 2.35 | NA | 2.46 | 0.10 | NA | 4.91 | 010 | ||||||||||||
| 68815 | A | Probe nasolacrimal duct | 3.20 | 14.08 | 2.92 | 0.14 | 17.42 | 6.26 | 010 | ||||||||||||
| 68840 | A | Explore/irrigate tear ducts | 1.25 | 1.62 | 1.00 | 0.05 | 2.92 | 2.30 | 010 | ||||||||||||
| 68850 | A | Injection for tear sac x-ray | 0.80 | 15.29 | 0.32 | 0.03 | 16.12 | 1.15 | 000 | ||||||||||||
| 68899 | C | Tear duct system surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 69000 | A | Drain external ear lesion | 1.45 | 2.14 | 0.59 | 0.10 | 3.69 | 2.14 | 010 | ||||||||||||
| 69005 | A | Drain external ear lesion | 2.11 | 2.55 | 2.11 | 0.16 | 4.82 | 4.38 | 010 | ||||||||||||
| 69020 | A | Drain outer ear canal lesion | 1.48 | 2.25 | 0.71 | 0.11 | 3.84 | 2.30 | 010 | ||||||||||||
| 69090 | N | Pierce earlobes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 69100 | A | Biopsy of external ear | 0.81 | 1.44 | 0.41 | 0.04 | 2.29 | 1.26 | 000 | ||||||||||||
| 69105 | A | Biopsy of external ear canal | 0.85 | 1.51 | 1.02 | 0.06 | 2.42 | 1.93 | 000 | ||||||||||||
| 69110 | A | Remove external ear, partial | 3.44 | 3.48 | 2.85 | 0.24 | 7.16 | 6.53 | 090 | ||||||||||||
| 69120 | A | Removal of external ear | 4.05 | NA | 4.68 | 0.31 | NA | 9.04 | 090 | ||||||||||||
| 69140 | A | Remove ear canal lesion(s) | 7.97 | NA | 8.24 | 0.56 | NA | 16.77 | 090 | ||||||||||||
| 69145 | A | Remove ear canal lesion(s) | 2.62 | 3.41 | 2.54 | 0.18 | 6.21 | 5.34 | 090 | ||||||||||||
| 69150 | A | Extensive ear canal surgery | 13.43 | NA | 11.38 | 1.07 | NA | 25.88 | 090 | ||||||||||||
| 69155 | A | Extensive ear/neck surgery | 20.80 | NA | 16.26 | 1.51 | NA | 38.57 | 090 | ||||||||||||
| 69200 | A | Clear outer ear canal | 0.77 | 1.45 | 0.77 | 0.05 | 2.27 | 1.59 | 000 | ||||||||||||
| 69205 | A | Clear outer ear canal | 1.20 | NA | 1.58 | 0.09 | NA | 2.87 | 010 | ||||||||||||
| 69210 | A | Remove impacted ear wax | 0.61 | 0.59 | 0.25 | 0.04 | 1.24 | 0.90 | 000 | ||||||||||||
| 69220 | A | Clean out mastoid cavity | 0.83 | 1.53 | 0.44 | 0.06 | 2.42 | 1.33 | 000 | ||||||||||||
| 69222 | A | Clean out mastoid cavity | 1.40 | 2.24 | 1.71 | 0.10 | 3.74 | 3.21 | 010 | ||||||||||||
| 69300 | R | Revise external ear | 6.36 | NA | 4.38 | 0.43 | NA | 11.17 | YYY | ||||||||||||
| 69310 | A | Rebuild outer ear canal | 10.79 | NA | 9.86 | 0.77 | NA | 21.42 | 090 | ||||||||||||
| 69320 | A | Rebuild outer ear canal | 16.96 | NA | 13.77 | 1.17 | NA | 31.90 | 090 | ||||||||||||
| 69399 | C | Outer ear surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 69400 | A | Inflate middle ear canal | 0.83 | 1.51 | 0.49 | 0.06 | 2.40 | 1.38 | 000 | ||||||||||||
| 69401 | A | Inflate middle ear canal | 0.63 | 1.41 | 0.34 | 0.04 | 2.08 | 1.01 | 000 | ||||||||||||
| 69405 | A | Catheterize middle ear canal | 2.63 | 3.09 | 1.50 | 0.18 | 5.90 | 4.31 | 010 | ||||||||||||
| 69410 | A | Inset middle ear (baffle) | 0.33 | 1.39 | 0.17 | 0.02 | 1.74 | 0.52 | 000 | ||||||||||||
| 69420 | A | Incision of eardrum | 1.33 | 2.35 | 0.75 | 0.10 | 3.78 | 2.18 | 010 | ||||||||||||
| 69421 | A | Incision of eardrum | 1.73 | 2.58 | 1.92 | 0.13 | 4.44 | 3.78 | 010 | ||||||||||||
| 69424 | A | Remove ventilating tube | 0.85 | 1.68 | 0.94 | 0.06 | 2.59 | 1.85 | 000 | ||||||||||||
| 69433 | A | Create eardrum opening | 1.52 | 2.32 | 0.88 | 0.11 | 3.95 | 2.51 | 010 | ||||||||||||
| 69436 | A | Create eardrum opening | 1.96 | NA | 2.05 | 0.14 | NA | 4.15 | 010 | ||||||||||||
| 69440 | A | Exploration of middle ear | 7.57 | NA | 7.41 | 0.53 | NA | 15.51 | 090 | ||||||||||||
| 69450 | A | Eardrum revision | 5.57 | NA | 6.18 | 0.39 | NA | 12.14 | 090 | ||||||||||||
| 69501 | A | Mastoidectomy | 9.07 | NA | 8.22 | 0.65 | NA | 17.94 | 090 | ||||||||||||
| 69502 | A | Mastoidectomy | 12.38 | NA | 10.80 | 0.86 | NA | 24.04 | 090 | ||||||||||||
| 69505 | A | Remove mastoid structures | 12.99 | NA | 10.94 | 0.92 | NA | 24.85 | 090 | ||||||||||||
| 69511 | A | Extensive mastoid surgery | 13.52 | NA | 11.45 | 0.96 | NA | 25.93 | 090 | ||||||||||||
| 69530 | A | Extensive mastoid surgery | 19.19 | NA | 15.06 | 1.32 | NA | 35.57 | 090 | ||||||||||||
| 69535 | A | Remove part of temporal bone | 36.14 | NA | 25.13 | 2.59 | NA | 63.86 | 090 | ||||||||||||
| 69540 | A | Remove ear lesion | 1.20 | 2.27 | 1.61 | 0.09 | 3.56 | 2.90 | 010 | ||||||||||||
| 69550 | A | Remove ear lesion | 10.99 | NA | 9.97 | 0.80 | NA | 21.76 | 090 | ||||||||||||
| 69552 | A | Remove ear lesion | 19.46 | NA | 14.81 | 1.36 | NA | 35.63 | 090 | ||||||||||||
| 69554 | A | Remove ear lesion | 33.16 | NA | 21.79 | 2.32 | NA | 57.27 | 090 | ||||||||||||
| 69601 | A | Mastoid surgery revision | 13.24 | NA | 11.97 | 0.92 | NA | 26.13 | 090 | ||||||||||||
| 69602 | A | Mastoid surgery revision | 13.58 | NA | 11.55 | 0.94 | NA | 26.07 | 090 | ||||||||||||
| 69603 | A | Mastoid surgery revision | 14.02 | NA | 11.80 | 1.00 | NA | 26.82 | 090 | ||||||||||||
| 69604 | A | Mastoid surgery revision | 14.02 | NA | 11.76 | 0.98 | NA | 26.76 | 090 | ||||||||||||
| 69605 | A | Mastoid surgery revision | 18.49 | NA | 14.37 | 1.29 | NA | 34.15 | 090 | ||||||||||||
| 69610 | A | Repair of eardrum | 4.43 | 4.27 | 3.47 | 0.31 | 9.01 | 8.21 | 010 | ||||||||||||
| 69620 | A | Repair of eardrum | 5.89 | 6.90 | 3.40 | 0.40 | 13.19 | 9.69 | 090 | ||||||||||||
| 69631 | A | Repair eardrum structures | 9.86 | NA | 9.38 | 0.69 | NA | 19.93 | 090 | ||||||||||||
| 69632 | A | Rebuild eardrum structures | 12.75 | NA | 11.73 | 0.89 | NA | 25.37 | 090 | ||||||||||||
| 69633 | A | Rebuild eardrum structures | 12.10 | NA | 11.36 | 0.84 | NA | 24.30 | 090 | ||||||||||||
| 69635 | A | Repair eardrum structures | 13.33 | NA | 11.41 | 0.87 | NA | 25.61 | 090 | ||||||||||||
| 69636 | A | Rebuild eardrum structures | 15.22 | NA | 13.23 | 1.07 | NA | 29.52 | 090 | ||||||||||||
| 69637 | A | Rebuild eardrum structures | 15.11 | NA | 13.16 | 1.06 | NA | 29.33 | 090 | ||||||||||||
| 69641 | A | Revise middle ear mastoid | 12.71 | NA | 11.06 | 0.89 | NA | 24.66 | 090 | ||||||||||||
| 69642 | A | Revise middle ear mastoid | 16.84 | NA | 14.16 | 1.18 | NA | 32.18 | 090 | ||||||||||||
| 69643 | A | Revise middle ear mastoid | 15.32 | NA | 13.24 | 1.08 | NA | 29.64 | 090 | ||||||||||||
| 69644 | A | Revise middle ear mastoid | 16.97 | NA | 14.22 | 1.19 | NA | 32.38 | 090 | ||||||||||||
| 69645 | A | Revise middle ear mastoid | 16.38 | NA | 13.77 | 1.16 | NA | 31.31 | 090 | ||||||||||||
| 69646 | A | Revise middle ear mastoid | 17.99 | NA | 14.83 | 1.26 | NA | 34.08 | 090 | ||||||||||||
| 69650 | A | Release middle ear bone | 9.66 | NA | 8.53 | 0.68 | NA | 18.87 | 090 | ||||||||||||
| 69660 | A | Revise middle ear bone | 11.90 | NA | 9.86 | 0.84 | NA | 22.60 | 090 | ||||||||||||
| 69661 | A | Revise middle ear bone | 15.74 | NA | 12.63 | 1.10 | NA | 29.47 | 090 | ||||||||||||
| 69662 | A | Revise middle ear bone | 15.44 | NA | 12.56 | 1.08 | NA | 29.08 | 090 | ||||||||||||
| 69666 | A | Repair middle ear structures | 9.75 | NA | 8.65 | 0.68 | NA | 19.08 | 090 | ||||||||||||
| 69667 | A | Repair middle ear structures | 9.76 | NA | 8.58 | 0.72 | NA | 19.06 | 090 | ||||||||||||
| 69670 | A | Remove mastoid air cells | 11.51 | NA | 10.36 | 0.78 | NA | 22.65 | 090 | ||||||||||||
| 69676 | A | Remove middle ear nerve | 9.52 | NA | 9.14 | 0.69 | NA | 19.35 | 090 | ||||||||||||
| 69700 | A | Close mastoid fistula | 8.23 | NA | 5.77 | 0.55 | NA | 14.55 | 090 | ||||||||||||
| 69710 | N | Implant/replace hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 69711 | A | Remove/repair hearing aid | 10.44 | NA | 9.62 | 0.62 | NA | 20.68 | 090 | ||||||||||||
| 69714 | A | Implant temple bone w/stimul | 14.00 | NA | 11.53 | 1.01 | NA | 26.54 | 090 | ||||||||||||
| 69715 | A | Temple bone implnt w/stimulat | 18.25 | NA | 14.05 | 1.32 | NA | 33.62 | 090 | ||||||||||||
| 69717 | A | Temple bone implant revision | 14.98 | NA | 11.46 | 1.08 | NA | 27.52 | 090 | ||||||||||||
| 69718 | A | Revise temple bone implant | 18.50 | NA | 14.20 | 1.34 | NA | 34.04 | 090 | ||||||||||||
| 69720 | A | Release facial nerve | 14.38 | NA | 12.85 | 1.03 | NA | 28.26 | 090 | ||||||||||||
| 69725 | A | Release facial nerve | 25.38 | NA | 17.97 | 1.78 | NA | 45.13 | 090 | ||||||||||||
| 69740 | A | Repair facial nerve | 15.96 | NA | 10.90 | 1.13 | NA | 27.99 | 090 | ||||||||||||
| 69745 | A | Repair facial nerve | 16.69 | NA | 12.80 | 1.00 | NA | 30.49 | 090 | ||||||||||||
| 69799 | C | Middle ear surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 69801 | A | Incise inner ear | 8.56 | NA | 7.96 | 0.60 | NA | 17.12 | 090 | ||||||||||||
| 69802 | A | Incise inner ear | 13.10 | NA | 11.37 | 0.91 | NA | 25.38 | 090 | ||||||||||||
| 69805 | A | Explore inner ear | 13.82 | NA | 10.91 | 0.97 | NA | 25.70 | 090 | ||||||||||||
| 69806 | A | Explore inner ear | 12.35 | NA | 10.82 | 0.86 | NA | 24.03 | 090 | ||||||||||||
| 69820 | A | Establish inner ear window | 10.34 | NA | 8.78 | 0.66 | NA | 19.78 | 090 | ||||||||||||
| 69840 | A | Revise inner ear window | 10.26 | NA | 9.00 | 0.64 | NA | 19.90 | 090 | ||||||||||||
| 69905 | A | Remove inner ear | 11.10 | NA | 9.94 | 0.77 | NA | 21.81 | 090 | ||||||||||||
| 69910 | A | Remove inner ear mastoid | 13.63 | NA | 11.42 | 0.94 | NA | 25.99 | 090 | ||||||||||||
| 69915 | A | Incise inner ear nerve | 21.23 | NA | 15.88 | 1.54 | NA | 38.65 | 090 | ||||||||||||
| 69930 | A | Implant cochlear device | 16.81 | NA | 12.94 | 1.19 | NA | 30.94 | 090 | ||||||||||||
| 69949 | C | Inner ear surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 69950 | A | Incise inner ear nerve | 25.64 | NA | 16.71 | 2.90 | NA | 45.25 | 090 | ||||||||||||
| 69955 | A | Release facial nerve | 27.04 | NA | 18.39 | 1.89 | NA | 47.32 | 090 | ||||||||||||
| 69960 | A | Release inner ear canal | 27.04 | NA | 18.40 | 2.43 | NA | 47.87 | 090 | ||||||||||||
| 69970 | A | Remove inner ear lesion | 30.04 | NA | 19.12 | 2.34 | NA | 51.50 | 090 | ||||||||||||
| 69979 | C | Temporal bone surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| 69990 | R | Microsurgery add-on | 3.47 | NA | 1.87 | 0.56 | NA | 5.90 | ZZZ | ||||||||||||
| 70010 | A | Contrast x-ray of brain | 1.19 | 4.53 | NA | 0.24 | 5.96 | NA | XXX | ||||||||||||
| 70010 | 26 | A | Contrast x-ray of brain | 1.19 | 0.42 | 0.42 | 0.06 | 1.67 | 1.67 | XXX | |||||||||||
| 70010 | TC | A | Contrast x-ray of brain | 0.00 | 4.11 | NA | 0.18 | 4.29 | NA | XXX | |||||||||||
| 70015 | A | Contrast x-ray of brain | 1.19 | 1.71 | NA | 0.12 | 3.02 | NA | XXX | ||||||||||||
| 70015 | 26 | A | Contrast x-ray of brain | 1.19 | 0.42 | 0.42 | 0.05 | 1.66 | 1.66 | XXX | |||||||||||
| 70015 | TC | A | Contrast x-ray of brain | 0.00 | 1.29 | NA | 0.07 | 1.36 | NA | XXX | |||||||||||
| 70030 | A | X-ray eye for foreign body | 0.17 | 0.45 | NA | 0.03 | 0.65 | NA | XXX | ||||||||||||
| 70030 | 26 | A | X-ray eye for foreign body | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 70030 | TC | A | X-ray eye for foreign body | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 70100 | A | X-ray exam of jaw | 0.18 | 0.56 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 70100 | 26 | A | X-ray exam of jaw | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 70100 | TC | A | X-ray exam of jaw | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 70110 | A | X-ray exam of jaw | 0.25 | 0.68 | NA | 0.04 | 0.97 | NA | XXX | ||||||||||||
| 70110 | 26 | A | X-ray exam of jaw | 0.25 | 0.09 | 0.09 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 70110 | TC | A | X-ray exam of jaw | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 70120 | A | X-ray exam of mastoids | 0.18 | 0.65 | NA | 0.04 | 0.87 | NA | XXX | ||||||||||||
| 70120 | 26 | A | X-ray exam of mastoids | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 70120 | TC | A | X-ray exam of mastoids | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 70130 | A | X-ray exam of mastoids | 0.34 | 0.86 | NA | 0.05 | 1.25 | NA | XXX | ||||||||||||
| 70130 | 26 | A | X-ray exam of mastoids | 0.34 | 0.12 | 0.12 | 0.01 | 0.47 | 0.47 | XXX | |||||||||||
| 70130 | TC | A | X-ray exam of mastoids | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 70134 | A | X-ray exam of middle ear | 0.34 | 0.82 | NA | 0.05 | 1.21 | NA | XXX | ||||||||||||
| 70134 | 26 | A | X-ray exam of middle ear | 0.34 | 0.12 | 0.12 | 0.01 | 0.47 | 0.47 | XXX | |||||||||||
| 70134 | TC | A | X-ray exam of middle ear | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX | |||||||||||
| 70140 | A | X-ray exam of facial bones | 0.19 | 0.66 | NA | 0.04 | 0.89 | NA | XXX | ||||||||||||
| 70140 | 26 | A | X-ray exam of facial bones | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX | |||||||||||
| 70140 | TC | A | X-ray exam of facial bones | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 70150 | A | X-ray exam of facial bones | 0.26 | 0.83 | NA | 0.05 | 1.14 | NA | XXX | ||||||||||||
| 70150 | 26 | A | X-ray exam of facial bones | 0.26 | 0.09 | 0.09 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 70150 | TC | A | X-ray exam of facial bones | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 70160 | A | X-ray exam of nasal bones | 0.17 | 0.56 | NA | 0.03 | 0.76 | NA | XXX | ||||||||||||
| 70160 | 26 | A | X-ray exam of nasal bones | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 70160 | TC | A | X-ray exam of nasal bones | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 70170 | A | X-ray exam of tear duct | 0.30 | 1.01 | NA | 0.06 | 1.37 | NA | XXX | ||||||||||||
| 70170 | 26 | A | X-ray exam of tear duct | 0.30 | 0.11 | 0.11 | 0.01 | 0.42 | 0.42 | XXX | |||||||||||
| 70170 | TC | A | X-ray exam of tear duct | 0.00 | 0.90 | NA | 0.05 | 0.95 | NA | XXX | |||||||||||
| 70190 | A | X-ray exam of eye sockets | 0.21 | 0.66 | NA | 0.04 | 0.91 | NA | XXX | ||||||||||||
| 70190 | 26 | A | X-ray exam of eye sockets | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | XXX | |||||||||||
| 70190 | TC | A | X-ray exam of eye sockets | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 70200 | A | X-ray exam of eye sockets | 0.28 | 0.84 | NA | 0.05 | 1.17 | NA | XXX | ||||||||||||
| 70200 | 26 | A | X-ray exam of eye sockets | 0.28 | 0.10 | 0.10 | 0.01 | 0.39 | 0.39 | XXX | |||||||||||
| 70200 | TC | A | X-ray exam of eye sockets | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 70210 | A | X-ray exam of sinuses | 0.17 | 0.65 | NA | 0.04 | 0.86 | NA | XXX | ||||||||||||
| 70210 | 26 | A | X-ray exam of sinuses | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 70210 | TC | A | X-ray exam of sinuses | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 70220 | A | X-ray exam of sinuses | 0.25 | 0.83 | NA | 0.05 | 1.13 | NA | XXX | ||||||||||||
| 70220 | 26 | A | X-ray exam of sinuses | 0.25 | 0.09 | 0.09 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 70220 | TC | A | X-ray exam of sinuses | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 70240 | A | X-ray exam, pituitary saddle | 0.19 | 0.46 | NA | 0.03 | 0.68 | NA | XXX | ||||||||||||
| 70240 | 26 | A | X-ray exam, pituitary saddle | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX | |||||||||||
| 70240 | TC | A | X-ray exam, pituitary saddle | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 70250 | A | X-ray exam of skull | 0.24 | 0.67 | NA | 0.04 | 0.95 | NA | XXX | ||||||||||||
| 70250 | 26 | A | X-ray exam of skull | 0.24 | 0.08 | 0.08 | 0.01 | 0.33 | 0.33 | XXX | |||||||||||
| 70250 | TC | A | X-ray exam of skull | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 70260 | A | X-ray exam of skull | 0.34 | 0.96 | NA | 0.06 | 1.36 | NA | XXX | ||||||||||||
| 70260 | 26 | A | X-ray exam of skull | 0.34 | 0.12 | 0.12 | 0.01 | 0.47 | 0.47 | XXX | |||||||||||
| 70260 | TC | A | X-ray exam of skull | 0.00 | 0.84 | NA | 0.05 | 0.89 | NA | XXX | |||||||||||
| 70300 | A | X-ray exam of teeth | 0.10 | 0.29 | NA | 0.03 | 0.42 | NA | XXX | ||||||||||||
| 70300 | 26 | A | X-ray exam of teeth | 0.10 | 0.04 | 0.04 | 0.01 | 0.15 | 0.15 | XXX | |||||||||||
| 70300 | TC | A | X-ray exam of teeth | 0.00 | 0.25 | NA | 0.02 | 0.27 | NA | XXX | |||||||||||
| 70310 | A | X-ray exam of teeth | 0.16 | 0.46 | NA | 0.03 | 0.65 | NA | XXX | ||||||||||||
| 70310 | 26 | A | X-ray exam of teeth | 0.16 | 0.07 | 0.07 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 70310 | TC | A | X-ray exam of teeth | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 70320 | A | Full mouth x-ray of teeth | 0.22 | 0.82 | NA | 0.05 | 1.09 | NA | XXX | ||||||||||||
| 70320 | 26 | A | Full mouth x-ray of teeth | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 70320 | TC | A | Full mouth x-ray of teeth | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 70328 | A | X-ray exam of jaw joint | 0.18 | 0.53 | NA | 0.03 | 0.74 | NA | XXX | ||||||||||||
| 70328 | 26 | A | X-ray exam of jaw joint | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 70328 | TC | A | X-ray exam of jaw joint | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 70330 | A | X-ray exam of jaw joints | 0.24 | 0.88 | NA | 0.05 | 1.17 | NA | XXX | ||||||||||||
| 70330 | 26 | A | X-ray exam of jaw joints | 0.24 | 0.08 | 0.08 | 0.01 | 0.33 | 0.33 | XXX | |||||||||||
| 70330 | TC | A | X-ray exam of jaw joints | 0.00 | 0.80 | NA | 0.04 | 0.84 | NA | XXX | |||||||||||
| 70332 | A | X-ray exam of jaw joint | 0.54 | 2.18 | NA | 0.12 | 2.84 | NA | XXX | ||||||||||||
| 70332 | 26 | A | X-ray exam of jaw joint | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 70332 | TC | A | X-ray exam of jaw joint | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 70336 | A | Magnetic image, jaw joint | 1.48 | 11.16 | NA | 0.56 | 13.20 | NA | XXX | ||||||||||||
| 70336 | 26 | A | Magnetic image, jaw joint | 1.48 | 0.52 | 0.52 | 0.07 | 2.07 | 2.07 | XXX | |||||||||||
| 70336 | TC | A | Magnetic image, jaw joint | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 70350 | A | X-ray head for orthodontia | 0.17 | 0.42 | NA | 0.03 | 0.62 | NA | XXX | ||||||||||||
| 70350 | 26 | A | X-ray head for orthodontia | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 70350 | TC | A | X-ray head for orthodontia | 0.00 | 0.36 | NA | 0.02 | 0.38 | NA | XXX | |||||||||||
| 70355 | A | Panoramic x-ray of jaws | 0.20 | 0.61 | NA | 0.04 | 0.85 | NA | XXX | ||||||||||||
| 70355 | 26 | A | Panoramic x-ray of jaws | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX | |||||||||||
| 70355 | TC | A | Panoramic x-ray of jaws | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 70360 | A | X-ray exam of neck | 0.17 | 0.45 | NA | 0.03 | 0.65 | NA | XXX | ||||||||||||
| 70360 | 26 | A | X-ray exam of neck | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 70360 | TC | A | X-ray exam of neck | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 70370 | A | Throat x-ray fluoroscopy | 0.32 | 1.35 | NA | 0.07 | 1.74 | NA | XXX | ||||||||||||
| 70370 | 26 | A | Throat x-ray fluoroscopy | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX | |||||||||||
| 70370 | TC | A | Throat x-ray fluoroscopy | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 70371 | A | Speech evaluation, complex | 0.84 | 2.29 | NA | 0.14 | 3.27 | NA | XXX | ||||||||||||
| 70371 | 26 | A | Speech evaluation, complex | 0.84 | 0.30 | 0.30 | 0.04 | 1.18 | 1.18 | XXX | |||||||||||
| 70371 | TC | A | Speech evaluation, complex | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 70373 | A | Contrast x-ray of larynx | 0.44 | 1.84 | NA | 0.11 | 2.39 | NA | XXX | ||||||||||||
| 70373 | 26 | A | Contrast x-ray of larynx | 0.44 | 0.15 | 0.15 | 0.02 | 0.61 | 0.61 | XXX | |||||||||||
| 70373 | TC | A | Contrast x-ray of larynx | 0.00 | 1.69 | NA | 0.09 | 1.78 | NA | XXX | |||||||||||
| 70380 | A | X-ray exam of salivary gland | 0.17 | 0.69 | NA | 0.04 | 0.90 | NA | XXX | ||||||||||||
| 70380 | 26 | A | X-ray exam of salivary gland | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 70380 | TC | A | X-ray exam of salivary gland | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 70390 | A | X-ray exam of salivary duct | 0.38 | 1.82 | NA | 0.11 | 2.31 | NA | XXX | ||||||||||||
| 70390 | 26 | A | X-ray exam of salivary duct | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX | |||||||||||
| 70390 | TC | A | X-ray exam of salivary duct | 0.00 | 1.69 | NA | 0.09 | 1.78 | NA | XXX | |||||||||||
| 70450 | A | Ct head/brain w/o dye | 0.85 | 4.78 | NA | 0.25 | 5.88 | NA | XXX | ||||||||||||
| 70450 | 26 | A | Ct head/brain w/o dye | 0.85 | 0.30 | 0.30 | 0.04 | 1.19 | 1.19 | XXX | |||||||||||
| 70450 | TC | A | Ct head/brain w/o dye | 0.00 | 4.48 | NA | 0.21 | 4.69 | NA | XXX | |||||||||||
| 70460 | A | Ct head/brain w/dye | 1.13 | 5.77 | NA | 0.30 | 7.20 | NA | XXX | ||||||||||||
| 70460 | 26 | A | Ct head/brain w/dye | 1.13 | 0.40 | 0.40 | 0.05 | 1.58 | 1.58 | XXX | |||||||||||
| 70460 | TC | A | Ct head/brain w/dye | 0.00 | 5.37 | NA | 0.25 | 5.62 | NA | XXX | |||||||||||
| 70470 | A | Ct head/brain w/ow dye | 1.27 | 7.16 | NA | 0.37 | 8.80 | NA | XXX | ||||||||||||
| 70470 | 26 | A | Ct head/brain w/ow dye | 1.27 | 0.45 | 0.45 | 0.06 | 1.78 | 1.78 | XXX | |||||||||||
| 70470 | TC | A | Ct head/brain w/ow dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 70480 | A | Ct orbit/ear/fossa w/o dye | 1.28 | 4.93 | NA | 0.27 | 6.48 | NA | XXX | ||||||||||||
| 70480 | 26 | A | Ct orbit/ear/fossa w/o dye | 1.28 | 0.45 | 0.45 | 0.06 | 1.79 | 1.79 | XXX | |||||||||||
| 70480 | TC | A | Ct orbit/ear/fossa w/o dye | 0.00 | 4.48 | NA | 0.21 | 4.69 | NA | XXX | |||||||||||
| 70481 | A | Ct orbit/ear/fossa w/dye | 1.38 | 5.85 | NA | 0.31 | 7.54 | NA | XXX | ||||||||||||
| 70481 | 26 | A | Ct orbit/ear/fossa w/dye | 1.38 | 0.48 | 0.48 | 0.06 | 1.92 | 1.92 | XXX | |||||||||||
| 70481 | TC | A | Ct orbit/ear/fossa w/dye | 0.00 | 5.37 | NA | 0.25 | 5.62 | NA | XXX | |||||||||||
| 70482 | A | Ct orbit/ear/fossa w/ow dye | 1.45 | 7.22 | NA | 0.37 | 9.04 | NA | XXX | ||||||||||||
| 70482 | 26 | A | Ct orbit/ear/fossa w/ow dye | 1.45 | 0.51 | 0.51 | 0.06 | 2.02 | 2.02 | XXX | |||||||||||
| 70482 | TC | A | Ct orbit/ear/fossa w/ow dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 70486 | A | Ct maxillofacial w/o dye | 1.14 | 4.88 | NA | 0.26 | 6.28 | NA | XXX | ||||||||||||
| 70486 | 26 | A | Ct maxillofacial w/o dye | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 70486 | TC | A | Ct maxillofacial w/o dye | 0.00 | 4.48 | NA | 0.21 | 4.69 | NA | XXX | |||||||||||
| 70487 | A | Ct maxillofacial w/dye | 1.30 | 5.83 | NA | 0.31 | 7.44 | NA | XXX | ||||||||||||
| 70487 | 26 | A | Ct maxillofacial w/dye | 1.30 | 0.46 | 0.46 | 0.06 | 1.82 | 1.82 | XXX | |||||||||||
| 70487 | TC | A | Ct maxillofacial w/dye | 0.00 | 5.37 | NA | 0.25 | 5.62 | NA | XXX | |||||||||||
| 70488 | A | Ct maxillofacial w/ow dye | 1.42 | 7.21 | NA | 0.37 | 9.00 | NA | XXX | ||||||||||||
| 70488 | 26 | A | Ct maxillofacial w/ow dye | 1.42 | 0.50 | 0.50 | 0.06 | 1.98 | 1.98 | XXX | |||||||||||
| 70488 | TC | A | Ct maxillofacial w/ow dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 70490 | A | Ct soft tissue neck w/o dye | 1.28 | 4.93 | NA | 0.27 | 6.48 | NA | XXX | ||||||||||||
| 70490 | 26 | A | Ct soft tissue neck w/o dye | 1.28 | 0.45 | 0.45 | 0.06 | 1.79 | 1.79 | XXX | |||||||||||
| 70490 | TC | A | Ct soft tissue neck w/o dye | 0.00 | 4.48 | NA | 0.21 | 4.69 | NA | XXX | |||||||||||
| 70491 | A | Ct soft tissue neck w/dye | 1.38 | 5.85 | NA | 0.31 | 7.54 | NA | XXX | ||||||||||||
| 70491 | 26 | A | Ct soft tissue neck w/dye | 1.38 | 0.48 | 0.48 | 0.06 | 1.92 | 1.92 | XXX | |||||||||||
| 70491 | TC | A | Ct soft tissue neck w/dye | 0.00 | 5.37 | NA | 0.25 | 5.62 | NA | XXX | |||||||||||
| 70492 | A | Ct sft tsue nck w/o w/dye | 1.45 | 7.22 | NA | 0.37 | 9.04 | NA | XXX | ||||||||||||
| 70492 | 26 | A | Ct sft tsue nck w/o w/dye | 1.45 | 0.51 | 0.51 | 0.06 | 2.02 | 2.02 | XXX | |||||||||||
| 70492 | TC | A | Ct sft tsue nck w/o w/dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 70496 | A | Ct angiography, head | 1.75 | 7.41 | NA | 0.56 | 9.72 | NA | XXX | ||||||||||||
| 70496 | 26 | A | Ct angiography, head | 1.75 | 0.70 | 0.70 | 0.08 | 2.53 | 2.53 | XXX | |||||||||||
| 70496 | TC | A | Ct angiography, head | 0.00 | 6.71 | NA | 0.48 | 7.19 | NA | XXX | |||||||||||
| 70498 | A | Ct angiography, neck | 1.75 | 7.41 | NA | 0.56 | 9.72 | NA | XXX | ||||||||||||
| 70498 | 26 | A | Ct angiography, neck | 1.75 | 0.70 | 0.70 | 0.08 | 2.53 | 2.53 | XXX | |||||||||||
| 70498 | TC | A | Ct angiography, neck | 0.00 | 6.71 | NA | 0.48 | 7.19 | NA | XXX | |||||||||||
| 70540 | A | Mri orbit/face/neck w/o dye | 1.35 | 11.11 | NA | 0.36 | 12.82 | NA | XXX | ||||||||||||
| 70540 | 26 | A | Mri orbit/face/neck w/o dye | 1.35 | 0.47 | 0.47 | 0.04 | 1.86 | 1.86 | XXX | |||||||||||
| 70540 | TC | A | Mri orbit/face/neck w/o dye | 0.00 | 10.64 | NA | 0.32 | 10.96 | NA | XXX | |||||||||||
| 70542 | A | Mri orbit/face/neck w/dye | 1.62 | 13.33 | NA | 0.44 | 15.39 | NA | XXX | ||||||||||||
| 70542 | 26 | A | Mri orbit/face/neck w/dye | 1.62 | 0.57 | 0.57 | 0.05 | 2.24 | 2.24 | XXX | |||||||||||
| 70542 | TC | A | Mri orbit/face/neck w/dye | 0.00 | 12.76 | NA | 0.39 | 13.15 | NA | XXX | |||||||||||
| 70543 | A | Mri orbt/fac/nck w/ow dye | 2.15 | 24.39 | NA | 0.77 | 27.31 | NA | XXX | ||||||||||||
| 70543 | 26 | A | Mri orbt/fac/nck w/ow dye | 2.15 | 0.75 | 0.75 | 0.07 | 2.97 | 2.97 | XXX | |||||||||||
| 70543 | TC | A | Mri orbt/fac/nck w/ow dye | 0.00 | 23.64 | NA | 0.70 | 24.34 | NA | XXX | |||||||||||
| 70544 | A | Mr angiography head w/o dye | 1.20 | 11.06 | NA | 0.54 | 12.80 | NA | XXX | ||||||||||||
| 70544 | 26 | A | Mr angiography head w/o dye | 1.20 | 0.42 | 0.42 | 0.05 | 1.67 | 1.67 | XXX | |||||||||||
| 70544 | TC | A | Mr angiography head w/o dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 70545 | A | Mr angiography head w/dye | 1.20 | 11.06 | NA | 0.54 | 12.80 | NA | XXX | ||||||||||||
| 70545 | 26 | A | Mr angiography head w/dye | 1.20 | 0.42 | 0.42 | 0.05 | 1.67 | 1.67 | XXX | |||||||||||
| 70545 | TC | A | Mr angiography head w/dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 70546 | A | Mr angiograph head w/ow dye | 1.80 | 21.92 | NA | 0.57 | 24.29 | NA | XXX | ||||||||||||
| 70546 | 26 | A | Mr angiograph head w/ow dye | 1.80 | 0.63 | 0.63 | 0.08 | 2.51 | 2.51 | XXX | |||||||||||
| 70546 | TC | A | Mr angiograph head w/ow dye | 0.00 | 21.29 | NA | 0.49 | 21.78 | NA | XXX | |||||||||||
| 70547 | A | Mr angiography neck w/o dye | 1.20 | 11.06 | NA | 0.54 | 12.80 | NA | XXX | ||||||||||||
| 70547 | 26 | A | Mr angiography neck w/o dye | 1.20 | 0.42 | 0.42 | 0.05 | 1.67 | 1.67 | XXX | |||||||||||
| 70547 | TC | A | Mr angiography neck w/o dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 70548 | A | Mr angiography neck w/dye | 1.20 | 11.06 | NA | 0.54 | 12.80 | NA | XXX | ||||||||||||
| 70548 | 26 | A | Mr angiography neck w/dye | 1.20 | 0.42 | 0.42 | 0.05 | 1.67 | 1.67 | XXX | |||||||||||
| 70548 | TC | A | Mr angiography neck w/dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 70549 | A | Mr angiograph neck w/ow dye | 1.80 | 21.92 | NA | 0.57 | 24.29 | NA | XXX | ||||||||||||
| 70549 | 26 | A | Mr angiograph neck w/ow dye | 1.80 | 0.63 | 0.63 | 0.08 | 2.51 | 2.51 | XXX | |||||||||||
| 70549 | TC | A | Mr angiograph neck w/ow dye | 0.00 | 21.29 | NA | 0.49 | 21.78 | NA | XXX | |||||||||||
| 70551 | A | Mri brain w/o dye | 1.48 | 11.16 | NA | 0.56 | 13.20 | NA | XXX | ||||||||||||
| 70551 | 26 | A | Mri brain w/o dye | 1.48 | 0.52 | 0.52 | 0.07 | 2.07 | 2.07 | XXX | |||||||||||
| 70551 | TC | A | Mri brain w/o dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 70552 | A | Mri brain w/dye | 1.78 | 13.40 | NA | 0.66 | 15.84 | NA | XXX | ||||||||||||
| 70552 | 26 | A | Mri brain w/dye | 1.78 | 0.64 | 0.64 | 0.08 | 2.50 | 2.50 | XXX | |||||||||||
| 70552 | TC | A | Mri brain w/dye | 0.00 | 12.76 | NA | 0.58 | 13.34 | NA | XXX | |||||||||||
| 70553 | A | Mri brain w/ow dye | 2.36 | 24.47 | NA | 1.19 | 28.02 | NA | XXX | ||||||||||||
| 70553 | 26 | A | Mri brain w/ow dye | 2.36 | 0.83 | 0.83 | 0.10 | 3.29 | 3.29 | XXX | |||||||||||
| 70553 | TC | A | Mri brain w/ow dye | 0.00 | 23.64 | NA | 1.09 | 24.73 | NA | XXX | |||||||||||
| 71010 | A | Chest x-ray | 0.18 | 0.51 | NA | 0.03 | 0.72 | NA | XXX | ||||||||||||
| 71010 | 26 | A | Chest x-ray | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 71010 | TC | A | Chest x-ray | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | |||||||||||
| 71015 | A | Chest x-ray | 0.21 | 0.57 | NA | 0.03 | 0.81 | NA | XXX | ||||||||||||
| 71015 | 26 | A | Chest x-ray | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | XXX | |||||||||||
| 71015 | TC | A | Chest x-ray | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 71020 | A | Chest x-ray | 0.22 | 0.67 | NA | 0.04 | 0.93 | NA | XXX | ||||||||||||
| 71020 | 26 | A | Chest x-ray | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 71020 | TC | A | Chest x-ray | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 71021 | A | Chest x-ray | 0.27 | 0.79 | NA | 0.05 | 1.11 | NA | XXX | ||||||||||||
| 71021 | 26 | A | Chest x-ray | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX | |||||||||||
| 71021 | TC | A | Chest x-ray | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX | |||||||||||
| 71022 | A | Chest x-ray | 0.31 | 0.81 | NA | 0.06 | 1.18 | NA | XXX | ||||||||||||
| 71022 | 26 | A | Chest x-ray | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX | |||||||||||
| 71022 | TC | A | Chest x-ray | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX | |||||||||||
| 71023 | A | Chest x-ray and fluoroscopy | 0.38 | 0.88 | NA | 0.06 | 1.32 | NA | XXX | ||||||||||||
| 71023 | 26 | A | Chest x-ray and fluoroscopy | 0.38 | 0.14 | 0.14 | 0.02 | 0.54 | 0.54 | XXX | |||||||||||
| 71023 | TC | A | Chest x-ray and fluoroscopy | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 71030 | A | Chest x-ray | 0.31 | 0.85 | NA | 0.05 | 1.21 | NA | XXX | ||||||||||||
| 71030 | 26 | A | Chest x-ray | 0.31 | 0.11 | 0.11 | 0.01 | 0.43 | 0.43 | XXX | |||||||||||
| 71030 | TC | A | Chest x-ray | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 71034 | A | Chest x-ray and fluoroscopy | 0.46 | 1.54 | NA | 0.09 | 2.09 | NA | XXX | ||||||||||||
| 71034 | 26 | A | Chest x-ray and fluoroscopy | 0.46 | 0.17 | 0.17 | 0.02 | 0.65 | 0.65 | XXX | |||||||||||
| 71034 | TC | A | Chest x-ray and fluoroscopy | 0.00 | 1.37 | NA | 0.07 | 1.44 | NA | XXX | |||||||||||
| 71035 | A | Chest x-ray | 0.18 | 0.56 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 71035 | 26 | A | Chest x-ray | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 71035 | TC | A | Chest x-ray | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 71040 | A | Contrast x-ray of bronchi | 0.58 | 1.59 | NA | 0.10 | 2.27 | NA | XXX | ||||||||||||
| 71040 | 26 | A | Contrast x-ray of bronchi | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX | |||||||||||
| 71040 | TC | A | Contrast x-ray of bronchi | 0.00 | 1.39 | NA | 0.07 | 1.46 | NA | XXX | |||||||||||
| 71060 | A | Contrast x-ray of bronchi | 0.74 | 2.35 | NA | 0.14 | 3.23 | NA | XXX | ||||||||||||
| 71060 | 26 | A | Contrast x-ray of bronchi | 0.74 | 0.26 | 0.26 | 0.03 | 1.03 | 1.03 | XXX | |||||||||||
| 71060 | TC | A | Contrast x-ray of bronchi | 0.00 | 2.09 | NA | 0.11 | 2.20 | NA | XXX | |||||||||||
| 71090 | A | X-ray pacemaker insertion | 0.54 | 1.82 | NA | 0.11 | 2.47 | NA | XXX | ||||||||||||
| 71090 | 26 | A | X-ray pacemaker insertion | 0.54 | 0.22 | 0.22 | 0.02 | 0.78 | 0.78 | XXX | |||||||||||
| 71090 | TC | A | X-ray pacemaker insertion | 0.00 | 1.60 | NA | 0.09 | 1.69 | NA | XXX | |||||||||||
| 71100 | A | X-ray exam of ribs | 0.22 | 0.62 | NA | 0.04 | 0.88 | NA | XXX | ||||||||||||
| 71100 | 26 | A | X-ray exam of ribs | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 71100 | TC | A | X-ray exam of ribs | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 71101 | A | X-ray exam of ribs/chest | 0.27 | 0.72 | NA | 0.04 | 1.03 | NA | XXX | ||||||||||||
| 71101 | 26 | A | X-ray exam of ribs/chest | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX | |||||||||||
| 71101 | TC | A | X-ray exam of ribs/chest | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 71110 | A | X-ray exam of ribs | 0.27 | 0.83 | NA | 0.05 | 1.15 | NA | XXX | ||||||||||||
| 71110 | 26 | A | X-ray exam of ribs | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX | |||||||||||
| 71110 | TC | A | X-ray exam of ribs | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 71111 | A | X-ray exam of ribs/chest | 0.32 | 0.95 | NA | 0.06 | 1.33 | NA | XXX | ||||||||||||
| 71111 | 26 | A | X-ray exam of ribs/chest | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX | |||||||||||
| 71111 | TC | A | X-ray exam of ribs/chest | 0.00 | 0.84 | NA | 0.05 | 0.89 | NA | XXX | |||||||||||
| 71120 | A | X-ray exam of breastbone | 0.20 | 0.69 | NA | 0.04 | 0.93 | NA | XXX | ||||||||||||
| 71120 | 26 | A | X-ray exam of breastbone | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX | |||||||||||
| 71120 | TC | A | X-ray exam of breastbone | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX | |||||||||||
| 71130 | A | X-ray exam of breastbone | 0.22 | 0.75 | NA | 0.04 | 1.01 | NA | XXX | ||||||||||||
| 71130 | 26 | A | X-ray exam of breastbone | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 71130 | TC | A | X-ray exam of breastbone | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX | |||||||||||
| 71250 | A | Ct thorax w/o dye | 1.16 | 6.02 | NA | 0.31 | 7.49 | NA | XXX | ||||||||||||
| 71250 | 26 | A | Ct thorax w/o dye | 1.16 | 0.41 | 0.41 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 71250 | TC | A | Ct thorax w/o dye | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 71260 | A | Ct thorax w/dye | 1.24 | 7.14 | NA | 0.36 | 8.74 | NA | XXX | ||||||||||||
| 71260 | 26 | A | Ct thorax w/dye | 1.24 | 0.43 | 0.43 | 0.05 | 1.72 | 1.72 | XXX | |||||||||||
| 71260 | TC | A | Ct thorax w/dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 71270 | A | Ct thorax w/ow dye | 1.38 | 8.88 | NA | 0.44 | 10.70 | NA | XXX | ||||||||||||
| 71270 | 26 | A | Ct thorax w/ow dye | 1.38 | 0.48 | 0.48 | 0.06 | 1.92 | 1.92 | XXX | |||||||||||
| 71270 | TC | A | Ct thorax w/ow dye | 0.00 | 8.40 | NA | 0.38 | 8.78 | NA | XXX | |||||||||||
| 71275 | A | Ct angiography, chest | 1.92 | 9.17 | NA | 0.38 | 11.47 | NA | XXX | ||||||||||||
| 71275 | 26 | A | Ct angiography, chest | 1.92 | 0.77 | 0.77 | 0.06 | 2.75 | 2.75 | XXX | |||||||||||
| 71275 | TC | A | Ct angiography, chest | 0.00 | 8.40 | NA | 0.32 | 8.72 | NA | XXX | |||||||||||
| 71550 | A | Mri chest w/o dye | 1.46 | 11.15 | NA | 0.41 | 13.02 | NA | XXX | ||||||||||||
| 71550 | 26 | A | Mri chest w/o dye | 1.46 | 0.51 | 0.51 | 0.04 | 2.01 | 2.01 | XXX | |||||||||||
| 71550 | TC | A | Mri chest w/o dye | 0.00 | 10.64 | NA | 0.37 | 11.01 | NA | XXX | |||||||||||
| 71551 | A | Mri chest w/dye | 1.73 | 13.36 | NA | 0.49 | 15.58 | NA | XXX | ||||||||||||
| 71551 | 26 | A | Mri chest w/dye | 1.73 | 0.60 | 0.60 | 0.06 | 2.39 | 2.39 | XXX | |||||||||||
| 71551 | TC | A | Mri chest w/dye | 0.00 | 12.76 | NA | 0.43 | 13.19 | NA | XXX | |||||||||||
| 71552 | A | Mri chest w/ow dye | 2.26 | 24.43 | NA | 0.64 | 27.33 | NA | XXX | ||||||||||||
| 71552 | 26 | A | Mri chest w/ow dye | 2.26 | 0.79 | 0.79 | 0.08 | 3.13 | 3.13 | XXX | |||||||||||
| 71552 | TC | A | Mri chest w/ow dye | 0.00 | 23.64 | NA | 0.56 | 24.20 | NA | XXX | |||||||||||
| 71555 | R | Mri angio chest w or w/o dye | 1.81 | 11.28 | NA | 0.57 | 13.66 | NA | XXX | ||||||||||||
| 71555 | 26 | R | Mri angio chest w or w/o dye | 1.81 | 0.64 | 0.64 | 0.08 | 2.53 | 2.53 | XXX | |||||||||||
| 71555 | TC | R | Mri angio chest w or w/o dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 72010 | A | X-ray exam of spine | 0.45 | 1.13 | NA | 0.08 | 1.66 | NA | XXX | ||||||||||||
| 72010 | 26 | A | X-ray exam of spine | 0.45 | 0.16 | 0.16 | 0.03 | 0.64 | 0.64 | XXX | |||||||||||
| 72010 | TC | A | X-ray exam of spine | 0.00 | 0.97 | NA | 0.05 | 1.02 | NA | XXX | |||||||||||
| 72020 | A | X-ray exam of spine | 0.15 | 0.44 | NA | 0.03 | 0.62 | NA | XXX | ||||||||||||
| 72020 | 26 | A | X-ray exam of spine | 0.15 | 0.05 | 0.05 | 0.01 | 0.21 | 0.21 | XXX | |||||||||||
| 72020 | TC | A | X-ray exam of spine | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 72040 | A | X-ray exam of neck spine | 0.22 | 0.65 | NA | 0.04 | 0.91 | NA | XXX | ||||||||||||
| 72040 | 26 | A | X-ray exam of neck spine | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 72040 | TC | A | X-ray exam of neck spine | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX | |||||||||||
| 72050 | A | X-ray exam of neck spine | 0.31 | 0.95 | NA | 0.07 | 1.33 | NA | XXX | ||||||||||||
| 72050 | 26 | A | X-ray exam of neck spine | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX | |||||||||||
| 72050 | TC | A | X-ray exam of neck spine | 0.00 | 0.84 | NA | 0.05 | 0.89 | NA | XXX | |||||||||||
| 72052 | A | X-ray exam of neck spine | 0.36 | 1.20 | NA | 0.07 | 1.63 | NA | XXX | ||||||||||||
| 72052 | 26 | A | X-ray exam of neck spine | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX | |||||||||||
| 72052 | TC | A | X-ray exam of neck spine | 0.00 | 1.07 | NA | 0.05 | 1.12 | NA | XXX | |||||||||||
| 72069 | A | X-ray exam of trunk spine | 0.22 | 0.56 | NA | 0.04 | 0.82 | NA | XXX | ||||||||||||
| 72069 | 26 | A | X-ray exam of trunk spine | 0.22 | 0.09 | 0.09 | 0.02 | 0.33 | 0.33 | XXX | |||||||||||
| 72069 | TC | A | X-ray exam of trunk spine | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 72070 | A | X-ray exam of thoracic spine | 0.22 | 0.70 | NA | 0.04 | 0.96 | NA | XXX | ||||||||||||
| 72070 | 26 | A | X-ray exam of thoracic spine | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 72070 | TC | A | X-ray exam of thoracic spine | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX | |||||||||||
| 72072 | A | X-ray exam of thoracic spine | 0.22 | 0.78 | NA | 0.05 | 1.05 | NA | XXX | ||||||||||||
| 72072 | 26 | A | X-ray exam of thoracic spine | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 72072 | TC | A | X-ray exam of thoracic spine | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX | |||||||||||
| 72074 | A | X-ray exam of thoracic spine | 0.22 | 0.94 | NA | 0.06 | 1.22 | NA | XXX | ||||||||||||
| 72074 | 26 | A | X-ray exam of thoracic spine | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 72074 | TC | A | X-ray exam of thoracic spine | 0.00 | 0.86 | NA | 0.05 | 0.91 | NA | XXX | |||||||||||
| 72080 | A | X-ray exam of trunk spine | 0.22 | 0.71 | NA | 0.05 | 0.98 | NA | XXX | ||||||||||||
| 72080 | 26 | A | X-ray exam of trunk spine | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX | |||||||||||
| 72080 | TC | A | X-ray exam of trunk spine | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 72090 | A | X-ray exam of trunk spine | 0.28 | 0.73 | NA | 0.05 | 1.06 | NA | XXX | ||||||||||||
| 72090 | 26 | A | X-ray exam of trunk spine | 0.28 | 0.10 | 0.10 | 0.02 | 0.40 | 0.40 | XXX | |||||||||||
| 72090 | TC | A | X-ray exam of trunk spine | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 72100 | A | X-ray exam of lower spine | 0.22 | 0.71 | NA | 0.05 | 0.98 | NA | XXX | ||||||||||||
| 72100 | 26 | A | X-ray exam of lower spine | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX | |||||||||||
| 72100 | TC | A | X-ray exam of lower spine | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 72110 | A | X-ray exam of lower spine | 0.31 | 0.97 | NA | 0.07 | 1.35 | NA | XXX | ||||||||||||
| 72110 | 26 | A | X-ray exam of lower spine | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX | |||||||||||
| 72110 | TC | A | X-ray exam of lower spine | 0.00 | 0.86 | NA | 0.05 | 0.91 | NA | XXX | |||||||||||
| 72114 | A | X-ray exam of lower spine | 0.36 | 1.26 | NA | 0.08 | 1.70 | NA | XXX | ||||||||||||
| 72114 | 26 | A | X-ray exam of lower spine | 0.36 | 0.13 | 0.13 | 0.03 | 0.52 | 0.52 | XXX | |||||||||||
| 72114 | TC | A | X-ray exam of lower spine | 0.00 | 1.13 | NA | 0.05 | 1.18 | NA | XXX | |||||||||||
| 72120 | A | X-ray exam of lower spine | 0.22 | 0.92 | NA | 0.07 | 1.21 | NA | XXX | ||||||||||||
| 72120 | 26 | A | X-ray exam of lower spine | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX | |||||||||||
| 72120 | TC | A | X-ray exam of lower spine | 0.00 | 0.84 | NA | 0.05 | 0.89 | NA | XXX | |||||||||||
| 72125 | A | Ct neck spine w/o dye | 1.16 | 6.02 | NA | 0.31 | 7.49 | NA | XXX | ||||||||||||
| 72125 | 26 | A | Ct neck spine w/o dye | 1.16 | 0.41 | 0.41 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 72125 | TC | A | Ct neck spine w/o dye | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 72126 | A | Ct neck spine w/dye | 1.22 | 7.14 | NA | 0.36 | 8.72 | NA | XXX | ||||||||||||
| 72126 | 26 | A | Ct neck spine w/dye | 1.22 | 0.43 | 0.43 | 0.05 | 1.70 | 1.70 | XXX | |||||||||||
| 72126 | TC | A | Ct neck spine w/dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 72127 | A | Ct neck spine w/ow dye | 1.27 | 8.85 | NA | 0.44 | 10.56 | NA | XXX | ||||||||||||
| 72127 | 26 | A | Ct neck spine w/ow dye | 1.27 | 0.45 | 0.45 | 0.06 | 1.78 | 1.78 | XXX | |||||||||||
| 72127 | TC | A | Ct neck spine w/ow dye | 0.00 | 8.40 | NA | 0.38 | 8.78 | NA | XXX | |||||||||||
| 72128 | A | Ct chest spine w/o dye | 1.16 | 6.02 | NA | 0.31 | 7.49 | NA | XXX | ||||||||||||
| 72128 | 26 | A | Ct chest spine w/o dye | 1.16 | 0.41 | 0.41 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 72128 | TC | A | Ct chest spine w/o dye | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 72129 | A | Ct chest spine w/dye | 1.22 | 7.14 | NA | 0.36 | 8.72 | NA | XXX | ||||||||||||
| 72129 | 26 | A | Ct chest spine w/dye | 1.22 | 0.43 | 0.43 | 0.05 | 1.70 | 1.70 | XXX | |||||||||||
| 72129 | TC | A | Ct chest spine w/dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 72130 | A | Ct chest spine w/ow dye | 1.27 | 8.85 | NA | 0.44 | 10.56 | NA | XXX | ||||||||||||
| 72130 | 26 | A | Ct chest spine w/ow dye | 1.27 | 0.45 | 0.45 | 0.06 | 1.78 | 1.78 | XXX | |||||||||||
| 72130 | TC | A | Ct chest spine w/ow dye | 0.00 | 8.40 | NA | 0.38 | 8.78 | NA | XXX | |||||||||||
| 72131 | A | Ct lumbar spine w/o dye | 1.16 | 6.02 | NA | 0.31 | 7.49 | NA | XXX | ||||||||||||
| 72131 | 26 | A | Ct lumbar spine w/o dye | 1.16 | 0.41 | 0.41 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 72131 | TC | A | Ct lumbar spine w/o dye | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 72132 | A | Ct lumbar spine w/dye | 1.22 | 7.14 | NA | 0.37 | 8.73 | NA | XXX | ||||||||||||
| 72132 | 26 | A | Ct lumbar spine w/dye | 1.22 | 0.43 | 0.43 | 0.06 | 1.71 | 1.71 | XXX | |||||||||||
| 72132 | TC | A | Ct lumbar spine w/dye | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 72133 | A | Ct lumbar spine w/ow dye | 1.27 | 8.85 | NA | 0.44 | 10.56 | NA | XXX | ||||||||||||
| 72133 | 26 | A | Ct lumbar spine w/ow dye | 1.27 | 0.45 | 0.45 | 0.06 | 1.78 | 1.78 | XXX | |||||||||||
| 72133 | TC | A | Ct lumbar spine w/ow dye | 0.00 | 8.40 | NA | 0.38 | 8.78 | NA | XXX | |||||||||||
| 72141 | A | Mri neck spine w/o dye | 1.60 | 11.20 | NA | 0.56 | 13.36 | NA | XXX | ||||||||||||
| 72141 | 26 | A | Mri neck spine w/o dye | 1.60 | 0.56 | 0.56 | 0.07 | 2.23 | 2.23 | XXX | |||||||||||
| 72141 | TC | A | Mri neck spine w/o dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 72142 | A | Mri neck spine w/dye | 1.92 | 13.45 | NA | 0.67 | 16.04 | NA | XXX | ||||||||||||
| 72142 | 26 | A | Mri neck spine w/dye | 1.92 | 0.69 | 0.69 | 0.09 | 2.70 | 2.70 | XXX | |||||||||||
| 72142 | TC | A | Mri neck spine w/dye | 0.00 | 12.76 | NA | 0.58 | 13.34 | NA | XXX | |||||||||||
| 72146 | A | Mri chest spine w/o dye | 1.60 | 12.38 | NA | 0.60 | 14.58 | NA | XXX | ||||||||||||
| 72146 | 26 | A | Mri chest spine w/o dye | 1.60 | 0.56 | 0.56 | 0.07 | 2.23 | 2.23 | XXX | |||||||||||
| 72146 | TC | A | Mri chest spine w/o dye | 0.00 | 11.82 | NA | 0.53 | 12.35 | NA | XXX | |||||||||||
| 72147 | A | Mri chest spine w/dye | 1.92 | 13.44 | NA | 0.67 | 16.03 | NA | XXX | ||||||||||||
| 72147 | 26 | A | Mri chest spine w/dye | 1.92 | 0.68 | 0.68 | 0.09 | 2.69 | 2.69 | XXX | |||||||||||
| 72147 | TC | A | Mri chest spine w/dye | 0.00 | 12.76 | NA | 0.58 | 13.34 | NA | XXX | |||||||||||
| 72148 | A | Mri lumbar spine w/o dye | 1.48 | 12.34 | NA | 0.60 | 14.42 | NA | XXX | ||||||||||||
| 72148 | 26 | A | Mri lumbar spine w/o dye | 1.48 | 0.52 | 0.52 | 0.07 | 2.07 | 2.07 | XXX | |||||||||||
| 72148 | TC | A | Mri lumbar spine w/o dye | 0.00 | 11.82 | NA | 0.53 | 12.35 | NA | XXX | |||||||||||
| 72149 | A | Mri lumbar spine w/dye | 1.78 | 13.40 | NA | 0.67 | 15.85 | NA | XXX | ||||||||||||
| 72149 | 26 | A | Mri lumbar spine w/dye | 1.78 | 0.64 | 0.64 | 0.09 | 2.51 | 2.51 | XXX | |||||||||||
| 72149 | TC | A | Mri lumbar spine w/dye | 0.00 | 12.76 | NA | 0.58 | 13.34 | NA | XXX | |||||||||||
| 72156 | A | Mri neck spine w/ow dye | 2.57 | 24.55 | NA | 1.20 | 28.32 | NA | XXX | ||||||||||||
| 72156 | 26 | A | Mri neck spine w/ow dye | 2.57 | 0.91 | 0.91 | 0.11 | 3.59 | 3.59 | XXX | |||||||||||
| 72156 | TC | A | Mri neck spine w/ow dye | 0.00 | 23.64 | NA | 1.09 | 24.73 | NA | XXX | |||||||||||
| 72157 | A | Mri chest spine w/ow dye | 2.57 | 24.54 | NA | 1.20 | 28.31 | NA | XXX | ||||||||||||
| 72157 | 26 | A | Mri chest spine w/ow dye | 2.57 | 0.90 | 0.90 | 0.11 | 3.58 | 3.58 | XXX | |||||||||||
| 72157 | TC | A | Mri chest spine w/ow dye | 0.00 | 23.64 | NA | 1.09 | 24.73 | NA | XXX | |||||||||||
| 72158 | A | Mri lumbar spine w/ow dye | 2.36 | 24.47 | NA | 1.20 | 28.03 | NA | XXX | ||||||||||||
| 72158 | 26 | A | Mri lumbar spine w/ow dye | 2.36 | 0.83 | 0.83 | 0.11 | 3.30 | 3.30 | XXX | |||||||||||
| 72158 | TC | A | Mri lumbar spine w/ow dye | 0.00 | 23.64 | NA | 1.09 | 24.73 | NA | XXX | |||||||||||
| 72159 | N | Mr angio spine w/ow dye | +1.80 | 12.54 | NA | 0.61 | 14.95 | NA | XXX | ||||||||||||
| 72159 | 26 | N | Mr angio spine w/ow dye | +1.80 | 0.72 | 0.72 | 0.08 | 2.60 | 2.60 | XXX | |||||||||||
| 72159 | TC | N | Mr angio spine w/ow dye | +0.00 | 11.82 | NA | 0.53 | 12.35 | NA | XXX | |||||||||||
| 72170 | A | X-ray exam of pelvis | 0.17 | 0.56 | NA | 0.03 | 0.76 | NA | XXX | ||||||||||||
| 72170 | 26 | A | X-ray exam of pelvis | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 72170 | TC | A | X-ray exam of pelvis | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 72190 | A | X-ray exam of pelvis | 0.21 | 0.70 | NA | 0.04 | 0.95 | NA | XXX | ||||||||||||
| 72190 | 26 | A | X-ray exam of pelvis | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | XXX | |||||||||||
| 72190 | TC | A | X-ray exam of pelvis | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 72191 | A | Ct angiograph pelv w/ow dye | 1.81 | 8.78 | NA | 0.38 | 10.97 | NA | XXX | ||||||||||||
| 72191 | 26 | A | Ct angiograph pelv w/ow dye | 1.81 | 0.72 | 0.72 | 0.06 | 2.59 | 2.59 | XXX | |||||||||||
| 72191 | TC | A | Ct angiograph pelv w/ow dye | 0.00 | 8.06 | NA | 0.32 | 8.38 | NA | XXX | |||||||||||
| 72192 | A | Ct pelvis w/o dye | 1.09 | 5.99 | NA | 0.31 | 7.39 | NA | XXX | ||||||||||||
| 72192 | 26 | A | Ct pelvis w/o dye | 1.09 | 0.38 | 0.38 | 0.05 | 1.52 | 1.52 | XXX | |||||||||||
| 72192 | TC | A | Ct pelvis w/o dye | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 72193 | A | Ct pelvis w/dye | 1.16 | 6.91 | NA | 0.35 | 8.42 | NA | XXX | ||||||||||||
| 72193 | 26 | A | Ct pelvis w/dye | 1.16 | 0.41 | 0.41 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 72193 | TC | A | Ct pelvis w/dye | 0.00 | 6.50 | NA | 0.30 | 6.80 | NA | XXX | |||||||||||
| 72194 | A | Ct pelvis w/ow dye | 1.22 | 8.49 | NA | 0.41 | 10.12 | NA | XXX | ||||||||||||
| 72194 | 26 | A | Ct pelvis w/ow dye | 1.22 | 0.43 | 0.43 | 0.05 | 1.70 | 1.70 | XXX | |||||||||||
| 72194 | TC | A | Ct pelvis w/ow dye | 0.00 | 8.06 | NA | 0.36 | 8.42 | NA | XXX | |||||||||||
| 72195 | A | Mri pelvis w/o dye | 1.46 | 11.15 | NA | 0.42 | 13.03 | NA | XXX | ||||||||||||
| 72195 | 26 | A | Mri pelvis w/o dye | 1.46 | 0.51 | 0.51 | 0.05 | 2.02 | 2.02 | XXX | |||||||||||
| 72195 | TC | A | Mri pelvis w/o dye | 0.00 | 10.64 | NA | 0.37 | 11.01 | NA | XXX | |||||||||||
| 72196 | A | Mri pelvis w/dye | 1.73 | 13.36 | NA | 0.48 | 15.57 | NA | XXX | ||||||||||||
| 72196 | 26 | A | Mri pelvis w/dye | 1.73 | 0.60 | 0.60 | 0.05 | 2.38 | 2.38 | XXX | |||||||||||
| 72196 | TC | A | Mri pelvis w/dye | 0.00 | 12.76 | NA | 0.43 | 13.19 | NA | XXX | |||||||||||
| 72197 | A | Mri pelvis w/ow dye | 2.26 | 24.43 | NA | 0.84 | 27.53 | NA | XXX | ||||||||||||
| 72197 | 26 | A | Mri pelvis w/ow dye | 2.26 | 0.79 | 0.79 | 0.08 | 3.13 | 3.13 | XXX | |||||||||||
| 72197 | TC | A | Mri pelvis w/ow dye | 0.00 | 23.64 | NA | 0.76 | 24.40 | NA | XXX | |||||||||||
| 72198 | N | Mr angio pelvis w/ow dye | +1.80 | 11.36 | NA | 0.57 | 13.73 | NA | XXX | ||||||||||||
| 72198 | 26 | N | Mr angio pelvis w/ow dye | +1.80 | 0.72 | 0.72 | 0.08 | 2.60 | 2.60 | XXX | |||||||||||
| 72198 | TC | N | Mr angio pelvis w/ow dye | +0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 72200 | A | X-ray exam sacroiliac joints | 0.17 | 0.56 | NA | 0.03 | 0.76 | NA | XXX | ||||||||||||
| 72200 | 26 | A | X-ray exam sacroiliac joints | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 72200 | TC | A | X-ray exam sacroiliac joints | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 72202 | A | X-ray exam sacroiliac joints | 0.19 | 0.66 | NA | 0.04 | 0.89 | NA | XXX | ||||||||||||
| 72202 | 26 | A | X-ray exam sacroiliac joints | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX | |||||||||||
| 72202 | TC | A | X-ray exam sacroiliac joints | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 72220 | A | X-ray exam of tailbone | 0.17 | 0.60 | NA | 0.04 | 0.81 | NA | XXX | ||||||||||||
| 72220 | 26 | A | X-ray exam of tailbone | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 72220 | TC | A | X-ray exam of tailbone | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 72240 | A | Contrast x-ray of neck spine | 0.91 | 4.82 | NA | 0.25 | 5.98 | NA | XXX | ||||||||||||
| 72240 | 26 | A | Contrast x-ray of neck spine | 0.91 | 0.31 | 0.31 | 0.04 | 1.26 | 1.26 | XXX | |||||||||||
| 72240 | TC | A | Contrast x-ray of neck spine | 0.00 | 4.51 | NA | 0.21 | 4.72 | NA | XXX | |||||||||||
| 72255 | A | Contrast x-ray, thorax spine | 0.91 | 4.41 | NA | 0.22 | 5.54 | NA | XXX | ||||||||||||
| 72255 | 26 | A | Contrast x-ray, thorax spine | 0.91 | 0.30 | 0.30 | 0.04 | 1.25 | 1.25 | XXX | |||||||||||
| 72255 | TC | A | Contrast x-ray, thorax spine | 0.00 | 4.11 | NA | 0.18 | 4.29 | NA | XXX | |||||||||||
| 72265 | A | Contrast x-ray, lower spine | 0.83 | 4.15 | NA | 0.22 | 5.20 | NA | XXX | ||||||||||||
| 72265 | 26 | A | Contrast x-ray, lower spine | 0.83 | 0.28 | 0.28 | 0.04 | 1.15 | 1.15 | XXX | |||||||||||
| 72265 | TC | A | Contrast x-ray, lower spine | 0.00 | 3.87 | NA | 0.18 | 4.05 | NA | XXX | |||||||||||
| 72270 | A | Contrast x-ray of spine | 1.33 | 6.25 | NA | 0.34 | 7.92 | NA | XXX | ||||||||||||
| 72270 | 26 | A | Contrast x-ray of spine | 1.33 | 0.46 | 0.46 | 0.07 | 1.86 | 1.86 | XXX | |||||||||||
| 72270 | TC | A | Contrast x-ray of spine | 0.00 | 5.79 | NA | 0.27 | 6.06 | NA | XXX | |||||||||||
| 72275 | A | Epidurography | 0.76 | 2.20 | NA | 0.21 | 3.17 | NA | XXX | ||||||||||||
| 72275 | 26 | A | Epidurography | 0.76 | 0.21 | 0.21 | 0.03 | 1.00 | 1.00 | XXX | |||||||||||
| 72275 | TC | A | Epidurography | 0.00 | 1.99 | NA | 0.18 | 2.17 | NA | XXX | |||||||||||
| 72285 | A | X-ray c/t spine disk | 1.16 | 8.35 | NA | 0.42 | 9.93 | NA | XXX | ||||||||||||
| 72285 | 26 | A | X-ray c/t spine disk | 1.16 | 0.39 | 0.39 | 0.06 | 1.61 | 1.61 | XXX | |||||||||||
| 72285 | TC | A | X-ray c/t spine disk | 0.00 | 7.96 | NA | 0.36 | 8.32 | NA | XXX | |||||||||||
| 72295 | A | X-ray of lower spine disk | 0.83 | 7.76 | NA | 0.37 | 8.96 | NA | XXX | ||||||||||||
| 72295 | 26 | A | X-ray of lower spine disk | 0.83 | 0.29 | 0.29 | 0.04 | 1.16 | 1.16 | XXX | |||||||||||
| 72295 | TC | A | X-ray of lower spine disk | 0.00 | 7.47 | NA | 0.33 | 7.80 | NA | XXX | |||||||||||
| 73000 | A | X-ray exam of collar bone | 0.16 | 0.56 | NA | 0.03 | 0.75 | NA | XXX | ||||||||||||
| 73000 | 26 | A | X-ray exam of collar bone | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73000 | TC | A | X-ray exam of collar bone | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 73010 | A | X-ray exam of shoulder blade | 0.17 | 0.56 | NA | 0.03 | 0.76 | NA | XXX | ||||||||||||
| 73010 | 26 | A | X-ray exam of shoulder blade | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73010 | TC | A | X-ray exam of shoulder blade | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 73020 | A | X-ray exam of shoulder | 0.15 | 0.50 | NA | 0.03 | 0.68 | NA | XXX | ||||||||||||
| 73020 | 26 | A | X-ray exam of shoulder | 0.15 | 0.05 | 0.05 | 0.01 | 0.21 | 0.21 | XXX | |||||||||||
| 73020 | TC | A | X-ray exam of shoulder | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | |||||||||||
| 73030 | A | X-ray exam of shoulder | 0.18 | 0.60 | NA | 0.04 | 0.82 | NA | XXX | ||||||||||||
| 73030 | 26 | A | X-ray exam of shoulder | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 73030 | TC | A | X-ray exam of shoulder | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 73040 | A | Contrast x-ray of shoulder | 0.54 | 2.18 | NA | 0.13 | 2.85 | NA | XXX | ||||||||||||
| 73040 | 26 | A | Contrast x-ray of shoulder | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX | |||||||||||
| 73040 | TC | A | Contrast x-ray of shoulder | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 73050 | A | X-ray exam of shoulders | 0.20 | 0.70 | NA | 0.05 | 0.95 | NA | XXX | ||||||||||||
| 73050 | 26 | A | X-ray exam of shoulders | 0.20 | 0.07 | 0.07 | 0.02 | 0.29 | 0.29 | XXX | |||||||||||
| 73050 | TC | A | X-ray exam of shoulders | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 73060 | A | X-ray exam of humerus | 0.17 | 0.60 | NA | 0.04 | 0.81 | NA | XXX | ||||||||||||
| 73060 | 26 | A | X-ray exam of humerus | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73060 | TC | A | X-ray exam of humerus | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 73070 | A | X-ray exam of elbow | 0.15 | 0.55 | NA | 0.03 | 0.73 | NA | XXX | ||||||||||||
| 73070 | 26 | A | X-ray exam of elbow | 0.15 | 0.05 | 0.05 | 0.01 | 0.21 | 0.21 | XXX | |||||||||||
| 73070 | TC | A | X-ray exam of elbow | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 73080 | A | X-ray exam of elbow | 0.17 | 0.60 | NA | 0.04 | 0.81 | NA | XXX | ||||||||||||
| 73080 | 26 | A | X-ray exam of elbow | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73080 | TC | A | X-ray exam of elbow | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 73085 | A | Contrast x-ray of elbow | 0.54 | 2.19 | NA | 0.13 | 2.86 | NA | XXX | ||||||||||||
| 73085 | 26 | A | Contrast x-ray of elbow | 0.54 | 0.20 | 0.20 | 0.03 | 0.77 | 0.77 | XXX | |||||||||||
| 73085 | TC | A | Contrast x-ray of elbow | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 73090 | A | X-ray exam of forearm | 0.16 | 0.56 | NA | 0.03 | 0.75 | NA | XXX | ||||||||||||
| 73090 | 26 | A | X-ray exam of forearm | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73090 | TC | A | X-ray exam of forearm | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 73092 | A | X-ray exam of arm, infant | 0.16 | 0.53 | NA | 0.03 | 0.72 | NA | XXX | ||||||||||||
| 73092 | 26 | A | X-ray exam of arm, infant | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73092 | TC | A | X-ray exam of arm, infant | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 73100 | A | X-ray exam of wrist | 0.16 | 0.53 | NA | 0.04 | 0.73 | NA | XXX | ||||||||||||
| 73100 | 26 | A | X-ray exam of wrist | 0.16 | 0.06 | 0.06 | 0.02 | 0.24 | 0.24 | XXX | |||||||||||
| 73100 | TC | A | X-ray exam of wrist | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 73110 | A | X-ray exam of wrist | 0.17 | 0.57 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 73110 | 26 | A | X-ray exam of wrist | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73110 | TC | A | X-ray exam of wrist | 0.00 | 0.51 | NA | 0.02 | 0.53 | NA | XXX | |||||||||||
| 73115 | A | Contrast x-ray of wrist | 0.54 | 1.70 | NA | 0.11 | 2.35 | NA | XXX | ||||||||||||
| 73115 | 26 | A | Contrast x-ray of wrist | 0.54 | 0.20 | 0.20 | 0.03 | 0.77 | 0.77 | XXX | |||||||||||
| 73115 | TC | A | Contrast x-ray of wrist | 0.00 | 1.50 | NA | 0.08 | 1.58 | NA | XXX | |||||||||||
| 73120 | A | X-ray exam of hand | 0.16 | 0.53 | NA | 0.03 | 0.72 | NA | XXX | ||||||||||||
| 73120 | 26 | A | X-ray exam of hand | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73120 | TC | A | X-ray exam of hand | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 73130 | A | X-ray exam of hand | 0.17 | 0.57 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 73130 | 26 | A | X-ray exam of hand | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73130 | TC | A | X-ray exam of hand | 0.00 | 0.51 | NA | 0.02 | 0.53 | NA | XXX | |||||||||||
| 73140 | A | X-ray exam of finger(s) | 0.13 | 0.44 | NA | 0.03 | 0.60 | NA | XXX | ||||||||||||
| 73140 | 26 | A | X-ray exam of finger(s) | 0.13 | 0.05 | 0.05 | 0.01 | 0.19 | 0.19 | XXX | |||||||||||
| 73140 | TC | A | X-ray exam of finger(s) | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 73200 | A | Ct upper extremity w/o dye | 1.09 | 5.09 | NA | 0.26 | 6.44 | NA | XXX | ||||||||||||
| 73200 | 26 | A | Ct upper extremity w/o dye | 1.09 | 0.38 | 0.38 | 0.05 | 1.52 | 1.52 | XXX | |||||||||||
| 73200 | TC | A | Ct upper extremity w/o dye | 0.00 | 4.71 | NA | 0.21 | 4.92 | NA | XXX | |||||||||||
| 73201 | A | Ct upper extremity w/dye | 1.16 | 6.02 | NA | 0.31 | 7.49 | NA | XXX | ||||||||||||
| 73201 | 26 | A | Ct upper extremity w/dye | 1.16 | 0.41 | 0.41 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 73201 | TC | A | Ct upper extremity w/dye | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 73202 | A | Ct uppr extremity w/ow dye | 1.22 | 7.48 | NA | 0.38 | 9.08 | NA | XXX | ||||||||||||
| 73202 | 26 | A | Ct uppr extremity w/ow dye | 1.22 | 0.43 | 0.43 | 0.06 | 1.71 | 1.71 | XXX | |||||||||||
| 73202 | TC | A | Ct uppr extremity w/ow dye | 0.00 | 7.05 | NA | 0.32 | 7.37 | NA | XXX | |||||||||||
| 73206 | A | Ct angio upr extrm w/ow dye | 1.81 | 7.77 | NA | 0.38 | 9.96 | NA | XXX | ||||||||||||
| 73206 | 26 | A | Ct angio upr extrm w/ow dye | 1.81 | 0.72 | 0.72 | 0.06 | 2.59 | 2.59 | XXX | |||||||||||
| 73206 | TC | A | Ct angio upr extrm w/ow dye | 0.00 | 7.05 | NA | 0.32 | 7.37 | NA | XXX | |||||||||||
| 73218 | A | Mri upper extremity w/o dye | 1.35 | 11.11 | NA | 0.36 | 12.82 | NA | XXX | ||||||||||||
| 73218 | 26 | A | Mri upper extremity w/o dye | 1.35 | 0.47 | 0.47 | 0.04 | 1.86 | 1.86 | XXX | |||||||||||
| 73218 | TC | A | Mri upper extremity w/o dye | 0.00 | 10.64 | NA | 0.32 | 10.96 | NA | XXX | |||||||||||
| 73219 | A | Mri upper extremity w/dye | 1.62 | 13.33 | NA | 0.44 | 15.39 | NA | XXX | ||||||||||||
| 73219 | 26 | A | Mri upper extremity w/dye | 1.62 | 0.57 | 0.57 | 0.05 | 2.24 | 2.24 | XXX | |||||||||||
| 73219 | TC | A | Mri upper extremity w/dye | 0.00 | 12.76 | NA | 0.39 | 13.15 | NA | XXX | |||||||||||
| 73220 | A | Mri uppr extremity w/ow dye | 2.15 | 24.39 | NA | 0.78 | 27.32 | NA | XXX | ||||||||||||
| 73220 | 26 | A | Mri uppr extremity w/ow dye | 2.15 | 0.75 | 0.75 | 0.08 | 2.98 | 2.98 | XXX | |||||||||||
| 73220 | TC | A | Mri uppr extremity w/ow dye | 0.00 | 23.64 | NA | 0.70 | 24.34 | NA | XXX | |||||||||||
| 73221 | A | Mri joint upr extrem w/o dye | 1.35 | 11.11 | NA | 0.36 | 12.82 | NA | XXX | ||||||||||||
| 73221 | 26 | A | Mri joint upr extrem w/o dye | 1.35 | 0.47 | 0.47 | 0.04 | 1.86 | 1.86 | XXX | |||||||||||
| 73221 | TC | A | Mri joint upr extrem w/o dye | 0.00 | 10.64 | NA | 0.32 | 10.96 | NA | XXX | |||||||||||
| 73222 | A | Mri joint upr extrem w/dye | 1.62 | 13.33 | NA | 0.44 | 15.39 | NA | XXX | ||||||||||||
| 73222 | 26 | A | Mri joint upr extrem w/dye | 1.62 | 0.57 | 0.57 | 0.05 | 2.24 | 2.24 | XXX | |||||||||||
| 73222 | TC | A | Mri joint upr extrem w/dye | 0.00 | 12.76 | NA | 0.39 | 13.15 | NA | XXX | |||||||||||
| 73223 | A | Mri joint upr extr w/ow dye | 2.15 | 24.39 | NA | 0.77 | 27.31 | NA | XXX | ||||||||||||
| 73223 | 26 | A | Mri joint upr extr w/ow dye | 2.15 | 0.75 | 0.75 | 0.07 | 2.97 | 2.97 | XXX | |||||||||||
| 73223 | TC | A | Mri joint upr extr w/ow dye | 0.00 | 23.64 | NA | 0.70 | 24.34 | NA | XXX | |||||||||||
| 73225 | N | Mr angio upr extr w/ow dye | +1.73 | 11.33 | NA | 0.57 | 13.63 | NA | XXX | ||||||||||||
| 73225 | 26 | N | Mr angio upr extr w/ow dye | +1.73 | 0.69 | 0.69 | 0.08 | 2.50 | 2.50 | XXX | |||||||||||
| 73225 | TC | N | Mr angio upr extr w/ow dye | +0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 73500 | A | X-ray exam of hip | 0.17 | 0.51 | NA | 0.03 | 0.71 | NA | XXX | ||||||||||||
| 73500 | 26 | A | X-ray exam of hip | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73500 | TC | A | X-ray exam of hip | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | |||||||||||
| 73510 | A | X-ray exam of hip | 0.21 | 0.61 | NA | 0.05 | 0.87 | NA | XXX | ||||||||||||
| 73510 | 26 | A | X-ray exam of hip | 0.21 | 0.07 | 0.07 | 0.02 | 0.30 | 0.30 | XXX | |||||||||||
| 73510 | TC | A | X-ray exam of hip | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 73520 | A | X-ray exam of hips | 0.26 | 0.72 | NA | 0.05 | 1.03 | NA | XXX | ||||||||||||
| 73520 | 26 | A | X-ray exam of hips | 0.26 | 0.09 | 0.09 | 0.02 | 0.37 | 0.37 | XXX | |||||||||||
| 73520 | TC | A | X-ray exam of hips | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 73525 | A | Contrast x-ray of hip | 0.54 | 2.19 | NA | 0.13 | 2.86 | NA | XXX | ||||||||||||
| 73525 | 26 | A | Contrast x-ray of hip | 0.54 | 0.20 | 0.20 | 0.03 | 0.77 | 0.77 | XXX | |||||||||||
| 73525 | TC | A | Contrast x-ray of hip | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 73530 | A | X-ray exam of hip | 0.29 | 0.60 | NA | 0.03 | 0.92 | NA | XXX | ||||||||||||
| 73530 | 26 | A | X-ray exam of hip | 0.29 | 0.10 | 0.10 | 0.01 | 0.40 | 0.40 | XXX | |||||||||||
| 73530 | TC | A | X-ray exam of hip | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 73540 | A | X-ray exam of pelvis hips | 0.20 | 0.61 | NA | 0.05 | 0.86 | NA | XXX | ||||||||||||
| 73540 | 26 | A | X-ray exam of pelvis hips | 0.20 | 0.07 | 0.07 | 0.02 | 0.29 | 0.29 | XXX | |||||||||||
| 73540 | TC | A | X-ray exam of pelvis hips | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 73542 | A | X-ray exam, sacroiliac joint | 0.59 | 2.16 | NA | 0.13 | 2.88 | NA | XXX | ||||||||||||
| 73542 | 26 | A | X-ray exam, sacroiliac joint | 0.59 | 0.17 | 0.17 | 0.03 | 0.79 | 0.79 | XXX | |||||||||||
| 73542 | TC | A | X-ray exam, sacroiliac joint | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 73550 | A | X-ray exam of thigh | 0.17 | 0.60 | NA | 0.04 | 0.81 | NA | XXX | ||||||||||||
| 73550 | 26 | A | X-ray exam of thigh | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73550 | TC | A | X-ray exam of thigh | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 73560 | A | X-ray exam of knee, 1 or 2 | 0.17 | 0.56 | NA | 0.04 | 0.77 | NA | XXX | ||||||||||||
| 73560 | 26 | A | X-ray exam of knee, 1 or 2 | 0.17 | 0.06 | 0.06 | 0.02 | 0.25 | 0.25 | XXX | |||||||||||
| 73560 | TC | A | X-ray exam of knee, 1 or 2 | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 73562 | A | X-ray exam of knee, 3 | 0.18 | 0.60 | NA | 0.05 | 0.83 | NA | XXX | ||||||||||||
| 73562 | 26 | A | X-ray exam of knee, 3 | 0.18 | 0.06 | 0.06 | 0.02 | 0.26 | 0.26 | XXX | |||||||||||
| 73562 | TC | A | X-ray exam of knee, 3 | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 73564 | A | X-ray exam, knee, 4 or more | 0.22 | 0.67 | NA | 0.05 | 0.94 | NA | XXX | ||||||||||||
| 73564 | 26 | A | X-ray exam, knee, 4 or more | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX | |||||||||||
| 73564 | TC | A | X-ray exam, knee, 4 or more | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 73565 | A | X-ray exam of knees | 0.17 | 0.54 | NA | 0.04 | 0.75 | NA | XXX | ||||||||||||
| 73565 | 26 | A | X-ray exam of knees | 0.17 | 0.07 | 0.07 | 0.02 | 0.26 | 0.26 | XXX | |||||||||||
| 73565 | TC | A | X-ray exam of knees | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 73580 | A | Contrast x-ray of knee joint | 0.54 | 2.68 | NA | 0.15 | 3.37 | NA | XXX | ||||||||||||
| 73580 | 26 | A | Contrast x-ray of knee joint | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX | |||||||||||
| 73580 | TC | A | Contrast x-ray of knee joint | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 73590 | A | X-ray exam of lower leg | 0.17 | 0.56 | NA | 0.03 | 0.76 | NA | XXX | ||||||||||||
| 73590 | 26 | A | X-ray exam of lower leg | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73590 | TC | A | X-ray exam of lower leg | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 73592 | A | X-ray exam of leg, infant | 0.16 | 0.53 | NA | 0.03 | 0.72 | NA | XXX | ||||||||||||
| 73592 | 26 | A | X-ray exam of leg, infant | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73592 | TC | A | X-ray exam of leg, infant | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 73600 | A | X-ray exam of ankle | 0.16 | 0.53 | NA | 0.03 | 0.72 | NA | XXX | ||||||||||||
| 73600 | 26 | A | X-ray exam of ankle | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73600 | TC | A | X-ray exam of ankle | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 73610 | A | X-ray exam of ankle | 0.17 | 0.57 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 73610 | 26 | A | X-ray exam of ankle | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73610 | TC | A | X-ray exam of ankle | 0.00 | 0.51 | NA | 0.02 | 0.53 | NA | XXX | |||||||||||
| 73615 | A | Contrast x-ray of ankle | 0.54 | 2.18 | NA | 0.13 | 2.85 | NA | XXX | ||||||||||||
| 73615 | 26 | A | Contrast x-ray of ankle | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX | |||||||||||
| 73615 | TC | A | Contrast x-ray of ankle | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 73620 | A | X-ray exam of foot | 0.16 | 0.53 | NA | 0.03 | 0.72 | NA | XXX | ||||||||||||
| 73620 | 26 | A | X-ray exam of foot | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73620 | TC | A | X-ray exam of foot | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |||||||||||
| 73630 | A | X-ray exam of foot | 0.17 | 0.57 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 73630 | 26 | A | X-ray exam of foot | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 73630 | TC | A | X-ray exam of foot | 0.00 | 0.51 | NA | 0.02 | 0.53 | NA | XXX | |||||||||||
| 73650 | A | X-ray exam of heel | 0.16 | 0.51 | NA | 0.03 | 0.70 | NA | XXX | ||||||||||||
| 73650 | 26 | A | X-ray exam of heel | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 73650 | TC | A | X-ray exam of heel | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | |||||||||||
| 73660 | A | X-ray exam of toe(s) | 0.13 | 0.44 | NA | 0.03 | 0.60 | NA | XXX | ||||||||||||
| 73660 | 26 | A | X-ray exam of toe(s) | 0.13 | 0.05 | 0.05 | 0.01 | 0.19 | 0.19 | XXX | |||||||||||
| 73660 | TC | A | X-ray exam of toe(s) | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 73700 | A | Ct lower extremity w/o dye | 1.09 | 5.09 | NA | 0.26 | 6.44 | NA | XXX | ||||||||||||
| 73700 | 26 | A | Ct lower extremity w/o dye | 1.09 | 0.38 | 0.38 | 0.05 | 1.52 | 1.52 | XXX | |||||||||||
| 73700 | TC | A | Ct lower extremity w/o dye | 0.00 | 4.71 | NA | 0.21 | 4.92 | NA | XXX | |||||||||||
| 73701 | A | Ct lower extremity w/dye | 1.16 | 6.02 | NA | 0.31 | 7.49 | NA | XXX | ||||||||||||
| 73701 | 26 | A | Ct lower extremity w/dye | 1.16 | 0.41 | 0.41 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 73701 | TC | A | Ct lower extremity w/dye | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 73702 | A | Ct lwr extremity w/ow dye | 1.22 | 7.48 | NA | 0.37 | 9.07 | NA | XXX | ||||||||||||
| 73702 | 26 | A | Ct lwr extremity w/ow dye | 1.22 | 0.43 | 0.43 | 0.05 | 1.70 | 1.70 | XXX | |||||||||||
| 73702 | TC | A | Ct lwr extremity w/ow dye | 0.00 | 7.05 | NA | 0.32 | 7.37 | NA | XXX | |||||||||||
| 73706 | A | Ct angio lwr extr w/ow dye | 1.90 | 7.81 | NA | 0.38 | 10.09 | NA | XXX | ||||||||||||
| 73706 | 26 | A | Ct angio lwr extr w/ow dye | 1.90 | 0.76 | 0.76 | 0.06 | 2.72 | 2.72 | XXX | |||||||||||
| 73706 | TC | A | Ct angio lwr extr w/ow dye | 0.00 | 7.05 | NA | 0.32 | 7.37 | NA | XXX | |||||||||||
| 73718 | A | Mri lower extremity w/o dye | 1.35 | 11.11 | NA | 0.36 | 12.82 | NA | XXX | ||||||||||||
| 73718 | 26 | A | Mri lower extremity w/o dye | 1.35 | 0.47 | 0.47 | 0.04 | 1.86 | 1.86 | XXX | |||||||||||
| 73718 | TC | A | Mri lower extremity w/o dye | 0.00 | 10.64 | NA | 0.32 | 10.96 | NA | XXX | |||||||||||
| 73719 | A | Mri lower extremity w/dye | 1.62 | 13.32 | NA | 0.44 | 15.38 | NA | XXX | ||||||||||||
| 73719 | 26 | A | Mri lower extremity w/dye | 1.62 | 0.56 | 0.56 | 0.05 | 2.23 | 2.23 | XXX | |||||||||||
| 73719 | TC | A | Mri lower extremity w/dye | 0.00 | 12.76 | NA | 0.39 | 13.15 | NA | XXX | |||||||||||
| 73720 | A | Mri lwr extremity w/ow dye | 2.15 | 24.39 | NA | 0.78 | 27.32 | NA | XXX | ||||||||||||
| 73720 | 26 | A | Mri lwr extremity w/ow dye | 2.15 | 0.75 | 0.75 | 0.08 | 2.98 | 2.98 | XXX | |||||||||||
| 73720 | TC | A | Mri lwr extremity w/ow dye | 0.00 | 23.64 | NA | 0.70 | 24.34 | NA | XXX | |||||||||||
| 73721 | A | Mri joint of lwr extre w/o d | 1.35 | 11.11 | NA | 0.36 | 12.82 | NA | XXX | ||||||||||||
| 73721 | 26 | A | Mri joint of lwr extre w/o d | 1.35 | 0.47 | 0.47 | 0.04 | 1.86 | 1.86 | XXX | |||||||||||
| 73721 | TC | A | Mri joint of lwr extre w/o d | 0.00 | 10.64 | NA | 0.32 | 10.96 | NA | XXX | |||||||||||
| 73722 | A | Mri joint of lwr extr w/dye | 1.62 | 13.33 | NA | 0.45 | 15.40 | NA | XXX | ||||||||||||
| 73722 | 26 | A | Mri joint of lwr extr w/dye | 1.62 | 0.57 | 0.57 | 0.06 | 2.25 | 2.25 | XXX | |||||||||||
| 73722 | TC | A | Mri joint of lwr extr w/dye | 0.00 | 12.76 | NA | 0.39 | 13.15 | NA | XXX | |||||||||||
| 73723 | A | Mri joint lwr extr w/ow dye | 2.15 | 24.39 | NA | 0.77 | 27.31 | NA | XXX | ||||||||||||
| 73723 | 26 | A | Mri joint lwr extr w/ow dye | 2.15 | 0.75 | 0.75 | 0.07 | 2.97 | 2.97 | XXX | |||||||||||
| 73723 | TC | A | Mri joint lwr extr w/ow dye | 0.00 | 23.64 | NA | 0.70 | 24.34 | NA | XXX | |||||||||||
| 73725 | R | Mr ang lwr ext w or w/o dye | 1.82 | 11.28 | NA | 0.57 | 13.67 | NA | XXX | ||||||||||||
| 73725 | 26 | R | Mr ang lwr ext w or w/o dye | 1.82 | 0.64 | 0.64 | 0.08 | 2.54 | 2.54 | XXX | |||||||||||
| 73725 | TC | R | Mr ang lwr ext w or w/o dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 74000 | A | X-ray exam of abdomen | 0.18 | 0.56 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 74000 | 26 | A | X-ray exam of abdomen | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 74000 | TC | A | X-ray exam of abdomen | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 74010 | A | X-ray exam of abdomen | 0.23 | 0.62 | NA | 0.04 | 0.89 | NA | XXX | ||||||||||||
| 74010 | 26 | A | X-ray exam of abdomen | 0.23 | 0.08 | 0.08 | 0.01 | 0.32 | 0.32 | XXX | |||||||||||
| 74010 | TC | A | X-ray exam of abdomen | 0.00 | 0.54 | NA | 0.03 | 0.57 | NA | XXX | |||||||||||
| 74020 | A | X-ray exam of abdomen | 0.27 | 0.68 | NA | 0.04 | 0.99 | NA | XXX | ||||||||||||
| 74020 | 26 | A | X-ray exam of abdomen | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX | |||||||||||
| 74020 | TC | A | X-ray exam of abdomen | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |||||||||||
| 74022 | A | X-ray exam series, abdomen | 0.32 | 0.81 | NA | 0.05 | 1.18 | NA | XXX | ||||||||||||
| 74022 | 26 | A | X-ray exam series, abdomen | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX | |||||||||||
| 74022 | TC | A | X-ray exam series, abdomen | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX | |||||||||||
| 74150 | A | Ct abdomen w/o dye | 1.19 | 5.79 | NA | 0.30 | 7.28 | NA | XXX | ||||||||||||
| 74150 | 26 | A | Ct abdomen w/o dye | 1.19 | 0.42 | 0.42 | 0.05 | 1.66 | 1.66 | XXX | |||||||||||
| 74150 | TC | A | Ct abdomen w/o dye | 0.00 | 5.37 | NA | 0.25 | 5.62 | NA | XXX | |||||||||||
| 74160 | A | Ct abdomen w/dye | 1.27 | 6.94 | NA | 0.36 | 8.57 | NA | XXX | ||||||||||||
| 74160 | 26 | A | Ct abdomen w/dye | 1.27 | 0.44 | 0.44 | 0.06 | 1.77 | 1.77 | XXX | |||||||||||
| 74160 | TC | A | Ct abdomen w/dye | 0.00 | 6.50 | NA | 0.30 | 6.80 | NA | XXX | |||||||||||
| 74170 | A | Ct abdomen w/ow dye | 1.40 | 8.55 | NA | 0.42 | 10.37 | NA | XXX | ||||||||||||
| 74170 | 26 | A | Ct abdomen w/ow dye | 1.40 | 0.49 | 0.49 | 0.06 | 1.95 | 1.95 | XXX | |||||||||||
| 74170 | TC | A | Ct abdomen w/ow dye | 0.00 | 8.06 | NA | 0.36 | 8.42 | NA | XXX | |||||||||||
| 74175 | A | Ct angio abdom w/ow dye | 1.90 | 8.82 | NA | 0.38 | 11.10 | NA | XXX | ||||||||||||
| 74175 | 26 | A | Ct angio abdom w/ow dye | 1.90 | 0.76 | 0.76 | 0.06 | 2.72 | 2.72 | XXX | |||||||||||
| 74175 | TC | A | Ct angio abdom w/ow dye | 0.00 | 8.06 | NA | 0.32 | 8.38 | NA | XXX | |||||||||||
| 74181 | A | Mri abdomen w/o dye | 1.46 | 11.15 | NA | 0.41 | 13.02 | NA | XXX | ||||||||||||
| 74181 | 26 | A | Mri abdomen w/o dye | 1.46 | 0.51 | 0.51 | 0.04 | 2.01 | 2.01 | XXX | |||||||||||
| 74181 | TC | A | Mri abdomen w/o dye | 0.00 | 10.64 | NA | 0.37 | 11.01 | NA | XXX | |||||||||||
| 74182 | A | Mri abdomen w/dye | 1.73 | 13.36 | NA | 0.49 | 15.58 | NA | XXX | ||||||||||||
| 74182 | 26 | A | Mri abdomen w/dye | 1.73 | 0.60 | 0.60 | 0.06 | 2.39 | 2.39 | XXX | |||||||||||
| 74182 | TC | A | Mri abdomen w/dye | 0.00 | 12.76 | NA | 0.43 | 13.19 | NA | XXX | |||||||||||
| 74183 | A | Mri abdomen w/ow dye | 2.26 | 24.43 | NA | 0.84 | 27.53 | NA | XXX | ||||||||||||
| 74183 | 26 | A | Mri abdomen w/ow dye | 2.26 | 0.79 | 0.79 | 0.08 | 3.13 | 3.13 | XXX | |||||||||||
| 74183 | TC | A | Mri abdomen w/ow dye | 0.00 | 23.64 | NA | 0.76 | 24.40 | NA | XXX | |||||||||||
| 74185 | R | Mri angio, abdom w or w/o dy | 1.80 | 11.27 | NA | 0.57 | 13.64 | NA | XXX | ||||||||||||
| 74185 | 26 | R | Mri angio, abdom w or w/o dy | 1.80 | 0.63 | 0.63 | 0.08 | 2.51 | 2.51 | XXX | |||||||||||
| 74185 | TC | R | Mri angio, abdom w or w/o dy | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 74190 | A | X-ray exam of peritoneum | 0.48 | 1.41 | NA | 0.08 | 1.97 | NA | XXX | ||||||||||||
| 74190 | 26 | A | X-ray exam of peritoneum | 0.48 | 0.17 | 0.17 | 0.02 | 0.67 | 0.67 | XXX | |||||||||||
| 74190 | TC | A | X-ray exam of peritoneum | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 74210 | A | Contrst x-ray exam of throat | 0.36 | 1.26 | NA | 0.07 | 1.69 | NA | XXX | ||||||||||||
| 74210 | 26 | A | Contrst x-ray exam of throat | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX | |||||||||||
| 74210 | TC | A | Contrst x-ray exam of throat | 0.00 | 1.13 | NA | 0.05 | 1.18 | NA | XXX | |||||||||||
| 74220 | A | Contrast x-ray, esophagus | 0.46 | 1.29 | NA | 0.07 | 1.82 | NA | XXX | ||||||||||||
| 74220 | 26 | A | Contrast x-ray, esophagus | 0.46 | 0.16 | 0.16 | 0.02 | 0.64 | 0.64 | XXX | |||||||||||
| 74220 | TC | A | Contrast x-ray, esophagus | 0.00 | 1.13 | NA | 0.05 | 1.18 | NA | XXX | |||||||||||
| 74230 | A | Cine/video x-ray, throat/eso | 0.53 | 1.43 | NA | 0.08 | 2.04 | NA | XXX | ||||||||||||
| 74230 | 26 | A | Cine/video x-ray, throat/eso | 0.53 | 0.19 | 0.19 | 0.02 | 0.74 | 0.74 | XXX | |||||||||||
| 74230 | TC | A | Cine/video x-ray, throat/eso | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 74235 | A | Remove esophagus obstruction | 1.19 | 2.90 | NA | 0.17 | 4.26 | NA | XXX | ||||||||||||
| 74235 | 26 | A | Remove esophagus obstruction | 1.19 | 0.41 | 0.41 | 0.05 | 1.65 | 1.65 | XXX | |||||||||||
| 74235 | TC | A | Remove esophagus obstruction | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 74240 | A | X-ray exam, upper gi tract | 0.69 | 1.63 | NA | 0.10 | 2.42 | NA | XXX | ||||||||||||
| 74240 | 26 | A | X-ray exam, upper gi tract | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 74240 | TC | A | X-ray exam, upper gi tract | 0.00 | 1.39 | NA | 0.07 | 1.46 | NA | XXX | |||||||||||
| 74241 | A | X-ray exam, upper gi tract | 0.69 | 1.65 | NA | 0.10 | 2.44 | NA | XXX | ||||||||||||
| 74241 | 26 | A | X-ray exam, upper gi tract | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 74241 | TC | A | X-ray exam, upper gi tract | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX | |||||||||||
| 74245 | A | X-ray exam, upper gi tract | 0.91 | 2.58 | NA | 0.15 | 3.64 | NA | XXX | ||||||||||||
| 74245 | 26 | A | X-ray exam, upper gi tract | 0.91 | 0.32 | 0.32 | 0.04 | 1.27 | 1.27 | XXX | |||||||||||
| 74245 | TC | A | X-ray exam, upper gi tract | 0.00 | 2.26 | NA | 0.11 | 2.37 | NA | XXX | |||||||||||
| 74246 | A | Contrst x-ray uppr gi tract | 0.69 | 1.80 | NA | 0.11 | 2.60 | NA | XXX | ||||||||||||
| 74246 | 26 | A | Contrst x-ray uppr gi tract | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 74246 | TC | A | Contrst x-ray uppr gi tract | 0.00 | 1.56 | NA | 0.08 | 1.64 | NA | XXX | |||||||||||
| 74247 | A | Contrst x-ray uppr gi tract | 0.69 | 1.84 | NA | 0.12 | 2.65 | NA | XXX | ||||||||||||
| 74247 | 26 | A | Contrst x-ray uppr gi tract | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 74247 | TC | A | Contrst x-ray uppr gi tract | 0.00 | 1.60 | NA | 0.09 | 1.69 | NA | XXX | |||||||||||
| 74249 | A | Contrst x-ray uppr gi tract | 0.91 | 2.76 | NA | 0.16 | 3.83 | NA | XXX | ||||||||||||
| 74249 | 26 | A | Contrst x-ray uppr gi tract | 0.91 | 0.32 | 0.32 | 0.04 | 1.27 | 1.27 | XXX | |||||||||||
| 74249 | TC | A | Contrst x-ray uppr gi tract | 0.00 | 2.44 | NA | 0.12 | 2.56 | NA | XXX | |||||||||||
| 74250 | A | X-ray exam of small bowel | 0.47 | 1.40 | NA | 0.08 | 1.95 | NA | XXX | ||||||||||||
| 74250 | 26 | A | X-ray exam of small bowel | 0.47 | 0.16 | 0.16 | 0.02 | 0.65 | 0.65 | XXX | |||||||||||
| 74250 | TC | A | X-ray exam of small bowel | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 74251 | A | X-ray exam of small bowel | 0.69 | 1.48 | NA | 0.09 | 2.26 | NA | XXX | ||||||||||||
| 74251 | 26 | A | X-ray exam of small bowel | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 74251 | TC | A | X-ray exam of small bowel | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 74260 | A | X-ray exam of small bowel | 0.50 | 1.58 | NA | 0.09 | 2.17 | NA | XXX | ||||||||||||
| 74260 | 26 | A | X-ray exam of small bowel | 0.50 | 0.17 | 0.17 | 0.02 | 0.69 | 0.69 | XXX | |||||||||||
| 74260 | TC | A | X-ray exam of small bowel | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX | |||||||||||
| 74270 | A | Contrast x-ray exam of colon | 0.69 | 1.86 | NA | 0.12 | 2.67 | NA | XXX | ||||||||||||
| 74270 | 26 | A | Contrast x-ray exam of colon | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 74270 | TC | A | Contrast x-ray exam of colon | 0.00 | 1.62 | NA | 0.09 | 1.71 | NA | XXX | |||||||||||
| 74280 | A | Contrast x-ray exam of colon | 0.99 | 2.47 | NA | 0.15 | 3.61 | NA | XXX | ||||||||||||
| 74280 | 26 | A | Contrast x-ray exam of colon | 0.99 | 0.35 | 0.35 | 0.04 | 1.38 | 1.38 | XXX | |||||||||||
| 74280 | TC | A | Contrast x-ray exam of colon | 0.00 | 2.12 | NA | 0.11 | 2.23 | NA | XXX | |||||||||||
| 74283 | A | Contrast x-ray exam of colon | 2.02 | 3.14 | NA | 0.21 | 5.37 | NA | XXX | ||||||||||||
| 74283 | 26 | A | Contrast x-ray exam of colon | 2.02 | 0.71 | 0.71 | 0.09 | 2.82 | 2.82 | XXX | |||||||||||
| 74283 | TC | A | Contrast x-ray exam of colon | 0.00 | 2.43 | NA | 0.12 | 2.55 | NA | XXX | |||||||||||
| 74290 | A | Contrast x-ray, gallbladder | 0.32 | 0.81 | NA | 0.05 | 1.18 | NA | XXX | ||||||||||||
| 74290 | 26 | A | Contrast x-ray, gallbladder | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX | |||||||||||
| 74290 | TC | A | Contrast x-ray, gallbladder | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX | |||||||||||
| 74291 | A | Contrast x-rays, gallbladder | 0.20 | 0.46 | NA | 0.03 | 0.69 | NA | XXX | ||||||||||||
| 74291 | 26 | A | Contrast x-rays, gallbladder | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX | |||||||||||
| 74291 | TC | A | Contrast x-rays, gallbladder | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 74300 | C | X-ray bile ducts/pancreas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 74300 | 26 | A | X-ray bile ducts/pancreas | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX | |||||||||||
| 74300 | TC | C | X-ray bile ducts/pancreas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 74301 | C | X-rays at surgery add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 74301 | 26 | A | X-rays at surgery add-on | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | ZZZ | |||||||||||
| 74301 | TC | C | X-rays at surgery add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |||||||||||
| 74305 | A | X-ray bile ducts/pancreas | 0.42 | 0.89 | NA | 0.06 | 1.37 | NA | XXX | ||||||||||||
| 74305 | 26 | A | X-ray bile ducts/pancreas | 0.42 | 0.15 | 0.15 | 0.02 | 0.59 | 0.59 | XXX | |||||||||||
| 74305 | TC | A | X-ray bile ducts/pancreas | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 74320 | A | Contrast x-ray of bile ducts | 0.54 | 3.18 | NA | 0.16 | 3.88 | NA | XXX | ||||||||||||
| 74320 | 26 | A | Contrast x-ray of bile ducts | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 74320 | TC | A | Contrast x-ray of bile ducts | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74327 | A | X-ray bile stone removal | 0.70 | 1.91 | NA | 0.12 | 2.73 | NA | XXX | ||||||||||||
| 74327 | 26 | A | X-ray bile stone removal | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX | |||||||||||
| 74327 | TC | A | X-ray bile stone removal | 0.00 | 1.67 | NA | 0.09 | 1.76 | NA | XXX | |||||||||||
| 74328 | A | Xray bile duct endoscopy | 0.70 | 3.24 | NA | 0.17 | 4.11 | NA | XXX | ||||||||||||
| 74328 | 26 | A | Xray bile duct endoscopy | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 74328 | TC | A | Xray bile duct endoscopy | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74329 | A | X-ray for pancreas endoscopy | 0.70 | 3.24 | NA | 0.17 | 4.11 | NA | XXX | ||||||||||||
| 74329 | 26 | A | X-ray for pancreas endoscopy | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 74329 | TC | A | X-ray for pancreas endoscopy | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74330 | A | X-ray bile/panc endoscopy | 0.90 | 3.31 | NA | 0.18 | 4.39 | NA | XXX | ||||||||||||
| 74330 | 26 | A | X-ray bile/panc endoscopy | 0.90 | 0.32 | 0.32 | 0.04 | 1.26 | 1.26 | XXX | |||||||||||
| 74330 | TC | A | X-ray bile/panc endoscopy | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74340 | A | X-ray guide for GI tube | 0.54 | 2.68 | NA | 0.14 | 3.36 | NA | XXX | ||||||||||||
| 74340 | 26 | A | X-ray guide for GI tube | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 74340 | TC | A | X-ray guide for GI tube | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 74350 | A | X-ray guide, stomach tube | 0.76 | 3.26 | NA | 0.17 | 4.19 | NA | XXX | ||||||||||||
| 74350 | 26 | A | X-ray guide, stomach tube | 0.76 | 0.27 | 0.27 | 0.03 | 1.06 | 1.06 | XXX | |||||||||||
| 74350 | TC | A | X-ray guide, stomach tube | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74355 | A | X-ray guide, intestinal tube | 0.76 | 2.75 | NA | 0.15 | 3.66 | NA | XXX | ||||||||||||
| 74355 | 26 | A | X-ray guide, intestinal tube | 0.76 | 0.26 | 0.26 | 0.03 | 1.05 | 1.05 | XXX | |||||||||||
| 74355 | TC | A | X-ray guide, intestinal tube | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 74360 | A | X-ray guide, GI dilation | 0.54 | 3.18 | NA | 0.16 | 3.88 | NA | XXX | ||||||||||||
| 74360 | 26 | A | X-ray guide, GI dilation | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 74360 | TC | A | X-ray guide, GI dilation | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74363 | A | X-ray, bile duct dilation | 0.88 | 6.10 | NA | 0.31 | 7.29 | NA | XXX | ||||||||||||
| 74363 | 26 | A | X-ray, bile duct dilation | 0.88 | 0.31 | 0.31 | 0.04 | 1.23 | 1.23 | XXX | |||||||||||
| 74363 | TC | A | X-ray, bile duct dilation | 0.00 | 5.79 | NA | 0.27 | 6.06 | NA | XXX | |||||||||||
| 74400 | A | Contrst x-ray, urinary tract | 0.49 | 1.77 | NA | 0.11 | 2.37 | NA | XXX | ||||||||||||
| 74400 | 26 | A | Contrst x-ray, urinary tract | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX | |||||||||||
| 74400 | TC | A | Contrst x-ray, urinary tract | 0.00 | 1.60 | NA | 0.09 | 1.69 | NA | XXX | |||||||||||
| 74410 | A | Contrst x-ray, urinary tract | 0.49 | 2.02 | NA | 0.11 | 2.62 | NA | XXX | ||||||||||||
| 74410 | 26 | A | Contrst x-ray, urinary tract | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX | |||||||||||
| 74410 | TC | A | Contrst x-ray, urinary tract | 0.00 | 1.85 | NA | 0.09 | 1.94 | NA | XXX | |||||||||||
| 74415 | A | Contrst x-ray, urinary tract | 0.49 | 2.18 | NA | 0.12 | 2.79 | NA | XXX | ||||||||||||
| 74415 | 26 | A | Contrst x-ray, urinary tract | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX | |||||||||||
| 74415 | TC | A | Contrst x-ray, urinary tract | 0.00 | 2.01 | NA | 0.10 | 2.11 | NA | XXX | |||||||||||
| 74420 | A | Contrst x-ray, urinary tract | 0.36 | 2.62 | NA | 0.14 | 3.12 | NA | XXX | ||||||||||||
| 74420 | 26 | A | Contrst x-ray, urinary tract | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX | |||||||||||
| 74420 | TC | A | Contrst x-ray, urinary tract | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 74425 | A | Contrst x-ray, urinary tract | 0.36 | 1.37 | NA | 0.08 | 1.81 | NA | XXX | ||||||||||||
| 74425 | 26 | A | Contrst x-ray, urinary tract | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX | |||||||||||
| 74425 | TC | A | Contrst x-ray, urinary tract | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 74430 | A | Contrast x-ray, bladder | 0.32 | 1.11 | NA | 0.07 | 1.50 | NA | XXX | ||||||||||||
| 74430 | 26 | A | Contrast x-ray, bladder | 0.32 | 0.11 | 0.11 | 0.02 | 0.45 | 0.45 | XXX | |||||||||||
| 74430 | TC | A | Contrast x-ray, bladder | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 74440 | A | X-ray, male genital tract | 0.38 | 1.20 | NA | 0.07 | 1.65 | NA | XXX | ||||||||||||
| 74440 | 26 | A | X-ray, male genital tract | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX | |||||||||||
| 74440 | TC | A | X-ray, male genital tract | 0.00 | 1.07 | NA | 0.05 | 1.12 | NA | XXX | |||||||||||
| 74445 | A | X-ray exam of penis | 1.14 | 1.46 | NA | 0.10 | 2.70 | NA | XXX | ||||||||||||
| 74445 | 26 | A | X-ray exam of penis | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX | |||||||||||
| 74445 | TC | A | X-ray exam of penis | 0.00 | 1.07 | NA | 0.05 | 1.12 | NA | XXX | |||||||||||
| 74450 | A | X-ray, urethra/bladder | 0.33 | 1.51 | NA | 0.09 | 1.93 | NA | XXX | ||||||||||||
| 74450 | 26 | A | X-ray, urethra/bladder | 0.33 | 0.12 | 0.12 | 0.02 | 0.47 | 0.47 | XXX | |||||||||||
| 74450 | TC | A | X-ray, urethra/bladder | 0.00 | 1.39 | NA | 0.07 | 1.46 | NA | XXX | |||||||||||
| 74455 | A | X-ray, urethra/bladder | 0.33 | 1.61 | NA | 0.10 | 2.04 | NA | XXX | ||||||||||||
| 74455 | 26 | A | X-ray, urethra/bladder | 0.33 | 0.11 | 0.11 | 0.02 | 0.46 | 0.46 | XXX | |||||||||||
| 74455 | TC | A | X-ray, urethra/bladder | 0.00 | 1.50 | NA | 0.08 | 1.58 | NA | XXX | |||||||||||
| 74470 | A | X-ray exam of kidney lesion | 0.54 | 1.37 | NA | 0.08 | 1.99 | NA | XXX | ||||||||||||
| 74470 | 26 | A | X-ray exam of kidney lesion | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 74470 | TC | A | X-ray exam of kidney lesion | 0.00 | 1.18 | NA | 0.06 | 1.24 | NA | XXX | |||||||||||
| 74475 | A | X-ray control, cath insert | 0.54 | 4.06 | NA | 0.20 | 4.80 | NA | XXX | ||||||||||||
| 74475 | 26 | A | X-ray control, cath insert | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 74475 | TC | A | X-ray control, cath insert | 0.00 | 3.87 | NA | 0.18 | 4.05 | NA | XXX | |||||||||||
| 74480 | A | X-ray control, cath insert | 0.54 | 4.06 | NA | 0.20 | 4.80 | NA | XXX | ||||||||||||
| 74480 | 26 | A | X-ray control, cath insert | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 74480 | TC | A | X-ray control, cath insert | 0.00 | 3.87 | NA | 0.18 | 4.05 | NA | XXX | |||||||||||
| 74485 | A | X-ray guide, GU dilation | 0.54 | 3.18 | NA | 0.17 | 3.89 | NA | XXX | ||||||||||||
| 74485 | 26 | A | X-ray guide, GU dilation | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX | |||||||||||
| 74485 | TC | A | X-ray guide, GU dilation | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74710 | A | X-ray measurement of pelvis | 0.34 | 1.12 | NA | 0.07 | 1.53 | NA | XXX | ||||||||||||
| 74710 | 26 | A | X-ray measurement of pelvis | 0.34 | 0.12 | 0.12 | 0.02 | 0.48 | 0.48 | XXX | |||||||||||
| 74710 | TC | A | X-ray measurement of pelvis | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 74740 | A | X-ray, female genital tract | 0.38 | 1.37 | NA | 0.08 | 1.83 | NA | XXX | ||||||||||||
| 74740 | 26 | A | X-ray, female genital tract | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX | |||||||||||
| 74740 | TC | A | X-ray, female genital tract | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 74742 | A | X-ray, fallopian tube | 0.61 | 3.23 | NA | 0.16 | 4.00 | NA | XXX | ||||||||||||
| 74742 | 26 | A | X-ray, fallopian tube | 0.61 | 0.24 | 0.24 | 0.02 | 0.87 | 0.87 | XXX | |||||||||||
| 74742 | TC | A | X-ray, fallopian tube | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 74775 | A | X-ray exam of perineum | 0.62 | 1.62 | NA | 0.10 | 2.34 | NA | XXX | ||||||||||||
| 74775 | 26 | A | X-ray exam of perineum | 0.62 | 0.23 | 0.23 | 0.03 | 0.88 | 0.88 | XXX | |||||||||||
| 74775 | TC | A | X-ray exam of perineum | 0.00 | 1.39 | NA | 0.07 | 1.46 | NA | XXX | |||||||||||
| 75552 | A | Heart mri for morph w/o dye | 1.60 | 11.20 | NA | 0.56 | 13.36 | NA | XXX | ||||||||||||
| 75552 | 26 | A | Heart mri for morph w/o dye | 1.60 | 0.56 | 0.56 | 0.07 | 2.23 | 2.23 | XXX | |||||||||||
| 75552 | TC | A | Heart mri for morph w/o dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 75553 | A | Heart mri for morph w/dye | 2.00 | 11.35 | NA | 0.58 | 13.93 | NA | XXX | ||||||||||||
| 75553 | 26 | A | Heart mri for morph w/dye | 2.00 | 0.71 | 0.71 | 0.09 | 2.80 | 2.80 | XXX | |||||||||||
| 75553 | TC | A | Heart mri for morph w/dye | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 75554 | A | Cardiac MRI/function | 1.83 | 11.33 | NA | 0.56 | 13.72 | NA | XXX | ||||||||||||
| 75554 | 26 | A | Cardiac MRI/function | 1.83 | 0.69 | 0.69 | 0.07 | 2.59 | 2.59 | XXX | |||||||||||
| 75554 | TC | A | Cardiac MRI/function | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 75555 | A | Cardiac MRI/limited study | 1.74 | 11.32 | NA | 0.56 | 13.62 | NA | XXX | ||||||||||||
| 75555 | 26 | A | Cardiac MRI/limited study | 1.74 | 0.68 | 0.68 | 0.07 | 2.49 | 2.49 | XXX | |||||||||||
| 75555 | TC | A | Cardiac MRI/limited study | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 75556 | N | Cardiac MRI/flow mapping | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 75600 | A | Contrast x-ray exam of aorta | 0.49 | 12.16 | NA | 0.56 | 13.21 | NA | XXX | ||||||||||||
| 75600 | 26 | A | Contrast x-ray exam of aorta | 0.49 | 0.20 | 0.20 | 0.02 | 0.71 | 0.71 | XXX | |||||||||||
| 75600 | TC | A | Contrast x-ray exam of aorta | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75605 | A | Contrast x-ray exam of aorta | 1.14 | 12.39 | NA | 0.59 | 14.12 | NA | XXX | ||||||||||||
| 75605 | 26 | A | Contrast x-ray exam of aorta | 1.14 | 0.43 | 0.43 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 75605 | TC | A | Contrast x-ray exam of aorta | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75625 | A | Contrast x-ray exam of aorta | 1.14 | 12.37 | NA | 0.59 | 14.10 | NA | XXX | ||||||||||||
| 75625 | 26 | A | Contrast x-ray exam of aorta | 1.14 | 0.41 | 0.41 | 0.05 | 1.60 | 1.60 | XXX | |||||||||||
| 75625 | TC | A | Contrast x-ray exam of aorta | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75630 | A | X-ray aorta, leg arteries | 1.79 | 13.14 | NA | 0.65 | 15.58 | NA | XXX | ||||||||||||
| 75630 | 26 | A | X-ray aorta, leg arteries | 1.79 | 0.67 | 0.67 | 0.08 | 2.54 | 2.54 | XXX | |||||||||||
| 75630 | TC | A | X-ray aorta, leg arteries | 0.00 | 12.47 | NA | 0.57 | 13.04 | NA | XXX | |||||||||||
| 75635 | A | Ct angio abdominal arteries | 2.40 | 9.02 | NA | 0.41 | 11.83 | NA | XXX | ||||||||||||
| 75635 | 26 | A | Ct angio abdominal arteries | 2.40 | 0.96 | 0.96 | 0.09 | 3.45 | 3.45 | XXX | |||||||||||
| 75635 | TC | A | Ct angio abdominal arteries | 0.00 | 8.06 | NA | 0.32 | 8.38 | NA | XXX | |||||||||||
| 75650 | A | Artery x-rays, head neck | 1.49 | 12.49 | NA | 0.61 | 14.59 | NA | XXX | ||||||||||||
| 75650 | 26 | A | Artery x-rays, head neck | 1.49 | 0.53 | 0.53 | 0.07 | 2.09 | 2.09 | XXX | |||||||||||
| 75650 | TC | A | Artery x-rays, head neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75658 | A | Artery x-rays, arm | 1.31 | 12.44 | NA | 0.60 | 14.35 | NA | XXX | ||||||||||||
| 75658 | 26 | A | Artery x-rays, arm | 1.31 | 0.48 | 0.48 | 0.06 | 1.85 | 1.85 | XXX | |||||||||||
| 75658 | TC | A | Artery x-rays, arm | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75660 | A | Artery x-rays, head neck | 1.31 | 12.44 | NA | 0.60 | 14.35 | NA | XXX | ||||||||||||
| 75660 | 26 | A | Artery x-rays, head neck | 1.31 | 0.48 | 0.48 | 0.06 | 1.85 | 1.85 | XXX | |||||||||||
| 75660 | TC | A | Artery x-rays, head neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75662 | A | Artery x-rays, head neck | 1.66 | 12.60 | NA | 0.62 | 14.88 | NA | XXX | ||||||||||||
| 75662 | 26 | A | Artery x-rays, head neck | 1.66 | 0.64 | 0.64 | 0.08 | 2.38 | 2.38 | XXX | |||||||||||
| 75662 | TC | A | Artery x-rays, head neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75665 | A | Artery x-rays, head neck | 1.31 | 12.43 | NA | 0.61 | 14.35 | NA | XXX | ||||||||||||
| 75665 | 26 | A | Artery x-rays, head neck | 1.31 | 0.47 | 0.47 | 0.07 | 1.85 | 1.85 | XXX | |||||||||||
| 75665 | TC | A | Artery x-rays, head neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75671 | A | Artery x-rays, head neck | 1.66 | 12.55 | NA | 0.62 | 14.83 | NA | XXX | ||||||||||||
| 75671 | 26 | A | Artery x-rays, head neck | 1.66 | 0.59 | 0.59 | 0.08 | 2.33 | 2.33 | XXX | |||||||||||
| 75671 | TC | A | Artery x-rays, head neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75676 | A | Artery x-rays, neck | 1.31 | 12.43 | NA | 0.61 | 14.35 | NA | XXX | ||||||||||||
| 75676 | 26 | A | Artery x-rays, neck | 1.31 | 0.47 | 0.47 | 0.07 | 1.85 | 1.85 | XXX | |||||||||||
| 75676 | TC | A | Artery x-rays, neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75680 | A | Artery x-rays, neck | 1.66 | 12.55 | NA | 0.62 | 14.83 | NA | XXX | ||||||||||||
| 75680 | 26 | A | Artery x-rays, neck | 1.66 | 0.59 | 0.59 | 0.08 | 2.33 | 2.33 | XXX | |||||||||||
| 75680 | TC | A | Artery x-rays, neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75685 | A | Artery x-rays, spine | 1.31 | 12.43 | NA | 0.60 | 14.34 | NA | XXX | ||||||||||||
| 75685 | 26 | A | Artery x-rays, spine | 1.31 | 0.47 | 0.47 | 0.06 | 1.84 | 1.84 | XXX | |||||||||||
| 75685 | TC | A | Artery x-rays, spine | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75705 | A | Artery x-rays, spine | 2.18 | 12.75 | NA | 0.65 | 15.58 | NA | XXX | ||||||||||||
| 75705 | 26 | A | Artery x-rays, spine | 2.18 | 0.79 | 0.79 | 0.11 | 3.08 | 3.08 | XXX | |||||||||||
| 75705 | TC | A | Artery x-rays, spine | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75710 | A | Artery x-rays, arm/leg | 1.14 | 12.38 | NA | 0.60 | 14.12 | NA | XXX | ||||||||||||
| 75710 | 26 | A | Artery x-rays, arm/leg | 1.14 | 0.42 | 0.42 | 0.06 | 1.62 | 1.62 | XXX | |||||||||||
| 75710 | TC | A | Artery x-rays, arm/leg | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75716 | A | Artery x-rays, arms/legs | 1.31 | 12.43 | NA | 0.60 | 14.34 | NA | XXX | ||||||||||||
| 75716 | 26 | A | Artery x-rays, arms/legs | 1.31 | 0.47 | 0.47 | 0.06 | 1.84 | 1.84 | XXX | |||||||||||
| 75716 | TC | A | Artery x-rays, arms/legs | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75722 | A | Artery x-rays, kidney | 1.14 | 12.39 | NA | 0.59 | 14.12 | NA | XXX | ||||||||||||
| 75722 | 26 | A | Artery x-rays, kidney | 1.14 | 0.43 | 0.43 | 0.05 | 1.62 | 1.62 | XXX | |||||||||||
| 75722 | TC | A | Artery x-rays, kidney | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75724 | A | Artery x-rays, kidneys | 1.49 | 12.56 | NA | 0.59 | 14.64 | NA | XXX | ||||||||||||
| 75724 | 26 | A | Artery x-rays, kidneys | 1.49 | 0.60 | 0.60 | 0.05 | 2.14 | 2.14 | XXX | |||||||||||
| 75724 | TC | A | Artery x-rays, kidneys | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75726 | A | Artery x-rays, abdomen | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75726 | 26 | A | Artery x-rays, abdomen | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75726 | TC | A | Artery x-rays, abdomen | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75731 | A | Artery x-rays, adrenal gland | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75731 | 26 | A | Artery x-rays, adrenal gland | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75731 | TC | A | Artery x-rays, adrenal gland | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75733 | A | Artery x-rays, adrenals | 1.31 | 12.43 | NA | 0.60 | 14.34 | NA | XXX | ||||||||||||
| 75733 | 26 | A | Artery x-rays, adrenals | 1.31 | 0.47 | 0.47 | 0.06 | 1.84 | 1.84 | XXX | |||||||||||
| 75733 | TC | A | Artery x-rays, adrenals | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75736 | A | Artery x-rays, pelvis | 1.14 | 12.37 | NA | 0.59 | 14.10 | NA | XXX | ||||||||||||
| 75736 | 26 | A | Artery x-rays, pelvis | 1.14 | 0.41 | 0.41 | 0.05 | 1.60 | 1.60 | XXX | |||||||||||
| 75736 | TC | A | Artery x-rays, pelvis | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75741 | A | Artery x-rays, lung | 1.31 | 12.42 | NA | 0.60 | 14.33 | NA | XXX | ||||||||||||
| 75741 | 26 | A | Artery x-rays, lung | 1.31 | 0.46 | 0.46 | 0.06 | 1.83 | 1.83 | XXX | |||||||||||
| 75741 | TC | A | Artery x-rays, lung | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75743 | A | Artery x-rays, lungs | 1.66 | 12.54 | NA | 0.61 | 14.81 | NA | XXX | ||||||||||||
| 75743 | 26 | A | Artery x-rays, lungs | 1.66 | 0.58 | 0.58 | 0.07 | 2.31 | 2.31 | XXX | |||||||||||
| 75743 | TC | A | Artery x-rays, lungs | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75746 | A | Artery x-rays, lung | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75746 | 26 | A | Artery x-rays, lung | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75746 | TC | A | Artery x-rays, lung | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75756 | A | Artery x-rays, chest | 1.14 | 12.44 | NA | 0.58 | 14.16 | NA | XXX | ||||||||||||
| 75756 | 26 | A | Artery x-rays, chest | 1.14 | 0.48 | 0.48 | 0.04 | 1.66 | 1.66 | XXX | |||||||||||
| 75756 | TC | A | Artery x-rays, chest | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75774 | A | Artery x-ray, each vessel | 0.36 | 12.09 | NA | 0.56 | 13.01 | NA | ZZZ | ||||||||||||
| 75774 | 26 | A | Artery x-ray, each vessel | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | ZZZ | |||||||||||
| 75774 | TC | A | Artery x-ray, each vessel | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | ZZZ | |||||||||||
| 75790 | A | Visualize A-V shunt | 1.84 | 1.93 | NA | 0.16 | 3.93 | NA | XXX | ||||||||||||
| 75790 | 26 | A | Visualize A-V shunt | 1.84 | 0.64 | 0.64 | 0.09 | 2.57 | 2.57 | XXX | |||||||||||
| 75790 | TC | A | Visualize A-V shunt | 0.00 | 1.29 | NA | 0.07 | 1.36 | NA | XXX | |||||||||||
| 75801 | A | Lymph vessel x-ray, arm/leg | 0.81 | 5.42 | NA | 0.29 | 6.52 | NA | XXX | ||||||||||||
| 75801 | 26 | A | Lymph vessel x-ray, arm/leg | 0.81 | 0.28 | 0.28 | 0.05 | 1.14 | 1.14 | XXX | |||||||||||
| 75801 | TC | A | Lymph vessel x-ray, arm/leg | 0.00 | 5.14 | NA | 0.24 | 5.38 | NA | XXX | |||||||||||
| 75803 | A | Lymph vessel x-ray,arms/legs | 1.17 | 5.55 | NA | 0.29 | 7.01 | NA | XXX | ||||||||||||
| 75803 | 26 | A | Lymph vessel x-ray,arms/legs | 1.17 | 0.41 | 0.41 | 0.05 | 1.63 | 1.63 | XXX | |||||||||||
| 75803 | TC | A | Lymph vessel x-ray,arms/legs | 0.00 | 5.14 | NA | 0.24 | 5.38 | NA | XXX | |||||||||||
| 75805 | A | Lymph vessel x-ray, trunk | 0.81 | 6.08 | NA | 0.31 | 7.20 | NA | XXX | ||||||||||||
| 75805 | 26 | A | Lymph vessel x-ray, trunk | 0.81 | 0.29 | 0.29 | 0.04 | 1.14 | 1.14 | XXX | |||||||||||
| 75805 | TC | A | Lymph vessel x-ray, trunk | 0.00 | 5.79 | NA | 0.27 | 6.06 | NA | XXX | |||||||||||
| 75807 | A | Lymph vessel x-ray, trunk | 1.17 | 6.20 | NA | 0.32 | 7.69 | NA | XXX | ||||||||||||
| 75807 | 26 | A | Lymph vessel x-ray, trunk | 1.17 | 0.41 | 0.41 | 0.05 | 1.63 | 1.63 | XXX | |||||||||||
| 75807 | TC | A | Lymph vessel x-ray, trunk | 0.00 | 5.79 | NA | 0.27 | 6.06 | NA | XXX | |||||||||||
| 75809 | A | Nonvascular shunt, x-ray | 0.47 | 0.91 | NA | 0.06 | 1.44 | NA | XXX | ||||||||||||
| 75809 | 26 | A | Nonvascular shunt, x-ray | 0.47 | 0.17 | 0.17 | 0.02 | 0.66 | 0.66 | XXX | |||||||||||
| 75809 | TC | A | Nonvascular shunt, x-ray | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 75810 | A | Vein x-ray, spleen/liver | 1.14 | 12.36 | NA | 0.60 | 14.10 | NA | XXX | ||||||||||||
| 75810 | 26 | A | Vein x-ray, spleen/liver | 1.14 | 0.40 | 0.40 | 0.06 | 1.60 | 1.60 | XXX | |||||||||||
| 75810 | TC | A | Vein x-ray, spleen/liver | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75820 | A | Vein x-ray, arm/leg | 0.70 | 1.15 | NA | 0.08 | 1.93 | NA | XXX | ||||||||||||
| 75820 | 26 | A | Vein x-ray, arm/leg | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 75820 | TC | A | Vein x-ray, arm/leg | 0.00 | 0.90 | NA | 0.05 | 0.95 | NA | XXX | |||||||||||
| 75822 | A | Vein x-ray, arms/legs | 1.06 | 1.77 | NA | 0.12 | 2.95 | NA | XXX | ||||||||||||
| 75822 | 26 | A | Vein x-ray, arms/legs | 1.06 | 0.37 | 0.37 | 0.05 | 1.48 | 1.48 | XXX | |||||||||||
| 75822 | TC | A | Vein x-ray, arms/legs | 0.00 | 1.40 | NA | 0.07 | 1.47 | NA | XXX | |||||||||||
| 75825 | A | Vein x-ray, trunk | 1.14 | 12.36 | NA | 0.60 | 14.10 | NA | XXX | ||||||||||||
| 75825 | 26 | A | Vein x-ray, trunk | 1.14 | 0.40 | 0.40 | 0.06 | 1.60 | 1.60 | XXX | |||||||||||
| 75825 | TC | A | Vein x-ray, trunk | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75827 | A | Vein x-ray, chest | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75827 | 26 | A | Vein x-ray, chest | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75827 | TC | A | Vein x-ray, chest | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75831 | A | Vein x-ray, kidney | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75831 | 26 | A | Vein x-ray, kidney | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75831 | TC | A | Vein x-ray, kidney | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75833 | A | Vein x-ray, kidneys | 1.49 | 12.49 | NA | 0.61 | 14.59 | NA | XXX | ||||||||||||
| 75833 | 26 | A | Vein x-ray, kidneys | 1.49 | 0.53 | 0.53 | 0.07 | 2.09 | 2.09 | XXX | |||||||||||
| 75833 | TC | A | Vein x-ray, kidneys | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75840 | A | Vein x-ray, adrenal gland | 1.14 | 12.38 | NA | 0.61 | 14.13 | NA | XXX | ||||||||||||
| 75840 | 26 | A | Vein x-ray, adrenal gland | 1.14 | 0.42 | 0.42 | 0.07 | 1.63 | 1.63 | XXX | |||||||||||
| 75840 | TC | A | Vein x-ray, adrenal gland | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75842 | A | Vein x-ray, adrenal glands | 1.49 | 12.48 | NA | 0.61 | 14.58 | NA | XXX | ||||||||||||
| 75842 | 26 | A | Vein x-ray, adrenal glands | 1.49 | 0.52 | 0.52 | 0.07 | 2.08 | 2.08 | XXX | |||||||||||
| 75842 | TC | A | Vein x-ray, adrenal glands | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75860 | A | Vein x-ray, neck | 1.14 | 12.39 | NA | 0.60 | 14.13 | NA | XXX | ||||||||||||
| 75860 | 26 | A | Vein x-ray, neck | 1.14 | 0.43 | 0.43 | 0.06 | 1.63 | 1.63 | XXX | |||||||||||
| 75860 | TC | A | Vein x-ray, neck | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75870 | A | Vein x-ray, skull | 1.14 | 12.38 | NA | 0.60 | 14.12 | NA | XXX | ||||||||||||
| 75870 | 26 | A | Vein x-ray, skull | 1.14 | 0.42 | 0.42 | 0.06 | 1.62 | 1.62 | XXX | |||||||||||
| 75870 | TC | A | Vein x-ray, skull | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75872 | A | Vein x-ray, skull | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75872 | 26 | A | Vein x-ray, skull | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75872 | TC | A | Vein x-ray, skull | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75880 | A | Vein x-ray, eye socket | 0.70 | 1.17 | NA | 0.08 | 1.95 | NA | XXX | ||||||||||||
| 75880 | 26 | A | Vein x-ray, eye socket | 0.70 | 0.27 | 0.27 | 0.03 | 1.00 | 1.00 | XXX | |||||||||||
| 75880 | TC | A | Vein x-ray, eye socket | 0.00 | 0.90 | NA | 0.05 | 0.95 | NA | XXX | |||||||||||
| 75885 | A | Vein x-ray, liver | 1.44 | 12.46 | NA | 0.60 | 14.50 | NA | XXX | ||||||||||||
| 75885 | 26 | A | Vein x-ray, liver | 1.44 | 0.50 | 0.50 | 0.06 | 2.00 | 2.00 | XXX | |||||||||||
| 75885 | TC | A | Vein x-ray, liver | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75887 | A | Vein x-ray, liver | 1.44 | 12.46 | NA | 0.60 | 14.50 | NA | XXX | ||||||||||||
| 75887 | 26 | A | Vein x-ray, liver | 1.44 | 0.50 | 0.50 | 0.06 | 2.00 | 2.00 | XXX | |||||||||||
| 75887 | TC | A | Vein x-ray, liver | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75889 | A | Vein x-ray, liver | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75889 | 26 | A | Vein x-ray, liver | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75889 | TC | A | Vein x-ray, liver | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75891 | A | Vein x-ray, liver | 1.14 | 12.36 | NA | 0.59 | 14.09 | NA | XXX | ||||||||||||
| 75891 | 26 | A | Vein x-ray, liver | 1.14 | 0.40 | 0.40 | 0.05 | 1.59 | 1.59 | XXX | |||||||||||
| 75891 | TC | A | Vein x-ray, liver | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75893 | A | Venous sampling by catheter | 0.54 | 12.15 | NA | 0.56 | 13.25 | NA | XXX | ||||||||||||
| 75893 | 26 | A | Venous sampling by catheter | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 75893 | TC | A | Venous sampling by catheter | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75894 | A | X-rays, transcath therapy | 1.31 | 23.38 | NA | 1.12 | 25.81 | NA | XXX | ||||||||||||
| 75894 | 26 | A | X-rays, transcath therapy | 1.31 | 0.46 | 0.46 | 0.07 | 1.84 | 1.84 | XXX | |||||||||||
| 75894 | TC | A | X-rays, transcath therapy | 0.00 | 22.92 | NA | 1.05 | 23.97 | NA | XXX | |||||||||||
| 75896 | A | X-rays, transcath therapy | 1.31 | 20.42 | NA | 0.97 | 22.70 | NA | XXX | ||||||||||||
| 75896 | 26 | A | X-rays, transcath therapy | 1.31 | 0.48 | 0.48 | 0.06 | 1.85 | 1.85 | XXX | |||||||||||
| 75896 | TC | A | X-rays, transcath therapy | 0.00 | 19.94 | NA | 0.91 | 20.85 | NA | XXX | |||||||||||
| 75898 | A | Follow-up angiography | 1.65 | 1.60 | NA | 0.12 | 3.37 | NA | XXX | ||||||||||||
| 75898 | 26 | A | Follow-up angiography | 1.65 | 0.60 | 0.60 | 0.07 | 2.32 | 2.32 | XXX | |||||||||||
| 75898 | TC | A | Follow-up angiography | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 75900 | A | Arterial catheter exchange | 0.49 | 20.09 | NA | 0.94 | 21.52 | NA | XXX | ||||||||||||
| 75900 | 26 | A | Arterial catheter exchange | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX | |||||||||||
| 75900 | TC | A | Arterial catheter exchange | 0.00 | 19.92 | NA | 0.92 | 20.84 | NA | XXX | |||||||||||
| 75940 | A | X-ray placement, vein filter | 0.54 | 12.15 | NA | 0.57 | 13.26 | NA | XXX | ||||||||||||
| 75940 | 26 | A | X-ray placement, vein filter | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX | |||||||||||
| 75940 | TC | A | X-ray placement, vein filter | 0.00 | 11.96 | NA | 0.54 | 12.50 | NA | XXX | |||||||||||
| 75945 | A | Intravascular us | 0.40 | 4.48 | NA | 0.23 | 5.11 | NA | XXX | ||||||||||||
| 75945 | 26 | A | Intravascular us | 0.40 | 0.15 | 0.15 | 0.03 | 0.58 | 0.58 | XXX | |||||||||||
| 75945 | TC | A | Intravascular us | 0.00 | 4.33 | NA | 0.20 | 4.53 | NA | XXX | |||||||||||
| 75946 | A | Intravascular us add-on | 0.40 | 2.32 | NA | 0.14 | 2.86 | NA | ZZZ | ||||||||||||
| 75946 | 26 | A | Intravascular us add-on | 0.40 | 0.14 | 0.14 | 0.03 | 0.57 | 0.57 | ZZZ | |||||||||||
| 75946 | TC | A | Intravascular us add-on | 0.00 | 2.18 | NA | 0.11 | 2.29 | NA | ZZZ | |||||||||||
| 75952 | C | Endovasc repair abdom aorta | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 75952 | 26 | A | Endovasc repair abdom aorta | 4.50 | 1.80 | 1.80 | 0.68 | 6.98 | 6.98 | XXX | |||||||||||
| 75952 | TC | C | Endovasc repair abdom aorta | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 75953 | C | Abdom aneurysm endovas rpr | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 75953 | 26 | A | Abdom aneurysm endovas rpr | 1.36 | 0.54 | 0.54 | 0.68 | 2.58 | 2.58 | XXX | |||||||||||
| 75953 | TC | C | Abdom aneurysm endovas rpr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 75960 | A | Transcatheter intro, stent | 0.82 | 14.45 | NA | 0.68 | 15.95 | NA | XXX | ||||||||||||
| 75960 | 26 | A | Transcatheter intro, stent | 0.82 | 0.30 | 0.30 | 0.04 | 1.16 | 1.16 | XXX | |||||||||||
| 75960 | TC | A | Transcatheter intro, stent | 0.00 | 14.15 | NA | 0.64 | 14.79 | NA | XXX | |||||||||||
| 75961 | A | Retrieval, broken catheter | 4.25 | 11.46 | NA | 0.64 | 16.35 | NA | XXX | ||||||||||||
| 75961 | 26 | A | Retrieval, broken catheter | 4.25 | 1.49 | 1.49 | 0.18 | 5.92 | 5.92 | XXX | |||||||||||
| 75961 | TC | A | Retrieval, broken catheter | 0.00 | 9.97 | NA | 0.46 | 10.43 | NA | XXX | |||||||||||
| 75962 | A | Repair arterial blockage | 0.54 | 15.15 | NA | 0.72 | 16.41 | NA | XXX | ||||||||||||
| 75962 | 26 | A | Repair arterial blockage | 0.54 | 0.20 | 0.20 | 0.03 | 0.77 | 0.77 | XXX | |||||||||||
| 75962 | TC | A | Repair arterial blockage | 0.00 | 14.95 | NA | 0.69 | 15.64 | NA | XXX | |||||||||||
| 75964 | A | Repair artery blockage, each | 0.36 | 8.10 | NA | 0.38 | 8.84 | NA | ZZZ | ||||||||||||
| 75964 | 26 | A | Repair artery blockage, each | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | ZZZ | |||||||||||
| 75964 | TC | A | Repair artery blockage, each | 0.00 | 7.97 | NA | 0.36 | 8.33 | NA | ZZZ | |||||||||||
| 75966 | A | Repair arterial blockage | 1.31 | 15.45 | NA | 0.75 | 17.51 | NA | XXX | ||||||||||||
| 75966 | 26 | A | Repair arterial blockage | 1.31 | 0.50 | 0.50 | 0.06 | 1.87 | 1.87 | XXX | |||||||||||
| 75966 | TC | A | Repair arterial blockage | 0.00 | 14.95 | NA | 0.69 | 15.64 | NA | XXX | |||||||||||
| 75968 | A | Repair artery blockage, each | 0.36 | 8.11 | NA | 0.37 | 8.84 | NA | ZZZ | ||||||||||||
| 75968 | 26 | A | Repair artery blockage, each | 0.36 | 0.14 | 0.14 | 0.01 | 0.51 | 0.51 | ZZZ | |||||||||||
| 75968 | TC | A | Repair artery blockage, each | 0.00 | 7.97 | NA | 0.36 | 8.33 | NA | ZZZ | |||||||||||
| 75970 | A | Vascular biopsy | 0.83 | 11.26 | NA | 0.54 | 12.63 | NA | XXX | ||||||||||||
| 75970 | 26 | A | Vascular biopsy | 0.83 | 0.30 | 0.30 | 0.04 | 1.17 | 1.17 | XXX | |||||||||||
| 75970 | TC | A | Vascular biopsy | 0.00 | 10.96 | NA | 0.50 | 11.46 | NA | XXX | |||||||||||
| 75978 | A | Repair venous blockage | 0.54 | 15.14 | NA | 0.71 | 16.39 | NA | XXX | ||||||||||||
| 75978 | 26 | A | Repair venous blockage | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 75978 | TC | A | Repair venous blockage | 0.00 | 14.95 | NA | 0.69 | 15.64 | NA | XXX | |||||||||||
| 75980 | A | Contrast xray exam bile duct | 1.44 | 5.64 | NA | 0.30 | 7.38 | NA | XXX | ||||||||||||
| 75980 | 26 | A | Contrast xray exam bile duct | 1.44 | 0.50 | 0.50 | 0.06 | 2.00 | 2.00 | XXX | |||||||||||
| 75980 | TC | A | Contrast xray exam bile duct | 0.00 | 5.14 | NA | 0.24 | 5.38 | NA | XXX | |||||||||||
| 75982 | A | Contrast xray exam bile duct | 1.44 | 6.29 | NA | 0.33 | 8.06 | NA | XXX | ||||||||||||
| 75982 | 26 | A | Contrast xray exam bile duct | 1.44 | 0.50 | 0.50 | 0.06 | 2.00 | 2.00 | XXX | |||||||||||
| 75982 | TC | A | Contrast xray exam bile duct | 0.00 | 5.79 | NA | 0.27 | 6.06 | NA | XXX | |||||||||||
| 75984 | A | Xray control catheter change | 0.72 | 2.10 | NA | 0.12 | 2.94 | NA | XXX | ||||||||||||
| 75984 | 26 | A | Xray control catheter change | 0.72 | 0.25 | 0.25 | 0.03 | 1.00 | 1.00 | XXX | |||||||||||
| 75984 | TC | A | Xray control catheter change | 0.00 | 1.85 | NA | 0.09 | 1.94 | NA | XXX | |||||||||||
| 75989 | A | Abscess drainage under x-ray | 1.19 | 3.41 | NA | 0.19 | 4.79 | NA | XXX | ||||||||||||
| 75989 | 26 | A | Abscess drainage under x-ray | 1.19 | 0.42 | 0.42 | 0.05 | 1.66 | 1.66 | XXX | |||||||||||
| 75989 | TC | A | Abscess drainage under x-ray | 0.00 | 2.99 | NA | 0.14 | 3.13 | NA | XXX | |||||||||||
| 75992 | A | Atherectomy, x-ray exam | 0.54 | 15.15 | NA | 0.71 | 16.40 | NA | XXX | ||||||||||||
| 75992 | 26 | A | Atherectomy, x-ray exam | 0.54 | 0.20 | 0.20 | 0.02 | 0.76 | 0.76 | XXX | |||||||||||
| 75992 | TC | A | Atherectomy, x-ray exam | 0.00 | 14.95 | NA | 0.69 | 15.64 | NA | XXX | |||||||||||
| 75993 | A | Atherectomy, x-ray exam | 0.36 | 8.11 | NA | 0.37 | 8.84 | NA | ZZZ | ||||||||||||
| 75993 | 26 | A | Atherectomy, x-ray exam | 0.36 | 0.14 | 0.14 | 0.01 | 0.51 | 0.51 | ZZZ | |||||||||||
| 75993 | TC | A | Atherectomy, x-ray exam | 0.00 | 7.97 | NA | 0.36 | 8.33 | NA | ZZZ | |||||||||||
| 75994 | A | Atherectomy, x-ray exam | 1.31 | 15.45 | NA | 0.75 | 17.51 | NA | XXX | ||||||||||||
| 75994 | 26 | A | Atherectomy, x-ray exam | 1.31 | 0.50 | 0.50 | 0.06 | 1.87 | 1.87 | XXX | |||||||||||
| 75994 | TC | A | Atherectomy, x-ray exam | 0.00 | 14.95 | NA | 0.69 | 15.64 | NA | XXX | |||||||||||
| 75995 | A | Atherectomy, x-ray exam | 1.31 | 15.42 | NA | 0.75 | 17.48 | NA | XXX | ||||||||||||
| 75995 | 26 | A | Atherectomy, x-ray exam | 1.31 | 0.47 | 0.47 | 0.06 | 1.84 | 1.84 | XXX | |||||||||||
| 75995 | TC | A | Atherectomy, x-ray exam | 0.00 | 14.95 | NA | 0.69 | 15.64 | NA | XXX | |||||||||||
| 75996 | A | Atherectomy, x-ray exam | 0.36 | 8.09 | NA | 0.37 | 8.82 | NA | ZZZ | ||||||||||||
| 75996 | 26 | A | Atherectomy, x-ray exam | 0.36 | 0.12 | 0.12 | 0.01 | 0.49 | 0.49 | ZZZ | |||||||||||
| 75996 | TC | A | Atherectomy, x-ray exam | 0.00 | 7.97 | NA | 0.36 | 8.33 | NA | ZZZ | |||||||||||
| 76000 | A | Fluoroscope examination | 0.17 | 1.31 | NA | 0.07 | 1.55 | NA | XXX | ||||||||||||
| 76000 | 26 | A | Fluoroscope examination | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 76000 | TC | A | Fluoroscope examination | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 76001 | A | Fluoroscope exam, extensive | 0.67 | 2.73 | NA | 0.15 | 3.55 | NA | XXX | ||||||||||||
| 76001 | 26 | A | Fluoroscope exam, extensive | 0.67 | 0.24 | 0.24 | 0.03 | 0.94 | 0.94 | XXX | |||||||||||
| 76001 | TC | A | Fluoroscope exam, extensive | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 76003 | A | Needle localization by x-ray | 0.54 | 1.43 | NA | 0.09 | 2.06 | NA | XXX | ||||||||||||
| 76003 | 26 | A | Needle localization by x-ray | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX | |||||||||||
| 76003 | TC | A | Needle localization by x-ray | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 76005 | A | Fluoroguide for spine inject | 0.60 | 1.41 | NA | 0.09 | 2.10 | NA | XXX | ||||||||||||
| 76005 | 26 | A | Fluoroguide for spine inject | 0.60 | 0.17 | 0.17 | 0.03 | 0.80 | 0.80 | XXX | |||||||||||
| 76005 | TC | A | Fluoroguide for spine inject | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 76006 | A | X-ray stress view | 0.41 | 0.20 | 0.20 | 0.04 | 0.65 | 0.65 | XXX | ||||||||||||
| 76010 | A | X-ray, nose to rectum | 0.18 | 0.56 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 76010 | 26 | A | X-ray, nose to rectum | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 76010 | TC | A | X-ray, nose to rectum | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 76012 | C | Percut vertebroplasty fluor | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 76012 | 26 | A | Percut vertebroplasty fluor | 1.31 | 0.52 | 0.52 | 0.23 | 2.06 | 2.06 | XXX | |||||||||||
| 76012 | TC | C | Percut vertebroplasty fluor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 76013 | C | Percut vertebroplasty, ct | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 76013 | 26 | A | Percut vertebroplasty, ct | 1.38 | 0.55 | 0.55 | 0.48 | 2.41 | 2.41 | XXX | |||||||||||
| 76013 | TC | C | Percut vertebroplasty, ct | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 76020 | A | X-rays for bone age | 0.19 | 0.57 | NA | 0.03 | 0.79 | NA | XXX | ||||||||||||
| 76020 | 26 | A | X-rays for bone age | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX | |||||||||||
| 76020 | TC | A | X-rays for bone age | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX | |||||||||||
| 76040 | A | X-rays, bone evaluation | 0.27 | 0.84 | NA | 0.07 | 1.18 | NA | XXX | ||||||||||||
| 76040 | 26 | A | X-rays, bone evaluation | 0.27 | 0.10 | 0.10 | 0.03 | 0.40 | 0.40 | XXX | |||||||||||
| 76040 | TC | A | X-rays, bone evaluation | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX | |||||||||||
| 76061 | A | X-rays, bone survey | 0.45 | 1.11 | NA | 0.07 | 1.63 | NA | XXX | ||||||||||||
| 76061 | 26 | A | X-rays, bone survey | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX | |||||||||||
| 76061 | TC | A | X-rays, bone survey | 0.00 | 0.95 | NA | 0.05 | 1.00 | NA | XXX | |||||||||||
| 76062 | A | X-rays, bone survey | 0.54 | 1.56 | NA | 0.09 | 2.19 | NA | XXX | ||||||||||||
| 76062 | 26 | A | X-rays, bone survey | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 76062 | TC | A | X-rays, bone survey | 0.00 | 1.37 | NA | 0.07 | 1.44 | NA | XXX | |||||||||||
| 76065 | A | X-rays, bone evaluation | 0.70 | 0.95 | NA | 0.05 | 1.70 | NA | XXX | ||||||||||||
| 76065 | 26 | A | X-rays, bone evaluation | 0.70 | 0.25 | 0.25 | 0.01 | 0.96 | 0.96 | XXX | |||||||||||
| 76065 | TC | A | X-rays, bone evaluation | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX | |||||||||||
| 76066 | A | Joint survey, single view | 0.31 | 1.17 | NA | 0.07 | 1.55 | NA | XXX | ||||||||||||
| 76066 | 26 | A | Joint survey, single view | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX | |||||||||||
| 76066 | TC | A | Joint survey, single view | 0.00 | 1.06 | NA | 0.05 | 1.11 | NA | XXX | |||||||||||
| 76070 | I | CT scan, bone density study | +0.25 | 2.90 | NA | 0.14 | 3.29 | NA | XXX | ||||||||||||
| 76070 | 26 | I | CT scan, bone density study | +0.25 | 0.10 | 0.10 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 76070 | TC | I | CT scan, bone density study | +0.00 | 2.80 | NA | 0.13 | 2.93 | NA | XXX | |||||||||||
| 76075 | A | Us exam, abdom, limited | 0.30 | 3.05 | NA | 0.15 | 3.50 | NA | XXX | ||||||||||||
| 76075 | 26 | A | Us exam, abdom, limited | 0.30 | 0.11 | 0.11 | 0.01 | 0.42 | 0.42 | XXX | |||||||||||
| 76075 | TC | A | Us exam, abdom, limited | 0.00 | 2.94 | NA | 0.14 | 3.08 | NA | XXX | |||||||||||
| 76076 | A | Dual energy x-ray study | 0.22 | 0.80 | NA | 0.05 | 1.07 | NA | XXX | ||||||||||||
| 76076 | 26 | A | Dual energy x-ray study | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 76076 | TC | A | Dual energy x-ray study | 0.00 | 0.72 | NA | 0.04 | 0.76 | NA | XXX | |||||||||||
| 76078 | A | Radiographic absorptiometry | 0.20 | 0.80 | NA | 0.05 | 1.05 | NA | XXX | ||||||||||||
| 76078 | 26 | A | Radiographic absorptiometry | 0.20 | 0.08 | 0.08 | 0.01 | 0.29 | 0.29 | XXX | |||||||||||
| 76078 | TC | A | Radiographic absorptiometry | 0.00 | 0.72 | NA | 0.04 | 0.76 | NA | XXX | |||||||||||
| 76080 | A | X-ray exam of fistula | 0.54 | 1.19 | NA | 0.07 | 1.80 | NA | XXX | ||||||||||||
| 76080 | 26 | A | X-ray exam of fistula | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 76080 | TC | A | X-ray exam of fistula | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 76085 | A | Computer mammogram add-on | 0.06 | 0.31 | NA | 0.02 | 0.39 | NA | ZZZ | ||||||||||||
| 76085 | 26 | A | Computer mammogram add-on | 0.06 | 0.02 | 0.02 | 0.01 | 0.09 | 0.09 | ZZZ | |||||||||||
| 76085 | TC | A | Computer mammogram add-on | 0.00 | 0.29 | NA | 0.01 | 0.30 | NA | XXX | |||||||||||
| 76086 | A | X-ray of mammary duct | 0.36 | 2.62 | NA | 0.14 | 3.12 | NA | XXX | ||||||||||||
| 76086 | 26 | A | X-ray of mammary duct | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX | |||||||||||
| 76086 | TC | A | X-ray of mammary duct | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 76088 | A | X-ray of mammary ducts | 0.45 | 3.64 | NA | 0.18 | 4.27 | NA | XXX | ||||||||||||
| 76088 | 26 | A | X-ray of mammary ducts | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX | |||||||||||
| 76088 | TC | A | X-ray of mammary ducts | 0.00 | 3.48 | NA | 0.16 | 3.64 | NA | XXX | |||||||||||
| 76090 | A | Mammogram, one breast | 0.70 | 1.25 | NA | 0.08 | 2.03 | NA | XXX | ||||||||||||
| 76090 | 26 | A | Mammogram, one breast | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 76090 | TC | A | Mammogram, one breast | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 76091 | A | Mammogram, both breasts | 0.87 | 1.54 | NA | 0.09 | 2.50 | NA | XXX | ||||||||||||
| 76091 | 26 | A | Mammogram, both breasts | 0.87 | 0.30 | 0.30 | 0.03 | 1.20 | 1.20 | XXX | |||||||||||
| 76091 | TC | A | Mammogram, both breasts | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 76092 | A | Mammogram, screening | 0.70 | 1.44 | NA | 0.09 | 2.23 | NA | XXX | ||||||||||||
| 76092 | 26 | A | Mammogram, screening | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 76092 | TC | A | Mammogram, screening | 0.00 | 1.19 | NA | 0.06 | 1.25 | NA | XXX | |||||||||||
| 76093 | A | Magnetic image, breast | 1.63 | 17.31 | NA | 0.83 | 19.77 | NA | XXX | ||||||||||||
| 76093 | 26 | A | Magnetic image, breast | 1.63 | 0.57 | 0.57 | 0.07 | 2.27 | 2.27 | XXX | |||||||||||
| 76093 | TC | A | Magnetic image, breast | 0.00 | 16.74 | NA | 0.76 | 17.50 | NA | XXX | |||||||||||
| 76094 | A | Magnetic image, both breasts | 1.63 | 23.28 | NA | 1.10 | 26.01 | NA | XXX | ||||||||||||
| 76094 | 26 | A | Magnetic image, both breasts | 1.63 | 0.57 | 0.57 | 0.07 | 2.27 | 2.27 | XXX | |||||||||||
| 76094 | TC | A | Magnetic image, both breasts | 0.00 | 22.71 | NA | 1.03 | 23.74 | NA | XXX | |||||||||||
| 76095 | A | Stereotactic breast biopsy | 1.59 | 7.36 | NA | 0.40 | 9.35 | NA | XXX | ||||||||||||
| 76095 | 26 | A | Stereotactic breast biopsy | 1.59 | 0.56 | 0.56 | 0.09 | 2.24 | 2.24 | XXX | |||||||||||
| 76095 | TC | A | Stereotactic breast biopsy | 0.00 | 6.80 | NA | 0.31 | 7.11 | NA | XXX | |||||||||||
| 76096 | A | X-ray of needle wire, breast | 0.56 | 1.44 | NA | 0.09 | 2.09 | NA | XXX | ||||||||||||
| 76096 | 26 | A | X-ray of needle wire, breast | 0.56 | 0.20 | 0.20 | 0.03 | 0.79 | 0.79 | XXX | |||||||||||
| 76096 | TC | A | X-ray of needle wire, breast | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 76098 | A | X-ray exam, breast specimen | 0.16 | 0.45 | NA | 0.03 | 0.64 | NA | XXX | ||||||||||||
| 76098 | 26 | A | X-ray exam, breast specimen | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 76098 | TC | A | X-ray exam, breast specimen | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | |||||||||||
| 76100 | A | X-ray exam of body section | 0.58 | 1.38 | NA | 0.09 | 2.05 | NA | XXX | ||||||||||||
| 76100 | 26 | A | X-ray exam of body section | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX | |||||||||||
| 76100 | TC | A | X-ray exam of body section | 0.00 | 1.18 | NA | 0.06 | 1.24 | NA | XXX | |||||||||||
| 76101 | A | Complex body section x-ray | 0.58 | 1.55 | NA | 0.10 | 2.23 | NA | XXX | ||||||||||||
| 76101 | 26 | A | Complex body section x-ray | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX | |||||||||||
| 76101 | TC | A | Complex body section x-ray | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76102 | A | Complex body section x-rays | 0.58 | 1.84 | NA | 0.12 | 2.54 | NA | XXX | ||||||||||||
| 76102 | 26 | A | Complex body section x-rays | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX | |||||||||||
| 76102 | TC | A | Complex body section x-rays | 0.00 | 1.64 | NA | 0.09 | 1.73 | NA | XXX | |||||||||||
| 76120 | A | Cine/video x-rays | 0.38 | 1.14 | NA | 0.07 | 1.59 | NA | XXX | ||||||||||||
| 76120 | 26 | A | Cine/video x-rays | 0.38 | 0.14 | 0.14 | 0.02 | 0.54 | 0.54 | XXX | |||||||||||
| 76120 | TC | A | Cine/video x-rays | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 76125 | A | Cine/ video x-rays add-on | 0.27 | 0.84 | NA | 0.05 | 1.16 | NA | ZZZ | ||||||||||||
| 76125 | 26 | A | Cine/ video x-rays add-on | 0.27 | 0.10 | 0.10 | 0.01 | 0.38 | 0.38 | ZZZ | |||||||||||
| 76125 | TC | A | Cine/ video x-rays add-on | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | ZZZ | |||||||||||
| 76140 | I | X-ray consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 76150 | A | X-ray exam, dry process | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | ||||||||||||
| 76350 | C | Special x-ray contrast study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 76355 | A | CAT scan for localization | 1.21 | 8.28 | NA | 0.41 | 9.90 | NA | XXX | ||||||||||||
| 76355 | 26 | A | CAT scan for localization | 1.21 | 0.44 | 0.44 | 0.06 | 1.71 | 1.71 | XXX | |||||||||||
| 76355 | TC | A | CAT scan for localization | 0.00 | 7.84 | NA | 0.35 | 8.19 | NA | XXX | |||||||||||
| 76360 | A | CAT scan for needle biopsy | 1.16 | 8.24 | NA | 0.40 | 9.80 | NA | XXX | ||||||||||||
| 76360 | 26 | A | CAT scan for needle biopsy | 1.16 | 0.40 | 0.40 | 0.05 | 1.61 | 1.61 | XXX | |||||||||||
| 76360 | TC | A | CAT scan for needle biopsy | 0.00 | 7.84 | NA | 0.35 | 8.19 | NA | XXX | |||||||||||
| 76362 | A | Cat scan for tissue ablation | 4.00 | 9.24 | NA | 1.38 | 14.62 | NA | XXX | ||||||||||||
| 76362 | 26 | A | Cat scan for tissue ablation | 4.00 | 1.40 | 1.40 | 0.17 | 5.57 | 5.57 | XXX | |||||||||||
| 76362 | TC | A | Cat scan for tissue ablation | 0.00 | 7.84 | NA | 1.21 | 9.05 | NA | XXX | |||||||||||
| 76370 | A | CAT scan for therapy guide | 0.85 | 3.10 | NA | 0.17 | 4.12 | NA | XXX | ||||||||||||
| 76370 | 26 | A | CAT scan for therapy guide | 0.85 | 0.30 | 0.30 | 0.04 | 1.19 | 1.19 | XXX | |||||||||||
| 76370 | TC | A | CAT scan for therapy guide | 0.00 | 2.80 | NA | 0.13 | 2.93 | NA | XXX | |||||||||||
| 76375 | A | 3d/holograph reconstr add-on | 0.16 | 3.42 | NA | 0.16 | 3.74 | NA | XXX | ||||||||||||
| 76375 | 26 | A | 3d/holograph reconstr add-on | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 76375 | TC | A | 3d/holograph reconstr add-on | 0.00 | 3.36 | NA | 0.15 | 3.51 | NA | XXX | |||||||||||
| 76380 | A | CAT scan follow-up study | 0.98 | 3.66 | NA | 0.19 | 4.83 | NA | XXX | ||||||||||||
| 76380 | 26 | A | CAT scan follow-up study | 0.98 | 0.34 | 0.34 | 0.04 | 1.36 | 1.36 | XXX | |||||||||||
| 76380 | TC | A | CAT scan follow-up study | 0.00 | 3.32 | NA | 0.15 | 3.47 | NA | XXX | |||||||||||
| 76390 | A | Mr spectroscopy | 1.40 | 11.14 | NA | 0.55 | 13.09 | NA | XXX | ||||||||||||
| 76390 | 26 | A | Mr spectroscopy | 1.40 | 0.50 | 0.50 | 0.06 | 1.96 | 1.96 | XXX | |||||||||||
| 76390 | TC | A | Mr spectroscopy | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 76393 | A | Mr guidance for needle place | 1.50 | 11.16 | NA | 0.53 | 13.19 | NA | XXX | ||||||||||||
| 76393 | 26 | A | Mr guidance for needle place | 1.50 | 0.52 | 0.52 | 0.07 | 2.09 | 2.09 | XXX | |||||||||||
| 76393 | TC | A | Mr guidance for needle place | 0.00 | 10.64 | NA | 0.46 | 11.10 | NA | XXX | |||||||||||
| 76394 | A | Mri for tissue ablation | 4.25 | 12.13 | NA | 1.43 | 17.81 | NA | XXX | ||||||||||||
| 76394 | 26 | A | Mri for tissue ablation | 4.25 | 1.49 | 1.49 | 0.14 | 5.88 | 5.88 | XXX | |||||||||||
| 76394 | TC | A | Mri for tissue ablation | 0.00 | 10.64 | NA | 1.29 | 11.93 | NA | XXX | |||||||||||
| 76400 | A | Magnetic image, bone marrow | 1.60 | 11.20 | NA | 0.56 | 13.36 | NA | XXX | ||||||||||||
| 76400 | 26 | A | Magnetic image, bone marrow | 1.60 | 0.56 | 0.56 | 0.07 | 2.23 | 2.23 | XXX | |||||||||||
| 76400 | TC | A | Magnetic image, bone marrow | 0.00 | 10.64 | NA | 0.49 | 11.13 | NA | XXX | |||||||||||
| 76490 | A | Us for tissue ablation | 2.00 | 2.13 | NA | 0.36 | 4.49 | NA | XXX | ||||||||||||
| 76490 | 26 | A | Us for tissue ablation | 2.00 | 0.69 | 0.69 | 0.12 | 2.81 | 2.81 | XXX | |||||||||||
| 76490 | TC | A | Us for tissue ablation | 0.00 | 1.44 | NA | 0.24 | 1.68 | NA | XXX | |||||||||||
| 76499 | C | Radiographic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 76499 | 26 | C | Radiographic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 76499 | TC | C | Radiographic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 76506 | A | Echo exam of head | 0.63 | 1.61 | NA | 0.10 | 2.34 | NA | XXX | ||||||||||||
| 76506 | 26 | A | Echo exam of head | 0.63 | 0.26 | 0.26 | 0.03 | 0.92 | 0.92 | XXX | |||||||||||
| 76506 | TC | A | Echo exam of head | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76511 | A | Echo exam of eye | 0.94 | 2.37 | NA | 0.08 | 3.39 | NA | XXX | ||||||||||||
| 76511 | 26 | A | Echo exam of eye | 0.94 | 0.45 | 0.45 | 0.02 | 1.41 | 1.41 | XXX | |||||||||||
| 76511 | TC | A | Echo exam of eye | 0.00 | 1.92 | NA | 0.06 | 1.98 | NA | XXX | |||||||||||
| 76512 | A | Echo exam of eye | 0.66 | 2.49 | NA | 0.09 | 3.24 | NA | XXX | ||||||||||||
| 76512 | 26 | A | Echo exam of eye | 0.66 | 0.31 | 0.31 | 0.01 | 0.98 | 0.98 | XXX | |||||||||||
| 76512 | TC | A | Echo exam of eye | 0.00 | 2.18 | NA | 0.08 | 2.26 | NA | XXX | |||||||||||
| 76513 | A | Echo exam of eye, water bath | 0.66 | 2.90 | NA | 0.09 | 3.65 | NA | XXX | ||||||||||||
| 76513 | 26 | A | Echo exam of eye, water bath | 0.66 | 0.32 | 0.32 | 0.01 | 0.99 | 0.99 | XXX | |||||||||||
| 76513 | TC | A | Echo exam of eye, water bath | 0.00 | 2.58 | NA | 0.08 | 2.66 | NA | XXX | |||||||||||
| 76516 | A | Echo exam of eye | 0.54 | 2.04 | NA | 0.07 | 2.65 | NA | XXX | ||||||||||||
| 76516 | 26 | A | Echo exam of eye | 0.54 | 0.26 | 0.26 | 0.01 | 0.81 | 0.81 | XXX | |||||||||||
| 76516 | TC | A | Echo exam of eye | 0.00 | 1.78 | NA | 0.06 | 1.84 | NA | XXX | |||||||||||
| 76519 | A | Echo exam of eye | 0.54 | 1.91 | NA | 0.07 | 2.52 | NA | XXX | ||||||||||||
| 76519 | 26 | A | Echo exam of eye | 0.54 | 0.26 | 0.26 | 0.01 | 0.81 | 0.81 | XXX | |||||||||||
| 76519 | TC | A | Echo exam of eye | 0.00 | 1.65 | NA | 0.06 | 1.71 | NA | XXX | |||||||||||
| 76529 | A | Echo exam of eye | 0.57 | 2.70 | NA | 0.08 | 3.35 | NA | XXX | ||||||||||||
| 76529 | 26 | A | Echo exam of eye | 0.57 | 0.27 | 0.27 | 0.01 | 0.85 | 0.85 | XXX | |||||||||||
| 76529 | TC | A | Echo exam of eye | 0.00 | 2.43 | NA | 0.07 | 2.50 | NA | XXX | |||||||||||
| 76536 | A | Us exam of head and neck | 0.56 | 1.55 | NA | 0.09 | 2.20 | NA | XXX | ||||||||||||
| 76536 | 26 | A | Us exam of head and neck | 0.56 | 0.20 | 0.20 | 0.02 | 0.78 | 0.78 | XXX | |||||||||||
| 76536 | TC | A | Us exam of head and neck | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76604 | A | Us exam, chest, b-scan | 0.55 | 1.43 | NA | 0.08 | 2.06 | NA | XXX | ||||||||||||
| 76604 | 26 | A | Us exam, chest, b-scan | 0.55 | 0.19 | 0.19 | 0.02 | 0.76 | 0.76 | XXX | |||||||||||
| 76604 | TC | A | Us exam, chest, b-scan | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 76645 | A | Us exam, breast(s) | 0.54 | 1.19 | NA | 0.08 | 1.81 | NA | XXX | ||||||||||||
| 76645 | 26 | A | Us exam, breast(s) | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX | |||||||||||
| 76645 | TC | A | Us exam, breast(s) | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 76700 | A | Us exam, abdom, complete | 0.81 | 2.15 | NA | 0.13 | 3.09 | NA | XXX | ||||||||||||
| 76700 | 26 | A | Us exam, abdom, complete | 0.81 | 0.28 | 0.28 | 0.04 | 1.13 | 1.13 | XXX | |||||||||||
| 76700 | TC | A | Us exam, abdom, complete | 0.00 | 1.87 | NA | 0.09 | 1.96 | NA | XXX | |||||||||||
| 76705 | A | Us exam, abdom, limited | 0.59 | 1.56 | NA | 0.10 | 2.25 | NA | XXX | ||||||||||||
| 76705 | 26 | A | Us exam, abdom, limited | 0.59 | 0.21 | 0.21 | 0.03 | 0.83 | 0.83 | XXX | |||||||||||
| 76705 | TC | A | Us exam, abdom, limited | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76770 | A | Us exam abdo back wall, comp | 0.74 | 2.13 | NA | 0.12 | 2.99 | NA | XXX | ||||||||||||
| 76770 | 26 | A | Us exam abdo back wall, comp | 0.74 | 0.26 | 0.26 | 0.03 | 1.03 | 1.03 | XXX | |||||||||||
| 76770 | TC | A | Us exam abdo back wall, comp | 0.00 | 1.87 | NA | 0.09 | 1.96 | NA | XXX | |||||||||||
| 76775 | A | Us exam abdo back wall, lim | 0.58 | 1.55 | NA | 0.10 | 2.23 | NA | XXX | ||||||||||||
| 76775 | 26 | A | Us exam abdo back wall, lim | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX | |||||||||||
| 76775 | TC | A | Us exam abdo back wall, lim | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76778 | A | Us exam kidney transplant | 0.74 | 2.13 | NA | 0.12 | 2.99 | NA | XXX | ||||||||||||
| 76778 | 26 | A | Us exam kidney transplant | 0.74 | 0.26 | 0.26 | 0.03 | 1.03 | 1.03 | XXX | |||||||||||
| 76778 | TC | A | Us exam kidney transplant | 0.00 | 1.87 | NA | 0.09 | 1.96 | NA | XXX | |||||||||||
| 76800 | A | Us exam, spinal canal | 1.13 | 1.73 | NA | 0.11 | 2.97 | NA | XXX | ||||||||||||
| 76800 | 26 | A | Us exam, spinal canal | 1.13 | 0.38 | 0.38 | 0.04 | 1.55 | 1.55 | XXX | |||||||||||
| 76800 | TC | A | Us exam, spinal canal | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76805 | A | Us exam, pg uterus, compl | 0.99 | 2.35 | NA | 0.14 | 3.48 | NA | XXX | ||||||||||||
| 76805 | 26 | A | Us exam, pg uterus, compl | 0.99 | 0.36 | 0.36 | 0.04 | 1.39 | 1.39 | XXX | |||||||||||
| 76805 | TC | A | Us exam, pg uterus, compl | 0.00 | 1.99 | NA | 0.10 | 2.09 | NA | XXX | |||||||||||
| 76810 | A | Us exam, pg uterus, mult | 1.97 | 4.74 | NA | 0.25 | 6.96 | NA | XXX | ||||||||||||
| 76810 | 26 | A | Us exam, pg uterus, mult | 1.97 | 0.75 | 0.75 | 0.07 | 2.79 | 2.79 | XXX | |||||||||||
| 76810 | TC | A | Us exam, pg uterus, mult | 0.00 | 3.99 | NA | 0.18 | 4.17 | NA | XXX | |||||||||||
| 76815 | A | Us exam, pg uterus limit | 0.65 | 1.60 | NA | 0.09 | 2.34 | NA | XXX | ||||||||||||
| 76815 | 26 | A | Us exam, pg uterus limit | 0.65 | 0.25 | 0.25 | 0.02 | 0.92 | 0.92 | XXX | |||||||||||
| 76815 | TC | A | Us exam, pg uterus limit | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76816 | A | Us exam pg uterus repeat | 0.57 | 1.28 | NA | 0.07 | 1.92 | NA | XXX | ||||||||||||
| 76816 | 26 | A | Us exam pg uterus repeat | 0.57 | 0.22 | 0.22 | 0.02 | 0.81 | 0.81 | XXX | |||||||||||
| 76816 | TC | A | Us exam pg uterus repeat | 0.00 | 1.06 | NA | 0.05 | 1.11 | NA | XXX | |||||||||||
| 76818 | A | Fetal biophy profile w/nst | 1.05 | 1.94 | NA | 0.12 | 3.11 | NA | XXX | ||||||||||||
| 76818 | 26 | A | Fetal biophy profile w/nst | 1.05 | 0.41 | 0.41 | 0.04 | 1.50 | 1.50 | XXX | |||||||||||
| 76818 | TC | A | Fetal biophy profile w/nst | 0.00 | 1.53 | NA | 0.08 | 1.61 | NA | XXX | |||||||||||
| 76819 | A | Fetal biophys profil w/o nst | 0.77 | 1.83 | NA | 0.10 | 2.70 | NA | XXX | ||||||||||||
| 76819 | 26 | A | Fetal biophys profil w/o nst | 0.77 | 0.30 | 0.30 | 0.02 | 1.09 | 1.09 | XXX | |||||||||||
| 76819 | TC | A | Fetal biophys profil w/o nst | 0.00 | 1.53 | NA | 0.08 | 1.61 | NA | XXX | |||||||||||
| 76825 | A | Echo exam of fetal heart | 1.67 | 2.50 | NA | 0.15 | 4.32 | NA | XXX | ||||||||||||
| 76825 | 26 | A | Echo exam of fetal heart | 1.67 | 0.63 | 0.63 | 0.06 | 2.36 | 2.36 | XXX | |||||||||||
| 76825 | TC | A | Echo exam of fetal heart | 0.00 | 1.87 | NA | 0.09 | 1.96 | NA | XXX | |||||||||||
| 76826 | A | Echo exam of fetal heart | 0.83 | 0.97 | NA | 0.07 | 1.87 | NA | XXX | ||||||||||||
| 76826 | 26 | A | Echo exam of fetal heart | 0.83 | 0.30 | 0.30 | 0.03 | 1.16 | 1.16 | XXX | |||||||||||
| 76826 | TC | A | Echo exam of fetal heart | 0.00 | 0.67 | NA | 0.04 | 0.71 | NA | XXX | |||||||||||
| 76827 | A | Echo exam of fetal heart | 0.58 | 1.85 | NA | 0.12 | 2.55 | NA | XXX | ||||||||||||
| 76827 | 26 | A | Echo exam of fetal heart | 0.58 | 0.22 | 0.22 | 0.02 | 0.82 | 0.82 | XXX | |||||||||||
| 76827 | TC | A | Echo exam of fetal heart | 0.00 | 1.63 | NA | 0.10 | 1.73 | NA | XXX | |||||||||||
| 76828 | A | Echo exam of fetal heart | 0.56 | 1.29 | NA | 0.09 | 1.94 | NA | XXX | ||||||||||||
| 76828 | 26 | A | Echo exam of fetal heart | 0.56 | 0.23 | 0.23 | 0.02 | 0.81 | 0.81 | XXX | |||||||||||
| 76828 | TC | A | Echo exam of fetal heart | 0.00 | 1.06 | NA | 0.07 | 1.13 | NA | XXX | |||||||||||
| 76830 | A | Us exam, transvaginal | 0.69 | 1.68 | NA | 0.11 | 2.48 | NA | XXX | ||||||||||||
| 76830 | 26 | A | Us exam, transvaginal | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 76830 | TC | A | Us exam, transvaginal | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76831 | A | Echo exam, uterus | 0.72 | 1.71 | NA | 0.10 | 2.53 | NA | XXX | ||||||||||||
| 76831 | 26 | A | Echo exam, uterus | 0.72 | 0.27 | 0.27 | 0.02 | 1.01 | 1.01 | XXX | |||||||||||
| 76831 | TC | A | Echo exam, uterus | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76856 | A | Us exam, pelvic, complete | 0.69 | 1.68 | NA | 0.11 | 2.48 | NA | XXX | ||||||||||||
| 76856 | 26 | A | Us exam, pelvic, complete | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 76856 | TC | A | Us exam, pelvic, complete | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76857 | A | Us exam, pelvic, limited | 0.38 | 1.13 | NA | 0.07 | 1.58 | NA | XXX | ||||||||||||
| 76857 | 26 | A | Us exam, pelvic, limited | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX | |||||||||||
| 76857 | TC | A | Us exam, pelvic, limited | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 76870 | A | Us exam, scrotum | 0.64 | 1.66 | NA | 0.11 | 2.41 | NA | XXX | ||||||||||||
| 76870 | 26 | A | Us exam, scrotum | 0.64 | 0.22 | 0.22 | 0.03 | 0.89 | 0.89 | XXX | |||||||||||
| 76870 | TC | A | Us exam, scrotum | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76872 | A | Echo exam, transrectal | 0.69 | 1.68 | NA | 0.12 | 2.49 | NA | XXX | ||||||||||||
| 76872 | 26 | A | Echo exam, transrectal | 0.69 | 0.24 | 0.24 | 0.04 | 0.97 | 0.97 | XXX | |||||||||||
| 76872 | TC | A | Echo exam, transrectal | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76873 | A | Echograp trans r, pros study | 1.55 | 2.53 | NA | 0.21 | 4.29 | NA | XXX | ||||||||||||
| 76873 | 26 | A | Echograp trans r, pros study | 1.55 | 0.54 | 0.54 | 0.08 | 2.17 | 2.17 | XXX | |||||||||||
| 76873 | TC | A | Echograp trans r, pros study | 0.00 | 1.99 | NA | 0.13 | 2.12 | NA | XXX | |||||||||||
| 76880 | A | Us exam, extremity | 0.59 | 1.56 | NA | 0.10 | 2.25 | NA | XXX | ||||||||||||
| 76880 | 26 | A | Us exam, extremity | 0.59 | 0.21 | 0.21 | 0.03 | 0.83 | 0.83 | XXX | |||||||||||
| 76880 | TC | A | Us exam, extremity | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76885 | A | Us exam infant hips, dynamic | 0.74 | 1.70 | NA | 0.11 | 2.55 | NA | XXX | ||||||||||||
| 6885 | 26 | A | Us exam infant hips, dynamic | 0.74 | 0.26 | 0.26 | 0.03 | 1.03 | 1.03 | XXX | |||||||||||
| 76885 | TC | A | Us exam infant hips, dynamic | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76886 | A | Us exam infant hips, static | 0.62 | 1.57 | NA | 0.10 | 2.29 | NA | XXX | ||||||||||||
| 76886 | 26 | A | Us exam infant hips, static | 0.62 | 0.22 | 0.22 | 0.03 | 0.87 | 0.87 | XXX | |||||||||||
| 76886 | TC | A | Us exam infant hips, static | 0.00 | 1.35 | NA | 0.07 | 1.42 | NA | XXX | |||||||||||
| 76930 | A | Echo guide, cardiocentesis | 0.67 | 1.71 | NA | 0.10 | 2.48 | NA | XXX | ||||||||||||
| 76930 | 26 | A | Echo guide, cardiocentesis | 0.67 | 0.27 | 0.27 | 0.02 | 0.96 | 0.96 | XXX | |||||||||||
| 76930 | TC | A | Echo guide, cardiocentesis | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76932 | A | Echo guide for heart biopsy | 0.67 | 1.71 | NA | 0.10 | 2.48 | NA | XXX | ||||||||||||
| 76932 | 26 | A | Echo guide for heart biopsy | 0.67 | 0.27 | 0.27 | 0.02 | 0.96 | 0.96 | XXX | |||||||||||
| 76932 | TC | A | Echo guide for heart biopsy | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76936 | A | Echo guide for artery repair | 1.99 | 6.68 | NA | 0.39 | 9.06 | NA | XXX | ||||||||||||
| 76936 | 26 | A | Echo guide for artery repair | 1.99 | 0.70 | 0.70 | 0.11 | 2.80 | 2.80 | XXX | |||||||||||
| 76936 | TC | A | Echo guide for artery repair | 0.00 | 5.98 | NA | 0.28 | 6.26 | NA | XXX | |||||||||||
| 76941 | A | Echo guide for transfusion | 1.34 | 1.98 | NA | 0.13 | 3.45 | NA | XXX | ||||||||||||
| 76941 | 26 | A | Echo guide for transfusion | 1.34 | 0.53 | 0.53 | 0.06 | 1.93 | 1.93 | XXX | |||||||||||
| 76941 | TC | A | Echo guide for transfusion | 0.00 | 1.45 | NA | 0.07 | 1.52 | NA | XXX | |||||||||||
| 76942 | A | Echo guide for biopsy | 0.67 | 1.67 | NA | 0.12 | 2.46 | NA | XXX | ||||||||||||
| 76942 | 26 | A | Echo guide for biopsy | 0.67 | 0.23 | 0.23 | 0.04 | 0.94 | 0.94 | XXX | |||||||||||
| 76942 | TC | A | Echo guide for biopsy | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76945 | A | Echo guide, villus sampling | 0.67 | 1.69 | NA | 0.10 | 2.46 | NA | XXX | ||||||||||||
| 76945 | 26 | A | Echo guide, villus sampling | 0.67 | 0.24 | 0.24 | 0.03 | 0.94 | 0.94 | XXX | |||||||||||
| 76945 | TC | A | Echo guide, villus sampling | 0.00 | 1.45 | NA | 0.07 | 1.52 | NA | XXX | |||||||||||
| 76946 | A | Echo guide for amniocentesis | 0.38 | 1.59 | NA | 0.09 | 2.06 | NA | XXX | ||||||||||||
| 76946 | 26 | A | Echo guide for amniocentesis | 0.38 | 0.15 | 0.15 | 0.01 | 0.54 | 0.54 | XXX | |||||||||||
| 76946 | TC | A | Echo guide for amniocentesis | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76948 | A | Echo guide, ova aspiration | 0.38 | 1.57 | NA | 0.10 | 2.05 | NA | XXX | ||||||||||||
| 76948 | 26 | A | Echo guide, ova aspiration | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX | |||||||||||
| 76948 | TC | A | Echo guide, ova aspiration | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76950 | A | Echo guidance radiotherapy | 0.58 | 1.45 | NA | 0.09 | 2.12 | NA | XXX | ||||||||||||
| 76950 | 26 | A | Echo guidance radiotherapy | 0.58 | 0.21 | 0.21 | 0.03 | 0.82 | 0.82 | XXX | |||||||||||
| 76950 | TC | A | Echo guidance radiotherapy | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 76965 | A | Echo guidance radiotherapy | 1.34 | 5.75 | NA | 0.31 | 7.40 | NA | XXX | ||||||||||||
| 76965 | 26 | A | Echo guidance radiotherapy | 1.34 | 0.46 | 0.46 | 0.07 | 1.87 | 1.87 | XXX | |||||||||||
| 76965 | TC | A | Echo guidance radiotherapy | 0.00 | 5.29 | NA | 0.24 | 5.53 | NA | XXX | |||||||||||
| 76970 | A | Ultrasound exam follow-up | 0.40 | 1.14 | NA | 0.07 | 1.61 | NA | XXX | ||||||||||||
| 76970 | 26 | A | Ultrasound exam follow-up | 0.40 | 0.14 | 0.14 | 0.02 | 0.56 | 0.56 | XXX | |||||||||||
| 76970 | TC | A | Ultrasound exam follow-up | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX | |||||||||||
| 76975 | A | GI endoscopic ultrasound | 0.81 | 1.73 | NA | 0.11 | 2.65 | NA | XXX | ||||||||||||
| 76975 | 26 | A | GI endoscopic ultrasound | 0.81 | 0.29 | 0.29 | 0.03 | 1.13 | 1.13 | XXX | |||||||||||
| 76975 | TC | A | GI endoscopic ultrasound | 0.00 | 1.44 | NA | 0.08 | 1.52 | NA | XXX | |||||||||||
| 76977 | A | Us bone density measure | 0.05 | 0.80 | NA | 0.05 | 0.90 | NA | XXX | ||||||||||||
| 76977 | 26 | A | Us bone density measure | 0.05 | 0.02 | 0.02 | 0.01 | 0.08 | 0.08 | XXX | |||||||||||
| 76977 | TC | A | Us bone density measure | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX | |||||||||||
| 76986 | A | Ultrasound guide intraoper | 1.20 | 2.91 | NA | 0.19 | 4.30 | NA | XXX | ||||||||||||
| 76986 | 26 | A | Ultrasound guide intraoper | 1.20 | 0.42 | 0.42 | 0.07 | 1.69 | 1.69 | XXX | |||||||||||
| 76986 | TC | A | Ultrasound guide intraoper | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 76999 | C | Echo examination procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 76999 | 26 | C | Echo examination procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 76999 | TC | C | Echo examination procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77261 | A | Radiation therapy planning | 1.39 | 0.56 | 0.56 | 0.06 | 2.01 | 2.01 | XXX | ||||||||||||
| 77262 | A | Radiation therapy planning | 2.11 | 0.82 | 0.82 | 0.09 | 3.02 | 3.02 | XXX | ||||||||||||
| 77263 | A | Radiation therapy planning | 3.14 | 1.23 | 1.23 | 0.13 | 4.50 | 4.50 | XXX | ||||||||||||
| 77280 | A | Set radiation therapy field | 0.70 | 3.55 | NA | 0.18 | 4.43 | NA | XXX | ||||||||||||
| 77280 | 26 | A | Set radiation therapy field | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 77280 | TC | A | Set radiation therapy field | 0.00 | 3.30 | NA | 0.15 | 3.45 | NA | XXX | |||||||||||
| 77285 | A | Set radiation therapy field | 1.05 | 5.67 | NA | 0.29 | 7.01 | NA | XXX | ||||||||||||
| 77285 | 26 | A | Set radiation therapy field | 1.05 | 0.38 | 0.38 | 0.04 | 1.47 | 1.47 | XXX | |||||||||||
| 77285 | TC | A | Set radiation therapy field | 0.00 | 5.29 | NA | 0.25 | 5.54 | NA | XXX | |||||||||||
| 77290 | A | Set radiation therapy field | 1.56 | 6.74 | NA | 0.35 | 8.65 | NA | XXX | ||||||||||||
| 77290 | 26 | A | Set radiation therapy field | 1.56 | 0.56 | 0.56 | 0.06 | 2.18 | 2.18 | XXX | |||||||||||
| 77290 | TC | A | Set radiation therapy field | 0.00 | 6.18 | NA | 0.29 | 6.47 | NA | XXX | |||||||||||
| 77295 | A | Set radiation therapy field | 4.57 | 28.18 | NA | 1.41 | 34.16 | NA | XXX | ||||||||||||
| 77295 | 26 | A | Set radiation therapy field | 4.57 | 1.65 | 1.65 | 0.18 | 6.40 | 6.40 | XXX | |||||||||||
| 77295 | TC | A | Set radiation therapy field | 0.00 | 26.53 | NA | 1.23 | 27.76 | NA | XXX | |||||||||||
| 77299 | C | Radiation therapy planning | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77299 | 26 | C | Radiation therapy planning | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77299 | TC | C | Radiation therapy planning | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77300 | A | Radiation therapy dose plan | 0.62 | 1.50 | NA | 0.09 | 2.21 | NA | XXX | ||||||||||||
| 77300 | 26 | A | Radiation therapy dose plan | 0.62 | 0.22 | 0.22 | 0.03 | 0.87 | 0.87 | XXX | |||||||||||
| 77300 | TC | A | Radiation therapy dose plan | 0.00 | 1.28 | NA | 0.06 | 1.34 | NA | XXX | |||||||||||
| 77301 | A | Radioltherapy dos plan, imrt | 8.00 | 29.72 | NA | 1.41 | 39.13 | NA | XXX | ||||||||||||
| 77301 | 26 | A | Radioltherapy dos plan, imrt | 8.00 | 3.19 | 3.19 | 0.18 | 11.37 | 11.37 | XXX | |||||||||||
| 77301 | TC | A | Radioltherapy dos plan, imrt | 0.00 | 26.53 | NA | 1.23 | 27.76 | NA | XXX | |||||||||||
| 77305 | A | Radiation therapy dose plan | 0.70 | 2.01 | NA | 0.12 | 2.83 | NA | XXX | ||||||||||||
| 77305 | 26 | A | Radiation therapy dose plan | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 77305 | TC | A | Radiation therapy dose plan | 0.00 | 1.76 | NA | 0.09 | 1.85 | NA | XXX | |||||||||||
| 77310 | A | Radiation therapy dose plan | 1.05 | 2.59 | NA | 0.15 | 3.79 | NA | XXX | ||||||||||||
| 77310 | 26 | A | Radiation therapy dose plan | 1.05 | 0.38 | 0.38 | 0.04 | 1.47 | 1.47 | XXX | |||||||||||
| 77310 | TC | A | Radiation therapy dose plan | 0.00 | 2.21 | NA | 0.11 | 2.32 | NA | XXX | |||||||||||
| 77315 | A | Radiation therapy dose plan | 1.56 | 3.09 | NA | 0.18 | 4.83 | NA | XXX | ||||||||||||
| 77315 | 26 | A | Radiation therapy dose plan | 1.56 | 0.56 | 0.56 | 0.06 | 2.18 | 2.18 | XXX | |||||||||||
| 77315 | TC | A | Radiation therapy dose plan | 0.00 | 2.53 | NA | 0.12 | 2.65 | NA | XXX | |||||||||||
| 77321 | A | Radiation therapy port plan | 0.95 | 4.18 | NA | 0.21 | 5.34 | NA | XXX | ||||||||||||
| 77321 | 26 | A | Radiation therapy port plan | 0.95 | 0.34 | 0.34 | 0.04 | 1.33 | 1.33 | XXX | |||||||||||
| 77321 | TC | A | Radiation therapy port plan | 0.00 | 3.84 | NA | 0.17 | 4.01 | NA | XXX | |||||||||||
| 77326 | A | Radiation therapy dose plan | 0.93 | 2.58 | NA | 0.15 | 3.66 | NA | XXX | ||||||||||||
| 77326 | 26 | A | Radiation therapy dose plan | 0.93 | 0.34 | 0.34 | 0.04 | 1.31 | 1.31 | XXX | |||||||||||
| 77326 | TC | A | Radiation therapy dose plan | 0.00 | 2.24 | NA | 0.11 | 2.35 | NA | XXX | |||||||||||
| 77327 | A | Radiation therapy dose plan | 1.39 | 3.80 | NA | 0.21 | 5.40 | NA | XXX | ||||||||||||
| 77327 | 26 | A | Radiation therapy dose plan | 1.39 | 0.50 | 0.50 | 0.06 | 1.95 | 1.95 | XXX | |||||||||||
| 77327 | TC | A | Radiation therapy dose plan | 0.00 | 3.30 | NA | 0.15 | 3.45 | NA | XXX | |||||||||||
| 77328 | A | Radiation therapy dose plan | 2.09 | 5.46 | NA | 0.30 | 7.85 | NA | XXX | ||||||||||||
| 77328 | 26 | A | Radiation therapy dose plan | 2.09 | 0.75 | 0.75 | 0.09 | 2.93 | 2.93 | XXX | |||||||||||
| 77328 | TC | A | Radiation therapy dose plan | 0.00 | 4.71 | NA | 0.21 | 4.92 | NA | XXX | |||||||||||
| 77331 | A | Special radiation dosimetry | 0.87 | 0.79 | NA | 0.06 | 1.72 | NA | XXX | ||||||||||||
| 77331 | 26 | A | Special radiation dosimetry | 0.87 | 0.31 | 0.31 | 0.04 | 1.22 | 1.22 | XXX | |||||||||||
| 77331 | TC | A | Special radiation dosimetry | 0.00 | 0.48 | NA | 0.02 | 0.50 | NA | XXX | |||||||||||
| 77332 | A | Radiation treatment aid(s) | 0.54 | 1.47 | NA | 0.08 | 2.09 | NA | XXX | ||||||||||||
| 77332 | 26 | A | Radiation treatment aid(s) | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 77332 | TC | A | Radiation treatment aid(s) | 0.00 | 1.28 | NA | 0.06 | 1.34 | NA | XXX | |||||||||||
| 77333 | A | Radiation treatment aid(s) | 0.84 | 2.10 | NA | 0.13 | 3.07 | NA | XXX | ||||||||||||
| 77333 | 26 | A | Radiation treatment aid(s) | 0.84 | 0.30 | 0.30 | 0.04 | 1.18 | 1.18 | XXX | |||||||||||
| 77333 | TC | A | Radiation treatment aid(s) | 0.00 | 1.80 | NA | 0.09 | 1.89 | NA | XXX | |||||||||||
| 77334 | A | Radiation treatment aid(s) | 1.24 | 3.54 | NA | 0.19 | 4.97 | NA | XXX | ||||||||||||
| 77334 | 26 | A | Radiation treatment aid(s) | 1.24 | 0.45 | 0.45 | 0.05 | 1.74 | 1.74 | XXX | |||||||||||
| 77334 | TC | A | Radiation treatment aid(s) | 0.00 | 3.09 | NA | 0.14 | 3.23 | NA | XXX | |||||||||||
| 77336 | A | Radiation physics consult | 0.00 | 2.83 | NA | 0.13 | 2.96 | NA | XXX | ||||||||||||
| 77370 | A | Radiation physics consult | 0.00 | 3.31 | NA | 0.15 | 3.46 | NA | XXX | ||||||||||||
| 77399 | C | External radiation dosimetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77399 | 26 | C | External radiation dosimetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77399 | TC | C | External radiation dosimetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77401 | A | Radiation treatment delivery | 0.00 | 1.68 | NA | 0.09 | 1.77 | NA | XXX | ||||||||||||
| 77402 | A | Radiation treatment delivery | 0.00 | 1.68 | NA | 0.09 | 1.77 | NA | XXX | ||||||||||||
| 77403 | A | Radiation treatment delivery | 0.00 | 1.68 | NA | 0.09 | 1.77 | NA | XXX | ||||||||||||
| 77404 | A | Radiation treatment delivery | 0.00 | 1.68 | NA | 0.09 | 1.77 | NA | XXX | ||||||||||||
| 77406 | A | Radiation treatment delivery | 0.00 | 1.68 | NA | 0.09 | 1.77 | NA | XXX | ||||||||||||
| 77407 | A | Radiation treatment delivery | 0.00 | 1.98 | NA | 0.10 | 2.08 | NA | XXX | ||||||||||||
| 77408 | A | Radiation treatment delivery | 0.00 | 1.98 | NA | 0.10 | 2.08 | NA | XXX | ||||||||||||
| 77409 | A | Radiation treatment delivery | 0.00 | 1.98 | NA | 0.10 | 2.08 | NA | XXX | ||||||||||||
| 77411 | A | Radiation treatment delivery | 0.00 | 1.98 | NA | 0.10 | 2.08 | NA | XXX | ||||||||||||
| 77412 | A | Radiation treatment delivery | 0.00 | 2.21 | NA | 0.11 | 2.32 | NA | XXX | ||||||||||||
| 77413 | A | Radiation treatment delivery | 0.00 | 2.21 | NA | 0.11 | 2.32 | NA | XXX | ||||||||||||
| 77414 | A | Radiation treatment delivery | 0.00 | 2.21 | NA | 0.11 | 2.32 | NA | XXX | ||||||||||||
| 77416 | A | Radiation treatment delivery | 0.00 | 2.21 | NA | 0.11 | 2.32 | NA | XXX | ||||||||||||
| 77417 | A | Radiology port film(s) | 0.00 | 0.56 | NA | 0.03 | 0.59 | NA | XXX | ||||||||||||
| 77418 | A | Radiation tx delivery, imrt | 0.00 | 16.07 | NA | 0.11 | 16.18 | NA | XXX | ||||||||||||
| 77427 | A | Radiation tx management, x5 | 3.31 | 1.19 | 1.19 | 0.14 | 4.64 | 4.64 | XXX | ||||||||||||
| 77431 | A | Radiation therapy management | 1.81 | 0.73 | 0.73 | 0.07 | 2.61 | 2.61 | XXX | ||||||||||||
| 77432 | A | Stereotactic radiation trmt | 7.93 | 3.25 | 3.25 | 0.33 | 11.51 | 11.51 | XXX | ||||||||||||
| 77470 | A | Special radiation treatment | 2.09 | 11.34 | NA | 0.58 | 14.01 | NA | XXX | ||||||||||||
| 77470 | 26 | A | Special radiation treatment | 2.09 | 0.75 | 0.75 | 0.09 | 2.93 | 2.93 | XXX | |||||||||||
| 77470 | TC | A | Special radiation treatment | 0.00 | 10.59 | NA | 0.49 | 11.08 | NA | XXX | |||||||||||
| 77499 | C | Radiation therapy management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77499 | 26 | C | Radiation therapy management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77499 | TC | C | Radiation therapy management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77520 | C | Proton trmt, simple w/o comp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77522 | C | Proton trmt, simple w/comp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77523 | C | Proton trmt, intermediate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77525 | C | Proton treatment, complex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77600 | R | Hyperthermia treatment | 1.56 | 3.44 | NA | 0.21 | 5.21 | NA | XXX | ||||||||||||
| 77600 | 26 | R | Hyperthermia treatment | 1.56 | 0.55 | 0.55 | 0.08 | 2.19 | 2.19 | XXX | |||||||||||
| 77600 | TC | R | Hyperthermia treatment | 0.00 | 2.89 | NA | 0.13 | 3.02 | NA | XXX | |||||||||||
| 77605 | R | Hyperthermia treatment | 2.09 | 4.62 | NA | 0.31 | 7.02 | NA | XXX | ||||||||||||
| 77605 | 26 | R | Hyperthermia treatment | 2.09 | 0.76 | 0.76 | 0.13 | 2.98 | 2.98 | XXX | |||||||||||
| 77605 | TC | R | Hyperthermia treatment | 0.00 | 3.86 | NA | 0.18 | 4.04 | NA | XXX | |||||||||||
| 77610 | R | Hyperthermia treatment | 1.56 | 3.44 | NA | 0.20 | 5.20 | NA | XXX | ||||||||||||
| 77610 | 26 | R | Hyperthermia treatment | 1.56 | 0.55 | 0.55 | 0.07 | 2.18 | 2.18 | XXX | |||||||||||
| 77610 | TC | R | Hyperthermia treatment | 0.00 | 2.89 | NA | 0.13 | 3.02 | NA | XXX | |||||||||||
| 77615 | R | Hyperthermia treatment | 2.09 | 4.60 | NA | 0.27 | 6.96 | NA | XXX | ||||||||||||
| 77615 | 26 | R | Hyperthermia treatment | 2.09 | 0.74 | 0.74 | 0.09 | 2.92 | 2.92 | XXX | |||||||||||
| 77615 | TC | R | Hyperthermia treatment | 0.00 | 3.86 | NA | 0.18 | 4.04 | NA | XXX | |||||||||||
| 77620 | R | Hyperthermia treatment | 1.56 | 3.47 | NA | 0.19 | 5.22 | NA | XXX | ||||||||||||
| 77620 | 26 | R | Hyperthermia treatment | 1.56 | 0.58 | 0.58 | 0.06 | 2.20 | 2.20 | XXX | |||||||||||
| 77620 | TC | R | Hyperthermia treatment | 0.00 | 2.89 | NA | 0.13 | 3.02 | NA | XXX | |||||||||||
| 77750 | A | Infuse radioactive materials | 4.91 | 3.04 | NA | 0.23 | 8.18 | NA | 090 | ||||||||||||
| 77750 | 26 | A | Infuse radioactive materials | 4.91 | 1.77 | 1.77 | 0.17 | 6.85 | 6.85 | 090 | |||||||||||
| 77750 | TC | A | Infuse radioactive materials | 0.00 | 1.27 | NA | 0.06 | 1.33 | NA | 090 | |||||||||||
| 77761 | A | Apply intrcav radiat simple | 3.81 | 3.51 | NA | 0.28 | 7.60 | NA | 090 | ||||||||||||
| 77761 | 26 | A | Apply intrcav radiat simple | 3.81 | 1.13 | 1.13 | 0.16 | 5.10 | 5.10 | 090 | |||||||||||
| 77761 | TC | A | Apply intrcav radiat simple | 0.00 | 2.38 | NA | 0.12 | 2.50 | NA | 090 | |||||||||||
| 77762 | A | Apply intrcav radiat interm | 5.72 | 5.42 | NA | 0.38 | 11.52 | NA | 090 | ||||||||||||
| 77762 | 26 | A | Apply intrcav radiat interm | 5.72 | 1.99 | 1.99 | 0.22 | 7.93 | 7.93 | 090 | |||||||||||
| 77762 | TC | A | Apply intrcav radiat interm | 0.00 | 3.43 | NA | 0.16 | 3.59 | NA | 090 | |||||||||||
| 77763 | A | Apply intrcav radiat compl | 8.57 | 7.38 | NA | 0.53 | 16.48 | NA | 090 | ||||||||||||
| 77763 | 26 | A | Apply intrcav radiat compl | 8.57 | 3.12 | 3.12 | 0.34 | 12.03 | 12.03 | 090 | |||||||||||
| 77763 | TC | A | Apply intrcav radiat compl | 0.00 | 4.26 | NA | 0.19 | 4.45 | NA | 090 | |||||||||||
| 77776 | A | Apply interstit radiat simpl | 4.66 | 3.72 | NA | 0.35 | 8.73 | NA | 090 | ||||||||||||
| 77776 | 26 | A | Apply interstit radiat simpl | 4.66 | 1.65 | 1.65 | 0.24 | 6.55 | 6.55 | 090 | |||||||||||
| 77776 | TC | A | Apply interstit radiat simpl | 0.00 | 2.07 | NA | 0.11 | 2.18 | NA | 090 | |||||||||||
| 77777 | A | Apply interstit radiat inter | 7.48 | 6.37 | NA | 0.50 | 14.35 | NA | 090 | ||||||||||||
| 77777 | 26 | A | Apply interstit radiat inter | 7.48 | 2.35 | 2.35 | 0.32 | 10.15 | 10.15 | 090 | |||||||||||
| 77777 | TC | A | Apply interstit radiat inter | 0.00 | 4.02 | NA | 0.18 | 4.20 | NA | 090 | |||||||||||
| 77778 | A | Apply iterstit radiat compl | 11.19 | 8.90 | NA | 0.69 | 20.78 | NA | 090 | ||||||||||||
| 77778 | 26 | A | Apply iterstit radiat compl | 11.19 | 4.02 | 4.02 | 0.47 | 15.68 | 15.68 | 090 | |||||||||||
| 77778 | TC | A | Apply iterstit radiat compl | 0.00 | 4.88 | NA | 0.22 | 5.10 | NA | 090 | |||||||||||
| 77781 | A | High intensity brachytherapy | 1.66 | 19.88 | NA | 0.95 | 22.49 | NA | 090 | ||||||||||||
| 77781 | 26 | A | High intensity brachytherapy | 1.66 | 0.60 | 0.60 | 0.07 | 2.33 | 2.33 | 090 | |||||||||||
| 77781 | TC | A | High intensity brachytherapy | 0.00 | 19.28 | NA | 0.88 | 20.16 | NA | 090 | |||||||||||
| 77782 | A | High intensity brachytherapy | 2.49 | 20.18 | NA | 0.98 | 23.65 | NA | 090 | ||||||||||||
| 77782 | 26 | A | High intensity brachytherapy | 2.49 | 0.90 | 0.90 | 0.10 | 3.49 | 3.49 | 090 | |||||||||||
| 77782 | TC | A | High intensity brachytherapy | 0.00 | 19.28 | NA | 0.88 | 20.16 | NA | 090 | |||||||||||
| 77783 | A | High intensity brachytherapy | 3.73 | 20.62 | NA | 1.03 | 25.38 | NA | 090 | ||||||||||||
| 77783 | 26 | A | High intensity brachytherapy | 3.73 | 1.34 | 1.34 | 0.15 | 5.22 | 5.22 | 090 | |||||||||||
| 77783 | TC | A | High intensity brachytherapy | 0.00 | 19.28 | NA | 0.88 | 20.16 | NA | 090 | |||||||||||
| 77784 | A | High intensity brachytherapy | 5.61 | 21.30 | NA | 1.10 | 28.01 | NA | 090 | ||||||||||||
| 77784 | 26 | A | High intensity brachytherapy | 5.61 | 2.02 | 2.02 | 0.22 | 7.85 | 7.85 | 090 | |||||||||||
| 77784 | TC | A | High intensity brachytherapy | 0.00 | 19.28 | NA | 0.88 | 20.16 | NA | 090 | |||||||||||
| 77789 | A | Apply surface radiation | 1.12 | 0.84 | NA | 0.05 | 2.01 | NA | 090 | ||||||||||||
| 77789 | 26 | A | Apply surface radiation | 1.12 | 0.41 | 0.41 | 0.03 | 1.56 | 1.56 | 090 | |||||||||||
| 77789 | TC | A | Apply surface radiation | 0.00 | 0.43 | NA | 0.02 | 0.45 | NA | 090 | |||||||||||
| 77790 | A | Radiation handling | 1.05 | 0.86 | NA | 0.06 | 1.97 | NA | XXX | ||||||||||||
| 77790 | 26 | A | Radiation handling | 1.05 | 0.38 | 0.38 | 0.04 | 1.47 | 1.47 | XXX | |||||||||||
| 77790 | TC | A | Radiation handling | 0.00 | 0.48 | NA | 0.02 | 0.50 | NA | XXX | |||||||||||
| 77799 | C | Radium/radioisotope therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 77799 | 26 | C | Radium/radioisotope therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 77799 | TC | C | Radium/radioisotope therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78000 | A | Thyroid, single uptake | 0.19 | 0.99 | NA | 0.06 | 1.24 | NA | XXX | ||||||||||||
| 78000 | 26 | A | Thyroid, single uptake | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX | |||||||||||
| 78000 | TC | A | Thyroid, single uptake | 0.00 | 0.92 | NA | 0.05 | 0.97 | NA | XXX | |||||||||||
| 78001 | A | Thyroid, multiple uptakes | 0.26 | 1.33 | NA | 0.07 | 1.66 | NA | XXX | ||||||||||||
| 78001 | 26 | A | Thyroid, multiple uptakes | 0.26 | 0.09 | 0.09 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 78001 | TC | A | Thyroid, multiple uptakes | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 78003 | A | Thyroid suppress/stimul | 0.33 | 1.04 | NA | 0.06 | 1.43 | NA | XXX | ||||||||||||
| 78003 | 26 | A | Thyroid suppress/stimul | 0.33 | 0.12 | 0.12 | 0.01 | 0.46 | 0.46 | XXX | |||||||||||
| 78003 | TC | A | Thyroid suppress/stimul | 0.00 | 0.92 | NA | 0.05 | 0.97 | NA | XXX | |||||||||||
| 78006 | A | Thyroid imaging with uptake | 0.49 | 2.44 | NA | 0.13 | 3.06 | NA | XXX | ||||||||||||
| 78006 | 26 | A | Thyroid imaging with uptake | 0.49 | 0.18 | 0.18 | 0.02 | 0.69 | 0.69 | XXX | |||||||||||
| 78006 | TC | A | Thyroid imaging with uptake | 0.00 | 2.26 | NA | 0.11 | 2.37 | NA | XXX | |||||||||||
| 78007 | A | Thyroid image, mult uptakes | 0.50 | 2.62 | NA | 0.14 | 3.26 | NA | XXX | ||||||||||||
| 78007 | 26 | A | Thyroid image, mult uptakes | 0.50 | 0.18 | 0.18 | 0.02 | 0.70 | 0.70 | XXX | |||||||||||
| 78007 | TC | A | Thyroid image, mult uptakes | 0.00 | 2.44 | NA | 0.12 | 2.56 | NA | XXX | |||||||||||
| 78010 | A | Thyroid imaging | 0.39 | 1.87 | NA | 0.11 | 2.37 | NA | XXX | ||||||||||||
| 78010 | 26 | A | Thyroid imaging | 0.39 | 0.14 | 0.14 | 0.02 | 0.55 | 0.55 | XXX | |||||||||||
| 78010 | TC | A | Thyroid imaging | 0.00 | 1.73 | NA | 0.09 | 1.82 | NA | XXX | |||||||||||
| 78011 | A | Thyroid imaging with flow | 0.45 | 2.45 | NA | 0.13 | 3.03 | NA | XXX | ||||||||||||
| 78011 | 26 | A | Thyroid imaging with flow | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX | |||||||||||
| 78011 | TC | A | Thyroid imaging with flow | 0.00 | 2.29 | NA | 0.11 | 2.40 | NA | XXX | |||||||||||
| 78015 | A | Thyroid met imaging | 0.67 | 2.68 | NA | 0.15 | 3.50 | NA | XXX | ||||||||||||
| 78015 | 26 | A | Thyroid met imaging | 0.67 | 0.24 | 0.24 | 0.03 | 0.94 | 0.94 | XXX | |||||||||||
| 78015 | TC | A | Thyroid met imaging | 0.00 | 2.44 | NA | 0.12 | 2.56 | NA | XXX | |||||||||||
| 78016 | A | Thyroid met imaging/studies | 0.82 | 3.62 | NA | 0.18 | 4.62 | NA | XXX | ||||||||||||
| 78016 | 26 | A | Thyroid met imaging/studies | 0.82 | 0.31 | 0.31 | 0.03 | 1.16 | 1.16 | XXX | |||||||||||
| 78016 | TC | A | Thyroid met imaging/studies | 0.00 | 3.31 | NA | 0.15 | 3.46 | NA | XXX | |||||||||||
| 78018 | A | Thyroid met imaging, body | 0.86 | 5.47 | NA | 0.27 | 6.60 | NA | XXX | ||||||||||||
| 78018 | 26 | A | Thyroid met imaging, body | 0.86 | 0.32 | 0.32 | 0.03 | 1.21 | 1.21 | XXX | |||||||||||
| 78018 | TC | A | Thyroid met imaging, body | 0.00 | 5.15 | NA | 0.24 | 5.39 | NA | XXX | |||||||||||
| 78020 | A | Thyroid met uptake | 0.60 | 1.47 | NA | 0.14 | 2.21 | NA | ZZZ | ||||||||||||
| 78020 | 26 | A | Thyroid met uptake | 0.60 | 0.23 | 0.23 | 0.02 | 0.85 | 0.85 | ZZZ | |||||||||||
| 78020 | TC | A | Thyroid met uptake | 0.00 | 1.24 | NA | 0.12 | 1.36 | NA | ZZZ | |||||||||||
| 78070 | A | Parathyroid nuclear imaging | 0.82 | 2.03 | NA | 0.12 | 2.97 | NA | XXX | ||||||||||||
| 78070 | 26 | A | Parathyroid nuclear imaging | 0.82 | 0.30 | 0.30 | 0.03 | 1.15 | 1.15 | XXX | |||||||||||
| 78070 | TC | A | Parathyroid nuclear imaging | 0.00 | 1.73 | NA | 0.09 | 1.82 | NA | XXX | |||||||||||
| 78075 | A | Adrenal nuclear imaging | 0.74 | 5.44 | NA | 0.27 | 6.45 | NA | XXX | ||||||||||||
| 78075 | 26 | A | Adrenal nuclear imaging | 0.74 | 0.29 | 0.29 | 0.03 | 1.06 | 1.06 | XXX | |||||||||||
| 78075 | TC | A | Adrenal nuclear imaging | 0.00 | 5.15 | NA | 0.24 | 5.39 | NA | XXX | |||||||||||
| 78099 | C | Endocrine nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78099 | 26 | C | Endocrine nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78099 | TC | C | Endocrine nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78102 | A | Bone marrow imaging, ltd | 0.55 | 2.15 | NA | 0.12 | 2.82 | NA | XXX | ||||||||||||
| 78102 | 26 | A | Bone marrow imaging, ltd | 0.55 | 0.21 | 0.21 | 0.02 | 0.78 | 0.78 | XXX | |||||||||||
| 78102 | TC | A | Bone marrow imaging, ltd | 0.00 | 1.94 | NA | 0.10 | 2.04 | NA | XXX | |||||||||||
| 78103 | A | Bone marrow imaging, mult | 0.75 | 3.28 | NA | 0.17 | 4.20 | NA | XXX | ||||||||||||
| 78103 | 26 | A | Bone marrow imaging, mult | 0.75 | 0.27 | 0.27 | 0.03 | 1.05 | 1.05 | XXX | |||||||||||
| 78103 | TC | A | Bone marrow imaging, mult | 0.00 | 3.01 | NA | 0.14 | 3.15 | NA | XXX | |||||||||||
| 78104 | A | Bone marrow imaging, body | 0.80 | 4.16 | NA | 0.21 | 5.17 | NA | XXX | ||||||||||||
| 78104 | 26 | A | Bone marrow imaging, body | 0.80 | 0.29 | 0.29 | 0.03 | 1.12 | 1.12 | XXX | |||||||||||
| 78104 | TC | A | Bone marrow imaging, body | 0.00 | 3.87 | NA | 0.18 | 4.05 | NA | XXX | |||||||||||
| 78110 | A | Plasma volume, single | 0.19 | 0.97 | NA | 0.06 | 1.22 | NA | XXX | ||||||||||||
| 78110 | 26 | A | Plasma volume, single | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX | |||||||||||
| 78110 | TC | A | Plasma volume, single | 0.00 | 0.90 | NA | 0.05 | 0.95 | NA | XXX | |||||||||||
| 78111 | A | Plasma volume, multiple | 0.22 | 2.52 | NA | 0.13 | 2.87 | NA | XXX | ||||||||||||
| 78111 | 26 | A | Plasma volume, multiple | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 78111 | TC | A | Plasma volume, multiple | 0.00 | 2.44 | NA | 0.12 | 2.56 | NA | XXX | |||||||||||
| 78120 | A | Red cell mass, single | 0.23 | 1.73 | NA | 0.10 | 2.06 | NA | XXX | ||||||||||||
| 78120 | 26 | A | Red cell mass, single | 0.23 | 0.09 | 0.09 | 0.01 | 0.33 | 0.33 | XXX | |||||||||||
| 78120 | TC | A | Red cell mass, single | 0.00 | 1.64 | NA | 0.09 | 1.73 | NA | XXX | |||||||||||
| 78121 | A | Red cell mass, multiple | 0.32 | 2.88 | NA | 0.13 | 3.33 | NA | XXX | ||||||||||||
| 78121 | 26 | A | Red cell mass, multiple | 0.32 | 0.12 | 0.12 | 0.01 | 0.45 | 0.45 | XXX | |||||||||||
| 78121 | TC | A | Red cell mass, multiple | 0.00 | 2.76 | NA | 0.12 | 2.88 | NA | XXX | |||||||||||
| 78122 | A | Blood volume | 0.45 | 4.54 | NA | 0.22 | 5.21 | NA | XXX | ||||||||||||
| 78122 | 26 | A | Blood volume | 0.45 | 0.17 | 0.17 | 0.02 | 0.64 | 0.64 | XXX | |||||||||||
| 78122 | TC | A | Blood volume | 0.00 | 4.37 | NA | 0.20 | 4.57 | NA | XXX | |||||||||||
| 78130 | A | Red cell survival study | 0.61 | 2.93 | NA | 0.15 | 3.69 | NA | XXX | ||||||||||||
| 78130 | 26 | A | Red cell survival study | 0.61 | 0.22 | 0.22 | 0.03 | 0.86 | 0.86 | XXX | |||||||||||
| 78130 | TC | A | Red cell survival study | 0.00 | 2.71 | NA | 0.12 | 2.83 | NA | XXX | |||||||||||
| 78135 | A | Red cell survival kinetics | 0.64 | 4.86 | NA | 0.24 | 5.74 | NA | XXX | ||||||||||||
| 78135 | 26 | A | Red cell survival kinetics | 0.64 | 0.23 | 0.23 | 0.03 | 0.90 | 0.90 | XXX | |||||||||||
| 78135 | TC | A | Red cell survival kinetics | 0.00 | 4.63 | NA | 0.21 | 4.84 | NA | XXX | |||||||||||
| 78140 | A | Red cell sequestration | 0.61 | 3.95 | NA | 0.20 | 4.76 | NA | XXX | ||||||||||||
| 78140 | 26 | A | Red cell sequestration | 0.61 | 0.21 | 0.21 | 0.03 | 0.85 | 0.85 | XXX | |||||||||||
| 78140 | TC | A | Red cell sequestration | 0.00 | 3.74 | NA | 0.17 | 3.91 | NA | XXX | |||||||||||
| 78160 | A | Plasma iron turnover | 0.33 | 3.60 | NA | 0.19 | 4.12 | NA | XXX | ||||||||||||
| 78160 | 26 | A | Plasma iron turnover | 0.33 | 0.12 | 0.12 | 0.03 | 0.48 | 0.48 | XXX | |||||||||||
| 78160 | TC | A | Plasma iron turnover | 0.00 | 3.48 | NA | 0.16 | 3.64 | NA | XXX | |||||||||||
| 78162 | A | Iron absorption exam | 0.45 | 3.22 | NA | 0.15 | 3.82 | NA | XXX | ||||||||||||
| 78162 | 26 | A | Iron absorption exam | 0.45 | 0.18 | 0.18 | 0.01 | 0.64 | 0.64 | XXX | |||||||||||
| 78162 | TC | A | Iron absorption exam | 0.00 | 3.04 | NA | 0.14 | 3.18 | NA | XXX | |||||||||||
| 78170 | A | Red cell iron utilization | 0.41 | 5.19 | NA | 0.27 | 5.87 | NA | XXX | ||||||||||||
| 78170 | 26 | A | Red cell iron utilization | 0.41 | 0.15 | 0.15 | 0.04 | 0.60 | 0.60 | XXX | |||||||||||
| 78170 | TC | A | Red cell iron utilization | 0.00 | 5.04 | NA | 0.23 | 5.27 | NA | XXX | |||||||||||
| 78172 | C | Total body iron estimation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78172 | 26 | A | Total body iron estimation | 0.53 | 0.20 | 0.20 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 78172 | TC | C | Total body iron estimation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78185 | A | Spleen imaging | 0.40 | 2.39 | NA | 0.13 | 2.92 | NA | XXX | ||||||||||||
| 78185 | 26 | A | Spleen imaging | 0.40 | 0.15 | 0.15 | 0.02 | 0.57 | 0.57 | XXX | |||||||||||
| 78185 | TC | A | Spleen imaging | 0.00 | 2.24 | NA | 0.11 | 2.35 | NA | XXX | |||||||||||
| 78190 | A | Platelet survival, kinetics | 1.09 | 5.83 | NA | 0.31 | 7.23 | NA | XXX | ||||||||||||
| 78190 | 26 | A | Platelet survival, kinetics | 1.09 | 0.40 | 0.40 | 0.06 | 1.55 | 1.55 | XXX | |||||||||||
| 78190 | TC | A | Platelet survival, kinetics | 0.00 | 5.43 | NA | 0.25 | 5.68 | NA | XXX | |||||||||||
| 78191 | A | Platelet survival | 0.61 | 7.19 | NA | 0.34 | 8.14 | NA | XXX | ||||||||||||
| 78191 | 26 | A | Platelet survival | 0.61 | 0.22 | 0.22 | 0.03 | 0.86 | 0.86 | XXX | |||||||||||
| 78191 | TC | A | Platelet survival | 0.00 | 6.97 | NA | 0.31 | 7.28 | NA | XXX | |||||||||||
| 78195 | A | Lymph system imaging | 1.20 | 4.31 | NA | 0.23 | 5.74 | NA | XXX | ||||||||||||
| 78195 | 26 | A | Lymph system imaging | 1.20 | 0.44 | 0.44 | 0.05 | 1.69 | 1.69 | XXX | |||||||||||
| 78195 | TC | A | Lymph system imaging | 0.00 | 3.87 | NA | 0.18 | 4.05 | NA | XXX | |||||||||||
| 78199 | C | Blood/lymph nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78199 | 26 | C | Blood/lymph nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78199 | TC | C | Blood/lymph nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78201 | A | Liver imaging | 0.44 | 2.40 | NA | 0.13 | 2.97 | NA | XXX | ||||||||||||
| 78201 | 26 | A | Liver imaging | 0.44 | 0.16 | 0.16 | 0.02 | 0.62 | 0.62 | XXX | |||||||||||
| 78201 | TC | A | Liver imaging | 0.00 | 2.24 | NA | 0.11 | 2.35 | NA | XXX | |||||||||||
| 78202 | A | Liver imaging with flow | 0.51 | 2.93 | NA | 0.14 | 3.58 | NA | XXX | ||||||||||||
| 78202 | 26 | A | Liver imaging with flow | 0.51 | 0.19 | 0.19 | 0.02 | 0.72 | 0.72 | XXX | |||||||||||
| 78202 | TC | A | Liver imaging with flow | 0.00 | 2.74 | NA | 0.12 | 2.86 | NA | XXX | |||||||||||
| 78205 | A | Liver imaging (3D) | 0.71 | 5.87 | NA | 0.29 | 6.87 | NA | XXX | ||||||||||||
| 78205 | 26 | A | Liver imaging (3D) | 0.71 | 0.26 | 0.26 | 0.03 | 1.00 | 1.00 | XXX | |||||||||||
| 78205 | TC | A | Liver imaging (3D) | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 78206 | A | Liver image (3d) w/flow | 0.96 | 5.96 | NA | 0.13 | 7.05 | NA | XXX | ||||||||||||
| 78206 | 26 | A | Liver image (3d) w/flow | 0.96 | 0.35 | 0.35 | 0.04 | 1.35 | 1.35 | XXX | |||||||||||
| 78206 | TC | A | Liver image (3d) w/flow | 0.00 | 5.61 | NA | 0.09 | 5.70 | NA | XXX | |||||||||||
| 78215 | A | Liver and spleen imaging | 0.49 | 2.97 | NA | 0.14 | 3.60 | NA | XXX | ||||||||||||
| 78215 | 26 | A | Liver and spleen imaging | 0.49 | 0.18 | 0.18 | 0.02 | 0.69 | 0.69 | XXX | |||||||||||
| 78215 | TC | A | Liver and spleen imaging | 0.00 | 2.79 | NA | 0.12 | 2.91 | NA | XXX | |||||||||||
| 78216 | A | Liver spleen image/flow | 0.57 | 3.52 | NA | 0.17 | 4.26 | NA | XXX | ||||||||||||
| 78216 | 26 | A | Liver spleen image/flow | 0.57 | 0.21 | 0.21 | 0.02 | 0.80 | 0.80 | XXX | |||||||||||
| 78216 | TC | A | Liver spleen image/flow | 0.00 | 3.31 | NA | 0.15 | 3.46 | NA | XXX | |||||||||||
| 78220 | A | Liver function study | 0.49 | 3.72 | NA | 0.18 | 4.39 | NA | XXX | ||||||||||||
| 78220 | 26 | A | Liver function study | 0.49 | 0.18 | 0.18 | 0.02 | 0.69 | 0.69 | XXX | |||||||||||
| 78220 | TC | A | Liver function study | 0.00 | 3.54 | NA | 0.16 | 3.70 | NA | XXX | |||||||||||
| 78223 | A | Hepatobiliary imaging | 0.84 | 3.78 | NA | 0.20 | 4.82 | NA | XXX | ||||||||||||
| 78223 | 26 | A | Hepatobiliary imaging | 0.84 | 0.30 | 0.30 | 0.04 | 1.18 | 1.18 | XXX | |||||||||||
| 78223 | TC | A | Hepatobiliary imaging | 0.00 | 3.48 | NA | 0.16 | 3.64 | NA | XXX | |||||||||||
| 78230 | A | Salivary gland imaging | 0.45 | 2.23 | NA | 0.13 | 2.81 | NA | XXX | ||||||||||||
| 78230 | 26 | A | Salivary gland imaging | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX | |||||||||||
| 78230 | TC | A | Salivary gland imaging | 0.00 | 2.07 | NA | 0.11 | 2.18 | NA | XXX | |||||||||||
| 78231 | A | Serial salivary imaging | 0.52 | 3.21 | NA | 0.16 | 3.89 | NA | XXX | ||||||||||||
| 78231 | 26 | A | Serial salivary imaging | 0.52 | 0.20 | 0.20 | 0.02 | 0.74 | 0.74 | XXX | |||||||||||
| 78231 | TC | A | Serial salivary imaging | 0.00 | 3.01 | NA | 0.14 | 3.15 | NA | XXX | |||||||||||
| 78232 | A | Salivary gland function exam | 0.47 | 3.54 | NA | 0.16 | 4.17 | NA | XXX | ||||||||||||
| 78232 | 26 | A | Salivary gland function exam | 0.47 | 0.18 | 0.18 | 0.01 | 0.66 | 0.66 | XXX | |||||||||||
| 78232 | TC | A | Salivary gland function exam | 0.00 | 3.36 | NA | 0.15 | 3.51 | NA | XXX | |||||||||||
| 78258 | A | Esophageal motility study | 0.74 | 3.01 | NA | 0.15 | 3.90 | NA | XXX | ||||||||||||
| 78258 | 26 | A | Esophageal motility study | 0.74 | 0.27 | 0.27 | 0.03 | 1.04 | 1.04 | XXX | |||||||||||
| 78258 | TC | A | Esophageal motility study | 0.00 | 2.74 | NA | 0.12 | 2.86 | NA | XXX | |||||||||||
| 78261 | A | Gastric mucosa imaging | 0.69 | 4.15 | NA | 0.21 | 5.05 | NA | XXX | ||||||||||||
| 78261 | 26 | A | Gastric mucosa imaging | 0.69 | 0.26 | 0.26 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 78261 | TC | A | Gastric mucosa imaging | 0.00 | 3.89 | NA | 0.18 | 4.07 | NA | XXX | |||||||||||
| 78262 | A | Gastroesophageal reflux exam | 0.68 | 4.29 | NA | 0.21 | 5.18 | NA | XXX | ||||||||||||
| 78262 | 26 | A | Gastroesophageal reflux exam | 0.68 | 0.25 | 0.25 | 0.03 | 0.96 | 0.96 | XXX | |||||||||||
| 78262 | TC | A | Gastroesophageal reflux exam | 0.00 | 4.04 | NA | 0.18 | 4.22 | NA | XXX | |||||||||||
| 78264 | A | Gastric emptying study | 0.78 | 4.20 | NA | 0.21 | 5.19 | NA | XXX | ||||||||||||
| 78264 | 26 | A | Gastric emptying study | 0.78 | 0.28 | 0.28 | 0.03 | 1.09 | 1.09 | XXX | |||||||||||
| 78264 | TC | A | Gastric emptying study | 0.00 | 3.92 | NA | 0.18 | 4.10 | NA | XXX | |||||||||||
| 78267 | X | Breath tst attain/anal c-14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78268 | X | Breath test analysis, c-14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78270 | A | Vit B-12 absorption exam | 0.20 | 1.54 | NA | 0.09 | 1.83 | NA | XXX | ||||||||||||
| 78270 | 26 | A | Vit B-12 absorption exam | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX | |||||||||||
| 78270 | TC | A | Vit B-12 absorption exam | 0.00 | 1.47 | NA | 0.08 | 1.55 | NA | XXX | |||||||||||
| 78271 | A | Vit B-12 absorp exam, IF | 0.20 | 1.63 | NA | 0.09 | 1.92 | NA | XXX | ||||||||||||
| 78271 | 26 | A | Vit B-12 absorp exam, IF | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX | |||||||||||
| 78271 | TC | A | Vit B-12 absorp exam, IF | 0.00 | 1.56 | NA | 0.08 | 1.64 | NA | XXX | |||||||||||
| 78272 | A | Vit B-12 absorp, combined | 0.27 | 2.30 | NA | 0.12 | 2.69 | NA | XXX | ||||||||||||
| 78272 | 26 | A | Vit B-12 absorp, combined | 0.27 | 0.10 | 0.10 | 0.01 | 0.38 | 0.38 | XXX | |||||||||||
| 78272 | TC | A | Vit B-12 absorp, combined | 0.00 | 2.20 | NA | 0.11 | 2.31 | NA | XXX | |||||||||||
| 78278 | A | Acute GI blood loss imaging | 0.99 | 4.98 | NA | 0.25 | 6.22 | NA | XXX | ||||||||||||
| 78278 | 26 | A | Acute GI blood loss imaging | 0.99 | 0.35 | 0.35 | 0.04 | 1.38 | 1.38 | XXX | |||||||||||
| 78278 | TC | A | Acute GI blood loss imaging | 0.00 | 4.63 | NA | 0.21 | 4.84 | NA | XXX | |||||||||||
| 78282 | C | GI protein loss exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78282 | 26 | A | GI protein loss exam | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX | |||||||||||
| 78282 | TC | C | GI protein loss exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78290 | A | Meckel's divert exam | 0.68 | 3.13 | NA | 0.16 | 3.97 | NA | XXX | ||||||||||||
| 78290 | 26 | A | Meckel's divert exam | 0.68 | 0.24 | 0.24 | 0.03 | 0.95 | 0.95 | XXX | |||||||||||
| 78290 | TC | A | Meckel's divert exam | 0.00 | 2.89 | NA | 0.13 | 3.02 | NA | XXX | |||||||||||
| 78291 | A | Leveen/shunt patency exam | 0.88 | 3.23 | NA | 0.17 | 4.28 | NA | XXX | ||||||||||||
| 78291 | 26 | A | Leveen/shunt patency exam | 0.88 | 0.32 | 0.32 | 0.04 | 1.24 | 1.24 | XXX | |||||||||||
| 78291 | TC | A | Leveen/shunt patency exam | 0.00 | 2.91 | NA | 0.13 | 3.04 | NA | XXX | |||||||||||
| 78299 | C | GI nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78299 | 26 | C | GI nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78299 | TC | C | GI nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78300 | A | Bone imaging, limited area | 0.62 | 2.58 | NA | 0.15 | 3.35 | NA | XXX | ||||||||||||
| 78300 | 26 | A | Bone imaging, limited area | 0.62 | 0.22 | 0.22 | 0.03 | 0.87 | 0.87 | XXX | |||||||||||
| 78300 | TC | A | Bone imaging, limited area | 0.00 | 2.36 | NA | 0.12 | 2.48 | NA | XXX | |||||||||||
| 78305 | A | Bone imaging, multiple areas | 0.83 | 3.78 | NA | 0.19 | 4.80 | NA | XXX | ||||||||||||
| 78305 | 26 | A | Bone imaging, multiple areas | 0.83 | 0.30 | 0.30 | 0.03 | 1.16 | 1.16 | XXX | |||||||||||
| 78305 | TC | A | Bone imaging, multiple areas | 0.00 | 3.48 | NA | 0.16 | 3.64 | NA | XXX | |||||||||||
| 78306 | A | Bone imaging, whole body | 0.86 | 4.37 | NA | 0.22 | 5.45 | NA | XXX | ||||||||||||
| 78306 | 26 | A | Bone imaging, whole body | 0.86 | 0.31 | 0.31 | 0.04 | 1.21 | 1.21 | XXX | |||||||||||
| 78306 | TC | A | Bone imaging, whole body | 0.00 | 4.06 | NA | 0.18 | 4.24 | NA | XXX | |||||||||||
| 78315 | A | Bone imaging, 3 phase | 1.02 | 4.91 | NA | 0.25 | 6.18 | NA | XXX | ||||||||||||
| 78315 | 26 | A | Bone imaging, 3 phase | 1.02 | 0.37 | 0.37 | 0.04 | 1.43 | 1.43 | XXX | |||||||||||
| 78315 | TC | A | Bone imaging, 3 phase | 0.00 | 4.54 | NA | 0.21 | 4.75 | NA | XXX | |||||||||||
| 78320 | A | Bone imaging (3D) | 1.04 | 6.00 | NA | 0.30 | 7.34 | NA | XXX | ||||||||||||
| 78320 | 26 | A | Bone imaging (3D) | 1.04 | 0.39 | 0.39 | 0.04 | 1.47 | 1.47 | XXX | |||||||||||
| 78320 | TC | A | Bone imaging (3D) | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 78350 | A | Bone mineral, single photon | 0.22 | 0.80 | NA | 0.05 | 1.07 | NA | XXX | ||||||||||||
| 78350 | 26 | A | Bone mineral, single photon | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 78350 | TC | A | Bone mineral, single photon | 0.00 | 0.72 | NA | 0.04 | 0.76 | NA | XXX | |||||||||||
| 78351 | N | Bone mineral, dual photon | +0.30 | 1.64 | 0.12 | 0.01 | 1.95 | 0.43 | XXX | ||||||||||||
| 78399 | C | Musculoskeletal nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78399 | 26 | C | Musculoskeletal nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78399 | TC | C | Musculoskeletal nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78414 | C | Non-imaging heart function | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78414 | 26 | A | Non-imaging heart function | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX | |||||||||||
| 78414 | TC | C | Non-imaging heart function | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78428 | A | Cardiac shunt imaging | 0.78 | 2.46 | NA | 0.14 | 3.38 | NA | XXX | ||||||||||||
| 78428 | 26 | A | Cardiac shunt imaging | 0.78 | 0.32 | 0.32 | 0.03 | 1.13 | 1.13 | XXX | |||||||||||
| 78428 | TC | A | Cardiac shunt imaging | 0.00 | 2.14 | NA | 0.11 | 2.25 | NA | XXX | |||||||||||
| 78445 | A | Vascular flow imaging | 0.49 | 1.94 | NA | 0.11 | 2.54 | NA | XXX | ||||||||||||
| 78445 | 26 | A | Vascular flow imaging | 0.49 | 0.18 | 0.18 | 0.02 | 0.69 | 0.69 | XXX | |||||||||||
| 78445 | TC | A | Vascular flow imaging | 0.00 | 1.76 | NA | 0.09 | 1.85 | NA | XXX | |||||||||||
| 78455 | A | Venous thrombosis study | 0.73 | 4.04 | NA | 0.20 | 4.97 | NA | XXX | ||||||||||||
| 78455 | 26 | A | Venous thrombosis study | 0.73 | 0.26 | 0.26 | 0.03 | 1.02 | 1.02 | XXX | |||||||||||
| 78455 | TC | A | Venous thrombosis study | 0.00 | 3.78 | NA | 0.17 | 3.95 | NA | XXX | |||||||||||
| 78456 | A | Acute venous thrombus image | 1.00 | 4.15 | NA | 0.28 | 5.43 | NA | XXX | ||||||||||||
| 78456 | 26 | A | Acute venous thrombus image | 1.00 | 0.37 | 0.37 | 0.04 | 1.41 | 1.41 | XXX | |||||||||||
| 78456 | TC | A | Acute venous thrombus image | 0.00 | 3.78 | NA | 0.24 | 4.02 | NA | XXX | |||||||||||
| 78457 | A | Venous thrombosis imaging | 0.77 | 2.81 | NA | 0.15 | 3.73 | NA | XXX | ||||||||||||
| 78457 | 26 | A | Venous thrombosis imaging | 0.77 | 0.28 | 0.28 | 0.03 | 1.08 | 1.08 | XXX | |||||||||||
| 78457 | TC | A | Venous thrombosis imaging | 0.00 | 2.53 | NA | 0.12 | 2.65 | NA | XXX | |||||||||||
| 78458 | A | Ven thrombosis images, bilat | 0.90 | 4.17 | NA | 0.20 | 5.27 | NA | XXX | ||||||||||||
| 78458 | 26 | A | Ven thrombosis images, bilat | 0.90 | 0.35 | 0.35 | 0.03 | 1.28 | 1.28 | XXX | |||||||||||
| 78458 | TC | A | Ven thrombosis images, bilat | 0.00 | 3.82 | NA | 0.17 | 3.99 | NA | XXX | |||||||||||
| 78459 | I | Heart muscle imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78459 | 26 | I | Heart muscle imaging (PET) | +1.88 | 0.75 | 0.75 | 0.08 | 2.71 | 2.71 | XXX | |||||||||||
| 78459 | TC | I | Heart muscle imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78460 | A | Heart muscle blood, single | 0.86 | 2.55 | NA | 0.14 | 3.55 | NA | XXX | ||||||||||||
| 78460 | 26 | A | Heart muscle blood, single | 0.86 | 0.31 | 0.31 | 0.03 | 1.20 | 1.20 | XXX | |||||||||||
| 78460 | TC | A | Heart muscle blood, single | 0.00 | 2.24 | NA | 0.11 | 2.35 | NA | XXX | |||||||||||
| 78461 | A | Heart muscle blood, multiple | 1.23 | 4.94 | NA | 0.26 | 6.43 | NA | XXX | ||||||||||||
| 78461 | 26 | A | Heart muscle blood, multiple | 1.23 | 0.46 | 0.46 | 0.05 | 1.74 | 1.74 | XXX | |||||||||||
| 78461 | TC | A | Heart muscle blood, multiple | 0.00 | 4.48 | NA | 0.21 | 4.69 | NA | XXX | |||||||||||
| 78464 | A | Heart image (3d), single | 1.09 | 7.12 | NA | 0.35 | 8.56 | NA | XXX | ||||||||||||
| 78464 | 26 | A | Heart image (3d), single | 1.09 | 0.41 | 0.41 | 0.04 | 1.54 | 1.54 | XXX | |||||||||||
| 78464 | TC | A | Heart image (3d), single | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 78465 | A | Heart image (3d), multiple | 1.46 | 11.76 | NA | 0.56 | 13.78 | NA | XXX | ||||||||||||
| 78465 | 26 | A | Heart image (3d), multiple | 1.46 | 0.56 | 0.56 | 0.05 | 2.07 | 2.07 | XXX | |||||||||||
| 78465 | TC | A | Heart image (3d), multiple | 0.00 | 11.20 | NA | 0.51 | 11.71 | NA | XXX | |||||||||||
| 78466 | A | Heart infarct image | 0.69 | 2.75 | NA | 0.15 | 3.59 | NA | XXX | ||||||||||||
| 78466 | 26 | A | Heart infarct image | 0.69 | 0.26 | 0.26 | 0.03 | 0.98 | 0.98 | XXX | |||||||||||
| 78466 | TC | A | Heart infarct image | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 78468 | A | Heart infarct image (ef) | 0.80 | 3.78 | NA | 0.19 | 4.77 | NA | XXX | ||||||||||||
| 78468 | 26 | A | Heart infarct image (ef) | 0.80 | 0.30 | 0.30 | 0.03 | 1.13 | 1.13 | XXX | |||||||||||
| 78468 | TC | A | Heart infarct image (ef) | 0.00 | 3.48 | NA | 0.16 | 3.64 | NA | XXX | |||||||||||
| 78469 | A | Heart infarct image (3D) | 0.92 | 5.31 | NA | 0.26 | 6.49 | NA | XXX | ||||||||||||
| 78469 | 26 | A | Heart infarct image (3D) | 0.92 | 0.35 | 0.35 | 0.03 | 1.30 | 1.30 | XXX | |||||||||||
| 78469 | TC | A | Heart infarct image (3D) | 0.00 | 4.96 | NA | 0.23 | 5.19 | NA | XXX | |||||||||||
| 78472 | A | Gated heart, planar, single | 0.98 | 5.60 | NA | 0.29 | 6.87 | NA | XXX | ||||||||||||
| 78472 | 26 | A | Gated heart, planar, single | 0.98 | 0.37 | 0.37 | 0.04 | 1.39 | 1.39 | XXX | |||||||||||
| 78472 | TC | A | Gated heart, planar, single | 0.00 | 5.23 | NA | 0.25 | 5.48 | NA | XXX | |||||||||||
| 78473 | A | Gated heart, multiple | 1.47 | 8.40 | NA | 0.40 | 10.27 | NA | XXX | ||||||||||||
| 78473 | 26 | A | Gated heart, multiple | 1.47 | 0.56 | 0.56 | 0.05 | 2.08 | 2.08 | XXX | |||||||||||
| 78473 | TC | A | Gated heart, multiple | 0.00 | 7.84 | NA | 0.35 | 8.19 | NA | XXX | |||||||||||
| 78478 | A | Heart wall motion add-on | 0.62 | 1.72 | NA | 0.10 | 2.44 | NA | ZZZ | ||||||||||||
| 78478 | 26 | A | Heart wall motion add-on | 0.62 | 0.24 | 0.24 | 0.02 | 0.88 | 0.88 | ZZZ | |||||||||||
| 78478 | TC | A | Heart wall motion add-on | 0.00 | 1.48 | NA | 0.08 | 1.56 | NA | ZZZ | |||||||||||
| 78480 | A | Heart function add-on | 0.62 | 1.72 | NA | 0.10 | 2.44 | NA | ZZZ | ||||||||||||
| 78480 | 26 | A | Heart function add-on | 0.62 | 0.24 | 0.24 | 0.02 | 0.88 | 0.88 | ZZZ | |||||||||||
| 78480 | TC | A | Heart function add-on | 0.00 | 1.48 | NA | 0.08 | 1.56 | NA | ZZZ | |||||||||||
| 78481 | A | Heart first pass, single | 0.98 | 5.35 | NA | 0.26 | 6.59 | NA | XXX | ||||||||||||
| 78481 | 26 | A | Heart first pass, single | 0.98 | 0.39 | 0.39 | 0.03 | 1.40 | 1.40 | XXX | |||||||||||
| 78481 | TC | A | Heart first pass, single | 0.00 | 4.96 | NA | 0.23 | 5.19 | NA | XXX | |||||||||||
| 78483 | A | Heart first pass, multiple | 1.47 | 8.05 | NA | 0.39 | 9.91 | NA | XXX | ||||||||||||
| 78483 | 26 | A | Heart first pass, multiple | 1.47 | 0.58 | 0.58 | 0.05 | 2.10 | 2.10 | XXX | |||||||||||
| 78483 | TC | A | Heart first pass, multiple | 0.00 | 7.47 | NA | 0.34 | 7.81 | NA | XXX | |||||||||||
| 78491 | I | Heart image (pet), single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78491 | 26 | I | Heart image (pet), single | +1.50 | 0.60 | 0.60 | 0.05 | 2.15 | 2.15 | XXX | |||||||||||
| 78491 | TC | I | Heart image (pet), single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78492 | I | Heart image (pet), multiple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78492 | 26 | I | Heart image (pet), multiple | +1.87 | 0.75 | 0.75 | 0.06 | 2.68 | 2.68 | XXX | |||||||||||
| 78492 | TC | I | Heart image (pet), multiple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78494 | A | Heart image, spect | 1.19 | 7.15 | NA | 0.29 | 8.63 | NA | XXX | ||||||||||||
| 78494 | 26 | A | Heart image, spect | 1.19 | 0.44 | 0.44 | 0.04 | 1.67 | 1.67 | XXX | |||||||||||
| 78494 | TC | A | Heart image, spect | 0.00 | 6.71 | NA | 0.25 | 6.96 | NA | XXX | |||||||||||
| 78496 | A | Heart first pass add-on | 0.50 | 6.91 | NA | 0.27 | 7.68 | NA | ZZZ | ||||||||||||
| 78496 | 26 | A | Heart first pass add-on | 0.50 | 0.20 | 0.20 | 0.02 | 0.72 | 0.72 | ZZZ | |||||||||||
| 78496 | TC | A | Heart first pass add-on | 0.00 | 6.71 | NA | 0.25 | 6.96 | NA | ZZZ | |||||||||||
| 78499 | C | Cardiovascular nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78499 | 26 | C | Cardiovascular nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78499 | TC | C | Cardiovascular nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78580 | A | Lung perfusion imaging | 0.74 | 3.53 | NA | 0.18 | 4.45 | NA | XXX | ||||||||||||
| 78580 | 26 | A | Lung perfusion imaging | 0.74 | 0.27 | 0.27 | 0.03 | 1.04 | 1.04 | XXX | |||||||||||
| 78580 | TC | A | Lung perfusion imaging | 0.00 | 3.26 | NA | 0.15 | 3.41 | NA | XXX | |||||||||||
| 78584 | A | Lung V/Q image single breath | 0.99 | 3.39 | NA | 0.18 | 4.56 | NA | XXX | ||||||||||||
| 78584 | 26 | A | Lung V/Q image single breath | 0.99 | 0.35 | 0.35 | 0.04 | 1.38 | 1.38 | XXX | |||||||||||
| 78584 | TC | A | Lung V/Q image single breath | 0.00 | 3.04 | NA | 0.14 | 3.18 | NA | XXX | |||||||||||
| 78585 | A | Lung V/Q imaging | 1.09 | 5.74 | NA | 0.30 | 7.13 | NA | XXX | ||||||||||||
| 78585 | 26 | A | Lung V/Q imaging | 1.09 | 0.39 | 0.39 | 0.05 | 1.53 | 1.53 | XXX | |||||||||||
| 78585 | TC | A | Lung V/Q imaging | 0.00 | 5.35 | NA | 0.25 | 5.60 | NA | XXX | |||||||||||
| 78586 | A | Aerosol lung image, single | 0.40 | 2.60 | NA | 0.14 | 3.14 | NA | XXX | ||||||||||||
| 78586 | 26 | A | Aerosol lung image, single | 0.40 | 0.14 | 0.14 | 0.02 | 0.56 | 0.56 | XXX | |||||||||||
| 78586 | TC | A | Aerosol lung image, single | 0.00 | 2.46 | NA | 0.12 | 2.58 | NA | XXX | |||||||||||
| 78587 | A | Aerosol lung image, multiple | 0.49 | 2.84 | NA | 0.14 | 3.47 | NA | XXX | ||||||||||||
| 78587 | 26 | A | Aerosol lung image, multiple | 0.49 | 0.18 | 0.18 | 0.02 | 0.69 | 0.69 | XXX | |||||||||||
| 78587 | TC | A | Aerosol lung image, multiple | 0.00 | 2.66 | NA | 0.12 | 2.78 | NA | XXX | |||||||||||
| 78588 | A | Perfusion lung image | 1.09 | 3.43 | NA | 0.20 | 4.72 | NA | XXX | ||||||||||||
| 78588 | 26 | A | Perfusion lung image | 1.09 | 0.39 | 0.39 | 0.05 | 1.53 | 1.53 | XXX | |||||||||||
| 78588 | TC | A | Perfusion lung image | 0.00 | 3.04 | NA | 0.15 | 3.19 | NA | XXX | |||||||||||
| 78591 | A | Vent image, 1 breath, 1 proj | 0.40 | 2.86 | NA | 0.14 | 3.40 | NA | XXX | ||||||||||||
| 78591 | 26 | A | Vent image, 1 breath, 1 proj | 0.40 | 0.15 | 0.15 | 0.02 | 0.57 | 0.57 | XXX | |||||||||||
| 78591 | TC | A | Vent image, 1 breath, 1 proj | 0.00 | 2.71 | NA | 0.12 | 2.83 | NA | XXX | |||||||||||
| 78593 | A | Vent image, 1 proj, gas | 0.49 | 3.46 | NA | 0.17 | 4.12 | NA | XXX | ||||||||||||
| 78593 | 26 | A | Vent image, 1 proj, gas | 0.49 | 0.18 | 0.18 | 0.02 | 0.69 | 0.69 | XXX | |||||||||||
| 78593 | TC | A | Vent image, 1 proj, gas | 0.00 | 3.28 | NA | 0.15 | 3.43 | NA | XXX | |||||||||||
| 78594 | A | Vent image, mult proj, gas | 0.53 | 4.92 | NA | 0.23 | 5.68 | NA | XXX | ||||||||||||
| 78594 | 26 | A | Vent image, mult proj, gas | 0.53 | 0.19 | 0.19 | 0.02 | 0.74 | 0.74 | XXX | |||||||||||
| 78594 | TC | A | Vent image, mult proj, gas | 0.00 | 4.73 | NA | 0.21 | 4.94 | NA | XXX | |||||||||||
| 78596 | A | Lung differential function | 1.27 | 7.17 | NA | 0.36 | 8.80 | NA | XXX | ||||||||||||
| 78596 | 26 | A | Lung differential function | 1.27 | 0.46 | 0.46 | 0.05 | 1.78 | 1.78 | XXX | |||||||||||
| 78596 | TC | A | Lung differential function | 0.00 | 6.71 | NA | 0.31 | 7.02 | NA | XXX | |||||||||||
| 78599 | C | Respiratory nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78599 | 26 | C | Respiratory nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78599 | TC | C | Respiratory nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78600 | A | Brain imaging, ltd static | 0.44 | 2.90 | NA | 0.14 | 3.48 | NA | XXX | ||||||||||||
| 78600 | 26 | A | Brain imaging, ltd static | 0.44 | 0.16 | 0.16 | 0.02 | 0.62 | 0.62 | XXX | |||||||||||
| 78600 | TC | A | Brain imaging, ltd static | 0.00 | 2.74 | NA | 0.12 | 2.86 | NA | XXX | |||||||||||
| 78601 | A | Brain imaging, ltd w/flow | 0.51 | 3.41 | NA | 0.17 | 4.09 | NA | XXX | ||||||||||||
| 78601 | 26 | A | Brain imaging, ltd w/flow | 0.51 | 0.18 | 0.18 | 0.02 | 0.71 | 0.71 | XXX | |||||||||||
| 78601 | TC | A | Brain imaging, ltd w/flow | 0.00 | 3.23 | NA | 0.15 | 3.38 | NA | XXX | |||||||||||
| 78605 | A | Brain imaging, complete | 0.53 | 3.42 | NA | 0.17 | 4.12 | NA | XXX | ||||||||||||
| 78605 | 26 | A | Brain imaging, complete | 0.53 | 0.19 | 0.19 | 0.02 | 0.74 | 0.74 | XXX | |||||||||||
| 78605 | TC | A | Brain imaging, complete | 0.00 | 3.23 | NA | 0.15 | 3.38 | NA | XXX | |||||||||||
| 78606 | A | Brain imaging, compl w/flow | 0.64 | 3.90 | NA | 0.20 | 4.74 | NA | XXX | ||||||||||||
| 78606 | 26 | A | Brain imaging, compl w/flow | 0.64 | 0.23 | 0.23 | 0.03 | 0.90 | 0.90 | XXX | |||||||||||
| 78606 | TC | A | Brain imaging, compl w/flow | 0.00 | 3.67 | NA | 0.17 | 3.84 | NA | XXX | |||||||||||
| 78607 | A | Brain imaging (3D) | 1.23 | 6.70 | NA | 0.34 | 8.27 | NA | XXX | ||||||||||||
| 78607 | 26 | A | Brain imaging (3D) | 1.23 | 0.47 | 0.47 | 0.05 | 1.75 | 1.75 | XXX | |||||||||||
| 78607 | TC | A | Brain imaging (3D) | 0.00 | 6.23 | NA | 0.29 | 6.52 | NA | XXX | |||||||||||
| 78608 | N | Brain imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78609 | N | Brain imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78610 | A | Brain flow imaging only | 0.30 | 1.61 | NA | 0.09 | 2.00 | NA | XXX | ||||||||||||
| 78610 | 26 | A | Brain flow imaging only | 0.30 | 0.11 | 0.11 | 0.01 | 0.42 | 0.42 | XXX | |||||||||||
| 78610 | TC | A | Brain flow imaging only | 0.00 | 1.50 | NA | 0.08 | 1.58 | NA | XXX | |||||||||||
| 78615 | A | Cerebral vascular flow image | 0.42 | 3.81 | NA | 0.19 | 4.42 | NA | XXX | ||||||||||||
| 78615 | 26 | A | Cerebral vascular flow image | 0.42 | 0.16 | 0.16 | 0.02 | 0.60 | 0.60 | XXX | |||||||||||
| 78615 | TC | A | Cerebral vascular flow image | 0.00 | 3.65 | NA | 0.17 | 3.82 | NA | XXX | |||||||||||
| 78630 | A | Cerebrospinal fluid scan | 0.68 | 5.02 | NA | 0.25 | 5.95 | NA | XXX | ||||||||||||
| 78630 | 26 | A | Cerebrospinal fluid scan | 0.68 | 0.24 | 0.24 | 0.03 | 0.95 | 0.95 | XXX | |||||||||||
| 78630 | TC | A | Cerebrospinal fluid scan | 0.00 | 4.78 | NA | 0.22 | 5.00 | NA | XXX | |||||||||||
| 78635 | A | CSF ventriculography | 0.61 | 2.67 | NA | 0.14 | 3.42 | NA | XXX | ||||||||||||
| 78635 | 26 | A | CSF ventriculography | 0.61 | 0.25 | 0.25 | 0.02 | 0.88 | 0.88 | XXX | |||||||||||
| 78635 | TC | A | CSF ventriculography | 0.00 | 2.42 | NA | 0.12 | 2.54 | NA | XXX | |||||||||||
| 78645 | A | CSF shunt evaluation | 0.57 | 3.47 | NA | 0.17 | 4.21 | NA | XXX | ||||||||||||
| 78645 | 26 | A | CSF shunt evaluation | 0.57 | 0.21 | 0.21 | 0.02 | 0.80 | 0.80 | XXX | |||||||||||
| 78645 | TC | A | CSF shunt evaluation | 0.00 | 3.26 | NA | 0.15 | 3.41 | NA | XXX | |||||||||||
| 78647 | A | Cerebrospinal fluid scan | 0.90 | 5.94 | NA | 0.29 | 7.13 | NA | XXX | ||||||||||||
| 78647 | 26 | A | Cerebrospinal fluid scan | 0.90 | 0.33 | 0.33 | 0.03 | 1.26 | 1.26 | XXX | |||||||||||
| 78647 | TC | A | Cerebrospinal fluid scan | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 78650 | A | CSF leakage imaging | 0.61 | 4.63 | NA | 0.22 | 5.46 | NA | XXX | ||||||||||||
| 78650 | 26 | A | CSF leakage imaging | 0.61 | 0.22 | 0.22 | 0.02 | 0.85 | 0.85 | XXX | |||||||||||
| 78650 | TC | A | CSF leakage imaging | 0.00 | 4.41 | NA | 0.20 | 4.61 | NA | XXX | |||||||||||
| 78660 | A | Nuclear exam of tear flow | 0.53 | 2.20 | NA | 0.12 | 2.85 | NA | XXX | ||||||||||||
| 78660 | 26 | A | Nuclear exam of tear flow | 0.53 | 0.19 | 0.19 | 0.02 | 0.74 | 0.74 | XXX | |||||||||||
| 78660 | TC | A | Nuclear exam of tear flow | 0.00 | 2.01 | NA | 0.10 | 2.11 | NA | XXX | |||||||||||
| 78699 | C | Nervous system nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78699 | 26 | C | Nervous system nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78699 | TC | C | Nervous system nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78700 | A | Kidney imaging, static | 0.45 | 3.05 | NA | 0.15 | 3.65 | NA | XXX | ||||||||||||
| 78700 | 26 | A | Kidney imaging, static | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX | |||||||||||
| 78700 | TC | A | Kidney imaging, static | 0.00 | 2.89 | NA | 0.13 | 3.02 | NA | XXX | |||||||||||
| 78701 | A | Kidney imaging with flow | 0.49 | 3.55 | NA | 0.17 | 4.21 | NA | XXX | ||||||||||||
| 78701 | 26 | A | Kidney imaging with flow | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX | |||||||||||
| 78701 | TC | A | Kidney imaging with flow | 0.00 | 3.38 | NA | 0.15 | 3.53 | NA | XXX | |||||||||||
| 78704 | A | Imaging renogram | 0.74 | 4.03 | NA | 0.20 | 4.97 | NA | XXX | ||||||||||||
| 78704 | 26 | A | Imaging renogram | 0.74 | 0.27 | 0.27 | 0.03 | 1.04 | 1.04 | XXX | |||||||||||
| 78704 | TC | A | Imaging renogram | 0.00 | 3.76 | NA | 0.17 | 3.93 | NA | XXX | |||||||||||
| 78707 | A | Kidney flow/function image | 0.96 | 4.59 | NA | 0.23 | 5.78 | NA | XXX | ||||||||||||
| 78707 | 26 | A | Kidney flow/function image | 0.96 | 0.35 | 0.35 | 0.04 | 1.35 | 1.35 | XXX | |||||||||||
| 78707 | TC | A | Kidney flow/function image | 0.00 | 4.24 | NA | 0.19 | 4.43 | NA | XXX | |||||||||||
| 78708 | A | Kidney flow/function image | 1.21 | 4.68 | NA | 0.24 | 6.13 | NA | XXX | ||||||||||||
| 78708 | 26 | A | Kidney flow/function image | 1.21 | 0.44 | 0.44 | 0.05 | 1.70 | 1.70 | XXX | |||||||||||
| 78708 | TC | A | Kidney flow/function image | 0.00 | 4.24 | NA | 0.19 | 4.43 | NA | XXX | |||||||||||
| 78709 | A | Kidney flow/function image | 1.41 | 4.75 | NA | 0.25 | 6.41 | NA | XXX | ||||||||||||
| 78709 | 26 | A | Kidney flow/function image | 1.41 | 0.51 | 0.51 | 0.06 | 1.98 | 1.98 | XXX | |||||||||||
| 78709 | TC | A | Kidney flow/function image | 0.00 | 4.24 | NA | 0.19 | 4.43 | NA | XXX | |||||||||||
| 78710 | A | Kidney imaging (3D) | 0.66 | 5.84 | NA | 0.29 | 6.79 | NA | XXX | ||||||||||||
| 78710 | 26 | A | Kidney imaging (3D) | 0.66 | 0.23 | 0.23 | 0.03 | 0.92 | 0.92 | XXX | |||||||||||
| 78710 | TC | A | Kidney imaging (3D) | 0.00 | 5.61 | NA | 0.26 | 5.87 | NA | XXX | |||||||||||
| 78715 | A | Renal vascular flow exam | 0.30 | 1.61 | NA | 0.09 | 2.00 | NA | XXX | ||||||||||||
| 78715 | 26 | A | Renal vascular flow exam | 0.30 | 0.11 | 0.11 | 0.01 | 0.42 | 0.42 | XXX | |||||||||||
| 78715 | TC | A | Renal vascular flow exam | 0.00 | 1.50 | NA | 0.08 | 1.58 | NA | XXX | |||||||||||
| 78725 | A | Kidney function study | 0.38 | 1.83 | NA | 0.10 | 2.31 | NA | XXX | ||||||||||||
| 78725 | 26 | A | Kidney function study | 0.38 | 0.14 | 0.14 | 0.01 | 0.53 | 0.53 | XXX | |||||||||||
| 78725 | TC | A | Kidney function study | 0.00 | 1.69 | NA | 0.09 | 1.78 | NA | XXX | |||||||||||
| 78730 | A | Urinary bladder retention | 0.36 | 1.52 | NA | 0.09 | 1.97 | NA | XXX | ||||||||||||
| 78730 | 26 | A | Urinary bladder retention | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX | |||||||||||
| 78730 | TC | A | Urinary bladder retention | 0.00 | 1.39 | NA | 0.07 | 1.46 | NA | XXX | |||||||||||
| 78740 | A | Ureteral reflux study | 0.57 | 2.22 | NA | 0.12 | 2.91 | NA | XXX | ||||||||||||
| 78740 | 26 | A | Ureteral reflux study | 0.57 | 0.21 | 0.21 | 0.02 | 0.80 | 0.80 | XXX | |||||||||||
| 78740 | TC | A | Ureteral reflux study | 0.00 | 2.01 | NA | 0.10 | 2.11 | NA | XXX | |||||||||||
| 78760 | A | Testicular imaging | 0.66 | 2.77 | NA | 0.15 | 3.58 | NA | XXX | ||||||||||||
| 78760 | 26 | A | Testicular imaging | 0.66 | 0.23 | 0.23 | 0.03 | 0.92 | 0.92 | XXX | |||||||||||
| 78760 | TC | A | Testicular imaging | 0.00 | 2.54 | NA | 0.12 | 2.66 | NA | XXX | |||||||||||
| 78761 | A | Testicular imaging/flow | 0.71 | 3.30 | NA | 0.17 | 4.18 | NA | XXX | ||||||||||||
| 78761 | 26 | A | Testicular imaging/flow | 0.71 | 0.26 | 0.26 | 0.03 | 1.00 | 1.00 | XXX | |||||||||||
| 78761 | TC | A | Testicular imaging/flow | 0.00 | 3.04 | NA | 0.14 | 3.18 | NA | XXX | |||||||||||
| 78799 | C | Genitourinary nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78799 | 26 | C | Genitourinary nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78799 | TC | C | Genitourinary nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78800 | A | Tumor imaging, limited area | 0.66 | 3.46 | NA | 0.18 | 4.30 | NA | XXX | ||||||||||||
| 78800 | 26 | A | Tumor imaging, limited area | 0.66 | 0.23 | 0.23 | 0.03 | 0.92 | 0.92 | XXX | |||||||||||
| 78800 | TC | A | Tumor imaging, limited area | 0.00 | 3.23 | NA | 0.15 | 3.38 | NA | XXX | |||||||||||
| 78801 | A | Tumor imaging, mult areas | 0.79 | 4.30 | NA | 0.21 | 5.30 | NA | XXX | ||||||||||||
| 78801 | 26 | A | Tumor imaging, mult areas | 0.79 | 0.29 | 0.29 | 0.03 | 1.11 | 1.11 | XXX | |||||||||||
| 78801 | TC | A | Tumor imaging, mult areas | 0.00 | 4.01 | NA | 0.18 | 4.19 | NA | XXX | |||||||||||
| 78802 | A | Tumor imaging, whole body | 0.86 | 5.57 | NA | 0.28 | 6.71 | NA | XXX | ||||||||||||
| 78802 | 26 | A | Tumor imaging, whole body | 0.86 | 0.32 | 0.32 | 0.03 | 1.21 | 1.21 | XXX | |||||||||||
| 78802 | TC | A | Tumor imaging, whole body | 0.00 | 5.25 | NA | 0.25 | 5.50 | NA | XXX | |||||||||||
| 78803 | A | Tumor imaging (3D) | 1.09 | 6.64 | NA | 0.33 | 8.06 | NA | XXX | ||||||||||||
| 78803 | 26 | A | Tumor imaging (3D) | 1.09 | 0.41 | 0.41 | 0.04 | 1.54 | 1.54 | XXX | |||||||||||
| 78803 | TC | A | Tumor imaging (3D) | 0.00 | 6.23 | NA | 0.29 | 6.52 | NA | XXX | |||||||||||
| 78805 | A | Abscess imaging, ltd area | 0.73 | 3.50 | NA | 0.18 | 4.41 | NA | XXX | ||||||||||||
| 78805 | 26 | A | Abscess imaging, ltd area | 0.73 | 0.27 | 0.27 | 0.03 | 1.03 | 1.03 | XXX | |||||||||||
| 78805 | TC | A | Abscess imaging, ltd area | 0.00 | 3.23 | NA | 0.15 | 3.38 | NA | XXX | |||||||||||
| 78806 | A | Abscess imaging, whole body | 0.86 | 6.43 | NA | 0.32 | 7.61 | NA | XXX | ||||||||||||
| 78806 | 26 | A | Abscess imaging, whole body | 0.86 | 0.32 | 0.32 | 0.03 | 1.21 | 1.21 | XXX | |||||||||||
| 78806 | TC | A | Abscess imaging, whole body | 0.00 | 6.11 | NA | 0.29 | 6.40 | NA | XXX | |||||||||||
| 78807 | A | Nuclear localization/abscess | 1.09 | 6.66 | NA | 0.33 | 8.08 | NA | XXX | ||||||||||||
| 78807 | 26 | A | Nuclear localization/abscess | 1.09 | 0.43 | 0.43 | 0.04 | 1.56 | 1.56 | XXX | |||||||||||
| 78807 | TC | A | Nuclear localization/abscess | 0.00 | 6.23 | NA | 0.29 | 6.52 | NA | XXX | |||||||||||
| 78810 | N | Tumor imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78810 | 26 | N | Tumor imaging (PET) | +1.93 | 0.77 | 0.77 | 0.09 | 2.79 | 2.79 | XXX | |||||||||||
| 78810 | TC | N | Tumor imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78890 | B | Nuclear medicine data proc | +0.05 | 1.26 | NA | 0.06 | 1.37 | NA | XXX | ||||||||||||
| 78890 | 26 | B | Nuclear medicine data proc | +0.05 | 0.02 | 0.02 | 0.01 | 0.08 | 0.08 | XXX | |||||||||||
| 78890 | TC | B | Nuclear medicine data proc | +0.00 | 1.24 | NA | 0.05 | 1.29 | NA | XXX | |||||||||||
| 78891 | B | Nuclear med data proc | +0.10 | 2.53 | NA | 0.12 | 2.75 | NA | XXX | ||||||||||||
| 78891 | 26 | B | Nuclear med data proc | +0.10 | 0.04 | 0.04 | 0.01 | 0.15 | 0.15 | XXX | |||||||||||
| 78891 | TC | B | Nuclear med data proc | +0.00 | 2.49 | NA | 0.11 | 2.60 | NA | XXX | |||||||||||
| 78990 | I | Provide diag radionuclide(s) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78999 | C | Nuclear diagnostic exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 78999 | 26 | C | Nuclear diagnostic exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 78999 | TC | C | Nuclear diagnostic exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 79000 | A | Init hyperthyroid therapy | 1.80 | 3.14 | NA | 0.19 | 5.13 | NA | XXX | ||||||||||||
| 79000 | 26 | A | Init hyperthyroid therapy | 1.80 | 0.65 | 0.65 | 0.07 | 2.52 | 2.52 | XXX | |||||||||||
| 79000 | TC | A | Init hyperthyroid therapy | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79001 | A | Repeat hyperthyroid therapy | 1.05 | 1.63 | NA | 0.10 | 2.78 | NA | XXX | ||||||||||||
| 79001 | 26 | A | Repeat hyperthyroid therapy | 1.05 | 0.39 | 0.39 | 0.04 | 1.48 | 1.48 | XXX | |||||||||||
| 79001 | TC | A | Repeat hyperthyroid therapy | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 79020 | A | Thyroid ablation | 1.81 | 3.13 | NA | 0.19 | 5.13 | NA | XXX | ||||||||||||
| 79020 | 26 | A | Thyroid ablation | 1.81 | 0.64 | 0.64 | 0.07 | 2.52 | 2.52 | XXX | |||||||||||
| 79020 | TC | A | Thyroid ablation | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79030 | A | Thyroid ablation, carcinoma | 2.10 | 3.26 | NA | 0.20 | 5.56 | NA | XXX | ||||||||||||
| 79030 | 26 | A | Thyroid ablation, carcinoma | 2.10 | 0.77 | 0.77 | 0.08 | 2.95 | 2.95 | XXX | |||||||||||
| 79030 | TC | A | Thyroid ablation, carcinoma | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79035 | A | Thyroid metastatic therapy | 2.52 | 3.43 | NA | 0.21 | 6.16 | NA | XXX | ||||||||||||
| 79035 | 26 | A | Thyroid metastatic therapy | 2.52 | 0.94 | 0.94 | 0.09 | 3.55 | 3.55 | XXX | |||||||||||
| 79035 | TC | A | Thyroid metastatic therapy | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79100 | A | Hematopoetic nuclear therapy | 1.32 | 3.00 | NA | 0.17 | 4.49 | NA | XXX | ||||||||||||
| 79100 | 26 | A | Hematopoetic nuclear therapy | 1.32 | 0.51 | 0.51 | 0.05 | 1.88 | 1.88 | XXX | |||||||||||
| 79100 | TC | A | Hematopoetic nuclear therapy | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79200 | A | Intracavitary nuclear trmt | 1.99 | 3.23 | NA | 0.19 | 5.41 | NA | XXX | ||||||||||||
| 79200 | 26 | A | Intracavitary nuclear trmt | 1.99 | 0.74 | 0.74 | 0.07 | 2.80 | 2.80 | XXX | |||||||||||
| 79200 | TC | A | Intracavitary nuclear trmt | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79300 | C | Interstitial nuclear therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 79300 | 26 | A | Interstitial nuclear therapy | 1.60 | 0.68 | 0.68 | 0.07 | 2.35 | 2.35 | XXX | |||||||||||
| 79300 | TC | C | Interstitial nuclear therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 79400 | A | Nonhemato nuclear therapy | 1.96 | 3.22 | NA | 0.20 | 5.38 | NA | XXX | ||||||||||||
| 79400 | 26 | A | Nonhemato nuclear therapy | 1.96 | 0.73 | 0.73 | 0.08 | 2.77 | 2.77 | XXX | |||||||||||
| 79400 | TC | A | Nonhemato nuclear therapy | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79420 | C | Intravascular nuclear ther | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 79420 | 26 | A | Intravascular nuclear ther | 1.51 | 0.54 | 0.54 | 0.06 | 2.11 | 2.11 | XXX | |||||||||||
| 79420 | TC | C | Intravascular nuclear ther | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 79440 | A | Nuclear joint therapy | 1.99 | 3.29 | NA | 0.20 | 5.48 | NA | XXX | ||||||||||||
| 79440 | 26 | A | Nuclear joint therapy | 1.99 | 0.80 | 0.80 | 0.08 | 2.87 | 2.87 | XXX | |||||||||||
| 79440 | TC | A | Nuclear joint therapy | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | |||||||||||
| 79900 | C | Provide ther radiopharm(s) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 79999 | C | Nuclear medicine therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 79999 | 26 | C | Nuclear medicine therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 79999 | TC | C | Nuclear medicine therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 80048 | X | Basic metabolic panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80050 | N | General health panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80051 | X | Electrolyte panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80053 | X | Comprehen metabolic panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80055 | I | Obstetric panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80061 | X | Lipid panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80069 | X | Renal function panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80072 | D | Arthritis panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80074 | X | Acute hepatitis panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80076 | X | Hepatic function panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80090 | X | Torch antibody panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80100 | X | Drug screen, qualitate/multi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80101 | X | Drug screen, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80102 | X | Drug confirmation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80103 | X | Drug analysis, tissue prep | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80150 | X | Assay of amikacin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80152 | X | Assay of amitriptyline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80154 | X | Assay of benzodiazepines | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80156 | X | Assay, carbamazepine, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80157 | X | Assay, carbamazepine, free | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80158 | X | Assay of cyclosporine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80160 | X | Assay of desipramine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80162 | X | Assay of digoxin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80164 | X | Assay, dipropylacetic acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80166 | X | Assay of doxepin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80168 | X | Assay of ethosuximide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80170 | X | Assay of gentamicin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80172 | X | Assay of gold | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80173 | X | Assay of haloperidol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80174 | X | Assay of imipramine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80176 | X | Assay of lidocaine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80178 | X | Assay of lithium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80182 | X | Assay of nortriptyline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80184 | X | Assay of phenobarbital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80185 | X | Assay of phenytoin, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80186 | X | Assay of phenytoin, free | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80188 | X | Assay of primidone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80190 | X | Assay of procainamide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80192 | X | Assay of procainamide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80194 | X | Assay of quinidine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80196 | X | Assay of salicylate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80197 | X | Assay of tacrolimus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80198 | X | Assay of theophylline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80200 | X | Assay of tobramycin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80201 | X | Assay of topiramate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80202 | X | Assay of vancomycin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80299 | X | Quantitative assay, drug | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80400 | X | Acth stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80402 | X | Acth stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80406 | X | Acth stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80408 | X | Aldosterone suppression eval | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80410 | X | Calcitonin stimul panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80412 | X | CRH stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80414 | X | Testosterone response | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80415 | X | Estradiol response panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80416 | X | Renin stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80417 | X | Renin stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80418 | X | Pituitary evaluation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80420 | X | Dexamethasone panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80422 | X | Glucagon tolerance panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80424 | X | Glucagon tolerance panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80426 | X | Gonadotropin hormone panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80428 | X | Growth hormone panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80430 | X | Growth hormone panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80432 | X | Insulin suppression panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80434 | X | Insulin tolerance panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80435 | X | Insulin tolerance panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80436 | X | Metyrapone panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80438 | X | TRH stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80439 | X | TRH stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80440 | X | TRH stimulation panel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 80500 | A | Lab pathology consultation | 0.37 | 0.21 | 0.17 | 0.01 | 0.59 | 0.55 | XXX | ||||||||||||
| 80502 | A | Lab pathology consultation | 1.33 | 0.63 | 0.61 | 0.05 | 2.01 | 1.99 | XXX | ||||||||||||
| 81000 | X | Urinalysis, nonauto w/scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81001 | X | Urinalysis, auto w/scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81002 | X | Urinalysis nonauto w/o scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81003 | X | Urinalysis, auto, w/o scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81005 | X | Urinalysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81007 | X | Urine screen for bacteria | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81015 | X | Microscopic exam of urine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81020 | X | Urinalysis, glass test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81025 | X | Urine pregnancy test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81050 | X | Urinalysis, volume measure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 81099 | X | Urinalysis test procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82000 | X | Assay of blood acetaldehyde | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82003 | X | Assay of acetaminophen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82009 | X | Test for acetone/ketones | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82010 | X | Acetone assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82013 | X | Acetylcholinesterase assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82016 | X | Acylcarnitines, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82017 | X | Acylcarnitines, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82024 | X | Assay of acth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82030 | X | Assay of adp amp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82040 | X | Assay of serum albumin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82042 | X | Assay of urine albumin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82043 | X | Microalbumin, quantitative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82044 | X | Microalbumin, semiquant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82055 | X | Assay of ethanol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82075 | X | Assay of breath ethanol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82085 | X | Assay of aldolase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82088 | X | Assay of aldosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82101 | X | Assay of urine alkaloids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82103 | X | Alpha-1-antitrypsin, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82104 | X | Alpha-1-antitrypsin, pheno | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82105 | X | Alpha-fetoprotein, serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82106 | X | Alpha-fetoprotein, amniotic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82108 | X | Assay of aluminum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82120 | X | Amines, vaginal fluid qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82127 | X | Amino acid, single qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82128 | X | Amino acids, mult qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82131 | X | Amino acids, single quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82135 | X | Assay, aminolevulinic acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82136 | X | Amino acids, quant, 2-5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82139 | X | Amino acids, quan, 6 or more | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82140 | X | Assay of ammonia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82143 | X | Amniotic fluid scan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82145 | X | Assay of amphetamines | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82150 | X | Assay of amylase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82154 | X | Androstanediol glucuronide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82157 | X | Assay of androstenedione | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82160 | X | Assay of androsterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82163 | X | Assay of angiotensin II | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82164 | X | Angiotensin I enzyme test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82172 | X | Assay of apolipoprotein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82175 | X | Assay of arsenic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82180 | X | Assay of ascorbic acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82190 | X | Atomic absorption | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82205 | X | Assay of barbiturates | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82232 | X | Assay of beta-2 protein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82239 | X | Bile acids, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82240 | X | Bile acids, cholylglycine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82247 | X | Bilirubin, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82248 | X | Bilirubin, direct | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82252 | X | Fecal bilirubin test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82261 | X | Assay of biotinidase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82270 | X | Test for blood, feces | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82273 | X | Test for blood, other source | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82274 | X | Assay test for blood, fecal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82286 | X | Assay of bradykinin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82300 | X | Assay of cadmium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82306 | X | Assay of vitamin D | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82307 | X | Assay of vitamin D | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82308 | X | Assay of calcitonin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82310 | X | Assay of calcium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82330 | X | Assay of calcium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82331 | X | Calcium infusion test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82340 | X | Assay of calcium in urine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82355 | X | Calculus analysis, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82360 | X | Calculus assay, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82365 | X | Calculus spectroscopy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82370 | X | X-ray assay, calculus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82373 | X | Assay, c-d transfer measure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82374 | X | Assay, blood carbon dioxide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82375 | X | Assay, blood carbon monoxide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82376 | X | Test for carbon monoxide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82378 | X | Carcinoembryonic antigen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82379 | X | Assay of carnitine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82380 | X | Assay of carotene | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82382 | X | Assay, urine catecholamines | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82383 | X | Assay, blood catecholamines | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82384 | X | Assay, three catecholamines | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82387 | X | Assay of cathepsin-d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82390 | X | Assay of ceruloplasmin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82397 | X | Chemiluminescent assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82415 | X | Assay of chloramphenicol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82435 | X | Assay of blood chloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82436 | X | Assay of urine chloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82438 | X | Assay, other fluid chlorides | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82441 | X | Test for chlorohydrocarbons | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82465 | X | Assay, bld/serum cholesterol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82480 | X | Assay, serum cholinesterase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82482 | X | Assay, rbc cholinesterase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82485 | X | Assay, chondroitin sulfate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82486 | X | Gas/liquid chromatography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82487 | X | Paper chromatography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82488 | X | Paper chromatography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82489 | X | Thin layer chromatography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82491 | X | Chromotography, quant, sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82492 | X | Chromotography, quant, mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82495 | X | Assay of chromium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82507 | X | Assay of citrate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82520 | X | Assay of cocaine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82523 | X | Collagen crosslinks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82525 | X | Assay of copper | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82528 | X | Assay of corticosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82530 | X | Cortisol, free | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82533 | X | Total cortisol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82540 | X | Assay of creatine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82541 | X | Column chromotography, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82542 | X | Column chromotography, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82543 | X | Column chromotograph/isotope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82544 | X | Column chromotograph/isotope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82550 | X | Assay of ck (cpk) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82552 | X | Assay of cpk in blood | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82553 | X | Creatine, MB fraction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82554 | X | Creatine, isoforms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82565 | X | Assay of creatinine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82570 | X | Assay of urine creatinine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82575 | X | Creatinine clearance test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82585 | X | Assay of cryofibrinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82595 | X | Assay of cryoglobulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82600 | X | Assay of cyanide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82607 | X | Vitamin B-12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82608 | X | B-12 binding capacity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82615 | X | Test for urine cystines | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82626 | X | Dehydroepiandrosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82627 | X | Dehydroepiandrosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82633 | X | Desoxycorticosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82634 | X | Deoxycortisol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82638 | X | Assay of dibucaine number | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82646 | X | Assay of dihydrocodeinone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82649 | X | Assay of dihydromorphinone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82651 | X | Assay of dihydrotestosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82652 | X | Assay of dihydroxyvitamin d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82654 | X | Assay of dimethadione | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82657 | X | Enzyme cell activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82658 | X | Enzyme cell activity, ra | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82664 | X | Electrophoretic test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82666 | X | Assay of epiandrosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82668 | X | Assay of erythropoietin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82670 | X | Assay of estradiol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82671 | X | Assay of estrogens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82672 | X | Assay of estrogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82677 | X | Assay of estriol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82679 | X | Assay of estrone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82690 | X | Assay of ethchlorvynol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82693 | X | Assay of ethylene glycol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82696 | X | Assay of etiocholanolone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82705 | X | Fats/lipids, feces, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82710 | X | Fats/lipids, feces, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82715 | X | Assay of fecal fat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82725 | X | Assay of blood fatty acids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82726 | X | Long chain fatty acids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82728 | X | Assay of ferritin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82731 | X | Assay of fetal fibronectin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82735 | X | Assay of fluoride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82742 | X | Assay of flurazepam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82746 | X | Blood folic acid serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82747 | X | Assay of folic acid, rbc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82757 | X | Assay of semen fructose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82759 | X | Assay of rbc galactokinase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82760 | X | Assay of galactose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82775 | X | Assay galactose transferase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82776 | X | Galactose transferase test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82784 | X | Assay of gammaglobulin igm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82785 | X | Assay of gammaglobulin ige | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82787 | X | Igg 1, 2, 3 or 4, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82800 | X | Blood pH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82803 | X | Blood gases: pH, pO2 pCO2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82805 | X | Blood gases W/02 saturation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82810 | X | Blood gases, O2 sat only | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82820 | X | Hemoglobin-oxygen affinity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82926 | X | Assay of gastric acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82928 | X | Assay of gastric acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82938 | X | Gastrin test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82941 | X | Assay of gastrin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82943 | X | Assay of glucagon | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82945 | X | Glucose other fluid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82946 | X | Glucagon tolerance test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82947 | X | Assay, glucose, blood quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82948 | X | Reagent strip/blood glucose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82950 | X | Glucose test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82951 | X | Glucose tolerance test (GTT) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82952 | X | GTT-added samples | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82953 | X | Glucose-tolbutamide test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82955 | X | Assay of g6pd enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82960 | X | Test for G6PD enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82962 | X | Glucose blood test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82963 | X | Assay of glucosidase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82965 | X | Assay of gdh enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82975 | X | Assay of glutamine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82977 | X | Assay of GGT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82978 | X | Assay of glutathione | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82979 | X | Assay, rbc glutathione | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82980 | X | Assay of glutethimide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 82985 | X | Glycated protein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83001 | X | Gonadotropin (FSH) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83002 | X | Gonadotropin (LH) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83003 | X | Assay, growth hormone (hgh) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83008 | X | Assay of guanosine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83010 | X | Assay of haptoglobin, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83012 | X | Assay of haptoglobins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83013 | X | H pylori analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83014 | X | H pylori drug admin/collect | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83015 | X | Heavy metal screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83018 | X | Quantitative screen, metals | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83020 | X | Hemoglobin electrophoresis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83020 | 26 | A | Hemoglobin electrophoresis | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 83021 | X | Hemoglobin chromotography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83026 | X | Hemoglobin, copper sulfate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83030 | X | Fetal hemoglobin, chemical | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83033 | X | Fetal hemoglobin assay, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83036 | X | Glycated hemoglobin test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83045 | X | Blood methemoglobin test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83050 | X | Blood methemoglobin assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83051 | X | Assay of plasma hemoglobin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83055 | X | Blood sulfhemoglobin test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83060 | X | Blood sulfhemoglobin assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83065 | X | Assay of hemoglobin heat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83068 | X | Hemoglobin stability screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83069 | X | Assay of urine hemoglobin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83070 | X | Assay of hemosiderin, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83071 | X | Assay of hemosiderin, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83080 | X | Assay of b hexosaminidase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83088 | X | Assay of histamine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83090 | X | Assay of homocystine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83150 | X | Assay of for hva | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83491 | X | Assay of corticosteroids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83497 | X | Assay of 5-hiaa | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83498 | X | Assay of progesterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83499 | X | Assay of progesterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83500 | X | Assay, free hydroxyproline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83505 | X | Assay, total hydroxyproline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83516 | X | Immunoassay, nonantibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83518 | X | Immunoassay, dipstick | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83519 | X | Immunoassay, nonantibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83520 | X | Immunoassay, RIA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83525 | X | Assay of insulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83527 | X | Assay of insulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83528 | X | Assay of intrinsic factor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83540 | X | Assay of iron | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83550 | X | Iron binding test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83570 | X | Assay of idh enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83582 | X | Assay of ketogenic steroids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83586 | X | Assay 17- ketosteroids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83593 | X | Fractionation, ketosteroids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83605 | X | Assay of lactic acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83615 | X | Lactate (LD) (LDH) enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83625 | X | Assay of ldh enzymes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83632 | X | Placental lactogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83633 | X | Test urine for lactose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83634 | X | Assay of urine for lactose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83655 | X | Assay of lead | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83661 | X | L/s ratio, fetal lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83662 | X | Foam stability, fetal lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83663 | X | Fluoro polarize, fetal lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83664 | X | Lamellar bdy, fetal lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83670 | X | Assay of lap enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83690 | X | Assay of lipase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83715 | X | Assay of blood lipoproteins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83716 | X | Assay of blood lipoproteins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83718 | X | Assay of lipoprotein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83719 | X | Assay of blood lipoprotein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83721 | X | Assay of blood lipoprotein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83727 | X | Assay of lrh hormone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83735 | X | Assay of magnesium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83775 | X | Assay of md enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83785 | X | Assay of manganese | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83788 | X | Mass spectrometry qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83789 | X | Mass spectrometry quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83805 | X | Assay of meprobamate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83825 | X | Assay of mercury | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83835 | X | Assay of metanephrines | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83840 | X | Assay of methadone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83857 | X | Assay of methemalbumin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83858 | X | Assay of methsuximide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83864 | X | Mucopolysaccharides | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83866 | X | Mucopolysaccharides screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83872 | X | Assay synovial fluid mucin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83873 | X | Assay of csf protein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83874 | X | Assay of myoglobin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83883 | X | Assay, nephelometry not spec | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83885 | X | Assay of nickel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83887 | X | Assay of nicotine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83890 | X | Molecule isolate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83891 | X | Molecule isolate nucleic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83892 | X | Molecular diagnostics | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83893 | X | Molecule dot/slot/blot | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83894 | X | Molecule gel electrophor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83896 | X | Molecular diagnostics | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83897 | X | Molecule nucleic transfer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83898 | X | Molecule nucleic ampli | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83901 | X | Molecule nucleic ampli | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83902 | X | Molecular diagnostics | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83903 | X | Molecule mutation scan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83904 | X | Molecule mutation identify | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83905 | X | Molecule mutation identify | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83906 | X | Molecule mutation identify | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83912 | X | Genetic examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83912 | 26 | A | Genetic examination | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 83915 | X | Assay of nucleotidase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83916 | X | Oligoclonal bands | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83918 | X | Organic acids, total, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83919 | X | Organic acids, qual, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83921 | X | Organic acid, single, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83925 | X | Assay of opiates | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83930 | X | Assay of blood osmolality | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83935 | X | Assay of urine osmolality | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83937 | X | Assay of osteocalcin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83945 | X | Assay of oxalate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83950 | X | Oncorprotein, her-2/neu | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83970 | X | Assay of parathormone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83986 | X | Assay of body fluid acidity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 83992 | X | Assay for phencyclidine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84022 | X | Assay of phenothiazine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84030 | X | Assay of blood pku | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84035 | X | Assay of phenylketones | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84060 | X | Assay acid phosphatase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84061 | X | Phosphatase, forensic exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84066 | X | Assay prostate phosphatase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84075 | X | Assay alkaline phosphatase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84078 | X | Assay alkaline phosphatase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84080 | X | Assay alkaline phosphatases | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84081 | X | Amniotic fluid enzyme test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84085 | X | Assay of rbc pg6d enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84087 | X | Assay phosphohexose enzymes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84100 | X | Assay of phosphorus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84105 | X | Assay of urine phosphorus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84106 | X | Test for porphobilinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84110 | X | Assay of porphobilinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84119 | X | Test urine for porphyrins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84120 | X | Assay of urine porphyrins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84126 | X | Assay of feces porphyrins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84127 | X | Assay of feces porphyrins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84132 | X | Assay of serum potassium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84133 | X | Assay of urine potassium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84134 | X | Assay of prealbumin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84135 | X | Assay of pregnanediol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84138 | X | Assay of pregnanetriol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84140 | X | Assay of pregnenolone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84143 | X | Assay of 17-hydroxypregneno | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84144 | X | Assay of progesterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84146 | X | Assay of prolactin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84150 | X | Assay of prostaglandin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84152 | X | Assay of psa, complexed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84153 | X | Assay of psa, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84154 | X | Assay of psa, free | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84155 | X | Assay of protein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84160 | X | Assay of serum protein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84165 | X | Assay of serum proteins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84165 | 26 | A | Assay of serum proteins | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 84181 | X | Western blot test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84181 | 26 | A | Western blot test | 0.37 | 0.15 | 0.15 | 0.01 | 0.53 | 0.53 | XXX | |||||||||||
| 84182 | X | Protein, western blot test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84182 | 26 | A | Protein, western blot test | 0.37 | 0.15 | 0.15 | 0.01 | 0.53 | 0.53 | XXX | |||||||||||
| 84202 | X | Assay RBC protoporphyrin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84203 | X | Test RBC protoporphyrin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84206 | X | Assay of proinsulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84207 | X | Assay of vitamin b-6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84210 | X | Assay of pyruvate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84220 | X | Assay of pyruvate kinase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84228 | X | Assay of quinine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84233 | X | Assay of estrogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84234 | X | Assay of progesterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84235 | X | Assay of endocrine hormone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84238 | X | Assay, nonendocrine receptor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84244 | X | Assay of renin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84252 | X | Assay of vitamin b-2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84255 | X | Assay of selenium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84260 | X | Assay of serotonin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84270 | X | Assay of sex hormone globul | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84275 | X | Assay of sialic acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84285 | X | Assay of silica | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84295 | X | Assay of serum sodium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84300 | X | Assay of urine sodium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84305 | X | Assay of somatomedin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84307 | X | Assay of somatostatin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84311 | X | Spectrophotometry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84315 | X | Body fluid specific gravity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84375 | X | Chromatogram assay, sugars | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84376 | X | Sugars, single, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84377 | X | Sugars, multiple, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84378 | X | Sugars single quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84379 | X | Sugars multiple quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84392 | X | Assay of urine sulfate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84402 | X | Assay of testosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84403 | X | Assay of total testosterone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84425 | X | Assay of vitamin b-1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84430 | X | Assay of thiocyanate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84432 | X | Assay of thyroglobulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84436 | X | Assay of total thyroxine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84437 | X | Assay of neonatal thyroxine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84439 | X | Assay of free thyroxine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84442 | X | Assay of thyroid activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84443 | X | Assay thyroid stim hormone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84445 | X | Assay of tsi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84446 | X | Assay of vitamin e | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84449 | X | Assay of transcortin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84450 | X | Transferase (AST) (SGOT) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84460 | X | Alanine amino (ALT) (SGPT) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84466 | X | Assay of transferrin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84478 | X | Assay of triglycerides | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84479 | X | Assay of thyroid (t3 or t4) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84480 | X | Assay, triiodothyronine (t3) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84481 | X | Free assay (FT-3) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84482 | X | Reverse assay (t3) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84484 | X | Assay of troponin, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84485 | X | Assay duodenal fluid trypsin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84488 | X | Test feces for trypsin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84490 | X | Assay of feces for trypsin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84510 | X | Assay of tyrosine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84512 | X | Assay of troponin, qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84520 | X | Assay of urea nitrogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84525 | X | Urea nitrogen semi-quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84540 | X | Assay of urine/urea-n | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84545 | X | Urea-N clearance test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84550 | X | Assay of blood/uric acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84560 | X | Assay of urine/uric acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84577 | X | Assay of feces/urobilinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84578 | X | Test urine urobilinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84580 | X | Assay of urine urobilinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84583 | X | Assay of urine urobilinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84585 | X | Assay of urine vma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84586 | X | Assay of vip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84588 | X | Assay of vasopressin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84590 | X | Assay of vitamin a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84591 | X | Assay of nos vitamin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84597 | X | Assay of vitamin k | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84600 | X | Assay of volatiles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84620 | X | Xylose tolerance test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84630 | X | Assay of zinc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84681 | X | Assay of c-peptide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84702 | X | Chorionic gonadotropin test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84703 | X | Chorionic gonadotropin assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84830 | X | Ovulation tests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 84999 | X | Clinical chemistry test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85002 | X | Bleeding time test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85007 | X | Differential WBC count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85008 | X | Nondifferential WBC count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85009 | X | Differential WBC count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85013 | X | Hematocrit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85014 | X | Hematocrit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85018 | X | Hemoglobin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85021 | X | Automated hemogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85022 | X | Automated hemogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85023 | X | Automated hemogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85024 | X | Automated hemogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85025 | X | Automated hemogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85027 | X | Automated hemogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85031 | X | Manual hemogram, cbc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85041 | X | Red blood cell (RBC) count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85044 | X | Reticulocyte count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85045 | X | Reticulocyte count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85046 | X | Reticyte/hgb concentrate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85048 | X | White blood cell (WBC) count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85060 | A | Blood smear interpretation | 0.45 | 0.19 | 0.19 | 0.02 | 0.66 | 0.66 | XXX | ||||||||||||
| 85095 | D | Bone marrow aspiration | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85097 | A | Bone marrow interpretation | 0.94 | 1.75 | 0.43 | 0.03 | 2.72 | 1.40 | XXX | ||||||||||||
| 85102 | D | Bone marrow biopsy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85130 | X | Chromogenic substrate assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85170 | X | Blood clot retraction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85175 | X | Blood clot lysis time | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85210 | X | Blood clot factor II test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85220 | X | Blood clot factor V test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85230 | X | Blood clot factor VII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85240 | X | Blood clot factor VIII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85244 | X | Blood clot factor VIII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85245 | X | Blood clot factor VIII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85246 | X | Blood clot factor VIII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85247 | X | Blood clot factor VIII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85250 | X | Blood clot factor IX test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85260 | X | Blood clot factor X test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85270 | X | Blood clot factor XI test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85280 | X | Blood clot factor XII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85290 | X | Blood clot factor XIII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85291 | X | Blood clot factor XIII test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85292 | X | Blood clot factor assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85293 | X | Blood clot factor assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85300 | X | Antithrombin III test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85301 | X | Antithrombin III test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85302 | X | Blood clot inhibitor antigen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85303 | X | Blood clot inhibitor test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85305 | X | Blood clot inhibitor assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85306 | X | Blood clot inhibitor test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85307 | X | Assay activated protein c | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85335 | X | Factor inhibitor test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85337 | X | Thrombomodulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85345 | X | Coagulation time | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85347 | X | Coagulation time | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85348 | X | Coagulation time | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85360 | X | Euglobulin lysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85362 | X | Fibrin degradation products | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85366 | X | Fibrinogen test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85370 | X | Fibrinogen test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85378 | X | Fibrin degradation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85379 | X | Fibrin degradation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85384 | X | Fibrinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85385 | X | Fibrinogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85390 | X | Fibrinolysins screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85390 | 26 | A | Fibrinolysins screen | 0.37 | 0.12 | 0.12 | 0.01 | 0.50 | 0.50 | XXX | |||||||||||
| 85400 | X | Fibrinolytic plasmin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85410 | X | Fibrinolytic antiplasmin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85415 | X | Fibrinolytic plasminogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85420 | X | Fibrinolytic plasminogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85421 | X | Fibrinolytic plasminogen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85441 | X | Heinz bodies, direct | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85445 | X | Heinz bodies, induced | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85460 | X | Hemoglobin, fetal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85461 | X | Hemoglobin, fetal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85475 | X | Hemolysin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85520 | X | Heparin assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85525 | X | Heparin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85530 | X | Heparin-protamine tolerance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85535 | D | Iron stain, blood cells | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85536 | X | Iron stain peripheral blood | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85540 | X | Wbc alkaline phosphatase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85547 | X | RBC mechanical fragility | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85549 | X | Muramidase | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85555 | X | RBC osmotic fragility | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85557 | X | RBC osmotic fragility | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85576 | X | Blood platelet aggregation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85576 | 26 | A | Blood platelet aggregation | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX | |||||||||||
| 85585 | X | Blood platelet estimation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85590 | X | Platelet count, manual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85595 | X | Platelet count, automated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85597 | X | Platelet neutralization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85610 | X | Prothrombin time | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85611 | X | Prothrombin test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85612 | X | Viper venom prothrombin time | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85613 | X | Russell viper venom, diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85635 | X | Reptilase test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85651 | X | Rbc sed rate, nonautomated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85652 | X | Rbc sed rate, automated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85660 | X | RBC sickle cell test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85670 | X | Thrombin time, plasma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85675 | X | Thrombin time, titer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85705 | X | Thromboplastin inhibition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85730 | X | Thromboplastin time, partial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85732 | X | Thromboplastin time, partial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85810 | X | Blood viscosity examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 85999 | X | Hematology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86000 | X | Agglutinins, febrile | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86001 | X | Allergen specific igg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86003 | X | Allergen specific IgE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86005 | X | Allergen specific IgE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86021 | X | WBC antibody identification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86022 | X | Platelet antibodies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86023 | X | Immunoglobulin assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86038 | X | Antinuclear antibodies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86039 | X | Antinuclear antibodies (ANA) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86060 | X | Antistreptolysin o, titer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86063 | X | Antistreptolysin o, screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86077 | A | Physician blood bank service | 0.94 | 0.48 | 0.43 | 0.03 | 1.45 | 1.40 | XXX | ||||||||||||
| 86078 | A | Physician blood bank service | 0.94 | 0.51 | 0.43 | 0.03 | 1.48 | 1.40 | XXX | ||||||||||||
| 86079 | A | Physician blood bank service | 0.94 | 0.50 | 0.44 | 0.03 | 1.47 | 1.41 | XXX | ||||||||||||
| 86140 | X | C-reactive protein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86141 | X | C-reactive protein, hs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86146 | X | Glycoprotein antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86147 | X | Cardiolipin antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86148 | X | Phospholipid antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86155 | X | Chemotaxis assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86156 | X | Cold agglutinin, screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86157 | X | Cold agglutinin, titer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86160 | X | Complement, antigen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86161 | X | Complement/function activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86162 | X | Complement, total (CH50) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86171 | X | Complement fixation, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86185 | X | Counterimmunoelectrophoresis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86215 | X | Deoxyribonuclease, antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86225 | X | DNA antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86226 | X | DNA antibody, single strand | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86235 | X | Nuclear antigen antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86243 | X | Fc receptor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86255 | X | Fluorescent antibody, screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86255 | 26 | A | Fluorescent antibody, screen | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 86256 | X | Fluorescent antibody, titer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86256 | 26 | A | Fluorescent antibody, titer | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 86277 | X | Growth hormone antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86280 | X | Hemagglutination inhibition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86294 | X | Immunoassay, tumor qual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86300 | X | Immunoassay, tumor ca 15-3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86301 | X | Immunoassay, tumor ca 19-9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86304 | X | Immunoassay, tumor, ca 125 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86308 | X | Heterophile antibodies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86309 | X | Heterophile antibodies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86310 | X | Heterophile antibodies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86316 | X | Immunoassay, tumor other | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86317 | X | Immunoassay, infectious agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86318 | X | Immunoassay, infectious agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86320 | X | Serum immunoelectrophoresis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86320 | 26 | A | Serum immunoelectrophoresis | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 86325 | X | Other immunoelectrophoresis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86325 | 26 | A | Other immunoelectrophoresis | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 86327 | X | Immunoelectrophoresis assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86327 | 26 | A | Immunoelectrophoresis assay | 0.42 | 0.20 | 0.20 | 0.01 | 0.63 | 0.63 | XXX | |||||||||||
| 86329 | X | Immunodiffusion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86331 | X | Immunodiffusion ouchterlony | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86332 | X | Immune complex assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86334 | X | Immunofixation procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86334 | 26 | A | Immunofixation procedure | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 86336 | X | Inhibin A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86337 | X | Insulin antibodies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86340 | X | Intrinsic factor antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86341 | X | Islet cell antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86343 | X | Leukocyte histamine release | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86344 | X | Leukocyte phagocytosis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86353 | X | Lymphocyte transformation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86359 | X | T cells, total count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86360 | X | T cell, absolute count/ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86361 | X | T cell, absolute count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86376 | X | Microsomal antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86378 | X | Migration inhibitory factor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86382 | X | Neutralization test, viral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86384 | X | Nitroblue tetrazolium dye | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86403 | X | Particle agglutination test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86406 | X | Particle agglutination test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86430 | X | Rheumatoid factor test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86431 | X | Rheumatoid factor, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86485 | C | Skin test, candida | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86490 | A | Coccidioidomycosis skin test | 0.00 | 0.28 | NA | 0.02 | 0.30 | NA | XXX | ||||||||||||
| 86510 | A | Histoplasmosis skin test | 0.00 | 0.30 | NA | 0.02 | 0.32 | NA | XXX | ||||||||||||
| 86580 | A | TB intradermal test | 0.00 | 0.24 | NA | 0.02 | 0.26 | NA | XXX | ||||||||||||
| 86585 | A | TB tine test | 0.00 | 0.19 | NA | 0.01 | 0.20 | NA | XXX | ||||||||||||
| 86586 | C | Skin test, unlisted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86590 | X | Streptokinase, antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86592 | X | Blood serology, qualitative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86593 | X | Blood serology, quantitative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86602 | X | Antinomyces antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86603 | X | Adenovirus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86606 | X | Aspergillus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86609 | X | Bacterium antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86611 | X | Bartonella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86612 | X | Blastomyces antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86615 | X | Bordetella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86617 | X | Lyme disease antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86618 | X | Lyme disease antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86619 | X | Borrelia antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86622 | X | Brucella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86625 | X | Campylobacter antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86628 | X | Candida antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86631 | X | Chlamydia antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86632 | X | Chlamydia igm antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86635 | X | Coccidioides antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86638 | X | Q fever antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86641 | X | Cryptococcus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86644 | X | CMV antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86645 | X | CMV antibody, IgM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86648 | X | Diphtheria antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86651 | X | Encephalitis antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86652 | X | Encephalitis antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86653 | X | Encephalitis antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86654 | X | Encephalitis antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86658 | X | Enterovirus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86663 | X | Epstein-barr antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86664 | X | Epstein-barr antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86665 | X | Epstein-barr antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86666 | X | Ehrlichia antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86668 | X | Francisella tularensis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86671 | X | Fungus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86674 | X | Giardia lamblia antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86677 | X | Helicobacter pylori | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86682 | X | Helminth antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86683 | D | Hemoglobin, fecal antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86684 | X | Hemophilus influenza | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86687 | X | Htlv-i antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86688 | X | Htlv-ii antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86689 | X | HTLV/HIV confirmatory test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86692 | X | Hepatitis, delta agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86694 | X | Herpes simplex test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86695 | X | Herpes simplex test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86696 | X | Herpes simplex type 2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86698 | X | Histoplasma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86701 | X | HIV-1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86702 | X | HIV-2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86703 | X | HIV-1/HIV-2, single assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86704 | X | Hep b core antibody, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86705 | X | Hep b core antibody, igm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86706 | X | Hep b surface antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86707 | X | Hep be antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86708 | X | Hep a antibody, total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86709 | X | Hep a antibody, igm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86710 | X | Influenza virus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86713 | X | Legionella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86717 | X | Leishmania antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86720 | X | Leptospira antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86723 | X | Listeria monocytogenes ab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86727 | X | Lymph choriomeningitis ab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86729 | X | Lympho venereum antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86732 | X | Mucormycosis antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86735 | X | Mumps antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86738 | X | Mycoplasma antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86741 | X | Neisseria meningitidis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86744 | X | Nocardia antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86747 | X | Parvovirus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86750 | X | Malaria antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86753 | X | Protozoa antibody nos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86756 | X | Respiratory virus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86757 | X | Rickettsia antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86759 | X | Rotavirus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86762 | X | Rubella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86765 | X | Rubeola antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86768 | X | Salmonella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86771 | X | Shigella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86774 | X | Tetanus antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86777 | X | Toxoplasma antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86778 | X | Toxoplasma antibody, igm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86781 | X | Treponema pallidum, confirm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86784 | X | Trichinella antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86787 | X | Varicella-zoster antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86790 | X | Virus antibody nos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86793 | X | Yersinia antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86800 | X | Thyroglobulin antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86803 | X | Hepatitis c ab test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86804 | X | Hep c ab test, confirm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86805 | X | Lymphocytotoxicity assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86806 | X | Lymphocytotoxicity assay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86807 | X | Cytotoxic antibody screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86808 | X | Cytotoxic antibody screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86812 | X | HLA typing, A, B, or C | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86813 | X | HLA typing, A, B, or C | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86816 | X | HLA typing, DR/DQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86817 | X | HLA typing, DR/DQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86821 | X | Lymphocyte culture, mixed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86822 | X | Lymphocyte culture, primed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86849 | X | Immunology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86850 | X | RBC antibody screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86860 | X | RBC antibody elution | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86870 | X | RBC antibody identification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86880 | X | Coombs test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86885 | X | Coombs test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86886 | X | Coombs test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86890 | X | Autologous blood process | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86891 | X | Autologous blood, op salvage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86900 | X | Blood typing, ABO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86901 | X | Blood typing, Rh (D) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86903 | X | Blood typing, antigen screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86904 | X | Blood typing, patient serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86905 | X | Blood typing, RBC antigens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86906 | X | Blood typing, Rh phenotype | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86910 | N | Blood typing, paternity test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86911 | N | Blood typing, antigen system | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86915 | X | Bone marrow/stem cell prep | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86920 | X | Compatibility test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86921 | X | Compatibility test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86922 | X | Compatibility test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86927 | X | Plasma, fresh frozen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86930 | X | Frozen blood prep | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86931 | X | Frozen blood thaw | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86932 | X | Frozen blood freeze/thaw | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86940 | X | Hemolysins/agglutinins, auto | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86941 | X | Hemolysins/agglutinins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86945 | X | Blood product/irradiation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86950 | X | Leukacyte transfusion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86965 | X | Pooling blood platelets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86970 | X | RBC pretreatment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86971 | X | RBC pretreatment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86972 | X | RBC pretreatment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86975 | X | RBC pretreatment, serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86976 | X | RBC pretreatment, serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86977 | X | RBC pretreatment, serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86978 | X | RBC pretreatment, serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86985 | X | Split blood or products | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 86999 | X | Transfusion procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87001 | X | Small animal inoculation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87003 | X | Small animal inoculation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87015 | X | Specimen concentration | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87040 | X | Blood culture for bacteria | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87045 | X | Feces culture, bacteria | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87046 | X | Stool cultr, bacteria, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87070 | X | Culture, bacteria, other | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87071 | X | Culture bacteri aerobic othr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87073 | X | Culture bacteria anaerobic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87075 | X | Culture bacteria anaerobic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87076 | X | Culture anaerobe ident, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87077 | X | Culture aerobic identify | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87081 | X | Culture screen only | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87084 | X | Culture of specimen by kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87086 | X | Urine culture/colony count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87088 | X | Urine bacteria culture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87101 | X | Skin fungi culture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87102 | X | Fungus isolation culture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87103 | X | Blood fungus culture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87106 | X | Fungi identification, yeast | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87107 | X | Fungi identification, mold | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87109 | X | Mycoplasma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87110 | X | Chlamydia culture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87116 | X | Mycobacteria culture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87118 | X | Mycobacteric identification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87140 | X | Culture type immunofluoresc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87143 | X | Culture typing, glc/hplc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87147 | X | Culture type, immunologic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87149 | X | Culture type, nucleic acid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87152 | X | Culture type pulse field gel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87158 | X | Culture typing, added method | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87164 | X | Dark field examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87164 | 26 | A | Dark field examination | 0.37 | 0.12 | 0.11 | 0.01 | 0.50 | 0.49 | XXX | |||||||||||
| 87166 | X | Dark field examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87168 | X | Macroscopic exam arthropod | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87169 | X | Macacroscopic exam parasite | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87172 | X | Pinworm exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87176 | X | Tissue homogenization, cultr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87177 | X | Ova and parasites smears | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87181 | X | Microbe susceptible, diffuse | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87184 | X | Microbe susceptible, disk | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87185 | X | Microbe susceptible, enzyme | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87186 | X | Microbe susceptible, mic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87187 | X | Microbe susceptible, mlc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87188 | X | Microbe suscept, macrobroth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87190 | X | Microbe suscept, mycobacteri | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87197 | X | Bactericidal level, serum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87198 | X | Cytomegalovirus antibody dfa | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87199 | X | Enterovirus antibody, dfa | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87205 | X | Smear, gram stain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87206 | X | Smear, fluorescent/acid stai | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87207 | X | Smear, special stain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87207 | 26 | A | Smear, special stain | 0.37 | 0.18 | 0.17 | 0.01 | 0.56 | 0.55 | XXX | |||||||||||
| 87210 | X | Smear, wet mount, saline/ink | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87220 | X | Tissue exam for fungi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87230 | X | Assay, toxin or antitoxin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87250 | X | Virus inoculate, eggs/animal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87252 | X | Virus inoculation, tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87253 | X | Virus inoculate tissue, addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87254 | X | Virus inoculation, shell via | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87260 | X | Adenovirus ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87265 | X | Pertussis ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87270 | X | Chlamydia trachomatis ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87272 | X | Cryptosporidum/gardia ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87273 | X | Herpes simplex 2, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87274 | X | Herpes simplex 1, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87275 | X | Influenza b, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87276 | X | Influenza a, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87277 | X | Legionella micdadei, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87278 | X | Legion pneumophilia ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87279 | X | Parainfluenza, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87280 | X | Respiratory syncytial ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87281 | X | Pneumocystis carinii, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87283 | X | Rubeola, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87285 | X | Treponema pallidum, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87290 | X | Varicella zoster, ag, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87299 | X | Antibody detection, nos, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87300 | X | Ag detection, polyval, if | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87301 | X | Adenovirus ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87320 | X | Chylmd trach ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87324 | X | Clostridium ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87327 | X | Cryptococcus neoform ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87328 | X | Cryptospor ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87332 | X | Cytomegalovirus ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87335 | X | E coli 0157 ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87336 | X | Entamoeb hist dispr, ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87337 | X | Entamoeb hist group, ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87338 | X | Hpylori, stool, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87339 | X | H pylori ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87340 | X | Hepatitis b surface ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87341 | X | Hepatitis b surface, ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87350 | X | Hepatitis be ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87380 | X | Hepatitis delta ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87385 | X | Histoplasma capsul ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87390 | X | Hiv-1 ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87391 | X | Hiv-2 ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87400 | X | Influenza a/b, ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87420 | X | Resp syncytial ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87425 | X | Rotavirus ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87427 | X | Shiga-like toxin ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87430 | X | Strep a ag, eia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87449 | X | Ag detect nos, eia, mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87450 | X | Ag detect nos, eia, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87451 | X | Ag detect polyval, eia, mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87470 | X | Bartonella, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87471 | X | Bartonella, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87472 | X | Bartonella, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87475 | X | Lyme dis, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87476 | X | Lyme dis, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87477 | X | Lyme dis, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87480 | X | Candida, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87481 | X | Candida, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87482 | X | Candida, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87485 | X | Chylmd pneum, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87486 | X | Chylmd pneum, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87487 | X | Chylmd pneum, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87490 | X | Chylmd trach, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87491 | X | Chylmd trach, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87492 | X | Chylmd trach, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87495 | X | Cytomeg, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87496 | X | Cytomeg, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87497 | X | Cytomeg, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87510 | X | Gardner vag, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87511 | X | Gardner vag, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87512 | X | Gardner vag, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87515 | X | Hepatitis b, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87516 | X | Hepatitis b, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87517 | X | Hepatitis b, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87520 | X | Hepatitis c, rna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87521 | X | Hepatitis c, rna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87522 | X | Hepatitis c, rna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87525 | X | Hepatitis g, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87526 | X | Hepatitis g, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87527 | X | Hepatitis g, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87528 | X | Hsv, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87529 | X | Hsv, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87530 | X | Hsv, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87531 | X | Hhv-6, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87532 | X | Hhv-6, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87533 | X | Hhv-6, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87534 | X | Hiv-1, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87535 | X | Hiv-1, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87536 | X | Hiv-1, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87537 | X | Hiv-2, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87538 | X | Hiv-2, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87539 | X | Hiv-2, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87540 | X | Legion pneumo, dna, dir prob | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87541 | X | Legion pneumo, dna, amp prob | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87542 | X | Legion pneumo, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87550 | X | Mycobacteria, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87551 | X | Mycobacteria, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87552 | X | Mycobacteria, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87555 | X | M.tuberculo, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87556 | X | M.tuberculo, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87557 | X | M.tuberculo, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87560 | X | M.avium-intra, dna, dir prob | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87561 | X | M.avium-intra, dna, amp prob | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87562 | X | M.avium-intra, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87580 | X | M.pneumon, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87581 | X | M.pneumon, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87582 | X | M.pneumon, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87590 | X | N.gonorrhoeae, dna, dir prob | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87591 | X | N.gonorrhoeae, dna, amp prob | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87592 | X | N.gonorrhoeae, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87620 | X | Hpv, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87621 | X | Hpv, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87622 | X | Hpv, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87650 | X | Strep a, dna, dir probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87651 | X | Strep a, dna, amp probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87652 | X | Strep a, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87797 | X | Detect agent nos, dna, dir | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87798 | X | Detect agent nos, dna, amp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87799 | X | Detect agent nos, dna, quant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87800 | X | Detect agnt mult, dna, direc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87801 | X | Detect agnt mult, dna, ampli | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87802 | X | Strep b assay w/optic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87803 | X | Clostridium toxin a w/optic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87804 | X | Influenza assay w/optic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87810 | X | Chylmd trach assay w/optic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87850 | X | N. gonorrhoeae assay w/optic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87880 | X | Strep a assay w/optic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87899 | X | Agent nos assay w/optic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87901 | X | Genotype, dna, hiv reverse t | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87902 | X | Genotype, dna, hepatitis C | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87903 | X | Phenotype, dna hiv w/culture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87904 | X | Phenotype, dna hiv w/clt add | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 87999 | X | Microbiology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88000 | N | Autopsy (necropsy), gross | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88005 | N | Autopsy (necropsy), gross | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88007 | N | Autopsy (necropsy), gross | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88012 | N | Autopsy (necropsy), gross | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88014 | N | Autopsy (necropsy), gross | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88016 | N | Autopsy (necropsy), gross | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88020 | N | Autopsy (necropsy), complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88025 | N | Autopsy (necropsy), complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88027 | N | Autopsy (necropsy), complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88028 | N | Autopsy (necropsy), complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88029 | N | Autopsy (necropsy), complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88036 | N | Limited autopsy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88037 | N | Limited autopsy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88040 | N | Forensic autopsy (necropsy) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88045 | N | Coroner's autopsy (necropsy) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88099 | N | Necropsy (autopsy) procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88104 | A | Cytopathology, fluids | 0.56 | 0.72 | NA | 0.04 | 1.32 | NA | XXX | ||||||||||||
| 88104 | 26 | A | Cytopathology, fluids | 0.56 | 0.26 | 0.26 | 0.02 | 0.84 | 0.84 | XXX | |||||||||||
| 88104 | TC | A | Cytopathology, fluids | 0.00 | 0.46 | NA | 0.02 | 0.48 | NA | XXX | |||||||||||
| 88106 | A | Cytopathology, fluids | 0.56 | 0.72 | NA | 0.04 | 1.32 | NA | XXX | ||||||||||||
| 88106 | 26 | A | Cytopathology, fluids | 0.56 | 0.26 | 0.26 | 0.02 | 0.84 | 0.84 | XXX | |||||||||||
| 88106 | TC | A | Cytopathology, fluids | 0.00 | 0.46 | NA | 0.02 | 0.48 | NA | XXX | |||||||||||
| 88107 | A | Cytopathology, fluids | 0.76 | 1.01 | NA | 0.05 | 1.82 | NA | XXX | ||||||||||||
| 88107 | 26 | A | Cytopathology, fluids | 0.76 | 0.35 | 0.35 | 0.03 | 1.14 | 1.14 | XXX | |||||||||||
| 88107 | TC | A | Cytopathology, fluids | 0.00 | 0.66 | NA | 0.02 | 0.68 | NA | XXX | |||||||||||
| 88108 | A | Cytopath, concentrate tech | 0.56 | 0.94 | NA | 0.04 | 1.54 | NA | XXX | ||||||||||||
| 88108 | 26 | A | Cytopath, concentrate tech | 0.56 | 0.26 | 0.26 | 0.02 | 0.84 | 0.84 | XXX | |||||||||||
| 88108 | TC | A | Cytopath, concentrate tech | 0.00 | 0.68 | NA | 0.02 | 0.70 | NA | XXX | |||||||||||
| 88125 | A | Forensic cytopathology | 0.26 | 0.30 | NA | 0.02 | 0.58 | NA | XXX | ||||||||||||
| 88125 | 26 | A | Forensic cytopathology | 0.26 | 0.12 | 0.12 | 0.01 | 0.39 | 0.39 | XXX | |||||||||||
| 88125 | TC | A | Forensic cytopathology | 0.00 | 0.18 | NA | 0.01 | 0.19 | NA | XXX | |||||||||||
| 88130 | X | Sex chromatin identification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88140 | X | Sex chromatin identification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88141 | A | Cytopath, c/v, interpret | 0.42 | 0.19 | 0.19 | 0.01 | 0.62 | 0.62 | XXX | ||||||||||||
| 88142 | X | Cytopath, c/v, thin layer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88143 | X | Cytopath, c/v, thin lyr redo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88144 | X | Cytopath, c/v, thin lyr redo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88145 | X | Cytopath, c/v, thin lyr sel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88147 | X | Cytopath, c/v, automated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88148 | X | Cytopath, c/v, auto rescreen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88150 | X | Cytopath, c/v, manual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88152 | X | Cytopath, c/v, auto redo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88153 | X | Cytopath, c/v, redo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88154 | X | Cytopath, c/v, select | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88155 | X | Cytopath, c/v, index add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88160 | A | Cytopath smear, other source | 0.50 | 1.01 | NA | 0.04 | 1.55 | NA | XXX | ||||||||||||
| 88160 | 26 | A | Cytopath smear, other source | 0.50 | 0.23 | 0.23 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 88160 | TC | A | Cytopath smear, other source | 0.00 | 0.78 | NA | 0.02 | 0.80 | NA | XXX | |||||||||||
| 88161 | A | Cytopath smear, other source | 0.50 | 1.22 | NA | 0.04 | 1.76 | NA | XXX | ||||||||||||
| 88161 | 26 | A | Cytopath smear, other source | 0.50 | 0.23 | 0.23 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 88161 | TC | A | Cytopath smear, other source | 0.00 | 0.99 | NA | 0.02 | 1.01 | NA | XXX | |||||||||||
| 88162 | A | Cytopath smear, other source | 0.76 | 0.73 | NA | 0.05 | 1.54 | NA | XXX | ||||||||||||
| 88162 | 26 | A | Cytopath smear, other source | 0.76 | 0.35 | 0.35 | 0.03 | 1.14 | 1.14 | XXX | |||||||||||
| 88162 | TC | A | Cytopath smear, other source | 0.00 | 0.38 | NA | 0.02 | 0.40 | NA | XXX | |||||||||||
| 88164 | X | Cytopath tbs, c/v, manual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88165 | X | Cytopath tbs, c/v, redo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88166 | X | Cytopath tbs, c/v, auto redo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88167 | X | Cytopath tbs, c/v, select | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88170 | D | Fine needle aspiration | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| 88170 | 26 | D | Fine needle aspiration | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88170 | TC | D | Fine needle aspiration | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| 88171 | D | Fine needle aspiration | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| 88171 | 26 | D | Fine needle aspiration | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88171 | TC | D | Fine needle aspiration | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| 88172 | A | Cytopathology eval of fna | 0.60 | 0.68 | NA | 0.04 | 1.32 | NA | XXX | ||||||||||||
| 88172 | 26 | A | Cytopathology eval of fna | 0.60 | 0.28 | 0.28 | 0.02 | 0.90 | 0.90 | XXX | |||||||||||
| 88172 | TC | A | Cytopathology eval of fna | 0.00 | 0.40 | NA | 0.02 | 0.42 | NA | XXX | |||||||||||
| 88173 | A | Cytopath eval, fna, report | 1.39 | 1.80 | NA | 0.07 | 3.26 | NA | XXX | ||||||||||||
| 88173 | 26 | A | Cytopath eval, fna, report | 1.39 | 0.64 | 0.64 | 0.05 | 2.08 | 2.08 | XXX | |||||||||||
| 88173 | TC | A | Cytopath eval, fna, report | 0.00 | 1.16 | NA | 0.02 | 1.18 | NA | XXX | |||||||||||
| 88180 | A | Cell marker study | 0.36 | 0.60 | NA | 0.03 | 0.99 | NA | XXX | ||||||||||||
| 88180 | 26 | A | Cell marker study | 0.36 | 0.17 | 0.17 | 0.01 | 0.54 | 0.54 | XXX | |||||||||||
| 88180 | TC | A | Cell marker study | 0.00 | 0.43 | NA | 0.02 | 0.45 | NA | XXX | |||||||||||
| 88182 | A | Cell marker study | 0.77 | 1.81 | NA | 0.06 | 2.64 | NA | XXX | ||||||||||||
| 88182 | 26 | A | Cell marker study | 0.77 | 0.36 | 0.36 | 0.03 | 1.16 | 1.16 | XXX | |||||||||||
| 88182 | TC | A | Cell marker study | 0.00 | 1.45 | NA | 0.03 | 1.48 | NA | XXX | |||||||||||
| 88199 | C | Cytopathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88199 | 26 | C | Cytopathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88199 | TC | C | Cytopathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88230 | X | Tissue culture, lymphocyte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88233 | X | Tissue culture, skin/biopsy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88235 | X | Tissue culture, placenta | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88237 | X | Tissue culture, bone marrow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88239 | X | Tissue culture, tumor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88240 | X | Cell cryopreserve/storage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88241 | X | Frozen cell preparation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88245 | X | Chromosome analysis, 20-25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88248 | X | Chromosome analysis, 50-100 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88249 | X | Chromosome analysis, 100 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88261 | X | Chromosome analysis, 5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88262 | X | Chromosome analysis, 15-20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88263 | X | Chromosome analysis, 45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88264 | X | Chromosome analysis, 20-25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88267 | X | Chromosome analys, placenta | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88269 | X | Chromosome analys, amniotic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88271 | X | Cytogenetics, dna probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88272 | X | Cytogenetics, 3-5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88273 | X | Cytogenetics, 10-30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88274 | X | Cytogenetics, 25-99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88275 | X | Cytogenetics, 100-300 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88280 | X | Chromosome karyotype study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88283 | X | Chromosome banding study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88285 | X | Chromosome count, additional | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88289 | X | Chromosome study, additional | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88291 | A | Cyto/molecular report | 0.52 | 0.23 | 0.23 | 0.02 | 0.77 | 0.77 | XXX | ||||||||||||
| 88299 | C | Cytogenetic study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88300 | A | Surgical path, gross | 0.08 | 0.34 | NA | 0.02 | 0.44 | NA | XXX | ||||||||||||
| 88300 | 26 | A | Surgical path, gross | 0.08 | 0.04 | 0.04 | 0.01 | 0.13 | 0.13 | XXX | |||||||||||
| 88300 | TC | A | Surgical path, gross | 0.00 | 0.30 | NA | 0.01 | 0.31 | NA | XXX | |||||||||||
| 88302 | A | Tissue exam by pathologist | 0.13 | 0.73 | NA | 0.03 | 0.89 | NA | XXX | ||||||||||||
| 88302 | 26 | A | Tissue exam by pathologist | 0.13 | 0.06 | 0.06 | 0.01 | 0.20 | 0.20 | XXX | |||||||||||
| 88302 | TC | A | Tissue exam by pathologist | 0.00 | 0.67 | NA | 0.02 | 0.69 | NA | XXX | |||||||||||
| 88304 | A | Tissue exam by pathologist | 0.22 | 0.95 | NA | 0.03 | 1.20 | NA | XXX | ||||||||||||
| 88304 | 26 | A | Tissue exam by pathologist | 0.22 | 0.10 | 0.10 | 0.01 | 0.33 | 0.33 | XXX | |||||||||||
| 88304 | TC | A | Tissue exam by pathologist | 0.00 | 0.85 | NA | 0.02 | 0.87 | NA | XXX | |||||||||||
| 88305 | A | Tissue exam by pathologist | 0.75 | 1.78 | NA | 0.05 | 2.58 | NA | XXX | ||||||||||||
| 88305 | 26 | A | Tissue exam by pathologist | 0.75 | 0.35 | 0.35 | 0.02 | 1.12 | 1.12 | XXX | |||||||||||
| 88305 | TC | A | Tissue exam by pathologist | 0.00 | 1.43 | NA | 0.03 | 1.46 | NA | XXX | |||||||||||
| 88307 | A | Tissue exam by pathologist | 1.59 | 2.71 | NA | 0.11 | 4.41 | NA | XXX | ||||||||||||
| 88307 | 26 | A | Tissue exam by pathologist | 1.59 | 0.74 | 0.74 | 0.06 | 2.39 | 2.39 | XXX | |||||||||||
| 88307 | TC | A | Tissue exam by pathologist | 0.00 | 1.97 | NA | 0.05 | 2.02 | NA | XXX | |||||||||||
| 88309 | A | Tissue exam by pathologist | 2.28 | 3.40 | NA | 0.13 | 5.81 | NA | XXX | ||||||||||||
| 88309 | 26 | A | Tissue exam by pathologist | 2.28 | 1.05 | 1.05 | 0.08 | 3.41 | 3.41 | XXX | |||||||||||
| 88309 | TC | A | Tissue exam by pathologist | 0.00 | 2.35 | NA | 0.05 | 2.40 | NA | XXX | |||||||||||
| 88311 | A | Decalcify tissue | 0.24 | 0.21 | NA | 0.02 | 0.47 | NA | XXX | ||||||||||||
| 88311 | 26 | A | Decalcify tissue | 0.24 | 0.11 | 0.11 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 88311 | TC | A | Decalcify tissue | 0.00 | 0.10 | NA | 0.01 | 0.11 | NA | XXX | |||||||||||
| 88312 | A | Special stains | 0.54 | 1.69 | NA | 0.03 | 2.26 | NA | XXX | ||||||||||||
| 88312 | 26 | A | Special stains | 0.54 | 0.25 | 0.25 | 0.02 | 0.81 | 0.81 | XXX | |||||||||||
| 88312 | TC | A | Special stains | 0.00 | 1.44 | NA | 0.01 | 1.45 | NA | XXX | |||||||||||
| 88313 | A | Special stains | 0.24 | 1.47 | NA | 0.02 | 1.73 | NA | XXX | ||||||||||||
| 88313 | 26 | A | Special stains | 0.24 | 0.11 | 0.11 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 88313 | TC | A | Special stains | 0.00 | 1.36 | NA | 0.01 | 1.37 | NA | XXX | |||||||||||
| 88314 | A | Histochemical stain | 0.45 | 0.86 | NA | 0.04 | 1.35 | NA | XXX | ||||||||||||
| 88314 | 26 | A | Histochemical stain | 0.45 | 0.20 | 0.20 | 0.02 | 0.67 | 0.67 | XXX | |||||||||||
| 88314 | TC | A | Histochemical stain | 0.00 | 0.66 | NA | 0.02 | 0.68 | NA | XXX | |||||||||||
| 88318 | A | Chemical histochemistry | 0.42 | 0.59 | NA | 0.02 | 1.03 | NA | XXX | ||||||||||||
| 88318 | 26 | A | Chemical histochemistry | 0.42 | 0.20 | 0.20 | 0.01 | 0.63 | 0.63 | XXX | |||||||||||
| 88318 | TC | A | Chemical histochemistry | 0.00 | 0.39 | NA | 0.01 | 0.40 | NA | XXX | |||||||||||
| 88319 | A | Enzyme histochemistry | 0.53 | 2.45 | NA | 0.04 | 3.02 | NA | XXX | ||||||||||||
| 88319 | 26 | A | Enzyme histochemistry | 0.53 | 0.24 | 0.24 | 0.02 | 0.79 | 0.79 | XXX | |||||||||||
| 88319 | TC | A | Enzyme histochemistry | 0.00 | 2.21 | NA | 0.02 | 2.23 | NA | XXX | |||||||||||
| 88321 | A | Microslide consultation | 1.30 | 0.62 | 0.60 | 0.04 | 1.96 | 1.94 | XXX | ||||||||||||
| 88323 | A | Microslide consultation | 1.35 | 1.37 | NA | 0.07 | 2.79 | NA | XXX | ||||||||||||
| 88323 | 26 | A | Microslide consultation | 1.35 | 0.63 | 0.63 | 0.05 | 2.03 | 2.03 | XXX | |||||||||||
| 88323 | TC | A | Microslide consultation | 0.00 | 0.74 | NA | 0.02 | 0.76 | NA | XXX | |||||||||||
| 88325 | A | Comprehensive review of data | 2.22 | 0.98 | 0.98 | 0.08 | 3.28 | 3.28 | XXX | ||||||||||||
| 88329 | A | Path consult introp | 0.67 | 0.39 | 0.31 | 0.02 | 1.08 | 1.00 | XXX | ||||||||||||
| 88331 | A | Path consult intraop, 1 bloc | 1.19 | 0.87 | NA | 0.07 | 2.13 | NA | XXX | ||||||||||||
| 88331 | 26 | A | Path consult intraop, 1 bloc | 1.19 | 0.55 | 0.55 | 0.04 | 1.78 | 1.78 | XXX | |||||||||||
| 88331 | TC | A | Path consult intraop, 1 bloc | 0.00 | 0.32 | NA | 0.03 | 0.35 | NA | XXX | |||||||||||
| 88332 | A | Path consult intraop, addl | 0.59 | 0.47 | NA | 0.04 | 1.10 | NA | XXX | ||||||||||||
| 88332 | 26 | A | Path consult intraop, addl | 0.59 | 0.27 | 0.27 | 0.02 | 0.88 | 0.88 | XXX | |||||||||||
| 88332 | TC | A | Path consult intraop, addl | 0.00 | 0.20 | NA | 0.02 | 0.22 | NA | XXX | |||||||||||
| 88342 | A | Immunocytochemistry | 0.85 | 1.43 | NA | 0.05 | 2.33 | NA | XXX | ||||||||||||
| 88342 | 26 | A | Immunocytochemistry | 0.85 | 0.39 | 0.39 | 0.03 | 1.27 | 1.27 | XXX | |||||||||||
| 88342 | TC | A | Immunocytochemistry | 0.00 | 1.04 | NA | 0.02 | 1.06 | NA | XXX | |||||||||||
| 88346 | A | Immunofluorescent study | 0.86 | 1.20 | NA | 0.05 | 2.11 | NA | XXX | ||||||||||||
| 88346 | 26 | A | Immunofluorescent study | 0.86 | 0.39 | 0.39 | 0.03 | 1.28 | 1.28 | XXX | |||||||||||
| 88346 | TC | A | Immunofluorescent study | 0.00 | 0.81 | NA | 0.02 | 0.83 | NA | XXX | |||||||||||
| 88347 | A | Immunofluorescent study | 0.86 | 1.90 | NA | 0.05 | 2.81 | NA | XXX | ||||||||||||
| 88347 | 26 | A | Immunofluorescent study | 0.86 | 0.38 | 0.38 | 0.03 | 1.27 | 1.27 | XXX | |||||||||||
| 88347 | TC | A | Immunofluorescent study | 0.00 | 1.52 | NA | 0.02 | 1.54 | NA | XXX | |||||||||||
| 88348 | A | Electron microscopy | 1.51 | 6.96 | NA | 0.11 | 8.58 | NA | XXX | ||||||||||||
| 88348 | 26 | A | Electron microscopy | 1.51 | 0.69 | 0.69 | 0.05 | 2.25 | 2.25 | XXX | |||||||||||
| 88348 | TC | A | Electron microscopy | 0.00 | 6.27 | NA | 0.06 | 6.33 | NA | XXX | |||||||||||
| 88349 | A | Scanning electron microscopy | 0.76 | 8.51 | NA | 0.08 | 9.35 | NA | XXX | ||||||||||||
| 88349 | 26 | A | Scanning electron microscopy | 0.76 | 0.35 | 0.35 | 0.03 | 1.14 | 1.14 | XXX | |||||||||||
| 88349 | TC | A | Scanning electron microscopy | 0.00 | 8.16 | NA | 0.05 | 8.21 | NA | XXX | |||||||||||
| 88355 | A | Analysis, skeletal muscle | 1.85 | 2.41 | NA | 0.12 | 4.38 | NA | XXX | ||||||||||||
| 88355 | 26 | A | Analysis, skeletal muscle | 1.85 | 0.86 | 0.86 | 0.07 | 2.78 | 2.78 | XXX | |||||||||||
| 88355 | TC | A | Analysis, skeletal muscle | 0.00 | 1.55 | NA | 0.05 | 1.60 | NA | XXX | |||||||||||
| 88356 | A | Analysis, nerve | 3.02 | 4.96 | NA | 0.16 | 8.14 | NA | XXX | ||||||||||||
| 88356 | 26 | A | Analysis, nerve | 3.02 | 1.37 | 1.37 | 0.10 | 4.49 | 4.49 | XXX | |||||||||||
| 88356 | TC | A | Analysis, nerve | 0.00 | 3.59 | NA | 0.06 | 3.65 | NA | XXX | |||||||||||
| 88358 | A | Analysis, tumor | 2.82 | 1.76 | NA | 0.16 | 4.74 | NA | XXX | ||||||||||||
| 88358 | 26 | A | Analysis, tumor | 2.82 | 1.30 | 1.30 | 0.10 | 4.22 | 4.22 | XXX | |||||||||||
| 88358 | TC | A | Analysis, tumor | 0.00 | 0.46 | NA | 0.06 | 0.52 | NA | XXX | |||||||||||
| 88362 | A | Nerve teasing preparations | 2.17 | 3.36 | NA | 0.12 | 5.65 | NA | XXX | ||||||||||||
| 88362 | 26 | A | Nerve teasing preparations | 2.17 | 0.99 | 0.99 | 0.07 | 3.23 | 3.23 | XXX | |||||||||||
| 88362 | TC | A | Nerve teasing preparations | 0.00 | 2.37 | NA | 0.05 | 2.42 | NA | XXX | |||||||||||
| 88365 | A | Tissue hybridization | 0.93 | 2.03 | NA | 0.05 | 3.01 | NA | XXX | ||||||||||||
| 88365 | 26 | A | Tissue hybridization | 0.93 | 0.43 | 0.43 | 0.03 | 1.39 | 1.39 | XXX | |||||||||||
| 88365 | TC | A | Tissue hybridization | 0.00 | 1.60 | NA | 0.02 | 1.62 | NA | XXX | |||||||||||
| 88371 | X | Protein, western blot tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88371 | 26 | A | Protein, western blot tissue | 0.37 | 0.15 | 0.14 | 0.01 | 0.53 | 0.52 | XXX | |||||||||||
| 88372 | X | Protein analysis w/probe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88372 | 26 | A | Protein analysis w/probe | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 88380 | C | Microdissection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88380 | 26 | C | Microdissection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88380 | TC | C | Microdissection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88399 | C | Surgical pathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 88399 | 26 | C | Surgical pathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88399 | TC | C | Surgical pathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 88400 | X | Bilirubin total transcut | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89050 | X | Body fluid cell count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89051 | X | Body fluid cell count | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89060 | X | Exam synovial fluid crystals | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89060 | 26 | A | Exam synovial fluid crystals | 0.37 | 0.18 | 0.17 | 0.01 | 0.56 | 0.55 | XXX | |||||||||||
| 89100 | A | Sample intestinal contents | 0.60 | 2.29 | 0.23 | 0.02 | 2.91 | 0.85 | XXX | ||||||||||||
| 89105 | A | Sample intestinal contents | 0.50 | 2.25 | 0.18 | 0.02 | 2.77 | 0.70 | XXX | ||||||||||||
| 89125 | X | Specimen fat stain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89130 | A | Sample stomach contents | 0.45 | 2.21 | 0.13 | 0.02 | 2.68 | 0.60 | XXX | ||||||||||||
| 89132 | A | Sample stomach contents | 0.19 | 1.15 | 0.05 | 0.01 | 1.35 | 0.25 | XXX | ||||||||||||
| 89135 | A | Sample stomach contents | 0.79 | 2.53 | 0.25 | 0.03 | 3.35 | 1.07 | XXX | ||||||||||||
| 89136 | A | Sample stomach contents | 0.21 | 2.05 | 0.08 | 0.01 | 2.27 | 0.30 | XXX | ||||||||||||
| 89140 | A | Sample stomach contents | 0.94 | 2.36 | 0.19 | 0.03 | 3.33 | 1.16 | XXX | ||||||||||||
| 89141 | A | Sample stomach contents | 0.85 | 3.14 | 0.40 | 0.03 | 4.02 | 1.28 | XXX | ||||||||||||
| 89160 | X | Exam feces for meat fibers | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89190 | X | Nasal smear for eosinophils | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89250 | X | Fertilization of oocyte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89251 | X | Culture oocyte w/embryos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89252 | X | Assist oocyte fertilization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89253 | X | Embryo hatching | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89254 | X | Oocyte identification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89255 | X | Prepare embryo for transfer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89256 | X | Prepare cryopreserved embryo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89257 | X | Sperm identification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89258 | X | Cryopreservation, embryo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89259 | X | Cryopreservation, sperm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89260 | X | Sperm isolation, simple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89261 | X | Sperm isolation, complex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89264 | X | Identify sperm tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89300 | X | Semen analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89310 | X | Semen analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89320 | X | Semen analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89321 | X | Semen analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89325 | X | Sperm antibody test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89329 | X | Sperm evaluation test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89330 | X | Evaluation, cervical mucus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89350 | A | Sputum specimen collection | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | ||||||||||||
| 89355 | X | Exam feces for starch | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89360 | A | Collect sweat for test | 0.00 | 0.43 | NA | 0.02 | 0.45 | NA | XXX | ||||||||||||
| 89365 | X | Water load test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89399 | C | Pathology lab procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 89399 | 26 | C | Pathology lab procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 89399 | TC | C | Pathology lab procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 90281 | I | Human ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90283 | I | Human ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90287 | I | Botulinum antitoxin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90288 | I | Botulism ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90291 | I | Cmv ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90296 | E | Diphtheria antitoxin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90371 | E | Hep b ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90375 | E | Rabies ig, im/sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90376 | E | Rabies ig, heat treated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90378 | X | Rsv ig, im, 50mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90379 | I | Rsv ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90384 | I | Rh ig, full-dose, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90385 | E | Rh ig, minidose, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90386 | I | Rh ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90389 | I | Tetanus ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90393 | E | Vaccina ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90396 | E | Varicella-zoster ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90399 | I | Immune globulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90471 | A | Immunization admin | 0.00 | 0.10 | NA | 0.01 | 0.11 | NA | XXX | ||||||||||||
| 90472 | A | Immunization admin, each add | 0.00 | 0.10 | NA | 0.01 | 0.11 | NA | ZZZ | ||||||||||||
| 90473 | N | Immune admin oral/nasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90474 | N | Immune admin oral/nasal addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 90476 | E | Adenovirus vaccine, type 4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90477 | E | Adenovirus vaccine, type 7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90581 | E | Anthrax vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90585 | E | Bcg vaccine, percut | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90586 | E | Bcg vaccine, intravesical | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90632 | E | Hep a vaccine, adult im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90633 | E | Hep a vacc, ped/adol, 2 dose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90634 | E | Hep a vacc, ped/adol, 3 dose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90636 | E | Hep a/hep b vacc, adult im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90645 | E | Hib vaccine, hboc, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90646 | E | Hib vaccine, prp-d, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90647 | E | Hib vaccine, prp-omp, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90648 | E | Hib vaccine, prp-t, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90657 | X | Flu vaccine, 6-35 mo, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90658 | X | Flu vaccine, 3 yrs, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90659 | X | Flu vaccine, whole, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90660 | X | Flu vaccine, nasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90665 | E | Lyme disease vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90669 | N | Pneumococcal vacc, ped5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90675 | E | Rabies vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90676 | E | Rabies vaccine, id | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90680 | E | Rotovirus vaccine, oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90690 | E | Typhoid vaccine, oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90691 | E | Typhoid vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90692 | E | Typhoid vaccine, h-p, sc/id | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90693 | E | Typhoid vaccine, akd, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90700 | E | Dtap vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90701 | E | Dtp vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90702 | E | Dt vaccine 7, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90703 | E | Tetanus vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90704 | E | Mumps vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90705 | E | Measles vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90706 | E | Rubella vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90707 | E | Mmr vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90708 | E | Measles-rubella vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90709 | E | Rubella mumps vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90710 | E | Mmrv vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90712 | E | Oral poliovirus vaccine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90713 | E | Poliovirus, ipv, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90716 | E | Chicken pox vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90717 | E | Yellow fever vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90718 | E | Td vaccine 7, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90719 | E | Diphtheria vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90720 | E | Dtp/hib vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90721 | E | Dtap/hib vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90723 | X | Dtap-hep b-ipv vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90725 | E | Cholera vaccine, injectable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90727 | E | Plague vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90732 | X | Pneumococcal vaccine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90733 | E | Meningococcal vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90735 | E | Encephalitis vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90740 | X | Hepb vacc, ill pat 3 dose im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90743 | X | Hep b vacc, adol, 2 dose, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90744 | X | Hepb vacc ped/adol 3 dose im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90746 | X | Hep b vaccine, adult, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90747 | X | Hepb vacc, ill pat 4 dose im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90748 | E | Hep b/hib vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90749 | E | Vaccine toxoid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90780 | A | IV infusion therapy, 1 hour | 0.00 | 1.06 | NA | 0.06 | 1.12 | NA | XXX | ||||||||||||
| 90781 | A | IV infusion, additional hour | 0.00 | 0.53 | NA | 0.03 | 0.56 | NA | ZZZ | ||||||||||||
| 90782 | T | Injection, sc/im | 0.00 | 0.10 | NA | 0.01 | 0.11 | NA | XXX | ||||||||||||
| 90783 | T | Injection, ia | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX | ||||||||||||
| 90784 | T | Injection, iv | 0.00 | 0.45 | NA | 0.03 | 0.48 | NA | XXX | ||||||||||||
| 90788 | T | Injection of antibiotic | 0.00 | 0.11 | NA | 0.01 | 0.12 | NA | XXX | ||||||||||||
| 90799 | C | Ther/prophylactic/dx inject | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90801 | A | Psy dx interview | 2.80 | 1.14 | 0.93 | 0.06 | 4.00 | 3.79 | XXX | ||||||||||||
| 90802 | A | Intac psy dx interview | 3.01 | 1.17 | 0.99 | 0.07 | 4.25 | 4.07 | XXX | ||||||||||||
| 90804 | A | Psytx, office, 20-30 min | 1.21 | 0.53 | 0.40 | 0.03 | 1.77 | 1.64 | XXX | ||||||||||||
| 90805 | A | Psytx, off, 20-30 min w/em | 1.37 | 0.59 | 0.44 | 0.03 | 1.99 | 1.84 | XXX | ||||||||||||
| 90806 | A | Psytx, off, 45-50 min | 1.86 | 0.75 | 0.62 | 0.04 | 2.65 | 2.52 | XXX | ||||||||||||
| 90807 | A | Psytx, off, 45-50 min w/em | 2.02 | 0.79 | 0.66 | 0.05 | 2.86 | 2.73 | XXX | ||||||||||||
| 90808 | A | Psytx, office, 75-80 min | 2.79 | 1.06 | 0.93 | 0.07 | 3.92 | 3.79 | XXX | ||||||||||||
| 90809 | A | Psytx, off, 75-80, w/em | 2.95 | 1.11 | 0.97 | 0.07 | 4.13 | 3.99 | XXX | ||||||||||||
| 90810 | A | Intac psytx, off, 20-30 min | 1.32 | 0.56 | 0.44 | 0.03 | 1.91 | 1.79 | XXX | ||||||||||||
| 90811 | A | Intac psytx, 20-30, w/em | 1.48 | 0.63 | 0.48 | 0.03 | 2.14 | 1.99 | XXX | ||||||||||||
| 90812 | A | Intac psytx, off, 45-50 min | 1.97 | 0.80 | 0.69 | 0.05 | 2.82 | 2.71 | XXX | ||||||||||||
| 90813 | A | Intac psytx, 45-50 min w/em | 2.13 | 0.87 | 0.71 | 0.05 | 3.05 | 2.89 | XXX | ||||||||||||
| 90814 | A | Intac psytx, off, 75-80 min | 2.90 | 1.15 | 1.01 | 0.07 | 4.12 | 3.98 | XXX | ||||||||||||
| 90815 | A | Intac psytx, 75-80 w/em | 3.06 | 1.15 | 1.02 | 0.07 | 4.28 | 4.15 | XXX | ||||||||||||
| 90816 | A | Psytx, hosp, 20-30 min | 1.25 | 0.57 | 0.43 | 0.03 | 1.85 | 1.71 | XXX | ||||||||||||
| 90817 | A | Psytx, hosp, 20-30 min w/em | 1.41 | 0.62 | 0.45 | 0.03 | 2.06 | 1.89 | XXX | ||||||||||||
| 90818 | A | Psytx, hosp, 45-50 min | 1.89 | 0.80 | 0.65 | 0.04 | 2.73 | 2.58 | XXX | ||||||||||||
| 90819 | A | Psytx, hosp, 45-50 min w/em | 2.05 | 0.83 | 0.66 | 0.05 | 2.93 | 2.76 | XXX | ||||||||||||
| 90821 | A | Psytx, hosp, 75-80 min | 2.83 | 1.11 | 0.97 | 0.06 | 4.00 | 3.86 | XXX | ||||||||||||
| 90822 | A | Psytx, hosp, 75-80 min w/em | 2.99 | 1.30 | 0.97 | 0.07 | 4.36 | 4.03 | XXX | ||||||||||||
| 90823 | A | Intac psytx, hosp, 20-30 min | 1.36 | 0.65 | 0.45 | 0.03 | 2.04 | 1.84 | XXX | ||||||||||||
| 90824 | A | Intac psytx, hsp 20-30 w/em | 1.52 | 0.70 | 0.50 | 0.03 | 2.25 | 2.05 | XXX | ||||||||||||
| 90826 | A | Intac psytx, hosp, 45-50 min | 2.01 | 0.89 | 0.68 | 0.04 | 2.94 | 2.73 | XXX | ||||||||||||
| 90827 | A | Intac psytx, hsp 45-50 w/em | 2.16 | 0.91 | 0.70 | 0.05 | 3.12 | 2.91 | XXX | ||||||||||||
| 90828 | A | Intac psytx, hosp, 75-80 min | 2.94 | 1.90 | 1.02 | 0.07 | 4.91 | 4.03 | XXX | ||||||||||||
| 90829 | A | Intac psytx, hsp 75-80 w/em | 3.10 | 1.23 | 1.02 | 0.07 | 4.40 | 4.19 | XXX | ||||||||||||
| 90845 | A | Psychoanalysis | 1.79 | 0.71 | 0.57 | 0.04 | 2.54 | 2.40 | XXX | ||||||||||||
| 90846 | R | Family psytx w/o patient | 1.83 | 0.73 | 0.62 | 0.04 | 2.60 | 2.49 | XXX | ||||||||||||
| 90847 | R | Family psytx w/patient | 2.21 | 0.86 | 0.75 | 0.05 | 3.12 | 3.01 | XXX | ||||||||||||
| 90849 | R | Multiple family group psytx | 0.59 | 0.31 | 0.20 | 0.01 | 0.91 | 0.80 | XXX | ||||||||||||
| 90853 | A | Group psychotherapy | 0.59 | 0.35 | 0.20 | 0.01 | 0.95 | 0.80 | XXX | ||||||||||||
| 90857 | A | Intac group psytx | 0.63 | 0.37 | 0.21 | 0.02 | 1.02 | 0.86 | XXX | ||||||||||||
| 90862 | A | Medication management | 0.95 | 0.44 | 0.31 | 0.02 | 1.41 | 1.28 | XXX | ||||||||||||
| 90865 | A | Narcosynthesis | 2.84 | 1.70 | 0.94 | 0.07 | 4.61 | 3.85 | XXX | ||||||||||||
| 90870 | A | Electroconvulsive therapy | 1.88 | 0.74 | 0.74 | 0.04 | 2.66 | 2.66 | 000 | ||||||||||||
| 90871 | A | Electroconvulsive therapy | 2.72 | NA | 1.04 | 0.06 | NA | 3.82 | 000 | ||||||||||||
| 90875 | N | Psychophysiological therapy | +1.20 | 0.90 | 0.48 | 0.03 | 2.13 | 1.71 | XXX | ||||||||||||
| 90876 | N | Psychophysiological therapy | +1.90 | 1.18 | 0.76 | 0.04 | 3.12 | 2.70 | XXX | ||||||||||||
| 90880 | A | Hypnotherapy | 2.19 | 0.91 | 0.71 | 0.05 | 3.15 | 2.95 | XXX | ||||||||||||
| 90882 | N | Environmental manipulation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90885 | B | Psy evaluation of records | +0.97 | 0.39 | 0.39 | 0.02 | 1.38 | 1.38 | XXX | ||||||||||||
| 90887 | B | Consultation with family | +1.48 | 0.83 | 0.59 | 0.03 | 2.34 | 2.10 | XXX | ||||||||||||
| 90889 | B | Preparation of report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90899 | C | Psychiatric service/therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90901 | A | Biofeedback train, any meth | 0.41 | 0.82 | 0.17 | 0.02 | 1.25 | 0.60 | 000 | ||||||||||||
| 90911 | A | Biofeedback peri/uro/rectal | 0.89 | 0.87 | 0.39 | 0.04 | 1.80 | 1.32 | 000 | ||||||||||||
| 90918 | A | ESRD related services, month | 11.18 | 5.53 | 5.53 | 0.30 | 17.01 | 17.01 | XXX | ||||||||||||
| 90919 | A | ESRD related services, month | 8.54 | 4.53 | 4.53 | 0.24 | 13.31 | 13.31 | XXX | ||||||||||||
| 90920 | A | ESRD related services, month | 7.27 | 4.02 | 4.02 | 0.19 | 11.48 | 11.48 | XXX | ||||||||||||
| 90921 | A | ESRD related services, month | 4.47 | 2.96 | 2.96 | 0.12 | 7.55 | 7.55 | XXX | ||||||||||||
| 90922 | A | ESRD related services, day | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | ||||||||||||
| 90923 | A | ESRD related services, day | 0.28 | 0.15 | 0.15 | 0.01 | 0.44 | 0.44 | XXX | ||||||||||||
| 90924 | A | ESRD related services, day | 0.24 | 0.13 | 0.13 | 0.01 | 0.38 | 0.38 | XXX | ||||||||||||
| 90925 | A | ESRD related services, day | 0.15 | 0.10 | 0.10 | 0.01 | 0.26 | 0.26 | XXX | ||||||||||||
| 90935 | A | Hemodialysis, one evaluation | 1.22 | NA | 0.86 | 0.03 | NA | 2.11 | 000 | ||||||||||||
| 90937 | A | Hemodialysis, repeated eval | 2.11 | NA | 1.20 | 0.06 | NA | 3.37 | 000 | ||||||||||||
| 90939 | X | Hemodialysis study, transcut | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90940 | X | Hemodialysis access study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90945 | A | Dialysis, one evaluation | 1.28 | NA | 0.89 | 0.04 | NA | 2.21 | 000 | ||||||||||||
| 90947 | A | Dialysis, repeated eval | 2.16 | NA | 1.24 | 0.06 | NA | 3.46 | 000 | ||||||||||||
| 90989 | X | Dialysis training, complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90993 | X | Dialysis training, incompl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 90997 | A | Hemoperfusion | 1.84 | NA | 1.10 | 0.05 | NA | 2.99 | 000 | ||||||||||||
| 90999 | C | Dialysis procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 91000 | A | Esophageal intubation | 0.73 | 0.32 | NA | 0.04 | 1.09 | NA | 000 | ||||||||||||
| 91000 | 26 | A | Esophageal intubation | 0.73 | 0.25 | 0.25 | 0.03 | 1.01 | 1.01 | 000 | |||||||||||
| 91000 | TC | A | Esophageal intubation | 0.00 | 0.07 | NA | 0.01 | 0.08 | NA | 000 | |||||||||||
| 91010 | A | Esophagus motility study | 1.25 | 2.60 | NA | 0.10 | 3.95 | NA | 000 | ||||||||||||
| 91010 | 26 | A | Esophagus motility study | 1.25 | 0.46 | 0.46 | 0.05 | 1.76 | 1.76 | 000 | |||||||||||
| 91010 | TC | A | Esophagus motility study | 0.00 | 2.14 | NA | 0.05 | 2.19 | NA | 000 | |||||||||||
| 91011 | A | Esophagus motility study | 1.50 | 2.71 | NA | 0.10 | 4.31 | NA | 000 | ||||||||||||
| 91011 | 26 | A | Esophagus motility study | 1.50 | 0.55 | 0.55 | 0.05 | 2.10 | 2.10 | 000 | |||||||||||
| 91011 | TC | A | Esophagus motility study | 0.00 | 2.16 | NA | 0.05 | 2.21 | NA | 000 | |||||||||||
| 91012 | A | Esophagus motility study | 1.46 | 2.35 | NA | 0.12 | 3.93 | NA | 000 | ||||||||||||
| 91012 | 26 | A | Esophagus motility study | 1.46 | 0.54 | 0.54 | 0.06 | 2.06 | 2.06 | 000 | |||||||||||
| 91012 | TC | A | Esophagus motility study | 0.00 | 1.81 | NA | 0.06 | 1.87 | NA | 000 | |||||||||||
| 91020 | A | Gastric motility | 1.44 | 2.96 | NA | 0.11 | 4.51 | NA | 000 | ||||||||||||
| 91020 | 26 | A | Gastric motility | 1.44 | 0.51 | 0.51 | 0.06 | 2.01 | 2.01 | 000 | |||||||||||
| 91020 | TC | A | Gastric motility | 0.00 | 2.45 | NA | 0.05 | 2.50 | NA | 000 | |||||||||||
| 91030 | A | Acid perfusion of esophagus | 0.91 | 2.27 | NA | 0.05 | 3.23 | NA | 000 | ||||||||||||
| 91030 | 26 | A | Acid perfusion of esophagus | 0.91 | 0.34 | 0.34 | 0.03 | 1.28 | 1.28 | 000 | |||||||||||
| 91030 | TC | A | Acid perfusion of esophagus | 0.00 | 1.93 | NA | 0.02 | 1.95 | NA | 000 | |||||||||||
| 91032 | A | Esophagus, acid reflux test | 1.21 | 2.26 | NA | 0.10 | 3.57 | NA | 000 | ||||||||||||
| 91032 | 26 | A | Esophagus, acid reflux test | 1.21 | 0.44 | 0.44 | 0.05 | 1.70 | 1.70 | 000 | |||||||||||
| 91032 | TC | A | Esophagus, acid reflux test | 0.00 | 1.82 | NA | 0.05 | 1.87 | NA | 000 | |||||||||||
| 91033 | A | Prolonged acid reflux test | 1.30 | 2.64 | NA | 0.14 | 4.08 | NA | 000 | ||||||||||||
| 91033 | 26 | A | Prolonged acid reflux test | 1.30 | 0.48 | 0.48 | 0.05 | 1.83 | 1.83 | 000 | |||||||||||
| 91033 | TC | A | Prolonged acid reflux test | 0.00 | 2.16 | NA | 0.09 | 2.25 | NA | 000 | |||||||||||
| 91052 | A | Gastric analysis test | 0.79 | 2.19 | NA | 0.05 | 3.03 | NA | 000 | ||||||||||||
| 91052 | 26 | A | Gastric analysis test | 0.79 | 0.29 | 0.29 | 0.03 | 1.11 | 1.11 | 000 | |||||||||||
| 91052 | TC | A | Gastric analysis test | 0.00 | 1.90 | NA | 0.02 | 1.92 | NA | 000 | |||||||||||
| 91055 | A | Gastric intubation for smear | 0.94 | 2.22 | NA | 0.06 | 3.22 | NA | 000 | ||||||||||||
| 91055 | 26 | A | Gastric intubation for smear | 0.94 | 0.28 | 0.28 | 0.04 | 1.26 | 1.26 | 000 | |||||||||||
| 91055 | TC | A | Gastric intubation for smear | 0.00 | 1.94 | NA | 0.02 | 1.96 | NA | 000 | |||||||||||
| 91060 | A | Gastric saline load test | 0.45 | 0.28 | NA | 0.04 | 0.77 | NA | 000 | ||||||||||||
| 91060 | 26 | A | Gastric saline load test | 0.45 | 0.15 | 0.15 | 0.02 | 0.62 | 0.62 | 000 | |||||||||||
| 91060 | TC | A | Gastric saline load test | 0.00 | 0.13 | NA | 0.02 | 0.15 | NA | 000 | |||||||||||
| 91065 | A | Breath hydrogen test | 0.20 | 4.55 | NA | 0.03 | 4.78 | NA | 000 | ||||||||||||
| 91065 | 26 | A | Breath hydrogen test | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | 000 | |||||||||||
| 91065 | TC | A | Breath hydrogen test | 0.00 | 4.48 | NA | 0.02 | 4.50 | NA | 000 | |||||||||||
| 91100 | A | Pass intestine bleeding tube | 1.08 | NA | 0.48 | 0.06 | NA | 1.62 | 000 | ||||||||||||
| 91105 | A | Gastric intubation treatment | 0.37 | NA | 0.21 | 0.02 | NA | 0.60 | 000 | ||||||||||||
| 91122 | A | Anal pressure record | 1.77 | 2.77 | NA | 0.17 | 4.71 | NA | 000 | ||||||||||||
| 91122 | 26 | A | Anal pressure record | 1.77 | 0.63 | 0.63 | 0.10 | 2.50 | 2.50 | 000 | |||||||||||
| 91122 | TC | A | Anal pressure record | 0.00 | 2.14 | NA | 0.07 | 2.21 | NA | 000 | |||||||||||
| 91123 | B | Irrigate fecal impaction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 91132 | C | Electrogastrography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 91132 | 26 | A | Electrogastrography | 0.52 | 0.21 | NA | 0.03 | 0.76 | NA | XXX | |||||||||||
| 91132 | TC | C | Electrogastrography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 91133 | C | Electrogastrography w/test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 91133 | 26 | A | Electrogastrography w/test | 0.66 | 0.26 | NA | 0.03 | 0.95 | NA | XXX | |||||||||||
| 91133 | TC | C | Electrogastrography w/test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 91299 | C | Gastroenterology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 91299 | 26 | C | Gastroenterology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 91299 | TC | C | Gastroenterology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 92002 | A | Eye exam, new patient | 0.88 | 0.96 | 0.38 | 0.02 | 1.86 | 1.28 | XXX | ||||||||||||
| 92004 | A | Eye exam, new patient | 1.67 | 1.71 | 0.73 | 0.03 | 3.41 | 2.43 | XXX | ||||||||||||
| 92012 | A | Eye exam established pat | 0.67 | 1.01 | 0.31 | 0.01 | 1.69 | 0.99 | XXX | ||||||||||||
| 92014 | A | Eye exam treatment | 1.10 | 1.40 | 0.50 | 0.02 | 2.52 | 1.62 | XXX | ||||||||||||
| 92015 | N | Refraction | +0.38 | 1.51 | 0.15 | 0.01 | 1.90 | 0.54 | XXX | ||||||||||||
| 92018 | A | New eye exam treatment | 2.50 | NA | 1.14 | 0.03 | NA | 3.67 | XXX | ||||||||||||
| 92019 | A | Eye exam treatment | 1.31 | NA | 0.61 | 0.03 | NA | 1.95 | XXX | ||||||||||||
| 92020 | A | Special eye evaluation | 0.37 | 0.95 | 0.17 | 0.01 | 1.33 | 0.55 | XXX | ||||||||||||
| 92060 | A | Special eye evaluation | 0.69 | 0.74 | NA | 0.02 | 1.45 | NA | XXX | ||||||||||||
| 92060 | 26 | A | Special eye evaluation | 0.69 | 0.31 | 0.31 | 0.01 | 1.01 | 1.01 | XXX | |||||||||||
| 92060 | TC | A | Special eye evaluation | 0.00 | 0.43 | NA | 0.01 | 0.44 | NA | XXX | |||||||||||
| 92065 | A | Orthoptic/pleoptic training | 0.37 | 1.19 | NA | 0.02 | 1.58 | NA | XXX | ||||||||||||
| 92065 | 26 | A | Orthoptic/pleoptic training | 0.37 | 0.15 | 0.15 | 0.01 | 0.53 | 0.53 | XXX | |||||||||||
| 92065 | TC | A | Orthoptic/pleoptic training | 0.00 | 1.04 | NA | 0.01 | 1.05 | NA | XXX | |||||||||||
| 92070 | A | Fitting of contact lens | 0.70 | 1.12 | 0.34 | 0.01 | 1.83 | 1.05 | XXX | ||||||||||||
| 92081 | A | Visual field examination(s) | 0.36 | 1.84 | NA | 0.02 | 2.22 | NA | XXX | ||||||||||||
| 92081 | 26 | A | Visual field examination(s) | 0.36 | 0.16 | 0.16 | 0.01 | 0.53 | 0.53 | XXX | |||||||||||
| 92081 | TC | A | Visual field examination(s) | 0.00 | 1.68 | NA | 0.01 | 1.69 | NA | XXX | |||||||||||
| 92082 | A | Visual field examination(s) | 0.44 | 0.85 | NA | 0.02 | 1.31 | NA | XXX | ||||||||||||
| 92082 | 26 | A | Visual field examination(s) | 0.44 | 0.20 | 0.20 | 0.01 | 0.65 | 0.65 | XXX | |||||||||||
| 92082 | TC | A | Visual field examination(s) | 0.00 | 0.65 | NA | 0.01 | 0.66 | NA | XXX | |||||||||||
| 92083 | A | Visual field examination(s) | 0.50 | 1.51 | NA | 0.02 | 2.03 | NA | XXX | ||||||||||||
| 92083 | 26 | A | Visual field examination(s) | 0.50 | 0.23 | 0.23 | 0.01 | 0.74 | 0.74 | XXX | |||||||||||
| 92083 | TC | A | Visual field examination(s) | 0.00 | 1.28 | NA | 0.01 | 1.29 | NA | XXX | |||||||||||
| 92100 | A | Serial tonometry exam(s) | 0.92 | 0.75 | 0.40 | 0.02 | 1.69 | 1.34 | XXX | ||||||||||||
| 92120 | A | Tonography eye evaluation | 0.81 | 0.81 | 0.31 | 0.02 | 1.64 | 1.14 | XXX | ||||||||||||
| 92130 | A | Water provocation tonography | 0.81 | 0.92 | 0.32 | 0.02 | 1.75 | 1.15 | XXX | ||||||||||||
| 92135 | A | Ophthalmic dx imaging | 0.35 | 1.48 | NA | 0.02 | 1.85 | NA | XXX | ||||||||||||
| 92135 | 26 | A | Ophthalmic dx imaging | 0.35 | 0.17 | 0.17 | 0.01 | 0.53 | 0.53 | XXX | |||||||||||
| 92135 | TC | A | Ophthalmic dx imaging | 0.00 | 1.31 | NA | 0.01 | 1.32 | NA | XXX | |||||||||||
| 92136 | A | Ophthalmic biometry | 0.54 | 1.52 | NA | 0.07 | 2.13 | NA | XXX | ||||||||||||
| 92136 | 26 | A | Ophthalmic biometry | 0.54 | 0.22 | 0.22 | 0.01 | 0.77 | 0.77 | XXX | |||||||||||
| 92136 | TC | A | Ophthalmic biometry | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX | |||||||||||
| 92140 | A | Glaucoma provocative tests | 0.50 | 1.01 | 0.22 | 0.01 | 1.52 | 0.73 | XXX | ||||||||||||
| 92225 | A | Special eye exam, initial | 0.38 | 0.23 | 0.17 | 0.01 | 0.62 | 0.56 | XXX | ||||||||||||
| 92226 | A | Special eye exam, subsequent | 0.33 | 0.22 | 0.15 | 0.01 | 0.56 | 0.49 | XXX | ||||||||||||
| 92230 | A | Eye exam with photos | 0.60 | 1.73 | 0.21 | 0.02 | 2.35 | 0.83 | XXX | ||||||||||||
| 92235 | A | Eye exam with photos | 0.81 | 2.62 | NA | 0.07 | 3.50 | NA | XXX | ||||||||||||
| 92235 | 26 | A | Eye exam with photos | 0.81 | 0.39 | 0.39 | 0.02 | 1.22 | 1.22 | XXX | |||||||||||
| 92235 | TC | A | Eye exam with photos | 0.00 | 2.23 | NA | 0.05 | 2.28 | NA | XXX | |||||||||||
| 92240 | A | Icg angiography | 1.10 | 5.24 | NA | 0.07 | 6.41 | NA | XXX | ||||||||||||
| 92240 | 26 | A | Icg angiography | 1.10 | 0.53 | 0.53 | 0.02 | 1.65 | 1.65 | XXX | |||||||||||
| 92240 | TC | A | Icg angiography | 0.00 | 4.71 | NA | 0.05 | 4.76 | NA | XXX | |||||||||||
| 92250 | A | Eye exam with photos | 0.44 | 1.37 | NA | 0.02 | 1.83 | NA | XXX | ||||||||||||
| 92250 | 26 | A | Eye exam with photos | 0.44 | 0.20 | 0.20 | 0.01 | 0.65 | 0.65 | XXX | |||||||||||
| 92250 | TC | A | Eye exam with photos | 0.00 | 1.17 | NA | 0.01 | 1.18 | NA | XXX | |||||||||||
| 92260 | A | Ophthalmoscopy/dynamometry | 0.20 | 0.24 | 0.10 | 0.01 | 0.45 | 0.31 | XXX | ||||||||||||
| 92265 | A | Eye muscle evaluation | 0.81 | 1.23 | NA | 0.04 | 2.08 | NA | XXX | ||||||||||||
| 92265 | 26 | A | Eye muscle evaluation | 0.81 | 0.38 | 0.38 | 0.02 | 1.21 | 1.21 | XXX | |||||||||||
| 92265 | TC | A | Eye muscle evaluation | 0.00 | 0.85 | NA | 0.02 | 0.87 | NA | XXX | |||||||||||
| 92270 | A | Electro-oculography | 0.81 | 1.15 | NA | 0.05 | 2.01 | NA | XXX | ||||||||||||
| 92270 | 26 | A | Electro-oculography | 0.81 | 0.37 | 0.37 | 0.03 | 1.21 | 1.21 | XXX | |||||||||||
| 92270 | TC | A | Electro-oculography | 0.00 | 0.78 | NA | 0.02 | 0.80 | NA | XXX | |||||||||||
| 92275 | A | Electroretinography | 1.01 | 1.25 | NA | 0.04 | 2.30 | NA | XXX | ||||||||||||
| 92275 | 26 | A | Electroretinography | 1.01 | 0.46 | 0.46 | 0.02 | 1.49 | 1.49 | XXX | |||||||||||
| 92275 | TC | A | Electroretinography | 0.00 | 0.79 | NA | 0.02 | 0.81 | NA | XXX | |||||||||||
| 92283 | A | Color vision examination | 0.17 | 0.74 | NA | 0.02 | 0.93 | NA | XXX | ||||||||||||
| 92283 | 26 | A | Color vision examination | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 92283 | TC | A | Color vision examination | 0.00 | 0.67 | NA | 0.01 | 0.68 | NA | XXX | |||||||||||
| 92284 | A | Dark adaptation eye exam | 0.24 | 1.75 | NA | 0.02 | 2.01 | NA | XXX | ||||||||||||
| 92284 | 26 | A | Dark adaptation eye exam | 0.24 | 0.09 | 0.09 | 0.01 | 0.34 | 0.34 | XXX | |||||||||||
| 92284 | TC | A | Dark adaptation eye exam | 0.00 | 1.66 | NA | 0.01 | 1.67 | NA | XXX | |||||||||||
| 92285 | A | Eye photography | 0.20 | 0.80 | NA | 0.02 | 1.02 | NA | XXX | ||||||||||||
| 92285 | 26 | A | Eye photography | 0.20 | 0.09 | 0.09 | 0.01 | 0.30 | 0.30 | XXX | |||||||||||
| 92285 | TC | A | Eye photography | 0.00 | 0.71 | NA | 0.01 | 0.72 | NA | XXX | |||||||||||
| 92286 | A | Internal eye photography | 0.66 | 3.00 | NA | 0.03 | 3.69 | NA | XXX | ||||||||||||
| 92286 | 26 | A | Internal eye photography | 0.66 | 0.32 | 0.32 | 0.01 | 0.99 | 0.99 | XXX | |||||||||||
| 92286 | TC | A | Internal eye photography | 0.00 | 2.68 | NA | 0.02 | 2.70 | NA | XXX | |||||||||||
| 92287 | A | Internal eye photography | 0.81 | 3.16 | 0.31 | 0.02 | 3.99 | 1.14 | XXX | ||||||||||||
| 92310 | N | Contact lens fitting | +1.17 | 1.10 | 0.47 | 0.03 | 2.30 | 1.67 | XXX | ||||||||||||
| 92311 | A | Contact lens fitting | 1.08 | 1.17 | 0.31 | 0.03 | 2.28 | 1.42 | XXX | ||||||||||||
| 92312 | A | Contact lens fitting | 1.26 | 1.17 | 0.45 | 0.03 | 2.46 | 1.74 | XXX | ||||||||||||
| 92313 | A | Contact lens fitting | 0.92 | 1.21 | 0.33 | 0.02 | 2.15 | 1.27 | XXX | ||||||||||||
| 92314 | N | Prescription of contact lens | +0.69 | 0.91 | 0.28 | 0.01 | 1.61 | 0.98 | XXX | ||||||||||||
| 92315 | A | Prescription of contact lens | 0.45 | 0.95 | 0.17 | 0.01 | 1.41 | 0.63 | XXX | ||||||||||||
| 92316 | A | Prescription of contact lens | 0.68 | 1.03 | 0.30 | 0.01 | 1.72 | 0.99 | XXX | ||||||||||||
| 92317 | A | Prescription of contact lens | 0.45 | 0.97 | 0.18 | 0.01 | 1.43 | 0.64 | XXX | ||||||||||||
| 92325 | A | Modification of contact lens | 0.00 | 0.38 | NA | 0.01 | 0.39 | NA | XXX | ||||||||||||
| 92326 | A | Replacement of contact lens | 0.00 | 1.55 | NA | 0.05 | 1.60 | NA | XXX | ||||||||||||
| 92330 | A | Fitting of artificial eye | 1.08 | 1.01 | 0.38 | 0.04 | 2.13 | 1.50 | XXX | ||||||||||||
| 92335 | A | Fitting of artificial eye | 0.45 | 0.99 | 0.17 | 0.01 | 1.45 | 0.63 | XXX | ||||||||||||
| 92340 | N | Fitting of spectacles | +0.37 | 0.68 | 0.15 | 0.01 | 1.06 | 0.53 | XXX | ||||||||||||
| 92341 | N | Fitting of spectacles | +0.47 | 0.72 | 0.19 | 0.01 | 1.20 | 0.67 | XXX | ||||||||||||
| 92342 | N | Fitting of spectacles | +0.53 | 0.74 | 0.21 | 0.01 | 1.28 | 0.75 | XXX | ||||||||||||
| 92352 | B | Special spectacles fitting | +0.37 | 0.68 | 0.15 | 0.01 | 1.06 | 0.53 | XXX | ||||||||||||
| 92353 | B | Special spectacles fitting | +0.50 | 0.73 | 0.20 | 0.02 | 1.25 | 0.72 | XXX | ||||||||||||
| 92354 | B | Special spectacles fitting | +0.00 | 8.41 | NA | 0.08 | 8.49 | NA | XXX | ||||||||||||
| 92355 | B | Special spectacles fitting | +0.00 | 4.11 | NA | 0.01 | 4.12 | NA | XXX | ||||||||||||
| 92358 | B | Eye prosthesis service | +0.00 | 0.92 | NA | 0.04 | 0.96 | NA | XXX | ||||||||||||
| 92370 | N | Repair adjust spectacles | +0.32 | 0.54 | 0.13 | 0.02 | 0.88 | 0.47 | XXX | ||||||||||||
| 92371 | B | Repair adjust spectacles | +0.00 | 0.59 | NA | 0.02 | 0.61 | NA | XXX | ||||||||||||
| 92390 | N | Supply of spectacles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92391 | N | Supply of contact lenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92392 | I | Supply of low vision aids | +0.00 | 3.84 | NA | 0.02 | 3.86 | NA | XXX | ||||||||||||
| 92393 | I | Supply of artificial eye | +0.00 | 11.92 | NA | 0.47 | 12.39 | NA | XXX | ||||||||||||
| 92395 | I | Supply of spectacles | +0.00 | 1.30 | NA | 0.08 | 1.38 | NA | XXX | ||||||||||||
| 92396 | I | Supply of contact lenses | +0.00 | 2.19 | NA | 0.06 | 2.25 | NA | XXX | ||||||||||||
| 92499 | C | Eye service or procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92499 | 26 | C | Eye service or procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 92499 | TC | C | Eye service or procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 92502 | A | Ear and throat examination | 1.51 | NA | 1.28 | 0.06 | NA | 2.85 | 000 | ||||||||||||
| 92504 | A | Ear microscopy examination | 0.18 | 1.10 | 0.09 | 0.01 | 1.29 | 0.28 | XXX | ||||||||||||
| 92506 | A | Speech/hearing evaluation | 0.86 | 1.72 | 0.43 | 0.04 | 2.62 | 1.33 | XXX | ||||||||||||
| 92507 | A | Speech/hearing therapy | 0.52 | 1.54 | 0.28 | 0.02 | 2.08 | 0.82 | XXX | ||||||||||||
| 92508 | A | Speech/hearing therapy | 0.26 | 1.77 | 0.15 | 0.01 | 2.04 | 0.42 | XXX | ||||||||||||
| 92510 | A | Rehab for ear implant | 1.50 | 2.11 | 0.83 | 0.06 | 3.67 | 2.39 | XXX | ||||||||||||
| 92511 | A | Nasopharyngoscopy | 0.84 | 1.36 | 0.42 | 0.03 | 2.23 | 1.29 | 000 | ||||||||||||
| 92512 | A | Nasal function studies | 0.55 | 1.13 | 0.17 | 0.02 | 1.70 | 0.74 | XXX | ||||||||||||
| 92516 | A | Facial nerve function test | 0.43 | 0.94 | 0.24 | 0.02 | 1.39 | 0.69 | XXX | ||||||||||||
| 92520 | A | Laryngeal function studies | 0.76 | 0.52 | 0.43 | 0.03 | 1.31 | 1.22 | XXX | ||||||||||||
| 92525 | I | Oral function evaluation | +1.50 | 1.69 | 0.60 | 0.07 | 3.26 | 2.17 | XXX | ||||||||||||
| 92526 | A | Oral function therapy | 0.55 | 1.55 | 0.27 | 0.02 | 2.12 | 0.84 | XXX | ||||||||||||
| 92531 | B | Spontaneous nystagmus study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92532 | B | Positional nystagmus test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92533 | B | Caloric vestibular test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92534 | B | Optokinetic nystagmus test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92541 | A | Spontaneous nystagmus test | 0.40 | 1.45 | NA | 0.04 | 1.89 | NA | XXX | ||||||||||||
| 92541 | 26 | A | Spontaneous nystagmus test | 0.40 | 0.20 | 0.20 | 0.02 | 0.62 | 0.62 | XXX | |||||||||||
| 92541 | TC | A | Spontaneous nystagmus test | 0.00 | 1.25 | NA | 0.02 | 1.27 | NA | XXX | |||||||||||
| 92542 | A | Positional nystagmus test | 0.33 | 1.39 | NA | 0.03 | 1.75 | NA | XXX | ||||||||||||
| 92542 | 26 | A | Positional nystagmus test | 0.33 | 0.17 | 0.17 | 0.01 | 0.51 | 0.51 | XXX | |||||||||||
| 92542 | TC | A | Positional nystagmus test | 0.00 | 1.22 | NA | 0.02 | 1.24 | NA | XXX | |||||||||||
| 92543 | A | Caloric vestibular test | 0.10 | 0.39 | NA | 0.02 | 0.51 | NA | XXX | ||||||||||||
| 92543 | 26 | A | Caloric vestibular test | 0.10 | 0.05 | 0.05 | 0.01 | 0.16 | 0.16 | XXX | |||||||||||
| 92543 | TC | A | Caloric vestibular test | 0.00 | 0.34 | NA | 0.01 | 0.35 | NA | XXX | |||||||||||
| 92544 | A | Optokinetic nystagmus test | 0.26 | 1.35 | NA | 0.03 | 1.64 | NA | XXX | ||||||||||||
| 92544 | 26 | A | Optokinetic nystagmus test | 0.26 | 0.13 | 0.13 | 0.01 | 0.40 | 0.40 | XXX | |||||||||||
| 92544 | TC | A | Optokinetic nystagmus test | 0.00 | 1.22 | NA | 0.02 | 1.24 | NA | XXX | |||||||||||
| 92545 | A | Oscillating tracking test | 0.23 | 1.32 | NA | 0.03 | 1.58 | NA | XXX | ||||||||||||
| 92545 | 26 | A | Oscillating tracking test | 0.23 | 0.12 | 0.12 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 92545 | TC | A | Oscillating tracking test | 0.00 | 1.20 | NA | 0.02 | 1.22 | NA | XXX | |||||||||||
| 92546 | A | Sinusoidal rotational test | 0.29 | 2.22 | NA | 0.03 | 2.54 | NA | XXX | ||||||||||||
| 92546 | 26 | A | Sinusoidal rotational test | 0.29 | 0.14 | 0.14 | 0.01 | 0.44 | 0.44 | XXX | |||||||||||
| 92546 | TC | A | Sinusoidal rotational test | 0.00 | 2.08 | NA | 0.02 | 2.10 | NA | XXX | |||||||||||
| 92547 | A | Supplemental electrical test | 0.00 | 1.21 | NA | 0.05 | 1.26 | NA | ZZZ | ||||||||||||
| 92548 | A | Posturography | 0.50 | 2.09 | NA | 0.13 | 2.72 | NA | XXX | ||||||||||||
| 92548 | 26 | A | Posturography | 0.50 | 0.28 | 0.28 | 0.02 | 0.80 | 0.80 | XXX | |||||||||||
| 92548 | TC | A | Posturography | 0.00 | 1.81 | NA | 0.11 | 1.92 | NA | XXX | |||||||||||
| 92551 | N | Pure tone hearing test, air | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92552 | A | Pure tone audiometry, air | 0.00 | 0.42 | NA | 0.03 | 0.45 | NA | XXX | ||||||||||||
| 92553 | A | Audiometry, air bone | 0.00 | 0.62 | NA | 0.05 | 0.67 | NA | XXX | ||||||||||||
| 92555 | A | Speech threshold audiometry | 0.00 | 0.36 | NA | 0.03 | 0.39 | NA | XXX | ||||||||||||
| 92556 | A | Speech audiometry, complete | 0.00 | 0.54 | NA | 0.05 | 0.59 | NA | XXX | ||||||||||||
| 92557 | A | Comprehensive hearing test | 0.00 | 1.13 | NA | 0.10 | 1.23 | NA | XXX | ||||||||||||
| 92559 | N | Group audiometric testing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92560 | N | Bekesy audiometry, screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92561 | A | Bekesy audiometry, diagnosis | 0.00 | 0.68 | NA | 0.05 | 0.73 | NA | XXX | ||||||||||||
| 92562 | A | Loudness balance test | 0.00 | 0.39 | NA | 0.03 | 0.42 | NA | XXX | ||||||||||||
| 92563 | A | Tone decay hearing test | 0.00 | 0.36 | NA | 0.03 | 0.39 | NA | XXX | ||||||||||||
| 92564 | A | Sisi hearing test | 0.00 | 0.45 | NA | 0.04 | 0.49 | NA | XXX | ||||||||||||
| 92565 | A | Stenger test, pure tone | 0.00 | 0.38 | NA | 0.03 | 0.41 | NA | XXX | ||||||||||||
| 92567 | A | Tympanometry | 0.00 | 0.50 | NA | 0.05 | 0.55 | NA | XXX | ||||||||||||
| 92568 | A | Acoustic reflex testing | 0.00 | 0.36 | NA | 0.03 | 0.39 | NA | XXX | ||||||||||||
| 92569 | A | Acoustic reflex decay test | 0.00 | 0.39 | NA | 0.03 | 0.42 | NA | XXX | ||||||||||||
| 92571 | A | Filtered speech hearing test | 0.00 | 0.37 | NA | 0.03 | 0.40 | NA | XXX | ||||||||||||
| 92572 | A | Staggered spondaic word test | 0.00 | 0.08 | NA | 0.01 | 0.09 | NA | XXX | ||||||||||||
| 92573 | A | Lombard test | 0.00 | 0.33 | NA | 0.03 | 0.36 | NA | XXX | ||||||||||||
| 92575 | A | Sensorineural acuity test | 0.00 | 0.28 | NA | 0.02 | 0.30 | NA | XXX | ||||||||||||
| 92576 | A | Synthetic sentence test | 0.00 | 0.42 | NA | 0.04 | 0.46 | NA | XXX | ||||||||||||
| 92577 | A | Stenger test, speech | 0.00 | 0.68 | NA | 0.06 | 0.74 | NA | XXX | ||||||||||||
| 92579 | A | Visual audiometry (vra) | 0.00 | 0.69 | NA | 0.05 | 0.74 | NA | XXX | ||||||||||||
| 92582 | A | Conditioning play audiometry | 0.00 | 0.69 | NA | 0.05 | 0.74 | NA | XXX | ||||||||||||
| 92583 | A | Select picture audiometry | 0.00 | 0.84 | NA | 0.07 | 0.91 | NA | XXX | ||||||||||||
| 92584 | A | Electrocochleography | 0.00 | 2.35 | NA | 0.17 | 2.52 | NA | XXX | ||||||||||||
| 92585 | A | Auditor evoke potent, compre | 0.50 | 1.98 | NA | 0.14 | 2.62 | NA | XXX | ||||||||||||
| 92585 | 26 | A | Auditor evoke potent, compre | 0.50 | 0.23 | 0.23 | 0.02 | 0.75 | 0.75 | XXX | |||||||||||
| 92585 | TC | A | Auditor evoke potent, compre | 0.00 | 1.75 | NA | 0.12 | 1.87 | NA | XXX | |||||||||||
| 92586 | A | Auditor evoke potent, limit | 0.00 | 1.75 | NA | 0.12 | 1.87 | NA | XXX | ||||||||||||
| 92587 | A | Evoked auditory test | 0.13 | 1.31 | NA | 0.10 | 1.54 | NA | XXX | ||||||||||||
| 92587 | 26 | A | Evoked auditory test | 0.13 | 0.07 | 0.07 | 0.01 | 0.21 | 0.21 | XXX | |||||||||||
| 92587 | TC | A | Evoked auditory test | 0.00 | 1.24 | NA | 0.09 | 1.33 | NA | XXX | |||||||||||
| 92588 | A | Evoked auditory test | 0.36 | 1.58 | NA | 0.12 | 2.06 | NA | XXX | ||||||||||||
| 92588 | 26 | A | Evoked auditory test | 0.36 | 0.18 | 0.18 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 92588 | TC | A | Evoked auditory test | 0.00 | 1.40 | NA | 0.11 | 1.51 | NA | XXX | |||||||||||
| 92589 | A | Auditory function test(s) | 0.00 | 0.51 | NA | 0.05 | 0.56 | NA | XXX | ||||||||||||
| 92590 | N | Hearing aid exam, one ear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92591 | N | Hearing aid exam, both ears | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92592 | N | Hearing aid check, one ear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92593 | N | Hearing aid check, both ears | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92594 | N | Electro hearng aid test, one | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92595 | N | Electro hearng aid tst, both | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92596 | A | Ear protector evaluation | 0.00 | 0.56 | NA | 0.05 | 0.61 | NA | XXX | ||||||||||||
| 92599 | C | ENT procedure/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 92599 | 26 | C | ENT procedure/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 92599 | TC | C | ENT procedure/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 92950 | A | Heart/lung resuscitation cpr | 3.80 | 1.59 | 1.18 | 0.21 | 5.60 | 5.19 | 000 | ||||||||||||
| 92953 | A | Temporary external pacing | 0.23 | NA | 0.23 | 0.01 | NA | 0.47 | 000 | ||||||||||||
| 92960 | A | Cardioversion electric, ext | 2.25 | 2.23 | 0.91 | 0.08 | 4.56 | 3.24 | 000 | ||||||||||||
| 92961 | A | Cardioversion, electric, int | 4.60 | NA | 1.85 | 0.17 | NA | 6.62 | 000 | ||||||||||||
| 92970 | A | Cardioassist, internal | 3.52 | NA | 1.27 | 0.17 | NA | 4.96 | 000 | ||||||||||||
| 92971 | A | Cardioassist, external | 1.77 | NA | 0.86 | 0.06 | NA | 2.69 | 000 | ||||||||||||
| 92973 | A | Percut coronary thrombectomy | 3.28 | NA | 1.37 | 0.17 | NA | 4.82 | ZZZ | ||||||||||||
| 92974 | A | Cath place, cardio brachytx | 3.00 | NA | 1.26 | 1.18 | NA | 5.44 | ZZZ | ||||||||||||
| 92975 | A | Dissolve clot, heart vessel | 7.25 | NA | 3.01 | 0.22 | NA | 10.48 | 000 | ||||||||||||
| 92977 | A | Dissolve clot, heart vessel | 0.00 | 7.65 | NA | 0.38 | 8.03 | NA | XXX | ||||||||||||
| 92978 | A | Intravasc us, heart add-on | 1.80 | 5.09 | NA | 0.26 | 7.15 | NA | ZZZ | ||||||||||||
| 92978 | 26 | A | Intravasc us, heart add-on | 1.80 | 0.76 | 0.76 | 0.06 | 2.62 | 2.62 | ZZZ | |||||||||||
| 92978 | TC | A | Intravasc us, heart add-on | 0.00 | 4.33 | NA | 0.20 | 4.53 | NA | ZZZ | |||||||||||
| 92979 | A | Intravasc us, heart add-on | 1.44 | 2.76 | NA | 0.15 | 4.35 | NA | ZZZ | ||||||||||||
| 92979 | 26 | A | Intravasc us, heart add-on | 1.44 | 0.58 | 0.58 | 0.04 | 2.06 | 2.06 | ZZZ | |||||||||||
| 92979 | TC | A | Intravasc us, heart add-on | 0.00 | 2.18 | NA | 0.11 | 2.29 | NA | ZZZ | |||||||||||
| 92980 | A | Insert intracoronary stent | 14.84 | NA | 6.22 | 0.78 | NA | 21.84 | 000 | ||||||||||||
| 92981 | A | Insert intracoronary stent | 4.17 | NA | 1.75 | 0.21 | NA | 6.13 | ZZZ | ||||||||||||
| 92982 | A | Coronary artery dilation | 10.98 | NA | 4.59 | 0.57 | NA | 16.14 | 000 | ||||||||||||
| 92984 | A | Coronary artery dilation | 2.97 | NA | 1.24 | 0.16 | NA | 4.37 | ZZZ | ||||||||||||
| 92986 | A | Revision of aortic valve | 21.80 | NA | 10.43 | 1.14 | NA | 33.37 | 090 | ||||||||||||
| 92987 | A | Revision of mitral valve | 22.70 | NA | 10.85 | 1.18 | NA | 34.73 | 090 | ||||||||||||
| 92990 | A | Revision of pulmonary valve | 17.34 | NA | 8.41 | 0.90 | NA | 26.65 | 090 | ||||||||||||
| 92992 | C | Revision of heart chamber | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 92993 | C | Revision of heart chamber | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | ||||||||||||
| 92995 | A | Coronary atherectomy | 12.09 | NA | 5.06 | 0.63 | NA | 17.78 | 000 | ||||||||||||
| 92996 | A | Coronary atherectomy add-on | 3.26 | NA | 1.37 | 0.17 | NA | 4.80 | ZZZ | ||||||||||||
| 92997 | A | Pul art balloon repr, percut | 12.00 | NA | 4.55 | 0.63 | NA | 17.18 | 000 | ||||||||||||
| 92998 | A | Pul art balloon repr, percut | 6.00 | NA | 2.06 | 0.31 | NA | 8.37 | ZZZ | ||||||||||||
| 93000 | A | Electrocardiogram, complete | 0.17 | 0.50 | NA | 0.03 | 0.70 | NA | XXX | ||||||||||||
| 93005 | A | Electrocardiogram, tracing | 0.00 | 0.43 | NA | 0.02 | 0.45 | NA | XXX | ||||||||||||
| 93010 | A | Electrocardiogram report | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX | ||||||||||||
| 93012 | A | Transmission of ecg | 0.00 | 2.24 | NA | 0.15 | 2.39 | NA | XXX | ||||||||||||
| 93014 | A | Report on transmitted ecg | 0.52 | 0.19 | 0.19 | 0.02 | 0.73 | 0.73 | XXX | ||||||||||||
| 93015 | A | Cardiovascular stress test | 0.75 | 1.90 | NA | 0.11 | 2.76 | NA | XXX | ||||||||||||
| 93016 | A | Cardiovascular stress test | 0.45 | 0.18 | 0.18 | 0.01 | 0.64 | 0.64 | XXX | ||||||||||||
| 93017 | A | Cardiovascular stress test | 0.00 | 1.60 | NA | 0.09 | 1.69 | NA | XXX | ||||||||||||
| 93018 | A | Cardiovascular stress test | 0.30 | 0.12 | 0.12 | 0.01 | 0.43 | 0.43 | XXX | ||||||||||||
| 93024 | A | Cardiac drug stress test | 1.17 | 1.55 | NA | 0.11 | 2.83 | NA | XXX | ||||||||||||
| 93024 | 26 | A | Cardiac drug stress test | 1.17 | 0.48 | 0.48 | 0.04 | 1.69 | 1.69 | XXX | |||||||||||
| 93024 | TC | A | Cardiac drug stress test | 0.00 | 1.07 | NA | 0.07 | 1.14 | NA | XXX | |||||||||||
| 93025 | A | Microvolt t-wave assess | 0.75 | 6.42 | NA | 0.11 | 7.28 | NA | XXX | ||||||||||||
| 93040 | A | Rhythm ECG with report | 0.16 | 0.19 | NA | 0.02 | 0.37 | NA | XXX | ||||||||||||
| 93041 | A | Rhythm ECG, tracing | 0.00 | 0.14 | NA | 0.01 | 0.15 | NA | XXX | ||||||||||||
| 93042 | A | Rhythm ECG, report | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | XXX | ||||||||||||
| 93224 | A | ECG monitor/report, 24 hrs | 0.52 | 3.47 | NA | 0.21 | 4.20 | NA | XXX | ||||||||||||
| 93225 | A | ECG monitor/record, 24 hrs | 0.00 | 1.18 | NA | 0.07 | 1.25 | NA | XXX | ||||||||||||
| 93226 | A | ECG monitor/report, 24 hrs | 0.00 | 2.08 | NA | 0.12 | 2.20 | NA | XXX | ||||||||||||
| 93227 | A | ECG monitor/review, 24 hrs | 0.52 | 0.21 | 0.21 | 0.02 | 0.75 | 0.75 | XXX | ||||||||||||
| 93230 | A | ECG monitor/report, 24 hrs | 0.52 | 3.72 | NA | 0.22 | 4.46 | NA | XXX | ||||||||||||
| 93231 | A | Ecg monitor/record, 24 hrs | 0.00 | 1.44 | NA | 0.09 | 1.53 | NA | XXX | ||||||||||||
| 93232 | A | ECG monitor/report, 24 hrs | 0.00 | 2.07 | NA | 0.11 | 2.18 | NA | XXX | ||||||||||||
| 93233 | A | ECG monitor/review, 24 hrs | 0.52 | 0.21 | 0.21 | 0.02 | 0.75 | 0.75 | XXX | ||||||||||||
| 93235 | A | ECG monitor/report, 24 hrs | 0.45 | 2.66 | NA | 0.13 | 3.24 | NA | XXX | ||||||||||||
| 93236 | A | ECG monitor/report, 24 hrs | 0.00 | 2.49 | NA | 0.12 | 2.61 | NA | XXX | ||||||||||||
| 93237 | A | ECG monitor/review, 24 hrs | 0.45 | 0.17 | 0.17 | 0.01 | 0.63 | 0.63 | XXX | ||||||||||||
| 93268 | A | ECG record/review | 0.52 | 3.62 | NA | 0.24 | 4.38 | NA | XXX | ||||||||||||
| 93270 | A | ECG recording | 0.00 | 1.18 | NA | 0.07 | 1.25 | NA | XXX | ||||||||||||
| 93271 | A | Ecg/monitoring and analysis | 0.00 | 2.24 | NA | 0.15 | 2.39 | NA | XXX | ||||||||||||
| 93272 | A | Ecg/review, interpret only | 0.52 | 0.20 | 0.20 | 0.02 | 0.74 | 0.74 | XXX | ||||||||||||
| 93278 | A | ECG/signal-averaged | 0.25 | 1.19 | NA | 0.10 | 1.54 | NA | XXX | ||||||||||||
| 93278 | 26 | A | ECG/signal-averaged | 0.25 | 0.10 | 0.10 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 93278 | TC | A | ECG/signal-averaged | 0.00 | 1.09 | NA | 0.09 | 1.18 | NA | XXX | |||||||||||
| 93303 | A | Echo transthoracic | 1.30 | 4.16 | NA | 0.23 | 5.69 | NA | XXX | ||||||||||||
| 93303 | 26 | A | Echo transthoracic | 1.30 | 0.50 | 0.50 | 0.04 | 1.84 | 1.84 | XXX | |||||||||||
| 93303 | TC | A | Echo transthoracic | 0.00 | 3.66 | NA | 0.19 | 3.85 | NA | XXX | |||||||||||
| 93304 | A | Echo transthoracic | 0.75 | 2.15 | NA | 0.13 | 3.03 | NA | XXX | ||||||||||||
| 93304 | 26 | A | Echo transthoracic | 0.75 | 0.30 | 0.30 | 0.02 | 1.07 | 1.07 | XXX | |||||||||||
| 93304 | TC | A | Echo transthoracic | 0.00 | 1.85 | NA | 0.11 | 1.96 | NA | XXX | |||||||||||
| 93307 | A | Echo exam of heart | 0.92 | 4.04 | NA | 0.22 | 5.18 | NA | XXX | ||||||||||||
| 93307 | 26 | A | Echo exam of heart | 0.92 | 0.38 | 0.38 | 0.03 | 1.33 | 1.33 | XXX | |||||||||||
| 93307 | TC | A | Echo exam of heart | 0.00 | 3.66 | NA | 0.19 | 3.85 | NA | XXX | |||||||||||
| 93308 | A | Echo exam of heart | 0.53 | 2.07 | NA | 0.13 | 2.73 | NA | XXX | ||||||||||||
| 93308 | 26 | A | Echo exam of heart | 0.53 | 0.22 | 0.22 | 0.02 | 0.77 | 0.77 | XXX | |||||||||||
| 93308 | TC | A | Echo exam of heart | 0.00 | 1.85 | NA | 0.11 | 1.96 | NA | XXX | |||||||||||
| 93312 | A | Echo transesophageal | 2.20 | 4.45 | NA | 0.32 | 6.97 | NA | XXX | ||||||||||||
| 93312 | 26 | A | Echo transesophageal | 2.20 | 0.86 | 0.86 | 0.08 | 3.14 | 3.14 | XXX | |||||||||||
| 93312 | TC | A | Echo transesophageal | 0.00 | 3.59 | NA | 0.24 | 3.83 | NA | XXX | |||||||||||
| 93313 | A | Echo transesophageal | 0.95 | 5.29 | 0.22 | 0.05 | 6.29 | 1.22 | XXX | ||||||||||||
| 93314 | A | Echo transesophageal | 1.25 | 4.10 | NA | 0.28 | 5.63 | NA | XXX | ||||||||||||
| 93314 | 26 | A | Echo transesophageal | 1.25 | 0.51 | 0.51 | 0.04 | 1.80 | 1.80 | XXX | |||||||||||
| 93314 | TC | A | Echo transesophageal | 0.00 | 3.59 | NA | 0.24 | 3.83 | NA | XXX | |||||||||||
| 93315 | A | Echo transesophageal | 2.78 | 4.70 | NA | 0.34 | 7.82 | NA | XXX | ||||||||||||
| 93315 | 26 | A | Echo transesophageal | 2.78 | 1.11 | 1.11 | 0.10 | 3.99 | 3.99 | XXX | |||||||||||
| 93315 | TC | A | Echo transesophageal | 0.00 | 3.59 | NA | 0.24 | 3.83 | NA | XXX | |||||||||||
| 93316 | A | Echo transesophageal | 0.95 | 6.39 | 0.25 | 0.05 | 7.39 | 1.25 | XXX | ||||||||||||
| 93317 | A | Echo transesophageal | 1.83 | 4.31 | NA | 0.30 | 6.44 | NA | XXX | ||||||||||||
| 93317 | 26 | A | Echo transesophageal | 1.83 | 0.72 | 0.72 | 0.06 | 2.61 | 2.61 | XXX | |||||||||||
| 93317 | TC | A | Echo transesophageal | 0.00 | 3.59 | NA | 0.24 | 3.83 | NA | XXX | |||||||||||
| 93318 | C | Echo transesophageal intraop | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93318 | 26 | A | Echo transesophageal intraop | 2.20 | 0.88 | NA | 0.06 | 3.14 | NA | XXX | |||||||||||
| 93318 | TC | C | Echo transesophageal intraop | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 93320 | A | Doppler echo exam, heart | 0.38 | 1.79 | NA | 0.11 | 2.28 | NA | ZZZ | ||||||||||||
| 93320 | 26 | A | Doppler echo exam, heart | 0.38 | 0.16 | 0.16 | 0.01 | 0.55 | 0.55 | ZZZ | |||||||||||
| 93320 | TC | A | Doppler echo exam, heart | 0.00 | 1.63 | NA | 0.10 | 1.73 | NA | ZZZ | |||||||||||
| 93321 | A | Doppler echo exam, heart | 0.15 | 1.12 | NA | 0.08 | 1.35 | NA | ZZZ | ||||||||||||
| 93321 | 26 | A | Doppler echo exam, heart | 0.15 | 0.06 | 0.06 | 0.01 | 0.22 | 0.22 | ZZZ | |||||||||||
| 93321 | TC | A | Doppler echo exam, heart | 0.00 | 1.06 | NA | 0.07 | 1.13 | NA | ZZZ | |||||||||||
| 93325 | A | Doppler color flow add-on | 0.07 | 2.78 | NA | 0.18 | 3.03 | NA | ZZZ | ||||||||||||
| 93325 | 26 | A | Doppler color flow add-on | 0.07 | 0.03 | 0.03 | 0.01 | 0.11 | 0.11 | ZZZ | |||||||||||
| 93325 | TC | A | Doppler color flow add-on | 0.00 | 2.75 | NA | 0.17 | 2.92 | NA | ZZZ | |||||||||||
| 93350 | A | Echo transthoracic | 1.48 | 2.28 | NA | 0.13 | 3.89 | NA | XXX | ||||||||||||
| 93350 | 26 | A | Echo transthoracic | 1.48 | 0.61 | 0.61 | 0.02 | 2.11 | 2.11 | XXX | |||||||||||
| 93350 | TC | A | Echo transthoracic | 0.00 | 1.67 | NA | 0.11 | 1.78 | NA | XXX | |||||||||||
| 93501 | A | Right heart catheterization | 3.02 | 17.23 | NA | 1.03 | 21.28 | NA | 000 | ||||||||||||
| 93501 | 26 | A | Right heart catheterization | 3.02 | 1.24 | 1.24 | 0.16 | 4.42 | 4.42 | 000 | |||||||||||
| 93501 | TC | A | Right heart catheterization | 0.00 | 15.99 | NA | 0.87 | 16.86 | NA | 000 | |||||||||||
| 93503 | A | Insert/place heart catheter | 2.91 | NA | 0.71 | 0.16 | NA | 3.78 | 000 | ||||||||||||
| 93505 | A | Biopsy of heart lining | 4.38 | 3.67 | NA | 0.36 | 8.41 | NA | 000 | ||||||||||||
| 93505 | 26 | A | Biopsy of heart lining | 4.38 | 1.80 | 1.80 | 0.23 | 6.41 | 6.41 | 000 | |||||||||||
| 93505 | TC | A | Biopsy of heart lining | 0.00 | 1.87 | NA | 0.13 | 2.00 | NA | 000 | |||||||||||
| 93508 | A | Cath placement, angiography | 4.10 | 13.64 | NA | 0.75 | 18.49 | NA | 000 | ||||||||||||
| 93508 | 26 | A | Cath placement, angiography | 4.10 | 1.71 | 1.71 | 0.21 | 6.02 | 6.02 | 000 | |||||||||||
| 93508 | TC | A | Cath placement, angiography | 0.00 | 11.93 | NA | 0.54 | 12.47 | NA | 000 | |||||||||||
| 93510 | A | Left heart catheterization | 4.33 | 36.77 | NA | 2.13 | 43.23 | NA | 000 | ||||||||||||
| 93510 | 26 | A | Left heart catheterization | 4.33 | 1.82 | 1.82 | 0.22 | 6.37 | 6.37 | 000 | |||||||||||
| 93510 | TC | A | Left heart catheterization | 0.00 | 34.95 | NA | 1.91 | 36.86 | NA | 000 | |||||||||||
| 93511 | A | Left heart catheterization | 5.03 | 36.12 | NA | 2.11 | 43.26 | NA | 000 | ||||||||||||
| 93511 | 26 | A | Left heart catheterization | 5.03 | 2.10 | 2.10 | 0.26 | 7.39 | 7.39 | 000 | |||||||||||
| 93511 | TC | A | Left heart catheterization | 0.00 | 34.02 | NA | 1.85 | 35.87 | NA | 000 | |||||||||||
| 93514 | A | Left heart catheterization | 7.05 | 36.79 | NA | 2.22 | 46.06 | NA | 000 | ||||||||||||
| 93514 | 26 | A | Left heart catheterization | 7.05 | 2.77 | 2.77 | 0.37 | 10.19 | 10.19 | 000 | |||||||||||
| 93514 | TC | A | Left heart catheterization | 0.00 | 34.02 | NA | 1.85 | 35.87 | NA | 000 | |||||||||||
| 93524 | A | Left heart catheterization | 6.95 | 47.32 | NA | 2.79 | 57.06 | NA | 000 | ||||||||||||
| 93524 | 26 | A | Left heart catheterization | 6.95 | 2.86 | 2.86 | 0.36 | 10.17 | 10.17 | 000 | |||||||||||
| 93524 | TC | A | Left heart catheterization | 0.00 | 44.46 | NA | 2.43 | 46.89 | NA | 000 | |||||||||||
| 93526 | A | Rt Lt heart catheters | 5.99 | 48.18 | NA | 2.81 | 56.98 | NA | 000 | ||||||||||||
| 93526 | 26 | A | Rt Lt heart catheters | 5.99 | 2.50 | 2.50 | 0.31 | 8.80 | 8.80 | 000 | |||||||||||
| 93526 | TC | A | Rt Lt heart catheters | 0.00 | 45.68 | NA | 2.50 | 48.18 | NA | 000 | |||||||||||
| 93527 | A | Rt Lt heart catheters | 7.28 | 47.49 | NA | 2.81 | 57.58 | NA | 000 | ||||||||||||
| 93527 | 26 | A | Rt Lt heart catheters | 7.28 | 3.03 | 3.03 | 0.38 | 10.69 | 10.69 | 000 | |||||||||||
| 93527 | TC | A | Rt Lt heart catheters | 0.00 | 44.46 | NA | 2.43 | 46.89 | NA | 000 | |||||||||||
| 93528 | A | Rt Lt heart catheters | 9.00 | 48.27 | NA | 2.90 | 60.17 | NA | 000 | ||||||||||||
| 93528 | 26 | A | Rt Lt heart catheters | 9.00 | 3.81 | 3.81 | 0.47 | 13.28 | 13.28 | 000 | |||||||||||
| 93528 | TC | A | Rt Lt heart catheters | 0.00 | 44.46 | NA | 2.43 | 46.89 | NA | 000 | |||||||||||
| 93529 | A | Rtlt heart catheterization | 4.80 | 46.46 | NA | 2.68 | 53.94 | NA | 000 | ||||||||||||
| 93529 | 26 | A | Rtlt heart catheterization | 4.80 | 2.00 | 2.00 | 0.25 | 7.05 | 7.05 | 000 | |||||||||||
| 93529 | TC | A | Rtlt heart catheterization | 0.00 | 44.46 | NA | 2.43 | 46.89 | NA | 000 | |||||||||||
| 93530 | A | Rt heart cath, congenital | 4.23 | 17.59 | NA | 1.11 | 22.93 | NA | 000 | ||||||||||||
| 93530 | 26 | A | Rt heart cath, congenital | 4.23 | 1.60 | 1.60 | 0.24 | 6.07 | 6.07 | 000 | |||||||||||
| 93530 | TC | A | Rt heart cath, congenital | 0.00 | 15.99 | NA | 0.87 | 16.86 | NA | 000 | |||||||||||
| 93531 | A | R l heart cath, congenital | 8.35 | 48.92 | NA | 2.96 | 60.23 | NA | 000 | ||||||||||||
| 93531 | 26 | A | R l heart cath, congenital | 8.35 | 3.24 | 3.24 | 0.46 | 12.05 | 12.05 | 000 | |||||||||||
| 93531 | TC | A | R l heart cath, congenital | 0.00 | 45.68 | NA | 2.50 | 48.18 | NA | 000 | |||||||||||
| 93532 | A | R l heart cath, congenital | 10.00 | 48.58 | NA | 2.95 | 61.53 | NA | 000 | ||||||||||||
| 93532 | 26 | A | R l heart cath, congenital | 10.00 | 4.12 | 4.12 | 0.52 | 14.64 | 14.64 | 000 | |||||||||||
| 93532 | TC | A | R l heart cath, congenital | 0.00 | 44.46 | NA | 2.43 | 46.89 | NA | 000 | |||||||||||
| 93533 | A | R l heart cath, congenital | 6.70 | 47.01 | NA | 2.86 | 56.57 | NA | 000 | ||||||||||||
| 93533 | 26 | A | R l heart cath, congenital | 6.70 | 2.55 | 2.55 | 0.43 | 9.68 | 9.68 | 000 | |||||||||||
| 93533 | TC | A | R l heart cath, congenital | 0.00 | 44.46 | NA | 2.43 | 46.89 | NA | 000 | |||||||||||
| 93536 | D | Insert circulation assi | 0.00 | NA | 0.00 | 0.00 | NA | 0.00 | 000 | ||||||||||||
| 93539 | A | Injection, cardiac cath | 0.40 | 0.84 | 0.17 | 0.01 | 1.25 | 0.58 | 000 | ||||||||||||
| 93540 | A | Injection, cardiac cath | 0.43 | 0.86 | 0.18 | 0.01 | 1.30 | 0.62 | 000 | ||||||||||||
| 93541 | A | Injection for lung angiogram | 0.29 | NA | 0.12 | 0.01 | NA | 0.42 | 000 | ||||||||||||
| 93542 | A | Injection for heart x-rays | 0.29 | NA | 0.12 | 0.01 | NA | 0.42 | 000 | ||||||||||||
| 93543 | A | Injection for heart x-rays | 0.29 | 0.55 | 0.12 | 0.01 | 0.85 | 0.42 | 000 | ||||||||||||
| 93544 | A | Injection for aortography | 0.25 | 0.53 | 0.10 | 0.01 | 0.79 | 0.36 | 000 | ||||||||||||
| 93545 | A | Inject for coronary x-rays | 0.40 | 0.85 | 0.17 | 0.01 | 1.26 | 0.58 | 000 | ||||||||||||
| 93555 | A | Imaging, cardiac cath | 0.81 | 6.27 | NA | 0.31 | 7.39 | NA | XXX | ||||||||||||
| 93555 | 26 | A | Imaging, cardiac cath | 0.81 | 0.34 | 0.34 | 0.03 | 1.18 | 1.18 | XXX | |||||||||||
| 93555 | TC | A | Imaging, cardiac cath | 0.00 | 5.93 | NA | 0.28 | 6.21 | NA | XXX | |||||||||||
| 93556 | A | Imaging, cardiac cath | 0.83 | 9.71 | NA | 0.45 | 10.99 | NA | XXX | ||||||||||||
| 93556 | 26 | A | Imaging, cardiac cath | 0.83 | 0.35 | 0.35 | 0.03 | 1.21 | 1.21 | XXX | |||||||||||
| 93556 | TC | A | Imaging, cardiac cath | 0.00 | 9.36 | NA | 0.42 | 9.78 | NA | XXX | |||||||||||
| 93561 | A | Cardiac output measurement | 0.50 | 0.67 | NA | 0.07 | 1.24 | NA | 000 | ||||||||||||
| 93561 | 26 | A | Cardiac output measurement | 0.50 | 0.16 | 0.16 | 0.02 | 0.68 | 0.68 | 000 | |||||||||||
| 93561 | TC | A | Cardiac output measurement | 0.00 | 0.51 | NA | 0.05 | 0.56 | NA | 000 | |||||||||||
| 93562 | A | Cardiac output measurement | 0.16 | 0.34 | NA | 0.04 | 0.54 | NA | 000 | ||||||||||||
| 93562 | 26 | A | Cardiac output measurement | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | 000 | |||||||||||
| 93562 | TC | A | Cardiac output measurement | 0.00 | 0.29 | NA | 0.03 | 0.32 | NA | 000 | |||||||||||
| 93571 | A | Heart flow reserve measure | 1.80 | 5.06 | NA | 0.31 | 7.17 | NA | ZZZ | ||||||||||||
| 93571 | 26 | A | Heart flow reserve measure | 1.80 | 0.73 | 0.73 | 0.11 | 2.64 | 2.64 | ZZZ | |||||||||||
| 93571 | TC | A | Heart flow reserve measure | 0.00 | 4.33 | NA | 0.20 | 4.53 | NA | ZZZ | |||||||||||
| 93572 | A | Heart flow reserve measure | 1.44 | 2.70 | NA | 0.28 | 4.42 | NA | ZZZ | ||||||||||||
| 93572 | 26 | A | Heart flow reserve measure | 1.44 | 0.52 | 0.52 | 0.17 | 2.13 | 2.13 | ZZZ | |||||||||||
| 93572 | TC | A | Heart flow reserve measure | 0.00 | 2.18 | NA | 0.11 | 2.29 | NA | ZZZ | |||||||||||
| 93600 | A | Bundle of His recording | 2.12 | 2.74 | NA | 0.22 | 5.08 | NA | 000 | ||||||||||||
| 93600 | 26 | A | Bundle of His recording | 2.12 | 0.89 | 0.89 | 0.11 | 3.12 | 3.12 | 000 | |||||||||||
| 93600 | TC | A | Bundle of His recording | 0.00 | 1.85 | NA | 0.11 | 1.96 | NA | 000 | |||||||||||
| 93602 | A | Intra-atrial recording | 2.12 | 1.94 | NA | 0.18 | 4.24 | NA | 000 | ||||||||||||
| 93602 | 26 | A | Intra-atrial recording | 2.12 | 0.88 | 0.88 | 0.12 | 3.12 | 3.12 | 000 | |||||||||||
| 93602 | TC | A | Intra-atrial recording | 0.00 | 1.06 | NA | 0.06 | 1.12 | NA | 000 | |||||||||||
| 93603 | A | Right ventricular recording | 2.12 | 2.46 | NA | 0.20 | 4.78 | NA | 000 | ||||||||||||
| 93603 | 26 | A | Right ventricular recording | 2.12 | 0.86 | 0.86 | 0.11 | 3.09 | 3.09 | 000 | |||||||||||
| 93603 | TC | A | Right ventricular recording | 0.00 | 1.60 | NA | 0.09 | 1.69 | NA | 000 | |||||||||||
| 93607 | D | Left ventricular recording | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 93607 | 26 | D | Left ventricular recording | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |||||||||||
| 93607 | TC | D | Left ventricular recording | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |||||||||||
| 93609 | A | Map tachycardia, add-on | 4.81 | 4.59 | NA | 0.66 | 10.06 | NA | ZZZ | ||||||||||||
| 93609 | 26 | A | Map tachycardia, add-on | 4.81 | 2.01 | 2.01 | 0.52 | 7.34 | 7.34 | ZZZ | |||||||||||
| 93609 | TC | A | Map tachycardia, add-on | 0.00 | 2.58 | NA | 0.14 | 2.72 | NA | ZZZ | |||||||||||
| 93610 | A | Intra-atrial pacing | 3.02 | 2.52 | NA | 0.25 | 5.79 | NA | 000 | ||||||||||||
| 93610 | 26 | A | Intra-atrial pacing | 3.02 | 1.23 | 1.23 | 0.17 | 4.42 | 4.42 | 000 | |||||||||||
| 93610 | TC | A | Intra-atrial pacing | 0.00 | 1.29 | NA | 0.08 | 1.37 | NA | 000 | |||||||||||
| 93612 | A | Intraventricular pacing | 3.02 | 2.76 | NA | 0.26 | 6.04 | NA | 000 | ||||||||||||
| 93612 | 26 | A | Intraventricular pacing | 3.02 | 1.23 | 1.23 | 0.17 | 4.42 | 4.42 | 000 | |||||||||||
| 93612 | TC | A | Intraventricular pacing | 0.00 | 1.53 | NA | 0.09 | 1.62 | NA | 000 | |||||||||||
| 93613 | C | Electrophys map, 3d, add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93613 | 26 | A | Electrophys map, 3d, add-on | 7.00 | 2.79 | 2.79 | 0.52 | 10.31 | 10.31 | XXX | |||||||||||
| 93613 | TC | C | Electrophys map, 3d, add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 93615 | A | Esophageal recording | 0.99 | 0.66 | NA | 0.05 | 1.70 | NA | 000 | ||||||||||||
| 93615 | 26 | A | Esophageal recording | 0.99 | 0.36 | 0.36 | 0.03 | 1.38 | 1.38 | 000 | |||||||||||
| 93615 | TC | A | Esophageal recording | 0.00 | 0.30 | NA | 0.02 | 0.32 | NA | 000 | |||||||||||
| 93616 | A | Esophageal recording | 1.49 | 0.80 | NA | 0.08 | 2.37 | NA | 000 | ||||||||||||
| 93616 | 26 | A | Esophageal recording | 1.49 | 0.50 | 0.50 | 0.06 | 2.05 | 2.05 | 000 | |||||||||||
| 93616 | TC | A | Esophageal recording | 0.00 | 0.30 | NA | 0.02 | 0.32 | NA | 000 | |||||||||||
| 93618 | A | Heart rhythm pacing | 4.26 | 5.54 | NA | 0.42 | 10.22 | NA | 000 | ||||||||||||
| 93618 | 26 | A | Heart rhythm pacing | 4.26 | 1.78 | 1.78 | 0.22 | 6.26 | 6.26 | 000 | |||||||||||
| 93618 | TC | A | Heart rhythm pacing | 0.00 | 3.76 | NA | 0.20 | 3.96 | NA | 000 | |||||||||||
| 93619 | A | Electrophysiology evaluation | 7.32 | 10.32 | NA | 0.77 | 18.41 | NA | 000 | ||||||||||||
| 93619 | 26 | A | Electrophysiology evaluation | 7.32 | 3.00 | 3.00 | 0.38 | 10.70 | 10.70 | 000 | |||||||||||
| 93619 | TC | A | Electrophysiology evaluation | 0.00 | 7.32 | NA | 0.39 | 7.71 | NA | 000 | |||||||||||
| 93620 | A | Electrophysiology evaluation | 11.59 | 13.33 | NA | 1.04 | 25.96 | NA | 000 | ||||||||||||
| 93620 | 26 | A | Electrophysiology evaluation | 11.59 | 4.82 | 4.82 | 0.60 | 17.01 | 17.01 | 000 | |||||||||||
| 93620 | TC | A | Electrophysiology evaluation | 0.00 | 8.51 | NA | 0.44 | 8.95 | NA | 000 | |||||||||||
| 93621 | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 93621 | 26 | A | Electrophysiology evaluation | 2.10 | 0.88 | 0.88 | 0.15 | 3.13 | 3.13 | ZZZ | |||||||||||
| 93621 | TC | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |||||||||||
| 93622 | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 93622 | 26 | A | Electrophysiology evaluation | 3.10 | 1.30 | 1.30 | 0.67 | 5.07 | 5.07 | ZZZ | |||||||||||
| 93622 | TC | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |||||||||||
| 93623 | C | Stimulation, pacing heart | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 93623 | 26 | A | Stimulation, pacing heart | 2.85 | 1.19 | 1.19 | 0.15 | 4.19 | 4.19 | ZZZ | |||||||||||
| 93623 | TC | C | Stimulation, pacing heart | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |||||||||||
| 93624 | A | Electrophysiologic study | 4.81 | 3.87 | NA | 0.36 | 9.04 | NA | 000 | ||||||||||||
| 93624 | 26 | A | Electrophysiologic study | 4.81 | 1.99 | 1.99 | 0.25 | 7.05 | 7.05 | 000 | |||||||||||
| 93624 | TC | A | Electrophysiologic study | 0.00 | 1.88 | NA | 0.11 | 1.99 | NA | 000 | |||||||||||
| 93631 | A | Heart pacing, mapping | 7.60 | 8.65 | NA | 1.17 | 17.42 | NA | 000 | ||||||||||||
| 93631 | 26 | A | Heart pacing, mapping | 7.60 | 2.81 | 2.81 | 0.66 | 11.07 | 11.07 | 000 | |||||||||||
| 93631 | TC | A | Heart pacing, mapping | 0.00 | 5.84 | NA | 0.51 | 6.35 | NA | 000 | |||||||||||
| 93640 | A | Evaluation heart device | 3.52 | 8.27 | NA | 0.53 | 12.32 | NA | 000 | ||||||||||||
| 93640 | 26 | A | Evaluation heart device | 3.52 | 1.46 | 1.46 | 0.18 | 5.16 | 5.16 | 000 | |||||||||||
| 93640 | TC | A | Evaluation heart device | 0.00 | 6.81 | NA | 0.35 | 7.16 | NA | 000 | |||||||||||
| 93641 | A | Electrophysiology evaluation | 5.93 | 9.28 | NA | 0.66 | 15.87 | NA | 000 | ||||||||||||
| 93641 | 26 | A | Electrophysiology evaluation | 5.93 | 2.47 | 2.47 | 0.31 | 8.71 | 8.71 | 000 | |||||||||||
| 93641 | TC | A | Electrophysiology evaluation | 0.00 | 6.81 | NA | 0.35 | 7.16 | NA | 000 | |||||||||||
| 93642 | A | Electrophysiology evaluation | 4.89 | 8.85 | NA | 0.51 | 14.25 | NA | 000 | ||||||||||||
| 93642 | 26 | A | Electrophysiology evaluation | 4.89 | 2.04 | 2.04 | 0.16 | 7.09 | 7.09 | 000 | |||||||||||
| 93642 | TC | A | Electrophysiology evaluation | 0.00 | 6.81 | NA | 0.35 | 7.16 | NA | 000 | |||||||||||
| 93650 | A | Ablate heart dysrhythm focus | 10.51 | NA | 4.32 | 0.55 | NA | 15.38 | 000 | ||||||||||||
| 93651 | A | Ablate heart dysrhythm focus | 16.25 | NA | 6.78 | 0.85 | NA | 23.88 | 000 | ||||||||||||
| 93652 | A | Ablate heart dysrhythm focus | 17.68 | NA | 7.36 | 0.92 | NA | 25.96 | 000 | ||||||||||||
| 93660 | A | Tilt table evaluation | 1.89 | 2.39 | NA | 0.08 | 4.36 | NA | 000 | ||||||||||||
| 93660 | 26 | A | Tilt table evaluation | 1.89 | 0.79 | 0.79 | 0.06 | 2.74 | 2.74 | 000 | |||||||||||
| 93660 | TC | A | Tilt table evaluation | 0.00 | 1.60 | NA | 0.02 | 1.62 | NA | 000 | |||||||||||
| 93662 | C | Intracardiac ecg (ice) | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 93662 | 26 | A | Intracardiac ecg (ice) | 2.80 | 1.12 | 1.12 | 0.41 | 4.33 | 4.33 | ZZZ | |||||||||||
| 93662 | TC | C | Intracardiac ecg (ice) | +0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| 93668 | N | Peripheral vascular rehab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93701 | A | Bioimpedance, thoracic | 0.17 | 0.78 | NA | 0.02 | 0.97 | NA | XXX | ||||||||||||
| 93701 | 26 | A | Bioimpedance, thoracic | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 93701 | TC | A | Bioimpedance, thoracic | 0.00 | 0.71 | NA | 0.01 | 0.72 | NA | XXX | |||||||||||
| 93720 | A | Total body plethysmography | 0.17 | 0.73 | NA | 0.06 | 0.96 | NA | XXX | ||||||||||||
| 93721 | A | Plethysmography tracing | 0.00 | 0.67 | NA | 0.05 | 0.72 | NA | XXX | ||||||||||||
| 93722 | A | Plethysmography report | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | ||||||||||||
| 93724 | A | Analyze pacemaker system | 4.89 | 5.80 | NA | 0.38 | 11.07 | NA | 000 | ||||||||||||
| 93724 | 26 | A | Analyze pacemaker system | 4.89 | 2.04 | 2.04 | 0.18 | 7.11 | 7.11 | 000 | |||||||||||
| 93724 | TC | A | Analyze pacemaker system | 0.00 | 3.76 | NA | 0.20 | 3.96 | NA | 000 | |||||||||||
| 93727 | A | Analyze ilr system | 0.52 | 0.21 | 0.21 | 0.05 | 0.78 | 0.78 | XXX | ||||||||||||
| 93731 | A | Analyze pacemaker system | 0.45 | 0.66 | NA | 0.05 | 1.16 | NA | XXX | ||||||||||||
| 93731 | 26 | A | Analyze pacemaker system | 0.45 | 0.19 | 0.19 | 0.02 | 0.66 | 0.66 | XXX | |||||||||||
| 93731 | TC | A | Analyze pacemaker system | 0.00 | 0.47 | NA | 0.03 | 0.50 | NA | XXX | |||||||||||
| 93732 | A | Analyze pacemaker system | 0.92 | 0.87 | NA | 0.06 | 1.85 | NA | XXX | ||||||||||||
| 93732 | 26 | A | Analyze pacemaker system | 0.92 | 0.38 | 0.38 | 0.03 | 1.33 | 1.33 | XXX | |||||||||||
| 93732 | TC | A | Analyze pacemaker system | 0.00 | 0.49 | NA | 0.03 | 0.52 | NA | XXX | |||||||||||
| 93733 | A | Telephone analy, pacemaker | 0.17 | 0.76 | NA | 0.06 | 0.99 | NA | XXX | ||||||||||||
| 93733 | 26 | A | Telephone analy, pacemaker | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| 93733 | TC | A | Telephone analy, pacemaker | 0.00 | 0.69 | NA | 0.05 | 0.74 | NA | XXX | |||||||||||
| 93734 | A | Analyze pacemaker system | 0.38 | 0.49 | NA | 0.03 | 0.90 | NA | XXX | ||||||||||||
| 93734 | 26 | A | Analyze pacemaker system | 0.38 | 0.16 | 0.16 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 93734 | TC | A | Analyze pacemaker system | 0.00 | 0.33 | NA | 0.02 | 0.35 | NA | XXX | |||||||||||
| 93735 | A | Analyze pacemaker system | 0.74 | 0.72 | NA | 0.06 | 1.52 | NA | XXX | ||||||||||||
| 93735 | 26 | A | Analyze pacemaker system | 0.74 | 0.30 | 0.30 | 0.03 | 1.07 | 1.07 | XXX | |||||||||||
| 93735 | TC | A | Analyze pacemaker system | 0.00 | 0.42 | NA | 0.03 | 0.45 | NA | XXX | |||||||||||
| 93736 | A | Telephone analy, pacemaker | 0.15 | 0.66 | NA | 0.06 | 0.87 | NA | XXX | ||||||||||||
| 93736 | 26 | A | Telephone analy, pacemaker | 0.15 | 0.06 | 0.06 | 0.01 | 0.22 | 0.22 | XXX | |||||||||||
| 93736 | TC | A | Telephone analy, pacemaker | 0.00 | 0.60 | NA | 0.05 | 0.65 | NA | XXX | |||||||||||
| 93737 | D | Analyze cardio/defibrillator | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| 93737 | 26 | D | Analyze cardio/defibrillator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 93737 | TC | D | Analyze cardio/defibrillator | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| 93738 | D | Analyze cardio/defibrillator | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| 93738 | 26 | D | Analyze cardio/defibrillator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 93738 | TC | D | Analyze cardio/defibrillator | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| 93740 | B | Temperature gradient studies | +0.16 | 0.21 | NA | 0.02 | 0.39 | NA | XXX | ||||||||||||
| 93740 | 26 | B | Temperature gradient studies | +0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 93740 | TC | B | Temperature gradient studies | +0.00 | 0.15 | NA | 0.01 | 0.16 | NA | XXX | |||||||||||
| 93741 | A | Analyze ht pace device sngl | 0.80 | 0.96 | NA | 0.05 | 1.81 | NA | XXX | ||||||||||||
| 93741 | 26 | A | Analyze ht pace device sngl | 0.80 | 0.33 | 0.33 | 0.02 | 1.15 | 1.15 | XXX | |||||||||||
| 93741 | TC | A | Analyze ht pace device sngl | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 93742 | A | Analyze ht pace device sngl | 0.91 | 1.01 | NA | 0.05 | 1.97 | NA | XXX | ||||||||||||
| 93742 | 26 | A | Analyze ht pace device sngl | 0.91 | 0.38 | 0.38 | 0.02 | 1.31 | 1.31 | XXX | |||||||||||
| 93742 | TC | A | Analyze ht pace device sngl | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 93743 | A | Analyze ht pace device dual | 1.03 | 1.13 | NA | 0.06 | 2.22 | NA | XXX | ||||||||||||
| 93743 | 26 | A | Analyze ht pace device dual | 1.03 | 0.43 | 0.43 | 0.03 | 1.49 | 1.49 | XXX | |||||||||||
| 93743 | TC | A | Analyze ht pace device dual | 0.00 | 0.70 | NA | 0.03 | 0.73 | NA | XXX | |||||||||||
| 93744 | A | Analyze ht pace device dual | 1.18 | 1.12 | NA | 0.06 | 2.36 | NA | XXX | ||||||||||||
| 93744 | 26 | A | Analyze ht pace device dual | 1.18 | 0.49 | 0.49 | 0.03 | 1.70 | 1.70 | XXX | |||||||||||
| 93744 | TC | A | Analyze ht pace device dual | 0.00 | 0.63 | NA | 0.03 | 0.66 | NA | XXX | |||||||||||
| 93760 | N | Cephalic thermogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93762 | N | Peripheral thermogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93770 | B | Measure venous pressure | +0.16 | 0.09 | NA | 0.02 | 0.27 | NA | XXX | ||||||||||||
| 93770 | 26 | B | Measure venous pressure | +0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX | |||||||||||
| 93770 | TC | B | Measure venous pressure | +0.00 | 0.03 | NA | 0.01 | 0.04 | NA | XXX | |||||||||||
| 93784 | N | Ambulatory BP monitoring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93786 | N | Ambulatory BP recording | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93788 | N | Ambulatory BP analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93790 | N | Review/report BP recording | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93797 | A | Cardiac rehab | 0.18 | 0.33 | 0.07 | 0.01 | 0.52 | 0.26 | 000 | ||||||||||||
| 93798 | A | Cardiac rehab/monitor | 0.28 | 0.44 | 0.11 | 0.01 | 0.73 | 0.40 | 000 | ||||||||||||
| 93799 | C | Cardiovascular procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 93799 | 26 | C | Cardiovascular procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 93799 | TC | C | Cardiovascular procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 93875 | A | Extracranial study | 0.22 | 1.13 | NA | 0.10 | 1.45 | NA | XXX | ||||||||||||
| 93875 | 26 | A | Extracranial study | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 93875 | TC | A | Extracranial study | 0.00 | 1.05 | NA | 0.09 | 1.14 | NA | XXX | |||||||||||
| 93880 | A | Extracranial study | 0.60 | 3.76 | NA | 0.33 | 4.69 | NA | XXX | ||||||||||||
| 93880 | 26 | A | Extracranial study | 0.60 | 0.22 | 0.22 | 0.04 | 0.86 | 0.86 | XXX | |||||||||||
| 93880 | TC | A | Extracranial study | 0.00 | 3.54 | NA | 0.29 | 3.83 | NA | XXX | |||||||||||
| 93882 | A | Extracranial study | 0.40 | 2.50 | NA | 0.22 | 3.12 | NA | XXX | ||||||||||||
| 93882 | 26 | A | Extracranial study | 0.40 | 0.15 | 0.15 | 0.04 | 0.59 | 0.59 | XXX | |||||||||||
| 93882 | TC | A | Extracranial study | 0.00 | 2.35 | NA | 0.18 | 2.53 | NA | XXX | |||||||||||
| 93886 | A | Intracranial study | 0.94 | 4.40 | NA | 0.37 | 5.71 | NA | XXX | ||||||||||||
| 93886 | 26 | A | Intracranial study | 0.94 | 0.40 | 0.40 | 0.05 | 1.39 | 1.39 | XXX | |||||||||||
| 93886 | TC | A | Intracranial study | 0.00 | 4.00 | NA | 0.32 | 4.32 | NA | XXX | |||||||||||
| 93888 | A | Intracranial study | 0.62 | 2.91 | NA | 0.26 | 3.79 | NA | XXX | ||||||||||||
| 93888 | 26 | A | Intracranial study | 0.62 | 0.24 | 0.24 | 0.04 | 0.90 | 0.90 | XXX | |||||||||||
| 93888 | TC | A | Intracranial study | 0.00 | 2.67 | NA | 0.22 | 2.89 | NA | XXX | |||||||||||
| 93922 | A | Extremity study | 0.25 | 1.18 | NA | 0.13 | 1.56 | NA | XXX | ||||||||||||
| 93922 | 26 | A | Extremity study | 0.25 | 0.09 | 0.09 | 0.02 | 0.36 | 0.36 | XXX | |||||||||||
| 93922 | TC | A | Extremity study | 0.00 | 1.09 | NA | 0.11 | 1.20 | NA | XXX | |||||||||||
| 93923 | A | Extremity study | 0.45 | 2.24 | NA | 0.22 | 2.91 | NA | XXX | ||||||||||||
| 93923 | 26 | A | Extremity study | 0.45 | 0.16 | 0.16 | 0.04 | 0.65 | 0.65 | XXX | |||||||||||
| 93923 | TC | A | Extremity study | 0.00 | 2.08 | NA | 0.18 | 2.26 | NA | XXX | |||||||||||
| 93924 | A | Extremity study | 0.50 | 2.43 | NA | 0.26 | 3.19 | NA | XXX | ||||||||||||
| 93924 | 26 | A | Extremity study | 0.50 | 0.18 | 0.18 | 0.05 | 0.73 | 0.73 | XXX | |||||||||||
| 93924 | TC | A | Extremity study | 0.00 | 2.25 | NA | 0.21 | 2.46 | NA | XXX | |||||||||||
| 93925 | A | Lower extremity study | 0.58 | 3.76 | NA | 0.33 | 4.67 | NA | XXX | ||||||||||||
| 93925 | 26 | A | Lower extremity study | 0.58 | 0.21 | 0.21 | 0.04 | 0.83 | 0.83 | XXX | |||||||||||
| 93925 | TC | A | Lower extremity study | 0.00 | 3.55 | NA | 0.29 | 3.84 | NA | XXX | |||||||||||
| 93926 | A | Lower extremity study | 0.39 | 2.51 | NA | 0.22 | 3.12 | NA | XXX | ||||||||||||
| 93926 | 26 | A | Lower extremity study | 0.39 | 0.14 | 0.14 | 0.03 | 0.56 | 0.56 | XXX | |||||||||||
| 93926 | TC | A | Lower extremity study | 0.00 | 2.37 | NA | 0.19 | 2.56 | NA | XXX | |||||||||||
| 93930 | A | Upper extremity study | 0.46 | 3.93 | NA | 0.34 | 4.73 | NA | XXX | ||||||||||||
| 93930 | 26 | A | Upper extremity study | 0.46 | 0.16 | 0.16 | 0.03 | 0.65 | 0.65 | XXX | |||||||||||
| 93930 | TC | A | Upper extremity study | 0.00 | 3.77 | NA | 0.31 | 4.08 | NA | XXX | |||||||||||
| 93931 | A | Upper extremity study | 0.31 | 2.62 | NA | 0.22 | 3.15 | NA | XXX | ||||||||||||
| 93931 | 26 | A | Upper extremity study | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX | |||||||||||
| 93931 | TC | A | Upper extremity study | 0.00 | 2.51 | NA | 0.20 | 2.71 | NA | XXX | |||||||||||
| 93965 | A | Extremity study | 0.35 | 1.17 | NA | 0.12 | 1.64 | NA | XXX | ||||||||||||
| 93965 | 26 | A | Extremity study | 0.35 | 0.13 | 0.13 | 0.02 | 0.50 | 0.50 | XXX | |||||||||||
| 93965 | TC | A | Extremity study | 0.00 | 1.04 | NA | 0.10 | 1.14 | NA | XXX | |||||||||||
| 93970 | A | Extremity study | 0.68 | 4.16 | NA | 0.38 | 5.22 | NA | XXX | ||||||||||||
| 93970 | 26 | A | Extremity study | 0.68 | 0.24 | 0.24 | 0.05 | 0.97 | 0.97 | XXX | |||||||||||
| 93970 | TC | A | Extremity study | 0.00 | 3.92 | NA | 0.33 | 4.25 | NA | XXX | |||||||||||
| 93971 | A | Extremity study | 0.45 | 2.77 | NA | 0.25 | 3.47 | NA | XXX | ||||||||||||
| 93971 | 26 | A | Extremity study | 0.45 | 0.16 | 0.16 | 0.03 | 0.64 | 0.64 | XXX | |||||||||||
| 93971 | TC | A | Extremity study | 0.00 | 2.61 | NA | 0.22 | 2.83 | NA | XXX | |||||||||||
| 93975 | A | Vascular study | 1.80 | 5.10 | NA | 0.47 | 7.37 | NA | XXX | ||||||||||||
| 93975 | 26 | A | Vascular study | 1.80 | 0.64 | 0.64 | 0.11 | 2.55 | 2.55 | XXX | |||||||||||
| 93975 | TC | A | Vascular study | 0.00 | 4.46 | NA | 0.36 | 4.82 | NA | XXX | |||||||||||
| 93976 | A | Vascular study | 1.21 | 3.41 | NA | 0.31 | 4.93 | NA | XXX | ||||||||||||
| 93976 | 26 | A | Vascular study | 1.21 | 0.43 | 0.43 | 0.06 | 1.70 | 1.70 | XXX | |||||||||||
| 93976 | TC | A | Vascular study | 0.00 | 2.98 | NA | 0.25 | 3.23 | NA | XXX | |||||||||||
| 93978 | A | Vascular study | 0.65 | 3.88 | NA | 0.36 | 4.89 | NA | XXX | ||||||||||||
| 93978 | 26 | A | Vascular study | 0.65 | 0.23 | 0.23 | 0.05 | 0.93 | 0.93 | XXX | |||||||||||
| 93978 | TC | A | Vascular study | 0.00 | 3.65 | NA | 0.31 | 3.96 | NA | XXX | |||||||||||
| 93979 | A | Vascular study | 0.44 | 2.59 | NA | 0.24 | 3.27 | NA | XXX | ||||||||||||
| 93979 | 26 | A | Vascular study | 0.44 | 0.16 | 0.16 | 0.04 | 0.64 | 0.64 | XXX | |||||||||||
| 93979 | TC | A | Vascular study | 0.00 | 2.43 | NA | 0.20 | 2.63 | NA | XXX | |||||||||||
| 93980 | A | Penile vascular study | 1.25 | 3.75 | NA | 0.35 | 5.35 | NA | XXX | ||||||||||||
| 93980 | 26 | A | Penile vascular study | 1.25 | 0.44 | 0.44 | 0.07 | 1.76 | 1.76 | XXX | |||||||||||
| 93980 | TC | A | Penile vascular study | 0.00 | 3.31 | NA | 0.28 | 3.59 | NA | XXX | |||||||||||
| 93981 | A | Penile vascular study | 0.44 | 3.21 | NA | 0.28 | 3.93 | NA | XXX | ||||||||||||
| 93981 | 26 | A | Penile vascular study | 0.44 | 0.15 | 0.15 | 0.02 | 0.61 | 0.61 | XXX | |||||||||||
| 93981 | TC | A | Penile vascular study | 0.00 | 3.06 | NA | 0.26 | 3.32 | NA | XXX | |||||||||||
| 93990 | A | Doppler flow testing | 0.25 | 2.46 | NA | 0.21 | 2.92 | NA | XXX | ||||||||||||
| 93990 | 26 | A | Doppler flow testing | 0.25 | 0.09 | 0.09 | 0.02 | 0.36 | 0.36 | XXX | |||||||||||
| 93990 | TC | A | Doppler flow testing | 0.00 | 2.37 | NA | 0.19 | 2.56 | NA | XXX | |||||||||||
| 94010 | A | Breathing capacity test | 0.17 | 0.82 | NA | 0.03 | 1.02 | NA | XXX | ||||||||||||
| 94010 | 26 | A | Breathing capacity test | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |||||||||||
| 94010 | TC | A | Breathing capacity test | 0.00 | 0.76 | NA | 0.02 | 0.78 | NA | XXX | |||||||||||
| 94014 | A | Patient recorded spirometry | 0.52 | 0.46 | NA | 0.03 | 1.01 | NA | XXX | ||||||||||||
| 94015 | A | Patient recorded spirometry | 0.00 | 0.29 | NA | 0.01 | 0.30 | NA | XXX | ||||||||||||
| 94016 | A | Review patient spirometry | 0.52 | 0.17 | 0.17 | 0.02 | 0.71 | 0.71 | XXX | ||||||||||||
| 94060 | A | Evaluation of wheezing | 0.31 | 1.36 | NA | 0.06 | 1.73 | NA | XXX | ||||||||||||
| 94060 | 26 | A | Evaluation of wheezing | 0.31 | 0.10 | 0.10 | 0.01 | 0.42 | 0.42 | XXX | |||||||||||
| 94060 | TC | A | Evaluation of wheezing | 0.00 | 1.26 | NA | 0.05 | 1.31 | NA | XXX | |||||||||||
| 94070 | A | Evaluation of wheezing | 0.60 | 3.38 | NA | 0.10 | 4.08 | NA | XXX | ||||||||||||
| 94070 | 26 | A | Evaluation of wheezing | 0.60 | 0.19 | 0.19 | 0.02 | 0.81 | 0.81 | XXX | |||||||||||
| 94070 | TC | A | Evaluation of wheezing | 0.00 | 3.19 | NA | 0.08 | 3.27 | NA | XXX | |||||||||||
| 94150 | B | Vital capacity test | +0.07 | 0.63 | NA | 0.02 | 0.72 | NA | XXX | ||||||||||||
| 94150 | 26 | B | Vital capacity test | +0.07 | 0.03 | 0.03 | 0.01 | 0.11 | 0.11 | XXX | |||||||||||
| 94150 | TC | B | Vital capacity test | +0.00 | 0.60 | NA | 0.01 | 0.61 | NA | XXX | |||||||||||
| 94200 | A | Lung function test (MBC/MVV) | 0.11 | 0.33 | NA | 0.03 | 0.47 | NA | XXX | ||||||||||||
| 94200 | 26 | A | Lung function test (MBC/MVV) | 0.11 | 0.04 | 0.04 | 0.01 | 0.16 | 0.16 | XXX | |||||||||||
| 94200 | TC | A | Lung function test (MBC/MVV) | 0.00 | 0.29 | NA | 0.02 | 0.31 | NA | XXX | |||||||||||
| 94240 | A | Residual lung capacity | 0.26 | 1.26 | NA | 0.05 | 1.57 | NA | XXX | ||||||||||||
| 94240 | 26 | A | Residual lung capacity | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 94240 | TC | A | Residual lung capacity | 0.00 | 1.18 | NA | 0.04 | 1.22 | NA | XXX | |||||||||||
| 94250 | A | Expired gas collection | 0.11 | 0.61 | NA | 0.02 | 0.74 | NA | XXX | ||||||||||||
| 94250 | 26 | A | Expired gas collection | 0.11 | 0.04 | 0.04 | 0.01 | 0.16 | 0.16 | XXX | |||||||||||
| 94250 | TC | A | Expired gas collection | 0.00 | 0.57 | NA | 0.01 | 0.58 | NA | XXX | |||||||||||
| 94260 | A | Thoracic gas volume | 0.13 | 0.38 | NA | 0.04 | 0.55 | NA | XXX | ||||||||||||
| 94260 | 26 | A | Thoracic gas volume | 0.13 | 0.04 | 0.04 | 0.01 | 0.18 | 0.18 | XXX | |||||||||||
| 94260 | TC | A | Thoracic gas volume | 0.00 | 0.34 | NA | 0.03 | 0.37 | NA | XXX | |||||||||||
| 94350 | A | Lung nitrogen washout curve | 0.26 | 1.01 | NA | 0.04 | 1.31 | NA | XXX | ||||||||||||
| 94350 | 26 | A | Lung nitrogen washout curve | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 94350 | TC | A | Lung nitrogen washout curve | 0.00 | 0.93 | NA | 0.03 | 0.96 | NA | XXX | |||||||||||
| 94360 | A | Measure airflow resistance | 0.26 | 0.50 | NA | 0.06 | 0.82 | NA | XXX | ||||||||||||
| 94360 | 26 | A | Measure airflow resistance | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 94360 | TC | A | Measure airflow resistance | 0.00 | 0.42 | NA | 0.05 | 0.47 | NA | XXX | |||||||||||
| 94370 | A | Breath airway closing volume | 0.26 | 2.03 | NA | 0.03 | 2.32 | NA | XXX | ||||||||||||
| 94370 | 26 | A | Breath airway closing volume | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 94370 | TC | A | Breath airway closing volume | 0.00 | 1.95 | NA | 0.02 | 1.97 | NA | XXX | |||||||||||
| 94375 | A | Respiratory flow volume loop | 0.31 | 0.46 | NA | 0.03 | 0.80 | NA | XXX | ||||||||||||
| 94375 | 26 | A | Respiratory flow volume loop | 0.31 | 0.10 | 0.10 | 0.01 | 0.42 | 0.42 | XXX | |||||||||||
| 94375 | TC | A | Respiratory flow volume loop | 0.00 | 0.36 | NA | 0.02 | 0.38 | NA | XXX | |||||||||||
| 94400 | A | CO 2 breathing response curve | 0.40 | 0.70 | NA | 0.06 | 1.16 | NA | XXX | ||||||||||||
| 94400 | 26 | A | CO 2 breathing response curve | 0.40 | 0.13 | 0.13 | 0.01 | 0.54 | 0.54 | XXX | |||||||||||
| 94400 | TC | A | CO 2 breathing response curve | 0.00 | 0.57 | NA | 0.05 | 0.62 | NA | XXX | |||||||||||
| 94450 | A | Hypoxia response curve | 0.40 | 0.85 | NA | 0.04 | 1.29 | NA | XXX | ||||||||||||
| 94450 | 26 | A | Hypoxia response curve | 0.40 | 0.12 | 0.12 | 0.02 | 0.54 | 0.54 | XXX | |||||||||||
| 94450 | TC | A | Hypoxia response curve | 0.00 | 0.73 | NA | 0.02 | 0.75 | NA | XXX | |||||||||||
| 94620 | A | Pulmonary stress test/simple | 0.64 | 1.66 | NA | 0.10 | 2.40 | NA | XXX | ||||||||||||
| 94620 | 26 | A | Pulmonary stress test/simple | 0.64 | 0.21 | 0.21 | 0.02 | 0.87 | 0.87 | XXX | |||||||||||
| 94620 | TC | A | Pulmonary stress test/simple | 0.00 | 1.45 | NA | 0.08 | 1.53 | NA | XXX | |||||||||||
| 94621 | A | Pulm stress test/complex | 1.42 | 1.25 | NA | 0.13 | 2.80 | NA | XXX | ||||||||||||
| 94621 | 26 | A | Pulm stress test/complex | 1.42 | 0.47 | 0.47 | 0.05 | 1.94 | 1.94 | XXX | |||||||||||
| 94621 | TC | A | Pulm stress test/complex | 0.00 | 0.78 | NA | 0.08 | 0.86 | NA | XXX | |||||||||||
| 94640 | A | Airway inhalation treatment | 0.00 | 0.74 | NA | 0.02 | 0.76 | NA | XXX | ||||||||||||
| 94642 | C | Aerosol inhalation treatment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 94650 | A | Pressure breathing (IPPB) | 0.00 | 0.67 | NA | 0.02 | 0.69 | NA | XXX | ||||||||||||
| 94651 | A | Pressure breathing (IPPB) | 0.00 | 0.62 | NA | 0.02 | 0.64 | NA | XXX | ||||||||||||
| 94652 | A | Pressure breathing (IPPB) | 0.00 | 0.77 | NA | 0.06 | 0.83 | NA | XXX | ||||||||||||
| 94656 | A | Initial ventilator mgmt | 1.22 | NA | 0.33 | 0.06 | NA | 1.61 | XXX | ||||||||||||
| 94657 | A | Continued ventilator mgmt | 0.83 | NA | 0.26 | 0.03 | NA | 1.12 | XXX | ||||||||||||
| 94660 | A | Pos airway pressure, CPAP | 0.76 | 0.67 | 0.24 | 0.03 | 1.46 | 1.03 | XXX | ||||||||||||
| 94662 | A | Neg press ventilation, cnp | 0.76 | NA | 0.24 | 0.02 | NA | 1.02 | XXX | ||||||||||||
| 94664 | A | Aerosol or vapor inhalations | 0.00 | 0.53 | NA | 0.03 | 0.56 | NA | XXX | ||||||||||||
| 94665 | A | Aerosol or vapor inhalations | 0.00 | 0.53 | NA | 0.04 | 0.57 | NA | XXX | ||||||||||||
| 94667 | A | Chest wall manipulation | 0.00 | 1.01 | NA | 0.04 | 1.05 | NA | XXX | ||||||||||||
| 94668 | A | Chest wall manipulation | 0.00 | 0.75 | NA | 0.02 | 0.77 | NA | XXX | ||||||||||||
| 94680 | A | Exhaled air analysis, o 2 | 0.26 | 1.17 | NA | 0.06 | 1.49 | NA | XXX | ||||||||||||
| 94680 | 26 | A | Exhaled air analysis, o 2 | 0.26 | 0.09 | 0.09 | 0.01 | 0.36 | 0.36 | XXX | |||||||||||
| 94680 | TC | A | Exhaled air analysis, o 2 | 0.00 | 1.08 | NA | 0.05 | 1.13 | NA | XXX | |||||||||||
| 94681 | A | Exhaled air analysis, o 2 /co 2 | 0.20 | 1.32 | NA | 0.11 | 1.63 | NA | XXX | ||||||||||||
| 94681 | 26 | A | Exhaled air analysis, o 2 /co 2 | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX | |||||||||||
| 94681 | TC | A | Exhaled air analysis, o 2 /co 2 | 0.00 | 1.25 | NA | 0.10 | 1.35 | NA | XXX | |||||||||||
| 94690 | A | Exhaled air analysis | 0.07 | 1.59 | NA | 0.04 | 1.70 | NA | XXX | ||||||||||||
| 94690 | 26 | A | Exhaled air analysis | 0.07 | 0.02 | 0.02 | 0.01 | 0.10 | 0.10 | XXX | |||||||||||
| 94690 | TC | A | Exhaled air analysis | 0.00 | 1.57 | NA | 0.03 | 1.60 | NA | XXX | |||||||||||
| 94720 | A | Monoxide diffusing capacity | 0.26 | 1.32 | NA | 0.06 | 1.64 | NA | XXX | ||||||||||||
| 94720 | 26 | A | Monoxide diffusing capacity | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 94720 | TC | A | Monoxide diffusing capacity | 0.00 | 1.24 | NA | 0.05 | 1.29 | NA | XXX | |||||||||||
| 94725 | A | Membrane diffusion capacity | 0.26 | 0.71 | NA | 0.11 | 1.08 | NA | XXX | ||||||||||||
| 94725 | 26 | A | Membrane diffusion capacity | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX | |||||||||||
| 94725 | TC | A | Membrane diffusion capacity | 0.00 | 0.63 | NA | 0.10 | 0.73 | NA | XXX | |||||||||||
| 94750 | A | Pulmonary compliance study | 0.23 | 1.06 | NA | 0.04 | 1.33 | NA | XXX | ||||||||||||
| 94750 | 26 | A | Pulmonary compliance study | 0.23 | 0.07 | 0.07 | 0.01 | 0.31 | 0.31 | XXX | |||||||||||
| 94750 | TC | A | Pulmonary compliance study | 0.00 | 0.99 | NA | 0.03 | 1.02 | NA | XXX | |||||||||||
| 94760 | T | Measure blood oxygen level | 0.00 | 0.10 | NA | 0.02 | 0.12 | NA | XXX | ||||||||||||
| 94761 | T | Measure blood oxygen level | 0.00 | 0.14 | NA | 0.05 | 0.19 | NA | XXX | ||||||||||||
| 94762 | A | Measure blood oxygen level | 0.00 | 0.74 | NA | 0.08 | 0.82 | NA | XXX | ||||||||||||
| 94770 | A | Exhaled carbon dioxide test | 0.15 | 0.91 | NA | 0.07 | 1.13 | NA | XXX | ||||||||||||
| 94770 | 26 | A | Exhaled carbon dioxide test | 0.15 | 0.04 | 0.04 | 0.01 | 0.20 | 0.20 | XXX | |||||||||||
| 94770 | TC | A | Exhaled carbon dioxide test | 0.00 | 0.87 | NA | 0.06 | 0.93 | NA | XXX | |||||||||||
| 94772 | C | Breath recording, infant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 94772 | 26 | C | Breath recording, infant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 94772 | TC | C | Breath recording, infant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 94799 | C | Pulmonary service/procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 94799 | 26 | C | Pulmonary service/procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 94799 | TC | C | Pulmonary service/procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 95004 | A | Allergy skin tests | 0.00 | 0.09 | NA | 0.01 | 0.10 | NA | XXX | ||||||||||||
| 95010 | A | Sensitivity skin tests | 0.15 | 0.45 | 0.07 | 0.01 | 0.61 | 0.23 | XXX | ||||||||||||
| 95015 | A | Sensitivity skin tests | 0.15 | 0.39 | 0.06 | 0.01 | 0.55 | 0.22 | XXX | ||||||||||||
| 95024 | A | Allergy skin tests | 0.00 | 0.14 | NA | 0.01 | 0.15 | NA | XXX | ||||||||||||
| 95027 | A | Skin end point titration | 0.00 | 0.14 | NA | 0.01 | 0.15 | NA | XXX | ||||||||||||
| 95028 | A | Allergy skin tests | 0.00 | 0.22 | NA | 0.01 | 0.23 | NA | XXX | ||||||||||||
| 95044 | A | Allergy patch tests | 0.00 | 0.19 | NA | 0.01 | 0.20 | NA | XXX | ||||||||||||
| 95052 | A | Photo patch test | 0.00 | 0.24 | NA | 0.01 | 0.25 | NA | XXX | ||||||||||||
| 95056 | A | Photosensitivity tests | 0.00 | 0.17 | NA | 0.01 | 0.18 | NA | XXX | ||||||||||||
| 95060 | A | Eye allergy tests | 0.00 | 0.33 | NA | 0.02 | 0.35 | NA | XXX | ||||||||||||
| 95065 | A | Nose allergy test | 0.00 | 0.19 | NA | 0.01 | 0.20 | NA | XXX | ||||||||||||
| 95070 | A | Bronchial allergy tests | 0.00 | 2.17 | NA | 0.02 | 2.19 | NA | XXX | ||||||||||||
| 95071 | A | Bronchial allergy tests | 0.00 | 2.77 | NA | 0.02 | 2.79 | NA | XXX | ||||||||||||
| 95075 | A | Ingestion challenge test | 0.95 | 0.80 | 0.43 | 0.03 | 1.78 | 1.41 | XXX | ||||||||||||
| 95078 | A | Provocative testing | 0.00 | 0.24 | NA | 0.02 | 0.26 | NA | XXX | ||||||||||||
| 95115 | A | Immunotherapy, one injection | 0.00 | 0.37 | NA | 0.02 | 0.39 | NA | 000 | ||||||||||||
| 95117 | A | Immunotherapy injections | 0.00 | 0.48 | NA | 0.02 | 0.50 | NA | 000 | ||||||||||||
| 95120 | I | Immunotherapy, one injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95125 | I | Immunotherapy, many antigens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95130 | I | Immunotherapy, insect venom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95131 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95132 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95133 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95134 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95144 | A | Antigen therapy services | 0.06 | 0.25 | 0.03 | 0.01 | 0.32 | 0.10 | 000 | ||||||||||||
| 95145 | A | Antigen therapy services | 0.06 | 0.47 | 0.03 | 0.01 | 0.54 | 0.10 | 000 | ||||||||||||
| 95146 | A | Antigen therapy services | 0.06 | 0.62 | 0.03 | 0.01 | 0.69 | 0.10 | 000 | ||||||||||||
| 95147 | A | Antigen therapy services | 0.06 | 0.91 | 0.03 | 0.01 | 0.98 | 0.10 | 000 | ||||||||||||
| 95148 | A | Antigen therapy services | 0.06 | 0.81 | 0.03 | 0.01 | 0.88 | 0.10 | 000 | ||||||||||||
| 95149 | A | Antigen therapy services | 0.06 | 1.04 | 0.03 | 0.01 | 1.11 | 0.10 | 000 | ||||||||||||
| 95165 | A | Antigen therapy services | 0.06 | 0.21 | 0.02 | 0.01 | 0.28 | 0.09 | 000 | ||||||||||||
| 95170 | A | Antigen therapy services | 0.06 | 0.26 | 0.02 | 0.01 | 0.33 | 0.09 | 000 | ||||||||||||
| 95180 | A | Rapid desensitization | 2.01 | 1.66 | 0.85 | 0.04 | 3.71 | 2.90 | 000 | ||||||||||||
| 95199 | C | Allergy immunology services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | ||||||||||||
| 95250 | A | Glucose monitoring, cont | 0.00 | 1.44 | NA | 0.01 | 1.45 | NA | XXX | ||||||||||||
| 95805 | A | Multiple sleep latency test | 1.88 | 5.89 | NA | 0.34 | 8.11 | NA | XXX | ||||||||||||
| 95805 | 26 | A | Multiple sleep latency test | 1.88 | 0.70 | 0.70 | 0.06 | 2.64 | 2.64 | XXX | |||||||||||
| 95805 | TC | A | Multiple sleep latency test | 0.00 | 5.19 | NA | 0.28 | 5.47 | NA | XXX | |||||||||||
| 95806 | A | Sleep study, unattended | 1.66 | 4.31 | NA | 0.32 | 6.29 | NA | XXX | ||||||||||||
| 95806 | 26 | A | Sleep study, unattended | 1.66 | 0.57 | 0.57 | 0.06 | 2.29 | 2.29 | XXX | |||||||||||
| 95806 | TC | A | Sleep study, unattended | 0.00 | 3.74 | NA | 0.26 | 4.00 | NA | XXX | |||||||||||
| 95807 | A | Sleep study, attended | 1.66 | 10.70 | NA | 0.40 | 12.76 | NA | XXX | ||||||||||||
| 95807 | 26 | A | Sleep study, attended | 1.66 | 0.56 | 0.56 | 0.05 | 2.27 | 2.27 | XXX | |||||||||||
| 95807 | TC | A | Sleep study, attended | 0.00 | 10.14 | NA | 0.35 | 10.49 | NA | XXX | |||||||||||
| 95808 | A | Polysomnography, 1-3 | 2.65 | 3.86 | NA | 0.44 | 6.95 | NA | XXX | ||||||||||||
| 95808 | 26 | A | Polysomnography, 1-3 | 2.65 | 0.99 | 0.99 | 0.09 | 3.73 | 3.73 | XXX | |||||||||||
| 95808 | TC | A | Polysomnography, 1-3 | 0.00 | 2.87 | NA | 0.35 | 3.22 | NA | XXX | |||||||||||
| 95810 | A | Polysomnography, 4 or more | 3.53 | 15.66 | NA | 0.47 | 19.66 | NA | XXX | ||||||||||||
| 95810 | 26 | A | Polysomnography, 4 or more | 3.53 | 1.26 | 1.26 | 0.12 | 4.91 | 4.91 | XXX | |||||||||||
| 95810 | TC | A | Polysomnography, 4 or more | 0.00 | 14.40 | NA | 0.35 | 14.75 | NA | XXX | |||||||||||
| 95811 | A | Polysomnography w/cpap | 3.80 | 13.63 | NA | 0.49 | 17.92 | NA | XXX | ||||||||||||
| 95811 | 26 | A | Polysomnography w/cpap | 3.80 | 1.34 | 1.34 | 0.13 | 5.27 | 5.27 | XXX | |||||||||||
| 95811 | TC | A | Polysomnography w/cpap | 0.00 | 12.29 | NA | 0.36 | 12.65 | NA | XXX | |||||||||||
| 95812 | A | Electroencephalogram (EEG) | 1.08 | 3.96 | NA | 0.13 | 5.17 | NA | XXX | ||||||||||||
| 95812 | 26 | A | Electroencephalogram (EEG) | 1.08 | 0.48 | 0.48 | 0.04 | 1.60 | 1.60 | XXX | |||||||||||
| 95812 | TC | A | Electroencephalogram (EEG) | 0.00 | 3.48 | NA | 0.09 | 3.57 | NA | XXX | |||||||||||
| 95813 | A | Electroencephalogram (EEG) | 1.73 | 5.53 | NA | 0.15 | 7.41 | NA | XXX | ||||||||||||
| 95813 | 26 | A | Electroencephalogram (EEG) | 1.73 | 0.73 | 0.73 | 0.06 | 2.52 | 2.52 | XXX | |||||||||||
| 95813 | TC | A | Electroencephalogram (EEG) | 0.00 | 4.80 | NA | 0.09 | 4.89 | NA | XXX | |||||||||||
| 95816 | A | Electroencephalogram (EEG) | 1.08 | 3.42 | NA | 0.12 | 4.62 | NA | XXX | ||||||||||||
| 95816 | 26 | A | Electroencephalogram (EEG) | 1.08 | 0.49 | 0.49 | 0.04 | 1.61 | 1.61 | XXX | |||||||||||
| 95816 | TC | A | Electroencephalogram (EEG) | 0.00 | 2.93 | NA | 0.08 | 3.01 | NA | XXX | |||||||||||
| 95819 | A | Electroencephalogram (EEG) | 1.08 | 4.34 | NA | 0.12 | 5.54 | NA | XXX | ||||||||||||
| 95819 | 26 | A | Electroencephalogram (EEG) | 1.08 | 0.49 | 0.49 | 0.04 | 1.61 | 1.61 | XXX | |||||||||||
| 95819 | TC | A | Electroencephalogram (EEG) | 0.00 | 3.85 | NA | 0.08 | 3.93 | NA | XXX | |||||||||||
| 95822 | A | Sleep electroencephalogram | 1.08 | 1.78 | NA | 0.15 | 3.01 | NA | XXX | ||||||||||||
| 95822 | 26 | A | Sleep electroencephalogram | 1.08 | 0.49 | 0.49 | 0.04 | 1.61 | 1.61 | XXX | |||||||||||
| 95822 | TC | A | Sleep electroencephalogram | 0.00 | 1.29 | NA | 0.11 | 1.40 | NA | XXX | |||||||||||
| 95824 | C | Electroencephalography | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95824 | 26 | A | Electroencephalography | 0.74 | 0.30 | 0.30 | 0.05 | 1.09 | 1.09 | ZZZ | |||||||||||
| 95824 | TC | C | Electroencephalography | +0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| 95827 | A | Night electroencephalogram | 1.08 | 2.64 | NA | 0.15 | 3.87 | NA | XXX | ||||||||||||
| 95827 | 26 | A | Night electroencephalogram | 1.08 | 0.46 | 0.46 | 0.03 | 1.57 | 1.57 | XXX | |||||||||||
| 95827 | TC | A | Night electroencephalogram | 0.00 | 2.18 | NA | 0.12 | 2.30 | NA | XXX | |||||||||||
| 95829 | A | Surgery electrocorticogram | 6.21 | 31.39 | NA | 0.33 | 37.93 | NA | XXX | ||||||||||||
| 95829 | 26 | A | Surgery electrocorticogram | 6.21 | 2.90 | 2.90 | 0.31 | 9.42 | 9.42 | XXX | |||||||||||
| 95829 | TC | A | Surgery electrocorticogram | 0.00 | 28.49 | NA | 0.02 | 28.51 | NA | XXX | |||||||||||
| 95830 | A | Insert electrodes for EEG | 1.70 | 3.76 | 0.78 | 0.07 | 5.53 | 2.55 | XXX | ||||||||||||
| 95831 | A | Limb muscle testing, manual | 0.28 | 0.52 | 0.12 | 0.01 | 0.81 | 0.41 | XXX | ||||||||||||
| 95832 | A | Hand muscle testing, manual | 0.29 | 0.48 | 0.11 | 0.01 | 0.78 | 0.41 | XXX | ||||||||||||
| 95833 | A | Body muscle testing, manual | 0.47 | 0.54 | 0.24 | 0.01 | 1.02 | 0.72 | XXX | ||||||||||||
| 95834 | A | Body muscle testing, manual | 0.60 | 0.59 | 0.28 | 0.02 | 1.21 | 0.90 | XXX | ||||||||||||
| 95851 | A | Range of motion measurements | 0.16 | 0.55 | 0.08 | 0.01 | 0.72 | 0.25 | XXX | ||||||||||||
| 95852 | A | Range of motion measurements | 0.11 | 0.49 | 0.05 | 0.01 | 0.61 | 0.17 | XXX | ||||||||||||
| 95857 | A | Tensilon test | 0.53 | 0.66 | 0.24 | 0.02 | 1.21 | 0.79 | XXX | ||||||||||||
| 95858 | A | Tensilon test myogram | 1.56 | 1.10 | NA | 0.07 | 2.73 | NA | XXX | ||||||||||||
| 95858 | 26 | A | Tensilon test myogram | 1.56 | 0.72 | 0.72 | 0.04 | 2.32 | 2.32 | XXX | |||||||||||
| 95858 | TC | A | Tensilon test myogram | 0.00 | 0.38 | NA | 0.03 | 0.41 | NA | XXX | |||||||||||
| 95860 | A | Muscle test, one limb | 0.96 | 1.18 | NA | 0.05 | 2.19 | NA | XXX | ||||||||||||
| 95860 | 26 | A | Muscle test, one limb | 0.96 | 0.45 | 0.45 | 0.03 | 1.44 | 1.44 | XXX | |||||||||||
| 95860 | TC | A | Muscle test, one limb | 0.00 | 0.73 | NA | 0.02 | 0.75 | NA | XXX | |||||||||||
| 95861 | A | Muscle test, two limbs | 1.54 | 1.42 | NA | 0.10 | 3.06 | NA | XXX | ||||||||||||
| 95861 | 26 | A | Muscle test, two limbs | 1.54 | 0.72 | 0.72 | 0.05 | 2.31 | 2.31 | XXX | |||||||||||
| 95861 | TC | A | Muscle test, two limbs | 0.00 | 0.70 | NA | 0.05 | 0.75 | NA | XXX | |||||||||||
| 95863 | A | Muscle test, 3 limbs | 1.87 | 1.76 | NA | 0.11 | 3.74 | NA | XXX | ||||||||||||
| 95863 | 26 | A | Muscle test, 3 limbs | 1.87 | 0.87 | 0.87 | 0.06 | 2.80 | 2.80 | XXX | |||||||||||
| 95863 | TC | A | Muscle test, 3 limbs | 0.00 | 0.89 | NA | 0.05 | 0.94 | NA | XXX | |||||||||||
| 95864 | A | Muscle test, 4 limbs | 1.99 | 2.62 | NA | 0.16 | 4.77 | NA | XXX | ||||||||||||
| 95864 | 26 | A | Muscle test, 4 limbs | 1.99 | 0.93 | 0.93 | 0.06 | 2.98 | 2.98 | XXX | |||||||||||
| 95864 | TC | A | Muscle test, 4 limbs | 0.00 | 1.69 | NA | 0.10 | 1.79 | NA | XXX | |||||||||||
| 95867 | A | Muscle test, head or neck | 0.79 | 0.92 | NA | 0.06 | 1.77 | NA | XXX | ||||||||||||
| 95867 | 26 | A | Muscle test, head or neck | 0.79 | 0.37 | 0.37 | 0.03 | 1.19 | 1.19 | XXX | |||||||||||
| 95867 | TC | A | Muscle test, head or neck | 0.00 | 0.55 | NA | 0.03 | 0.58 | NA | XXX | |||||||||||
| 95868 | A | Muscle test, head or neck | 1.18 | 1.23 | NA | 0.08 | 2.49 | NA | XXX | ||||||||||||
| 95868 | 26 | A | Muscle test, head or neck | 1.18 | 0.57 | 0.57 | 0.04 | 1.79 | 1.79 | XXX | |||||||||||
| 95868 | TC | A | Muscle test, head or neck | 0.00 | 0.66 | NA | 0.04 | 0.70 | NA | XXX | |||||||||||
| 95869 | A | Muscle test, thor paraspinal | 0.37 | 0.37 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 95869 | 26 | A | Muscle test, thor paraspinal | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 95869 | TC | A | Muscle test, thor paraspinal | 0.00 | 0.20 | NA | 0.02 | 0.22 | NA | XXX | |||||||||||
| 95870 | A | Muscle test, nonparaspinal | 0.37 | 0.37 | NA | 0.03 | 0.77 | NA | XXX | ||||||||||||
| 95870 | 26 | A | Muscle test, nonparaspinal | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX | |||||||||||
| 95870 | TC | A | Muscle test, nonparaspinal | 0.00 | 0.20 | NA | 0.02 | 0.22 | NA | XXX | |||||||||||
| 95872 | A | Muscle test, one fiber | 1.50 | 1.25 | NA | 0.08 | 2.83 | NA | XXX | ||||||||||||
| 95872 | 26 | A | Muscle test, one fiber | 1.50 | 0.68 | 0.68 | 0.04 | 2.22 | 2.22 | XXX | |||||||||||
| 95872 | TC | A | Muscle test, one fiber | 0.00 | 0.57 | NA | 0.04 | 0.61 | NA | XXX | |||||||||||
| 95875 | A | Limb exercise test | 1.10 | 1.38 | NA | 0.09 | 2.57 | NA | XXX | ||||||||||||
| 95875 | 26 | A | Limb exercise test | 1.10 | 0.49 | 0.49 | 0.04 | 1.63 | 1.63 | XXX | |||||||||||
| 95875 | TC | A | Limb exercise test | 0.00 | 0.89 | NA | 0.05 | 0.94 | NA | XXX | |||||||||||
| 95900 | A | Motor nerve conduction test | 0.42 | 0.73 | NA | 0.03 | 1.18 | NA | XXX | ||||||||||||
| 95900 | 26 | A | Motor nerve conduction test | 0.42 | 0.20 | 0.20 | 0.01 | 0.63 | 0.63 | XXX | |||||||||||
| 95900 | TC | A | Motor nerve conduction test | 0.00 | 0.53 | NA | 0.02 | 0.55 | NA | XXX | |||||||||||
| 95903 | A | Motor nerve conduction test | 0.60 | 0.51 | NA | 0.04 | 1.15 | NA | XXX | ||||||||||||
| 95903 | 26 | A | Motor nerve conduction test | 0.60 | 0.27 | 0.27 | 0.02 | 0.89 | 0.89 | XXX | |||||||||||
| 95903 | TC | A | Motor nerve conduction test | 0.00 | 0.24 | NA | 0.02 | 0.26 | NA | XXX | |||||||||||
| 95904 | A | Sense nerve conduction test | 0.34 | 0.64 | NA | 0.03 | 1.01 | NA | XXX | ||||||||||||
| 95904 | 26 | A | Sense nerve conduction test | 0.34 | 0.16 | 0.16 | 0.01 | 0.51 | 0.51 | XXX | |||||||||||
| 95904 | TC | A | Sense nerve conduction test | 0.00 | 0.48 | NA | 0.02 | 0.50 | NA | XXX | |||||||||||
| 95920 | A | Intraop nerve test add-on | 2.11 | 2.23 | NA | 0.20 | 4.54 | NA | ZZZ | ||||||||||||
| 95920 | 26 | A | Intraop nerve test add-on | 2.11 | 0.99 | 0.99 | 0.14 | 3.24 | 3.24 | ZZZ | |||||||||||
| 95920 | TC | A | Intraop nerve test add-on | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | ZZZ | |||||||||||
| 95921 | A | Autonomic nerv function test | 0.90 | 0.70 | NA | 0.05 | 1.65 | NA | XXX | ||||||||||||
| 95921 | 26 | A | Autonomic nerv function test | 0.90 | 0.34 | 0.34 | 0.03 | 1.27 | 1.27 | XXX | |||||||||||
| 95921 | TC | A | Autonomic nerv function test | 0.00 | 0.36 | NA | 0.02 | 0.38 | NA | XXX | |||||||||||
| 95922 | A | Autonomic nerv function test | 0.96 | 0.79 | NA | 0.05 | 1.80 | NA | XXX | ||||||||||||
| 95922 | 26 | A | Autonomic nerv function test | 0.96 | 0.43 | 0.43 | 0.03 | 1.42 | 1.42 | XXX | |||||||||||
| 95922 | TC | A | Autonomic nerv function test | 0.00 | 0.36 | NA | 0.02 | 0.38 | NA | XXX | |||||||||||
| 95923 | A | Autonomic nerv function test | 0.90 | 2.57 | NA | 0.05 | 3.52 | NA | XXX | ||||||||||||
| 95923 | 26 | A | Autonomic nerv function test | 0.90 | 0.40 | 0.40 | 0.03 | 1.33 | 1.33 | XXX | |||||||||||
| 95923 | TC | A | Autonomic nerv function test | 0.00 | 2.17 | NA | 0.02 | 2.19 | NA | XXX | |||||||||||
| 95925 | A | Somatosensory testing | 0.54 | 1.10 | NA | 0.07 | 1.71 | NA | XXX | ||||||||||||
| 95925 | 26 | A | Somatosensory testing | 0.54 | 0.24 | 0.24 | 0.02 | 0.80 | 0.80 | XXX | |||||||||||
| 95925 | TC | A | Somatosensory testing | 0.00 | 0.86 | NA | 0.05 | 0.91 | NA | XXX | |||||||||||
| 95926 | A | Somatosensory testing | 0.54 | 1.11 | NA | 0.07 | 1.72 | NA | XXX | ||||||||||||
| 95926 | 26 | A | Somatosensory testing | 0.54 | 0.25 | 0.25 | 0.02 | 0.81 | 0.81 | XXX | |||||||||||
| 95926 | TC | A | Somatosensory testing | 0.00 | 0.86 | NA | 0.05 | 0.91 | NA | XXX | |||||||||||
| 95927 | A | Somatosensory testing | 0.54 | 1.13 | NA | 0.08 | 1.75 | NA | XXX | ||||||||||||
| 95927 | 26 | A | Somatosensory testing | 0.54 | 0.27 | 0.27 | 0.03 | 0.84 | 0.84 | XXX | |||||||||||
| 95927 | TC | A | Somatosensory testing | 0.00 | 0.86 | NA | 0.05 | 0.91 | NA | XXX | |||||||||||
| 95930 | A | Visual evoked potential test | 0.35 | 0.84 | NA | 0.02 | 1.21 | NA | XXX | ||||||||||||
| 95930 | 26 | A | Visual evoked potential test | 0.35 | 0.16 | 0.16 | 0.01 | 0.52 | 0.52 | XXX | |||||||||||
| 95930 | TC | A | Visual evoked potential test | 0.00 | 0.68 | NA | 0.01 | 0.69 | NA | XXX | |||||||||||
| 95933 | A | Blink reflex test | 0.59 | 1.01 | NA | 0.07 | 1.67 | NA | XXX | ||||||||||||
| 95933 | 26 | A | Blink reflex test | 0.59 | 0.27 | 0.27 | 0.02 | 0.88 | 0.88 | XXX | |||||||||||
| 95933 | TC | A | Blink reflex test | 0.00 | 0.74 | NA | 0.05 | 0.79 | NA | XXX | |||||||||||
| 95934 | A | H-reflex test | 0.51 | 0.44 | NA | 0.04 | 0.99 | NA | XXX | ||||||||||||
| 95934 | 26 | A | H-reflex test | 0.51 | 0.24 | 0.24 | 0.02 | 0.77 | 0.77 | XXX | |||||||||||
| 95934 | TC | A | H-reflex test | 0.00 | 0.20 | NA | 0.02 | 0.22 | NA | XXX | |||||||||||
| 95936 | A | H-reflex test | 0.55 | 0.45 | NA | 0.04 | 1.04 | NA | XXX | ||||||||||||
| 95936 | 26 | A | H-reflex test | 0.55 | 0.25 | 0.25 | 0.02 | 0.82 | 0.82 | XXX | |||||||||||
| 95936 | TC | A | H-reflex test | 0.00 | 0.20 | NA | 0.02 | 0.22 | NA | XXX | |||||||||||
| 95937 | A | Neuromuscular junction test | 0.65 | 0.60 | NA | 0.04 | 1.29 | NA | XXX | ||||||||||||
| 95937 | 26 | A | Neuromuscular junction test | 0.65 | 0.28 | 0.28 | 0.02 | 0.95 | 0.95 | XXX | |||||||||||
| 95937 | TC | A | Neuromuscular junction test | 0.00 | 0.32 | NA | 0.02 | 0.34 | NA | XXX | |||||||||||
| 95950 | A | Ambulatory eeg monitoring | 1.51 | 4.93 | NA | 0.44 | 6.88 | NA | XXX | ||||||||||||
| 95950 | 26 | A | Ambulatory eeg monitoring | 1.51 | 0.70 | 0.70 | 0.08 | 2.29 | 2.29 | XXX | |||||||||||
| 95950 | TC | A | Ambulatory eeg monitoring | 0.00 | 4.23 | NA | 0.36 | 4.59 | NA | XXX | |||||||||||
| 95951 | A | EEG monitoring/videorecord | 6.00 | 16.38 | NA | 0.58 | 22.96 | NA | XXX | ||||||||||||
| 95951 | 26 | A | EEG monitoring/videorecord | 6.00 | 2.72 | 2.72 | 0.20 | 8.92 | 8.92 | XXX | |||||||||||
| 95951 | TC | A | EEG monitoring/videorecord | 0.00 | 13.66 | NA | 0.38 | 14.04 | NA | XXX | |||||||||||
| 95953 | A | EEG monitoring/computer | 3.08 | 7.39 | NA | 0.46 | 10.93 | NA | XXX | ||||||||||||
| 95953 | 26 | A | EEG monitoring/computer | 3.08 | 1.38 | 1.38 | 0.10 | 4.56 | 4.56 | XXX | |||||||||||
| 95953 | TC | A | EEG monitoring/computer | 0.00 | 6.01 | NA | 0.36 | 6.37 | NA | XXX | |||||||||||
| 95954 | A | EEG monitoring/giving drugs | 2.45 | 4.43 | NA | 0.15 | 7.03 | NA | XXX | ||||||||||||
| 95954 | 26 | A | EEG monitoring/giving drugs | 2.45 | 1.07 | 1.07 | 0.10 | 3.62 | 3.62 | XXX | |||||||||||
| 95954 | TC | A | EEG monitoring/giving drugs | 0.00 | 3.36 | NA | 0.05 | 3.41 | NA | XXX | |||||||||||
| 95955 | A | EEG during surgery | 1.01 | 2.26 | NA | 0.19 | 3.46 | NA | XXX | ||||||||||||
| 95955 | 26 | A | EEG during surgery | 1.01 | 0.40 | 0.40 | 0.05 | 1.46 | 1.46 | XXX | |||||||||||
| 95955 | TC | A | EEG during surgery | 0.00 | 1.86 | NA | 0.14 | 2.00 | NA | XXX | |||||||||||
| 95956 | A | Eeg monitoring, cable/radio | 3.08 | 7.43 | NA | 0.47 | 10.98 | NA | XXX | ||||||||||||
| 95956 | 26 | A | Eeg monitoring, cable/radio | 3.08 | 1.35 | 1.35 | 0.11 | 4.54 | 4.54 | XXX | |||||||||||
| 95956 | TC | A | Eeg monitoring, cable/radio | 0.00 | 6.08 | NA | 0.36 | 6.44 | NA | XXX | |||||||||||
| 95957 | A | EEG digital analysis | 1.98 | 2.52 | NA | 0.17 | 4.67 | NA | XXX | ||||||||||||
| 95957 | 26 | A | EEG digital analysis | 1.98 | 0.90 | 0.90 | 0.07 | 2.95 | 2.95 | XXX | |||||||||||
| 95957 | TC | A | EEG digital analysis | 0.00 | 1.62 | NA | 0.10 | 1.72 | NA | XXX | |||||||||||
| 95958 | A | EEG monitoring/function test | 4.25 | 3.51 | NA | 0.29 | 8.05 | NA | XXX | ||||||||||||
| 95958 | 26 | A | EEG monitoring/function test | 4.25 | 1.86 | 1.86 | 0.18 | 6.29 | 6.29 | XXX | |||||||||||
| 95958 | TC | A | EEG monitoring/function test | 0.00 | 1.65 | NA | 0.11 | 1.76 | NA | XXX | |||||||||||
| 95961 | A | Electrode stimulation, brain | 2.97 | 2.67 | NA | 0.24 | 5.88 | NA | XXX | ||||||||||||
| 95961 | 26 | A | Electrode stimulation, brain | 2.97 | 1.43 | 1.43 | 0.18 | 4.58 | 4.58 | XXX | |||||||||||
| 95961 | TC | A | Electrode stimulation, brain | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX | |||||||||||
| 95962 | A | Electrode stim, brain add-on | 3.21 | 2.72 | NA | 0.23 | 6.16 | NA | ZZZ | ||||||||||||
| 95962 | 26 | A | Electrode stim, brain add-on | 3.21 | 1.48 | 1.48 | 0.17 | 4.86 | 4.86 | ZZZ | |||||||||||
| 95962 | TC | A | Electrode stim, brain add-on | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | ZZZ | |||||||||||
| 95965 | C | Meg, spontaneous | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95965 | 26 | A | Meg, spontaneous | 8.00 | 3.19 | 3.19 | 0.20 | 11.39 | 11.39 | XXX | |||||||||||
| 95965 | TC | C | Meg, spontaneous | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 95966 | C | Meg, evoked, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 95966 | 26 | A | Meg, evoked, single | 4.00 | 1.60 | 1.60 | 0.18 | 5.78 | 5.78 | XXX | |||||||||||
| 95966 | TC | C | Meg, evoked, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| 95967 | C | Meg, evoked, each addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 95967 | 26 | A | Meg, evoked, each addl | 3.50 | 1.40 | 1.40 | 0.17 | 5.07 | 5.07 | ZZZ | |||||||||||
| 95967 | TC | C | Meg, evoked, each addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |||||||||||
| 95970 | A | Analyze neurostim, no prog | 0.45 | 0.18 | 0.16 | 0.03 | 0.66 | 0.64 | XXX | ||||||||||||
| 95971 | A | Analyze neurostim, simple | 0.78 | 0.28 | 0.24 | 0.06 | 1.12 | 1.08 | XXX | ||||||||||||
| 95972 | A | Analyze neurostim, complex | 1.50 | 0.62 | 0.51 | 0.17 | 2.29 | 2.18 | XXX | ||||||||||||
| 95973 | A | Analyze neurostim, complex | 0.92 | 0.42 | 0.36 | 0.07 | 1.41 | 1.35 | ZZZ | ||||||||||||
| 95974 | A | Cranial neurostim, complex | 3.00 | 1.37 | 1.37 | 0.15 | 4.52 | 4.52 | XXX | ||||||||||||
| 95975 | A | Cranial neurostim, complex | 1.70 | 0.78 | 0.78 | 0.07 | 2.55 | 2.55 | ZZZ | ||||||||||||
| 95999 | C | Neurological procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 96000 | A | Motion analysis, video/3d | 1.80 | NA | 0.72 | 0.02 | NA | 2.54 | XXX | ||||||||||||
| 96001 | A | Motion test w/ft press meas | 2.15 | NA | 0.86 | 0.02 | NA | 3.03 | XXX | ||||||||||||
| 96002 | A | Dynamic surface emg | 0.41 | NA | 0.16 | 0.02 | NA | 0.59 | XXX | ||||||||||||
| 96003 | A | Dynamic fine wire emg | 0.37 | NA | 0.15 | 0.03 | NA | 0.55 | XXX | ||||||||||||
| 96004 | A | Phys review of motion tests | 1.80 | 0.72 | 0.72 | 0.08 | 2.60 | 2.60 | XXX | ||||||||||||
| 96100 | A | Psychological testing | 0.00 | 1.67 | NA | 0.15 | 1.82 | NA | XXX | ||||||||||||
| 96105 | A | Assessment of aphasia | 0.00 | 1.67 | NA | 0.15 | 1.82 | NA | XXX | ||||||||||||
| 96110 | C | Developmental test, lim | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 96111 | A | Developmental test, extend | 0.00 | 1.67 | NA | 0.15 | 1.82 | NA | XXX | ||||||||||||
| 96115 | A | Neurobehavior status exam | 0.00 | 1.67 | NA | 0.15 | 1.82 | NA | XXX | ||||||||||||
| 96117 | A | Neuropsych test battery | 0.00 | 1.67 | NA | 0.15 | 1.82 | NA | XXX | ||||||||||||
| 96150 | A | Assess hlth/behave, init | 0.50 | 0.21 | 0.20 | 0.02 | 0.73 | 0.72 | XXX | ||||||||||||
| 96151 | A | Assess hlth/behave, subseq | 0.48 | 0.21 | 0.19 | 0.02 | 0.71 | 0.69 | XXX | ||||||||||||
| 96152 | A | Intervene hlth/behave, indiv | 0.46 | 0.20 | 0.18 | 0.02 | 0.68 | 0.66 | XXX | ||||||||||||
| 96153 | A | Intervene hlth/behave, group | 0.10 | 0.04 | 0.04 | 0.01 | 0.15 | 0.15 | XXX | ||||||||||||
| 96154 | A | Interv hlth/behav, fam w/pt | 0.45 | 0.19 | 0.18 | 0.02 | 0.66 | 0.65 | XXX | ||||||||||||
| 96155 | A | Interv hlth/behav fam no pt | 0.44 | 0.18 | 0.18 | 0.02 | 0.64 | 0.64 | XXX | ||||||||||||
| 96400 | A | Chemotherapy, sc/im | 0.00 | 0.13 | NA | 0.01 | 0.14 | NA | XXX | ||||||||||||
| 96405 | A | Intralesional chemo admin | 0.52 | 1.88 | 0.24 | 0.02 | 2.42 | 0.78 | 000 | ||||||||||||
| 96406 | A | Intralesional chemo admin | 0.80 | 2.94 | 0.41 | 0.02 | 3.76 | 1.23 | 000 | ||||||||||||
| 96408 | A | Chemotherapy, push technique | 0.00 | 0.92 | NA | 0.05 | 0.97 | NA | XXX | ||||||||||||
| 96410 | A | Chemotherapy infusion method | 0.00 | 1.47 | NA | 0.07 | 1.54 | NA | XXX | ||||||||||||
| 96412 | A | Chemo, infuse method add-on | 0.00 | 1.09 | NA | 0.06 | 1.15 | NA | ZZZ | ||||||||||||
| 96414 | A | Chemo, infuse method add-on | 0.00 | 1.27 | NA | 0.07 | 1.34 | NA | XXX | ||||||||||||
| 96420 | A | Chemotherapy, push technique | 0.00 | 1.18 | NA | 0.07 | 1.25 | NA | XXX | ||||||||||||
| 96422 | A | Chemotherapy infusion method | 0.00 | 1.17 | NA | 0.07 | 1.24 | NA | XXX | ||||||||||||
| 96423 | A | Chemo, infuse method add-on | 0.00 | 0.46 | NA | 0.02 | 0.48 | NA | ZZZ | ||||||||||||
| 96425 | A | Chemotherapy infusion method | 0.00 | 1.36 | NA | 0.07 | 1.43 | NA | XXX | ||||||||||||
| 96440 | A | Chemotherapy, intracavitary | 2.37 | 7.99 | 1.06 | 0.12 | 10.48 | 3.55 | 000 | ||||||||||||
| 96445 | A | Chemotherapy, intracavitary | 2.20 | 8.74 | 1.08 | 0.07 | 11.01 | 3.35 | 000 | ||||||||||||
| 96450 | A | Chemotherapy, into CNS | 1.89 | 6.79 | 0.95 | 0.06 | 8.74 | 2.90 | 000 | ||||||||||||
| 96520 | A | Pump refilling, maintenance | 0.00 | 0.84 | NA | 0.05 | 0.89 | NA | XXX | ||||||||||||
| 96530 | A | Pump refilling, maintenance | 0.00 | 1.01 | NA | 0.05 | 1.06 | NA | XXX | ||||||||||||
| 96542 | A | Chemotherapy injection | 1.42 | 4.70 | 0.55 | 0.05 | 6.17 | 2.02 | XXX | ||||||||||||
| 96545 | B | Provide chemotherapy agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 96549 | C | Chemotherapy, unspecified | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 96567 | A | Photodynamic tx, skin | 0.00 | 1.63 | NA | 0.03 | 1.66 | NA | XXX | ||||||||||||
| 96570 | A | Photodynamic tx, 30 min | 1.10 | 0.46 | 0.38 | 0.04 | 1.60 | 1.52 | ZZZ | ||||||||||||
| 96571 | A | Photodynamic tx, addl 15 min | 0.55 | 0.22 | 0.20 | 0.02 | 0.79 | 0.77 | ZZZ | ||||||||||||
| 96900 | A | Ultraviolet light therapy | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | ||||||||||||
| 96902 | B | Trichogram | +0.41 | 0.25 | 0.16 | 0.01 | 0.67 | 0.58 | XXX | ||||||||||||
| 96910 | A | Photochemotherapy with UV-B | 0.00 | 1.37 | NA | 0.03 | 1.40 | NA | XXX | ||||||||||||
| 96912 | A | Photochemotherapy with UV-A | 0.00 | 1.54 | NA | 0.04 | 1.58 | NA | XXX | ||||||||||||
| 96913 | A | Photochemotherapy, UV-A or B | 0.00 | 2.26 | NA | 0.08 | 2.34 | NA | XXX | ||||||||||||
| 96999 | C | Dermatological procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97001 | A | Pt evaluation | 1.20 | 0.56 | 0.37 | 0.10 | 1.86 | 1.67 | XXX | ||||||||||||
| 97002 | A | Pt re-evaluation | 0.60 | 0.35 | 0.27 | 0.04 | 0.99 | 0.91 | XXX | ||||||||||||
| 97003 | A | Ot evaluation | 1.20 | 0.69 | 0.32 | 0.05 | 1.94 | 1.57 | XXX | ||||||||||||
| 97004 | A | Ot re-evaluation | 0.60 | 0.69 | 0.12 | 0.02 | 1.31 | 0.74 | XXX | ||||||||||||
| 97005 | I | Athletic train eval | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97006 | I | Athletic train reeval | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97010 | B | Hot or cold packs therapy | +0.06 | 0.04 | 0.04 | 0.01 | 0.11 | 0.11 | XXX | ||||||||||||
| 97012 | A | Mechanical traction therapy | 0.25 | 0.11 | 0.11 | 0.01 | 0.37 | 0.37 | XXX | ||||||||||||
| 97014 | A | Electric stimulation therapy | 0.18 | 0.19 | 0.19 | 0.01 | 0.38 | 0.38 | XXX | ||||||||||||
| 97016 | A | Vasopneumatic device therapy | 0.18 | 0.14 | 0.14 | 0.01 | 0.33 | 0.33 | XXX | ||||||||||||
| 97018 | A | Paraffin bath therapy | 0.06 | 0.12 | 0.12 | 0.01 | 0.19 | 0.19 | XXX | ||||||||||||
| 97020 | A | Microwave therapy | 0.06 | 0.05 | 0.05 | 0.01 | 0.12 | 0.12 | XXX | ||||||||||||
| 97022 | A | Whirlpool therapy | 0.17 | 0.26 | 0.26 | 0.01 | 0.44 | 0.44 | XXX | ||||||||||||
| 97024 | A | Diathermy treatment | 0.06 | 0.05 | 0.05 | 0.01 | 0.12 | 0.12 | XXX | ||||||||||||
| 97026 | A | Infrared therapy | 0.06 | 0.05 | 0.05 | 0.01 | 0.12 | 0.12 | XXX | ||||||||||||
| 97028 | A | Ultraviolet therapy | 0.08 | 0.06 | 0.06 | 0.01 | 0.15 | 0.15 | XXX | ||||||||||||
| 97032 | A | Electrical stimulation | 0.25 | 0.21 | 0.21 | 0.01 | 0.47 | 0.47 | XXX | ||||||||||||
| 97033 | A | Electric current therapy | 0.26 | 0.12 | 0.12 | 0.02 | 0.40 | 0.40 | XXX | ||||||||||||
| 97034 | A | Contrast bath therapy | 0.21 | 0.14 | 0.14 | 0.01 | 0.36 | 0.36 | XXX | ||||||||||||
| 97035 | A | Ultrasound therapy | 0.21 | 0.08 | 0.08 | 0.01 | 0.30 | 0.30 | XXX | ||||||||||||
| 97036 | A | Hydrotherapy | 0.28 | 0.34 | 0.34 | 0.01 | 0.63 | 0.63 | XXX | ||||||||||||
| 97039 | A | Physical therapy treatment | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX | ||||||||||||
| 97110 | A | Therapeutic exercises | 0.45 | 0.25 | 0.25 | 0.03 | 0.73 | 0.73 | XXX | ||||||||||||
| 97112 | A | Neuromuscular reeducation | 0.45 | 0.29 | 0.29 | 0.02 | 0.76 | 0.76 | XXX | ||||||||||||
| 97113 | A | Aquatic therapy/exercises | 0.44 | 0.33 | 0.33 | 0.03 | 0.80 | 0.80 | XXX | ||||||||||||
| 97116 | A | Gait training therapy | 0.40 | 0.21 | 0.21 | 0.02 | 0.63 | 0.63 | XXX | ||||||||||||
| 97124 | A | Massage therapy | 0.35 | 0.21 | 0.21 | 0.01 | 0.57 | 0.57 | XXX | ||||||||||||
| 97139 | A | Physical medicine procedure | 0.21 | 0.21 | 0.21 | 0.01 | 0.43 | 0.43 | XXX | ||||||||||||
| 97140 | A | Manual therapy | 0.43 | 0.23 | 0.23 | 0.02 | 0.68 | 0.68 | XXX | ||||||||||||
| 97150 | A | Group therapeutic procedures | 0.27 | 0.20 | 0.20 | 0.02 | 0.49 | 0.49 | XXX | ||||||||||||
| 97504 | A | Orthotic training | 0.45 | 0.25 | 0.25 | 0.03 | 0.73 | 0.73 | XXX | ||||||||||||
| 97520 | A | Prosthetic training | 0.45 | 0.21 | 0.21 | 0.02 | 0.68 | 0.68 | XXX | ||||||||||||
| 97530 | A | Therapeutic activities | 0.44 | 0.45 | 0.45 | 0.02 | 0.91 | 0.91 | XXX | ||||||||||||
| 97532 | A | Cognitive skills development | 0.44 | 0.17 | 0.17 | 0.01 | 0.62 | 0.62 | XXX | ||||||||||||
| 97533 | A | Sensory integration | 0.44 | 0.21 | 0.21 | 0.01 | 0.66 | 0.66 | XXX | ||||||||||||
| 97535 | A | Self care mngment training | 0.45 | 0.35 | 0.35 | 0.02 | 0.82 | 0.82 | XXX | ||||||||||||
| 97537 | A | Community/work reintegration | 0.45 | 0.20 | 0.20 | 0.01 | 0.66 | 0.66 | XXX | ||||||||||||
| 97542 | A | Wheelchair mngment training | 0.45 | 0.22 | 0.22 | 0.01 | 0.68 | 0.68 | XXX | ||||||||||||
| 97545 | R | Work hardening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97546 | R | Work hardening add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 97601 | A | Wound(s) care, selective | 0.50 | 1.90 | 1.90 | 0.04 | 2.44 | 2.44 | XXX | ||||||||||||
| 97602 | B | Wound(s) care non-selective | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97703 | A | Prosthetic checkout | 0.25 | 0.44 | 0.44 | 0.02 | 0.71 | 0.71 | XXX | ||||||||||||
| 97750 | A | Physical performance test | 0.45 | 0.24 | 0.24 | 0.02 | 0.71 | 0.71 | XXX | ||||||||||||
| 97780 | N | Acupuncture w/o stimul | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97781 | N | Acupuncture w/stimul | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97799 | C | Physical medicine procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 97802 | A | Medical nutrition, indiv, in | 0.00 | 0.45 | 0.45 | 0.01 | 0.46 | 0.46 | XXX | ||||||||||||
| 97803 | A | Med nutrition, indiv, subseq | 0.00 | 0.45 | 0.45 | 0.01 | 0.46 | 0.46 | XXX | ||||||||||||
| 97804 | A | Medical nutrition, group | 0.00 | 0.17 | 0.17 | 0.01 | 0.18 | 0.18 | XXX | ||||||||||||
| 98925 | A | Osteopathic manipulation | 0.45 | 0.38 | 0.14 | 0.01 | 0.84 | 0.60 | 000 | ||||||||||||
| 98926 | A | Osteopathic manipulation | 0.65 | 0.44 | 0.25 | 0.02 | 1.11 | 0.92 | 000 | ||||||||||||
| 98927 | A | Osteopathic manipulation | 0.87 | 0.52 | 0.31 | 0.03 | 1.42 | 1.21 | 000 | ||||||||||||
| 98928 | A | Osteopathic manipulation | 1.03 | 0.59 | 0.38 | 0.03 | 1.65 | 1.44 | 000 | ||||||||||||
| 98929 | A | Osteopathic manipulation | 1.19 | 0.65 | 0.39 | 0.04 | 1.88 | 1.62 | 000 | ||||||||||||
| 98940 | A | Chiropractic manipulation | 0.45 | 0.25 | 0.13 | 0.01 | 0.71 | 0.59 | 000 | ||||||||||||
| 98941 | A | Chiropractic manipulation | 0.65 | 0.31 | 0.19 | 0.02 | 0.98 | 0.86 | 000 | ||||||||||||
| 98942 | A | Chiropractic manipulation | 0.87 | 0.37 | 0.25 | 0.03 | 1.27 | 1.15 | 000 | ||||||||||||
| 98943 | N | Chiropractic manipulation | +0.40 | 0.34 | 0.16 | 0.01 | 0.75 | 0.57 | XXX | ||||||||||||
| 99000 | B | Specimen handling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99001 | B | Specimen handling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99002 | B | Device handling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99024 | B | Postop follow-up visit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99025 | B | Initial surgical evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99050 | B | Medical services after hrs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99052 | B | Medical services at night | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99054 | B | Medical servcs, unusual hrs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99056 | B | Non-office medical services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99058 | B | Office emergency care | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99070 | B | Special supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99071 | B | Patient education materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99075 | N | Medical testimony | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99078 | B | Group health education | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99080 | B | Special reports or forms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99082 | C | Unusual physician travel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99090 | B | Computer data analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99091 | B | Collect/review data from pt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99100 | B | Special anesthesia service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 99116 | B | Anesthesia with hypothermia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 99135 | B | Special anesthesia procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 99140 | B | Emergency anesthesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 99141 | B | Sedation, iv/im or inhalant | +0.80 | 2.12 | 0.39 | 0.04 | 2.96 | 1.23 | XXX | ||||||||||||
| 99142 | B | Sedation, oral/rectal/nasal | +0.60 | 1.24 | 0.31 | 0.03 | 1.87 | 0.94 | XXX | ||||||||||||
| 99170 | A | Anogenital exam, child | 1.75 | 2.02 | 0.55 | 0.07 | 3.84 | 2.37 | 000 | ||||||||||||
| 99172 | N | Ocular function screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99173 | N | Visual acuity screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99175 | A | Induction of vomiting | 0.00 | 1.32 | NA | 0.08 | 1.40 | NA | XXX | ||||||||||||
| 99183 | A | Hyperbaric oxygen therapy | 2.34 | NA | 0.77 | 0.12 | NA | 3.23 | XXX | ||||||||||||
| 99185 | A | Regional hypothermia | 0.00 | 0.61 | NA | 0.03 | 0.64 | NA | XXX | ||||||||||||
| 99186 | A | Total body hypothermia | 0.00 | 1.69 | NA | 0.37 | 2.06 | NA | XXX | ||||||||||||
| 99190 | X | Special pump services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99191 | X | Special pump services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99192 | X | Special pump services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99195 | A | Phlebotomy | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX | ||||||||||||
| 99199 | C | Special service/proc/report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99201 | A | Office/outpatient visit, new | 0.45 | 0.47 | 0.16 | 0.02 | 0.94 | 0.63 | XXX | ||||||||||||
| 99202 | A | Office/outpatient visit, new | 0.88 | 0.77 | 0.33 | 0.05 | 1.70 | 1.26 | XXX | ||||||||||||
| 99203 | A | Office/outpatient visit, new | 1.34 | 1.12 | 0.50 | 0.08 | 2.54 | 1.92 | XXX | ||||||||||||
| 99204 | A | Office/outpatient visit, new | 2.00 | 1.51 | 0.74 | 0.10 | 3.61 | 2.84 | XXX | ||||||||||||
| 99205 | A | Office/outpatient visit, new | 2.67 | 1.80 | 0.98 | 0.12 | 4.59 | 3.77 | XXX | ||||||||||||
| 99211 | A | Office/outpatient visit, est | 0.17 | 0.38 | 0.06 | 0.01 | 0.56 | 0.24 | XXX | ||||||||||||
| 99212 | A | Office/outpatient visit, est | 0.45 | 0.53 | 0.17 | 0.02 | 1.00 | 0.64 | XXX | ||||||||||||
| 99213 | A | Office/outpatient visit, est | 0.67 | 0.69 | 0.24 | 0.03 | 1.39 | 0.94 | XXX | ||||||||||||
| 99214 | A | Office/outpatient visit, est | 1.10 | 1.04 | 0.41 | 0.04 | 2.18 | 1.55 | XXX | ||||||||||||
| 99215 | A | Office/outpatient visit, est | 1.77 | 1.36 | 0.66 | 0.07 | 3.20 | 2.50 | XXX | ||||||||||||
| 99217 | A | Observation care discharge | 1.28 | NA | 0.45 | 0.05 | NA | 1.78 | XXX | ||||||||||||
| 99218 | A | Observation care | 1.28 | NA | 0.45 | 0.05 | NA | 1.78 | XXX | ||||||||||||
| 99219 | A | Observation care | 2.14 | NA | 0.75 | 0.08 | NA | 2.97 | XXX | ||||||||||||
| 99220 | A | Observation care | 2.99 | NA | 1.06 | 0.11 | NA | 4.16 | XXX | ||||||||||||
| 99221 | A | Initial hospital care | 1.28 | NA | 0.47 | 0.05 | NA | 1.80 | XXX | ||||||||||||
| 99222 | A | Initial hospital care | 2.14 | NA | 0.77 | 0.08 | NA | 2.99 | XXX | ||||||||||||
| 99223 | A | Initial hospital care | 2.99 | NA | 1.08 | 0.10 | NA | 4.17 | XXX | ||||||||||||
| 99231 | A | Subsequent hospital care | 0.64 | NA | 0.24 | 0.02 | NA | 0.90 | XXX | ||||||||||||
| 99232 | A | Subsequent hospital care | 1.06 | NA | 0.39 | 0.03 | NA | 1.48 | XXX | ||||||||||||
| 99233 | A | Subsequent hospital care | 1.51 | NA | 0.55 | 0.05 | NA | 2.11 | XXX | ||||||||||||
| 99234 | A | Observ/hosp same date | 2.56 | NA | 0.93 | 0.11 | NA | 3.60 | XXX | ||||||||||||
| 99235 | A | Observ/hosp same date | 3.42 | NA | 1.21 | 0.13 | NA | 4.76 | XXX | ||||||||||||
| 99236 | A | Observ/hosp same date | 4.27 | NA | 1.49 | 0.17 | NA | 5.93 | XXX | ||||||||||||
| 99238 | A | Hospital discharge day | 1.28 | NA | 0.51 | 0.04 | NA | 1.83 | XXX | ||||||||||||
| 99239 | A | Hospital discharge day | 1.75 | NA | 0.71 | 0.05 | NA | 2.51 | XXX | ||||||||||||
| 99241 | A | Office consultation | 0.64 | 0.62 | 0.24 | 0.04 | 1.30 | 0.92 | XXX | ||||||||||||
| 99242 | A | Office consultation | 1.29 | 1.03 | 0.50 | 0.09 | 2.41 | 1.88 | XXX | ||||||||||||
| 99243 | A | Office consultation | 1.72 | 1.38 | 0.67 | 0.10 | 3.20 | 2.49 | XXX | ||||||||||||
| 99244 | A | Office consultation | 2.58 | 1.83 | 0.98 | 0.13 | 4.54 | 3.69 | XXX | ||||||||||||
| 99245 | A | Office consultation | 3.43 | 2.29 | 1.30 | 0.16 | 5.88 | 4.89 | XXX | ||||||||||||
| 99251 | A | Initial inpatient consult | 0.66 | NA | 0.26 | 0.04 | NA | 0.96 | XXX | ||||||||||||
| 99252 | A | Initial inpatient consult | 1.32 | NA | 0.53 | 0.08 | NA | 1.93 | XXX | ||||||||||||
| 99253 | A | Initial inpatient consult | 1.82 | NA | 0.72 | 0.09 | NA | 2.63 | XXX | ||||||||||||
| 99254 | A | Initial inpatient consult | 2.64 | NA | 1.03 | 0.11 | NA | 3.78 | XXX | ||||||||||||
| 99255 | A | Initial inpatient consult | 3.65 | NA | 1.41 | 0.15 | NA | 5.21 | XXX | ||||||||||||
| 99261 | A | Follow-up inpatient consult | 0.42 | NA | 0.16 | 0.02 | NA | 0.60 | XXX | ||||||||||||
| 99262 | A | Follow-up inpatient consult | 0.85 | NA | 0.32 | 0.03 | NA | 1.20 | XXX | ||||||||||||
| 99263 | A | Follow-up inpatient consult | 1.27 | NA | 0.48 | 0.04 | NA | 1.79 | XXX | ||||||||||||
| 99271 | A | Confirmatory consultation | 0.45 | 0.67 | 0.17 | 0.03 | 1.15 | 0.65 | XXX | ||||||||||||
| 99272 | A | Confirmatory consultation | 0.84 | 0.89 | 0.32 | 0.06 | 1.79 | 1.22 | XXX | ||||||||||||
| 99273 | A | Confirmatory consultation | 1.19 | 1.13 | 0.47 | 0.07 | 2.39 | 1.73 | XXX | ||||||||||||
| 99274 | A | Confirmatory consultation | 1.73 | 1.41 | 0.68 | 0.09 | 3.23 | 2.50 | XXX | ||||||||||||
| 99275 | A | Confirmatory consultation | 2.31 | 1.68 | 0.88 | 0.10 | 4.09 | 3.29 | XXX | ||||||||||||
| 99281 | A | Emergency dept visit | 0.33 | NA | 0.09 | 0.02 | NA | 0.44 | XXX | ||||||||||||
| 99282 | A | Emergency dept visit | 0.55 | NA | 0.15 | 0.03 | NA | 0.73 | XXX | ||||||||||||
| 99283 | A | Emergency dept visit | 1.24 | NA | 0.32 | 0.08 | NA | 1.64 | XXX | ||||||||||||
| 99284 | A | Emergency dept visit | 1.95 | NA | 0.49 | 0.12 | NA | 2.56 | XXX | ||||||||||||
| 99285 | A | Emergency dept visit | 3.06 | NA | 0.75 | 0.19 | NA | 4.00 | XXX | ||||||||||||
| 99288 | B | Direct advanced life support | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99289 | I | Pt transport, 30-74 min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99290 | I | Pt transport, addl 30 min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 99291 | A | Critical care, first hour | 4.00 | 1.63 | 1.34 | 0.14 | 5.77 | 5.48 | XXX | ||||||||||||
| 99292 | A | Critical care, addl 30 min | 2.00 | 0.92 | 0.66 | 0.07 | 2.99 | 2.73 | ZZZ | ||||||||||||
| 99295 | A | Neonatal critical care | 16.00 | NA | 4.53 | 0.70 | NA | 21.23 | XXX | ||||||||||||
| 99296 | A | Neonatal critical care | 8.00 | NA | 2.58 | 0.23 | NA | 10.81 | XXX | ||||||||||||
| 99297 | A | Neonatal critical care | 4.00 | NA | 1.32 | 0.12 | NA | 5.44 | XXX | ||||||||||||
| 99298 | A | Neonatal critical care | 2.75 | NA | 0.97 | 0.10 | NA | 3.82 | XXX | ||||||||||||
| 99301 | A | Nursing facility care | 1.20 | 0.70 | 0.42 | 0.04 | 1.94 | 1.66 | XXX | ||||||||||||
| 99302 | A | Nursing facility care | 1.61 | 0.98 | 0.57 | 0.05 | 2.64 | 2.23 | XXX | ||||||||||||
| 99303 | A | Nursing facility care | 2.01 | 1.21 | 0.70 | 0.06 | 3.28 | 2.77 | XXX | ||||||||||||
| 99311 | A | Nursing fac care, subseq | 0.60 | 0.49 | 0.21 | 0.02 | 1.11 | 0.83 | XXX | ||||||||||||
| 99312 | A | Nursing fac care, subseq | 1.00 | 0.68 | 0.35 | 0.03 | 1.71 | 1.38 | XXX | ||||||||||||
| 99313 | A | Nursing fac care, subseq | 1.42 | 0.87 | 0.50 | 0.04 | 2.33 | 1.96 | XXX | ||||||||||||
| 99315 | A | Nursing fac discharge day | 1.13 | 0.74 | 0.40 | 0.04 | 1.91 | 1.57 | XXX | ||||||||||||
| 99316 | A | Nursing fac discharge day | 1.50 | 0.95 | 0.53 | 0.05 | 2.50 | 2.08 | XXX | ||||||||||||
| 99321 | A | Rest home visit, new patient | 0.71 | 0.49 | NA | 0.02 | 1.22 | NA | XXX | ||||||||||||
| 99322 | A | Rest home visit, new patient | 1.01 | 0.70 | NA | 0.03 | 1.74 | NA | XXX | ||||||||||||
| 99323 | A | Rest home visit, new patient | 1.28 | 0.93 | NA | 0.04 | 2.25 | NA | XXX | ||||||||||||
| 99331 | A | Rest home visit, est pat | 0.60 | 0.47 | NA | 0.02 | 1.09 | NA | XXX | ||||||||||||
| 99332 | A | Rest home visit, est pat | 0.80 | 0.59 | NA | 0.03 | 1.42 | NA | XXX | ||||||||||||
| 99333 | A | Rest home visit, est pat | 1.00 | 0.73 | NA | 0.03 | 1.76 | NA | XXX | ||||||||||||
| 99341 | A | Home visit, new patient | 1.01 | 0.56 | NA | 0.05 | 1.62 | NA | XXX | ||||||||||||
| 99342 | A | Home visit, new patient | 1.52 | 0.87 | NA | 0.05 | 2.44 | NA | XXX | ||||||||||||
| 99343 | A | Home visit, new patient | 2.27 | 1.29 | NA | 0.07 | 3.63 | NA | XXX | ||||||||||||
| 99344 | A | Home visit, new patient | 3.03 | 1.57 | NA | 0.10 | 4.70 | NA | XXX | ||||||||||||
| 99345 | A | Home visit, new patient | 3.79 | 1.86 | NA | 0.12 | 5.77 | NA | XXX | ||||||||||||
| 99347 | A | Home visit, est patient | 0.76 | 0.49 | NA | 0.03 | 1.28 | NA | XXX | ||||||||||||
| 99348 | A | Home visit, est patient | 1.26 | 0.74 | NA | 0.04 | 2.04 | NA | XXX | ||||||||||||
| 99349 | A | Home visit, est patient | 2.02 | 1.08 | NA | 0.06 | 3.16 | NA | XXX | ||||||||||||
| 99350 | A | Home visit, est patient | 3.03 | 1.47 | NA | 0.10 | 4.60 | NA | XXX | ||||||||||||
| 99354 | A | Prolonged service, office | 1.77 | 1.46 | 0.66 | 0.06 | 3.29 | 2.49 | ZZZ | ||||||||||||
| 99355 | A | Prolonged service, office | 1.77 | 1.24 | 0.65 | 0.06 | 3.07 | 2.48 | ZZZ | ||||||||||||
| 99356 | A | Prolonged service, inpatient | 1.71 | NA | 0.61 | 0.06 | NA | 2.38 | ZZZ | ||||||||||||
| 99357 | A | Prolonged service, inpatient | 1.71 | NA | 0.63 | 0.06 | NA | 2.40 | ZZZ | ||||||||||||
| 99358 | B | Prolonged serv, w/o contact | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 99359 | B | Prolonged serv, w/o contact | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| 99360 | X | Physician standby services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99361 | B | Physician/team conference | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99362 | B | Physician/team conference | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99371 | B | Physician phone consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99372 | B | Physician phone consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99373 | B | Physician phone consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99374 | B | Home health care supervision | +1.10 | 1.47 | 0.44 | 0.04 | 2.61 | 1.58 | XXX | ||||||||||||
| 99377 | B | Hospice care supervision | +1.10 | 1.47 | 0.44 | 0.04 | 2.61 | 1.58 | XXX | ||||||||||||
| 99379 | B | Nursing fac care supervision | +1.10 | 1.47 | 0.44 | 0.03 | 2.60 | 1.57 | XXX | ||||||||||||
| 99380 | B | Nursing fac care supervision | +1.73 | 1.72 | 0.69 | 0.05 | 3.50 | 2.47 | XXX | ||||||||||||
| 99381 | N | Prev visit, new, infant | +1.19 | 1.50 | 0.48 | 0.04 | 2.73 | 1.71 | XXX | ||||||||||||
| 99382 | N | Prev visit, new, age 1-4 | +1.36 | 1.54 | 0.54 | 0.04 | 2.94 | 1.94 | XXX | ||||||||||||
| 99383 | N | Prev visit, new, age 5-11 | +1.36 | 1.48 | 0.54 | 0.04 | 2.88 | 1.94 | XXX | ||||||||||||
| 99384 | N | Prev visit, new, age 12-17 | +1.53 | 1.55 | 0.61 | 0.05 | 3.13 | 2.19 | XXX | ||||||||||||
| 99385 | N | Prev visit, new, age 18-39 | +1.53 | 1.55 | 0.61 | 0.05 | 3.13 | 2.19 | XXX | ||||||||||||
| 99386 | N | Prev visit, new, age 40-64 | +1.88 | 1.74 | 0.75 | 0.06 | 3.68 | 2.69 | XXX | ||||||||||||
| 99387 | N | Prev visit, new, 65 over | +2.06 | 1.87 | 0.82 | 0.06 | 3.99 | 2.94 | XXX | ||||||||||||
| 99391 | N | Prev visit, est, infant | +1.02 | 1.02 | 0.41 | 0.03 | 2.07 | 1.46 | XXX | ||||||||||||
| 99392 | N | Prev visit, est, age 1-4 | +1.19 | 1.09 | 0.48 | 0.04 | 2.32 | 1.71 | XXX | ||||||||||||
| 99393 | N | Prev visit, est, age 5-11 | +1.19 | 1.06 | 0.48 | 0.04 | 2.29 | 1.71 | XXX | ||||||||||||
| 99394 | N | Prev visit, est, age 12-17 | +1.36 | 1.15 | 0.54 | 0.04 | 2.55 | 1.94 | XXX | ||||||||||||
| 99395 | N | Prev visit, est, age 18-39 | +1.36 | 1.18 | 0.54 | 0.04 | 2.58 | 1.94 | XXX | ||||||||||||
| 99396 | N | Prev visit, est, age 40-64 | +1.53 | 1.27 | 0.61 | 0.05 | 2.85 | 2.19 | XXX | ||||||||||||
| 99397 | N | Prev visit, est, 65 over | +1.71 | 1.37 | 0.68 | 0.05 | 3.13 | 2.44 | XXX | ||||||||||||
| 99401 | N | Preventive counseling, indiv | +0.48 | 0.62 | 0.19 | 0.01 | 1.11 | 0.68 | XXX | ||||||||||||
| 99402 | N | Preventive counseling, indiv | +0.98 | 0.86 | 0.39 | 0.02 | 1.86 | 1.39 | XXX | ||||||||||||
| 99403 | N | Preventive counseling, indiv | +1.46 | 1.10 | 0.58 | 0.03 | 2.59 | 2.07 | XXX | ||||||||||||
| 99404 | N | Preventive counseling, indiv | +1.95 | 1.35 | 0.78 | 0.04 | 3.34 | 2.77 | XXX | ||||||||||||
| 99411 | N | Preventive counseling, group | +0.15 | 0.18 | 0.06 | 0.01 | 0.34 | 0.22 | XXX | ||||||||||||
| 99412 | N | Preventive counseling, group | +0.25 | 0.24 | 0.10 | 0.01 | 0.50 | 0.36 | XXX | ||||||||||||
| 99420 | N | Health risk assessment test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99429 | N | Unlisted preventive service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99431 | A | Initial care, normal newborn | 1.17 | NA | 0.39 | 0.04 | NA | 1.60 | XXX | ||||||||||||
| 99432 | A | Newborn care, not in hosp | 1.26 | 1.12 | 0.50 | 0.06 | 2.44 | 1.82 | XXX | ||||||||||||
| 99433 | A | Normal newborn care/hospital | 0.62 | NA | 0.21 | 0.02 | NA | 0.85 | XXX | ||||||||||||
| 99435 | A | Newborn discharge day hosp | 1.50 | NA | 0.54 | 0.05 | NA | 2.09 | XXX | ||||||||||||
| 99436 | A | Attendance, birth | 1.50 | 0.50 | 0.50 | 0.05 | 2.05 | 2.05 | XXX | ||||||||||||
| 99440 | A | Newborn resuscitation | 2.93 | NA | 1.17 | 0.11 | NA | 4.21 | XXX | ||||||||||||
| 99450 | N | Life/disability evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99455 | R | Disability examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99456 | R | Disability examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99499 | C | Unlisted em service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99500 | I | Home visit, prenatal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99501 | I | Home visit, postnatal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99502 | I | Home visit, nb care | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99503 | I | Home visit, resp therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99504 | I | Home visit, mech ventilator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99505 | I | Home visit, stoma care | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99506 | I | Home visit, im injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99507 | I | Home visit, cath maintain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99508 | I | Home visit, sleep studies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99509 | I | Home visit, day life activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99510 | I | Home visit, sing/m/fam couns | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99511 | I | Home visit, fecal/enema mgmt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99512 | I | Home visit, hemodialysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99539 | I | Home visit, nos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99551 | I | Home infuse, pain mgmt, iv/sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99552 | I | Home infuse pain mgmt, epid/ith | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99553 | I | Home infuse, tocolytic tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99554 | I | Home infuse, hormone/platelet | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99555 | I | Home infuse, chemotheraphy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99556 | I | Home infuse, antibio/fung/vir | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99557 | I | Home infuse, anticoagulant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99558 | I | Home infuse, immunotherapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99559 | I | Home infuse, periton dialysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99560 | I | Home infuse, entero nutrition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99561 | I | Home infuse, hydration tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99562 | I | Home infuse, parent nutrition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99563 | I | Home admin, pentamidine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99564 | I | Home infuse, antihemophil agnt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99565 | I | Home infuse, proteinase inhib | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99566 | I | Home infuse, iv therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99567 | I | Home infuse, sympath agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99568 | I | Home infuse, misc drug, daily | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 99569 | I | Home infuse, each addl tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0021 | I | Outside state ambulance serv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0080 | I | Noninterest escort in non er | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0090 | I | Interest escort in non er | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0100 | I | Nonemergency transport taxi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0110 | I | Nonemergency transport bus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0120 | I | Noner transport mini-bus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0130 | I | Noner transport wheelch van | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0140 | I | Nonemergency transport air | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0160 | I | Noner transport case worker | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0170 | I | Noner transport parking fees | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0180 | I | Noner transport lodgng recip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0190 | I | Noner transport meals recip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0200 | I | Noner transport lodgng escrt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0210 | I | Noner transport meals escort | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0380 | X | Basic life support mileage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0382 | X | Basic support routine suppls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0384 | X | Bls defibrillation supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0390 | X | Advanced life support mileag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0392 | X | Als defibrillation supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0394 | X | Als IV drug therapy supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0396 | X | Als esophageal intub suppls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0398 | X | Als routine disposble suppls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0420 | X | Ambulance waiting 1⁄2 hr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0422 | X | Ambulance 02 life sustaining | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0424 | X | Extra ambulance attendant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0425 | X | Ground mileage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0426 | X | Als 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0427 | X | ALS1-emergency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0428 | X | bls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0429 | X | BLS-emergency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0430 | X | Fixed wing air transport | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0431 | X | Rotary wing air transport | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0432 | X | PI volunteer ambulance co | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0433 | X | als 2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0434 | X | Specialty care transport | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0435 | X | Fixed wing air mileage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0436 | X | Rotary wing air mileage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0888 | N | Noncovered ambulance mileage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A0999 | X | Unlisted ambulance service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4206 | I | 1 CC sterile syringeneedle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4207 | I | 2 CC sterile syringeneedle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4208 | I | 3 CC sterile syringeneedle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4209 | I | 5+ CC sterile syringeneedle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4210 | N | Nonneedle injection device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4211 | P | Supp for self-adm injections | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4212 | P | Non coring needle or stylet | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4213 | I | 20+ CC syringe only | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4214 | P | 30 CC sterile water/saline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4215 | I | Sterile needle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4220 | P | Infusion pump refill kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4221 | X | Maint drug infus cath per wk | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4222 | X | Drug infusion pump supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4230 | X | Infus insulin pump non needl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4231 | X | Infusion insulin pump needle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4232 | X | Syringe w/needle insulin 3cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4244 | I | Alcohol or peroxide per pint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4245 | I | Alcohol wipes per box | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4246 | I | Betadine/phisohex solution | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4247 | I | Betadine/iodine swabs/wipes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4250 | N | Urine reagent strips/tablets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4253 | P | Blood glucose/reagent strips | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4254 | X | Battery for glucose monitor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4255 | X | Glucose monitor platforms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4256 | P | Calibrator solution/chips | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4257 | X | Replace Lensshield Cartridge | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4258 | P | Lancet device each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4259 | P | Lancets per box | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4260 | N | Levonorgestrel implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4261 | N | Cervical cap contraceptive | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4262 | B | Temporary tear duct plug | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4263 | I | Permanent tear duct plug | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4265 | P | Paraffin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4270 | B | Disposable endoscope sheath | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4280 | X | Brst prsths adhsv attchmnt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4290 | X | Sacral nerve stim test lead | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4300 | B | Cath impl vasc access portal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4301 | P | Implantable access syst perc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4305 | P | Drug delivery system =50 ML | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4306 | P | Drug delivery system =5 ML | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4310 | P | Insert tray w/o bag/cath | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4311 | P | Catheter w/o bag 2-way latex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4312 | P | Cath w/o bag 2-way silicone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4313 | P | Catheter w/bag 3-way | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4314 | P | Cath w/drainage 2-way latex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4315 | P | Cath w/drainage 2-way silcne | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4316 | P | Cath w/drainage 3-way | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4319 | X | Sterile H 2 O irrigation solut | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4320 | P | Irrigation tray | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4321 | X | Cath therapeutic irrig agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4322 | P | Irrigation syringe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4323 | P | Saline irrigation solution | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4324 | X | Male ext cath w/adh coating | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4325 | X | Male ext cath w/adh strip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4326 | P | Male external catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4327 | P | Fem urinary collect dev cup | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4328 | P | Fem urinary collect pouch | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4329 | D | External catheter start set | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4330 | P | Stool collection pouch | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4331 | X | Extension drainage tubing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4332 | X | Lubricant for cath insertion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4333 | X | Urinary cath anchor device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4334 | X | Urinary cath leg strap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4335 | P | Incontinence supply | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4338 | P | Indwelling catheter latex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4340 | P | Indwelling catheter special | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4344 | P | Cath indw foley 2 way silicn | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4346 | P | Cath indw foley 3 way | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4347 | P | Male external catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4348 | X | Male ext cath extended wear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4351 | P | Straight tip urine catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4352 | P | Coude tip urinary catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4353 | X | Intermittent urinary cath | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4354 | P | Cath insertion tray w/bag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4355 | P | Bladder irrigation tubing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4356 | P | Ext ureth clmp or compr dvc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4357 | P | Bedside drainage bag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4358 | P | Urinary leg or abdomen bag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4359 | P | Urinary suspensory w/o leg b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4360 | N | Adult incontinence garment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4361 | P | Ostomy face plate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4362 | P | Solid skin barrier | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4364 | P | Adhesive, liquid or equal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4365 | X | Adhesive remover wipes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4367 | P | Ostomy belt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4368 | X | Ostomy filter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4369 | X | Skin barrier liquid per oz | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4370 | X | Skin barrier paste per oz | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4371 | X | Skin barrier powder per oz | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4372 | X | Skin barrier solid 4x4 equiv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4373 | X | Skin barrier with flange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4374 | X | Skin barrier extended wear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4375 | X | Drainable plastic pch w fcpl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4376 | X | Drainable rubber pch w fcplt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4377 | X | Drainable plstic pch w/o fp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4378 | X | Drainable rubber pch w/o fp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4379 | X | Urinary plastic pouch w fcpl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4380 | X | Urinary rubber pouch w fcplt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4381 | X | Urinary plastic pouch w/o fp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4382 | X | Urinary hvy plstc pch w/o fp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4383 | X | Urinary rubber pouch w/o fp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4384 | X | Ostomy faceplt/silicone ring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4385 | X | Ost skn barrier sld ext wear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4386 | X | Ost skn barrier w flng ex wr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4387 | X | Ost clsd pouch w att st barr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4388 | X | Drainable pch w ex wear barr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4389 | X | Drainable pch w st wear barr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4390 | X | Drainable pch ex wear convex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4391 | X | Urinary pouch w ex wear barr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4392 | X | Urinary pouch w st wear barr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4393 | X | Urine pch w ex wear bar conv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4394 | X | Ostomy pouch liq deodorant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4395 | X | Ostomy pouch solid deodorant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4396 | X | Peristomal hernia supprt blt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4397 | P | Irrigation supply sleeve | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4398 | P | Ostomy irrigation bag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4399 | P | Ostomy irrig cone/cath w brs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4400 | P | Ostomy irrigation set | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4402 | P | Lubricant per ounce | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4404 | P | Ostomy ring each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4421 | P | Ostomy supply misc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4454 | P | Tape all types all sizes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4455 | P | Adhesive remover per ounce | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4460 | P | Elastic compression bandage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4462 | X | Abdmnl drssng holder/binder | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4464 | N | Joint support device/garment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4465 | P | Non-elastic extremity binder | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4470 | P | Gravlee jet washer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4480 | P | Vabra aspirator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4481 | X | Tracheostoma filter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4483 | X | Moisture exchanger | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4490 | N | Above knee surgical stocking | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4495 | N | Thigh length surg stocking | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4500 | N | Below knee surgical stocking | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4510 | N | Full length surg stocking | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4550 | I | Surgical trays | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4554 | N | Disposable underpads | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4556 | P | Electrodes, pair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4557 | P | Lead wires, pair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4558 | P | Conductive paste or gel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4561 | X | Pessary rubber, any type | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4562 | X | Pessary, non rubber, any type | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4565 | X | Slings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4570 | I | Splint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4572 | X | Rib belt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4575 | N | Hyperbaric o2 chamber disps | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4580 | I | Cast supplies (plaster) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4590 | I | Special casting material | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4595 | X | TENS suppl 2 lead per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4608 | X | Transtracheal oxygen cath | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4611 | X | Heavy duty battery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4612 | X | Battery cables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4613 | X | Battery charger | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4614 | X | Hand-held PEFR meter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4615 | X | Cannula nasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4616 | X | Tubing (oxygen) per foot | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4617 | X | Mouth piece | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4618 | X | Breathing circuits | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4619 | X | Face tent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4620 | X | Variable concentration mask | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4621 | X | Tracheotomy mask or collar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4622 | X | Tracheostomy or larngectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4623 | X | Tracheostomy inner cannula | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4624 | X | Tracheal suction tube | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4625 | X | Trach care kit for new trach | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4626 | X | Tracheostomy cleaning brush | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4627 | N | Spacer bag/reservoir | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4628 | X | Oropharyngeal suction cath | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4629 | X | Tracheostomy care kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4630 | X | Repl bat t.e.n.s. own by pt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4631 | X | Wheelchair battery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4635 | X | Underarm crutch pad | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4636 | X | Handgrip for cane etc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4637 | X | Repl tip cane/crutch/walker | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4640 | X | Alternating pressure pad | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4641 | E | Diagnostic imaging agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4642 | E | Satumomab pendetide per dose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4643 | E | High dose contrast MRI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4644 | E | Contrast 100-199 MGs iodine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4645 | E | Contrast 200-299 MGs iodine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4646 | E | Contrast 300-399 MGs iodine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4647 | B | Supp- paramagnetic contr mat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4649 | P | Surgical supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4650 | D | Supp esrd centrifuge | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4651 | X | Calibrated microcap tube | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4652 | X | Microcapillary tube sealant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4655 | D | Esrd syringe/needle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4656 | X | Dialysis needle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4657 | X | Dialysis syringe w/wo needle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4660 | X | Sphyg/bp app w cuff and stet | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4663 | X | Dialysis blood pressure cuff | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4670 | N | Automatic bp monitor, dial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4680 | X | Actificial carbon filter, ea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4690 | X | Dialyzer, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4700 | D | Standard dialysate solution | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4705 | D | Bicarb dialysate solution | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4706 | X | Bicarbonate conc sol per gal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4707 | X | Bicarbonate conc pow per pac | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4708 | X | Acetate conc sol per gallon | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4709 | X | Acid conc sol per gallon | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4712 | X | Sterile water inj per 10 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4714 | X | Treated water per gallon | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4719 | X | "Y set" tubing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4720 | X | Dialysat sol fld vol 249cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4721 | X | Dialysat sol fld vol 999cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4722 | X | Dialys sol fld vol 1999cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4723 | X | Dialys sol fld vol 2999cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4724 | X | Dialys sol fld vol 3999cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4725 | X | Dialys sol fld vol 4999cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4726 | X | Dialys sol fld vol 5999cc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4730 | X | Fistula cannulation set, ea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4735 | D | Local/topical anesthetics | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4736 | X | Topical anesthetic, per gram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4737 | X | Inj anesthetic per 10 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4740 | X | Shunt accessory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4750 | X | Art or venous blood tubing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4755 | X | Comb art/venous blood tubing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4760 | X | Dialysate sol test kit, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4765 | X | Dialysate conc pow per pack | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4766 | X | Dialysate conc sol add 10 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4770 | X | Blood collection tube/vacuum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4771 | X | Serum clotting time tube | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4772 | X | Blood glucose test strips | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4773 | X | Occult blood test strips | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4774 | X | Ammonia test strips | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4780 | D | Esrd sterilizing agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4790 | D | Esrd cleansing agents | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4800 | D | Heparin/antidote dialysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4801 | X | Heparin per 1000 units | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4802 | X | Protamine sulfate per 50 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4820 | D | Supplies hemodialysis kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4850 | D | Rubber tipped hemostats | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4860 | X | Disposable catheter tips | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4870 | X | Plumb/elec wk hm hemo equip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4880 | D | Water storage tanks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4890 | R | Repair/maint cont hemo equip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4900 | D | Capd supply kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4901 | D | Ccpd supply kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4905 | D | Ipd supply kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4910 | D | Esrd nonmedical supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4911 | X | Drain bag/bottle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4912 | D | Gomco drain bottle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4913 | X | Misc dialysis supplies noc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4914 | D | Preparation kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4918 | X | Venous pressure clamp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4919 | D | Supp dialysis dialyzer holde | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4920 | D | Harvard pressure clamp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4921 | D | Measuring cylinder | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4927 | X | Non-sterile gloves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4928 | X | Surgical mask | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A4929 | X | Tourniquet for dialysis, ea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5051 | P | Pouch clsd w barr attached | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5052 | P | Clsd ostomy pouch w/o barr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5053 | P | Clsd ostomy pouch faceplate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5054 | P | Clsd ostomy pouch w/flange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5055 | P | Stoma cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5061 | P | Pouch drainable w barrier at | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5062 | P | Drnble ostomy pouch w/o barr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5063 | P | Drain ostomy pouch w/flange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5064 | D | Drain ostomy pouch w/fceplte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5071 | P | Urinary pouch w/barrier | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5072 | P | Urinary pouch w/o barrier | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5073 | P | Urinary pouch on barr w/flng | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5074 | D | Urinary pouch w/faceplate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5075 | D | Urinary pouch on faceplate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5081 | P | Continent stoma plug | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5082 | P | Continent stoma catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5093 | P | Ostomy accessory convex inse | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5102 | P | Bedside drain btl w/wo tube | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5105 | P | Urinary suspensory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5112 | P | Urinary leg bag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5113 | P | Latex leg strap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5114 | P | Foam/fabric leg strap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5119 | P | Skin barrier wipes box pr 50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5121 | P | Solid skin barrier 6x6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5122 | P | Solid skin barrier 8x8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5123 | P | Skin barrier with flange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5126 | P | Disk/foam pad + or - adhesive | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5131 | P | Appliance cleaner | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5200 | X | Percutaneous catheter anchor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5500 | X | Diab shoe for density insert | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5501 | X | Diabetic custom molded shoe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5502 | D | Diabetic shoe density insert | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5503 | X | Diabetic shoe w/roller/rockr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5504 | X | Diabetic shoe with wedge | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5505 | X | Diab shoe w/metatarsal bar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5506 | X | Diabetic shoe w/off set heel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5507 | X | Modification diabetic shoe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5508 | X | Diabetic deluxe shoe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5509 | X | Direct heat form shoe insert | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5510 | X | Compression form shoe insert | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A5511 | X | Custom fab molded shoe inser | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6000 | X | Wound warming wound cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6010 | X | Collagen based wound filler | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6020 | D | Collagen wound dressing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6021 | X | Collagen dressing =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6022 | X | Collagen drsg6=48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6023 | X | Collagen dressing 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6024 | X | Collagen dsg wound filler | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6025 | I | Silicone gel sheet, each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6154 | P | Wound pouch each | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6196 | P | Alginate dressing =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6197 | P | Alginate drsg 16 =48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6198 | P | alginate dressing 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6199 | P | Alginate drsg wound filler | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6200 | X | Compos drsg =16 no border | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6201 | X | Compos drsg 16=48 no bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6202 | X | Compos drsg 48 no border | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6203 | P | Composite drsg =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6204 | P | Composite drsg 16=48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6205 | P | Composite drsg 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6206 | P | Contact layer =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6207 | P | Contact layer 16=48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6208 | P | Contact layer 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6209 | P | Foam drsg =16 sq in w/o bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6210 | P | Foam drg 16=48 sq in w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6211 | P | Foam drg 48 sq in w/o brdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6212 | P | Foam drg =16 sq in w/border | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6213 | P | Foam drg 16=48 sq in w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6214 | P | Foam drg 48 sq in w/border | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6215 | P | Foam dressing wound filler | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6216 | P | Non-sterile gauze =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6217 | P | Non-sterile gauze 16=48 sq | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6218 | P | Non-sterile gauze 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6219 | P | Gauze =16 sq in w/border | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6220 | P | Gauze 16 =48 sq in w/bordr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6221 | P | Gauze 48 sq in w/border | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6222 | P | Gauze =16 in no w/sal w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6223 | P | Gauze 16=48 no w/sal w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6224 | P | Gauze 48 in no w/sal w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6228 | P | Gauze =16 sq in water/sal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6229 | P | Gauze 16=48 sq in watr/sal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6230 | P | Gauze 48 sq in water/salne | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6231 | X | Hydrogel dsg =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6232 | X | Hydrogel dsg 16=48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6233 | X | Hydrogel dressing 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6234 | P | Hydrocolld drg =16 w/o bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6235 | P | Hydrocolld drg 16=48 w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6236 | P | Hydrocolld drg 48 in w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6237 | P | Hydrocolld drg =16 in w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6238 | P | Hydrocolld drg 16=48 w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6239 | P | Hydrocolld drg 48 in w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6240 | P | Hydrocolld drg filler paste | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6241 | P | Hydrocolloid drg filler dry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6242 | P | Hydrogel drg =16 in w/o bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6243 | P | Hydrogel drg 16=48 w/o bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6244 | P | Hydrogel drg 48 in w/o bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6245 | P | Hydrogel drg =16 in w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6246 | P | Hydrogel drg 16=48 in w/b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6247 | P | Hydrogel drg 48 sq in w/b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6248 | P | Hydrogel drsg gel filler | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6250 | P | Skin seal protect moisturizr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6251 | P | Absorpt drg =16 sq in w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6252 | P | Absorpt drg 16=48 w/o bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6253 | P | Absorpt drg 48 sq in w/o b | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6254 | P | Absorpt drg =16 sq in w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6255 | P | Absorpt drg 16=48 in w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6256 | P | Absorpt drg 48 sq in w/bdr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6257 | P | Transparent film =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6258 | P | Transparent film 16=48 in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6259 | P | Transparent film 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6260 | P | Wound cleanser any type/size | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6261 | P | Wound filler gel/paste/oz | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6262 | P | Wound filler dry form/gram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6263 | P | Non-sterile elastic gauze/yd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6264 | P | Non-sterile no elastic gauze | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6265 | P | Tape per 18 sq inches | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6266 | P | Impreg gauze no h20/sal/yard | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6402 | P | Sterile gauze =16 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6403 | P | Sterile gauze 16=48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6404 | P | Sterile gauze 48 sq in | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6405 | P | Sterile elastic gauze/yd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A6406 | P | Sterile non-elastic gauze/yd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7000 | X | Disposable canister for pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7001 | X | Nondisposable pump canister | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7002 | X | Tubing used w suction pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7003 | X | Nebulizer administration set | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7004 | X | Disposable nebulizer sml vol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7005 | X | Nondisposable nebulizer set | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7006 | X | Filtered nebulizer admin set | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7007 | X | Lg vol nebulizer disposable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7008 | X | Disposable nebulizer prefill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7009 | X | Nebulizer reservoir bottle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7010 | X | Disposable corrugated tubing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7011 | X | Nondispos corrugated tubing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7012 | X | Nebulizer water collec devic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7013 | X | Disposable compressor filter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7014 | X | Compressor nondispos filter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7015 | X | Aerosol mask used w nebulize | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7016 | X | Nebulizer dome mouthpiece | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7017 | X | Nebulizer not used w oxygen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7018 | X | Water distilled w/nebulizer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7019 | X | Saline solution dispenser | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7020 | X | Sterile H 2 O or NSS w lgv neb | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7501 | X | Tracheostoma valve w diaphra | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7502 | X | Replacement diaphragm/fplate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7503 | X | HMES filter holder or cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7504 | X | Tracheostoma HMES filter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7505 | X | HMES or trach valve housing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7506 | X | HMES/trachvalve adhesive disk | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7507 | X | Integrated filter holder | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7508 | X | Housing Integrated Adhesiv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A7509 | X | Heat moisture exchange sys | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9150 | E | Misc/exper non-prescript dru | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9160 | D | Podiatrist non-covered servi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9170 | D | Chiropractor non-covered ser | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9190 | D | Misc/expe personal comfort i | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9270 | N | Non-covered item or service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9300 | N | Exercise equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9500 | E | Technetium TC 99m sestamibi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9502 | X | Technetium TC 99M tetrofosmin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9503 | E | Technetium TC 99m medronate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9504 | X | Technetium tc 99m apcitide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9505 | E | Thallous chloride TL 201/mci | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9507 | X | Indium/111 capromab pendetid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9508 | X | Iobenguane sulfate I-131 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9510 | X | Technetium TC99m Disofenin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9511 | X | Technetium TC 99m depreotide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9600 | X | Strontium-89 chloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9605 | X | Samarium sm153 lexidronamm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9700 | X | Echocardiography Contrast | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9900 | X | Supply/accessory/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| A9901 | X | Delivery/set up/dispensing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0120 | N | Periodic oral evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0140 | N | Limit oral eval problm focus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0150 | R | Comprehensve oral evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0160 | N | Extensv oral eval prob focus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0170 | N | Re-eval,est pt,problem focus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0210 | I | Intraor complete film series | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0220 | I | Intraoral periapical first f | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0230 | I | Intraoral periapical ea add | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0240 | R | Intraoral occlusal film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0250 | R | Extraoral first film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0260 | R | Extraoral ea additional film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0270 | R | Dental bitewing single film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0272 | R | Dental bitewings two films | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0274 | R | Dental bitewings four films | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0277 | R | Vert bitewings-sev to eight | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0290 | I | Dental film skull/facial bon | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0310 | I | Dental saliography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0320 | I | Dental tmj arthrogram incl i | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0321 | I | Dental other tmj films | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0322 | I | Dental tomographic survey | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0330 | I | Dental panoramic film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0340 | I | Dental cephalometric film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0350 | I | Oral/facial images | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0415 | N | Bacteriologic study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0425 | N | Caries susceptibility test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0460 | R | Pulp vitality test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0470 | N | Diagnostic casts | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0472 | R | Gross exam, prep report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0473 | R | Micro exam, prep report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0474 | R | Micro w/exam of surg margins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0480 | R | Cytopath smear prep report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D0501 | R | Histopathologic examinations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0502 | R | Other oral pathology procedu | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D0999 | R | Unspecified diagnostic proce | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D1110 | N | Dental prophylaxis adult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1120 | N | Dental prophylaxis child | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1201 | N | Topical fluor w/prophy child | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1203 | N | Topical fluor w/o prophy chi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1204 | N | Topical fluor w/o prophy adu | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1205 | N | Topical fluoride w/ prophy a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1310 | N | Nutri counsel-control caries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1320 | N | Tobacco counseling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1330 | N | Oral hygiene instruction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1351 | N | Dental sealant per tooth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D1510 | R | Space maintainer fxd unilat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D1515 | R | Fixed bilat space maintainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D1520 | R | Remove unilat space maintain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D1525 | R | Remove bilat space maintain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D1550 | R | Recement space maintainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D2110 | N | Amalgam one surface primary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2120 | N | Amalgam two surfaces primary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2130 | N | Amalgam three surfaces prima | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2131 | N | Amalgam four/more surf prima | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2140 | N | Amalgam one surface permanen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2150 | N | Amalgam two surfaces permane | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2160 | N | Amalgam three surfaces perma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2161 | N | Amalgam 4 or surfaces perm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2330 | N | Resin one surface-anterior | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2331 | N | Resin two surfaces-anterior | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2332 | N | Resin three surfaces-anterio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2335 | N | Resin 4/ surf or w/incis an | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2336 | N | Composite resin crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2337 | N | Compo resin crown ant-perm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2380 | N | Resin one surf poster primar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2381 | N | Resin two surf poster primar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2382 | N | Resin three/more surf post p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2385 | N | Resin one surf poster perman | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2386 | N | Resin two surf poster perman | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2387 | N | Resin three/more surf post p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2388 | N | Resin four/more, post perm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2410 | N | Dental gold foil one surface | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2420 | N | Dental gold foil two surface | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2430 | N | Dental gold foil three surfa | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2510 | N | Dental inlay metalic 1 surf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2520 | N | Dental inlay metallic 2 surf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2530 | N | Dental inlay metl 3/more sur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2542 | N | Dental onlay metallic 2 surf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2543 | N | Dental onlay metallic 3 surf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2544 | N | Dental onlay metl 4/more sur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2610 | N | Inlay porcelain/ceramic 1 su | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2620 | N | Inlay porcelain/ceramic 2 su | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2630 | N | Dental onlay porc 3/more sur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2642 | N | Dental onlay porcelin 2 surf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2643 | N | Dental onlay porcelin 3 surf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2644 | N | Dental onlay porc 4/more sur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2650 | N | Inlay composite/resin one su | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2651 | N | Inlay composite/resin two su | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2652 | N | Dental inlay resin 3/mre sur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2662 | N | Dental onlay resin 2 surface | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2663 | N | Dental onlay resin 3 surface | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2664 | N | Dental onlay resin 4/more sur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2710 | N | Crown resin laboratory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2720 | N | Crown resin w/high noble me | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2721 | N | Crown resin w/base metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2722 | N | Crown resin w/noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2740 | N | Crown porcelain/ceramic subs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2750 | N | Crown porcelain w/h noble m | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2751 | N | Crown porcelain fused base m | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2752 | N | Crown porcelain w/noble met | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2780 | N | Crown 3/4 cast hi noble met | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2781 | N | Crown 3/4 cast base metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2782 | N | Crown 3⁄4 cast noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2783 | N | Crown 3⁄4 porcelain/ceramic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2790 | N | Crown full cast high noble m | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2791 | N | Crown full cast base metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2792 | N | Crown full cast noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2799 | N | Provisional crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2910 | N | Dental recement inlay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2920 | N | Dental recement crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2930 | N | Prefab stnlss steel crwn pri | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2931 | N | Prefab stnlss steel crown pe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2932 | N | Prefabricated resin crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2933 | N | Prefab stainless steel crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2940 | N | Dental sedative filling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2950 | N | Core build-up incl any pins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2951 | N | Tooth pin retention | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2952 | N | Post and core cast + crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2953 | N | Each addtnl cast post | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2954 | N | Prefab post/core + crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2955 | N | Post removal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2957 | N | Each addtnl prefab post | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2960 | N | Laminate labial veneer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2961 | N | Lab labial veneer resin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2962 | N | Lab labial veneer porcelain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2970 | R | Temporary-fractured tooth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D2980 | N | Crown repair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D2999 | R | Dental unspec restorative pr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D3110 | N | Pulp cap direct | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3120 | N | Pulp cap indirect | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3220 | N | Therapeutic pulpotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3221 | N | Gross pulpal debridement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3230 | N | Pulpal therapy anterior prim | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3240 | N | Pulpal therapy posterior pri | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3310 | N | Anterior | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3320 | N | Root canal therapy 2 canals | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3330 | N | Root canal therapy 3 canals | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3331 | N | Non-surg tx root canal obs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3332 | N | Incomplete endodontic tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3333 | N | Internal root repair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3346 | N | Retreat root canal anterior | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3347 | N | Retreat root canal bicuspid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3348 | N | Retreat root canal molar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3351 | N | Apexification/recalc initial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3352 | N | Apexification/recalc interim | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3353 | N | Apexification/recalc final | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3410 | N | Apicoect/perirad surg anter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3421 | N | Root surgery bicuspid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3425 | N | Root surgery molar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3426 | N | Root surgery ea add root | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3430 | N | Retrograde filling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3450 | N | Root amputation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3460 | R | Endodontic endosseous implan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D3470 | N | Intentional replantation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3910 | N | Isolation-tooth w/rubb dam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3920 | N | Tooth splitting | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3950 | N | Canal prep/fitting of dowel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D3999 | R | Endodontic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4210 | I | Gingivectomy/plasty per quad | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4211 | I | Gingivectomy/plasty per toot | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4220 | N | Gingival curettage per quadr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4240 | N | Gingival flap proc w/planin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4245 | N | Apically positioned flap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4249 | N | Crown lengthen hard tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4260 | R | Osseous surgery per quadrant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4263 | R | Bone replce graft first site | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4264 | R | Bone replce graft each add | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4266 | N | Guided tiss regen resorble | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4267 | N | Guided tiss regen nonresorb | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4268 | R | Surgical revision procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4270 | R | Pedicle soft tissue graft pr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4271 | R | Free soft tissue graft proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4273 | R | Subepithelial tissue graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4274 | N | Distal/proximal wedge proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4320 | N | Provision splnt intracoronal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4321 | N | Provisional splint extracoro | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4341 | N | Periodontal scaling root | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4355 | R | Full mouth debridement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4381 | R | Localized chemo delivery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D4910 | N | Periodontal maint procedures | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4920 | N | Unscheduled dressing change | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D4999 | N | Unspecified periodontal proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5110 | N | Dentures complete maxillary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5120 | N | Dentures complete mandible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5130 | N | Dentures immediat maxillary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5140 | N | Dentures immediat mandible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5211 | N | Dentures maxill part resin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5212 | N | Dentures mand part resin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5213 | N | Dentures maxill part metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5214 | N | Dentures mandibl part metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5281 | N | Removable partial denture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5410 | N | Dentures adjust cmplt maxil | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5411 | N | Dentures adjust cmplt mand | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5421 | N | Dentures adjust part maxill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5422 | N | Dentures adjust part mandbl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5510 | N | Dentur repr broken compl bas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5520 | N | Replace denture teeth complt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5610 | N | Dentures repair resin base | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5620 | N | Rep part denture cast frame | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5630 | N | Rep partial denture clasp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5640 | N | Replace part denture teeth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5650 | N | Add tooth to partial denture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5660 | N | Add clasp to partial denture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5710 | N | Dentures rebase cmplt maxil | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5711 | N | Dentures rebase cmplt mand | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5720 | N | Dentures rebase part maxill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5721 | N | Dentures rebase part mandbl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5730 | N | Denture reln cmplt maxil ch | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5731 | N | Denture reln cmplt mand chr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5740 | N | Denture reln part maxil chr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5741 | N | Denture reln part mand chr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5750 | N | Denture reln cmplt max lab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5751 | N | Denture reln cmplt mand lab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5760 | N | Denture reln part maxil lab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5761 | N | Denture reln part mand lab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5810 | N | Denture interm cmplt maxill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5811 | N | Denture interm cmplt mandbl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5820 | N | Denture interm part maxill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5821 | N | Denture interm part mandbl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5850 | N | Denture tiss conditn maxill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5851 | N | Denture tiss condtin mandbl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5860 | N | Overdenture complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5861 | N | Overdenture partial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5862 | N | Precision attachment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5867 | N | Replacement of precision att | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5875 | N | Prosthesis modification | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5899 | N | Removable prosthodontic proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5911 | R | Facial moulage sectional | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D5912 | R | Facial moulage complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D5913 | I | Nasal prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5914 | I | Auricular prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5915 | I | Orbital prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5916 | I | Ocular prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5919 | I | Facial prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5922 | I | Nasal septal prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5923 | I | Ocular prosthesis interim | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5924 | I | Cranial prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5925 | I | Facial augmentation implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5926 | I | Replacement nasal prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5927 | I | Auricular replacement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5928 | I | Orbital replacement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5929 | I | Facial replacement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5931 | I | Surgical obturator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5932 | I | Postsurgical obturator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5933 | I | Refitting of obturator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5934 | I | Mandibular flange prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5935 | I | Mandibular denture prosth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5936 | I | Temp obturator prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5937 | I | Trismus appliance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5951 | R | Feeding aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D5952 | I | Pediatric speech aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5953 | I | Adult speech aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5954 | I | Superimposed prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5955 | I | Palatal lift prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5958 | I | Intraoral con def inter plt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5959 | I | Intraoral con def mod palat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5960 | I | Modify speech aid prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5982 | I | Surgical stent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5983 | R | Radiation applicator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D5984 | R | Radiation shield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D5985 | R | Radiation cone locator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D5986 | N | Fluoride applicator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5987 | R | Commissure splint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D5988 | I | Surgical splint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D5999 | I | Maxillofacial prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6010 | I | Odontics endosteal implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6020 | I | Odontics abutment placement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6040 | I | Odontics eposteal implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6050 | I | Odontics transosteal implnt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6055 | I | Implant connecting bar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6056 | N | Prefabricated abutment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6057 | N | Custom abutment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6058 | N | Abutment supported crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6059 | N | Abutment supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6060 | N | Abutment supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6061 | N | Abutment supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6062 | N | Abutment supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6063 | N | Abutment supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6064 | N | Abutment supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6065 | N | Implant supported crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6066 | N | Implant supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6067 | N | Implant supported mtl crown | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6068 | N | Abutment supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6069 | N | Abutment supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6070 | N | Abutment supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6071 | N | Abutment supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6072 | N | Abutment supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6073 | N | Abutment supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6074 | N | Abutment supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6075 | N | Implant supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6076 | N | Implant supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6077 | N | Implant supported retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6078 | N | Implnt/abut suprtd fixd dent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6079 | N | Implnt/abut suprtd fixd dent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6080 | I | Implant maintenance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6090 | I | Repair implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6095 | I | Odontics repr abutment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6100 | I | Removal of implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6199 | I | Implant procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6210 | N | Prosthodont high noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6211 | N | Bridge base metal cast | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6212 | N | Bridge noble metal cast | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6240 | N | Bridge porcelain high noble | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6241 | N | Bridge porcelain base metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6242 | N | Bridge porcelain nobel metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6245 | N | Bridge porcelain/ceramic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6250 | N | Bridge resin w/high noble | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6251 | N | Bridge resin base metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6252 | N | Bridge resin w/noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6519 | N | Inlay/onlay porce/ceramic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6520 | N | Dental retainer two surfaces | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6530 | N | Retainer metallic 3+ surface | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6543 | N | Dental retainr onlay 3 surf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6544 | N | Dental retainr onlay 4/more | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6545 | N | Dental retainr cast metl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6548 | N | Porcelain/ceramic retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6720 | N | Retain crown resin w/hi nble | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6721 | N | Crown resin w/base metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6722 | N | Crown resin w/noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6740 | N | Crown porcelain/ceramic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6750 | N | Crown porcelain high noble | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6751 | N | Crown porcelain base metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6752 | N | Crown porcelain noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6780 | N | Crown 3⁄4 high noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6781 | N | Crown 3⁄4 cast based metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6782 | N | Crown 3⁄4 cast noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6783 | N | Crown 3⁄4 porcelain/ceramic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6790 | N | Crown full high noble metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6791 | N | Crown full base metal cast | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6792 | N | Crown full noble metal cast | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6920 | R | Dental connector bar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D6930 | N | Dental recement bridge | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6940 | N | Stress breaker | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6950 | N | Precision attachment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6970 | N | Post core plus retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6971 | N | Cast post bridge retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6972 | N | Prefab post core plus reta | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6973 | N | Core build up for retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6975 | N | Coping metal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6976 | N | Each addtnl cast post | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6977 | N | Each addtl prefab post | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6980 | N | Bridge repair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D6999 | N | Fixed prosthodontic proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7110 | R | Oral surgery single tooth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7120 | R | Each add tooth extraction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7130 | R | Tooth root removal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7210 | R | Rem imp tooth w/mucoper flp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7220 | R | Impact tooth remov soft tiss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7230 | R | Impact tooth remov part bony | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7240 | R | Impact tooth remov comp bony | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7241 | R | Impact tooth rem bony w/comp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7250 | R | Tooth root removal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7260 | R | Oral antral fistula closure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7270 | N | Tooth reimplantation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7272 | N | Tooth transplantation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7280 | N | Exposure impact tooth orthod | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7281 | N | Exposure tooth aid eruption | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7285 | I | Biopsy of oral tissue hard | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7286 | I | Biopsy of oral tissue soft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7290 | N | Repositioning of teeth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7291 | R | Transseptal fiberotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7310 | I | Alveoplasty w/ extraction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7320 | I | Alveoplasty w/o extraction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7340 | I | Vestibuloplasty ridge extens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7350 | I | Vestibuloplasty exten graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7410 | I | Rad exc lesion up to 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7420 | I | Lesion 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7430 | I | Exc benign tumor to 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7431 | I | Benign tumor exc 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7440 | I | Malig tumor exc to 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7441 | I | Malig tumor 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7450 | I | Rem odontogen cyst to 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7451 | I | Rem odontogen cyst 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7460 | I | Rem nonodonto cyst to 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7461 | I | Rem nonodonto cyst 1.25 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7465 | I | Lesion destruction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7471 | I | Rem exostosis any site | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7480 | I | Partial ostectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7490 | I | Mandible resection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7510 | I | Id absc intraoral soft tiss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7520 | I | Id abscess extraoral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7530 | I | Removal fb skin/areolar tiss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7540 | I | Removal of fb reaction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7550 | I | Removal of sloughed off bone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7560 | I | Maxillary sinusotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7610 | I | Maxilla open reduct simple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7620 | I | Clsd reduct simpl maxilla fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7630 | I | Open red simpl mandible fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7640 | I | Clsd red simpl mandible fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7650 | I | Open red simp malar/zygom fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7660 | I | Clsd red simp malar/zygom fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7670 | I | Closd rductn splint alveolus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7680 | I | Reduct simple facial bone fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7710 | I | Maxilla open reduct compound | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7720 | I | Clsd reduct compd maxilla fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7730 | I | Open reduct compd mandble fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7740 | I | Clsd reduct compd mandble fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7750 | I | Open red comp malar/zygma fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7760 | I | Clsd red comp malar/zygma fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7770 | I | Open reduc compd alveolus fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7780 | I | Reduct compnd facial bone fx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7810 | I | Tmj open reduct-dislocation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7820 | I | Closed tmp manipulation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7830 | I | Tmj manipulation under anest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7840 | I | Removal of tmj condyle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7850 | I | Tmj meniscectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7852 | I | Tmj repair of joint disc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7854 | I | Tmj excisn of joint membrane | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7856 | I | Tmj cutting of a muscle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7858 | I | Tmj reconstruction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7860 | I | Tmj cutting into joint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7865 | I | Tmj reshaping components | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7870 | I | Tmj aspiration joint fluid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7871 | N | Lysis + lavage w catheters | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7872 | I | Tmj diagnostic arthroscopy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7873 | I | Tmj arthroscopy lysis adhesn | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7874 | I | Tmj arthroscopy disc reposit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7875 | I | Tmj arthroscopy synovectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7876 | I | Tmj arthroscopy discectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7877 | I | Tmj arthroscopy debridement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7880 | I | Occlusal orthotic appliance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7899 | I | Tmj unspecified therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7910 | I | Dent sutur recent wnd to 5 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7911 | I | Dental suture wound to 5 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7912 | I | Suture complicate wnd 5 cm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7920 | I | Dental skin graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7940 | R | Reshaping bone orthognathic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D7941 | I | Bone cutting ramus closed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7943 | I | Cutting ramus open w/graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7944 | I | Bone cutting segmented | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7945 | I | Bone cutting body mandible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7946 | I | Reconstruction maxilla total | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7947 | I | Reconstruct maxilla segment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7948 | I | Reconstruct midface no graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7949 | I | Reconstruct midface w/graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7950 | I | Mandible graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7955 | I | Repair maxillofacial defects | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7960 | I | Frenulectomy/frenulotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7970 | I | Excision hyperplastic tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7971 | I | Excision pericoronal gingiva | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7980 | I | Sialolithotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7981 | I | Excision of salivary gland | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7982 | I | Sialodochoplasty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7983 | I | Closure of salivary fistula | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7990 | I | Emergency tracheotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7991 | I | Dental coronoidectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7995 | I | Synthetic graft facial bones | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7996 | I | Implant mandible for augment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7997 | N | Appliance removal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D7999 | I | Oral surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8010 | N | Limited dental tx primary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8020 | N | Limited dental tx transition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8030 | N | Limited dental tx adolescent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8040 | N | Limited dental tx adult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8050 | N | Intercep dental tx primary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8060 | N | Intercep dental tx transitn | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8070 | N | Compre dental tx transition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8080 | N | Compre dental tx adolescent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8090 | N | Compre dental tx adult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8210 | N | Orthodontic rem appliance tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8220 | N | Fixed appliance therapy habt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8660 | N | Preorthodontic tx visit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8670 | N | Periodic orthodontc tx visit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8680 | N | Orthodontic retention | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8690 | N | Orthodontic treatment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8691 | N | Repair ortho appliance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8692 | N | Replacement retainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D8999 | N | Orthodontic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9110 | R | Tx dental pain minor proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9210 | I | Dent anesthesia w/o surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9211 | I | Regional block anesthesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9212 | I | Trigeminal block anesthesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9215 | I | Local anesthesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9220 | I | General anesthesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9221 | I | General anesthesia ea ad 15m | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9230 | R | Analgesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9241 | I | Intravenous sedation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9242 | I | IV sedation ea ad 30 m | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9248 | R | Sedation (non-iv) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9310 | I | Dental consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9410 | I | Dental house call | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9420 | I | Hospital call | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9430 | I | Office visit during hours | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9440 | I | Office visit after hours | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9610 | I | Dent therapeutic drug inject | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9630 | R | Other drugs/medicaments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9910 | N | Dent appl desensitizing med | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9911 | N | Appl desensitizing resin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9920 | N | Behavior management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9930 | R | Treatment of complications | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9940 | R | Dental occlusal guard | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9941 | N | Fabrication athletic guard | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9950 | R | Occlusion analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9951 | R | Limited occlusal adjustment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9952 | R | Complete occlusal adjustment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| D9970 | N | Enamel microabrasion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9971 | N | Odontoplasty 1-2 teeth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9972 | N | Extrnl bleaching per arch | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9973 | N | Extrnl bleaching per tooth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9974 | N | Intrnl bleaching per tooth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| D9999 | I | Adjunctive procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0001 | X | Drawing blood for specimen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0002 | A | Temporary urinary catheter | 0.50 | 3.32 | 0.17 | 0.03 | 3.85 | 0.70 | 000 | ||||||||||||
| G0004 | A | ECG transm phys review int | 0.52 | 7.10 | NA | 0.45 | 8.07 | NA | XXX | ||||||||||||
| G0005 | A | ECG 24 hour recording | 0.00 | 1.18 | NA | 0.07 | 1.25 | NA | XXX | ||||||||||||
| G0006 | A | ECG transmission analysis | 0.00 | 5.71 | NA | 0.36 | 6.07 | NA | XXX | ||||||||||||
| G0007 | A | ECG phy review interpret | 0.52 | 0.21 | 0.21 | 0.02 | 0.75 | 0.75 | XXX | ||||||||||||
| G0008 | X | Admin influenza virus vac | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0009 | X | Admin pneumococcal vaccine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0010 | X | Admin hepatitis b vaccine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0015 | A | Post symptom ECG tracing | 0.00 | 5.71 | NA | 0.36 | 6.07 | NA | XXX | ||||||||||||
| G0016 | D | Post symptom ECG md review | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0025 | I | Collagen skin test kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0026 | X | Fecal leukocyte examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0027 | X | Semen analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0030 | C | PET imaging prev PET single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0030 | 26 | A | PET imaging prev PET single | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX | |||||||||||
| G0030 | TC | C | PET imaging prev PET single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0031 | C | PET imaging prev PET multple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0031 | 26 | A | PET imaging prev PET multple | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX | |||||||||||
| G0031 | TC | C | PET imaging prev PET multple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0032 | C | PET follow SPECT 78464 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0032 | 26 | A | PET follow SPECT 78464 singl | 1.50 | 0.52 | 0.52 | 0.05 | 2.07 | 2.07 | XXX | |||||||||||
| G0032 | TC | C | PET follow SPECT 78464 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0033 | C | PET follow SPECT 78464 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0033 | 26 | A | PET follow SPECT 78464 mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX | |||||||||||
| G0033 | TC | C | PET follow SPECT 78464 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0034 | C | PET follow SPECT 76865 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0034 | 26 | A | PET follow SPECT 76865 singl | 1.50 | 0.52 | 0.52 | 0.05 | 2.07 | 2.07 | XXX | |||||||||||
| G0034 | TC | C | PET follow SPECT 76865 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0035 | C | PET follow SPECT 78465 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0035 | 26 | A | PET follow SPECT 78465 mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX | |||||||||||
| G0035 | TC | C | PET follow SPECT 78465 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0036 | C | PET follow cornry angio sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0036 | 26 | A | PET follow cornry angio sing | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX | |||||||||||
| G0036 | TC | C | PET follow cornry angio sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0037 | C | PET follow cornry angio mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0037 | 26 | A | PET follow cornry angio mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX | |||||||||||
| G0037 | TC | C | PET follow cornry angio mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0038 | C | PET follow myocard perf sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0038 | 26 | A | PET follow myocard perf sing | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX | |||||||||||
| G0038 | TC | C | PET follow myocard perf sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0039 | C | PET follow myocard perf mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0039 | 26 | A | PET follow myocard perf mult | 1.87 | 0.70 | 0.70 | 0.07 | 2.64 | 2.64 | XXX | |||||||||||
| G0039 | TC | C | PET follow myocard perf mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0040 | C | PET follow stress echo singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0040 | 26 | A | PET follow stress echo singl | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX | |||||||||||
| G0040 | TC | C | PET follow stress echo singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0041 | C | PET follow stress echo mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0041 | 26 | A | PET follow stress echo mult | 1.87 | 0.70 | 0.70 | 0.05 | 2.62 | 2.62 | XXX | |||||||||||
| G0041 | TC | C | PET follow stress echo mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0042 | C | PET follow ventriculogm sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0042 | 26 | A | PET follow ventriculogm sing | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX | |||||||||||
| G0042 | TC | C | PET follow ventriculogm sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0043 | C | PET follow ventriculogm mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0043 | 26 | A | PET follow ventriculogm mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX | |||||||||||
| G0043 | TC | C | PET follow ventriculogm mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0044 | C | PET following rest ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0044 | 26 | A | PET following rest ECG singl | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX | |||||||||||
| G0044 | TC | C | PET following rest ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0045 | C | PET following rest ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0045 | 26 | A | PET following rest ECG mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX | |||||||||||
| G0045 | TC | C | PET following rest ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0046 | C | PET follow stress ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0046 | 26 | A | PET follow stress ECG singl | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX | |||||||||||
| G0046 | TC | C | PET follow stress ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0047 | C | PET follow stress ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0047 | 26 | A | PET follow stress ECG mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX | |||||||||||
| G0047 | TC | C | PET follow stress ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0050 | A | Residual urine by ultrasound | 0.00 | 0.81 | NA | 0.04 | 0.85 | NA | XXX | ||||||||||||
| G0101 | A | CA screen; pelvic/breast exam | 0.45 | 0.52 | 0.18 | 0.01 | 0.98 | 0.64 | XXX | ||||||||||||
| G0102 | A | Prostate ca screening; dre | 0.17 | 0.38 | 0.06 | 0.01 | 0.56 | 0.24 | XXX | ||||||||||||
| G0103 | X | Psa, total screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0104 | A | CA screen; flexi sigmoidscope | 0.96 | 1.92 | 0.53 | 0.05 | 2.93 | 1.54 | 000 | ||||||||||||
| G0105 | A | Colorectal scrn; hi risk ind | 3.70 | 8.79 | 1.77 | 0.20 | 12.69 | 5.67 | 000 | ||||||||||||
| G0106 | A | Colon CA screen; barium enema | 0.99 | 2.47 | NA | 0.15 | 3.61 | NA | XXX | ||||||||||||
| G0106 | 26 | A | Colon CA screen; barium enema | 0.99 | 0.35 | 0.35 | 0.04 | 1.38 | 1.38 | XXX | |||||||||||
| G0106 | TC | A | Colon CA screen; barium enema | 0.00 | 2.12 | NA | 0.11 | 2.23 | NA | XXX | |||||||||||
| G0107 | X | CA screen; fecal blood test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0108 | A | Diab manage trn per indiv | 0.00 | 1.64 | NA | 0.01 | 1.65 | NA | XXX | ||||||||||||
| G0109 | A | Diab manage trn ind/group | 0.00 | 0.96 | NA | 0.01 | 0.97 | NA | XXX | ||||||||||||
| G0110 | R | Nett pulm-rehab educ; ind | 0.90 | 0.67 | 0.36 | 0.03 | 1.60 | 1.29 | XXX | ||||||||||||
| G0111 | R | Nett pulm-rehab educ; group | 0.27 | 0.29 | 0.11 | 0.01 | 0.57 | 0.39 | XXX | ||||||||||||
| G0112 | R | Nett; nutrition guid, initial | 1.72 | 1.24 | 0.69 | 0.05 | 3.01 | 2.46 | XXX | ||||||||||||
| G0113 | R | Nett; nutrition guid, subseqnt | 1.29 | 0.97 | 0.51 | 0.04 | 2.30 | 1.84 | XXX | ||||||||||||
| G0114 | R | Nett; psychosocial consult | 1.20 | 0.49 | 0.48 | 0.03 | 1.72 | 1.71 | XXX | ||||||||||||
| G0115 | R | Nett; psychological testing | 1.20 | 0.57 | 0.48 | 0.04 | 1.81 | 1.72 | XXX | ||||||||||||
| G0116 | R | Nett; psychosocial counsel | 1.11 | 0.69 | 0.44 | 0.04 | 1.84 | 1.59 | XXX | ||||||||||||
| G0117 | T | Glaucoma scrn hgh risk direc | 0.45 | 0.97 | 0.22 | 0.02 | 1.44 | 0.69 | XXX | ||||||||||||
| G0118 | T | Glaucoma scrn hgh risk direc | 0.17 | 0.84 | 0.08 | 0.01 | 1.02 | 0.26 | XXX | ||||||||||||
| G0120 | A | Colon ca scrn; barium enema | 0.99 | 2.47 | NA | 0.15 | 3.61 | NA | XXX | ||||||||||||
| G0120 | 26 | A | Colon ca scrn; barium enema | 0.99 | 0.35 | 0.35 | 0.04 | 1.38 | 1.38 | XXX | |||||||||||
| G0120 | TC | A | Colon ca scrn; barium enema | 0.00 | 2.12 | NA | 0.11 | 2.23 | NA | XXX | |||||||||||
| G0121 | A | Colon ca scrn not hi rsk ind | 3.70 | 8.79 | 1.77 | 0.20 | 12.69 | 5.67 | 000 | ||||||||||||
| G0122 | N | Colon ca scrn; barium enema | +0.99 | 2.52 | NA | 0.15 | 3.66 | NA | XXX | ||||||||||||
| G0122 | 26 | N | Colon ca scrn; barium enema | +0.99 | 0.40 | 0.40 | 0.04 | 1.43 | 1.43 | XXX | |||||||||||
| G0122 | TC | N | Colon ca scrn; barium enema | +0.00 | 2.12 | NA | 0.11 | 2.23 | NA | XXX | |||||||||||
| G0123 | X | Screen cerv/vag thin layer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0124 | A | Screen c/v thin layer by MD | 0.42 | 0.19 | 0.19 | 0.01 | 0.62 | 0.62 | XXX | ||||||||||||
| G0125 | A | PET img WhBD sgl pulm ring | 1.50 | 56.10 | NA | 2.00 | 59.60 | NA | XXX | ||||||||||||
| G0125 | 26 | A | PET img WhBD sgl pulm ring | 1.50 | 0.52 | 0.52 | 0.05 | 2.07 | 2.07 | XXX | |||||||||||
| G0125 | TC | A | PET img WhBD sgl pulm ring | 0.00 | 55.58 | NA | 1.95 | 57.53 | NA | XXX | |||||||||||
| G0126 | D | Lung image (PET) staging | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| G0126 | 26 | D | Lung image (PET) staging | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0126 | TC | D | Lung image (PET) staging | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| G0127 | R | Trim nail(s) | 0.17 | 0.26 | 0.07 | 0.01 | 0.44 | 0.25 | 000 | ||||||||||||
| G0128 | R | CORF skilled nursing service | 0.08 | 0.03 | 0.03 | 0.01 | 0.12 | 0.12 | XXX | ||||||||||||
| G0130 | A | Single energy x-ray study | 0.22 | 0.90 | NA | 0.05 | 1.17 | NA | XXX | ||||||||||||
| G0130 | 26 | A | Single energy x-ray study | 0.22 | 0.11 | 0.11 | 0.01 | 0.34 | 0.34 | XXX | |||||||||||
| G0130 | TC | A | Single energy x-ray study | 0.00 | 0.79 | NA | 0.04 | 0.83 | NA | XXX | |||||||||||
| G0131 | A | CT scan, bone density study | 0.25 | 3.18 | NA | 0.14 | 3.57 | NA | XXX | ||||||||||||
| G0131 | 26 | A | CT scan, bone density study | 0.25 | 0.13 | 0.13 | 0.01 | 0.39 | 0.39 | XXX | |||||||||||
| G0131 | TC | A | CT scan, bone density study | 0.00 | 3.05 | NA | 0.13 | 3.18 | NA | XXX | |||||||||||
| G0132 | A | CT scan, bone density study | 0.22 | 0.90 | NA | 0.05 | 1.17 | NA | XXX | ||||||||||||
| G0132 | 26 | A | CT scan, bone density study | 0.22 | 0.11 | 0.11 | 0.01 | 0.34 | 0.34 | XXX | |||||||||||
| G0132 | TC | A | CT scan, bone density study | 0.00 | 0.79 | NA | 0.04 | 0.83 | NA | XXX | |||||||||||
| G0141 | A | Scr c/v cyto, autosys and md | 0.42 | 0.19 | 0.19 | 0.01 | 0.62 | 0.62 | XXX | ||||||||||||
| G0143 | X | Scr c/v cyto, thinlayer,rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0144 | X | Scr c/v cyto, thinlayer,rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0145 | X | Scr c/v cyto, thinlayer,rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0147 | X | Scr c/v cyto, automated sys | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0148 | X | Scr c/v cyto, autosys, rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0163 | D | Pet for rec of colorectal ca | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| G0163 | 26 | D | Pet for rec of colorectal ca | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0163 | TC | D | Pet for rec of colorectal ca | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| G0164 | D | Pet for lymphoma staging | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| G0164 | 26 | D | Pet for lymphoma staging | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0164 | TC | D | Pet for lymphoma staging | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| G0165 | D | Pet, rec of melanoma/met ca | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| G0165 | 26 | D | Pet, rec of melanoma/met ca | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0165 | TC | D | Pet, rec of melanoma/met ca | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| G0166 | A | Extrnl counterpulse, per tx | 0.07 | 4.17 | 0.03 | 0.01 | 4.25 | 0.11 | XXX | ||||||||||||
| G0167 | C | Hyperbaric oz tx; no md reqrd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0168 | A | Wound closure by adhesive | 0.45 | 2.33 | 0.19 | 0.01 | 2.79 | 0.65 | 000 | ||||||||||||
| G0173 | X | Stereo radoisurgery, complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0174 | D | Intensitymodulatedradiation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0175 | X | OPPS Service, sched team conf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0176 | X | OPPS/PHP; activity therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0177 | X | OPPS/PHP; train educ serv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0178 | D | Intensitymodulatedradiation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0179 | A | MD recertification HHA PT | 0.45 | 1.21 | NA | 0.01 | 1.67 | NA | XXX | ||||||||||||
| G0180 | A | MD certification HHA patient | 0.67 | 1.29 | NA | 0.02 | 1.98 | NA | XXX | ||||||||||||
| G0181 | A | Home health care supervision | 1.73 | 1.57 | NA | 0.06 | 3.36 | NA | XXX | ||||||||||||
| G0182 | A | Hospice care supervision | 1.73 | 1.97 | NA | 0.06 | 3.76 | NA | XXX | ||||||||||||
| G0184 | D | Ocular photdynamicTx 2nd eye | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | ||||||||||||
| G0185 | C | Transpuppillary thermotx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| G0186 | C | Dstry eye lesn, fdr vssl tech | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| G0187 | C | Dstry mclr drusen, photocoag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | ||||||||||||
| G0188 | D | Xray lwr extrmty-full lngth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0188 | 26 | D | Xray lwr extrmty-full lngth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0188 | TC | D | Xray lwr extrmty-full lngth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0190 | D | Immunization administration | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0191 | D | Immunization admin, each add | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0192 | N | Immunization oral/intranasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0193 | C | Endoscopicstudyswallowfunctn | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0194 | C | Sensorytestingendoscopicstud | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0195 | A | Clinicalevalswallowingfunct | 1.50 | 1.95 | 0.76 | 0.07 | 3.52 | 2.33 | XXX | ||||||||||||
| G0196 | A | Eval of swallowing with radio opa | 1.50 | 1.95 | 0.76 | 0.07 | 3.52 | 2.33 | XXX | ||||||||||||
| G0197 | A | Eval of pt for prescip speech devi | 1.35 | 2.11 | 0.75 | 0.04 | 3.50 | 2.14 | XXX | ||||||||||||
| G0198 | A | Patient adapation train for spe | 0.99 | 1.14 | 0.58 | 0.03 | 2.16 | 1.60 | XXX | ||||||||||||
| G0199 | A | Reevaluation of patient uses pec | 1.01 | 1.92 | 0.56 | 0.03 | 2.96 | 1.60 | XXX | ||||||||||||
| G0200 | A | Eval of patient prescip of voice p | 1.35 | 2.11 | 0.75 | 0.04 | 3.50 | 2.14 | XXX | ||||||||||||
| G0201 | A | Modi for training in use voice pro | 0.99 | 1.14 | 0.58 | 0.03 | 2.16 | 1.60 | XXX | ||||||||||||
| G0202 | A | Screening mammographydigital | 0.70 | 2.70 | NA | 0.09 | 3.49 | NA | XXX | ||||||||||||
| G0202 | 26 | A | Screening mammographydigital | 0.70 | 0.28 | 0.28 | 0.03 | 1.01 | 1.01 | XXX | |||||||||||
| G0202 | TC | A | Screening mammographydigital | 0.00 | 2.42 | NA | 0.06 | 2.48 | NA | XXX | |||||||||||
| G0203 | D | Screen mammographyfilmdigital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0204 | A | Diagnostic mammographydigital | 0.87 | 2.73 | NA | 0.09 | 3.69 | NA | XXX | ||||||||||||
| G0204 | 26 | A | Diagnostic mammographydigital | 0.87 | 0.35 | 0.35 | 0.03 | 1.25 | 1.25 | XXX | |||||||||||
| G0204 | TC | A | Diagnostic mammographydigital | 0.00 | 2.38 | NA | 0.06 | 2.44 | NA | XXX | |||||||||||
| G0205 | D | Diagnostic mammographyfilmpro | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0205 | 26 | D | Diagnostic mammographyfilmpro | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0205 | TC | D | Diagnostic mammographyfilmpro | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0206 | A | Diagnostic mammographydigital | 0.70 | 2.20 | NA | 0.08 | 2.98 | NA | XXX | ||||||||||||
| G0206 | 26 | A | Diagnostic mammographydigital | 0.70 | 0.28 | 0.28 | 0.03 | 1.01 | 1.01 | XXX | |||||||||||
| G0206 | TC | A | Diagnostic mammographydigital | 0.00 | 1.92 | NA | 0.05 | 1.97 | NA | XXX | |||||||||||
| G0207 | D | Diagnostic mammography film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0207 | 26 | D | Diagnostic mammography film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0207 | TC | D | Diagnostic mammography film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0210 | C | PET img WhBD ring dxlung ca | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0210 | 26 | A | PET img WhBD ring dxlung ca | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0210 | TC | C | PET img WhBD ring dxlung ca | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0211 | C | PET img WhBD ring init lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0211 | 26 | A | PET img WhBD ring init lung | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0211 | TC | C | PET img WhBD ring init lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0212 | C | PET img WhBD ring restag lun | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0212 | 26 | A | PET img WhBD ring restag lun | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0212 | TC | C | PET img WhBD ring restag lun | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0213 | C | PET img WhBD ring dx colorec | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0213 | 26 | A | PET img WhBD ring dx colorec | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0213 | TC | C | PET img WhBD ring dx colorec | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0214 | C | PET img WhBD ring init colre | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0214 | 26 | A | PET img WhBD ring init colre | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0214 | TC | C | PET img WhBD ring init colre | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0215 | C | PET img WhBD restag col | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0215 | 26 | A | PET img WhBD restag col | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0215 | TC | C | PET img WhBD restag col | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0216 | C | PET img WhBD ring dx melanom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0216 | 26 | A | PET img WhBD ring dx melanom | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0216 | TC | C | PET img WhBD ring dx melanom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0217 | C | PET img WhBD ring init melan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0217 | 26 | A | PET img WhBD ring init melan | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0217 | TC | C | PET img WhBD ring init melan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0218 | C | PET img WhBD ring restag mel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0218 | 26 | A | PET img WhBD ring restag mel | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0218 | TC | C | PET img WhBD ring restag mel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0219 | N | PET img WhBD ring noncov ind | +1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | ||||||||||||
| G0219 | 26 | N | PET img WhBD ring noncov ind | +1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0219 | TC | N | PET img WhBD ring noncov ind | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0220 | C | PET img WhBD ring dx lymphom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0220 | 26 | A | PET img WhBD ring dx lymphom | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0220 | TC | C | PET img WhBD ring dx lymphom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0221 | C | PET img WhBD ring init lymph | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0221 | 26 | A | PET img WhBD ring init lymph | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0221 | TC | C | PET img WhBD ring init lymph | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0222 | C | PET img WhBD ring resta lymp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0222 | 26 | A | PET img WhBD ring resta lymp | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0222 | TC | C | PET img WhBD ring resta lymp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0223 | C | PET img WhBD reg ring dx hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0223 | 26 | A | PET img WhBD reg ring dx hea | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0223 | TC | C | PET img WhBD reg ring dx hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0224 | C | PET img WhBD reg ring ini hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0224 | 26 | A | PET img WhBD reg ring ini hea | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0224 | TC | C | PET img WhBD reg ring ini hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0225 | C | PET img WhBD ring restag hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0225 | 26 | A | PET img WhBD ring restag hea | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0225 | TC | C | PET img WhBD ring restag hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0226 | C | PET img WhBD dx esophag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0226 | 26 | A | PET img WhBD dx esophag | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0226 | TC | C | PET img WhBD dx esophag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0227 | C | PET img WhBD ini esopha | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0227 | 26 | A | PET img WhBD ini esopha | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0227 | TC | C | PET img WhBD ini esopha | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0228 | C | PET img WhBD ring restg esop | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0228 | 26 | A | PET img WhBD ring restg esop | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0228 | TC | C | PET img WhBD ring restg esop | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0229 | C | PET img metabolic brain ring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0229 | 26 | A | PET img metabolic brain ring | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0229 | TC | C | PET img metabolic brain ring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0230 | C | PET myocard viability ring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0230 | 26 | A | PET myocard viability ring | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0230 | TC | C | PET myocard viability ring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0231 | C | PET WhBD colorec; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0231 | 26 | A | PET WhBD colorec; gamma cam | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0231 | TC | C | PET WhBD colorec; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0232 | C | PET WhBD lymphoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0232 | 26 | A | PET WhBD lymphoma; gamma cam | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0232 | TC | C | PET WhBD lymphoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0233 | C | PET WhBD melanoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0233 | 26 | A | PET WhBD melanoma; gamma cam | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0233 | TC | C | PET WhBD melanoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0234 | C | PET WhBD pulm nod; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0234 | 26 | A | PET WhBD pulm nod; gamma cam | 1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX | |||||||||||
| G0234 | TC | C | PET WhBD pulm nod; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| G0236 | A | digital film convert diag ma | 0.06 | 0.31 | NA | 0.02 | 0.39 | NA | ZZZ | ||||||||||||
| G0236 | 26 | A | digital film convert diag ma | 0.06 | 0.02 | 0.02 | 0.01 | 0.09 | 0.09 | ZZZ | |||||||||||
| G0236 | TC | A | digital film convert diag ma | 0.00 | 0.29 | NA | 0.01 | 0.30 | NA | ZZZ | |||||||||||
| G0237 | A | Therapeutic procd strg endur | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | ||||||||||||
| G0238 | C | Oth resp proc, indiv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0239 | C | Oth resp proc, group | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0240 | A | Critic care by MD transport | 4.00 | 1.60 | 1.60 | 0.14 | 5.74 | 5.74 | XXX | ||||||||||||
| G0241 | A | Each additional 30 minutes | 2.00 | 0.80 | 0.80 | 0.07 | 2.87 | 2.87 | ZZZ | ||||||||||||
| G0242 | X | Multisource photon ster plan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0243 | X | Multisour photon stero treat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G0244 | X | Observ care by facility topt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9001 | X | MCCD, initial rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9002 | X | MCCD, maintenance rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9003 | X | MCCD, risk adj hi, initial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9004 | X | MCCD, risk adj lo, initial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9005 | X | MCCD, risk adj, maintenance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9006 | X | MCCD, Home monitoring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9007 | X | MCCD, sch team conf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9008 | X | MCCD, phys coor-care ovrsght | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9009 | X | MCCD, risk adj, level 3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9010 | X | MCCD, risk adj, level 4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9011 | X | MCCD, risk adj, level 5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9012 | X | Other Specified Case Mgmt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| G9016 | N | Demo-smoking cessation coun | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0001 | I | Alcohol and/or drug assess | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0002 | I | Alcohol and/or drug screenin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0003 | I | Alcohol and/or drug screenin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0004 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0005 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0006 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0007 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0008 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0009 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0010 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0011 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0012 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0013 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0014 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0015 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0016 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0017 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0018 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0019 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0020 | I | Alcohol and/or drug services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0021 | I | Alcohol and/or drug training | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0022 | I | Alcohol and/or drug interven | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0023 | I | Alcohol and/or drug outreach | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0024 | I | Alcohol and/or drug preventi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0025 | I | Alcohol and/or drug preventi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0026 | I | Alcohol and/or drug preventi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0027 | I | Alcohol and/or drug preventi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0028 | I | Alcohol and/or drug preventi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0029 | I | Alcohol and/or drug preventi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H0030 | I | Alcohol and/or drug hotline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H1000 | I | Prenatal care atrisk assessm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H1001 | I | Antepartum management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H1002 | I | Care coordination prenatal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H1003 | I | Prenatal at risk education | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H1004 | I | Follow up home visit/prental | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| H1005 | I | Prenatal care enhanced srv pk | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0120 | E | Tetracyclin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0130 | E | Abciximab injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0150 | E | Injection adenosine 6 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0151 | E | Adenosine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0170 | E | Adrenalin epinephrin inject | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0190 | E | Inj biperiden lactate/5 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0200 | E | Alatrofloxacin mesylate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0205 | E | Alglucerase injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0207 | E | Amifostine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0210 | E | Methyldopate hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0256 | E | Alpha 1 proteinase inhibitor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0270 | E | Alprostadil for injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0275 | E | Alprostadil urethral suppos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0280 | E | Aminophyllin 250 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0282 | E | Amiodarone HCl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0285 | E | Amphotericin B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0286 | E | Amphotericin B lipid complex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0290 | E | Ampicillin 500 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0295 | E | Ampicillin sodium per 1.5 gm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0300 | E | Amobarbital 125 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0330 | E | Succinycholine chloride inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0340 | D | Nandrolon phenpropionate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0350 | E | Injection anistreplase 30 u | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0360 | E | Hydralazine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0380 | E | Inj metaraminol bitartrate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0390 | E | Chloroquine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0395 | E | Arbutamine HCl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0400 | D | Inj trimethaphan camsylate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0456 | E | Azithromycin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0460 | E | Atropine sulfate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0470 | E | Dimecaprol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0475 | E | Baclofen 10 MG injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0476 | E | Baclofen intrathecal trial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0500 | E | Dicyclomine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0510 | D | Benzquinamide injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0515 | E | Inj benztropine mesylate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0520 | E | Bethanechol chloride inject | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0530 | E | Penicillin g benzathine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0540 | E | Penicillin g benzathine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0550 | E | Penicillin g benzathine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0560 | E | Penicillin g benzathine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0570 | E | Penicillin g benzathine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0580 | E | Penicillin g benzathine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0585 | E | Botulinum toxin a per unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0587 | E | Botulinum toxin type B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0590 | D | Ethylnorepinephrine hcl inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0600 | E | Edetate calcium disodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0610 | E | Calcium gluconate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0620 | E | Calcium glycer lact/10 ML | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0630 | E | Calcitonin salmon injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0635 | E | Calcitriol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0640 | E | Leucovorin calcium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0670 | E | Inj mepivacaine HCL/10 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0690 | E | Cefazolin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0692 | E | Cefepime HCl for injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0694 | E | Cefoxitin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0695 | D | Cefonocid sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0696 | E | Ceftriaxone sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0697 | E | Sterile cefuroxime injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0698 | E | Cefotaxime sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0702 | E | Betamethasone acetsod phosp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0704 | E | Betamethasone sod phosp/4 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0706 | E | Caffeine citrate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0710 | E | Cephapirin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0713 | E | Inj ceftazidime per 500 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0715 | E | Ceftizoxime sodium/500 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0720 | E | Chloramphenicol sodium injec | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0725 | E | Chorionic gonadotropin/1000u | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0730 | D | Chlorpheniramin maleate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0735 | E | Clonidine hydrochloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0740 | E | Cidofovir injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0743 | E | Cilastatin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0744 | E | Ciprofloxacin iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0745 | E | Inj codeine phosphate/30 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0760 | E | Colchicine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0770 | E | Colistimethate sodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0780 | E | Prochlorperazine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0800 | E | Corticotropin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0810 | D | Cortisone injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0835 | E | Inj cosyntropin per 0.25 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0850 | E | Cytomegalovirus imm IV /vial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0895 | E | Deferoxamine mesylate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0900 | E | Testosterone enanthate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0945 | E | Brompheniramine maleate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J0970 | E | Estradiol valerate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1000 | E | Depo-estradiol cypionate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1020 | E | Methylprednisolone 20 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1030 | E | Methylprednisolone 40 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1040 | E | Methylprednisolone 80 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1050 | E | Medroxyprogesterone inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1055 | N | Medroxyprogester acetate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1056 | E | MA/EC contraceptive injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1060 | E | Testosterone cypionate 1 ML | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1070 | E | Testosterone cypionate 100 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1080 | E | Testosterone cypionate 200 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1090 | D | Testosterone cypionate 50 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1095 | E | Inj dexamethasone acetate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1100 | E | Dexamethasone sodium phos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1110 | E | Inj dihydroergotamine mesylt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1120 | E | Acetazolamid sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1160 | E | Digoxin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1165 | E | Phenytoin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1170 | E | Hydromorphone injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1180 | E | Dyphylline injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1190 | E | Dexrazoxane HCl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1200 | E | Diphenhydramine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1205 | E | Chlorothiazide sodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1212 | E | Dimethyl sulfoxide 50% 50 ML | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1230 | E | Methadone injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1240 | E | Dimenhydrinate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1245 | E | Dipyridamole injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1250 | E | Inj dobutamine HCL/250 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1260 | E | Dolasetron mesylate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1270 | E | Injection, doxercalciferol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1320 | E | Amitriptyline injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1325 | E | Epoprostenol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1327 | E | Eptifibatide injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1330 | E | Ergonovine maleate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1362 | D | Erythromycin glucep/250 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1364 | E | Erythro lactobionate/500 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1380 | E | Estradiol valerate 10 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1390 | E | Estradiol valerate 20 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1410 | E | Inj estrogen conjugate 25 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1435 | E | Injection estrone per 1 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1436 | E | Etidronate disodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1438 | E | Etanercept injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1440 | E | Filgrastim 300 mcg injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1441 | E | Filgrastim 480 mcg injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1450 | E | Fluconazole | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1452 | E | Intraocular Fomivirsen na | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1455 | E | Foscarnet sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1460 | E | Gamma globulin 1 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1470 | E | Gamma globulin 2 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1480 | E | Gamma globulin 3 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1490 | E | Gamma globulin 4 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1500 | E | Gamma globulin 5 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1510 | E | Gamma globulin 6 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1520 | E | Gamma globulin 7 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1530 | E | Gamma globulin 8 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1540 | E | Gamma globulin 9 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1550 | E | Gamma globulin 10 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1560 | E | Gamma globulin 10 CC inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1561 | E | Immune globulin 500 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1563 | E | IV immune globulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1565 | E | RSV-ivig | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1570 | E | Ganciclovir sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1580 | E | Garamycin gentamicin inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1590 | E | Gatifloxacin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1600 | E | Gold sodium thiomaleate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1610 | E | Glucagon hydrochloride/1 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1620 | E | Gonadorelin hydroch/ 100 mcg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1626 | E | Granisetron HCl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1630 | E | Haloperidol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1631 | E | Haloperidol decanoate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1642 | E | Inj heparin sodium per 10 u | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1644 | E | Inj heparin sodium per 1000u | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1645 | E | Dalteparin sodium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1650 | E | Inj enoxaparin sodium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1655 | E | Tinzaparin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1670 | E | Tetanus immune globulin inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1690 | D | Prednisolone tebutate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1700 | E | Hydrocortisone acetate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1710 | E | Hydrocortisone sodium ph inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1720 | E | Hydrocortisone sodium succ i | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1730 | E | Diazoxide injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1739 | D | Hydroxyprogesterone cap 125 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1741 | D | Hydroxyprogesterone cap 250 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1742 | E | Ibutilide fumarate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1745 | E | Infliximab injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1750 | E | Iron dextran | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1755 | E | Iron sucrose injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1785 | E | Injection imiglucerase /unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1790 | E | Droperidol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1800 | E | Propranolol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1810 | E | Droperidol/fentanyl inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1820 | E | Insulin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1825 | E | Interferon beta-1a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1830 | E | Interferon beta-1b/.25 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1835 | E | Intraconazole injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1840 | E | Kanamycin sulfate 500 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1850 | E | Kanamycin sulfate 75 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1885 | E | Ketorolac tromethamine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1890 | E | Cephalothin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1910 | E | Kutapressin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1930 | D | Propiomazine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1940 | E | Furosemide injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1950 | E | Leuprolide acetate/3.75 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1955 | E | Inj levocarnitine per 1 gm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1956 | E | Levofloxacin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1960 | E | Levorphanol tartrate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1970 | D | Methotrimeprazine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1980 | E | Hyoscyamine sulfate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J1990 | E | Chlordiazepoxide injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2000 | E | Lidocaine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2010 | E | Lincomycin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2020 | E | Linezolid injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2060 | E | Lorazepam injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2150 | E | Mannitol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2175 | E | Meperidine hydrochl/100 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2180 | E | Meperidine/promethazine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2210 | E | Methylergonovin maleate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2240 | D | Metocurine iodide injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2250 | E | Inj midazolam hydrochloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2260 | E | Inj milrinone lactate/5 ML | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2270 | E | Morphine sulfate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2271 | E | Morphine so4 injection 100mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2275 | E | Morphine sulfate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2300 | E | Inj nalbuphine hydrochloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2310 | E | Inj naloxone hydrochloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2320 | E | Nandrolone decanoate 50 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2321 | E | Nandrolone decanoate 100 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2322 | E | Nandrolone decanoate 200 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2330 | D | Thiothixene injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2350 | D | Niacinamide/niacin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2352 | E | Octreotide acetate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2355 | E | Oprelvekin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2360 | E | Orphenadrine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2370 | E | Phenylephrine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2400 | E | Chloroprocaine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2405 | E | Ondansetron hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2410 | E | Oxymorphone hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2430 | E | Pamidronate disodium/30 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2440 | E | Papaverin hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2460 | E | Oxytetracycline injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2480 | D | Hydrochlorides of opium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2500 | E | Paricalcitol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2510 | E | Penicillin g procaine inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2512 | D | Inj pentagastrin per 2 ML | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2515 | E | Pentobarbital sodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2540 | E | Penicillin g potassium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2543 | E | Piperacillin/tazobactam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2545 | E | Pentamidine isethionte/300mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2550 | E | Promethazine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2560 | E | Phenobarbital sodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2590 | E | Oxytocin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2597 | E | Inj desmopressin acetate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2640 | D | Prednisolone sodium ph inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2650 | E | Prednisolone acetate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2670 | E | Totazoline hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2675 | D | Inj progesterone per 50 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2680 | E | Fluphenazine decanoate 25 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2690 | E | Procainamide hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2700 | E | Oxacillin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2710 | E | Neostigmine methylslfte inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2720 | E | Inj protamine sulfate/10 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2725 | E | Inj protirelin per 250 mcg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2730 | E | Pralidoxime chloride inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2760 | E | Phentolaine mesylate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2765 | E | Metoclopramide hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2770 | E | Quinupristin/dalfopristin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2780 | E | Ranitidine hydrochloride inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2790 | E | Rho (D) immune globulin inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2792 | E | Rho(D) immune globulin h, sd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2795 | E | Ropivacaine HCl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2800 | E | Methocarbamol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2810 | E | Inj theophylline per 40 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2820 | E | Sargramostim injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2860 | D | Secobarbital sodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2910 | E | Aurothioglucose injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2912 | E | Sodium chloride injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2915 | E | NA Ferric Gluconate Complex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2920 | E | Methylprednisolone injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2930 | E | Methylprednisolone injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2940 | E | Somatrem injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2941 | E | Somatropin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2950 | E | Promazine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2970 | D | Methicillin sodium injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2993 | E | Reteplase injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2995 | E | Inj streptokinase/250,000 IU | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J2997 | E | Alteplase recombinant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3000 | E | Streptomycin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3010 | E | Fentanyl citrate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3030 | E | Sumatriptan succinate/6 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3070 | E | Pentazocine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3080 | D | Chlorprothixene injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3100 | E | Tenecteplase injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3105 | E | Terbutaline sulfate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3120 | E | Testosterone enanthate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3130 | E | Testosterone enanthate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3140 | E | Testosterone suspension inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3150 | E | Testosteron propionate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3230 | E | Chlorpromazine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3240 | E | Thyrotropin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3245 | E | Tirofiban hydrochloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3250 | E | Trimethobenzamide hcl inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3260 | E | Tobramycin sulfate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3265 | E | Injection torsemide 10 mg/ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3270 | D | Imipramine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3280 | E | Thiethylperazine maleate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3301 | E | Triamcinolone acetonide inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3302 | E | Triamcinolone diacetate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3303 | E | Triamcinolone hexacetonl inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3305 | E | Inj trimetrexate glucoronate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3310 | E | Perphenazine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3320 | E | Spectinomycn di-hcl inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3350 | E | Urea injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3360 | E | Diazepam injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3364 | E | Urokinase 5,000 IU injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3365 | E | Urokinase 250,000 IU inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3370 | R | Vancomycin hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3390 | D | Methoxamine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3395 | E | Verteporfin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3400 | E | Triflupromazine hcl inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3410 | E | Hydroxyzine hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3420 | E | Vitamin b12 injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3430 | E | Vitamin k phytonadione inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3450 | D | Mephentermine sulfate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3470 | E | Hyaluronidase injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3475 | E | Inj magnesium sulfate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3480 | E | Inj potassium chloride | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3485 | E | Zidovudine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3490 | E | Drugs unclassified injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3520 | N | Edetate disodium per 150 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3530 | E | Nasal vaccine inhalation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3535 | N | Metered dose inhaler drug | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J3570 | N | Laetrile amygdalin vit B17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7030 | E | Normal saline solution infus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7040 | E | Normal saline solution infus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7042 | E | 5% dextrose/normal saline | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7050 | E | Normal saline solution infus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7051 | E | Sterile saline/water | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7060 | E | 5% dextrose/water | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7070 | E | D5w infusion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7100 | E | Dextran 40 infusion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7110 | E | Dextran 75 infusion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7120 | E | Ringers lactate infusion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7130 | E | Hypertonic saline solution | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7190 | X | Factor viii | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7191 | X | Factor VIII (porcine) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7192 | X | Factor viii recombinant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7193 | E | Factor IX non-recombinant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7194 | X | Factor ix complex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7195 | E | Factor IX recombinant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7197 | X | Antithrombin iii injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7198 | E | Anti-inhibitor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7199 | E | Hemophilia clot factor noc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7300 | N | Intraut copper contraceptive | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7302 | N | Levonorgestrel iu contracept | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7308 | E | Aminolevulinic acid hcl top | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7310 | E | Ganciclovir long act implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7315 | D | Sodium hyaluronate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7316 | E | Sodium hyaluronate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7320 | E | Hylan G-F 20 injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7330 | E | Cultured chondrocytes implnt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7340 | E | Metabolic active D/E tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7500 | X | Azathioprine oral 50 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7501 | X | Azathioprine parenteral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7502 | E | Cyclosporine oral 100 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7504 | X | Lymphocyte immune globulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7505 | X | Monoclonal antibodies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7506 | X | Prednisone oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7507 | E | Tacrolimus oral per 1 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7508 | E | Tacrolimus oral per 5 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7509 | X | Methylprednisolone oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7510 | X | Prednisolone oral per 5 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7511 | E | Antithymocyte globuln rabbit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7513 | E | Daclizumab, parenteral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7515 | E | Cyclosporine oral 25 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7516 | E | Cyclosporin parenteral 250 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7517 | E | Mycophenolate mofetil oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7520 | E | Sirolimus, oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7525 | E | Tacrolimus injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7599 | X | Immunosuppressive drug noc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7608 | E | Acetylcysteine inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7618 | E | Albuterol inh sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7619 | E | Albuterol inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7622 | E | Beclomethasome inhalatn sol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7624 | E | Betamethasome inhalation sol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7626 | E | Budesonide inhalation sol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7628 | E | Bitolterol mes inhal sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7629 | E | Bitolterol mes inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7631 | E | Cromolyn sodium inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7635 | E | Atropine inhal sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7636 | E | Atropine inhal sol unit dose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7637 | E | Dexamethasone inhal sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7638 | E | Dexamethasone inhal sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7639 | E | Dornase alpha inhal sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7641 | E | Flunisolide, inhalation sol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7642 | E | Glycopyrrolate inhal sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7643 | E | Glycopyrrolate inhal sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7644 | E | Ipratropium brom inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7648 | E | Isoetharine hcl inh sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7649 | E | Isoetharine hcl inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7658 | E | Isoproterenolhcl inh sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7659 | E | Isoproterenol hcl inh sol ud | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7668 | E | Metaproterenol inh sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7669 | E | Metaproterenol inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7680 | E | Terbutaline so4 inh sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7681 | E | Terbutaline so4 inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7682 | E | Tobramycin inhalation sol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7683 | E | Triamcinolone inh sol con | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7684 | E | Triamcinolone inh sol u d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7699 | E | Inhalation solution for DME | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J7799 | E | Non-inhalation drug for DME | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8499 | N | Oral prescrip drug non chemo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8510 | E | Oral busulfan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8520 | E | Capecitabine, oral, 150 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8521 | E | Capecitabine, oral, 500 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8530 | E | Cyclophosphamide oral 25 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8560 | E | Etoposide oral 50 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8600 | E | Melphalan oral 2 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8610 | E | Methotrexate oral 2.5 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8700 | E | Temozolmide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J8999 | E | Oral prescription drug chemo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9000 | E | Doxorubic hcl 10 MG vl chemo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9001 | E | Doxorubicin hcl liposome inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9015 | E | Aldesleukin/single use vial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9017 | E | Arsenic trioxide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9020 | E | Asparaginase injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9031 | E | Bcg live intravesical vac | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9040 | E | Bleomycin sulfate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9045 | E | Carboplatin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9050 | E | Carmus bischl nitro inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9060 | E | Cisplatin 10 MG injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9062 | E | Cisplatin 50 MG injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9065 | E | Inj cladribine per 1 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9070 | E | Cyclophosphamide 100 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9080 | E | Cyclophosphamide 200 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9090 | E | Cyclophosphamide 500 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9091 | E | Cyclophosphamide 1.0 grm inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9092 | E | Cyclophosphamide 2.0 grm inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9093 | E | Cyclophosphamide lyophilized | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9094 | E | Cyclophosphamide lyophilized | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9095 | E | Cyclophosphamide lyophilized | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9096 | E | Cyclophosphamide lyophilized | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9097 | E | Cyclophosphamide lyophilized | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9100 | E | Cytarabine hcl 100 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9110 | E | Cytarabine hcl 500 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9120 | E | Dactinomycin actinomycin d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9130 | E | Dacarbazine 10 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9140 | E | Dacarbazine 200 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9150 | E | Daunorubicin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9151 | E | Daunorubicin citrate liposom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9160 | E | Denileukin diftitox, 300 mcg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9165 | E | Diethylstilbestrol injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9170 | E | Docetaxel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9180 | E | Epirubicin HCl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9181 | E | Etoposide 10 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9182 | E | Etoposide 100 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9185 | E | Fludarabine phosphate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9190 | E | Fluorouracil injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9200 | E | Floxuridine injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9201 | E | Gemcitabine HCl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9202 | E | Goserelin acetate implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9206 | E | Irinotecan injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9208 | E | Ifosfomide injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9209 | E | Mesna injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9211 | E | Idarubicin hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9212 | E | Interferon alfacon-1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9213 | E | Interferon alfa-2a inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9214 | E | Interferon alfa-2b inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9215 | E | Interferon alfa-n3 inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9216 | E | Interferon gamma 1-b inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9217 | E | Leuprolide acetate suspnsion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9218 | E | Leuprolide acetate injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9219 | E | Leuprolide acetate implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9230 | E | Mechlorethamine hcl inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9245 | E | Inj melphalan hydrochl 50 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9250 | E | Methotrexate sodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9260 | E | Methotrexate sodium inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9265 | E | Paclitaxel injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9266 | E | Pegaspargase/singl dose vial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9268 | E | Pentostatin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9270 | E | Plicamycin (mithramycin) inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9280 | E | Mitomycin 5 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9290 | E | Mitomycin 20 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9291 | E | Mitomycin 40 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9293 | E | Mitoxantrone hydrochl/5 MG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9300 | E | Gemtuzumab ozogamicin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9310 | E | Rituximab cancer treatment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9320 | E | Streptozocin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9340 | E | Thiotepa injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9350 | E | Topotecan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9355 | E | Trastuzumab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9357 | E | Valrubicin, 200 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9360 | E | Vinblastine sulfate inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9370 | E | Vincristine sulfate 1 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9375 | E | Vincristine sulfate 2 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9380 | E | Vincristine sulfate 5 MG inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9390 | E | Vinorelbine tartrate/10 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9600 | E | Porfimer sodium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| J9999 | E | Chemotherapy drug | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| M0064 | A | Visit for drug monitoring | 0.37 | 0.25 | 0.12 | 0.01 | 0.63 | 0.50 | XXX | ||||||||||||
| M0075 | N | Cellular therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| M0076 | N | Prolotherapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| M0100 | N | Intragastric hypothermia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| M0300 | N | IV chelationtherapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| M0301 | N | Fabric wrapping of aneurysm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| M0302 | D | Assessment of cardiac output | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | ||||||||||||
| M0302 | 26 | D | Assessment of cardiac output | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |||||||||||
| M0302 | TC | D | Assessment of cardiac output | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |||||||||||
| P2028 | X | Cephalin floculation test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P2029 | X | Congo red blood test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P2031 | N | Hair analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P2033 | X | Blood thymol turbidity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P2038 | X | Blood mucoprotein | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P3000 | X | Screen pap by tech w md supv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P3001 | A | Screening pap smear by phys | 0.42 | 0.19 | 0.19 | 0.01 | 0.62 | 0.62 | XXX | ||||||||||||
| P7001 | I | Culture bacterial urine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9010 | E | Whole blood for transfusion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9011 | E | Blood split unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9012 | E | Cryoprecipitate each unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9016 | E | RBC leukocytes reduced | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9017 | E | One donor fresh frozn plasma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9019 | E | Platelets, each unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9020 | E | Plaelet rich plasma unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9021 | E | Red blood cells unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9022 | E | Washed red blood cells unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9023 | X | Frozen plasma, pooled, sd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9031 | X | Platelets leukocytes reduced | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9032 | X | Platelets, irradiated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9033 | X | Platelets leukoreduced irrad | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9034 | X | Platelets, pheresis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9035 | X | Platelet pheres leukoreduced | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9036 | X | Platelet pheresis irradiated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9037 | X | Plate pheres leukoredu irrad | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9038 | X | RBC irradiated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9039 | X | RBC deglycerolized | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9040 | X | RBC leukoreduced irradiated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9041 | X | Albumin (human), 5%, 50 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9042 | D | Albumin (human), 25% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9043 | X | Plasma protein fract,t5%,50 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9044 | X | Cryoprecipitatereducedplasma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9045 | X | Albumin (human), 5%, 250 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9046 | X | Albumin (human), 25%, 20 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9047 | X | Albumin (human), 25%, 50 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9048 | X | Plasmaprotein fract, 5%, 250 ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9050 | X | Granulocytes, pheresis unit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9603 | X | One-way allow prorated miles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9604 | X | One-way allow prorated trip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9612 | X | Catheterize for urine spec | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| P9615 | X | Urine specimen collect mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0035 | A | Cardiokymography | 0.17 | 0.44 | NA | 0.03 | 0.64 | NA | XXX | ||||||||||||
| Q0035 | 26 | A | Cardiokymography | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX | |||||||||||
| Q0035 | TC | A | Cardiokymography | 0.00 | 0.37 | NA | 0.02 | 0.39 | NA | XXX | |||||||||||
| Q0091 | A | Obtaining screen pap smear | 0.37 | 0.68 | 0.15 | 0.01 | 1.06 | 0.53 | XXX | ||||||||||||
| Q0092 | A | Set up port x-ray equipment | 0.00 | 0.30 | NA | 0.01 | 0.31 | NA | XXX | ||||||||||||
| Q0111 | X | Wet mounts/w preparations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0112 | X | Potassium hydroxide preps | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0113 | X | Pinworm examinations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0114 | X | Fern test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0115 | X | Post-coital mucous exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0136 | E | Non esrd epoetin alpha inj | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0144 | D | Azithromycin dihydrate, oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0160 | D | Factor IX non-recombinant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0161 | D | Factor IX recombinant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0163 | X | Diphenhydramine HCl 50 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0164 | X | Prochlorperazine maleate 5 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0165 | X | Prochlorperazine maleate 10 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0166 | X | Granisetron HCl 1 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0167 | X | Dronabinol 2.5 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0168 | X | Dronabinol 5 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0169 | X | Promethazine HCl 12.5 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0170 | X | Promethazine HCl 25 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0171 | X | Chlorpromazine HCl 10 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0172 | X | Chlorpromazine HCl 25 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0173 | X | Trimethobenzamide HCl 250 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0174 | X | Thiethylperazine maleate 10 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0175 | X | Perphenazine 4 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0176 | X | Perphenazine 8 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0177 | X | Hydroxyzine pamoate 25 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0178 | X | Hydroxyzine pamoate 50 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0179 | X | Ondansetron HCl 8 mg oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0180 | X | Dolasetron mesylate oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0181 | X | Unspecified oral anti-emetic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0183 | X | Nonmetabolic active tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0184 | X | Metabolically active tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0185 | D | Metabolic active D/E tissue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q0187 | E | Factor viia recombinant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q1001 | X | Ntiol category 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q1002 | X | Ntiol category 2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q1003 | X | Ntiol category 3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q1004 | X | Ntiol category 4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q1005 | X | Ntiol category 5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2001 | N | Oral cabergoline 0.5 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2002 | E | Elliotts b solution per ml | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2003 | E | Aprotinin, 10,000 kiu | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2004 | E | Bladder calculi irrig sol | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2005 | E | Corticorelin ovine triflutat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2006 | E | Digoxin immune fab (ovine) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2007 | E | Ethanolamine oleate 100 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2008 | E | Fomepizole, 15 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2009 | E | Fosphenytoin, 50 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2010 | E | Glatiramer acetate, per dose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2011 | E | Hemin, per 1 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2012 | E | Pegademase bovine, 25 iu | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2013 | E | Pentastarch 10% solution | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2014 | E | Sermorelin acetate, 0.5 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2015 | D | Somatrem, 5 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2016 | D | Somatropin, 1 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2017 | E | Teniposide, 50 mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2018 | E | Urofollitropin, 75 iu | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2019 | E | Basiliximab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2020 | E | Histrelin acetate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2021 | E | Lepirudin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q2022 | E | VonWillebrandFactrCmplxperIU | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3001 | E | Brachytherapy Radioelements | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3002 | E | Gallium ga 67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3003 | E | Technetium tc99m bicisate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3004 | E | Xenon xe 133 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3005 | E | Technetium tc99m mertiatide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3006 | E | Technetium tc99m glucepatate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3007 | E | Sodium phosphate p32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3008 | E | Indium 111-in pentetreotide | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3009 | E | Technetium tc99m oxidronate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3010 | E | Technetium tc99mlabeledrbcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3011 | E | Chromic phosphate p32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3012 | E | Cyanocobalamin cobalt co57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3013 | D | Verteporfin injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3014 | E | Telehealth facility fee | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q3017 | E | ALS assessment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4001 | X | Cast sup body cast plaster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4002 | X | Cast sup body cast fiberglas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4003 | X | Cast sup shoulder cast plstr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4004 | X | Cast sup shoulder cast fbrgl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4005 | X | Cast sup long arm adult plst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4006 | X | Cast sup long arm adult fbrg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4007 | X | Cast sup long arm ped plster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4008 | X | Cast sup long arm ped fbrgls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4009 | X | Cast sup sht arm adult plstr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4010 | X | Cast sup sht arm adult fbrgl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4011 | X | Cast sup sht arm ped plaster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4012 | X | Cast sup sht arm ped fbrglas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4013 | X | Cast sup gauntlet plaster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4014 | X | Cast sup gauntlet fiberglass | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4015 | X | Cast sup gauntlet ped plster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4016 | X | Cast sup gauntlet ped fbrgls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4017 | X | Cast sup lng arm splint plst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4018 | X | Cast sup lng arm splint fbrg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4019 | X | Cast sup lng arm splnt ped p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4020 | X | Cast sup lng arm splnt ped f | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4021 | X | Cast sup sht arm splint plst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4022 | X | Cast sup sht arm splint fbrg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4023 | X | Cast sup sht arm splnt ped p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4024 | X | Cast sup sht arm splnt ped f | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4025 | X | Cast sup hip spica plaster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4026 | X | Cast sup hip spica fiberglas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4027 | X | Cast sup hip spica ped plstr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4028 | X | Cast sup hip spica ped fbrgl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4029 | X | Cast sup long leg plaster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4030 | X | Cast sup long leg fiberglass | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4031 | X | Cast sup lng leg ped plaster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4032 | X | Cast sup lng leg ped fbrgls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4033 | X | Cast sup lng leg cylinder pl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4034 | X | Cast sup lng leg cylinder fb | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4035 | X | Cast sup lng leg cylndr ped p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4036 | X | Cast sup lng leg cylndr ped f | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4037 | X | Cast sup shrt leg plaster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4038 | X | Cast sup shrt leg fiberglass | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4039 | X | Cast sup shrt leg ped plster | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4040 | X | Cast sup shrt leg ped fbrgls | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4041 | X | Cast sup lng leg splnt plstr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4042 | X | Cast sup lng leg splnt fbrgl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4043 | X | Cast sup lng leg splnt ped p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4044 | X | Cast sup lng leg splnt ped f | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4045 | X | Cast sup sht leg splnt plstr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4046 | X | Cast sup sht leg splnt fbrgl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4047 | X | Cast sup sht leg splnt ped p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4048 | X | Cast sup sht leg splnt ped f | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4049 | X | Finger splint, static | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4050 | X | Cast supplies unlisted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q4051 | X | Splint supplies misc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9920 | E | Epoetin with hct = 20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9921 | E | Epoetin with hct = 21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9922 | E | Epoetin with hct = 22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9923 | E | Epoetin with hct = 23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9924 | E | Epoetin with hct = 24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9925 | E | Epoetin with hct = 25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9926 | E | Epoetin with hct = 26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9927 | E | Epoetin with hct = 27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9928 | E | Epoetin with hct = 28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9929 | E | Epoetin with hct = 29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9930 | E | Epoetin with hct = 30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9931 | E | Epoetin with hct = 31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9932 | E | Epoetin with hct = 32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9933 | E | Epoetin with hct = 33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9934 | E | Epoetin with hct = 34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9935 | E | Epoetin with hct = 35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9936 | E | Epoetin with hct = 36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9937 | E | Epoetin with hct = 37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9938 | E | Epoetin with hct = 38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9939 | E | Epoetin with hct = 39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| Q9940 | E | Epoetin with hct = 40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| R0070 | C | Transport portable x-ray | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| R0075 | C | Transport port x-ray multipl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| R0076 | B | Transport portable EKG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1000 | I | Private duty/independent nsg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1001 | I | Nursing assessment/evaluatn | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1002 | I | RN services up to 15 minutes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1003 | I | LPN/LVN services up to 15 min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1004 | I | Nsg aide service up to 15 min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1005 | I | Respite care service 15 min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1006 | I | Family/Couple Counseling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1007 | I | Treatment Plan Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1008 | I | Day Treatment for Individual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1009 | I | Child Sitting Services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1010 | I | Meals when Receive Services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1011 | I | Alcohol/Substance Abuse NOC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1012 | I | Alcohol/Substance Abuse Skil | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1013 | I | Sign Lang/Oral Interpreter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1014 | I | Telehealth transmit, per min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| T1015 | I | Clinic service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2020 | X | Vision svcs frames purchases | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2025 | N | Eyeglasses delux frames | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2100 | X | Lens spher single plano 4.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2101 | X | Single visn sphere 4.12-7.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2102 | X | Singl visn sphere 7.12-20.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2103 | X | Spherocylindr 4.00d/12-2.00d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2104 | X | Spherocylindr 4.00d/2.12-4d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2105 | X | Spherocylinder 4.00d/4.25-6d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2106 | X | Spherocylinder 4.00d/6.00d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2107 | X | Spherocylinder 4.25d/12-2d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2108 | X | Spherocylinder 4.25d/2.12-4d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2109 | X | Spherocylinder 4.25d/4.25-6d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2110 | X | Spherocylinder 4.25d/over 6d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2111 | X | Spherocylindr 7.25d/.25-2.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2112 | X | Spherocylindr 7.25d/2.25-4d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2113 | X | Spherocylindr 7.25d/4.25-6d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2114 | X | Spherocylinder over 12.00d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2115 | X | Lens lenticular bifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2116 | X | Nonaspheric lens bifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2117 | X | Aspheric lens bifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2118 | X | Lens aniseikonic single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2199 | X | Lens single vision not oth c | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2200 | X | Lens spher bifoc plano 4.00d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2201 | X | Lens sphere bifocal 4.12-7.0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2202 | X | Lens sphere bifocal 7.12-20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2203 | X | Lens sphcyl bifocal 4.00d/.1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2204 | X | Lens sphcy bifocal 4.00d/2.1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2205 | X | Lens sphcy bifocal 4.00d/4.2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2206 | X | Lens sphcy bifocal 4.00d/ove | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2207 | X | Lens sphcy bifocal 4.25-7d/ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2208 | X | Lens sphcy bifocal 4.25-7/2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2209 | X | Lens sphcy bifocal 4.25-7/4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2210 | X | Lens sphcy bifocal 4.25-7/ov | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2211 | X | Lens sphcy bifo 7.25-12/.25- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2212 | X | Lens sphcyl bifo 7.25-12/2.2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2213 | X | Lens sphcyl bifo 7.25-12/4.2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2214 | X | Lens sphcyl bifocal over 12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2215 | X | Lens lenticular bifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2216 | X | Lens lenticular nonaspheric | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2217 | X | Lens lenticular aspheric bif | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2218 | X | Lens aniseikonic bifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2219 | X | Lens bifocal seg width over | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2220 | X | Lens bifocal add over 3.25d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2299 | X | Lens bifocal speciality | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2300 | X | Lens sphere trifocal 4.00d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2301 | X | Lens sphere trifocal 4.12-7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2302 | X | Lens sphere trifocal 7.12-20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2303 | X | Lens sphcy trifocal 4.0/.12- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2304 | X | Lens sphcy trifocal 4.0/2.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2305 | X | Lens sphcy trifocal 4.0/4.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2306 | X | Lens sphcyl trifocal 4.00/6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2307 | X | Lens sphcy trifocal 4.25-7/ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2308 | X | Lens sphc trifocal 4.25-7/2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2309 | X | Lens sphc trifocal 4.25-7/4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2310 | X | Lens sphc trifocal 4.25-7/6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2311 | X | Lens sphc trifo 7.25-12/.25- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2312 | X | Lens sphc trifo 7.25-12/2.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2313 | X | Lens sphc trifo 7.25-12/4.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2314 | X | Lens sphcyl trifocal over 12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2315 | X | Lens lenticular trifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2316 | X | Lens lenticular nonaspheric | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2317 | X | Lens lenticular aspheric tri | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2318 | X | Lens aniseikonic trifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2319 | X | Lens trifocal seg width 28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2320 | X | Lens trifocal add over 3.25d | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2399 | X | Lens trifocal speciality | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2410 | X | Lens variab asphericity sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2430 | X | Lens variable asphericity bi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2499 | X | Variable asphericity lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2500 | X | Contact lens pmma spherical | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2501 | X | Cntct lens pmma-toric/prism | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2502 | X | Contact lens pmma bifocal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2503 | X | Cntct lens pmma color vision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2510 | X | Cntct gas permeable sphericl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2511 | X | Cntct toric prism ballast | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2512 | X | Cntct lens gas permbl bifocl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2513 | X | Contact lens extended wear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2520 | P | Contact lens hydrophilic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2521 | X | Cntct lens hydrophilic toric | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2522 | X | Cntct lens hydrophil bifocl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2523 | X | Cntct lens hydrophil extend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2530 | X | Contact lens gas impermeable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2531 | X | Contact lens gas permeable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2599 | X | Contact lens/es other type | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2600 | X | Hand held low vision aids | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2610 | X | Single lens spectacle mount | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2615 | X | Telescop/othr compound lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2623 | X | Plastic eye prosth custom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2624 | X | Polishing artifical eye | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2625 | X | Enlargemnt of eye prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2626 | X | Reduction of eye prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2627 | X | Scleral cover shell | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2628 | X | Fabrication fitting | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2629 | X | Prosthetic eye other type | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2630 | X | Anter chamber intraocul lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2631 | X | Iris support intraoclr lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2632 | X | Post chmbr intraocular lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2700 | X | Balance lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2710 | X | Glass/plastic slab off prism | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2715 | X | Prism lens/es | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2718 | X | Fresnell prism press-on lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2730 | X | Special base curve | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2740 | X | Rose tint plastic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2741 | X | Non-rose tint plastic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2742 | X | Rose tint glass | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2743 | X | Non-rose tint glass | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2744 | X | Tint photochromatic lens/es | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2750 | X | Anti-reflective coating | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2755 | X | UV lens/es | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2760 | X | Scratch resistant coating | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2770 | X | Occluder lens/es | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2780 | X | Oversize lens/es | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2781 | X | Progressive lens per lens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2785 | X | Corneal tissue processing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2790 | X | Amniotic membrane | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V2799 | X | Miscellaneous vision service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5008 | N | Hearing screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5010 | N | Assessment for hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5011 | N | Hearing aid fitting/checking | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5014 | N | Hearing aid repair/modifying | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5020 | N | Conformity evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5030 | N | Body-worn hearing aid air | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5040 | N | Body-worn hearing aid bone | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5050 | N | Hearing aid monaural in ear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5060 | N | Behind ear hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5070 | N | Glasses air conduction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5080 | N | Glasses bone conduction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5090 | N | Hearing aid dispensing fee | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5100 | N | Body-worn bilat hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5110 | N | Hearing aid dispensing fee | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5120 | N | Body-worn binaur hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5130 | N | In ear binaural hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5140 | N | Behind ear binaur hearing ai | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5150 | N | Glasses binaural hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5160 | N | Dispensing fee binaural | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5170 | N | Within ear cros hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5180 | N | Behind ear cros hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5190 | N | Glasses cros hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5200 | N | Cros hearing aid dispens fee | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5210 | N | In ear bicros hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5220 | N | Behind ear bicros hearing ai | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5230 | N | Glasses bicros hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5240 | N | Dispensing fee bicros | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5241 | N | Dispensing fee, monaural | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5242 | N | Hearing aid, monaural, cic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5243 | N | Hearing aid, monaural, itc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5244 | N | Hearing aid, prog, mon, cic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5245 | N | Hearing aid, prog, mon, itc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5246 | N | Hearing aid, prog, mon, ite | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5247 | N | Hearing aid, prog, mon, bte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5248 | N | Hearing aid, binaural, cic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5249 | N | Hearing aid, binaural, itc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5250 | N | Hearing aid, prog, bin, cic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5251 | N | Hearing aid, prog, bin, itc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5252 | N | Hearing aid, prog, bin, ite | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5253 | N | Hearing aid, prog, bin, bte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5254 | N | Hearing aid, digit, mon, cic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5255 | N | Hearing aid, digit, mon, itc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5256 | N | Hearing aid, digit, mon, ite | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5257 | N | Hearing aid, digit, mon, bte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5258 | N | Hearing aid, digit, bin, cic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5259 | N | Hearing aid, digit, bin, itc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5260 | N | Hearing aid, digit, bin, ite | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5261 | N | Hearing aid, digit, bin, bte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5262 | N | Hearing aid, disp, monaural | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5263 | N | Hearing aid, disp, binaural | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5264 | N | Ear mold/insert | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5265 | N | Ear mold/insert, disp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5266 | N | Battery for hearing device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5267 | N | Hearing aid supply/accessory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5268 | N | ALD Telephone Amplifier | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5269 | N | Alerting device, any type | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5270 | N | ALD, TV amplifier, any type | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5271 | N | ALD, TV caption decoder | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5272 | N | Tdd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5273 | N | ALD for cochlear implant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5274 | N | ALD unspecified | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5275 | N | Ear impression | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5299 | R | Hearing service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5336 | N | Repair communication device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5362 | R | Speech screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5363 | R | Language screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| V5364 | R | Dysphagia screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | ||||||||||||
| 1 CPT codes and descriptions only are copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. | |||||||||||||||||||||
| 2 Copyright 1994 American Dental Association. All rights reserved. | |||||||||||||||||||||
| 3 +Indicates RVUs are not used for Medicare payment. | |||||||||||||||||||||
| CPT1 /HCPCS2 | MOD | Status | Description | Physician Work RVUs3 | Fully implemented non-facility PE RVUs | Fully implemented facility PE RVUs | Mal- practice RVUs | Fully implemented non-facility total | Fully implemented facility total | Global |
|---|---|---|---|---|---|---|---|---|---|---|
| 11981 | A | Insert drug implant device | 1.48 | 1.58 | 0.59 | 0.14 | 3.20 | 2.21 | XXX | |
| 11982 | A | Remove drug implant device | 1.78 | 1.70 | 0.71 | 0.17 | 3.65 | 2.66 | XXX | |
| 11983 | A | Remove/insert drug implant | 3.30 | 2.31 | 1.32 | 0.31 | 5.92 | 4.93 | XXX | |
| 20526 | A | Ther injection carpal tunnel | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | |
| 20551 | A | Inject tendon origin/insert | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | |
| 20552 | A | Inject trigger point, 1 or 2 | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | |
| 20553 | A | Inject trigger points, 3 | 0.86 | 0.78 | 0.39 | 0.06 | 1.70 | 1.31 | 000 | |
| 24300 | A | Manipulate elbow w/anesth | 3.75 | NA | 5.46 | 0.52 | NA | 9.73 | 090 | |
| 24332 | A | Tenolysis, triceps | 7.45 | NA | 5.23 | 0.77 | NA | 13.45 | 090 | |
| 24343 | A | Repr elbow lat ligmnt w/tiss | 8.65 | NA | 7.91 | 1.21 | NA | 17.77 | 090 | |
| 24344 | A | Reconstruct elbow lat ligmnt | 14.00 | NA | 10.87 | 1.95 | NA | 26.82 | 090 | |
| 24345 | A | Repr elbw med ligmnt w/tiss | 8.65 | NA | 7.91 | 1.21 | NA | 17.77 | 090 | |
| 24346 | A | Reconstruct elbow med ligmnt | 14.00 | NA | 10.87 | 1.95 | NA | 26.82 | 090 | |
| 25001 | A | Incise flexor carpi radialis | 3.38 | NA | 4.30 | 0.45 | NA | 8.13 | 090 | |
| 25024 | A | Decompress forearm 2 spaces | 9.50 | NA | 8.17 | 1.20 | NA | 18.87 | 090 | |
| 25025 | A | Decompress forearm 2 spaces | 16.54 | NA | 12.05 | 1.91 | NA | 30.50 | 090 | |
| 25259 | A | Manipulate wrist w/anesthes | 3.75 | NA | 5.35 | 0.52 | NA | 9.62 | 090 | |
| 25275 | A | Repair forearm tendon sheath | 8.50 | NA | 7.53 | 1.11 | NA | 17.14 | 090 | |
| 25394 | A | Repair carpal bone, shorten | 10.40 | NA | 8.43 | 1.15 | NA | 19.98 | 090 | |
| 25430 | A | Vasc graft into carpal bone | 9.25 | NA | 7.82 | 0.56 | NA | 17.63 | 090 | |
| 25431 | A | Repair nonunion carpal bone | 10.44 | NA | 6.42 | 0.56 | NA | 17.42 | 090 | |
| 25651 | A | Pin ulnar styloid fracture | 5.36 | NA | 4.39 | 0.73 | NA | 10.48 | 090 | |
| 25652 | A | Treat fracture ulnar styloid | 7.60 | NA | 6.90 | 0.97 | NA | 15.47 | 090 | |
| 25671 | A | Pin radioulnar dislocation | 6.00 | NA | 6.02 | 0.75 | NA | 12.77 | 090 | |
| 26340 | A | Manipulate finger w/anesth | 2.50 | NA | 4.53 | 0.32 | NA | 7.35 | 090 | |
| 26587 | A | Reconstruct extra finger | 14.05 | 4.67 | NA | 1.08 | 19.80 | NA | 090 | |
| 28299 | A | Correction of bunion | 10.58 | 11.55 | 9.21 | 1.24 | 23.37 | 21.03 | 090 | |
| 29086 | A | Apply finger cast | 0.62 | 0.81 | 0.50 | 0.07 | 1.50 | 1.19 | 000 | |
| 29805 | A | Shoulder arthroscopy, dx | 5.89 | 3.23 | 3.23 | 0.83 | 9.95 | 9.95 | 090 | |
| 29806 | A | Shoulder arthroscopy/surgery | 14.37 | NA | 11.33 | 2.01 | NA | 27.71 | 090 | |
| 29807 | A | Shoulder arthroscopy/surgery | 13.90 | NA | 11.06 | 2.01 | NA | 26.97 | 090 | |
| 29824 | A | Shoulder arthroscopy/surgery | 8.25 | NA | 7.48 | 1.16 | NA | 16.89 | 090 | |
| 29900 | A | Mcp joint arthroscopy, dx | 5.42 | NA | 5.88 | 0.69 | NA | 11.99 | 090 | |
| 29901 | A | Mcp joint arthroscopy, surg | 6.13 | NA | 6.28 | 0.81 | NA | 13.22 | 090 | |
| 29902 | A | Mcp joint arthroscopy, surg | 6.70 | NA | 6.60 | 0.89 | NA | 14.19 | 090 | |
| 33967 | A | Insert ia percut device | 4.85 | 2.01 | 1.96 | 0.27 | 7.13 | 7.08 | 000 | |
| 33979 | C | Insert intracorporeal device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 33980 | C | Remove intracorporeal device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
| 35646 | A | Artery bypass graft | 31.00 | NA | 13.26 | 2.98 | NA | 47.24 | 090 | |
| 35647 | A | Artery bypass graft | 28.00 | NA | 11.97 | 2.98 | NA | 42.95 | 090 | |
| 35685 | A | Bypass graft patency/patch | 4.05 | NA | 1.50 | 0.41 | NA | 5.96 | ZZZ | |
| 35686 | A | Bypass graft/av fist patency | 3.35 | NA | 1.24 | 0.34 | NA | 4.93 | ZZZ | |
| 36002 | A | Pseudoaneurysm injection trt | 1.96 | 2.95 | 1.03 | 0.08 | 4.99 | 3.07 | 000 | |
| 36400 | A | Drawing blood | 0.38 | 0.72 | 0.10 | 0.01 | 1.11 | 0.49 | XXX | |
| 36820 | A | Av fusion/forearm vein | 14.00 | NA | 6.56 | 1.53 | NA | 22.09 | 090 | |
| 43239 | A | Upper GI endoscopy, biopsy | 2.87 | 6.79 | 1.27 | 0.14 | 9.80 | 4.28 | 000 | |
| 43313 | A | Esophagoplasty congential | 45.28 | NA | 22.01 | 5.43 | NA | 72.72 | 090 | |
| 43314 | A | Tracheo-esophagoplasty cong | 50.27 | NA | 24.07 | 5.53 | NA | 79.87 | 090 | |
| 44120 | A | Removal of small intestine | 17.00 | NA | 7.67 | 1.46 | NA | 26.13 | 090 | |
| 44126 | A | Enterectomy w/taper, cong | 35.50 | NA | 18.03 | 0.36 | NA | 53.89 | 090 | |
| 44127 | A | Enterectomy w/o taper, cong | 41.00 | NA | 20.56 | 0.41 | NA | 61.97 | 090 | |
| 44128 | A | Enterectomy cong, add-on | 4.45 | NA | 1.78 | 0.45 | NA | 6.68 | ZZZ | |
| 44160 | A | Removal of colon | 18.62 | NA | 8.65 | 1.55 | NA | 28.82 | 090 | |
| 44203 | A | Lap resect s/intestine, addl | 4.45 | NA | 1.60 | 0.45 | NA | 6.50 | ZZZ | |
| 44204 | A | Laparo partial colectomy | 25.08 | NA | 10.46 | 1.83 | NA | 37.37 | 090 | |
| 44205 | A | Lap colectomy part w/ileum | 22.23 | NA | 9.31 | 1.55 | NA | 33.09 | 090 | |
| 45136 | A | Excise ileoanal reservoir | 27.30 | NA | 12.66 | 2.19 | NA | 42.15 | 090 | |
| 45380 | A | Colonoscopy and biopsy | 4.44 | 9.28 | 2.05 | 0.21 | 13.93 | 6.70 | 000 | |
| 46020 | A | Placement of seton | 2.90 | 3.09 | 2.36 | 0.22 | 6.21 | 5.48 | 010 | |
| 47370 | A | Laparo ablate liver tumor rf | 18.00 | 7.19 | 7.19 | 0.85 | 26.04 | 26.04 | 090 | |
| 47371 | A | Laparo ablate liver cryosug | 16.94 | 6.76 | 6.76 | 0.85 | 24.55 | 24.55 | 090 | |
| 47380 | A | Open ablate liver tumor rf | 21.25 | 8.48 | 8.48 | 0.85 | 30.58 | 30.58 | 090 | |
| 47381 | A | Open ablate liver tumor cryo | 21.00 | 8.38 | 8.38 | 0.85 | 30.23 | 30.23 | 090 | |
| 47382 | A | Percut ablate liver rf | 12.00 | NA | 5.37 | 0.85 | NA | 18.22 | 010 | |
| 49491 | A | Repairing hern premie reduc | 11.13 | NA | 5.65 | 1.00 | NA | 17.78 | 090 | |
| 49492 | A | Rpr ing hern premie, blocked | 14.03 | NA | 6.40 | 1.42 | NA | 21.85 | 090 | |
| 52001 | A | Cystoscopy, removal of clots | 2.37 | NA | 0.98 | 0.32 | NA | 3.67 | 000 | |
| 52347 | A | Cystoscopy, resect ducts | 5.28 | NA | 2.14 | 0.33 | NA | 7.75 | 000 | |
| 53431 | A | Reconstruct urethra/bladder | 19.89 | 7.94 | 7.94 | 1.25 | 29.08 | 29.08 | 090 | |
| 53444 | A | Insert tandem cuff | 13.40 | NA | 6.66 | 0.79 | NA | 20.85 | 090 | |
| 53446 | A | Remove uro sphincter | 10.23 | NA | 8.46 | 0.61 | NA | 19.30 | 090 | |
| 53447 | A | Remove/replace ur sphincter | 13.49 | NA | 7.90 | 0.79 | NA | 22.18 | 090 | |
| 53448 | A | Remov/replc ur sphinctr comp | 21.15 | NA | 12.35 | 1.27 | NA | 34.77 | 090 | |
| 53853 | A | Prostatic water thermother | 4.14 | 52.75 | 2.55 | 0.38 | 57.27 | 7.07 | 090 | |
| 54162 | A | Lysis penil circumcis lesion | 3.00 | NA | 2.91 | 0.18 | NA | 6.09 | 010 | |
| 54163 | A | Repair of circumcision | 3.00 | NA | 2.54 | 0.18 | NA | 5.72 | 010 | |
| 54164 | A | Frenulotomy of penis | 2.50 | NA | 2.37 | 0.15 | NA | 5.02 | 010 | |
| 54406 | A | Remove multi-comp penis pros | 12.10 | NA | 6.09 | 0.80 | NA | 18.99 | 090 | |
| 54408 | A | Repair multi-comp penis pros | 12.75 | NA | 6.46 | 0.80 | NA | 20.01 | 090 | |
| 54410 | A | Remove/replace penis prosth | 15.50 | NA | 7.36 | 0.80 | NA | 23.66 | 090 | |
| 54411 | A | Remv/replc penis pros, comp | 16.00 | NA | 8.98 | 0.80 | NA | 25.78 | 090 | |
| 54415 | A | Remove self-contd penis pros | 8.20 | NA | 5.35 | 0.55 | NA | 14.10 | 090 | |
| 54416 | A | Remv/repl penis contain pros | 10.87 | NA | 6.94 | 0.55 | NA | 18.36 | 090 | |
| 54417 | A | Remv/replc penis pros, compl | 14.19 | NA | 7.89 | 0.55 | NA | 22.63 | 090 | |
| 56605 | A | Biopsy of vulva/perineum | 1.10 | 1.90 | 0.50 | 0.11 | 3.11 | 1.71 | 000 | |
| 56810 | A | Repair of perineum | 4.13 | NA | 2.91 | 0.41 | NA | 7.45 | 010 | |
| 57155 | A | Insert uteri tandems/ovoids | 6.27 | NA | 3.67 | 0.63 | NA | 10.57 | 090 | |
| 58100 | A | Biopsy of uterus lining | 1.53 | 1.56 | 0.76 | 0.07 | 3.16 | 2.36 | 000 | |
| 58346 | A | Insert heyman uteri capsule | 6.75 | NA | 3.84 | 0.68 | NA | 11.27 | 090 | |
| 58953 | A | Tah, rad dissect for debulk | 32.00 | NA | 15.59 | 3.20 | NA | 50.79 | 090 | |
| 58954 | A | Tah, rad debulk/lymph remove | 35.00 | NA | 16.71 | 3.50 | NA | 55.21 | 090 | |
| 59001 | A | Amniocentesis, therapeutic | 3.00 | NA | 1.37 | 0.23 | NA | 4.60 | 000 | |
| 64561 | A | Implant neuroelectrodes | 6.74 | 15.28 | 3.83 | 0.11 | 22.13 | 10.68 | 010 | |
| 64581 | A | Implant neuroelectrodes | 13.50 | NA | 6.72 | 0.37 | NA | 20.59 | 090 | |
| 64821 | A | Remove sympathetic nerves | 8.75 | NA | 7.09 | 0.99 | NA | 16.83 | 090 | |
| 64822 | A | Remove sympathetic nerves | 8.75 | NA | 7.09 | 0.99 | NA | 16.83 | 090 | |
| 64823 | A | Remove sympathetic nerves | 10.37 | NA | 7.89 | 1.17 | NA | 19.43 | 090 | |
| 67225 | A | Eye photodynamic ther add-on | 0.47 | 0.24 | 0.19 | 0.50 | 1.21 | 1.16 | ZZZ | |
| 76085 | A | Computer mammogram add-on | 0.06 | 0.31 | NA | 0.02 | 0.39 | NA | ZZZ | |
| 76092 | A | Mammogram, screening | 0.70 | 1.44 | NA | 0.09 | 2.23 | NA | XXX | |
| 76362 | A | Cat scan for tissue ablation | 4.00 | 9.24 | NA | 1.38 | 14.62 | NA | XXX | |
| 76394 | A | Mri for tissue ablation | 4.25 | 12.13 | NA | 1.43 | 17.81 | NA | XXX | |
| 76490 | A | Us for tissue ablation | 2.00 | 2.13 | NA | 0.36 | 4.49 | NA | XXX | |
| 76819 | A | Fetal biophys profil w/o nst | 0.77 | 1.83 | NA | 0.10 | 2.70 | NA | XXX | |
| 77301 | A | Radioltherapy dos plan, imrt | 8.00 | 29.72 | NA | 1.41 | 39.13 | NA | XXX | |
| 77418 | A | Radiation tx delivery, imrt | 0.00 | 16.07 | NA | 0.11 | 16.18 | NA | XXX | |
| 88380 | C | Microdissection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 90471 | A | Immunization admin | 0.00 | 0.10 | NA | 0.01 | 0.11 | NA | XXX | |
| 90472 | A | Immunization admin, each add | 0.00 | 0.10 | NA | 0.01 | 0.11 | NA | ZZZ | |
| 90473 | N | Immune admin oral/nasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 90474 | N | Immune admin oral/nasal addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
| 90939 | X | Hemodialysis study, transcut | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 91123 | B | Irrigate fecal impaction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 92136 | A | Ophthalmic biometry | 0.54 | 1.52 | NA | 0.07 | 2.13 | NA | XXX | |
| 92973 | A | Percut coronary thrombectomy | 3.28 | NA | 1.37 | 0.17 | NA | 4.82 | ZZZ | |
| 92974 | A | Cath place, cardio brachytx | 3.00 | NA | 1.26 | 1.18 | NA | 5.44 | ZZZ | |
| 93025 | A | Microvolt t-wave assess | 0.75 | 6.42 | NA | 0.11 | 7.28 | NA | XXX | |
| 93609 | A | Map tachycardia, add-on | 4.81 | 4.59 | NA | 0.66 | 10.06 | NA | ZZZ | |
| 93613 | C | Electrophys map, 3d, add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 93621 | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
| 93622 | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
| 93701 | A | Bioimpedance, thoracic | 0.17 | 0.78 | NA | 0.02 | 0.97 | NA | XXX | |
| 95250 | A | Glucose monitoring, cont | 0.00 | 1.44 | NA | 0.01 | 1.45 | NA | XXX | |
| 95875 | A | Limb exercise test | 1.10 | 1.38 | NA | 0.09 | 2.57 | NA | XXX | |
| 95965 | C | Meg, spontaneous | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 95966 | C | Meg, evoked, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 95967 | C | Meg, evoked, each addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
| 96000 | A | Motion analysis, video/3d | 1.80 | NA | 0.72 | 0.02 | NA | 2.54 | XXX | |
| 96001 | A | Motion test w/ft press meas | 2.15 | NA | 0.86 | 0.02 | NA | 3.03 | XXX | |
| 96002 | A | Dynamic surface emg | 0.41 | NA | 0.16 | 0.02 | NA | 0.59 | XXX | |
| 96003 | A | Dynamic fine wire emg | 0.37 | NA | 0.15 | 0.03 | NA | 0.55 | XXX | |
| 96004 | A | Phys review of motion tests | 1.80 | 0.72 | 0.72 | 0.08 | 2.60 | 2.60 | XXX | |
| 96150 | A | Assess hlth/behave, init | 0.50 | 0.21 | 0.20 | 0.02 | 0.73 | 0.72 | XXX | |
| 96151 | A | Assess hlth/behave, subseq | 0.48 | 0.21 | 0.19 | 0.02 | 0.71 | 0.69 | XXX | |
| 96152 | A | Intervene hlth/behave, indiv | 0.46 | 0.20 | 0.18 | 0.02 | 0.68 | 0.66 | XXX | |
| 96153 | A | Intervene hlth/behave, group | 0.10 | 0.04 | 0.04 | 0.01 | 0.15 | 0.15 | XXX | |
| 96154 | A | Interv hlth/behav, fam w/pt | 0.45 | 0.19 | 0.18 | 0.02 | 0.66 | 0.65 | XXX | |
| 96155 | A | Interv hlth/behav fam no pt | 0.44 | 0.18 | 0.18 | 0.02 | 0.64 | 0.64 | XXX | |
| 96567 | A | Photodynamic tx, skin | 0.00 | 1.63 | NA | 0.03 | 1.66 | NA | XXX | |
| 97602 | B | Wound(s) care non-selective | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 97802 | A | Medical nutrition, indiv, in | 0.00 | 0.45 | 0.45 | 0.01 | 0.46 | 0.46 | XXX | |
| 97803 | A | Med nutrition, indiv, subseq | 0.00 | 0.45 | 0.45 | 0.01 | 0.46 | 0.46 | XXX | |
| 97804 | A | Medical nutrition, group | 0.00 | 0.17 | 0.17 | 0.01 | 0.18 | 0.18 | XXX | |
| 99091 | B | Collect/review data from pt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 99289 | I | Pt transport, 30-74 min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
| 99290 | I | Pt transport, addl 30 min | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
| G0117 | T | Glaucoma scrn hgh risk direc | 0.45 | 0.97 | 0.22 | 0.02 | 1.44 | 0.69 | XXX | |
| G0118 | T | Glaucoma scrn hgh risk direc | 0.17 | 0.84 | 0.08 | 0.01 | 1.02 | 0.26 | XXX | |
| G0202 | 26 | A | Screeningmammographydigital | 0.70 | 0.28 | 0.28 | 0.03 | 1.01 | 1.01 | XXX |
| G0204 | 26 | A | Diagnosticmammographydigital | 0.87 | 0.35 | 0.35 | 0.03 | 1.25 | 1.25 | XXX |
| G0206 | 26 | A | Diagnosticmammographydigital | 0.70 | 0.28 | 0.28 | 0.03 | 1.01 | 1.01 | XXX |
| G0236 | 26 | A | digital film convert diag ma | 0.06 | 0.02 | 0.02 | 0.01 | 0.09 | 0.09 | ZZZ |
| 1 CPT codes and descriptions only are copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. | ||||||||||
| 2 Copyright 1994 American Dental Association. All rights reserved. | ||||||||||
| 3 + Indicates RVUs are not used for Medicare payment. | ||||||||||
| Carrier No. | Locality No. | Locality name | Work | Practice expense | Malpractice |
|---|---|---|---|---|---|
| 00510 | 00 | ALABAMA | 0.978 | 0.870 | 0.807 |
| 00831 | 01 | ALASKA | 1.064 | 1.172 | 1.223 |
| 00832 | 00 | ARIZONA | 0.994 | 0.978 | 1.111 |
| 00520 | 13 | ARKANSAS | 0.953 | 0.847 | 0.340 |
| 31146 | 26 | ANAHEIM/SANTA ANA, CA | 1.037 | 1.184 | 0.955 |
| 31146 | 18 | LOS ANGELES, CA | 1.056 | 1.139 | 0.955 |
| 31140 | 03 | MARIN/NAPA/SOLANO, CA | 1.015 | 1.248 | 0.687 |
| 31140 | 07 | OAKLAND/BERKELEY, CA | 1.041 | 1.235 | 0.687 |
| 31140 | 05 | SAN FRANCISCO, CA | 1.068 | 1.458 | 0.687 |
| 31140 | 06 | SAN MATEO, CA | 1.048 | 1.432 | 0.687 |
| 31140 | 09 | SANTA CLARA, CA | 1.063 | 1.380 | 0.639 |
| 31146 | 17 | VENTURA, CA | 1.028 | 1.125 | 0.783 |
| 31146 | 99 | REST OF CALIFORNIA* | 1.007 | 1.034 | 0.748 |
| 31140 | 99 | REST OF CALIFORNIA* | 1.007 | 1.034 | 0.748 |
| 00824 | 01 | COLORADO | 0.985 | 0.992 | 0.840 |
| 00591 | 00 | CONNECTICUT | 1.050 | 1.156 | 0.966 |
| 00902 | 01 | DELAWARE | 1.019 | 1.035 | 0.712 |
| 00903 | 01 | DC + MD/VA SUBURBS | 1.050 | 1.166 | 0.909 |
| 00590 | 03 | FORT LAUDERDALE, FL | 0.996 | 1.018 | 1.877 |
| 00590 | 04 | MIAMI, FL | 1.015 | 1.052 | 2.528 |
| 00590 | 99 | REST OF FLORIDA | 0.975 | 0.946 | 1.265 |
| 00511 | 01 | ATLANTA, GA | 1.006 | 1.059 | 0.935 |
| 00511 | 99 | REST OF GEORGIA | 0.970 | 0.892 | 0.935 |
| 00833 | 01 | HAWAII/GUAM | 0.997 | 1.124 | 0.834 |
| 05130 | 00 | IDAHO | 0.960 | 0.881 | 0.497 |
| 00952 | 16 | CHICAGO, IL | 1.028 | 1.092 | 1.797 |
| 00952 | 12 | EAST ST. LOUIS, IL | 0.988 | 0.924 | 1.691 |
| 00952 | 15 | SUBURBAN CHICAGO, IL | 1.006 | 1.071 | 1.645 |
| 00952 | 99 | REST OF ILLINOIS | 0.964 | 0.889 | 1.157 |
| 00630 | 00 | INDIANA | 0.981 | 0.922 | 0.481 |
| 00826 | 00 | IOWA | 0.959 | 0.876 | 0.596 |
| 00650 | 00 | KANSAS* | 0.963 | 0.895 | 0.756 |
| 00740 | 04 | KANSAS* | 0.963 | 0.895 | 0.756 |
| 00660 | 00 | KENTUCKY | 0.970 | 0.866 | 0.877 |
| 00528 | 01 | NEW ORLEANS, LA | 0.998 | 0.945 | 1.283 |
| 00528 | 99 | REST OF LOUISIANA | 0.968 | 0.870 | 1.073 |
| 31142 | 03 | SOUTHERN MAINE | 0.979 | 0.999 | 0.666 |
| 31142 | 99 | REST OF MAINE | 0.961 | 0.910 | 0.666 |
| 00901 | 01 | BALTIMORE/SURR. CNTYS, MD | 1.021 | 1.038 | 0.916 |
| 00901 | 99 | REST OF MARYLAND | 0.984 | 0.972 | 0.774 |
| 31143 | 01 | METROPOLITAN BOSTON | 1.041 | 1.239 | 0.784 |
| 31143 | 99 | REST OF MASSACHUSETTS | 1.010 | 1.129 | 0.784 |
| 00953 | 01 | DETROIT, MI | 1.043 | 1.038 | 2.738 |
| 00953 | 99 | REST OF MICHIGAN | 0.997 | 0.938 | 1.571 |
| 00954 | 00 | MINNESOTA | 0.990 | 0.974 | 0.452 |
| 00512 | 00 | MISSISSIPPI | 0.957 | 0.837 | 0.779 |
| 00740 | 02 | METROPOLITAN KANSAS CITY, MO | 0.988 | 0.967 | 0.846 |
| 00523 | 01 | METROPOLITAN ST. LOUIS, MO | 0.994 | 0.938 | 0.846 |
| 00740 | 99 | REST OF MISSOURI* | 0.946 | 0.825 | 0.793 |
| 00523 | 99 | REST OF MISSOURI* | 0.946 | 0.825 | 0.793 |
| 00751 | 01 | MONTANA | 0.950 | 0.876 | 0.727 |
| 00655 | 00 | NEBRASKA | 0.948 | 0.877 | 0.430 |
| 00834 | 00 | NEVADA | 1.005 | 1.039 | 1.209 |
| 31144 | 40 | NEW HAMPSHIRE | 0.986 | 1.030 | 0.825 |
| 00805 | 01 | NORTHERN NJ | 1.058 | 1.193 | 0.860 |
| 00805 | 99 | REST OF NEW JERSEY | 1.029 | 1.110 | 0.860 |
| 00521 | 05 | NEW MEXICO | 0.973 | 0.900 | 0.902 |
| 00803 | 01 | MANHATTAN, NY | 1.094 | 1.351 | 1.668 |
| 00803 | 02 | NYC SUBURBS/LONG I., NY | 1.068 | 1.251 | 1.952 |
| 00803 | 03 | POUGHKPSIE/N NYC SUBURBS, NY | 1.011 | 1.075 | 1.275 |
| 14330 | 04 | QUEENS, NY | 1.058 | 1.228 | 1.871 |
| 00801 | 99 | REST OF NEW YORK | 0.998 | 0.944 | 0.764 |
| 05535 | 00 | NORTH CAROLINA | 0.970 | 0.931 | 0.595 |
| 00820 | 01 | NORTH DAKOTA | 0.950 | 0.880 | 0.657 |
| 16360 | 00 | OHIO | 0.988 | 0.944 | 0.957 |
| 00522 | 00 | OKLAHOMA | 0.968 | 0.876 | 0.444 |
| 00835 | 01 | PORTLAND, OR | 0.996 | 1.049 | 0.436 |
| 00835 | 99 | REST OF OREGON | 0.961 | 0.933 | 0.436 |
| 00865 | 01 | METROPOLITAN PHILADELPHIA, PA | 1.023 | 1.092 | 1.413 |
| 00865 | 99 | REST OF PENNSYLVANIA | 0.989 | 0.929 | 0.774 |
| 00973 | 20 | PUERTO RICO | 0.881 | 0.712 | 0.275 |
| 00870 | 01 | RHODE ISLAND | 1.017 | 1.065 | 0.883 |
| 00880 | 01 | SOUTH CAROLINA | 0.974 | 0.904 | 0.279 |
| 00820 | 02 | SOUTH DAKOTA | 0.935 | 0.878 | 0.406 |
| 05440 | 35 | TENNESSEE | 0.975 | 0.900 | 0.592 |
| 00900 | 31 | AUSTIN, TX | 0.986 | 0.996 | 0.859 |
| 00900 | 20 | BEAUMONT, TX | 0.992 | 0.890 | 1.338 |
| 00900 | 09 | BRAZORIA, TX | 0.992 | 0.978 | 1.338 |
| 00900 | 11 | DALLAS, TX | 1.010 | 1.065 | 0.931 |
| 00900 | 28 | FORT WORTH, TX | 0.987 | 0.981 | 0.931 |
| 00900 | 15 | GALVESTON, TX | 0.988 | 0.969 | 1.338 |
| 00900 | 18 | HOUSTON, TX | 1.020 | 1.007 | 1.336 |
| 00900 | 99 | REST OF TEXAS | 0.966 | 0.880 | 0.956 |
| 00910 | 09 | UTAH | 0.976 | 0.941 | 0.644 |
| 31145 | 50 | VERMONT | 0.973 | 0.986 | 0.539 |
| 00973 | 50 | VIRGIN ISLANDS | 0.965 | 1.023 | 1.002 |
| 00904 | 00 | VIRGINIA | 0.984 | 0.938 | 0.500 |
| 00836 | 02 | SEATTLE (KING CNTY), WA | 1.005 | 1.100 | 0.788 |
| 00836 | 99 | REST OF WASHINGTON | 0.981 | 0.972 | 0.788 |
| 16510 | 16 | WEST VIRGINIA | 0.963 | 0.850 | 1.378 |
| 00951 | 00 | WISCONSIN | 0.981 | 0.929 | 0.939 |
| 00825 | 21 | WYOMING | 0.967 | 0.895 | 1.005 |
| * Payment locality is serviced by two carriers. | |||||
| Note: Work GPCI reflects only 1⁄4 work GPCI in accordance with section 1848(e)(1)(A)(iii) of the Social Security Act. GPCIs rescaled by the following factors for budget neutrality: Work = 0.99699; Practice Expense = 0.99235; Malpractice Expense = 1.00215. | |||||
| CLINICAL LABORATORY SERVICES | |
| INCLUDE CPT codes for all clinical laboratory services in the 80000 series, except EXCLUDE CPT codes for the following blood component collection services: | |
| 86890 | Autologous blood process |
| 86891 | Autologous blood, op salvage |
| 86915 | Bone marrow/stem cell prep |
| 86927 | Plasma, fresh frozen |
| 86930 | Frozen blood prep |
| 86931 | Frozen blood thaw |
| 86932 | Frozen blood freeze/thaw |
| 86945 | Blood product/irradiation |
| 86950 | Leukacyte transfusion |
| 86965 | Pooling blood platelets |
| 86985 | Split blood or products |
| INCLUDE the following HCPCS level 2 codes for other clinical laboratory services: | |
| G0001 | Drawing blood for specimen |
| G0026 | Fecal leukocyte examination |
| G0027 | Semen analysis |
| G0103 | Psa, total screening |
| G0107 | CA screen; fecal blood test |
| G0123 | Screen cerv/vag thin layer |
| G0124 | Screen c/v thin layer by MD |
| G0141 | Scr c/v cyto,autosys and md |
| G0143-G0145 | Scr c/v cyto,thinlayer, rescr |
| G0147 | Scr c/v cyto, automated sys |
| G0148 | Scr c/v cyto, autosys, rescr |
| P2028 | Cephalin floculation test |
| P2029 | Congo red blood test |
| P2031 | Hair analysis |
| P2033 | Blood thymol turbidity |
| P2038 | Blood mucoprotein |
| P3000 | Screen pap by tech w md supv |
| P3001 | Screening pap smear by phys |
| P7001 | Culture bacterial urine |
| P9612 | Catheterize for urine spec |
| P9615 | Urine specimen collect mult |
| Q0111 | Wet mounts/w preparations |
| Q0112 | Potassium hydroxide preps |
| Q0113 | Pinworm examinations |
| Q0114 | Fern test |
| Q0115 | Post-coital mucous exam |
| PHYSICAL THERAPY/OCCUPATIONAL THERAPY/SPEECH-LANGUAGE PATHOLOGY | |
| INCLUDE the following CPT codes for the physical therapy/occupational therapy/speech-language pathology services in the 97000 series: | |
| 97001 | Pt evaluation |
| 97002 | Pt re-evaluation |
| 97003 | Ot evaluation |
| 97004 | Ot re-evaluation |
| 97010 | Hot or cold packs therapy |
| 97012 | Mechanical traction therapy |
| 97014 | Electric stimulation therapy |
| 97016 | Vasopneumatic device therapy |
| 97018 | Paraffin bath therapy |
| 97020 | Microwave therapy |
| 97022 | Whirlpool therapy |
| 97024 | Diathermy treatment |
| 97026 | Infrared therapy |
| 97028 | Ultraviolet therapy |
| 97032 | Electrical stimulation |
| 97033 | Electric current therapy |
| 97034 | Contrast bath therapy |
| 97035 | Ultrasound therapy |
| 97036 | Hydrotherapy |
| 97039 | Physical therapy treatment |
| 97110 | Therapeutic exercises |
| 97112 | Neuromuscular reeducation |
| 97113 | Aquatic therapy/exercises |
| 97116 | Gait training therapy |
| 97124 | Massage therapy |
| 97139 | Physical medicine procedure |
| 97140 | Manual therapy |
| 97150 | Group therapeutic procedures |
| 97504 | Orthotic training |
| 97520 | Prosthetic training |
| 97530 | Therapeutic activities |
| 97532 | Cognitive skills development |
| 97533 | Sensory integration |
| 97535 | Self care mngment training |
| 97537 | Community/work reintegration |
| 97542 | Wheelchair mngment training |
| 97545 | Work hardening |
| 97546 | Work hardening add-on |
| 97703 | Prosthetic checkout |
| 97750 | Physical performance test |
| 97799 | Physical medicine procedure |
| INCLUDE CPT codes for physical therapy/occupational therapy/speech-language pathology services not in the 97000 series: | |
| 64550 | Apply neurostimulator |
| 90901 | Biofeedback train, any meth |
| 90911 | Biofeedback peri/uro/rectal |
| 92506 | Speech/hearing evaluation |
| 92507-92508 | Speech/hearing therapy |
| 92510 | Rehab for ear implant |
| 92526 | Oral function therapy |
| 93797 | Cardiac rehab |
| 93798 | Cardiac rehab/monitor |
| 94667-94668 | Chest wall manipulation |
| 94762 | Measure blood oxygen level |
| 95831 | Limb muscle testing, manual |
| 95832 | Hand muscle testing, manual |
| 95833-95834 | Body muscle testing, manual |
| 95851-95852 | Range of motion measurements |
| 96000 | Motion analysis, video/3d |
| 96001 | Motion test w/ft press meas |
| 96002 | Dynamic surface emg |
| 96003 | Dynamic fine wire emg |
| 96105 | Assessment of aphasia |
| 96110 | Developmental test, lim |
| 96111 | Developmental test, extend |
| 96115 | Neurobehavior status exam |
| INCLUDE HCPCS level 2 codes for the following physical therapy/occupational therapy/speech-language pathology services: | |
| G0193 | Endoscopic study swallow functn |
| G0194 | Sensory testing endoscopic stud |
| G0195 | Clinical eval swallowing funct |
| G0196 | Eval of swallowing with radioopa |
| G0197 | Eval of pt for prescip speech devi |
| G0198 | Patient adapation train for spe |
| G0199 | Reevaluation of patient use spec |
| G0200 | Eval of patient prescip of voice p |
| G0201 | Modi for training in use voice pro |
| Q0086 | Physical therapy evaluation/ |
| RADIOLOGY | |
| INCLUDE the following radiology and certain other imaging services in the CPT 70000 series: | |
| 70100-70110 | X-ray exam of jaw |
| 70120-70130 | X-ray exam of mastoids |
| 70134 | X-ray exam of middle ear |
| 70140-70150 | X-ray exam of facial bones |
| 70160 | X-ray exam of nasal bones |
| 70190-70200 | X-ray exam of eye sockets |
| 70210-70220 | X-ray exam of sinuses |
| 70240 | X-ray exam, pituitary saddle |
| 70250-70260 | X-ray exam of skull |
| 70300-70310 | X-ray exam of teeth |
| 70320 | Full mouth x-ray of teeth |
| 70328 | X-ray exam of jaw joint |
| 70330 | X-ray exam of jaw joints |
| 70336 | Magnetic image, jaw joint |
| 70350 | X-ray head for orthodontia |
| 70355 | Panoramic x-ray of jaws |
| 70360 | X-ray exam of neck |
| 70370 | Throat x-ray fluoroscopy |
| 70371 | Speech evaluation, complex |
| 70380 | X-ray exam of salivary gland |
| 70450 | Ct head/brain w/o dye |
| 70460 | Ct head/brain w/dye |
| 70470 | Ct head/brain w/ow dye |
| 70480 | Ct orbit/ear/fossa w/o dye |
| 70481 | Ct orbit/ear/fossa w/dye |
| 70482 | Ct orbit/ear/fossa w/ow dye |
| 70486 | Ct maxillofacial w/o dye |
| 70487 | Ct maxillofacial w/dye |
| 70488 | Ct maxillofacial w/ow dye |
| 70490 | Ct soft tissue neck w/o dye |
| 70491 | Ct soft tissue neck w/dye |
| 70492 | Ct sft tsue nck w/o w/dye |
| 70496 | Ct angiography, head |
| 70498 | Ct angiography, neck |
| 70540 | Mri orbit/face/neck w/o dye |
| 70542 | Mri orbit/face/neck w/dye |
| 70543 | Mri orbt/fac/nck w/ow dye |
| 70544 | Mr angiography head w/o dye |
| 70545 | Mr angiography head w/dye |
| 70546 | Mr angiograph head w/ow dye |
| 70547 | Mr angiography neck w/o dye |
| 70548 | Mr angiography neck w/dye |
| 70549 | Mr angiograph neck w/ow dye |
| 70551 | Mri brain w/o dye |
| 70552 | Mri brain w/dye |
| 70553 | Mri brain w/ow dye |
| 71010-71022 | Chest x-ray |
| 71023 | Chest x-ray and fluoroscopy |
| 71030 | Chest x-ray |
| 71034 | Chest x-ray and fluoroscopy |
| 71035 | Chest x-ray |
| 71100 | X-ray exam of ribs |
| 71101 | X-ray exam of ribs/chest |
| 71110 | X-ray exam of ribs |
| 71111 | X-ray exam of ribs/ chest |
| 71120-71130 | X-ray exam of breastbone |
| 71250 | Ct thorax w/o dye |
| 71260 | Ct thorax w/dye |
| 71270 | Ct thorax w/ow dye |
| 71275 | Ct angiography, chest |
| 71550 | Mri chest w/o dye |
| 71551 | Mri chest w/dye |
| 71552 | Mri chest w/ow dye |
| 71555 | Mri angio chest w or w/o dye |
| 72010-72020 | X-ray exam of spine |
| 72040-72052 | X-ray exam of neck spine |
| 72069 | X-ray exam of trunk spine |
| 72070-72074 | X-ray exam of thoracic spine |
| 72080-72090 | X-ray exam of trunk spine |
| 72100-72120 | X-ray exam of lower spine |
| 72125 | Ct neck spine w/o dye |
| 72126 | Ct neck spine w/dye |
| 72127 | Ct neck spine w/ow dye |
| 72128 | Ct chest spine w/o dye |
| 72129 | Ct chest spine w/dye |
| 72130 | Ct chest spine w/ow dye |
| 72131 | Ct lumbar spine w/o dye |
| 72132 | Ct lumbar spine w/dye |
| 72133 | Ct lumbar spine w/ow dye |
| 72141 | Mri neck spine w/o dye |
| 72142 | Mri neck spine w/dye |
| 72146 | Mri chest spine w/o dye |
| 72147 | Mri chest spine w/dye |
| 72148 | Mri lumbar spine w/o dye |
| 72149 | Mri lumbar spine w/dye |
| 72156 | Mri neck spine w/ow dye |
| 72157 | Mri chest spine w/ow dye |
| 72158 | Mri lumbar spine w/ow dye |
| 72170-72190 | X-ray exam of pelvis |
| 72191 | Ct angiograph pelv w/ow dye |
| 72192 | Ct pelvis w/o dye |
| 72193 | Ct pelvis w/dye |
| 72194 | Ct pelvis w/ow dye |
| 72195 | Mri pelvis w/o dye |
| 72196 | Mri pelvis w/dye |
| 72197 | Mri pelvis w/o w dye |
| 72200-72202 | X-ray exam sacroiliac joints |
| 72220 | X-ray exam of tailbone |
| 73000 | X-ray exam of collar bone |
| 73010 | X-ray exam of shoulder blade |
| 73020-73030 | X-ray exam of shoulder |
| 73050 | X-ray exam of shoulders |
| 73060 | X-ray exam of humerus |
| 73070-73080 | X-ray exam of elbow |
| 73090 | X-ray exam of forearm |
| 73092 | X-ray exam of arm, infant |
| 73100-73110 | X-ray exam of wrist |
| 73120-73130 | X-ray exam of hand |
| 73140 | X-ray exam of finger(s) |
| 73200 | Ct upper extremity w/o dye |
| 73201 | Ct upper extremity w/dye |
| 73202 | Ct uppr extremity w/ow dye |
| 73206 | Ct angio upr extrm w/ow dye |
| 73218 | Mri upper extremity w/o dye |
| 73219 | Mri upper extremity w/dye |
| 73220 | Mri uppr extremity w/ow dye |
| 73221 | Mri joint upr extrem w/o dye |
| 73222 | Mri joint upr extrem w/ dye |
| 73223 | Mri joint upr extr w/ow dye |
| 73500-73510 | X-ray exam of hip |
| 73520 | X-ray exam of hips |
| 73540 | X-ray exam of pelvis hips |
| 73550 | X-ray exam of thigh |
| 73560 | X-ray exam of knee, 1 or 2 |
| 73562 | X-ray exam of knee, 3 |
| 73564 | X-ray exam, knee, 4 or more |
| 73565 | X-ray exam of knees |
| 73590 | X-ray exam of lower leg |
| 73592 | X-ray exam of leg, infant |
| 73600-73610 | X-ray exam of ankle |
| 73620-73630 | X-ray exam of foot |
| 73650 | X-ray exam of heel |
| 73660 | X-ray exam of toe(s) |
| 73700 | Ct lower extremity w/o dye |
| 73701 | Ct lower extremity w/dye |
| 73702 | Ct lwr extremity w/ow dye |
| 73706 | Ct angio lwr extr w/ow dye |
| 73718 | Mri lower extremity w/o dye |
| 73719 | Mri lower extremity w/dye |
| 73720 | Mri lwr extremity w/ow dye |
| 73721 | Mri joint of lwr extre w/o d |
| 73722 | Mri joint of lwr extr w/dye |
| 73723 | Mri joint lwr extr w/ow dye |
| 73725 | Mr ang lwr ext w or w/o dye |
| 74000-74020 | X-ray exam of abdomen |
| 74022 | X-ray exam series, abdomen |
| 74150 | Ct abdomen w/o dye |
| 74160 | Ct abdomen w/dye |
| 74170 | Ct abdomen w/ow dye |
| 74175 | Ct angio abdom w/ow dye |
| 74181 | Mri abdomen w/o dye |
| 74182 | Mri abdomen w/dye |
| 74183 | Mri abdomen w/ow dye |
| 74185 | Mri angio, abdom w or w/o dy |
| 74210 | Contrst x-ray exam of throat |
| 74220 | Contrast x-ray, esophagus |
| 74230 | Cine/video x-ray, throat/eso |
| 74240-74245 | X-ray exam, upper gi tract |
| 74246-74249 | Contrst x-ray uppr gi tract |
| 74250 | X-ray exam of small bowel |
| 74290 | Contrast x-ray, gallbladder |
| 74291 | Contrast x-rays, gallbladder |
| 74710 | X-ray measurement of pelvis |
| 75552 | Heart mri for morph w/o dye |
| 75553 | Heart mri for morph w/dye |
| 75554 | Cardiac MRI/function |
| 75555 | Cardiac MRI/limited study |
| 75635 | Ct angio abdominal arteries |
| 76000 | Fluoroscope examination |
| 76006 | X-ray stress view |
| 76010 | X-ray, nose to rectum |
| 76020 | X-rays for bone age |
| 76040 | X-rays, bone evaluation |
| 76061-76062 | X-rays, bone survey |
| 76065 | X-rays, bone evaluation |
| 76066 | Joint survey, single view |
| 76085 | Computer mammogram add-on |
| 76090 | Mammogram, one breast |
| 76091 | Mammogram, both breasts |
| 76092 | Mammogram, screening |
| 76093 | Magnetic image, breast |
| 76094 | Magnetic image, both breasts |
| 76100 | X-ray exam of body section |
| 76101 | Complex body section x-ray |
| 76102 | Complex body section x-rays |
| 76120 | Cine/video x-rays |
| 76125 | Cine/ video x-rays add-on |
| 76150 | X-ray exam, dry process |
| 76370 | CAT scan for therapy guide |
| 76375 | 3d/holograph reconstr add-on |
| 76380 | CAT scan follow-up study |
| 76390 | Mr spectroscopy |
| 76400 | Magnetic image, bone marrow |
| 76499 | Radiographic procedure |
| 76506 | Echo exam of head |
| 76511-76512 | Echo exam of eye |
| 76513 | Echo exam of eye, water bath |
| 76516-76519 | Echo exam of eye |
| 76536 | Us exam of head and neck |
| 76604 | Us exam, chest, b-scan |
| 76645 | Us exam, breast(s) |
| 76700 | Us exam, abdom, complete |
| 76705 | Us exam, abdom, limited |
| 76770 | Us exam abdo back wall, comp |
| 76775 | Us exam abdo back wall, lim |
| 76778 | Us exam kidney transplant |
| 76800 | Us exam, spinal canal |
| 76805 | Us exam, pg uterus, compl |
| 76810 | Us exam, pg uterus, mult |
| 76815 | Us exam, pg uterus limit |
| 76816 | Us exam pg uterus repeat |
| 76818 | Fetal biophy profile w/nst |
| 76819 | Fetal biophys profil w/o nst |
| 76825-76828 | Echo exam of fetal heart |
| 76830 | Us exam, transvaginal |
| 76831 | Echo exam, uterus |
| 76856 | Us exam, pelvic, complete |
| 76857 | Us exam, pelvic, limited |
| 76870 | Us exam, scrotum |
| 76872 | Echo exam, transrectal |
| 76873 | Echograp trans r, pros study |
| 76880 | Us exam, extremity |
| 76885 | Us exam infant hips, dynamic |
| 76886 | Us exam infant hips, static |
| 76970 | Ultrasound exam follow-up |
| 76977 | Us bone density measure |
| 76999 | Echo examination procedure |
| INCLUDE the following CPT codes for echocardiography and vascular ultrasound: | |
| 93303-93304 | Echo transthoracic |
| 93307-93308 | Echo exam of heart |
| 93320-93321 | Doppler echo exam, heart, if used in conjunction with 93303-93308 |
| 93325 | Doppler color flow add-on, if used in conjunction with 93303-93308 |
| 93875-93882 | Extracranial study |
| 93886-93888 | Intracranial study |
| 93922-93924 | Extremity study |
| 93925-93926 | Lower extremity study |
| 93930-93931 | Upper extremity study |
| 93965-93971 | Extremity study |
| 93975-93979 | Vascular study |
| 93980-93981 | Penile vascular study |
| 93990 | Doppler flow testing |
| INCLUDE miscellaneous other HCPCS level 2 codes for radiology and certain other imaging services: | |
| G0050 | Residual urine by ultrasound |
| G0131-132 | CT scan, bone density study |
| G0188 | Xray lwr extrmty-full lngth |
| G0202 | Screening mammography digital |
| G0204 | Diagnostic mammography digital |
| G0206 | Diagnostic mammography digital |
| G0236 | digital film convert diag ma |
| R0070 | Transport portable x-ray |
| R0075 | Transport port x-ray multipl |
| RADIATION THERAPY SERVICES AND SUPPLIES | |
| INCLUDE CPT codes for all radiation therapy services and supplies in the CPT 70000 series: | |
| 77261-77263 | Radiation therapy planning |
| 77280-77295 | Set radiation therapy field |
| 77299 | Radiation therapy planning |
| 77300 | Radiation therapy dose plan |
| 77301 | Radioltherapy dos plan, imrt |
| 77305-77315 | Radiation therapy dose plan |
| 77321 | Radiation therapy port plan |
| 77326-77328 | Radiation therapy dose plan |
| 77331 | Special radiation dosimetry |
| 77332-77334 | Radiation treatment aid(s) |
| 77336-77370 | Radiation physics consult |
| 77399 | External radiation dosimetry |
| 77401-77416 | Radiation treatment delivery |
| 77417 | Radiology port film(s) |
| 77418 | Radiation tx delivery, imrt |
| 77427 | Radiation tx management, x5 |
| 77431 | Radiation therapy management |
| 77432 | Stereotactic radiation trmt |
| 77470 | Special radiation treatment |
| 77499 | Radiation therapy management |
| 77520 | Proton trmt, simple w/o comp |
| 77522 | Proton trmt, simple w/comp |
| 77523 | Proton trmt, intermediate |
| 77525 | Proton treatment, complex |
| 77600-77620 | Hyperthermia treatment |
| 77750 | Infuse radioactive materials |
| 77761 | Apply intrcav radiat simple |
| 77762 | Apply intrcav radiat interm |
| 77763 | Apply intrcav radiat compl |
| 77776 | Apply interstit radiat simpl |
| 77777 | Apply interstit radiat inter |
| 77778 | Apply iterstit radiat compl |
| 77781-77784 | High intensity brachytherapy |
| 77789 | Apply surface radiation |
| 77790 | Radiation handling |
| 77799 | Radium/radioisotope therapy |
| INCLUDE CPT codes for radiation therapy classified elsewhere: | |
| 31643 | Diag bronchoscope/catheter |
| 50559 | Renal endoscopy/radiotracer |
| 55859 | Percut/needle insert, pros |
| 61770 | Incise skull for treatment |
| 61793 | Focus radiation beam |
| 92974 | Cath place, cardio brachytx |
| PREVENTIVE SCREENING TESTS, IMMUNIZATIONS AND VACCINES | |
| The following CPT and HCPCS codes are excluded under § 411.355(h) as screening tests: | |
| 76085 | Computer mammogram add-on |
| 76092 | Mammogram, screening |
| 76977 | Us bone density measure |
| G0103 | Psa, total screening |
| G0107 | CA screen; fecal blood test |
| G0123 | Screen cerv/vag thin layer |
| G0124 | Screen c/v thin layer by MD |
| G0141 | Scr c/v cyto, autosys and md |
| G0143-G0145 | Scr c/v cyto, thinlayer, rescr |
| G0147 | Scr c/v cyto, automated sys |
| G0148 | Scr c/v cyto, autosys, rescr |
| G0202 | Screening mammography digital |
| P3000 | Screen pap by tech w md supv |
| P3001 | Screening pap smear by phys |
| The following CPT and HCPCS codes are excluded under § 411.355(h) as vaccines: | |
| 90657 | Flu vaccine, 6-35 mo, im |
| 90658 | Flu vaccine, 3 yrs, im |
| 90659 | Flu vacine, whole, im |
| 90732 | Pneumococcal vaccine |
| 90748 | Hep b/hib vaccine, im |
| Q3018 | Hepatitis B vaccine |
| DRUGS USED BY PATIENTS UNDERGOING DIALYSIS | |
| The following HCPCS codes are excluded under § 411.355(g) as EPO and other dialysis related outpatient prescription drugs furnished in or by an ESRD facility: | |
| J0635 | Calcitriol injection |
| J0895 | Deferoxamine mesylate inj |
| J1270 | Injection, doxercalciferol |
| J1750 | Iron dextran |
| J1755 | Iron sucrose injection |
| J2915 | NA Ferric Gluconate Complex |
| J2997 | Alteplase recombinant |
| Q9920 | Epoetin with hct =20 |
| Q9921 | Epoetin with hct = 21 |
| Q9922 | Epoetin with hct = 22 |
| Q9923 | Epoetin with hct = 23 |
| Q9924 | Epoetin with hct = 24 |
| Q9925 | Epoetin with hct = 25 |
| Q9926 | Epoetin with hct = 26 |
| Q9927 | Epoetin with hct = 27 |
| Q9928 | Epoetin with hct = 28 |
| Q9929 | Epoetin with hct = 29 |
| Q9930 | Epoetin with hct = 30 |
| Q9931 | Epoetin with hct = 31 |
| Q9932 | Epoetin with hct = 32 |
| Q9933 | Epoetin with hct = 33 |
| Q9934 | Epoetin with hct = 34 |
| Q9935 | Epoetin with hct = 35 |
| Q9936 | Epoetin with hct = 36 |
| Q9937 | Epoetin with hct = 37 |
| Q9938 | Epoetin with hct = 38 |
| Q9939 | Epoetin with hct = 39 |
| Q9940 | Epoetin with hct = 40 |
| 1 CPT codes and descriptions only are copyright 2001 American Medical Association. All rights are reserved and applicable FARS/DFARS clauses apply. | |
[FR Doc. 01-27275 Filed 10-31-01; 8:45 am]
BILLING CODE 4120-01-P